PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Francesconi, M; Lehner, B				Francesconi, Mirko; Lehner, Ben			The effects of genetic variation on gene expression dynamics during development	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C. ELEGANS; SELECTION; GENOTYPE; ROLES	The development of a multicellular organism and physiological responses require massive coordinated changes in gene expression across several cell and tissue types(1-3). Polymorphic regions of the genome that influence gene expression levels have been identified by expression quantitative trait locus (eQTL) mapping in many species(4-6), including loci that have cell-dependent(7,8), tissue-dependent(9) and age-dependent(10) effects. However, there has been no comprehensive characterization of how polymorphisms influence the complex dynamic patterns of gene expression that occur during development and in physiology. Here we describe an efficient experimental design to infer gene expression dynamics from single expression profiles in different genotypes, and apply it to characterize the effect of local (cis) and distant (trans) genetic variation on gene expression at high temporal resolution throughout a 12-hour period of the development of Caenorhabditis elegans. Taking dynamic variation into account identifies >50% more cis-eQTLs, including more than 900 that alter the dynamics of expression during this period. Local sequence polymorphisms extensively affect the timing, rate, magnitude and shape of expression changes. Indeed, many local sequence variants both increase and decrease gene expression, depending on the time-point profiled. Expression dynamics during this 12-hour period are also influenced extensively in trans by distal loci. In particular, several trans loci influence genes with quite diverse dynamic expression patterns, but they do so primarily during a common time interval. Trans loci can therefore act as modifiers of expression during a particular period of development. This study provides the first characterization, to our knowledge, of the effect of local and distant genetic variation on the dynamics of gene expression throughout an extensive time period. Moreover, the approach developed here should facilitate the genetic dissection of other dynamic processes, including potentially development, physiology and disease progression in humans.	[Francesconi, Mirko; Lehner, Ben] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [Francesconi, Mirko; Lehner, Ben] UPF, Barcelona 08003, Spain; [Lehner, Ben] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Lehner, B (corresponding author), Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Dr Aiguader 88, Barcelona 08003, Spain.	ben.lehner@crg.eu	francesconi, mirko/O-8080-2015; Lehner, Ben/L-3413-2014; Lehner, Ben/ABH-6562-2020	francesconi, mirko/0000-0002-8702-0877; Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124	ERASysBio + ERANET 'GRAPPLE'; ERC; MICINN [BFU2008-00365, BFU2011-26206]; AGAUR; EMBO; EU [277899]; EMBL-CRG Systems Biology Program; ICREA Funding Source: Custom	ERASysBio + ERANET 'GRAPPLE'; ERC(European Research Council (ERC)European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); EMBO(European Molecular Biology Organization (EMBO)); EU(European Commission); EMBL-CRG Systems Biology Program; ICREA(ICREA)	This work was funded by ERASysBio + ERANET 'GRAPPLE', an ERC Starting Grant, MICINN BFU2008-00365 and BFU2011-26206, AGAUR, the EMBO Young Investigator Program, EU Framework 7 project 277899 4DCellFate, and by the EMBL-CRG Systems Biology Program. We thank J. Kammenga, B. Snoek, M. Sterken and F. Supek for discussions and/or comments on the manuscript.	Ackermann M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003514; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Capra EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004055; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gutteling EW, 2007, HEREDITY, V98, P28, DOI 10.1038/sj.hdy.6800894; Kirienko NV, 2007, DEV BIOL, V305, P674, DOI 10.1016/j.ydbio.2007.02.021; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rockman MV, 2008, GENETICS, V179, P1069, DOI 10.1534/genetics.107.083873; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Tormene P, 2009, ARTIF INTELL MED, V45, P11, DOI 10.1016/j.artmed.2008.11.007; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179	28	78	79	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					208	+		10.1038/nature12772	http://dx.doi.org/10.1038/nature12772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24270809				2022-12-28	WOS:000329441500037
J	Collins, FS; Hamburg, MA				Collins, Francis S.; Hamburg, Margaret A.			First FDA Authorization for Next-Generation Sequencer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The FDA has granted marketing authorization for a high-throughput genomic sequencer, Illumina's MiSeqDx, which will allow the development of innumerable new genome-based tests. Access to genomic data may transform research, clinical care, and patient engagement. This year marks 60 years since James Watson and Francis Crick described the structure of DNA and 10 years since the complete sequencing of the human genome. Fittingly, today the Food and Drug Administration (FDA) has granted marketing authorization for the first high-throughput (next-generation) genomic sequencer, Illumina's MiSeqDx, which will allow the development and use of innumerable new genome-based tests. When a global team of researchers sequenced that first human genome, it took more than a decade and cost hundreds of millions of dollars. Today, because of federal and private investment, sequencing technologies have advanced dramatically, and a human genome ...	[Collins, Francis S.] NIH, Off Director, Bethesda, MD 20892 USA; [Hamburg, Margaret A.] US Dept HHS, US FDA, Off Commissioner, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA)	Collins, FS (corresponding author), NIH, Off Director, Bldg 10, Bethesda, MD 20892 USA.							Food and Drug Administration, 2013, PAV WAY PERS MED FDA; Food-and-Drug-Administration, 2013, TABL PHARM BIOM DRUG; Furie B, 2013, NEW ENGL J MED, V369, P2345, DOI 10.1056/NEJMe1313682; Hudson KL, 2011, NEW ENGL J MED, V365, P1033, DOI 10.1056/NEJMra1010517; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634	5	128	134	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2369	2371		10.1056/NEJMp1314561	http://dx.doi.org/10.1056/NEJMp1314561			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	274DQ	24251383	Green Published			2022-12-28	WOS:000328586000003
J	McNamara, CW; Lee, MCS; Lim, CS; Lim, SH; Roland, J; Nagle, A; Simon, O; Yeung, BKS; Chatterjee, AK; McCormack, SL; Manary, MJ; Zeeman, AM; Dechering, KJ; Kumar, TRS; Henrich, PP; Gagaring, K; Ibanez, M; Kato, N; Kuhen, KL; Fischli, C; Rottmann, M; Plouffe, DM; Bursulaya, B; Meister, S; Rameh, L; Trappe, J; Haasen, D; Timmerman, M; Sauerwein, RW; Suwanarusk, R; Russell, B; Renia, L; Nosten, F; Tully, DC; Kocken, CHM; Glynne, RJ; Bodenreider, C; Fidock, DA; Diagana, TT; Winzeler, EA				McNamara, Case W.; Lee, Marcus C. S.; Lim, Chek Shik; Lim, Siau Hoi; Roland, Jason; Nagle, Advait; Simon, Oliver; Yeung, Bryan K. S.; Chatterjee, Arnab K.; McCormack, Susan L.; Manary, Micah J.; Zeeman, Anne-Marie; Dechering, Koen J.; Kumar, T. R. Santha; Henrich, Philipp P.; Gagaring, Kerstin; Ibanez, Maureen; Kato, Nobutaka; Kuhen, Kelli L.; Fischli, Christoph; Rottmann, Matthias; Plouffe, David M.; Bursulaya, Badry; Meister, Stephan; Rameh, Lucia; Trappe, Joerg; Haasen, Dorothea; Timmerman, Martijn; Sauerwein, Robert W.; Suwanarusk, Rossarin; Russell, Bruce; Renia, Laurent; Nosten, Francois; Tully, David C.; Kocken, Clemens H. M.; Glynne, Richard J.; Bodenreider, Christophe; Fidock, David A.; Diagana, Thierry T.; Winzeler, Elizabeth A.			Targeting Plasmodium PI(4)K to eliminate malaria	NATURE			English	Article							ZINC-FINGER NUCLEASES; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; SACCHAROMYCES-CEREVISIAE; DRUG DISCOVERY; FALCIPARUM; KINASE; VIVAX; YEAST; TRANSMISSION; POTENT	Achieving the goal of malaria elimination will depend on targeting Plasmodium pathways essential across all life stages. Here we identify a lipid kinase, phosphatidylinositol-4-OH kinase (PI(4)K), as the target of imidazopyrazines, a new antimalarial compound class that inhibits the intracellular development of multiple Plasmodium species at each stage of infection in the vertebrate host. Imidazopyrazines demonstrate potent preventive, therapeutic, and transmission-blocking activity in rodent malaria models, are active against blood-stage field isolates of the major human pathogens P. falciparum and P. vivax, and inhibit liver-stage hypnozoites in the simian parasite P. cynomolgi. We show that imidazopyrazines exert their effect through inhibitory interaction with the ATP-binding pocket of PI(4)K, altering the intracellular distribution of phosphatidylinositol-4-phosphate. Collectively, our data define PI(4)K as a key Plasmodium vulnerability, opening up new avenues of target-based discovery to identify drugs with an ideal activity profile for the prevention, treatment and elimination of malaria.	[McNamara, Case W.; Roland, Jason; Nagle, Advait; Chatterjee, Arnab K.; McCormack, Susan L.; Gagaring, Kerstin; Ibanez, Maureen; Kato, Nobutaka; Kuhen, Kelli L.; Plouffe, David M.; Bursulaya, Badry; Tully, David C.; Glynne, Richard J.; Winzeler, Elizabeth A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Lee, Marcus C. S.; Kumar, T. R. Santha; Henrich, Philipp P.; Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Lim, Chek Shik; Lim, Siau Hoi; Simon, Oliver; Yeung, Bryan K. S.; Diagana, Thierry T.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Manary, Micah J.; Meister, Stephan; Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Zeeman, Anne-Marie; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands; [Dechering, Koen J.; Timmerman, Martijn; Sauerwein, Robert W.] TropIQ Hlth Sci, NL-6525 GA Nijmegen, Netherlands; [Fischli, Christoph; Rottmann, Matthias] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Rottmann, Matthias] Univ Basel, CH-4003 Basel, Switzerland; [Rameh, Lucia] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Trappe, Joerg; Haasen, Dorothea] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [Suwanarusk, Rossarin; Russell, Bruce; Renia, Laurent] ASTAR, Singapore Immunol Network, Lab Malaria Immunobiol, Biopolis, Singapore 138648, Singapore; [Russell, Bruce] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117545, Singapore; [Nosten, Francois] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 7BN, England; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot 63110, Thailand; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA	Novartis; Columbia University; Novartis; University of California System; University of California San Diego; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Boston University; Novartis; Radboud University Nijmegen; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Columbia University	Winzeler, EA (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	thierry.diagana@novartis.com; ewinzeler@ucsd.edu	Nosten, Francois/AAC-5509-2019; Suwanarusk, Rossarin/E-2115-2013; Winzeler, Elizabeth/AAP-6752-2020; Renia, Laurent/E-2117-2011; Russell, Bruce/A-9240-2011; Sauerwein, Robert/C-8519-2013; Meister, Stephan/M-6608-2014	Nosten, Francois/0000-0002-7951-0745; Suwanarusk, Rossarin/0000-0002-7310-245X; Winzeler, Elizabeth/0000-0002-4049-2113; Renia, Laurent/0000-0003-0349-1557; Russell, Bruce/0000-0003-2333-4348; Meister, Stephan/0000-0003-2436-7037; Rottmann, Matthias/0000-0002-2207-7899; Yeung, Bryan KS/0000-0002-8866-1764; Kocken, Clemens/0000-0002-4784-1734; Lee, Marcus/0000-0002-4973-0915; Fidock, David/0000-0001-6753-8938; Zeeman, Anne-Marie/0000-0002-0157-4669	Wellcome Trust [WT078285, WT096157]; Medicines for Malaria Venture (MMV); Swiss Tropical and Public Health Institute; Columbia University; Novartis Institute for Tropical Diseases; Singapore Immunology Network and Horizontal Programme on Infectious Diseases under the Agency Science Technology and Research (A*STAR, Singapore); Wellcome Trust (UK); Wellcome Trust (UK), as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Bill and Melinda Gates Foundation; National Institutes of Health [R01AI090141, R01085584, R01079709]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090141, R01AI103058, R01AI079709, R01AI085584] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Medicines for Malaria Venture (MMV); Swiss Tropical and Public Health Institute; Columbia University; Novartis Institute for Tropical Diseases; Singapore Immunology Network and Horizontal Programme on Infectious Diseases under the Agency Science Technology and Research (A*STAR, Singapore); Wellcome Trust (UK)(Wellcome Trust); Wellcome Trust (UK), as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Miller for critical review of the manuscript and figure design. We also thank A. Rodriguez and the insectary core facility team at New York University for reliable supplies of malaria-infected mosquitoes. We gratefully acknowledge translational research grants (WT078285 and WT096157) from the Wellcome Trust and funding from the Medicines for Malaria Venture (MMV) to the Genomics Institute of the Novartis Research Foundation, the Swiss Tropical and Public Health Institute, Columbia University, the Novartis Institute for Tropical Diseases, the Singapore Immunology Network and Horizontal Programme on Infectious Diseases under the Agency Science Technology and Research (A*STAR, Singapore), and the Wellcome Trust (UK). Shoklo Malaria Research Unit is sponsored by The Wellcome Trust (UK), as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. E. A. W. and D. A. F. are supported by grants from the Bill and Melinda Gates Foundation, MMV, and the National Institutes of Health (R01AI090141 to E. A. W. and R01085584 and R01079709 to D.A.F.).	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; D'Alessandro S, 2013, J ANTIMICROB CHEMOTH, V68, P2048, DOI 10.1093/jac/dkt165; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Dechering KJ, 1997, MOL BIOCHEM PARASIT, V89, P235, DOI 10.1016/S0166-6851(97)00123-0; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Fidock DA, 1998, MOL PHARMACOL, V54, P1140, DOI 10.1124/mol.54.6.1140; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kruger T, 2010, MOL BIOCHEM PARASIT, V172, P149, DOI 10.1016/j.molbiopara.2010.03.020; LaMarche MJ, 2012, ANTIMICROB AGENTS CH, V56, P5149, DOI 10.1128/AAC.00946-12; Li C, 2013, DRUG DISCOV TODAY, V18, P71, DOI 10.1016/j.drudis.2012.09.004; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Mandl A, 2007, MOL CELL BIOL, V27, P8098, DOI 10.1128/MCB.00756-07; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Mayinger P, 2012, BBA-MOL CELL BIOL L, V1821, P1104, DOI 10.1016/j.bbalip.2012.01.002; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Onishi M, 2010, MOL CELL BIOL, V30, P2057, DOI 10.1128/MCB.01529-09; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Polevoy G, 2009, J CELL BIOL, V187, P847, DOI 10.1083/jcb.200908107; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Russell BM, 2003, ANTIMICROB AGENTS CH, V47, P170, DOI 10.1128/AAC.47.1.170-173.2003; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; van Pelt-Koops JC, 2012, ANTIMICROB AGENTS CH, V56, P3544, DOI 10.1128/AAC.06377-11; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005	46	285	292	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					248	+		10.1038/nature12782	http://dx.doi.org/10.1038/nature12782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24284631	Green Accepted, Green Submitted			2022-12-28	WOS:000328121500030
J	Wegener, M				Wegener, Martin			Metamaterials Beyond Optics	SCIENCE			English	Editorial Material							ELASTICITY		[Wegener, Martin] Karlsruhe Inst Technol, Inst Appl Phys, Inst Nanotechnol, D-76131 Karlsruhe, Germany; [Wegener, Martin] Karlsruhe Inst Technol, DFG Ctr Funct Nanostruct, D-76131 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology	Wegener, M (corresponding author), Karlsruhe Inst Technol, Inst Appl Phys, Inst Nanotechnol, D-76131 Karlsruhe, Germany.	martin.wegener@kit.edu	Wegener, Martin/S-5456-2016; Wegener, Martin/ABD-5353-2021	Wegener, Martin/0000-0002-9770-2441; Wegener, Martin/0000-0002-9770-2441				Kadic M, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/12/126501; Kadic M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4709436; Kauranen M, 2012, NAT PHOTONICS, V6, P737, DOI [10.1038/NPHOTON.2012.244, 10.1038/nphoton.2012.244]; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Lee SH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.054301; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Milton GW, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/248; Milton GW, 1995, J ENG MATER-T ASME, V117, P483, DOI 10.1115/1.2804743; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Ros A, 2005, NATURE, V436, P928, DOI [10.1038/436928a, 10.1038/436792a]; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Schittny R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.195901; Soukoulis CM, 2007, SCIENCE, V315, P47, DOI 10.1126/science.1136481; Soukoulis CM, 2011, NAT PHOTONICS, V5, P523, DOI [10.1038/NPHOTON.2011.154, 10.1038/nphoton.2011.154]; Yang F, 2013, ADV FUNCT MATER, V23, P4306, DOI 10.1002/adfm.201300226	15	114	120	9	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					939	940		10.1126/science.1246545	http://dx.doi.org/10.1126/science.1246545			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264981				2022-12-28	WOS:000327223500028
J	Nishida, T; Hakuno, D; Baden, LR				Nishida, Takafumi; Hakuno, Daihiko; Baden, Lindsey R.			Endocardial Calcification in Behcet's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 68-year-old man who had Behcet's disease with a 30-year history of oral and genital ulcers and erythema nodosum presented with progressive leg edema and dyspnea. The physical examination revealed varices of the chest and abdominal wall. A 68-year-old man who had Behcet's disease with a 30-year history of oral and genital ulcers and erythema nodosum presented with progressive leg edema and dyspnea. The physical examination revealed varices of the chest and abdominal wall (Panel A), caused by collateral circulation associated with obstruction of the superior vena cava (SVC). Chest computed tomography (CT) showed SVC obstruction (Panel B, arrows) and dilatation of the inferior vena cava (arrowhead). Endocardial calcification on the midlateral and apical wall (Panel C, arrow) was more extensive than that seen on imaging performed 11 years earlier (Panel D, arrow), and there was increased ...	[Nishida, Takafumi; Hakuno, Daihiko] Natl Def Med Coll, Saitama, Japan	National Defense Medical College - Japan	Nishida, T (corresponding author), Natl Def Med Coll, Saitama, Japan.	hakuno@ndmc.ac.jp							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					E28	E28		10.1056/NEJMicm1305579	http://dx.doi.org/10.1056/NEJMicm1305579			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256400				2022-12-28	WOS:000327163000001
J	Richards, T				Richards, Tessa			Tell us how it was for you	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Greaves F, 2012, ARCH INTERN MED, V172, P435, DOI 10.1001/archinternmed.2011.1675; Hodgkin P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6701; King's Fund, TRANSF PAT EXP; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f83; Richards T, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6913	6	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6872	10.1136/bmj.f6872	http://dx.doi.org/10.1136/bmj.f6872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KF	24259329				2022-12-28	WOS:000327457400010
J	Gordon, D; Taddei-Peters, W; Mascette, A; Antman, M; Kaufmann, PG; Lauer, MS				Gordon, David; Taddei-Peters, Wendy; Mascette, Alice; Antman, Melissa; Kaufmann, Peter G.; Lauer, Michael S.			Publication of Trials Funded by the National Heart, Lung, and Blood Institute	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIAS	Background Rapid publication of clinical trials is essential in order for the findings to yield maximal benefits for public health and scientific progress. Factors affecting the speed of publication of the main results of government-funded trials have not been well characterized. Methods We analyzed 244 extramural randomized clinical trials of cardiovascular interventions that were supported by the National Heart, Lung, and Blood Institute (NHLBI). We selected trials for which data collection had been completed between January 1, 2000, and December 31, 2011. Our primary outcome measure was the time between completion of the trial and publication of the main results in a peer-reviewed journal. Results As of March 31, 2012, the main results of 156 trials (64%) had been published (Kaplan-Meier median time to publication, 25 months, with 57% published within 30 months). Trials that focused on clinical events were published more rapidly than those that focused on surrogate measures (median, 9 months vs. 31 months; P<0.001). The only independent predictors of more rapid publication were a focus on clinical events rather than surrogate end points (adjusted publication rate ratio, 2.11; 95% confidence interval, 1.26 to 3.53; P = 0.004) and higher costs of conducting the trial, up to a threshold of approximately $5 million (P<0.001). The 37 trials that focused on clinical events and cost at least $5 million accounted for 67% of the funds spent on clinical trials but received 82% of the citations. After adjustment of the analysis for a focus on clinical events and for cost, trial results that were classified as positive were published more quickly than those classified as negative. Conclusions Results of less than two thirds of NHLBI-funded randomized clinical trials of cardiovascular interventions were published within 30 months after completion of the trial. Trials that focused on clinical events were published more quickly than those that focused on surrogate end points.	[Gordon, David; Taddei-Peters, Wendy; Mascette, Alice] NHLBI, Off Special Projects, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Antman, Melissa] NHLBI, Off Sci & Technol, Bethesda, MD 20892 USA; [Kaufmann, Peter G.] NHLBI, Clin Applicat & Prevent Branch, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Lauer, Michael S.] NHLBI, Off Director, Div Cardiovasc Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lauer, MS (corresponding author), 6701 Rockledge Dr,Rm 8128, Bethesda, MD 20892 USA.	lauerm@nhlbi.nih.gov	Lauer, Michael/L-9656-2013	Lauer, Michael/0000-0002-9217-8177	National Heart, Lung, and Blood Institute	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute.	BERLIN JA, 1989, J AM STAT ASSOC, V84, P381; Davis CE, 1986, MODERN STAT METHODS, P140; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Galis ZS, 2012, CIRC RES, V111, P833, DOI 10.1161/CIRCRESAHA.112.279596; Gan HK, 2012, J NATL CANCER I, V104, P590, DOI 10.1093/jnci/djs141; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Hsich E, 2011, CIRC-CARDIOVASC QUAL, V4, P39, DOI 10.1161/CIRCOUTCOMES.110.939371; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292	12	79	79	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1926	1934		10.1056/NEJMsa1300237	http://dx.doi.org/10.1056/NEJMsa1300237			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300MP	24224625	Green Accepted			2022-12-28	WOS:000330468300010
J	Willyard, C				Willyard, Cassandra			STEM CELLS A time to heal	NATURE			English	Editorial Material							SPINAL-CORD-INJURY											Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Park JH, 2012, NEUROSURGERY, V70, P1238, DOI 10.1227/NEU.0b013e31824387f9; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Zhang YW, 2006, STEM CELLS DEV, V15, P943, DOI 10.1089/scd.2006.15.943	6	10	10	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S4	S6		10.1038/503S4a	http://dx.doi.org/10.1038/503S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24227005				2022-12-28	WOS:000326894200003
J	Brenner, H; Kloor, M; Pox, CP				Brenner, Hermann; Kloor, Matthias; Pox, Christian Peter			Colorectal cancer	LANCET			English	Article							III COLON-CANCER; ADVANCED RECTAL-CANCER; DOSE-RESPONSE METAANALYSIS; TOTAL MESORECTAL EXCISION; SHORT-COURSE RADIOTHERAPY; OCCULT BLOOD-TEST; MICROSATELLITE INSTABILITY; ADJUVANT THERAPY; LIVER METASTASES; RANDOMIZED-TRIAL	More than 1.2 million patients are diagnosed with colorectal cancer every year, and more than 600 000 die from the disease. Incidence strongly varies globally and is closely linked to elements of a so-called western lifestyle. Incidence is higher in men than women and strongly increases with age; median age at diagnosis is about 70 years in developed countries. Despite strong hereditary components, most cases of colorectal cancer are sporadic and develop slowly over several years through the adenoma-carcinoma sequence. The cornerstones of therapy are surgery, neoadjuvant radiotherapy (for patients with rectal cancer), and adjuvant chemotherapy (for patients with stage III/IV and high-risk stage II colon cancer). 5-year relative survival ranges from greater than 90% in patients with stage I disease to slightly greater than 10% in patients with stage IV disease. Screening has been shown to reduce colorectal cancer incidence and mortality, but organised screening programmes are still to be implemented in most countries.	[Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Consortium DKTK, Heidelberg, Germany; [Kloor, Matthias] Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumor Biol, Heidelberg, Germany; [Pox, Christian Peter] Ruhr Univ Bochum, Dept Med, Bochum, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruhr University Bochum	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany.	h.brenner@dkfz.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572	Eiken Chemicals and EpiGenomics; German Research Council (Deutsche Forschungsgemeinschaft); German Federal Ministry of Education and Research (Bundesministerium fur Blidung und Forschung); German Cancer Aid (Deutsche Krebshilfe)	Eiken Chemicals and EpiGenomics; German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (Bundesministerium fur Blidung und Forschung); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	HB's research group has received research support from Eiken Chemicals and EpiGenomics, and travel support from Falk Foundation. HB's research group receives grant support from the German Research Council (Deutsche Forschungsgemeinschaft), the German Federal Ministry of Education and Research (Bundesministerium fur Blidung und Forschung), and the German Cancer Aid (Deutsche Krebshilfe). MK's research group receives grant support from the German Research Council (Deutsche Forschungsgemeinschaft) and the German Cancer Aid (Deutsche Krebshilfe). CPP has received support from the German Cancer Aid (Deutsche Krebshilfe). CPP received honoraria from Falk, Hitachi, and Roche, and travel support from Roche.	ADLOFF M, 1989, AM J SURG, V157, P299, DOI 10.1016/0002-9610(89)90555-2; Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Al-Sukhni E, 2012, ANN SURG ONCOL, V19, P2212, DOI 10.1245/s10434-011-2210-5; Alberts SR, 2012, JAMA-J AM MED ASSOC, V307, P1383, DOI 10.1001/jama.2012.385; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Arnold D, 2010, GUT, V59, P838, DOI 10.1136/gut.2009.196006; Aschele C, 2011, J CLIN ONCOL, V29, P2773, DOI 10.1200/JCO.2010.34.4911; Aune D, 2012, ANN ONCOL, V23, P37, DOI 10.1093/annonc/mdr269; Aune Dagfinn, 2011, BMJ, V343, pd6617, DOI 10.1136/bmj.d6617; Aune D, 2011, GASTROENTEROLOGY, V141, P106, DOI 10.1053/j.gastro.2011.04.013; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Bettington M, 2013, HISTOPATHOLOGY, V62, P367, DOI 10.1111/his.12055; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boleij A, 2011, CLIN INFECT DIS, V53, P870, DOI 10.1093/cid/cir609; Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Bosetti C, 2011, INT J CANCER, V129, P180, DOI 10.1002/ijc.25653; Boyle T, 2012, JNCI-J NATL CANCER I, V104, P1548, DOI 10.1093/jnci/djs354; Brenner H, 2013, J CLIN EPIDEMIOL, V66, P1144, DOI 10.1016/j.jclinepi.2013.05.008; Brenner H, 2013, EUR J CANCER, V49, P3049, DOI 10.1016/j.ejca.2013.04.023; Brenner H, 2012, INT J CANCER, V131, P1649, DOI 10.1002/ijc.26192; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506; Burn John, 2013, Recent Results Cancer Res, V191, P157, DOI 10.1007/978-3-642-30331-9_9; Burton S, 2006, BRIT J CANCER, V94, P351, DOI 10.1038/sj.bjc.6602947; Caricato M, 2006, EJSO-EUR J SURG ONC, V32, P126, DOI 10.1016/j.ejso.2005.11.001; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Choi DJ, 2010, J SURG ONCOL, V102, P588, DOI 10.1002/jso.21651; de Gramont A, 2012, LANCET ONCOL, V13, P1225, DOI 10.1016/S1470-2045(12)70509-0; de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; de Wit M, 2013, CLIN BIOCHEM, V46, P466, DOI 10.1016/j.clinbiochem.2012.10.039; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Dolcetti R, 1999, AM J PATHOL, V154, P1805, DOI 10.1016/S0002-9440(10)65436-3; Duffy MJ, 2011, INT J CANCER, V128, P03; Dunlop MG, 2013, GUT, V62, P871, DOI 10.1136/gutjnl-2011-300537; Elmunzer BJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001352; Evans J, 2011, SEMIN RADIAT ONCOL, V21, P169, DOI 10.1016/j.semradonc.2011.02.002; Fallik D, 2003, CANCER RES, V63, P5738; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Floriani I, 2010, J MAGN RESON IMAGING, V31, P19, DOI 10.1002/jmri.22010; Frasson M, 2011, CANCER-AM CANCER SOC, V117, P3118, DOI 10.1002/cncr.25866; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Guo P, 2012, ANN ONCOL, V23, P2755, DOI 10.1093/annonc/mds069; Haller DG, 2011, J CLIN ONCOL, V29, P1465, DOI 10.1200/JCO.2010.33.6297; HEALD RJ, 1986, LANCET, V1, P1479; Heinemann V, 2013, CANCER TREAT REV, V39, P592, DOI 10.1016/j.ctrv.2012.12.011; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hofheinz RD, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70116-X; Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Jiang Y, 2011, EUR J EPIDEMIOL, V26, P863, DOI 10.1007/s10654-011-9617-y; Jung SB, 2012, CANCER RES TREAT, V44, P179, DOI 10.4143/crt.2012.44.3.179; Kaminski MF, 2012, ENDOSCOPY, V44, P695, DOI 10.1055/s-0032-1306895; Kaur H, 2012, RADIOGRAPHICS, V32, P389, DOI 10.1148/rg.322115122; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kirke R, 2007, J COMPUT ASSIST TOMO, V31, P569, DOI 10.1097/rct.0b013e318032e8c9; Kloor M, 2012, LANCET ONCOL, V13, P598, DOI 10.1016/S1470-2045(12)70109-2; Knudsen AB, 2010, JNCI-J NATL CANCER I, V102, P1238, DOI 10.1093/jnci/djq242; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuhry E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003432.pub2; Lange CPE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050266; Lansdorp-Vogelaar I, 2011, EPIDEMIOL REV, V33, P88, DOI 10.1093/epirev/mxr004; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Leufkens AM, 2011, SCAND J GASTROENTERO, V46, P887, DOI 10.3109/00365521.2011.574732; Levin TR, 2011, EPIDEMIOL REV, V33, P101, DOI 10.1093/epirev/mxr007; Liang PS, 2009, INT J CANCER, V124, P2406, DOI 10.1002/ijc.24191; Liang Y, 2008, EJSO-EUR J SURG ONC, V34, P1217, DOI 10.1016/j.ejso.2007.11.004; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin KJ, 2012, INT J CANCER, V130, P419, DOI 10.1002/ijc.26026; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Lochhead P, 2013, CLIN GASTROENTEROL H, V11, P109, DOI 10.1016/j.cgh.2012.08.037; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; MacDermid E, 2009, COLORECTAL DIS, V11, P291, DOI 10.1111/j.1463-1318.2008.01580.x; Mishra SI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008465.pub2; Mitry E, 2010, GUT, V59, P1383, DOI 10.1136/gut.2010.211557; Morton UKD, 2012, LANCET ONCOL, V13, P1152, DOI 10.1016/S1470-2045(12)70348-0; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Ngan SY, 2012, J CLIN ONCOL, V30, P3827, DOI 10.1200/JCO.2012.42.9597; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Papadimitriou CA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-10; Park SH, 2012, GUT, V61, P1716, DOI 10.1136/gutjnl-2011-301135; Parsons MT, 2012, J MED GENET, V49, P151, DOI 10.1136/jmedgenet-2011-100714; Phipps AI, 2011, CANCER-AM CANCER SOC, V117, P4948, DOI 10.1002/cncr.26114; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Puli SR, 2010, DIGEST DIS SCI, V55, P1221, DOI 10.1007/s10620-009-0862-9; Puli S, 2009, ANN SURG ONCOL, V16, P254, DOI 10.1245/s10434-008-0231-5; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Rafaelsen SR, 2011, COLORECTAL DIS, V13, P420, DOI 10.1111/j.1463-1318.2010.02288.x; Rodel C, 2012, DIGEST DIS, V30, P102, DOI 10.1159/000342038; Rothwell PM, 2011, OBSTET GYNECOL SURV, V66, P222, DOI 10.1097/OGX.0b013e318225cec2; Roy HK, 2003, GUT, V52, P1665, DOI 10.1136/gut.52.12.1665; Ruers TJM, 2009, J NUCL MED, V50, P1036, DOI 10.2967/jnumed.109.063040; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Segelman J, 2009, COLORECTAL DIS, V11, P768, DOI 10.1111/j.1463-1318.2008.01648.x; Shia J, 2003, AM J SURG PATHOL, V27, P1407, DOI 10.1097/00000478-200311000-00002; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sietses C, 2010, SURG ENDOSC, V24, P1917, DOI 10.1007/s00464-009-0874-8; Sobin L., 2009, TNM CLASSIFICATION M, V7th edn; Sonnenberg A, 2013, AM J GASTROENTEROL, V108, P208, DOI 10.1038/ajg.2012.407; Stock C, 2012, GASTROINTEST ENDOSC, V75, P621, DOI 10.1016/j.gie.2011.10.025; Tan KK, 2009, J GASTROINTEST SURG, V13, P642, DOI 10.1007/s11605-008-0757-7; Taylor DP, 2010, GASTROENTEROLOGY, V138, P877, DOI 10.1053/j.gastro.2009.11.044; Theodoratou E, 2012, JNCI-J NATL CANCER I, V104, P1433, DOI 10.1093/jnci/djs369; Trastulli S, 2012, COLORECTAL DIS, V14, pE277, DOI 10.1111/j.1463-1318.2012.02985.x; Trastulli S, 2012, COLORECTAL DIS, V14, pE134, DOI 10.1111/j.1463-1318.2011.02907.x; Twelves C, 2012, ANN ONCOL, V23, P1190, DOI 10.1093/annonc/mdr366; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Vart G, 2012, PREV MED, V55, P87, DOI 10.1016/j.ypmed.2012.05.006; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997; West NP, 2010, J CLIN ONCOL, V28, P272, DOI 10.1200/JCO.2009.24.1448; Wille-Jorgensen P, 2013, COLORECTAL DIS, V15, P410, DOI 10.1111/codi.12013; Wu SJ, 2012, AM J MED, V125, P551, DOI 10.1016/j.amjmed.2012.01.022; Yothers G, 2011, J CLIN ONCOL, V29, P3768, DOI 10.1200/JCO.2011.36.4539; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zell JA, 2010, CANCER PREV RES, V3, P865, DOI 10.1158/1940-6207.CAPR-09-0262	137	2067	2209	30	569	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1490	1502		10.1016/S0140-6736(13)61649-9	http://dx.doi.org/10.1016/S0140-6736(13)61649-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24225001				2022-12-28	WOS:000335325800030
J	Zhou, LJ; Hang, J; Zhou, YL; Wan, RX; Lu, GF; Yin, P; Yan, CY; Shi, YG				Zhou, Lijun; Hang, Jing; Zhou, Yulin; Wan, Ruixue; Lu, Guifeng; Yin, Ping; Yan, Chuangye; Shi, Yigong			Crystal structures of the Lsm complex bound to the 3 ' end sequence of U6 small nuclear RNA	NATURE			English	Article							SM-LIKE PROTEINS; SNRNA; U1; YEAST; CORE; U2; U4; RIBONUCLEOPROTEINS; CHAPERONE; DOMAIN	Splicing of precursor messenger RNA (pre-mRNA) in eukaryotic cells is carried out by the spliceosome(1), which consists of five small nuclear ribonucleoproteins (snRNPs) and a number of accessory factors and enzymes(2). Each snRNP contains a ring-shaped subcomplex of seven proteins and a specific RNA molecule(2-4). The U6 snRNP contains a unique heptameric Lsm protein complex, which specifically recognizes the U6 small nuclear RNA at its 3' end. Here we report the crystal structures of the heptameric Lsm complex, both by itself and in complex with a 3' fragment of U6 snRNA, at 2.8 angstrom resolution. Each of the seven Lsm proteins interacts with two neighbouring Lsm components to form a doughnut-shaped assembly, with the order Lsm3-2-8-4-7-5-6. The four uridine nucleotides at the 3' end of U6 snRNA are modularly recognized by Lsm3, Lsm2, Lsm8 and Lsm4, with the uracil base specificity conferred by a highly conserved asparagine residue. The uracil base at the extreme 3' end is sandwiched by His 36 and Arg 69 from Lsm3, through pi-pi and cation-pi interactions, respectively. The distinctive end-recognition of U6 snRNA by the Lsm complex contrasts with RNA binding by the Sm complex in the other snRNPs. The structural features and associated biochemical analyses deepen mechanistic understanding of the U6 snRNP function in pre-mRNA splicing.	[Zhou, Lijun; Zhou, Yulin; Shi, Yigong] Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China; [Zhou, Lijun; Hang, Jing; Yin, Ping; Yan, Chuangye; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Zhou, Lijun; Hang, Jing; Yin, Ping; Yan, Chuangye; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Hang, Jing; Wan, Ruixue; Lu, Guifeng; Yan, Chuangye] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X; Zhou, Lijun/0000-0002-0393-4787	National Natural Science Foundation of China [31130002, 31021002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank S. Huang and J. He at SSRF beamline BL17U and N. Shimizu, T. Kumasaka, and S. Baba at the Spring-8 beamline BL41XU for on-site assistance. This work was supported by funds from National Natural Science Foundation of China projects 31130002 and 31021002.	Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERGET SM, 1986, CELL, V46, P691, DOI 10.1016/0092-8674(86)90344-2; BLACK DL, 1986, CELL, V46, P697, DOI 10.1016/0092-8674(86)90345-4; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; DATTA B, 1991, NATURE, V352, P821, DOI 10.1038/352821a0; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FABRIZIO P, 1994, SCIENCE, V264, P261, DOI 10.1126/science.8146658; He WH, 2000, CURR OPIN CELL BIOL, V12, P346, DOI 10.1016/S0955-0674(00)00098-3; HINTERBERGER M, 1983, J BIOL CHEM, V258, P2604; JANDROSITZ A, 1995, EMBO J, V14, P820, DOI 10.1002/j.1460-2075.1995.tb07060.x; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Karaduman R, 2006, J MOL BIOL, V356, P1248, DOI 10.1016/j.jmb.2005.12.013; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Licht K, 2008, RNA, V14, P1532, DOI 10.1261/rna.1129608; LUND E, 1992, SCIENCE, V255, P327, DOI 10.1126/science.1549778; Martin-Tumasz S, 2011, NUCLEIC ACIDS RES, V39, P7837, DOI 10.1093/nar/gkr455; Martin-Tumasz S, 2010, RNA, V16, P792, DOI 10.1261/rna.1913310; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore M., 1993, RNA WORLD, P303; Nilsen Timothy W, 2013, Cold Spring Harb Protoc, V2013, P180, DOI 10.1101/pdb.prot072942; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Will C. L., 2006, RNA WORLD, P181; WU J, 1991, NATURE, V352, P818, DOI 10.1038/352818a0; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zaric B, 2005, J BIOL CHEM, V280, P16066, DOI 10.1074/jbc.M414481200	37	67	77	2	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					116	+		10.1038/nature12803	http://dx.doi.org/10.1038/nature12803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24240276				2022-12-28	WOS:000330648100043
J	Schwartz, S; Agarwala, SD; Mumbach, MR; Jovanovic, M; Mertins, P; Shishkin, A; Tabach, Y; Mikkelsen, TS; Satija, R; Ruvkun, G; Carr, SA; Lander, ES; Fink, GR; Regev, A				Schwartz, Schraga; Agarwala, Sudeep D.; Mumbach, Maxwell R.; Jovanovic, Marko; Mertins, Philipp; Shishkin, Alexander; Tabach, Yuval; Mikkelsen, Tarjei S.; Satija, Rahul; Ruvkun, Gary; Carr, Steven A.; Lander, Eric S.; Fink, Gerald R.; Regev, Aviv			High-Resolution Mapping Reveals a Conserved, Widespread, Dynamic mRNA Methylation Program in Yeast Meiosis	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR-RNA; N-6-METHYLADENOSINE; TRANSCRIPTION; IME4; DIVERGENCE; M(6)A-SEQ; SEQUENCES; RESIDUES; PATHWAY	N-6-methyladenosine (m(6)A) is the most ubiquitous mRNA base modification, but little is known about its precise location, temporal dynamics, and regulation. Here, we generated genomic maps of m(6)A sites in meiotic yeast transcripts at nearly single-nucleotide resolution, identifying 1,308 putatively methylated sites within 1,183 transcripts. We validated eight out of eight methylation sites in different genes with direct genetic analysis, demonstrated that methylated sites are significantly conserved in a related species, and built a model that predicts methylated sites directly from sequence. Sites vary in their methylation profiles along a dense meiotic time course and are regulated both locally, via predictable methylatability of each site, and globally, through the core meiotic circuitry. The methyltransferase complex components localize to the yeast nucleolus, and this localization is essential for mRNA methylation. Our data illuminate a conserved, dynamically regulated methylation program in yeast meiosis and provide an important resource for studying the function of this epitranscriptomic modification.	[Schwartz, Schraga; Mumbach, Maxwell R.; Jovanovic, Marko; Mertins, Philipp; Shishkin, Alexander; Mikkelsen, Tarjei S.; Satija, Rahul; Carr, Steven A.; Lander, Eric S.; Fink, Gerald R.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Agarwala, Sudeep D.; Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tabach, Yuval; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Tabach, Yuval; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Fink, GR (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	gfink@wi.mit.edu; aregev@broadinstitute.org	Carr, Steven A./AAH-8366-2019; Tabach, Yuval/Q-8488-2019; Mikkelsen, Tarjei S/A-1306-2007; Satija, Rahul/AAF-9564-2019	Mikkelsen, Tarjei S/0000-0002-8133-3135; Schwartz, Schraga/0000-0002-3671-9709; Mumbach, Maxwell/0000-0002-5570-6663	National Institutes of Health [GM035010, U54 HG003067]; Broad Institute Funds; NHGRI Pioneer Award; HHMI; HFSP fellowship; NATIONAL CANCER INSTITUTE [R01CA119176, DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035010, R01GM035010, R01GM098647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute Funds; NHGRI Pioneer Award; HHMI(Howard Hughes Medical Institute); HFSP fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank Lindsey Dollard and Anna Symbor-Nagrabska for expert technical assistance; Hannah Blitzblau, Mitchell Guttman, and Dmitry Ter-Ovanesyan for fruitful discussions and technical advice; and Leslie Gaffney for making the figures beautiful. The anti-Fob1 antibody was kindly provided by Dr. Stephen Bell. G.R.F. is an American Cancer Society Professor of Genetics. This work was supported by National Institutes of Health Grants GM035010 (G.R.F) and U54 HG003067 (E.S.L.) and Broad Institute Funds. A.R. was supported by an NHGRI Pioneer Award and HHMI. S.S. was supported by an HFSP fellowship.	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bokar JA, 1997, RNA, V3, P1233; Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; BRINGMANN P, 1987, FEBS LETT, V213, P309, DOI 10.1016/0014-5793(87)81512-0; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; DESROSIERS RC, 1975, BIOCHEMISTRY-US, V14, P4367, DOI 10.1021/bi00691a004; DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541; NARAYAN P, 1994, NUCLEIC ACIDS RES, V22, P419, DOI 10.1093/nar/22.3.419; POTASHKIN JA, 1990, MOL CELL BIOL, V10, P3524, DOI 10.1128/MCB.10.7.3524; Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175; SCHIBLER U, 1977, J MOL BIOL, V115, P695, DOI 10.1016/0022-2836(77)90110-3; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Tabach Y, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.50; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	35	422	454	2	77	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1409	1421		10.1016/j.cell.2013.10.047	http://dx.doi.org/10.1016/j.cell.2013.10.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24269006	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000328271100022
J	Slutsky, AS; Ranieri, VM				Slutsky, Arthur S.; Ranieri, V. Marco			Ventilator-Induced Lung Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; HIGH-FREQUENCY OSCILLATION; NEUROMUSCULAR BLOCKING-AGENTS; RANDOMIZED CONTROLLED-TRIAL; EXTRACORPOREAL CO2 REMOVAL; LOWER TIDAL VOLUMES; MECHANICAL VENTILATION; PROTECTIVE-VENTILATION; PULMONARY-EDEMA		[Slutsky, Arthur S.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Slutsky, Arthur S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Ranieri, V. Marco] Univ Turin, Osped S Giovanni Battista Molinette, Dipartimento Anestesia & Med Stati Crit, Turin, Italy	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Slutsky, AS (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	slutskya@smh.ca	Ranieri, Marco/AFX-8152-2022		Gambro; GlaxoSmithKline; Maquet Medical; Novalung; Hemodec; Drager; Maquet; Faron Pharmaceuticals; Covidien; University of Turin; Ikaria	Gambro; GlaxoSmithKline(GlaxoSmithKline); Maquet Medical; Novalung; Hemodec; Drager; Maquet; Faron Pharmaceuticals; Covidien; University of Turin; Ikaria	Dr. Slutsky reports receiving payment for serving on an advisory board at Ikaria, receiving consulting fees from Gambro, GlaxoSmithKline, Maquet Medical, Novalung, and Hemodec and lecture fees from Drager, having an equity interest in Apeiron, and receiving royalties through his institution from Maquet Medical; and Dr. Ranieri, receiving payment for serving on advisory boards at Hemodec and Maquet, receiving consulting fees from Hemodec, Maquet, Faron Pharmaceuticals, and Covidien, and receiving payment for work on a patent owned by Drager and the University of Turin. No other potential conflict of interest relevant to this article was reported.	Albert RK, 2012, AM J RESP CRIT CARE, V185, P702, DOI 10.1164/rccm.201109-1667PP; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; [Anonymous], 1967, Minn Med, V50, P1693; ARDS Clinical Trials Network, 2003, CRIT CARE MED, V31, P2592, DOI 10.1097/01.CCM.0000090001.91640.45; AVIGNON P D, 1956, Acta Med Scand Suppl, V316, P86; Bein T, 2013, INTENS CARE MED, V39, P847, DOI 10.1007/s00134-012-2787-6; Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; BOUHUYS A, 1969, NATURE, V221, P1199, DOI 10.1038/2211199a0; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Broccard A, 2000, CRIT CARE MED, V28, P295, DOI 10.1097/00003246-200002000-00001; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brower RG, 2004, CRIT CARE MED, V32, P907; Cabrera-Benitez NE, 2012, CRIT CARE MED, V40, P510, DOI 10.1097/CCM.0b013e31822f09d7; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Ferguson ND, 2008, J APPL PHYSIOL, V104, P1230, DOI 10.1152/japplphysiol.01226.2007; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Forel JM, 2006, CRIT CARE MED, V34, P2749, DOI 10.1097/01.CCM.0000239435.87433.0D; Fothergill J, 1744, COLL MED LOND; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Gattinoni L, 2005, INTENS CARE MED, V31, P776, DOI 10.1007/s00134-005-2627-z; GATTINONI L, 1979, INT J ARTIF ORGANS, V2, P282; Grasso S, 2007, AM J RESP CRIT CARE, V176, P761, DOI 10.1164/rccm.200702-193OC; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; HICKLING KG, 1990, INTENS CARE MED, V16, P372, DOI 10.1007/BF01735174; LACHMANN B, 1992, INTENS CARE MED, V18, P319, DOI 10.1007/BF01694358; LASSEN HCA, 1953, LANCET, V264, P37; Macklin MT, 1944, MEDICINE, V23, P281, DOI 10.1097/00005792-194412000-00001; Malhotra A, 2013, NEW ENGL J MED, V368, P863, DOI 10.1056/NEJMe1300103; MASCHERONI D, 1988, INTENS CARE MED, V15, P8; Mascia L, 2010, JAMA-J AM MED ASSOC, V304, P2620, DOI 10.1001/jama.2010.1796; MAUNDER RJ, 1984, ARCH INTERN MED, V144, P1447, DOI 10.1001/archinte.144.7.1447; MEAD J, 1970, J APPL PHYSIOL, V28, P596, DOI 10.1152/jappl.1970.28.5.596; Murphy DB, 2000, AM J RESP CRIT CARE, V162, P27, DOI 10.1164/ajrccm.162.1.9908110; Murphy DB, 2002, AM J RESP CRIT CARE, V166, P1517; Nahum A, 1997, CRIT CARE MED, V25, P1733, DOI 10.1097/00003246-199710000-00026; NASH G, 1967, NEW ENGL J MED, V276, P368, DOI 10.1056/NEJM196702162760702; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Piedalue Fran, 2003, Respir Care Clin N Am, V9, P495, DOI 10.1016/S1078-5337(03)00037-6; RAHN H, 1946, AM J PHYSIOL, V146, P161, DOI 10.1152/ajplegacy.1946.146.2.161; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Slutsky AS, 2010, NEW ENGL J MED, V363, P1176, DOI 10.1056/NEJMe1007136; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Slutsky AS, 2006, NEW ENGL J MED, V354, P1839, DOI 10.1056/NEJMe068045; Sud S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2327; Sud S, 2010, INTENS CARE MED, V36, P585, DOI 10.1007/s00134-009-1748-1; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Uhlig S, 2004, TRENDS PHARMACOL SCI, V25, P592, DOI 10.1016/j.tips.2004.09.002; Valenza F, 2005, CRIT CARE MED, V33, P361, DOI 10.1097/01.CCM.0000150660.45376.7C; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716; Zin W. A., 2005, PHYSL BASIS RESP DIS, P639	59	1068	1130	6	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2126	2136		10.1056/NEJMra1208707	http://dx.doi.org/10.1056/NEJMra1208707			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24283226				2022-12-28	WOS:000327467500010
J	Jones, MH; Bewsher, D; Brown, DS				Jones, M. H.; Bewsher, D.; Brown, D. S.			Imaging of a Circumsolar Dust Ring Near the Orbit of Venus	SCIENCE			English	Article							SOLAR-SYSTEM; HELIOSPHERIC IMAGERS; RESONANT SIGNATURES; STEREO MISSION; ZODIACAL CLOUD; DEBRIS DISKS; MODEL; COMETARY; SEARCH; ORIGIN	The gravitational interaction of dust in the zodiacal cloud with individual planets is expected to give rise to ringlike features: Such a circumsolar ring has been observed associated with Earth, but such resonance rings have not been confirmed to exist for other planets. Here, we report on sensitive photometric observations, based on imaging from the STEREO mission, that confirm the existence of a dust ring at the orbit of Venus. The maximum overdensity of dust in this ring, compared to the zodiacal cloud, is similar to 10%. The radial density profile of this ring differs from the model used to describe Earth's ring in that it has two distinct steplike components, with one step being interior and the other exterior to the orbit of Venus.	[Jones, M. H.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Bewsher, D.; Brown, D. S.] Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England	Open University - UK; University of Central Lancashire	Jones, MH (corresponding author), Open Univ, Dept Phys Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	m.h.jones@open.ac.uk		Bewsher, Danielle/0000-0002-6351-5170; Brown, Daniel/0000-0002-1618-8816; Jones, Mark/0000-0001-6217-8574				Brown DS, 2009, SOL PHYS, V254, P185, DOI 10.1007/s11207-008-9277-6; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; DERMOTT SF, 1994, NATURE, V369, P719, DOI 10.1038/369719a0; Eyles CJ, 2009, SOL PHYS, V254, P387, DOI 10.1007/s11207-008-9299-0; GRUN E, 1985, ICARUS, V62, P244, DOI 10.1016/0019-1035(85)90121-6; Hahn JM, 2002, ICARUS, V158, P360, DOI 10.1006/icar.2002.6881; HONG SS, 1985, ASTRON ASTROPHYS, V146, P67; JACKSON AA, 1989, NATURE, V337, P629, DOI 10.1038/337629a0; Kaiser ML, 2008, SPACE SCI REV, V136, P5, DOI 10.1007/s11214-007-9277-0; Kalas P, 2005, NATURE, V435, P1067, DOI 10.1038/nature03601; Kelsall T, 1998, ASTROPHYS J, V508, P44, DOI 10.1086/306380; Koutchmy S., 1985, F CORONA CIRCUMSOLAR, P63, DOI [10.1007/978-94-009-5464-9_14, DOI 10.1007/978-94-009-5464-9_14]; KRASNOPOLSKY VA, 1979, PLANET SPACE SCI, V27, P951, DOI 10.1016/0032-0633(79)90025-4; Kuchner MJ, 2003, ASTROPHYS J, V588, P1110, DOI 10.1086/374213; Kuchner MJ, 2000, ICARUS, V145, P44, DOI 10.1006/icar.1999.6318; Leinert C, 2007, ASTRON ASTROPHYS, V472, P335, DOI 10.1051/0004-6361:20077682; Mustill AJ, 2011, MON NOT R ASTRON SOC, V413, P554, DOI 10.1111/j.1365-2966.2011.18201.x; Nesvorny D, 2010, ASTROPHYS J, V713, P816, DOI 10.1088/0004-637X/713/2/816; Reach WT, 2010, ICARUS, V209, P848, DOI 10.1016/j.icarus.2010.06.034; REACH WT, 1995, NATURE, V374, P521, DOI 10.1038/374521a0; Rowan-Robinson M, 2013, MON NOT R ASTRON SOC, V429, P2894, DOI 10.1093/mnras/sts471; WEIDENSCHILLING SJ, 1993, ICARUS, V104, P244, DOI 10.1006/icar.1993.1099	23	23	24	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					960	963		10.1126/science.1243194	http://dx.doi.org/10.1126/science.1243194			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264987	Green Accepted			2022-12-28	WOS:000327223500038
J	Raushel, FM				Raushel, Frank M.			Not an Oxidase, But a Peroxidase	SCIENCE			English	Editorial Material							FOSFOMYCIN; BIOSYNTHESIS; EPOXIDASE; BOND		Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Raushel, FM (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	raushel@chem.tamu.edu	Raushel, Frank/B-7125-2015	Raushel, Frank/0000-0002-5918-3089				Chang WC, 2013, NATURE, V496, P114, DOI 10.1038/nature11998; Cicchillo RM, 2009, NATURE, V459, P871, DOI 10.1038/nature07972; Falagas ME, 2009, INT J ANTIMICROB AG, V34, P111, DOI 10.1016/j.ijantimicag.2009.03.009; HAMMERSCHMIDT F, 1991, J CHEM SOC PERK T 1, P1993, DOI 10.1039/p19910001993; HAMMERSCHMIDT F, 1991, J ORG CHEM, V56, P2364, DOI 10.1021/jo00007a022; HIDAKA T, 1995, MOL GEN GENET, V249, P274, DOI 10.1007/BF00290527; Higgins LJ, 2005, NATURE, V437, P838, DOI 10.1038/nature03924; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; Milaczewska A, 2013, CHEM-EUR J, V19, P770, DOI 10.1002/chem.201202825; Wang C, 2013, SCIENCE, V342, P991, DOI 10.1126/science.1240373	11	0	0	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					943	944		10.1126/science.1247233	http://dx.doi.org/10.1126/science.1247233			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264984				2022-12-28	WOS:000327223500031
J	Lathan, C; Frank, DA				Lathan, Christopher; Frank, David A.			Review: Low-dose CT screening reduces lung cancer and mortality in current or former smokers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lathan, Christopher; Frank, David A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Lathan, C (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.							Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Jacobson FL, 2012, J THORAC CARDIOV SUR, V144, P25, DOI 10.1016/j.jtcvs.2012.05.059; U.S. Preventive Services Task Force, AHRQ PUBLICATION; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022	5	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10							JC3	10.7326/0003-4819-159-10-201311190-02003	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247693				2022-12-28	WOS:000328732700002
J	Boyd, IL; Freer-Smith, PH; Gilligan, CA; Godfray, HCJ				Boyd, I. L.; Freer-Smith, P. H.; Gilligan, C. A.; Godfray, H. C. J.			The Consequence of Tree Pests and Diseases for Ecosystem Services	SCIENCE			English	Review							CHESTNUT CASTANEA-DENTATA; MOUNTAIN PINE-BEETLE; FOREST ECOSYSTEMS; CLIMATE-CHANGE; BIODIVERSITY CONSERVATION; VEGETATION CHANGE; CARBON STORAGE; INVASION; PATTERNS; DISTURBANCE	Trees and forests provide a wide variety of ecosystem services in addition to timber, food, and other provisioning services. New approaches to pest and disease management are needed that take into account these multiple services and the different stakeholders they benefit, as well as the likelihood of greater threats in the future resulting from globalization and climate change. These considerations will affect priorities for both basic and applied research and how trade and phytosanitary regulations are formulated.	[Boyd, I. L.] Univ St Andrews, St Andrews KY18 9LB, Fife, Scotland; [Freer-Smith, P. H.] Forest Res, Farnham GU10 4LH, Surrey, England; [Gilligan, C. A.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Godfray, H. C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of St Andrews; University of Cambridge; University of Oxford	Boyd, IL (corresponding author), Univ St Andrews, St Andrews KY18 9LB, Fife, Scotland.	ilb@st-andrews.ac.uk			Biotechnology and Biological Sciences Research Council [BB/B502379/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Allen CD, 2007, ECOSYSTEMS, V10, P797, DOI 10.1007/s10021-007-9057-4; [Anonymous], 2012, WHAT MONEY CANT BUY; ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P247, DOI 10.1016/0378-1127(94)90114-7; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Azaele S, 2006, NATURE, V444, P926, DOI 10.1038/nature05320; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; BenDor TK, 2006, ECOL MODEL, V197, P221, DOI 10.1016/j.ecolmodel.2006.03.003; Berg EE, 2006, FOREST ECOL MANAG, V227, P219, DOI 10.1016/j.foreco.2006.02.038; Bergseng E, 2012, SCAND J FOREST RES, V27, P337, DOI 10.1080/02827581.2011.637509; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brasier CM, 2010, PLANT PATHOL, V59, P186, DOI 10.1111/j.1365-3059.2009.02157.x; Brockerhoff EG, 2013, FOREST ECOL MANAG, V301, P43, DOI 10.1016/j.foreco.2012.09.018; Cahill DM, 2008, AUST J BOT, V56, P279, DOI 10.1071/BT07159; CALTAGIRONE LE, 1989, ANNU REV ENTOMOL, V34, P1, DOI 10.1146/annurev.en.34.010189.000245; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Cobb RC, 2012, J ECOL, V100, P712, DOI 10.1111/j.1365-2745.2012.01960.x; Cook AR, 2008, J R SOC INTERFACE, V5, P1203, DOI 10.1098/rsif.2008.0030; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; Department for Environment Food and Rural Affairs, 2012, IND PAN FOR FIN REP; Department for Environmental Food and Rural Affairs, 2013, TREE HLTH PLANT BIOS; Donovan GH, 2013, AM J PREV MED, V44, P139, DOI 10.1016/j.amepre.2012.09.066; Dwyer G, 2000, AM NAT, V156, P105, DOI 10.1086/303379; Dymond CC, 2010, ECOSYSTEMS, V13, P917, DOI 10.1007/s10021-010-9364-z; Elliott KJ, 2008, PLANT ECOL, V197, P155, DOI 10.1007/s11258-007-9352-3; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Fettig CJ, 2007, FOREST ECOL MANAG, V238, P24, DOI 10.1016/j.foreco.2006.10.011; Filipe JAN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002328; Food and Agriculture Organization of the United Nations (FAO), 2010, ASSESSMENT; Garnas JR, 2011, J ECOL, V99, P532, DOI 10.1111/j.1365-2745.2010.01791.x; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gray DR, 2006, FOREST CHRON, V82, P550, DOI 10.5558/tfc82550-4; Grunwald NJ, 2008, MOL PLANT PATHOL, V9, P729, DOI [10.1111/j.1364-3703.2008.00500.x, 10.1111/J.1364-3703.2008.00500.X]; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Harwood TD, 2009, ECOL MODEL, V220, P3353, DOI 10.1016/j.ecolmodel.2009.08.014; Hessburg PF, 2000, FOREST ECOL MANAG, V136, P53, DOI 10.1016/S0378-1127(99)00263-7; Jacobs DF, 2007, BIOL CONSERV, V137, P497, DOI 10.1016/j.biocon.2007.03.013; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Johnson WC, 2012, BIOSCIENCE, V62, P123, DOI 10.1525/bio.2012.62.2.6; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Kowalski T, 2006, FOREST PATHOL, V36, P264, DOI 10.1111/j.1439-0329.2006.00453.x; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Lindenmayer DB, 2004, SCIENCE, V303, P1303, DOI 10.1126/science.1093438; Loo J, 2009, BIOL INVASIONS, V11, P81, DOI 10.1007/s10530-008-9321-3; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Lu M, 2011, ECOLOGY, V92, P2013, DOI 10.1890/11-0687.1; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Maier H, 2003, BRIT J DERMATOL, V149, P990, DOI 10.1111/j.1365-2133.2003.05673.x; Malmstrom CM, 2000, GLOBAL CHANGE BIOL, V6, P35, DOI 10.1046/j.1365-2486.2000.06012.x; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; Mckinney LV, 2012, FUNGAL ECOL, V5, P663, DOI 10.1016/j.funeco.2012.05.004; McLaughlin J. A., 1996, P ADV BOR MIX MAN ON, P167; Meentemeyer RK, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00192.1; Mills P, 2011, PHILOS T R SOC B, V366, P2035, DOI 10.1098/rstb.2010.0411; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Paoletti M, 2006, MOL ECOL, V15, P249, DOI 10.1111/j.1365-294X.2005.02728.x; Parnell S, 2009, PHYTOPATHOLOGY, V99, P1370, DOI 10.1094/PHYTO-99-12-1370; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Potter C, 2011, PHILOS T R SOC B, V366, P1966, DOI 10.1098/rstb.2010.0395; Preisler HK, 2012, ECOLOGY, V93, P2421, DOI 10.1890/11-1412.1; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Roques Alain, 2010, New Zealand Journal of Forestry Science, V40, pS77; Roy S, 2012, URBAN FOR URBAN GREE, V11, P351, DOI 10.1016/j.ufug.2012.06.006; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Smith RM, 2007, AGR FOREST ENTOMOL, V9, P307, DOI 10.1111/j.1461-9563.2007.00349.x; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; THOMAS JA, 1991, BUTTERFLIES BRIT IRE; Turner RK, 2008, ENVIRON RESOUR ECON, V39, P25, DOI 10.1007/s10640-007-9176-6; Valle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057519; Verbyla D, 2008, GLOBAL ECOL BIOGEOGR, V17, P547, DOI 10.1111/j.1466-8238.2008.00396.x; von Oheimb G, 2007, ACTA OECOL, V31, P229, DOI 10.1016/j.actao.2006.12.001; Waage JK, 2008, AGR SYST, V99, P1, DOI 10.1016/j.agsy.2008.08.001; Waring KM, 2005, FOREST ECOL MANAG, V209, P27, DOI 10.1016/j.foreco.2005.01.008; Werner RA, 2006, FOREST ECOL MANAG, V227, P195, DOI 10.1016/j.foreco.2006.02.050; Wingfield Michael J., 2010, New Zealand Journal of Forestry Science, V40, pS95; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x; Wu T, 2011, RESTOR ECOL, V19, P441, DOI 10.1111/j.1526-100X.2011.00788.x	92	295	304	11	349	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					823	+	1235773	10.1126/science.1235773	http://dx.doi.org/10.1126/science.1235773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233727				2022-12-28	WOS:000326923000027
J	Brimioulle, R; Bach, T				Brimioulle, R.; Bach, T.			Enantioselective Lewis Acid Catalysis of Intramolecular Enone [2+2] Photocycloaddition Reactions	SCIENCE			English	Article							PHOTOCHEMICAL-REACTIONS; COUMARINS; PHOTODIMERIZATION; CYCLOADDITION; ALKALOIDS; MECHANISM	Asymmetric catalysis of photochemical cycloadditions has been limited by the challenge of suppressing the unselective background reaction. Here, we report that the high cross-section pi pi* transition of 5,6-dihydro-4-pyridones, a versatile class of enone substrates, undergoes a >50 nanometer (nm) bathochromic absorption shift upon Lewis acid coordination. Based on this observation, enantioselective intramolecular [2+2] photocycloaddition reactions (82 to 90% enantiomeric excess) were achieved with these substrates using 0.5 equivalents of a chiral Lewis acid upon irradiation at a wavelength of 366 nm. One of the products was applied as a key intermediate in the total synthesis of (+)-lupinine and the formal synthesis of (+)-thermopsine. Several enones show similar bathochromic shifts in the presence of a Lewis acid, indicating that chiral Lewis acid catalysis may be a general approach toward enantioselective enone [2+2] photocycloadditions.	[Bach, T.] Tech Univ Munich, Lehrstuhl Organ Chem 1, D-85747 Garching, Germany; Tech Univ Munich, Catalysis Res Ctr, D-85747 Garching, Germany	Technical University of Munich; Technical University of Munich	Bach, T (corresponding author), Tech Univ Munich, Lehrstuhl Organ Chem 1, D-85747 Garching, Germany.	thorsten.bach@ch.tum.de	Bach, Thorsten/M-2850-2014	Bach, Thorsten/0000-0002-1342-0202	Deutsche Forschungsgemeinschaft (Graduiertenkolleg GRK 1626 Chemical Photocatalysis); Fonds der Chemischen Industrie; Directorate For Geosciences [1636445] Funding Source: National Science Foundation; Division Of Ocean Sciences [1203892] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft (Graduiertenkolleg GRK 1626 Chemical Photocatalysis)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the Deutsche Forschungsgemeinschaft (Graduiertenkolleg GRK 1626 Chemical Photocatalysis) and by the Fonds der Chemischen Industrie (scholarship to R. B.). We thank O. Ackermann for help in conducting HPLC analyses.	ADAMSON G, 1995, J CHEM SOC CHEM COMM, P1783, DOI 10.1039/c39950001783; Bach T, 2011, ANGEW CHEM INT EDIT, V50, P1000, DOI 10.1002/anie.201002845; Brimioulle R, 2012, CHEM-EUR J, V18, P7552, DOI 10.1002/chem.201104032; Canales E, 2007, J AM CHEM SOC, V129, P12686, DOI 10.1021/ja0765262; Ciamician G, 1912, Science, V36, P385, DOI 10.1126/science.36.926.385; Ciamician G, 1908, BER DTSCH CHEM GES, V41, P1928, DOI 10.1002/cber.19080410272; Comins DL, 2002, ORG LETT, V4, P1611, DOI 10.1021/ol025820q; Comins DL, 1998, CHEM COMMUN, P2509, DOI 10.1039/a807448h; COMINS DL, 1994, J CHEM SOC CHEM COMM, P2681, DOI 10.1039/c39940002681; Crimmins M. T., 1993, ORG REACT, V44, P297; DALE JA, 1973, J AM CHEM SOC, V95, P512, DOI 10.1021/ja00783a034; Gorner H, 2008, PHOTOCHEM PHOTOBIOL, V84, P1224, DOI 10.1111/j.1751-1097.2008.00339.x; Gray D, 2006, ANGEW CHEM INT EDIT, V45, P2419, DOI 10.1002/anie.200504015; GUERRY P, 1991, HELV CHIM ACTA, V74, P163, DOI 10.1002/hlca.19910740118; GUERRY P, 1989, J CHEM SOC CHEM COMM, P1727, DOI 10.1039/c39890001727; GUERRY P, 1987, CHIMIA, V41, P341; Guo H, 2010, ANGEW CHEM INT EDIT, V49, P7782, DOI 10.1002/anie.201003619; Hajri M, 2013, TETRAHEDRON LETT, V54, P1029, DOI 10.1016/j.tetlet.2012.12.073; Hehn J. P., 2009, HDB SYNTHETIC PHOTOC, P171; Hoye TR, 2007, NAT PROTOC, V2, P2451, DOI 10.1038/nprot.2007.354; Iriondo-Alberdi J, 2007, EUR J ORG CHEM, V2007, P4801, DOI 10.1002/ejoc.200700239; Karrer P, 1928, HELV CHIM ACTA, V11, P1062, DOI 10.1002/hlca.192801101126; LEWIS FD, 1989, J AM CHEM SOC, V111, P8653, DOI 10.1021/ja00205a015; LEWIS FD, 1983, J AM CHEM SOC, V105, P3344, DOI 10.1021/ja00348a069; Muller C, 2009, ANGEW CHEM INT EDIT, V48, P6640, DOI 10.1002/anie.200901603; NUGENT WA, 1993, SCIENCE, V259, P479, DOI 10.1126/science.259.5094.479; Patai S., 1989, PHOTOCHEMISTYR ENONE, P623; ROBINS DJ, 1992, MAGN RESON CHEM, V30, P1125, DOI 10.1002/mrc.1260301118; Sakamoto M, 2008, J AM CHEM SOC, V130, P1132, DOI 10.1021/ja077912m; SCHUSTER DI, 1993, CHEM REV, V93, P3, DOI 10.1021/cr00017a001; TOLBERT LM, 1982, J AM CHEM SOC, V104, P1742, DOI 10.1021/ja00370a053; WINKLER JD, 1995, CHEM REV, V95, P2003, DOI 10.1021/cr00038a010	32	218	219	7	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					840	843		10.1126/science.1244809	http://dx.doi.org/10.1126/science.1244809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233720				2022-12-28	WOS:000326923000033
J	Good, MC; Vahey, MD; Skandarajah, A; Fletcher, DA; Heald, R				Good, Matthew C.; Vahey, Michael D.; Skandarajah, Arunan; Fletcher, Daniel A.; Heald, Rebecca			Cytoplasmic Volume Modulates Spindle Size During Embryogenesis	SCIENCE			English	Article							FUNCTION IN-VITRO; MITOTIC SPINDLE; EGG EXTRACTS; ELEGANS EMBRYOS; CELL GEOMETRY; LENGTH; XENOPUS; MICROTUBULES; GROWTH; DYNAMICS	Rapid and reductive cell divisions during embryogenesis require that intracellular structures adapt to a wide range of cell sizes. The mitotic spindle presents a central example of this flexibility, scaling with the dimensions of the cell to mediate accurate chromosome segregation. To determine whether spindle size regulation is achieved through a developmental program or is intrinsically specified by cell size or shape, we developed a system to encapsulate cytoplasm from Xenopus eggs and embryos inside cell-like compartments of defined sizes. Spindle size was observed to shrink with decreasing compartment size, similar to what occurs during early embryogenesis, and this scaling trend depended on compartment volume rather than shape. Thus, the amount of cytoplasmic material provides a mechanism for regulating the size of intracellular structures.	[Good, Matthew C.; Heald, Rebecca] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Good, Matthew C.; Vahey, Michael D.; Skandarajah, Arunan; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Good, Matthew C.; Vahey, Michael D.; Skandarajah, Arunan; Fletcher, Daniel A.] Univ Calif Berkeley, Biophys Grp, Berkeley, CA 94720 USA; [Good, Matthew C.] Univ Calif Berkeley, Miller Inst Basic Res Sci, Berkeley, CA 94720 USA; [Fletcher, Daniel A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Fletcher, DA (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	fletch@berkeley.edu; bheald@berkeley.edu	Good, Matthew C/GLS-0964-2022	Good, Matthew/0000-0002-6367-1034; Heald, Rebecca/0000-0001-6671-6528	Miller Institute for Basic Science Research; NIH [GM074751, GM098766]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098766, R01GM074751] Funding Source: NIH RePORTER	Miller Institute for Basic Science Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by fellowships from the Miller Institute for Basic Science Research (M. C. G.), NIH (M. D. V.), and NSF (A. S.). This work was also supported by NIH grants (GM074751, D. A. F.) and (GM098766, R. H.). We thank J. Wilbur, K. Helmke, F. Nedelec, K. Weis, M. Welch, H. Ramage, K. Nyberg, N. Metrakos, the Berkeley BioChIP NSF Research Experience for Undergraduates program, and members of the Heald and Fletcher labs. The authors declare no competing financial interests. Data described can be found in the main figures and supplementary materials.	Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Brun L, 2009, P NATL ACAD SCI USA, V106, P21173, DOI 10.1073/pnas.0910774106; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Conklin EG, 1912, J EXP ZOOL, V12, P1, DOI 10.1002/jez.1400120102; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Decker M, 2011, CURR BIOL, V21, P1259, DOI 10.1016/j.cub.2011.06.002; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hara Y, 2013, MOL BIOL CELL, V24, P1411, DOI 10.1091/mbc.E12-07-0528; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kafri R, 2013, NATURE, V494, P480, DOI 10.1038/nature11897; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Lattao R, 2012, J CELL SCI, V125, P584, DOI 10.1242/jcs.101469; Levy DL, 2012, ANNU REV CELL DEV BI, V28, P113, DOI 10.1146/annurev-cellbio-092910-154158; Loughlin R, 2011, CELL, V147, P1397, DOI 10.1016/j.cell.2011.11.014; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Pinot M, 2009, CURR BIOL, V19, P954, DOI 10.1016/j.cub.2009.04.027; Pinot M, 2012, P NATL ACAD SCI USA, V109, P11705, DOI 10.1073/pnas.1121583109; Reber SB, 2013, NAT CELL BIOL, V15, P1116, DOI 10.1038/ncb2834; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Wilbur JD, 2013, ELIFE, V2, DOI 10.7554/eLife.00290; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092	30	175	177	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					856	860		10.1126/science.1243147	http://dx.doi.org/10.1126/science.1243147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233724	Green Accepted			2022-12-28	WOS:000326923000038
J	Le Saout, S; Hoffmann, M; Shi, YC; Hughes, A; Bernard, C; Brooks, TM; Bertzky, B; Butchart, SHM; Stuart, SN; Badman, T; Rodrigues, ASL				Le Saout, Soizic; Hoffmann, Michael; Shi, Yichuan; Hughes, Adrian; Bernard, Cyril; Brooks, Thomas M.; Bertzky, Bastian; Butchart, Stuart H. M.; Stuart, Simon N.; Badman, Tim; Rodrigues, Ana S. L.			Protected Areas and Effective Biodiversity Conservation	SCIENCE			English	Editorial Material							TARGETS		[Le Saout, Soizic; Bernard, Cyril; Rodrigues, Ana S. L.] CNRS, CEFE, UMR5175, F-34293 Montpellier, France; [Hoffmann, Michael; Shi, Yichuan; Hughes, Adrian; Brooks, Thomas M.; Stuart, Simon N.; Badman, Tim] Int Union Conservat Nat, CH-1196 Gland, Switzerland; [Hoffmann, Michael; Shi, Yichuan; Bertzky, Bastian; Stuart, Simon N.] World Conservat Monitoring Ctr, United Nations Environm Programme, Cambridge CB3 0DL, England; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia; [Butchart, Stuart H. M.] BirdLife Int, Cambridge CB3 0NA, England; [Stuart, Simon N.] Conservat Int, Arlington, VA 22202 USA; [Stuart, Simon N.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Stuart, Simon N.] Al Ain Zoo, Abu Dhabi, U Arab Emirates	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Tasmania; BirdLife International; Conservation International; University of Bath	Rodrigues, ASL (corresponding author), CNRS, CEFE, UMR5175, F-34293 Montpellier, France.	ana.rodrigues@cefe.cnrs.fr	Bertzky, Bastian/I-6909-2013; Butchart, Stuart/AAJ-1852-2021; Hoffmann, Michael/E-6419-2010; Butchart, Stuart HM/Y-2711-2018; Rodrigues, Ana S.L./A-5914-2009; Rodrigues, Ana/GYQ-6273-2022	Bertzky, Bastian/0000-0001-7025-4733; Butchart, Stuart/0000-0002-1140-4049; Hoffmann, Michael/0000-0003-4785-2254; Rodrigues, Ana S.L./0000-0003-4775-0127; Brooks, Thomas/0000-0001-8159-3116; Hughes, Adrian/0000-0002-0807-6646				Bertzky B., 2012, PROTECTED PLANET REP; Bertzky B., 2013, TERRESTRIAL BIODIVER; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Courchamp F, 2003, SCIENCE, V302, P1532, DOI 10.1126/science.1089492; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Hartley A. J., 2007, ASSESSMENT AFRICAN P; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IUCN (International Union for Conservation of Nature), 2012, 2012 IUCN RED LIST T; IUCN U.-W., 2012, WORLD DAT PROT AR WD; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Moilanen A., 2009, SPATIAL CONSERVATION; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; SCBD, 2010, COP 10 DEC X 2 STRAT	18	339	365	8	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					803	805		10.1126/science.1239268	http://dx.doi.org/10.1126/science.1239268			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	251IY	24233709				2022-12-28	WOS:000326923000018
J	Nijman, SMB; Friend, SH				Nijman, Sebastian M. B.; Friend, Stephen H.			Potential of the Synthetic Lethality Principle	SCIENCE			English	Editorial Material							GENETIC INTERACTIONS; INHIBITION; THERAPY; CANCER; PHENOTYPE; YEAST; EGFR		[Nijman, Sebastian M. B.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Friend, Stephen H.] Sage Bionetworks, Seattle, WA 98109 USA	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Nijman, SMB (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	snijman@cemm.oeaw.ac.at; friend@sagebase.org		Nijman, Sebastian/0000-0003-0464-6661				Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609	14	51	57	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					809	811		10.1126/science.1244669	http://dx.doi.org/10.1126/science.1244669			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233712				2022-12-28	WOS:000326923000021
J	Serrano-Saiz, E; Poole, RJ; Felton, T; Zhang, FF; De La Cruz, ED; Hobert, O				Serrano-Saiz, Esther; Poole, Richard J.; Felton, Terry; Zhang, Feifan; De La Cruz, Estanisla Daniel; Hobert, Oliver			Modular Control of Glutamatergic Neuronal Identity in C. elegans by Distinct Homeodomain Proteins	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; RECEPTOR GENE-EXPRESSION; HOMEOBOX GENE; NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; DIFFERENTIATION; IDENTIFICATION; TRANSPORTER; BEHAVIOR; SPECIFICATION	The choice of using one of many possible neurotransmitter systems is a critical step in defining the identity of an individual neuron type. We show here that the key defining feature of glutamatergic neurons, the vesicular glutamate transporter EAT-4/VGLUT, is expressed in 38 of the 118 anatomically defined neuron classes of the C. elegans nervous system. We show that distinct cis-regulatory modules drive expression of eat-4/VGLUT in distinct glutamatergic neuron classes. We identify 13 different transcription factors, 11 of them homeodomain proteins, that act in distinct combinations in 25 different glutamatergic neuron classes to initiate and maintain eat-4/VGLUT expression. We show that the adoption of a glutamatergic phenotype is linked to the adoption of other terminal identity features of a neuron, including cotransmitter phenotypes. Examination of mouse orthologs of these homeodomain proteins resulted in the identification of mouse LHX1 as a regulator of glutamatergic neurons in the brainstem.	[Serrano-Saiz, Esther; Poole, Richard J.; Felton, Terry; Zhang, Feifan; De La Cruz, Estanisla Daniel; Hobert, Oliver] Columbia Univ, Med Ctr, HHMI, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Poole, Richard J.; Felton, Terry] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	Columbia University; Howard Hughes Medical Institute; University of London; University College London	Serrano-Saiz, E (corresponding author), Columbia Univ, Med Ctr, HHMI, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	es2754@columbia.edu; or38@columbia.edu	Serrano-Saiz, Esther/AAO-7791-2021; Saiz, Esther Serrano/AAJ-8469-2020	Saiz, Esther Serrano/0000-0003-0077-878X; Poole, Richard/0000-0001-6414-2479; Hobert, Oliver/0000-0002-7634-2854	NIH [R01NS039996-05, R01NS050266-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266, R01NS039996] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Q. Chen for expert assistance in generating transgenic strains, A. Goldsmith for generating the eat-4 locus reporter, members of the C. elegans community for providing strains, A. Boyanov for expert assistance in whole-genome sequencing, G. Minevich for initial identification of three mutants that affect ser-2 expression in OLL, J. Crissman, L. Khrimian, M. Peterson, J. Hou, B. Wu and U. Aghayeva for help with generating strains, M. Oren for examining eat-4 expression in the male tail, J. Dodd for providing LHX antibody, several colleagues cited in the text for communicating unpublished results and members of the Hobert lab, Iva Greenwald and Piali Sengupta for comments on the manuscript. This work was funded by the NIH (R01NS039996-05; R01NS050266-03). O. H. is an Investigator of the Howard Hughes Medical Institute.	Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Badea TC, 2003, J NEUROSCI, V23, P2314; Baird-Titus JM, 2006, J MOL BIOL, V356, P1137, DOI 10.1016/j.jmb.2005.12.007; Baran R, 1999, DEVELOPMENT, V126, P2241; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; BOULIN T, 2006, REPORTER GENE FUSION, P1, DOI [10.1895/wormbook.1.106.1, DOI 10.1895/WORMBOOK.1.106.1]; Brandt JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034014; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Brockie Penelope J, 2006, WormBook, P1; Burglin TR, 2001, DEVELOPMENT, V128, P779; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chang HC, 2011, NATURE, V480, P525, DOI 10.1038/nature10643; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Duggan A, 1998, DEVELOPMENT, V125, P4107; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Guillermin ML, 2011, GENETICS, V189, P1327, DOI 10.1534/genetics.111.133835; Hobert O, 1998, J NEUROSCI, V18, P2084; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Jafari G, 2011, J NEUROSCI, V31, P8948, DOI 10.1523/JNEUROSCI.1692-11.2011; Kage E, 2005, CURR BIOL, V15, P1554, DOI 10.1016/j.cub.2005.07.057; Kagoshima H, 2013, DEV BIOL, V380, P314, DOI 10.1016/j.ydbio.2013.04.009; Kim K, 2010, DEVELOPMENT, V137, P963, DOI 10.1242/dev.044719; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Kwan KM, 2002, GENESIS, V32, P118, DOI 10.1002/gene.10074; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lee D, 2008, MOL CELLS, V25, P50; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Nolan KM, 2002, GENE DEV, V16, P3061, DOI 10.1101/gad.1027702; Ohnishi N, 2011, EMBO J, V30, P1376, DOI 10.1038/emboj.2011.13; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Q Ma, 2006, TRANSCRIPTION FACTOR; Sarafi-Reinach TR, 2001, DEVELOPMENT, V128, P3269; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Seal RP, 2006, CURR OPIN PHARMACOL, V6, P114, DOI 10.1016/j.coph.2005.12.001; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Zhao Y, 2007, P NATL ACAD SCI USA, V104, P13182, DOI 10.1073/pnas.0705464104	54	154	156	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					659	673		10.1016/j.cell.2013.09.052	http://dx.doi.org/10.1016/j.cell.2013.09.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243022	Green Accepted, Bronze			2022-12-28	WOS:000326571800019
J	Benoit, RM; Frey, D; Hilbert, M; Kevenaar, JT; Wieser, MM; Stirnimann, CU; McMillan, D; Ceska, T; Lebon, F; Jaussi, R; Steinmetz, MO; Schertler, GFX; Hoogenraad, CC; Capitani, G; Kammerer, RA				Benoit, Roger M.; Frey, Daniel; Hilbert, Manuel; Kevenaar, Josta T.; Wieser, Mara M.; Stirnimann, Christian U.; McMillan, David; Ceska, Tom; Lebon, Florence; Jaussi, Rolf; Steinmetz, Michel O.; Schertler, Gebhard F. X.; Hoogenraad, Casper C.; Capitani, Guido; Kammerer, Richard A.			Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A	NATURE			English	Article							LOW PH; DESIGN; PRION; DNA; AGGREGATION; PREDICTION; DYNAMICS; RECEPTOR; BINDING; MOTIFS	Botulinum neurotoxin A (BoNT/A) belongs to the most dangerous class of bioweapons(1). Despite this, BoNT/A is used to treat a wide range of common medical conditions such as migraines and a variety of ocular motility and movement disorders(2). BoNT/A is probably best known for its use as an antiwrinkle agent in cosmetic applications (including Botox and Dysport)(3). BoNT/A application causes long-lasting flaccid paralysis of muscles through inhibiting the release of the neurotransmitter acetylcholine by cleaving synaptosomal-associated protein 25 (SNAP-25) within presynaptic nerve terminals(4). Two types of BoNT/A receptor have been identified, both of which are required for BoNT/A toxicity and are therefore likely to cooperate with each other(5): gangliosides and members of the synaptic vesicle glycoprotein 2 (SV2) family, which are putative transporter proteins that are predicted to have 12 transmembrane domains, associate with the receptor-binding domain of the toxin(5). Recently, fibroblast growth factor receptor 3 (FGFR3) has also been reported to be a potential BoNT/A receptor(6). In SV2 proteins, the BoNT/A-binding site has been mapped to the luminal domain(7), but the molecular details of the interaction between BoNT/A and SV2 are unknown. Here we determined the high-resolution crystal structure of the BoNT/A receptor-binding domain (BoNT/A-RBD) in complex with the SV2C luminal domain (SV2C-LD). SV2C-LD consists of a right-handed, quadrilateral beta-helix that associates with BoNT/A-RBD mainly through backbone-to-backbone interactions at open beta-strand edges, in a manner that resembles the inter-strand interactions in amyloid structures. Competition experiments identified a peptide that inhibits the formation of the complex. Our findings provide a strong platform for the development of novel antitoxin agents and for the rational design of BoNT/A variants with improved therapeutic properties.	[Benoit, Roger M.; Frey, Daniel; Hilbert, Manuel; Wieser, Mara M.; Jaussi, Rolf; Steinmetz, Michel O.; Schertler, Gebhard F. X.; Capitani, Guido; Kammerer, Richard A.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Kevenaar, Josta T.; Hoogenraad, Casper C.] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Stirnimann, Christian U.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [McMillan, David; Ceska, Tom] UCB NewMed, UCB Pharma, UCB Celltech, Slough SL1 4EN, Berks, England; [Lebon, Florence] UCB NewMed, UCB Pharma, B-1420 Braine Lalleud, Belgium; [Schertler, Gebhard F. X.] ETH, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Utrecht University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Celltech Group Ltd; UCB Pharma SA; UCB Pharma SA; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kammerer, RA (corresponding author), Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland.	richard.kammerer@psi.ch	Hoogenraad, Casper/B-8866-2011; Schertler, Gebhard/M-9512-2014; Steinmetz, Michel O/AAA-3349-2022	Hoogenraad, Casper/0000-0002-2666-0758; Steinmetz, Michel O/0000-0001-6157-3687; Schertler, Gebhard F.X./0000-0002-5846-6810; Benoit, Roger/0000-0001-9420-7739; Stirnimann, Christian/0000-0002-1030-8864; Kammerer, Richard/0000-0003-4570-5197	UCB Pharma, UCB NewMedicines; Swiss National Science Foundation [310030B_138659]; Netherlands Organization for Scientific Research (NWO-ALW-VICI); Netherlands Organization for Health Research and Development (ZonMW-TOP)	UCB Pharma, UCB NewMedicines; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands Organization for Scientific Research (NWO-ALW-VICI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMW-TOP)(Netherlands Organization for Health Research and Development)	We thank A. Blanc for performing the mass spectrometry analysis of the recombinant proteins and L. Knecht for help with protein production. This work was supported by UCB Pharma, UCB NewMedicines. This work was also supported by the Swiss National Science Foundation (grant 310030B_138659), The Netherlands Organization for Scientific Research (NWO-ALW-VICI) and The Netherlands Organization for Health Research and Development (ZonMW-TOP).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anderson ER, 2004, AM J HEALTH-SYST PH, V61, pS24, DOI 10.1093/ajhp/61.suppl_6.S24; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benoit RM, 2006, PROTEIN EXPRES PURIF, V45, P66, DOI 10.1016/j.pep.2005.09.022; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bryan AW, 2011, P NATL ACAD SCI USA, V108, P11099, DOI 10.1073/pnas.1017504108; Cai S., 2007, Infectious Disorders - Drug Targets, V7, P47, DOI 10.2174/187152607780090667; Carruthers J, 2004, CLIN DERMATOL, V22, P89, DOI 10.1016/j.clindermatol.2003.11.013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000245; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Hegde SS, 2005, SCIENCE, V308, P1480, DOI 10.1126/science.1110699; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jacky BPS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003369; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kapitein LC, 2010, METHOD CELL BIOL, V97, P111, DOI 10.1016/S0091-679X(10)97007-6; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Markey AC, 2000, CLIN EXP DERMATOL, V25, P173, DOI 10.1046/j.1365-2230.2000.00606.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Spangler SA, 2013, J CELL BIOL, V201, P915, DOI 10.1083/jcb.201301011; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun SH, 2012, BIOCHEMISTRY-US, V51, P5655, DOI 10.1021/bi3004928; Sun SH, 2011, CELL HOST MICROBE, V10, P237, DOI 10.1016/j.chom.2011.06.012; Vetting MW, 2011, ACTA CRYSTALLOGR F, V67, P296, DOI 10.1107/S1744309110053315; Vetting MW, 2006, BIOCHEMISTRY-US, V45, P1, DOI 10.1021/bi052130w; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Zhang YL, 1998, ANAL BIOCHEM, V261, P139, DOI 10.1006/abio.1998.2738	45	77	83	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					108	+		10.1038/nature12732	http://dx.doi.org/10.1038/nature12732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24240280				2022-12-28	WOS:000329163300033
J	Chung, WS; Clarke, LE; Wang, GX; Stafford, BK; Sher, A; Chakraborty, C; Joung, J; Foo, LC; Thompson, A; Chen, CF; Smith, SJ; Barres, BA				Chung, Won-Suk; Clarke, Laura E.; Wang, Gordon X.; Stafford, Benjamin K.; Sher, Alexander; Chakraborty, Chandrani; Joung, Julia; Foo, Lynette C.; Thompson, Andrew; Chen, Chinfei; Smith, Stephen J.; Barres, Ben A.			Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways	NATURE			English	Article							CELL CORPSE ENGULFMENT; RETINAL WAVES; RECEPTOR; PHAGOCYTOSIS; KINASE; SEGREGATION; REFINEMENT; CLEARANCE; MICROGLIA; ROLES	To achieve its precise neural connectivity, the developing mammalian nervous system undergoes extensive activity-dependent synapse remodelling. Recently, microglial cells have been shown to be responsible for a portion of synaptic pruning, but the remaining mechanisms remain unknown. Here we report a new role for astrocytes in actively engulfing central nervous system synapses. This process helps to mediate synapse elimination, requires the MEGF10 and MERTK phagocytic pathways, and is strongly dependent on neuronal activity. Developing mice deficient in both astrocyte pathways fail to refine their retinogeniculate connections normally and retain excess functional synapses. Finally, we show that in the adult mouse brain, astrocytes continuously engulf both excitatory and inhibitory synapses. These studies reveal a novel role for astrocytes in mediating synapse elimination in the developing and adult brain, identify MEGF10 and MERTK as critical proteins in the synapse remodelling underlying neural circuit refinement, and have important implications for understanding learning and memory as well as neurological disease processes.	[Chung, Won-Suk; Clarke, Laura E.; Chakraborty, Chandrani; Joung, Julia; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Wang, Gordon X.; Smith, Stephen J.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Stafford, Benjamin K.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Sher, Alexander] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Sher, Alexander] Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA; [Foo, Lynette C.] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Thompson, Andrew; Chen, Chinfei] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA	Stanford University; Stanford University; University of Michigan System; University of Michigan; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Harvard University; Boston Children's Hospital; Harvard Medical School	Chung, WS (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	wschung@stanford.edu	Joung, Julia/HCH-8944-2022; Chung, Won-Suk/B-9011-2016	Chung, Won-Suk/0000-0003-1060-9007; Sher, Alexander/0000-0001-6655-6456; Smith, Stephen/0000-0002-2290-8701; Wang, Gordon/0000-0002-2707-7118	NIH [NS069375, 5 R21NS072556]; Damon Runyon Cancer Research Foundation [DRG 2020-09]; EMBO ALTF fellowship; Mcknight Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375, R01NS075252, R21NS072556] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; EMBO ALTF fellowship; Mcknight Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Vollrath for discussions and MERTK antibody. We also thank H. M. Lee for helping us set up electrophysiology experiments as well as for discussions. Part of the data was acquired at Stanford Neuroscience Microscopy Service (NMS), supported by NIH NS069375. W.-S.C. was supported in part by a postdoctoral fellowship from the Damon Runyon Cancer Research Foundation (DRG 2020-09). L. E. C. was supported in part by an EMBO ALTF fellowship. This work was supported by grants from the NIH (5 R21NS072556, B. A. B.) and a Brain Disorder Award from the Mcknight Foundation to B. A. B. We thank V. and S. Coates for their generous support.	Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beletskii A, 2005, BIOTECHNIQUES, V39, P894, DOI 10.2144/000112001; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hochreiter-Hufford A., 2013, COLD SPRING HARB PER, V5; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Huberman AD, 2002, J NEUROSCI, V22, P9419; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Peters A., 1976, FINE STRUCTURE NERVO; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; SHATZ CJ, 1986, ANNU REV NEUROSCI, V9, P171, DOI 10.1146/annurev.ne.09.030186.001131; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tasdemir-Yilmaz O., GENES DEV IN PRESS; Tung TT, 2013, J BIOCHEM, V153, P483, DOI 10.1093/jb/mvt014; Wang G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002671; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	39	673	686	9	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					394	+		10.1038/nature12776	http://dx.doi.org/10.1038/nature12776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24270812	Green Accepted, Green Submitted			2022-12-28	WOS:000328575300043
J	Assie, G; Libe, R; Espiard, S; Rizk-Rabin, M; Guimier, A; Luscap, W; Barreau, O; Lefevre, L; Sibony, M; Guignat, L; Rodriguez, S; Perlemoine, K; Rene-Corail, F; Letourneur, F; Trabulsi, B; Poussier, A; Chabbert-Buffet, N; Borson-Chazot, F; Groussin, L; Bertagna, X; Stratakis, CA; Ragazzon, B; Bertherat, J				Assie, Guillaume; Libe, Rossella; Espiard, Stephanie; Rizk-Rabin, Marthe; Guimier, Anne; Luscap, Windy; Barreau, Olivia; Lefevre, Lucile; Sibony, Mathilde; Guignat, Laurence; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Letourneur, Franck; Trabulsi, Bilal; Poussier, Alix; Chabbert-Buffet, Nathalie; Borson-Chazot, Francoise; Groussin, Lionel; Bertagna, Xavier; Stratakis, Constantine A.; Ragazzon, Bruno; Bertherat, Jerome			ARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; ADRENOCORTICAL TUMORS; GENE-EXPRESSION; FREQUENT; PROTEIN; RECEPTORS; HYPERCORTISOLISM; PATHWAY; DISEASE; CANCERS	BackgroundCorticotropin-independent macronodular adrenal hyperplasia may be an incidental finding or it may be identified during evaluation for Cushing's syndrome. Reports of familial cases and the involvement of both adrenal glands suggest a genetic origin of this condition. MethodsWe genotyped blood and tumor DNA obtained from 33 patients with corticotropin-independent macronodular adrenal hyperplasia (12 men and 21 women who were 30 to 73 years of age), using single-nucleotide polymorphism arrays, microsatellite markers, and whole-genome and Sanger sequencing. The effects of armadillo repeat containing 5 (ARMC5) inactivation and overexpression were tested in cell-culture models. ResultsThe most frequent somatic chromosome alteration was loss of heterozygosity at 16p (in 8 of 33 patients for whom data were available [24%]). The most frequent mutation identified by means of whole-genome sequencing was in ARMC5, located at 16p11.2. ARMC5 mutations were detected in tumors obtained from 18 of 33 patients (55%). In all cases, both alleles of ARMC5 carried mutations: one germline and the other somatic. In 4 patients with a germline ARMC5 mutation, different nodules from the affected adrenals harbored different secondary ARMC5 alterations. Transcriptome-based classification of corticotropin-independent macronodular adrenal hyperplasia indicated that ARMC5 mutations influenced gene expression, since all cases with mutations clustered together. ARMC5 inactivation decreased steroidogenesis in vitro, and its overexpression altered cell survival. ConclusionsSome cases of corticotropin-independent macronodular adrenal hyperplasia appear to be genetic, most often with inactivating mutations of ARMC5, a putative tumor-suppressor gene. Genetic testing for this condition, which often has a long and insidious prediagnostic course, might result in earlier identification and better management. (Funded by Agence Nationale de la Recherche and others.)	[Assie, Guillaume; Libe, Rossella; Espiard, Stephanie; Rizk-Rabin, Marthe; Guimier, Anne; Luscap, Windy; Barreau, Olivia; Lefevre, Lucile; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Letourneur, Franck; Groussin, Lionel; Bertagna, Xavier; Ragazzon, Bruno; Bertherat, Jerome] Inst Cochin, INSERM Unite 1016, CNRS, UMR 8104, Paris, France; [Assie, Guillaume; Espiard, Stephanie; Guimier, Anne; Barreau, Olivia; Lefevre, Lucile; Sibony, Mathilde; Perlemoine, Karine; Rene-Corail, Fernande; Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] Univ Paris 05, Fac Med Paris Descartes, Sorbonne Paris Cite, Paris, France; [Assie, Guillaume; Libe, Rossella; Barreau, Olivia; Guignat, Laurence; Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] Referral Ctr Rare Adrenal Dis, Dept Endocrinol, Paris, France; [Sibony, Mathilde] Hop Cochin, AP HP, Dept Pathol, F-75674 Paris, France; [Chabbert-Buffet, Nathalie] Hop Tenon, Dept Obstet & Gynecol, Unit Endocrinol, F-75970 Paris, France; [Trabulsi, Bilal] Ctr Hosp, Ctr Bretagne, Unit Endocrinol, Noyal Pontivy, France; [Poussier, Alix] Hotel Dieu Creusot, Unit Endocrinol, Le Creusot, France; [Borson-Chazot, Francoise] Grp Hosp Est, Dept Endocrinol Lyon Est, Bron, France; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Endocrinol Inter Inst, Training Program, NIH, Bethesda, MD USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bertherat, J (corresponding author), Hop Cochin, Serv Malad Endocriniennes & Metab, Ctr Reference Malad Rares Surrenale, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	jerome.bertherat@cch.aphp.fr	Stratakis, Constantine/AAP-4745-2020; Ragazzon, Bruno/E-6541-2017; Rizk-Rabin, Marthe/A-1698-2018	Ragazzon, Bruno/0000-0001-9476-4973; Assie, Guillaume/0000-0001-9590-0906; Sibony, Mathilde/0000-0002-1282-8732; Groussin, Lionel/0000-0003-1476-475X; Rizk-Rabin, Marthe/0000-0003-1558-737X; Rodriguez, Stephanie/0000-0003-4520-144X; libe, rossella/0000-0003-2881-6362; RONDOF, Windy/0000-0002-8160-4900; BERTHERAT, Jerome/0000-0003-2551-3008; Borson-Chazot, Francoise/0000-0003-2515-7840; Guimier, Anne/0000-0002-4759-0621	Agence Nationale de la Recherche [ANR-10-Blan-1136]; Corticomedullosurrenale Tumeur Endocrine Network (Programme Hospitalier de Recherche Clinique grant) [AOM95201]; Assistance Publique-Hopitaux de Paris (Clinical Research Center) [Genhyper P061006]; Institut National du Cancer [Recherche Translationelle 2009-RT-02]; Seventh Framework Program of the European Commission [F2-2010-259735]; INSERM (Contrat d'Interface); Conny-Maeva Charitable Foundation; intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Corticomedullosurrenale Tumeur Endocrine Network (Programme Hospitalier de Recherche Clinique grant); Assistance Publique-Hopitaux de Paris (Clinical Research Center); Institut National du Cancer(Institut National du Cancer (INCA) France); Seventh Framework Program of the European Commission; INSERM (Contrat d'Interface)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Conny-Maeva Charitable Foundation; intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported in part by grants from Agence Nationale de la Recherche (ANR-10-Blan-1136), Corticomedullosurrenale Tumeur Endocrine Network (Programme Hospitalier de Recherche Clinique grant AOM95201), Assistance Publique-Hopitaux de Paris (Clinical Research Center Grant Genhyper P061006), Institut National du Cancer (Recherche Translationelle 2009-RT-02), the Seventh Framework Program of the European Commission (F2-2010-259735), INSERM (Contrat d'Interface, to Dr. Assie), the Conny-Maeva Charitable Foundation, and the intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Antonini SR, 2006, CLIN ENDOCRINOL, V64, P29, DOI 10.1111/j.1365-2265.2005.02411.x; Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Assie G, 2010, J CLIN ENDOCR METAB, V95, pE253, DOI 10.1210/jc.2009-2281; Bertherat J, 2005, J CLIN ENDOCR METAB, V90, P1302, DOI 10.1210/jc.2004-1256; Bourdeau I, 2001, J CLIN ENDOCR METAB, V86, P5534, DOI 10.1210/jc.86.11.5534; Carney JA, 2011, AM J SURG PATHOL, V35, P1311, DOI 10.1097/PAS.0b013e31821ec4ce; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; FINDLAY JC, 1993, J CLIN ENDOCR METAB, V76, P189, DOI 10.1210/jc.76.1.189; Gagliardi L, 2009, CLIN ENDOCRINOL, V70, P883, DOI 10.1111/j.1365-2265.2008.03471.x; Gaujoux S, 2010, CLIN CANCER RES, V16, P5133, DOI 10.1158/1078-0432.CCR-10-1497; Gicquel C, 2001, CANCER RES, V61, P6762; Groussin L, 2000, J CLIN ENDOCR METAB, V85, P345, DOI 10.1210/jc.85.1.345; Hsiao HP, 2009, J CLIN ENDOCR METAB, V94, P2930, DOI 10.1210/jc.2009-0516; LACROIX A, 1992, NEW ENGL J MED, V327, P974, DOI 10.1056/NEJM199210013271402; Lacroix A, 2010, CLIN ENDOCRINOL, V73, P1, DOI 10.1111/j.1365-2265.2009.03689.x; Lacroix A, 2009, BEST PRACT RES CL EN, V23, P245, DOI 10.1016/j.beem.2008.10.011; Libe R, 2008, CLIN CANCER RES, V14, P4016, DOI 10.1158/1078-0432.CCR-08-0106; Libe R, 2007, CLIN CANCER RES, V13, P844, DOI 10.1158/1078-0432.CCR-06-2085; Libe R, 2011, J CLIN ENDOCR METAB, V96, pE208, DOI 10.1210/jc.2010-1704; Libe R, 2010, EUR J ENDOCRINOL, V163, P129, DOI 10.1530/EJE-10-0195; Matyakhina L, 2005, J CLIN ENDOCR METAB, V90, P3773, DOI 10.1210/jc.2004-2377; Ragazzon B, 2009, CANCER RES, V69, P7278, DOI 10.1158/0008-5472.CAN-09-1601; REZNIK Y, 1992, NEW ENGL J MED, V327, P981, DOI 10.1056/NEJM199210013271403; Rizk-Rabin M, 2008, CANCER EPIDEM BIOMAR, V17, P2275, DOI 10.1158/1055-9965.EPI-07-2924; Swain JM, 1998, ARCH SURG-CHICAGO, V133, P541, DOI 10.1001/archsurg.133.5.541; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Vezzosi D, 2007, EUR J ENDOCRINOL, V156, P21, DOI 10.1530/eje.1.02324; Yoshida M, 2011, ENDOCR J, V58, P269, DOI 10.1507/endocrj.K10E-218	29	220	231	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2105	2114		10.1056/NEJMoa1304603	http://dx.doi.org/10.1056/NEJMoa1304603			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24283224	Green Accepted			2022-12-28	WOS:000327467500008
J	Ryan, K; Moroney, P				Ryan, Katie; Moroney, Paul			Hallux Varus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ryan, Katie; Moroney, Paul] Cappagh Natl Orthopaed Hosp, Dublin, Ireland		Ryan, K (corresponding author), Cappagh Natl Orthopaed Hosp, Dublin, Ireland.			Moroney, Paul/0000-0002-4496-8537					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2137	2137		10.1056/NEJMicm1213412	http://dx.doi.org/10.1056/NEJMicm1213412			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24283227				2022-12-28	WOS:000327467500011
J	Spence, D				Spence, Des			Labelled for life	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Callard F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4312; Centers for Disease Control and Prevention, 2011, MENT HLTH BAS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2013	347								f7037	10.1136/bmj.f7037	http://dx.doi.org/10.1136/bmj.f7037			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263GF	24284339				2022-12-28	WOS:000327794500008
J	Kent, A				Kent, Alastair			Commentary: Patients will need knowledgeable guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Genet Alliance UK, London N1 3QP, England		Kent, A (corresponding author), Genet Alliance UK, London N1 3QP, England.	alastair@geneticalliance.org.uk							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2013	347								f6991	10.1136/bmj.f6991	http://dx.doi.org/10.1136/bmj.f6991			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FN	24285799				2022-12-28	WOS:000327792500004
J	Nardone, A; Delpech, V; Gill, ON; Fenton, KA; Anderson, J				Nardone, Anthony; Delpech, Valerie; Gill, O. Noel; Fenton, Kevin A.; Anderson, Jane			HIV in the UK: test, test, and test again	LANCET			English	Editorial Material							TRANSMISSION; MEN; SEX		[Nardone, Anthony; Delpech, Valerie; Gill, O. Noel] Publ Hlth England, Hlth Protect Directorate, Ctr Dis Surveillance & Control, HIV & STI Dept, London NW9 5EQ, England; [Fenton, Kevin A.; Anderson, Jane] Publ Hlth England, Hlth Wellbeing Directorate, London NW9 5EQ, England	Public Health England; Public Health England	Nardone, A (corresponding author), Publ Hlth England, Hlth Protect Directorate, Ctr Dis Surveillance & Control, HIV & STI Dept, London NW9 5EQ, England.	anthony.nardone@phe.gov.uk	Anderson, Jane/A-1632-2012	Anderson, Jane/0000-0001-5294-8707; Nardone, Anthony/0000-0003-1138-0937; delpech, valerie/0000-0002-9952-8109				Birrell PJ, 2013, LANCET INFECT DIS, V13, P313, DOI 10.1016/S1473-3099(12)70341-9; British HIV Association British Association of Sexual Health and HIV British Infection Society, UK NAT GUID HIV TEST; Brown AE, 2013, HIV MED, V14, P563, DOI 10.1111/hiv.12066; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Department of Health, 2013, MOD HIV RUL BETT PRO; Ellis S, 2012, CLIN MED, V12, P430, DOI 10.7861/clinmedicine.12-5-430; Hartney T, 2014, HIV MED, V15, P251, DOI 10.1111/hiv.12099; Health Protection Agency, 2012, HIV UK 2012 REP; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; National Institute for Health and Care Excellence, 2011, INCR UPT HIV TEST ME; Ogunyemi A, 2013, PUBL HLTH ENGL C WAR; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Public Health England, 2011, TIM TEST HIV EXP HEA; Sullivan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052845	14	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1687	1688		10.1016/S0140-6736(13)62377-6	http://dx.doi.org/10.1016/S0140-6736(13)62377-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259PX	24267988				2022-12-28	WOS:000327539900009
J	Dean, J				Dean, John			Referral mismanagement systems	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Exeter	Dean, J (corresponding author), Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England.	lub.dub@virgin.net						Imison Candace, 2010, REFERRAL MANAGEMENT	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2013	347								f7014	10.1136/bmj.f7014	http://dx.doi.org/10.1136/bmj.f7014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KZ	24270509				2022-12-28	WOS:000327459500012
J	Ham, C				Ham, Chris			Balancing budgets or protecting patient safety	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Ham, C (corresponding author), Kings Fund, London, England.	c.ham@kingsfund.org.uk						Appleby J., 2013, IS HLTH SOCIAL CARE; Appleby J., 2013, BMJ-BRIT MED J, V347, pf6287; Lintern S., 2013, NURSING TIMES; O'Dowd A., 2013, BMJ-BRIT MED J, V347, pf7023	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2013	347								f6943	10.1136/bmj.f6943	http://dx.doi.org/10.1136/bmj.f6943			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KZ	24270551				2022-12-28	WOS:000327459500005
J	Koel, BF; Burke, DF; Bestebroer, TM; van der Vliet, S; Zondag, GCM; Vervaet, G; Skepner, E; Lewis, NS; Spronken, MIJ; Russell, CA; Eropkin, MY; Hurt, AC; Barr, IG; de Jong, JC; Rimmelzwaan, GF; Osterhaus, ADME; Fouchier, RAM; Smith, DJ				Koel, Bjorn F.; Burke, David F.; Bestebroer, Theo M.; van der Vliet, Stefan; Zondag, Gerben C. M.; Vervaet, Gaby; Skepner, Eugene; Lewis, Nicola S.; Spronken, Monique I. J.; Russell, Colin A.; Eropkin, Mikhail Y.; Hurt, Aeron C.; Barr, Ian G.; de Jong, Jan C.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Smith, Derek J.			Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution	SCIENCE			English	Article							A VIRUSES; HEMAGGLUTININ; ANTIBODY; RECOGNITION	The molecular basis of antigenic drift was determined for the hemagglutinin (HA) of human influenza A/H3N2 virus. From 1968 to 2003, antigenic change was caused mainly by single amino acid substitutions, which occurred at only seven positions in HA immediately adjacent to the receptor binding site. Most of these substitutions were involved in antigenic change more than once. Equivalent positions were responsible for the recent antigenic changes of influenza B and A/H1N1 viruses. Substitution of a single amino acid at one of these positions substantially changed the virus-specific antibody response in infected ferrets. These findings have potentially far-reaching consequences for understanding the evolutionary mechanisms that govern influenza viruses.	[Koel, Bjorn F.; Bestebroer, Theo M.; van der Vliet, Stefan; Vervaet, Gaby; Spronken, Monique I. J.; de Jong, Jan C.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Smith, Derek J.] Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands; [Burke, David F.; Skepner, Eugene; Lewis, Nicola S.; Smith, Derek J.] Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Cambridge CB2 3EJ, England; [Burke, David F.; Skepner, Eugene; Lewis, Nicola S.; Russell, Colin A.; Smith, Derek J.] Univ Cambridge, WHO Collaborating Ctr Modeling Evolut & Control E, Cambridge CB2 3EJ, England; [Zondag, Gerben C. M.] BaseClear BV, NL-2333 CC Leiden, Netherlands; [Zondag, Gerben C. M.] Leiden Univ, Luris, NL-2333 AA Leiden, Netherlands; [Russell, Colin A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Eropkin, Mikhail Y.] All Union Influenza Res Inst, St Petersburg 197376, Russia; [Hurt, Aeron C.; Barr, Ian G.] VIDRL, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3051, Australia; [Smith, Derek J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; University of Cambridge; University of Cambridge; Leiden University; Leiden University - Excl LUMC; University of Cambridge; Victorian Infectious Diseases Reference Laboratory; World Health Organization; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl; dsmith@zoo.cam.ac.uk	Russell, Colin/ABE-7106-2020; Smith, Derek/Z-3075-2019; Burke, David F/C-2091-2013; Fouchier, Ron A/A-1911-2014	Smith, Derek/0000-0002-2393-1890; Burke, David F/0000-0001-8830-3951; Fouchier, Ron A/0000-0001-8095-2869; Hurt, Aeron/0000-0003-1826-4314; Eropkin, Mikhail/0000-0002-3306-847X; Russell, Colin/0000-0002-2113-162X; Barr, Ian/0000-0002-7351-418X	NWO VICI grant; National Institute of Allergy and Infectious Diseases [HHSN266200700010C]; NIH [DP1-OD000490-01]; European Union [223498, 278976]; Human Frontier Science Program [P0050/2008]; Australian Government Department of Health and Aging; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	NWO VICI grant(Netherlands Organization for Scientific Research (NWO)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Human Frontier Science Program(Human Frontier Science Program); Australian Government Department of Health and Aging(Australian GovernmentDepartment of Health & Ageing); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Aban, G. van Amerongen, C. Baas, R. van Beek, M. de Graaf, S. Herfst, S. James, M. Linster, K. Sutherland-Cash, and C. Whittleston for excellent technical assistance and discussions. D.F.B. and D.J.S. acknowledge the use of the CamGrid distributed computing resource. Supported by an NWO VICI grant, National Institute of Allergy and Infectious Diseases contract HHSN266200700010C, NIH Director's Pioneer Award DP1-OD000490-01, European Union FP7 program EMPERIE (223498), European Union FP7 program ANTIGONE (278976), and program grant P0050/2008 from the Human Frontier Science Program. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Aging. A.D.M.E.O. (on behalf of Viroclinics Biosciences B.V.) has advisory affiliations with GSK, Novartis, and Roche. A.D.M.E.O. and G.F.R. are consultants for Viroclinics Biosciences BV. A/H3N2 virus sequences were previously published by Smith et al. (16). The sequences of the influenza A/H1N1 and B viruses used in this study are available from the GISAID EpiFlu Database (www.gisaid.org) and are listed in table S6.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Akazawa M, 2003, VALUE HEALTH, V6, P107, DOI 10.1046/j.1524-4733.2003.00209.x; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; de Wit E, 2007, J GEN VIROL, V88, P1281, DOI 10.1099/vir.0.82452-0; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Zhai WW, 2007, J MOL EVOL, V65, P340, DOI 10.1007/s00239-007-9019-7	21	357	374	5	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					976	979		10.1126/science.1244730	http://dx.doi.org/10.1126/science.1244730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264991				2022-12-28	WOS:000327223500042
J	Mitchell, L; Brook, E; Lee, JE; Buizert, C; Sowers, T				Mitchell, Logan; Brook, Ed; Lee, James E.; Buizert, Christo; Sowers, Todd			Constraints on the Late Holocene Anthropogenic Contribution to the Atmospheric Methane Budget	SCIENCE			English	Article							PREINDUSTRIAL; ANTARCTICA; EMISSIONS	The origin of the late preindustrial Holocene (LPIH) increase in atmospheric methane concentrations has been much debated. Hypotheses invoking changes in solely anthropogenic sources or solely natural sources have been proposed to explain the increase in concentrations. Here two high-resolution, high-precision ice core methane concentration records from Greenland and Antarctica are presented and are used to construct a high-resolution record of the methane inter-polar difference (IPD). The IPD record constrains the latitudinal distribution of emissions and shows that LPIH emissions increased primarily in the tropics, with secondary increases in the subtropical Northern Hemisphere. Anthropogenic and natural sources have different latitudinal characteristics, which are exploited to demonstrate that both anthropogenic and natural sources are needed to explain LPIH changes in methane concentration.	[Mitchell, Logan; Brook, Ed; Lee, James E.; Buizert, Christo] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Sowers, Todd] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Sowers, Todd] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	Oregon State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mitchell, L (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	logan.e.mitchell@gmail.com	Mitchell, Logan E/A-5481-2011	Mitchell, Logan E/0000-0002-8749-954X; Buizert, Christo/0000-0002-2227-1747; Lee, James/0000-0002-9137-1530	NSF Office of Polar Programs (OPP) [0538578, 0520523, 0944584, 0538538]; NASA/Oregon Space Grant Consortium [NNG05GJ85H]; NOAA Climate and Global Change Fellowship Program; NSF [0230396, 0440817, 0944348, 0944266]; NSF OPP; Directorate For Geosciences [1043518, 0538578] Funding Source: National Science Foundation	NSF Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NASA/Oregon Space Grant Consortium(National Aeronautics & Space Administration (NASA)); NOAA Climate and Global Change Fellowship Program; NSF(National Science Foundation (NSF)); NSF OPP(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF Office of Polar Programs (OPP) grants 0538578, 0520523, 0944584, and 0538538; and by NASA/Oregon Space Grant Consortium grant NNG05GJ85H and the NOAA Climate and Global Change Fellowship Program, administered by the University Corporation for Atmospheric Research (C.B.). We thank two anonymous reviewers whose comments greatly improved the manuscript; B. Markle, A. Morin, B. Williams, and J. Edwards for assisting in sample preparation and analysis; T. Marik, who provided the original eight-box model code (BOSCAGE); J. Severinghaus and G. Etiope, who contributed preliminary results from their work; T. Konijnendijk, J. Van Etten, and J. Singarayer, who provided model data from their published works; the WAIS Divide Science Coordination Office at the Desert Research Institute, Reno, NV for the collection and distribution of the WAIS Divide ice core (K. Taylor, NSF grants 0230396, 0440817, 0944348, and 0944266-University of New Hampshire); NSF OPP, which funds the Ice Drilling Program Office and Ice Drilling Design and Operations group for coring activities; NSF, which funds the National Ice Core Laboratory, which curated and processed the core; Raytheon Polar Services, which provided logistics support in Antarctica; and the 109th New York Air National Guard for airlift in Antarctica. Data and description can be downloaded from the NOAA National Climate Data Center (www.ncdc.noaa.gov/paleo/paleo.html). EBAMM model code is archived with L.E.M.'s thesis (31), available online at http://ir.library.oregonstate.edu/xmlui/handle/1957/37906.	Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fudge TJ, 2013, NATURE, V500, P440, DOI 10.1038/nature12376; Fuller DQ, 2011, HOLOCENE, V21, P743, DOI 10.1177/0959683611398052; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Houweling S, 2000, J GEOPHYS RES-ATMOS, V105, P17243, DOI 10.1029/2000JD900193; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; KHALIL MAK, 1983, J GEOPHYS RES-OCEANS, V88, P5131, DOI 10.1029/JC088iC09p05131; Konijnendijk TYM, 2011, CLIM PAST, V7, P635, DOI 10.5194/cp-7-635-2011; Lassey KR, 2007, ATMOS CHEM PHYS, V7, P2119, DOI 10.5194/acp-7-2119-2007; Macfarlane DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025005; Marik T., 1998, THESIS U HEIDELBERG; Mitchell L. E., 2013, THESIS OREGON STATE; Mitchell LE, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001441; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Naik V, 2013, ATMOS CHEM PHYS, V13, P5277, DOI 10.5194/acp-13-5277-2013; NAKAZAWA T, 1993, GEOPHYS RES LETT, V20, P943, DOI 10.1029/93GL00776; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Ruddiman WF, 2011, HOLOCENE, V21, P865, DOI 10.1177/0959683610387172; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Ruddiman WF, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000207; Ruddiman WF, 2008, QUATERNARY SCI REV, V27, P1291, DOI 10.1016/j.quascirev.2008.03.007; Ruddiman WF, 2009, QUATERNARY SCI REV, V28, P3011, DOI 10.1016/j.quascirev.2009.05.022; Sapart CJ, 2012, NATURE, V490, P85, DOI 10.1038/nature11461; Singarayer JS, 2011, NATURE, V470, P82, DOI 10.1038/nature09739; Wang XF, 2006, QUATERNARY SCI REV, V25, P3391, DOI 10.1016/j.quascirev.2006.02.009	30	60	60	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					964	966		10.1126/science.1238920	http://dx.doi.org/10.1126/science.1238920			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264988				2022-12-28	WOS:000327223500039
J	Banito, A; Lowe, SW				Banito, Ana; Lowe, Scott W.			A New Development in Senescence	CELL			English	Editorial Material							FIBROSIS; CANCER	Cellular senescence is implicated in several pathological responses in the adult, with important repercussions in tumor suppression, wound healing, and aging. Two studies by Munoz-Espin et al. and Storer et al. now reveal that senescence contributes to embryonic development, suggesting a primordial role in normal physiology.	[Banito, Ana; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	lowes@mskcc.org	Banito, Ana/P-6168-2017	Banito, Ana/0000-0003-2188-0003	NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG016379, R01AG016379] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA013106, P30 CA008748] Funding Source: Medline; NIA NIH HHS [AG16379, R01 AG016379, R56 AG016379] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Nacher V, 2006, J VASC RES, V43, P581, DOI 10.1159/000096076; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	10	38	38	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					977	978		10.1016/j.cell.2013.10.050	http://dx.doi.org/10.1016/j.cell.2013.10.050			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267881	Green Accepted, Bronze			2022-12-28	WOS:000327500600001
J	Sutherland, WJ; Spiegelhalter, D; Burgman, MA				Sutherland, William J.; Spiegelhalter, David; Burgman, Mark A.			Twenty tips for interpreting scientific claims	NATURE			English	Editorial Material							RISK		[Sutherland, William J.] Univ Cambridge, Dept Zool, Cambridge CB2 1TN, England; [Spiegelhalter, David] Univ Cambridge, Ctr Math Sci, Cambridge CB2 1TN, England; [Burgman, Mark A.] Univ Melbourne, Sch Bot, Ctr Excellence Biosecur Risk Anal, Parkville, Vic 3052, Australia	University of Cambridge; University of Cambridge; University of Melbourne	Sutherland, WJ (corresponding author), Univ Cambridge, Dept Zool, Cambridge CB2 1TN, England.	wjs32@cam.ac.uk		Sutherland, William/0000-0002-6498-0437; Burgman, Mark/0000-0003-0435-4829				Allan N, 1984, RELIABILITY EVALUATI, Vsecond, DOI DOI 10.1007/978-1-4615-7731-7; Borsuk ME, 2003, J WATER RES PL-ASCE, V129, P271, DOI 10.1061/(ASCE)0733-9496(2003)129:4(271); Doubleday R, 2012, NATURE, V485, P301, DOI 10.1038/485301a; Fidler F., 2004, J SOCIO-ECON, V33, P615, DOI [10.1016/j.socec.2004.09.035, DOI 10.1016/J.SOCEC.2004.09.035]; FISCHHOFF B, 1982, AM STAT, V36, P240, DOI 10.2307/2683835; HUSKISSON EC, 1974, BMJ-BRIT MED J, V4, P196, DOI 10.1136/bmj.4.5938.196; Marvier M, 2002, ECOL APPL, V12, P1119, DOI 10.1890/1051-0761(2002)012[1119:IRAFNS]2.0.CO;2; Maslova E, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.5; Millar RB, 2004, FISH RES, V70, P397, DOI 10.1016/j.fishres.2004.08.016	9	70	72	154	1048	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					335	337		10.1038/503335a	http://dx.doi.org/10.1038/503335a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24273799	Bronze			2022-12-28	WOS:000327163200018
J	Wehrli, B				Wehrli, Bernhard			BIOGEOCHEMISTRY Conduits of the carbon cycle	NATURE			English	Editorial Material									[Wehrli, Bernhard] ETH, Inst Biogeochem & Pollutant Dynam, CH-8092 Zurich, Switzerland; [Wehrli, Bernhard] Swiss Fed Inst Aquat Sci & Technol, Kastanienbaum, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Wehrli, B (corresponding author), ETH, Inst Biogeochem & Pollutant Dynam, CH-8092 Zurich, Switzerland.	bernhard.wehrli@eawag.ch	Wehrli, Bernhard/B-4420-2008; Wehrli, Bernhard/A-4406-2013; Wehrli, Bernhard/M-3847-2019	Wehrli, Bernhard/0000-0001-7029-1972; Wehrli, Bernhard/0000-0001-7029-1972; Wehrli, Bernhard/0000-0001-7029-1972				Abril G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002457; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Feng XJ, 2013, P NATL ACAD SCI USA, V110, P14168, DOI 10.1073/pnas.1307031110; Raymond P.A., 2012, LIMNOL OCEANOGR FLUI, V2, P41, DOI [10.1215/21573689-1597669, DOI 10.1215/21573689-1597669]; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Stumm W, 1995, AQUATIC CHEM CHEM EQ, V3rd, DOI [DOI 10.1094/ASBCMOA-BEER-13, 10.1094/asbcmoa-beer-13]; Tockner K, 2009, RIVERS OF EUROPE, 1ST EDITION, P1; Zurbrugg R, 2013, BIOGEOSCIENCES, V10, P23, DOI 10.5194/bg-10-23-2013	10	47	54	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					346	347		10.1038/503346a	http://dx.doi.org/10.1038/503346a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24256800				2022-12-28	WOS:000327163200027
J	Abed, HS; Wittert, GA; Leong, DP; Shirazi, MG; Bahrami, B; Middeldorp, ME; Lorimer, MF; Lau, DH; Antic, NA; Brooks, AG; Abhayaratna, WP; Kalman, JM; Sanders, P				Abed, Hany S.; Wittert, Gary A.; Leong, Darryl P.; Shirazi, Masoumeh G.; Bahrami, Bobak; Middeldorp, Melissa E.; Lorimer, Michelle F.; Lau, Dennis H.; Antic, Nicholas A.; Brooks, Anthony G.; Abhayaratna, Walter P.; Kalman, Jonathan M.; Sanders, Prashanthan			Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; QUALITY-OF-LIFE; ALCOHOL-CONSUMPTION; BLOOD-PRESSURE; SINUS RHYTHM; OBESITY; RECOMMENDATIONS; HYPERTENSION; PERFORMANCE; MECHANISMS	IMPORTANCE Obesity is a risk factor for atrial fibrillation. Whether weight reduction and cardiometabolic risk factor management can reduce the burden of atrial fibrillation is not known. OBJECTIVE To determine the effect of weight reduction and management of cardiometabolic risk factors on atrial fibrillation burden and cardiac structure. DESIGN, SETTING, AND PATIENTS Single-center, partially blinded, randomized controlled study conducted between June 2010 and December 2011 in Adelaide, Australia, among overweight and obese ambulatory patients (N = 150) with symptomatic atrial fibrillation. Patients underwent a median of 15 months of follow-up. INTERVENTIONS Patients were randomized to weight management (intervention) or general lifestyle advice (control). Both groups underwent intensive management of cardiometabolic risk factors. MAIN OUTCOMES AND MEASURES The primary outcomes were Atrial Fibrillation Severity Scale scores: symptom burden and symptom severity. Scores were measured every 3 months from baseline to 15 months. Secondary outcomes performed at baseline and 12 months were total atrial fibrillation episodes and cumulative duration measured by 7-day Holter, echocardiographic left atrial area, and interventricular septal thickness. RESULTS Of 248 patients screened, 150 were randomized (75 per group) and underwent follow-up. The intervention group showed a significantly greater reduction, compared with the control group, in weight (14.3 and 3.6 kg, respectively; P<.001) and in atrial fibrillation symptom burden scores (11.8 and 2.6 points, P<.001), symptom severity scores (8.4 and 1.7 points, P<.001), number of episodes (2.5 and no change, P=.01), and cumulative duration (692-minute decline and 419-minute increase, P=.002). Additionally, there was a reduction in interventricular septal thickness in the intervention and control groups (1.1 and 0.6 mm, P=.02) and left atrial area (3.5 and 1.9 cm(2), P=.02). CONCLUSIONS AND RELEVANCE In this study, weight reduction with intensive risk factor management resulted in a reduction in atrial fibrillation symptom burden and severity and in beneficial cardiac remodeling. These findings support therapy directed at weight and risk factors in the management of atrial fibrillation.	[Abed, Hany S.; Leong, Darryl P.; Shirazi, Masoumeh G.; Bahrami, Bobak; Middeldorp, Melissa E.; Lau, Dennis H.; Brooks, Anthony G.; Sanders, Prashanthan] Univ Adelaide, Ctr Heart Rhythm Disorders, Adelaide, SA, Australia; [Abed, Hany S.; Wittert, Gary A.; Leong, Darryl P.; Shirazi, Masoumeh G.; Bahrami, Bobak; Middeldorp, Melissa E.; Lau, Dennis H.; Brooks, Anthony G.; Sanders, Prashanthan] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Abed, Hany S.; Wittert, Gary A.] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia; [Lorimer, Michelle F.] Univ Adelaide, Data Management & Anal Ctr, Sch Populat Hlth & Clin Practice, Adelaide, SA, Australia; [Antic, Nicholas A.] Repatriat Gen Hosp, Adelaide Inst Sleep Hlth, Adelaide, SA, Australia; [Abhayaratna, Walter P.] Australian Natl Univ, Coll Med Biol & Environm, Canberra, ACT, Australia; [Abhayaratna, Walter P.] Canberra Hosp, Canberra, ACT, Australia; [Kalman, Jonathan M.] Univ Melbourne, Royal Melbourne Hosp, Dept Cardiol, Melbourne, Vic 3050, Australia; [Kalman, Jonathan M.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	University of Adelaide; Royal Adelaide Hospital; University of Adelaide; University of Adelaide; Flinders University South Australia; Australian National University; Australian National University; Canberra Hospital; Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Sanders, P (corresponding author), Royal Adelaide Hosp, Dept Cardiol, Ctr Heart Rhythm Disorders, Adelaide, SA 5000, Australia.	prash.sanders@adelaide.edu.au	Middeldorp, Melissa/C-6414-2019; Lau, Dennis H/G-6234-2013; wittert, gary/AAE-2398-2019; Sanders, Prashanthan/D-7641-2013	Middeldorp, Melissa/0000-0002-4106-9771; Lau, Dennis H/0000-0001-7753-1318; Sanders, Prashanthan/0000-0003-3803-8429; Lorimer, Michelle/0000-0003-3785-4395; Wittert, Gary/0000-0001-6818-6065; Abhayaratna, Walter/0000-0002-4908-0641	University of Adelaide; Centre of Heart Rhythm Disorders at the University of Adelaide; Prima Health Solutions Pty Ltd. Prima Health Solutions; Abbott Australia	University of Adelaide; Centre of Heart Rhythm Disorders at the University of Adelaide; Prima Health Solutions Pty Ltd. Prima Health Solutions; Abbott Australia(Abbott Laboratories)	This study was sponsored by the University of Adelaide. It was supported by funds from the Centre of Heart Rhythm Disorders at the University of Adelaide. The meal replacements were provided without cost by Prima Health Solutions Pty Ltd. Prima Health Solutions had no other involvement in the study. OBEMAN was developed by Dr Wittert with funding from Abbott Australia. The IP for the software is fully held by Dr Wittert and was used without the payment of any license fees.	Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; BONNET MH, 1992, SLEEP, V15, P526; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Cocco G, 2011, J CLIN HYPERTENS, V13, P23, DOI 10.1111/j.1751-7176.2010.00380.x; Coyne KS, 2006, VALUE HEALTH, V9, P348, DOI 10.1111/j.1524-4733.2006.00124.x; Dimitri H, 2012, HEART RHYTHM, V9, P321, DOI 10.1016/j.hrthm.2011.10.017; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Dorian P, 2000, J AM COLL CARDIOL, V36, P1303, DOI 10.1016/S0735-1097(00)00886-X; Elobeid MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006624; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Fontes JD, 2012, AM J CARDIOL, V109, P87, DOI 10.1016/j.amjcard.2011.08.008; Gottdiener JS, 1998, CIRCULATION, V98, P140, DOI 10.1161/01.CIR.98.2.140; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1; Khoo J, 2010, INT J OBESITY, V34, P1396, DOI 10.1038/ijo.2010.76; KLATSKY AL, 1977, NEW ENGL J MED, V296, P1194, DOI 10.1056/NEJM197705262962103; Kodama S, 2011, J AM COLL CARDIOL, V57, P427, DOI 10.1016/j.jacc.2010.08.641; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Madrid AH, 2002, CIRCULATION, V106, P331, DOI 10.1161/01.CIR.0000022665.18619.83; Marcus GM, 2008, PACE, V31, P266, DOI 10.1111/j.1540-8159.2008.00985.x; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Munger TM, 2012, J AM COLL CARDIOL, V60, P851, DOI 10.1016/j.jacc.2012.03.042; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Pena JM, 2012, EUR HEART J, V33, P531, DOI 10.1093/eurheartj/ehr460; Russo C, 2011, J AM COLL CARDIOL, V57, P1368, DOI 10.1016/j.jacc.2010.10.042; Singh SN, 2006, J AM COLL CARDIOL, V48, P721, DOI 10.1016/j.jacc.2006.03.051; Stritzke J, 2009, J AM COLL CARDIOL, V54, P1982, DOI 10.1016/j.jacc.2009.07.034; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Tsang TSM, 2008, EUR HEART J, V29, P2227, DOI 10.1093/eurheartj/ehn324; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wachtell K, 2005, J AM COLL CARDIOL, V45, P712, DOI 10.1016/j.jacc.2004.10.068; Wachtell K, 2010, BLOOD PRESSURE, V19, P169, DOI 10.3109/08037051.2010.481811; Wanahita N, 2008, AM HEART J, V155, P310, DOI 10.1016/j.ahj.2007.10.004; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wong CX, 2011, J AM COLL CARDIOL, V57, P1745, DOI 10.1016/j.jacc.2010.11.045; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017	42	548	560	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2050	2060		10.1001/jama.2013.280521	http://dx.doi.org/10.1001/jama.2013.280521			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240932	Bronze			2022-12-28	WOS:000327098900021
J	Oldham, J				Oldham, John			Reform reform: an essay by John Oldham	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Global Hlth Innovat, London SW7 2AZ, England	Imperial College London	Oldham, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Global Hlth Innovat, London SW7 2AZ, England.	john.oldham@quest4quality.co.uk						[Anonymous], 2012, FIN REP MID STAFF NH; *DEP HLTH, NHS PLAN 2000; Department of Health, LONG TERM COND STRAT; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Oldham J, 2009, JAMA-J AM MED ASSOC, V301, P965, DOI 10.1001/jama.2009.228; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; Smith R, 2013, MED J COLOSSAL PROBL	7	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6716	10.1136/bmj.f6716	http://dx.doi.org/10.1136/bmj.f6716			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KF	24259323				2022-12-28	WOS:000327457400003
J	Hazel, J; Krutkramelis, K; Mooney, P; Tomschik, M; Gerow, K; Oakey, J; Gatlin, JC				Hazel, James; Krutkramelis, Kaspars; Mooney, Paul; Tomschik, Miroslav; Gerow, Ken; Oakey, John; Gatlin, J. C.			Changes in Cytoplasmic Volume Are Sufficient to Drive Spindle Scaling	SCIENCE			English	Article							MITOTIC SPINDLE; MICROTUBULE ASTERS; CELL; TRANSITION; POSITION; GROWTH; SIZE	The mitotic spindle must function in cell types that vary greatly in size, and its dimensions scale with the rapid, reductive cell divisions that accompany early stages of development. The mechanism responsible for this scaling is unclear, because uncoupling cell size from a developmental or cellular context has proven experimentally challenging. We combined microfluidic technology with Xenopus egg extracts to characterize spindle assembly within discrete, geometrically defined volumes of cytoplasm. Reductions in cytoplasmic volume, rather than developmental cues or changes in cell shape, were sufficient to recapitulate spindle scaling observed in Xenopus embryos. Thus, mechanisms extrinsic to the spindle, specifically a limiting pool of cytoplasmic component(s), play a major role in determining spindle size.	[Hazel, James; Mooney, Paul; Tomschik, Miroslav; Gatlin, J. C.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Krutkramelis, Kaspars; Oakey, John] Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA; [Gerow, Ken] Univ Wyoming, Dept Stat, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming; University of Wyoming	Gatlin, JC (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	jgatlin@uwyo.edu	, Miroslav/AAD-9416-2020	, Miroslav/0000-0002-0758-6169; Gatlin, Jesse/0000-0002-5417-225X	NIH [R01 GM102428, R15 GM101636, P20RR016474, P20GM103432]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102428, R15GM101636, P20GM103432] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Salmon and T. Mitchison for their insightful reviews of the manuscript; M. Wuhr for comments on the work and for providing access to raw data originally presented in (2); L. Edens, C. Geisler, D. Fay, and D. Levy in the Molecular Biology Department at the University of Wyoming for their critical review of the manuscript and helpful suggestions; and A. Groen for providing labeled anti-NuMA used in these studies. This work was supported by NIH grants R01 GM102428 (to J.C.G.) and R15 GM101636 (to J.O.) and by the NIH-funded Wyoming IDeA Networks of Biomedical Research Excellence program (P20RR016474 and P20GM103432).	Bird SL, 2013, MOL BIOL CELL, V24, P2506, DOI 10.1091/mbc.E13-03-0150; Chan YHM, 2010, ORGANOGENESIS, V6, P88, DOI 10.4161/org.6.2.11464; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Decker M, 2011, CURR BIOL, V21, P1259, DOI 10.1016/j.cub.2011.06.002; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Gatlin JC, 2009, CURR BIOL, V19, P287, DOI 10.1016/j.cub.2009.01.055; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; Hara Y, 2009, CURR BIOL, V19, P1549, DOI 10.1016/j.cub.2009.07.050; Holy TE, 1997, P NATL ACAD SCI USA, V94, P6228, DOI 10.1073/pnas.94.12.6228; Hyman A. A., 2008, NOVART FDN SYMP, V237, P164; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Ludington WB, 2012, CURR BIOL, V22, P2173, DOI 10.1016/j.cub.2012.09.040; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Mitchison T, 2012, CYTOSKELETON, V69, P738, DOI 10.1002/cm.21050; Montorzi M, 2000, MOL REPROD DEV, V55, P75, DOI 10.1002/(SICI)1098-2795(200001)55:1<75::AID-MRD10>3.0.CO;2-Z; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Tolic-Norrelykke IM, 2004, CURR BIOL, V14, P1181, DOI 10.1016/j.cub.2004.06.029; Wilbur JD, 2013, ELIFE, V2, DOI 10.7554/eLife.00290; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Wuhr M, 2009, CELL CYCLE, V8, P1115; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024	25	134	135	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					853	856		10.1126/science.1243110	http://dx.doi.org/10.1126/science.1243110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233723	Green Accepted			2022-12-28	WOS:000326923000037
J	Hooton, TM; Roberts, PL; Cox, ME; Stapleton, AE				Hooton, Thomas M.; Roberts, Pacita L.; Cox, Marsha E.; Stapleton, Ann E.			Voided Midstream Urine Culture and Acute Cystitis in Premenopausal Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE UNCOMPLICATED CYSTITIS; TRACT-INFECTIONS; URETHRAL SYNDROME; BACTERIURIA; PYELONEPHRITIS; CIPROFLOXACIN; EPIDEMIOLOGY; DIAGNOSIS	Background The cause of acute uncomplicated cystitis is determined on the basis of cultures of voided midstream urine, but few data guide the interpretation of such results, especially when gram-positive bacteria grow. Methods Women from 18 to 49 years of age with symptoms of cystitis provided specimens of midstream urine, after which we collected urine by means of a urethral catheter for culture (catheter urine). We compared microbial species and colony counts in the paired specimens. The primary outcome was a comparison of positive predictive values and negative predictive values of organisms grown in midstream urine, with the presence or absence of the organism in catheter urine used as the reference. Results The analysis of 236 episodes of cystitis in 226 women yielded 202 paired specimens of midstream urine and catheter urine that could be evaluated. Cultures were positive for uropathogens in 142 catheter specimens (70%), 4 of which had more than one uropathogen, and in 157 midstream specimens (78%). The presence of Escherichia coli in midstream urine was highly predictive of bladder bacteriuria even at very low counts, with a positive predictive value of 102 colony-forming units (CFU) per milliliter of 93% (Spearman's r = 0.944). In contrast, in midstream urine, enterococci (in 10% of cultures) and group B streptococci (in 12% of cultures) were not predictive of bladder bacteriuria at any colony count (Spearman's r = 0.322 for enterococci and 0.272 for group B streptococci). Among 41 episodes in which enterococcus, group B streptococci, or both were found in midstream urine, E. coli grew from catheter urine cultures in 61%. Conclusions Cultures of voided midstream urine in healthy premenopausal women with acute uncomplicated cystitis accurately showed evidence of bladder E. coli but not of enterococci or group B streptococci, which are often isolated with E. coli but appear to rarely cause cystitis by themselves.	[Hooton, Thomas M.] Univ Miami, Sch Med, Dept Med, Miami, FL USA; [Roberts, Pacita L.; Cox, Marsha E.; Stapleton, Ann E.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	University of Miami; University of Washington; University of Washington Seattle	Hooton, TM (corresponding author), Dept Med, Clin Res Bldg,1120 NW 14th St,Suite 853, Miami, FL 33136 USA.	thooton@med.miami.edu	Stapleton, Ann E/N-2428-2015	Stapleton, Ann E/0000-0003-0130-8659	National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK088830, P01 DK053369, ORWH SCOR P50 DK064540]; Merck; Pinnacle Pharmaceuticals; National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088830, P50DK064540, P01DK053369] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Merck(Merck & Company); Pinnacle Pharmaceuticals; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.	Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Barr Richard H., 1948, CALIFORNIA MED, V68, P437; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; Cai T, 2009, J CHEMOTHERAPY, V21, P535, DOI 10.1179/joc.2009.21.5.535; CURRAN JW, 1977, SEX TRANSM DIS, V4, P119, DOI 10.1097/00007435-197707000-00012; FIHN SD, 1988, J INFECT DIS, V157, P196, DOI 10.1093/infdis/157.1.196; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; GALLAGHER DJ, 1965, BMJ-BRIT MED J, V1, P622, DOI 10.1136/bmj.1.5435.622; Gupta K, 2001, ANN INTERN MED, V135, P9, DOI 10.7326/0003-4819-135-1-200107030-00004; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Hooton TM, 2012, JAMA-J AM MED ASSOC, V307, P583, DOI 10.1001/jama.2012.80; Hooton TM, 2005, JAMA-J AM MED ASSOC, V293, P949, DOI 10.1001/jama.293.8.949; Kahlmeter G, 2003, INT J ANTIMICROB AG, V22, pS49, DOI 10.1016/S0924-8579(03)00229-2; Kallen AJ, 2006, ARCH INTERN MED, V166, P635, DOI 10.1001/archinte.166.6.635; Kass, 1960, BIOLOGY PYELONEPHRIT, P399; KASS EH, 1956, T ASSOC AM PHYSICIAN, V69, P56; KASS EH, 1960, ARCH INTERN MED, V105, P194, DOI 10.1001/archinte.1960.00270140016003; KASS EH, 1962, ANN INTERN MED, V56, P46, DOI 10.7326/0003-4819-56-1-46; Little P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c199; MABECK CE, 1969, ACTA MED SCAND, V186, P35; Marple CD, 1941, ANN INTERN MED, V14, P2220, DOI 10.7326/0003-4819-14-12-2220; Matsumoto T, 2012, J INFECT CHEMOTHER, V18, P597, DOI 10.1007/s10156-012-0419-2; McIsaac Warren J, 2008, Can J Infect Dis Med Microbiol, V19, P287; MONZON OT, 1958, NEW ENGL J MED, V259, P764, DOI 10.1056/NEJM195810162591603; Naber KG, 2008, EUR UROL, V54, P1164, DOI 10.1016/j.eururo.2008.05.010; NORDEN CW, 1968, ANNU REV MED, V19, P431, DOI 10.1146/annurev.me.19.020168.002243; Ronald A, 2002, AM J MED, V113, p14S; SANFORD JP, 1956, AM J MED, V20, P88, DOI 10.1016/0002-9343(56)90175-9; Schappert Susan M, 2011, Vital Health Stat 13, P1; STAMEY TA, 1971, CALIF MED, V115, P1; STAMM WE, 1980, NEW ENGL J MED, V303, P409, DOI 10.1056/NEJM198008213030801; STAMM WE, 1982, NEW ENGL J MED, V307, P463, DOI 10.1056/NEJM198208193070802; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11	34	157	167	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1883	1891		10.1056/NEJMoa1302186	http://dx.doi.org/10.1056/NEJMoa1302186			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300MP	24224622	Green Accepted			2022-12-28	WOS:000330468300007
J	Guest, JA; Quincy, L				Guest, James A.; Quincy, Lynn			Consumers Gaining Ground in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Guest, James A.] Consumer Reports, Yonkers, NY 10703 USA; [Quincy, Lynn] Consurmer Reports, Washington, DC USA		Guest, JA (corresponding author), Consumer Reports, 101 Truman Ave, Yonkers, NY 10703 USA.	jguest@consumer.org						James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Millman J., 2013, POLITICO PAVIA  0319; Quincy L., 2012, WHATS DOOR CONSUMERS; Quincy L., 2013, EARLY EXPERIENCE NEW; The American College of Obstetricians and Gynecologists Committee on Obstetric Practice the Society for Maternal-Fetal Medicine, 2013, NONM IND EARL TERM D, P561	5	6	6	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1939	1940		10.1001/jama.2013.282000	http://dx.doi.org/10.1001/jama.2013.282000			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219947				2022-12-28	WOS:000326832900016
J	Jones, K; Saxon, L; Cunningham, W; Adams, P				Jones, Katie; Saxon, Leanne; Cunningham, William; Adams, Phil		Guideline Dev Grp	Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jones, Katie; Saxon, Leanne] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Cunningham, William] Hadrian Primary Care Alliance, Corbridge, England; [Adams, Phil] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England	Royal College of Physicians; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Jones, K (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	katie.jones@rcplondon.ac.uk						[Anonymous], 2007, SEC PREV PRIM SEC CA; British Medical Association Royal Pharmaceutical Society of Great Britain, 2013, 66 BMA RPS; National Institute for Health and Care Excellence, 2013, MYOC INF ST SEGM EL; National Institute for Health and Care Excellence, 2010, CLOP MOD REL DIP PRE; National Institute for Health and Care Excellence, 2009, PRAS TREATM AC COR S; National Institute for Health and Care Excellence, QUAL OUTC FRAM NICE; National Institute for Health and Care Excellence, 2011, TIC TREATM AC COR SY; National Institute for Health and Care Excellence, 2004, DYSP MAN DYSP AD PRI; National Institute for Health and Care Excellence, 2006, OB PREV ID ASS MAN O; National Institute for Health and Care Excellence, 2013, SEC PREV PRIM SEC CA; National Institute for Health and Care Excellence, 2004, CLOP TREATM NON ST S, V80; National Institute for Health and Care Excellence, 2010, UNST ANG NSTEMI EARL; National Institute for Health and Care Excellence, 2008, CARD RISK ASS MOD BL; National Institute for Health and Care Excellence, 2006, BRIEF INT REF SMOK C BRIEF INT REF SMOK C	14	27	28	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2013	347								f6544	10.1136/bmj.f6544	http://dx.doi.org/10.1136/bmj.f6544			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254GO	24227827				2022-12-28	WOS:000327153200001
J	Panzer, RJ; Gitomer, RS; Greene, WH; Webster, PR; Landry, KR; Riccobono, CA				Panzer, Robert J.; Gitomer, Richard S.; Greene, William H.; Webster, Patricia Reagan; Landry, Kevin R.; Riccobono, Charles A.			Increasing Demands for Quality Measurement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE	Measurement of health care quality and patient safety is rapidly evolving, in response to long-term needs and more recent efforts to reform the US health system around "value." Development and choice of quality measures is now guided by a national quality strategy and priorities, with a public-private partnership, the National Quality Forum, helping determine the most worthwhile measures for evaluating and rewarding quality and safety of patient care. Yet there remain a number of challenges, including diverse purposes for quality measurement, limited availability of true clinical measures leading to frequent reliance on claims data with its flaws in determining quality, fragmentation of measurement systems with redundancy and conflicting conclusions, few high-quality comprehensive measurement systems and registries, and rapid expansion of required measures with hundreds of measures straining resources. The proliferation of quality measures at the clinician, hospital, and insurer level has created challenges and logistical problems. Recommendations include raising the bar for qualtiy measurements to achieve transformational rather than incremental change in the US quality measurement system, promoting a logical set of measures for the various levels of the health system, leaving room for internal organizational improvement, harmonizing the various national and local quality measurement systems, anchoring on National Quality Forum additions and subtractions of measures to be applied, reducing reliance on and retiring claims-based measures as quickly as possible, promoting comprehensive measurement such as through registries with deep understanding of patient risk factors and outcomes, reducing attention to proprietary report cards, prompt but careful transition to measures from electronic health records, and allocation of sufficient resources to accomplish the goals of an efficient, properly focused measurement system.	[Panzer, Robert J.] Univ Rochester, Med Ctr, Dept Med, Div Gen Med, Rochester, NY 14642 USA; [Panzer, Robert J.; Webster, Patricia Reagan] Univ Rochester, Med Ctr, Dept Publ Hlth Sci, Div Healthcare Management, Rochester, NY 14642 USA; [Gitomer, Richard S.] Emory Healthcare Network, Atlanta, GA USA; [Gitomer, Richard S.] Emory Univ, Sch Med, Atlanta, GA USA; [Greene, William H.; Landry, Kevin R.] Med Ctr Insurance Co, New York, NY USA; [Greene, William H.] SUNY Stony Brook, Sch Med, Dept Med, Stony Brook, NY 11794 USA; [Riccobono, Charles A.] Hackensack Univ, Med Ctr, Hackensack, NJ USA	University of Rochester; University of Rochester; Emory University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hackensack University Medical Center	Panzer, RJ (corresponding author), Univ Rochester, Med Ctr, Dept Med, 601 Elmwood Ave,Box 612, Rochester, NY 14642 USA.	robert_panzer@urmc.rochester.edu						American Heart Association, GET GUID HEART FAIL; [Anonymous], EL PROF MEAN US TABL; [Anonymous], 2013, TEACH QUAL REP; [Anonymous], 2011, ACCOUNTABILITY MEASU; [Anonymous], 2011, NATL STRATEGY QUALIT; Berenson RA, 2013, ACHIEVING POTENTIAL, P1; Berwick DM, 2003, MED CARE, V41, pI30; Centers for Medicare and Medicaid Services, PHYS QUAL REP SYST; Centers for Medicare & Medicaid Services, 2012, HOSP INP QUAL REP IQ; Centers for Medicare & Medicaid Services, 2012, FED REGISTER, V77, P53554; Centers for Medicare & Medicaid Services, EL HOSP CAH MEAN US; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; *CTR MED MED SERV, HOSP ACQ COND HAC AC; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; ELLWOOD PM, 1988, NEW ENGL J MED, V318, P1549, DOI 10.1056/NEJM198806093182329; Federman AD, 2011, HEALTH POLICY, V102, P229, DOI 10.1016/j.healthpol.2011.05.003; Glance LG, 2011, ANESTH ANALG, V112, P958, DOI 10.1213/ANE.0b013e31820e778d; Halasyamani LK, 2007, CONFLICTING MEASURES; HANYS, 2013, HANYS REP CARD HOSP; Hospital Association of New York State, 2008, HANYS REP CARD HOSP; IEZZONI LI, 1995, ANN INTERN MED, V123, P763, DOI 10.7326/0003-4819-123-10-199511150-00004; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Institute of Medicine, 2000, ERR IS HUMAN BUILDIN; Kaafarani HMA, 2011, J AM COLL SURGEONS, V212, P924, DOI 10.1016/j.jamcollsurg.2010.07.007; Lilford R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2016; Malenka D J, 1998, Jt Comm J Qual Improv, V24, P594; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Meyer GS, 2012, BMJ QUAL SAF, V21, P964, DOI 10.1136/bmjqs-2012-001081; National Quality Forum, ABCS MEAS; National Quality Forum, 2012 NQF REP C; National Quality Forum, CONS FOC PUBL REP NA; National Research Council, 1994, AM HLTH TRANS PROT I; Nelson EC, 2008, JT COMM J QUAL PATIE, V34, P367, DOI 10.1016/S1553-7250(08)34047-1; Neuhauser D, 1990, Int J Technol Assess Health Care, V6, P307; New York State Department of Health, CARD DIS DAT STAT; New York State Department of Health, HOSP ACQ INF HAI RAT; New York State Department of Health, TRAUM SYST REP; Pronovost PJ, 2007, JAMA-J AM MED ASSOC, V298, P1800, DOI 10.1001/jama.298.15.1800; Pronovost PJ, 2011, HEALTH AFFAIR, V30, P569, DOI 10.1377/hlthaff.2011.0049; Rau J., 2013, KAISER HLTH NEW 0318; Rothberg MB, 2008, HEALTH AFFAIR, V27, P1680, DOI 10.1377/hlthaff.27.6.1680; Schmaltz SP, 2011, J HOSP MED, V6, P454, DOI 10.1002/jhm.905; The Joint Commission, 2013, FACTS ORYX HOSP NAT	43	100	100	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1971	1980		10.1001/jama.2013.282047	http://dx.doi.org/10.1001/jama.2013.282047			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219953				2022-12-28	WOS:000326832900022
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: gabapentin and pregabalin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MISUSE											Centers for Disease Control and Prevention (CDC), 2013, POL IMP PRESCR PAINK; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Maskell PD, 2013, BMJ; Millar J, 2013, EMERG MED J, V30, P874, DOI DOI 10.1136/EMERMED-2013-203113.20; Moore RA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007938.pub2; Moore RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007076.pub2; Moore RA, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD008242.PUB2; NICE CfCPa, 2010, NEUR PAIN PHARM MAN; Schifano F, 2011, PSYCHOTHER PSYCHOSOM, V80, P118, DOI 10.1159/000321079; Smith BH, 2012, BRIT J GEN PRACT, V62, P406, DOI 10.3399/bjgp12X653516; US Drug Enforcement Agency (DEA), DRUG SCHED; Wiffen PJ, 2013, COCHRANE DB SYST REV, V6	14	25	27	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2013	347								f6747	10.1136/bmj.f6747	http://dx.doi.org/10.1136/bmj.f6747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XT	24212252				2022-12-28	WOS:000326890800014
J	Yu, XF; Rollins, D; Ruhn, KA; Stubblefield, JJ; Green, CB; Kashiwada, M; Rothman, PB; Takahashi, JS; Hooper, LV				Yu, Xiaofei; Rollins, Darcy; Ruhn, Kelly A.; Stubblefield, Jeremy J.; Green, Carla B.; Kashiwada, Masaki; Rothman, Paul B.; Takahashi, Joseph S.; Hooper, Lora V.			T(H)17 Cell Differentiation Is Regulated by the Circadian Clock	SCIENCE			English	Article							REV-ERB-ALPHA; T-HELPER-CELLS; TRANSCRIPTION; ARCHITECTURE; HOMEOSTASIS; MICROBIOTA; MAMMALS; E4BP4; GENE	Circadian clocks regulate numerous physiological processes that vary across the day-night (diurnal) cycle, but if and how the circadian clock regulates the adaptive immune system is mostly unclear. Interleukin-17-producing CD4(+) T helper (T(H)17) cells are proinflammatory immune cells that protect against bacterial and fungal infections at mucosal surfaces. Their lineage specification is regulated by the orphan nuclear receptor ROR gamma t. We show that the transcription factor NFIL3 suppresses T(H)17 cell development by directly binding and repressing the Ror gamma t promoter. NFIL3 links T(H)17 cell development to the circadian clock network through the transcription factor REV-ERB alpha. Accordingly, T(H)17 lineage specification varies diurnally and is altered in Rev-erba(-/-) mice. Light-cycle disruption elevated intestinal T(H)17 cell frequencies and increased susceptibility to inflammatory disease. Thus, lineage specification of a key immune cell is under direct circadian control.	[Yu, Xiaofei; Rollins, Darcy; Ruhn, Kelly A.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Stubblefield, Jeremy J.; Green, Carla B.; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Kashiwada, Masaki; Rothman, Paul B.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Takahashi, Joseph S.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012; Yu, Xiaofei/J-9245-2017; yu, Xiaofei/E-7100-2011; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Yu, Xiaofei/0000-0002-1712-331X; Takahashi, Joseph S./0000-0003-0384-8878	NIH [R01 DK070855]; Burroughs Wellcome Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24590088] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank C. Behrendt, C. Clements, and S. Murray for assistance with mouse experiments. M. Izumo provided advice and assistance with the circadian cycle experiments, and B. Li for help with the EMSA. We also thank F. Yarovinsky for critical reading of the manuscript. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. The MODE-K cells were supplied to the authors under a materials transfer agreement from Inserm. J.S.T. is cofounder, scientific advisory board member and paid consultant of Reset Therapeutics, Inc., a biotech company working on circadian rhythms and metabolism. This work was supported by NIH R01 DK070855 (L.V.H.), a Burroughs Wellcome Foundation New Investigators in the Pathogenesis of Infectious Diseases Award (L.V.H.), and the Howard Hughes Medical Institute (J.S.T. and L.V.H.).	Arjona A, 2012, TRENDS IMMUNOL, V33, P607, DOI 10.1016/j.it.2012.08.007; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Bollinger T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029801; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Maloy KJ, 2008, MUCOSAL IMMUNOL, V1, P339, DOI 10.1038/mi.2008.28; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504	27	254	267	4	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					727	730		10.1126/science.1243884	http://dx.doi.org/10.1126/science.1243884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202171	Green Accepted			2022-12-28	WOS:000326647600040
J	Saharia, KK; Koup, RA				Saharia, Kapil K.; Koup, Richard A.			T Cell Susceptibility to HIV Influences Outcome of Opportunistic Infections	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; MYCOBACTERIUM-TUBERCULOSIS INFECTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; ACTIVE ANTIRETROVIRAL THERAPY; CYTOMEGALOVIRUS-SPECIFIC CD4(+); INTERFERON-GAMMA-RECEPTOR; MEDIATED IMMUNE-RESPONSES; END-ORGAN DISEASE; LANGERHANS CELLS	During HIV infection, the timing of opportunistic infections is not always associated with severity of CD4 T cell depletion, and different opportunistic pathogens reactivate at different CD4 T cell thresholds. Here, we examine how differences in the phenotype and function of pathogen-specific CD4 T cells influence susceptibility to HIV infection. By focusing on three common opportunistic infections (Mycobacterium tuberculosis, human papillomavirus, and cytomegalovirus), we investigate how differential depletion of pathogen-specific CD4 T cells impacts the natural history of these pathogens in HIV infection. A broader understanding of this relationship can better inform treatment strategies against copathogens.	[Saharia, Kapil K.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Saharia, Kapil K.] Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA; [Koup, Richard A.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Koup, RA (corresponding author), NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	rkoup@mail.nih.gov			Intramural NIH HHS [ZIA AI005014-12] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005073] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Adler DH, 2010, CURR HIV RES, V8, P493, DOI 10.2174/157016210793499240; Barry AP, 2007, J IMMUNOL, V178, P8002, DOI 10.4049/jimmunol.178.12.8002; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Bates M, 2013, CURR OPIN PULM MED, V19, P229, DOI 10.1097/MCP.0b013e32835f4fe4; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Bronke C, 2005, J INFECT DIS, V191, P873, DOI 10.1086/427828; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Caruso AM, 1999, J IMMUNOL, V162, P5407; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Casazza JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000646; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; COLEMAN N, 1994, AM J CLIN PATHOL, V102, P768, DOI 10.1093/ajcp/102.6.768; Connor JP, 1999, GYNECOL ONCOL, V75, P130, DOI 10.1006/gyno.1999.5559; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Dal Maso L, 2009, BRIT J CANCER, V100, P840, DOI 10.1038/sj.bjc.6604923; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; de Jong A, 2004, CANCER RES, V64, P5449, DOI 10.1158/0008-5472.CAN-04-0831; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Diedrich CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009611; EVANDER M, 1995, J INFECT DIS, V171, P1026, DOI 10.1093/infdis/171.4.1026; Farhat S, 2009, INT J GYNECOL CANCER, V19, P508, DOI 10.1111/IGC.0b013e3181a388c4; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Franceschi S, 2010, BRIT J CANCER, V103, P416, DOI 10.1038/sj.bjc.6605756; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Geldmacher C, 2012, TRENDS IMMUNOL, V33, P207, DOI 10.1016/j.it.2012.01.011; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, HUM IMMUNOL, V65, P500, DOI 10.1016/j.humimm.2004.02.012; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Heuts F, 2013, P NATL ACAD SCI USA, V110, P6482, DOI 10.1073/pnas.1219985110; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Hu HT, 2013, BLOOD, V121, P1136, DOI 10.1182/blood-2012-07-446278; Insinga RP, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-119; Jacobson MA, 2001, J INFECT DIS, V183, P1399, DOI 10.1086/319854; Jaspan HB, 2011, J INFECT DIS, V204, P1550, DOI 10.1093/infdis/jir591; Kadish AS, 2002, CANCER EPIDEM BIOMAR, V11, P483; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; KAMIJO R, 1993, J EXP MED, V178, P1435, DOI 10.1084/jem.178.4.1435; Khan N, 2004, J IMMUNOL, V173, P7481, DOI 10.4049/jimmunol.173.12.7481; Komanduri KV, 2001, VIROLOGY, V279, P459, DOI 10.1006/viro.2000.0697; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; LANG DJ, 1989, J ACQ IMMUN DEF SYND, V2, P540; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Lin PL, 2012, AIDS RES HUM RETROV, V28, P1693, DOI [10.1089/aid.2012.0028, 10.1089/AID.2012.0028]; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lodi S, 2013, THORAX, V68, P207, DOI 10.1136/thoraxjnl-2012-201740; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Luchters SMF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-18; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Matthews K, 2003, J VIROL, V77, P8378, DOI 10.1128/JVI.77.15.8378-8385.2003; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Minga AK, 2008, JAIDS-J ACQ IMM DEF, V48, P350, DOI 10.1097/QAI.0b013e3181775e55; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; MUNOZ A, 1993, AM J EPIDEMIOL, V137, P423, DOI 10.1093/oxfordjournals.aje.a116691; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Nakagawa M, 2000, J INFECT DIS, V182, P595, DOI 10.1086/315706; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Nowak RG, 2011, J INFECT DIS, V203, P1182, DOI 10.1093/infdis/jiq172; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Patel NR, 2009, J LEUKOCYTE BIOL, V86, P53, DOI [10.1189/JLB.0908574, 10.1189/jlb.0908574]; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; PERTEL P, 1992, J ACQ IMMUN DEF SYND, V5, P1069; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Powles T, 2009, J CLIN ONCOL, V27, P884, DOI 10.1200/JCO.2008.19.6626; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; REDDEHASE MJ, 1985, J VIROL, V55, P264, DOI 10.1128/JVI.55.2.264-273.1985; RIDDELL SR, 1992, SCIENCE, V257, P238; Sarkar AK, 2005, GYNECOL ONCOL, V99, pS251, DOI 10.1016/j.ygyno.2005.07.099; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Schluger NW, 2002, CHEST, V122, P597, DOI 10.1378/chest.122.2.597; Scriba TJ, 2012, AM J RESP CRIT CARE, V185, P769, DOI 10.1164/rccm.201108-1548OC; Sester M, 2002, J VIROL, V76, P3748, DOI 10.1128/JVI.76.8.3748-3755.2002; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Slight SR, 2013, J CLIN INVEST, V123, P712, DOI 10.1172/JCI65728; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; TAY SK, 1987, BRIT J OBSTET GYNAEC, V94, P10, DOI 10.1111/j.1471-0528.1987.tb02244.x; Theiler RN, 2010, OBSTET GYNECOL, V115, P1150, DOI 10.1097/AOG.0b013e3181e00927; Tu WW, 2004, J IMMUNOL, V172, P3260, DOI 10.4049/jimmunol.172.5.3260; Van Crevel R, 2003, ADV EXP MED BIOL, V531, P241; VESSEY CJ, 1995, J PATHOL, V176, P151, DOI 10.1002/path.1711760208; Viard JP, 2011, AIDS, V25, P1305, DOI 10.1097/QAD.0b013e328347f6f7; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wang CH, 2011, J INFECT DIS, V203, P479, DOI 10.1093/infdis/jiq083; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilkinson KA, 2009, AM J RESP CRIT CARE, V180, P674, DOI 10.1164/rccm.200904-0568OC; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Yanik EL, 2013, CLIN INFECT DIS, V57, P756, DOI 10.1093/cid/cit369; Yazdanpanah Y, 2001, INT J EPIDEMIOL, V30, P864, DOI 10.1093/ije/30.4.864; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	113	29	29	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					505	514		10.1016/j.cell.2013.09.045	http://dx.doi.org/10.1016/j.cell.2013.09.045			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243010	Bronze, Green Accepted			2022-12-28	WOS:000326571800006
J	Xie, D; Boyle, AP; Wu, LF; Zhai, J; Kawli, T; Snyder, M				Xie, Dan; Boyle, Alan P.; Wu, Linfeng; Zhai, Jie; Kawli, Trupti; Snyder, Michael			Dynamic trans-Acting Factor Colocalization in Human Cells	CELL			English	Article							PROTEIN INTERACTION NETWORK; ZINC-FINGER PROTEINS; REGULATORY NETWORK; BINDING-SITES; DROSOPHILA; DIFFERENTIATION; EXPRESSION; MODENCODE; ELEMENTS; GENOME	Different trans-acting factors (TFs) collaborate and act in concert at distinct loci to perform accurate regulation of their target genes. To date, the cobinding of TF pairs has been investigated in a limited context both in terms of the number of factors within a cell type and across cell types and the extent of combinatorial colocalizations. Here, we use an approach to analyze TF colocalization within a cell type and across multiple cell lines at an unprecedented level. We extend this approach with largescale mass spectrometry analysis of immunoprecipitations of 50 TFs. Our combined approach reveals large numbers of interesting TF-TF associations. We observe extensive change in TF colocalizations both within a cell type exposed to different conditions and across multiple cell types. We show distinct functional annotations and properties of different TF cobinding patterns and provide insights into the complex regulatory landscape of the cell.	[Xie, Dan; Boyle, Alan P.; Wu, Linfeng; Zhai, Jie; Kawli, Trupti; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Boyle, Alan/I-1848-2014	Boyle, Alan/0000-0002-2081-1105; Snyder, Michael/0000-0003-0784-7987	NHGRI [U54HG004558, U54HG006996]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003156, U54HG006996, K99HG007356, U54HG004558] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the ENCODE consortium for providing data used in these analyses. The HeLa cells used in this study were derived from Henrietta Lacks, and we are grateful to her and her family for their contributions to biomedical research. This project is funded by NHGRI grants U54HG004558 and U54HG006996. M. P. S. is a cofounder and scientific advisory board (SAB) member of Personalis. He is on the SAB of Genapsys.	Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Choi H, 2012, CURR PROTOC BIOINFOR, V39, P8151; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Higo S, 2010, J BIOL CHEM, V285, P31337, DOI 10.1074/jbc.M110.155788; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; IGARASHI K, 1995, P NATL ACAD SCI USA, V92, P7445, DOI 10.1073/pnas.92.16.7445; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Rosnoblet C, 2011, BIOCHEM BIOPH RES CO, V413, P206, DOI 10.1016/j.bbrc.2011.08.059; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Vesanto J, 2005, SOM TOOLBOX IMPLEMEN; Xie D, 2008, GENOME RES, V18, P1325, DOI 10.1101/gr.072769.107; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48	31	100	101	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					713	724		10.1016/j.cell.2013.09.043	http://dx.doi.org/10.1016/j.cell.2013.09.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243024	Green Accepted, Bronze			2022-12-28	WOS:000326571800023
J	Mohr, JP; Parides, MK; Stapf, C; Moquete, E; Moy, CS; Overbey, JR; Salman, RAS; Vicaut, E; Young, WL; Houdart, E; Cordonnier, C; Stefani, MA; Hartmann, A; von Kummer, R; Biondi, A; Berkefeld, J; Klijn, CJM; Harkness, K; Libman, R; Barreau, X; Moskowitz, AJ				Mohr, J. P.; Parides, Michael K.; Stapf, Christian; Moquete, Ellen; Moy, Claudia S.; Overbey, Jessica R.; Salman, Rustam Al-Shahi; Vicaut, Eric; Young, William L.; Houdart, Emmanuel; Cordonnier, Charlotte; Stefani, Marco A.; Hartmann, Andreas; von Kummer, Rudiger; Biondi, Alessandra; Berkefeld, Joachim; Klijn, Catharina J. M.; Harkness, Kirsty; Libman, Richard; Barreau, Xavier; Moskowitz, Alan J.		Int ARUBA Investigators	Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial	LANCET			English	Article							HEMORRHAGE; PROGRESS; SURGERY	Background The clinical benefit of preventive eradication of unruptured brain arteriovenous malformations remains uncertain. A Randomised trial of Unruptured Brain Arteriovenous malformations (ARUBA) aims to compare the risk of death and symptomatic stroke in patients with an unruptured brain arteriovenous malformation who are allocated to either medical management alone or medical management with interventional therapy. Methods Adult patients (>= 18 years) with an unruptured brain arteriovenous malformation were enrolled into this trial at 39 clinical sites in nine countries. Patients were randomised (by web-based system, in a 1: 1 ratio, with random permuted block design [block size 2, 4, or 6], stratified by clinical site) to medical management with interventional therapy (ie, neurosurgery, embolisation, or stereotactic radiotherapy, alone or in combination) or medical management alone (ie, pharmacological therapy for neurological symptoms as needed). Patients, clinicians, and investigators are aware of treatment assignment. The primary outcome is time to the composite endpoint of death or symptomatic stroke; the primary analysis is by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00389181. Findings Randomisation was started on April 4, 2007, and was stopped on April 15, 2013, when a data and safety monitoring board appointed by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health recommended halting randomisation because of superiority of the medical management group (log-rank Z statistic of 4.10, exceeding the prespecified stopping boundary value of 2.87). At this point, outcome data were available for 223 patients (mean follow-up 33.3 months [SD 19.7]), 114 assigned to interventional therapy and 109 to medical management. The primary endpoint had been reached by 11 (10.1%) patients in the medical management group compared with 35 (30.7%) in the interventional therapy group. The risk of death or stroke was significantly lower in the medical management group than in the interventional therapy group (hazard ratio 0.27, 95% CI 0.14-0.54). No harms were identified, other than a higher number of strokes (45 vs 12, p<0.0001) and neurological deficits unrelated to stroke (14 vs 1, p=0.0008) in patients allocated to interventional therapy compared with medical management. Interpretation The ARUBA trial showed that medical management alone is superior to medical management with interventional therapy for the prevention of death or stroke in patients with unruptured brain arteriovenous malformations followed up for 33 months. The trial is continuing its observational phase to establish whether the disparities will persist over an additional 5 years of follow-up.	[Mohr, J. P.; Stapf, Christian] Columbia Univ, Neurol Inst, Med Ctr, New York, NY USA; [Parides, Michael K.; Moquete, Ellen; Overbey, Jessica R.; Moskowitz, Alan J.] Icahn Sch Med Mt Sinai, Dept Hlth Evidence & Policy, Int Ctr Hlth Outcomes & Innovat Res, New York, NY USA; [Stapf, Christian] Univ Paris Diderot Sorbonne Paris Cite, Hop Lariboisiere, AP HP, Dept Neurol, Paris, France; [Stapf, Christian] Univ Paris Diderot Sorbonne Paris Cite, Hop Lariboisiere, AP HP, DHU NeuroVasc, Paris, France; [Houdart, Emmanuel] Univ Paris Diderot Sorbonne Paris Cite, Hop Lariboisiere, AP HP, Dept Neuroradiol, Paris, France; [Vicaut, Eric] Univ Paris Diderot Sorbonne Paris Cite, Hop Lariboisiere, AP HP, Unite Rech Clin, Paris, France; [Moy, Claudia S.] NINDS, NIH, Bethesda, MD 20892 USA; [Salman, Rustam Al-Shahi] Univ Edinburgh, Ctr Clin Brain Sci, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [Young, William L.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Cordonnier, Charlotte] Univ Lille Nord France, CHRU Lille, Dept Neurol, Lille, France; [Stefani, Marco A.] Hosp Clin Porto Alegre, Dept Neurol & Neurosurg, Porto Alegre, RS, Brazil; [Hartmann, Andreas] Charite, D-13353 Berlin, Germany; [Hartmann, Andreas] Klinikum Frankfurt Oder, Dept Neurol, Frankfurt, Germany; [von Kummer, Rudiger] Univ Hosp Dresden, Dept Neuroradiol, Dresden, Germany; [Biondi, Alessandra] Univ Franche Comte, Jean Minjoz Hosp, Dept Neuroradiol & Endovasc Therapy, F-25030 Besancon, France; [Berkefeld, Joachim] Univ Frankfurt Klinikum, Dept Neuroradiol, Frankfurt, Germany; [Klijn, Catharina J. M.] Univ Med Ctr, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Harkness, Kirsty] Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2JF, S Yorkshire, England; [Libman, Richard] North Shore Long Isl Jewish Med Ctr, Dept Neurol, New Hyde Pk, NY USA; [Barreau, Xavier] CHU Pellegrin, Dept Diagnost & Intervent Neuroimaging, Bordeaux, France	Columbia University; Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Edinburgh; University of California System; University of California San Francisco; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Universite de Franche-Comte; CHU Besancon; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Utrecht University; Utrecht University Medical Center; University of Sheffield; Northwell Health; CHU Bordeaux	Stapf, C (corresponding author), Hop Lariboisiere, AP HP, Dept Neurol, Neurovasc Unit, F-75175 Paris 10, France.	christian.stapf@lrb.aphp.fr	STEFANI, MARCO ANTONIO/C-3993-2013; von Kummer, Rüdiger/AAA-4478-2019; Parides, Michael/GON-8474-2022; van Dijk, J. Marc C./C-1078-2013; Klijn, C.J.M./E-1700-2016; Cordonnier, Charlotte/O-3258-2017; Mohr, J/AAO-9694-2020	STEFANI, MARCO ANTONIO/0000-0002-4728-8764; von Kummer, Rüdiger/0000-0003-0119-4604; van Dijk, J. Marc C./0000-0002-0814-5680; Klijn, C.J.M./0000-0002-8495-4578; Cordonnier, Charlotte/0000-0002-5697-6892; NONENT, Michel/0000-0002-1317-8997; Guilbert, Francois/0000-0002-7866-0493; Javadpour, Mohsen/0000-0001-9836-1741; Moulin, thierry/0000-0002-6639-8117; Wollenweber, Frank Arne/0000-0002-9375-405X; Dichgans, Martin/0000-0002-0654-387X; Gregson, Barbara/0000-0003-4868-9137; Timsit, Serge/0000-0003-0346-8576; Stapf, Christian/0000-0002-3193-1006; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Moskowitz, Alan/0000-0002-4412-9450; Overbey, Jessica/0000-0001-7283-1661; Klurfan, Paula/0000-0002-6481-2329; Touze, Emmanuel/0000-0002-7254-2162; Biondi, Alessandra/0000-0002-3185-0740	National Institute of Neurological Diosorders and Stroke of the US National Institutes of Health [U01NS051483, U01 NS051566]; National Institutes of Health, National Institute of Neurological Disorders and Stroke; MRC [G1002605] Funding Source: UKRI; Medical Research Council [G1002605] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS051566, U01NS051483] Funding Source: NIH RePORTER	National Institute of Neurological Diosorders and Stroke of the US National Institutes of Health; National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health, National Institute of Neurological Disorders and Stroke.; This paper is dedicated in memoriam to our colleague and friend William L Young, in recognition of his contribution to brain arteriovenous malformations research and to the ARUBA trial. We thank patients who participate in this trial. This trial is funded internationally by the National Institute of Neurological Diosorders and Stroke of the US National Institutes of Health via cooperative agreements U01NS051483 (CCC; J.P. Mohr, PI) and U01 NS051566 (DCC; A.J. Moskowitz, PI). No commercial funding sources have been involved. ARUBA has been officially adopted by the UK Stroke Research Network and endorsed by the Societe Francaise Neurovasculaire (SFNV). Initial results have been presented at the European Stroke Conference; London, UK; May 28-31, 2013.	Al-Shahi R, 2003, STROKE, V34, P1163, DOI 10.1161/01.STR.0000069018.90456.C9; Al-Shahi R, 2005, PRACT NEUROL, V5, P194; Atkinson RP, 2001, STROKE, V32, P1430; BARNETT HJM, 1980, STROKE, V11, P137, DOI 10.1161/01.STR.11.2.137; BARNETT HJM, 1987, NEW ENGL J MED, V316, P817, DOI 10.1056/NEJM198703263161320; Choi JH, 2006, STROKE, V37, P1243, DOI 10.1161/01.STR.0000217970.18319.7d; Davis SM, 2007, STROKE, V38, P3312, DOI 10.1161/STROKEAHA.107.504621; Dorman PJ, 1997, BRIT MED J, V315, P461, DOI 10.1136/bmj.315.7106.461; Halim AX, 2004, STROKE, V35, P1697, DOI 10.1161/01.STR.0000130988.44824.29; Hartmann A, 2005, STROKE, V36, P2431, DOI 10.1161/01.STR.0000185723.98111.75; La Piana R, 2013, INTERV NEURORADIOL, V19, P329, DOI 10.1177/159101991301900310; Laakso A, 2008, NEUROSURGERY, V63, P244, DOI 10.1227/01.NEU.0000320439.27895.24; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mohr JP, 2010, STROKE, V41, pE537, DOI 10.1161/STROKEAHA.110.580274; Mohr JP, 2004, CEREBROVASC DIS, V18, P258, DOI 10.1159/000080292; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Ogilvy CS, 2001, STROKE, V32, P1458, DOI 10.1161/01.STR.32.6.1458; ONDRA SL, 1990, J NEUROSURG, V73, P387, DOI 10.3171/jns.1990.73.3.0387; Powers WJ, 2011, JAMA-J AM MED ASSOC, V306, P1983, DOI 10.1001/jama.2011.1610; Ross J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003436.pub3; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; Stapf C, 2006, NEUROLOGY, V66, P1350, DOI 10.1212/01.wnl.0000210524.68507.87; Stapf C, 2006, CURR OPIN NEUROL, V19, P63, DOI 10.1097/01.wco.0000200546.14668.78; Stapf C, 2003, STROKE, V34, pE29, DOI 10.1161/01.STR.0000068784.36838.19; van Beijnum J, 2011, JAMA-J AM MED ASSOC, V306, P2011, DOI 10.1001/jama.2011.1632; Beijnum J, 2009, BRAIN, V132, P537, DOI 10.1093/brain/awn318; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wedderburn CJ, 2008, LANCET NEUROL, V7, P223, DOI 10.1016/S1474-4422(08)70026-7	30	662	684	3	78	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					614	621		10.1016/S0140-6736(13)62302-8	http://dx.doi.org/10.1016/S0140-6736(13)62302-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KP	24268105	Green Accepted			2022-12-28	WOS:000331137700030
J	Acevedo, A; Brodsky, L; Andino, R				Acevedo, Ashley; Brodsky, Leonid; Andino, Raul			Mutational and fitness landscapes of an RNA virus revealed through population sequencing	NATURE			English	Article							NUCLEOTIDE SUBSTITUTIONS; SUBSTRATE RECOGNITION; PROTEIN; POLYMERASE; ATTENUATION; DNA	RNA viruses exist as genetically diverse populations(1). It is thought that diversity and genetic structure of viral populations determine the rapid adaptation observed in RNA viruses(2) and hence their pathogenesis(3). However, our understanding of the mechanisms underlying virus evolution has been limited by the inability to accurately describe the genetic structure of virus populations. Next-generation sequencing technologies generate data of sufficient depth to characterize virus populations, but are limited in their utility because most variants are present at very low frequencies and are thus indistinguishable from next-generation sequencing errors. Here we present an approach that reduces next-generation sequencing errors and allows the description of virus populations with unprecedented accuracy. Using this approach, we define the mutation rates of poliovirus and uncover the mutation landscape of the population. Furthermore, by monitoring changes in variant frequencies on serially passaged populations, we determined fitness values for thousands of mutations across the viral genome. Mapping of these fitness values onto three-dimensional structures of viral proteins offers a powerful approach for exploring structure-function relationships and potentially uncovering new functions. To our knowledge, our study provides the first single-nucleotide fitness landscape of an evolving RNA virus and establishes a general experimental platform for studying the genetic changes underlying the evolution of virus populations.	[Acevedo, Ashley; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA; [Brodsky, Leonid] Univ Haifa, Tauber Bioinformat Res Ctr, IL-31905 Haifa, Israel; [Brodsky, Leonid] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31905 Haifa, Israel	University of California System; University of California San Francisco; University of Haifa; University of Haifa	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA.	raul.andino@ucsf.edu			National Science Foundation; NIAID [AI091575, AI36178, AI40085]; DARPA Prophecy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040085, R56AI036178, R21AI040085, R21AI036178, P01AI091575, R01AI036178] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DARPA Prophecy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Frydman, S. Bianco, H. Dawes, K. Ehmsen and members of the Andino laboratory for critical reading of the manuscript and G. Schroth, M. Harrison, P. Wassam and T. Collins for technical advice. This work was financially supported by a National Science Foundation graduate research fellowship to A.A., NIAID AI091575, AI36178 and AI40085 to R.A., and DARPA Prophecy to R.A. and L.B.	Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair WS, 1996, VIROLOGY, V218, P1, DOI 10.1006/viro.1996.0160; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Cuevas JM, 2012, MOL BIOL EVOL, V29, P17, DOI 10.1093/molbev/msr179; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; DEWALT PG, 1990, VIROLOGY, V174, P504, DOI 10.1016/0042-6822(90)90104-Y; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; Draper NR., 1998, WILEY SERIES PROBABI, V3rd ed.; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-44; Gelman A, 2004, BAYESIAN DATA ANAL, V2nd, DOI [10.2307/2988417, DOI 10.2307/2988417]; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; GOULD S J, 1970, Journal of the History of Biology, V3, P189, DOI 10.1007/BF00137351; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HAMMERLE T, 1991, J BIOL CHEM, V266, P5412; HELLEN CUT, 1992, J VIROL, V66, P3330, DOI 10.1128/JVI.66.6.3330-3338.1992; Herold J, 2000, J VIROL, V74, P6394, DOI 10.1128/JVI.74.14.6394-6400.2000; Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kimura M, 1983, NEUTRAL THEORY MOL E, P55; Lama J, 1998, J GEN VIROL, V79, P1911, DOI 10.1099/0022-1317-79-8-1911; LAMA J, 1995, J BIOL CHEM, V270, P14430, DOI 10.1074/jbc.270.24.14430; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lou D. I., P NATL ACAD IN PRESS; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Orr HA, 2000, GENETICS, V155, P961; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4	39	242	245	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					686	+		10.1038/nature12861	http://dx.doi.org/10.1038/nature12861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24284629	Green Accepted			2022-12-28	WOS:000330321000042
J	Criqui, MH; Denenberg, JO; Ix, JH; McClelland, RL; Wassel, CL; Rifkin, DE; Carr, JJ; Budoff, MJ; Allison, MA				Criqui, Michael H.; Denenberg, Julie O.; Ix, Joachim H.; McClelland, Robyn L.; Wassel, Christina L.; Rifkin, Dena E.; Carr, Jeffrey J.; Budoff, Matthew J.; Allison, Matthew A.			Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; CT ANGIOGRAPHY; CALCIFICATION; ATHEROSCLEROSIS; SCORE	IMPORTANCE Coronary artery calcium (CAC), measured by computed tomography (CT), has strong predictive value for incident cardiovascular disease (CVD) events. The standard CAC score is the Agatston, which is weighted upward for greater calcium density. However, some data suggest increased plaque calcium density may be protective for CVD. OBJECTIVE To determine the independent associations of CAC volume and CAC density with incident CVD events. DESIGN, SETTING, AND PARTICIPANTS Multicenter, prospective observational MESA study (Multi-Ethnic Study of Atherosclerosis), conducted at 6 US field centers of 3398 men and women from 4 race/ethnicity groups; non-Hispanic white, African American, Hispanic, and Chinese. Participants were aged 45-84 years, free of known CVD at baseline, had CAC greater than 0 on their baseline CT, and were followed up through October 2010. MAIN OUTCOMES AND MEASURES Incident coronary heart disease (CHD) and all CVD events RESULTS During a median of 7.6 years of follow-up, there were 175 CHD events and an additional 90 other CVD events for a total of 265 CVD events. With both lnCAC volume and CAC density scores in the same multivariable model, the lnCAC volume score showed an independent association with incident CHD, with a hazard ratio (HR) of 1.81 (95% CI, 1.47-2.23) per standard deviation (SD = 1.6) increase, absolute risk increase 6.1 per 1000 person-years, and for CVD an HR of 1.68 (95% CI, 1.42-1.98) per SD increase, absolute risk increase 7.9 per 1000 person-years. Conversely, the CAC density score showed an independent inverse association, with an HR of 0.73 (95% CI, 0.58-0.91) per SD (SD = 0.7) increase for CHD, absolute risk decrease 5.5 per 1000 person-years, and an HR of 0.71 (95% CI, 0.60-0.85) per SD increase for CVD, absolute risk decrease 8.2 per 1000 person years. Area under the receiver operating characteristic curve analyses showed significantly improved risk prediction with the addition of the density score to a model containing the volume score for both CHD and CVD. In the intermediate CVD risk group, the area under the curve for CVD increased from 0.53 (95% CI, 0.48-0.59) to 0.59 (95% CI, 0.54-0.64), P = .02. CONCLUSIONS AND RELEVANCE CAC volume was positively and independently associated with CHD and CVD risk. At any level of CAC volume, CAC density was inversely and significantly associated with CHD and CVD risk. The role of CAC density should be considered when evaluating current CAC scoring systems.	[Criqui, Michael H.; Denenberg, Julie O.; Allison, Matthew A.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Criqui, Michael H.; Ix, Joachim H.; Rifkin, Dena E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [McClelland, Robyn L.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wassel, Christina L.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Carr, Jeffrey J.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Budoff, Matthew J.] Harbor UCLA Med Ctr, Div Cardiol, Los Angeles Biomed Res Inst, Los Angeles, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Criqui, MH (corresponding author), Univ Calif San Diego, Dept Family & Prevent Med, 9500 Gilman Dr,MC 0607, La Jolla, CA 92093 USA.	mcriqui@ucsd.edu	Carr, John/AAN-7531-2021; Budoff, Matthew/ABD-5175-2021; Carr, John Jeffrey/A-1938-2012	Carr, John/0000-0002-4398-8237; Budoff, Matthew/0000-0002-9616-1946; Carr, John Jeffrey/0000-0002-4398-8237; Allison, Matthew/0000-0003-0777-8272; Rifkin, Dena/0000-0002-1278-5795	NHLBI [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95169]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095162, N01HC095163, N01HC095159, N01HC095160, N01HC095169, N01HC095165, N01HC095164, N01HC095161] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, R43HL095169, R43HL095161, R21HL095165, R43HL095160, R01HL095163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK091521] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The MESA study was supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, and N01-HC-95169 from the NHLBI.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allison MA, 2004, ARTERIOSCL THROM VAS, V24, P331, DOI 10.1161/01.ATV.0000110786.02097.0c; Arguelles W, 2011, CIRCULATION, V124; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Brown ER, 2008, RADIOLOGY, V247, P669, DOI 10.1148/radiol.2473071469; Budoff MJ, 2009, AM HEART J, V158, P554, DOI 10.1016/j.ahj.2009.08.007; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Detrano R, 1996, J AM COLL CARDIOL, V27, P285, DOI 10.1016/0735-1097(95)00460-2; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HODGSON JM, 1993, J AM COLL CARDIOL, V21, P35, DOI 10.1016/0735-1097(93)90714-C; Hoffmann U, 2008, AM J CARDIOL, V102, P1136, DOI 10.1016/j.amjcard.2008.06.038; Hou ZH, 2012, JACC-CARDIOVASC IMAG, V5, P990, DOI 10.1016/j.jcmg.2012.06.006; Houslay ES, 2006, HEART, V92, P1207, DOI 10.1136/hrt.2005.080929; Inoue K, 2010, JACC-CARDIOVASC IMAG, V3, P691, DOI 10.1016/j.jcmg.2010.04.011; Leber AW, 2003, AM J CARDIOL, V91, P714, DOI 10.1016/S0002-9149(02)03411-2; Liang CJ, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-14; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; Nelson JC, 2005, RADIOLOGY, V235, P403, DOI 10.1148/radiol.2352040515; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; Shemesh J, 2003, RADIOLOGY, V226, P483, DOI 10.1148/radiol.2262011903; Shemesh J, 2010, RADIOLOGY, V257, P541, DOI 10.1148/radiol.10100383; Terry JG, 2007, AM J CARDIOL, V99, P1714, DOI 10.1016/j.amjcard.2007.01.060; Williams M, 2008, JACC-CARDIOVASC IMAG, V1, P61, DOI 10.1016/j.jcmg.2007.09.001; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	31	357	370	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					271	278		10.1001/jama.2013.282535	http://dx.doi.org/10.1001/jama.2013.282535			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24247483	Green Accepted, Bronze			2022-12-28	WOS:000329566400019
J	Traverse, JH; Henry, TD; Pepine, CJ; Willerson, JT; Ellis, SG				Traverse, Jay H.; Henry, Timothy D.; Pepine, Carl J.; Willerson, James T.; Ellis, Stephen G.			One-Year Follow-up of Intracoronary Stem Cell Delivery on Left Ventricular Function Following ST-Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Traverse, Jay H.; Henry, Timothy D.] Abbott NW Hosp, Minneapolis Heart Inst, Minneapolis, MN 55407 USA; [Pepine, Carl J.] Univ Florida, Sch Med, Gainesville, FL USA; [Willerson, James T.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA; [Ellis, Stephen G.] Cleveland Clin Fdn, Cleveland, OH 44195 USA	Minneapolis Heart Institute Foundation; State University System of Florida; University of Florida; Saint Lukes Episcopal Hospital; Texas Heart Institute; Cleveland Clinic Foundation	Traverse, JH (corresponding author), Minneapolis Heart Inst, 920 E 28th St,Ste 300, Minneapolis, MN 55407 USA.	trave004@umn.edu		Pepine, Carl/0000-0002-6011-681X	NHLBI NIH HHS [UM1 HL087394, UM1 HL087318, UM1 HL087366, U01 HL087318, U01 HL087366, 5 UO1 HL087318-04, UM1 HL087365] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087318, UM1HL087394, U01HL087366, UM1HL087365, UM1HL087318, UM1HL087366] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; Traverse JH, 2009, AM HEART J, V158, P356, DOI 10.1016/j.ahj.2009.06.009	2	27	29	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					301	302		10.1001/jama.2013.282674	http://dx.doi.org/10.1001/jama.2013.282674			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24247415	Bronze, Green Accepted			2022-12-28	WOS:000329566400023
J	Johnson, SC; Yanos, ME; Kayser, EB; Quintana, A; Sangesland, M; Castanza, A; Uhde, L; Hui, J; Wall, VZ; Gagnidze, A; Oh, K; Wasko, BM; Ramos, FJ; Palmiter, RD; Rabinovitch, PS; Morgan, PG; Sedensky, MM; Kaeberlein, M				Johnson, Simon C.; Yanos, Melana E.; Kayser, Ernst-Bernhard; Quintana, Albert; Sangesland, Maya; Castanza, Anthony; Uhde, Lauren; Hui, Jessica; Wall, Valerie Z.; Gagnidze, Arni; Oh, Kelly; Wasko, Brian M.; Ramos, Fresnida J.; Palmiter, Richard D.; Rabinovitch, Peter S.; Morgan, Philip G.; Sedensky, Margaret M.; Kaeberlein, Matt			mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome	SCIENCE			English	Article							COMPLEX-I DEFICIENCY; SUBUNIT; NDUFS4; MICE	Mitochondrial dysfunction contributes to numerous health problems, including neurological and muscular degeneration, cardiomyopathies, cancer, diabetes, and pathologies of aging. Severe mitochondrial defects can result in childhood disorders such as Leigh syndrome, for which there are no effective therapies. We found that rapamycin, a specific inhibitor of the mechanistic target of rapamycin (mTOR) signaling pathway, robustly enhances survival and attenuates disease progression in a mouse model of Leigh syndrome. Administration of rapamycin to these mice, which are deficient in the mitochondrial respiratory chain subunit Ndufs4 [NADH dehydrogenase (ubiquinone) Fe-S protein 4], delays onset of neurological symptoms, reduces neuroinflammation, and prevents brain lesions. Although the precise mechanism of rescue remains to be determined, rapamycin induces a metabolic shift toward amino acid catabolism and away from glycolysis, alleviating the buildup of glycolytic intermediates. This therapeutic strategy may prove relevant for a broad range of mitochondrial diseases.	[Johnson, Simon C.; Yanos, Melana E.; Sangesland, Maya; Castanza, Anthony; Uhde, Lauren; Hui, Jessica; Wall, Valerie Z.; Gagnidze, Arni; Oh, Kelly; Wasko, Brian M.; Ramos, Fresnida J.; Rabinovitch, Peter S.; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Yanos, Melana E.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Kayser, Ernst-Bernhard; Morgan, Philip G.; Sedensky, Margaret M.] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Quintana, Albert] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Quintana, Albert] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@uw.edu	Quintana, Albert/N-5544-2015; Wasko, Brian/N-2580-2019; Castanza, Anthony/AAQ-7137-2021; Wasko, Brian/J-9814-2019	Quintana, Albert/0000-0003-1674-7160; Castanza, Anthony/0000-0001-9795-0720; Wasko, Brian/0000-0002-7090-086X; Johnson, Simon/0000-0002-1942-3674; Zebertavage, Lauren/0000-0003-2507-4084; Sangesland, Maya/0000-0001-8316-039X	University of Washington School of Medicine; Department of Pathology; NIH [T32AG000057, T32ES007032]; Amgen Scholar summer research scholarship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057, R01AG039390] Funding Source: NIH RePORTER	University of Washington School of Medicine; Department of Pathology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Scholar summer research scholarship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the University of Washington School of Medicine and Department of Pathology for funding to M. K. that allowed these studies to be performed. Supported by NIH training grant T32AG000057 (S.C.J., M.E.Y., and F.J.R.), NIH training grant T32ES007032 (B.M.W.), and an Amgen Scholar summer research scholarship (M.S.).	Arii J, 2000, AM J NEURORADIOL, V21, P1502; Blagosklonny MV, 2010, CELL CYCLE, V9, P683, DOI 10.4161/cc.9.4.10766; Breuer ME, 2013, IUBMB LIFE, V65, P202, DOI 10.1002/iub.1127; Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Patel KP, 2012, MOL GENET METAB, V106, P384, DOI 10.1016/j.ymgme.2012.03.016; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Scacco S, 2000, J BIOL CHEM, V275, P17578, DOI 10.1074/jbc.M001174200; Schleit J, 2013, AGING CELL, V12, P1050, DOI 10.1111/acel.12130; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P23, DOI 10.1016/j.critrevonc.2005.03.012; VANERVEN PMM, 1987, CLIN NEUROL NEUROSUR, V89, P217, DOI 10.1016/S0303-8467(87)80020-3	15	329	334	11	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1524	1528		10.1126/science.1244360	http://dx.doi.org/10.1126/science.1244360			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24231806	Green Accepted			2022-12-28	WOS:000328644300063
J	Trigo, MD; Miller-Jones, JCA; Migliari, S; Broderick, JW; Tzioumis, T				Trigo, Maria Diaz; Miller-Jones, James C. A.; Migliari, Simone; Broderick, Jess W.; Tzioumis, Tasso			Baryons in the relativistic jets of the stellar-mass black-hole candidate 4U 1630-47	NATURE			English	Article							GAMMA-RAY EMISSION; ACCRETION DISKS; TEV NEUTRINOS; XMM-NEWTON; RADIO; LINE; TELESCOPE; MODEL; STATE; POWER	Accreting black holes are known to power relativistic jets, both in stellar-mass binary systems and at the centres of galaxies. The power carried away by the jets, and, hence, the feedback they provide to their surroundings, depends strongly on their composition. Jets containing a baryonic component should carry significantly more energy than electron-positron jets. Energetic considerations(1,2) and circular-polarization measurements(3) have provided conflicting circumstantial evidence for the presence or absence of baryons in jets, and the only system in which they have been unequivocally detected is the peculiar X-ray binary SS 433 (refs 4, 5). Here we report the detection of Doppler-shifted X-ray emission lines from a more typical black-hole candidate X-ray binary, 4U 1630-47, coincident with the reappearance of radio emission from the jets of the source. We argue that these lines arise from baryonic matter in a jet travelling at approximately two-thirds the speed of light, thereby establishing the presence of baryons in the jet. Such baryonic jets are more likely to be powered by the accretion disk(6) than by the spin of the black hole(7), and if the baryons can be accelerated to relativistic speeds, the jets should be strong sources of gamma-rays and neutrino emission.	[Trigo, Maria Diaz] European So Observ, D-85748 Garching, Germany; [Miller-Jones, James C. A.] Curtin Univ, Int Ctr Radio Astron Res, Perth, WA 6845, Australia; [Migliari, Simone] Univ Barcelona, Dept Astron & Meteorol, E-08028 Barcelona, Spain; [Broderick, Jess W.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Tzioumis, Tasso] CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia	European Southern Observatory; Curtin University; University of Barcelona; University of Southampton; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Trigo, MD (corresponding author), European So Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany.	mdiaztri@eso.org	Miller-Jones, James C. A./B-2411-2013; Broderick, Jess/AAD-2450-2019	Miller-Jones, James C. A./0000-0003-3124-2814; Broderick, Jess/0000-0002-2239-6099; Diaz Trigo, Maria/0000-0001-7796-4279	Commonwealth of Australia; Australian Research Council [DP120102393]; Spanish Ministerio de Economia y Competitividad; European Social Funds through a Ramon y Cajal Fellowship; Spanish Ministerio de Ciencia e Innovacion [AYA2010-21782-C03-01]; ESA member states; USA (NASA)	Commonwealth of Australia(Australian Government); Australian Research Council(Australian Research Council); Spanish Ministerio de Economia y Competitividad(Spanish Government); European Social Funds through a Ramon y Cajal Fellowship(Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ESA member states(European Space Agency); USA (NASA)(National Aeronautics & Space Administration (NASA))	This work was based on observations obtained with XMM-Newton, a European Space Agency (ESA) science mission with instruments and contributions directly funded by ESA member states and the USA (NASA). We thank the XMM-Newton team for the fast scheduling of these observations and the EPIC calibration team for advice. ATCA is part of the Australia Telescope National Facility which is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. This work was supported by the Australian Research Council's 'Discovery Projects' funding scheme (J.C.A.M.-J.; project number DP120102393), the Spanish Ministerio de Economia y Competitividad and European Social Funds through a Ramon y Cajal Fellowship (S. M.) and the Spanish Ministerio de Ciencia e Innovacion (S. M.; grant AYA2010-21782-C03-01). M. D. T. thanks A. Maury, A. Zdziarski and C. Done for discussions, in which regard J.C.A.M.-J. thanks M. Middleton and S. M. thanks G. Romero, V. Bosch-Ramon, G. Miniutti and S. Motta.	Abdo AA, 2009, SCIENCE, V326, P1512, DOI 10.1126/science.1182174; Abe Y, 2005, PUBL ASTRON SOC JPN, V57, P629, DOI 10.1093/pasj/57.4.629; Aiello S, 2007, ASTROPART PHYS, V28, P1, DOI 10.1016/j.astropartphys.2007.03.003; Arnaud KA, 1996, ASTR SOC P, V101, P17; Augusteijn T, 2001, ASTRON ASTROPHYS, V375, P447, DOI 10.1051/0004-6361:20010855; BEGELMAN MC, 1980, ASTROPHYS J, V238, P722, DOI 10.1086/158029; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; Cui W, 2000, ASTROPHYS J, V529, P952, DOI 10.1086/308314; Done C, 2010, MON NOT R ASTRON SOC, V407, P2287, DOI 10.1111/j.1365-2966.2010.17092.x; Dunn RJH, 2005, MON NOT R ASTRON SOC, V364, P1343, DOI 10.1111/j.1365-2966.2005.09673.x; Fender RP, 2002, MON NOT R ASTRON SOC, V336, P39, DOI 10.1046/j.1365-8711.2002.05701.x; Gallo E, 2005, NATURE, V436, P819, DOI 10.1038/nature03879; Guainazzi M., 2012, XMMSOCCALTN0083; Heinz S, 2006, ASTROPHYS J, V636, P316, DOI 10.1086/497954; Hjellming RM, 1999, ASTROPHYS J, V514, P383, DOI 10.1086/306948; KOTANI T, 1994, PUBL ASTRON SOC JPN, V46, pL147; Kuulkers E, 1998, ASTROPHYS J, V494, P753, DOI 10.1086/305248; Levinson A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.171101; MARGON B, 1979, ASTROPHYS J, V233, pL63, DOI 10.1086/183077; Marshall HL, 2002, ASTROPHYS J, V564, P941, DOI 10.1086/324398; McClintock J. E., 2006, COMPACT STELLAR XRAY, P157, DOI DOI 10.2277/0521826594; McMullin JP, 2007, ASTR SOC P, V376, P127; Miller JM, 2007, ANNU REV ASTRON ASTR, V45, P441, DOI 10.1146/annurev.astro.45.051806.110555; Miniutti G, 2006, MON NOT R ASTRON SOC, V366, P115, DOI 10.1111/j.1365-2966.2005.09805.x; Mirabel IF, 1997, ASTROPHYS J, V477, pL45, DOI 10.1086/310509; Narayan R, 2012, MON NOT R ASTRON SOC, V419, pL69, DOI 10.1111/j.1745-3933.2011.01181.x; Ng C, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200913575; Piano G, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219145; Protassov R, 2002, ASTROPHYS J, V571, P545, DOI 10.1086/339856; Romero GE, 2003, ASTRON ASTROPHYS, V410, pL1, DOI [10.1051/0004-6361:20031314-1, 10.1051/0004-6361:20031314]; Russell DM, 2013, MON NOT R ASTRON SOC, V431, P405, DOI 10.1093/mnras/stt176; Russell DM, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/1/L19; Sault RJ, 1995, ASTR SOC P, V77, P433; Tavani M, 2009, NATURE, V462, P620, DOI 10.1038/nature08578; Vila GS, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201118106; Wardle JFC, 1998, NATURE, V395, P457, DOI 10.1038/26675; Wilson WE, 2011, MON NOT R ASTRON SOC, V416, P832, DOI 10.1111/j.1365-2966.2011.19054.x; Worrall DM, 2009, ASTRON ASTROPHYS REV, V17, P1, DOI 10.1007/s00159-008-0016-7	39	57	57	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					260	+		10.1038/nature12672	http://dx.doi.org/10.1038/nature12672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24226774	Green Submitted			2022-12-28	WOS:000328121500032
J	Barouch, DH				Barouch, Dan H.			The Quest for an HIV-1 Vaccine - Moving Forward	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EFFICACY TRIAL; DOUBLE-BLIND; INFECTION; THAILAND	The challenges in the development of a prophylactic HIV-1 vaccine are unprecedented in the history of vaccinology. But there are reasons for optimism, and indeed, several promising vaccine concepts are currently moving toward clinical efficacy trials. Vaccines have historically been the most effective biomedical interventions for controlling global infectious diseases. The development of a safe and effective vaccine against human immunodeficiency virus type 1 (HIV-1) is therefore a critical research priority. Although other HIV-1 prevention efforts based on behavioral risk reduction, male circumcision, topical microbicides, preexposure prophylaxis, and treatment as prevention have had substantial effects on HIV-1 transmission rates, it is likely that a vaccine will be required to end the global HIV-1 epidemic. The challenges in the development of a prophylactic HIV-1 vaccine, however, are unprecedented in the history of vaccinology. First, HIV-1 exhibits tremendous ...	[Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.] Harvard Univ, Sch Med, Boston, MA USA; [Barouch, Dan H.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Barouch, Dan H.] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.		Barouch, Dan/Y-3918-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084794, U19AI078526, U19AI096040, U19AI095985] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI096040, R01 AI084794, U19 AI095985, U19 AI078526] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492	5	16	18	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2073	2076		10.1056/NEJMp1312711	http://dx.doi.org/10.1056/NEJMp1312711			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	258OB	24283223	Green Accepted			2022-12-28	WOS:000327467500003
J	Braithwaite, RS				Braithwaite, R. Scott			EBM's Six Dangerous Words	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									NYU, Sch Med, Dept Populat Hlth, New York, NY 10012 USA	New York University	Braithwaite, RS (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 10012 USA.	scott.braithwaite@nyumc.org		Braithwaite, Ronald Scott/0000-0001-7067-3655				ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Bardes CL, 2012, NEW ENGL J MED, V366, P782, DOI 10.1056/NEJMp1200070; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Braithwaite RS, 2011, J GEN INTERN MED, V26, P543, DOI 10.1007/s11606-010-1599-z; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; KASSIRER JP, 1987, ANN INTERN MED, V106, P275, DOI 10.7326/0003-4819-106-2-275; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459	8	21	23	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2149	2150		10.1001/jama.2013.281996	http://dx.doi.org/10.1001/jama.2013.281996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24281458				2022-12-28	WOS:000327404400021
J	Roehr, B				Roehr, Bob			What will climate change mean for infectious disease? As global climate change becomes more apparent with each passing day, predicting how that will play out in shifting patterns of disease remains very much conjecture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Chowdhary A, 2013, J ANTIMICROB CHEMOTH	3	1	2	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2013	347								f6713	10.1136/bmj.f6713	http://dx.doi.org/10.1136/bmj.f6713			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FA	24277338				2022-12-28	WOS:000327791000002
J	Donley, EA				Donley, Elizabeth A.			A View on Energy Transfer Between Cold Atoms	SCIENCE			English	Editorial Material									NIST, Div Time & Frequency, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Donley, EA (corresponding author), NIST, Div Time & Frequency, Boulder, CO 80305 USA.	edonley@boulder.nist.gov	Donley, Elizabeth/O-4916-2019	Donley, Elizabeth/0000-0002-3439-4322				Collini E, 2013, CHEM SOC REV, V42, P4932, DOI 10.1039/c3cs35444j; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Gunter G, 2013, SCIENCE, V342, P954, DOI 10.1126/science.1244843; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Muller M, 2012, ADV ATOM MOL OPT PHY, V61, P1, DOI 10.1016/B978-0-12-396482-3.00001-6	6	0	0	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					942	943		10.1126/science.1247392	http://dx.doi.org/10.1126/science.1247392			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264983				2022-12-28	WOS:000327223500030
J	Sieweke, MH; Allen, JE				Sieweke, Michael H.; Allen, Judith E.			Beyond Stem Cells: Self-Renewal of Differentiated Macrophages	SCIENCE			English	Review							COLONY-STIMULATING FACTOR; TISSUE-RESIDENT MACROPHAGES; CENTRAL-NERVOUS-SYSTEM; LANGERHANS CELLS; BLOOD MONOCYTES; BONE-MARROW; ALVEOLAR MACROPHAGE; FACTOR-I; C-MYB; HEMATOPOIETIC-CELLS	In many mammalian tissues, mature differentiated cells are replaced by self-renewing stem cells, either continuously during homeostasis or in response to challenge and injury. For example, hematopoietic stem cells generate all mature blood cells, including monocytes, which have long been thought to be the major source of tissue macrophages. Recently, however, major macrophage populations were found to be derived from embryonic progenitors and to renew independently of hematopoietic stem cells. This process may not require progenitors, as mature macrophages can proliferate in response to specific stimuli indefinitely and without transformation or loss of functional differentiation. These findings suggest that macrophages are mature differentiated cells that may have a self-renewal potential similar to that of stem cells.	[Sieweke, Michael H.] Aix Marseille Univ, CIML, UM2, F-13288 Marseille 09, France; [Sieweke, Michael H.] INSERM, U1104, F-13258 Marseille, France; [Sieweke, Michael H.] CNRS, UMR7280, Marseille, France; [Sieweke, Michael H.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Allen, Judith E.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Allen, Judith E.] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Edinburgh; University of Edinburgh	Sieweke, MH (corresponding author), Aix Marseille Univ, CIML, UM2, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sieweke@ciml.univ-mrs.fr; j.allen@ed.ac.uk	Allen, Judith E/C-9198-2011; Sieweke, Michael/AAR-7515-2020	Allen, Judith E/0000-0002-3829-066X; Sieweke, Michael/0000-0002-3228-9537	Agence Nationale de la Recherche [ANR-11-BSV3-0026]; Medical Research Council UK [MR/K01207X1, MR/J001929/1]; Wellcome Trust; European Union [Health-2009-4.3.1-1, 242131]; MRC [MR/K01207X/1, MR/J001929/1] Funding Source: UKRI; Medical Research Council [MR/J001929/1, MR/K01207X/1] Funding Source: researchfish	Agence Nationale de la Recherche(French National Research Agency (ANR)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	M.H.S. was supported by the Agence Nationale de la Recherche (ANR-11-BSV3-0026) and is a Fondation pour la Recherche Medicale (DEq. 20071210559 and DEq. 20110421320) and INSERM-Helmholtz group leader. J.A. received funding from the Medical Research Council UK (MR/K01207X1 and MR/J001929/1), the Wellcome Trust, and European Union FP7 Health-2009-4.3.1-1, 242131 (E PIAF).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; ALBLAS ABV, 1979, J EXP MED, V149, P1504, DOI DOI 10.1004/JEM.149.6.1504; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arpa L, 2009, EUR J IMMUNOL, V39, P514, DOI 10.1002/eji.200838283; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; BAUMBACH WR, 1986, J VIROL, V59, P276, DOI 10.1128/JVI.59.2.276-283.1986; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; BITTERMAN PB, 1984, J CLIN INVEST, V74, P460, DOI 10.1172/JCI111443; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cheng M, 1999, J BIOL CHEM, V274, P6553, DOI 10.1074/jbc.274.10.6553; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; COGGLE JE, 1984, J LEUKOCYTE BIOL, V35, P317; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Fejer G, 2013, P NATL ACAD SCI USA, V110, pE2191, DOI 10.1073/pnas.1302877110; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; GODLESKI JJ, 1972, J EXP MED, V136, P630, DOI 10.1084/jem.136.3.630; GOLDE DW, 1974, NEW ENGL J MED, V290, P875, DOI 10.1056/NEJM197404182901603; GOLDE DW, 1974, NATURE, V247, P373, DOI 10.1038/247373a0; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hegde SP, 1998, MOL CELL BIOL, V18, P2729, DOI 10.1128/MCB.18.5.2729; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Isbel NM, 2001, NEPHROL DIAL TRANSPL, V16, P1638, DOI 10.1093/ndt/16.8.1638; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jose MD, 2003, AM J TRANSPLANT, V3, P294, DOI 10.1034/j.1600-6143.2003.00068.x; Karp CL, 2012, J EXP MED, V209, P427, DOI 10.1084/jem.20120295; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Klappacher GW, 2002, CELL, V109, P169, DOI 10.1016/S0092-8674(02)00714-6; Koenen HJPM, 1996, CANCER IMMUNOL IMMUN, V42, P310, DOI 10.1007/s002620050288; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; LANGER SJ, 1992, MOL CELL BIOL, V12, P5355, DOI 10.1128/MCB.12.12.5355; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; LIN HS, 1975, J EXP MED, V142, P877, DOI 10.1084/jem.142.4.877; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Milner JD, 2010, BLOOD, V116, P2476, DOI 10.1182/blood-2009-11-255174; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Randolph GJ, 2013, IMMUNITY, V38, P619, DOI 10.1016/j.immuni.2013.04.002; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; ROUSSEL MF, 1994, ONCOGENE, V9, P405; ROUSSEL MF, 1994, J CELL SCI, P105; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Ruckerl D, 2012, BLOOD, V120, P2307, DOI 10.1182/blood-2012-02-408252; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; SAWYER RT, 1982, LAB INVEST, V46, P165; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Soza-Ried C, 2010, P NATL ACAD SCI USA, V107, P17304, DOI 10.1073/pnas.1004640107; Sullivan J, 1997, J BIOL CHEM, V272, P1943, DOI 10.1074/jbc.272.3.1943; Tagliani E, 2011, J EXP MED, V208, P1901, DOI 10.1084/jem.20110866; THOMAS ED, 1976, SCIENCE, V192, P1016, DOI 10.1126/science.775638; THOMPSON RA, 1970, J EXP MED, V131, P629, DOI 10.1084/jem.131.4.629; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; Ungar J, 1935, AM J PATHOL, V11, P681; VALOH C, 2007, J EXP MED, V204, P171, DOI DOI 10.1084/JEM.20061011; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VIROLAINEN M, 1968, J EXP MED, V127, P943, DOI 10.1084/jem.127.5.943; VOLKMAN A, 1966, J EXP MED, V124, P241, DOI 10.1084/jem.124.2.241; VOLKMAN A, 1983, LAB INVEST, V49, P291; VOLKMAN A, 1965, BRIT J EXP PATHOL, V46, P62; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; YAMADA M, 1990, J LEUKOCYTE BIOL, V47, P195, DOI 10.1002/jlb.47.3.195; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	95	330	338	5	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					946	+		10.1126/science.1242974	http://dx.doi.org/10.1126/science.1242974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264994				2022-12-28	WOS:000327223500033
J	Vermeulen, L; Morrissey, E; van der Heijden, M; Nicholson, AM; Sottoriva, A; Buczacki, S; Kemp, R; Tavare, S; Winton, DJ				Vermeulen, Louis; Morrissey, Edward; van der Heijden, Maartje; Nicholson, Anna M.; Sottoriva, Andrea; Buczacki, Simon; Kemp, Richard; Tavare, Simon; Winton, Douglas J.			Defining Stem Cell Dynamics in Models of Intestinal Tumor Initiation	SCIENCE			English	Article							CLONAL EVOLUTION; TUMORIGENESIS; POPULATIONS; PROGRESSION; MUTATIONS; CANCER; LGR5	Cancer is a disease in which cells accumulate genetic aberrations that are believed to confer a clonal advantage over cells in the surrounding tissue. However, the quantitative benefit of frequently occurring mutations during tumor development remains unknown. We quantified the competitive advantage of Apc loss, Kras activation, and P53 mutations in the mouse intestine. Our findings indicate that the fate conferred by these mutations is not deterministic, and many mutated stem cells are replaced by wild-type stem cells after biased, but still stochastic events. Furthermore, P53 mutations display a condition-dependent advantage, and especially in colitis-affected intestines, clones harboring mutations in this gene are favored. Our work confirms the previously theoretical notion that the tissue architecture of the intestine suppresses the accumulation of mutated lineages.	[Vermeulen, Louis; Morrissey, Edward; van der Heijden, Maartje; Nicholson, Anna M.; Buczacki, Simon; Kemp, Richard; Tavare, Simon; Winton, Douglas J.] Univ Cambridge, Cambridge Inst, Canc Res UK, Cambridge CB2 0RE, England; [Vermeulen, Louis; van der Heijden, Maartje] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands; [Sottoriva, Andrea] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Tavare, Simon] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam; University of Southern California; University of Southern California	Vermeulen, L (corresponding author), Univ Cambridge, Cambridge Inst, Canc Res UK, Robinson Way, Cambridge CB2 0RE, England.	l.vermeulen@amc.uva.nl	Vermeulen, Louis/B-7488-2008	Vermeulen, Louis/0000-0002-6066-789X; Morrissey, Edward/0000-0003-1021-5358; Sottoriva, Andrea/0000-0001-6709-9533; Kemp, Richard/0000-0002-0121-7709; Buczacki, Simon/0000-0002-2975-416X	Cancer Research UK; Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society); Cancer Research UK [19556, 17044] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society); Cancer Research UK(Cancer Research UK)	We thank the Cambridge Institute Biological Resource Unit for animal husbandry and F. De Sousa E Melo, J. P. Medema, and P. Calabrese for useful discussion. This work was supported by Cancer Research UK; L.V. received a fellowship from the Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society). We declare no competing financial interests.	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Calabrese P, 2004, AM J PATHOL, V164, P1337, DOI 10.1016/S0002-9440(10)63220-8; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fischer JM, 2012, ONCOGENE, V31, P2028, DOI 10.1038/onc.2011.385; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Leedham SJ, 2009, GASTROENTEROLOGY, V136, P542, DOI 10.1053/j.gastro.2008.10.086; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Michor F, 2004, CELL CYCLE, V3, P358; Nowak MA, 2003, P NATL ACAD SCI USA, V100, P14966, DOI 10.1073/pnas.2535419100; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016	18	269	271	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					995	998		10.1126/science.1243148	http://dx.doi.org/10.1126/science.1243148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264992				2022-12-28	WOS:000327223500047
J	De Vlaminck, I; Khush, KK; Strehl, C; Kohli, B; Luikart, H; Neff, NF; Okamoto, J; Snyder, TM; Cornfield, DN; Nicolls, MR; Weill, D; Bernstein, D; Valantine, HA; Quake, SR				De Vlaminck, Iwijn; Khush, Kiran K.; Strehl, Calvin; Kohli, Bitika; Luikart, Helen; Neff, Norma F.; Okamoto, Jennifer; Snyder, Thomas M.; Cornfield, David N.; Nicolls, Mark R.; Weill, David; Bernstein, Daniel; Valantine, Hannah A.; Quake, Stephen R.			Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy	CELL			English	Article							TRANSPLANT RECIPIENTS; INFECTION; DIAGNOSIS; VIRUSES; HEART; PHARMACOKINETICS; CYTOMEGALOVIRUS; POLYOMAVIRUS; BIOMARKERS; MICROBIOTA	There are few substantive methods to measure the health of the immune system, and the connection between immune strength and the viral component of the microbiome is poorly understood. Organ transplant recipients are treated with posttransplant therapies that combine immunosuppressive and antiviral drugs, offering a window into the effects of immune modulation on the virome. We used sequencing of cell-free DNA in plasma to investigate drug-virome interactions in a cohort of organ transplant recipients (656 samples, 96 patients) and find that antivirals and immunosuppressants strongly affect the structure of the virome in plasma. We observe marked virome compositional dynamics at the onset of the therapy and find that the total viral load increases with immunosuppression, whereas the bacterial component of the microbiome remains largely unaffected. The data provide insight into the relationship between the human virome, the state of the immune system, and the effects of pharmacological treatment and offer a potential application of the virome state to predict immunocompetence.	[De Vlaminck, Iwijn; Neff, Norma F.; Okamoto, Jennifer; Snyder, Thomas M.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [De Vlaminck, Iwijn; Neff, Norma F.; Okamoto, Jennifer; Snyder, Thomas M.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [De Vlaminck, Iwijn; Neff, Norma F.; Okamoto, Jennifer; Snyder, Thomas M.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Khush, Kiran K.; Strehl, Calvin; Kohli, Bitika; Luikart, Helen; Valantine, Hannah A.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Cornfield, David N.; Nicolls, Mark R.; Weill, David] Stanford Univ, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Bernstein, Daniel] Stanford Univ, Sch Med, Div Pediat Cardiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu	De Vlaminck, Iwijn/P-6479-2015; Nicolls, Mark/K-6085-2019	De Vlaminck, Iwijn/0000-0001-6085-7311; Bernstein, Daniel/0000-0001-7761-5853; Snyder, Thomas/0000-0001-7256-7821; Khush, Kiran/0000-0001-9697-5926	NIH [RC4AI092673, K23HL091143]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095686, R01HL070628, P01HL108797, K23HL091143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092673] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000251] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant RC4AI092673 and K23HL091143 (K.K.) and the Howard Hughes Medical Institute.	Avivi I, 2004, BIOL BLOOD MARROW TR, V10, P186, DOI 10.1016/j.bbmt.2003.11.001; Bruno B, 2003, BIOL BLOOD MARROW TR, V9, P341, DOI 10.1016/S1083-8791(03)00102-2; Budde K, 2011, CLIN PHARMACOL THER, V90, P316, DOI 10.1038/clpt.2011.111; CHESTERS PM, 1983, J INFECT DIS, V147, P676, DOI 10.1093/infdis/147.4.676; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Fishman JA, 2007, CLIN TRANSPLANT, V21, P149, DOI 10.1111/j.1399-0012.2006.00618.x; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; JUSKO WJ, 1995, CLIN PHARMACOL THER, V57, P281, DOI 10.1016/0009-9236(95)90153-1; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Madsen CD., 2002, HIV CLIN TRIALS, V3, P287, DOI DOI 10.1310/hct.2002.3.4.004; Marboe CC, 2005, J HEART LUNG TRANSPL, V24, pS219, DOI 10.1016/j.healun.2005.04.001; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Oksanen J., 2007, COMMUN ECOL PACK, V10, P631; Potena L, 2007, J CLIN MICROBIOL, V45, P1804, DOI 10.1128/JCM.01362-06; Razonable RR, 2011, MAYO CLIN PROC, V86, P1009, DOI 10.4065/mcp.2011.0309; Razonable RR, 2005, J INFECT DIS, V192, P1331, DOI [10.1086/466529, 10.1086/466532]; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rossano JW, 2009, J HEART LUNG TRANSPL, V28, P26, DOI 10.1016/j.healun.2008.10.001; Saraiva F, 2011, TRANSPL P, V43, P1908, DOI 10.1016/j.transproceed.2011.03.010; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Slifkin M, 2004, DRUGS, V64, P2763, DOI 10.2165/00003495-200464240-00004; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; TeKippe EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050937; Thom K, 2007, J MED VIROL, V79, P1, DOI 10.1002/jmv.20756; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Venkataramanan R, 1995, CLIN PHARMACOKINET, V29, P404, DOI 10.2165/00003088-199529060-00003; Weber G, 2002, NAT GENET, V30, P141, DOI 10.1038/ng818; Wieland E, 2010, THER DRUG MONIT, V32, P560, DOI 10.1097/FTD.0b013e3181efb3d2; Wylie KM, 2012, TRANSL RES, V160, P283, DOI 10.1016/j.trsl.2012.03.006; Xia LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027992; Xu YH, 2003, GENOMICS, V81, P329, DOI 10.1016/S0888-7543(02)00043-5; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; zur Hausen H, 2009, CURR TOP MICROBIOL, V331, P109	39	284	292	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1178	1187		10.1016/j.cell.2013.10.034	http://dx.doi.org/10.1016/j.cell.2013.10.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267896	Green Accepted, Bronze			2022-12-28	WOS:000327500600020
J	Derex, M; Beugin, MP; Godelle, B; Raymond, M				Derex, Maxime; Beugin, Marie-Pauline; Godelle, Bernard; Raymond, Michel			Experimental evidence for the influence of group size on cultural complexity	NATURE			English	Article							DEMOGRAPHY; EVOLUTION	The remarkable ecological and demographic success of humanity is largely attributed to our capacity for cumulative culture(1-3). The accumulation of beneficial cultural innovations across generations is puzzling because transmission events are generally imperfect, although there is large variance in fidelity. Events of perfect cultural transmission and innovations should be more frequent in a large population(4). As a consequence, a large population size may be a prerequisite for the evolution of cultural complexity(4,5), although anthropological studies have produced mixed results(6-9) and empirical evidence is lacking(10). Here we use a dual-task computer game to show that cultural evolution strongly depends on population size, as players in larger groups maintained higher cultural complexity. We found that when group size increases, cultural knowledge is less deteriorated, improvements to existing cultural traits are more frequent, and cultural trait diversity is maintained more often. Our results demonstrate how changes in group size can generate both adaptive cultural evolution and maladaptive losses of culturally acquired skills. As humans live in habitats for which they are ill-suited without specific cultural adaptations(11,12), it suggests that, in our evolutionary past, group-size reduction may have exposed human societies to significant risks, including societal collapse(13).	[Derex, Maxime; Beugin, Marie-Pauline; Godelle, Bernard; Raymond, Michel] Univ Montpellier 2, F-34095 Montpellier 5, France; [Raymond, Michel] CNRS, Inst Evolutionary Sci, Montpellier, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Derex, M (corresponding author), Univ Montpellier 2, Pl Eugene Bataillon, F-34095 Montpellier 5, France.	maxime.derex@gmail.com	Raymond, Michel/C-9049-2015	Derex, Maxime/0000-0002-1512-6496; Raymond, Michel/0000-0002-1714-6984				Basalla G., 1988, EVOLUTION TECHNOLOGY; BOYD R, 1995, ETHOL SOCIOBIOL, V16, P125, DOI 10.1016/0162-3095(94)00073-G; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; Caldwell CA, 2010, LEARN BEHAV, V38, P310, DOI 10.3758/LB.38.3.310; Claidiere N, 2010, P R SOC B, V277, P651, DOI 10.1098/rspb.2009.1615; Collard M., 2005, CAN J ARCHAEOL J CAN, V29, P1; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; Derex M, 2013, EVOLUTION, V67, P688, DOI 10.1111/j.1558-5646.2012.01804.x; Diamond, 1999, GUNS GERMS STEEL FAT; DIAMOND JM, 1978, NATURE, V273, P185, DOI 10.1038/273185a0; Flynn E, 2010, LEARN BEHAV, V38, P284, DOI 10.3758/LB.38.3.284; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J, 2011, PHILOS T R SOC B, V366, P1139, DOI 10.1098/rstb.2010.0323; Henrich Joseph, 2002, J COGN CULT, P87; Kline MA, 2010, P ROY SOC B-BIOL SCI, V277, P2559, DOI 10.1098/rspb.2010.0452; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Lewis HM, 2012, PHILOS T R SOC B, V367, P2171, DOI 10.1098/rstb.2012.0119; Marquet PA, 2012, P NATL ACAD SCI USA, V109, P14754, DOI 10.1073/pnas.1116724109; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Read D., 2012, UC LOS ANGELES HUM C; Read D, 2008, AM ANTIQUITY, V73, P599, DOI 10.2307/25470520; Richerson P.J., 2005, NOT GENES ALONE; Smaldino P. E., BEHAV BRAIN IN PRESS; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tomasello Michael, 1996, P319, DOI 10.1016/B978-012273965-1/50016-9	28	167	170	3	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					389	+		10.1038/nature12774	http://dx.doi.org/10.1038/nature12774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KG	24226775				2022-12-28	WOS:000327163200039
J	Willsey, AJ; Sanders, SJ; Li, MF; Dong, S; Tebbenkamp, AT; Muhle, RA; Reilly, SK; Lin, L; Fertuzinhos, S; Miller, JA; Murtha, MT; Bichsel, C; Niu, W; Cotney, J; Ercan-Sencicek, AG; Gockley, J; Gupta, AR; Han, WQ; He, X; Hoffman, EJ; Klei, L; Lei, J; Liu, WZ; Liu, L; Lu, C; Xu, XM; Zhu, Y; Mane, SM; Lein, ES; Wei, LP; Noonan, JP; Roeder, K; Devlin, B; Sestan, N; State, MW				Willsey, A. Jeremy; Sanders, Stephan J.; Li, Mingfeng; Dong, Shan; Tebbenkamp, Andrew T.; Muhle, Rebecca A.; Reilly, Steven K.; Lin, Leon; Fertuzinhos, Sofia; Miller, Jeremy A.; Murtha, Michael T.; Bichsel, Candace; Niu, Wei; Cotney, Justin; Ercan-Sencicek, A. Gulhan; Gockley, Jake; Gupta, Abha R.; Han, Wenqi; He, Xin; Hoffman, Ellen J.; Klei, Lambertus; Lei, Jing; Liu, Wenzhong; Liu, Li; Lu, Cong; Xu, Xuming; Zhu, Ying; Mane, Shrikant M.; Lein, Ed S.; Wei, Liping; Noonan, James P.; Roeder, Kathryn; Devlin, Bernie; Sestan, Nenad; State, Matthew W.			Coexpression Networks Implicate Human Midfetal Deep Cortical Projection Neurons in the Pathogenesis of Autism	CELL			English	Article							SPECTRUM DISORDERS; NOVO MUTATIONS; GENES; RISK; CNVS	Autism spectrum disorder (ASD) is a complex developmental syndrome of unknown etiology. Recent studies employing exome- and genome-wide sequencing have identified nine high-confidence ASD (hcASD) genes. Working from the hypothesis that ASD-associated mutations in these biologically pleiotropic genes will disrupt intersecting developmental processes to contribute to a common phenotype, we have attempted to identify time periods, brain regions, and cell types in which these genes converge. We have constructed coexpression networks based on the hcASD "seed'' genes, leveraging a rich expression data set encompassing multiple human brain regions across human development and into adulthood. By assessing enrichment of an independent set of probable ASD (pASD) genes, derived from the same sequencing studies, we demonstrate a key point of convergence in midfetal layer 5/6 cortical projection neurons. This approach informs when, where, and in what cell types mutations in these specific genes may be productively studied to clarify ASD pathophysiology.	[Willsey, A. Jeremy; Sanders, Stephan J.; Dong, Shan; Muhle, Rebecca A.; Reilly, Steven K.; Niu, Wei; Cotney, Justin; Gockley, Jake; Liu, Wenzhong; Noonan, James P.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Willsey, A. Jeremy; Sanders, Stephan J.; State, Matthew W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Li, Mingfeng; Tebbenkamp, Andrew T.; Fertuzinhos, Sofia; Bichsel, Candace; Han, Wenqi; Xu, Xuming; Zhu, Ying; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Li, Mingfeng; Tebbenkamp, Andrew T.; Muhle, Rebecca A.; Fertuzinhos, Sofia; Bichsel, Candace; Niu, Wei; Han, Wenqi; Xu, Xuming; Zhu, Ying; Noonan, James P.; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Dong, Shan; Wei, Liping] Peking Univ, Sch Life Sci, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Muhle, Rebecca A.; Niu, Wei; Ercan-Sencicek, A. Gulhan; Gupta, Abha R.; Hoffman, Ellen J.; State, Matthew W.] Yale Univ, Sch Med, Child Study Ctr, New Haven, CT 06510 USA; [Lin, Leon] Yale Univ, Dept Computat Biol & Bioinformat, New Haven, CT 06511 USA; [Miller, Jeremy A.; Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Murtha, Michael T.; Ercan-Sencicek, A. Gulhan; Hoffman, Ellen J.; State, Matthew W.] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT 06510 USA; [Gupta, Abha R.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [He, Xin; Roeder, Kathryn] Carnegie Mellon Univ, Ray & Stephanie Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Lei, Jing; Liu, Li; Lu, Cong; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Mane, Shrikant M.] Yale Univ, Sch Med, Yale Ctr Genom Anal, New Haven, CT 06417 USA; [Wei, Liping] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA	Yale University; University of California System; University of California San Francisco; Yale University; Yale University; Peking University; Yale University; Yale University; Allen Institute for Brain Science; Yale University; Yale University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Yale University; National Institute of Biological Sciences, Beijing; Yale University	Devlin, B (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA.	devlinbj@upmc.edu; nenad.sestan@yale.edu; matthew.state@ucsf.edu	Noonan, James/ABF-1320-2021; Liu, Li/G-1897-2015; Sanders, Stephan/S-8645-2019; Zhu, Ying/T-2268-2019; State, Matthew/W-2256-2019; Cotney, Justin L/ABE-8500-2021; Hoffman, Ellen J/N-3421-2017; DONG, Shan/GVS-5706-2022; Willsey, A Jeremy/H-3001-2019	Cotney, Justin L/0000-0001-8230-2157; Hoffman, Ellen J/0000-0002-5083-1369; Willsey, A Jeremy/0000-0002-9922-3612; Zhu, Ying/0000-0002-6594-3734; Lei, Jing/0000-0003-3104-9387; Reilly, Steven/0000-0003-3140-1483; Lin, Zhixiang/0000-0001-9301-947X; Tebbenkamp, Andrew/0000-0002-9015-3427; State, Matthew/0000-0003-1624-8302; Dong, Shan/0000-0001-9130-0225; Gockley, Jake/0000-0001-7993-5308; Sanders, Stephan/0000-0001-9112-5148; Roeder, Kathryn/0000-0002-8869-6254	Overlook International Foundation; Simons Foundation; Kavli Foundation; National Institute of Mental Health [RC2 MH089956, U01 MH081896, R37 MH057881]; Foster-Davis Foundation Inc. (NARSAD DI); Howard Hughes Medical Institute; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, RC2MH089956, U01MH081896, T32MH018268, R25MH077823] Funding Source: NIH RePORTER	Overlook International Foundation; Simons Foundation; Kavli Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Foster-Davis Foundation Inc. (NARSAD DI); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to the families participating in the Simons Foundation Autism Research Initiative (SFARI) Simplex Collection (SSC). This work was supported by a gift from the Overlook International Foundation (to M. W. S., N. S., B. D., K. R., and J. N.), as well as grants from the Simons Foundation (to M. W. S., N. S., K. R., and J. N.), the Kavli Foundation (to N. S.), the National Institute of Mental Health (RC2 MH089956 to M. W. S., U01 MH081896 to N. S., and R37 MH057881 to B. D. and K. R.), the Foster-Davis Foundation Inc. (NARSAD DI to N. S.), the Howard Hughes Medical Institute (International Student Research Fellowship to both S. J. S. and W. H.), and the Canadian Institutes of Health Research (Doctoral Foreign Study Award to A. J. W.). We would like to thank the SSC principal investigators (A. L. Beaudet, R. Bernier, J. Constantino, E. H. Cook, Jr, E. Fombonne, D. Geschwind, D. E. Grice, A. Klin, D. H. Ledbetter, C. Lord, C. L. Martin, D. M. Martin, R. Maxim, J. Miles, O. Ousley, B. Peterson, J. Piggot, C. Saulnier, M. W. State, W. Stone, J. S. Sutcliffe, C. A. Walsh, and E. Wijsman) and the coordinators and staff at the SSC clinical sites; the SFARI staff, in particular M. Benedetti; the Rutgers University Cell and DNA repository for accessing biomaterials; the Yale Center of Genomic Analysis, in particular J. Overton, S. Umlauf, I. Tikhonova, and A. Lopez, for generating sequencing data; T. Brooks-Boone, N. Wright-Davis, and M. Wojciechowski for their help in administering the project at Yale; and H. Rankin for unwavering support.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003443; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schmidt E.F., 2013, COLD SPRING HARB PRO, V2013; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013	27	562	568	2	81	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					997	1007		10.1016/j.cell.2013.10.020	http://dx.doi.org/10.1016/j.cell.2013.10.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267886	Green Accepted, Bronze			2022-12-28	WOS:000327500600006
J	Kahan, S; Osborn, R				Kahan, Scott; Osborn, Robyn			Weight loss was greater with Weight Watchers than with a behavioral program plus Weight Watchers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kahan, Scott] George Washington Univ, Washington, DC 20052 USA; [Osborn, Robyn] Natl Ctr Weight & Wellness, Washington, DC USA	George Washington University	Kahan, S (corresponding author), George Washington Univ, Washington, DC 20052 USA.			Kahan, Scott/0000-0002-3080-0661				Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Shaw K, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003818.pub2	3	0	0	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10							JC5	10.7326/0003-4819-159-10-201311190-02005	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247695				2022-12-28	WOS:000328732700004
J	Uchino, K				Uchino, Ken			Strong stimulation acupuncture with needle manipulation improved recovery in Bell palsy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Uchino, K (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.		Uchino, Ken/ABC-1611-2021	Uchino, Ken/0000-0001-9468-4172					0	3	3	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10							JC8	10.7326/0003-4819-159-10-201311190-02008	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247698				2022-12-28	WOS:000328732700007
J	Spence, D				Spence, Des			Big pharma and big medicine in big trouble	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 15	2013	347								f6900	10.1136/bmj.f6900	http://dx.doi.org/10.1136/bmj.f6900			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254HR	24243980				2022-12-28	WOS:000327156300013
J	Sen, A				Sen, Amartya			What's happening in Bangladesh?	LANCET			English	Editorial Material									Harvard Univ, Dept Econ, Littauer Ctr, Cambridge, MA 02138 USA	Harvard University	Sen, A (corresponding author), Harvard Univ, Dept Econ, Littauer Ctr, Cambridge, MA 02138 USA.	asen@fas.harvard.edu						Adams AM, 2013, LANCET; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Brody Miriam, 2004, VINDICATION RIGHTS W; Cash RA, 2013, LANCET; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Dreze J., 2013, UNCERTAIN GLORY INDI, DOI 10.2307/j.ctt32bcbm; El Arifeen S, 2013, LANCET	7	19	20	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					1966	1968		10.1016/S0140-6736(13)62162-5	http://dx.doi.org/10.1016/S0140-6736(13)62162-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269EI	24268609				2022-12-28	WOS:000328223700011
J	Smith, G; Smolin, JA				Smith, Graeme; Smolin, John A.			An exactly solvable model for quantum communications	NATURE			English	Article							CLASSICAL CAPACITY; GAUSSIAN CHANNELS	Information theory establishes the ultimate limits on performance for noisy communication systems(1). Accurate models of physical communication devices must include quantum effects, but these typically make the theory intractable(2-5). As a result, communication capacities-the maximum possible rates of data transmission-are not known, even for transmission between two users connected by an electromagnetic waveguide with Gaussian noise(6). Here we present an exactly solvable model of communication with a fully quantum electromagnetic field. This gives explicit expressions for all point-to-point capacities of noisy quantum channels, with implications for quantum key distribution and fibre-optic communications. We also develop a theory of quantum communication networks by solving some rudimentary models including broadcast and multiple-access channels. We compare the predictions of our model with the orthodox Gaussian model and in all cases find agreement to within a few bits. At high signal-to-noise ratios, our simple model captures the relevant physics while remaining amenable to exact solution.	[Smith, Graeme; Smolin, John A.] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Smith, G (corresponding author), IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA.	gsbsmith@gmail.com			DARPA QUEST programme [HR0011-09-C-0047]	DARPA QUEST programme	This work was supported by the DARPA QUEST programme under contract no. HR0011-09-C-0047.	Bennett CH, 1996, PHYS REV A, V54, P3824, DOI 10.1103/PhysRevA.54.3824; Cover T. M, 1991, ELEMENTS INFORM THEO, P374; Cover TM, 1998, IEEE T INFORM THEORY, V44, P2524, DOI 10.1109/18.720547; DiVincenzo DP, 1998, PHYS REV A, V57, P830, DOI 10.1103/PhysRevA.57.830; Eisert J, 2007, QUANTUM INFORMATION WITH CONTINOUS VARIABLES OF ATOMS AND LIGHT, P23, DOI 10.1142/9781860948169_0002; El Gamal A., 2011, NETWORK INFORM THEOR; Giovannetti V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.027902; Gordon J.P., 1964, QUANTUM ELECT COHERE, P156; Guha S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.032303; Hastings MB, 2009, NAT PHYS, V5, P255, DOI 10.1038/NPHYS1224; Holevo AS, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.032312; Holevo AS, 1998, IEEE T INFORM THEORY, V44, P269, DOI 10.1109/18.651037; Holevo AS., 1973, P 2 JAP USSR S PROB, ppp 104, DOI [10.1007/BFb0061483, DOI 10.1007/BFB0061483]; Horodecki K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160502; Richardson T, 2003, IEEE COMMUN MAG, V41, P126, DOI 10.1109/MCOM.2003.1222728; Schumacher B, 1997, PHYS REV A, V56, P131, DOI 10.1103/PhysRevA.56.131; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shor P.W, 1996, QUANTUM ERROR CORREC; Smith G, 2008, SCIENCE, V321, P1812, DOI 10.1126/science.1162242; Smith G, 2011, NAT PHOTONICS, V5, P624, DOI [10.1038/NPHOTON.2011.203, 10.1038/nphoton.2011.203]; Smith G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120503; Tse D., 2007, P ALL C COMM CONTR C, P721; Wilde MM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140501; Wolf MM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.130501; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; Yen BJ, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.062312	29	4	4	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					263	267		10.1038/nature12669	http://dx.doi.org/10.1038/nature12669			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24240277	Green Submitted			2022-12-28	WOS:000328121500033
J	Parsa, A; Kao, WHL; Xie, DW; Astor, BC; Li, M; Hsu, CY; Feldman, HI; Parekh, RS; Kusek, JW; Greene, TH; Fink, JC; Anderson, AH; Choi, MJ; Wright, JT; Lash, JP; Freedman, BI; Ojo, A; Winkler, CA; Raj, DS; Kopp, JB; He, J; Jensvold, NG; Tao, KX; Lipkowitz, MS; Appel, LJ				Parsa, Afshin; Kao, W. H. Linda; Xie, Dawei; Astor, Brad C.; Li, Man; Hsu, Chi-yuan; Feldman, Harold I.; Parekh, Rulan S.; Kusek, John W.; Greene, Tom H.; Fink, Jeffrey C.; Anderson, Amanda H.; Choi, Michael J.; Wright, Jackson T., Jr.; Lash, James P.; Freedman, Barry I.; Ojo, Akinlolu; Winkler, Cheryl A.; Raj, Dominic S.; Kopp, Jeffrey B.; He, Jiang; Jensvold, Nancy G.; Tao, Kaixiang; Lipkowitz, Michael S.; Appel, Lawrence J.		AASK Study Investigators; CRIC Study Investigators	APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAGE RENAL-DISEASE; BASE-LINE CHARACTERISTICS; RACIAL-DIFFERENCES; INSUFFICIENCY COHORT; FUNCTION DECLINE; GENE; MYH9; GFR; PARTICIPANTS; CKD	BackgroundAmong patients in the United States with chronic kidney disease, black patients are at increased risk for end-stage renal disease, as compared with white patients. MethodsIn two studies, we examined the effects of variants in the gene encoding apolipoprotein L1 (APOL1) on the progression of chronic kidney disease. In the African American Study of Kidney Disease and Hypertension (AASK), we evaluated 693 black patients with chronic kidney disease attributed to hypertension. In the Chronic Renal Insufficiency Cohort (CRIC) study, we evaluated 2955 white patients and black patients with chronic kidney disease (46% of whom had diabetes) according to whether they had 2 copies of high-risk APOL1 variants (APOL1 high-risk group) or 0 or 1 copy (APOL1 low-risk group). In the AASK study, the primary outcome was a composite of end-stage renal disease or a doubling of the serum creatinine level. In the CRIC study, the primary outcomes were the slope in the estimated glomerular filtration rate (eGFR) and the composite of end-stage renal disease or a reduction of 50% in the eGFR from baseline. ResultsIn the AASK study, the primary outcome occurred in 58.1% of the patients in the APOL1 high-risk group and in 36.6% of those in the APOL1 low-risk group (hazard ratio in the high-risk group, 1.88; P<0.001). There was no interaction between APOL1 status and trial interventions or the presence of baseline proteinuria. In the CRIC study, black patients in the APOL1 high-risk group had a more rapid decline in the eGFR and a higher risk of the composite renal outcome than did white patients, among those with diabetes and those without diabetes (P<0.001 for all comparisons). ConclusionsRenal risk variants in APOL1 were associated with the higher rates of end-stage renal disease and progression of chronic kidney disease that were observed in black patients as compared with white patients, regardless of diabetes status. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.)	[Parsa, Afshin; Fink, Jeffrey C.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Kao, W. H. Linda; Li, Man; Appel, Lawrence J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Choi, Michael J.; Appel, Lawrence J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Kao, W. H. Linda; Appel, Lawrence J.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Xie, Dawei; Feldman, Harold I.; Anderson, Amanda H.; Tao, Kaixiang] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xie, Dawei; Feldman, Harold I.; Anderson, Amanda H.; Tao, Kaixiang] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Astor, Brad C.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Hsu, Chi-yuan] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Parekh, Rulan S.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Parekh, Rulan S.] Univ Hlth Network, Toronto, ON, Canada; [Kusek, John W.; Kopp, Jeffrey B.] NIDDK, NIH, Bethesda, MD 20892 USA; [Winkler, Cheryl A.] NCI, Ctr Canc Res, SAIC Frederick, Frederick, MD USA; [Greene, Tom H.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Wright, Jackson T., Jr.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Lash, James P.] Univ Illinois, Coll Med, Chicago, IL USA; [Freedman, Barry I.] Wake Forest Sch Med, Winston Salem, NC USA; [Ojo, Akinlolu] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Raj, Dominic S.] George Washington Univ, Sch Med, Washington, DC USA; [Lipkowitz, Michael S.] Georgetown Univ, Sch Med, Washington, DC USA; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Hsu, Chi-yuan; Jensvold, Nancy G.] Kaiser Permanente No Calif, Oakland, CA USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Utah System of Higher Education; University of Utah; Case Western Reserve University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Wake Forest University; University of Michigan System; University of Michigan; George Washington University; Georgetown University; Tulane University; Kaiser Permanente	Appel, LJ (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-642, Baltimore, MD 21287 USA.	lappel@jhmi.edu	Kopp, Jeffrey B/O-2681-2015; Soliman, Elsayed Z/AAD-7135-2020; Li, Man/AAX-3400-2020; He, Jiang/AAF-5303-2020; Appel, Larry/GLT-2608-2022; Parekh, Rulan/AAQ-4411-2020	Kopp, Jeffrey B/0000-0001-9052-186X; Soliman, Elsayed Z/0000-0001-5632-8150; Li, Man/0000-0002-3839-0281; He, Jiang/0000-0002-8286-9652; Parekh, Rulan/0000-0001-6313-5752; Greene, Tom/0000-0002-3706-7570; Fink, Jeffrey/0000-0002-5622-5052	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CANCER INSTITUTE [ZIABC010022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887, UL1RR024989, M01RR000080, P20RR011104, M01RR000071, UL1RR024131, M01RR016500, M01RR000827, K12RR023250, M01RR000052, UL1RR025005, UL1RR024134, UL1RR029879, P20RR011145, UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061028, U01DK060963, K24DK002818, ZIADK043308, U01DK060902, U01DK061021, U01DK061022, U01DK060984, U01DK060980, U01DK060990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson AH, 2012, AM J KIDNEY DIS, V60, P250, DOI 10.1053/j.ajkd.2012.04.012; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Appel LJ, 2003, J AM SOC NEPHROL, V14, pS166, DOI 10.1097/01.ASN.0000070081.15137.C0; Barbour SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2422, DOI 10.1093/ndt/gfq283; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Choi AI, 2009, AM J MED, V122, P672, DOI 10.1016/j.amjmed.2008.11.021; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Derose SF, 2013, AM J KIDNEY DIS, V62, P236, DOI 10.1053/j.ajkd.2013.01.019; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Fischer MJ, 2011, AM J KIDNEY DIS, V58, P214, DOI 10.1053/j.ajkd.2011.05.010; Foster MC, 2013, J AM SOC NEPHROL, V24, P1484, DOI 10.1681/ASN.2013010113; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Friedman DJ, 2011, J AM SOC NEPHROL, V22, P2098, DOI 10.1681/ASN.2011050519; Genovese G, 2013, NAT REV NEPHROL, V9, P240, DOI 10.1038/nrneph.2013.34; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; Hall YN, 2005, KIDNEY INT, V68, P2310, DOI 10.1111/j.1523-1755.2005.00691.x; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lash, 2011, CLIN J AM SOC NEPHRO, V6, P2548; Lash JP, 2009, CLIN J AM SOC NEPHRO, V4, P1302, DOI 10.2215/CJN.00070109; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Lipkowitz MS, 2013, KIDNEY INT, V83, P114, DOI 10.1038/ki.2012.263; Lipworth L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048407; Madhavan SM, 2011, J AM SOC NEPHROL, V22, P2119, DOI 10.1681/ASN.2011010069; Matsha TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052529; MCCLELLAN W, 1988, AM J KIDNEY DIS, V12, P285, DOI 10.1016/S0272-6386(88)80221-X; McClellan W, 2006, J AM SOC NEPHROL, V17, P1710, DOI 10.1681/ASN.2005111200; Pays E, 2009, CURR OPIN IMMUNOL, V21, P493, DOI 10.1016/j.coi.2009.05.024; Peralta CA, 2013, AM J KIDNEY DIS, V62, P261, DOI 10.1053/j.ajkd.2013.01.012; Pollak MR, 2012, CURR OPIN NEPHROL HY, V21, P179, DOI 10.1097/MNH.0b013e32835012ab; Reeves-Daniel AM, 2011, AM J TRANSPLANT, V11, P1025, DOI 10.1111/j.1600-6143.2011.03513.x; Sika M, 2007, AM J KIDNEY DIS, V50, P78, DOI 10.1053/j.ajkd.2007.03.004; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; WALKER WG, 1992, JAMA-J AM MED ASSOC, V268, P3085, DOI 10.1001/jama.268.21.3085; Wright JT, 2006, JAMA-J AM MED ASSOC, V295, P2726	42	505	515	12	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2183	2196		10.1056/NEJMoa1310345	http://dx.doi.org/10.1056/NEJMoa1310345			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24206458	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000327801100005
J	Engmann, C; Wall, S; Darmstadt, G; Valsangkar, B; Claeson, M				Engmann, Cyril; Wall, Stephen; Darmstadt, Gary; Valsangkar, Bina; Claeson, Mariam		Istanbul KMC Acceleration Meeting	Consensus on kangaroo mother care acceleration	LANCET			English	Editorial Material									[Engmann, Cyril; Darmstadt, Gary; Claeson, Mariam] Bill & Melinda Gates Fdn, Maternal Newborn & Child Hlth, Seattle, WA 98102 USA; [Wall, Stephen; Valsangkar, Bina] Save Children Saving Newborn Lives, Washington, DC USA	Bill & Melinda Gates Foundation; Save the Children	Engmann, C (corresponding author), Bill & Melinda Gates Fdn, Maternal Newborn & Child Hlth, Seattle, WA 98102 USA.	cyril.engmann@gatesfoundation.org	Valsangkar, Bina/CAF-1920-2022; Darmstadt, Gary/AAU-7488-2020	Darmstadt, Gary/0000-0002-7522-5824				UNICEF, 2017, LEVELS TRENDS CHILD	2	48	48	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					E26	E27		10.1016/S0140-6736(13)62293-X	http://dx.doi.org/10.1016/S0140-6736(13)62293-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259QF	24246562				2022-12-28	WOS:000327540700001
J	George, J; Majeed, W; Mackenzie, IS; MacDonald, TM; Wei, L				George, Jacob; Majeed, Waseem; Mackenzie, Isla S.; MacDonald, Thomas M.; Wei, Li			Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; MORTALITY; SALT; POTASSIUM; REDUCTION	Objective To determine whether patients taking formulations of drugs that contain sodium have a higher incidence of cardiovascular events compared with patients on non-sodium formulations of the same drugs. Design Nested case-control study. Setting UK Primary Care Patients registered on the Clinical Practice Research Datalink (CPRD). Participants All patients aged 18 or over who were prescribed at least two prescriptions of sodium-containing formulations or matched standard formulations of the same drug between January 1987 and December 2010. Main outcome measures Composite primary outcome of incident non-fatal myocardial infarction, incident non-fatal stroke, or vascular death. We performed 1: 1 incidence density sampling matched controls using the UK Clinical Practice Research Datalink (CPRD). For the secondary analyses, cases were patients with the individual components of the primary study composite endpoint of hypertension, incident heart failure, and all cause mortality. Results 1 292 337 patients were included in the study cohort. Mean follow-up time was 7.23 years. A total of 61 072 patients with an incident cardiovascular event were matched with controls. For the primary endpoint of incident non-fatal myocardial infarction, incident non-fatal stroke, or vascular death the adjusted odds ratio for exposure to sodium-containing drugs was 1.16 (95% confidence interval 1.12 to 1.21). The adjusted odds ratios for the secondary endpoints were 1.22 (1.16 to 1.29) for incident non-fatal stroke, 1.28 (1.23 to 1.33) for all cause mortality, 7.18 (6.74 to 7.65) for hypertension, 0.98 (0.93 to 1.04) for heart failure, 0.94 (0.88 to 1.00) for incident non-fatal myocardial infarction, and 0.70 (0.31 to 1.59) for vascular death. The median time from date of first prescription (that is, date of entry into cohort) to first event was 3.92 years. Conclusions Exposure to sodium-containing formulations of effervescent, dispersible, and soluble medicines was associated with significantly increased odds of adverse cardiovascular events compared with standard formulations of those same drugs. Sodium-containing formulations should be prescribed with caution only if the perceived benefits outweigh these risks.	[George, Jacob] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland; [Majeed, Waseem] Ninewells Hosp, NHS Tayside, Dundee DD1 9SY, Scotland; [Mackenzie, Isla S.; MacDonald, Thomas M.; Wei, Li] Univ Dundee, Ninewells Hosp & Med Sch, Med Monitoring Unit, Dundee DD1 9SY, Scotland; [Mackenzie, Isla S.; MacDonald, Thomas M.; Wei, Li] Univ Dundee, Ninewells Hosp & Med Sch, Hypertens Res Ctr, Dundee DD1 9SY, Scotland; [Wei, Li] UCL Sch Pharm, Dept Practice & Policy, London WC1H 9JP, England	University of Dundee; University of Dundee; University of Dundee; University of London; University College London	MacDonald, TM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Monitoring Unit, Dundee DD1 9SY, Scotland.	tom@memo.dundee.ac.uk		Majeed, Waseem/0000-0001-7836-0610; MacDonald, Thomas/0000-0001-5189-6669; George, Jacob/0000-0001-8154-8278; Mackenzie, Isla/0000-0002-3680-7127	TENOVUS Scotland [T10/12]	TENOVUS Scotland	This study was funded by TENOVUS Scotland (ref T10/12). The funder had no role in the design, conduct or data interpretation of the study.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Alderman MH, 1998, LANCET, V351, P781, DOI 10.1016/S0140-6736(97)09092-2; Alderman MH, 2012, CURR HYPERTENS REP, V14, P193, DOI 10.1007/s11906-012-0275-6; Azoulay L, 2013, THROMB HAEMOSTASIS, V109, P431, DOI 10.1160/TH12-08-0542; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; DAHL LK, 1954, ARCH INTERN MED, V94, P525, DOI 10.1001/archinte.1954.00250040017003; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; ELLIOTT P, 1988, BRIT MED J, V297, P319; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Food Standards Agency, 2002, HLTH IN WORTH ITS SA; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Gupta D, 2012, CIRCULATION, V126, P479, DOI 10.1161/CIRCULATIONAHA.111.062430; Haddy FJ, 2006, AM J PHYSIOL-REG I, V290, pR546, DOI 10.1152/ajpregu.00491.2005; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Institute of Medicine, 2010, STRAT RED SOD INT US; Li XY, 2012, CNS NEUROSCI THER, V18, P691, DOI 10.1111/j.1755-5949.2012.00355.x; Lim PO, 2001, HYPERTENSION, V37, P856, DOI 10.1161/01.HYP.37.3.856; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235; Tzemos N, 2008, HYPERTENSION, V51, P1525, DOI 10.1161/HYPERTENSIONAHA.108.109868; Ubeda A, 2009, PHARMACOEPIDEM DR S, V18, P417, DOI 10.1002/pds.1701; Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257	23	41	43	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2013	347								f6954	10.1136/bmj.f6954	http://dx.doi.org/10.1136/bmj.f6954			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FN	24284017	hybrid, Green Published			2022-12-28	WOS:000327792500003
J	Fier, PS; Hartwig, JF				Fier, Patrick S.; Hartwig, John F.			Selective C-H Fluorination of Pyridines and Diazines Inspired by a Classic Amination Reaction	SCIENCE			English	Article							BASE-INITIATED REACTIONS; FUNCTIONALIZATION; HALOPYRIDINES; HETEROARENES; METALATION	Fluorinated heterocycles are prevalent in pharmaceuticals, agrochemicals, and materials. However, reactions that incorporate fluorine into heteroarenes are limited in scope and can be hazardous. We present a broadly applicable and safe method for the site-selective fluorination of a single carbon-hydrogen bond in pyridines and diazines using commercially available silver(II) fluoride. The reactions occur at ambient temperature within 1 hour with exclusive selectivity for fluorination adjacent to nitrogen. The mild conditions allow access to fluorinated derivatives of medicinally important compounds, as well as a range of 2-substituted pyridines prepared by subsequent nucleophilic displacement of fluoride. Mechanistic studies demonstrate that the pathway of a classic pyridine amination can be adapted for selective fluorination of a broad range of nitrogen heterocycles.	[Fier, Patrick S.; Hartwig, John F.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hartwig, JF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jhartwig@berkeley.edu			NIH [R37GM-55382]; Chevron; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055382] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chevron; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH (R37GM-55382) for support of this work and Chevron for a fellowship to P.S.F. A provisional patent application has been filed on this reaction.	Adams DJ, 1999, CHEM SOC REV, V28, P225, DOI 10.1039/a808707e; ANDRAE D, 1990, THEOR CHIM ACTA, V77, P123, DOI 10.1007/BF01114537; Begue J.-P., 2008, BIOORGANIC MED CHEM; BELL TW, 1987, J ORG CHEM, V52, P3847, DOI 10.1021/jo00226a023; Bobbio C, 2005, J ORG CHEM, V70, P3039, DOI 10.1021/jo047979h; BRADLOW HI, 1949, J ORG CHEM, V14, P509, DOI 10.1021/jo01156a002; Chambers RD, 1999, J CHEM SOC PERK T 1, P803, DOI 10.1039/a809838g; Cherng YH, 2002, TETRAHEDRON, V58, P4931, DOI 10.1016/S0040-4020(02)00424-6; Erian AW, 2001, J HETEROCYCLIC CHEM, V38, P793, DOI 10.1002/jhet.5570380401; ESTEL L, 1988, J ORG CHEM, V53, P2740, DOI 10.1021/jo00247a016; Fujiwara Y, 2012, NATURE, V492, P95, DOI 10.1038/nature11680; FUKUHARA T, 1988, J FLUORINE CHEM, V38, P435, DOI 10.1016/S0022-1139(00)81078-7; GUNGOR T, 1981, J ORGANOMET CHEM, V215, P139, DOI 10.1016/S0022-328X(00)80124-2; Honda T, 2003, HETEROCYCLES, V59, P169, DOI 10.3987/COM-02-S11; KAUFFMANN T, 1983, CHEM BER-RECL, V116, P992, DOI 10.1002/cber.19831160316; Kirsch P., 2013, MODERN FLUOROORGANIC; KISELYOV AS, 1994, SYNTHETIC COMMUN, V24, P2387, DOI 10.1080/00397919408019063; Kling A, 2003, BIOORGAN MED CHEM, V11, P1319, DOI 10.1016/S0968-0896(02)00616-8; Kraikivskii PB, 2012, J ORGANOMET CHEM, V715, P43, DOI 10.1016/j.jorganchem.2012.05.035; Kraikivskii PB, 2011, J ORGANOMET CHEM, V696, P3376, DOI 10.1016/j.jorganchem.2011.07.022; Kraikivskii PB, 2009, J ORGANOMET CHEM, V694, P3912, DOI 10.1016/j.jorganchem.2009.08.010; Kuduk SD, 2005, ORG LETT, V7, P577, DOI 10.1021/ol047688v; Leahy DK, 2012, ORG PROCESS RES DEV, V16, P244, DOI 10.1021/op2003634; LOUPY A, 1991, HETEROCYCLES, V32, P1947, DOI 10.3987/COM-91-5819; MCGILL CK, 1988, ADV HETEROCYCL CHEM, V44, P1, DOI 10.1016/S0065-2725(08)60261-5; MEINERT H, 1965, Z CHEM, V5, P64; MINISCI F, 1989, HETEROCYCLES, V28, P489, DOI 10.3987/REV-88-SR1; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; O'Hara F, 2013, J AM CHEM SOC, V135, P12122, DOI 10.1021/ja406223k; PIERS E, 1974, CAN J CHEM, V52, P3563, DOI 10.1139/v74-532; SCHROEDER H, 1962, J ORG CHEM, V27, P2580, DOI 10.1021/jo01054a066; Simons J. H., 1948, U.S. Patent, Patent No. [2,447,717, 2447717]; Sun H, 2006, ANGEW CHEM INT EDIT, V45, P2720, DOI 10.1002/anie.200504555; Thomas S, 2003, ORG LETT, V5, P3867, DOI 10.1021/ol035430j; Umemoto T, 1996, J FLUORINE CHEM, V77, P161, DOI 10.1016/0022-1139(96)03402-1; UMEMOTO T, 1989, J ORG CHEM, V54, P1726, DOI 10.1021/jo00268a041; UMEMOTO T, 1987, TETRAHEDRON LETT, V28, P2705, DOI 10.1016/S0040-4039(00)96186-0; VANDERPUY M, 1987, TETRAHEDRON LETT, V28, P255, DOI 10.1016/S0040-4039(00)95700-9; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; ZWEIG A, 1980, J ORG CHEM, V45, P3597, DOI 10.1021/jo01306a011	40	170	175	3	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					956	960		10.1126/science.1243759	http://dx.doi.org/10.1126/science.1243759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264986				2022-12-28	WOS:000327223500037
J	Koedinger, KR; Booth, JL; Klahr, D				Koedinger, Kenneth R.; Booth, Julie L.; Klahr, David			Instructional Complexity and the Science to Constrain It	SCIENCE			English	Editorial Material							PRINCIPLES		[Koedinger, Kenneth R.; Klahr, David] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Booth, Julie L.] Temple Univ, Philadelphia, PA 19122 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Koedinger, KR (corresponding author), Carnegie Mellon Univ, Pittsburgh, PA 15213 USA.	koedinger@cmu.edu	Booth, Julie/K-5371-2016	Booth, Julie/0000-0003-2300-2116				Andersen E, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1275; Barab S, 2006, CAMB HANDB PSYCHOL, P153; Bjork RA, 2013, ANNU REV PSYCHOL, V64, P417, DOI 10.1146/annurev-psych-113011-143823; Bradshaw G.F., 1992, MINN STUD PHILOS SCI, P239; Corbett A. T., 2001, P ACM CHI 2001 C HUM, P245; Dunlosky J, 2013, PSYCHOL SCI PUBL INT, V14, P4, DOI 10.1177/1529100612453266; Dynarski M., 2007, EFFECTIVENESS READIN; Goldstone RL, 2005, J LEARN SCI, V14, P69, DOI 10.1207/s15327809jls1401_4; Goska RE, 1996, J EDUC PSYCHOL, V88, P249; IES U.S. Department of Education Researcher-Practitioner Partnerships in Education Research, RES PRACT PARTN ED R; Kalyuga S, 2003, EDUC PSYCHOL-US, V38, P23, DOI 10.1207/S15326985EP3801_4; Kalyuga S, 2007, EDUC PSYCHOL REV, V19, P387, DOI 10.1007/s10648-007-9051-6; Kaminski JA, 2008, SCIENCE, V320, P454, DOI 10.1126/science.1154659; Klahr D, 2013, P NATL ACAD SCI USA, V110, P14075, DOI 10.1073/pnas.1212738110; Koedinger KR, 2012, COGNITIVE SCI, V36, P757, DOI 10.1111/j.1551-6709.2012.01245.x; Li J., 2005, J SCI EDUC TECHNOL, V14, P217, DOI DOI 10.1007/S10956-005-4423-5; Lomas Derek, 2013, P SIGCHI C HUM FACT, P89, DOI 10.1145/2470654.2470668; Nan Li, 2012, Intelligent Tutoring Systems. Proceedings 11th International Conference (ITS 2012), P185, DOI 10.1007/978-3-642-30950-2_24; PAIVIO A, 1965, J VERB LEARN VERB BE, V4, P32, DOI 10.1016/S0022-5371(65)80064-0; Pane J. F., 2013, WORKING PAPER; Pashler H., 2007, ORG INSTRUCTION STUD, DOI [10.1037/e607972011-001, DOI 10.1037/E607972011-001]; Pavlik PI, 2008, J EXP PSYCHOL-APPL, V14, P101, DOI 10.1037/1076-898X.14.2.101; Resnick L. B., 2013, SOCIALIZING INTELLIG; Roschelle J, 2010, AM EDUC RES J, V47, P833, DOI 10.3102/0002831210367426; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Simon H. A., 1969, SCI ARTIFICIAL; VANLEHN K, 1987, ARTIF INTELL, V31, P1, DOI 10.1016/0004-3702(87)90080-4; WOZNIAK PA, 1994, ACTA NEUROBIOL EXP, V54, P59; Wylie R., 2009, P 31 ANN C COGNITIVE, P1300	30	92	92	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					935	937		10.1126/science.1238056	http://dx.doi.org/10.1126/science.1238056			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EZ	24264979				2022-12-28	WOS:000327223500026
J	Mack, MJ; Brennan, JM; Brindis, R; Carroll, J; Edwards, F; Grover, F; Shahian, D; Tuzcu, EM; Peterson, ED; Rumsfeld, JS; Hewitt, K; Shewan, C; Michaels, J; Christensen, B; Christian, A; O'Brien, S; Holmes, D				Mack, Michael J.; Brennan, J. Matthew; Brindis, Ralph; Carroll, John; Edwards, Fred; Grover, Fred; Shahian, David; Tuzcu, E. Murat; Peterson, Eric D.; Rumsfeld, John S.; Hewitt, Kathleen; Shewan, Cynthia; Michaels, Joan; Christensen, Barb; Christian, Alexander; O'Brien, Sean; Holmes, David		STS ACC TVT Registry	Outcomes Following Transcatheter Aortic Valve Replacement in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							END-POINT DEFINITIONS; MEDICAL DEVICES; IMPLANTATION; SURVEILLANCE; REGISTRY; STENOSIS	IMPORTANCE Transcatheter aortic valve replacement (TAVR) was approved by the US Food and Drug Administration for the treatment of severe, symptomatic aortic stenosis and inoperable status (in 2011) and high-risk but operable status (starting in 2012). A national registry (the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy [STS/ACC TVT] Registry) was initiated to meet a condition for Medicare coverage and also facilitates outcome assessment and comparison with other trials and international registries. OBJECTIVE To report the initial US commercial experience with TAVR. DESIGN, SETTING, AND PARTICIPANTS We obtained results from all eligible US TAVR cases (n=7710) from 224 participating registry hospitals following the Edwards Sapien XT device commercialization (November 2011-May 2013). MAIN OUTCOMES AND MEASURES Primary outcomes included all-cause in-hospital mortality and stroke following TAVR. Secondary analyses included procedural complications and outcomes by clinical indication and access site. Device implantation success was defined as successful vascular access, deployment of a single device in the proper anatomic position, appropriate valve function without either moderate or severe AR, and successful retrieval of the delivery system. Thirty-day outcomes are presented for a representative 3133 cases (40.6%) at 114 centers with at least 80% complete follow-up reporting. RESULTS The 7710 patients who underwent TAVR included 1559 (20%) cases that were inoperable and 6151 (80%) cases that were high-risk but operable. The median age was 84 years (interquartile range [IQR], 78-88 years); 3783 patients (49%) were women and the median STS predicted risk of mortality was 7% (IQR, 5%-11%). At baseline, 2176 patients (75%) were either not at all satisfied (1297 patients [45%]) or mostly dissatisfied (879 patients [30%]) with their symptom status; 2198 (72%) had a 5-m walk time longer than 6 seconds (slow gait speed). The most common vascular access approach was transfemoral (4972 patients [64%]), followed by transapical (2197 patients [29%]) and other alternative approaches (536 patients [7%]); successful device implantation occurred in 7069 patients (92%; 95% CI, 91%-92%). The observed incidence of in-hospital mortality was 5.5% (95% CI, 5.0%-6.1%). Other major complications included stroke (2.0%; 95% CI, 1.7%-2.4%), dialysis-dependent renal failure (1.9%; 95% CI, 1.6%-2.2%), and major vascular injury (6.4%; 95% CI, 5.8%-6.9%). Median hospital stay was 6 days (IQR, 4-10 days), with 4613 (63%) discharged home. Among patients with available follow-up at 30 days (n=3133), the incidence of mortality was 7.6% (95% CI, 6.7%-8.6%) (noncardiovascular cause, 52%); a stroke had occurred in 2.8% (95% CI, 2.3%-3.5%), new dialysis in 2.5% (95% CI, 2.0%-3.1%), and reintervention in 0.5% (95% CI, 0.3%-0.8%). CONCLUSIONS AND RELEVANCE Among patients undergoing TAVR at US centers in the STS/ACC TVT Registry, device implantation success was achieved in 92% of cases, the overall in-hospital mortality rate was 5.5%, and the stroke rate was 2.0%. Although these postmarket US approval findings are comparable with prior published trial data and international experience, long-term follow-up is essential to assess continued efficacy and safety.	[Mack, Michael J.] Heart Hosp Baylor Plano, Baylor Healthcare Syst, Plano, TX USA; [Brennan, J. Matthew; Peterson, Eric D.; Christensen, Barb; O'Brien, Sean] Duke Clin Res Inst, Durham, NC USA; [Brindis, Ralph] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Carroll, John; Grover, Fred; Rumsfeld, John S.] Univ Colorado, Denver, CO 80202 USA; [Edwards, Fred] Univ Florida, Jacksonville, FL USA; [Shahian, David] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tuzcu, E. Murat] Cleveland Clin, Cleveland, OH 44106 USA; [Hewitt, Kathleen; Michaels, Joan; Christensen, Barb] Amer Coll Cardiol, Washington, DC USA; [Shewan, Cynthia] Soc Thorac Surg, Chicago, IL USA; [Holmes, David] Mayo Clin, Rochester, MN USA	Baylor Health Care System; Duke University; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Denver; State University System of Florida; University of Florida; Harvard University; Massachusetts General Hospital; Cleveland Clinic Foundation; American College of Cardiology; Society of Thoracic Surgeons; Mayo Clinic	Mack, MJ (corresponding author), Baylor Hlth Care Syst, 1100 Allied Dr, Plano, TX 75093 USA.	michael.mack@baylorhealth.edu	Peterson, Eric David/ABF-5033-2021; Doğan, Ali/AAN-5331-2020		American College of Cardiology Foundation; Society of Thoracic Surgeons	American College of Cardiology Foundation(General Electric); Society of Thoracic Surgeons	This study was funded by the American College of Cardiology Foundation and the Society of Thoracic Surgeons.	American College of Cardiology; Society of Thoracic Surgeons, ACC STS TVT REG DAT; American College of Cardiology; Society of Thoracic Surgeons, ACC STS TVT REG NCDR; Cardiac Interventions Today, 2013, CARDIAC INTERVE 0923; Carroll JD, 2013, J AM COLL CARDIOL, V62, P1026, DOI 10.1016/j.jacc.2013.03.060; Centers for Medicare and Medicaid Services, NAT COV DET NCD TRAN; Department of Health and Human Services, 2011, CORR REG PREM APPR A; Garin O, 2014, HEART FAIL REV, V19, P359, DOI 10.1007/s10741-013-9394-7; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Hamm CW, 2013, EUR HEART J, DOI 10.1093/eurheart/eht381; Hauser RG, 2012, NEW ENGL J MED, V366, P873, DOI 10.1056/NEJMp1114695; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1093/ejcts/ezs533, 10.1016/j.jacc.2012.09.001]; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Resnic FS, 2012, NEW ENGL J MED, V366, P875, DOI 10.1056/NEJMp1114865; Rumsfeld JS, 2010, JAMA-J AM MED ASSOC, V304, P2065, DOI 10.1001/jama.2010.1648; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Society of Thoracic Surgeons, ONL STS RISK CALC; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; U.S. Food and Drug Administration, 2012, FDA EXP APPR US SAP; US Food and Drug Administration, 2012, STRENGTH NAT SYST ME; Wilson Christopher M, 2013, Cardiopulm Phys Ther J, V24, P36	22	364	373	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2069	2077		10.1001/jama.2013.282043	http://dx.doi.org/10.1001/jama.2013.282043			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240934	Bronze			2022-12-28	WOS:000327098900023
J	Warm, EJ; Goetz, C				Warm, Eric J.; Goetz, Celine			Too Smart for Primary Care?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Warm, Eric J.] Univ Cincinnati, Cincinnati, OH 45267 USA; New York Presbyterian Hosp, New York, NY USA	University System of Ohio; University of Cincinnati; NewYork-Presbyterian Hospital	Warm, EJ (corresponding author), Univ Cincinnati, 231 Albert Sabin Way,Mail Locat 0557, Cincinnati, OH 45267 USA.	warmej@ucmail.uc.edu		Goetz, Celine/0000-0001-7874-8930					0	7	7	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10					709	+		10.7326/0003-4819-159-10-201311190-00009	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247675				2022-12-28	WOS:000328732700019
J	Cannon, B				Cannon, Bill			SENSATION AND LOSS	NATURE			English	Editorial Material																			0	7	7	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S2	S3		10.1038/503S2a	http://dx.doi.org/10.1038/503S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24227004	Bronze			2022-12-28	WOS:000326894200002
J	Fustin, JM; Doi, M; Yamaguchi, Y; Hida, H; Nishimura, S; Yoshida, M; Isagawa, T; Morioka, MS; Kakeya, H; Manabe, I; Okamura, H				Fustin, Jean-Michel; Doi, Masao; Yamaguchi, Yoshiaki; Hida, Hayashi; Nishimura, Shinichi; Yoshida, Minoru; Isagawa, Takayuki; Morioka, Masaki Suimye; Kakeya, Hideaki; Manabe, Ichiro; Okamura, Hitoshi			RNA-Methylation-Dependent RNA Processing Controls the Speed of the Circadian Clock	CELL			English	Article							PRE-MESSENGER-RNA; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; S-ADENOSYLHOMOCYSTEINE; TRANSCRIPTION; OSCILLATION; MECHANISM; LIVER; ABUNDANCE	The eukaryotic biological clock involves a negative transcription-translation feedback loop in which clock genes regulate their own transcription and that of output genes of metabolic significance. While around 10% of the liver transcriptome is rhythmic, only about a fifth is driven by de novo transcription, indicating mRNA processing is a major circadian component. Here, we report that inhibition of transmethylation reactions elongates the circadian period. RNA sequencing then reveals methylation inhibition causes widespread changes in the transcription of the RNA processing machinery, associated with m(6)A-RNA methylation. We identify m(6)A sites on many clock gene transcripts and show that specific inhibition of m(6)A methylation by silencing of the m(6)A methylase Mettl3 is sufficient to elicit circadian period elongation and RNA processing delay. Analysis of the circadian nucleocytoplasmic distribution of clock genes Per2 and Arntl then revealed an uncoupling between steady-state pre-mRNA and cytoplasmic mRNA rhythms when m(6)A methylation is inhibited.	[Fustin, Jean-Michel; Doi, Masao; Yamaguchi, Yoshiaki; Hida, Hayashi; Okamura, Hitoshi] Kyoto Univ, Dept Syst Biol, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Nishimura, Shinichi; Kakeya, Hideaki] Kyoto Univ, Dept Syst Chemotherapy & Mol Sci, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Yoshida, Minoru] RIKEN, Chem Genet Lab, Wako, Saitama 3510198, Japan; [Isagawa, Takayuki; Morioka, Masaki Suimye; Manabe, Ichiro] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan	Kyoto University; Kyoto University; RIKEN; University of Tokyo	Okamura, H (corresponding author), Kyoto Univ, Dept Syst Biol, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimo Adachi Cho, Kyoto 6068501, Japan.	okamurah@pharm.kyoto-u.ac.jp	Manabe, Ichiro/E-1529-2014; Yamaguchi, Yoshiaki/K-9418-2013; Fustin, Jean-Michel/R-6621-2019; Manabe, Ichiro/AAE-5105-2021; Nishimura, Shinichi/AGE-1316-2022; Doi, Masao/J-9267-2019; Yoshida, Minoru/C-8049-2014; Kakeya, Hideaki/B-3527-2012	Yamaguchi, Yoshiaki/0000-0003-4126-542X; Fustin, Jean-Michel/0000-0002-6200-6075; Nishimura, Shinichi/0000-0002-5998-3780; Doi, Masao/0000-0001-6264-9217; Yoshida, Minoru/0000-0002-4376-5674; Kakeya, Hideaki/0000-0002-4293-7331; Okamura, Hitoshi/0000-0002-3013-4881	Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS [24111526, 24240058, 25560426, 23390203]; SRF; Takeda Science Foundation; Grants-in-Aid for Scientific Research [21228003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SRF; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Satchin Panda from the Salk Institute for the kind gift of U2OS Arntl-luc cells. This work was supported by Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by grants from JSPS (24111526, 24240058, and 25560426), SRF, and the Takeda Science Foundation (to H.O.). This work was also supported by the Funding Program for Next Generation World-Leading Researchers (NEXT program) from the JSPS (to M. D.) and by Grants-in-Aid for Scientific Research from the JSPS (23390203) (to I.M).	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BACKLUND PS, 1986, EUR J BIOCHEM, V160, P245, DOI 10.1111/j.1432-1033.1986.tb09963.x; Carmel R., 2001, HOMOCYSTEINE HLTH DI; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Cole MD, 2009, ONCOGENE, V28, P1169, DOI 10.1038/onc.2008.463; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Doi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1316; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fernandez-Sanchez ME, 2009, MOL CELL BIOL, V29, P6182, DOI 10.1128/MCB.00973-09; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Miyazaki K, 2007, GENES CELLS, V12, P1225, DOI 10.1111/j.1365-2443.2007.01129.x; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ripperger JA, 2011, FEBS LETT, V585, P1406, DOI 10.1016/j.febslet.2011.04.047; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; ROSBASH M, 1995, CURR OPIN GENET DEV, V5, P662, DOI 10.1016/0959-437X(95)80037-9; SCHALINSKE KL, 1992, BIOFACTORS, V3, P265; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valekunja UK, 2013, P NATL ACAD SCI USA, V110, P1554, DOI 10.1073/pnas.1214168110; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wilkins AK, 2007, PLOS COMPUT BIOL, V3, P2476, DOI 10.1371/journal.pcbi.0030242; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	39	622	643	6	135	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					793	806		10.1016/j.cell.2013.10.026	http://dx.doi.org/10.1016/j.cell.2013.10.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209618	Bronze			2022-12-28	WOS:000326934300010
J	Goodchild, S				Goodchild, Sophie			How private providers are feeling the pinch	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												goodchildsophie@hotmail.com						BMA, 2013, DOCT FEES INCR THREA; Competition Commission, PRIV HEALTHC MARK IN; Harrop-Griffiths W, 2013, TIMES; Laing and Buisson, 2013, LAINGS HEALTHCARE MA	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2013	347								f6592	10.1136/bmj.f6592	http://dx.doi.org/10.1136/bmj.f6592			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XQ	24201564				2022-12-28	WOS:000326890500007
J	Halperin, DT				Halperin, Daniel T.			Scaling up of family planning in low-income countries: lessons from Ethiopia	LANCET			English	Editorial Material							REPRODUCTIVE HEALTH; POPULATION-POLICY; TRANSITION; PROGRAMS; ABORTION; WOMEN		[Halperin, Daniel T.] Ponce Sch Med & Hlth Sci, Publ Hlth Program, Ponce, PR 00732 USA; [Halperin, Daniel T.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Halperin, Daniel T.] Secretaria Nacl Educ Super Ciencia Tecnol & Innov, Quito, Ecuador	University of North Carolina; University of North Carolina Chapel Hill	Halperin, DT (corresponding author), Ponce Sch Med & Hlth Sci, Publ Hlth Program, Ponce, PR 00732 USA.	dhalpe@gmail.com						Admassie A, 2009, J DEV EFFECT, V1, P430, DOI 10.1080/19439340903375724; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Alemayehu M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-6; Becker G. S., 1991, TREATISE FAMILY ENLA; Bongaarts J, 2011, SCIENCE, V333, P574, DOI 10.1126/science.1207558; Campbell MM, 2013, J FAM PLAN REPROD H, V39, P44, DOI 10.1136/jfprhc-2012-100405; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Cates W, 2010, SCIENCE, V329, P1603, DOI 10.1126/science.1197080; Central Statistical Agency of Ethiopia, 2011, ETH DEM HLTH SURV 20; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; DAVIS K, 1967, SCIENCE, V158, P730, DOI 10.1126/science.158.3802.730; Gallo MF, 2013, CONTRACEPTION, V88, P657, DOI 10.1016/j.contraception.2013.06.008; Garenne M., DHS ANAL STUDIES; Gillespie D, 2004, LANCET, V363, P74, DOI 10.1016/S0140-6736(03)15179-3; Habumuremyi PD, 2012, LANCET, V380, P78, DOI 10.1016/S0140-6736(12)60904-0; Halperin D, 2008, SCIENCE, V321, P1632; Jacobstein R, 2013, STUD FAMILY PLANN, V44, P85, DOI 10.1111/j.1728-4465.2013.00345.x; Jacobstein R, 2009, STUD FAMILY PLANN, V40, P147, DOI 10.1111/j.1728-4465.2009.00197.x; Janowitz B, 2012, STUD FAMILY PLANN, V43, P57, DOI 10.1111/j.1728-4465.2012.00302.x; Kirk D, 1996, POP STUD-J DEMOG, V50, P361, DOI 10.1080/0032472031000149536; Leibenstein Harvey, 1957, EC BACKWARDNESS EC G; Lindstorm D.P., 2003, GENUS, V59, P147; [Malawi Ministry of Healthand Rwanda Ministry of Health Ethiopia Federal Ministry of Health USAID/Population and Reproductive Health USAID/Africa Bureau], 2012, 3 SUCC SUBS AFR FAM; PHILLIPS JF, 1988, STUD FAMILY PLANN, V19, P313, DOI 10.2307/1966627; Potts M, 2011, FOREIGN POLICY; Potts M, 2011, INT PERSPECT SEX R H, V37, P95, DOI 10.1363/3709511; Prata N, 2011, J FAM PLAN REPROD H, V37, P196, DOI 10.1136/jfprhc-2011-100174; Prata N, 2011, B WORLD HEALTH ORGAN, V89, P556, DOI 10.2471/BLT.11.086710; Pritchett LH, 1994, POPUL DEV REV, V20; Rosenthal E., 2012, NY TIMES; Say L, 2005, ACCELERATING UNIVERS; Sibanda A, 2003, STUD FAMILY PLANN, V34; Solo J, 2008, FAMILY PLANNING RWAN; Sundaram A., 2010, ISSUES BRIEF; UNICEF/Ethiopia Ministry of Health, 2010, HEWS HLTH POSTPERFOR	36	11	11	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1264	1267		10.1016/S0140-6736(13)62032-2	http://dx.doi.org/10.1016/S0140-6736(13)62032-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24231388				2022-12-28	WOS:000334104600030
J	Ding, YL; Tang, Y; Kwok, CK; Zhang, Y; Bevilacqua, PC; Assmann, SM				Ding, Yiliang; Tang, Yin; Kwok, Chun Kit; Zhang, Yu; Bevilacqua, Philip C.; Assmann, Sarah M.			In vivo genome-wide profiling of RNA secondary structure reveals novel regulatory features	NATURE			English	Article							RIBOSOMAL-RNA; ENVIRONMENTAL RESPONSES; OXYGEN DEPRIVATION; PRIMER EXTENSION; TRANSLATION; POLYADENYLATION; TRANSCRIPTOME; PREDICTION; INTRON	RNA structure has critical roles in processes ranging from ligand sensing to the regulation of translation, polyadenylation and splicing(1-4). However, a lack of genome-wide in vivo RNA structural data has limited our understanding of how RNA structure regulates gene expression in living cells. Here we present a high-throughput, genome-wide in vivo RNA structure probing method, structure-seq, in which dimethyl sulphate methylation of unprotected adenines and cytosines is identified by next-generation sequencing. Application of this method to Arabidopsis thaliana seedlings yielded the first in vivo genome-wide RNA structure map at nucleotide resolution for any organism, with quantitative structural information across more than 10,000 transcripts. Our analysis reveals a three-nucleotide periodic repeat pattern in the structure of coding regions, as well as a less-structured region immediately upstream of the start codon, and shows that these features are strongly correlated with translation efficiency. We also find patterns of strong and weak secondary structure at sites of alternative polyadenylation, as well as strong secondary structure at 59 splice sites that correlates with unspliced events. Notably, in vivo structures of messenger RNAs annotated for stress responses are poorly predicted in silico, whereas mRNA structures of genes related to cell function maintenance are well predicted. Global comparison of several structural features between these two categories shows that the mRNAs associated with stress responses tend to have more single-strandedness, longer maximal loop length and higher free energy per nucleotide, features that may allow these RNAs to undergo conformational changes in response to environmental conditions. Structure-seq allows the RNA structurome and its biological roles to be interrogated on a genome-wide scale and should be applicable to any organism.	[Ding, Yiliang; Tang, Yin; Assmann, Sarah M.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Ding, Yiliang; Kwok, Chun Kit; Bevilacqua, Philip C.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Ding, Yiliang; Tang, Yin; Kwok, Chun Kit; Bevilacqua, Philip C.; Assmann, Sarah M.] Penn State Univ, Ctr RNA Mol Biol, University Pk, PA 16802 USA; [Tang, Yin; Zhang, Yu; Assmann, Sarah M.] Penn State Univ, Bioinformat & Genom Grad Program, University Pk, PA 16802 USA; [Zhang, Yu] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Bevilacqua, Philip C.; Assmann, Sarah M.] Penn State Univ, Plant Biol Grad Program, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	pcb5@psu.edu; sma3@psu.edu	DING, YILIANG/B-2242-2015; Tang, Yin/M-5401-2018	Ding, Yiliang/0000-0003-4161-6365; Bevilacqua, Philip/0000-0001-8074-3434; KWOK, Chun Kit/0000-0001-9175-8543	Human Frontier Science Program (HFSP) [RGP0002/2009-C]; Penn State Eberly College of Science; Penn State Huck Institutes HITS; National Science Foundation [OCI-0821527]	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Penn State Eberly College of Science; Penn State Huck Institutes HITS; National Science Foundation(National Science Foundation (NSF))	This research is supported by Human Frontier Science Program (HFSP) grant RGP0002/2009-C, the Penn State Eberly College of Science, and a Penn State Huck Institutes HITS grant to P.C.B. and S.M.A. We thank F. Pugh, Y. Li, A. Chan and K. Yen for help with Illumina sequencing; D. Mathews and A. Spasic for advice on RNA structure analysis; M. Axtell for reading of the manuscript; and P. Raghavan for access to the CyberSTAR server, funded by the National Science Foundation through grant OCI-0821527. We also thank L. Song, D. Chadalavada and S. Ghosh for discussions.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Branco-Price C, 2005, ANN BOT-LONDON, V96, P647, DOI 10.1093/aob/mci217; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jin YF, 2011, RNA BIOL, V8, P450, DOI 10.4161/rna.8.3.15388; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAWLEY PD, 1963, BIOCHEM J, V89, P127, DOI 10.1042/bj0890127; Li F, 2012, PLANT CELL, V24, P4346, DOI 10.1105/tpc.112.104232; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Misra VK, 2002, J MOL BIOL, V317, P507, DOI 10.1006/jmbi.2002.5422; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; Oh E, 2012, NAT CELL BIOL, V14, P802, DOI 10.1038/ncb2545; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; SENECOFF JF, 1992, PLANT MOL BIOL, V18, P219, DOI 10.1007/BF00034951; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Shen YJ, 2011, GENOME RES, V21, P1478, DOI 10.1101/gr.114744.110; Smith CJ, 2012, PHLEBOLOGY, V27, P305, DOI 10.1258/phleb.2012.012J06; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; WEEKS KM, 1991, CELL, V66, P577, DOI 10.1016/0092-8674(81)90020-9; Wells SE, 2000, METHOD ENZYMOL, V318, P479; ZAUG AJ, 1995, RNA, V1, P363; Zemora G, 2010, RNA BIOL, V7, P634, DOI 10.4161/rna.7.6.13554; Zheng Q, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001141	37	496	511	8	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					696	+		10.1038/nature12756	http://dx.doi.org/10.1038/nature12756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24270811				2022-12-28	WOS:000330321000044
J	Yamauchi, Y; Riel, JM; Stoytcheva, Z; Ward, MA				Yamauchi, Yasuhiro; Riel, Jonathan M.; Stoytcheva, Zoia; Ward, Monika A.			Two Y Genes Can Replace the Entire Y Chromosome for Assisted Reproduction in the Mouse	SCIENCE			English	Article							SEX-DETERMINING REGION; MICE; EXPRESSION; INITIATION; SPERMIOGENESIS; DEFICIENCY; FERTILITY; SRY	The Y chromosome is thought to be important for male reproduction. We have previously shown that, with the use of assisted reproduction, live offspring can be obtained from mice lacking the entire Y chromosome long arm. Here, we demonstrate that live mouse progeny can also be generated by using germ cells from males with the Y chromosome contribution limited to only two genes, the testis determinant factor Sry and the spermatogonial proliferation factor Eif2s3y. Sry is believed to function primarily in sex determination during fetal life. Eif2s3y may be the only Y chromosome gene required to drive mouse spermatogenesis, allowing formation of haploid germ cells that are functional in assisted reproduction. Our findings are relevant, but not directly translatable, to human male infertility cases.	[Yamauchi, Yasuhiro; Riel, Jonathan M.; Stoytcheva, Zoia; Ward, Monika A.] Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, Honolulu, HI 96822 USA	University of Hawaii System	Ward, MA (corresponding author), Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, 1960 East West Rd, Honolulu, HI 96822 USA.	mward@hawaii.edu			NIH [HD072380, HD058059, GM103457]; Hawaii Community Foundation [13ADVC-60314]; NIH grants National Institute on Minority Health and Health Disparities [NIH. G12 MD007601]; National Institute of General Medical Sciences, NIH [P30 GM103341]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072380] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD058059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457, P30GM103341] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hawaii Community Foundation; NIH grants National Institute on Minority Health and Health Disparities; National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The work was supported by NIH HD072380, HD058059, and GM103457 (Project 2) and Hawaii Community Foundation 13ADVC-60314 grants to M. A. W. The authors thank P. Burgoyne for providing paternal stock mice for breeding, overall support, and insightful discussions and N. Vernet from P. Burgoyne's group for sharing protocols and expertise on histological and DNA content analyses. We are grateful to numerous students who have helped with mouse genotyping. Histological sections were prepared by John A. Burns School of Medicine Histopathology Core supported by NIH grants National Institute on Minority Health and Health Disparities, NIH. G12 MD007601 and the National Institute of General Medical Sciences, NIH, P30 GM103341.	Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS199, DOI 10.1016/j.fertnstert.2008.08.033; BURGOYNE PS, 1992, CELL, V71, P391, DOI 10.1016/0092-8674(92)90509-B; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Ehrmann IE, 1998, HUM MOL GENET, V7, P1725, DOI 10.1093/hmg/7.11.1725; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Gianaroli L, 1999, FERTIL STERIL, V72, P539, DOI 10.1016/S0015-0282(99)00285-X; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; Kleiman SE, 2007, HUM REPROD, V22, P151, DOI 10.1093/humrep/del341; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; Mitchell M J, 2000, Results Probl Cell Differ, V28, P233; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Riel JM, 2013, J CELL SCI, V126, P803, DOI 10.1242/jcs.114488; Saremi A, 2002, ARCH ANDROLOGY, V48, P315, DOI 10.1080/01485010290031637; Sargent CA, 1999, J MED GENET, V36, P670; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; STERN C, 1957, AM J HUM GENET, V9, P147; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Tamashiro KLK, 1999, J ASSIST REPROD GEN, V16, P315, DOI 10.1023/A:1020406016312; Vernet N, 2012, REPRODUCTION, V144, P433, DOI 10.1530/REP-12-0158; Vernet N, 2011, CURR BIOL, V21, P787, DOI 10.1016/j.cub.2011.03.057; Yamauchi Y, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r66; Yamauchi Y, 2009, BIOL REPROD, V81, P353, DOI 10.1095/biolreprod.109.076307	29	55	59	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					69	72		10.1126/science.1242544	http://dx.doi.org/10.1126/science.1242544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24263135	Green Accepted			2022-12-28	WOS:000329162000049
J	Courtin, J; Chaudun, F; Rozeske, RR; Karalis, N; Gonzalez-Campo, C; Wurtz, H; Abdi, A; Baufreton, J; Bienvenu, TCM; Herry, C				Courtin, Julien; Chaudun, Fabrice; Rozeske, Robert R.; Karalis, Nikolaos; Gonzalez-Campo, Cecilia; Wurtz, Helene; Abdi, Azzedine; Baufreton, Jerome; Bienvenu, Thomas C. M.; Herry, Cyril			Prefrontal parvalbumin interneurons shape neuronal activity to drive fear expression	NATURE			English	Article							HIPPOCAMPAL THETA; PRELIMBIC CORTEX; OSCILLATIONS; SYNCHRONIZATION; EXTINCTION; AMYGDALA; NETWORK; MODULATION; CIRCUITS; RESET	Synchronization of spiking activity in neuronal networks is a fundamental process that enables the precise transmission of information to drive behavioural responses(1-3). Incortical areas, synchronization of principal-neuron spiking activity is an effective mechanism for information coding that is regulated by GABA (gamma-aminobutyric acid)-ergic interneurons through the generation of neuronal oscillations(4,5). Although neuronal synchrony has been demonstrated to be crucial for sensory, motor and cognitive processing(6-8), it has not been investigated at the level of defined circuits involved in the control of emotional behaviour. Converging evidence indicates that fear behaviour is regulated by the dorsomedial prefrontal cortex(9-12) (dmPFC). This control over fear behaviour relies on the activation of specific prefrontal projections to the basolateral complex of the amygdala (BLA), a structure that encodes associative fear memories(13-15). However, it remains to be established how the precise temporal control of fear behaviour is achieved at the level of prefrontal circuits. Here we use single-unit recordings and optogenetic manipulations in behaving mice to show that fear expression is causally related to the phasic inhibition of prefrontal parvalbumin interneurons (PVINs). Inhibition of PVIN activity disinhibits prefrontal projection neurons and synchronizes their firing by resetting local theta oscillations, leading to fear expression. Our results identify two complementary neuronal mechanisms mediated by PVINs that precisely coordinate and enhance the neuronal activity of prefrontal projection neurons to drive fear expression.	[Courtin, Julien; Chaudun, Fabrice; Rozeske, Robert R.; Karalis, Nikolaos; Gonzalez-Campo, Cecilia; Wurtz, Helene; Bienvenu, Thomas C. M.; Herry, Cyril] INSERM, Neuroctr Magendie, U862, F-33077 Bordeaux, France; [Courtin, Julien; Chaudun, Fabrice; Rozeske, Robert R.; Karalis, Nikolaos; Gonzalez-Campo, Cecilia; Wurtz, Helene; Bienvenu, Thomas C. M.; Herry, Cyril] Univ Bordeaux, Neuroctr Magendie, U862, F-33077 Bordeaux, France; [Abdi, Azzedine; Baufreton, Jerome] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France; [Abdi, Azzedine; Baufreton, Jerome] CNRS, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Herry, C (corresponding author), INSERM, Neuroctr Magendie, U862, 146 Rue Leo Saignat, F-33077 Bordeaux, France.	cyril.herry@inserm.fr	Herry, Cyril/AAP-9902-2020; courtin, julien/AAH-2380-2022; courtin, julien/AEN-1402-2022; Karalis, Nikolaos/U-4987-2017	Herry, Cyril/0000-0003-2973-0843; courtin, julien/0000-0002-6454-3245; courtin, julien/0000-0002-6454-3245; Karalis, Nikolaos/0000-0002-1804-9756; Bienvenu, Thomas/0000-0002-7416-0504; Baufreton, Jerome/0000-0002-2623-6375	French National Research Agency [ANR-2010-BLAN-1442-01, ANR-10-EQPX-08 OPTOPATH]; European Research Council (ERC) under the European Union [281168]; Fonds AXA pour la recherche doctoral fellowship; Conseil Regional d'Aquitaine	French National Research Agency(French National Research Agency (ANR)); European Research Council (ERC) under the European Union(European Research Council (ERC)); Fonds AXA pour la recherche doctoral fellowship(AXA Research Fund); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	We thank members of the Herry laboratory, K. Benchenane and D. Dupret for comments on the manuscript, K. Deisseroth and E. Boyden for generously sharing material, J. Bacelo, S. Wolff and P. Tovote for technical and computational assistance, the Bordeaux Imaging center of the University of Bordeaux, and C. Poujol and S. Marais for technical assistance with microscopy. This work was supported by grants from the French National Research Agency (ANR-2010-BLAN-1442-01; ANR-10-EQPX-08 OPTOPATH), the European Research Council (ERC) under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no. 281168, a Fonds AXA pour la recherche doctoral fellowship (J. C.) and the Conseil Regional d'Aquitaine. T. C. M. B is a fellow of Ecole de l'Inserm Liliane Bettencourt-MD-PhD program, France.	Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1979, ELECTROEN CLIN NEURO, V47, P64, DOI 10.1016/0013-4694(79)90033-6; Chang CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011971; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; DISCALA G, 1987, PHYSIOL BEHAV, V40, P55, DOI 10.1016/0031-9384(87)90185-5; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Knapska E, 2012, P NATL ACAD SCI USA, V109, P17093, DOI 10.1073/pnas.1202087109; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Livneh U, 2012, NEURON, V75, P133, DOI 10.1016/j.neuron.2012.05.016; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; McCartney H, 2004, HIPPOCAMPUS, V14, P684, DOI 10.1002/hipo.20019; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	30	298	302	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					92	+		10.1038/nature12755	http://dx.doi.org/10.1038/nature12755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24256726				2022-12-28	WOS:000329163300030
J	Poole, J; Mavromatis, K; Binongo, JN; Khan, A; Li, QN; Khayata, M; Rocco, E; Topel, M; Zhang, X; Brown, C; Corriere, MA; Murrow, J; Sher, S; Clement, S; Ashraf, K; Rashed, A; Kabbany, T; Neuman, R; Morris, A; Ali, A; Hayek, S; Oshinski, J; Yoon, YS; Waller, EK; Quyyumi, AA				Poole, Joseph; Mavromatis, Kreton; Binongo, Jose N.; Khan, Ali; Li, Qunna; Khayata, Mohamed; Rocco, Elizabeth; Topel, Matthew; Zhang, Xin; Brown, Charlene; Corriere, Matthew A.; Murrow, Jonathan; Sher, Salman; Clement, Stephanie; Ashraf, Khuram; Rashed, Amr; Kabbany, Tarek; Neuman, Robert; Morris, Alanna; Ali, Arshad; Hayek, Salim; Oshinski, John; Yoon, Young-sup; Waller, Edmund K.; Quyyumi, Arshed A.			Effect of Progenitor Cell Mobilization With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Peripheral Artery Disease A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANKLE BRACHIAL INDEX; ENDOTHELIAL-CELLS; LIMB ISCHEMIA; GM-CSF; BLOOD; STEM; WALKING; TRANSPLANTATION; REGENERATION; THERAPY	IMPORTANCE Many patients with peripheral artery disease (PAD) have walking impairment despite therapy. Experimental studies in animals demonstrate improved perfusion in ischemic hind limb after mobilization of bone marrow progenitor cells (PCs), but whether this is effective in patients with PAD is unknown. OBJECTIVE To investigate whether therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF) improves exercise capacity in patients with intermittent claudication. DESIGN, SETTING, AND PARTICIPANTS In a phase 2 double-blind, placebo-controlled study, 159 patients (median [SD] age, 64 [8] years; 87% male, 37% with diabetes) with intermittent claudication were enrolled at medical centers affiliated with Emory University in Atlanta, Georgia, between January 2010 and July 2012. INTERVENTIONS Participants were randomized (1:1) to received 4 weeks of subcutaneous injections of GM-CSF (leukine), 500 mu g/day 3 times a week, or placebo. Both groups were encouraged to walk to claudication daily. MAIN OUTCOMES AND MEASURES The primary outcome was peak treadmill walking time (PWT) at 3 months. Secondary outcomes were PWT at 6 months and changes in circulating PC levels, ankle brachial index (ABI), and walking impairment questionnaire (WIQ) and 36-item Short-Form Health Survey (SF-36) scores. RESULTS Of the 159 patients randomized, 80 were assigned to the GM-CSF group. The mean (SD) PWT at 3 months increased in the GM-CSF group from 296 (151) seconds to 405 (248) seconds (mean change, 109 seconds [95% CI, 67 to 151]) and in the placebo group from 308 (161) seconds to 376 (182) seconds (change of 56 seconds [95% CI, 14 to 98]), but this difference was not significant (mean difference in change in PWT, 53 seconds [95% CI, -6 to 112], P = .08). At 3 months, compared with placebo, GM-CSF improved the physical functioning subscore of the SF-36 questionnaire by 11.4 (95% CI, 6.7 to 16.1) vs 4.8 (95% CI, -0.1 to 9.6), with a mean difference in change for GM-CSF vs placebo of 7.5 (95% CI, 1.0 to 14.0; P = .03). Similarly, the distance score of the WIQ improved by 12.5 (95% CI, 6.4 to 18.7) vs 4.8 (95% CI, -0.2 to 9.8) with GM-CSF compared with placebo (mean difference in change, 7.9 [95% CI, 0.2 to 15.7], P = .047). There were no significant differences in the ABI, WIQ distance and speed scores, claudication onset time, or mental or physical component scores of the SF-36 between the groups. CONCLUSIONS AND RELEVANCE Therapy with GM-CSF 3 times a week did not improve treadmill walking performance at the 3-month follow-up. The improvements in some secondary outcomes with GM-CSF suggest that it may warrant further study in patients with claudication.	[Poole, Joseph; Khan, Ali; Khayata, Mohamed; Rocco, Elizabeth; Topel, Matthew; Sher, Salman; Ashraf, Khuram; Rashed, Amr; Kabbany, Tarek; Neuman, Robert; Morris, Alanna; Ali, Arshad; Hayek, Salim; Yoon, Young-sup; Waller, Edmund K.; Quyyumi, Arshed A.] Emory Univ, Sch Med, Div Cardiol, Emory Clin Cardiovasc Res Inst, Atlanta, GA 30322 USA; [Mavromatis, Kreton; Brown, Charlene; Corriere, Matthew A.] Atlanta Vet Affairs Med Ctr, Div Cardiol, Decatur, GA USA; [Binongo, Jose N.; Li, Qunna; Zhang, Xin] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Clement, Stephanie; Oshinski, John] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA; [Murrow, Jonathan] Univ Georgia, Georgia Regents Univ, Augusta, GA USA; [Corriere, Matthew A.] Emory Univ, Sch Med, Div Vasc & Endovasc Surg, Atlanta, GA 30322 USA; [Waller, Edmund K.] Emory Univ, Sch Med, Dept Hematol Oncol, Atlanta, GA 30322 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Rollins School Public Health; Emory University; University System of Georgia; Augusta University; University of Georgia; Emory University; Emory University	Quyyumi, AA (corresponding author), Emory Univ, Sch Med, Dept Med, Div Cardiol, 1462 Clifton Rd NE,Ste 507, Atlanta, GA 30322 USA.	aquyyum@emory.edu	Khayata, Mohamed/I-5288-2015; Waller, Edmund K/AAP-3055-2020; Hayek, Salim S./E-6932-2013	Hayek, Salim S./0000-0003-0180-349X; KHAYATA, MOHAMED/0000-0001-8116-4311	National Heart, Blood, and Lung Institute [1RC2HL101515-01]; National Institutes of Health [UL1 RR025008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101515] Funding Source: NIH RePORTER	National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Blood, and Lung Institute (1RC2HL101515-01) and by the National Institutes of Health (UL1 RR025008). The GM-CSF was supplied by sanofi-aventis.	Ahimastos AA, 2013, JAMA-J AM MED ASSOC, V309, P453, DOI 10.1001/jama.2012.216237; Arai M, 2006, CIRC J, V70, P1093, DOI 10.1253/circj.70.1093; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BERENSON RJ, 1992, TRANSPL P, V24, P3032; Buschmann IR, 2001, ATHEROSCLEROSIS, V159, P343, DOI 10.1016/S0021-9150(01)00637-2; BUSSOLINO F, 1991, J CLIN INVEST, V87, P986, DOI 10.1172/JCI115107; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; Fischmeister G, 2000, CURR OPIN HEMATOL, V7, P150, DOI 10.1097/00062752-200005000-00004; Fischmeister G, 1999, ANN HEMATOL, V78, P117, DOI 10.1007/s002770050487; GARDNER AW, 1991, MED SCI SPORT EXER, V23, P402; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hashimoto S, 2001, J IMMUNOL, V167, P3619, DOI 10.4049/jimmunol.167.7.3619; Heiss C, 2005, J AM COLL CARDIOL, V45, P1441, DOI 10.1016/j.jacc.2004.12.074; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Krause DS, 1996, BLOOD, V87, P1; LANE TA, 1995, BLOOD, V85, P275, DOI 10.1182/blood.V85.1.275.bloodjournal851275; Lane TA, 1999, TRANSFUSION, V39, P39, DOI 10.1046/j.1537-2995.1999.39199116893.x; McDermott MM, 2007, J AM COLL CARDIOL, V50, P974, DOI 10.1016/j.jacc.2007.05.030; McDermott MM, 2013, JAMA-J AM MED ASSOC, V310, P57, DOI 10.1001/jama.2013.7231; McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Norgren L, 2007, J ENDOVASC THER, V14, P743, DOI 10.1583/1545-1550(2007)14[743:TISFOR]2.0.CO;2; Ostchega Y, 2007, J AM GERIATR SOC, V55, P583, DOI 10.1111/j.1532-5415.2007.01123.x; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Sacramento CB, 2009, J GENE MED, V11, P345, DOI 10.1002/jgm.1298; Seiler C, 2001, CIRCULATION, V104, P2012, DOI 10.1161/hc4201.097835; Shi Qun, 1998, Blood, V92, P362; Subramaniyam V, 2009, AM HEART J, V158, P53, DOI 10.1016/j.ahj.2009.04.014; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; van Royen N, 2005, CIRCULATION, V112, P1040, DOI 10.1161/CIRCULATIONAHA.104.529552; Zbinden R, 2004, HEART, V90, P945, DOI 10.1136/hrt.2003.018259	40	26	26	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2631	2639		10.1001/jama.2013.282540	http://dx.doi.org/10.1001/jama.2013.282540			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24247554	Green Accepted			2022-12-28	WOS:000328818000015
J	Adams, AM; Rabbani, A; Ahmed, S; Mahmood, SS; Al-Sabir, A; Rashid, SF; Evans, TG				Adams, Alayne M.; Rabbani, Atonu; Ahmed, Shamim; Mahmood, Shehrin Shaila; Al-Sabir, Ahmed; Rashid, Sabina F.; Evans, Timothy G.			Explaining equity gains in child survival in Bangladesh: scale, speed, and selectivity in health and development	LANCET			English	Article							MICROFINANCE; COVERAGE; PROGRAM; CREDIT; WOMEN	By disaggregating gains in child health in Bangladesh over the past several decades, significant improvements in gender and socioeconomic inequities have been revealed. With the use of a social determinants of health approach, key features of the country's development experience can be identified that help explain its unexpected health trajectory. The systematic equity orientation of health and socioeconomic development in Bangladesh, and the implementation attributes of scale, speed, and selectivity, have been important drivers of health improvement. Despite this impressive pro-equity trajectory, there remain significant residual inequities in survival of girls and lower wealth quintiles as well as a host of new health and development challenges such as urbanisation, chronic disease, and climate change. Further progress in sustaining and enhancing equity-oriented achievements in health hinges on stronger governance and longer-term systems thinking regarding how to effectively promote inclusive and equitable development within and beyond the health system.	[Adams, Alayne M.; Mahmood, Shehrin Shaila] Icddr B, Ctr Equ & Hlth Syst, Dhaka 1000, Bangladesh; [Rabbani, Atonu] Univ Dhaka, Dept Econ, Dhaka 1000, Bangladesh; [Ahmed, Shamim] WaterAid, Dhaka, Bangladesh; [Al-Sabir, Ahmed] Natl Inst Populat Res & Training NIPORT, Dhaka, Bangladesh; [Rashid, Sabina F.] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Evans, Timothy G.] World Bank, Washington, DC 20433 USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of Dhaka; Bangladesh Rural Advancement Committee BRAC; BRAC University; The World Bank	Adams, AM (corresponding author), Icddr B, Ctr Equ & Hlth Syst, GPO Box 128, Dhaka 1000, Bangladesh.	aadams@icddrb.org	Rabbani, Atonu/R-3033-2017	Rabbani, Atonu/0000-0002-3821-4106; Adams, Alayne/0000-0002-0961-9825; Mahmood, Shehrin Shaila/0000-0002-6546-9120	Rockefeller Foundation	Rockefeller Foundation	We are grateful to the Bangladesh Lancet Series Advisory Group and the panel of external reviewers for their valuable suggestions. Many thanks to Richard Cash for his editorial support, and to Mabub Elahi Chowdhury, Md Monjur Rahman, and Akib Khan for their assistance with data and data visualisation. This paper is part of a series on Bangladesh sponsored by the Rockefeller Foundation.	Adams AM, 2004, GLOBAL HLTH CHALLENG; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Amin S., 1994, BANGLADESH DEV STUDI, V22, P121; Anand S, 2001, CHALLENGING INEQUITI, P49; BANBEIS, 2012, BANBEIS ONL DAT; Bangladesh Rural Advancement Committee, 2012, BRAC ANN REP 2012; Barai MK, 2012, SAGE OPEN, V2, DOI 10.1177/2158244012439073; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; Chowdhury A.M.R., 1996, SIMPLE SOLUTION TEAC; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; CLELAND J, 1989, J BIOSOC SCI, P13; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Das NC, 2011, ASSET TRANSFER PROGR; DFID, 2005, IMP BIG NGOS POV DEM; Diderichsen, 2001, CHALLENGING INEQUITI; DSOUZA S, 1980, POPUL DEV REV, V6, P257, DOI 10.2307/1972730; El Arifeen S, 2013, LANCET; Evans TG, 1999, WORLD DEV, V27, P419, DOI 10.1016/S0305-750X(98)00134-X; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Government of the People's Republic of Bangladesh Ministry of Health and Family Welfare (MOHFW), 2011, STRAT PLAN HLTH POP; Hashemi SM, 1996, WORLD DEV, V24, P635, DOI 10.1016/0305-750X(95)00159-A; Hosseinpoor AR, 2012, B WORLD HEALTH ORGAN, V90, P588, DOI 10.2471/BLT.11.097378; Houweling Tanja Aj, 2007, Int J Equity Health, V6, P15, DOI 10.1186/1475-9276-6-15; Husain A.M, 1998, POVERTY ALLEVIATION; Islam MA, 2011, MAKING TUBERCULOSIS; Jamil K, 1999, HEALTH POLICY PLANN, V14, P49, DOI 10.1093/heapol/14.1.49; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Khandker SR, 2005, WORLD BANK ECON REV, V19, P263, DOI 10.1093/wber/lhi008; Khosla N., 2009, J INT WOMENS STUDIES, V11, P289; Mahmud W., 2008, INDIAN J HUMAN DEV, V2, P79; Matlab Health and Demographic Surveillance System, MATL REG HLTH DEM EV; Microcredit Regulatory Authority, 2009, NGO MFIS BANGL STAT; MITA R, 1995, STUD FAMILY PLANN, V26, P1, DOI 10.2307/2138046; MITRA S, 1997, BANGLADESH DEMOGRAPH; MITRA SNA, 1994, BANGLADESH DEMOGRAPH; Morduch J, 1999, J ECON LIT, V37, P1569, DOI 10.1257/jel.37.4.1569; Morduch J., 2009, IMPACT MICROCREDIT P; Morduch J., 2002, ANAL EFFECTS MICROFI; Nath RS, 2009, ED WATCH 2008 STATE; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) Mitra and Associates Macro International, 2009, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) Mitra and Associates ORC Macro, 2004, BANGL DEM HLTH SURV; NIPORT, 2012, BANGL MAT MORT HEALT; NIPORT Mitra and Associates and ORC Macro, 2001, BANGL DEM HLTH SURV; Pitt M., 2003, POLICY REWORKING P, V2998; Rabbani A, 2009, J BIOSOC SCI, V41, P645, DOI 10.1017/S0021932009990058; Rabbani M., 2008, CRAFTING GRADUATION; Rashid SF, 2006, REPROD HEALTH MATTER, V14, P151, DOI 10.1016/S0968-8080(06)27221-5; Saha T., 2003, BANGLADESH DISTRICT; Sanyal P, 2009, AM SOCIOL REV, V74, P529, DOI 10.1177/000312240907400402; Sawyer CC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001287; Schurmann AT, 2009, J HEALTH POPUL NUTR, V27, P505; Sen A, 2002, HEALTH ECON, V11, P659, DOI 10.1002/hec.762; Smilie Ian, 2009, FREEDOM WANT REMARKA; United Nations Children's Fund (UNICEF), 2010, PROGR CHILDR ACH MDG; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD URB PROSP 2011; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; WHO, 2012, 20 NAT IMM DAY NID C; World Bank. Poverty Reduction Economic Management Finance and Private Sector Development Sector Unit, 2008, POV RED EC MAN FIN P; Yunus M, 2009, BANKER POOR MICROLEN; Zaman H., 2004, MICROFINANCE BANGLAD	63	42	45	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					2027	2037		10.1016/S0140-6736(13)62060-7	http://dx.doi.org/10.1016/S0140-6736(13)62060-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269EI	24268604				2022-12-28	WOS:000328223700029
J	Larson, EB; Yaffe, K; Langa, KM				Larson, Eric B.; Yaffe, Kristine; Langa, Kenneth M.			New Insights into the Dementia Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVALENCE; TRENDS		[Larson, Eric B.] Univ Washington, Grp Hlth Res Inst, Seattle, WA 98195 USA; [Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Larson, Eric B.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Yaffe, Kristine] San Francisco Vet Affairs VA Med Ctr, San Francisco, CA USA; [Langa, Kenneth M.] Univ Michigan, Div Gen Med, VA Ann Arbor Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Larson, EB (corresponding author), Univ Washington, Grp Hlth Res Inst, Seattle, WA 98195 USA.			Langa, Kenneth/0000-0002-2798-1836	NATIONAL INSTITUTE ON AGING [U01AG006781, U01AG009740, K24AG031155, P01AG031098] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG031098, U01 AG009740, K24 AG031155, U01 AG006781] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Manton K C, 2005, Adv Gerontol, V16, P30; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6	5	218	223	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2275	2277		10.1056/NEJMp1311405	http://dx.doi.org/10.1056/NEJMp1311405			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	268FV	24283198	Green Accepted			2022-12-28	WOS:000328156300003
J	Kleckner, N; Zickler, D; Witz, G				Kleckner, Nancy; Zickler, Denise; Witz, Guillaume			Chromosome Capture Brings It All Together	SCIENCE			English	Editorial Material							MODEL		[Kleckner, Nancy; Witz, Guillaume] Harvard Univ, Dept Mol Biol, Cambridge, MA 01568 USA; [Zickler, Denise] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France	Harvard University; UDICE-French Research Universities; Universite Paris Saclay	Kleckner, N (corresponding author), Harvard Univ, Dept Mol Biol, 52 Oxford St, Cambridge, MA 01568 USA.	kleckner@fas.harvard.edu		Witz, Guillaume/0000-0003-1562-4265	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025326, R01GM025326, R01GM044794] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM044794, R01 GM025326, R01 GM044794, GM025326, R37 GM025326] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; KEYL HG, 1975, CHROMOSOMA, V51, P75, DOI 10.1007/BF00285810; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; LAEMMLI UK, 1977, COLD SPRING HARB SYM, V42, P351; LOIDL J, 1995, CHROMOSOMA, V104, P183; Maeshima K, 2005, CHROMOSOMA, V114, P365, DOI 10.1007/s00412-005-0023-7; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Poirier MG, 2002, P NATL ACAD SCI USA, V99, P15393, DOI 10.1073/pnas.232442599; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Strick R, 1995, CELL, V83, P1137, DOI 10.1016/0092-8674(95)90140-X	15	13	13	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					940	941		10.1126/science.1247514	http://dx.doi.org/10.1126/science.1247514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264982	Green Accepted			2022-12-28	WOS:000327223500029
J	Lieberman, P				Lieberman, Philip			Synapses, Language, and Being Human	SCIENCE			English	Editorial Material							BASAL GANGLIA; DISORDER; SPEECH		Brown Univ, Providence, RI 02912 USA	Brown University	Lieberman, P (corresponding author), Brown Univ, 190 Thayer St, Providence, RI 02912 USA.	phil-ip_lieberman@brown.edu						Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; Lieberman P, 2013, UNPREDICTABLE SPECIES: WHAT MAKES HUMANS UNIQUE, P1; Maricic T, 2013, MOL BIOL EVOL, V30, P844, DOI 10.1093/molbev/mss271; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326; NAESER MA, 1982, ARCH NEUROL-CHICAGO, V39, P2, DOI 10.1001/archneur.1982.00510130004002; Reimers-Kipping S, 2011, NEUROSCIENCE, V175, P75, DOI 10.1016/j.neuroscience.2010.11.042; Sia GM, 2013, SCIENCE, V342, P987, DOI 10.1126/science.1245079; Smoel M., 2013, NAT REV NEUROSCI, V14, P119; Stuss D.T., 1986, FRONTAL LOBES; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930	14	2	3	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					944	945		10.1126/science.1247515	http://dx.doi.org/10.1126/science.1247515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EZ	24264985				2022-12-28	WOS:000327223500032
J	Rez, P; Treacy, MMJ				Rez, Peter; Treacy, Michael M. J.			Three-dimensional imaging of dislocations	NATURE			English	Letter							RESOLUTION		[Rez, Peter; Treacy, Michael M. J.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Rez, P (corresponding author), Arizona State Univ, Dept Phys, POB 871504, Tempe, AZ 85287 USA.	treacy@asu.edu						ANSTIS GR, 1979, ACTA CRYSTALLOGR A, V35, P511, DOI 10.1107/S056773947900125X; Chen CC, 2013, NATURE, V496, P74, DOI 10.1038/nature12009; HILLYARD S, 1993, ULTRAMICROSCOPY, V49, P14, DOI 10.1016/0304-3991(93)90209-G; HIRSCH PB, 1965, ELECTRON MICROS, P165; JESSON DE, 1995, P R SOC-MATH PHYS SC, V449, P273, DOI 10.1098/rspa.1995.0044; Rez P., 1976, THESIS OXFORD U; Treacy M. M. J., 1981, I PHYSICS C SERIES, V61, P263	8	6	6	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					E1	E1		10.1038/nature12660	http://dx.doi.org/10.1038/nature12660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24256805	Bronze			2022-12-28	WOS:000327163200001
J	Chuong, EB; Feschotte, C				Chuong, Edward B.; Feschotte, Cedric			Transposons Up the Dosage	SCIENCE			English	Editorial Material							SEX-CHROMOSOMES; ELEMENTS; EVOLUTION; COMPENSATION		[Chuong, Edward B.; Feschotte, Cedric] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Chuong, EB (corresponding author), Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA.	edwardc@genetics.utah.edu; cedric@genetics.utah.edu		Chuong, Edward/0000-0002-5392-937X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077582] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077582, R01-GM077582] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Alekseyenko AA, 2013, GENE DEV, V27, P853, DOI 10.1101/gad.215426.113; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Ellison CE, 2013, SCIENCE, V342, P846, DOI 10.1126/science.1239552; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Kaiser VB, 2010, ANNU REV GENET, V44, P91, DOI 10.1146/annurev-genet-102209-163600; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058	13	5	5	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					812	813		10.1126/science.1246659	http://dx.doi.org/10.1126/science.1246659			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233714				2022-12-28	WOS:000326923000023
J	Fineberg, HV				Fineberg, Harvey V.			Toward a New Social Compact for Health Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Inst Med, Washington, DC 20001 USA		Fineberg, HV (corresponding author), Inst Med, 500 5th St NW, Washington, DC 20001 USA.	fineberg@nas.edu						Carulli AJ, 2013, AM J PHYSIOL-GASTR L, V305, pG761, DOI 10.1152/ajpgi.00297.2013; Federation of American Societies for Experimental Biology, PREDICTABLE AND SUST; National Research Council, 2012, RESEARCH UNIVERSITIE; National Research Council, 2007, RISING ABOVE THE GAT; President's council of Advisors on Science and Technology, 2012, REPORT TO THE PRESID; ResearchAmerica, 2011 US INVESTMENT I; Yu W, CHINA DAILY	7	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1923	1924		10.1001/jama.2013.282368	http://dx.doi.org/10.1001/jama.2013.282368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219939				2022-12-28	WOS:000326832900008
J	Hastings, MH				Hastings, Michael H.			m(6)A mRNA Methylation: A New Circadian Pacesetter	CELL			English	Editorial Material							CLOCK	The purpose of m(6)A methylation of RNA, first observed in the 1970s, has been a longstanding mystery. Fustin et al. now show that it regulates RNA processing and determines the period and oscillatory stability of the mammalian circadian clockwork.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Hastings, MH (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	mha@mrc-lmb.cam.ac.uk		Hastings, Michael Harvey/0000-0001-8576-6651				Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; McGlincy NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r54; Meyer P, 2006, SCIENCE, V311, P226, DOI 10.1126/science.1118126; Sahar Saurabh, 2013, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-642-25950-0_2	7	30	32	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					740	741		10.1016/j.cell.2013.10.028	http://dx.doi.org/10.1016/j.cell.2013.10.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209613	Bronze			2022-12-28	WOS:000326934300004
J	Marx, V				Marx, Vivien			BRAIN MAPPING IN HIGH RESOLUTION	NATURE			English	Editorial Material																		Advisory Committee to the NIH Director, 2013, INT REP BRAIN RES AD; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Mikula S, 2012, NAT METHODS, V9, P1198, DOI [10.1038/nmeth.2213, 10.1038/NMETH.2213]; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	5	40	42	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					147	152		10.1038/503147a	http://dx.doi.org/10.1038/503147a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201287	Bronze			2022-12-28	WOS:000326585600051
J	Stenberg, K; Axelson, H; Sheehan, P; Anderson, I; Gulmezoglu, AM; Temmerman, M; Mason, E; Friedman, HS; Bhutta, ZA; Lawn, JE; Sweeny, K; Tulloch, J; Hansen, P; Chopra, M; Gupta, A; Vogel, JP; Ostergren, M; Rasmussen, B; Levin, C; Boyle, C; Kuruvilla, S; Koblinsky, M; Walker, N; de Francisco, A; Novcic, N; Presern, C; Jamison, D; Bustreo, F				Stenberg, Karin; Axelson, Henrik; Sheehan, Peter; Anderson, Ian; Guelmezoglu, A. Metin; Temmerman, Marleen; Mason, Elizabeth; Friedman, Howard S.; Bhutta, Zulfiqar A.; Lawn, Joy E.; Sweeny, Kim; Tulloch, Jim; Hansen, Peter; Chopra, Mickey; Gupta, Anuradha; Vogel, Joshua P.; Ostergren, Mikael; Rasmussen, Bruce; Levin, Carol; Boyle, Colin; Kuruvilla, Shyama; Koblinsky, Marjorie; Walker, Neff; de Francisco, Andres; Novcic, Nebojsa; Presern, Carole; Jamison, Dean; Bustreo, Flavia		Study Grp Global Investment	Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework	LANCET			English	Article							OFFICIAL DEVELOPMENT ASSISTANCE; MILLENNIUM DEVELOPMENT GOALS; CLIMATE-CHANGE; REPRODUCTIVE HEALTH; LOW-INCOME; INTERVENTIONS; NEWBORN; MORTALITY; COUNTDOWN; COVERAGE	A new Global Investment Framework for Women's and Children's Health demonstrates how investment in women's and children's health will secure high health, social, and economic returns. We costed health systems strengthening and six investment packages for: maternal and newborn health, child health, immunisation, family planning, HIV/AIDS, and malaria. Nutrition is a cross-cutting theme. We then used simulation modelling to estimate the health and socioeconomic returns of these investments. Increasing health expenditure by just $5 per person per year up to 2035 in 74 high-burden countries could yield up to nine times that value in economic and social benefits. These returns include greater gross domestic product (GDP) growth through improved productivity, and prevention of the needless deaths of 147 million children, 32 million stillbirths, and 5 million women by 2035. These gains could be achieved by an additional investment of $30 billion per year, equivalent to a 2% increase above current spending.	[Stenberg, Karin] World Hlth Org, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland; [Bustreo, Flavia] World Hlth Org, CH-1211 Geneva, Switzerland; [Guelmezoglu, A. Metin; Temmerman, Marleen; Vogel, Joshua P.] World Hlth Org, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Mason, Elizabeth; Ostergren, Mikael] World Hlth Org, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Axelson, Henrik] World Hlth Org, Dept Hlth Syst Governance & Financing, Phnom Penh, Cambodia; [Kuruvilla, Shyama; de Francisco, Andres; Novcic, Nebojsa; Presern, Carole] World Hlth Org, Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Bhutta, Zulfiqar A.] SickKids Ctr Global Child Hlth, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Hansen, Peter] GAVI Alliance, Geneva, Switzerland; [Walker, Neff] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lawn, Joy E.] London Sch Hyg & Trop Med, London WC1, England; [Chopra, Mickey] UNICEF, Hlth Sect, New York, NY USA; [Friedman, Howard S.] Populat Fund, New York, NY USA; [Koblinsky, Marjorie] Agcy Int Dev, Washington, DC USA; [Sheehan, Peter; Sweeny, Kim; Rasmussen, Bruce] Victoria Univ, Melbourne, Vic 8001, Australia; [Levin, Carol; Jamison, Dean] Univ Washington, Seattle, WA 98195 USA; [Boyle, Colin] Univ Calif San Francisco, San Francisco, CA 94143 USA	World Health Organization; World Health Organization; World Health Organization; World Health Organization; World Health Organization; World Health Organization; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; UNICEF; Victoria University; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	Stenberg, K (corresponding author), World Hlth Org, Dept Hlth Syst Governance & Financing, Ave Appia, CH-1211 Geneva, Switzerland.	stenbergk@who.int	Lawn, Joy/ABE-6382-2020; Vogel, Joshua/K-7649-2019	Lawn, Joy/0000-0002-4573-1443; Vogel, Joshua/0000-0002-3214-7096; Sheehan, Peter/0000-0001-9450-8371; BAKER, AMELIA/0000-0002-8246-7581; Kuruvilla, Shyama/0000-0002-0327-4467	Government of Australia; Bill & Melinda Gates Foundation; Government of Canada; MacArthur Foundation; Government of the Netherlands; Government of Norway; Government of Sweden; Government of the UK; Government of the USA; World Bank	Government of Australia; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Government of Canada(CGIAR); MacArthur Foundation; Government of the Netherlands(Netherlands Government); Government of Norway; Government of Sweden; Government of the UK; Government of the USA; World Bank(The World Bank India)	The WHO and the Partnership for Maternal, Newborn, and Child Health (PMNCH) acknowledges the financial support received from all of its donors to date in 2013, whose support enabled the development of this article through direct funding, or through funding of other WHO and PMNCH work streams that informed ideas presented in this report. Furthermore, direct funding for the Investment Framework analysis, including a meeting of the Study Group, was provided by the Governments of Norway and Italy. PMNCH acknowledges financial support received from the following donors in 2013 ( in alphabetical order): Government of Australia, Bill & Melinda Gates Foundation, Government of Canada, MacArthur Foundation, Government of the Netherlands, Government of Norway, Government of Sweden, Government of the UK, Government of the USA, and the World Bank.	AbouZahr C, 2010, LANCET, V375, P619, DOI 10.1016/S0140-6736(09)60004-0; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; [Anonymous], 2013, WHO REC PREV TREATM; Ashraf QH, 2013, POPUL DEV REV, V39, P97, DOI 10.1111/j.1728-4457.2013.00575.x; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Azenha GS, 2013, B WORLD HEALTH ORGAN, V91, P704, DOI 10.2471/BLT.13.117622; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Black RE, 2013, LANCET, V382, P372, DOI 10.1016/S0140-6736(13)60988-5; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blencowe H, 2013, PEDIAT RES IN PRESS; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Bryant L, 2009, B WORLD HEALTH ORGAN, V87, P852, DOI 10.2471/BLT.08.062562; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; CARMMA, 2013, CAMP ACC RED MAT NEW; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cheng JJ, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-4; Cropper M, 2011, ANNU REV RESOUR ECON, V3, P313, DOI 10.1146/annurev.resource.012809.103949; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Deogan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051420; Fryatt R, 2010, LANCET, V375, P419, DOI 10.1016/S0140-6736(09)61833-X; Global Strategy for Women's and Children's health, 2013, BACKGR PAP FIN EST G; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Harmonization for Health in Africa, 2013, INV HLTH AFR CAS STR; Hsu J, 2013, LANCET, V381, P1772, DOI 10.1016/S0140-6736(13)60762-X; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Independent Expert Review Group on Information and Accountability for Women's and Children's Health, 2013, EV WOM EV CHILD COMM; International Health Partnership, 2013, ONEHEALTH TOOL; Jamison D, 2013, INFECT DIS INJURY RE; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kinfu Y, 2009, B WORLD HEALTH ORGAN, V87, P225, DOI 10.2471/BLT.08.051599; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maternal Newborn and Child Health Network for Asia and the Pacific, 2009, INV MAT NEWB CHILD H; McMichael AJ, 2013, NEW ENGL J MED, V368, P1335, DOI 10.1056/NEJMra1109341; Merson M, 2012, GLOBAL HLTH DIS PROG, P757; Miller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076477; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Partnership for Maternal Newborn and Child Health (PMNCH), 2013, AN PROGR COMM GLOB S; Pitt C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001332; PMNCH WHO Aga Khan University, 2013, ESS INT COMM GUID GL; Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0; Scaling Up Nutrition, 2013, IMPR MAT CHILD NUTR; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shakur H, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-40; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Speidel JJ, 2007, POPUL ENVIRON, V28, P247, DOI 10.1007/s11111-007-0051-8; Spencer M, 2009, HLTH GROWTH; Stenberg K, 2010, RESPONDING CHALLENGE; Stephenson J, 2013, LANCET, V382, P1665, DOI 10.1016/S0140-6736(13)61460-9; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stover J, 2010, SEX TRANSM INFECT S2, V86, pii16; Taskforce on Innovative International Financing for Health Systems, 2013, CONSTR SCAL COSTS WO; The Partnership for Maternal. Newborn and Child Health, 2011, PMNCH KNOWL SUMM 15; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; UN Foundation, 2012, EV WOM EV CHILD; UN Secretary-General, 2010, UN GLOB STRAT WOM CH; UNHCR, DISPL NEW 21 CENT CH; UNICEF, 2017, LEVELS TRENDS CHILD; UNICEF, 2012, COUNTD 2015 MAT NEWB; UNICEF, 2009, STATE WORLDS CHILDRE; United Nations, 2013, NEW GLOB PARTN ER PO; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; USAID, 2013, AIM COMP PROGR MAK H; USAID, 2013, FAMPLAN COMP PROGR P; Varkey P, 2010, J WOMENS HLTH, V19, P71; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; Wheeler D, 2010, WORKING PAPER; WHO, 2013, CONSTR SCAL HLTH REL; WHO, 2010, TRENDS MAT MORT 1990; WHO, 2013, TASK SHIFT GLOB REC; WHO, 2013, ASS MON VACC PREV DI; WHO Eastern Mediterranean Region Office, 2013, SCAL INT E MED REG W; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; World Health Organisation, 2013, GLOB HLTH EXP DAT; World Health Organization, 2013, CHOOS INT AR COST EF; World Health Organization, 2001, MACR HLTH INV HLTH E; World Health Organization and UNICEF, 2013, COUNTD 2015 ACC MAT; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	90	200	206	0	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1333	1354		10.1016/S0140-6736(13)62231-X	http://dx.doi.org/10.1016/S0140-6736(13)62231-X			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LQ	24263249				2022-12-28	WOS:000334104900032
J	Cash, RA; Halder, SR; Husain, M; Islam, MS; Mallick, FH; May, MA; Rahman, M; Rahman, MA				Cash, Richard A.; Halder, Shantana R.; Husain, Mushtuq; Islam, Md Sirajul; Mallick, Fuad H.; May, Maria A.; Rahman, Mahmudur; Rahman, M. Aminur			Reducing the health effect of natural hazards in Bangladesh	LANCET			English	Article							DHAKA CITY; CYCLONE; DISASTER; DISEASE; FLOODS	Bangladesh, with a population of 151 million people, is a country that is particularly prone to natural disasters: 26% of the population are affected by cyclones and 70% live in flood-prone regions. Mortality and morbidity from these events have fallen substantially in the past 50 years, partly because of improvements in disaster management. Thousands of cyclone shelters have been built and government and civil society have mobilised strategies to provide early warning and respond quickly. Increasingly, flood and cyclone interventions have leveraged community resilience, and general activities for poverty reduction have integrated disaster management. Furthermore, overall population health has improved greatly on the basis of successful public health activities, which has helped to mitigate the effect of natural disasters. Challenges to the maintenance and reduction of the effect of cyclones and floods include rapid urbanisation and the growing effect of global warming. Although the effects of earthquakes are unknown, some efforts to prepare for this type of event are underway.	[Cash, Richard A.] Publ Hlth Fdn India, New Delhi, India; [Cash, Richard A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Halder, Shantana R.] Govt Bangladesh, Comprehens Disaster Management Programme, Disaster Management & Relief Bhaban, Dhaka, Bangladesh; [Husain, Mushtuq; Rahman, Mahmudur] Inst Epidemiol & Dis Control Res, Dhaka, Bangladesh; [Islam, Md Sirajul] Int Ctr Diarrhoeal Dis Res, Environm Microbiol Lab, Dhaka 1000, Bangladesh; [Mallick, Fuad H.; Rahman, M. Aminur] BRAC Univ, Dept Architecture, Postgrad Programs Disaster Management, Dhaka, Bangladesh; [May, Maria A.] BRAC, BRAC Ctr, Social Innovat Lab, Dhaka 1212, Bangladesh	Public Health Foundation of India; Harvard University; Harvard T.H. Chan School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; Bangladesh Rural Advancement Committee BRAC	May, MA (corresponding author), BRAC, BRAC Ctr, Social Innovat Lab, Dhaka 1212, Bangladesh.	maria.a@brac.net		Rahman, Mohammad Aminur/0000-0003-4775-6748				Adams AM, 2013, LANCET; Ahmed F., 2007, BANGLADESH CYCLONE S; Ahmed S, 1992, CRISIS DEV, P819; Ahmed SM, 1999, EXPERIENCES DELUGE F, P1; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Akhter SH, 2010, EARTHQUAKES DHAKA; [Anonymous], 2004, MONS FLOODS 2004 POS; [Anonymous], 2010, NAT PLAN DIS MAN; BERN C, 1993, B WORLD HEALTH ORGAN, V71, P73; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; CHOWDHURY AMR, 1993, DISASTERS, V17, P291, DOI 10.1111/j.1467-7717.1993.tb00503.x; Chowdhury M, 1992, CRISIS DEV COPING DI, P101; CUSTERS P, 1992, ECON POLIT WEEKLY, V27, P327; DOW K, 1992, GEOFORUM, V23, P417, DOI 10.1016/0016-7185(92)90052-6; Fernandes A, 2012, B WORLD HEALTH ORGAN, V90, P631, DOI 10.2471/BLT.12.104901; Government of Bangladesh, 2008, CYCL SIDR BANGL DAM; Haque MM, 1992, CRISIS DEV COPING DI, P27; Haque U, 2012, B WORLD HEALTH ORGAN, V90, P150, DOI 10.2471/BLT.11.088302; Hossain H, 1992, CRISIS DEV, P13; International Flood Network, 2009, FLOOD INF IMP CYCL A; IRIN News, 2012, IRIN NEWS       0222; Islam MS, 2011, T ROY SOC TROP MED H, V105, P341, DOI 10.1016/j.trstmh.2011.03.003; Islam MS, 2007, J APPL MICROBIOL, V103, P80, DOI 10.1111/j.1365-2672.2006.03234.x; Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/ERI.11.155, 10.1586/eri.11.155]; Mallick FH, 2008, J S ASIA DISASTER ST, V1, P59; Mollica R, 2006, HEALING INVISIBLE WO; Paul BK, 2011, NAT HAZARDS, V56, P841, DOI 10.1007/s11069-010-9595-5; Paul BK, 1997, GEOFORUM, V28, P121, DOI 10.1016/S0016-7185(97)00004-3; Pelling Mark, 2003, VULNERABILITY CITIES; Potsdam Institute for Climate Impact Research and Climate Analytics, 2013, TURN HEAT CLIM EXTR; Rahman MA, HAZARDS DISASTERS SO; Rashid SF, 2000, DISASTERS, V24, P240, DOI 10.1111/1467-7717.00145; Robinson S., 2007, BANGLADESH SURVIVED; Roy P, 2011, DISTANCE SAVED FRAGI; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067; Shafie H, 2009, ENDOWED WISDOM KNOWL; Shultz JM, 2005, EPIDEMIOL REV, V27, P21, DOI 10.1093/epirev/mxi011; SOMMER A, 1972, LANCET, V1, P1029; Tod I, 2008, ASSESSMENT EFFECTIVE; Zimmermann M, 2010, DIS RISK RED PROGR B	40	35	36	2	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2094	2103		10.1016/S0140-6736(13)61948-0	http://dx.doi.org/10.1016/S0140-6736(13)61948-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24268610	Green Submitted			2022-12-28	WOS:000328687800031
J	Shankar, S; Hatridge, M; Leghtas, Z; Sliwa, KM; Narla, A; Vool, U; Girvin, SM; Frunzio, L; Mirrahimi, M; Devoret, MH				Shankar, S.; Hatridge, M.; Leghtas, Z.; Sliwa, K. M.; Narla, A.; Vool, U.; Girvin, S. M.; Frunzio, L.; Mirrahimi, M.; Devoret, M. H.			Autonomously stabilized entanglement between two superconducting quantum bits	NATURE			English	Article							PHOTON	Quantum error correction codes are designed to protect an arbitrary state of a multi-qubit register from decoherence-induced errors(1), but their implementation is an outstanding challenge in the development of large-scale quantum computers. The first step is to stabilize a non-equilibrium state of a simple quantum system, such as a quantum bit (qubit) or a cavity mode, in the presence of decoherence. This has recently been accomplished using measurement-based feedback schemes(2-5). The next step is to prepare and stabilize a state of a composite system(6-8). Here we demonstrate the stabilization of an entangled Bell state of a quantum register of two superconducting qubits for an arbitrary time. Our result is achieved using an autonomous feedback scheme that combines continuous drives along with a specifically engineered coupling between the two-qubit register and a dissipative reservoir. Similar autonomous feedback techniques have been used for qubit reset(9), single-qubit state stabilization(10), and the creation(11) and stabilization(6) of states of multipartite quantum systems. Unlike conventional, measurement-based schemes, the autonomous approach uses engineered dissipation to counteract decoherence(12-15), obviating the need for a complicated external feedback loop to correct errors. Instead, the feedback loop is built into the Hamiltonian such that the steady state of the system in the presence of drives and dissipation is a Bell state, an essential building block for quantum information processing. Such autonomous schemes, which are broadly applicable to a variety of physical systems, as demonstrated by the accompanying paper on trapped ion qubits(16), will be an essential tool for the implementation of quantum error correction.	[Shankar, S.; Hatridge, M.; Leghtas, Z.; Sliwa, K. M.; Narla, A.; Vool, U.; Girvin, S. M.; Frunzio, L.; Mirrahimi, M.; Devoret, M. H.] Yale Univ, Dept Phys & Appl Phys, New Haven, CT 06520 USA; [Mirrahimi, M.] INRIA Paris Rocquencourt, F-78153 Le Chesnay, France	Yale University	Shankar, S (corresponding author), Yale Univ, Dept Phys & Appl Phys, New Haven, CT 06520 USA.	shyam.shankar@yale.edu; michel.devoret@yale.edu	Narla, Anirudh/AAG-2987-2019; Frunzio, Luigi/O-1573-2019; Shankar, Shyam/K-5127-2013	Narla, Anirudh/0000-0002-1498-8641; Frunzio, Luigi/0000-0002-0272-5481; Shankar, Shyam/0000-0002-1311-9508; Vool, Uri/0000-0001-6024-8241; Leghtas, Zaki/0000-0002-9172-1537; Mirrahimi, Mazyar/0000-0001-9471-6031	Yale Institute for Nanoscience and Quantum Engineering; National Science Foundation (NSF) MRSEC [DMR 1119826]; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) [W911NF-09-1-0369]; US Army Research Office [W911NF-09-1-0514]; NSF [DMR 1006060, DMR 0653377, DMR 1004406]; Agence National de la Recherche [EPOQ2ANR-09-JCJC-0070]	Yale Institute for Nanoscience and Quantum Engineering; National Science Foundation (NSF) MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA); US Army Research Office; NSF(National Science Foundation (NSF)); Agence National de la Recherche(French National Research Agency (ANR))	Facility use was supported by the Yale Institute for Nanoscience and Quantum Engineering and the National Science Foundation (NSF) MRSEC DMR 1119826. This research was supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) W911NF-09-1-0369, by the US Army Research Office W911NF-09-1-0514, and by the NSF DMR 1006060 and DMR 0653377. M. M. acknowledges partial support from the Agence National de la Recherche under the project EPOQ2ANR-09-JCJC-0070. S. M. G. and Z.L. acknowledge support from the NSF DMR 1004406. All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI or the US government.	Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Bergeal N, 2010, NATURE, V465, P64, DOI 10.1038/nature09035; Brakhane S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.173601; Campagne-Ibarcq P, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021008; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Filipp S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.200402; Hatridge M, 2013, SCIENCE, V339, P178, DOI 10.1126/science.1226897; Houck AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.080502; ITANO WM, 1990, PHYS REV A, V41, P2295, DOI 10.1103/PhysRevA.41.2295; Johnson JE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.050506; Kastoryano MJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.090502; Kerckhoff J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.040502; Krauter H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.080503; Lalumiere K, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.040301; Lecocq F, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/31/315302; Leghtas Z, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.120501; Motzoi F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.110501; Murch KW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.183602; Nielsen M.A., 2004, QUANTUM COMPUTATION, V1st ed.; Nigg SE, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.240502; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Poyatos JF, 1996, PHYS REV LETT, V77, P4728, DOI 10.1103/PhysRevLett.77.4728; Reed M. D., 2013, THESIS YALE U; Reichle R, 2006, NATURE, V443, P838, DOI 10.1038/nature05146; Rigetti C., 2009, THESIS YALE U, P174; Riste D, 2013, NATURE, V502, P350, DOI 10.1038/nature12513; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.240502; Sarlette A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.010402; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Schreier JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180502; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Sears AP, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.180504; Slichter DH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.153601; Tornberg L, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.012329; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245	41	233	242	5	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					419	+		10.1038/nature12802	http://dx.doi.org/10.1038/nature12802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24270808	Green Submitted			2022-12-28	WOS:000328575300048
J	Hasson, SA; Kane, LA; Yamano, K; Huang, CH; Sliter, DA; Buehler, E; Wang, CX; Heman-Ackah, SM; Hessa, T; Guha, R; Martin, SE; Youle, RJ				Hasson, Samuel A.; Kane, Lesley A.; Yamano, Koji; Huang, Chiu-Hui; Sliter, Danielle A.; Buehler, Eugen; Wang, Chunxin; Heman-Ackah, Sabrina M.; Hessa, Tara; Guha, Rajarshi; Martin, Scott E.; Youle, Richard J.			High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy	NATURE			English	Article							MITOCHONDRIA; RECRUITMENT; SENSITIVITY; ACTIVATION; MUTATIONS; PROMOTES; COMPLEX	An increasing body of evidence points to mitochondrial dysfunction as a contributor to the molecular pathogenesis of neurodegenerative diseases such as Parkinson's disease(1). Recent studies of the Parkinson's disease associated genes PINK1 (ref. 2) and parkin (PARK2, ref. 3) indicate that they may act in a quality control pathway preventing the accumulation of dysfunctional mitochondria(4-8). Here we elucidate regulators that have an impact on parkin translocation to damaged mitochondria with genome-wide small interfering RNA (siRNA) screens coupled to high-content microscopy. Screening yielded gene candidates involved in diverse cellular processes that were subsequently validated in low-throughput assays. This led to characterization of TOMM7 as essential for stabilizing PINK1 on the outer mitochondrial membrane following mitochondrial damage. We also discovered that HSPA1L (HSP70 family member) and BAG4 have mutually opposing roles in the regulation of parkin translocation. The screens revealed that SIAH3, found to localize to mitochondria, inhibits PINK1 accumulation after mitochondrial insult, reducing parkin translocation. Overall, our screens provide a rich resource to understand mitochondrial quality control.	[Hasson, Samuel A.; Kane, Lesley A.; Yamano, Koji; Huang, Chiu-Hui; Sliter, Danielle A.; Wang, Chunxin; Hessa, Tara; Youle, Richard J.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Hasson, Samuel A.; Buehler, Eugen; Guha, Rajarshi; Martin, Scott E.] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Heman-Ackah, Sabrina M.] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA	Youle, RJ (corresponding author), NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.	youler@ninds.nih.gov	Huang, Chiu-Hui/O-1061-2018; Wang, Chunxin/B-9312-2016	Huang, Chiu-Hui/0000-0003-1485-5731; Wang, Chunxin/0000-0001-6015-6806; Hasson, Samuel/0000-0003-2258-0678	Japan Society for Promotion of Science; NIGMS Research Associate Program; NIH, NINDS; Trans-NIH RNAi initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003123] Funding Source: NIH RePORTER	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIGMS Research Associate Program; NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Trans-NIH RNAi initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Tuzmen for qRT-PCR assistance; C. Klumpp for automation; D. Maric for FACS sorting; C. Smith for microscopy assistance; H. Jaffe for mass spectrometry analyses; R. Fields (NINDS) for lentivirus assistance; N. Malik for iPS-derived neurons; the NINDS DNA Sequencing Facility; K. Mihara for the TOMM7 antibody and A. Koretsky and N. Caplen for support. Research was supported by the Japan Society for Promotion of Science Postdoctoral Fellowship for Research Abroad (K.Y.), the NIGMS Research Associate Program, the Intramural Research Program of the NIH, NINDS and the Trans-NIH RNAi initiative.	Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Burman JL, 2012, P NATL ACAD SCI USA, V109, P10438, DOI 10.1073/pnas.1120688109; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kato H, 2008, BIOCHEM BIOPH RES CO, V369, P958, DOI 10.1016/j.bbrc.2008.02.150; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510; Sudbery I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-175; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107	30	249	265	8	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					291	+		10.1038/nature12748	http://dx.doi.org/10.1038/nature12748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24270810	Green Accepted, Green Published			2022-12-28	WOS:000328121500039
J	Aartsen, MG; Abbasi, R; Abdou, Y; Ackermann, M; Adams, J; Aguitar, JA; Alders, M; Altmann, D; Auffenberg, J; Bai, X; Baker, M; Barwick, SW; Baum, V; Bay, R; Beatty, JJ; Bechet, S; Tjus, JB; Becker, KH; Benabderrahmane, ML; BenZvi, S; Berghaus, P; Berley, D; Bernardini, E; Bernhard, A; Bertrand, D; Besson, DZ; Binder, G; Bindig, D; Bissok, M; Blaufuss, E; Blumenthal, J; Boersma, DJ; Boliaichuk, S; Bohm, C; Bose, D; Boeser, S; Botner, O; Brayeur, L; Bretz, HP; Brown, AM; Bruijn, R; Brunner, J; Carson, M; Casey, J; Casier, M; Chirkin, D; Christov, A; Christy, B; Clark, K; Cleverrnann, F; Coenders, S; Cohen, S; Cowen, DF; Silva, AHC; Danninger, M; Daughhetee, J; Davis, JC; Day, M; De Clercq, C; De Ridder, S; Desiati, P; de Vries, KD; de With, M; DeYoung, T; Diaz-Velez, JC; Dunkman, M; Eagan, R; Eberhardt, B; Eichmann, B; Eisch, J; Ellsworth, RW; Euler, S; Evenson, PA; Fadiran, O; Fazely, AR; Fedynitch, A; Feinzeig, J; Feusels, T; Filimonov, K; Finley, C; Fischer-Wasels, T; Flis, S; Franckowiak, A; Frantzen, K; Fuchs, T; Gaisser, TK; Gallagher, J; Gerhardt, L; Gladstone, L; Glusenkamp, T; Goldschmidt, A; Golup, G; Gonzalez, JG; Goodman, JA; Gora, D; Grandmont, DT; Grant, D; Gross, A; Ha, C; Ismail, AH; Hallen, P; Hallgren, A; Halzen, F; Hanson, K; Heerernan, D; Heinen, D; Helbing, K; Hellauer, R; Hickford, S; Hill, GC; Hoffman, KD; Hoffmann, R; Homeier, A; Hoshina, K; Huelsnitz, W; Hulth, PO; Hultqvist, K; Hussain, S; Ishihara, A; Jacobi, E; Jacobsen, J; Jagielski, K; Japaridze, GS; Jero, K; Jlelati, O; Kaminsky, B; Kappes, A; Karg, T; Karle, A; Kelley, JL; Kiryluk, J; Klas, J; Klein, SR; Koohne, JH; Kohnen, C; Kolanoski, H; Koepke, L; Kopper, C; Kopper, S; Koskinen, DJ; Kowalski, M; Krasberg, M; Krings, K; Kroll, G; Kunnen, J; Kurahashi, N; Kowabara, T; Labare, M; Landsman, H; Larson, MJ; Lesiak-Bzdak, M; Leuermann, M; Leute, J; Lunemann, J; Madsen, J; Maggi, G; Maruyama, R; Mase, K; Matis, HS; McNally, F; Meagher, K; Merck, M; Meures, T; Miarecki, S; Middell, E; Milke, N; Miller, J; Mohrmann, L; Montaruli, T; Morse, R; Nahnhauer, R; Naumann, U; Niederhausen, H; Nowicki, SC; Nygren, DR; Obertacke, A; Odrowski, S; Olivas, A; O'Murchadha, A; Paul, L; Pepper, JA; de los Heros, CP; Pfendner, C; Pieloth, D; Pinat, E; Posselt, J; Price, PB; Przybylski, GT; Radel, L; Rameez, M; Rawlins, K; Redl, P; Reimann, R; Resconi, E; Rhode, W; Ribordy, M; Richman, M; Riedel, B; Rodrigues, JP; Rott, C; Ruhe, T; Ruzybayev, B; Ryckbosch, D; Saba, SM; Salameh, T; Sander, HG; Santander, M; Sarkar, S; Schatto, K; Scheriau, F; Schmidt, T; Schmitz, M; Schoenen, S; Schoneberg, S; Schonwald, A; Schukraft, A; Schulte, L; Schulz, O; Seckel, D; Sestayo, Y; Seunarine, S; Shanidze, R; Sheremata, C; Smith, MWE; Soldin, D; Spiczak, GA; Spiering, C; Stamatikos, M; Stanev, T; Stasik, A; Stezelberger, T; Stokstad, RG; Stossl, A; Strahler, EA; Strom, R; Sullivan, GW; Taavola, H; Taboada, I; Tamburro, A; Tepe, A; Ter-Antonyan, S; Tesic, G; Tilav, S; Toale, PA; Toscana, S; Unger, E; Usner, M; van Eijndhoven, N; Van Overloop, A; van Santen, J; Vehring, M; Voge, M; Vraeghe, M; Walck, C; Waldenmaier, T; Wallraff, M; Weaver, C; Wellons, M; Wendt, C; Westerhoff, S; Whitehorn, N; Wiebe, K; Wiebusch, CH; Williams, DR; Wissing, H; Wolf, M; Wood, TR; Woschnagg, K; Xu, DL; Xu, XW; Yanez, JP; Yodh, G; Yoshida, S; Zarzhitsky, P; Ziemann, J; Zierke, S; Zoll, M				Aartsen, M. G.; Abbasi, R.; Abdou, Y.; Ackermann, M.; Adams, J.; Aguitar, J. A.; Alders, M.; Altmann, D.; Auffenberg, J.; Ba, X.; Baker, M.; Barwick, S. W.; Baum, V.; Bay, R.; Beatty, J. J.; Bechet, S.; Tjus, J. Becker; Becker, K-H.; Benabderrahmane, M. L.; BenZvi, S.; Berghaus, P.; Berley, D.; Bernardini, E.; Bernhard, A.; Bertrand, D.; Besson, D. Z.; Binder, G.; Bindig, D.; Bissok, M.; Blaufuss, E.; Blumenthal, J.; Boersma, D. J.; Boliaichuk, S.; Bohm, C.; Bose, D.; Boeser, S.; Botner, O.; Brayeur, L.; Bretz, H-P.; Brown, A. M.; Bruijn, R.; Brunner, J.; Carson, M.; Casey, J.; Casier, M.; Chirkin, D.; Christov, A.; Christy, B.; Clark, K.; Cleverrnann, F.; Coenders, S.; Cohen, S.; Cowen, D. F.; Silva, A. H. Cruz; Danninger, M.; Daughhetee, J.; Davis, J. C.; Day, M.; De Clercq, C.; Ridder, S. De; Desiati, P.; de Vries, K. D.; de With, M.; DeYoung, T.; Diaz-Velez, J. C.; Dunkman, M.; Eagan, R.; Eberhardt, B.; Eichmann, B.; Eisch, J.; Ellsworth, R. W.; Euler, S.; Evenson, P. A.; Fadiran, O.; Fazely, A. R.; Fedynitch, A.; Feinzeig, J.; Feusels, T.; Filimonov, K.; Finley, C.; Fischer-Wasels, T.; Flis, S.; Franckowiak, A.; Frantzen, K.; Fuchs, T.; Gaisser, T. K.; Gallagher, J.; Gerhardt, L.; Gladstone, L.; Gluesenkamp, T.; Goldschmidt, A.; Golup, G.; Gonzalez, J. G.; Goodman, J. A.; Gora, D.; Grandmont, D. T.; Grant, D.; Gross, A.; Ha, C.; Ismail, A. Haj; Hallen, P.; Hallgren, A.; Halzen, F.; Hanson, K.; Heerernan, D.; Heinen, D.; Helbing, K.; Hellauer, R.; Hickford, S.; Hill, G. C.; Hoffman, K. D.; Hoffmann, R.; Homeier, A.; Hoshina, K.; Huelsnitz, W.; Hulth, P. O.; Hultqvist, K.; Hussain, S.; Ishihara, A.; Jacobi, E.; Jacobsen, J.; Jagielski, K.; Japaridze, G. S.; Jero, K.; Jlelati, O.; Kaminsky, B.; Kappes, A.; Karg, T.; Karle, A.; Kelley, J. L.; Kiryluk, J.; Klaes, J.; Klein, S. R.; Koehne, J-H.; Kohnen, C.; Kolanoski, H.; Koepke, L.; Kopper, C.; Kopper, S.; Koskinen, D. J.; Kowalski, M.; Krasberg, M.; Krings, K.; Kroll, G.; Kunnen, J.; Kurahashi, N.; Kowabara, T.; Labare, M.; Landsman, H.; Larson, M. J.; Lesiak-Bzdak, M.; Leuermann, M.; Leute, J.; Luenemann, J.; Madsen, J.; Maggi, G.; Maruyama, R.; Mase, K.; Matis, H. S.; McNally, F.; Meagher, K.; Merck, M.; Meures, T.; Miarecki, S.; Middell, E.; Milke, N.; Miller, J.; Mohrmann, L.; Montaruli, T.; Morse, R.; Nahnhauer, R.; Naumann, U.; Niederhausen, H.; Nowicki, S. C.; Nygren, D. R.; Obertacke, A.; Odrowski, S.; Olivas, A.; O'Murchadha, A.; Paul, L.; Pepper, J. A.; de los Heros, C. Perez; Pfendner, C.; Pieloth, D.; Pinat, E.; Posselt, J.; Price, P. B.; Przybylski, G. T.; Raedel, L.; Rameez, M.; Rawlins, K.; Redl, P.; Reimann, R.; Resconi, E.; Rhode, W.; Ribordy, M.; Richman, M.; Riedel, B.; Rodrigues, J. P.; Rott, C.; Ruhe, T.; Ruzybayev, B.; Ryckbosch, D.; Saba, S.; Salameh, T.; Sander, H-G.; Santander, M.; Sarkar, S.; Schatto, K.; Scheriau, F.; Schmidt, T.; Schmitz, M.; Schoenen, S.; Schoeneberg, S.; Schoenwald, A.; Schukraft, A.; Schulte, L.; Schulz, O.; Seckel, D.; Sestayo, Y.; Seunarine, S.; Shanidze, R.; Sheremata, C.; Smith, M. W. E.; Soldin, D.; Spiczak, G. A.; Spiering, C.; Stamatikos, M.; Stanev, T.; Stasik, A.; Stezelberger, T.; Stokstad, R. G.; Stoessl, A.; Strahler, E. A.; Strom, R.; Sullivan, G. W.; Taavola, H.; Taboada, I.; Tamburro, A.; Tepe, A.; Ter-Antonyan, S.; Tesic, G.; Tilav, S.; Toale, P. A.; Toscana, S.; Unger, E.; Usner, M.; van Eijndhoven, N.; Van Overloop, A.; van Santen, J.; Vehring, M.; Voge, M.; Vraeghe, M.; Walck, C.; Waldenmaier, T.; Wallraff, M.; Weaver, Ch; Wellons, M.; Wendt, C.; Westerhoff, S.; Whitehorn, N.; Wiebe, K.; Wiebusch, C. H.; Williams, D. R.; Wissing, H.; Wolf, M.; Wood, T. R.; Woschnagg, K.; Xu, D. L.; Xu, X. W.; Yanez, J. P.; Yodh, G.; Yoshida, S.; Zarzhitsky, P.; Ziemann, J.; Zierke, S.; Zoll, M.		IceCube Collaboration	Evidence for High-Energy Extraterrestrial Neutrinos at the IceCube Detector	SCIENCE			English	Article								We report on results of an all-sky search for high-energy neutrino events interacting within the IceCube neutrino detector conducted between May 2010 and May 2012. The search follows up on the previous detection of two PeV neutrino events, with improved sensitivity and extended energy coverage down to about 30 TeV. Twenty-six additional events were observed, substantially more than expected from atmospheric backgrounds. Combined, both searches reject a purely atmospheric origin for the 28 events at the 4 sigma level. These 28 events, which include the highest energy neutrinos ever observed, have flavors, directions, and energies inconsistent with those expected from the atmospheric muon and neutrino backgrounds. These properties are, however, consistent with generic predictions for an additional component of extraterrestrial origin.	[Bissok, M.; Blumenthal, J.; Coenders, S.; Euler, S.; Hallen, P.; Heinen, D.; Jagielski, K.; Krings, K.; Leuermann, M.; Paul, L.; Raedel, L.; Reimann, R.; Schoenen, S.; Schukraft, A.; Vehring, M.; Wallraff, M.; Wiebusch, C. H.; Zierke, S.] Rhein Westfal TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; [Aartsen, M. G.; Hill, G. C.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Rawlins, K.] Univ Alaska Anchorage, Dept Phys & Astron, Anchorage, AK 99508 USA; [Japaridze, G. S.] Clark Atlanta Univ, CTSPS, Atlanta, GA 30314 USA; [Casey, J.; Daughhetee, J.; Taboada, I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Casey, J.; Daughhetee, J.; Taboada, I.] Georgia Inst Technol, Ctr Relativist Astrophys, Atlanta, GA 30332 USA; [Fazely, A. R.; Ter-Antonyan, S.; Xu, X. W.] Southern Univ, Dept Phys, Baton Rouge, LA 70813 USA; [Bay, R.; Binder, G.; Filimonov, K.; Gerhardt, L.; Ha, C.; Klein, S. R.; Miarecki, S.; Price, P. B.; Woschnagg, K.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Binder, G.; Gerhardt, L.; Goldschmidt, A.; Ha, C.; Klein, S. R.; Matis, H. S.; Miarecki, S.; Nygren, D. R.; Przybylski, G. T.; Stezelberger, T.; Stokstad, R. G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Altmann, D.; de With, M.; Kappes, A.; Kolanoski, H.; Waldenmaier, T.] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Tjus, J. Becker; Eichmann, B.; Fedynitch, A.; Saba, S.; Schoeneberg, S.; Unger, E.] Ruhr Univ Bochum, Fak Phys & Astron, D-44780 Bochum, Germany; [Boeser, S.; Franckowiak, A.; Homeier, A.; Kowalski, M.; Schulte, L.; Stasik, A.; Usner, M.; Voge, M.] Univ Bonn, Inst Phys, D-53115 Bonn, Germany; [Bechet, S.; Bertrand, D.; Hanson, K.; Heerernan, D.; Meures, T.; O'Murchadha, A.; Pinat, E.] Univ Libre Bruxelles, Sci Fac CP230, B-1050 Brussels, Belgium; [Bose, D.; Brayeur, L.; Casier, M.; De Clercq, C.; de Vries, K. D.; Golup, G.; Kunnen, J.; Maggi, G.; Miller, J.; Strahler, E. A.; van Eijndhoven, N.] Vrije Univ Brussel, Dierist ELEM, B-1050 Brussels, Belgium; [Ishihara, A.; Mase, K.; Yoshida, S.] Chiba Univ, Dept Phys, Chiba 2638522, Japan; [Adams, J.; Brown, A. M.; Hickford, S.] Univ Canterbury, Dept Phys & Astron, Christchurch 1, New Zealand; [Berley, D.; Blaufuss, E.; Christy, B.; Ellsworth, R. W.; Goodman, J. A.; Hellauer, R.; Hoffman, K. D.; Huelsnitz, W.; Meagher, K.; Olivas, A.; Redl, P.; Richman, M.; Schmidt, T.; Sullivan, G. W.; Wissing, H.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Beatty, J. J.; Davis, J. C.; Pfendner, C.; Stamatikos, M.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Beatty, J. J.; Davis, J. C.; Pfendner, C.; Stamatikos, M.] Ohio State Univ, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Beatty, J. J.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Cleverrnann, F.; Frantzen, K.; Fuchs, T.; Koehne, J-H.; Milke, N.; Pieloth, D.; Rhode, W.; Ruhe, T.; Scheriau, F.; Schmitz, M.; Ziemann, J.] TU Dortmund Univ, Dept Phys, D-44221 Dortmund, Germany; [Boliaichuk, S.; Grandmont, D. T.; Grant, D.; Nowicki, S. C.; Odrowski, S.; Sheremata, C.; Wood, T. R.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Aguitar, J. A.; Christov, A.; Montaruli, T.; Rameez, M.] Univ Geneva, Dept Phys Nucl & Corpusculaire, CH-1211 Geneva, Switzerland; [Abdou, Y.; Carson, M.; Ridder, S. De; Feusels, T.; Ismail, A. Haj; Jlelati, O.; Labare, M.; Ryckbosch, D.; Van Overloop, A.; Vraeghe, M.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium; [Barwick, S. W.; Yodh, G.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Bruijn, R.; Cohen, S.; Ribordy, M.] Ecole Polytech Fed Lausanne, High Energy Phys Lab, CH-1015 Lausanne, Switzerland; [Besson, D. Z.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Gallagher, J.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Abbasi, R.; Alders, M.; Auffenberg, J.; Baker, M.; BenZvi, S.; Chirkin, D.; Day, M.; Desiati, P.; Diaz-Velez, J. C.; Eisch, J.; Fadiran, O.; Feinzeig, J.; Gladstone, L.; Halzen, F.; Hoshina, K.; Jacobsen, J.; Jero, K.; Karle, A.; Kelley, J. L.; Kopper, C.; Krasberg, M.; Kurahashi, N.; Landsman, H.; Maruyama, R.; McNally, F.; Merck, M.; Morse, R.; Riedel, B.; Rodrigues, J. P.; Santander, M.; Toscana, S.; van Santen, J.; Weaver, Ch; Wellons, M.; Wendt, C.; Westerhoff, S.; Whitehorn, N.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Abbasi, R.; Alders, M.; Auffenberg, J.; Baker, M.; BenZvi, S.; Chirkin, D.; Day, M.; Desiati, P.; Diaz-Velez, J. C.; Eisch, J.; Fadiran, O.; Feinzeig, J.; Gladstone, L.; Halzen, F.; Hoshina, K.; Jacobsen, J.; Jero, K.; Karle, A.; Kelley, J. L.; Kopper, C.; Krasberg, M.; Kurahashi, N.; Landsman, H.; Maruyama, R.; McNally, F.; Merck, M.; Morse, R.; Riedel, B.; Rodrigues, J. P.; Santander, M.; Toscana, S.; van Santen, J.; Weaver, Ch; Wellons, M.; Wendt, C.; Westerhoff, S.; Whitehorn, N.] Univ Wisconsin, Wisconsin IceCube Particle Astrophys Ctr, Madison, WI 53706 USA; [Baum, V.; Eberhardt, B.; Koepke, L.; Kroll, G.; Luenemann, J.; Sander, H-G.; Schatto, K.; Wiebe, K.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Kohnen, C.] Univ Mons, B-7000 Mons, Belgium; [Bernhard, A.; Gross, A.; Leute, J.; Resconi, E.; Schulz, O.; Sestayo, Y.] Tech Univ Munich, D-85748 Garching, Germany; [Ba, X.; Evenson, P. A.; Gaisser, T. K.; Gonzalez, J. G.; Hussain, S.; Kowabara, T.; Ruzybayev, B.; Seckel, D.; Stanev, T.; Tamburro, A.; Tilav, S.] Univ Delaware, Bartol Res Inst, Newark, DE 19716 USA; [Ba, X.; Evenson, P. A.; Gaisser, T. K.; Gonzalez, J. G.; Hussain, S.; Kowabara, T.; Ruzybayev, B.; Seckel, D.; Stanev, T.; Tamburro, A.; Tilav, S.] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Sarkar, S.] Univ Oxford, Dept Phys, Oxford OX1 3NP, England; [Madsen, J.; Seunarine, S.; Spiczak, G. A.] Univ Wisconsin, Dept Phys, River Falls, WI 54022 USA; [Bohm, C.; Danninger, M.; Finley, C.; Flis, S.; Hulth, P. O.; Hultqvist, K.; Walck, C.; Wolf, M.; Zoll, M.] Stockholm Univ, Oskar Klein Ctr, SE-10691 Stockholm, Sweden; [Bohm, C.; Danninger, M.; Finley, C.; Flis, S.; Hulth, P. O.; Hultqvist, K.; Walck, C.; Wolf, M.; Zoll, M.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Kiryluk, J.; Lesiak-Bzdak, M.; Niederhausen, H.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Rott, C.] Sungkyonkwan Univ, Dept Phys, Suwon 440746, South Korea; [Larson, M. J.; Pepper, J. A.; Toale, P. A.; Williams, D. R.; Xu, D. L.; Zarzhitsky, P.] Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA; [Cowen, D. F.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Clark, K.; Cowen, D. F.; DeYoung, T.; Dunkman, M.; Eagan, R.; Koskinen, D. J.; Salameh, T.; Smith, M. W. E.; Tesic, G.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Boersma, D. J.; Botner, O.; Hallgren, A.; de los Heros, C. Perez; Strom, R.; Taavola, H.] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Becker, K-H.; Bindig, D.; Fischer-Wasels, T.; Helbing, K.; Hoffmann, R.; Klaes, J.; Kopper, S.; Naumann, U.; Obertacke, A.; Posselt, J.; Soldin, D.; Tepe, A.] Univ Wuppertal, Dept Phys, D-42119 Wuppertal, Germany; [Ackermann, M.; Benabderrahmane, M. L.; Berghaus, P.; Bernardini, E.; Bretz, H-P.; Brunner, J.; Silva, A. H. Cruz; Gluesenkamp, T.; Gora, D.; Jacobi, E.; Kaminsky, B.; Karg, T.; Middell, E.; Mohrmann, L.; Nahnhauer, R.; Schoenwald, A.; Shanidze, R.; Spiering, C.; Stoessl, A.; Yanez, J. P.] DESY, D-15735 Zeuthen, Germany	RWTH Aachen University; University of Adelaide; University of Alaska System; University of Alaska Anchorage; Clark Atlanta University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Southern University System; Southern University & A&M College; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Humboldt University of Berlin; Ruhr University Bochum; University of Wurzburg; University of Bonn; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Chiba University; University of Canterbury; University System of Maryland; University of Maryland College Park; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Dortmund University of Technology; University of Alberta; University of Geneva; Ghent University; University of California System; University of California Irvine; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Kansas; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Johannes Gutenberg University of Mainz; University of Mons; Technical University of Munich; University of Delaware; University of Delaware; University of Oxford; University of Wisconsin System; Oskar Klein Centre; Stockholm University; Stockholm University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Alabama System; University of Alabama Tuscaloosa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Uppsala University; University of Wuppertal; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Kopper, C (corresponding author), Univ Wisconsin, Dept Phys, Madison, WI 53706 USA.	ckopper@icecube.wisc.edu; naoko@icecube.wisc.edu; nwhitehorn@icecube.wisc.edu	Auffenberg, Jan/D-3954-2014; Maruyama, Reina/A-1064-2013; Kopper, Claudio/N-5824-2019; Tjus, Julia/G-8145-2012; Resconi, Elisa/I-3874-2016; Ha, C/GZL-9046-2022; Taavola, Henric/B-4497-2011; Ahlers, Markus/V-8757-2017; Reimann, René/AAS-8239-2020; Bernardini, Elisa/AAA-4810-2020; Sarkar, Subir/G-5978-2011; Goodman, Jordan A/J-4188-2018; Fedynitch, Anatoli/AAQ-9927-2021; Hallen, Patrick/ABD-7121-2020; Wiebusch, Christopher H.V./G-6490-2012; Rott, Carsten/ABB-1304-2021; Christov, Asen/S-4508-2018; Brunner, Juergen/G-3540-2015; Ismail, Abd Al Karim Haj/AAD-9991-2019; DeYoung, Tyce/O-6895-2019; Díaz Vélez, Juan Carlos/T-2788-2018; Sarkar, Subir/GPT-4902-2022; Beatty, James/D-9310-2011; Whitehorn, Nathan/HDM-8864-2022; Díaz Vélez, Juan Carlos/AAD-5211-2022; Matis, Howard/AAO-2082-2021; Sánchez, Juan Antonio Aguilar/H-4467-2015; Heinen, Dirk/ABF-7280-2020; Gora, Dariusz/M-8695-2018; Gonzalez, Javier G/G-2520-2017; Ha, Chang Hyon/AAR-8120-2021; Koskinen, David J/G-3236-2014; Rameez, Mohamed/N-1671-2016; Kowalski, Marek/G-5546-2012; Miller, Jonathan/R-8518-2017	Auffenberg, Jan/0000-0002-1185-9094; Maruyama, Reina/0000-0003-2794-512X; Tjus, Julia/0000-0002-1748-7367; Resconi, Elisa/0000-0003-0705-2770; Taavola, Henric/0000-0002-2604-2810; Ahlers, Markus/0000-0003-0709-5631; Reimann, René/0000-0002-1983-8271; Bernardini, Elisa/0000-0003-3108-1141; Sarkar, Subir/0000-0002-3542-858X; Goodman, Jordan A/0000-0002-9790-1299; Fedynitch, Anatoli/0000-0003-2837-3477; Wiebusch, Christopher H.V./0000-0002-6418-3008; Rott, Carsten/0000-0002-6958-6033; Christov, Asen/0000-0001-8121-5860; Brunner, Juergen/0000-0002-5052-7236; Ismail, Abd Al Karim Haj/0000-0003-4941-5154; DeYoung, Tyce/0000-0003-4873-3783; Díaz Vélez, Juan Carlos/0000-0002-0087-0693; Beatty, James/0000-0003-0481-4952; Whitehorn, Nathan/0000-0002-3157-0407; Díaz Vélez, Juan Carlos/0000-0002-0087-0693; Sánchez, Juan Antonio Aguilar/0000-0003-2252-9514; Gora, Dariusz/0000-0002-4853-5974; Gonzalez, Javier G/0000-0001-8746-2846; Koskinen, David J/0000-0002-0514-5917; Kappes, Alexander/0000-0003-1315-3711; van Eijndhoven, Nick/0000-0001-5558-3328; BenZvi, Segev/0000-0001-5537-4710; Mohrmann, Lars/0000-0002-9667-8654; Toscano, Simona/0000-0002-1860-2240; Rameez, Mohamed/0000-0001-5023-5631; Pollmann, Anna/0000-0002-2492-043X; Montaruli, Teresa/0000-0001-5014-2152; Klein, Spencer/0000-0003-2841-6553; Bose, Debanjan/0000-0003-1071-5854; Santander, Juan Marcos/0000-0001-7297-8217; Benabderrahmane, Mohamed Lotfi/0000-0003-4410-5886; Schukraft, Anne/0000-0002-9112-5479; Desiati, Paolo/0000-0001-9768-1858; Kowalski, Marek/0000-0001-8594-8666; Yoshida, Shigeru/0000-0003-2480-5105; Strom, Rickard/0000-0002-4496-1626; Karg, Timo/0000-0003-3251-2126; Daughhetee, Jacob/0000-0001-5220-7159; Helbing, Klaus/0000-0003-2072-4172; De Clercq, Catherine/0000-0001-5266-7059; Danninger, Matthias/0000-0002-7807-7484; Taboada, Ignacio/0000-0003-3509-3457; Miller, Jonathan/0000-0002-7992-8033; Ha, Chang Hyon/0000-0002-9598-8589; Carson, Michael/0000-0003-0400-7819; Hill, Gary/0000-0001-8881-6802; de Vries, Krijn/0000-0002-9842-4068; Ter-Antonyan, Samvel/0000-0002-5788-1369; Ackermann, Markus/0000-0001-8952-588X; Meagher, Kevin/0000-0003-3967-1533; Spiczak, Glenn/0000-0002-0030-0519; Heinen, Dirk/0000-0002-4502-7288; Kolanoski, Hermann/0000-0003-0435-2524	U.S. National Science Foundation-Office of Polar Programs; U.S. National Science Foundation-Physics Division; University of Wisconsin Alumni Research Foundation; Grid Laboratory of Wisconsin (GLOW) grid infrastructure at the University of Wisconsin-Madison; Open Science Grid (OSG) grid infrastructure; U.S. Department of Energy; National Energy Research Scientific Computing Center; Louisiana Optical Network Initiative (LONI); Natural Sciences and Engineering Research Council of Canada; WestGrid; Compute/Calcul Canada; Swedish Research Council; Swedish Polar Research Secretariat; Swedish National Infrastructure for Computing (SNIC); Knut and Alice Wallenberg Foundation, Sweden; German Ministry for Education and Research (BMBF); Deutsche Forschungsgemeinschaft (DFG); Helmholtz Alliance for Astroparticle Physics (HAP); Research Department of Plasmas with Complex Interactions (Bochum), Germany; Fund for Scientific Research (FNRS-FWO),; FWO Odysseus programme; Flanders Institute to encourage scientific and technological research in industry (IWT); Belgian Federal Science Policy Office (Belspo); University of Oxford, UK; Marsden Fund, New Zealand; Australian Research Council; Japan Society for Promotion of Science (JSPS); Swiss National Science Foundation (SNSF), Switzerland; National Research Foundation of Korea (NRF); STFC [ST/J000507/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J000507/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1307472] Funding Source: National Science Foundation; Division Of Physics [1210052, 1205403, 0969661] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [25105005] Funding Source: KAKEN	U.S. National Science Foundation-Office of Polar Programs(National Science Foundation (NSF)); U.S. National Science Foundation-Physics Division(National Science Foundation (NSF)); University of Wisconsin Alumni Research Foundation; Grid Laboratory of Wisconsin (GLOW) grid infrastructure at the University of Wisconsin-Madison; Open Science Grid (OSG) grid infrastructure; U.S. Department of Energy(United States Department of Energy (DOE)); National Energy Research Scientific Computing Center; Louisiana Optical Network Initiative (LONI); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); WestGrid; Compute/Calcul Canada; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Polar Research Secretariat; Swedish National Infrastructure for Computing (SNIC); Knut and Alice Wallenberg Foundation, Sweden(Knut & Alice Wallenberg Foundation); German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Alliance for Astroparticle Physics (HAP); Research Department of Plasmas with Complex Interactions (Bochum), Germany; Fund for Scientific Research (FNRS-FWO),(FWOFonds de la Recherche Scientifique - FNRS); FWO Odysseus programme; Flanders Institute to encourage scientific and technological research in industry (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Federal Science Policy Office (Belspo)(Belgian Federal Science Policy Office); University of Oxford, UK; Marsden Fund, New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Australian Research Council(Australian Research Council); Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swiss National Science Foundation (SNSF), Switzerland(Swiss National Science Foundation (SNSF)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge support from the following agencies: U.S. National Science Foundation-Office of Polar Programs, U.S. National Science Foundation-Physics Division, University of Wisconsin Alumni Research Foundation, the Grid Laboratory of Wisconsin (GLOW) grid infrastructure at the University of Wisconsin-Madison, and the Open Science Grid (OSG) grid infrastructure; U.S. Department of Energy, National Energy Research Scientific Computing Center, and the Louisiana Optical Network Initiative (LONI) grid computing resources; Natural Sciences and Engineering Research Council of Canada, WestGrid, and Compute/Calcul Canada; Swedish Research Council, Swedish Polar Research Secretariat, Swedish National Infrastructure for Computing (SNIC), and Knut and Alice Wallenberg Foundation, Sweden; German Ministry for Education and Research (BMBF), Deutsche Forschungsgemeinschaft (DFG), Helmholtz Alliance for Astroparticle Physics (HAP), and Research Department of Plasmas with Complex Interactions (Bochum), Germany; Fund for Scientific Research (FNRS-FWO), FWO Odysseus programme, Flanders Institute to encourage scientific and technological research in industry (IWT), and Belgian Federal Science Policy Office (Belspo); University of Oxford, UK; Marsden Fund, New Zealand; Australian Research Council; Japan Society for Promotion of Science (JSPS); the Swiss National Science Foundation (SNSF), Switzerland; and National Research Foundation of Korea (NRF). Additional data and resources are available in the supplementary materials. These include displays of the neutrino candidate events and list precise arrival times, as well as machine-readable tabular neutrino effective areas (Fig. 7). IceCube data are archived at http://www.icecube.wisc.edu/science/data.	Aartsen MG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.021103; Aartsen MG, 2013, NUCL INSTRUM METH A, V711, P73, DOI 10.1016/j.nima.2013.01.054; Abbasi R, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/45; Abbasi R, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.082001; Abbasi R, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.092003; Abbasi R, 2010, NUCL INSTRUM METH A, V618, P139, DOI 10.1016/j.nima.2010.03.102; Abbasi R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.221102; Abdo AA, 2008, ASTROPHYS J, V688, P1078, DOI 10.1086/592213; Achterberg A, 2006, ASTROPART PHYS, V26, P155, DOI 10.1016/j.astropartphys.2006.06.007; Ackermann M, 2013, SCIENCE, V339, P807, DOI 10.1126/science.1231160; Braun J, 2008, ASTROPART PHYS, V29, P299, DOI 10.1016/j.astropartphys.2008.02.007; BUGAEV EV, 1989, NUOVO CIMENTO C, V12, P41, DOI 10.1007/BF02509070; Choubey S, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.113006; Cooper-Sarkar A, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/01/075; Enberg R, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.043005; Fedynitch A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.114024; Gaisser T. K., 2013, HIGH ENERGY PHYS PHE; Gaisser TK, 2012, ASTROPART PHYS, V35, P801, DOI 10.1016/j.astropartphys.2012.02.010; Heck D., 1998, 6019 FZKA; Honda M, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.043006; IceCube Collaboration, 2013, PHYS REV LETT, V110; IceCube Collaboration, 2013, ARXIV13056811 ICECUB; Ioka K, 2005, ASTROPHYS J, V633, P1013, DOI 10.1086/466514; Pakvasa S, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/02/005; Radel L, 2013, ASTROPART PHYS, V44, P102, DOI 10.1016/j.astropartphys.2013.01.015; Schonert S, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.043009; Schukraft A, 2013, NUCL PHYS B-PROC SUP, V237, P266, DOI 10.1016/j.nuclphysbps.2013.04.105; Waxman E, 1997, PHYS REV LETT, V78, P2292, DOI 10.1103/PhysRevLett.78.2292	28	892	900	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					947	+		10.1126/science.1242856	http://dx.doi.org/10.1126/science.1242856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264993	Green Published, Green Submitted			2022-12-28	WOS:000327223500034
J	Chappell, LC; Seed, PT; Myers, J; Taylor, RS; Kenny, LC; Dekker, GA; Walker, JJ; McCowan, LME; North, RA; Poston, L				Chappell, Lucy C.; Seed, Paul T.; Myers, Jenny; Taylor, Rennae S.; Kenny, Louise C.; Dekker, Gustaaf A.; Walker, James J.; McCowan, Lesley M. E.; North, Robyn A.; Poston, Lucilla			Exploration and confirmation of factors associated with uncomplicated pregnancy in nulliparous women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; BLOOD-PRESSURE; BIRTH-WEIGHT; PREECLAMPSIA; RECOMMENDATIONS; COMPLICATIONS; EMPLOYMENT; DIET; AGE	Objective To identify factors at 15 and 20 weeks' gestation associated with a subsequent uncomplicated pregnancy. Design Prospective international multicentre observational cohort study. Setting Auckland, New Zealand and Adelaide, Australia (exploration and local replication dataset) and Manchester, Leeds, and London, United Kingdom, and Cork, Republic of Ireland (external confirmation dataset). Participants 5628 healthy nulliparous women with a singleton pregnancy. Main outcome measure Uncomplicated pregnancy, defined as a normotensive pregnancy delivered at >37 weeks' gestation, resulting in a liveborn baby not small for gestational age, and the absence of any other significant pregnancy complications. In a stepwise logistic regression the comparison group was women with a complicated pregnancy. Results Of the 5628 women, 3452 (61.3%) had an uncomplicated pregnancy. Factors that reduced the likelihood of an uncomplicated pregnancy included increased body mass index (relative risk 0.74, 95% confidence intervals 0.65 to 0.84), misuse of drugs in the first trimester (0.90, 0.84 to 0.97), mean diastolic blood pressure (for each 5 mm Hg increase 0.92, 0.91 to 0.94), and mean systolic blood pressure (for each 5 mm Hg increase 0.95, 0.94 to 0.96). Beneficial factors were prepregnancy fruit intake at least three times daily (1.09, 1.01 to 1.18) and being in paid employment (per eight hours' increase 1.02, 1.01 to 1.04). Detrimental factors not amenable to alteration were a history of hypertension while using oral contraception, socioeconomic index, family history of any hypertensive complications in pregnancy, vaginal bleeding during pregnancy, and increasing uterine artery resistance index. Smoking in pregnancy was noted to be a detrimental factor in the initial two datasets but did not remain in the final model. Conclusions This study identified factors associated with normal pregnancy through adoption of a novel hypothesis generating approach, which has shifted the emphasis away from adverse outcomes towards uncomplicated pregnancies. Although confirmation in other cohorts is necessary, this study implies that individually targeted lifestyle interventions (normalising maternal weight, increasing prepregnancy fruit intake, reducing blood pressure, stopping misuse of drugs) may increase the likelihood of normal pregnancy outcomes.	[Chappell, Lucy C.; Seed, Paul T.; North, Robyn A.; Poston, Lucilla] Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London WC2R 2LS, England; [Chappell, Lucy C.; Seed, Paul T.; North, Robyn A.; Poston, Lucilla] Kings Hlth Partners, London, England; [Myers, Jenny] Univ Manchester, Manchester Acad Hlth Sci Ctr, Maternal & Fetal Hlth Res Ctr, Manchester M13 9PL, Lancs, England; [Myers, Jenny] Cent Manchester Fdn Trust, Manchester, Lancs, England; [Taylor, Rennae S.; McCowan, Lesley M. E.] Univ Auckland, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Auckland 1, New Zealand; [Kenny, Louise C.] Natl Univ Ireland Univ Coll Cork, Dept Obstet & Gynaecol, Irish Ctr Fetal & Neonatal Translat Res INFANT, Cork, Ireland; [Dekker, Gustaaf A.] Univ Adelaide, Lyell McEwin Hosp, Dept Obstet & Gynaecol, Adelaide, SA 5005, Australia; [Walker, James J.] Univ Leeds, St James Univ Hosp, Reprod & Perinatal Hlth Res Grp, Leeds, W Yorkshire, England	University of London; King's College London; University of London; King's College London; University of Manchester; University of Auckland; University College Cork; Lyell McEwin Hospital; University of Adelaide; Saint James's University Hospital; University of Leeds	Chappell, LC (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London WC2R 2LS, England.	lucy.chappell@kcl.ac.uk	Seed, Paul T/C-4435-2008; Kenny, Louise/X-6329-2019; Kenny, Louise C/G-1112-2011	Seed, Paul T/0000-0001-7904-7933; Kenny, Louise/0000-0002-9011-759X; Kenny, Louise C/0000-0002-9011-759X; Poston, Lucilla/0000-0003-1100-2821; McCowan, Lesley/0000-0001-9915-7873; Myers, Jenny/0000-0003-0913-2096; Walker, James/0000-0002-8922-083X; Taylor, Rennae/0000-0003-1718-9332	New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council [04/198]; Evelyn Bond Fund, Auckland District Health Board Charitable Trust; Premier's Science and Research Fund, South Australian Government; Guy's and St Thomas' Charity, Tommy's Charity; UK National Health Services (NEAT), University of Manchester Proof of Concept Funding, National Institute for Health Research [FSD025]; Health Research Board, Ireland [CSA/2007/2]; Action Medical research endowment fund; Manchester Biomedical Research Centre; National Institute for Health Research [NIHR-CS-011-020] Funding Source: researchfish	New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council; Evelyn Bond Fund, Auckland District Health Board Charitable Trust; Premier's Science and Research Fund, South Australian Government; Guy's and St Thomas' Charity, Tommy's Charity; UK National Health Services (NEAT), University of Manchester Proof of Concept Funding, National Institute for Health Research; Health Research Board, Ireland; Action Medical research endowment fund; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council (04/198); Evelyn Bond Fund, Auckland District Health Board Charitable Trust; Premier's Science and Research Fund, South Australian Government; Guy's and St Thomas' Charity, Tommy's Charity; UK National Health Services (NEAT grant FSD025), University of Manchester Proof of Concept Funding, National Institute for Health Research; Health Research Board, Ireland (CSA/2007/2). JM is supported by an Action Medical research endowment fund and Manchester Biomedical Research Centre. The study funders had no role in the study design, data analysis, or writing of this report.	Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Conover EA, 2012, BIRTH DEFECTS RES A, V94, P570, DOI 10.1002/bdra.23034; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Dietz PM, 2010, AM J PREV MED, V39, P45, DOI 10.1016/j.amepre.2010.03.009; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Hackam DG, 2010, CAN J CARDIOL, V26, P249, DOI 10.1016/S0828-282X(10)70379-2; Haggarty P, 2009, BRIT J NUTR, V102, P1487, DOI 10.1017/S0007114509990444; Health Council of the Netherlands, 2010, IS HLTH STAT AB DYN; HENRIKSEN TB, 1994, BRIT J OBSTET GYNAEC, V101, P858, DOI 10.1111/j.1471-0528.1994.tb13546.x; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Inskip HM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b481; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Jansen PW, 2010, OCCUP ENVIRON MED, V67, P387, DOI 10.1136/oem.2009.046300; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Kuczkowski KM, 2007, CURR OPIN OBSTET GYN, V19, P578, DOI 10.1097/GCO.0b013e3282f1bf17; Macdonald-Wallis C, 2011, J HYPERTENS, V29, P1703, DOI 10.1097/HJH.0b013e328349eec6; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; McCowan L, 2007, ACTRN12607000551493; McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x; Mikkelsen TB, 2008, ACTA OBSTET GYN SCAN, V87, P325, DOI 10.1080/00016340801899347; Mikkelsen TB, 2006, SCAND J PUBLIC HEALT, V34, P616, DOI 10.1080/14034940600717688; National Institute for Health and Care Excellence, 2008, ANT CAR ROUT CAR HLT; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Peindl KS, 2004, J AFFECT DISORDERS, V80, P37, DOI 10.1016/S0165-0327(03)00052-1; Saraswat L, 2010, BJOG-INT J OBSTET GY, V117, P245, DOI 10.1111/j.1471-0528.2009.02427.x; Seaton SE, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001100; Shaikh H, 2010, SEMIN FETAL NEONAT M, V15, P77, DOI 10.1016/j.siny.2009.10.003; Smith LK, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6654; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; The Information Centre for Health and Social Care, 2013, STAT ALC ENGL 2009; van Oppenraaij RHF, 2009, HUM REPROD UPDATE, V15, P409, DOI 10.1093/humupd/dmp009; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Whitworth M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007536.pub2; World Health Organization, 2013, MDG 5 IMPR MAT HLTH	38	30	30	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 21	2013	347								f6398	10.1136/bmj.f6398	http://dx.doi.org/10.1136/bmj.f6398			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KL	24270055	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000327458100001
J	Richards, T				Richards, Tessa			Journey of a patient editor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						Treasure T, 2007, BMJ-BRIT MED J, V334, P831, DOI 10.1136/bmj.39161.403218.AD	1	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6913	10.1136/bmj.f6913	http://dx.doi.org/10.1136/bmj.f6913			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KF	24259330	Bronze			2022-12-28	WOS:000327457400011
J	Parikh, CR				Parikh, Chirag R.			Review: Non-calcium-based phosphate binders reduce mortality compared with calcium-based binders in CKD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Yale Univ, Program Appl Translat Res, New Haven, CT 06520 USA	Yale University	Parikh, CR (corresponding author), Yale Univ, Program Appl Translat Res, New Haven, CT 06520 USA.			Parikh, Chirag/0000-0001-9051-7385				Bushinsky DA, 1998, LANCET, V352, P306, DOI 10.1016/S0140-6736(97)12331-5; Tonelli M, 2010, NEW ENGL J MED, V362, P1312, DOI 10.1056/NEJMra0912522	2	1	1	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10							JC2	10.7326/0003-4819-159-10-201311190-02002	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247692				2022-12-28	WOS:000328732700001
J	Sutherland, WJ				Sutherland, William J.			Review by quality not quantity for better policy	NATURE			English	Editorial Material									Univ Cambridge, Dept Zool, Cambridge CB2 1TN, England	University of Cambridge	Sutherland, WJ (corresponding author), Univ Cambridge, Dept Zool, Cambridge CB2 1TN, England.	w.sutherland@zoo.cam.ac.uk		Sutherland, William/0000-0002-6498-0437					0	15	16	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					167	167		10.1038/503167a	http://dx.doi.org/10.1038/503167a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24226852	Bronze			2022-12-28	WOS:000326894200013
J	Holmes, D				Holmes, David			Roger Williams: at the forefront of hepatology	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1547	1547		10.1016/S0140-6736(13)62313-2	http://dx.doi.org/10.1016/S0140-6736(13)62313-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247NE	24209816				2022-12-28	WOS:000326623900014
J	Giancotti, FG				Giancotti, Filippo G.			Mechanisms Governing Metastatic Dormancy and Reactivation	CELL			English	Review							CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; MAMMARY-CARCINOMA CELLS; BREAST-CANCER; TUMOR-CELLS; BONE-MARROW; PROGENITOR CELLS; TENASCIN-C; BALANCED PROLIFERATION; ANGIOGENIC SWITCH	Many cancer patients suffer from metastatic relapse several years after they have undergone radical surgery. Early cancer cell dissemination followed by a protracted period of dormancy potentially explains this prevalent clinical behavior. Increasing evidence suggests that the metastasis-initiating cells are cancer stem cells or revert to this functional state upon infiltrating a target organ. Their entry into dormancy and subsequent reactivation are governed by intrinsic programs and by contextual cues, which resemble those regulating the self-renewal capability of adult stem cells. In addition, metastatic cells undergoing reactivation are nursed by specialized extracellular matrix niches, which support positive signals, such as Wnt and Notch, and attenuate negative signals, such as BMP. In spite of significant remaining uncertainties, these findings provide a framework to understand the logic of metastatic dormancy and reactivation and open new avenues for therapeutic intervention.	[Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, Sloan Kettering Inst Canc Res, New York, NY 10065 USA; [Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Metastasis Res Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, Sloan Kettering Inst Canc Res, New York, NY 10065 USA.	f-giancotti@ski.mskcc.org			N.C.I.; D.O.D.; NATIONAL CANCER INSTITUTE [R01CA175712] Funding Source: NIH RePORTER	N.C.I.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); D.O.D.(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	I am indebted to Hua Gao, who spearheaded research on metastatic dormancy and reactivation in my laboratory; to all the participants in the Cancer Cell Biology Work-in-Progress meetings of SKI for their insight into tumor evolution and metastasis; and to Jon Cooper for comments on the manuscript. Research in my laboratory is supported by grants from the N.C.I. and the D.O.D.	Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Asselin-Labat ML, 2011, MOL CELL BIOL, V31, P4609, DOI 10.1128/MCB.05766-11; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Buell Joseph F, 2004, Ann Transplant, V9, P53; Cameron MD, 2000, CANCER RES, V60, P2541; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Demicheli R, 2007, NAT CLIN PRACT ONCOL, V4, P699, DOI 10.1038/ncponc0999; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Freedland SJ, 2007, J UROLOGY, V177, P1985, DOI 10.1016/j.juro.2007.01.137; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Gokhale PJ, 2012, CURR OPIN GENET DEV, V22, P403, DOI 10.1016/j.gde.2012.07.006; Greco FA, 2009, SEMIN ONCOL, V36, P6, DOI 10.1053/j.seminoncol.2008.10.007; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Klauber-DeMore N, 2001, CLIN CANCER RES, V7, P2434; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; MCNICHOLS DW, 1981, J UROLOGY, V126, P17, DOI 10.1016/S0022-5347(17)54359-1; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Midwood KS, 2004, MOL BIOL CELL, V15, P5670, DOI 10.1091/mbc.E04-08-0759; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Naumov GN, 2002, CANCER RES, V62, P2162; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; NOBLE RL, 1977, CANCER RES, V37, P82; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Nummela P, 2012, AM J PATHOL, V180, P1663, DOI 10.1016/j.ajpath.2011.12.035; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rabinovsky R, 2007, ADV CANCER RES, V97, P189, DOI 10.1016/S0065-230X(06)97008-0; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Reichert M, 2013, GENE DEV, V27, P288, DOI 10.1101/gad.204453.112; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Schindlbeck C, 2005, BREAST CANCER RES, V7, pR1174, DOI 10.1186/bcr1360; SCHLIMOK G, 1990, J CLIN ONCOL, V8, P831, DOI 10.1200/JCO.1990.8.5.831; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sneddon JB, 2007, CELL STEM CELL, V1, P607, DOI 10.1016/j.stem.2007.11.009; Strauss DC, 2010, LANCET ONCOL, V11, P790, DOI 10.1016/S1470-2045(10)70024-3; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Taylor DP, 2013, CLIN CANCER RES, V19, P1063, DOI 10.1158/1078-0432.CCR-12-3180; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tsao HS, 1997, CANCER, V79, P2361; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Weinberg RA, 2008, APMIS, V116, P548, DOI 10.1111/j.1600-0463.2008.001168.x; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; WIJSMAN JH, 1991, BRIT J CANCER, V64, P463, DOI 10.1038/bjc.1991.332; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006376; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	136	359	376	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					750	764		10.1016/j.cell.2013.10.029	http://dx.doi.org/10.1016/j.cell.2013.10.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209616	Green Accepted, Bronze			2022-12-28	WOS:000326934300007
J	Madhani, HD				Madhani, Hiten D.			The Frustrated Gene: Origins of Eukaryotic Gene Expression	CELL			English	Article							MESSENGER-RNA DECAY; COMPARATIVE GENOMICS; EVOLUTION; DNA; METHYLATION; PROTEIN; INTERFERENCE; INTRONS; YEAST; SPLICEOSOME	Eukarytotic gene expression is frustrated by a series of steps that are generally not observed in prokaryotes and are therefore not essential for the basic chemistry of transcription and translation. Their evolution may have been driven by the need to defend against parasitic nucleic acids.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com		Madhani, Hiten/0000-0001-7400-6657	NIGMS NIH HHS [R01 GM071801, GM071801] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071801] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ammar R, 2012, ELIFE, V1, DOI 10.7554/eLife.00078; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Belew AT, 2011, NUCLEIC ACIDS RES, V39, P2799, DOI 10.1093/nar/gkq1220; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Craig N., 2002, MOBILE GENETIC ELEME; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Dawkins Richard, 1976, SELFISH GENE; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; EHRENFELD E, 1982, CELL, V28, P435, DOI 10.1016/0092-8674(82)90195-7; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Gornik SG, 2012, CURR BIOL, V22, P2303, DOI 10.1016/j.cub.2012.10.036; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; HICKEY DA, 1982, GENETICS, V101, P519; Hollien J, 2013, BBA-MOL CELL RES, V1833, P2458, DOI 10.1016/j.bbamcr.2013.01.016; James ER, 2002, CELL DEATH DIFFER, V9, P355, DOI 10.1038/sj.cdd.4400986; Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; Law JA, 2013, NATURE, V498, P385, DOI 10.1038/nature12178; Le Hir H, 2008, CELL, V133, P213, DOI 10.1016/j.cell.2008.04.002; Li VC, 2009, MOL BIOL EVOL, V26, P1103, DOI 10.1093/molbev/msp030; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Nakano K, 2013, MICROBES INFECT, V15, P491, DOI 10.1016/j.micinf.2013.03.006; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Peng JC, 2013, CURR OPIN CELL BIOL, V25, P190, DOI 10.1016/j.ceb.2013.01.010; Pikaard C. S., 2013, COLD SPRING HARB SYM, V77, P205; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; Roth SL, 2011, J VIROL, V85, P7393, DOI 10.1128/JVI.00635-11; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; Smolle M, 2013, EPIGENETICS-US, V8, P10, DOI 10.4161/epi.23333; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351; Werner M, 2011, NUCLEIC ACIDS RES, V39, P4756, DOI 10.1093/nar/gkr038; YU YT, 1995, RNA, V1, P46; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	42	30	30	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					744	749		10.1016/j.cell.2013.10.003	http://dx.doi.org/10.1016/j.cell.2013.10.003			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209615	Bronze, Green Accepted			2022-12-28	WOS:000326934300006
J	Ragsdale, EJ; Muller, MR; Rodelsperger, C; Sommer, RJ				Ragsdale, Erik J.; Mueller, Manuela R.; Roedelsperger, Christian; Sommer, Ralf J.			A Developmental Switch Coupled to the Evolution of Plasticity Acts through a Sulfatase	CELL			English	Article							NEMATODE PRISTIONCHUS-PACIFICUS; LA REUNION ISLAND; PHENOTYPIC PLASTICITY; MODEL SYSTEM; ACTIVE-SITE; N. SP; DIPLOGASTRIDAE; ORIGIN; SEX; ARYLSULFATASE	Developmental plasticity has been suggested to facilitate phenotypic diversity, but the molecular mechanisms underlying this relationship are little understood. We analyzed a feeding dimorphism in Pristionchus nematodes whereby one of two alternative adult mouth forms is executed after an irreversible developmental decision. By integrating developmental genetics with functional tests in phenotypically divergent populations and species, we identified a regulator of plasticity, eud-1, that acts in a developmental switch. eud-1 mutations eliminate one mouth form, whereas overexpression of eud-1 fixes it. EUD-1 is a sulfatase that acts dosage dependently, is necessary and sufficient to control the sexual dimorphism of feeding forms, and has a conserved function in Pristionchus evolution. It is epistatic to known signaling cascades and results from lineage-specific gene duplications. EUD-1 thus executes a developmental switch for morphological plasticity in the adult stage, showing that regulatory pathways can evolve by terminal addition of new genes.	[Ragsdale, Erik J.; Mueller, Manuela R.; Roedelsperger, Christian; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, D-72076 Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, D-72076 Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	, roedelsberg/Q-3831-2019; Ragsdale, Erik J./AAB-4536-2019	, roedelsberg/0000-0002-7905-9675; Ragsdale, Erik J./0000-0002-9367-8552	Max Planck Society; Alexander von Humboldt Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was funded by the Max Planck Society and by a fellowship from the Alexander von Humboldt Foundation awarded to E.J.R. We thank Gabi Eberhardt for support in next-generation sequencing, and we thank Vahan Serobyan for assistance with RNA-seq experiments. We also thank Adrian Streit and Benjamin Schlager for conceptual discussions and helpful suggestions on the project.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Antebi A, 2000, GENE DEV, V14, P1512; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Bose N, 2012, ANGEW CHEM INT EDIT, V51, P12438, DOI 10.1002/anie.201206797; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Carroll BT, 2006, J BIOL CHEM, V281, P35989, DOI 10.1074/jbc.M606086200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; DODGSON KS, 1953, BIOCHEM J, V55, P315, DOI 10.1042/bj0550315; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; GLOSSL J, 1979, BIOCHEM J, V181, P37; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; Hattori K, 2006, J BIOCHEM, V139, P355, DOI 10.1093/jb/mvj041; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann Matthias, 2006, Front Zool, V3, P14, DOI 10.1186/1742-9994-3-14; Herrmann M, 2010, BIOL J LINN SOC, V100, P170, DOI 10.1111/j.1095-8312.2010.01410.x; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kanzaki N, 2013, J NEMATOL, V45, P172; Kanzaki N, 2013, ZOOL SCI, V30, P680, DOI 10.2108/zsj.30.680; Kanzaki N, 2013, J NEMATOL, V45, P78; Kanzaki N, 2012, J NEMATOL, V44, P80; Kanzaki N, 2012, ZOOL SCI, V29, P403, DOI 10.2108/zsj.29.403; Kiontke K, 2010, CURR BIOL, V20, pR710, DOI 10.1016/j.cub.2010.07.009; Litjens T, 1996, AM J HUM GENET, V58, P1127; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Miller SW, 2003, EVOL DEV, V5, P251, DOI 10.1046/j.1525-142X.2003.03032.x; Mitsunaga-Nakatsubo K, 2009, DEV GENES EVOL, V219, P281, DOI 10.1007/s00427-009-0289-5; Moczek AP, 2007, EVOL DEV, V9, P299, DOI 10.1111/j.1525-142X.2007.00162.x; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Morgan K, 2012, MOL ECOL, V21, P250, DOI 10.1111/j.1365-294X.2011.05382.x; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Pigliucci M., 2001, SYN ECO EVO; Pires da Silva A., 2006, C ELEGANS RES COMMUN; Ragsdale EJ, 2013, ZOOL J LINN SOC-LOND, V168, P671, DOI 10.1111/zoj.12041; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Schlager B, 2009, GENESIS, V47, P300, DOI 10.1002/dvg.20499; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Serobyan V, 2013, EVOL DEV, V15, P161, DOI 10.1111/ede.12030; Sommer RJ, 2013, MOL ECOL, V22, P2380, DOI 10.1111/mec.12286; Sudhaus W., 2003, Journal of Nematode Morphology and Systematics, V6, P43; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Waldow A, 1999, J BIOL CHEM, V274, P12284, DOI 10.1074/jbc.274.18.12284; West-Eberhard Mary Jane, 2003, pi; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Wilkins A.S., 2002, EVOLUTION DEV PATHWA	47	116	116	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					922	933		10.1016/j.cell.2013.09.054	http://dx.doi.org/10.1016/j.cell.2013.09.054			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209628	Bronze			2022-12-28	WOS:000326934300020
J	Azria, D; Lemanski, C				Azria, David; Lemanski, Claire			Intraoperative radiotherapy for breast cancer	LANCET			English	Editorial Material							FOLLOW-UP; IRRADIATION; HYPOFRACTIONATION; IORT		[Azria, David] Inst Canc Montpellier, Dept Radiat Oncol, F-34298 Montpellier, France; Inst Canc Montpellier, INSERM, U896, F-34298 Montpellier, France	UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Azria, D (corresponding author), Inst Canc Montpellier, Dept Radiat Oncol, F-34298 Montpellier, France.	david.azria@icm.unicancer.fr						Andre F, 2010, ONCOLOGIST, V15, P476, DOI 10.1634/theoncologist.2009-0150; Bartelink H, 2001, NEW ENGL J MED, V345, P1378, DOI 10.1056/NEJMoa010874; Bartelink H, 2008, LANCET, V371, P1050, DOI 10.1016/S0140-6736(08)60349-9; Dubois JB, 1997, FRONT RADIAT THER ON, V31, P131; Dubois JB, 2011, RADIOTHER ONCOL, V98, P298, DOI 10.1016/j.radonc.2011.01.017; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; GUNDERSON LL, 1983, INT J RADIAT ONCOL, V9, P1597, DOI 10.1016/0360-3016(83)90411-X; Haviland JS, 2013, LANCET ONCOL, V14, P1086, DOI 10.1016/S1470-2045(13)70386-3; Hughes KS, 2013, J CLIN ONCOL, V31, P2382, DOI 10.1200/JCO.2012.45.2615; Lemanski C, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-191; Merrick HW, 1997, FRONT RADIAT THER ON, V31, P126; Poortmans P, 2013, EUR CANC C AMST SEPT; Schiller DE, 2008, ANN SURG ONCOL, V15, P833, DOI 10.1245/s10434-007-9711-2; Smith BD, 2009, INT J RADIAT ONCOL, V74, P987, DOI 10.1016/j.ijrobp.2009.02.031; Vaidya JS, 2014, LANCET, V383, P603, DOI 10.1016/S0140-6736(13)61950-9; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; Veronesi U, 2013, LANCET ONCOL, DOI DOI 10.1016/S1040-2045(13)70497-2; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260	18	8	9	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					578	581		10.1016/S0140-6736(13)62304-1	http://dx.doi.org/10.1016/S0140-6736(13)62304-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KP	24224998	hybrid			2022-12-28	WOS:000331137700007
J	Fu, G; Casas, J; Rigaud, S; Rybakin, V; Lambolez, F; Brzostek, J; Hoerter, JAH; Paster, W; Acuto, O; Cheroutre, H; Sauer, K; Gascoigne, NRJ				Fu, Guo; Casas, Javier; Rigaud, Stephanie; Rybakin, Vasily; Lambolez, Florence; Brzostek, Joanna; Hoerter, John A. H.; Paster, Wolfgang; Acuto, Oreste; Cheroutre, Hilde; Sauer, Karsten; Gascoigne, Nicholas R. J.			Themis sets the signal threshold for positive and negative selection in T-cell development	NATURE			English	Article							TYROSINE PHOSPHATASE SHP-1; THYMOCYTE SELECTION; MULTIPLE COMMON; SELF-PEPTIDES; RECEPTOR; TCR; ACTIVATION; PROTEIN; IDENTIFICATION; STRENGTH	Development of a self-tolerant T-cell receptor (TCR) repertoire with the potential to recognize the universe of infectious agents depends on proper regulation of TCR signalling. The repertoire is whittled down during T-cell development in the thymus by the ability of quasi-randomly generated TCRs to interact with selfpeptides presented by major histocompatibility complex (MHC) proteins. Low-affinity TCR interactions with self-MHC proteins generate weak signals that initiate 'positive selection', causing maturation of CD4- or CD8ab-expressing 'single-positive' thymocytes from CD4(+)CD8 alpha beta(+) 'double-positive' precursors(1). These develop into mature naive T cells of the secondary lymphoid organs. TCR interaction with high-affinity agonist self-ligands results in 'negative selection' by activation-induced apoptosis or 'agonist selection' of functionally differentiated self-antigen-experienced T cells(2,3). Here we show that positive selection is enabled by the ability of the T-cell-specific protein Themis(4-9) to specifically attenuate TCR signal strength via SHP1 recruitment and activation in response to low-but not high-affinity TCR engagement. Themis acts as an analog-to-digital converter translating graded TCR affinity into clear-cut selection outcome. By dampening mild TCR signals Themis increases the affinity threshold for activation, enabling positive selection of T cells with a naive phenotype in response to low-affinity self-antigens.	[Fu, Guo; Casas, Javier; Rigaud, Stephanie; Rybakin, Vasily; Brzostek, Joanna; Hoerter, John A. H.; Sauer, Karsten; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Casas, Javier; Rybakin, Vasily; Brzostek, Joanna; Gascoigne, Nicholas R. J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117545, Singapore; [Casas, Javier; Rybakin, Vasily; Brzostek, Joanna; Gascoigne, Nicholas R. J.] Natl Univ Singapore, Immunol Programme, Singapore 117545, Singapore; [Lambolez, Florence; Cheroutre, Hilde] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Paster, Wolfgang; Acuto, Oreste] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Sauer, Karsten] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; National University of Singapore; National University of Singapore; La Jolla Institute for Immunology; University of Oxford; Scripps Research Institute	Gascoigne, NRJ (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	micnrjg@nus.edu.sg	Rybakin, Vasily/J-6310-2019; Casas, Javier/K-7190-2015	Rybakin, Vasily/0000-0002-5093-1757; Casas, Javier/0000-0002-6413-8127; Paster, Wolfgang/0000-0002-5537-2886; Brzostek, Joanna/0000-0002-5621-2649	NIH [AI073870, DK094173, GM065230, DP1OD006433, GM100785, AI070845, T32AI07244]; Wellcome Trust [GR076558MA]; National University of Singapore; Spanish Ministerio de Ciencia e Innovacion (MICIIN); American Chemical Society; The Leukemia & Lymphoma Society Scholar Award [1440-11]; National Institute of Allergy and Infectious Diseases, the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070845, R56AI073870, R01AI073870, T32AI007244, R01AI064584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK094173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100785, R01GM065230] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006433] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); National University of Singapore(National University of Singapore); Spanish Ministerio de Ciencia e Innovacion (MICIIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); American Chemical Society(American Chemical Society); The Leukemia & Lymphoma Society Scholar Award; National Institute of Allergy and Infectious Diseases, the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. L. Chen and Y. Xing for technical advice. We thank J. Ampudia, S. Vallee, J. Hu and S. Feldstein for help, and the National Institutes of Health (NIH) Tetramer Core Facility for production of MHC-I tetramers. Supported by NIH grants AI073870, DK094173 and GM065230 to N.R.J.G., DP1OD006433 to H. C., GM100785 and AI070845 to K. S.; Wellcome Trust Grant GR076558MA to O.A., and by the National University of Singapore. J. C. was supported by a fellowship from the Spanish Ministerio de Ciencia e Innovacion (MICIIN), J. A. H. H. by the Irving S. Sigal Fellowship of the American Chemical Society and NIH training grant T32AI07244, and K. S. by The Leukemia & Lymphoma Society Scholar Award 1440-11. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the NIH, or other funding agencies. This is manuscript number 21592 from The Scripps Research Institute.	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Carter JD, 1999, INT IMMUNOL, V11, P1999, DOI 10.1093/intimm/11.12.1999; Cheroutre H, 2008, CURR OPIN IMMUNOL, V20, P185, DOI 10.1016/j.coi.2008.03.009; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fu G, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002058; Fu G, 2009, J IMMUNOL METHODS, V350, P194, DOI 10.1016/j.jim.2009.07.009; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Hammond KJL, 2001, J IMMUNOL, V167, P1164, DOI 10.4049/jimmunol.167.3.1164; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Johnson DJ, 2013, J EXP MED, V210, P1419, DOI 10.1084/jem.20122239; Juang J, 2010, J EXP MED, V207, P1223, DOI 10.1084/jem.20092170; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Lesourne R, 2012, J IMMUNOL, V189, P1154, DOI 10.4049/jimmunol.1200123; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Minoo P, 2004, BLOOD, V103, P1398, DOI 10.1182/blood-2003-07-2617; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Plas DR, 1999, J IMMUNOL, V162, P5680; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Rybakin V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043191; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Simoneau M, 2008, J BIOL CHEM, V283, P25544, DOI 10.1074/jbc.M804177200; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Zhang JY, 1999, J IMMUNOL, V163, P3012	44	85	86	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					441	+		10.1038/nature12718	http://dx.doi.org/10.1038/nature12718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24226767	Green Accepted			2022-12-28	WOS:000328575300053
J	Humayun, M; Nemchin, A; Zanda, B; Hewins, RH; Grange, M; Kennedy, A; Lorand, JP; Gopel, C; Fieni, C; Pont, S; Deldicque, D				Humayun, M.; Nemchin, A.; Zanda, B.; Hewins, R. H.; Grange, M.; Kennedy, A.; Lorand, J. -P.; Goepel, C.; Fieni, C.; Pont, S.; Deldicque, D.			Origin and age of the earliest Martian crust from meteorite NWA 7533	NATURE			English	Article							X-RAY SPECTROMETER; SIDEROPHILE ELEMENTS; LUNAR METEORITES; MAGMA OCEAN; U-PB; MARS; EVOLUTION; CRYSTALLIZATION; SIGNATURES; BRECCIAS	The ancient cratered terrain of the southern highlands of Mars is thought to hold clues to the planet's early differentiation(1,2), but until now no meteoritic regolith breccias have been recovered from Mars. Here we show that the meteorite Northwest Africa (NWA) 7533 (paired with meteorite NWA 7034(3)) is a polymict breccia consisting of a fine-grained interclast matrix containing clasts of igneous-textured rocks and fine-grained clast-laden impact melt rocks. High abundances of meteoritic siderophiles (for example nickel and iridium) found throughout the rock reach a level in the fine-grained portions equivalent to 5 per cent CI chondritic input, which is comparable to the highest levels found in lunar breccias. Furthermore, analyses of three leucocratic monzonite clasts show a correlation between nickel, iridium and magnesium consistent with differentiation from impact melts. Compositionally, all the fine-grained material is alkalic basalt, chemically identical (except for sulphur, chlorine and zinc) to soils from Gusev crater. Thus, we propose that NWA 7533 is a Martian regolith breccia. It contains zircons for which we measured an age of 4,428 +/- 25 million years, which were later disturbed 1,712 +/- 85 million years ago. This evidence for early crustal differentiation implies that the Martian crust, and its volatile inventory(4), formed in about the first 100 million years of Martian history, coeval with earliest crust formation on the Moon(5) and the Earth(6). In addition, incompatible element abundances in clast-laden impact melt rocks and interclast matrix provide a geochemical estimate of the average thickness of the Martian crust (50 kilometres) comparable to that estimated geophysically(2,7).	[Humayun, M.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32310 USA; [Humayun, M.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Nemchin, A.; Grange, M.] Curtin Univ, Dept Appl Geol, Perth, WA 6845, Australia; [Zanda, B.; Hewins, R. H.; Fieni, C.; Pont, S.] CNRS, Lab Mineral & Cosmochim Museum, F-75005 Paris, France; [Zanda, B.; Hewins, R. H.; Fieni, C.; Pont, S.] Museum Natl Hist Nat, F-75005 Paris, France; [Zanda, B.; Hewins, R. H.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA; [Kennedy, A.] Curtin Univ, Dept Appl Phys, Perth, WA 6845, Australia; [Lorand, J. -P.] Univ Nantes, Lab Planetol & Geodynam Nantes, CNRS, UMR 6112, F-44322 Nantes 3, France; [Goepel, C.] Univ Paris Diderot, Inst Phys Globe, Sorbonne Paris Cite, CNRS,UMR 7154, F-75005 Paris, France; [Deldicque, D.] Ecole Normale Super, UMR 8538, F-75231 Paris 5, France	State University System of Florida; Florida State University; State University System of Florida; Florida State University; Curtin University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Rutgers State University New Brunswick; Curtin University; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Humayun, M (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32310 USA.	humayun@magnet.fsu.edu	Humayun, Munir/A-1247-2007; IMPMC, ROCKS @/U-8478-2017; Gopel, Christa/AAN-1657-2021; Gopel, Christa M/A-5660-2011; Zanda, Brigitte M/D-6787-2015	Zanda, Brigitte M/0000-0002-4210-7151; Humayun, Munir/0000-0001-8516-9435; Grange, Marion/0000-0001-6405-8795; Nemchin, Alexander/0000-0002-3955-3409	NASA [NNX10AI37G]; Programme National de Planetologie, France; ARC Centre of Excellence CCFS	NASA(National Aeronautics & Space Administration (NASA)); Programme National de Planetologie, France; ARC Centre of Excellence CCFS(Australian Research Council)	We thank L. Labenne for providing samples of NWA 7533 for this study. We thank M. Fialin and F. Couffignal for help with the electron microprobe. We thank the NASA Cosmochemistry Program for support to M.H. (NNX10AI37G) and the Programme National de Planetologie, France, for support to B.Z. M.G. thanks the ARC Centre of Excellence CCFS for funding. We thank H. McSween for comments.	Agee CB, 2013, SCIENCE, V339, P780, DOI 10.1126/science.1228858; Aoudjehane HC, 2012, SCIENCE, V338, P785, DOI 10.1126/science.1224514; Brandon AD, 2012, GEOCHIM COSMOCHIM AC, V76, P206, DOI 10.1016/j.gca.2011.09.047; Campbell AJ, 2002, GEOCHIM COSMOCHIM AC, V66, P647, DOI 10.1016/S0016-7037(01)00794-3; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Compston W., 1984, Journal of Geophysical Research, V89, P525, DOI 10.1029/JB089iS02p0B525; Debaille V, 2007, NATURE, V450, P525, DOI 10.1038/nature06317; Di Achille G, 2010, NAT GEOSCI, V3, P459, DOI 10.1038/NGEO891; Foley CN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002019; Gaboardi M, 2009, J ANAL ATOM SPECTROM, V24, P1188, DOI 10.1039/b900876d; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Humayun M, 2007, GEOCHIM COSMOCHIM AC, V71, P4609, DOI 10.1016/j.gca.2007.07.014; Humayun M, 2012, METEORIT PLANET SCI, V47, P1191, DOI 10.1111/j.1945-5100.2012.01371.x; Humayun M, 2010, J ANAL ATOM SPECTROM, V25, P998, DOI 10.1039/c001391a; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; Jochum KP, 2011, GEOSTAND GEOANAL RES, V35, P397, DOI 10.1111/j.1751-908X.2011.00120.x; Kong P, 1999, GEOCHIM COSMOCHIM AC, V63, P1865, DOI 10.1016/S0016-7037(99)00030-7; Korotev RL, 2009, METEORIT PLANET SCI, V44, P1287, DOI 10.1111/j.1945-5100.2009.tb01223.x; Ludwig K. R., 2008, SPEC PUBL BERKELEY G; Ludwig K. R., 2009, SPEC PUBL BERKELEY G, V4; Marty B, 2002, EARTH PLANET SC LETT, V196, P251, DOI 10.1016/S0012-821X(01)00612-4; McSween HY, 2009, SCIENCE, V324, P736, DOI 10.1126/science.1165871; Nelson D. R., 1996, GEOLOGICAL SURVEY W, V1997, P1; Nemchin A, 2009, NAT GEOSCI, V2, P133, DOI 10.1038/NGEO417; Nemchin AA, 2008, GEOCHIM COSMOCHIM AC, V72, P668, DOI 10.1016/j.gca.2007.11.009; Nimmo F, 2005, ANNU REV EARTH PL SC, V33, P133, DOI 10.1146/annurev.earth.33.092203.122637; Norman MD, 2002, EARTH PLANET SC LETT, V202, P217, DOI 10.1016/S0012-821X(02)00780-X; Palme H., 1978, P LUNAR PLANET SCI C, V9, P25; Pidgeon R., 1994, 8 INT C GEOCHR COSM; Rudnick, 2003, TREATISE GEOCHEMISTR, V3, P1, DOI [10.1016/B0-08-043751-6/03016-4, DOI 10.1016/B0-08-043751-6/03016-4, 10.1016/B978-0-08-095975-7.00301-6.]; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; STACEY JS, 1975, EARTH PLANET SC LETT, V26, P207, DOI 10.1016/0012-821X(75)90088-6; Stolper EM, 2013, SCIENCE, V341, DOI 10.1126/science.1239463; Taylor GJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002676; Tuff J, 2013, NATURE, V498, P342, DOI 10.1038/nature12225; Walker RJ, 2008, GEOCHIM COSMOCHIM AC, V72, P2198, DOI 10.1016/j.gca.2008.01.021; Wanke H., 1977, LUN PLAN SCI C, P2191; WARREN PH, 1983, EARTH PLANET SC LETT, V64, P175, DOI 10.1016/0012-821X(83)90202-9; Warren PH, 1999, GEOCHIM COSMOCHIM AC, V63, P2105, DOI 10.1016/S0016-7037(99)00156-8; Warren PH, 2005, METEORIT PLANET SCI, V40, P989, DOI 10.1111/j.1945-5100.2005.tb00169.x; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550; Williams I.S., 1998, REV EC GEOLOGY, V7, P1, DOI DOI 10.1080/07474938808800138; Wingate MTD, 2000, CHEM GEOL, V168, P75, DOI 10.1016/S0009-2541(00)00184-4; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	46	226	228	0	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					513	+		10.1038/nature12764	http://dx.doi.org/10.1038/nature12764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24256724				2022-12-28	WOS:000327464200040
J	Yelenik, SG; D'Antonio, CM				Yelenik, Stephanie G.; D'Antonio, Carla M.			Self-reinforcing impacts of plant invasions change over time	NATURE			English	Article							DRY HAWAIIAN WOODLANDS; BIOLOGICAL INVASIONS; RESTORATION ECOLOGY; NITROGEN DYNAMICS; EXOTIC GRASSES; SOIL FEEDBACKS; C-4 GRASSES; FIRE; STATES; SUCCESSION	Returning native species to habitats degraded by biological invasions is a critical conservation goal(1). A leading hypothesis poses that exotic plant dominance is self-reinforced by impacts on ecosystem processes, leading to persistent stable states(2-6). Invaders have been documented to modify fire regimes, alter soil nutrients or shift microbial communities in ways that feed back to benefit themselves over competitors(2,5-7). However, few studies have followed invasions through time to ask whether ecosystem impacts and feedbacks persist(8,9). Here we return to woodland sites in Hawai'i Volcanoes National Park that were invaded by exotic C-4 grasses in the 1960s, the ecosystem impacts of which were studied intensively in the 1990s(10-12). We show that positive feedbacks between exotic grasses and soil nitrogen cycling have broken down, but rather than facilitating native vegetation, the weakening feedbacks facilitate new exotic species. Data from the 1990s showed that exotic grasses increased nitrogen-mineralization rates by two-to fourfold, but were nitrogen-limited(10,12,13). Thus, the impacts of the invader created a positive feedback early in the invasion. We now show that annual net soil nitrogen mineralization has since dropped to pre-invasion levels. In addition, a seedling outplanting experiment that varied soil nitrogen and grass competition demonstrates that the changing impacts of grasses do not favour native species re-establishment. Instead, decreased nitrogen availability most benefits another aggressive invader, the nitrogen-fixing tree Morella faya. Long-term studies of invasions may reveal that ecosystem impacts and feedbacks shift over time, but that this may not benefit native species recovery.	[Yelenik, Stephanie G.; D'Antonio, Carla M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Yelenik, SG (corresponding author), US Geol Survey, Pacific Isl Ecosyst Res Ctr, Hawaii Natl Pk, HI 96718 USA.	syelenik@usgs.gov	Yelenik, Stephanie/ABC-8265-2020	Yelenik, Stephanie/0000-0002-9011-0769	National Science Foundation [DEB 1029168]	National Science Foundation(National Science Foundation (NSF))	We thank M. Mack for previous data. We thank S. McDaniel and S. Doyle for native seed and the National Park Service for field site access and laboratory and greenhouse facilities. N. DiManno, V. Vincent, T. Kalei, T. D'Antonio-Dudley, K. Roehr, W. Buckley, M. Wasser and C. French helped with field work and N. DiManno, V. Vincent and S. Ma helped with laboratory work. We are appreciative of early manuscript comments from E. Mordecai and statistical advice from K. Brinck. This research was funded by National Science Foundation grant DEB 1029168.	Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; BEATTY SW, 1992, MADRONO, V39, P54; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; D'Antonio CM, 2006, BIOTROPICA, V38, P458, DOI 10.1111/j.1744-7429.2006.00170.x; D'Antonio CM, 2011, ECOL APPL, V21, P1617, DOI 10.1890/10-0638.1; D'Antonio CM, 2001, ECOLOGY, V82, P89, DOI 10.1890/0012-9658(2001)082[0089:FIDOTI]2.0.CO;2; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dobson AP, 1997, SCIENCE, V277, P515, DOI 10.1126/science.277.5325.515; Funk JL, 2008, TRENDS ECOL EVOL, V23, P695, DOI 10.1016/j.tree.2008.07.013; HUGHES F, 1991, ECOLOGY, V72, P743, DOI 10.2307/2937215; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Levine JM, 2006, ECOL LETT, V9, P1005, DOI 10.1111/j.1461-0248.2006.00949.x; Mack MC, 2003, ECOL APPL, V13, P154, DOI 10.1890/1051-0761(2003)013[0154:EGACOS]2.0.CO;2; Mack MC, 2001, ECOL APPL, V11, P1323, DOI 10.1890/1051-0761(2001)011[1323:AOENDB]2.0.CO;2; MACK MC, 1998, THESIS U CALIFORNIA; Nadelhoffer K. J., 1994, STABLE ISOTOPES ECOL, V316, P22; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scowcroft PG, 2013, NEW FOREST, V44, P409, DOI 10.1007/s11056-012-9352-6; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Sullivan JJ, 2007, NEW ZEAL J ECOL, V31, P22; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; van der Putten WH, 2007, ISME J, V1, P28, DOI 10.1038/ismej.2007.9; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Yelenik SG, 2011, ECOLOGY, V92, P66, DOI 10.1890/10-0465.1	30	98	104	7	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					517	+		10.1038/nature12798	http://dx.doi.org/10.1038/nature12798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24256723				2022-12-28	WOS:000327464200041
J	Levin, L; Luder, L				Levin, Liran; Luder, Liat			Jaw Lesion and Discomfort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; FREQUENCY		[Levin, Liran] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Div Periodontol, Boston, MA 02115 USA; [Levin, Liran; Luder, Liat] Technion Israel Inst Technol, Fac Med, Sch Grad Dent, Dept Periodontol, Haifa, Israel	Harvard University; Harvard School of Dental Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Levin, L (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave,Room 305, Boston, MA 02115 USA.	liranl@technion.ac.il						Cheng A, 2009, AUST DENT J, V54, pS51, DOI 10.1111/j.1834-7819.2009.01143.x; Ficarra G, 2005, J CLIN PERIODONTOL, V32, P1123, DOI 10.1111/j.1600-051X.2005.00842.x; Goss A, 2010, J ORAL MAXIL SURG, V68, P337, DOI 10.1016/j.joms.2009.09.037; Lee Cameron Y S, 2007, J Oral Implantol, V33, P371, DOI 10.1563/1548-1336(2007)33[371:UOPPIT]2.0.CO;2; Levin L, 2007, J AM DENT ASSOC, V138, P1218, DOI 10.14219/jada.archive.2007.0346; Mas A, 2010, ARCH DERMATOL, V146, P1301, DOI 10.1001/archdermatol.2010.318-a; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Sedghizadeh PP, 2009, J AM DENT ASSOC, V140, P61, DOI 10.14219/jada.archive.2009.0019; Yarom N, 2007, OSTEOPOROSIS INT, V18, P1363, DOI 10.1007/s00198-007-0384-2	10	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2195	2196		10.1001/jama.2013.282405	http://dx.doi.org/10.1001/jama.2013.282405			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24281463				2022-12-28	WOS:000327404400029
J	Chiu, YT				Chiu, Yu-Tzu			Typhoon Haiyan: Philippines faces long road to recovery	LANCET			English	Editorial Material																			0	12	12	1	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1691	1692		10.1016/S0140-6736(13)62380-6	http://dx.doi.org/10.1016/S0140-6736(13)62380-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259PX	24278979				2022-12-28	WOS:000327539900012
J	Lane, R				Lane, Richard			Mushtaque Chowdhury: seeking health transition in Bangladesh	LANCET			English	Biographical-Item																		CHOWDHURY M, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1695	1695		10.1016/S0140-6736(13)62306-5	http://dx.doi.org/10.1016/S0140-6736(13)62306-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259PX	24267991	Bronze			2022-12-28	WOS:000327539900014
J	Nesbitt, AD; Kosky, CA; Leschziner, GD				Nesbitt, Alexander D.; Kosky, Christopher A.; Leschziner, Guy D.			Insular seizures causing sleep-related breathlessness	LANCET			English	Editorial Material									[Nesbitt, Alexander D.; Kosky, Christopher A.; Leschziner, Guy D.] Guys & St Thomas NHS Fdn Trust, Sleep Disorders Ctr, London, England	Guy's & St Thomas' NHS Foundation Trust	Leschziner, GD (corresponding author), Guys Hosp, Sleep Disorders Ctr, Nuffield House, London SE1 9RT, England.	guy.leschziner@gstt.nhs.uk		Kosky, Christopher/0000-0001-7652-2516				Davis KA, 2008, J CLIN SLEEP MED, V4, P586; Isnard J, 2004, EPILEPSIA, V45, P1079, DOI 10.1111/j.0013-9580.2004.68903.x; Kriegel MF, 2012, J CLIN NEUROPHYSIOL, V29, P385, DOI 10.1097/WNP.0b013e31826bd82e; Penfield W, 1954, EPILEPSY FUNCTIONAL; Sevcencu C, 2010, EPILEPSIA, V51, P725, DOI 10.1111/j.1528-1167.2009.02479.x	5	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1756	1756		10.1016/S0140-6736(13)61997-2	http://dx.doi.org/10.1016/S0140-6736(13)61997-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259PX	24268004				2022-12-28	WOS:000327539900033
J	Lee, NN; Chalamcharla, VR; Reyes-Turcu, F; Mehta, S; Zofall, M; Balachandran, V; Dhakshnamoorthy, J; Taneja, N; Yamanaka, S; Zhou, M; Grewal, SIS				Lee, Nathan N.; Chalamcharla, Venkata R.; Reyes-Turcu, Francisca; Mehta, Sameet; Zofall, Martin; Balachandran, Vanivilasini; Dhakshnamoorthy, Jothy; Taneja, Nitika; Yamanaka, Soichiro; Zhou, Ming; Grewal, Shiv I. S.			Mtr4-like Protein Coordinates Nuclear RNA Processing for Heterochromatin Assembly and for Telomere Maintenance	CELL			English	Article							LONG NONCODING RNAS; YEAST SCHIZOSACCHAROMYCES-POMBE; DIRECTED DNA METHYLATION; MEIOTIC MESSENGER-RNAS; FISSION YEAST; POLY(A)-BINDING PROTEIN; SELECTIVE ELIMINATION; QUALITY-CONTROL; ANTISENSE RNA; S. POMBE	The regulation of protein-coding and noncoding RNAs is linked to nuclear processes, including chromatin modifications and gene silencing. However, the mechanisms that distinguish RNAs and mediate their functions are poorly understood. We describe a nuclear RNA-processing network in fission yeast with a core module comprising the Mtr4-like protein, Mtl1, and the zinc-finger protein, Red1. The Mtl1-Red1 core promotes degradation of mRNAs and noncoding RNAs and associates with different proteins to assemble heterochromatin via distinct mechanisms. Mtl1 also forms Red1-independent interactions with evolutionarily conserved proteins named Nrl1 and Ctr1, which associate with splicing factors. Whereas Nrl1 targets transcripts with cryptic introns to form heterochromatin at developmental genes and retrotransposons, Ctr1 functions in processing intron-containing telomerase RNA. Together with our discovery of widespread cryptic introns, including in noncoding RNAs, these findings reveal unique cellular strategies for recognizing regulatory RNAs and coordinating their functions in response to developmental and environmental cues.	[Lee, Nathan N.; Chalamcharla, Venkata R.; Reyes-Turcu, Francisca; Mehta, Sameet; Zofall, Martin; Balachandran, Vanivilasini; Dhakshnamoorthy, Jothy; Taneja, Nitika; Yamanaka, Soichiro; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA; [Lee, Nathan N.] NIH, Bethesda, MD 20892 USA; [Lee, Nathan N.] Johns Hopkins Univ, Grad Partnership Program, Bethesda, MD 20892 USA; [Zhou, Ming] Frederick Natl Lab Canc Res, Lab Prote & Analyt Technol, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	TANEJA, NITIKA/T-5633-2017; Mehta, Sameet/A-1936-2011; TANEJA, NITIKA/AAY-8446-2021	TANEJA, NITIKA/0000-0002-5513-5282; Mehta, Sameet/0000-0002-3029-3217; TANEJA, NITIKA/0000-0002-5513-5282; Grewal, Shiv/0000-0002-4552-9261	Intramural Research Program of the National Institutes of Health (NIH); National Cancer Institute and utilized the Helix Systems; Biowulf Linux cluster at the NIH; NATIONAL CANCER INSTITUTE [ZIABC010523] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute and utilized the Helix Systems; Biowulf Linux cluster at the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. FitzGerald for intron analysis, R. Allshire for the cwf10-1 mutant, J. Barrowman for her valuable help in editing the manuscript, and M. Lichten for comments. This research was supported by the Intramural Research Program of the National Institutes of Health (NIH) and by the National Cancer Institute and utilized the Helix Systems and the Biowulf Linux cluster at the NIH.	Ausin I, 2012, EPIGENETICS-US, V7, P29, DOI 10.4161/epi.7.1.18782; Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Bitton DA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.90; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; Chinen M, 2010, J BIOL CHEM, V285, P5630, DOI 10.1074/jbc.M109.074393; Cho YS, 2012, MOL CELLS, V34, P315, DOI 10.1007/s10059-012-0157-4; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hiriart E, 2012, EMBO J, V31, P2296, DOI 10.1038/emboj.2012.105; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kiely CM, 2011, MOL CELL BIOL, V31, P4193, DOI 10.1128/MCB.05568-11; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Lemieux C, 2011, MOL CELL, V44, P108, DOI 10.1016/j.molcel.2011.06.035; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Tang W, 2012, NATURE, V484, P260, DOI 10.1038/nature10924; Tashiro S, 2013, GENES CELLS, V18, P327, DOI 10.1111/gtc.12038; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yamamoto M, 2010, P JPN ACAD B-PHYS, V86, P788, DOI 10.2183/pjab.86.788; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Zhang CJ, 2013, EMBO J, V32, P1128, DOI 10.1038/emboj.2013.49; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	58	125	126	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1061	1074		10.1016/j.cell.2013.10.027	http://dx.doi.org/10.1016/j.cell.2013.10.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24210919	Green Accepted, Bronze			2022-12-28	WOS:000327500600011
J	Mamdani, H; Vettese, TE; Baden, LR				Mamdani, Hirva; Vettese, Theresa E.; Baden, Lindsey R.			Pulmonary Emboli Caused by Mercury	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 40-year-old man presented with headache, dry cough, and dyspnea that had begun 3 days earlier. Physical examination revealed labile mood, intention tremor, and tender subcutaneous nodules on the left forearm. A 40-year-old man presented with headache, dry cough, and dyspnea that had begun 3 days earlier. Physical examination revealed labile mood, intention tremor, and tender subcutaneous nodules on the left forearm. The oxygen saturation was 92% while he was breathing 2 liters of oxygen per minute through a nasal cannula. A chest radiograph (Panel A) revealed innumerable small, high-density opacities diffusely distributed throughout both lungs. Laboratory testing revealed a urine mercury level of 1249 g per liter (reference range, 0 to 10) and a serum mercury level of more than 160 g per liter (798 nmol per liter; reference range, ...	[Mamdani, Hirva] Detroit Med Ctr, Detroit, MI 48201 USA; [Vettese, Theresa E.] Wayne State Univ, Sch Med, Detroit, MI USA	Detroit Medical Center; Wayne State University	Mamdani, H (corresponding author), Detroit Med Ctr, Detroit, MI 48201 USA.		Mamdani, Hirva/AAF-1645-2019						0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					2031	2031		10.1056/NEJMicm1307913	http://dx.doi.org/10.1056/NEJMicm1307913			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256381				2022-12-28	WOS:000327163000011
J	Richardson, K; Schoen, M; French, B; Umscheid, CA; Mitchell, MD; Arnold, SE; Heidenreich, PA; Rader, DJ; deGoma, EM				Richardson, Karl; Schoen, Marisa; French, Benjamin; Umscheid, Craig A.; Mitchell, Matthew D.; Arnold, Steven E.; Heidenreich, Paul A.; Rader, Daniel J.; deGoma, Emil M.			Statins and Cognitive Function	ANNALS OF INTERNAL MEDICINE			English	Review							LIPID-LOWERING AGENTS; MODERATE ALZHEIMER-DISEASE; QUALITY-OF-LIFE; INCIDENT DEMENTIA; CONTROLLED-TRIAL; REDUCED RISK; DOUBLE-BLIND; MEMORY LOSS; PRAVASTATIN; SIMVASTATIN	Background: Despite the U. S. Food and Drug Administration (FDA) warning regarding cognitive impairment, the relationship between statins and cognition remains unknown. Purpose: To examine the effect of statins on cognition. Data Sources: PubMed, Embase, and Cochrane Library from inception through October 2012; FDA databases from January 1986 through March 2012. Study Selection: Randomized, controlled trials (RCTs) and cohort, case-control, and cross-sectional studies evaluating cognition in patients receiving statins. Data Extraction: Two reviewers extracted data, 1 reviewer assessed study risk of bias, and 1 reviewer checked all assessments. Data Synthesis: Among statin users, low-quality evidence suggested no increased incidence of Alzheimer disease and no difference in cognitive performance related to procedural memory, attention, or motor speed. Moderate-quality evidence suggested no increased incidence of dementia or mild cognitive impairment or any change in cognitive performance related to global cognitive performance scores, executive function, declarative memory, processing speed, or visuoperception. Examination of the FDA post-marketing surveillance databases revealed a low reporting rate for cognitive-related adverse events with statins that was similar to the rates seen with other commonly prescribed cardiovascular medications. Limitations: The absence of many well-powered RCTs for most outcomes resulted in final strengths of evidence that were low or moderate. Imprecision, inconsistency, and risk of bias also limited the strength of findings. Conclusion: Larger and better-designed studies are needed to draw unequivocal conclusions about the effect of statins on cognition. Published data do not suggest an adverse effect of statins on cognition; however, the strength of available evidence is limited, particularly with regard to high-dose statins.	Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn Hlth Syst, Philadelphia, PA USA; Stanford Univ, Med Ctr, Stanford, CA 94305 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Stanford University	deGoma, EM (corresponding author), Perelman Ctr Adv Med, Heart & Vasc Ctr, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	deGoma@uphs.upenn.edu	Heidenreich, Paul/AAU-6864-2021; Mitchell, Matthew/AAP-5852-2020; Mitchell, Matthew D/H-3784-2011	Heidenreich, Paul/0000-0001-7730-8490; Mitchell, Matthew/0000-0003-3065-1608; Mitchell, Matthew D/0000-0003-3065-1608	National Institutes of Health; Pfizer; Bristol Myers Squibb; Johnson and Johnson; Merck; AstraZeneca; Aegerion; Amgen; Novartis; Regenerol	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Bristol Myers Squibb(Bristol-Myers Squibb); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck(Merck & Company); AstraZeneca(AstraZeneca); Aegerion; Amgen(Amgen); Novartis(Novartis); Regenerol	National Institutes of Health, Pfizer, Bristol Myers Squibb, Johnson and Johnson, Merck. Dr. Rader: Personal fees: AstraZeneca, Pfizer, Merck. Dr. deGoma: Personal fees: Aegerion; Grants: Pfizer, Amgen, Novartis, Regenerol.	Ali Shafqut, 2010, J Ayub Med Coll Abbottabad, V22, P225; Ancelin ML, 2012, J ALZHEIMERS DIS, V30, P629, DOI 10.3233/JAD-2012-120064; Anderson S., 2011, US TODAY; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Arvanitakis Z, 2008, NEUROLOGY, V70, P1795, DOI 10.1212/01.wnl.0000288181.00826.63; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Benito-Leon J, 2010, J ALZHEIMERS DIS, V21, P95, DOI 10.3233/JAD-2010-100180; Berk-Planken I, 2002, DIABETES CARE, V25, P1250, DOI 10.2337/diacare.25.7.1250; Bernick C, 2005, NEUROLOGY, V65, P1388, DOI 10.1212/01.wnl.0000182897.18229.ec; Bettermann K, 2012, J STROKE CEREBROVASC, V21, P436, DOI 10.1016/j.jstrokecerebrovasdis.2010.11.002; Beydoun MA, 2011, J EPIDEMIOL COMMUN H, V65, P949, DOI 10.1136/jech.2009.100826; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Carlsson CM, 2002, DRUG AGING, V19, P793, DOI 10.2165/00002512-200219100-00008; Carlsson CM, 2008, J ALZHEIMERS DIS, V13, P187; Carlsson CM, 2009, ALZ DIS ASSOC DIS, V23, P11, DOI 10.1097/WAD.0b013e3181850188; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b; CUTLER N, 1995, BRIT J CLIN PHARMACO, V39, P333, DOI 10.1111/j.1365-2125.1995.tb04458.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deschaintre Y, 2009, NEUROLOGY, V73, P674, DOI 10.1212/WNL.0b013e3181b59bf3; Ellul J, 2007, J NEUROL NEUROSUR PS, V78, P233, DOI 10.1136/jnnp.2006.104034; Evans MA, 2009, PHARMACOTHERAPY, V29, P800, DOI 10.1592/phco.29.7.800; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Galatti L, 2006, PHARMACOTHERAPY, V26, P1190, DOI 10.1592/phco.26.8.1190; GENGO F, 1995, CLIN CARDIOL, V18, P209, DOI 10.1002/clc.4960180406; Gibellato MG, 2001, AVIAT SPACE ENVIR MD, V72, P805; Glasser SP, 2010, CLIN CARDIOL, V33, P280, DOI 10.1002/clc.20758; Goldfine AB, 2012, NEW ENGL J MED, V366, P1752, DOI 10.1056/NEJMp1203020; Green Robert C, 2006, Alzheimers Dement, V2, P96, DOI 10.1016/j.jalz.2006.02.003; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Hajjar L, 2002, J GERONTOL A-BIOL, V57, pM414, DOI 10.1093/gerona/57.7.M414; HARRISON RWS, 1994, BRIT J CLIN PHARMACO, V37, P231, DOI 10.1111/j.1365-2125.1994.tb04268.x; Healy D, 2009, BMJ CASE REP, V2009; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Horsdal HT, 2009, ALZ DIS ASSOC DIS, V23, P18, DOI 10.1097/WAD.0b013e318180f55b; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jukema JW, 2012, J AM COLL CARDIOL, V60, P875, DOI 10.1016/j.jacc.2012.07.007; King DS, 2003, PHARMACOTHERAPY, V23, P1663, DOI 10.1592/phco.23.15.1663.31953; KOSTIS JB, 1994, J CLIN PHARMACOL, V34, P989, DOI 10.1002/j.1552-4604.1994.tb01971.x; Li G, 2010, J AM GERIATR SOC, V58, P1311, DOI 10.1111/j.1532-5415.2010.02906.x; Manschot SM, 2007, DIABETOLOGIA, V50, P2388, DOI 10.1007/s00125-007-0792-z; Masse I, 2005, J NEUROL NEUROSUR PS, V76, P1624, DOI 10.1136/jnnp.2005.063388; Muldoon MF, 2000, AM J MED, V108, P538, DOI 10.1016/S0002-9343(00)00353-3; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Okeahialam BN, 2012, CURR DRUG SAF, V7, P33, DOI 10.2174/157488612800492690; Orsi A, 2001, PHARMACOTHERAPY, V21, P767, DOI 10.1592/phco.21.7.767.34577; Parikh NM, 2011, INT J GERIATR PSYCH, V26, P749, DOI 10.1002/gps.2604; Parker BA, 2010, PHARMACOTHERAPY, V30, P625, DOI 10.1592/phco.30.6.625; Prajapati S, 2011, J POSTGRAD MED, V57, P291, DOI 10.4103/0022-3859.90078; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Rea TD, 2005, ARCH NEUROL-CHICAGO, V62, P1047, DOI 10.1001/archneur.62.7.1047; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Rockwood K, 2007, NEUROEPIDEMIOLOGY, V29, P201, DOI 10.1159/000111583; Rodriguez EG, 2002, J AM GERIATR SOC, V50, P1852, DOI 10.1046/j.1532-5415.2002.50515.x; Rosenberg PB, 2008, AM J GERIAT PSYCHIAT, V16, P883, DOI 10.1097/JGP.0b013e318181276a; ROTH T, 1992, CLIN CARDIOL, V15, P426; Sano M, 2011, NEUROLOGY, V77, P556, DOI 10.1212/WNL.0b013e318228bf11; Santanello NC, 1997, J AM GERIATR SOC, V45, P8, DOI 10.1111/j.1532-5415.1997.tb00971.x; Scudder LS, 2012, MEDSCAPE; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Sparks DL, 2008, CURR ALZHEIMER RES, V5, P416, DOI 10.2174/156720508785132316; Sparks DL, 2010, NEURODEGENER DIS, V7, P183, DOI 10.1159/000295660; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Starr JM, 2004, INT J GERIATR PSYCH, V19, P327, DOI 10.1002/gps.1093; Strom BL, 2006, JAMA-J AM MED ASSOC, V295, P2072, DOI 10.1001/jama.295.17.2072; Summers MJ, 2007, PHARMACOTHERAPY, V27, P183, DOI 10.1592/phco.27.2.183; Szwast SJ, 2007, NEUROLOGY, V69, P1873, DOI 10.1212/01.wnl.0000279333.77404.d7; Tatley M, 2007, DRUG SAFETY, V30, P195, DOI 10.2165/00002018-200730030-00003; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720; Winblad B, 2007, DRUG AGING, V24, P57, DOI 10.2165/00002512-200724010-00004; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Yaffe K, 2002, ARCH NEUROL-CHICAGO, V59, P378, DOI 10.1001/archneur.59.3.378; Zamrini E, 2004, NEUROEPIDEMIOLOGY, V23, P94, DOI 10.1159/000073981; Zandi PP, 2005, ARCH GEN PSYCHIAT, V62, P217, DOI 10.1001/archpsyc.62.2.217	84	177	177	0	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10					688	+		10.7326/0003-4819-159-10-201311190-00007	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247674				2022-12-28	WOS:000328732700017
J	Tulchinsky, TH; Ramlawi, A; Abdeen, Z; Grotto, I; Flahault, A				Tulchinsky, Theodore H.; Ramlawi, Asad; Abdeen, Ziad; Grotto, Itamar; Flahault, Antoine			Polio lessons 2013: Israel, the West Bank, and Gaza	LANCET			English	Editorial Material							POLIOMYELITIS		[Tulchinsky, Theodore H.] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Braun Sch Publ Hlth, Jerusalem, Israel; [Ramlawi, Asad] Palestinian Author, Minist Hlth, Ramallah, West Bank, Palestine; [Abdeen, Ziad] Al Quds Univ, Al Quds Nutr & Hlth Res Inst, Jerusalem, Israel; [Grotto, Itamar] Ben Gurion Univ Negev, Fac Hlth Sci, Publ Hlth Serv, Minist Hlth, Beer Sheva, Israel; [Grotto, Itamar] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel; [Flahault, Antoine] Sorbonne Paris Cite, Descartes Sch Med, Ctr Virchow Villerme, Paris, France	Hebrew University of Jerusalem; Hadassah University Medical Center; Ben Gurion University; Ben Gurion University; UDICE-French Research Universities; Universite Paris Cite	Tulchinsky, TH (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Braun Sch Publ Hlth, Jerusalem, Israel.	tedt@hadassah.org.il	Grotto, Itamar/F-2028-2012; Abdeen, Ziad/AAC-7889-2019	Grotto, Itamar/0000-0002-3363-3715				Anis E, 2013, EURO SURVEILL, V18; [Anonymous], 2013, LANCET, V382, P1381; [Anonymous], 2013, POL ER ENDG STRAT PL; Global Polio Eradication Initiative, 2013, RAM ROT RESC; Global Polio Eradication Initiative, 2013, POL WEEK; GOLDBLUM N, 1994, B WORLD HEALTH ORGAN, V72, P783; Kew Olen M., 2012, Morbidity and Mortality Weekly Report, V61, P741; State of Palestine Ministry of Health. MOH-PHIC, 2006, COMM DIS HLTH STAT P; TULCHINSKY T, 1989, AM J PUBLIC HEALTH, V79, P1648, DOI 10.2105/AJPH.79.12.1648; WHO, 2013, IMP WILD POL DET ENV; WHO, 2013, GLOB AL RESP WILD PO; WHO, 2013, GLOB AL RESP POL DET; WHO, 2013, GLOB AL RESP POL SYR; WHO. Polio Eradication Initiative, OCC PAL TERR CERT ST	14	18	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1611	1612		10.1016/S0140-6736(13)62331-4	http://dx.doi.org/10.1016/S0140-6736(13)62331-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	24238546				2022-12-28	WOS:000327140700005
J	Patel, K				Patel, Kinesh			Sir David who?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 15	2013	347								f6899	10.1136/bmj.f6899	http://dx.doi.org/10.1136/bmj.f6899			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254HR	24243979				2022-12-28	WOS:000327156300012
J	Johns, EJ				Johns, Edward J.			Resistant hypertension and renal denervation: 3 years on	LANCET			English	Editorial Material									Natl Univ Ireland Univ Coll Cork, Dept Physiol, Cork, Ireland	University College Cork	Johns, EJ (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Physiol, Cork, Ireland.	e.j.johns@ucc.ie		Johns, Edward/0000-0001-8344-7059				Burnier M, 2013, HYPERTENSION, V62, P218, DOI 10.1161/HYPERTENSIONAHA.113.00687; DiBona GF, 2010, AM J PHYSIOL-REG I, V298, pR245, DOI 10.1152/ajpregu.00647.2009; Hering D, 2013, J HYPERTENS, V31, P1893, DOI 10.1097/HJH.0b013e3283622e58; KAYE DM, 1993, CIRCULATION, V88, P1110, DOI 10.1161/01.CIR.88.3.1110; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Mahfoud F, 2013, CIRCULATION, V128, P132, DOI 10.1161/CIRCULATIONAHA.112.000949; Mulder J, 2013, AM J PHYSIOL-REG I, V304, pR675, DOI 10.1152/ajpregu.00599.2012; Persu A, 2013, EXPERT REV CARDIOVAS, V11, P739, DOI [10.1586/erc.13.52, 10.1586/ERC.13.52]; Prochnau D, 2013, EXPERT REV MED DEVIC, V10, P247, DOI [10.1586/ERD.13.1, 10.1586/erd.13.1]	10	2	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					583	584		10.1016/S0140-6736(13)61999-6	http://dx.doi.org/10.1016/S0140-6736(13)61999-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KP	24210778				2022-12-28	WOS:000331137700009
J	Auyeung, E; Li, TING; Senesi, AJ; Schmucker, AL; Pals, BC; de la Cruz, MO; Mirkin, CA				Auyeung, Evelyn; Li, Ting I. N. G.; Senesi, Andrew J.; Schmucker, Abrin L.; Pals, Bridget C.; de la Cruz, Monica Olvera; Mirkin, Chad A.			DNA-mediated nanoparticle crystallization into Wulff polyhedra	NATURE			English	Article							SUPERLATTICES; EVOLUTION; GROWTH; SHAPE; SIZE	Crystallization is a fundamental and ubiquitous process much studied over the centuries. But although the crystallization of atoms is fairly well understood(1,2), it remains challenging to predict reliably the outcome of molecular crystallization processes that are complicated by various molecular interactions and solvent involvement. This difficulty also applies to nanoparticles: high-quality three-dimensional crystals(3-6) are mostly produced using drying and sedimentation techniques that are often impossible to rationalize and control to give a desired crystal symmetry, lattice spacing and habit (crystal shape). In principle, DNA-mediated assembly of nanoparticles offers an ideal opportunity for studying nanoparticle crystallization(7-17): a well-defined set of rules have been developed to target desired lattice symmetries and lattice constants(8,9,18), and the occurrence of features such as grain boundaries and twinning in DNA superlattices and traditional crystals comprised of molecular or atomic building blocks suggests that similar principles govern their crystallization. But the presence of charged biomolecules, interparticle spacings of tens of nanometres, and the realization so far of only polycrystalline DNA-interconnected nanoparticle superlattices, all suggest that DNA-guided crystallization may differ from traditional crystal growth. Here we show that very slow cooling, over several days, of solutions of complementary-DNA-modified nanoparticles through the melting temperature of the system gives the thermodynamic product with a specific and uniform crystal habit. We find that our nanoparticle assemblies have the Wulff equilibrium crystal structure that is predicted from theoretical considerations and molecular dynamics simulations, thus establishing that DNA hybridization can direct nanoparticle assembly along a pathway that mimics atomic crystallization.	[Auyeung, Evelyn; Li, Ting I. N. G.; de la Cruz, Monica Olvera; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Auyeung, Evelyn; Li, Ting I. N. G.; Senesi, Andrew J.; Schmucker, Abrin L.; Pals, Bridget C.; de la Cruz, Monica Olvera; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Senesi, Andrew J.; Schmucker, Abrin L.; de la Cruz, Monica Olvera; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010; de la Cruz, Monica Olvera/X-2039-2019; de la Cruz, Monica Olvera/N-6359-2018; Schmucker, Abrin L/A-7426-2010	de la Cruz, Monica Olvera/0000-0002-9802-3627; Mirkin, Chad/0000-0002-6634-7627; Schmucker, Abrin/0000-0002-3534-2145; Li, Ting/0000-0002-0778-6371	Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative (MURI) [FA9550-11-1-0275]; National Science Foundation Materials Research Science and Engineering Center at the Materials Research Center of Northwestern University [DMR-1121262]; Non-equilibrium Energy Research Center (NERC), an Energy Frontier Research Center; Department of Energy (DoE), Office of Science, Office of Basic Energy Sciences [DE-SC0000989]; National Defense Science and Engineering Graduate (NDSEG) Fellowship [32 CFR 168a]; Ryan Fellowship from Northwestern University; DoE [DE-AC02-06CH11357]; US Department of Defense National Security Science and Engineering Faculty Fellowship [FA9550-10-1-0167]; Direct For Mathematical & Physical Scien [1121262] Funding Source: National Science Foundation	Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative (MURI)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); National Science Foundation Materials Research Science and Engineering Center at the Materials Research Center of Northwestern University; Non-equilibrium Energy Research Center (NERC), an Energy Frontier Research Center(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Department of Energy (DoE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Defense Science and Engineering Graduate (NDSEG) Fellowship; Ryan Fellowship from Northwestern University; DoE(United States Department of Energy (DOE)); US Department of Defense National Security Science and Engineering Faculty Fellowship; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	C. A. M. and M.O.d.l.C. acknowledge support from the following awards: the Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative (MURI) FA9550-11-1-0275, the National Science Foundation Materials Research Science and Engineering Center programme DMR-1121262 at the Materials Research Center of Northwestern University, and the Non-equilibrium Energy Research Center (NERC), an Energy Frontier Research Center funded by the Department of Energy (DoE), Office of Science, Office of Basic Energy Sciences under Award DE-SC0000989. E. A. acknowledges a National Defense Science and Engineering Graduate (NDSEG) Fellowship (number 32 CFR 168a). T. L. acknowledges a Ryan Fellowship from Northwestern University. T. L. thanks S. Dhakal and K. Kohlstedt for sharing scripts on the colloid model and S. Patala and J. Zwanikken for discussions. SAXS experiments were carried out at the Dupont-Northwestern-Dow Collaborative Access Team beam line at the Advanced Photon Source (APS) at Argonne National Laboratory, and use of the APS was supported by the DoE (DE-AC02-06CH11357). The electron microscopy work was performed at the Electron Probe Instrumentation Center of the NU Atomic and Nanoscale Characterization Experimental Center at Northwestern University. The computational work was performed using the TARDIS computer cluster supported by the US Department of Defense National Security Science and Engineering Faculty Fellowship (number FA9550-10-1-0167).	Abrosimov NV, 1997, J CRYST GROWTH, V174, P182, DOI 10.1016/S0022-0248(96)01102-5; Auyeung E, 2012, ADV MATER, V24, P5181, DOI 10.1002/adma.201202069; Auyeung E, 2012, NAT NANOTECHNOL, V7, P24, DOI [10.1038/nnano.2011.222, 10.1038/NNANO.2011.222]; Che JG, 1998, PHYS REV B, V57, P1875, DOI 10.1103/PhysRevB.57.1875; Compton OC, 2007, J AM CHEM SOC, V129, P7793, DOI 10.1021/ja069033q; Cutler JI, 2012, J AM CHEM SOC, V134, P1376, DOI 10.1021/ja209351u; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Knorowski C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215501; Li TING, 2013, J AM CHEM SOC, V135, P8535, DOI 10.1021/ja312644h; Li TING, 2012, NANO LETT, V12, P2509, DOI 10.1021/nl300679e; Macfarlane RJ, 2013, SCIENCE, V341, P1222, DOI 10.1126/science.1241402; Macfarlane RJ, 2013, ANGEW CHEM INT EDIT, V52, P5688, DOI 10.1002/anie.201209336; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Macfarlane RJ, 2010, ANGEW CHEM INT EDIT, V49, P4589, DOI 10.1002/anie.201000633; MACKENZIE JK, 1962, J PHYS CHEM SOLIDS, V23, P185, DOI 10.1016/0022-3697(62)90001-X; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nagaoka Y, 2012, J AM CHEM SOC, V134, P2868, DOI 10.1021/ja209062d; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Rupich SM, 2010, J AM CHEM SOC, V132, P289, DOI 10.1021/ja9074425; Senesi AJ, 2013, ANGEW CHEM INT EDIT, V52, P6624, DOI 10.1002/anie.201301936; SUNDQUIST BE, 1964, ACTA METALL MATER, V12, P67, DOI 10.1016/0001-6160(64)90055-0; Wang T, 2013, CHEM SOC REV, V42, P2804, DOI 10.1039/c2cs35318k; Wulff G, 1901, Z KRYSTALLOGR MINERA, V34, P449, DOI 10.1524/zkri.1901.34.1.449; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Zhang C, 2013, NAT MATER, V12, P741, DOI [10.1038/NMAT3647, 10.1038/nmat3647]; Zwanikken JW, 2011, J PHYS CHEM C, V115, P16368, DOI 10.1021/jp205583j	28	311	314	24	540	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					73	77		10.1038/nature12739	http://dx.doi.org/10.1038/nature12739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24284632				2022-12-28	WOS:000329163300026
J	Boskovski, MT; Yuan, SAL; Pedersen, NB; Goth, CK; Makova, S; Clausen, H; Brueckner, M; Khokha, MK				Boskovski, Marko T.; Yuan, Shiaulou; Pedersen, Nis Borbye; Goth, Christoffer Knak; Makova, Svetlana; Clausen, Henrik; Brueckner, Martina; Khokha, Mustafa K.			The heterotaxy gene GALNT11 glycosylates Notch to orchestrate cilia type and laterality	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; CONGENITAL HEART-DISEASE; LEFT-RIGHT AXIS; LEFTWARD FLOW; O-GLYCOSYLATION; FLUID-FLOW; XENOPUS EMBRYOS; NODE; PROTEIN; MOUSE	Heterotaxy is a disorder of left-right body patterning, or laterality, that is associated with major congenital heart disease(1). The aetiology and mechanisms underlying most cases of human heterotaxy are poorly understood. In vertebrates, laterality is initiated at the embryonic left-right organizer, where motile cilia generate leftward flow that is detected by immotile sensory cilia, which transduce flow into downstream asymmetric signals(2-6). The mechanism that specifies these two cilia types remains unknown. Here we show that the N-acetylgalactosamine-type O-glycosylation enzyme GALNT11 is crucial to such determination. We previously identified GALNT11 as a candidate disease gene in a patient with heterotaxy(7), and now demonstrate, in Xenopus tropicalis, that galnt11 activates Notch signalling. GALNT11 O-glycosylates human NOTCH1 peptides in vitro, thereby supporting a mechanism of Notch activation either by increasing ADAM17-mediated ectodomain shedding of the Notch receptor or by modification of specific EGF repeats. We further developed a quantitative live imaging technique for Xenopus left-right organizer cilia and show that Galnt11-mediated Notch1 signalling modulates the spatial distribution and ratio of motile and immotile cilia at the left-right organizer. galnt11 or notch1 depletion increases the ratio of motile cilia at the expense of immotile cilia and produces a laterality defect reminiscent of loss of the ciliary sensor Pkd2. By contrast, Notch overexpression decreases this ratio, mimicking the ciliopathy primary ciliary dyskinesia. Together our data demonstrate that Galnt11 modifies Notch, establishing an essential balance between motile and immotile cilia at the left-right organizer to determine laterality, and reveal a novel mechanism for human heterotaxy.	[Boskovski, Marko T.; Yuan, Shiaulou; Makova, Svetlana; Brueckner, Martina; Khokha, Mustafa K.] Yale Univ, Sch Med, Dept Pediat & Genet, Program Vertebrate Dev Biol, New Haven, CT 06520 USA; [Pedersen, Nis Borbye; Goth, Christoffer Knak; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, DK-2200 Copenhagen N, Denmark	Yale University; University of Copenhagen	Khokha, MK (corresponding author), Yale Univ, Sch Med, Dept Pediat & Genet, Program Vertebrate Dev Biol, 333 Cedar St, New Haven, CT 06520 USA.	mustafa.khokha@yale.edu	Borbye-Lorenzen, Nis/J-6369-2014; clausen, henrik/AAD-8016-2021	Borbye-Lorenzen, Nis/0000-0003-3725-4533; Goth, Christoffer/0000-0002-5766-1411; Yuan, Shiaulou/0000-0002-5061-6132; Clausen, Henrik/0000-0002-0915-5055	National Center for Research Resources/National Institutes of Health (NIH) [TL 1 RR024137]; NIH Roadmap for Medical Research; NIH [5T32HD00709436, R01HL093280, DE018825, DE018824]; Danish National Research Foundation [DNRF107]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024137] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018825, R01DE018824] Funding Source: NIH RePORTER	National Center for Research Resources/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Foundation(Danmarks Grundforskningsfond); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the patients and their families, who are the inspiration for this study. We thank S. Kubek and M. Slocum for animal husbandry. We thank U. Mandel, M. Vester-Christensen, T. D. Madsen and S. B. Levery for help with generation of polyclonal antibodies, recombinant GALNT enzymes, in vitro glycosylation experiments and mass spectrometry. Thanks to the Center for Cellular and Molecular Imaging at Yale for assistance with SEM/TEM (C. Rahner and M. Graham) and confocal imaging. Thanks to C. Kintner and Z. Sun for reagents. Thanks to R. Harland, K. Liem, R. Lifton, J. McGrath, A. Horwich and Z. Sun for critical reading of the manuscript. M. T. B. was supported by grant number TL 1 RR024137 from the National Center for Research Resources/National Institutes of Health (NIH) and NIH Roadmap for Medical Research. S.Y. was supported by NIH training grant 5T32HD00709436. This work was supported by NIH R01HL093280 to M. B. and NIH DE018825, DE018824 to M. K. K., and the Danish National Research Foundation (DNRF107) to H.C.	Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bisgrove BW, 2012, DEV BIOL, V363, P166, DOI 10.1016/j.ydbio.2011.12.030; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chung MI, 2012, DEV BIOL, V363, P155, DOI 10.1016/j.ydbio.2011.12.029; Deblandre GA, 1999, DEVELOPMENT, V126, P4715; del Viso Florencia, 2012, Methods Mol Biol, V917, P33, DOI 10.1007/978-1-61779-992-1_3; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Kato Y, 2011, CELL MOL LIFE SCI, V68, P2555, DOI 10.1007/s00018-011-0695-5; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Rana NA, 2011, CURR OPIN STRUC BIOL, V21, P583, DOI 10.1016/j.sbi.2011.08.008; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Sutherland MJ, 2009, AM J MED GENET C, V151C, P307, DOI 10.1002/ajmg.c.30228; Vick P, 2009, DEV BIOL, V331, P281, DOI 10.1016/j.ydbio.2009.05.547; Vonica A, 2007, DEV BIOL, V303, P281, DOI 10.1016/j.ydbio.2006.09.039; Walentek P, 2012, CELL REP, V1, P516, DOI 10.1016/j.celrep.2012.03.005; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	40	116	125	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					456	+		10.1038/nature12723	http://dx.doi.org/10.1038/nature12723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24226769	Green Accepted			2022-12-28	WOS:000328575300056
J	Haibe-Kains, B; El-Hachem, N; Birkbak, NJ; Jin, AC; Beck, AH; Aerts, HJWL; Quackenbush, J				Haibe-Kains, Benjamin; El-Hachem, Nehme; Birkbak, Nicolai Juul; Jin, Andrew C.; Beck, Andrew H.; Aerts, Hugo J. W. L.; Quackenbush, John			Inconsistency in large pharmacogenomic studies	NATURE			English	Article							DRUG; SET	Two large-scale pharmacogenomic studies were published recently in this journal. Genomic data are well correlated between studies; however, the measured drug response data are highly discordant. Although the source of inconsistencies remains uncertain, it has potential implications for using these outcome measures to assess gene-drug associations or select potential anticancer drugs on the basis of their reported results.	[Haibe-Kains, Benjamin; El-Hachem, Nehme] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada; [Haibe-Kains, Benjamin] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Birkbak, Nicolai Juul] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Jin, Andrew C.; Beck, Andrew H.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Jin, Andrew C.; Beck, Andrew H.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Aerts, Hugo J. W. L.; Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Aerts, Hugo J. W. L.; Quackenbush, John] Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02215 USA; [Aerts, Hugo J. W. L.] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol & Radiol,Med Sch, Boston, MA 02215 USA; [Aerts, Hugo J. W. L.] Maastricht Univ, Dept Radiat Oncol, NL-6200 MD Maastricht, Netherlands; [Quackenbush, John] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Technical University of Denmark; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Maastricht University; Harvard University; Dana-Farber Cancer Institute	Haibe-Kains, B (corresponding author), Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada.	bhaibeka@uhnresearch.ca	Haibe-Kains, Benjamin/D-3702-2011; Aerts, Hugo/ABF-2821-2020; Aerts, Hugo/P-6350-2015	Haibe-Kains, Benjamin/0000-0002-7684-0079; Aerts, Hugo/0000-0002-2122-2003; Aerts, Hugo/0000-0002-2122-2003; Birkbak, Nicolai/0000-0003-1613-9587; El-Hachem, Nehme/0000-0002-5778-5342; Quackenbush, John/0000-0002-2702-5879	IRCM; Klarman Family Foundation; NIH [CA087969]; Villum Kann Rasmussen Foundation; Dr Miriam and Sheldon G. Adelson Medical Research Foundation; NCI GAME-ON Cancer Post-GWAS initiative [U19 CA148065-01]; NATIONAL CANCER INSTITUTE [U19CA148065, P01CA087969] Funding Source: NIH RePORTER	IRCM; Klarman Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Villum Kann Rasmussen Foundation(Villum Fonden); Dr Miriam and Sheldon G. Adelson Medical Research Foundation; NCI GAME-ON Cancer Post-GWAS initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Archambault for his insightful comments on the comparative study between experimental protocols used in the large pharmacogenomic studies investigated in this work. The authors would like to thank the investigators of the Cancer Genome Project, the Cancer Cell Line Encyclopedia and the GlaxoSmithKline cell line study who have made their invaluable data available to the scientific community. N.E.-H. was supported by an IRCM doctoral fellowship. A. H. B. was supported by an award from the Klarman Family Foundation and by support from NIH grant CA087969. N.J.B. was funded The Villum Kann Rasmussen Foundation. J. Q. was supported grants from the Dr Miriam and Sheldon G. Adelson Medical Research Foundation and from the NCI GAME-ON Cancer Post-GWAS initiative (U19 CA148065-01).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barretina J, 2012, NATURE, V492, P290, DOI 10.1038/nature11735; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Papillon-Cavanagh S, 2013, J AM MED INFORM ASSN, V20, P597, DOI 10.1136/amiajnl-2012-001442; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sim J, 2005, PHYS THER, V85, P257; Spearman C, 2010, INT J EPIDEMIOL, V39, P1137, DOI 10.1093/ije/dyq191; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Weinstein JN, 2012, NATURE, V483, P544, DOI 10.1038/483544a; Yamori T, 2003, CANCER CHEMOTH PHARM, V52, pS74, DOI 10.1007/s00280-003-0649-1	18	337	340	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					389	+		10.1038/nature12831	http://dx.doi.org/10.1038/nature12831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24284626	Green Accepted			2022-12-28	WOS:000328575300042
J	Alfandre, D; Schumann, JH				Alfandre, David; Schumann, John Henning			What Is Wrong With Discharges Against Medical Advice (and How to Fix Them)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Alfandre, David] NYU, Sch Med, VA Natl Ctr Eth Hlth Care, New York, NY 10010 USA; [Schumann, John Henning] Univ Oklahoma, Sch Community Med, Dept Internal Med, Tulsa, OK USA	New York University; University of Oklahoma System; University of Oklahoma - Tulsa	Alfandre, D (corresponding author), NYU, Sch Med, VA Natl Ctr Eth Hlth Care, 423 E 23rd St,10P6, New York, NY 10010 USA.	david.alfandre@va.gov		Alfandre, David/0000-0001-9778-7580				Alfandre D, 2013, J GEN INTERN MED, V28, P1657, DOI 10.1007/s11606-013-2540-z; BECKMAN HB, 1994, ARCH INTERN MED, V154, P1365, DOI 10.1001/archinte.154.12.1365; Devitt PJ, 2000, J FAM PRACTICE, V49, P224; Fiscella K, 2007, AM J MED, V120, P1047, DOI 10.1016/j.amjmed.2007.08.024; Glasgow JM, 2010, J GEN INTERN MED, V25, P926, DOI 10.1007/s11606-010-1371-4; Schaefer GR, 2012, J GEN INTERN MED, V27, P825, DOI 10.1007/s11606-012-1984-x; Schumann J., 2012, CAN IGNORING MED ADV	7	19	19	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2393	2394		10.1001/jama.2013.280887	http://dx.doi.org/10.1001/jama.2013.280887			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24216713				2022-12-28	WOS:000328030900014
J	Santoso, A; McGregor, S; Jin, FF; Cai, WJ; England, MH; An, SI; McPhaden, MJ; Guilyardi, E				Santoso, Agus; McGregor, Shayne; Jin, Fei-Fei; Cai, Wenju; England, Matthew H.; An, Soon-Il; McPhaden, Michael J.; Guilyardi, Eric			Late-twentieth-century emergence of the El Nino propagation asymmetry and future projections	NATURE			English	Article							TROPICAL PACIFIC; SURFACE-TEMPERATURE; ENSO DYNAMICS; OCEAN; FEEDBACK; OSCILLATION; IMPACT	The El Nino/Southern Oscillation (ENSO) is the Earth's most prominent source of interannual climate variability, exerting profound worldwide effects(1-7). Despite decades of research, its behaviour continues to challenge scientists. In the eastern equatorial Pacific Ocean, the anomalously cool sea surface temperatures (SSTs) found during La Nina events and the warm waters of modest El Nino events both propagate westwards, as in the seasonal cycle(7). In contrast, SST anomalies propagate eastwards during extreme El Nino events, prominently in the post-1976 period(7-10), spurring unusual weather events worldwide with costly consequences(3-6,11). The cause of this propagation asymmetry is currently unknown(10). Here we trace the cause of the asymmetry to the variations in upper ocean currents in the equatorial Pacific, whereby the westward-flowing currents are enhanced during La Nina events but reversed during extreme El Nino events. Our results highlight that propagation asymmetry is favoured when the westward mean equatorial currents weaken, as is projected to be the case under global warming(12-14). By analysing past and future climate simulations of an ensemble of models with more realistic propagation, we find a doubling in the occurrences of El Nino events that feature prominent eastward propagation characteristics in a warmer world. Our analysis thus suggests that more frequent emergence of propagation asymmetry will be an indication of the Earth's warming climate.	[Santoso, Agus; McGregor, Shayne; England, Matthew H.] Univ New S Wales, Australian Res Council ARC Ctr Excellence Climate, Sydney, NSW 2052, Australia; [Santoso, Agus; McGregor, Shayne; England, Matthew H.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Jin, Fei-Fei] Univ Hawaii Manoa, SOEST, Dept Meteorol, Honolulu, HI 96822 USA; [Cai, Wenju] CSIRO, Marine & Atmospher Res, Aspendale, Vic 3195, Australia; [An, Soon-Il] Yonsei Univ, Dept Atmospher Sci, Seoul 120749, South Korea; [McPhaden, Michael J.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Guilyardi, Eric] Univ Paris 06, CNRS, IPSL, Lab Oceanog & Climat Experimentat & Approches Num, F-75252 Paris 05, France; [Guilyardi, Eric] Univ Reading, Dept Meteorol, Natl Ctr Atmospher Sci NCAS Climate, Reading RG6 6BB, Berks, England	University of New South Wales Sydney; University of New South Wales Sydney; University of Hawaii System; University of Hawaii Manoa; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Yonsei University; National Oceanic Atmospheric Admin (NOAA) - USA; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Reading	Santoso, A (corresponding author), Univ New S Wales, Australian Res Council ARC Ctr Excellence Climate, Level 4 Mathews Bldg, Sydney, NSW 2052, Australia.	a.santoso@unsw.edu.au	Santoso, Agus/P-1918-2019; England, Matthew H/A-7539-2011; McPhaden, Michael J/D-9799-2016; AN, SOON-IL/CWF-6596-2022; Cai, Wenju/C-2864-2012; Santoso, Agus/J-7350-2012; Guilyardi, Eric/D-4868-2011	Santoso, Agus/0000-0001-7749-8124; England, Matthew H/0000-0001-9696-2930; McPhaden, Michael J/0000-0002-8423-5805; Cai, Wenju/0000-0001-6520-0829; Santoso, Agus/0000-0001-7749-8124; Guilyardi, Eric/0000-0002-2255-8625; McGregor, Shayne/0000-0003-3222-7042	Australian Research Council; Australian Climate Change Science Programme; National Research Foundation of Korea; Korean government (MEST) [NRF-2009-C1AAA001-2009-0093042]; NOAA; Natural Environment Research Council [ncas10009] Funding Source: researchfish	Australian Research Council(Australian Research Council); Australian Climate Change Science Programme; National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling and all modelling groups for making the CMIP data available. We thank F. Avila and J. Kajtar for downloading and processing the climate models data sets. A. S., S. M. and M. H. E. are supported by the Australian Research Council. W. C. is supported by the Australian Climate Change Science Programme. S.-I.A. was supported by the National Research Foundation of Korea funded by the Korean government (MEST) (grant number NRF-2009-C1AAA001-2009-0093042). M. J. M. is supported by NOAA. This is PMEL contribution number 3977.	Aiken CM, 2013, GEOPHYS RES LETT, V40, P1612, DOI 10.1002/grl.50264; An SI, 2000, GEOPHYS RES LETT, V27, P2573, DOI 10.1029/1999GL011090; An SI, 1999, J METEOROL SOC JPN, V77, P1151, DOI 10.2151/jmsj1965.77.6_1151; An SI, 2004, J CLIMATE, V17, P2399, DOI 10.1175/1520-0442(2004)017<2399:NAAOE>2.0.CO;2; Balmaseda MA, 2008, MON WEATHER REV, V136, P3018, DOI 10.1175/2008MWR2433.1; Balmaseda MA, 2013, Q J ROY METEOR SOC, V139, P1132, DOI 10.1002/qj.2063; Behringer D. W., 2007, 11 S INT OBS ASS SYS, P1; Bove MC, 1998, B AM METEOROL SOC, V79, P2477, DOI 10.1175/1520-0477(1998)079<2477:EOENOO>2.0.CO;2; Cai WJ, 2012, NATURE, V488, P365, DOI 10.1038/nature11358; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Changnon SA, 1999, B AM METEOROL SOC, V80, P1819, DOI 10.1175/1520-0477(1999)080<1819:IOENOG>2.0.CO;2; Choi J, 2009, J CLIMATE, V22, P6597, DOI 10.1175/2009JCLI2782.1; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; DiNezio PN, 2009, J CLIMATE, V22, P4873, DOI 10.1175/2009JCLI2982.1; Efron B., 1993, INTRO BOOTSTRAP, P168; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Fedorov AV, 2001, J CLIMATE, V14, P3086, DOI 10.1175/1520-0442(2001)014<3086:ASAOTO>2.0.CO;2; Frauen C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044444; Giese BS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006695; GRAHAM NE, 1987, SCIENCE, V238, P657, DOI 10.1126/science.238.4827.657; Guilyardi E, 2006, CLIM DYNAM, V26, P329, DOI 10.1007/s00382-005-0084-6; Jin FF, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016356; JIN FF, 1993, J ATMOS SCI, V50, P3477, DOI 10.1175/1520-0469(1993)050<3477:MOITOI>2.0.CO;2; Kang IS, 2001, J METEOROL SOC JPN, V79, P1, DOI 10.2151/jmsj.79.1; Kim ST, 2011, CLIM DYNAM, V36, P1609, DOI [10.1007/s00382-010-0872-5, 10.1007/s00382-010-0796-0]; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Liang J, 2012, J CLIMATE, V25, P7590, DOI 10.1175/JCLI-D-11-00490.1; Liu ZY, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000172; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; McPhaden MJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038774; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; ROBERTS J, 1978, J GEOPHYS RES-OCEANS, V83, P5510, DOI 10.1029/JC083iC11p05510; Santoso A, 2012, J CLIMATE, V25, P7743, DOI 10.1175/JCLI-D-11-00287.1; Seidel HF, 1999, J GEOPHYS RES-OCEANS, V104, P7849, DOI 10.1029/1999JC900036; Sen Gupta A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051447; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trenberth KE, 2001, J CLIMATE, V14, P1697, DOI 10.1175/1520-0442(2001)014<1697:LIOENO>2.0.CO;2; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Vincent EM, 2011, CLIM DYNAM, V36, P1881, DOI 10.1007/s00382-009-0716-3; Wallace JM, 1998, J GEOPHYS RES-OCEANS, V103, P14241, DOI 10.1029/97JC02905; Wang B, 2002, CLIM DYNAM, V18, P475, DOI [10.1007/s00328-001-0189-5, 10.1007/s00382-001-0189-5]; Wilhite DA, 1987, CLIMATE CRISIS, P75	44	95	96	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					126	+		10.1038/nature12683	http://dx.doi.org/10.1038/nature12683			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24240279	Green Submitted			2022-12-28	WOS:000327851700044
J	Mercer, CH; Tanton, C; Prah, P; Erens, B; Sonnenberg, P; Clifton, S; Macdowall, W; Lewis, R; Field, N; Datta, J; Copas, AJ; Phelps, A; Wellings, K; Johnson, AM				Mercer, Catherine H.; Tanton, Clare; Prah, Philip; Erens, Bob; Sonnenberg, Pam; Clifton, Soazig; Macdowall, Wendy; Lewis, Ruth; Field, Nigel; Datta, Jessica; Copas, Andrew J.; Phelps, Andrew; Wellings, Kaye; Johnson, Anne M.			Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)	LANCET			English	Article							TRANSMITTED INFECTIONS; BEHAVIOR; HEALTH; PREVALENCE; SAMPLE	Background Sexual behaviour and relationships are key components of wellbeing and are affected by social norms, attitudes, and health. We present data on sexual behaviours and attitudes in Britain (England, Scotland, and Wales) from the three National Surveys of Sexual Attitudes and Lifestyles (Natsal). Methods We used a multistage, clustered, and stratified probability sample design. Within each of the 1727 sampled postcode sectors for Natsal-3, 30 or 36 addresses were randomly selected and then assigned to interviewers. To oversample individuals aged 16-34 years, we randomly allocated addresses to either the core sample (in which individuals aged 16-74 years were eligible) or the boost sample (in which only individuals aged 16-34 years were eligible). Interviewers visited all sampled addresses between Sept 6, 2010, and Aug 31, 2012, and randomly selected one eligible individual from each household to be invited to participate. Participants completed the survey in their own homes through computer-assisted face-to-face interviews and self-interview. We analysed data from this survey, weighted to account for unequal selection probabilities and non-response to correct for differences in sex, age group, and region according to 2011 Census figures. We then compared data from participants aged 16-44 years from Natsal-1 (1990-91), Natsal-2 (1999-2001), and Natsal-3. Findings Interviews were completed with 15 162 participants (6293 men, 8869 women) from 26 274 eligible addresses (57.7%). 82.1% (95% CI 81.0-83.1%) of men and 77.7% (76.7-78.7%) of women reported at least one sexual partner of the opposite sex in the past year. The proportion generally decreased with age, as did the range of sexual practices with partners of the opposite sex, especially in women. The increased sexual activity and diversity reported in Natsal-2 in individuals aged 16-44 years when compared with Natsal-1 has generally been sustained in Natsal-3, but in men has generally not risen further. However, in women, the number of male sexual partners over the lifetime (age-adjusted odds ratio 1.18, 95% CI 1.08-1.28), proportion reporting ever having had a sexual experience with genital contact with another woman (1.69, 1.43-2.00), and proportion reporting at least one female sexual partner in the past 5 years (2.00, 1.59-2.51) increased in Natsal-3 compared with Natsal-2. While reported number of occasions of heterosexual intercourse in the past 4 weeks had reduced since Natsal-2, we recorded an expansion of heterosexual repertoires-particularly in oral and anal sex-over time. Acceptance of same-sex partnerships and intolerance of non-exclusivity in marriage increased in men and women in Natsal-3. Interpretation Sexual lifestyles in Britain have changed substantially in the past 60 years, with changes in behaviour seeming greater in women than men. The continuation of sexual activity into later life-albeit reduced in range and frequency-emphasises that attention to sexual health and wellbeing is needed throughout the life course.	[Mercer, Catherine H.; Tanton, Clare; Prah, Philip; Erens, Bob; Sonnenberg, Pam; Clifton, Soazig; Field, Nigel; Copas, Andrew J.; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London WC1E 6JB, England; [Erens, Bob] Univ London London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1E 7HT, England; [Macdowall, Wendy; Lewis, Ruth; Datta, Jessica; Wellings, Kaye] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Clifton, Soazig; Phelps, Andrew] NatCen Social Res, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Mercer, CH (corresponding author), UCL, Res Dept Infect & Populat Hlth, Mortimer Market Ctr, London WC1E 6JB, England.	c.mercer@ucl.ac.uk	Weatherburn, Peter/AAC-2701-2019; Field, Nigel/ABG-3948-2020; Lewis, Ruth/K-2833-2019	Macdowall, Wendy/0000-0001-5868-8336; Erens, Bob/0000-0002-4430-954X; Tanton, Clare/0000-0002-4612-1858; Field, Nigel/0000-0002-2825-6652; Mercer, Catherine/0000-0002-4220-5034; Copas, Andrew/0000-0001-8968-5963; Prah, Philip/0000-0002-4742-9686; Lewis, Ruth/0000-0002-6768-6188; Johnson, Anne/0000-0003-1330-7100; Clifton, Soazig/0000-0002-4171-0805; Erens, Robert/0000-0002-3054-504X; Sonnenberg, Pam/0000-0002-1067-1583	UK Medical Research Council; Wellcome Trust; Economic and Social Research Council; Department of Health; MRC [G0701757] Funding Source: UKRI; Medical Research Council [G0701757] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10244, CL-2010-18-010] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Grants from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Social Research Council and the Department of Health.	American Association for Public Opinion Research (AAPOR), 2016, STAND DEF FIN DISP C; [Anonymous], 2001, STRAT FRAM PROM SEX; Bajos N, 2010, AIDS, V24, P1185, DOI 10.1097/QAD.0b013e328336ad52; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Betts P, 2010, APPL ALTERNATIVE MOD; Bouman WP, 2001, INT J GERIATR PSYCH, V16, P27, DOI 10.1002/1099-1166(200101)16:1<27::AID-GPS267>3.3.CO;2-J; Chandra A, 2011, SEXUAL BEHAV SEXUAL; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Copas AJ, 2002, SEX TRANSM INFECT, V78, P26, DOI 10.1136/sti.78.1.26; Craig R, 2011, HLTH SURVEY ENGLAND; Erens B, 3 NATL SURVEY SEXUAL; Erens B, 2001, NATL SURVEY SEXUAL A; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Fenton KA, 2005, LANCET, V365, P1246, DOI 10.1016/S0140-6736(05)74813-3; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Field N, 2013, LANCET, V382, P1830, DOI 10.1016/S0140-6736(13)62222-9; Fitzpatrick TR, 2000, EDUC GERONTOL, V26, P427, DOI 10.1080/03601270050111850; General Register Office for Scotland, 2011, 2011 CENS; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Gott M, 2003, SOC SCI MED, V56, P1617, DOI 10.1016/S0277-9536(02)00180-6; Gray M., 2009, NATL SURVEY SEXUAL A; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Johnson AM, 2001, AIDS, V15, P111, DOI 10.1097/00002030-200101050-00016; Johnson AM, 1994, NATL SURVEY SEXUAL A; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Nicoll A, 2001, SEX TRANSM INFECT, V77, P242, DOI 10.1136/sti.77.4.242; Office for National Statistics, 2012, STAT B FAM HOUS 2012; Office for National Statistics, CENS DAT; Office for National Statistics, 2010, STAND OCC CLASS 2010, V1-3; Park A, 2012, BRIT SOCIAL ATTITUDE; Payne R. A., 2012, Health Statistics Quarterly, P22; Prah P, 2014, SEX TRANSM INFECT, V90, P90, DOI 10.1136/sextrans-2013-051360; Public Health England, 2013, SEX TRANSM INF CHLAM; Scottish Government, 2005, RESP RESP STRAT ACT; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P106, DOI 10.1111/j.1467-842X.2003.tb00797.x; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Turner KME, 2006, SEX TRANSM INFECT, V82, P496, DOI 10.1136/sti.2005.019067; UK Department of Health, 2013, FRAM SEX HLTH IMPR E; UK Department of Health, 2010, NAT STRAT SEX HLTH H; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4; WELLINGS K, 1990, NATURE, V348, P276, DOI 10.1038/348276a0; Wellings K, 1994, SEXUAL BEHAV BRITAIN; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; World Health Organization, 2006, DEF SEX HLTH REP TEC	46	491	491	2	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1781	1794		10.1016/S0140-6736(13)62035-8	http://dx.doi.org/10.1016/S0140-6736(13)62035-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24286784	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000327540700023
J	Liu, JF; Bregman, JN; Bai, Y; Justham, S; Crowther, P				Liu, Ji-Feng; Bregman, Joel N.; Bai, Yu; Justham, Stephen; Crowther, Paul			Puzzling accretion onto a black hole in the ultraluminous X-ray source M 101 ULX-1	NATURE			English	Article							MASS; M101; METALLICITY; CONSTRAINTS; ABUNDANCE; EMISSION; BINARIES; SYSTEMS; CHANDRA; STARS	There are two proposed explanations for ultraluminous X-ray sources(1,2) (ULXs) with luminosities in excess of 10(39) erg s(-1). They could be intermediate-mass black holes (more than 100-1,000 solar masses, M-circle dot) radiating at sub-maximal (sub-Eddington) rates, as in Galactic black-hole X-ray binaries but with larger, cooler accretion disks(3-5). Alternatively, they could be stellar-mass black holes radiating at Eddington or super-Eddington rates(2,6). On its discovery, M 101 ULX-1(4,7) had a luminosity of 3 x 10(39) erg s(-1) and a supersoft thermal disk spectrum with an exceptionally low temperature-uncomplicated by photons energized by a corona of hot electrons-more consistent with the expected appearance of an accreting intermediate-mass black hole(3,4). Here we report optical spectroscopic monitoring of M 101 ULX-1. We confirm the previous suggestion(8) that the system contains a Wolf-Rayet star, and reveal that the orbital period is 8.2 days. The black hole has a minimum mass of 5 M-circle dot, and more probably a mass of 20 M-circle dot-30 M-circle dot, but we argue that it is very unlikely to be an intermediate-mass black hole. Therefore, its exceptionally soft spectra at high Eddington ratios violate the expectations for accretion onto stellar-mass black holes(9-11). Accretion must occur from captured stellar wind, which has hitherto been thought to be so inefficient that it could not power an ultraluminous source(12,13).	[Liu, Ji-Feng; Bai, Yu; Justham, Stephen] Chinese Acad Sci, Natl Astron Observ, Key Lab Opt Astron, Beijing 100012, Peoples R China; [Bregman, Joel N.] Univ Michigan, Dept Astron, Ann Arbor, MI 48105 USA; [Crowther, Paul] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England	Chinese Academy of Sciences; National Astronomical Observatory, CAS; University of Michigan System; University of Michigan; University of Sheffield	Liu, JF (corresponding author), Chinese Acad Sci, Natl Astron Observ, Key Lab Opt Astron, 20A Datun Rd, Beijing 100012, Peoples R China.	jfliu@nao.cas.cn	Bai, Yu/E-2902-2016	Bai, Yu/0000-0002-4740-3857; Bregman, Joel/0000-0001-6276-9526; Crowther, Paul/0000-0001-6000-6920	NASA [PF6-70043]; Chinese Academy of Sciences [KJCX2-EW-T01]; National Science Foundation of China [NSFC-11273028, NSFC-11333004]; STFC [ST/J001589/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001589/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank J. McClintock, R. Di Stefano, Q.-Z. Liu, X.-D. Li, F. Yuan and S.-N. Zhang for discussions. J.-F.L. acknowledges support for this work provided by NASA through the Chandra Fellowship Program (grant PF6-70043), support from the Chinese Academy of Sciences through grant KJCX2-EW-T01 and support by the National Science Foundation of China through grants NSFC-11273028 and NSFC-11333004. The paper is based on observations obtained at the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the NSF on behalf of the Gemini partnership: the National Science Foundation (United States), the National Research Council (Canada), CONICYT (Chile), the Australian Research Council (Australia), Ministerio da Ciencia, Tecnologia e Inovacao (Brazil) and Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina).	Barnard R, 2008, ASTRON ASTROPHYS, V488, P697, DOI 10.1051/0004-6361:20077975; Belczynski K, 2010, ASTROPHYS J, V714, P1217, DOI 10.1088/0004-637X/714/2/1217; Blecha L, 2006, ASTROPHYS J, V642, P427, DOI 10.1086/500727; Bresolin F, 2007, ASTROPHYS J, V656, P186, DOI 10.1086/510380; Carpano S, 2007, ASTRON ASTROPHYS, V466, pL17, DOI 10.1051/0004-6361:20077363; Crowther PA, 2010, MON NOT R ASTRON SOC, V403, pL41, DOI 10.1111/j.1745-3933.2010.00811.x; Crowther PA, 2006, ASTRON ASTROPHYS, V449, P711, DOI 10.1051/0004-6361:20054298; Crowther PA, 2007, ANNU REV ASTRON ASTR, V45, P177, DOI 10.1146/annurev.astro.45.051806.110615; Cseh D, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/1/L5; Ergma E, 1998, ASTRON ASTROPHYS, V333, P151; Esin AA, 1997, ASTROPHYS J, V489, P865, DOI 10.1086/304829; Fabbiano G, 2005, SCIENCE, V307, P533, DOI 10.1126/science.1107110; Frank J., 2002, ACCRETION POWER ASTR, V3rd; Freedman WL, 2001, ASTROPHYS J, V553, P47, DOI 10.1086/320638; Girardi L, 2002, ASTRON ASTROPHYS, V391, P195, DOI 10.1051/0004-6361:20020612; Gladstone J., 2013, PREPRINT; Gladstone JC, 2009, MON NOT R ASTRON SOC, V397, P1836, DOI 10.1111/j.1365-2966.2009.15123.x; HAMANN WR, 1993, ASTRON ASTROPHYS, V274, P397; Hillier DJ, 1998, ASTROPHYS J, V496, P407, DOI 10.1086/305350; ILLARIONOV AF, 1975, ASTRON ASTROPHYS, V39, P185; Kong A. K. H., 2005, P 22 TEX S REL ASTR, P606; Kong AKH, 2005, ASTROPHYS J, V632, pL107, DOI 10.1086/498020; Kong AKH, 2004, ASTROPHYS J, V617, pL49, DOI 10.1086/427025; Kuntz KD, 2005, ASTROPHYS J, V620, pL31, DOI 10.1086/428571; Linden T, 2010, ASTROPHYS J, V725, P1984, DOI 10.1088/0004-637X/725/2/1984; Liu J, 2008, ASTROPHYS J LETT, V674, pL73, DOI 10.1086/529071; Liu JF, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/89; Liu JF, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/1/10; Liu JF, 2009, ASTROPHYS J, V704, P1628, DOI 10.1088/0004-637X/704/2/1628; Madhusudhan N, 2006, ASTROPHYS J, V640, P918, DOI 10.1086/500238; McClintock J.E., 2006, BLACK HOLE BINARIES, V39, P157; Middleton MJ, 2013, NATURE, V493, P187, DOI 10.1038/nature11697; Miller JM, 2004, ASTROPHYS J, V614, pL117, DOI 10.1086/425316; Miller MC, 2002, MON NOT R ASTRON SOC, V330, P232, DOI 10.1046/j.1365-8711.2002.05112.x; Mohamed S, 2012, BALT ASTRON, V21, P88; Mukai K, 2005, ASTROPHYS J, V634, P1085, DOI 10.1086/497110; Osterbrock D. E., 2006, ASTROPHYSICS GASEOUS; Pettini M, 2004, MON NOT R ASTRON SOC, V348, pL59, DOI 10.1111/j.1365-2966.2004.07591.x; Prestwich AH, 2007, ASTROPHYS J, V669, P21; Rappaport SA, 2005, MON NOT R ASTRON SOC, V356, P401, DOI 10.1111/j.1365-2966.2004.08489.x; Roberts TP, 2011, ASTRON NACHR, V332, P398, DOI 10.1002/asna.201011508; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Silverman JM, 2008, ASTROPHYS J LETT, V678, pL17, DOI 10.1086/588096; Smith LF, 1996, MON NOT R ASTRON SOC, V281, P163, DOI 10.1093/mnras/281.1.163; Steiner JF, 2009, ASTROPHYS J LETT, V701, pL83, DOI 10.1088/0004-637X/701/2/L83; Zwart SFP, 2004, NATURE, V428, P724, DOI 10.1038/nature02448	48	130	133	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					500	+		10.1038/nature12762	http://dx.doi.org/10.1038/nature12762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24284727	Green Submitted			2022-12-28	WOS:000327464200037
J	Aljoudi, AS				Aljoudi, Abdullah S.			A University of the Hajj?	LANCET			English	Editorial Material									Univ Dammam, Dept Family & Community Med, Al Khobar 31952, Saudi Arabia	Imam Abdulrahman Bin Faisal University	Aljoudi, AS (corresponding author), Univ Dammam, Dept Family & Community Med, POB 31987, Al Khobar 31952, Saudi Arabia.	draljoudi@yahoo.com						Ahmed QA, 2013, LANCET, V381, P1521, DOI 10.1016/S0140-6736(13)60764-3; Alamro N., 2013, AL WATAN        1010; AlGahtani YM, 1995, EPIDEMIOL INFECT, V115, P399, DOI 10.1017/S0950268800058556; Ghafour A., 2013, ARAB NEWS       1001; Guilera J-F, 2002, EMERG INFECT DIS, V8, P753; Kickbusch I, 2007, B WORLD HEALTH ORGAN, V85, P230, DOI 10.2471/BLT.06.039222; Memish ZA, 2012, LANCET INFECT DIS, V12, P56, DOI 10.1016/S1473-3099(11)70337-1	7	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1689	1689		10.1016/S0140-6736(13)62340-5	http://dx.doi.org/10.1016/S0140-6736(13)62340-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259PX	24267989	Bronze, Green Published			2022-12-28	WOS:000327539900010
J	Das, P; Horton, R				Das, Pamela; Horton, Richard			Bangladesh: innovating for health	LANCET			English	Editorial Material									[Das, Pamela; Horton, Richard] The Lancet, London NW1 7BY, England		Das, P (corresponding author), The Lancet, London NW1 7BY, England.							Adams AM, 2013, LANCET; Ahmed SM, 2013, LANCET; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Cash RA, 2013, LANCET; Chowdhury AMR, 2013, LANCET; El Arifeen S, 2013, LANCET	6	15	15	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1681	1682		10.1016/S0140-6736(13)62294-1	http://dx.doi.org/10.1016/S0140-6736(13)62294-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259PX	24267987				2022-12-28	WOS:000327539900005
J	Powe, CE; Evans, MK; Wenger, J; Zonderman, AB; Berg, AH; Nalls, M; Tamez, H; Zhang, DS; Bhan, I; Karumanchi, SA; Powe, NR; Thadhani, R				Powe, Camille E.; Evans, Michele K.; Wenger, Julia; Zonderman, Alan B.; Berg, Anders H.; Nalls, Michael; Tamez, Hector; Zhang, Dongsheng; Bhan, Ishir; Karumanchi, S. Ananth; Powe, Neil R.; Thadhani, Ravi			Vitamin D-Binding Protein and Vitamin D Status of Black Americans and White Americans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; RANDOMIZED CONTROLLED-TRIAL; D DEFICIENCY; 25-HYDROXYVITAMIN D; HIP-FRACTURES; SERUM 25-HYDROXYVITAMIN-D; PARATHYROID-HORMONE; AFRICAN-AMERICANS; D INSUFFICIENCY; OLDER-ADULTS	BackgroundLow levels of total 25-hydroxyvitamin D are common among black Americans. Vitamin D-binding protein has not been considered in the assessment of vitamin D deficiency. MethodsIn the Healthy Aging in Neighborhoods of Diversity across the Life Span cohort of blacks and whites (2085 participants), we measured levels of total 25-hydroxyvitamin D, vitamin D-binding protein, and parathyroid hormone as well as bone mineral density (BMD). We genotyped study participants for two common polymorphisms in the vitamin D-binding protein gene (rs7041 and rs4588). We estimated levels of bioavailable 25-hydroxyvitamin D in homozygous participants. ResultsMean (SE) levels of both total 25-hydroxyvitamin D and vitamin D-binding protein were lower in blacks than in whites (total 25-hydroxyvitamin D, 15.60.2 ng per milliliter vs. 25.80.4 ng per milliliter, P<0.001; vitamin D-binding protein, 1683 g per milliliter vs. 337 +/- 5 g per milliliter, P<0.001). Genetic polymorphisms independently appeared to explain 79.4% and 9.9% of the variation in levels of vitamin D-binding protein and total 25-hydroxyvitamin D, respectively. BMD was higher in blacks than in whites (1.05 +/- 0.01 g per square centimeter vs. 0.94 +/- 0.01 g per square centimeter, P<0.001). Levels of parathyroid hormone increased with decreasing levels of total or bioavailable 25-hydroxyvitamin D (P<0.001 for both relationships), yet within each quintile of parathyroid hormone concentration, blacks had significantly lower levels of total 25-hydroxyvitamin D than whites. Among homozygous participants, blacks and whites had similar levels of bioavailable 25-hydroxyvitamin D overall (2.9 +/- 0.1 ng per milliliter and 3.1 +/- 0.1 ng per milliliter, respectively; P=0.71) and within quintiles of parathyroid hormone concentration. Conclusions Community-dwelling black Americans, as compared with whites, had low levels of total 25-hydroxyvitamin D and vitamin D-binding protein, resulting in similar concentrations of estimated bioavailable 25-hydroxyvitamin D. Racial differences in the prevalence of common genetic polymorphisms provide a likely explanation for this observation.	[Powe, Camille E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wenger, Julia; Tamez, Hector; Bhan, Ishir; Thadhani, Ravi] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Berg, Anders H.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Berg, Anders H.] Harvard Univ, Sch Med, Boston, MA USA; [Zhang, Dongsheng; Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Zhang, Dongsheng; Karumanchi, S. Ananth] Howard Hughes Med Inst, Boston, MA 02115 USA; [Evans, Michele K.; Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA; [Nalls, Michael] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Powe, Neil R.] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; [Powe, Neil R.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Evans, MK (corresponding author), NIA, NIH, Biomed Res Ctr, 251 Bayview Blvd,Suite 100,Rm 4C-222, Baltimore, MD 21224 USA.	me42v@nih.gov; rthadhani@mgh.harvard.edu	Karumanchi, Subbian Ananth/AAI-1694-2021; Evans, Michele Kim/AAE-4776-2019; Zonderman, Alan B/A-5807-2013	Zonderman, Alan B/0000-0003-3530-2319; Zonderman, Alan B/0000-0002-6523-4778; Evans, Michele/0000-0002-8546-2831	National Institute on Aging; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK094872, R01DK094486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000513] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institute on Aging and others.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Aloia JF, 2005, ARCH INTERN MED, V165, P1618, DOI 10.1001/archinte.165.14.1618; Aloia JF, 2008, AM J CLIN NUTR, V88, p545S, DOI 10.1093/ajcn/88.2.545S; ARNAUD J, 1993, HUM GENET, V92, P183; Bertrand KA, 2012, BRIT J NUTR, V108, P1889, DOI 10.1017/S0007114511007409; BIKLE DD, 1989, ENDOCRINOLOGY, V124, P649, DOI 10.1210/endo-124-2-649; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; BRAUN A, 1992, HUM GENET, V89, P401; Cauley JA, 2005, JAMA-J AM MED ASSOC, V293, P2102, DOI 10.1001/jama.293.17.2102; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; CLEMENS TL, 1982, LANCET, V1, P74; CONSTANS J, 1985, AM J PHYS ANTHROPOL, V68, P107, DOI 10.1002/ajpa.1330680110; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Evans MK, 2010, ETHNIC DIS, V20, P267; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Gutierrez OM, 2011, OSTEOPOROSIS INT, V22, P1745, DOI 10.1007/s00198-010-1383-2; Hannan MT, 2008, J CLIN ENDOCR METAB, V93, P40, DOI 10.1210/jc.2007-1217; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kritchevsky SB, 2012, J CLIN ENDOCR METAB, V97, P4156, DOI 10.1210/jc.2012-1551; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Mitchell DM, 2012, ENDOCR PRACT, V18, P914, DOI 10.4158/EP12072.OR; MORI Y, 1990, J CLIN ENDOCR METAB, V70, P804, DOI 10.1210/jcem-70-3-804; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Rosen CJ, 2012, J CLIN ENDOCR METAB, V97, P1146, DOI 10.1210/jc.2011-2218; Safadi FF, 1999, J CLIN INVEST, V103, P239, DOI 10.1172/JCI5244; Sai AJ, 2011, J CLIN ENDOCR METAB, V96, pE436, DOI 10.1210/jc.2010-1886; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wright NC, 2012, OSTEOPOROSIS INT, V23, P2283, DOI 10.1007/s00198-011-1877-6	41	749	764	4	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					1991	2000		10.1056/NEJMoa1306357	http://dx.doi.org/10.1056/NEJMoa1306357			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256378	Green Accepted			2022-12-28	WOS:000327163000007
J	Silberstein, L; Scadden, DT				Silberstein, Lev; Scadden, David T.			Blood Scent	CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS	Blood cell production is tightly regulated by cell-intrinsic mechanisms and environmental factors. The study by Utpal Banerjee and colleagues and colleagues reveals that, in Drosophila, olfactory signals control hematopoietic progenitor maintenance, thus uncovering a physiological link between sensory perception and hematopoietic response to environmental stress.	[Silberstein, Lev; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Silberstein, Lev; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Silberstein, Lev; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Silberstein, Lev; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	david_scadden@harvard.edu						Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Donne John, 1623, DEVOTIONS EMERGENT O; Epstein JB, 2002, BONE MARROW TRANSPL, V30, P785, DOI 10.1038/sj.bmt.1703716; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Mendez-Ferrer S, 2009, CURR OPIN HEMATOL, V16, P235, DOI 10.1097/MOH.0b013e32832bd0f5; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shim J, 2013, CELL, V155, P1141, DOI 10.1016/j.cell.2013.10.032; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Steidl U, 2004, BLOOD, V104, P81, DOI 10.1182/blood-2004-01-0373	9	0	0	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					981	982		10.1016/j.cell.2013.11.006	http://dx.doi.org/10.1016/j.cell.2013.11.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267883	Bronze			2022-12-28	WOS:000327500600003
J	Barreto, JA; Wang, Y; Dodson, JA; Desai, MM; Sugeng, L; Geirsson, A; Krumholz, HM				Barreto-Filho, Jose Augusto; Wang, Yun; Dodson, John A.; Desai, Mayur M.; Sugeng, Lissa; Geirsson, Arnar; Krumholz, Harlan M.			Trends in Aortic Valve Replacement for Elderly Patients in the United States, 1999-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROFILING HOSPITAL PERFORMANCE; VALVULAR HEART-DISEASE; ACC/AHA 2006 GUIDELINES; ASSOCIATION TASK-FORCE; 30-DAY MORTALITY-RATES; QUALITY-OF-CARE; RACIAL DISPARITIES; MECHANICAL VALVE; SURGERY; MANAGEMENT	IMPORTANCE There is a need to describe contemporary outcomes of surgical aortic valve replacement (AVR) as the population ages and transcatheter options emerge. OBJECTIVE To assess procedure rates and outcomes of surgical AVR over time. DESIGN, SETTING, AND PARTICIPANTS A serial cross-sectional cohort study of 82 755 924 Medicare fee-for-service beneficiaries undergoing AVR in the United States between 1999 and 2011. MAIN OUTCOMES AND MEASURES Procedure rates for surgical AVR alone and with coronary artery bypass graft (CABG) surgery, 30-day and 1-year mortality, and 30-day readmission rates. RESULTS The AVR procedure rate increased by 19 (95% CI, 19-20) procedures per 100 000 person-years over the 12-year period (P<.001), with an age-, sex-, and race-adjusted rate increase of 1.6% (95% CI, 1.0%-1.8%) per year. Mortality decreased at 30 days (absolute decrease, 3.4%; 95% CI, 3.0%-3.8%; adjusted annual decrease, 4.1%; 95% CI, 3.7%-4.4%) per year and at 1 year (absolute decrease, 2.6%; 95% CI, 2.1%-3.2%; adjusted annual decrease, 2.5%; 95% CI, 2.3%-2.8%). Thirty-day all-cause readmission also decreased by 1.1% (95% CI, 0.9%-1.3%) per year. Aortic valve replacement with CABG surgery decreased, women and black patients had lower procedure and higher mortality rates, and mechanical prosethetic implants decreased, but 23.9% of patients 85 years and older continued to receive a mechanical prosthesis in 2011. CONCLUSIONS AND RELEVANCE Between 1999 and 2011, the rate of surgical AVR for elderly patients in the United States increased and outcomes improved substantially. Medicare data preclude the identification of the causes of the findings and the trends in procedure rates and outcomes cannot be causally linked. Nevertheless, the findings may be a useful benchmark for outcomes with surgical AVR for older patients eligible for surgery considering newer transcatheter treatments.	[Barreto-Filho, Jose Augusto] Univ Fed Sergipe, Div Cardiol, Aracaju, Sergipe, Brazil; [Barreto-Filho, Jose Augusto] Clin & Hosp Sao Lucas, Aracaju, Sergipe, Brazil; [Barreto-Filho, Jose Augusto; Wang, Yun; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Wang, Yun] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wang, Yun; Sugeng, Lissa; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Dodson, John A.] Brigham & Womens Hosp, Dept Internal Med, Div Aging, Boston, MA 02115 USA; [Desai, Mayur M.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06510 USA; [Desai, Mayur M.; Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Geirsson, Arnar] Yale Univ, Sch Med, Sect Cardiac Surg, Dept Surg, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA	Universidade Federal de Sergipe; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Harvard University; Brigham & Women's Hospital; Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; Geirsson, Arnar/S-4735-2019	Desai, Mayur/0000-0001-6616-0945; Sugeng, Lissa/0000-0002-5614-691X; Sugeng, Lissa/0000-0001-6406-3690	National Heart, Lung, and Blood Institute [U01HL105270-04]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil) [3436-10-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant U01HL105270-04 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. During the time that this work was conducted, Dr Barreto-Filho was a postdoctoral fellow at Yale University supported by grant 3436-10-1 from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil).	Aoyagi S, 2010, HEART VESSELS, V25, P522, DOI 10.1007/s00380-010-0009-0; Ashikhmina EA, 2011, CIRCULATION, V124, P1070, DOI 10.1161/CIRCULATIONAHA.110.987560; Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259; Barnett SD, 2009, J THORAC CARDIOV SUR, V137, P1422, DOI 10.1016/j.jtcvs.2008.08.071; BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901; Bonow R O, 1998, J Heart Valve Dis, V7, P672; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; Carabello BA, 2009, LANCET, V373, P956, DOI 10.1016/S0140-6736(09)60211-7; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Cohn LH, 2007, CURR OPIN CARDIOL, V22, P92, DOI 10.1097/HCO.0b013e32802086bc; Dunning J, 2011, J THORAC CARDIOV SUR, V142, P776, DOI 10.1016/j.jtcvs.2011.04.048; Edwards FH, 2001, J AM COLL CARDIOL, V37, P885, DOI 10.1016/S0735-1097(00)01202-X; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Goodney PP, 2003, ANN THORAC SURG, V76, P1131, DOI 10.1016/S0003-4975(03)00827-0; Grube E, 2008, CIRC-CARDIOVASC INTE, V1, P167, DOI 10.1161/CIRCINTERVENTIONS.108.819839; HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801; Iung B, 1993, J Heart Valve Dis, V2, P430; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Kaiser Family Foundation, MED ADV 2010 DAT SPO; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kodali SK, 2012, CIRCULATION, V125, P975, DOI 10.1161/CIRCULATIONAHA.111.087965; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Kuller LH, 2005, NEW ENGL J MED, V353, P2081; Langanay T, 2012, ANN THORAC SURG, V93, P70, DOI 10.1016/j.athoracsur.2011.07.033; Lee R, 2011, ANN THORAC SURG, V91, P677, DOI 10.1016/j.athoracsur.2010.11.009; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Supino Phyllis G, 2006, Heart Fail Clin, V2, P379, DOI 10.1016/j.hfc.2006.09.010; Thourani VH, 2008, ANN THORAC SURG, V86, P1458, DOI 10.1016/j.athoracsur.2008.06.036; Tillquist MN, 2011, PATIENT PREFER ADHER, V5, P91, DOI 10.2147/PPA.S16420; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Vaishnava P, 2011, NAT REV CARDIOL, V8, P173, DOI 10.1038/nrcardio.2010.203; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001	42	114	117	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2078	2085		10.1001/jama.2013.282437	http://dx.doi.org/10.1001/jama.2013.282437			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240935	Green Accepted, Bronze			2022-12-28	WOS:000327098900024
J	Deb, S; Wijeysundera, HC; Ko, DT; Tsubota, H; Hill, S; Fremes, SE				Deb, Saswata; Wijeysundera, Harindra C.; Ko, Dennis T.; Tsubota, Hideki; Hill, Samantha; Fremes, Stephen E.			Coronary Artery Bypass Graft Surgery vs Percutaneous Interventions in Coronary Revascularization A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							VENTRICULAR SYSTOLIC DYSFUNCTION; DRUG-ELUTING STENTS; FOLLOW-UP; ECHOCARDIOGRAPHIC HEART; DIABETIC-PATIENTS; TASK-FORCE; DISEASE; OUTCOMES; METAANALYSIS; MORTALITY	IMPORTANCE Ischemic heart disease is the leading cause of death globally. Coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) are the revascularization options for ischemic heart disease. However, the choice of the most appropriate revascularization modality is controversial in some patient subgroups. OBJECTIVE To summarize the current evidence comparing the effectiveness of CABG surgery and PCI in patients with unprotected left main disease (ULMD, in which there is >50% left main coronary stenosis without protective bypass grafts), multivessel coronary artery disease (CAD), diabetes, or left ventricular dysfunction (LVD). EVIDENCE REVIEW A search of OvidSP MEDLINE, EMBASE, and Cochrane databases between January 2007 and June 2013, limited to randomized clinical trials (RCTs) and meta-analysis of trials and/or observational studies comparing CABG surgery with PCI was performed. Bibliographies of relevant studies were also searched. Mortality and major adverse cardiac and cerebrovascular events (MACCE, defined as all-cause mortality, myocardial infarction, stroke, and repeat revascularization) were reported wherever possible. FINDINGS Thirteen RCTs and 5 meta-analyses were included. CABG surgery should be recommended in patients with ULMD, multivessel CAD, or LVD, if the severity of coronary disease is deemed to be complex (SYNTAX >22) due to lower cardiac events associated with CABG surgery. In cases in which coronary disease is less complex (SYNTAX <= 22) and/or the patient is a higher surgical risk, PCI should be considered. For patients with diabetes and multivessel CAD, CABG surgery should be recommended as standard therapy irrespective of the severity of coronary anatomy, given improved long-term survival and lower cardiac events (5-year MACCE, 18.7% for CABG surgery vs 26.6% for PCI; P=.005). Overall, the incidence of repeat revascularization is higher after PCI, whereas stroke is higher after CABG surgery. Current literature emphasizes the importance of a heart-team approach that should consider coronary anatomy, patient characteristics, and local expertise in revascularization options. Literature pertaining to revascularization options in LVD is scarce predominantly due to LVD being an exclusion factor in most studies. CONCLUSIONS AND RELEVANCE Both CABG surgery and PCI are reasonable options for patients with advanced CAD. Patients with diabetes generally have better outcomes with CABG surgery than PCI. In cases of ULMD, multivessel CAD, or LVD, CABG surgery should be favored in patients with complex coronary lesions and anatomy and PCI in less complicated coronary disease or deemed a high surgical risk. A heart-team approach should evaluate coronary disease complexity, patient comorbidities, patient preferences, and local expertise.	[Deb, Saswata; Wijeysundera, Harindra C.; Tsubota, Hideki; Hill, Samantha; Fremes, Stephen E.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol & Cardiac Surg, Toronto, ON, Canada; [Deb, Saswata; Wijeysundera, Harindra C.; Ko, Dennis T.; Fremes, Stephen E.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Wijeysundera, Harindra C.; Ko, Dennis T.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	Fremes, SE (corresponding author), Sunnybrook Hlth Sci Ctr, Div Cardiac Surg, Schulich Heart Ctr, 2075 Bayview Ave,Room H410, Toronto, ON M4N 3M5, Canada.	stephen.fremes@sunnybrook.ca	Fremes, Stephen E/P-7928-2015; Wijeysundera, Harindra/AAA-6058-2020	Fremes, Stephen E/0000-0003-1723-3049; Ko, Dennis/0000-0001-6840-8051; Wijeysundera, Harindra/0000-0001-8464-1080; Tsubota, Hideki/0000-0001-5817-6613	Vanier Canada Graduate Scholarship from the Canadian Institute of Health Research; Heart and Stroke Foundation of Canada; Heart and Stroke Foundation; Ontario Provincial Office; Bernard S. Goldman Chair in Cardiovascular Surgery	Vanier Canada Graduate Scholarship from the Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Ontario Provincial Office; Bernard S. Goldman Chair in Cardiovascular Surgery	This work was supported by the Vanier Canada Graduate Scholarship from the Canadian Institute of Health Research (Dr Deb), the Distinguished Clinician Scientist Award from the Heart and Stroke Foundation of Canada (Dr Wijeysundera), Clinician Scientist Award from the Heart and Stroke Foundation, Ontario Provincial Office (Dr Ko), and the Bernard S. Goldman Chair in Cardiovascular Surgery (Dr Fremes).	Allman KC, 2002, J AM COLL CARDIOL, V39, P1151, DOI 10.1016/S0735-1097(02)01726-6; Aronson D, 2010, REV ENDOCR METAB DIS, V11, P75, DOI 10.1007/s11154-010-9135-3; Bakhai A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004588.pub3; Booth J, 2008, CIRCULATION, V118, P381, DOI 10.1161/CIRCULATIONAHA.107.739144; Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; Cao C, 2013, J THORAC CARDIOV SUR, V145, P738, DOI 10.1016/j.jtcvs.2012.02.004; ClinicalTrials.gov, EXC CLIN TRIAL; Cohn WE, 2010, TEX HEART I J, V37, P328; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; EMOND M, 1994, CIRCULATION, V90, P2645, DOI 10.1161/01.CIR.90.6.2645; Fajadet J, 2012, EUR HEART J, V33, P36, DOI 10.1093/eurheartj/ehr426; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Garner William Lance, 2007, Proc (Bayl Univ Med Cent), V20, P339; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Gheorghiade M, 2006, CIRCULATION, V114, P1202, DOI 10.1161/CIRCULATIONAHA.106.623199; Head SJ, 2013, EUR HEART J, V34, P2510, DOI 10.1093/eurheartj/eht059; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Hobbs FDR, 2007, EUR HEART J, V28, P1128, DOI 10.1093/eurheartj/ehm102; Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669; Iqbal J, 2013, BRIT MED BULL, V106, P193, DOI 10.1093/bmb/ldt009; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kamalesh M, 2013, J AM COLL CARDIOL, V61, P808, DOI 10.1016/j.jacc.2012.11.044; Kappetein AP, 2013, EUR J CARDIO-THORAC, V43, P1006, DOI 10.1093/ejcts/ezt017; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Kirmani BH, 2013, EUR J CARDIOTHORAC S; Konstantinov IE, 1997, ANN THORAC SURG, V64, P1522, DOI 10.1016/S0003-4975(97)00928-4; Kunadian V, 2012, CORONARY ARTERY DIS, V23, P469, DOI 10.1097/MCA.0b013e3283587804; Kunadian V, 2011, EUR J HEART FAIL, V13, P773, DOI 10.1093/eurjhf/hfr037; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Polomsky M, 2012, CIRC J, V76, P784, DOI 10.1253/circj.CJ-12-0111; Rahimtoola SH, 2008, JACC-CARDIOVASC IMAG, V1, P536, DOI 10.1016/j.jcmg.2008.05.009; Roberts CS, 2000, ANN THORAC SURG, V69, P1315, DOI 10.1016/S0003-4975(00)01216-9; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Taggart DP, 2008, J AM COLL CARDIOL, V51, P885, DOI 10.1016/j.jacc.2007.09.067; Takagi H, 2012, INT J CARDIOL, V159, P230, DOI 10.1016/j.ijcard.2012.05.046; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Unger F, 2003, J THORAC CARDIOV SUR, V125, P809, DOI 10.1067/mtc.2003.401; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Zhang F, 2012, DIABETES RES CLIN PR, V97, P178, DOI 10.1016/j.diabres.2012.03.020	46	183	190	2	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2086	2095		10.1001/jama.2013.281718	http://dx.doi.org/10.1001/jama.2013.281718			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240936	Bronze			2022-12-28	WOS:000327098900025
J	Mordwinkin, NM; Lee, AS; Wu, JC				Mordwinkin, Nicholas M.; Lee, Andrew S.; Wu, Joseph C.			Patient-Specific Stem Cells and Cardiovascular Drug Discovery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mordwinkin, Nicholas M.; Lee, Andrew S.; Wu, Joseph C.] Stanford Univ, Stanford Cardiovasc Inst, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Mordwinkin, Nicholas M.; Lee, Andrew S.; Wu, Joseph C.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Wu, JC (corresponding author), Stanford Univ, 265 Campus Dr,Room G1120B, Stanford, CA 94305 USA.	joewu@stanford.edu	Lee, Andrew/GVU-2817-2022; Wu, Joseph/H-1067-2013	Wu, Joseph/0000-0002-6068-8041; Mordwinkin, Nicholas/0000-0002-3019-0170	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393, R01HL113006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009035] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL113006, U01 HL107393] Funding Source: Medline; NIBIB NIH HHS [T32 EB009035] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Abassi YA, 2012, BRIT J PHARMACOL, V165, P1424, DOI 10.1111/j.1476-5381.2011.01623.x; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Ferri N, 2013, PHARMACOL THERAPEUT, V138, P470, DOI 10.1016/j.pharmthera.2013.03.005; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Paul SM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004452; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934	9	30	30	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2039	2040		10.1001/jama.2013.282409	http://dx.doi.org/10.1001/jama.2013.282409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240927	Green Accepted			2022-12-28	WOS:000327098900016
J	Kingsland, JP; Swinyard, PW				Kingsland, James P.; Swinyard, Peter W.			Should general practices open for longer?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kingsland, James P.] Natl Assoc Primary Care, London W1G 9DP, England; [Swinyard, Peter W.] Family Doctor Assoc, Heywood OL10 4NN, England		Kingsland, JP (corresponding author), Natl Assoc Primary Care, London W1G 9DP, England.	james.kingsland@nhs.net; peter.swinyard@nhs.net						Agarwal S, 2012, EMERG MED J, V29, DOI 10.1136/emermed-2011-200585; Chauhan M, 2012, J PUBLIC HEALTH-UK, V34, P584, DOI 10.1093/pubmed/fds024; Commonwealth Fund Commission on a High Performing Health System, 2013, CONFRONTING COSTS ST; Cowling TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066699; Davies P, 2010, BMJ-BRIT MED J, V341, pc6287; DEPARTMENT OF HEALTH, 2000, THE NHS PLAN; Health and Social Care Information Centre, 1995, TRENDS IN CONSULTATI; Ipsos MORI, GP PATIENT SURVEY 20; NHS Employers, THE NEW GMS CONTRACT; Salisbury C, 2007, AN EVALUATION OF ADV; Starfield B, 2009, HUMANIT SOC, V33, P56, DOI DOI 10.1177/016059760903300105	11	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2013	347								f6832	10.1136/bmj.f6832	http://dx.doi.org/10.1136/bmj.f6832			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258JY	24255922				2022-12-28	WOS:000327456700010
J	Bangalore, S; Toklu, B; Amoroso, N; Fusaro, M; Kumar, S; Hannan, EL; Faxon, DP; Feit, F				Bangalore, Sripal; Toklu, Bora; Amoroso, Nicholas; Fusaro, Mario; Kumar, Sunil; Hannan, Edward L.; Faxon, David P.; Feit, Frederick			Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM OUTCOMES; PATIENT-YEARS; FOLLOW-UP; THROMBOSIS; TRIALS; RISK	Objective To compare the efficacy and safety of biodegradable polymer drug eluting stents with those of bare metal stents and durable polymer drug eluting stents. Design Mixed treatment comparison meta-analysis of 258 544 patient years of follow-up from randomized trials. Data sources and study selection PubMed, Embase, and Central were searched for randomized trials comparing any of the Food and Drug Administration approved durable polymer drug eluting stents (sirolimus eluting, paclitaxel eluting, cobalt chromium everolimus eluting, platinum chromium everolimus eluting, zotarolimus eluting-Endeavor, and zotarolimus eluting-Resolute) or biodegradable polymer drug eluting stents, with each other or against bare metal stents. Outcomes Long term efficacy (target vessel revascularization, target lesion revascularization) and safety (death, myocardial infarction, stent thrombosis). Landmark analysis at more than one year was evaluated to assess the potential late benefit of biodegradable polymer drug eluting stents. Results From 126 randomized trials and 258 544 patient years of follow-up, for long term efficacy (target vessel revascularization), biodegradable polymer drug eluting stents were superior to paclitaxel eluting stents (rate ratio 0.66, 95% credibility interval 0.57 to 0.78) and zotarolimus eluting stent-Endeavor (0.69, 0.56 to 0.84) but not to newer generation durable polymer drug eluting stents (for example: 1.03, 0.89 to 1.21 versus cobalt chromium everolimus eluting stents). Similarly, biodegradable polymer drug eluting stents were superior to paclitaxel eluting stents (rate ratio 0.61, 0.37 to 0.89) but inferior to cobalt chromium everolimus eluting stents (2.04, 1.27 to 3.35) for long term safety (definite stent thrombosis). In the landmark analysis after one year, biodegradable polymer drug eluting stents were superior to sirolimus eluting stents for definite stent thrombosis (rate ratio 0.29, 0.10 to 0.82) but were associated with increased mortality compared with cobalt chromium everolimus eluting stents (1.52, 1.02 to 2.22). Overall, among all stent types, the newer generation durable polymer drug eluting stents (zotarolimus eluting stent-Resolute, cobalt chromium everolimus eluting stents, and platinum chromium everolimus eluting stents) were the most efficacious (lowest target vessel revascularization rate) stents, and cobalt chromium everolimus eluting stents were the safest with significant reductions in definite stent thrombosis (rate ratio 0.35, 0.21 to 0.53), myocardial infarction (0.65, 0.55 to 0.75), and death (0.72, 0.58 to 0.90) compared with bare metal stents. Conclusions Biodegradable polymer drug eluting stents are superior to first generation durable polymer drug eluting stents but not to newer generation durable polymer stents in reducing target vessel revascularization. Newer generation durable polymer stents, and especially cobalt chromium everolimus eluting stents, have the best combination of efficacy and safety. The utility of biodegradable polymer stents in the context of excellent clinical outcomes with newer generation durable polymer stents needs to be proven.	[Bangalore, Sripal; Amoroso, Nicholas; Fusaro, Mario; Feit, Frederick] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Toklu, Bora] Virginia Commonwealth Univ, Richmond, VA USA; [Hannan, Edward L.] SUNY Albany, Sch Publ Hlth, Albany, NY USA; [Faxon, David P.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kumar, Sunil] Univ Nebraska, Omaha, NE 68182 USA	New York University; Virginia Commonwealth University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; Brigham & Women's Hospital; University of Nebraska System	Bangalore, S (corresponding author), NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY 10016 USA.	sripalbangalore@gmail.com		Bangalore, Sripal/0000-0001-9485-0652				Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Bradburn M, 1998, STATA TECH B REPRINT, V8, P86; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; De Luca G, 2012, ARCH INTERN MED, V172, P611, DOI 10.1001/archinternmed.2012.758; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Kereiakes DJ, 2012, EUROINTERVENTION, V8, P187, DOI 10.4244/EIJV8I2A32; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Law Mary, 2003, Physical & Occupational Therapy in Pediatrics, V23, P1; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560; Sabate M, 2012, EXAMINATION 2 YEAR P; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Sarno G, 2011, EUR HEART J, V32, P509; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stettler C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1331; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4	27	140	146	1	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2013	347								f6625	10.1136/bmj.f6625	http://dx.doi.org/10.1136/bmj.f6625			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XT	24212107	hybrid, Green Published			2022-12-28	WOS:000326890800003
J	Clawson, GA				Clawson, Gary A.			Fusion for Moving	SCIENCE			English	Editorial Material							CIRCULATING TUMOR-CELLS; MESENCHYMAL TRANSITION		[Clawson, Gary A.] Penn State Univ, Gittlen Canc Res Fdn, Dept Pathol, Hershey, PA 17033 USA; [Clawson, Gary A.] Penn State Univ, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Clawson, GA (corresponding author), Penn State Univ, Gittlen Canc Res Fdn, Dept Pathol, Hershey, PA 17033 USA.	gac4@psu.edu			NCI NIH HHS [CA170121] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA170121] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Clawson GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041052; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Denz A, 2010, J SURG RES, V160, P29, DOI 10.1016/j.jss.2009.03.048; Funamizu N, 2013, INT J CANCER, V132, P785, DOI 10.1002/ijc.27736; Itakura E, 2011, AM J SURG PATHOL, V35, P1657, DOI 10.1097/PAS.0b013e3182322cf7; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Sergeant G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-527; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yuan T, 2013, GENET MOL RES, V12, P6629, DOI [10.4238/2013.January.4.3, 10.4238/2013.Janruary.4.3]	15	31	33	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					699	700		10.1126/science.1244270	http://dx.doi.org/10.1126/science.1244270			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202164				2022-12-28	WOS:000326647600027
J	Mante, V; Sussillo, D; Shenoy, KV; Newsome, WT				Mante, Valerio; Sussillo, David; Shenoy, Krishna V.; Newsome, William T.			Context-dependent computation by recurrent dynamics in prefrontal cortex	NATURE			English	Article							PERCEPTUAL DECISION; PARIETAL CORTEX; AREA MT; ATTENTION; MEMORY; SELECTION; MODEL	Prefrontal cortex is thought to have a fundamental role in flexible, context-dependent behaviour, but the exact nature of the computations underlying this role remains largely unknown. In particular, individual prefrontal neurons often generate remarkably complex responses that defy deep understanding of their contribution to behaviour. Here we study prefrontal cortex activity in macaque monkeys trained to flexibly select and integrate noisy sensory inputs towards a choice. We find that the observed complexity and functional roles of single neurons are readily understood in the framework of a dynamical process unfolding at the level of the population. The population dynamics can be reproduced by a trained recurrent neural network, which suggests a previously unknown mechanism for selection and integration of task-relevant inputs. This mechanism indicates that selection and integration are two aspects of a single dynamical process unfolding within the same prefrontal circuits, and potentially provides a novel, general framework for understanding context-dependent computations.	[Mante, Valerio; Newsome, William T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Mante, Valerio; Shenoy, Krishna V.; Newsome, William T.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Sussillo, David; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Sussillo, David; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Mante, V (corresponding author), Univ Zurich, ETH Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland.	valerio@ini.phys.ethz.ch; sussillo@stanford.edu	Newsome, William T./W-7171-2019	Sussillo, David/0000-0003-1620-1264	HHMI; Air Force Research Laboratory [FA9550-07-1-0537]; NIH Director's Pioneer Award [1DP1OD006409]; DARPA REPAIR [N66001-10-C-2010]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Air Force Research Laboratory; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA REPAIR; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Powell, S. Fong and J. Brown for technical assistance, L. Abbott, for conversations on non-normal dynamics, and L. Stryer, S. Hohl, S. Ganguli, M. Sahani, R. Kiani, C. Moore and T. Bhattacharya for discussions. V. M. and W.T.N. were supported by HHMI and the Air Force Research Laboratory (FA9550-07-1-0537); D. S. and K. V. S. by an NIH Director's Pioneer Award (1DP1OD006409) and DARPA REPAIR (N66001-10-C-2010).	Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Deco G, 2003, EUR J NEUROSCI, V18, P2374, DOI 10.1046/j.1460-9568.2003.02956.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Huk AC, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00086; Katzner S, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.012.2009; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Machens CK, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00126; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Martens J., 2011, P 28 INT C MACH LEAR, P1033; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Roy JE, 2010, J NEUROSCI, V30, P8519, DOI 10.1523/JNEUROSCI.4837-09.2010; Salinas E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-47; Sasaki R, 2009, NEURON, V62, P147, DOI 10.1016/j.neuron.2009.02.019; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; SEJNOWSKI TJ, 1976, BIOL CYBERN, V22, P203, DOI 10.1007/BF00365086; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Sigala N, 2008, P NATL ACAD SCI USA, V105, P11969, DOI 10.1073/pnas.0802569105; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Zenon A, 2012, NATURE, V489, P434, DOI 10.1038/nature11497; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	50	713	715	3	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					78	+		10.1038/nature12742	http://dx.doi.org/10.1038/nature12742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201281	Green Accepted			2022-12-28	WOS:000326585600035
J	Xu, C; Tabebordbar, M; Iovino, S; Ciarlo, C; Liu, JX; Castiglioni, A; Price, E; Liu, M; Barton, ER; Kahn, CR; Wagers, AJ; Zon, LI				Xu, Cong; Tabebordbar, Mohammadsharif; Iovino, Salvatore; Ciarlo, Christie; Liu, Jingxia; Castiglioni, Alessandra; Price, Emily; Liu, Min; Barton, Elisabeth R.; Kahn, C. Ronald; Wagers, Amy J.; Zon, Leonard I.			A Zebrafish Embryo Culture System Defines Factors that Promote Vertebrate Myogenesis across Species	CELL			English	Article							MUSCLE STEM-CELLS; SKELETAL-MUSCLE; SATELLITE CELLS; ADENYLATE-CYCLASE; SELF-RENEWAL; CYCLIC-AMP; EXPRESSION; PATHWAY; PROGENITORS; FORSKOLIN	Ex vivo expansion of satellite cells and directed differentiation of pluripotent cells to mature skeletal muscle have proved difficult challenges for regenerative biology. Using a zebrafish embryo culture system with reporters of early and late skeletal muscle differentiation, we examined the influence of 2,400 chemicals on myogenesis and identified six that expanded muscle progenitors, including three GSK3 beta inhibitors, two calpain inhibitors, and one adenylyl cyclase activator, forskolin. Forskolin also enhanced proliferation of mouse satellite cells in culture and maintained their ability to engraft muscle in vivo. A combination of bFGF, forskolin, and the GSK3 beta inhibitor BIO induced skeletal muscle differentiation in human induced pluripotent stem cells (iPSCs) and produced engraftable myogenic progenitors that contributed to muscle repair in vivo. In summary, these studies reveal functionally conserved pathways regulating myogenesis across species and identify chemical compounds that expand mouse satellite cells and differentiate human iPSCs into engraftable muscle.	[Xu, Cong; Ciarlo, Christie; Liu, Jingxia; Price, Emily; Zon, Leonard I.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Xu, Cong; Ciarlo, Christie; Liu, Jingxia; Price, Emily; Zon, Leonard I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Xu, Cong; Tabebordbar, Mohammadsharif; Ciarlo, Christie; Liu, Jingxia; Castiglioni, Alessandra; Price, Emily; Wagers, Amy J.; Zon, Leonard I.] Harvard Stem Cell Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; [Xu, Cong; Tabebordbar, Mohammadsharif; Iovino, Salvatore; Ciarlo, Christie; Liu, Jingxia; Price, Emily; Kahn, C. Ronald; Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Tabebordbar, Mohammadsharif; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Iovino, Salvatore; Castiglioni, Alessandra; Kahn, C. Ronald; Wagers, Amy J.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Castiglioni, Alessandra] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Liu, Min] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Iovino, Salvatore; Wagers, Amy J.] Harvard Univ, Sch Med, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Vita-Salute San Raffaele University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Harvard Medical School	Wagers, AJ (corresponding author), Harvard Stem Cell Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	amy_wagers@harvard.edu; zon@enders.tch.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Castiglioni, Alessandra/0000-0002-1761-9761; Xu, Cong/0000-0003-3689-5945	NIH [P30DK036836, DP2OD004345, UO1HL100402, DK31036]; HHMI; NIH NIDDK [R24DK092760-03, 5P30 DK49216-19]; NIH NCI [5R01CA103846-10]; NIH NHLBI [5U01HL10001-05]; Novo Nordisk Diabetes Center in Copenhagen; Paul D. Wellstone Muscular Dystrophy Research Center [U54 AR052646]; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE [R01CA103846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R01DK033201, R37DK031036, R24DK092760, P30DK036836, P30DK049216, R01DK055545] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Novo Nordisk Diabetes Center in Copenhagen; Paul D. Wellstone Muscular Dystrophy Research Center; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Schlaeger for helpful discussions; W. Yee of hESC Core Facility at Children's Hospital Boston for screening support; K. Zhu for mouse satellite cell differentiation data analysis; E. Durand for cAMP assay assistance; J. LaVecchio, S. Ionescu, A. Wakabayashi, and G. Buruzula of Joslin's HSCI/DERC Flow Cytometry Core (NIH award P30DK036836); and the HSCRB/HSCI Flow Cytometry Core at Harvard for excellent flow cytometry support. We thank C. Cahill of Joslin's electron microscopy core for help with EM and immune-gold assays, and we thank C. Cowan and L. Daheron of the HSCI iPSC Core Facility for assistance with human iPSC generation. This work was supported by HHMI, NIH NIDDK R24DK092760-03, NIH NIDDK 5P30 DK49216-19, NIH NCI 5R01CA103846-10, and NIH NHLBI 5U01HL10001-05 to L.I.Z.; NIH DP2OD004345 and UO1HL100402 to A. J. W.; NIH DK31036 to C. R. K.; the Novo Nordisk Diabetes Center in Copenhagen to C. R. K.; the Paul D. Wellstone Muscular Dystrophy Research Center (U54 AR052646 to E. R. B.); and the Harvard Stem Cell Institute to A. J. W. A. J. W is an Early Career Scientist of the Howard Hughes Medical Institute. L.I.Z. is an Investigator of the Howard Hughes Medical Institute, a founder and stockholder of Fate, Inc., and a scientific advisor for Stemgent.	Awaya T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051638; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; CARLSEN RC, 1975, J PHYSIOL-LONDON, V247, P343, DOI 10.1113/jphysiol.1975.sp010935; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Fan LC, 2006, METHOD ENZYMOL, V418, P64, DOI 10.1016/S0076-6879(06)18004-0; Fisher ME, 2002, DEVELOPMENT, V129, P1307; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Hinits Y, 2009, DEVELOPMENT, V136, P403, DOI 10.1242/dev.028019; Huang HG, 2012, CELL REP, V2, P695, DOI 10.1016/j.celrep.2012.08.015; Ju BS, 2003, DEV DYNAM, V227, P14, DOI 10.1002/dvdy.10273; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; LEPEUCH CJ, 1979, BIOCHEMISTRY-US, V18, P5267, DOI 10.1021/bi00591a001; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; METZGER H, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1248; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rodriguez G, 2013, J BIOL CHEM, V288, P7137, DOI 10.1074/jbc.M112.408765; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schnapp E, 2009, J CELL SCI, V122, P481, DOI 10.1242/jcs.038356; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Stewart R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024714; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tedesco FS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003541; Thisse B, 2001, ZFIN DIRECT DATA SUB; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yano Y, 2007, ONCOL REP, V18, P441; ZALIN RJ, 1975, EXP CELL RES, V93, P55, DOI 10.1016/0014-4827(75)90422-X; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080	50	112	120	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					909	921		10.1016/j.cell.2013.10.023	http://dx.doi.org/10.1016/j.cell.2013.10.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209627	Green Accepted, Bronze			2022-12-28	WOS:000326934300019
J	Barends, TRM; Foucar, L; Botha, S; Doak, RB; Shoeman, RL; Nass, K; Koglin, JE; Williams, GJ; Boutet, S; Messerschmidt, M; Schlichting, I				Barends, Thomas R. M.; Foucar, Lutz; Botha, Sabine; Doak, R. Bruce; Shoeman, Robert L.; Nass, Karol; Koglin, Jason E.; Williams, Garth J.; Boutet, Sebastien; Messerschmidt, Marc; Schlichting, Ilme			De novo protein crystal structure determination from X-ray free-electron laser data	NATURE			English	Article							SERIAL FEMTOSECOND CRYSTALLOGRAPHY; ROOM-TEMPERATURE; RADIATION-DAMAGE; PHOTOSYSTEM-II; DIFFRACTION; NANOCRYSTALLOGRAPHY; SOFTWARE	The determination of protein crystal structures is hampered by the need for macroscopic crystals. X-ray free-electron lasers (FELs) provide extremely intense pulses of femtosecond duration, which allow data collection from nanometre- to micrometre-sized crystals(1-4) in a 'diffraction-before-destruction' approach. So far, all protein structure determinations carried out using FELs have been based on previous knowledge of related, known structures(1-5). Here we show that X-ray FEL data can be used for de novo protein structure determination, that is, without previous knowledge about the structure. Using the emerging technique of serial femtosecond crystallography(1-4,6), we performed single-wavelength anomalous scattering measurements on microcrystals of the well-established model system lysozyme, in complex with a lanthanide compound. Using Monte-Carlo integration(6,7), we obtained high-quality diffraction intensities from which experimental phases could be determined, resulting in an experimental electron density map good enough for automated building of the protein structure. This demonstrates the feasibility of determining novel protein structures using FELs. We anticipate that serial femtosecond crystallography will become an important tool for the structure determination of proteins that are difficult to crystallize, such as membrane proteins(1,2,8).	[Barends, Thomas R. M.; Foucar, Lutz; Botha, Sabine; Doak, R. Bruce; Shoeman, Robert L.; Nass, Karol; Schlichting, Ilme] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Doak, R. Bruce] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Koglin, Jason E.; Williams, Garth J.; Boutet, Sebastien; Messerschmidt, Marc] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	Max Planck Society; Arizona State University; Arizona State University-Tempe; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Barends, TRM (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany.	thomas.barends@mpimf-heidelberg.mpg.de; ilme.schlichting@mpimf-heidelberg.mpg.de	Messerschmidt, Marc/F-3796-2010; Nass, Karol/K-1970-2012; Schlichting, Ilme/I-1339-2013; Messerschmidt, Marc/Y-8929-2019	Messerschmidt, Marc/0000-0002-8641-3302; Nass, Karol/0000-0001-8843-1566; Messerschmidt, Marc/0000-0002-8641-3302	LCLS Ultrafast Science Instruments (LUSI) project; US Department of Energy, Office of Basic Energy Sciences; Max Planck Society; EU	LCLS Ultrafast Science Instruments (LUSI) project; US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Max Planck Society(Max Planck SocietyFoundation CELLEX); EU(European Commission)	Portions of this research were carried out at the Linac Coherent Light Source, a National User Facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The CXI instrument was funded by the LCLS Ultrafast Science Instruments (LUSI) project funded by the US Department of Energy, Office of Basic Energy Sciences. We acknowledge support from the Max Planck Society and from the EU for an Incoming Scientist Award to R. B. D. We thank the staff at the LCLS for their support and are grateful to S. Pesch and R. van Gessel (Bracco Imaging Konstanz and Singen, Germany) for the gift of the sample of gadoteridol. We thank H. Zimmermann for suggestions, W. Kabsch for discussions and J. Wray for critically reading the manuscript. In addition, we acknowledge L. Hammon and C. Patty for laboratory support, and the MCC staff for the beam they provided. We are indebted to C. Roome and F. Koeck for computing support.	Amann J, 2012, NAT PHOTONICS, V6, P693, DOI [10.1038/nphoton.2012.180, 10.1038/NPHOTON.2012.180]; Banumathi S, 2004, ACTA CRYSTALLOGR D, V60, P1085, DOI 10.1107/S0907444904007917; Barends TRM, 2013, ACTA CRYSTALLOGR D, V69, P838, DOI 10.1107/S0907444913002448; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Foucar L, 2012, COMPUT PHYS COMMUN, V183, P2207, DOI 10.1016/j.cpc.2012.04.023; Girard E, 2002, ACTA CRYSTALLOGR D, V58, P1, DOI 10.1107/S0907444901016444; Johansson LC, 2012, NAT METHODS, V9, P263, DOI [10.1038/NMETH.1867, 10.1038/nmeth.1867]; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kern J, 2012, P NATL ACAD SCI USA, V109, P9721, DOI 10.1073/pnas.1204598109; Kirian RA, 2011, ACTA CRYSTALLOGR A, V67, P131, DOI 10.1107/S0108767310050981; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Panjikar S, 2002, J APPL CRYSTALLOGR, V35, P261, DOI 10.1107/S0021889802002509; Ravelli RBG, 2003, STRUCTURE, V11, P217, DOI 10.1016/S0969-2126(03)00006-6; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sierra RG, 2012, ACTA CRYSTALLOGR D, V68, P1584, DOI 10.1107/S0907444912038152; Son SK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.218102; Spence JCH, 2011, OPT EXPRESS, V19, P2866, DOI 10.1364/OE.19.002866; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weiss MS, 2001, STRUCTURE, V9, P771, DOI 10.1016/S0969-2126(01)00647-5; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312	30	215	221	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					244	+		10.1038/nature12773	http://dx.doi.org/10.1038/nature12773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24270807				2022-12-28	WOS:000329441500044
J	Ackermann, M; Ajello, M; Asano, K; Atwood, WB; Axelsson, M; Baldini, L; Ballet, J; Barbiellini, G; Baring, MG; Bastieri, D; Bechtol, K; Bellazzini, R; Bissaldi, E; Bonamente, E; Bregeon, J; Brigida, M; Bruel, P; Buehler, R; Burgess, JM; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Cecchi, C; Chaplin, V; Charles, E; Chekhtman, A; Cheung, CC; Chiang, J; Chiaro, G; Ciprini, S; Claus, R; Cleveland, W; Cohen-Tanugi, J; Collazzi, A; Cominsky, LR; Connaughton, V; Conrad, J; Cutini, S; D'Ammando, F; de Angelis, A; DeKlotz, M; de Palma, F; Dermer, CD; Desiante, R; Diekmann, A; Di Venere, L; Drell, PS; Drlica-Wagner, A; Favuzzi, C; Fegan, SJ; Ferrara, EC; Finke, J; Fitzpatrick, G; Focke, WB; Franckowiak, A; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gehrels, N; Germani, S; Gibby, M; Giglietto, N; Giles, M; Giordano, F; Giroletti, M; Godfrey, G; Granot, J; Grenier, IA; Grove, JE; Gruber, D; Guiriec, S; Hadasch, D; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Horan, D; Hughes, RE; Inoue, Y; Jogler, T; Johannesson, G; Johnson, WN; Kawano, T; Knodlseder, J; Kocevski, D; Kuss, M; Lande, J; Larsson, S; Latronico, L; Longo, F; Loparco, F; Lovellette, MN; Lubrano, P; Mayer, M; Mazziotta, MN; McEnery, JE; Michelson, PF; Mizuno, T; Moiseev, AA; Monzani, ME; Moretti, E; Morselli, A; Moskalenko, IV; Murgia, S; Nemmen, R; Nuss, E; Ohno, M; Ohsugi, T; Okumura, A; Omodei, N; Orienti, M; Paneque, D; Pelassa, V; Perkins, JS; Pesce-Rollins, M; Petrosian, V; Piron, F; Pivato, G; Porter, TA; Racusin, JL; Raino, S; Rando, R; Razzano, M; Razzaque, S; Reimer, A; Reimer, O; Ritz, S; Roth, M; Ryde, F; Sartori, A; Parkinson, PMS; Scargle, JD; Schulz, A; Sgro, C; Siskind, EJ; Sonbas, E; Spandre, G; Spinelli, P; Tajima, H; Takahashi, H; Thayer, JG; Thayer, JB; Thompson, DJ; Tibaldo, L; Tinivella, M; Torres, DF; Tosti, G; Troja, E; Usher, TL; Vandenbroucke, J; Vasileiou, V; Vianello, G; Vitale, V; Winer, BL; Wood, KS; Yamazaki, R; Younes, G; Yu, HF; Zhu, SJ; Bhat, PN; Briggs, MS; Byrne, D; Foley, S; Goldstein, A; Jenke, P; Kippen, RM; Kouveliotou, C; McBreen, S; Meegan, C; Paciesas, WS; Preece, R; Rau, A; Tierney, D; van der Horst, AJ; von Kienlin, A; Wilson-Hodge, C; Xiong, S; Cusumano, G; La Parola, V; Cummings, JR				Ackermann, M.; Ajello, M.; Asano, K.; Atwood, W. B.; Axelsson, M.; Baldini, L.; Ballet, J.; Barbiellini, G.; Baring, M. G.; Bastieri, D.; Bechtol, K.; Bellazzini, R.; Bissaldi, E.; Bonamente, E.; Bregeon, J.; Brigida, M.; Bruel, P.; Buehler, R.; Burgess, J. Michael; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Cecchi, C.; Chaplin, V.; Charles, E.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Chiaro, G.; Ciprini, S.; Claus, R.; Cleveland, W.; Cohen-Tanugi, J.; Collazzi, A.; Cominsky, L. R.; Connaughton, V.; Conrad, J.; Cutini, S.; D'Ammando, F.; de Angelis, A.; DeKlotz, M.; de Palma, F.; Dermer, C. D.; Desiante, R.; Diekmann, A.; Di Venere, L.; Drell, P. S.; Drlica-Wagner, A.; Favuzzi, C.; Fegan, S. J.; Ferrara, E. C.; Finke, J.; Fitzpatrick, G.; Focke, W. B.; Franckowiak, A.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gehrels, N.; Germani, S.; Gibby, M.; Giglietto, N.; Giles, M.; Giordano, F.; Giroletti, M.; Godfrey, G.; Granot, J.; Grenier, I. A.; Grove, J. E.; Gruber, D.; Guiriec, S.; Hadasch, D.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Horan, D.; Hughes, R. E.; Inoue, Y.; Jogler, T.; Johannesson, G.; Johnson, W. N.; Kawano, T.; Knoedlseder, J.; Kocevski, D.; Kuss, M.; Lande, J.; Larsson, S.; Latronico, L.; Longo, F.; Loparco, F.; Lovellette, M. N.; Lubrano, P.; Mayer, M.; Mazziotta, M. N.; McEnery, J. E.; Michelson, P. F.; Mizuno, T.; Moiseev, A. A.; Monzani, M. E.; Moretti, E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nemmen, R.; Nuss, E.; Ohno, M.; Ohsugi, T.; Okumura, A.; Omodei, N.; Orienti, M.; Paneque, D.; Pelassa, V.; Perkins, J. S.; Pesce-Rollins, M.; Petrosian, V.; Piron, F.; Pivato, G.; Porter, T. A.; Racusin, J. L.; Raino, S.; Rando, R.; Razzano, M.; Razzaque, S.; Reimer, A.; Reimer, O.; Ritz, S.; Roth, M.; Ryde, F.; Sartori, A.; Parkinson, P. M. Saz; Scargle, J. D.; Schulz, A.; Sgro, C.; Siskind, E. J.; Sonbas, E.; Spandre, G.; Spinelli, P.; Tajima, H.; Takahashi, H.; Thayer, J. G.; Thayer, J. B.; Thompson, D. J.; Tibaldo, L.; Tinivella, M.; Torres, D. F.; Tosti, G.; Troja, E.; Usher, T. L.; Vandenbroucke, J.; Vasileiou, V.; Vianello, G.; Vitale, V.; Winer, B. L.; Wood, K. S.; Yamazaki, R.; Younes, G.; Yu, H. -F.; Zhu, S. J.; Bhat, P. N.; Briggs, M. S.; Byrne, D.; Foley, S.; Goldstein, A.; Jenke, P.; Kippen, R. M.; Kouveliotou, C.; McBreen, S.; Meegan, C.; Paciesas, W. S.; Preece, R.; Rau, A.; Tierney, D.; van der Horst, A. J.; von Kienlin, A.; Wilson-Hodge, C.; Xiong, S.; Cusumano, G.; La Parola, V.; Cummings, J. R.			Fermi-LAT Observations of the Gamma-Ray Burst GRB 130427A	SCIENCE			English	Article							LARGE-AREA TELESCOPE; HIGH-ENERGY EMISSION; SPECTRAL COMPONENT; AFTERGLOW; PROMPT	The observations of the exceptionally bright gamma-ray burst (GRB) 130427A by the Large Area Telescope aboard the Fermi Gamma-ray Space Telescope provide constraints on the nature of these unique astrophysical sources. GRB 130427A had the largest fluence, highest-energy photon (95 GeV), longest gamma-ray duration (20 hours), and one of the largest isotropic energy releases ever observed from a GRB. Temporal and spectral analyses of GRB 130427A challenge the widely accepted model that the nonthermal high-energy emission in the afterglow phase of GRBs is synchrotron emission radiated by electrons accelerated at an external shock.	[Ackermann, M.; Buehler, R.; Mayer, M.; Schulz, A.] Deutsch Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany; [Ajello, M.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Asano, K.] Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan; [Atwood, W. B.; Razzano, M.; Ritz, S.; Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Atwood, W. B.; Razzano, M.; Ritz, S.; Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Axelsson, M.; Larsson, S.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Axelsson, M.; Conrad, J.; Larsson, S.; Moretti, E.; Ryde, F.] AlbaNova, Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Axelsson, M.; Moretti, E.; Ryde, F.] AlbaNova, Royal Inst Technol KTH, Dept Phys, SE-10691 Stockholm, Sweden; [Baldini, L.] Univ Pisa, I-56127 Pisa, Italy; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Kuss, M.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.; Tinivella, M.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Grenier, I. A.] Univ Paris Diderot, CEA Saclay, Serv Astrophys, Lab AIM,CEA IRFU CNRS, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Desiante, R.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Baring, M. G.] Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; [Bastieri, D.; Buson, S.; Rando, R.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Chiaro, G.; Pivato, G.; Rando, R.] Univ Padua, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Bechtol, K.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Di Venere, L.; Drell, P. S.; Drlica-Wagner, A.; Focke, W. B.; Franckowiak, A.; Funk, S.; Godfrey, G.; Hayashida, M.; Inoue, Y.; Jogler, T.; Kocevski, D.; Lande, J.; Michelson, P. F.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Okumura, A.; Omodei, N.; Paneque, D.; Petrosian, V.; Porter, T. A.; Reimer, A.; Reimer, O.; Tajima, H.; Thayer, J. G.; Thayer, J. B.; Tibaldo, L.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.] Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Dept Phys, Stanford, CA 94305 USA; [Bechtol, K.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Di Venere, L.; Drell, P. S.; Drlica-Wagner, A.; Focke, W. B.; Franckowiak, A.; Funk, S.; Godfrey, G.; Hayashida, M.; Inoue, Y.; Jogler, T.; Kocevski, D.; Lande, J.; Michelson, P. F.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Okumura, A.; Omodei, N.; Paneque, D.; Petrosian, V.; Porter, T. A.; Reimer, A.; Reimer, O.; Tajima, H.; Thayer, J. G.; Thayer, J. B.; Tibaldo, L.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Bissaldi, E.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Bissaldi, E.] Univ Trieste, I-34127 Trieste, Italy; [Bonamente, E.; Cecchi, C.; Germani, S.; Lubrano, P.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Horan, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Burgess, J. Michael; Chaplin, V.; Connaughton, V.; Pelassa, V.; Bhat, P. N.; Briggs, M. S.; Goldstein, A.; Jenke, P.; Meegan, C.; Preece, R.; Xiong, S.] Univ Alabama, Ctr Space Plasma & Aeronom Res, Huntsville, AL 35899 USA; [Caliandro, G. A.; Hadasch, D.; Torres, D. F.] CSIC, Inst Ciencies Espai IEEE, Barcelona 08193, Spain; [Caraveo, P. A.; Sartori, A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Chekhtman, A.] George Mason Univ, Coll Sci, Ctr Earth Observing & Space Res, Fairfax, VA 22030 USA; [Chekhtman, A.] Naval Res Lab, Washington, DC 20375 USA; [Cheung, C. C.; Dermer, C. D.; Finke, J.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Wood, K. S.] Naval Res Lab, Div Space Sci, Washington, DC 20375 USA; [Ciprini, S.; Cutini, S.] Agenzia Spaziale Italiana Sci Data Ctr, I-00044 Rome, Italy; [Ciprini, S.; Cutini, S.] Osserv Astron Roma, Ist Nazl Astrofis, I-00040 Rome, Italy; [Cleveland, W.; Sonbas, E.; Younes, G.; Paciesas, W. S.] Univ Space Res Assoc, Columbia, MD 21044 USA; [Cohen-Tanugi, J.; Nuss, E.; Piron, F.; Vasileiou, V.] Univ Montpellier 2, CNRS, IN2P3, Lab Univers & Particules Montpellier, Montpellier, France; [Collazzi, A.; Guiriec, S.] NASA, Postdoctoral Program, Washington, DC USA; [Cominsky, L. R.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Conrad, J.; Larsson, S.] Stockholm Univ, AlbaNova, Dept Phys, SE-10691 Stockholm, Sweden; [Conrad, J.] Royal Swedish Acad Sci, SE-10405 Stockholm, Sweden; [D'Ammando, F.; Giroletti, M.; Orienti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [de Angelis, A.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.] Ist Nazl Fis Nucl, Sez Trieste, Grp Collegato Udine, I-33100 Udine, Italy; [DeKlotz, M.] Stellar Solut Inc, Palo Alto, CA 94306 USA; [Diekmann, A.; Gibby, M.; Giles, M.] Jacobs Technol, Huntsville, AL 35806 USA; [Ferrara, E. C.; Gehrels, N.; Guiriec, S.; Harding, A. K.; Hays, E.; McEnery, J. E.; Nemmen, R.; Perkins, J. S.; Racusin, J. L.; Sonbas, E.; Thompson, D. J.; Troja, E.; Cummings, J. R.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Fitzpatrick, G.; Byrne, D.; Foley, S.; McBreen, S.; Tierney, D.] Univ Coll Dublin, Dublin 4, Ireland; [Fukazawa, Y.; Hanabata, Y.; Kawano, T.; Ohno, M.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Granot, J.] Open Univ Israel, Dept Nat Sci, IL-43537 Raanana, Israel; [Gruber, D.; Yu, H. -F.; Foley, S.; McBreen, S.; Rau, A.; von Kienlin, A.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Hayashida, M.] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Hughes, R. E.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Johannesson, G.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Knoedlseder, J.] CNRS, IRAP, F-31028 Toulouse 4, France; [Knoedlseder, J.] Univ Toulouse, UPS OMP, IRAP, GAHEC, Toulouse, France; [Latronico, L.] Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy; [McEnery, J. E.; Moiseev, A. A.; Troja, E.; Zhu, S. J.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [McEnery, J. E.; Moiseev, A. A.; Troja, E.; Zhu, S. J.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Mizuno, T.; Ohsugi, T.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Moiseev, A. A.; Perkins, J. S.] CRESST, Greenbelt, MD 20771 USA; [Moiseev, A. A.; Perkins, J. S.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Okumura, A.; Tajima, H.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Paneque, D.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Perkins, J. S.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Perkins, J. S.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Razzaque, S.] Univ Johannesburg, Dept Phys, ZA-2006 Auckland Pk, South Africa; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Sonbas, E.] Adyaman Univ, TR-02040 Adyaman, Turkey; [Torres, D. F.] ICREA, Barcelona, Spain; [Vianello, G.] CIFS, I-10133 Turin, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Yamazaki, R.] Aoyama Gakuin Univ, Dept Phys & Math, Sagamihara, Kanagawa 2525258, Japan; [Younes, G.; Kouveliotou, C.; Wilson-Hodge, C.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Kippen, R. M.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [van der Horst, A. J.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Cusumano, G.; La Parola, V.] INAF Ist Astrofis Spaziale & Fis Cosm, I-90146 Palermo, Italy; [Cummings, J. R.] Univ Maryland Baltimore Cty, Ctr Res & Explorat Space Sci & Technol, Baltimore, MD 21250 USA	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of California System; University of California Berkeley; University of Tokyo; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Stockholm University; Oskar Klein Centre; Royal Institute of Technology; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Rice University; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Alabama System; University of Alabama Huntsville; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Istituto Nazionale Astrofisica (INAF); George Mason University; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory; Agenzia Spaziale Italiana (ASI); Istituto Nazionale Astrofisica (INAF); Universities Space Research Association (USRA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; National Aeronautics & Space Administration (NASA); California State University System; Sonoma State University; Stockholm University; Royal Swedish Academy of Sciences; Istituto Nazionale Astrofisica (INAF); University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University College Dublin; Hiroshima University; Open University Israel; Max Planck Society; Kyoto University; University System of Ohio; Ohio State University; University of Iceland; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Istituto Nazionale di Fisica Nucleare (INFN); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Hiroshima University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Istituto Nazionale di Fisica Nucleare (INFN); Nagoya University; Max Planck Society; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; University of Johannesburg; University of Innsbruck; University of Innsbruck; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Adiyaman University; ICREA; University of Rome Tor Vergata; Aoyama Gakuin University; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Amsterdam; Istituto Nazionale Astrofisica (INAF); University System of Maryland; University of Maryland Baltimore County	Chiang, J (corresponding author), Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Dept Phys, Stanford, CA 94305 USA.	jchiang@slac.stanford.edu; charles.dermer@nrl.navy.mil; nicola.omodei@stanford.edu; giacomov@slac.stanford.edu; sjzhu@umd.edu; shaolin.xiong@uah.edu	Sgrò, Carmelo/K-3395-2016; Jóhannesson, Guðlaugur/ABC-7216-2020; Giglietto, Nicola/Y-2425-2019; Funk, Stefan/AAI-1568-2021; Gargano, Fabio/AAD-5121-2021; Di Venere, Leonardo/C-7619-2017; Nemmen, Rodrigo/O-6841-2014; Rando, Riccardo/O-1302-2019; Troja, Eleonora/AAB-3604-2020; Torres, Diego F/ABD-7940-2020; Loparco, Francesco/O-8847-2015; Caraveo, Patrizia/AAL-5708-2020; Takahashi, Hiromitsu H/T-2713-2017; Funk, Stefan/B-7629-2015; Troja, Eleonora/I-5282-2017; Sonbas, Eda/AAJ-5517-2021; Bissaldi, Elisabetta/K-7911-2016; Fukazawa, Yasushi/G-2081-2017; Morselli, Aldo/G-6769-2011; Reimer, Anita/K-5822-2015; Johnson, Neil/G-3309-2014; Okumura, Akira/I-2468-2014; Hays, Elizabeth/D-3257-2012; Mazziotta, Mario N/O-8867-2015; Jóhannesson, Guðlaugur/O-8741-2015; Reimer, Olaf/A-3117-2013; Chaplin, Vandiver/AAN-6228-2021; cohen-tanugi, Johann/ABB-1481-2021; Bastieri, Denis/AAC-5917-2020; Ryde, Felix/AAE-1086-2021; Torres, Diego F./O-9422-2016; giglietto, nicola/I-8951-2012; Yu, Hoi-Fung/ABC-8507-2020; Torres, Diego F./AAF-7931-2019; Cutini, Sara/ABB-1787-2020; Gargano, Fabio/O-8934-2015; Moskalenko, Igor V/A-1301-2007; Tajima, Hiroyasu/I-6228-2014; Bissaldi, Elisabetta/AAB-2443-2021; Hadasch, Daniela/N-7819-2016	Jóhannesson, Guðlaugur/0000-0003-1458-7036; Giglietto, Nicola/0000-0002-9021-2888; Funk, Stefan/0000-0002-2012-0080; Gargano, Fabio/0000-0002-5055-6395; Di Venere, Leonardo/0000-0003-0703-824X; Nemmen, Rodrigo/0000-0003-3956-0331; Rando, Riccardo/0000-0001-6992-818X; Troja, Eleonora/0000-0002-1869-7817; Loparco, Francesco/0000-0002-1173-5673; Caraveo, Patrizia/0000-0003-2478-8018; Takahashi, Hiromitsu H/0000-0001-6314-5897; Funk, Stefan/0000-0002-2012-0080; Troja, Eleonora/0000-0002-1869-7817; Bissaldi, Elisabetta/0000-0001-9935-8106; Fukazawa, Yasushi/0000-0002-0921-8837; Morselli, Aldo/0000-0002-7704-9553; Reimer, Anita/0000-0001-8604-7077; Okumura, Akira/0000-0002-3055-7964; Mazziotta, Mario N/0000-0001-9325-4672; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Reimer, Olaf/0000-0001-6953-1385; Chaplin, Vandiver/0000-0002-4074-0391; cohen-tanugi, Johann/0000-0001-9022-4232; Bastieri, Denis/0000-0002-6954-8862; Ryde, Felix/0000-0002-9769-8016; Torres, Diego F./0000-0002-1522-9065; giglietto, nicola/0000-0002-9021-2888; Yu, Hoi-Fung/0000-0001-5643-7445; Torres, Diego F./0000-0002-1522-9065; Cutini, Sara/0000-0002-1271-2924; Gargano, Fabio/0000-0002-5055-6395; Moskalenko, Igor V/0000-0001-6141-458X; Tajima, Hiroyasu/0000-0002-1721-7252; Bissaldi, Elisabetta/0000-0001-9935-8106; Hadasch, Daniela/0000-0001-8663-6461; Raino', Silvia/0000-0002-9181-0345; De Angelis, Alessandro/0000-0002-3288-2517; Razzaque, Soebur/0000-0002-0130-2460; Cameron, Robert/0000-0003-0942-2747; Grenier, Isabelle/0000-0003-3274-674X; Preece, Robert/0000-0003-1626-7335; D'Ammando, Filippo/0000-0001-7618-7527; van der Horst, Alexander/0000-0001-9149-6707; Fusco, Piergiorgio/0000-0002-9383-2425; Ajello, Marco/0000-0002-6584-1703; Porter, Troy/0000-0002-2621-4440; Granot, Jonathan/0000-0001-8530-8941; orienti, monica/0000-0003-4470-7094; Buehler, Rolf/0000-0003-4425-6641; de Palma, Francesco/0000-0001-5898-2834; Baldini, Luca/0000-0002-9785-7726; Sgro', Carmelo/0000-0001-5676-6214; Ackermann, Markus/0000-0001-8952-588X; Omodei, Nicola/0000-0002-5448-7577; Zhu, Sylvia/0000-0002-6468-8292; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Moretti, Elena/0000-0001-5477-9097; Giroletti, Marcello/0000-0002-8657-8852; McBreen, Sheila/0000-0002-1477-618X; Charles, Eric/0000-0002-3925-7802; Giordano, Francesco/0000-0002-8651-2394; Cusumano, Giancarlo/0000-0002-8151-1990; Vianello, Giacomo/0000-0002-2553-0839; Petrosian, Vahe'/0000-0002-2670-8942; Sonbas, Eda/0000-0002-6909-192X; Tibaldo, Luigi/0000-0001-7523-570X; Buson, Sara/0000-0002-3308-324X; La Parola, Valentina/0000-0002-8087-6488; Cheung, Chi (Teddy)/0000-0002-4377-0174; Pesce-Rollins, Melissa/0000-0003-1790-8018; Inoue, Yoshiyuki/0000-0002-7272-1136; Burgess, James/0000-0003-3345-9515; Spandre, Gloria/0000-0003-0802-3453; Larsson, Stefan/0000-0003-0716-107X; Ciprini, Stefano/0000-0002-0712-2479; Cecchi, Claudia/0000-0002-2192-8233	ICREA Funding Source: Custom; Grants-in-Aid for Scientific Research [25800151] Funding Source: KAKEN	ICREA(ICREA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abdo AA, 2009, ASTROPHYS J LETT, V706, pL138, DOI 10.1088/0004-637X/706/1/L138; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; BAND D, 1993, ASTROPHYS J, V413, P281, DOI 10.1086/172995; BLANDFORD RD, 1976, PHYS FLUIDS, V19, P1130, DOI 10.1063/1.861619; Blaufuss E., 2013, 14520 GCN, P14520; Cenko SB, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/29; Dermer CD, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/7/122; Dermer CD, 2000, ASTROPHYS J, V537, P785, DOI 10.1086/309061; Gehrels N, 2013, FRONT PHYS-BEIJING, V8, P661, DOI 10.1007/s11467-013-0282-3; Ghisellini G, 2010, MON NOT R ASTRON SOC, V403, P926, DOI 10.1111/j.1365-2966.2009.16171.x; Giannios D, 2008, ASTRON ASTROPHYS, V480, P305, DOI 10.1051/0004-6361:20079085; Goldstein A, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/1/19; Granot J, 2008, ASTROPHYS J, V677, P92, DOI 10.1086/526414; GUILBERT PW, 1983, MON NOT R ASTRON SOC, V205, P593, DOI 10.1093/mnras/205.3.593; HURLEY K, 1994, NATURE, V372, P652, DOI 10.1038/372652a0; Kumar P, 2009, MON NOT R ASTRON SOC, V400, pL75, DOI 10.1111/j.1745-3933.2009.00766.x; Liu RY, 2013, ASTROPHYS J LETT, V773, DOI 10.1088/2041-8205/773/2/L20; Maselli A, 2014, SCIENCE, V343, P48, DOI 10.1126/science.1242279; Meegan C, 2009, ASTROPHYS J, V702, P791, DOI 10.1088/0004-637X/702/1/791; Murase K, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/2/L16; Perley D., 2013, 14494 GCN; Piran T, 2010, ASTROPHYS J LETT, V718, pL63, DOI 10.1088/2041-8205/718/2/L63; Razzaque S, 2004, ASTROPHYS J, V613, P1072, DOI 10.1086/423166; Sari R, 2001, ASTROPHYS J, V548, P787, DOI 10.1086/319003; Tam PHT, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/1/L13; Vestrand WT, 2014, SCIENCE, V343, P38, DOI 10.1126/science.1242316; von Kienlin A., 2013, 14473 GCN; Wiersema K., 2013, GCN CIRC, P15178; Zhang B, 2001, ASTROPHYS J, V559, P110, DOI 10.1086/322400	30	173	179	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					42	47		10.1126/science.1242353	http://dx.doi.org/10.1126/science.1242353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24263133	Green Submitted, Green Published			2022-12-28	WOS:000329162000042
J	Rubertsson, S; Lindgren, E; Smekal, D; Ostlund, O; Silfverstolpe, J; Lichtveld, RA; Boomars, R; Ahlstedt, B; Skoog, G; Kastberg, R; Halliwell, D; Box, M; Herlitz, J; Karlsten, R				Rubertsson, Sten; Lindgren, Erik; Smekal, David; Ostlund, Ollie; Silfverstolpe, Johan; Lichtveld, Robert A.; Boomars, Rene; Ahlstedt, Bjorn; Skoog, Gunnar; Kastberg, Robert; Halliwell, David; Box, Martyn; Herlitz, Johan; Karlsten, Rolf			Mechanical Chest Compressions and Simultaneous Defibrillation vs Conventional Cardiopulmonary Resuscitation in Out-of-Hospital Cardiac Arrest The LINC Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENTRICULAR-FIBRILLATION; PERFUSION-PRESSURE; BLOOD-FLOW; DEVICE; LUCAS; SURVIVAL; QUALITY	IMPORTANCE A strategy using mechanical chest compressions might improve the poor outcome in out-of-hospital cardiac arrest, but such a strategy has not been tested in large clinical trials. OBJECTIVE To determine whether administering mechanical chest compressions with defibrillation during ongoing compressions (mechanical CPR), compared with manual cardiopulmonary resuscitation (manual CPR), according to guidelines, would improve 4-hour survival. DESIGN, SETTING, AND PARTICIPANTS Multicenter randomized clinical trial of 2589 patients with out-of-hospital cardiac arrest conducted between January 2008 and February 2013 in 4 Swedish, 1 British, and 1 Dutch ambulance services and their referring hospitals. Duration of follow-up was 6 months. INTERVENTIONS Patients were randomized to receive either mechanical chest compressions (LUCAS Chest Compression System, Physio-Control/Jolife AB) combined with defibrillation during ongoing compressions (n = 1300) or to manual CPR according to guidelines (n = 1289). MAIN OUTCOMES AND MEASURES Four-hour survival, with secondary end points of survival up to 6 months with good neurological outcome using the Cerebral Performance Category (CPC) score. A CPC score of 1 or 2 was classified as a good outcome. RESULTS Four-hour survival was achieved in 307 patients (23.6%) with mechanical CPR and 305 (23.7%) with manual CPR (risk difference, -0.05%; 95% CI, -3.3% to 3.2%; P > .99). Survival with a CPC score of 1 or 2 occurred in 98 (7.5%) vs 82 (6.4%) (risk difference, 1.18%; 95% CI, -0.78% to 3.1%) at intensive care unit discharge, in 108 (8.3%) vs 100 (7.8%) (risk difference, 0.55%; 95% CI, -1.5% to 2.6%) at hospital discharge, in 105 (8.1%) vs 94 (7.3%) (risk difference, 0.78%; 95% CI, -1.3% to 2.8%) at 1 month, and in 110 (8.5%) vs 98 (7.6%) (risk difference, 0.86%; 95% CI, -1.2% to 3.0%) at 6 months with mechanical CPR and manual CPR, respectively. Among patients surviving at 6 months, 99% in the mechanical CPR group and 94% in the manual CPR group had CPC scores of 1 or 2. CONCLUSIONS AND RELEVANCE Among adults with out-of-hospital cardiac arrest, there was no significant difference in 4-hour survival between patients treated with the mechanical CPR algorithm or those treated with guideline-adherent manual CPR. The vast majority of survivors in both groups had good neurological outcomes by 6 months. In clinical practice, mechanical CPR using the presented algorithm did not result in improved effectiveness compared with manual CPR.	[Rubertsson, Sten; Lindgren, Erik; Smekal, David; Karlsten, Rolf] Uppsala Univ, Dept Surg Sci Anaesthesiol & Intens Care, SE-75185 Uppsala, Sweden; [Ostlund, Ollie] Uppsala Univ, Uppsala Clin Res Ctr, SE-75185 Uppsala, Sweden; [Silfverstolpe, Johan] Reg Skane Prehosp Ctr, Lund, Sweden; [Silfverstolpe, Johan] Skane Univ Hosp, Lund, Sweden; [Lichtveld, Robert A.; Boomars, Rene] Reg Ambulance Serv Utrecht, Utrecht, Netherlands; [Ahlstedt, Bjorn] Vasteras Hosp, Vasteras, Sweden; [Skoog, Gunnar; Kastberg, Robert] Gavle Cent Hosp, Gavle, Sweden; [Halliwell, David; Box, Martyn] South Western Ambulance Serv NHS Fdn Trust Abbey, Exeter, Devon, England; [Herlitz, Johan] Ctr Prehosp Res Western Sweden, Gothenburg, Sweden; [Herlitz, Johan] Univ Coll Boras, Gothenburg, Sweden; [Herlitz, Johan] Sahlgrens Univ Hosp, Gothenburg, Sweden	Uppsala University; Uppsala University; Lund University; Skane University Hospital; Vasteras Central Hospital; University of Boras; Sahlgrenska University Hospital	Rubertsson, S (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Dept Surg Sci Anaestesiol & Intens Care, SE-75185 Uppsala, Sweden.	sten.rubertsson@akademiska.se	Smekal, David/AAG-5334-2021	Ostlund, Ollie/0000-0001-8028-2308; Smekal, David/0000-0002-3563-6450; Lichtveld, Robert/0000-0002-3957-7056; Karlsten, Rolf/0000-0003-3923-4093	Uppsala University; Physio-Control/Jolife AB	Uppsala University; Physio-Control/Jolife AB	This work was supported by institutional grants from Uppsala University and by Physio-Control/Jolife AB.	Aufderheide TP, 2011, LANCET, V377, P301, DOI 10.1016/S0140-6736(10)62103-4; Axelsson C, 2009, RESUSCITATION, V80, P1099, DOI 10.1016/j.resuscitation.2009.08.006; Axelsson C, 2006, RESUSCITATION, V71, P47, DOI 10.1016/j.resuscitation.2006.02.011; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Eftestol T, 2002, CIRCULATION, V105, P2270, DOI 10.1161/01.CIR.0000016362.42586.FE; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; JENNETT B, 1975, LANCET, V1, P480; Kramer-Johansen J, 2007, RESUSCITATION, V73, P212, DOI 10.1016/j.resuscitation.2006.09.006; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Olasveengen TM, 2008, RESUSCITATION, V76, P185, DOI 10.1016/j.resuscitation.2007.07.001; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; Rubertsson S, 2005, RESUSCITATION, V65, P357, DOI 10.1016/j.resuscitation.2004.12.006; RUBERTSSON S, 1995, CRIT CARE MED, V23, P1984, DOI 10.1097/00003246-199512000-00007; Rubertsson S, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-5; Sato Y, 1997, CRIT CARE MED, V25, P733, DOI 10.1097/00003246-199705000-00005; Smekal D, 2011, RESUSCITATION, V82, P702, DOI 10.1016/j.resuscitation.2011.01.032; Steen S, 2003, RESUSCITATION, V58, P249, DOI 10.1016/S0300-9572(03)00265-X; Steen S, 2002, RESUSCITATION, V55, P285, DOI 10.1016/S0300-9572(02)00271-X; Valenzuela TD, 1997, CIRCULATION, V96, P3308; Wagner H, 2010, RESUSCITATION, V81, P383, DOI 10.1016/j.resuscitation.2009.11.006; WEIL MH, 1985, CRIT CARE MED, V13, P907, DOI 10.1097/00003246-198511000-00011; Wik L, 2005, RESUSCITATION, V66, P391, DOI 10.1016/j.resuscitation.2005.03.011; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389	26	274	295	0	37	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					53	61		10.1001/jama.2013.282538	http://dx.doi.org/10.1001/jama.2013.282538			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24240611				2022-12-28	WOS:000329161400018
J	Erdmann, J; Stark, K; Esslinger, UB; Rumpf, PM; Koesling, D; de Wit, C; Kaiser, FJ; Braunholz, D; Medack, A; Fischer, M; Zimmermann, ME; Tennstedt, S; Graf, E; Eck, S; Aherrahrou, Z; Nahrstaedt, J; Willenborg, C; Bruse, P; Braenne, I; Nothen, MM; Hofmann, P; Braund, PS; Mergia, E; Reinhard, W; Burgdorf, C; Schreiber, S; Balmforth, AJ; Hall, AS; Bertram, L; Steinhagen-Thiessen, E; Li, SC; Marz, W; Reilly, M; Kathiresan, S; McPherson, R; Walter, U; Ott, J; Samani, NJ; Strom, TM; Meitinger, T; Hengstenberg, C; Schunkert, H				Erdmann, Jeanette; Stark, Klaus; Esslinger, Ulrike B.; Rumpf, Philipp Moritz; Koesling, Doris; de Wit, Cor; Kaiser, Frank J.; Braunholz, Diana; Medack, Anja; Fischer, Marcus; Zimmermann, Martina E.; Tennstedt, Stephanie; Graf, Elisabeth; Eck, Sebastian; Aherrahrou, Zouhair; Nahrstaedt, Janja; Willenborg, Christina; Bruse, Petra; Braenne, Ingrid; Noethen, Markus M.; Hofmann, Per; Braund, Peter S.; Mergia, Evanthia; Reinhard, Wibke; Burgdorf, Christof; Schreiber, Stefan; Balmforth, Anthony J.; Hall, Alistair S.; Bertram, Lars; Steinhagen-Thiessen, Elisabeth; Li, Shu-Chen; Maerz, Winfried; Reilly, Muredach; Kathiresan, Sekar; McPherson, Ruth; Walter, Ulrich; Ott, Jurg; Samani, Nilesh J.; Strom, Tim M.; Meitinger, Thomas; Hengstenberg, Christian; Schunkert, Heribert		CARDIoGRAM	Dysfunctional nitric oxide signalling increases risk of myocardial infarction	NATURE			English	Article							SOLUBLE GUANYLATE-CYCLASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DISEASE	Myocardial infarction, a leading cause of death intheWesternworld(1), usually occurs when the fibrous cap overlying an atherosclerotic plaque in a coronary artery ruptures. The resulting exposure of blood to the atherosclerotic material then triggers thrombus formation, which occludes the artery(2). The importance of genetic predisposition to coronary artery disease and myocardial infarction is best documented by the predictive value of a positive family history(3). Nextgeneration sequencing in families with several affected individuals has revolutionized mutation identification(4). Here we report the segregation of two private, heterozygous mutations in two functionally relatedgenes, GUCY1A3 (p.Leu163Phefs*24) andCCT7 (p.Ser525Leu), in an extended myocardial infarction family. GUCY1A3 encodes the alpha 1 subunit of soluble guanylyl cyclase (alpha 1-sGC)(5), and CCT7 encodes CCT eta, a member of the tailless complex polypeptide 1 ring complex(6), which, among other functions, stabilizes soluble guanylyl cyclase. After stimulation with nitric oxide, soluble guanylyl cyclase generates cGMP, which induces vasodilation and inhibits platelet activation(7). Wedemonstratein vitro that mutations inbothGUCY1A3 and CCT7 severely reduce alpha 1-sGC as well as beta 1-sGC protein content, and impair soluble guanylyl cyclase activity. Moreover, platelets from digenic mutation carriers contained less soluble guanylyl cyclase protein and consequently displayed reduced nitric-oxideinduced cGMP formation. Mice deficient in alpha 1-sGC protein displayed accelerated thrombus formation in themicrocirculation after local trauma. Starting with a severely affected family, we have identified a link between impaired soluble-guanylyl-cyclase-dependent nitric oxide signalling and myocardial infarction risk, possibly through accelerated thrombus formation. Reversing this defect may provide a new therapeutic target for reducing the risk of myocardial infarction.	[Erdmann, Jeanette; Medack, Anja; Tennstedt, Stephanie; Aherrahrou, Zouhair; Nahrstaedt, Janja; Willenborg, Christina; Bruse, Petra; Braenne, Ingrid] Med Univ Lubeck, Inst Integrat & Expt Genom, D-23562 Lubeck, Germany; [Erdmann, Jeanette; de Wit, Cor; Kaiser, Frank J.; Aherrahrou, Zouhair; Willenborg, Christina] German Ctr Cardiovasc Res DZHK, D-23562 Lubeck, Germany; [Stark, Klaus; Esslinger, Ulrike B.; Fischer, Marcus; Zimmermann, Martina E.] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Stark, Klaus] Univ Regensburg, Dept Genet Epidemiol, D-93053 Regensburg, Germany; [Esslinger, Ulrike B.] INSERM, UMR S937, Paris, France; [Rumpf, Philipp Moritz; Reinhard, Wibke; Burgdorf, Christof; Meitinger, Thomas; Hengstenberg, Christian; Schunkert, Heribert] Deutsch Herzzentrum Munich, D-80636 Munich, Germany; [Rumpf, Philipp Moritz; Reinhard, Wibke; Burgdorf, Christof; Meitinger, Thomas; Hengstenberg, Christian; Schunkert, Heribert] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-80636 Munich, Germany; [Rumpf, Philipp Moritz; Reinhard, Wibke; Hengstenberg, Christian; Schunkert, Heribert] German Ctr Cardiovasc Res DZHK, D-80636 Munich, Germany; [Koesling, Doris; Mergia, Evanthia] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44801 Bochum, Germany; [de Wit, Cor] Med Univ Lubeck, Inst Physiol, D-23562 Lubeck, Germany; [Kaiser, Frank J.; Braunholz, Diana] Med Univ Lubeck, Inst Humangenet, D-23562 Lubeck, Germany; [Graf, Elisabeth; Eck, Sebastian; Strom, Tim M.; Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Graf, Elisabeth; Eck, Sebastian; Strom, Tim M.; Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Noethen, Markus M.; Hofmann, Per] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Noethen, Markus M.] Univ Bonn, Res Ctr Life & Brain, Dept Genom, D-53127 Bonn, Germany; [Hofmann, Per] Univ Basel Hosp, Div Med Genet, CH-4003 Basel, Switzerland; [Hofmann, Per] Univ Basel, Dept Biomed, CH-4003 Basel, Switzerland; [Braund, Peter S.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Braund, Peter S.; Samani, Nilesh J.] Glenfield Gen Hosp, Leicester Natl Inst Hlth Res Biomed Res Unit Card, Leicester LE1 7RH, Leics, England; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Balmforth, Anthony J.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Multidisciplinary Cardiovasc Res Ctr, Div Cardiovasc & Diabet Res, Leeds LS2 9JT, W Yorkshire, England; [Hall, Alistair S.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Multidisciplinary Cardiovasc Res Ctr, Div Cardiovasc & Neuronal Remodelling, Leeds LS2 9JT, W Yorkshire, England; [Bertram, Lars] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Steinhagen-Thiessen, Elisabeth] Charite, Charite Res Grp Geriatr, D-10117 Berlin, Germany; [Li, Shu-Chen] Max Planck Inst Human Dev, Ctr Lifespan Psychol, D-14195 Berlin, Germany; [Li, Shu-Chen] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, D-68165 Mannheim, Germany; [Maerz, Winfried] Synlab Serv GmbH, Business Dev, D-68165 Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Med Clin 5, D-68167 Mannheim, Germany; [Reilly, Muredach] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02215 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02215 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02215 USA; [Kathiresan, Sekar] Broad Inst Harvard & Massachusetts Inst Technol M, Program Med & Populat Genet, Cambridge, MA 02215 USA; [McPherson, Ruth] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Walter, Ulrich] Univ Med Mainz, CTH, D-55131 Mainz, Germany; [Walter, Ulrich] German Ctr Cardiovasc Res DZHK, D-55131 Mainz, Germany; [Ott, Jurg] Chinese Acad Sci, Inst Psychol, Beijing 100864, Peoples R China; [Ott, Jurg] Rockefeller Univ, Lab Stat Genet, New York, NY 10065 USA	University of Lubeck; German Centre for Cardiovascular Research; University of Regensburg; University of Regensburg; Institut National de la Sante et de la Recherche Medicale (Inserm); German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Ruhr University Bochum; University of Lubeck; University of Lubeck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Bonn; University of Bonn; University of Basel; University of Basel; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Kiel; University of Leeds; University of Leeds; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Technische Universitat Dresden; SYNLAB Group; SYNLAB Group; Medical University of Graz; Ruprecht Karls University Heidelberg; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Ottawa; University of Ottawa Heart Institute; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research; Chinese Academy of Sciences; Institute of Psychology, CAS; Rockefeller University	Hengstenberg, C (corresponding author), Deutsch Herzzentrum Munich, D-80636 Munich, Germany.	jeanette.erdmann@iieg.uni-luebeck.de; hengstenberg@dhm.mhn.de	Erdmann, Jeanette/A-4417-2009; Gudnason, Vilmundur/K-6885-2015; Walter, ulrich/W-2478-2017; Hall, Alistair/K-1953-2019; Willenborg, Christina/D-2668-2012; Tennstedt, Stephanie/F-3637-2018; Hengstenberg, Christian/U-5485-2019; Stark, Klaus/L-7367-2013; Altshuler, David M/A-4476-2009; Peters, Annette/A-6117-2011; Li, Shu-Chen/K-7838-2012; Boehm, Bernhard Otto/F-8750-2015; Meitinger, Thomas/O-1318-2015; Zimmermann, Martina/AAL-2990-2021; Erdmann, Jeanette/P-7513-2014; Bertram, Lars/K-3889-2015; de Wit, Cor/A-5560-2009	Gudnason, Vilmundur/0000-0001-5696-0084; Walter, ulrich/0000-0001-6784-2307; Willenborg, Christina/0000-0001-5217-6882; Tennstedt, Stephanie/0000-0001-9063-3087; Stark, Klaus/0000-0002-7832-1942; Altshuler, David M/0000-0002-7250-4107; Peters, Annette/0000-0001-6645-0985; Li, Shu-Chen/0000-0002-5520-5789; Zimmermann, Martina/0000-0002-6916-4404; Erdmann, Jeanette/0000-0002-4486-6231; Bertram, Lars/0000-0002-0108-124X; de Wit, Cor/0000-0003-4621-0399; Nothen, Markus/0000-0002-8770-2464; Melander, Olle/0000-0002-2581-484X; Zeller, Tanja/0000-0003-3379-2641; Meitinger, Thomas/0000-0002-8838-8403; Reilly, Muredach/0000-0002-3035-9386; Nelson, Christopher/0000-0001-8025-2897; Li, Shu-Chen/0000-0001-8409-5390; Hall, Alistair/0000-0003-0306-7887; Wagner, Arnika/0000-0002-0339-8259; Van Duijn, Cornelia/0000-0002-2374-9204; Aherrahrou, Zouhair/0000-0002-1241-8733; Kleber, Marcus/0000-0003-0663-7275	Deutsche Forschungsgemeinschaft; German Federal Ministry of Education and Research (BMBF) [01GS0417, 01GS0832]; EU [LSHM-CT-2006-037593]; ENGAGE [201413]; GEUVADIS [261123]; binational BMBF/ANR funded project CARDomics [01KU0908A]; Universitat zu Lubeck; University Hospital of Regensburg, Germany; The German Federal Ministry for Education and Research [16SV5538]; NSFC from Chinese Government [30730057]; British Heart Foundation; Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; BMBF [01EO1003]; DFG; National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); ENGAGE; GEUVADIS; binational BMBF/ANR funded project CARDomics(French National Research Agency (ANR)); Universitat zu Lubeck; University Hospital of Regensburg, Germany; The German Federal Ministry for Education and Research; NSFC from Chinese Government; British Heart Foundation(British Heart Foundation); Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all the family members who participated in this research. Without the continuous support of these patients over more than 15 years, the present work would not have been possible. We would like to thank S. Wrobel, S. Stark, A. Liebers, K. Franke, J. Stegmann-Frehse, M. Behrensen, M. Schmid, J. Eckhold, D. Wollner, U. Krabbe and J. Simon for technical assistance. Furthermore, we would like to thank M. Becker, N. Buchholz, I. Demuth, R. Eckardt, H. Heekeren, U. Lindenberger, M. Lovden, L. Muller, W. Nietfeld, G. Pawelec, F. Schmiedeck, T. Siedler and G. G. Wagner for their contributions to BASE-II. We also would like to thank S. Herterich and S. Gambaryan for advice, and B. Mayer, U. Hubauer, K.-H. Ameln and A. Grosshennig for help with GerMIFS. We thank WTCCC+ and the WTCCC-CAD2 investigators for access to their data. The study is supported by the Deutsche Forschungsgemeinschaft and the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 (01GS0417) and NGFN-plus (01GS0832)), the FP6 and FP7 EU-funded integrated projects Cardiogenics (LSHM-CT-2006-037593), ENGAGE (201413), and GEUVADIS (261123), the binational BMBF/ANR funded project CARDomics (01KU0908A), the local focus programs 'Kardiovaskulare Genomforschung' and 'Medizinische Genetik' of the Universitat zu Lubeck, and the University Hospital of Regensburg, Germany. The German Federal Ministry for Education and Research provided funding for BASE-II (BMBF; grant no. 16SV5538). Support by NSFC grant 30730057 from the Chinese Government (to J.O.) is gratefully acknowledged. N. J. S. holds a Chair funded by the British Heart Foundation, and is supported by the Leicester NIHR Biomedical Research Unit in Cardiovascular Disease. U. W. is supported by the BMBF(01EO1003). M. M. N. is a member of the DFG-funded Excellence Cluster ImmunoSensation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Fischer M, 2005, CIRCULATION, V111, P855, DOI 10.1161/01.CIR.0000155611.41961.BB; Haenle MM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-233; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; Preuss UW, 2003, EUR ARCH PSY CLIN N, V253, P275, DOI 10.1007/s00406-003-0440-7; RISCH N, 1990, AM J HUM GENET, V46, P242; Ritsch A, 2010, CIRCULATION, V121, P366, DOI 10.1161/CIRCULATIONAHA.109.875013; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060; World Health Organization, 2021, TOP 10 CAUS DEATH; Zabel U, 1998, BIOCHEM J, V335, P51, DOI 10.1042/bj3350051	28	195	200	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					432	+		10.1038/nature12722	http://dx.doi.org/10.1038/nature12722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24213632				2022-12-28	WOS:000328575300051
J	Cameron, JC; Wilson, SC; Bernstein, SL; Kerfeld, CA				Cameron, Jeffrey C.; Wilson, Steven C.; Bernstein, Susan L.; Kerfeld, Cheryl A.			Biogenesis of a Bacterial Organelle: The Carboxysome Assembly Pathway	CELL			English	Article							SALMONELLA-TYPHIMURIUM; SYNECHOCOCCUS PCC7942; CARBONIC-ANHYDRASE; PHOTOSYSTEM-II; PROTEIN; CYANOBACTERIUM; SHELL; ETHANOLAMINE; ENTERICA; MUTANT	The carboxysome is a protein-based organelle for carbon fixation in cyanobacteria, keystone organisms in the global carbon cycle. It is composed of thousands of subunits including hexameric and pentameric proteins that form a shell to encapsulate the enzymes ribulose 1,5-bisphosphate carboxylase/oxygenase and carbonic anhydrase. Here, we describe the stages of carboxysome assembly and the requisite gene products necessary for progression through each. Our results demonstrate that, unlike membrane-bound organelles of eukaryotes, in carboxysomes the interior of the compartment forms first, at a distinct site within the cell. Subsequently, shell proteins encapsulate this procarboxysome, inducing budding and distribution of functional organelles within the cell. We propose that the principles of carboxysome assembly that we have uncovered extend to diverse bacterial microcompartments.	[Cameron, Jeffrey C.; Wilson, Steven C.; Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Bernstein, Susan L.; Kerfeld, Cheryl A.] US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Synthet Biol Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kerfeld, CA (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	ckerfeld@lbl.gov		Wilson, Steven/0000-0002-7382-3388	NSF Emerging Frontiers Program [EF1105897]	NSF Emerging Frontiers Program	We thank members of the Kerfeld laboratory for helpful discussions. We thank Dr. Gustaf Sandh for construction of the Delta K2-O deletion plasmid and Patrick Shih for generating BglBrick modified neutral site vectors. We thank Dr. Kent McDonald, Reena Zalpuri, and Desiree Stanley for assistance with electron microscopy. We thank Dr. Susan Golden for providing pAM2314, pAM1573, and pAM2991 vectors and Dr. David Savage for providing pDFS648. Funding for this work was provided by the NSF Emerging Frontiers Program (EF1105897).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; Bove AM, 2013, BIOCHEMISTRY-US, V52, P1419, DOI 10.1021/bi301651n; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Cai F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007521; CANNON GC, 1991, J BACTERIOL, V173, P1565, DOI 10.1128/jb.173.4.1565-1568.1991; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Choudhary S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033342; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Goclaw-Binder H, 2012, ENVIRON MICROBIOL, V14, P680, DOI 10.1111/j.1462-2920.2011.02620.x; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; KRALL JP, 1992, PHYSIOL PLANTARUM, V86, P180, DOI 10.1111/j.1399-3054.1992.tb01328.x; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Long BM, 2010, PLANT PHYSIOL, V153, P285, DOI 10.1104/pp.110.154948; Ludwig M, 2000, J PHYCOL, V36, P1109, DOI 10.1046/j.1529-8817.2000.00028.x; MARCO E, 1994, APPL ENVIRON MICROB, V60, P1018, DOI 10.1128/AEM.60.3.1018-1020.1994; MARCUS Y, 1992, PLANTA, V187, P511, DOI 10.1007/BF00199970; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; ORUS MI, 1995, PLANT PHYSIOL, V107, P1159, DOI 10.1104/pp.107.4.1159; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; PRICE GD, 1989, PLANT PHYSIOL, V91, P514, DOI 10.1104/pp.91.2.514; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Rae BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043871; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; So AKC, 2002, PLANTA, V214, P456, DOI 10.1007/s004250100638; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Takahashi S, 2005, BBA-BIOENERGETICS, V1708, P352, DOI 10.1016/j.bbabio.2005.04.003; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	43	174	181	4	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1131	1140		10.1016/j.cell.2013.10.044	http://dx.doi.org/10.1016/j.cell.2013.10.044			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267892	Bronze			2022-12-28	WOS:000327500600016
J	Chen, RQ; Zhang, J; Fan, N; Teng, ZQ; Wu, Y; Yang, HW; Tang, YP; Sun, H; Song, YP; Chen, C				Chen, Rongqing; Zhang, Jian; Fan, Ni; Teng, Zhao-qian; Wu, Yan; Yang, Hongwei; Tang, Ya-ping; Sun, Hao; Song, Yunping; Chen, Chu			Delta(9)-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling	CELL			English	Article							LONG-TERM POTENTIATION; CB1 CANNABINOID RECEPTORS; RAT CEREBRAL-CORTEX; ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL; CHRONIC DELTA-9-TETRAHYDROCANNABINOL; IN-VIVO; MODULATION; CYCLOOXYGENASE-2; PROSTAGLANDINS; TRANSMISSION	Marijuana has been used for thousands of years as a treatment for medical conditions. However, untoward side effects limit its medical value. Here, we show that synaptic and cognitive impairments following repeated exposure to D-9-tetrahydrocannabinol (Delta(9)-THC) are associated with the induction of cyclooxygenase-2 (COX-2), an inducible enzyme that converts arachidonic acid to prostanoids in the brain. COX-2 induction by Delta(9)-THC is mediated via CB1 receptor-coupled G protein beta gamma subunits. Pharmacological or genetic inhibition of COX-2 blocks downregulation and internalization of glutamate receptor subunits and alterations of the dendritic spine density of hippocampal neurons induced by repeated Delta(9)-THC exposures. Ablation of COX-2 also eliminates Delta(9)-THC-impaired hippocampal long-term synaptic plasticity, working, and fear memories. Importantly, the beneficial effects of decreasing beta-amyloid plaques and neurodegeneration by Delta(9)-THC in Alzheimer's disease animals are retained in the presence of COX-2 inhibition. These results suggest that the applicability of medical marijuana would be broadened by concurrent inhibition of COX-2.	[Chen, Rongqing; Zhang, Jian; Fan, Ni; Teng, Zhao-qian; Wu, Yan; Yang, Hongwei; Sun, Hao; Song, Yunping; Chen, Chu] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Chen, Chu] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Otorhinolaryngol, New Orleans, LA 70112 USA; [Tang, Ya-ping] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Cell Biol & Anat, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Chen, C (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA.	chen502@gmail.com	Teng, Zhao-Qian/AAD-1033-2021; Tang, Ya-Ping/A-1035-2011; Song, Yunping/GNM-6096-2022; Teng, Zhao-Qian/J-6260-2015	Teng, Zhao-Qian/0000-0002-7232-3381; Teng, Zhao-Qian/0000-0002-7232-3381; Chen, Rongqing/0000-0002-1668-8554; Tang, Ya-Ping/0000-0002-0445-4072	National Institutes of Health [R01NS054886, R01NS076815]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054886, R01NS076815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Xin-Yun Huang (Weill Medical College of Cornell University) for providing us with beta 1 and gamma 2 plasmids; Dr. James Pickel (NIMH transgenic core) for providing us with CB1R knockout mice; Ms. Hongmin Jin for technical support; and NIDA and MIMH Drug Supply Programs for providing Delta<SUP>9</SUP>-THC, Rimonabant, and Celebrex. This work was supported by grants from National Institutes of Health R01NS054886 and R01NS076815 to C.C.	Akaneya Y, 2006, J NEUROSCI, V26, P10209, DOI 10.1523/JNEUROSCI.3028-06.2006; Alger BE, 2009, CURR TOP BEHAV NEURO, V1, P141, DOI 10.1007/978-3-540-88955-7_6; Bahr BA, 2006, EXPERT OPIN INV DRUG, V15, P351, DOI 10.1517/13543784.15.4.351; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Brock TG, 1999, J BIOL CHEM, V274, P11660, DOI 10.1074/jbc.274.17.11660; BURSTEIN SH, 1989, MOL PHARMACOL, V35, P6; Campbell VA, 2007, BRIT J PHARMACOL, V152, P655, DOI 10.1038/sj.bjp.0707446; Carlini EA, 2004, TOXICON, V44, P461, DOI 10.1016/j.toxicon.2004.05.009; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Chen C, 2006, BIOCHEM BIOPH RES CO, V340, P435, DOI 10.1016/j.bbrc.2005.12.021; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Chen X, 2011, NEUROSCIENCE, V178, P159, DOI 10.1016/j.neuroscience.2011.01.024; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Cowley TR, 2008, EUR J NEUROSCI, V27, P2999, DOI 10.1111/j.1460-9568.2008.06251.x; Dave KA, 2010, NEURON GLIA BIOL, V6, P201, DOI 10.1017/S1740925X10000244; Delaney AJ, 2007, NEURON, V56, P880, DOI 10.1016/j.neuron.2007.10.022; Du HZ, 2011, BRIT J PHARMACOL, V163, P1533, DOI 10.1111/j.1476-5381.2011.01444.x; Egashira N, 2007, J PHARMACOL SCI, V105, P361, DOI 10.1254/jphs.FP0071247; FAIRBAIRN JW, 1980, BRIT J PHARMACOL, V69, P491, DOI 10.1111/j.1476-5381.1980.tb07039.x; FAIRBAIRN JW, 1979, BRIT J PHARMACOL, V67, P379, DOI 10.1111/j.1476-5381.1979.tb08691.x; Fan N, 2010, J NEUROCHEM, V112, P691, DOI 10.1111/j.1471-4159.2009.06489.x; Ferraro L, 2001, CEREB CORTEX, V11, P728, DOI 10.1093/cercor/11.8.728; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Gowran A, 2011, CNS NEUROSCI THER, V17, P637, DOI 10.1111/j.1755-5949.2010.00195.x; Guo J, 2004, MOL PHARMACOL, V65, P665, DOI 10.1124/mol.65.3.665; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Hoffman AF, 2007, LEARN MEMORY, V14, P63, DOI 10.1101/lm.439007; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Lichtman AH, 1996, PSYCHOPHARMACOLOGY, V126, P125, DOI 10.1007/BF02246347; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Lovinger David M., 2008, V184, P435; Marchalant Y, 2008, BIOMED PHARMACOTHER, V62, P212, DOI 10.1016/j.biopha.2008.02.004; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mato S, 2005, J NEUROSCI, V25, P11619, DOI 10.1523/JNEUROSCI.2294-05.2005; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Messinis L, 2006, NEUROLOGY, V66, P737, DOI 10.1212/01.wnl.0000201279.83203.c6; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; PEREZREYES M, 1991, LIFE SCI, V48, P507, DOI 10.1016/0024-3205(91)90465-N; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pope HG, 2001, ARCH GEN PSYCHIAT, V58, P909, DOI 10.1001/archpsyc.58.10.909; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Rubino T, 2009, HIPPOCAMPUS, V19, P763, DOI 10.1002/hipo.20554; Russo EB, 2007, CHEM BIODIVERS, V4, P1614, DOI 10.1002/cbdv.200790144; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Sanzgiri RP, 1999, J NEUROBIOL, V41, P221, DOI 10.1002/(SICI)1097-4695(19991105)41:2<221::AID-NEU5>3.3.CO;2-1; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; Suarez I, 2004, DEV NEUROSCI-BASEL, V26, P45, DOI 10.1159/000080711; Suarez I, 2004, CEREBELLUM, V3, P66, DOI 10.1080/14734220310017230; Teather LA, 2002, LEARN MEMORY, V9, P41, DOI 10.1101/lm.43602; Tomasini MC, 2002, J NEUROSCI RES, V68, P449, DOI 10.1002/jnr.10242; Tonini R, 2006, J NEUROSCI, V26, P5810, DOI 10.1523/JNEUROSCI.5469-05.2006; Yao LN, 2003, P NATL ACAD SCI USA, V100, P14379, DOI 10.1073/pnas.2336093100; Zhang J, 2008, J BIOL CHEM, V283, P22601, DOI 10.1074/jbc.M800524200	59	115	120	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1154	1165		10.1016/j.cell.2013.10.042	http://dx.doi.org/10.1016/j.cell.2013.10.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267894	Green Accepted, Bronze			2022-12-28	WOS:000327500600018
J	Watchko, JF; Tiribelli, C				Watchko, Jon F.; Tiribelli, Claudio			Bilirubin-Induced Neurologic Damage - Mechanisms and Management Approaches	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VS. CONSERVATIVE PHOTOTHERAPY; BLOOD-BRAIN INTERFACES; UNCONJUGATED BILIRUBIN; GUNN RAT; CORTICAL-NEURONS; GLIAL-CELLS; NEUROTOXICITY; EXPRESSION; ACTIVATION; APOPTOSIS	The complex cascade of molecular and cellular events leading to bilirubin-induced neurotoxicity remains incompletely delineated. This review discusses bilirubin-induced brain damage and recent insights into its pathogenesis and prevention. Neonatal unconjugated hyperbilirubinemia and resultant clinical jaundice affect up to approximately 85% of newborns. Although this condition is generally a benign, transitional phenomenon, unconjugated bilirubin levels that can pose a direct threat of serious brain injury develop in a small proportion of neonates. Acute bilirubin encephalopathy may ensue and progress to kernicterus (chronic bilirubin encephalopathy), a permanent disabling neurologic condition that is classically characterized by the extrapyramidal movement disorders of dystonia, choreoathetosis, or both; hearing loss due to auditory neuropathy spectrum disorders; and oculomotor pareses.(1) These central nervous system (CNS) sequelae reflect the regional CNS topography of bilirubin-induced neuropathology, which ...	[Watchko, Jon F.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Newborn Med, Pittsburgh, PA 15261 USA; [Tiribelli, Claudio] Univ Trieste, Ctr Studi Fegato, Fdn Italiana Fegato, Trieste, Italy; [Tiribelli, Claudio] Univ Trieste, Dept Med Sci, Trieste, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Trieste; University of Trieste	Tiribelli, C (corresponding author), Fdn Italiana Fegato, Ctr Studi Fegato, Bldg Q,AREA Sci Pk,Basovizza Campus, I-34149 Trieste, Italy.	ctliver@csf.units.it	Tiribelli, Claudio/A-4716-2014	Tiribelli, Claudio/0000-0001-6596-7595				Abu-Bakar A, 2005, BIOCHEM PHARMACOL, V70, P1527, DOI 10.1016/j.bcp.2005.08.009; Ahdab-Barmada M, 2000, MG CLIN PED, P75; AHLFORS CE, 1994, PEDIATRICS, V93, P488; Ahlfors CE, 2010, CURR OPIN PEDIATR, V22, P129, DOI 10.1097/MOP.0b013e328336eb28; *AM AC PED SUBC HY, 2004, PEDIATRICS, V0114, P01138; Bender GJ, 2007, PEDIATRICS, V120, P1067, DOI 10.1542/peds.2006-3024; Bhutani Vinod K, 2004, J Perinatol, V24, P650, DOI 10.1038/sj.jp.7211152; Bortolussi G, 2012, FASEB J, V26, P1052, DOI 10.1096/fj.11-195461; Brites D, 2012, CARE JAUNDICED NEONA, P115; Brites D, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00088; Brites D, 2011, SEMIN PERINATOL, V35, P114, DOI 10.1053/j.semperi.2011.02.004; Brito MA, 2008, NEUROTOXICOLOGY, V29, P259, DOI 10.1016/j.neuro.2007.11.002; Brito MA, 2010, MOL MED, V16, P372, DOI 10.2119/molmed.2009.00152; CASHORE WJ, 1983, ACTA PAEDIATR SCAND, V72, P415, DOI 10.1111/j.1651-2227.1983.tb09739.x; CHOWDHURY JR, 1993, ADV VET SCI COMP MED, V37, P149; Corich L, 2009, BIOCHEM J, V417, P305, DOI 10.1042/BJ20080918; Daood M, 2008, NEUROPEDIATRICS, V39, P211, DOI 10.1055/s-0028-1103272; Daood MJ, 2009, J PERINATOL, V29, pS14, DOI 10.1038/jp.2008.218; Daood MJ, 2006, PEDIATR RES, V60, P44, DOI 10.1203/01.pdr.0000219561.07550.04; Daood MJ, 2012, PEDIATR RES, V72, P455, DOI 10.1038/pr.2012.111; Deganuto M, 2010, PROTEOMICS, V10, P1645, DOI 10.1002/pmic.200900579; Falcao AS, 2007, J NEUROSCI RES, V85, P1229, DOI 10.1002/jnr.21227; Falcao AS, 2013, NEUROCHEM RES, V38, P644, DOI 10.1007/s11064-012-0963-2; Fernandes A, 2009, DEV NEUROBIOL, V69, P568, DOI 10.1002/dneu.20727; Gamaleldin R, 2011, PEDIATRICS, V128, pE925, DOI 10.1542/peds.2011-0206; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Gazzin S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00089; Gazzin S, 2012, PEDIATR RES, V71, P653, DOI 10.1038/pr.2012.23; Gazzin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016165; Geiger AS, 2007, NEONATOLOGY, V92, P219, DOI 10.1159/000103740; Gennuso F, 2004, P NATL ACAD SCI USA, V101, P2470, DOI 10.1073/pnas.0308452100; Ghersi-Egea JF, 2009, CURR PHARM DESIGN, V15, P2893, DOI 10.2174/138161209789058147; Giraudi PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029078; Gunn CH, 1938, J HERED, V29, P137, DOI 10.1093/oxfordjournals.jhered.a104478; Hansen TWR, 2009, ACTA PAEDIATR, V98, P1689, DOI 10.1111/j.1651-2227.2009.01409.x; Ip S, 2004, PEDIATRICS, V114, pE130, DOI 10.1542/peds.114.1.e130; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Johnson L, 2009, J PERINATOL S1, V29, pS25S; KAPITULNIK J, 1987, BIOCHEM J, V242, P297, DOI 10.1042/bj2420297; KAPITULNIK J, 1993, MOL PHARMACOL, V43, P722; Lasky RE, 2012, PEDIATR RES, V71, P77, DOI 10.1038/pr.2011.17; Lin SZ, 2005, EUR J NEUROSCI, V22, P21, DOI 10.1111/j.1460-9568.2005.04182.x; Maisels M J, 2012, CARE JAUNDICED NEONA, P175; Maisels MJ, 2004, PEDIATRICS, V114, P297; Maisels MJ, 2012, CARE JAUNDICED NEONA, P195; Manning D, 2007, ARCH DIS CHILD-FETAL, V92, P342, DOI 10.1136/adc.2006.105361; McDonagh AF, 2006, PEDIATRICS, V117, P523, DOI 10.1542/peds.2005-2073; McDonagh AF, 2009, PEDIATRICS, V123, P67, DOI 10.1542/peds.2008-0492; Morris BH, 2008, NEW ENGL J MED, V359, P1885, DOI 10.1056/NEJMoa0803024; Mreihil K, 2010, PEDIATR RES, V67, P656, DOI 10.1203/PDR.0b013e3181dcedc0; Newman TB, 2006, NEW ENGL J MED, V354, P1889, DOI 10.1056/NEJMoa054244; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Ollinger R, 2007, CELL CYCLE, V6, P3078, DOI 10.4161/cc.6.24.5022; Ollinger R, 2007, CELL CYCLE, V6, P39, DOI 10.4161/cc.6.1.3700; Ogunlesi T A, 2007, Niger J Med, V16, P354; Oh W, 2013, ACTA PAEDIATR, V102, P326, DOI 10.1111/apa.12157; Ostrow JD, 2004, TRENDS MOL MED, V10, P65, DOI 10.1016/j.molmed.2003.12.003; Ostrow JD, 2003, PEDIATR RES, V54, P926, DOI 10.1203/01.PDR.0000103388.01854.91; Palmela I, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00022; Roca L, 2006, PEDIATR RES, V60, P724, DOI 10.1203/01.pdr.0000245992.89965.94; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; Schulz S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00068; Sgro M, 2012, PEDIATRICS, V130, pE886, DOI 10.1542/peds.2012-0253; Shapiro SM, 2012, CARE JAUNDICED NEONA, P229; Shapiro SM, 2010, SEMIN FETAL NEONAT M, V15, P157, DOI 10.1016/j.siny.2009.12.004; Silva SL, 2010, NEUROBIOL DIS, V40, P663, DOI 10.1016/j.nbd.2010.08.010; Slusher TM, 2012, CARE JAUNDICED NEONA, P263; Vader-van Imhoff DE, BARTRIAL MANAGEMENT; Vaz AR, 2010, J NEUROCHEM, V112, P56, DOI 10.1111/j.1471-4159.2009.06429.x; Vitek L, 2009, CURR PHARM DESIGN, V15, P2869, DOI 10.2174/138161209789058237; Watchko JF, 2006, NEUROMOL MED, V8, P513, DOI 10.1385/NMM:8:4:513; Weisiger RA, 2001, J BIOL CHEM, V276, P29953, DOI 10.1074/jbc.M104628200; Wennberg RP, 2012, CLIN CHEM, V58, P811, DOI 10.1373/clinchem.2012.183962; Wennberg RP, 2006, PEDIATRICS, V117, P474, DOI 10.1542/peds.2005-0395; Zabetta CDC, 2013, NEONATOLOGY, V103, P177, DOI 10.1159/000345425; Zipursky A, 2011, ARCH DIS CHILD-FETAL, V96, pF84, DOI 10.1136/adc.2009.181172; Zucker SD, 1999, J BIOL CHEM, V274, P10852, DOI 10.1074/jbc.274.16.10852	77	199	215	3	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					2021	2030		10.1056/NEJMra1308124	http://dx.doi.org/10.1056/NEJMra1308124			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256380				2022-12-28	WOS:000327163000010
J	Thalmann, O; Shapiro, B; Cui, P; Schuenemann, VJ; Sawyer, SK; Greenfield, DL; Germonpre, MB; Sablin, MV; Lopez-Giraldez, F; Domingo-Roura, X; Napierala, H; Uerpmann, HP; Loponte, DM; Acosta, AA; Giemsch, L; Schmitz, RW; Worthington, B; Buikstra, JE; Druzhkova, A; Graphodatsky, AS; Ovodov, ND; Wahlberg, N; Freedman, AH; Schweizer, RM; Koepfli, KP; Leonard, JA; Meyer, M; Krause, J; Paabo, S; Green, RE; Wayne, RK				Thalmann, O.; Shapiro, B.; Cui, P.; Schuenemann, V. J.; Sawyer, S. K.; Greenfield, D. L.; Germonpre, M. B.; Sablin, M. V.; Lopez-Giraldez, F.; Domingo-Roura, X.; Napierala, H.; Uerpmann, H-P.; Loponte, D. M.; Acosta, A. A.; Giemsch, L.; Schmitz, R. W.; Worthington, B.; Buikstra, J. E.; Druzhkova, A.; Graphodatsky, A. S.; Ovodov, N. D.; Wahlberg, N.; Freedman, A. H.; Schweizer, R. M.; Koepfli, K. -P.; Leonard, J. A.; Meyer, M.; Krause, J.; Paabo, S.; Green, R. E.; Wayne, R. K.			Complete Mitochondrial Genomes of Ancient Canids Suggest a European Origin of Domestic Dogs	SCIENCE			English	Article							EVOLUTION; MULTIPLE; GENETICS; WOLVES; WOLF; DNA	The geographic and temporal origins of the domestic dog remain controversial, as genetic data suggest a domestication process in East Asia beginning 15,000 years ago, whereas the oldest doglike fossils are found in Europe and Siberia and date to >30,000 years ago. We analyzed the mitochondrial genomes of 18 prehistoric canids from Eurasia and the New World, along with a comprehensive panel of modern dogs and wolves. The mitochondrial genomes of all modern dogs are phylogenetically most closely related to either ancient or modern canids of Europe. Molecular dating suggests an onset of domestication there 18,800 to 32,100 years ago. These findings imply that domestic dogs are the culmination of a process that initiated with European hunter-gatherers and the canids with whom they interacted.	[Thalmann, O.; Wahlberg, N.] Univ Turku, Dept Biol, Sect Genet & Physiol, SF-20500 Turku, Finland; [Shapiro, B.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Cui, P.; Sawyer, S. K.; Meyer, M.; Paabo, S.] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Schuenemann, V. J.; Uerpmann, H-P.; Krause, J.] Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany; [Greenfield, D. L.; Freedman, A. H.; Schweizer, R. M.; Wayne, R. K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Germonpre, M. B.] Royal Belgian Inst Nat Sci, Operat Direct Earth & Hist Life, B-1000 Brussels, Belgium; [Sablin, M. V.] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Lopez-Giraldez, F.] Yale Univ, Yale Ctr Genome Anal, West Haven, CT 06516 USA; [Domingo-Roura, X.] IRTA, Genet Conservacio, Barcelona 08348, Spain; [Napierala, H.] Univ Munich, Inst Palaeoanat & Hist Vet Med, D-80539 Munich, Germany; [Napierala, H.] ArchaeoBioCtr LMU, D-80539 Munich, Germany; [Loponte, D. M.; Acosta, A. A.] Consejo Nacl Invest Cient & Tecn, Inst Nacl Antropol & Pensamiento Latinoamer, RA-1033 Buenos Aires, DF, Argentina; [Giemsch, L.; Schmitz, R. W.] Landschaftsverband Rheinland LVR Landesmuseum Bon, D-53115 Bonn, Germany; [Giemsch, L.] Univ Bonn, Inst Archaeol & Cultural Anthropol, Dept Prehist & Protohist, D-53113 Bonn, Germany; [Worthington, B.] Southeastern Archaeological Res ,Inc, Newberry, FL 32669 USA; [Buikstra, J. E.] Arizona State Univ, Sch Human Evolut & Social Change, Ctr Bioarchaeol Res, Tempe, AZ 85287 USA; [Druzhkova, A.; Graphodatsky, A. S.] Russian Acad Sci, Dept Genom Div & Evolut, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia; [Ovodov, N. D.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Novosibirsk, Russia; [Koepfli, K. -P.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg 199034, Russia; [Leonard, J. A.] Conservat & Evolutionary Genet Grp EBD CSIC, Estn Biol Donana, Seville 41093, Spain; [Green, R. E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of Turku; University of California System; University of California Santa Cruz; Max Planck Society; Eberhard Karls University of Tubingen; University of California System; University of California Los Angeles; Royal Belgian Institute of Natural Sciences; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Yale University; IRTA; University of Munich; University of Munich; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Bonn; Arizona State University; Arizona State University-Tempe; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Saint Petersburg State University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of California System; University of California Santa Cruz	Thalmann, O (corresponding author), Univ Turku, Dept Biol, Sect Genet & Physiol, Itainen Pitkakatu 4, SF-20500 Turku, Finland.	olatha@utu.fi; rwayne@eeb.ucla.edu	Graphodatsky, Alexander/B-4922-2010; López-Giráldez, Francesc/A-5251-2011; OBRIEN, STEPHEN/ABD-1346-2020; Druzhkova, Anna/N-2011-2015; Krause, Johannes/AFP-2642-2022; Germonpré, Mietje/O-5952-2014; Koepfli, Klaus-Peter/AAT-9320-2020; Mikhail, Sablin/K-7835-2013; Krause, Johannes/E-6640-2015; Wahlberg, Niklas/B-7765-2008; Leonard, Jennifer/A-7894-2010	Graphodatsky, Alexander/0000-0002-8282-1085; López-Giráldez, Francesc/0000-0001-7476-9822; Krause, Johannes/0000-0001-9144-3920; Germonpré, Mietje/0000-0001-8865-0937; Mikhail, Sablin/0000-0002-2773-7454; Krause, Johannes/0000-0001-5475-4690; Wahlberg, Niklas/0000-0002-1259-3363; Thalmann, Olaf/0000-0003-1700-0130; Freedman, Adam/0000-0003-4714-3925; Sawyer, Susanna/0000-0002-8477-6089; Schweizer, Rena/0000-0002-8812-8177; Green, Richard/0000-0003-0516-5827; Shapiro, Beth/0000-0002-2733-7776; Leonard, Jennifer/0000-0003-0291-7819	E. Aaltonen foundation; Turun Yliopistosaatio; Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Russian Foundation for Basic Research; NSF [OPP 9617068, EF-1021387]; Carl Zeiss Foundation; Max Planck Society; Marie Curie Intra European Fellowship within the 7th European Community Framework Program; Division Of Environmental Biology [1021397] Funding Source: National Science Foundation	E. Aaltonen foundation; Turun Yliopistosaatio; Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NSF(National Science Foundation (NSF)); Carl Zeiss Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); Marie Curie Intra European Fellowship within the 7th European Community Framework Program(European Commission); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Mitochondrial sequences have been deposited at the NCBI database with the accession numbers (KF661036 to KF661096), and a complete alignment is available as a supplementary file. We would like to thank all colleagues who provided samples for this study, the Illinois State Museum and the Center for American Archeology for allowing us to sample the material from the Koster site, and the American Museum of Natural History, New York. O.T. is grateful to D. Wegmann and D. Schwochow-Thalmann for helpful discussions and comments on the manuscript; M. Bruneaux for help with R; and A. v. Haeseler for helpful advice with TREE-PUZZLE and IQ-TREE. We thank D. Ward, M. Riesenberg, J. Beier, I. Bergmann, H. Mutlu, and S. Bealek for assistance with ancient DNA extractions. R. E. G. is president of Dovetail Genomics. Financial support for this study was provided from the E. Aaltonen foundation and the Turun Yliopistosaatio to O.T.; Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, and Russian Foundation for Basic Research grants to A. S. G.; and NSF support to R. K. W. and B. S. (OPP 9617068, EF-1021387). J. K. and V. J. S. were supported by the Carl Zeiss Foundation. This work was further supported by the Max Planck Society. O.T. is financed by a Marie Curie Intra European Fellowship within the 7th European Community Framework Program. The authors declare no conflict of interest.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Baales M., 1996, MONGRAPHIEN RGZM MAI, V38, P106; Crockford SJ, 2012, J ARCHAEOL SCI, V39, P2797, DOI 10.1016/j.jas.2012.04.033; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Malmstrom H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-71; Napierala H, 2012, INT J OSTEOARCHAEOL, V22, P127, DOI 10.1002/oa.1182; NOBIS G, 1979, UMSCHAU, V79, P610; OLSEN SJ, 1977, SCIENCE, V197, P533, DOI 10.1126/science.197.4303.533; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; van Asch B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1142; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814	24	327	341	2	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					871	874		10.1126/science.1243650	http://dx.doi.org/10.1126/science.1243650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233726				2022-12-28	WOS:000326923000042
J	Dunleavy, K; Pittaluga, S; Shovlin, M; Steinberg, SM; Cole, D; Grant, C; Widemann, B; Staudt, LM; Jaffe, ES; Little, RF; Wilson, WH				Dunleavy, Kieron; Pittaluga, Stefania; Shovlin, Margaret; Steinberg, Seth M.; Cole, Diane; Grant, Cliona; Widemann, Brigitte; Staudt, Louis M.; Jaffe, Elaine S.; Little, Richard F.; Wilson, Wyndham H.			Low-Intensity Therapy in Adults with Burkitt's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOSE-ADJUSTED EPOCH; NON-HODGKINS-LYMPHOMA; EVENT-FREE SURVIVAL; B-CELL LYMPHOMAS; CODOX-M/IVAC; ANTIRETROVIRAL THERAPY; CHEMOTHERAPY REGIMEN; CHILDREN; RITUXIMAB; DOXORUBICIN	BACKGROUND Burkitt's lymphoma is an aggressive B-cell lymphoma that occurs in children and adults and is largely curable with the use of intensive and toxic chemotherapy. Current treatments are less effective and have more severe side effects in adults and patients with immunodeficiency than in children. METHODS We studied low-intensity treatment consisting of infused etoposide, doxorubicin, and cyclophosphamide with vincristine, prednisone, and rituximab (EPOCH-R) in patients with untreated Burkitt's lymphoma. Two EPOCH-R regimens were tested: a standard dose-adjusted combination in human immunodeficiency virus (HIV)-negative patients (DA-EPOCH-R group) and a lower-dose short-course combination with a double dose of rituximab in HIV-positive patients (SC-EPOCH-RR group). RESULTS A total of 30 consecutive patients were treated; 19 patients were in the DA-EPOCH-R group, and 11 in the SC-EPOCH-RR group. The overall median age of the patients was 33 years, and 40% were 40 years of age or older; 73% of the patients had intermediate-risk disease, and 10% had high-risk disease. The principal toxic events, fever and neutropenia, were observed during 22% of the DA-EPOCH-R treatment cycles and 10% of the SC-EPOCH-RR treatment cycles. The tumor lysis syndrome developed in 1 patient; no treatment-related deaths occurred. The median cumulative doses of doxorubicin-etoposide and cyclophosphamide administered in the SC-EPOCH-RR group were 47% and 57% lower, respectively, than those administered in the DA-EPOCH-R group. With median follow-up times of 86 months in the DA-EPOCH-R group and 73 months in the SC-EPOCH-RR group, the rates of freedom from progression of disease and overall survival were, respectively, 95% and 100% with DA-EPOCH-R and 100% and 90% with SC-EPOCH-RR. None of the patients died from Burkitt's lymphoma. CONCLUSIONS In this uncontrolled prospective study, low-intensity EPOCH-R-based treatment was highly effective in adults with sporadic or immunodeficiency-associated Burkitt's lymphoma.	[Dunleavy, Kieron; Pittaluga, Stefania; Shovlin, Margaret; Steinberg, Seth M.; Cole, Diane; Grant, Cliona; Widemann, Brigitte; Staudt, Louis M.; Jaffe, Elaine S.; Little, Richard F.; Wilson, Wyndham H.] NCI, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wilson, WH (corresponding author), NCI, Lymphoid Malignancy Branch, Bldg 10,Rm 4N-115,9000 Rockville Pike, Bethesda, MD 20892 USA.	wilsonw@mail.nih.gov	Staudt, Louis/AAC-5324-2019; Jaffe, Elaine/G-8981-2014	Jaffe, Elaine/0000-0003-4632-0301	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIASC000550, ZIASC006741, ZIABC011070] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute; ClinicalTrials.gov numbers, NCT00001337 and NCT00006436.	Barnes JA, 2011, ANN ONCOL, V22, P1859, DOI 10.1093/annonc/mdq677; Blum KA, 2004, BLOOD, V104, P3009, DOI 10.1182/blood-2004-02-0405; Burkhardt B, 2011, LEUKEMIA, V25, P153, DOI 10.1038/leu.2010.245; BURKITT D, 1958, BRIT J SURG, V46, P218, DOI 10.1002/bjs.18004619704; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cortes J, 2002, CANCER, V94, P1492, DOI 10.1002/cncr.10365; Divine M, 2005, ANN ONCOL, V16, P1928, DOI 10.1093/annonc/mdi403; Dunleavy K, 2013, NEW ENGL J MED, V368, P1408, DOI 10.1056/NEJMoa1214561; Dunleavy K, 2010, BLOOD, V115, P3017, DOI 10.1182/blood-2009-11-253039; Gerrard M, 2008, BRIT J HAEMATOL, V141, P840, DOI 10.1111/j.1365-2141.2008.07144.x; Gibaldi M, 1982, PHARMACOKINETICS; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Kasamon YL, 2013, LEUKEMIA LYMPHOMA, V54, P483, DOI 10.3109/10428194.2012.715346; Kirwan M, 2009, HUM MUTAT, V30, P1567, DOI 10.1002/humu.21115; Kontny NE, 2013, CANCER CHEMOTH PHARM, V71, P749, DOI 10.1007/s00280-013-2069-1; Little RF, 2003, BLOOD, V101, P4653, DOI 10.1182/blood-2002-11-3589; Longo, 1996, J CLIN ONCOL, V14, P1969; LONGO DL, 1994, J CLIN ONCOL, V12, P2153, DOI 10.1200/JCO.1994.12.10.2153; Magrath I, 1996, J CLIN ONCOL, V14, P925, DOI 10.1200/JCO.1996.14.3.925; Mead GM, 2002, ANN ONCOL, V13, P1264, DOI 10.1093/annonc/mdf253; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Montoto S, 2010, AIDS, V24, P851, DOI 10.1097/QAD.0b013e3283301578; OCONNOR PM, 1991, CANCER RES, V51, P6550; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Offer H, 2002, CARCINOGENESIS, V23, P1025, DOI 10.1093/carcin/23.6.1025; Patte C, 2001, BLOOD, V97, P3370, DOI 10.1182/blood.V97.11.3370; Patte C, 2007, BLOOD, V109, P2773, DOI 10.1182/blood-2006-07-036673; Ratain MJ, 2001, PHARM CANC CHEMOTHER; Reiter A, 2000, BLOOD, V95, P416; Reiter A, 1999, BLOOD, V94, P3294; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Sutton L, 2001, BRIT J HAEMATOL, V112, P900, DOI 10.1046/j.1365-2141.2001.02661.x; Swerdlow SH, 2008, WHO CLASSIFICATION T; TAUB R, 1984, CELL, V36, P339, DOI 10.1016/0092-8674(84)90227-7; Todeschini G, 2012, AM J HEMATOL, V87, P22, DOI 10.1002/ajh.22189; Wang ES, 2003, CANCER-AM CANCER SOC, V98, P1196, DOI 10.1002/cncr.11628; Warren KE, 2000, CANCER CHEMOTH PHARM, V45, P207, DOI 10.1007/s002800050031; Wasterlid T, 2013, ANN ONCOL, V24, P1879, DOI 10.1093/annonc/mdt058; Wilson WH, 2002, BLOOD, V99, P2685, DOI 10.1182/blood.V99.8.2685; Wilson WH, 2008, J CLIN ONCOL, V26, P2717, DOI 10.1200/JCO.2007.13.1391; Wilson WH, 2012, HAEMATOL-HEMATOL J, V97, P758, DOI 10.3324/haematol.2011.056531	41	214	220	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1915	1925		10.1056/NEJMoa1308392	http://dx.doi.org/10.1056/NEJMoa1308392			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300MP	24224624	Green Accepted			2022-12-28	WOS:000330468300009
J	Spijker, J; MacInnes, J				Spijker, Jeroen; MacInnes, John			Population ageing: the timebomb that isn't?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIFE EXPECTANCY; BEHAVIOR; HEALTH		[Spijker, Jeroen; MacInnes, John] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh EH8 9LD, Midlothian, Scotland; [Spijker, Jeroen] Ctr Estudis Demog, Barcelona, Spain	University of Edinburgh; Centre d'Estudis Demografics (CED)	Spijker, J (corresponding author), Univ Edinburgh, Sch Social & Polit Sci, Edinburgh EH8 9LD, Midlothian, Scotland.	j.spijker@ed.ac.uk	Spijker, Jeroen/T-8333-2019	Spijker, Jeroen/0000-0002-3957-9553	ESRC [ES/K004611/1, ES/G027153/1] Funding Source: UKRI; Economic and Social Research Council [ES/K004611/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Bongaarts J, 2004, POPUL DEV REV, V30, P1, DOI 10.1111/j.1728-4457.2004.00001.x; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cocco JF, 2012, J FINANC ECON, V103, P507, DOI 10.1016/j.jfineco.2011.10.002; Crimmins EM, 2004, ANNU REV PUBL HEALTH, V25, P79, DOI 10.1146/annurev.publhealth.25.102802.124401; Doyle Y, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3926; DYER O., 2006, BMJ-BRIT MED J, V332, P1052, DOI [10.1136/bmj.332.7549.1052-c, DOI 10.1136/BMJ.332.7549.1052-C]; HAMERMESH DS, 1985, Q J ECON, V100, P389, DOI 10.2307/1885388; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Lutz W, 2008, J POPUL AGEING, V1, P75, DOI 10.1007/s12062-009-9005-5; Lutz W, 2009, POPUL DEV REV, V35, P357, DOI 10.1111/j.1728-4457.2009.00282.x; Mason A, 2006, NBER WORKING PAPER S, V12770; Office for National Statistics, LAB MARK STAT; Office for National Statistics, 2011, NAT POP PROJ 2010 BA; Polder JJ, 2002, EUR J PUBLIC HEALTH, V12, P57, DOI 10.1093/eurpub/12.1.57; Rau R, 2008, POPUL DEV REV, V34, P747, DOI 10.1111/j.1728-4457.2008.00249.x; RYDER NB, 1975, POPUL INDEX, V41, P3, DOI 10.2307/2734140; Sanderson WC, 2007, DEMOGR RES, V16, P27, DOI 10.4054/DemRes.2007.16.2; Sanderson WC, 2010, SCIENCE, V329, P1287, DOI 10.1126/science.1193647; Schoeni RF, 2008, MILBANK Q, V86, P47, DOI 10.1111/j.1468-0009.2007.00513.x; van Solinge H, 2010, EUR J PUBLIC HEALTH, V20, P47, DOI 10.1093/eurpub/ckp118; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984	21	59	63	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2013	347								f6598	10.1136/bmj.f6598	http://dx.doi.org/10.1136/bmj.f6598			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254FR	24222481	Green Published, Green Submitted			2022-12-28	WOS:000327150600002
J	Skolnik, N				Skolnik, Neil			PERSONAL VIEW Don't restrict funding from drug companies for doctors' education	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL-EDUCATION		[Skolnik, Neil] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Skolnik, Neil] Abington Mem Hosp, Family Med Residency Program, Abington, PA 19046 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Abington Memorial Hospital	Skolnik, N (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.	nskolnik@comcast.net						Association of American Medical Colleges, 2008, IND FUND MED ED REP; Avorn J, 2011, NEW ENGL J MED, V364, P1185, DOI 10.1056/NEJMp1011713; Donnell RW, 2009, SHOULD WE ELIMINATE; Kocher R, 2011, NEW ENGL J MED, V364, P1790, DOI 10.1056/NEJMp1101959; Lo B, 2009, CONFLICT INTEREST ME; Morris L, 2009, NEW ENGL J MED, V361, P2478, DOI 10.1056/NEJMsb0905411; National Center for Health S, 2010, HLTH US 2009 SPECIAL; Relman AS, 2008, JAMA-J AM MED ASSOC, V300, P1071, DOI 10.1001/jama.300.9.1071; Rothman DJ, 2008, JAMA-J AM MED ASSOC, V300, P1067, DOI 10.1001/jama.300.9.1067; Steinbrook R, 2008, NEW ENGL J MED, V359, P559, DOI 10.1056/NEJMp0805309	10	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2013	347								f6452	10.1136/bmj.f6452	http://dx.doi.org/10.1136/bmj.f6452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XT	24212106				2022-12-28	WOS:000326890800002
J	Kim, HS; Mendiratta, S; Kim, J; Pecot, CV; Larsen, JE; Zubovych, I; Seo, BY; Kim, J; Eskiocak, B; Chung, H; McMillan, E; Wu, S; De Brabander, J; Komurov, K; Toombs, JE; Wei, SG; Peyton, M; Williams, N; Gazdar, AF; Posner, BA; Brekken, RA; Sood, AK; Deberardinis, RJ; Roth, MG; Minna, JD; White, MA				Kim, Hyun Seok; Mendiratta, Saurabh; Kim, Jiyeon; Pecot, Chad Victor; Larsen, Jill E.; Zubovych, Iryna; Seo, Bo Yeun; Kim, Jimi; Eskiocak, Banu; Chung, Hannah; McMillan, Elizabeth; Wu, Sherry; De Brabander, Jef; Komurov, Kakajan; Toombs, Jason E.; Wei, Shuguang; Peyton, Michael; Williams, Noelle; Gazdar, Adi F.; Posner, Bruce A.; Brekken, Rolf A.; Sood, Anil K.; Deberardinis, Ralph J.; Roth, Michael G.; Minna, John D.; White, Michael A.			Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer	CELL			English	Article							PROTEIN; APOPTOSIS; GENE; INFLAMMASOMES; RIPOPTOSOME; INHIBITORS; ASSEMBLES; COATOMER; SURVIVAL; PLATFORM	Context-specific molecular vulnerabilities that arise during tumor evolution represent an attractive intervention target class. However, the frequency and diversity of somatic lesions detected among lung tumors can confound efforts to identify these targets. To confront this challenge, we have applied parallel screening of chemical and genetic perturbations within a panel of molecularly annotated NSCLC lines to identify intervention opportunities tightly linked to molecular response indicators predictive of target sensitivity. Anchoring this analysis on a matched tumor/normal cell model from a lung adenocarcinoma patient identified three distinct target/response-indicator pairings that are represented with significant frequencies (6%-16%) in the patient population. These include NLRP3 mutation/inflammasome activation-dependent FLIP addiction, co-occurring KRAS and LKB1 mutation-driven COPI addiction, and selective sensitivity to a synthetic indolotriazine that is specified by a seven-gene expression signature. Target efficacies were validated in vivo, and mechanism-of-action studies informed generalizable principles underpinning cancer cell biology.	[Kim, Hyun Seok; Mendiratta, Saurabh; Seo, Bo Yeun; Kim, Jimi; Eskiocak, Banu; Chung, Hannah; McMillan, Elizabeth; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Kim, Jiyeon; Deberardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Larsen, Jill E.; Toombs, Jason E.; Peyton, Michael; Gazdar, Adi F.; Brekken, Rolf A.; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Zubovych, Iryna; De Brabander, Jef; Wei, Shuguang; Williams, Noelle; Posner, Bruce A.; Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Pecot, Chad Victor; Wu, Sherry] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Komurov, Kakajan] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Cincinnati Children's Hospital Medical Center	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Sood, Anoop Kumar/A-7344-2013; Kim, Jimi/AAL-8563-2021; Larsen, Jill E/G-3787-2010	Sood, Anoop Kumar/0000-0001-5702-4108; Larsen, Jill E/0000-0001-7806-3931; Kim, Jimi/0000-0002-6764-9934; Roth, Michael/0000-0002-9056-332X	NIH [CA71443, CA129451, CA176284, CA148225, CA70907]; Robert Welch Foundation [I-1414]; Logenbaugh Foundation; CPRIT [RP101496, RP110708];  [P30CA142543]; NATIONAL CANCER INSTITUTE [T32CA009666, RC2CA148225, R01CA157996, U54CA151668, U01CA176284, P30CA142543, R01CA071443, P50CA070907, P30CA016672, R01CA129451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027805] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); Logenbaugh Foundation; CPRIT; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank John Heymach and Lauren Byers (MD Anderson) for sharing HCC4017-SNP array data; Robert Collins for sharing Exome-seq data from normal tissue samples; and Peter Hammerman for sharing TCGA gene expression data. This study was supported by grants from the NIH (CA71443, CA129451, CA176284, CA148225, and CA70907), the Robert Welch Foundation (I-1414), the Logenbaugh Foundation, and CPRIT (RP101496, RP110708). Shared facilities were supported in part by P30CA142543. M.A.W., M.G.R., B.A.P., and J.D.M. are members of the NCI Cancer Target and Discovery (CTD<SUP>2</SUP>) Network.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Guedat P, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S14; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Masumoto J, 2006, BIOCHEM BIOPH RES CO, V346, P968, DOI 10.1016/j.bbrc.2006.06.002; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Petersen SL, 2010, P NATL ACAD SCI USA, V107, P11936, DOI 10.1073/pnas.1005667107; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; WATHELET MG, 1988, FEBS LETT, V231, P164, DOI 10.1016/0014-5793(88)80724-5; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Young RM, 2013, GENE DEV, V27, P1115, DOI 10.1101/gad.198630.112; Zhao LQ, 2011, MOL CANCER THER, V10, P2415, DOI 10.1158/1535-7163.MCT-11-0401	48	126	130	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					552	566		10.1016/j.cell.2013.09.041	http://dx.doi.org/10.1016/j.cell.2013.09.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243015	Green Accepted, Bronze			2022-12-28	WOS:000326571800011
J	Pollier, J; Moses, T; Gonzalez-Guzman, M; De Geyter, N; Lippens, S; Vanden Bossche, R; Marhavy, P; Kremer, A; Morreel, K; Guerin, CJ; Tava, A; Oleszek, W; Thevelein, JM; Campos, N; Goormachtig, S; Goossens, A				Pollier, Jacob; Moses, Tessa; Gonzalez-Guzman, Miguel; De Geyter, Nathan; Lippens, Saskia; Vanden Bossche, Robin; Marhavy, Peter; Kremer, Anna; Morreel, Kris; Guerin, Christopher J.; Tava, Aldo; Oleszek, Wieslaw; Thevelein, Johan M.; Campos, Narciso; Goormachtig, Sofie; Goossens, Alain			The protein quality control system manages plant defence compound synthesis	NATURE			English	Article							3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; TRITERPENOID GLYCOSIDES; MEDICAGO; BIOSYNTHESIS; DEGRADATION; SAPONINS; GENE; IDENTIFICATION; EVOLUTION; SOFTWARE	Jasmonates are ubiquitous oxylipin-derived phytohormones that are essential in the regulation of many development, growth and defence processes. Across the plant kingdom, jasmonates act as elicitors of the production of bioactive secondary metabolites that serve in defence against attackers(1-3). Knowledge of the conserved jasmonate perception and early signalling machineries is increasing(3-6), but the downstream mechanisms that regulate defence metabolism remain largely unknown. Here we show that, in the legume Medicago truncatula, jasmonate recruits the endoplasmic-reticulum-associated degradation (ERAD) quality control system to manage the production of triterpene saponins, widespread bioactive compounds that share a biogenic origin with sterols(7-9). An ERAD-type RING membrane-anchor E3 ubiquitin ligase is co-expressed with saponin synthesis enzymes to control the activity of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the rate-limiting enzyme in the supply of the ubiquitous terpene precursor isopentenyl diphosphate. Thus, unrestrained bioactive saponin accumulation is prevented and plant development and integrity secured. This control apparatus is equivalent to the ERAD system that regulates sterol synthesis in yeasts and mammals but that uses distinct E3 ubiquitin ligases, of the HMGR degradation 1 (HRD1) type, to direct destruction of HMGR(10-13). Hence, the general principles for the management of sterol and triterpene saponin biosynthesis are conserved across eukaryotes but can be controlled by divergent regulatory cues.	[Pollier, Jacob; Moses, Tessa; Gonzalez-Guzman, Miguel; De Geyter, Nathan; Vanden Bossche, Robin; Marhavy, Peter; Morreel, Kris; Goormachtig, Sofie; Goossens, Alain] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Pollier, Jacob; Moses, Tessa; Gonzalez-Guzman, Miguel; De Geyter, Nathan; Vanden Bossche, Robin; Marhavy, Peter; Morreel, Kris; Goormachtig, Sofie; Goossens, Alain] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Moses, Tessa; Thevelein, Johan M.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Belgium; [Moses, Tessa; Thevelein, Johan M.] VIB, Dept Mol Microbiol, B-3001 Louvain, Belgium; [Lippens, Saskia; Kremer, Anna; Guerin, Christopher J.] VIB, VIB Bio Imaging Core Gent, B-9052 Ghent, Belgium; [Lippens, Saskia; Kremer, Anna; Guerin, Christopher J.] VIB, Inflammat Res Ctr, B-9052 Ghent, Belgium; [Tava, Aldo] Ctr Ric Prod Foraggere & Lattiero Casearie, Consiglio Ric & Sperimentaz Agr, I-26900 Lodi, Italy; [Oleszek, Wieslaw] State Res Inst, Inst Soil Sci & Plant Cultivat, Dept Biochem, PL-24100 Pulawy, Poland; [Campos, Narciso] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Campos, Narciso] Consorci CSIC IRTA UAB UB, Ctr Recerca Agrigen, Dept Mol Genet, Barcelona 08193, Spain	Flanders Institute for Biotechnology (VIB); Ghent University; KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Institute of Soil Science & Plant Cultivation; University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA	Goossens, A (corresponding author), VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	alain.goossens@psb.vib-ugent.be	Pollier, Jacob/B-3091-2012; Gonzalez-Guzman, Miguel/N-6878-2019; Guerin, Christopher/AAM-3233-2020; Moses, Tessa/AAU-7383-2021; Thevelein, Johan M./AAK-4203-2021; Gonzalez-Guzman, Miguel/F-2318-2014; Campos, Narciso/L-3608-2017	Pollier, Jacob/0000-0002-1134-9238; Gonzalez-Guzman, Miguel/0000-0003-1000-9255; Moses, Tessa/0000-0001-9366-4727; Gonzalez-Guzman, Miguel/0000-0003-1000-9255; Marhavy, Peter/0000-0002-0178-2230; Lippens, Saskia/0000-0002-8261-3462; Oleszek, Wieslaw/0000-0002-4189-6603; Goossens, Alain/0000-0002-1599-551X; Thevelein, Johan/0000-0002-2626-0180; Campos, Narciso/0000-0002-9685-0549; Aldo, Tava/0000-0003-4657-4053; Goormachtig, Sofie/0000-0001-6195-9889	Agency for Innovation by Science and Technology in Flanders [SBO040093]; European Union [222716]; Spanish Ministerio de Economia y Competitividad [BFU2011-24208]; VIB International PhD Fellowship Program; Agency for Innovation by Science and Technology	Agency for Innovation by Science and Technology in Flanders; European Union(European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government); VIB International PhD Fellowship Program; Agency for Innovation by Science and Technology	We thank W. Ardiles-Diaz, S. Carbonelle, R. Dasseville, R. De Rycke and L. Ingelbrecht for technical assistance, and R. Dixon, H. Ezura, R. Hampton, A. Stolz and D. Wolf for providing plant and yeast materials. This research has received funding from the Agency for Innovation by Science and Technology in Flanders ('Strategisch Basisonderzoek' Combiplan project SBO040093), the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement number 222716 SMARTCELL and the Spanish Ministerio de Economia y Competitividad under grant BFU2011-24208. T. M. and N.D.G. are indebted to the VIB International PhD Fellowship Program and the Agency for Innovation by Science and Technology for predoctoral fellowships, respectively. J.P. and S. L. are postdoctoral fellows of the Research Foundation Flanders (FWO).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bassard JE, 2012, PLANT CELL, V24, P4465, DOI 10.1105/tpc.112.102566; Bialy Z, 2006, J AGR FOOD CHEM, V54, P2520, DOI 10.1021/jf0581628; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; De Sutter V, 2005, PLANT J, V44, P1065, DOI 10.1111/j.1365-313X.2005.02586.x; Dixon RA, 2003, PLANT PHYSIOL, V131, P878, DOI 10.1104/pp.102.017319; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hemmerlin A, 2013, PLANT SCI, V203, P41, DOI 10.1016/j.plantsci.2012.12.008; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kevei Z, 2007, PLANT CELL, V19, P3974, DOI 10.1105/tpc.107.053975; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kobayashi T, 2002, THEOR APPL GENET, V104, P779, DOI 10.1007/s00122-001-0838-4; Leivar P, 2011, PLANT CELL, V23, P1494, DOI 10.1105/tpc.110.074278; Memelink J, 2009, PHYTOCHEMISTRY, V70, P1560, DOI 10.1016/j.phytochem.2009.09.004; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Morreel K, 2010, ANAL CHEM, V82, P8095, DOI 10.1021/ac100968g; Moses T, 2013, NEW PHYTOL, V200, P27, DOI 10.1111/nph.12325; Mylona P, 2008, PLANT CELL, V20, P201, DOI 10.1105/tpc.107.056531; OLESZEK W, 1990, J SCI FOOD AGR, V53, P477, DOI 10.1002/jsfa.2740530406; OLESZEK W, 1990, J AGR FOOD CHEM, V38, P1810, DOI 10.1021/jf00099a006; Osbourn A, 2011, NAT PROD REP, V28, P1261, DOI 10.1039/c1np00015b; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pollier J, 2011, J NAT PROD, V74, P1462, DOI 10.1021/np200218r; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tava A, 2005, J AGR FOOD CHEM, V53, P9954, DOI 10.1021/jf052468x; Tava A, 2011, J AGR FOOD CHEM, V59, P6142, DOI 10.1021/jf2005854; Tava A, 2009, J AGR FOOD CHEM, V57, P2826, DOI 10.1021/jf8036984; Underwood BA, 2006, PLANT BIOTECHNOL J, V4, P317, DOI 10.1111/j.1467-7652.2006.00183.x; van Damme D, 2006, PLANT CELL, V18, P3502, DOI 10.1105/tpc.106.040923; Van Leene J, 2007, MOL CELL PROTEOMICS, V6, P1226, DOI 10.1074/mcp.M700078-MCP200; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wilke SA, 2013, J NEUROSCI, V33, P507, DOI 10.1523/JNEUROSCI.1600-12.2013; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	50	84	86	3	159	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					148	+		10.1038/nature12685	http://dx.doi.org/10.1038/nature12685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24213631	Green Submitted, Green Accepted			2022-12-28	WOS:000327851700049
J	Viaud, S; Saccheri, F; Mignot, G; Yamazaki, T; Daillere, R; Hannani, D; Enot, DP; Pfirschke, C; Engblom, C; Pittet, MJ; Schlitzer, A; Ginhoux, F; Apetoh, L; Chachaty, E; Woerther, PL; Eberl, G; Berard, M; Ecobichon, C; Clermont, D; Bizet, C; Gaboriau-Routhiau, V; Cerf-Bensussan, N; Opolon, P; Yessaad, N; Vivier, E; Ryffel, B; Elson, CO; Dore, J; Kroemer, G; Lepage, P; Boneca, IG; Ghiringhelli, F; Zitvogel, L				Viaud, Sophie; Saccheri, Fabiana; Mignot, Gregoire; Yamazaki, Takahiro; Daillere, Romain; Hannani, Dalil; Enot, David P.; Pfirschke, Christina; Engblom, Camilla; Pittet, Mikael J.; Schlitzer, Andreas; Ginhoux, Florent; Apetoh, Lionel; Chachaty, Elisabeth; Woerther, Paul-Louis; Eberl, Gerard; Berard, Marion; Ecobichon, Chantal; Clermont, Dominique; Bizet, Chantal; Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine; Opolon, Paule; Yessaad, Nadia; Vivier, Eric; Ryffel, Bernhard; Elson, Charles O.; Dore, Joel; Kroemer, Guido; Lepage, Patricia; Boneca, Ivo Gomperts; Ghiringhelli, Francois; Zitvogel, Laurence			The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide	SCIENCE			English	Article							BARRIER; CELLS	Cyclophosphamide is one of several clinically important cancer drugs whose therapeutic efficacy is due in part to their ability to stimulate antitumor immune responses. Studying mouse models, we demonstrate that cyclophosphamide alters the composition of microbiota in the small intestine and induces the translocation of selected species of Gram-positive bacteria into secondary lymphoid organs. There, these bacteria stimulate the generation of a specific subset of "pathogenic" T helper 17 (pT(H)17) cells and memory T(H)1 immune responses. Tumor-bearing mice that were germ-free or that had been treated with antibiotics to kill Gram-positive bacteria showed a reduction in pT(H)17 responses, and their tumors were resistant to cyclophosphamide. Adoptive transfer of pT(H)17 cells partially restored the antitumor efficacy of cyclophosphamide. These results suggest that the gut microbiota help shape the anticancer immune response.	[Viaud, Sophie; Saccheri, Fabiana; Yamazaki, Takahiro; Daillere, Romain; Hannani, Dalil; Zitvogel, Laurence] INSERM, U1015, Equipe Labellisee Ligue Natl Canc, Inst Gustave Roussy, Villejuif, France; [Zitvogel, Laurence] Inst Gustave Roussy, Ctr Invest Clin Biotherapie, CICBT 507, Villejuif, France; [Viaud, Sophie; Daillere, Romain; Zitvogel, Laurence] Univ Paris Sud, Le Kremlin Bicetre, France; [Mignot, Gregoire; Apetoh, Lionel; Ghiringhelli, Francois] INSERM, U866, Ctr Georges Francois Leclerc, Dijon, France; [Mignot, Gregoire; Apetoh, Lionel; Ghiringhelli, Francois] INSERM, Grp Avenir, Dijon, France; [Ghiringhelli, Francois] Univ Bourgogne, Fac Med, Dijon, France; [Enot, David P.; Kroemer, Guido] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Enot, David P.; Kroemer, Guido] Inst Gustave Roussy, Metab & Cell Biol, Villejuif, France; [Pfirschke, Christina; Engblom, Camilla; Pittet, Mikael J.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Pfirschke, Christina; Engblom, Camilla; Pittet, Mikael J.] Harvard Univ, Sch Med, Boston, MA USA; [Schlitzer, Andreas; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN Agcy Sci, Singapore, Singapore; [Chachaty, Elisabeth; Woerther, Paul-Louis] Inst Gustave Roussy, Microbiol Serv, Villejuif, France; [Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, Paris, France; [Berard, Marion] Inst Pasteur, Animalerie Cent, Paris, France; [Ecobichon, Chantal; Boneca, Ivo Gomperts] Inst Pasteur, Unit Biol & Genet Bacterial Cell Wall, Paris, France; [Ecobichon, Chantal; Boneca, Ivo Gomperts] INSERM, Grp Avenir, Paris, France; [Clermont, Dominique; Bizet, Chantal] Inst Pasteur, Collect Inst Pasteur, Paris, France; [Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine; Dore, Joel; Lepage, Patricia] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine] Univ Paris 05, INSERM, U989, F-75730 Paris, France; [Opolon, Paule] Inst Gustave Roussy, IFR54, Villejuif, France; [Opolon, Paule] Inst Gustave Roussy, IRCIV, Lab Pathol Expt, Villejuif, France; [Yessaad, Nadia; Vivier, Eric] Aix Marseille Univ UM2, Ctr Immunol Marseille Luminy, Marseille, France; [Yessaad, Nadia; Vivier, Eric] INSERM, UMR 1104, F-13258 Marseille, France; [Yessaad, Nadia; Vivier, Eric] Ctr Natl Rech Sci, UMR 7280, Marseille, France; [Yessaad, Nadia; Vivier, Eric] Hop Conception, Assistance Publ Hop Marseille, Marseille, France; [Ryffel, Bernhard] Univ Orleans, CNRS, Lab Mol & Expt Immunol & Neurogenet, UMR 7355, Orleans, France; [Elson, Charles O.] Univ Alabama Birmingham, Birmingham, AL USA; [Dore, Joel; Lepage, Patricia] AgroParisTech, Micalis UMR1319, F-78352 Jouy En Josas, France; [Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Georges-Francois Leclerc; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Agency for Science Technology & Research (A*STAR); UNICANCER; Gustave Roussy; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Alabama System; University of Alabama Birmingham; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), INSERM, U1015, Equipe Labellisee Ligue Natl Canc, Inst Gustave Roussy, Villejuif, France.	laurence.zitvogel@gustaveroussy.fr	Mignot, Grégoire/R-4976-2017; GABORIAU-ROUTHIAU, Valérie/H-9493-2017; Vivier, Eric/F-8939-2010; Cerf-Bensussan, nadine/H-9505-2017; Pittet, Mikael/ABD-6300-2021; Dore, Joel/ABA-8921-2020; Boneca, Ivo G/H-1677-2014; Hannani, Dalil/AAH-4598-2019; Apetoh, Lionel/G-3310-2014; Schlitzer, Andreas/R-2237-2016; Apetoh, Lionel/AIC-2384-2022; WOERTHER, Paul-Louis/AAC-4637-2019; Kroemer, Guido/AAY-9859-2020; Lepage, Patricia/D-4362-2014; Eberl, Gerard/A-1160-2013; Woerther, Paul-Louis/ABD-9084-2020; KROEMER, Guido/B-4263-2013	Mignot, Grégoire/0000-0002-0682-0152; GABORIAU-ROUTHIAU, Valérie/0000-0002-7662-4034; Vivier, Eric/0000-0001-7022-8287; Cerf-Bensussan, nadine/0000-0003-0665-1245; Boneca, Ivo G/0000-0001-8122-509X; Hannani, Dalil/0000-0001-5097-1401; Apetoh, Lionel/0000-0002-2774-438X; Schlitzer, Andreas/0000-0001-7662-3712; Apetoh, Lionel/0000-0002-2774-438X; Lepage, Patricia/0000-0002-9501-6771; Woerther, Paul-Louis/0000-0002-6957-9482; KROEMER, Guido/0000-0002-9334-4405; ZITVOGEL, laurence/0000-0003-1596-0998; Eberl, Gerard/0000-0002-1119-5638; ghiringhelli, francois/0000-0002-5465-8305	Institut National du Cancer (INCa); la Ligue contre le cancer (LIGUE labelisee); SIRIC Socrates; LABEX; PACRI Onco-Immunology; European Research Council [202283]; NIH [P01DK071176]; NATIONAL CANCER INSTITUTE [P50CA086355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176] Funding Source: NIH RePORTER	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); la Ligue contre le cancer (LIGUE labelisee); SIRIC Socrates; LABEX; PACRI Onco-Immunology; European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Angelique (Institut Pasteur), C. Flament, M. Vetizou (Gustave Roussy), and K. LeRoux (INRA) for technical assistance. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by Institut National du Cancer (INCa), la Ligue contre le cancer (LIGUE labelisee, L.Z., G.K.), SIRIC Socrates, LABEX, and PACRI Onco-Immunology, European Research Council Advanced Grant (to G.K.), and European Research Council starting grant (PGNfromSHAPEtoVIR no. 202283 to I.G.B.), and partially supported by NIH grant P01DK071176 (C.O.E.).	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Fishman N, 2006, AM J INFECT CONTROL, V34, pS64, DOI 10.1016/j.ajic.2006.05.229; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Ghiringhelli F, 2004, EUR J IMMUNOL, V34, P336, DOI 10.1002/eji.200324181; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Rice LB, 2006, AM J INFECT CONTROL, V34, pS11, DOI 10.1016/j.ajic.2006.05.220; Schiavoni G, 2011, CANCER RES, V71, P768, DOI 10.1158/0008-5472.CAN-10-2788; Sistigu A, 2011, SEMIN IMMUNOPATHOL, V33, P369, DOI 10.1007/s00281-011-0245-0; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Viaud S, 2011, CANCER RES, V71, P661, DOI 10.1158/0008-5472.CAN-10-1259; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang J, 2013, EUR J PHARMACOL, V714, P120, DOI 10.1016/j.ejphar.2013.06.006; Zwielehner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028654	24	1147	1244	24	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					971	976		10.1126/science.1240537	http://dx.doi.org/10.1126/science.1240537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264990	Green Accepted			2022-12-28	WOS:000327223500041
J	Bissell, M				Bissell, Mina			The risks of the replication drive	NATURE			English	Editorial Material							BASEMENT-MEMBRANE; DIFFERENTIATION		Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bissell, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	mjbissell@lbl.gov			NCI NIH HHS [R37 CA064786] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA064786] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2013, NATURE, V496, P398; [Anonymous], 2012, NATURE MED, V18, P1443; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Naik G., 2011, THE WALL STREET JOUR; Onodera Y., J CLIN INVEST IN THE; Ordinario E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051786; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Wadman M, 2013, NATURE, V500, P14, DOI 10.1038/500014a	9	56	58	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					333	334		10.1038/503333a	http://dx.doi.org/10.1038/503333a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24273798	Bronze			2022-12-28	WOS:000327163200017
J	Taylor, MS; LaCava, J; Mita, P; Molloy, KR; Huang, CRL; Li, DH; Adney, EM; Jiang, H; Burns, KH; Chait, BT; Rout, MP; Boeke, JD; Dai, LX				Taylor, Martin S.; LaCava, John; Mita, Paolo; Molloy, Kelly R.; Huang, Cheng Ran Lisa; Li, Donghui; Adney, Emily M.; Jiang, Hua; Burns, Kathleen H.; Chait, Brian T.; Rout, Michael P.; Boeke, Jef D.; Dai, Lixin			Affinity Proteomics Reveals Human Host Factors Implicated in Discrete Stages of LINE-1 Retrotransposition	CELL			English	Article							PRIMED REVERSE TRANSCRIPTION; LONG INTERSPERSED ELEMENT-1; HUMAN L1 RETROTRANSPOSITION; ORF1 PROTEIN; RNA INTERFERENCE; DNA-REPLICATION; CULTURED-CELLS; ENDONUCLEASE; COMPLEXES; REQUIREMENTS	LINE-1s are active human DNA parasites that are agents of genome dynamics in evolution and disease. These streamlined elements require host factors to complete their life cycles, whereas hosts have developed mechanisms to combat retrotransposition's mutagenic effects. As such, endogenous L1 expression levels are extremely low, creating a roadblock for detailed interactomic analyses. Here, we describe a system to express and purify highly active L1 RNP complexes from human suspension cell culture and characterize the copurified proteome, identifying 37 high-confidence candidate interactors. These data sets include known interactors PABPC1 and MOV10 and, with in-cell imaging studies, suggest existence of at least three types of compositionally and functionally distinct L1 RNPs. Among the findings, UPF1, a key nonsense-mediated decay factor, and PCNA, the polymerase-delta-associated sliding DNA clamp, were identified and validated. PCNA interacts with ORF2p via a PIP box motif; mechanistic studies suggest that this occurs during or immediately after target-primed reverse transcription.	[Taylor, Martin S.; Mita, Paolo; Huang, Cheng Ran Lisa; Li, Donghui; Adney, Emily M.; Boeke, Jef D.; Dai, Lixin] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Taylor, Martin S.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [LaCava, John; Jiang, Hua; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10021 USA; [Mita, Paolo; Huang, Cheng Ran Lisa; Li, Donghui; Adney, Emily M.; Boeke, Jef D.; Dai, Lixin] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Molloy, Kelly R.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; [Huang, Cheng Ran Lisa; Li, Donghui; Adney, Emily M.; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Rockefeller University; Johns Hopkins University; Rockefeller University; Johns Hopkins University; Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.	jboeke@jhmi.edu; lxdai@jhmi.edu	Li, Donghui/AAE-9310-2021; Rout, Michael/Y-7090-2018; LaCava, John P/H-2840-2013	LaCava, John P/0000-0002-6307-7713; Burns, Kathleen/0000-0003-1620-3761; Taylor, Martin/0000-0003-1560-9276; Rout, Michael/0000-0003-2010-706X; Taylor, Martin/0000-0001-5824-142X	NIH [U54 GM103511, R01 GM36481, U54 GM103520, P41 GM103314]; NATIONAL CANCER INSTITUTE [R01CA163705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103314, U54GM103520, U54GM103511, T32GM007814, P50GM107632, R01GM036481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jeffrey Han for gifts of antibodies and helpful discussions; Phil Cole and Carolyn Machamer for helpful discussion and critical reading of the manuscript; Jennifer Wang, Chih-Yung Lee, and Geraldine Seydoux for assistance with confocal microscopy and helpful discussions; and Yana Li, Dan Leahy, Jennifer Kavran, and Jacqueline McCabe for help with suspension cell culture. The DNA template for artwork in Figure 7 was adapted from http://www.dragonartz.net with permission. This work was supported in part by NIH grant U54 GM103511 to M.P.R. and B.T.C., grants R01 GM36481 and U54 GM103520 to J.D.B., and grant P41 GM103314 to B.T.C.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; An WF, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-2; Arjan-Odedra S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-53; Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Beattie TR, 2011, BIOCHEM SOC T, V39, P70, DOI 10.1042/BST0390070; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Belancio VP, 2007, GENE, V390, P98, DOI 10.1016/j.gene.2006.07.029; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Buzdin A, 2002, GENOMICS, V80, P402, DOI 10.1006/geno.2002.6843; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Dai LX, 2012, MOL CELL BIOL, V32, P4323, DOI 10.1128/MCB.06785-11; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Domanski Michal, 2012, Biotechniques, V0, P1, DOI 10.2144/000113864; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Fuchs G, 2006, NAT STRUCT MOL BIOL, V13, P1002, DOI 10.1038/nsmb1156; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Goodier JL, 2013, NUCLEIC ACIDS RES, V41, P7401, DOI 10.1093/nar/gkt512; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Goodier JL, 2010, HUM MOL GENET, V19, P1712, DOI 10.1093/hmg/ddq048; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Khazina E, 2011, NAT STRUCT MOL BIOL, V18, P1006, DOI 10.1038/nsmb.2097; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kubota T, 2013, MOL CELL, V50, P273, DOI 10.1016/j.molcel.2013.02.012; Kulpa DA, 2005, HUM MOL GENET, V14, P3237, DOI 10.1093/hmg/ddi354; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Mandal PK, 2013, HUM MOL GENET, V22, P3730, DOI 10.1093/hmg/ddt225; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; O'Donnell KA, 2013, P NATL ACAD SCI USA, V110, pE2706, DOI 10.1073/pnas.1302504110; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Peddigari S, 2013, NUCLEIC ACIDS RES, V41, P575, DOI 10.1093/nar/gks1075; Repanas K, 2007, NUCLEIC ACIDS RES, V35, P4914, DOI 10.1093/nar/gkm516; Repanas K, 2009, PROTEINS, V74, P917, DOI 10.1002/prot.22201; Rosenbaum J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003906; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shigeoka T, 2012, NUCLEIC ACIDS RES, V40, P6887, DOI 10.1093/nar/gks344; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Soifer HS, 2005, NUCLEIC ACIDS RES, V33, P846, DOI 10.1093/nar/gki223; Suzuki J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000461; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Tani H, 2012, RNA BIOL, V9, P1370, DOI 10.4161/rna.22360; Ulrich HD, 2011, FEBS LETT, V585, P2861, DOI 10.1016/j.febslet.2011.05.028; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weichenrieder O, 2004, STRUCTURE, V12, P975, DOI 10.1016/j.str.2004.04.011; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	70	122	124	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1034	1048		10.1016/j.cell.2013.10.021	http://dx.doi.org/10.1016/j.cell.2013.10.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267889	Green Accepted, Bronze			2022-12-28	WOS:000327500600009
J	Kussmaul, WG				Kussmaul, William G., III			Too Lazy for Primary Care?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Med Coll Penn & Hahnemann Univ, Philadelphia, PA 19102 USA	Drexel University	Kussmaul, WG (corresponding author), Med Coll Penn & Hahnemann Univ, 230 North Broad St,Room 1536,South Tower, Philadelphia, PA 19102 USA.	w.kussmaul@verizon.net						COLWILL JM, 1992, NEW ENGL J MED, V326, P387, DOI 10.1056/NEJM199202063260606; Leigh JP, 2011, ARCH INTERN MED, V171, P1211, DOI 10.1001/archinternmed.2011.294; Mintz M, 2013, PRIMARY CARE PROGR; Novak S, 2013, NY TIMES; Senf JH, 2003, J AM BOARD FAM PRACT, V16, P502, DOI 10.3122/jabfm.16.6.502	5	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10					711	+		10.7326/0003-4819-159-10-201311190-00010	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-00010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247676				2022-12-28	WOS:000328732700020
J	Ji, N; Middelkoop, TC; Mentink, RA; Betist, MC; Tonegawa, S; Mooijman, D; Korswagen, HC; van Oudenaarden, A				Ji, Ni; Middelkoop, Teije C.; Mentink, Remco A.; Betist, Marco C.; Tonegawa, Satto; Mooijman, Dylan; Korswagen, Hendrik C.; van Oudenaarden, Alexander			Feedback Control of Gene Expression Variability in the Caenorhabditis elegans Wnt Pathway	CELL			English	Article							SINGLE-MOLECULE LEVEL; POSITIVE-FEEDBACK; C-ELEGANS; FLUCTUATING ENVIRONMENTS; NOISE-PROPAGATION; PHENOTYPIC DIVERSITY; REGULATORY NETWORKS; STOCHASTIC NATURE; ESCHERICHIA-COLI; CELL-MIGRATION	Variability in gene expression contributes to phenotypic heterogeneity even in isogenic populations. Here, we used the stereotyped, Wnt signaling-dependent development of the Caenorhabditis elegans Q neuroblast to probe endogenous mechanisms that control gene expression variability. We found that the key Hox gene that orients Q neuroblast migration exhibits increased gene expression variability in mutants in which Wnt pathway activity has been perturbed. Distinct features of the gene expression distributions prompted us on a systematic search for regulatory interactions, revealing a network of interlocked positive and negative feedback loops. Interestingly, positive feedback appeared to cooperate with negative feedback to reduce variability while keeping the Hox gene expression at elevated levels. A minimal model correctly predicts the increased gene expression variability across mutants. Our results highlight the influence of gene network architecture on expression variability and implicate feedback regulation as an effective mechanism to ensure developmental robustness.	[Ji, Ni] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Middelkoop, Teije C.; Mentink, Remco A.; Betist, Marco C.; Mooijman, Dylan; Korswagen, Hendrik C.; van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Middelkoop, Teije C.; Mentink, Remco A.; Betist, Marco C.; Mooijman, Dylan; Korswagen, Hendrik C.; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Tonegawa, Satto] Milton Acad, Milton, MA 02186 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Korswagen, HC (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	r.korswagen@hubrecht.eu; a.vanoudenaarden@hubrecht.eu	van Oudenaarden, Alexander/AAA-1705-2019; Middelkoop, Teije/AGH-5328-2022; Korswagen, Hendrik/I-8782-2012	Middelkoop, Teije/0000-0002-0346-6143; Mentink, Remco/0000-0003-1005-7767	NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; NIH Pioneer award [DP1CA174420]; ERC Advanced grant [2011-294325_GeneNoiseControl]; Dutch Cancer Society [HUBR 2008-4114]; NATIONAL CANCER INSTITUTE [U54CA143874, DP1CA174420] Funding Source: NIH RePORTER	NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC Advanced grant; Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874), a NIH Pioneer award (DP1CA174420), an ERC Advanced grant (2011-294325_GeneNoiseControl) (A.v.O.), and a grant from the Dutch Cancer Society (HUBR 2008-4114) (H. C. K.). We thank N. Paquin for MosSCI cloning vector, N. Bhatla and Y. Zheng for help with strain construction, D. Grun for identifying enriched MAB-5 binding motifs, K. Cadigan for information on putative TCF binding sites, J. Goncalves and Y. Yuan for discussion on network inference, C. Kenyon, K. Shen, H. Sawa, H. R. Horvitz, and the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis) for strains and transgenes, and we also thank H. R. Horvitz, J. Slotine, E. Nedivi, E. Sontag, D. Del Vecchio, G. Neuert, S. Itzkovitz, M. Bienko, and T. Okubo for critical discussion on the project.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Aranda-Anzaldo A, 2003, MECH AGEING DEV, V124, P711, DOI 10.1016/S0047-6374(03)00089-7; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Boettiger AN, 2013, CELL REP, V3, P8, DOI 10.1016/j.celrep.2012.12.015; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Bruggeman FJ, 2002, J THEOR BIOL, V218, P507, DOI 10.1006/jtbi.2002.3096; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chung HJ, 2005, MOL CELLS, V20, P157; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Harris J, 1996, DEVELOPMENT, V122, P3117; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Nijhout HF, 2002, BIOESSAYS, V24, P553, DOI 10.1002/bies.10093; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Sato A, 1999, DEVELOPMENT, V126, P4421; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290	71	59	60	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					869	880		10.1016/j.cell.2013.09.060	http://dx.doi.org/10.1016/j.cell.2013.09.060			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209624	Bronze			2022-12-28	WOS:000326934300016
J	Ho, YC; Shan, L; Hosmane, NN; Wang, J; Laskey, SB; Rosenbloom, DIS; Lai, J; Blankson, JN; Siliciano, JD; Siliciano, RF				Ho, Ya-Chi; Shan, Liang; Hosmane, Nina N.; Wang, Jeffrey; Laskey, Sarah B.; Rosenbloom, Daniel I. S.; Lai, Jun; Blankson, Joel N.; Siliciano, Janet D.; Siliciano, Robert F.			Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; LONG TERMINAL REPEAT; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; RNA-POLYMERASE; IN-VIVO; TYPE-1; PROMOTER	Antiretroviral therapy fails to cure HIV-1 infection because latent proviruses persist in resting CD4(+) T cells. T cell activation reverses latency, but <1% of proviruses are induced to release infectious virus after maximum in vitro activation. The noninduced proviruses are generally considered defective but have not been characterized. Analysis of 213 noninduced proviral clones from treated patients showed 88.3% with identifiable defects but 11.7% with intact genomes and normal long terminal repeat (LTR) function. Using direct sequencing and genome synthesis, we reconstructed full-length intact noninduced proviral clones and demonstrated growth kinetics comparable to reconstructed induced proviruses from the same patients. Noninduced proviruses have unmethylated promoters and are integrated into active transcription units. Thus, it cannot be excluded that they may become activated in vivo. The identification of replication-competent noninduced proviruses indicates that the size of the latent reservoir-and, hence, the barrier to cure-may be up to 60-fold greater than previously estimated.	[Ho, Ya-Chi; Shan, Liang; Hosmane, Nina N.; Laskey, Sarah B.; Lai, Jun; Blankson, Joel N.; Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Wang, Jeffrey] Louisiana State Univ, Sch Med, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Rosenbloom, Daniel I. S.] Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Harvard University; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu	Shan, Liang/ABB-9210-2021	Ho, Ya-Chi/0000-0002-7046-0147	amfAR as part of the amfAR Research Collaboration on HIV Eradication (ARCHE); Martin Delaney CARE and DARE Collaboratories (National Institutes of Health [NIH] [AI096113, AI096109]; NIH [AI043222]; Johns Hopkins Center for AIDS Research; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, U19AI096113, U19AI096109, R37AI051178, R01AI043222] Funding Source: NIH RePORTER	amfAR as part of the amfAR Research Collaboration on HIV Eradication (ARCHE); Martin Delaney CARE and DARE Collaboratories (National Institutes of Health [NIH]; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Center for AIDS Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all study participants. We thank S. Alireza Rabi, Gregory Laird, and Drs. Stuart Ray and Joel Pomerantz for critical advice; Linda Alston for patient recruitment; David Walker for advice on CpG methylation; and Dr. Gautam Sahu for PCR suggestions. This work was supported by amfAR as part of the amfAR Research Collaboration on HIV Eradication (ARCHE) and also by the Martin Delaney CARE and DARE Collaboratories (National Institutes of Health [NIH] Grants AI096113 and AI096109), by NIH Grant AI043222, by the Johns Hopkins Center for AIDS Research, and by the Howard Hughes Medical Institute. Y.-C.H. is a Howard Hughes Medical Institute International Student Research Fellow.	Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; Blazkova J, 2012, J VIROL, V86, P5390, DOI 10.1128/JVI.00040-12; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Chakraborty AK, 2010, NAT REV IMMUNOL, V10, P59, DOI 10.1038/nri2688; Chavez L, 2011, METHODS, V53, P47, DOI 10.1016/j.ymeth.2010.05.009; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Durand CM, 2012, J INFECT DIS, V205, P1014, DOI 10.1093/infdis/jir884; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sanchez G, 1997, J VIROL, V71, P2233, DOI 10.1128/JVI.71.3.2233-2240.1997; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; SELBY MJ, 1990, CELL, V62, P769, DOI 10.1016/0092-8674(90)90121-T; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shan L, 2011, J VIROL, V85, P5384, DOI 10.1128/JVI.02536-10; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Spivak AM, 2011, J VIROL, V85, P10399, DOI 10.1128/JVI.05409-11; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VICENZI E, 1994, J VIROL, V68, P7879, DOI 10.1128/JVI.68.12.7879-7890.1994; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2007, CYTOKINE, V39, P63, DOI 10.1016/j.cyto.2007.05.017; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	58	907	921	3	85	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					540	551		10.1016/j.cell.2013.09.020	http://dx.doi.org/10.1016/j.cell.2013.09.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243014	Bronze, Green Accepted			2022-12-28	WOS:000326571800010
J	Frieden, TR; King, SMC; Wright, JS				Frieden, Thomas R.; King, Sallyann M. Coleman; Wright, Janet S.			Protocol-Based Treatment of Hypertension A Critical Step on the Pathway to Progress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-PRESSURE; TRENDS		[Frieden, Thomas R.; King, Sallyann M. Coleman; Wright, Janet S.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.	tfrieden@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Handler J, 2011, J AM SOC HYPERTENS, V5, P197, DOI 10.1016/j.jash.2011.03.002; Hypertension Detection Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.1979.03300230018021; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Luepker RV, 2012, CIRCULATION, V126, P1852, DOI 10.1161/CIRCULATIONAHA.112.098517; Valderrama Amy L., 2012, Morbidity and Mortality Weekly Report, V61, P703	7	47	47	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					21	22		10.1001/jama.2013.282615	http://dx.doi.org/10.1001/jama.2013.282615			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24231925				2022-12-28	WOS:000329161400010
J	Kruse, AC; Ring, AM; Manglik, A; Hu, JX; Hu, K; Eitel, K; Hubner, H; Pardon, E; Valant, C; Sexton, PM; Christopoulos, A; Felder, CC; Gmeiner, P; Steyaert, J; Weis, WI; Garcia, KC; Wess, J; Kobilka, BK				Kruse, Andrew C.; Ring, Aaron M.; Manglik, Aashish; Hu, Jianxin; Hu, Kelly; Eitel, Katrin; Huebner, Harald; Pardon, Els; Valant, Celine; Sexton, Patrick M.; Christopoulos, Arthur; Felder, Christian C.; Gmeiner, Peter; Steyaert, Jan; Weis, William I.; Garcia, K. Christopher; Wess, Juergen; Kobilka, Brian K.			Activation and allosteric modulation of a muscarinic acetylcholine receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; SITE-DIRECTED MUTAGENESIS; BINDING-SITE; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; AMINO-ACIDS; IDENTIFICATION; NANOBODY; LIGANDS	Despite recent advances in crystallography and the availability of G-protein-coupled receptor (GPCR) structures, little is known about the mechanism of their activation process, as only the beta(2) adrenergic receptor (beta(2)AR) and rhodopsin have been crystallized in fully active conformations. Here we report the structure of an agonist-bound, active state of the human M2 muscarinic acetylcholine receptor stabilized by a G-protein mimetic camelid antibody fragment isolated by conformational selection using yeast surface display. In addition to the expected changes in the intracellular surface, the structure reveals larger conformational changes in the extracellular region and orthosteric binding site than observed in the active states of the beta(2)AR and rhodopsin. We also report the structure of the M2 receptor simultaneously bound to the orthosteric agonist iperoxo and the positive allosteric modulator LY2119620. This structure reveals that LY2119620 recognizes a largely pre-formed binding site in the extracellular vestibule of the iperoxo-bound receptor, inducing a slight contraction of this outer binding pocket. These structures offer important insights into the activation mechanism and allosteric modulation of muscarinic receptors.	[Kruse, Andrew C.; Ring, Aaron M.; Manglik, Aashish; Weis, William I.; Garcia, K. Christopher; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ring, Aaron M.; Weis, William I.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Hu, Jianxin; Hu, Kelly; Wess, Juergen] NIDDKD, Mol Signaling Sect, Bioorgan Chem Lab, Bethesda, MD 20892 USA; [Eitel, Katrin; Huebner, Harald; Gmeiner, Peter] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91052 Erlangen, Germany; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Pardon, Els; Steyaert, Jan] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Valant, Celine; Sexton, Patrick M.; Christopoulos, Arthur] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Valant, Celine; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Felder, Christian C.] Eli Lilly & Co, Neurosci, Indianapolis, IN 46285 USA	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Erlangen Nuremberg; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Monash University; Eli Lilly	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	kobilka@stanford.edu	Christopoulos, Arthur/B-6207-2013; Steyaert, Jan/H-4662-2011; Weis, William I/G-1437-2011; Sexton, Patrick M/B-1319-2008; Gmeiner, Peter/N-5275-2015; steyaert, jan/GQP-7811-2022	Christopoulos, Arthur/0000-0003-4442-3294; Steyaert, Jan/0000-0002-3825-874X; Weis, William I/0000-0002-5583-6150; Sexton, Patrick M/0000-0001-8902-2473; Valant, Celine/0000-0002-2509-7465; Pardon, Els/0000-0002-2466-0172; Kobilka, Brian/0000-0001-5958-3990; Ring, Aaron/0000-0003-3699-2446; Felder, Christian/0000-0003-1134-8881; Gmeiner, Peter/0000-0002-4127-197X	National Science Foundation [1223785]; Stanford Medical Scientist Training Program; American Heart Association; Ruth L. Kirschstein National Research Service Award; National Institutes of Health [NS02847123, GM08311806]; Mathers Foundation; Deutsche Forschungsgemeinschaft [GM 13/10-1]; National Health and Medical Research Council (NHMRC) of Australia [519461]; NHMRC; Howard Hughes Medical Institute; Intramural Research Program, NIDDK; NIH; US Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294, U19GM106990] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Stanford Medical Scientist Training Program; American Heart Association(American Heart Association); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural Research Program, NIDDK; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the National Science Foundation (graduate fellowship to A. C. K., and Award 1223785 to B. K. K.), the Stanford Medical Scientist Training Program (A. M. and A. M. R.), the American Heart Association (A. M.), the Ruth L. Kirschstein National Research Service Award (A. M. R.), National Institutes of Health grants NS02847123 and GM08311806 (B. K. K.), the Mathers Foundation (B. K. K., W. I. W. and K. C. G.), the Deutsche Forschungsgemeinschaft for the grant GM 13/10-1 (K. E., H. H., P. G.), the National Health and Medical Research Council (NHMRC) of Australia program grant 519461 (P. M. S. and A. C.), NHMRC Principal Research Fellowships (P. M. S. and A. C.), and the Howard Hughes Medical Institute (K. C. G.). This work was supported in part by the Intramural Research Program, NIDDK, NIH, US Department of Health and Human Services (J.H., K. H. and J.W.). We thank K. Leach for performing ERK assays, and B. Davie and P. Scammells for synthesis of iperoxo. We thank H. Xiao, C. H. Croy and D. A. Schober for functional characterization of LY2119620. We thank T. S. Kobilka for preparation of affinity chromatography reagents and F. S. Thian for help with cell culture.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Broach JR, 1996, NATURE, V384, P14; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Canals M, 2012, J BIOL CHEM, V287, P650, DOI 10.1074/jbc.M111.314278; Chee MJS, 2008, J BIOL CHEM, V283, P33337, DOI 10.1074/jbc.M804671200; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; De Amici M, 2010, MED RES REV, V30, P463, DOI 10.1002/med.20166; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Digby GJ, 2010, MOL BIOSYST, V6, P1345, DOI 10.1039/c002938f; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Heitz F, 1999, EUR J PHARMACOL, V380, P183, DOI 10.1016/S0014-2999(99)00439-2; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; HUDGINS PM, 1972, J PHARMACOL EXP THER, V182, P303; Ichlyama S, 2006, FEBS LETT, V580, P23, DOI 10.1016/j.febslet.2005.11.042; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kloeckner J, 2010, TETRAHEDRON LETT, V51, P3470, DOI 10.1016/j.tetlet.2010.04.130; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; KUBO T, 1986, FEBS LETT, V209, P367, DOI 10.1016/0014-5793(86)81144-9; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Mohr K, 2003, RECEPTOR CHANNEL, V9, P229, DOI 10.1080/10606820308264; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETERSON GL, 1984, P NATL ACAD SCI-BIOL, V81, P4993, DOI 10.1073/pnas.81.15.4993; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SHAPIRO RA, 1989, BIOCHEMISTRY-US, V28, P8946, DOI 10.1021/bi00448a039; SPALDING TA, 1994, J BIOL CHEM, V269, P4092; Valant C, 2012, MOL PHARMACOL, V81, P41, DOI 10.1124/mol.111.074872; Vogel WK, 1997, MOL PHARMACOL, V52, P1087, DOI 10.1124/mol.52.6.1087; WESS J, 1992, J BIOL CHEM, V267, P19313; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	48	640	656	11	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					101	+		10.1038/nature12735	http://dx.doi.org/10.1038/nature12735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24256733	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000327851700039
J	Wohl, DA; Golin, C; Rosen, DL; May, JM; White, BL				Wohl, David Alain; Golin, Carol; Rosen, David L.; May, Jeanine M.; White, Becky L.			Detection of Undiagnosed HIV Among State Prison Entrants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wohl, David Alain] Univ N Carolina, Chapel Hill, NC 27599 USA; [Golin, Carol; May, Jeanine M.; White, Becky L.] Univ N Carolina, Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; [Rosen, David L.] Univ N Carolina, Ctr Infect Dis, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wohl, DA (corresponding author), Univ N Carolina, 130 Mason Farm Rd, Chapel Hill, NC 27599 USA.	wohl@med.unc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD069204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH094250, R01MH079720, F30MH077546] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altice FL, 1998, J ACQ IMMUN DEF SYND, V18, P444, DOI 10.1097/00042560-199808150-00005; [Anonymous], 2008 HIV STD SURV RE; [Anonymous], HIV PRISONS; Braithwaite RL, 2003, AM J PUBLIC HEALTH, V93, P759, DOI 10.2105/AJPH.93.5.759; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558	6	17	17	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2198	2199		10.1001/jama.2013.280740	http://dx.doi.org/10.1001/jama.2013.280740			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24281464	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000327404400030
J	Butler, J; Fonarow, GC; Gheorghiade, M				Butler, Javed; Fonarow, Gregg C.; Gheorghiade, Mihai			Need for Increased Awareness and Evidence-Based Therapies for Patients Hospitalized for Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; RATES		[Butler, Javed] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA 90024 USA; [Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60601 USA	Emory University; University of California System; University of California Los Angeles; Northwestern University; Feinberg School of Medicine	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 201 E Huron,Galter 3-150, Chicago, IL 60601 USA.	m-gheorghiade@northwestern.edu	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093				Allen LA, 2008, JAMA-J AM MED ASSOC, V299, P2533, DOI 10.1001/jama.299.21.2533; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2013, JAMA-J AM MED ASSOC, V309, P1125, DOI 10.1001/jama.2013.1954; Gheorghiade M, 2012, HEART FAIL REV, V17, P485, DOI 10.1007/s10741-011-9280-0; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a	8	30	30	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2035	2036		10.1001/jama.2013.282815	http://dx.doi.org/10.1001/jama.2013.282815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240925				2022-12-28	WOS:000327098900014
J	Bard, E				Bard, Edouard			Out of the African Humid Period	SCIENCE			English	Editorial Material							SAHARA; TERMINATION		[Bard, Edouard] Coll France, F-13545 Aix En Provence, France; [Bard, Edouard] Aix Marseille Univ, CEREGE, CNRS, IRD,CdF, F-13545 Aix En Provence, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Bard, E (corresponding author), Coll France, F-13545 Aix En Provence, France.	bard@cerege.fr	Bard, Edouard/G-7717-2014					Amaral PGC, 2013, CLIM PAST, V9, P223, DOI 10.5194/cp-9-223-2013; Brovkin V, 2008, SCIENCE, V322, DOI 10.1126/science.1163381; Claussen M, 2013, NAT GEOSCI, V6, P954, DOI [10.1038/ngeo1962, 10.1038/NGEO1962]; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Fleitmann D, 2007, QUATERNARY SCI REV, V26, P170, DOI 10.1016/j.quascirev.2006.04.012; Francus P, 2013, SEDIMENTOLOGY, V60, P911, DOI 10.1111/j.1365-3091.2012.01370.x; Garcin Y, 2012, EARTH PLANET SC LETT, V331, P322, DOI 10.1016/j.epsl.2012.03.016; IPCC, 2013, CONTRIBUTION WORKING; Jung SJA, 2004, EARTH PLANET SC LETT, V221, P27, DOI 10.1016/S0012-821X(04)00095-0; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; McGee D, 2013, EARTH PLANET SC LETT, V371, P163, DOI 10.1016/j.epsl.2013.03.054; ROBERTS N, 1998, HOLOCENE ENV HIST; Schuster M, 2005, QUATERNARY SCI REV, V24, P1821, DOI 10.1016/j.quascirev.2005.02.001; Tierney JE, 2013, SCIENCE, V342, P843, DOI 10.1126/science.1240411	15	17	17	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					808	809		10.1126/science.1246519	http://dx.doi.org/10.1126/science.1246519			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233711				2022-12-28	WOS:000326923000020
J	Conley, ME; Fruman, DA				Conley, Mary Ellen; Fruman, David A.			Can Cancer Drugs Treat Immunodeficiency?	SCIENCE			English	Editorial Material							B-CELL DEVELOPMENT; P85-ALPHA SUBUNIT; 3-KINASE; P110-DELTA; MUTATIONS; PATHWAY		[Conley, Mary Ellen] Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38163 USA; [Fruman, David A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Fruman, David A.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA	University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Irvine; University of California System; University of California Irvine	Conley, ME (corresponding author), Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38163 USA.	mconley@uthsc.edu; dfruman@uci.edu						Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fruman DA, 2011, CANCER DISCOV, V1, P562, DOI 10.1158/2159-8290.CD-11-0249; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lucas C. L., 2013, NAT IMMUNOL, DOI [10.103/ni.2771, DOI 10.103/NI.2771]; Okkenhaug K, 2002, SCIENCE, V297, P1031; Puri KD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00256; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882	15	7	7	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					814	815		10.1126/science.1246760	http://dx.doi.org/10.1126/science.1246760			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233715				2022-12-28	WOS:000326923000024
J	Giles, SL; Lester, F				Giles, Sarah Louise; Lester, Felicia			Should women with HIV, or at high risk of contracting HIV, use progestogen-containing contraception?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HORMONAL CONTRACEPTION; DISEASE PROGRESSION; DEPOT MEDROXYPROGESTERONE; ACQUISITION; TRANSMISSION; SAFETY		[Giles, Sarah Louise] Uganda River Life Minist, Masaka, Uganda; [Lester, Felicia] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California San Francisco	Giles, SL (corresponding author), Uganda River Life Minist, POB 985, Masaka, Uganda.	sarahgiles35@yahoo.co.uk						Baeten JM, 2007, AIDS, V21, P1771, DOI 10.1097/QAD.0b013e328270388a; Blish CA, 2011, AM J REPROD IMMUNOL, V65, P302, DOI 10.1111/j.1600-0897.2010.00930.x; Butler AR, 2013, AIDS, V27, P105, DOI 10.1097/QAD.0b013e32835a5a52; Crook A, 2013, 20 C RETR OPP INF AT; Curtis KM, 2009, AIDS, V23, pS55, DOI 10.1097/01.aids.0000363778.58203.b6; Day S, 2013, 20 C RETR OPP INF AT; Draper BH, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005214.pub2; Hapgood JP, 2004, TRENDS PHARMACOL SCI, V25, P554, DOI 10.1016/j.tips.2004.09.005; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; McCoy SI, 2013, AIDS, V27, P1001, DOI 10.1097/QAD.0b013e32835da401; Morrison CS, 2011, JAIDS-J ACQ IMM DEF, V57, P157, DOI 10.1097/QAI.0b013e318214ba4a; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Phillips SJ, 2013, AIDS, V27, P787, DOI 10.1097/QAD.0b013e32835bb672; Polis C, 2013, 20 C RETR OPP INF AT, P113; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Polis CB, 2013, AIDS, V27, P493, DOI 10.1097/QAD.0b013e32835ad539; Polis CB, 2010, AIDS, V24, P1937, DOI 10.1097/QAD.0b013e32833b3282; Stringer EM, 2009, AIDS, V23, pS69, DOI 10.1097/01.aids.0000363779.65827.e0; Stringer EM, 2009, AIDS, V23, P1377, DOI 10.1097/QAD.0b013e32832cbca8; Stringer EM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.031; Tepper Naomi K., 2012, Morbidity and Mortality Weekly Report, V61, P449; United Nations Department of Economic and Social Affairs Population Division, WORLD CONTR US 2011; Watts DH, 2008, CONTRACEPTION, V77, P84, DOI 10.1016/j.contraception.2007.10.002; WHO, 2015, MED EL CRIT CONTR US, V5th; World Health Organization Department of Reproductive Health, 2012, WHO TECHN STAT HORM	25	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 14	2013	347								f6695	10.1136/bmj.f6695	http://dx.doi.org/10.1136/bmj.f6695			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254HF	24231179				2022-12-28	WOS:000327155000003
J	Lambrecht, BN; Hammad, H				Lambrecht, Bart N.; Hammad, Hamida			Asthma and Coagulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECEPTOR 4		[Lambrecht, Bart N.] Univ Ghent, VIB Inflammat Res Ctr, B-9000 Ghent, Belgium; Univ Ghent, Dept Resp Med, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Lambrecht, BN (corresponding author), Univ Ghent, VIB Inflammat Res Ctr, B-9000 Ghent, Belgium.		Hammad, Hamida/J-9391-2015; Lambrecht, Bart N/K-2484-2014	Hammad, Hamida/0000-0003-3762-8603; Lambrecht, Bart N/0000-0003-4376-6834				Arnot CJ, 2010, J BIOL CHEM, V285, P19502, DOI 10.1074/jbc.M109.098186; de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342	5	28	28	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1964	1966		10.1056/NEJMcibr1311045	http://dx.doi.org/10.1056/NEJMcibr1311045			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300MP	24224631	Green Published			2022-12-28	WOS:000330468300016
J	Miyamachi, T; Schuh, T; Markl, T; Bresch, C; Balashov, T; Stohr, A; Karlewski, C; Andre, S; Marthaler, M; Hoffmann, M; Geilhufe, M; Ostanin, S; Hergert, W; Mertig, I; Schon, G; Ernst, A; Wulfhekel, W				Miyamachi, Toshio; Schuh, Tobias; Maerkl, Tobias; Bresch, Christopher; Balashov, Timofey; Stoehr, Alexander; Karlewski, Christian; Andre, Stephan; Marthaler, Michael; Hoffmann, Martin; Geilhufe, Matthias; Ostanin, Sergey; Hergert, Wolfram; Mertig, Ingrid; Schoen, Gerd; Ernst, Arthur; Wulfhekel, Wulf			Stabilizing the magnetic moment of single holmium atoms by symmetry	NATURE			English	Article							SPIN; ANISOTROPY; SURFACE	Single magnetic atoms, and assemblies of such atoms, on nonmagnetic surfaces have recently attracted attention owing to their potential use in high-density magnetic data storage and as a platform for quantum computing(1-8). A fundamental problem resulting from their quantum mechanical nature is that the localized magnetic moments of these atoms are easily destabilized by interactions with electrons, nuclear spins and lattice vibrations of the substrate(3-5). Even when large magnetic fields are applied to stabilize the magnetic moment, the observed lifetimes remain rather short(5,6) (less than a microsecond). Several routes for stabilizing the magnetic moment against fluctuations have been suggested, such as using thin insulating layers between the magnetic atom and the substrate to suppress the interactions with the substrate's conduction electrons(2,3,5), or coupling several magnetic moments together to reduce their quantum mechanical fluctuations(7,8). Here we show that the magnetic moments of single holmium atoms on a highly conductive metallic substrate can reach lifetimes of the order of minutes. The necessary decoupling from the thermal bath of electrons, nuclear spins and lattice vibrations is achieved by a remarkable combination of several symmetries intrinsic to the system: time reversal symmetry, the internal symmetries of the total angular momentum and the point symmetry of the local environment of the magnetic atom.	[Miyamachi, Toshio; Schuh, Tobias; Maerkl, Tobias; Bresch, Christopher; Balashov, Timofey; Stoehr, Alexander; Wulfhekel, Wulf] Karlsruhe Inst Technol KIT, Inst Phys, D-76131 Karlsruhe, Germany; [Miyamachi, Toshio] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Stoehr, Alexander] Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; [Karlewski, Christian; Andre, Stephan; Marthaler, Michael; Schoen, Gerd] Karlsruhe Inst Technol KIT, Inst Theoret Festkorperphys, D-76131 Karlsruhe, Germany; [Hoffmann, Martin; Geilhufe, Matthias; Ostanin, Sergey; Mertig, Ingrid; Ernst, Arthur] Max Planck Inst Mikrostrukturphys, D-06120 Halle, Germany; [Hoffmann, Martin; Hergert, Wolfram; Mertig, Ingrid] Univ Halle Wittenberg, Inst Phys, D-06099 Halle, Germany; [Ernst, Arthur] Univ Leipzig, Wilhelm Ostwald Inst Phys & Theoret Chem, D-04103 Leipzig, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Tokyo; Max Planck Society; Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Martin Luther University Halle Wittenberg; Leipzig University	Wulfhekel, W (corresponding author), Karlsruhe Inst Technol KIT, Inst Phys, Wolfgang Gaede Str 1, D-76131 Karlsruhe, Germany.	wulf.wulfhekel@kit.edu	Ernst, Arthur/K-1836-2012; Marthaler, Michael/J-3295-2013; Hoffmann, Martin/G-4675-2016; Schön, Gerd/A-3582-2008; Geilhufe, Matthias/S-5773-2018; Miyamachi, Toshio/Q-3428-2018	Hoffmann, Martin/0000-0002-8426-725X; Geilhufe, Matthias/0000-0001-9285-0165; Miyamachi, Toshio/0000-0002-9623-1190; Balashov, Timofey/0000-0003-0966-7920; Maerkl, Tobias/0000-0002-4206-5086; Ernst, Arthur/0000-0003-4005-6781	German Science Foundation (DFG) [Wu349/4-2, SPP 1538]; DFG Collaborative Research Centre [SFB 762]	German Science Foundation (DFG)(German Research Foundation (DFG)); DFG Collaborative Research Centre(German Research Foundation (DFG))	We acknowledge funding by the German Science Foundation (DFG) grant number Wu349/4-2, the DFG priority programme SPP 1538 Spin Caloric Transport and the DFG Collaborative Research Centre SFB 762 Functionality of Oxide Interfaces. The calculations were performed at the Rechenzentrum Garching of the Max Planck Society.	ANISIMOV VI, 1991, PHYS REV B, V44, P943, DOI 10.1103/PhysRevB.44.943; Balashov T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.257203; BLEANEY B, 1953, REP PROG PHYS, V16, P108, DOI 10.1088/0034-4885/16/1/304; Coey J. M. D., 2009, MAGNETISM MAGNETIC M, P114; Fransson J, 2009, NANO LETT, V9, P2414, DOI 10.1021/nl901066a; Gambardella P, 2003, SCIENCE, V300, P1130, DOI 10.1126/science.1082857; Hafner J, 2008, J COMPUT CHEM, V29, P2044, DOI 10.1002/jcc.21057; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Hirjibehedin CF, 2007, SCIENCE, V317, P1199, DOI 10.1126/science.1146110; Khajetoorians AA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.037205; Khajetoorians AA, 2013, SCIENCE, V339, P55, DOI 10.1126/science.1228519; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Loth S, 2012, SCIENCE, V335, P196, DOI 10.1126/science.1214131; Loth S, 2010, SCIENCE, V329, P1628, DOI [10.1126/science.1191688, 10.1126/science.191688]; Luders M, 2001, J PHYS-CONDENS MAT, V13, P8587, DOI 10.1088/0953-8984/13/38/305; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; RICHTER M, 1992, PHYS REV B, V46, P13919, DOI 10.1103/PhysRevB.46.13919; Rusponi S, 2003, NAT MATER, V2, P546, DOI 10.1038/nmat930; Schuh T, 2012, NANO LETT, V12, P4805, DOI 10.1021/nl302250n; Schuh T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104401; Wiesendanger R, 2009, REV MOD PHYS, V81, P1495, DOI 10.1103/RevModPhys.81.1495; Wybourne B. G., 1965, SPECTROSCOPIC PROPER, P166; ZELLER R, 1979, PHYS REV LETT, V42, P1713, DOI 10.1103/PhysRevLett.42.1713; Zhang L, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3646468; Zhou LH, 2010, NAT PHYS, V6, P187, DOI 10.1038/NPHYS1514	25	108	108	2	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					242	246		10.1038/nature12759	http://dx.doi.org/10.1038/nature12759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24226888				2022-12-28	WOS:000326894200047
J	van Loo, AF; Fedorov, A; Lalumiere, K; Sanders, BC; Blais, A; Wallraff, A				van Loo, Arjan F.; Fedorov, Arkady; Lalumiere, Kevin; Sanders, Barry C.; Blais, Alexandre; Wallraff, Andreas			Photon-Mediated Interactions Between Distant Artificial Atoms	SCIENCE			English	Article								Photon-mediated interactions between atoms are of fundamental importance in quantum optics, quantum simulations, and quantum information processing. The exchange of real and virtual photons between atoms gives rise to nontrivial interactions, the strength of which decreases rapidly with distance in three dimensions. Here, we use two superconducting qubits in an open one-dimensional transmission line to study much stronger photon-mediated interactions. Making use of the possibility to tune these qubits by more than a quarter of their transition frequency, we observe both coherent exchange interactions at an effective separation of 3 lambda/4 and the creation of super-and subradiant states at a separation of one photon wavelength lambda. In this system, collective atom-photon interactions and applications in quantum communication may be explored.	[van Loo, Arjan F.; Fedorov, Arkady; Wallraff, Andreas] ETH, Dept Phys, CH-8093 Zurich, Switzerland; [Lalumiere, Kevin; Blais, Alexandre] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada; [Sanders, Barry C.] Univ Calgary, Inst Quantum Sci & Technol, Calgary, AB T2N 1N4, Canada	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Sherbrooke; University of Calgary	van Loo, AF (corresponding author), ETH, Dept Phys, CH-8093 Zurich, Switzerland.	arjan@phys.ethz.ch	Blais, Alexandre/E-3315-2010; Sanders, Barry C/A-3891-2008; Fedorov, Arkady/AAW-6070-2021; Wallraff, Andreas J/C-2130-2009; Fedorov, Arkady/F-4764-2012	Blais, Alexandre/0000-0002-0591-2012; Sanders, Barry C/0000-0002-8326-8912; Fedorov, Arkady/0000-0002-9815-0968; Wallraff, Andreas J/0000-0002-3476-4485; Fedorov, Arkady/0000-0002-9815-0968; van Loo, Arjan Ferdinand/0000-0001-8038-3088	Canadian Institute for Advanced Research; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures; ETH Zurich	Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures; ETH Zurich(ETH Zurich)	We acknowledge financial support by Canadian Institute for Advanced Research, Natural Sciences and Engineering Research Council of Canada, Alberta Innovates Technology Futures, and ETH Zurich, and we thank Calcul Quebec and Compute Canada for computational resources. Furthermore, we thank L. Steffen for sample fabrication, C. Lang and Y. Salathe for realizing the firmware for measuring power spectral densities using field-programmable gate array-based electronics, M. Boissonneault for help with numerical simulations, and V. Sandoghdar for initial discussions motivating this work.	Abdumalikov AA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.043604; Abdumalikov AA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.193601; Akimov AV, 2007, NATURE, V450, P402, DOI 10.1038/nature06230; Astafiev O, 2010, SCIENCE, V327, P840, DOI 10.1126/science.1181918; Chang DE, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035420; Chang DE, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.053002; Chang DE, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063003; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; DeVoe RG, 1996, PHYS REV LETT, V76, P2049, DOI 10.1103/PhysRevLett.76.2049; Eschner J, 2001, NATURE, V413, P495, DOI 10.1038/35097017; Filipp S, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.063827; Goban A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.033603; Gonzalez-Tudela A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.020501; Hoi IC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.053601; Hoi IC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.263601; Hoi IC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.073601; Hwang J, 2009, NATURE, V460, P76, DOI 10.1038/nature08134; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Lalumiere K, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043806; Leung PM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.253603; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Martin-Cano D, 2010, NANO LETT, V10, P3129, DOI 10.1021/nl101876f; Mollow B. R., 1969, Physical Review, V188, P1969, DOI 10.1103/PhysRev.188.1969; Nayak KP, 2007, OPT EXPRESS, V15, P5431, DOI 10.1364/OE.15.005431; Shen JT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.213001; Vetsch E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203603; Zheng HX, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.043832	28	348	351	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1494	1496		10.1126/science.1244324	http://dx.doi.org/10.1126/science.1244324			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24231805	Green Submitted			2022-12-28	WOS:000328644300053
J	El Arifeen, S; Christou, A; Reichenbach, L; Osman, FA; Azad, K; Islam, KS; Ahmed, F; Perry, HB; Peters, DH				El Arifeen, Shams; Christou, Aliki; Reichenbach, Laura; Osman, Ferdous Arfina; Azad, Kishwar; Islam, Khaled Shamsul; Ahmed, Faruque; Perry, Henry B.; Peters, David H.			Community-based approaches and partnerships: innovations in health-service delivery in Bangladesh	LANCET			English	Article							FAMILY-PLANNING WORKERS; TUBERCULOSIS-CONTROL; IMPACT; MANAGEMENT; GOVERNMENT; RESOURCES; PNEUMONIA; COVERAGE; DIARRHEA; PROGRAM	In Bangladesh, rapid advancements in coverage of many health interventions have coincided with impressive reductions in fertility and rates of maternal, infant, and childhood mortality. These advances, which have taken place despite such challenges as widespread poverty, political instability, and frequent natural disasters, warrant careful analysis of Bangladesh's approach to health-service delivery in the past four decades. With reference to success stories, we explore strategies in health-service delivery that have maximised reach and improved health outcomes. We identify three distinctive features that have enabled Bangladesh to improve health-service coverage and health outcomes: (1) experimentation with, and widespread application of, large-scale community-based approaches, especially investment in community health workers using a doorstep delivery approach; (2) experimentation with informal and contractual partnership arrangements that capitalise on the ability of non-governmental organisations to generate community trust, reach the most deprived populations, and address service gaps; and (3) rapid adoption of context-specific innovative technologies and policies that identify country-specific systems and mechanisms. Continued development of innovative, community-based strategies of health-service delivery, and adaptation of new technologies, are needed to address neglected and emerging health challenges, such as increasing access to skilled birth attendance, improvement of coverage of antenatal care and of nutritional status, the effects of climate change, and chronic disease. Past experience should guide future efforts to address rising public health concerns for Bangladesh and other underdeveloped countries.	[El Arifeen, Shams; Christou, Aliki; Reichenbach, Laura] Icddr B, Dhaka 1212, Bangladesh; [Osman, Ferdous Arfina] Univ Dhaka, Dhaka 1000, Bangladesh; [Azad, Kishwar] Diabet Assoc Bangladesh, Dhaka, Bangladesh; [Islam, Khaled Shamsul] Minist Hlth & Family Welf, Dhaka, Bangladesh; [Ahmed, Faruque] BRAC, Dhaka, Bangladesh; [Perry, Henry B.; Peters, David H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of Dhaka; Bangladesh Rural Advancement Committee BRAC; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Reichenbach, L (corresponding author), Icddr B, Dhaka 1212, Bangladesh.	laura.reichenbach@gmail.com	Christou, Aliki/D-1249-2018	Christou, Aliki/0000-0001-9525-8255; Arifeen, Shams/0000-0002-5372-5932; Peters, David/0000-0001-8377-3444	Rockefeller Foundation	Rockefeller Foundation	We thank the members of the Lancet Bangladesh Series Steering Committee for providing constructive comments on a previous draft of the paper; the Rockefeller Foundation for a grant that enabled this work; and icddr,b for logistical support. We would like to especially acknowledge the contributions of coauthor Khaled Shamsul Islam who died because of a road traffic accident during the preparation of this manuscript.	Adams AM, 2013, LANCET; Ahmed F., 2008, REACHING THOSE MOST; Ahmed S. M., 2008, BRAC U J, VV, P39; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Ahmed SM, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-3; Ahsan SS, 1998, BANGLADESHS EXPERIEN; Alam K, 2012, HEALTH POLICY PLANN, V27, P477, DOI 10.1093/heapol/czr059; [Anonymous], 2011, STAT COMM BAS HLTH W; [Anonymous], NAT TUB CONTR PROGR; [Anonymous], 1994, DETERMINANTS REPROD; [Anonymous], 2004, HUM RES HLTH OV CRIS; Arends-Kuenning M, 2001, DEMOGRAPHY, V38, P481, DOI 10.1353/dem.2001.0032; Asian Development Bank, 2007, BANGL URB PRIM HLTH; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Bangladesh Health Watch, 2008, HLTH WORKF BANGL WHO; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Barkat-e-Khuda, 1996, Health Transit Rev, V6 Suppl, P155; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Bhuiya A., 2009, HLTH RURAL MASSES IN; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bleich SN, 2011, HEALTH POLICY, V100, P282, DOI 10.1016/j.healthpol.2010.09.004; BRAC, 2011, BRAC BANGL ANN REP 2; BRAC, 2009, BRAC ANN REP 2009; BRAC, 2013, BRAC ANN REP 2012; Chowdhury A.M.R., 1996, SIMPLE SOLUTION TEAC; Chowdhury AMR, 1997, LANCET, V350, P169, DOI 10.1016/S0140-6736(96)11311-8; Chowdhury S, 2011, BJOG-INT J OBSTET GY, V118, P36, DOI 10.1111/j.1471-0528.2011.03111.x; Chowdhury T., 2009, PAY PERF WORKSH CEB; Christopher JB, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-27; Department for International Development (DFID), 2005, MAINT MOM MDGS IMP E; Department of Census and Statistics & Ministry of Healthcare and Nutrition, 2009, SRI LANK DEM HLTH SU; Diabetic Association of Bangladesh, DAB BEG JOURN WHICH; Gardner CA, 2007, HEALTH AFFAIR, V26, P1052, DOI 10.1377/hlthaff.26.4.1052; Gauri V, 2005, WORLD DEV, V33, P2045, DOI 10.1016/j.worlddev.2005.05.009; General Economics Division Planning Commission Government of the People's Republic of Bangladesh, 2010, MILL DEV GOALS BANGL; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Government of Bangladesh, 1976, BANGL NAT POP POL OU; Haaga JG, 1996, STUD FAMILY PLANN, V27, P76, DOI 10.2307/2138135; Hadi A, 2003, B WORLD HEALTH ORGAN, V81, P183; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Haque MS, 2002, INT POLIT SCI REV, V23, P411, DOI 10.1177/0192512102023004006; Harvard Medical School, 2011, BRACS TUB PROGR PION; Hogerzeil HV, 2004, BRIT MED J, V329, P1169, DOI 10.1136/bmj.329.7475.1169; Hossain MB, 1996, STUD FAMILY PLANN, V27, P98, DOI 10.2307/2138137; Human Resources Development Unit Government of the People's Republic of Bangladesh Ministry of Health and Family Welfare, 2011, HRD DAT SHEET 2011; Huq M., 1991, NEAR MIRACLE BANGLAD; Huq MN, 1990, BANGLADESH FERTILITY; Islam MA, 2011, JOINING FORCES PUBLI, P73; Jamil K, 1999, HEALTH POLICY PLANN, V14, P49, DOI 10.1093/heapol/14.1.49; Khan M, 1996, DETERMINANTS CONTRAC; Khan MM, 1998, EXPANDED PROGRAM IMM; Khan S H, 1998, Health Care Superv, V17, P37; Koehlmoos T.P., 2011, GOOD HLTH LOW COST, V25, P47; Lovell C, 1993, REACHING HLTH ALL, P212; Mabud MA, 2005, DEMOGRAPHIC IMPLICAT; Ministry of Health and Family Welfare, 2012, HLTH B 2012; Ministry of Health and Family Welfare, 2011, HLTH B 2011; Ministry of Health and Population Control (MOHPC)[Bangladesh], 1978, BANGL FERT SURV 1975; Ministry of Health and Population (Nepal) New ERA ICF International, 2012, NEP DEM HLTH SURV 20; MITRA S, 1997, BANGLADESH DEMOGRAPH; Mitra SN, 1985, BANGLADESH CONTRACEP; Mitra SN, 1987, BANGLADESH CONTRACEP; Mitra SN, 1990, BANGLADESH CONTRACEP; MITRA SNA, 1994, BANGLADESH DEMOGRAPH; Nargis M, 2010, STUDY HLTH WORKFORCE; National Institute of Population Research and Training (NIPORT) Mitra and Associates Macro International, 2009, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) Mitra and Associates ORC Macro, 2004, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) USAID UN Population Fund AusAID Measure Evaluation International Centre for Diarrhoeal Disease Research Bangladesh ( icddr b), 2011, BANGL MAT MOR HLTH C; NGO Affairs Bureau Bangladesh, 2011, FLOW FOR GRANT FUND; NIPORT Mitra and Associates and ORC Macro, 2001, BANGL DEM HLTH SURV; NIPORT Mitra and Associates MEASURE DHS ICF International, 2012, BANGL DEM HLTH SURV; NIPORT ORC Macro Johns Hopkins University icddr b, 2003, BANGL MAT HLTH SERV; Normand C, 2006, ASSESSMENT COMMUNITY; Osman FA, 2008, PUBLIC PRIVATE PARTN; Perry HB, 2000, HLTH ALL BANGLADESH; Perry HB, 2002, COMMUNITY BASED HLTH, P31; Peters D, 2012, NATURE, V487, P163, DOI 10.1038/487163a; Phillips J.F., 2003, EVIDENCE BASED DEV H; Phillips JF, 2003, INT FAM PLAN PERSPEC, V29, P138, DOI 10.2307/3181080; PHILLIPS JF, 1984, STUD FAMILY PLANN, V15, P62, DOI 10.2307/1966047; Planning Commission, 2010, MILL DEV GOALS BANGL; Rahaim S, 2011, BANGLADESH PRIVATE S; Rajbhandari S, 2010, INT J GYNECOL OBSTET, V108, P282, DOI 10.1016/j.ijgo.2009.11.006; Rohde J., 2005, LEARNING REACH HLTH, P1; Ross J.A., 2007, GLOBAL FAMILY PLANNI, P325, DOI [https://doi.org/10.1596/978-0-8213-6951-7, DOI 10.1596/978-0-8213-6951-7]; Rosskam E, 2011, STATE WORLDS MIDWIFE; Routh S, 1997, DEV ALTERNATIVE SERV; RTI International Bangladesh, 2011, COH TRAIN COMM HLTH; Salim MAH, 2006, B WORLD HEALTH ORGAN, V84, P479, DOI 10.2471/BLT.05.023929; Sanghvi H, 2010, INT J GYNECOL OBSTET, V108, P276, DOI 10.1016/j.ijgo.2009.12.003; Schuler SR, 1995, INT FAM PLAN PERSPEC, V21, P132, DOI 10.2307/2133319; Shimul SN., 2011, RES MONOGR SER, V7; SIMMONS R, 1988, STUD FAMILY PLANN, V19, P29, DOI 10.2307/1966737; Standing H, 2008, SOC SCI MED, V66, P2096, DOI 10.1016/j.socscimed.2008.01.046; Talukdar L., 1991, NEAR MIRACLE IMMUNIZ, P57; The NGO Affairs Bureau, 2013, LIST NGOS 31 JUL; The World Bank, 2005, EC GOV NONG ORG NGOS; Ullah AZ, 2006, HEALTH POLICY PLANN, V21, P143, DOI 10.1093/heapol/czj014; UNICEF, 2002, WHAT WORKS CHILDR S; United Nations Children's Fund (UNICEF), 2012, PNEUM DIARRH TACKL D; USAID, 2012, MEAS DEM HLTH SURV; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; West M.A., 1990, AM PSYCHOL ASS, P309, DOI DOI 10.1037/0021-9010.92.5.1414; White H, 2005, MAINTAINING MOMENTUM; WHO, 2010, 5 JOINT MON MISS BAN; WHO, 2006, WORK TOG HLTH WORLD; Winch PJ, 2005, HEALTH POLICY PLANN, V20, P199, DOI 10.1093/heapol/czi027; World Bank, 2003, BANGL PRIV SECT ASS; World Bank, WORLD DATABANK; World Health Organisation, 2012, TUB CONTR S E AS REG; World Health Organization, 2007, COMM HLTH WORK WHAT; World Health Organization, GLOB HLTH OBS DAT RE; Zaman S, 2005, LEARNING REACH HLTH	113	127	127	2	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					2012	2026		10.1016/S0140-6736(13)62149-2	http://dx.doi.org/10.1016/S0140-6736(13)62149-2			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269EI	24268607				2022-12-28	WOS:000328223700028
J	Verhoef, TI; Ragia, G; de Boer, A; Barallon, R; Kolovou, G; Kolovou, V; Konstantinides, S; Le Cessie, S; Maltezos, E; van der Meer, FJM; Redekop, WK; Remkes, M; Rosendaal, FR; van Schie, RMF; Tavridou, A; Tziakas, D; Wadelius, M; Manolopoulos, VG; Maitland-van der Zee, AH				Verhoef, Talitha I.; Ragia, Georgia; de Boer, Anthonius; Barallon, Rita; Kolovou, Genovefa; Kolovou, Vana; Konstantinides, Stavros; Le Cessie, Saskia; Maltezos, Efstratios; van der Meer, Felix J. M.; Redekop, William K.; Remkes, Mary; Rosendaal, Frits R.; van Schie, Rianne M. F.; Tavridou, Anna; Tziakas, Dimitrios; Wadelius, Mia; Manolopoulos, Vangelis G.; Maitland-van der Zee, Anke H.		EU-PACT Grp	A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ANTICOAGULANT-THERAPY; VKORC1 GENOTYPES; WARFARIN; CYP2C9; PHARMACOGENETICS; INTENSITY; OUTCOMES	BackgroundObservational evidence suggests that the use of a genotype-guided dosing algorithm may increase the effectiveness and safety of acenocoumarol and phenprocoumon therapy. MethodsWe conducted two single-blind, randomized trials comparing a genotype-guided dosing algorithm that included clinical variables and genotyping for CYP2C9 and VKORC1 with a dosing algorithm that included only clinical variables, for the initiation of acenocoumarol or phenprocoumon treatment in patients with atrial fibrillation or venous thromboembolism. The primary outcome was the percentage of time in the target range for the international normalized ratio (INR; target range, 2.0 to 3.0) in the 12-week period after the initiation of therapy. Owing to low enrollment, the two trials were combined for analysis. The primary outcome was assessed in patients who remained in the trial for at least 10 weeks. ResultsA total of 548 patients were enrolled (273 patients in the genotype-guided group and 275 in the control group). The follow-up was at least 10 weeks for 239 patients in the genotype-guided group and 245 in the control group. The percentage of time in the therapeutic INR range was 61.6% for patients receiving genotype-guided dosing and 60.2% for those receiving clinically guided dosing (P=0.52). There were no significant differences between the two groups for several secondary outcomes. The percentage of time in the therapeutic range during the first 4 weeks after the initiation of treatment in the two groups was 52.8% and 47.5% (P=0.02), respectively. There were no significant differences with respect to the incidence of bleeding or thromboembolic events. ConclusionsGenotype-guided dosing of acenocoumarol or phenprocoumon did not improve the percentage of time in the therapeutic INR range during the 12 weeks after the initiation of therapy. (Funded by the European Commission Seventh Framework Programme and others; EU-PACT ClinicalTrials.gov numbers, NCT01119261 and NCT01119274.)	[Verhoef, Talitha I.; de Boer, Anthonius; van Schie, Rianne M. F.; Maitland-van der Zee, Anke H.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, NL-3508 TB Utrecht, Netherlands; [Le Cessie, Saskia] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Le Cessie, Saskia; Rosendaal, Frits R.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [van der Meer, Felix J. M.; Rosendaal, Frits R.] Leiden Univ, Dept Thrombosis & Hemostasis, Med Ctr, Leiden, Netherlands; [Redekop, William K.] Erasmus Univ, Inst Med Technol, Rotterdam, Netherlands; [Remkes, Mary] Atal Med Diagnost Ctr, Amsterdam, Netherlands; [Ragia, Georgia; Tavridou, Anna; Manolopoulos, Vangelis G.] Democritus Univ Thrace, Sch Med, Pharmacol Lab, Alexandroupolis 68100, Greece; [Konstantinides, Stavros; Tziakas, Dimitrios] Democritus Univ Thrace, Sch Med, Univ Cardiol Dept, Alexandroupolis 68100, Greece; [Maltezos, Efstratios] Democritus Univ Thrace, Dept Internal Med 2, Alexandroupolis 68100, Greece; [Tavridou, Anna; Manolopoulos, Vangelis G.] Acad Gen Hosp Alexandroupolis, Clin Pharmacol Unit, Alexandroupolis, Greece; [Kolovou, Genovefa; Kolovou, Vana] Onassis Cardiac Surg Ctr, Cardiol Dept 1, Athens, Greece; [Barallon, Rita] LGC, Teddington, Middx, England; [Wadelius, Mia] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Democritus University of Thrace; Democritus University of Thrace; Democritus University of Thrace; Onassis Cardiac Surgery Center; Uppsala University; Uppsala University Hospital	Maitland-van der Zee, AH (corresponding author), Univ Utrecht, Fac Sci, Div Pharmacoepidemiol & Clin Pharmacol, POB 80 082, NL-3508 TB Utrecht, Netherlands.	emanolop@med.duth.gr; a.h.maitland@uu.nl	Konstantinides, Stavros/AAL-3174-2021; Rosendaal, Frits/Q-3842-2017; Wadelius, Mia/C-7740-2016; Tziakas, Dimitrios/AAO-8230-2021; le+Cessie, Saskia/HGC-8966-2022; Redekop, Ken/AAA-2423-2020; Manolopoulos, Vangelis G/J-3312-2015; Pirmohamed, Munir/H-6004-2011; Maitland-van der Zee, Anke/I-9572-2016	Konstantinides, Stavros/0000-0001-6359-7279; Rosendaal, Frits/0000-0003-2558-7496; Wadelius, Mia/0000-0002-6368-2622; Tziakas, Dimitrios/0000-0002-4982-9181; Manolopoulos, Vangelis G/0000-0003-0849-5469; Pirmohamed, Munir/0000-0002-7534-7266; le Cessie, Saskia/0000-0003-2154-4923; Redekop, Ken/0000-0001-9538-4083; Maltezos, Efstratios/0000-0002-5827-2661; Maitland-van der Zee, Anke/0000-0002-0414-3442	European Commission Seventh Framework Programme [HEALTH F2 2009 223062]; GlaxoSmithKline; Swedish Research Council (Medicine); Swedish Heart-Lung Foundation; Clinical Research Support at Uppsala University	European Commission Seventh Framework Programme(European Commission); GlaxoSmithKline(GlaxoSmithKline); Swedish Research Council (Medicine)(Swedish Research Council); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Clinical Research Support at Uppsala University	Supported by a grant from the European Commission Seventh Framework Programme (HEALTH F2 2009 223062) and by funding from GlaxoSmithKline (to Dr. Maitland-van der Zee) and the Swedish Research Council (Medicine), the Swedish Heart-Lung Foundation, and Clinical Research Support at Uppsala University (to Dr. Wadelius).	Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Bodin L, 2005, BLOOD, V106, P135, DOI 10.1182/blood-2005-01-0341; Burmester JK, 2011, GENET MED, V13, P509, DOI 10.1097/GIM.0b013e31820ad77d; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Kirchheiner J, 2004, PHARMACOGENETICS, V14, P19, DOI 10.1097/00008571-200401000-00002; Lenzini PA, 2008, J THROMB HAEMOST, V6, P1655, DOI 10.1111/j.1538-7836.2008.03095.x; Merli GJ, 2009, J THROMB THROMBOLYS, V27, P293, DOI 10.1007/s11239-008-0219-9; Oake N, 2008, CAN MED ASSOC J, V179, P235, DOI 10.1503/cmaj.080171; Pengo V, 2006, J THROMB THROMBOLYS, V21, P73, DOI 10.1007/s11239-006-5580-y; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; van Schie RMF, 2009, PHARMACOGENOMICS, V10, P1687, DOI [10.2217/pgs.09.125, 10.2217/PGS.09.125]; Verhoef TI, 2012, J THROMB HAEMOST, V10, P2610, DOI 10.1111/jth.12007; Verhoef TI, 2012, J THROMB HAEMOST, V10, P606, DOI 10.1111/j.1538-7836.2012.04633.x; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; Wang MS, 2012, INT J MED SCI, V9, P472, DOI 10.7150/ijms.4637	17	167	176	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2304	2312		10.1056/NEJMoa1311388	http://dx.doi.org/10.1056/NEJMoa1311388			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24251360	Green Published, Bronze			2022-12-28	WOS:000328156300008
J	Alobid, I; Bernal-Sprekelsen, M				Alobid, Isam; Bernal-Sprekelsen, Manuel			Cerebrospinal Fluid Otorhinorrhea	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								An 83-year-old man with a history of epilepsy and remote trauma to the head started treatment with continuous positive airway pressure because of sleep apnea. Two months later, he was admitted to the clinic with fever, headaches, and watery fluid dripping from his right nostril. An 83-year-old man with a history of epilepsy and remote trauma to the head started treatment with continuous positive airway pressure (CPAP) because of sleep apnea. Two months later, he was admitted to the clinic with fever, headaches, and watery fluid dripping from his right nostril. Streptococcal meningitis was diagnosed. Otorhinolaryngologic examination was initially unrevealing, although fluid subsequently collected from the right nostril was positive for beta-trace protein. The patient stated that, during the past 10 years, he had had intermittent watery rhinorrhea from the right nostril. Computed tomography (CT) and magnetic resonance imaging (MRI) of the skull base showed ...	[Alobid, Isam; Bernal-Sprekelsen, Manuel] Hosp Clin Barcelona, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona	Alobid, I (corresponding author), Hosp Clin Barcelona, Barcelona, Spain.	isamobid@hotmail.com	Bernal-Sprekelsen, Manuel/AAG-4299-2021; Bernal-Sprekelsen, Manuel/AAJ-7568-2021	Bernal-Sprekelsen, Manuel/0000-0001-8191-9833; 					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					E29	E29		10.1056/NEJMicm1300806	http://dx.doi.org/10.1056/NEJMicm1300806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24283247				2022-12-28	WOS:000327467500001
J	Shalaby, MS; Kuti, K; Walker, G				Shalaby, Mohamed Sameh; Kuti, Kamal; Walker, Gregor			Intestinal malrotation and volvulus in infants and children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEWBORN		[Shalaby, Mohamed Sameh; Kuti, Kamal; Walker, Gregor] Royal Hosp Sick Children, Dept Paediat Surg, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow	Shalaby, MS (corresponding author), Royal Hosp Sick Children, Dept Paediat Surg, Glasgow G3 8SJ, Lanark, Scotland.	mshalaby@doctors.org.uk	Shalaby, Mohamed Sameh/F-7217-2014	Shalaby, Mohamed Sameh/0000-0002-6161-5784				Applegate Kimberly E, 2009, Pediatr Radiol, V39 Suppl 2, pS161, DOI 10.1007/s00247-009-1177-x; Durkin ET, 2008, J AM COLL SURGEONS, V206, P658, DOI 10.1016/j.jamcollsurg.2007.11.020; Millar A J W, 2003, Semin Pediatr Surg, V12, P229, DOI 10.1053/j.sempedsurg.2003.08.003; MILLAR AJW, 1987, PEDIATR SURG INT, V2, P172; Orzech N, 2006, J PEDIATR SURG, V41, P1005, DOI 10.1016/j.jpedsurg.2005.12.070; POWELL DM, 1989, J PEDIATR SURG, V24, P777, DOI 10.1016/S0022-3468(89)80535-4; Radwan R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4441; Sizemore AW, 2008, PEDIATR RADIOL, V38, P518, DOI 10.1007/s00247-008-0762-8; Walker GM, 2006, BRIT MED J, V332, P1363, DOI 10.1136/bmj.38859.614352.55; Walker GM, 2007, J PEDIATR SURG, V42, P714, DOI 10.1016/j.jpedsurg.2006.12.017	10	20	22	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2013	347								f6949	10.1136/bmj.f6949	http://dx.doi.org/10.1136/bmj.f6949			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FN	24285798				2022-12-28	WOS:000327792500002
J	Keohane, C; McMullin, MF; Harrison, C				Keohane, Clodagh; McMullin, Mary Frances; Harrison, Claire			The diagnosis and management of erythrocytosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONGENITAL HEART-DISEASE; HYPOXIC LUNG-DISEASE; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; FOLLOW-UP; HEMATOCRIT; SECONDARY; HYDROXYUREA; LOSARTAN; SURVIVAL		[Keohane, Clodagh; Harrison, Claire] Guys & St Thomas NHS Fdn Trust, Dept Haematol, London SE1 9RT, England; [McMullin, Mary Frances] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Dept Haematol, Belfast, Antrim, North Ireland	Guy's & St Thomas' NHS Foundation Trust; Queens University Belfast	Harrison, C (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Haematol, London SE1 9RT, England.	Claire.Harrison@gstt.nhs.uk	McMullin, Mary Frances/AAG-6078-2021; McMullin, Mary F/AAF-6472-2020	McMullin, Mary Frances/0000-0002-0773-0204; 				[Anonymous], 1980, ANN INTERN MED, V93, P391; BAKRIS GL, 1990, NEW ENGL J MED, V323, P86, DOI 10.1056/NEJM199007123230203; Barbui T, 2009, BLOOD, V114, P759, DOI 10.1182/blood-2009-02-206797; BERK PD, 1986, SEMIN HEMATOL, V23, P132; BURGE PS, 1975, LANCET, V1, P1266; Cranston JM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001744.pub2; Criner G J, 2000, Respir Care, V45, P105; Crockett AJ, 2001, INTERN MED J, V31, P448, DOI 10.1046/j.1445-5994.2001.00103.x; Diller GP, 2007, CIRCULATION, V115, P1039, DOI 10.1161/CIRCULATIONAHA.105.592386; Finazzi G, 2000, BRIT J HAEMATOL, V110, P577, DOI 10.1046/j.1365-2141.2000.02188.x; FLENLEY DC, 1981, LANCET, V1, P681; GAGNON DR, 1994, AM HEART J, V127, P674, DOI 10.1016/0002-8703(94)90679-3; HARRISON BDW, 1982, BRIT J DIS CHEST, V76, P313, DOI 10.1016/0007-0971(82)90067-5; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Julian BA, 1998, J AM SOC NEPHROL, V9, P1104; Kiladjian JJ, 2011, J CLIN ONCOL, V29, P3907, DOI 10.1200/JCO.2011.36.0792; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; Lowe GDO, 1999, BEST PRACT RES CL HA, V12, P435, DOI 10.1053/beha.1999.0035; Marchioli R, 2005, J CLIN ONCOL, V23, P2224, DOI 10.1200/JCO.2005.07.062; Marchioli R, 2013, NEW ENGL J MED, V368, P22, DOI 10.1056/NEJMoa1208500; McMullin MF, 2005, BRIT J HAEMATOL, V130, P174, DOI 10.1111/j.1365-2141.2005.05535.x; Mehta J, 2013, LEUK LYMPHOMA; MESSINEZY M, 1990, CLIN LAB HAEMATOL, V12, P121, DOI 10.1111/ijlh.1990.12.2.121; Messinezy M, 1997, BRIT J HAEMATOL, V98, P103, DOI 10.1046/j.1365-2141.1997.1552969.x; Nielsen T, 2003, AM J HEMATOL, V74, P26, DOI 10.1002/ajh.10375; Passamonti F, 2004, AM J MED, V117, P755, DOI 10.1016/j.amjmed.2004.06.032; PERLOFF JK, 1988, ANN INTERN MED, V109, P406, DOI 10.7326/0003-4819-109-5-406; RIUNITI O, 1995, ANN INTERN MED, V123, P656, DOI 10.7326/0003-4819-123-9-199511010-00003; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; WADE JPH, 1981, BRIT MED J, V283, P689, DOI 10.1136/bmj.283.6293.689; WEDZICHA JA, 1983, BMJ-BRIT MED J, V286, P511, DOI 10.1136/bmj.286.6364.511; WEINREB NJ, 1975, SEMIN HEMATOL, V12, P397; WEISSE AB, 1975, AM J MED, V58, P92, DOI 10.1016/0002-9343(75)90538-0; WICKRE CG, 1983, KIDNEY INT, V23, P731, DOI 10.1038/ki.1983.86; Yildiz A, 2001, TRANSPLANTATION, V72, P542, DOI 10.1097/00007890-200108150-00035	35	42	44	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2013	347								f6667	10.1136/bmj.f6667	http://dx.doi.org/10.1136/bmj.f6667			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258JQ	24246666	Green Published			2022-12-28	WOS:000327455900001
J	May, M				May, Mike			REGENERATIVE MEDICINE Rebuilding the backbone	NATURE			English	Editorial Material							INTERVERTEBRAL DISC											Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108; Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Wang ZL, 2013, SPINE, V38, P1501, DOI 10.1097/BRS.0b013e31828976c1	7	8	8	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S7	S9		10.1038/503S7a	http://dx.doi.org/10.1038/503S7a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24227006	Bronze			2022-12-28	WOS:000326894200004
J	Pathman, DE; Goldberg, L; Konrad, TR; Morgan, JC				Pathman, Donald E.; Goldberg, Lynda; Konrad, Thomas R.; Morgan, Jennifer Craft			State Repayment Programs for Health Care Education Loans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Pathman, Donald E.; Goldberg, Lynda; Konrad, Thomas R.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Goldberg, Lynda] Ohio State Univ, Columbus, OH 43210 USA; [Morgan, Jennifer Craft] Georgia State Univ, Inst Gerontol, Atlanta, GA 30303 USA; [Morgan, Jennifer Craft] Univ N Carolina, Dept Allied Hlth Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; University System of Georgia; Georgia State University; University of North Carolina; University of North Carolina Chapel Hill	Pathman, DE (corresponding author), Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Blvd,UNC CB 7590, Chapel Hill, NC 27599 USA.	don_pathman@unc.edu	Konrad, Thomas R./AAT-9276-2020	Pathman, Donald/0000-0002-6708-3707; Konrad, Thomas R/0000-0002-5269-0440	PHS HHS [5U1CRH03714-04-00] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Association of American Medical Colleges, LOAN REP FORG SCHOL; Pathman DE, 2000, JAMA-J AM MED ASSOC, V284, P2084, DOI 10.1001/jama.284.16.2084; Pathman DE, 2012, J AM BOARD FAM MED, V25, P723, DOI 10.3122/jabfm.2012.05.110261; Rural Assistance Center, FUND TYP LOAN REP PR; US Department of Health and Human Services Data Warehouse, DES HLTH PROF SHORT; US Department of Health and Human Services; Health Resources and Services Administration, 2012, FY 2012 ONL PERF APP	6	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1982	1984		10.1001/jama.2013.281644	http://dx.doi.org/10.1001/jama.2013.281644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219954	Bronze			2022-12-28	WOS:000326832900023
J	Doulatov, S; Daley, GQ				Doulatov, Sergei; Daley, George Q.			A Stem Cell Perspective on Cellular Engineering	SCIENCE			English	Editorial Material							HEMATOPOIETIC PROGENITORS; DIFFERENTIATION CULTURES; FIBROBLASTS		[Doulatov, Sergei] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Broad Inst, Boston, MA 02115 USA; Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Doulatov, S (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu						Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888	12	22	22	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					700	702		10.1126/science.1238363	http://dx.doi.org/10.1126/science.1238363			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202165				2022-12-28	WOS:000326647600028
J	Weinberger, AD; Weinberger, LS				Weinberger, Ariel D.; Weinberger, Leor S.			Stochastic Fate Selection in HIV-Infected Patients	CELL			English	Editorial Material							GENE-EXPRESSION; DECISION-MAKING	Classic studies proposed that stochastic variability ("noise") can drive biological fate switching, enhancing evolutionary success. Now, Ho et al. report that HIV's reactivation from dormant (latently infected) patient cells-the major barrier to an HIV cure-is inherently stochastic. Eradicating an incompletely inducible (probabilistic) viral phenotype will require inventive approaches.	[Weinberger, Ariel D.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Weinberger, Leor S.] Gladstone Inst, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Harvard University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Weinberger, LS (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.	leor.weinberger@gladstone.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI102520] Funding Source: NIH RePORTER; NIAID NIH HHS [F32 AI102520, AI102520] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2011, CSH PERSPECT MED, DOI DOI 10.1101/cshperspect.a007096; Arkin A, 1998, GENETICS, V149, P1633; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034	9	38	38	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					497	499		10.1016/j.cell.2013.09.039	http://dx.doi.org/10.1016/j.cell.2013.09.039			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243007	Bronze			2022-12-28	WOS:000326571800003
J	Chetchotisakd, P; Chierakul, W; Chaowagul, W; Anunnatsiri, S; Phimda, K; Mootsikapun, P; Chaisuksant, S; Pilaikul, J; Thinkhamrop, B; Phiphitaporn, S; Susaengrat, W; Toondee, C; Wongrattanacheewin, S; Wuthiekanun, V; Chantratita, N; Thaipadungpanit, J; Day, NP; Limmathurotsakul, D; Peacock, SJ				Chetchotisakd, Ploenchan; Chierakul, Wirongrong; Chaowagul, Wipada; Anunnatsiri, Siriluck; Phimda, Kriangsak; Mootsikapun, Piroon; Chaisuksant, Seksan; Pilaikul, Jiraporn; Thinkhamrop, Bandit; Phiphitaporn, Sunchai; Susaengrat, Wattanachai; Toondee, Chalongchai; Wongrattanacheewin, Surasakdi; Wuthiekanun, Vanaporn; Chantratita, Narisara; Thaipadungpanit, Janjira; Day, Nicholas P.; Limmathurotsakul, Direk; Peacock, Sharon J.			Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial	LANCET			English	Article							BURKHOLDERIA-PSEUDOMALLEI; NORTHEAST THAILAND; RECURRENT MELIOIDOSIS; MAINTENANCE THERAPY; CHLORAMPHENICOL; COTRIMOXAZOLE; SUSCEPTIBILITY; EPIDEMIOLOGY; RESISTANCE; RELAPSE	Background Melioidosis, an infectious disease caused by the Gram-negative bacillus Burkholderia pseudomallei, is difficult to cure. Antimicrobial treatment comprises intravenous drugs for at least 10 days, followed by oral drugs for at least 12 weeks. The standard oral regimen based on trial evidence is trimethoprim-sulfamethoxaxole (TMP-SMX) plus doxycycline. This regimen is used in Thailand but is associated with side-effects and poor adherence by patients, and TMP-SMX alone is recommended in Australia. We compared the efficacy and side-effects of TMP-SMX with TMP-SMX plus doxycycline for the oral phase of melioidosis treatment. Methods For this multi-centre, double-blind, non-inferiority, randomised placebo-controlled trial, we enrolled patients (aged >= 15 years) from five centres in northeast Thailand with culture-confirmed melioidosis who had received a course of parenteral antimicrobial drugs. Using a computer-generated sequence, we randomly assigned patients to receive TMP-SMX plus placebo or TMP-SMX plus doxycycline for 20 weeks (1:1; block size of ten, stratified by study site). We followed patients up every 4 months for 1 year and annually thereafter to the end of the study. The primary endpoint was culture-confirmed recurrent melioidosis, and the non-inferiority margin was a hazard ratio (HR) of 1.7. This study is registered with www.controlled-trials.com, number ISRCTN86140460. Findings We enrolled and randomly assigned 626 patients: 311 to TMP-SMX plus placebo and 315 to TMP-SMX plus doxycycline. 16 patients (5%) in the TMP-SMX plus placebo group and 21 patients (7%) in the TMP-SMX plus doxycycline group developed culture-confirmed recurrent melioidosis (HR 0.81; 95% CI 0.42-1.55). The criterion for non-inferiority was met (p=0.01). Adverse drug reactions were less common in the TMP-SMX plus placebo group than in the TMP-SMX plus doxycycline group (122 [39%] vs 167 [53%]). Interpretation Our findings suggest that TMP-SMX is not inferior to TMP-SMX plus doxycycline for the oral phase of melioidosis treatment, and is preferable on the basis of safety and tolerance by patients.	[Chetchotisakd, Ploenchan; Anunnatsiri, Siriluck; Mootsikapun, Piroon; Wongrattanacheewin, Surasakdi] Khon Kaen Univ, Fac Med, Khon Kaen, Thailand; [Chetchotisakd, Ploenchan; Anunnatsiri, Siriluck; Wongrattanacheewin, Surasakdi] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Chantratita, Narisara; Thaipadungpanit, Janjira; Day, Nicholas P.; Limmathurotsakul, Direk; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand; [Chaowagul, Wipada] Sappasithiprasong Hosp, Ubon Ratchathani, Thailand; [Phimda, Kriangsak; Phiphitaporn, Sunchai] Udon Thani Hosp, Udon Thani, Thailand; [Chaisuksant, Seksan; Susaengrat, Wattanachai] Khon Kaen Hosp, Khon Kaen, Thailand; [Pilaikul, Jiraporn; Toondee, Chalongchai] Mahasarakam Hosp, Mahasarakam, Thailand; [Thinkhamrop, Bandit] Khon Kaen Univ, Fac Publ Hlth, Khon Kaen, Thailand; [Day, Nicholas P.] Univ Oxford, Churchill Hosp, Oxford, England; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 2QQ, England	Khon Kaen University; Khon Kaen University; Mahidol University; Khon Kaen University; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	direk@tropmedres.ac	Thaipadungpanit, Janjira/ABF-9857-2021; Chierakul, Wirongrong/AAC-3226-2020; Peacock, Sharon J/ABE-6331-2020; Chantratita, Narisara/P-2169-2019	Thaipadungpanit, Janjira/0000-0002-6184-3381; Chierakul, Wirongrong/0000-0003-2103-9425; Peacock, Sharon/0000-0002-1718-2782; Limmathurotsakul, Direk/0000-0001-7240-5320	Thailand Research Fund; Melioidosis Research Center; Center of Excellence in Specific Health Problems in Greater Mekong Sub-region cluster; Wellcome Trust; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, through the Center of Excellence in Specific Health Problems in Greater Mekong Sub-region cluster (SHeP-GMS), Khon Kaen University; Wellcome Trust [077166/Z/05/A, 089275/Z/09/Z]	Thailand Research Fund(Thailand Research Fund (TRF)); Melioidosis Research Center; Center of Excellence in Specific Health Problems in Greater Mekong Sub-region cluster; Wellcome Trust(Wellcome TrustEuropean Commission); Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, through the Center of Excellence in Specific Health Problems in Greater Mekong Sub-region cluster (SHeP-GMS), Khon Kaen University; Wellcome Trust(Wellcome TrustEuropean Commission)	Thailand Research Fund, the Melioidosis Research Center, the Center of Excellence in Specific Health Problems in Greater Mekong Sub-region cluster, and the Wellcome Trust.; Partial results of this study were discussed at a workshop on the treatment of and post-exposure prophylaxis for Burkholderia pseudomallei and Burkholderia mallei infection (Nov 30, 2010; Townsville, QLD, Australia), 5 and at the World Melioidosis Congress (Dec 1-3, 2010, Townsville, QLD, Australia). We thank all patients, their relatives, staff of the hospitals who participated in the study, and the data and safety monitoring board, including Bart Currie, Boonmee Sathapatayavongs, and Visanu Thamlikitkul. The drugs used in this study were made and donated by the Siam Pharmaceutical Company. The study was funded by the Thailand Research Fund; the Melioidosis Research Center; the Higher Education Research Promotion and National Research University Project of Thailand; the Office of the Higher Education Commission, through the Center of Excellence in Specific Health Problems in Greater Mekong Sub-region cluster (SHeP-GMS), Khon Kaen University; and the Wellcome Trust (077166/Z/05/A and 089275/Z/09/Z).	Chantratita N, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000182; Chaowagul W, 1999, CLIN INFECT DIS, V29, P375, DOI 10.1086/520218; Chaowagul W, 2005, ANTIMICROB AGENTS CH, V49, P4020, DOI 10.1128/AAC.49.10.4020-4025.2005; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng AC, 2008, AM J TROP MED HYG, V78, P208, DOI 10.4269/ajtmh.2008.78.208; Cheng AC, 2009, ANTIMICROB AGENTS CH, V53, P4193, DOI 10.1128/AAC.01301-08; Chetchotisakd Ploenchan, 2001, American Journal of Tropical Medicine and Hygiene, V64, P24; Chusri S, 2012, AM J TROP MED HYG, V87, P927, DOI 10.4269/ajtmh.2012.12-0136; Clinical and Laboratory Standards Institute, 2006, M100S16 CLIN LAB STA; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Limmathurotsakul D, 2007, J CLIN MICROBIOL, V45, P3830, DOI 10.1128/JCM.01297-07; Limmathurotsakul D, 2006, CLIN INFECT DIS, V43, P979, DOI 10.1086/507632; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002072; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Lipsitz Rebecca, 2012, Emerg Infect Dis, V18, pe2, DOI 10.3201/eid1812.120638; Maharjan B, 2005, J CLIN MICROBIOL, V43, P6032, DOI 10.1128/JCM.43.12.6032-6034.2005; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Piliouras P, 2002, INT J ANTIMICROB AG, V19, P427, DOI 10.1016/S0924-8579(02)00016-X; Pocock SJ, 2003, FUND CLIN PHARMACOL, V17, P483, DOI 10.1046/j.1472-8206.2003.00162.x; RAJCHANUVONG A, 1995, T ROY SOC TROP MED H, V89, P546, DOI 10.1016/0035-9203(95)90104-3; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wuthiekanun V, 2005, J ANTIMICROB CHEMOTH, V55, P1029, DOI 10.1093/jac/dki151; Wuthiekanun V, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000496	28	71	71	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					807	814		10.1016/S0140-6736(13)61951-0	http://dx.doi.org/10.1016/S0140-6736(13)61951-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24284287	hybrid, Green Published			2022-12-28	WOS:000332398700027
J	Fisher, DA; Harris, PNA				Fisher, Dale A.; Harris, Patrick N. A.			Melioidosis: refining management of a tropical time bomb	LANCET			English	Editorial Material							BURKHOLDERIA-PSEUDOMALLEI; NORTHEAST THAILAND; RECURRENT MELIOIDOSIS; RELAPSE		[Fisher, Dale A.] Natl Univ Singapore Hosp, Dept Med, Singapore 119228, Singapore; Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 119228, Singapore	National University of Singapore; National University of Singapore	Fisher, DA (corresponding author), Natl Univ Singapore Hosp, Dept Med, Singapore 119228, Singapore.	mdcfda@nus.edu.sg	Harris, Patrick/P-3813-2014	Harris, Patrick/0000-0002-2895-0345				[Anonymous], 1967, TIME; Chaowagul W, 1999, CLIN INFECT DIS, V29, P375, DOI 10.1086/520218; Chetchotisakd P, 2014, LANCET, V383, P807, DOI 10.1016/S0140-6736(13)61951-0; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P311, DOI 10.1093/jac/24.3.311; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Limmathurotsakul D, 2007, J CLIN MICROBIOL, V45, P3830, DOI 10.1128/JCM.01297-07; Limmathurotsakul D, 2006, CLIN INFECT DIS, V43, P979, DOI 10.1086/507632; Maharjan B, 2005, J CLIN MICROBIOL, V43, P6032, DOI 10.1128/JCM.43.12.6032-6034.2005; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wuthiekanun V, 2006, AM J TROP MED HYG, V74, P1074, DOI 10.4269/ajtmh.2006.74.1074	13	13	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					762	764		10.1016/S0140-6736(13)62143-1	http://dx.doi.org/10.1016/S0140-6736(13)62143-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24284288	hybrid			2022-12-28	WOS:000332398700007
J	Nuckols, TK; Anderson, L; Popescu, I; Diamant, AL; Doyle, B; Di Capua, P; Chou, R				Nuckols, Teryl K.; Anderson, Laura; Popescu, Ioana; Diamant, Allison L.; Doyle, Brian; Di Capua, Paul; Chou, Roger			Opioid Prescribing: A Systematic Review and Critical Appraisal of Guidelines for Chronic Pain	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC NONCANCER PAIN; CLINICAL-PRACTICE GUIDELINES; PHYSICIANS ASIPP GUIDELINES; AGREE II; CANADIAN GUIDELINE; AMERICAN SOCIETY; THERAPY; VALIDATION; QUALITY; METAANALYSIS	Background: Deaths due to prescription opioid overdoses have increased dramatically. High-quality guidelines could help clinicians mitigate risks associated with opioid therapy. Purpose: To evaluate the quality and content of guidelines on the use of opioids for chronic pain. Data Sources: MEDLINE, National Guideline Clearinghouse, specialty society Web sites, and international guideline clearinghouses (searched in July 2013). Study Selection: Guidelines published between January 2007 and July 2013 addressing the use of opioids for chronic pain in adults were selected. Guidelines on specific settings, populations, and conditions were excluded. Data Extraction: Guidelines and associated systematic reviews were evaluated using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument and A Measurement Tool to Assess Systematic Reviews (AMSTAR), respectively, and recommendations for mitigating opioid-related risks were compared. Data Synthesis: Thirteen guidelines met selection criteria. Overall AGREE II scores were 3.00 to 6.20 (on a scale of 1 to 7). The AMSTAR ratings were poor to fair for 10 guidelines. Two received high AGREE II and AMSTAR scores. Most guidelines recommend that clinicians avoid doses greater than 90 to 200 mg of morphine equivalents per day, have additional knowledge to prescribe methadone, recognize risks of fentanyl patches, titrate cautiously, and reduce doses by at least 25% to 50% when switching opioids. Guidelines also agree that opioid risk assessment tools, written treatment agreements, and urine drug testing can mitigate risks. Most recommendations are supported by observational data or expert consensus. Limitation: Exclusion of non-English-language guidelines and reliance on published information. Conclusion: Despite limited evidence and variable development methods, recent guidelines on chronic pain agree on several opioid risk mitigation strategies, including upper dosing thresholds; cautions with certain medications; attention to drug-drug and drug-disease interactions; and use of risk assessment tools, treatment agreements, and urine drug testing. Future research should directly examine the effectiveness of opioid risk mitigation strategies.	Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; RAND Corp, Santa Monica, CA USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; RAND Corporation; Oregon Health & Science University	Nuckols, TK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med, 911 Broxton Ave, Los Angeles, CA 90095 USA.	tnuckols@mednet.ucla.edu	Scott, Teryl Nuckols/AAH-9711-2021	Chou, Roger/0000-0001-9889-8610; Doyle, Brian/0000-0003-2782-2306; di capua, paul/0000-0003-1583-2232	California Department of Industrial Relations; California Commission on Health and Safety and Workers' Compensation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017954] Funding Source: NIH RePORTER	California Department of Industrial Relations; California Commission on Health and Safety and Workers' Compensation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	California Department of Industrial Relations and California Commission on Health and Safety and Workers' Compensation.	American College of Occupational and Environmental Medicine, 2008, ACOEM GUID CHRON US; American Pain Society American Academy of Pain Medicine, 2009, GUID US CHRON OP THE; [Anonymous], 2001, JAMA-J AM MED ASSOC, V286, P1461; Becker WC, 2011, ARCH INTERN MED, V171, P1034, DOI 10.1001/archinternmed.2011.217; Berland DW, 2012, MANAGING CHRONIC NON; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Burda BU, 2011, J CLIN EPIDEMIOL, V64, P968, DOI 10.1016/j.jclinepi.2010.12.005; Butler SF, 2004, PAIN, V112, P65, DOI 10.1016/j.pain.2004.07.026; Butler SF, 2008, J PAIN, V9, P360, DOI 10.1016/j.jpain.2007.11.014; Butler SF, 2007, PAIN, V130, P144, DOI 10.1016/j.pain.2007.01.014; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; California Division of Workers' Compensation, 2009, MED TREATM SCHED CHR; Campbell CI, 2010, AM J PUBLIC HEALTH, V100, P2541, DOI 10.2105/AJPH.2009.180646; Chan W, 2010, OTOLARYNGOL HEAD NEC, V143, P59; Chou R, 2009, POL ARCH MED WEWN, V119, P469, DOI 10.20452/pamw.741; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Colorado Division of Workers' Compensation, 2011, CHRON PAIN DIS MED T; Dembe A, 2012, AM J IND MED, V55, P313, DOI 10.1002/ajim.21021; Department of Veterans Affairs Department of Defense, 2012, CLIN PRACT GUID MAN; Drug and Alcohol Services South Australia, 2008, OP PRESCR CHRON PAIN; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; European Medicines Agency, 2013, DOC LIB; Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x; Ferrell B, 2009, J AM GERIATR SOC, V57, P1331, DOI 10.1111/j.1532-5415.2009.02376.x; Fine PG, 2009, J PAIN SYMPTOM MANAG, V38, P418, DOI 10.1016/j.jpainsymman.2009.06.002; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Franklin GM, 2012, AM J IND MED, V55, P325, DOI 10.1002/ajim.21998; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Furlan AD, 2010, CAN MED ASSOC J, V182, P923, DOI 10.1503/cmaj.100187; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Gupta Samir, 2009, Can Respir J, V16, pe62; Harris SR, 2012, CANCER-AM CANCER SOC, V118, P2312, DOI 10.1002/cncr.27461; Health Care Association of New Jersey, 2006, PAIN MAN GUID; Ho KY, 2013, ANN ACAD MED SINGAP, V42, P138; Institute for Clinical Systems Improvement, 2011, ASS MAN CHRON PAIN; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Kahan M., 2011, CAN FAM PHYSICIAN, V57, pe407; Kahan M, 2011, CAN FAM PHYSICIAN, V57, pe419; Kahan M, 2011, CAN FAM PHYSICIAN, V57, P1269; Kahan M, 2011, CAN FAM PHYSICIAN, V57, P1257; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Katz LY, 2011, COMPR PSYCHIAT, V52, P638, DOI 10.1016/j.comppsych.2010.12.001; Loder E, 2012, HEADACHE, V52, P930, DOI 10.1111/j.1526-4610.2012.02185.x; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS1; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS67; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P91; MAX MB, 1995, JAMA-J AM MED ASSOC, V274, P1874, DOI 10.1001/jama.1995.03530230060032; Murphy SL, 2010, NATL VITAL STAT REPO; National Disease Management Guidelines Programme, 2012, GERM DIS MAN GUID; National Opioid Use Guideline Group, 2010, CAN GUID SAF EFF US; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Noble M, 2008, J PAIN SYMPTOM MANAG, V35, P214, DOI 10.1016/j.jpainsymman.2007.03.015; Nuckols TK, 2008, J GEN INTERN MED, V23, P37, DOI 10.1007/s11606-007-0440-9; Nuckols TK, 2012, REPORT CALIFORNIA DE; Office of National Drug Control Policy, 2012, PRESCR DRUG AB; Papaleontiou M, 2010, J AM GERIATR SOC, V58, P1353, DOI 10.1111/j.1532-5415.2010.02920.x; Passik SD, 2004, CLIN THER, V26, P552, DOI 10.1016/S0149-2918(04)90057-4; Passik Steven D, 2006, Pain Pract, V6, P69; Patient Safety VHA, 2019, OP THER GUID ADH REP; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Rolfs Robert T, 2010, J Pain Palliat Care Pharmacother, V24, P219, DOI 10.3109/15360288.2010.503265; Rosenquist RW, 2010, ANESTHESIOLOGY, V112, P810, DOI 10.1097/ALN.0b013e3181c43103; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Stannard C., 2010, OPIOIDS PERSISTENT P; The Joint Commission, 2012, FACTS PAIN MAN; U.S. Food and Drug Administration, 2007, FDA PUBL HLTH ADV IM; Utah Department of Health, 2009, UT CLIN GUID PRESCR; van Dijk LJEW, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-7; Warner Margaret, 2009, NCHS Data Brief, P1; Washington State Department of Labor & Industries, 2012, MED TREATM GUID; Work Loss Data Institute, 2011, PAIN CHRON	78	231	240	0	150	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					38	+		10.7326/0003-4819-160-1-201401070-00732	http://dx.doi.org/10.7326/0003-4819-160-1-201401070-00732			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	297IS	24217469	Green Accepted			2022-12-28	WOS:000330249700005
J	Yanovski, SZ; Yanovski, JA				Yanovski, Susan Z.; Yanovski, Jack A.			Long-term Drug Treatment for Obesity A Systematic and Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; CARDIOVASCULAR-DISEASE RISK; PLACEBO-CONTROLLED TRIAL; LIFE-STYLE INTERVENTION; PRIMARY-CARE PRACTICE; WEIGHT-LOSS; BODY-WEIGHT; RANDOMIZED-TRIAL; PHARMACOLOGICAL-TREATMENT; ORLISTAT TREATMENT	IMPORTANCE Thirty-six percent of US adults are obese, and many cannot lose sufficient weight to improve health with lifestyle interventions alone. OBJECTIVE To conduct a systematic review of medications currently approved in the United States for obesity treatment in adults. We also discuss off-label use of medications studied for obesity and provide considerations for obesity medication use in clinical practice. EVIDENCE REVIEW A PubMed search from inception through September 2013 was performed to find meta-analyses, systematic reviews, and randomized, placebo-controlled trials for currently approved obesity medications lasting at least 1 year that had a primary or secondary outcome of body weight change, included at least 50 participants per group, reported at least 50% retention, and reported results on an intention-to-treat basis. Studies of medications approved for other purposes but tested for obesity treatment were also reviewed. FINDINGS Obesity medications approved for long-term use, when prescribed with lifestyle interventions, produce additional weight loss relative to placebo ranging from approximately 3% of initial weight for orlistat and lorcaserin to 9% for top-dose (15/92 mg) phentermine plus topiramate-extended release at 1 year. The proportion of patients achieving clinically meaningful (at least 5%) weight loss ranges from 37% to 47% for lorcaserin, 35% to 73% for orlistat, and 67% to 70% for top-dose phentermine plus topiramate-extended release. All 3 medications produce greater improvements in many cardiometabolic risk factors than placebo, but no obesity medication has been shown to reduce cardiovascular morbidity or mortality. Most prescriptions are for noradrenergic medications, despite their approval only for short-term use and limited data for their long-term safety and efficacy. CONCLUSIONS AND RELEVANCE Medications approved for long-term obesity treatment, when used as an adjunct to lifestyle intervention, lead to greater mean weight loss and an increased likelihood of achieving clinically meaningful 1-year weight loss relative to placebo. By discontinuing medication in patients who do not respond with weight loss of at least 5%, clinicians can decrease their patients' exposure to the risks and costs of drug treatment when there is little prospect of long-term benefit.	[Yanovski, Susan Z.] NIDDK, Div Digest Dis & Nutr, Bethesda, MD 20892 USA; [Yanovski, Jack A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Obes, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yanovski, SZ (corresponding author), NIDDK, Off Obes Res, 6707 Democracy Blvd,Room 675, Bethesda, MD 20892 USA.	sy29f@nih.gov		Yanovski, Jack/0000-0001-8542-1637	Intramural Research Program of NICHD [1ZIAHD000641]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641] Funding Source: NIH RePORTER	Intramural Research Program of NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The conduct of this research was supported in part by the Intramural Research Program of NICHD grant 1ZIAHD000641 (to Dr J. Yanovski). The National Institute of Diabetes and Digestive and Kidney Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development had no role in the design and conduct of the study, collection, management, analysis, or interpretation of the data, preparation of the manuscript for publication, or decision to submit the manuscript for publication, but did review the manuscript and approve its submission.	ABC Passport, ABC PASSPORT DRUG AB; Allison DB, 2012, OBESITY, V20, P330, DOI 10.1038/oby.2011.330; Apovian CM, 2013, OBESITY, V21, P935, DOI 10.1002/oby.20309; Aronne LJ, 2010, OBESITY, V18, P1739, DOI 10.1038/oby.2009.478; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Berne C, 2005, DIABETIC MED, V22, P612, DOI 10.1111/j.1464-5491.2004.01474.x; Blanck HM, 2004, PREV MED, V39, P1243, DOI 10.1016/j.ypmed.2004.04.040; Bray GA, 2012, DIABETES CARE, V35, P731, DOI 10.2337/dc11-1299; Broom I, 2002, INT J CLIN PRACT, V56, P494; Carvajal R, 2013, ANN NY ACAD SCI, V1281, P191, DOI 10.1111/nyas.12004; Cavaliere H, 2001, INT J OBESITY, V25, P1095, DOI 10.1038/sj.ijo.0801645; Chan EW, 2013, OBES REV, V14, P383, DOI 10.1111/obr.12015; Colman E, 2012, NEW ENGL J MED, V367, P1577, DOI 10.1056/NEJMp1211277; Colman E, 2012, CIRCULATION, V125, P2156, DOI 10.1161/CIRCULATIONAHA.111.028381; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235; Davidson MH, 2013, AM J CARDIOL, V111, P1131, DOI 10.1016/j.amjcard.2012.12.038; Derosa G, 2012, J CLIN PHARM THER, V37, P187, DOI 10.1111/j.1365-2710.2011.01280.x; Drucker DJ, 2011, J CLIN ENDOCR METAB, V96, P2027, DOI 10.1210/jc.2011-0599; Eisai Inc, 2013, BELVIQ LORCASERIN HY; Erdmann J, 2004, ALIMENT PHARM THER, V19, P1173, DOI 10.1111/j.1365-2036.2004.01966.x; Fidler MC, 2011, J CLIN ENDOCR METAB, V96, P3067, DOI 10.1210/jc.2011-1256; Finer N, 2006, DIABETES OBES METAB, V8, P206, DOI 10.1111/j.1463-1326.2005.00481.x; Finer N, 2000, INT J OBESITY, V24, P306, DOI 10.1038/sj.ijo.0801128; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Gadde KM, 2012, ARCH INTERN MED, V172, P1557, DOI 10.1001/2013.jamainternmed.99; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Gadde KM, 2009, EXPERT OPIN PHARMACO, V10, P921, DOI [10.1517/14656560902824152, 10.1517/14656560902824152 ]; Garber AJ, 2013, ENDOCR PRACT, V19, P100, DOI 10.4158/EP12325.OR; Garvey WT, 2013, ENDOCR PRACT, V19, P864, DOI 10.4158/EP13263.RA; Garvey WT, 2012, AM J CLIN NUTR, V95, P297, DOI 10.3945/ajcn.111.024927; Golden J, 2012, US FOOD AND DRUG ADM; GOLDSTEIN DJ, 1994, INT J OBESITY, V18, P129; Greenway Frank L, 2005, Expert Opin Drug Saf, V4, P1083, DOI 10.1517/14740338.4.6.1083; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; Haddock CK, 2002, INT J OBESITY, V26, P262, DOI 10.1038/sj.ijo.0801889; HADLER AJ, 1968, J CLIN PHARMACOL N D, V8, P113, DOI 10.1002/j.1552-4604.1968.tb00256.x; Hampp C, 2013, PHARMACOTHERAPY, V33, P1299, DOI 10.1002/phar.1342; Hanefeld M, 2002, DIABETES OBES METAB, V4, P415, DOI 10.1046/j.1463-1326.2002.00237.x; Hauptman J, 2000, ARCH FAM MED, V9, P160, DOI 10.1001/archfami.9.2.160; Hendricks EJ, 2011, OBESITY, V19, P2351, DOI 10.1038/oby.2011.94; Hendricks EJ, 2009, OBESITY, V17, P1730, DOI 10.1038/oby.2009.69; Hill JO, 1999, AM J CLIN NUTR, V69, P1108; Hollander PA, 1998, DIABETES CARE, V21, P1288, DOI 10.2337/diacare.21.8.1288; Hutton B, 2004, AM J CLIN NUTR, V80, P1461, DOI 10.1093/ajcn/80.6.1461; Ioannides-Demos LL, 2005, DRUGS, V65, P1391, DOI 10.2165/00003495-200565100-00006; Johansson K, 2010, OBES REV, V11, P777, DOI 10.1111/j.1467-789X.2009.00693.x; Kahan S, 2013, CURR OBES REP, V2, P128, DOI 10.1007/s13679-013-0052-0; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krempf M, 2003, INT J OBESITY, V27, P591, DOI 10.1038/sj.ijo.0802281; Lauer MS, 2012, ANN INTERN MED, V157, P139, DOI 10.7326/0003-4819-157-2-201207170-00438; LeBlanc E, 2011, REPORT NO 11 05159 E; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; Lindgarde F, 2000, J INTERN MED, V248, P245, DOI 10.1046/j.1365-2796.2000.00720.x; Maayan L, 2010, NEUROPSYCHOPHARMACOL, V35, P1520, DOI 10.1038/npp.2010.21; Margulis AV, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.008; Middleton KMR, 2012, OBES REV, V13, P509, DOI 10.1111/j.1467-789X.2011.00972.x; Miles JM, 2002, DIABETES CARE, V25, P1123, DOI 10.2337/diacare.25.7.1123; Monami M, 2012, EXP DIABETES RES, DOI 10.1155/2012/672658; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; MUNRO JF, 1968, BRIT MED J, V1, P352, DOI 10.1136/bmj.1.5588.352; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 2013, THE EFFECTS OF EXENA; Nordisk Novo, 2013, EFFECT OF LIRAGLUTID; O'Neil PM, 2012, OBESITY, V20, P1426, DOI 10.1038/oby.2012.66; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Orexigen Therapeutics Inc, 2012, OREXIGEN ANNOUNCES A; Padwal R, 2007, INT J OBESITY, V31, P1567, DOI 10.1038/sj.ijo.0803631; Padwal R, 2003, INT J OBESITY, V27, P1437, DOI 10.1038/sj.ijo.0802475; Rissanen A, 2003, INT J OBESITY, V27, P103, DOI 10.1038/sj.ijo.0802165; Roberts MD, 2012, NEW DRUG APPLICATION, P32; Roche Laboratories Inc, 2009, XENICAL ORLISTAT CAP; Rosenstock J, 2010, DIABETES CARE, V33, P1173, DOI 10.2337/dc09-1203; Rossner S, 2000, OBES RES, V8, P49, DOI 10.1038/oby.2000.8; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; RUNYAN JW, 1962, CURR THER RES CLIN E, V4, P270; Ryan DH, 2013, CURR HYPERTENS REP, V15, P182, DOI 10.1007/s11906-013-0343-6; Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu; SILVERSTONE T, 1974, PRACTITIONER, V213, P245; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; Singh-Franco D, 2011, DIABETES OBES METAB, V13, P169, DOI 10.1111/j.1463-1326.2010.01337.x; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Swinburn BA, 2005, DIABETES OBES METAB, V7, P254, DOI 10.1111/j.1463-1326.2004.00467.x; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tran PT, 2012, SUMMARY MINUTES OF T; Tran PT, 2010, SUMMARY MINUTES OF T; US Department of Health and Human Services National Institutes of Health, 2013, NIH PUBLICATION; US Food and Drug Administration, 2011, VIVUS DATA ON FILE N; Vivus Inc, 2013, QSYMIA PHENTERMINE A; Vivus Inc, 2013, NDA 22580 QSYMIA PHE; Wadden TA, 2013, INT J OBESITY, V37, pS3, DOI 10.1038/ijo.2013.90; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; Wadden TA, 2013, INT J OBES LOND, V37, P1514, DOI [DOI 10.1038/IJO.2013.148, 10.1038/ijo.2013.148]; Wadden TA, 2011, OBESITY, V19, P110, DOI 10.1038/oby.2010.147; Wadden TA, 2009, OBESITY, V17, P713, DOI 10.1038/oby.2008.637; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P595, DOI 10.1038/clpt.1992.70; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039062	99	540	557	3	97	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					74	86		10.1001/jama.2013.281361	http://dx.doi.org/10.1001/jama.2013.281361			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24231879	Green Accepted			2022-12-28	WOS:000329161400020
J	Adams, AM; Ahmed, T; El Arifeen, S; Evans, TG; Huda, T; Reichenbach, L				Adams, Alayne M.; Ahmed, Tanvir; El Arifeen, Shams; Evans, Timothy G.; Huda, Tanvir; Reichenbach, Laura		Lancet Bangladesh Team	Innovation for universal health coverage in Bangladesh: a call to action	LANCET			English	Article							DRINKING-WATER; CARE; INSURANCE; SALINITY	A post-Millennium Development Goals agenda for health in Bangladesh should be defined to encourage a second generation of health-system innovations under the clarion call of universal health coverage. This agenda should draw on the experience of the first generation of innovations that underlie the country's impressive health achievements and creatively address future health challenges. Central to the reform process will be the development of a multipronged strategic approach that: responds to existing demands in a way that assures affordable, equitable, high-quality health care from a pluralistic health system; anticipates health-care needs in a period of rapid health and social transition; and addresses underlying structural issues that otherwise might hamper progress. A pragmatic reform agenda for achieving universal health coverage in Bangladesh should include development of a long-term national human resources policy and action plan, establishment of a national insurance system, building of an interoperable electronic health information system, investment to strengthen the capacity of the Ministry of Health and Family Welfare, and creation of a supraministerial council on health. Greater political, financial, and technical investment to implement this reform agenda offers the prospect of a stronger, more resilient, sustainable, and equitable health system.	[Adams, Alayne M.; Ahmed, Tanvir] Int Ctr Diarrhoeal Dis Res, Ctr Equ & Hlth Syst, Dhaka 1000, Bangladesh; [El Arifeen, Shams; Huda, Tanvir] Int Ctr Diarrhoeal Dis Res, Ctr Child Hlth & Adolescent Hlth, Dhaka 1000, Bangladesh; [Reichenbach, Laura] Int Ctr Diarrhoeal Dis Res, Ctr Reprod Hlth, Dhaka 1000, Bangladesh; [Evans, Timothy G.] World Bank, Washington, DC 20433 USA	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); The World Bank	Adams, AM (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Equ & Hlth Syst, Dhaka 1000, Bangladesh.	aadams@icddrb.org	Christou, Aliki/D-1249-2018	Christou, Aliki/0000-0001-9525-8255; Arifeen, Shams/0000-0002-5372-5932; Mahmood, Shehrin Shaila/0000-0002-6546-9120; Adams, Alayne/0000-0002-0961-9825; Peters, David/0000-0001-8377-3444; rasheed, sabrina/0000-0002-7444-200X	Rockefeller Foundation; ESRC [ES/J018651/1] Funding Source: UKRI	Rockefeller Foundation; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This call to action is endorsed by Fazle Hasan Abed (BRAC), A K Azad Khan (Bangladesh Diabetic Association), Rounaq Jahan (Centre for Policy Dialogue), Shahla Khatun (formerly Dhaka Medical College), and Hossain Zillur Rahman (Power and Participation Research Centre). We thank the Rockefeller Foundation for supporting the research, reflection, and dialogue that has allowed the story of health in Bangladesh to be told.	Adams AM, 2013, LANCET; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Bangladesh Health Watch, 2008, STAT HLTH BANGL 2007, P1212; Barkat A, 2012, MOVING UNIVERSAL HLT, P25; Begum S., 2000, PUBLIC PRIVATE MIX H; BRAC, NONCOMM DIS NCD PROG; Cash RA, 2013, LANCET; Cavaniol C., 2020, UNIVERSAL HLTH COVER; Chaudhury N, 2004, WORLD BANK ECON REV, V18, P423, DOI 10.1093/wber/lhh047; Chow AT, 2013, BIOGEOCHEMISTRY, V112, P571, DOI 10.1007/s10533-012-9750-z; Chowdhury, 2018, CREATING CULTURE INN; Chowdhury A.M.R., 1996, SIMPLE SOLUTION TEAC; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Chowdhury NT, 2010, WATER POLICY, V12, P32, DOI 10.2166/wp.2009.112; Directorate General of Health Services, 2012, HLTH B 2012; El Arifeen S, 2013, LANCET; Evans TG, 2012, MOVING UNIVERSAL HLT, P111; Ferrinho Paulo, 2004, Hum Resour Health, V2, P14, DOI 10.1186/1478-4491-2-14; Government of Bangladesh, 2013, ANN REP REV 2012; Gruen R, 2002, SOC SCI MED, V54, P267, DOI 10.1016/S0277-9536(01)00026-0; Hashima-E-Nasreen, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7017; HLSP (Mott MacDonald), 2010, BANGL HLTH SECT PROF; Hussain M, 1993, RETHINKING POVERTY; Khan A, 2008, LANCET, V371, P385, DOI 10.1016/S0140-6736(08)60197-X; Khan AE, 2011, ENVIRON HEALTH PERSP, V119, P1328, DOI 10.1289/ehp.1002804; Khan IR, 2012, LESSON LEARNING URBA; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Ministry of Health and Family Welfare, 2010, BANGL NAT HLTH ACC 1; MOHFW, 2009, BANGL HLTH WORKF STR; MOHFW, 2012, HLTH POP NUTR SECT D; Nahar S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-11; National Institute of Population Research and Training (NIPORT) MEASURE Evaluation International Centre for Diarrhoeal Disease Research Bangladesh (ICDDR B) and Associates for Community and Population Research (ACPR), 2008, 2006 BANGL URB HLTH; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Rannan-Eliya RP, 2005, 2 EUITAP PROJ; Schneider P, 2006, HEALTH ECON, V15, P19, DOI 10.1002/hec.1014; Streatfield PK, 2008, J HEALTH POPUL NUTR, V26, P261; Uddin MK, 2011, AUST J CROP SCI, V5, P620; UN, 2010, WORLD POP PROSP 2010; United Nations, 2012, UN GEN ASS 66 SESS A; UPPR (Urban Partnerships for Poverty Reduction), 2011, URB PARTN POV RED PO; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; World Bank, HLTH EXP PER CAP PPP; World Bank, 2015, LEVERAGING URBANIZAT; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	46	39	39	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2104	2111		10.1016/S0140-6736(13)62150-9	http://dx.doi.org/10.1016/S0140-6736(13)62150-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24268605				2022-12-28	WOS:000328687800032
J	Califf, RM; Platt, R				Califf, Robert M.; Platt, Richard			Embedding Cardiovascular Research Into Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Califf, Robert M.] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Califf, Robert M.] Duke Univ, Duke Translat Med Inst, Durham, NC 27710 USA; [Platt, Richard] Harvard Univ, Sch Med, Dept Populat Med, Harvard Pilgrim Hlth Care Inst, Boston, MA USA	Duke University; Duke University; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Califf, RM (corresponding author), Duke Univ, Sch Med, Duke Translat Med Inst, 200 Trent Dr,1117 Davison Bldg,DUMC 3701, Durham, NC 27710 USA.	robert.califf@duke.edu			National Center for Complementary & Integrative Health [U54AT007748] Funding Source: NIH RePORTER; NCCIH NIH HHS [1U54AT007748-01] Funding Source: Medline	National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Antman EM, 2012, JAMA-J AM MED ASSOC, V308, P1743, DOI 10.1001/jama.2012.14841; Frobert O, 2010, INT J CARDIOL, V145, P572, DOI 10.1016/j.ijcard.2010.05.044; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Hess CN, 2013, AM HEART J, V166, P421, DOI 10.1016/j.ahj.2013.06.013; Olsen L, LEARN HEALTHC SYST W; Solomon MZ, 43 HAST CTR; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205	7	30	30	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2037	2038		10.1001/jama.2013.282771	http://dx.doi.org/10.1001/jama.2013.282771			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240926				2022-12-28	WOS:000327098900015
J	Dharmarajan, K; Hsieh, AF; Lin, Z; Bueno, H; Ross, JS; Horwitz, LI; Barreto, JA; Kim, N; Suter, LG; Bernheim, SM; Drye, EE; Krumholz, HM				Dharmarajan, Kumar; Hsieh, Angela F.; Lin, Zhenqiu; Bueno, Hector; Ross, Joseph S.; Horwitz, Leora I.; Barreto-Filho, Jose Augusto; Kim, Nancy; Suter, Lisa G.; Bernheim, Susannah M.; Drye, Elizabeth E.; Krumholz, Harlan M.			Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; RISK-STANDARDIZED MORTALITY; URBAN-RURAL DIFFERENCES; SAFETY-NET HOSPITALS; HEART-FAILURE; PATIENT OUTCOMES; HEALTH-CARE; RATES; REHOSPITALIZATION	Objectives To determine whether high performing hospitals with low 30 day risk standardized readmission rates have a lower proportion of readmissions from specific diagnoses and time periods after admission or instead have a similar distribution of readmission diagnoses and timing to lower performing institutions. Design Retrospective cohort study. Setting Medicare beneficiaries in the United States. Participants Patients aged 65 and older who were readmitted within 30 days after hospital admission for heart failure, acute myocardial infarction, or pneumonia in 2007-09. Main outcome measures Readmission diagnoses were classified with a modified version of the Centers for Medicare and Medicaid Services' condition categories, and readmission timing was classified by day (0-30) after hospital discharge. Hospital 30 day risk standardized readmission rates over the three years of study were calculated with public reporting methods of the US federal government, and hospitals were categorized with bootstrap analysis as having high, average, or low readmission performance for each index condition. High and low performing hospitals had >= 95% probability of having an interval estimate respectively less than or greater than the national 30 day readmission rate over the three year period of study. All remaining hospitals were considered average performers. Results For readmissions in the 30 days after the index admission, there were 320 003 after 1 291 211 admissions for heart failure (4041 hospitals), 102 536 after 517 827 admissions for acute myocardial infarction (2378 hospitals), and 208 438 after 1 135 932 admissions for pneumonia (4283 hospitals). The distribution of readmissions by diagnosis was similar across categories of hospital performance for all three conditions. High performing hospitals had fewer readmissions for all common diagnoses. Median time to readmission was similar by hospital performance for heart failure and acute myocardial infarction, though was 1.4 days longer among high versus low performing hospitals for pneumonia (P<0.001). Findings were unchanged after adjustment for other hospital characteristics potentially associated with readmission patterns. Conclusions High performing hospitals have proportionately fewer 30 day readmissions without differences in readmission diagnoses and timing, suggesting the possible benefit of strategies that lower risk of readmission globally rather than for specific diagnoses or time periods after hospital stay.	[Dharmarajan, Kumar] Columbia Univ, Med Ctr, Dept Internal Med, Div Cardiol, New York, NY 10032 USA; [Hsieh, Angela F.; Lin, Zhenqiu; Bernheim, Susannah M.; Drye, Elizabeth E.; Krumholz, Harlan M.] Yale Univ, New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA; [Bueno, Hector] Univ Gregorio Maranon, Gen Hosp, Dept Cardiol, Madrid 28007, Spain; [Ross, Joseph S.; Horwitz, Leora I.; Kim, Nancy] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Barreto-Filho, Jose Augusto] Univ Fed Sergipe, Div Cardiol, BR-49060100 Aracaju, Sergipe, Brazil; [Drye, Elizabeth E.] Yale Univ, Sch Med, Rheumatol Sect, New Haven, CT 06520 USA	Columbia University; Yale University; General University Gregorio Maranon Hospital; Yale University; Universidade Federal de Sergipe; Yale University	Dharmarajan, K (corresponding author), Columbia Univ, Med Ctr, Dept Internal Med, Div Cardiol, 630 West 168th St,Box 93,PH 10-203, New York, NY 10032 USA.	kumar.dharmarajan@columbia.edu	Bueno, Hector/I-3910-2015; , Harlan/AAI-2875-2020; Horwitz, Leora/ABD-1292-2020; Horwitz, Leora/A-6959-2009	Bueno, Hector/0000-0003-0277-7596; Ross, Joseph/0000-0002-9218-3320; Horwitz, Leora/0000-0003-1800-6040	National Heart, Lung, and Blood Institute; National Heart, Lung, and Blood Institute [T32HL007854]; Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A Hartford Foundation; American Federation for Aging Research; National Institute on Aging [K08AG032886, K08AG038336]; American Federation for Aging Research through the Paul B Beeson Career Development Award Program; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil) [3436-10-1]; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute [1U01HL105270-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270, T32HL007854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG038336, K08AG032886] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A Hartford Foundation; American Federation for Aging Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B Beeson Career Development Award Program; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Heart, Lung, and Blood Institute, which had no role in the design, conduct, or analysis of the study or in the decision to submit the manuscript for publication. KD was supported by grant T32HL007854 from the National Heart, Lung, and Blood Institute and as a Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A Hartford Foundation and the American Federation for Aging Research during the time that the work was conducted. JSR and LIH are supported by grants K08AG032886 and K08AG038336 from the National Institute on Aging and by the American Federation for Aging Research through the Paul B Beeson Career Development Award Program, respectively. JAB-F was supported by grant 3436-10-1 from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil) during the time that the work was conducted. HMK is supported by grant 1U01HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the American Federation for Aging Research.	Ash AS, 2012, STAT ISSUES ASSESSIN; Baldrige Performance Excellence Program, 2013, 2013 2014 HLTH CAR C; Baldwin LM, 2010, J RURAL HEALTH, V26, P51, DOI 10.1111/j.1748-0361.2009.00265.x; Bernheim SM, 2007, AM HEART J, V153, P313, DOI 10.1016/j.ahj.2006.10.037; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Bradley EH, 2012, ANN INTERN MED, V156, P618, DOI 10.7326/0003-4819-156-9-201205010-00003; Bucholz EM, 2011, AM J CARDIOL, V108, P943, DOI 10.1016/j.amjcard.2011.05.023; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Centers for Medicare and Medicaid Services, 2011, MED HOSP QUAL CHARTB; Centers for Medicare and Medicaid Services, MED HOSP COMP QUAL C; Chan L, 2006, J RURAL HEALTH, V22, P140, DOI 10.1111/j.1748-0361.2006.00022.x; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Department of Health and Human Services, 2013, PROGR REP CMS US SEN; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; Dunlay SM, 2012, ANN INTERN MED, V157, P11, DOI 10.7326/0003-4819-157-1-201207030-00004; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; Evangelista LS, 2000, AM J CARDIOL, V86, P1339, DOI 10.1016/S0002-9149(00)01238-8; Gaskin DJ, 2001, HEALTH SERV RES, V36, P25; Hammill BG, 2011, CIRC-CARDIOVASC QUAL, V4, P60, DOI 10.1161/CIRCOUTCOMES.110.954693; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hartman L, 2007, J RURAL HEALTH, V23, P254, DOI 10.1111/j.1748-0361.2007.00098.x; Howie-Esquivel J, 2012, AM J CRIT CARE, V21, pE65, DOI 10.4037/ajcc2012382; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Kaboli PJ, 2012, ANN INTERN MED, V157, P837, DOI 10.7326/0003-4819-157-12-201212180-00003; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Lutfiyya MN, 2007, INT J QUAL HEALTH C, V19, P141, DOI 10.1093/intqhc/mzm010; National Quality Forum, 2008, NAT VOL CONS STAND H; Neupane B, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-22; O'Connor CM, 2010, AM HEART J, V159, P841, DOI 10.1016/j.ahj.2010.02.023; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Probst JC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-40; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Ross JS, 2012, HEALTH AFFAIR, V31, P1739, DOI 10.1377/hlthaff.2011.1028; Shah SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047420; Sheikh K, 2001, ARCH INTERN MED, V161, P737, DOI 10.1001/archinte.161.5.737; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564	52	65	68	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6571	10.1136/bmj.f6571	http://dx.doi.org/10.1136/bmj.f6571			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	258KF	24259033	hybrid, Green Published			2022-12-28	WOS:000327457400001
J	McLean, RC; Jessup, M				McLean, Rhondalyn C.; Jessup, Mariell			The Challenge of Treating Heart Failure A Diverse Disease Affecting Diverse Populations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; UPDATE		[McLean, Rhondalyn C.; Jessup, Mariell] Univ Penn, Perelman Sch Med, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA	University of Pennsylvania	Jessup, M (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Cardiovasc, 2 E Perelman Pavil,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	jessupm@uphs.upenn.edu		Jessup, Mariell/0000-0002-3010-0112				Bahrarni H, 2008, ARCH INTERN MED, V168, P2138, DOI 10.1001/archinte.168.19.2138; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hsich EM, 2009, J AM COLL CARDIOL, V54, P491, DOI 10.1016/j.jacc.2009.02.066; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003; Thomas KL, 2011, AM HEART J, V161, P746, DOI 10.1016/j.ahj.2011.01.012; Williams SA, 2002, PSYCHOSOM MED, V64, P6, DOI 10.1097/00006842-200201000-00002	10	9	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2033	2034		10.1001/jama.2013.282773	http://dx.doi.org/10.1001/jama.2013.282773			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240924				2022-12-28	WOS:000327098900013
J	Hall, WJ				Hall, William J.			Review: Pharmacist care improves therapeutic and safety outcomes in older adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Rochester, Sch Med, Rochester, NY 14627 USA	University of Rochester	Hall, WJ (corresponding author), Univ Rochester, Sch Med, Rochester, NY 14627 USA.							Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10							JC6	10.7326/0003-4819-159-10-201311190-02006	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247696				2022-12-28	WOS:000328732700005
J	Cripton, P				Cripton, Peter			Protecting the neck	NATURE			English	Editorial Material									Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Cripton, P (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	cripton@mech.ubc.ca	Cripton, Peter Alec/AAC-8268-2020	Cripton, Peter Alec/0000-0002-5067-0833				Dressler D, 2012, AM SOC TEST MATER, V1553, P235, DOI 10.1520/STP104525; Newell RS, 2013, J BIOMECH, V46, P2837, DOI 10.1016/j.jbiomech.2013.08.013	2	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S13	S13		10.1038/503S13a	http://dx.doi.org/10.1038/503S13a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24227000				2022-12-28	WOS:000326894200006
J	Mead, S; Gandhi, S; Beck, J; Caine, D; Gallujipali, D; Carswell, C; Hyare, H; Joiner, S; Ayling, H; Lashley, T; Linehan, JM; Al-Doujaily, H; Sharps, B; Revesz, T; Sandberg, MK; Reilly, MM; Koltzenburg, M; Forbes, A; Rudge, P; Brandner, S; Warren, JD; Wadsworth, JDF; Wood, NW; Holton, JL; Collinge, J				Mead, Simon; Gandhi, Sonia; Beck, Jon; Caine, Diana; Gallujipali, Dillip; Carswell, Christopher; Hyare, Harpreet; Joiner, Susan; Ayling, Hilary; Lashley, Tammaryn; Linehan, Jacqueline M.; Al-Doujaily, Huda; Sharps, Bernadette; Revesz, Tamas; Sandberg, Malin K.; Reilly, Mary M.; Koltzenburg, Martin; Forbes, Alastair; Rudge, Peter; Brandner, Sebastian; Warren, Jason D.; Wadsworth, Jonathan D. F.; Wood, Nicholas W.; Holton, Janice L.; Collinge, John			A Novel Prion Disease Associated with Diarrhea and Autonomic Neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; PROTEIN GENE; TRANSGENIC MICE; VARIANT; PRNP; MUTATIONS; PHENOTYPE; CLASSIFICATION; AMYLOIDOSIS	BackgroundHuman prion diseases, although variable in clinicopathological phenotype, generally present as neurologic or neuropsychiatric conditions associated with rapid multifocal central nervous system degeneration that is usually dominated by dementia and cerebellar ataxia. Approximately 15% of cases of recognized prion disease are inherited and associated with coding mutations in the gene encoding prion protein (PRNP). The availability of genetic diagnosis has led to a progressive broadening of the recognized spectrum of disease. MethodsWe used longitudinal clinical assessments over a period of 20 years at one hospital combined with genealogical, neuropsychological, neurophysiological, neuroimaging, pathological, molecular genetic, and biochemical studies, as well as studies of animal transmission, to characterize a novel prion disease in a large British kindred. We studied 6 of 11 affected family members in detail, along with autopsy or biopsy samples obtained from 5 family members. ResultsWe identified a PRNP Y163X truncation mutation and describe a distinct and consistent phenotype of chronic diarrhea with autonomic failure and a length-dependent axonal, predominantly sensory, peripheral polyneuropathy with an onset in early adulthood. Cognitive decline and seizures occurred when the patients were in their 40s or 50s. The deposition of prion protein amyloid was seen throughout peripheral organs, including the bowel and peripheral nerves. Neuropathological examination during end-stage disease showed the deposition of prion protein in the form of frequent cortical amyloid plaques, cerebral amyloid angiopathy, and tauopathy. A unique pattern of abnormal prion protein fragments was seen in brain tissue. Transmission studies in laboratory mice were negative. ConclusionsAbnormal forms of prion protein that were found in multiple peripheral tissues were associated with diarrhea, autonomic failure, and neuropathy. (Funded by the U.K. Medical Research Council and others.) Prions cause a variety of CNS illnesses, such as Creutzfeldt-Jakob disease. In this British kindred, a prion-associated process was associated with chronic diarrhea and autonomic dysfunction, a finding that extends the known disorders caused by these aberrant proteins. The prion diseases are transmissible, fatal, neurodegenerative disorders that may be inherited or acquired or that may occur spontaneously as sporadic Creutzfeldt-Jakob disease.(1) The transmissible agent, or prion, is thought to comprise misfolded and aggregated forms of the normal cell-surface prion protein. Prion propagation is thought to occur by means of seeded protein polymerization, a process involving the binding and templated misfolding of normal cellular prion protein. Similar processes are increasingly recognized as relevant to other, more common neurodegenerative diseases. In prion and other neurodegenerative disorders, the aggregates of misfolded protein in the central nervous system are highly heterogeneous, occurring ...	[Mead, Simon; Beck, Jon; Carswell, Christopher; Joiner, Susan; Linehan, Jacqueline M.; Al-Doujaily, Huda; Sharps, Bernadette; Sandberg, Malin K.; Brandner, Sebastian; Wadsworth, Jonathan D. F.; Collinge, John] UCL, Inst Neurol, MRC, Prion Unit, London WC1E 6BT, England; [Gandhi, Sonia; Wood, Nicholas W.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1E 6BT, England; [Warren, Jason D.] UCL, Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat Dis, London WC1E 6BT, England; [Reilly, Mary M.] UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1E 6BT, England; [Mead, Simon; Caine, Diana; Gallujipali, Dillip; Hyare, Harpreet; Rudge, Peter; Collinge, John] Natl Hosp Neurol & Neurosurg, Natl Prion Clin, London, England; [Forbes, Alastair] UCL Hosp Natl Hlth Serv Trust, London, England; [Ayling, Hilary; Lashley, Tammaryn; Revesz, Tamas; Holton, Janice L.] Queen Sq Brain Bank, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Collinge, J (corresponding author), UCL Inst Neurol, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Holton, Janice L/F-6831-2011; GAJULAPALLI, RAMA DILIP/K-5585-2019; Koltzenburg, Martin/C-1349-2008; Wood, Nicholas W/C-2505-2009; Revesz, Tamas/A-8732-2010; Beck, Jon/GRX-8457-2022; Brandner, Sebastian/J-4562-2014; Lashley, Tammaryn/D-2583-2009	Holton, Janice L/0000-0002-3882-5249; GAJULAPALLI, RAMA DILIP/0000-0003-2872-7132; Koltzenburg, Martin/0000-0001-9181-5966; Wood, Nicholas W/0000-0002-9500-3348; Revesz, Tamas/0000-0003-2501-0259; Brandner, Sebastian/0000-0002-9821-0342; Wadsworth, Jonathan/0000-0002-4797-2259; Reilly, Mary/0000-0003-0686-905X; Forbes, Alastair/0000-0001-7416-9843; Lashley, Tammaryn/0000-0001-7389-0348; Warren, Jason/0000-0002-5405-0826; Mead, Simon/0000-0002-4326-1468	U.K. Medical Research Council (MRC); Reta Lila Weston Institute of Neurological Studies; Alzheimer's Research UK; Multiple System Atrophy Trust; National Institute for Health Research (NIHR) Biomedical Research Centre at the University College London Hospitals NHS Foundation Trust and University College London; NIHR Dementia Biomedical Research Unit; National Institutes of Neurological Diseases and Stroke and Office of Rare Diseases Research [U54NS065712]; Wellcome Trust Senior Clinical Fellowship; Wellcome Trust/MRC Neuro-degeneration award [WT089698]; MRC [G0802497, MC_U123160655, MC_U123192748, MC_U123160651, MR/K000608/1] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_U123160651, G0802497, MR/K000608/1, MC_U123160655] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10376] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065712] Funding Source: NIH RePORTER	U.K. Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Reta Lila Weston Institute of Neurological Studies; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Multiple System Atrophy Trust; National Institute for Health Research (NIHR) Biomedical Research Centre at the University College London Hospitals NHS Foundation Trust and University College London; NIHR Dementia Biomedical Research Unit; National Institutes of Neurological Diseases and Stroke and Office of Rare Diseases Research; Wellcome Trust Senior Clinical Fellowship(Wellcome Trust); Wellcome Trust/MRC Neuro-degeneration award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the U.K. Medical Research Council (MRC) (in part to Dr. Reilly), the Reta Lila Weston Institute of Neurological Studies (to Dr. Holton and Ms. Ayling), Alzheimer's Research UK (to Drs. Holton, Revesz, and Lashley), the Multiple System Atrophy Trust (to Drs. Holton and Revesz), the National Institute for Health Research (NIHR) Biomedical Research Centre at the University College London Hospitals NHS Foundation Trust and University College London, the NIHR Dementia Biomedical Research Unit, the National Institutes of Neurological Diseases and Stroke and Office of Rare Diseases Research (U54NS065712, to Dr. Reilly), a Wellcome Trust Senior Clinical Fellowship (to Dr. Warren), and a Wellcome Trust/MRC Neuro-degeneration award (WT089698).	Beck JA, 2010, HUM MUTAT, V31, pE1551, DOI 10.1002/humu.21281; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cortelli P, 1991, Clin Auton Res, V1, P15, DOI 10.1007/BF01826053; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Edgeworth JA, 2011, J GEN VIROL, V92, P718, DOI 10.1099/vir.0.027201-0; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hill AF, 2006, BRAIN, V129, P676, DOI 10.1093/brain/awl013; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; Jayadev S, 2011, ANN NEUROL, V69, P712, DOI 10.1002/ana.22264; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Lee AM, 2011, VIROLOGY, V411, P1, DOI 10.1016/j.virol.2010.12.012; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Montagna P, 2003, LANCET NEUROL, V2, P167, DOI 10.1016/S1474-4422(03)00323-5; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; PORTALUPPI F, 1994, HYPERTENSION, V23, P569, DOI 10.1161/01.HYP.23.5.569; Stohr J, 2011, P NATL ACAD SCI USA, V108, P21223, DOI 10.1073/pnas.1117827108; Trifilo MJ, 2006, SCIENCE, V313, P94, DOI 10.1126/science.1128635; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wadsworth JDF, 2008, P NATL ACAD SCI USA, V105, P3885, DOI 10.1073/pnas.0800190105	28	83	87	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1904	1914		10.1056/NEJMoa1214747	http://dx.doi.org/10.1056/NEJMoa1214747			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251AN	24224623	Green Accepted			2022-12-28	WOS:000326899000001
J	Striepen, B				Striepen, Boris			Time to tackle cryptosporidiosis	NATURE			English	Editorial Material							PARVUM; PROTECTION; NITAZOXANIDE; MORTALITY; CHILDREN; HOMINIS; GENOME		Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Striepen, B (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	striepen@uga.edu		Striepen, Boris/0000-0002-7426-432X				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; Bessoff K, 2013, ANTIMICROB AGENTS CH, V57, P1804, DOI 10.1128/AAC.02460-12; Jenkins M, 2004, J PARASITOL, V90, P1178, DOI 10.1645/GE-3333RN; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Okhuysen PC, 1998, INFECT IMMUN, V66, P441, DOI 10.1128/IAI.66.2.441-443.1998; Rossignol JFA, 2001, J INFECT DIS, V184, P103, DOI 10.1086/321008; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sheoran A, 2012, J INFECT DIS, V205, P1019, DOI 10.1093/infdis/jir874; Umejiego NN, 2008, CHEM BIOL, V15, P70, DOI 10.1016/j.chembiol.2007.12.010; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977	12	130	133	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					189	191		10.1038/503189a	http://dx.doi.org/10.1038/503189a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24236315	Bronze			2022-12-28	WOS:000326894200022
J	Cole, TB				Cole, Thomas B.			Houses at Murnau	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1898	1899		10.1001/jama.2013.5405	http://dx.doi.org/10.1001/jama.2013.5405			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219925				2022-12-28	WOS:000326832900001
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING Obamacare's rocky road	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				[Anonymous], 2013, WALL STREET J; [Anonymous], 2012, DYING COV DEADL CONS; Kamerow D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c500; Kristof Nicholas, 2013, NY TIMES; McCarthy M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6597; McCarthy M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6596; Sundby EL., 2013, WALL STREET J; US Centers for Medicare and Medicaid Services, 2014, STAT MED CHIP INC EL	8	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2013	347								f6805	10.1136/bmj.f6805	http://dx.doi.org/10.1136/bmj.f6805			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FR	24222677				2022-12-28	WOS:000327150600019
J	Williams, R; Horton, R				Williams, Roger; Horton, Richard			Liver disease in the UK: a Lancet Commission	LANCET			English	Editorial Material							ALCOHOL		[Williams, Roger] Fdn Liver Res, Inst Hepatol London, London WC1E 6HX, England; [Horton, Richard] The Lancet, London NW1 7BY, England	University of London; University College London	Williams, R (corresponding author), Fdn Liver Res, Inst Hepatol London, London WC1E 6HX, England.	r.williams@researchinliver.org.uk						[Anonymous], 2013, MEAS UN REV PAT WHO; Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Cobbold JFL, 2013, FRONTLINE GASTROENTE, V4, P263, DOI 10.1136/flgastro-2013-100319; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Moriarty KJ, 2011, FRONTLINE GASTROENTE, V2, P77, DOI 10.1136/fg.2010.002105; Namgyal P, 2003, J HEPATOL, V39, pS77, DOI 10.1016/S0168-8278(03)00269-1; Office for National Statistics, 2013, STATISTICAL BULLETIN; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Sheron N, 2012, LANCET, V379, P687, DOI 10.1016/S0140-6736(12)60244-X; Williams R, 2013, LANCET, V381, P2164, DOI 10.1016/S0140-6736(13)61438-5	10	13	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1537	1538		10.1016/S0140-6736(13)62152-2	http://dx.doi.org/10.1016/S0140-6736(13)62152-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247NE	24209811				2022-12-28	WOS:000326623900006
J	Carslaw, KS; Lee, LA; Reddington, CL; Pringle, KJ; Rap, A; Forster, PM; Mann, GW; Spracklen, DV; Woodhouse, MT; Regayre, LA; Pierce, JR				Carslaw, K. S.; Lee, L. A.; Reddington, C. L.; Pringle, K. J.; Rap, A.; Forster, P. M.; Mann, G. W.; Spracklen, D. V.; Woodhouse, M. T.; Regayre, L. A.; Pierce, J. R.			Large contribution of natural aerosols to uncertainty in indirect forcing	NATURE			English	Article							CLOUD CONDENSATION NUCLEI; SULFATE AEROSOL; NUMBER CONCENTRATIONS; GLOBAL-MODEL; GLOMAP-MODE; CLIMATE; SENSITIVITY; IMPACT; EMISSIONS; MICROPHYSICS	The effect of anthropogenic aerosols on cloud droplet concentrations and radiative properties is the source of one of the largest uncertainties in the radiative forcing of climate over the industrial period. This uncertainty affects our ability to estimate how sensitive the climate is to greenhouse gas emissions. Here we perform a sensitivity analysis on a global model to quantify the uncertainty in cloud radiative forcing over the industrial period caused by uncertainties in aerosol emissions and processes. Our results show that 45 per cent of the variance of aerosol forcing since about 1750 arises from uncertainties in natural emissions of volcanic sulphur dioxide, marine dimethylsulphide, biogenic volatile organic carbon, biomass burning and sea spray. Only 34 per cent of the variance is associated with anthropogenic emissions. The results point to the importance of understanding pristine pre-industrial-like environments, with natural aerosols only, and suggest that improved measurements and evaluation of simulated aerosols in polluted present-day conditions will not necessarily result in commensurate reductions in the uncertainty of forcing estimates.	[Carslaw, K. S.; Lee, L. A.; Reddington, C. L.; Pringle, K. J.; Rap, A.; Forster, P. M.; Mann, G. W.; Spracklen, D. V.; Woodhouse, M. T.; Regayre, L. A.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Mann, G. W.] Univ Leeds, Natl Ctr Atmospher Sci, Leeds LS2 9JT, W Yorkshire, England; [Pierce, J. R.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA	University of Leeds; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Leeds; Colorado State University	Carslaw, KS (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	k.s.carslaw@leeds.ac.uk	Carslaw, Ken S/C-8514-2009; Forster, Piers M/F-9829-2010; Regayre, Leighton/AAD-1898-2019; Lee, Lindsay/AAZ-8216-2021; Lee, Lindsay/C-1902-2014; Reddington, Carly LS/I-3390-2015; Pierce, Jeffrey R/E-4681-2013; Spracklen, Dominick/AAA-6257-2019; Woodhouse, Matthew T/E-4808-2013; Spracklen, Dominick V/B-4890-2014; Rap, Alexandru/G-7532-2016; Mann, Graham/L-9529-2017; Pringle, Kirsty/A-4697-2013	Carslaw, Ken S/0000-0002-6800-154X; Forster, Piers M/0000-0002-6078-0171; Regayre, Leighton/0000-0003-2699-929X; Lee, Lindsay/0000-0002-8029-6328; Lee, Lindsay/0000-0002-8029-6328; Reddington, Carly LS/0000-0002-5990-4966; Pierce, Jeffrey R/0000-0002-4241-838X; Woodhouse, Matthew T/0000-0002-9892-4492; Rap, Alexandru/0000-0002-2319-6769; Mann, Graham/0000-0003-1746-2837; Pringle, Kirsty/0000-0003-2190-5258	Natural Environment Research Council [NE/G006172/1, NE/J024252/1]; EC [FP7-ENV-2010-265148]; National Centre for Atmospheric Science; Royal Society; EPSRC [EP/I014721/1] Funding Source: UKRI; NERC [NE/G006172/1, NE/J024252/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I014721/1] Funding Source: researchfish; Natural Environment Research Council [NE/G015015/1, 1230782] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EC(European CommissionEuropean Commission Joint Research Centre); National Centre for Atmospheric Science; Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research has received funding from the Natural Environment Research Council AEROS project (project number NE/G006172/1) and GASSP project (project number NE/J024252/1), the EC Seventh Framework Programme under grant agreement FP7-ENV-2010-265148 (Integrated Project PEGASOS), and the National Centre for Atmospheric Science. K. S. C. and P. M. F. are currently Royal Society Wolfson Merit Award holders.	Ackerman AS, 2004, NATURE, V432, P1014, DOI 10.1038/nature03174; Andreae MO, 2008, EARTH-SCI REV, V89, P13, DOI 10.1016/j.earscirev.2008.03.001; Andreae MO, 2007, SCIENCE, V315, P50, DOI 10.1126/science.1136529; Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Andres RJ, 1998, J GEOPHYS RES-ATMOS, V103, P25251, DOI 10.1029/98JD02091; Arnold SR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005998; Bastos L., 2011, TECHNOMETRICS, V4, P425; Bellouin N, 2013, ATMOS CHEM PHYS, V13, P3027, DOI 10.5194/acp-13-3027-2013; Bellouin N, 2013, ATMOS CHEM PHYS, V13, P2045, DOI 10.5194/acp-13-2045-2013; Bond TC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003697; Browse J, 2012, ATMOS CHEM PHYS, V12, P6775, DOI 10.5194/acp-12-6775-2012; Chipperfield MP, 2006, Q J ROY METEOR SOC, V132, P1179, DOI 10.1256/qj.05.51; Cofala J, 2005, SCENARIOS WORLD ANTH; Dentener F, 2006, ATMOS CHEM PHYS, V6, P4321, DOI 10.5194/acp-6-4321-2006; Edwards JM, 1996, Q J ROY METEOR SOC, V122, P689, DOI 10.1002/qj.49712253107; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fountoukis C, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005591; Gong SL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002079; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Guo H, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045020; Hill AA, 2009, J ATMOS SCI, V66, P1450, DOI 10.1175/2008JAS2909.1; Hoose C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038568; Jones A, 2001, J GEOPHYS RES-ATMOS, V106, P20293, DOI 10.1029/2000JD000089; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Korhonen H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009718; Lamarque JF, 2010, ATMOS CHEM PHYS, V10, P7017, DOI 10.5194/acp-10-7017-2010; Lee LA, 2013, ATMOS CHEM PHYS, V13, P8879, DOI 10.5194/acp-13-8879-2013; Lee LA, 2012, ATMOS CHEM PHYS, V12, P9739, DOI 10.5194/acp-12-9739-2012; Liao H, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001260; Liu XH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005674; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; Lohmann U, 2010, ATMOS CHEM PHYS, V10, P11373, DOI 10.5194/acp-10-11373-2010; Lu ML, 2005, J ATMOS SCI, V62, P3909, DOI 10.1175/JAS3584.1; Luo G, 2011, ATMOS CHEM PHYS, V11, P1949, DOI 10.5194/acp-11-1949-2011; Manktelow PT, 2010, ATMOS CHEM PHYS, V10, P365, DOI 10.5194/acp-10-365-2010; Manktelow PT, 2009, ATMOS CHEM PHYS, V9, P3253, DOI 10.5194/acp-9-3253-2009; Mann GW, 2012, ATMOS CHEM PHYS, V12, P4449, DOI 10.5194/acp-12-4449-2012; Mann GW, 2010, GEOSCI MODEL DEV, V3, P519, DOI 10.5194/gmd-3-519-2010; Morales R, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013233; Neelin JD, 2010, P NATL ACAD SCI USA, V107, P21349, DOI 10.1073/pnas.1015473107; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; Otto A, 2013, NAT GEOSCI, V6, P415, DOI 10.1038/ngeo1836; Pan WW, 1998, J GEOPHYS RES-ATMOS, V103, P3815, DOI 10.1029/97JD02809; Peng YR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004922; Penner JE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051870; Penner JE, 2011, P NATL ACAD SCI USA, V108, P13404, DOI 10.1073/pnas.1018526108; Pringle KJ, 2012, ATMOS CHEM PHYS, V12, P11647, DOI 10.5194/acp-12-11647-2012; Quaas J, 2009, ATMOS CHEM PHYS, V9, P8697, DOI 10.5194/acp-9-8697-2009; Rap A, 2013, GEOPHYS RES LETT, V40, P3297, DOI 10.1002/grl.50441; Reddington CL, 2011, ATMOS CHEM PHYS, V11, P12007, DOI 10.5194/acp-11-12007-2011; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Schmidt A, 2012, ATMOS CHEM PHYS, V12, P7321, DOI 10.5194/acp-12-7321-2012; Schmidt A, 2011, P NATL ACAD SCI USA, V108, P15710, DOI 10.1073/pnas.1108569108; Spracklen DV, 2011, ATMOS CHEM PHYS, V11, P12109, DOI 10.5194/acp-11-12109-2011; Spracklen DV, 2011, ATMOS CHEM PHYS, V11, P9067, DOI 10.5194/acp-11-9067-2011; Spracklen DV, 2010, ATMOS CHEM PHYS, V10, P4775, DOI 10.5194/acp-10-4775-2010; Spracklen DV, 2005, ATMOS CHEM PHYS, V5, P2227, DOI 10.5194/acp-5-2227-2005; Stevens B, 2009, NATURE, V461, P607, DOI 10.1038/nature08281; Stevens RG, 2012, ATMOS CHEM PHYS, V12, P189, DOI 10.5194/acp-12-189-2012; Stocks BJ, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000484; TWOMEY S, 1991, ATMOS ENVIRON A-GEN, V25, P2435, DOI 10.1016/0960-1686(91)90159-5; van der Werf GR, 2003, GLOBAL CHANGE BIOL, V9, P547, DOI 10.1046/j.1365-2486.2003.00604.x; Wilson J, 2001, J GEOPHYS RES-ATMOS, V106, P34081, DOI 10.1029/2000JD000198; Woodhouse MT, 2013, ATMOS CHEM PHYS, V13, P2723, DOI 10.5194/acp-13-2723-2013; Woodhouse MT, 2010, ATMOS CHEM PHYS, V10, P7545, DOI 10.5194/acp-10-7545-2010	66	601	606	33	504	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					67	+		10.1038/nature12674	http://dx.doi.org/10.1038/nature12674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201280				2022-12-28	WOS:000326585600033
J	Pearce, LR; Atanassova, N; Banton, MC; Bottomley, B; van der Klaauw, AA; Revelli, JP; Hendricks, A; Keogh, JM; Henning, E; Doree, D; Jeter-Jones, S; Garg, S; Bochukova, EG; Bounds, R; Ashford, S; Gayton, E; Hindmarsh, PC; Shield, JPH; Crowne, E; Barford, D; Wareham, NJ; O'Rahilly, S; Murphy, MP; Powell, DR; Barroso, I; Farooqi, IS				Pearce, Laura R.; Atanassova, Neli; Banton, Matthew C.; Bottomley, Bill; van der Klaauw, Agatha A.; Revelli, Jean-Pierre; Hendricks, Audrey; Keogh, Julia M.; Henning, Elana; Doree, Deon; Jeter-Jones, Sabrina; Garg, Sumedha; Bochukova, Elena G.; Bounds, Rebecca; Ashford, Sofie; Gayton, Emma; Hindmarsh, Peter C.; Shield, Julian P. H.; Crowne, Elizabeth; Barford, David; Wareham, Nick J.; O'Rahilly, Stephen; Murphy, Michael P.; Powell, David R.; Barroso, Ines; Farooqi, I. Sadaf		Uk10k Consortium	KSR2 Mutations Are Associated with Obesity, Insulin Resistance, and Impaired Cellular Fuel Oxidation	CELL			English	Article							KINASE SUPPRESSOR; SYNAPTIC PLASTICITY; ENERGY-EXPENDITURE; MAPK SCAFFOLD; GENE ENCODES; AMP-KINASE; RAS; ACTIVATION; SPECTRUM; MODULATION	Kinase suppressor of Ras 2 (KSR2) is an intracellular scaffolding protein involved in multiple signaling pathways. Targeted deletion of Ksr2 leads to obesity in mice, suggesting a role in energy homeostasis. We explored the role of KSR2 in humans by sequencing 2,101 individuals with severe early-onset obesity and 1,536 controls. We identified multiple rare variants in KSR2 that disrupt signaling through the Raf-MEK-ERK pathway and impair cellular fatty acid oxidation and glucose oxidation in transfected cells; effects that can be ameliorated by the commonly prescribed antidiabetic drug, metformin. Mutation carriers exhibit hyperphagia in childhood, low heart rate, reduced basal metabolic rate and severe insulin resistance. These data establish KSR2 as an important regulator of energy intake, energy expenditure, and substrate utilization in humans. Modulation of KSR2-mediated effects may represent a novel therapeutic strategy for obesity and type 2 diabetes.	[Pearce, Laura R.; Atanassova, Neli; Banton, Matthew C.; van der Klaauw, Agatha A.; Keogh, Julia M.; Henning, Elana; Garg, Sumedha; Bochukova, Elena G.; Bounds, Rebecca; Ashford, Sofie; O'Rahilly, Stephen; Barroso, Ines; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Pearce, Laura R.; Atanassova, Neli; Banton, Matthew C.; van der Klaauw, Agatha A.; Keogh, Julia M.; Henning, Elana; Garg, Sumedha; Bochukova, Elena G.; Bounds, Rebecca; Ashford, Sofie; O'Rahilly, Stephen; Barroso, Ines; Farooqi, I. Sadaf] Wellcome Trust MRC Inst Metab Sci, NIHR Cambridge Biomed Res Ctr, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Bottomley, Bill; Hendricks, Audrey; Gayton, Emma; Barroso, Ines; Uk10k Consortium] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Revelli, Jean-Pierre; Doree, Deon; Jeter-Jones, Sabrina; Powell, David R.] Lexicon Pharmaceut, The Woodlands, TX 77381 USA; [Hindmarsh, Peter C.] UCL, Inst Child Hlth, London WC1E 6BT, England; [Shield, Julian P. H.; Crowne, Elizabeth] Univ Bristol, Bristol BS2 8BJ, Avon, England; [Shield, Julian P. H.; Crowne, Elizabeth] Bristol Royal Hosp Children, Bristol BS2 8BJ, Avon, England; [Barford, David] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; [Wareham, Nick J.] Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Murphy, Michael P.] Wellcome Trust Res Labs, MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Lexicon Pharmaceuticals; University of London; University College London; University of Bristol; Bristol Royal Hospital For Children; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute	Farooqi, IS (corresponding author), Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk	Murphy, Michael P/C-2120-2009; Shield, Julian PH/D-6297-2014; Hendricks, Audrey/I-4127-2016; Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	Murphy, Michael P/0000-0003-1115-9618; Shield, Julian PH/0000-0003-2601-7575; Hendricks, Audrey/0000-0002-7152-0287; O'Rahilly, Stephen/0000-0003-2199-4449; Barford, David/0000-0001-8810-950X; Barroso, Ines/0000-0001-5800-4520; van der Klaauw, Agatha/0000-0001-6971-8828; Bochukova, Elena/0000-0003-0275-1548; Farooqi, Sadaf/0000-0001-7609-3504; Banton, Matthew/0000-0002-9199-7170; Pearce, Laura/0000-0002-7768-6851; Kelly, Kirsten/0000-0003-4234-543X	Wellcome Trust [098497/Z/12/Z, 077016/Z/05/Z, 096106/Z/11/Z]; Medical Research Council [MC_U106179471]; NIHR Cambridge Biomedical Research Centre; European Research Council; MRC [G0600717, G0502115, MC_UU_12015/1, MC_UU_12012/1, G0900554, MC_UP_1201/6] Funding Source: UKRI; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [G0600717B, G0502115, MC_UP_1201/6, MC_UU_12012/1, MC_UU_12015/1, G0900554, G0600717, MC_UU_12012/5/B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268, NF-SI-0512-10135, NF-SI-0507-10380] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We are indebted to the participants and their families for their participation and to the physicians involved in the Genetics of Obesity Study (GOOS). We thank Brian Lam for help with flow cytometry; Matthew Gratian, Margaret Robinson, and Patrycia Kozik for microscopy advice and Pamela Pun for assistance using the Seahorse XF analyzer. This work was supported by the Wellcome Trust (098497/Z/12/Z; 077016/Z/05/Z; 096106/Z/11/Z) (ISF and LRP), Medical Research Council (MC_U106179471) (NW), NIHR Cambridge Biomedical Research Centre (ISF, IB and SOR), and European Research Council (ISF). This study makes use of data generated by the UK10K Consortium (WT091310). A full list of the investigators who contributed to the generation of the data is available from http://www.UK10K.org.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Brommage R, 2008, OBESITY, V16, P2362, DOI 10.1038/oby.2008.361; Canal F, 2011, FASEB J, V25, P2362, DOI 10.1096/fj.10-173153; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963, DOI 10.1093/ajcn/54.6.963; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fernandez MR, 2012, MOL CELL BIOL, V32, P3718, DOI 10.1128/MCB.06754-11; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Lanctot AA, 2013, DEV CELL, V25, P241, DOI 10.1016/j.devcel.2013.04.006; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Liu L, 2009, BBA-PROTEINS PROTEOM, V1794, P1485, DOI 10.1016/j.bbapap.2009.06.016; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Revelli JP, 2011, OBESITY, V19, P1010, DOI 10.1038/oby.2010.282; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Schuler AM, 2005, MOL GENET METAB, V85, P7, DOI 10.1016/j.ymgme.2004.09.006; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X	43	112	114	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					765	777		10.1016/j.cell.2013.09.058	http://dx.doi.org/10.1016/j.cell.2013.09.058			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209692	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000326934300008
J	Palesch, D; Kirchhoff, F				Palesch, David; Kirchhoff, Frank			First Steps toward a Globally Effective HIV/AIDS Vaccine	CELL			English	Editorial Material							RHESUS-MONKEYS; HIV-1; INFECTION; RESPONSES; COVERAGE	The enormous diversity of HIV-1 presents a formidable challenge for developing an effective AIDS vaccine. In this issue of Cell, Barouch et al. show that bioinformatically designed antigens, pieced together from multiple HIV immune epitopes, partially protect rhesus macaques from simian-human immunodeficiency virus infection. This "mosaic" approach holds promise for the development of broadly protective vaccines.	[Palesch, David; Kirchhoff, Frank] Univ Ulm, Med Ctr, Inst Mol Virol, D-89081 Ulm, Germany	Ulm University	Kirchhoff, F (corresponding author), Univ Ulm, Med Ctr, Inst Mol Virol, Meyerhofstr 1, D-89081 Ulm, Germany.	frank.kirchhoff@uni-ulm.de	Kirchhoff, Frank/O-8367-2018	Kirchhoff, Frank/0000-0002-7052-2360				Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108	10	6	6	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					495	497		10.1016/j.cell.2013.10.012	http://dx.doi.org/10.1016/j.cell.2013.10.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243006	Bronze			2022-12-28	WOS:000326571800002
J	Acker, MA; Parides, MK; Perrault, LP; Moskowitz, AJ; Gelijns, AC; Voisine, P; Smith, PK; Hung, JW; Blackstone, EH; Puskas, JD; Argenziano, M; Gammie, JS; Mack, M; Ascheim, DD; Bagiella, E; Moquete, EG; Ferguson, TB; Horvath, KA; Geller, NL; Miller, MA; Woo, YJ; D'Alessandro, DA; Ailawadi, G; Dagenais, F; Gardner, TJ; O'Gara, PT; Michler, RE; Kron, IL				Acker, Michael A.; Parides, Michael K.; Perrault, Louis P.; Moskowitz, Alan J.; Gelijns, Annetine C.; Voisine, Pierre; Smith, Peter K.; Hung, Judy W.; Blackstone, Eugene H.; Puskas, John D.; Argenziano, Michael; Gammie, James S.; Mack, Michael; Ascheim, Deborah D.; Bagiella, Emilia; Moquete, Ellen G.; Ferguson, T. Bruce; Horvath, Keith A.; Geller, Nancy L.; Miller, Marissa A.; Woo, Y. Joseph; D'Alessandro, David A.; Ailawadi, Gorav; Dagenais, Francois; Gardner, Timothy J.; O'Gara, Patrick T.; Michler, Robert E.; Kron, Irving L.			Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM SURVIVAL; CARDIAC-RESYNCHRONIZATION THERAPY; END-SYSTOLIC VOLUME; HEART-FAILURE; SURGICAL-MANAGEMENT; IMPACT; RECONSTRUCTION; ANNULOPLASTY; PREDICTORS; VALSARTAN	BackgroundIschemic mitral regurgitation is associated with a substantial risk of death. Practice guidelines recommend surgery for patients with a severe form of this condition but acknowledge that the supporting evidence for repair or replacement is limited. MethodsWe randomly assigned 251 patients with severe ischemic mitral regurgitation to undergo either mitral-valve repair or chordal-sparing replacement in order to evaluate efficacy and safety. The primary end point was the left ventricular end-systolic volume index (LVESVI) at 12 months, as assessed with the use of a Wilcoxon rank-sum test in which deaths were categorized below the lowest LVESVI rank. ResultsAt 12 months, the mean LVESVI among surviving patients was 54.625.0 ml per square meter of body-surface area in the repair group and 60.731.5 ml per square meter in the replacement group (mean change from baseline, -6.6 and -6.8 ml per square meter, respectively). The rate of death was 14.3% in the repair group and 17.6% in the replacement group (hazard ratio with repair, 0.79; 95% confidence interval, 0.42 to 1.47; P=0.45 by the log-rank test). There was no significant between-group difference in LVESVI after adjustment for death (z score, 1.33; P=0.18). The rate of moderate or severe recurrence of mitral regurgitation at 12 months was higher in the repair group than in the replacement group (32.6% vs. 2.3%, P<0.001). There were no significant between-group differences in the rate of a composite of major adverse cardiac or cerebrovascular events, in functional status, or in quality of life at 12 months. ConclusionsWe observed no significant difference in left ventricular reverse remodeling or survival at 12 months between patients who underwent mitral-valve repair and those who underwent mitral-valve replacement. Replacement provided a more durable correction of mitral regurgitation, but there was no significant between-group difference in clinical outcomes. (Funded by the National Institutes of Health and the Canadian Institutes of Health; ClinicalTrials.gov number, NCT00807040.)	[Acker, Michael A.; Woo, Y. Joseph] Univ Penn, Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; [Parides, Michael K.; Moskowitz, Alan J.; Gelijns, Annetine C.; Ascheim, Deborah D.; Bagiella, Emilia; Moquete, Ellen G.] Mt Sinai Sch Med, Int Ctr Hlth Outcomes & Innovat Res, Dept Hlth Evidence & Policy, New York, NY USA; [Argenziano, Michael] Columbia Univ, Coll Phys & Surg, Div Cardiothorac Surg, Dept Surg, New York, NY 10027 USA; [D'Alessandro, David A.; Michler, Robert E.] Montefiore Med Ctr, Dept Cardiothorac Surg, New York, NY USA; [D'Alessandro, David A.; Michler, Robert E.] Albert Einstein Coll Med, New York, NY USA; [Perrault, Louis P.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Voisine, Pierre; Dagenais, Francois] Hop Laval, Inst Univ Cardiol Quebec, Quebec City, PQ, Canada; [Smith, Peter K.] Duke Univ, Med Ctr, Dept Surg, Div Cardiovasc & Thorac Surg, Durham, NC 27710 USA; [Ferguson, T. Bruce] E Carolina Univ, E Carolina Heart Inst, Dept Cardiovasc Sci, Greenville, NC USA; [Hung, Judy W.] Massachusetts Gen Hosp, Echocardiog Core Lab, Boston, MA 02114 USA; [O'Gara, Patrick T.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Blackstone, Eugene H.] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH USA; [Puskas, John D.] Emory Univ, Sch Med, Div Cardiothorac Surg, Clin Res Unit, Atlanta, GA 30322 USA; [Gammie, James S.] Univ Maryland, Sch Med, Div Cardiac Surg, Baltimore, MD 21201 USA; [Mack, Michael] Baylor Res Inst, Dallas, TX USA; [Horvath, Keith A.] Suburban Hosp, Ctr Heart, NIH, Bethesda, MD USA; [Geller, Nancy L.] Off Biostatist Res, Bethesda, MD USA; [Miller, Marissa A.] Div Cardiovasc Sci, Bethesda, MD USA; [Ailawadi, Gorav; Kron, Irving L.] Univ Virginia, Sch Med, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA; [Gardner, Timothy J.] Ctr Heart & Vasc Hlth, Newark, DE USA	University of Pennsylvania; Icahn School of Medicine at Mount Sinai; Columbia University; Montefiore Medical Center; Yeshiva University; Universite de Montreal; Laval University; Duke University; University of North Carolina; East Carolina University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation; Emory University; University System of Maryland; University of Maryland Baltimore; Baylor Scott & White Health; Baylor University Medical Center; National Institutes of Health (NIH) - USA; University of Virginia	Gelijns, AC (corresponding author), Icahn Sch Med Mt Sinai, Dept Hlth Evidence & Policy, 1 Gustave L Levy Pl,Box 1077, New York, NY 10029 USA.	annetine.gelijns@mssm.edu	Parides, Michael/GON-8474-2022; D'Alessandro, David/AAU-3589-2021	Holubkov, Richard/0000-0003-0431-3381; Moskowitz, Alan/0000-0002-4412-9450	National Heart, Lung, and Blood Institute [U01 HL088942]; National Institute of Neurological Diseases and Stroke, National Institutes of Health; Canadian Institutes of Health Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL088942, UM1HL088925, UM1HL088955] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Diseases and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a cooperative agreement (U01 HL088942) with the National Heart, Lung, and Blood Institute and the National Institute of Neurological Diseases and Stroke, National Institutes of Health, and by the Canadian Institutes of Health Research.	Al-Radi OO, 2005, ANN THORAC SURG, V79, P1260, DOI 10.1016/j.athoracsur.2004.09.044; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; [Anonymous], AD CARD SURG DAT EX; Bax JJ, 2004, CIRCULATION, V110, pII103, DOI 10.1161/01.CIR-0000138196.06772.4e; Bonow RO, 2010, CIRCULATION, V121, pE443, DOI 10.1161/CIR.0b013e3181e3e359; BOUCHARD D, 2013, J THORAC CARDIOVASC; Carson P, 2003, J CARD FAIL, V9, P164, DOI 10.1054/jcaf.2003.22; Di Donato M, 2010, EUR J HEART FAIL, V12, P375, DOI 10.1093/eurjhf/hfq020; Di Salvo TG, 2010, J AM COLL CARDIOL, V55, P271, DOI 10.1016/j.jacc.2009.08.059; Ellis SG, 2002, AM J CARDIOL, V89, P315, DOI 10.1016/S0002-9149(01)02231-7; Gammie JS, 2009, ANN THORAC SURG, V87, P1431, DOI 10.1016/j.athoracsur.2009.01.064; Ghio S, 2009, EUR J HEART FAIL, V11, P480, DOI 10.1093/eurjhf/hfp034; Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; Grossi EA, 2001, J THORAC CARDIOV SUR, V122, P1107, DOI 10.1067/mtc.2001.116945; Hung J, 2004, CIRCULATION, V110, pII85, DOI 10.1161/01.CIR.0000138192.65015.45; Kang DH, 2006, CIRCULATION, V114, pI499, DOI 10.1161/CIRCULATIONAHA.105.000398; Konstam MA, 2003, J CARD FAIL, V9, P350, DOI 10.1054/j.cardfail.2003.09.001; Kramer DG, 2010, J AM COLL CARDIOL, V56, P392, DOI 10.1016/j.jacc.2010.05.011; Lamas GA, 1997, CIRCULATION, V96, P827; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Levine RA, 2005, CIRCULATION, V112, P745, DOI 10.1161/CIRCULATIONAHA.104.486720; Magne J, 2009, CIRCULATION, V120, pS104, DOI 10.1161/CIRCULATIONAHA.108.843995; Magne J, 2009, CARDIOLOGY, V112, P244, DOI 10.1159/000151693; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037; Micovic S, 2008, HEART SURG FORUM, V11, pE340, DOI 10.1532/HSF98.20081087; Milano CA, 2008, ANN THORAC SURG, V86, P735, DOI 10.1016/j.athoracsur.2008.05.017; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Perrault LP, 2012, J THORAC CARDIOV SUR, V143, P1396, DOI 10.1016/j.jtcvs.2011.05.030; Reece TB, 2004, ANN SURG, V239, P671, DOI 10.1097/01.sla.0000124297.40815.86; Silberman S, 2006, ISRAEL MED ASSOC J, V8, P17; *SOC THOR SURG, YEARS 2008 2012 AD C; Solomon SD, 2005, CIRCULATION, V111, P3411, DOI 10.1161/CIRCULATIONAHA.104.508093; Sutton MS, 1997, CIRCULATION, V96, P3294; Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Vassileva CM, 2011, EUR J CARDIO-THORAC, V39, P295, DOI 10.1016/j.ejcts.2010.06.034; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Yiu SF, 2000, CIRCULATION, V102, P1400, DOI 10.1161/01.CIR.102.12.1400; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	43	561	575	1	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					23	32		10.1056/NEJMoa1312808	http://dx.doi.org/10.1056/NEJMoa1312808			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284XA	24245543	Green Accepted			2022-12-28	WOS:000329354100007
J	Heldman, AW; DiFede, DL; Fishman, JE; Zambrano, JP; Trachtenberg, BH; Karantalis, V; Mushtaq, M; Williams, AR; Suncion, VY; McNiece, IK; Ghersin, E; Soto, V; Lopera, G; Miki, R; Willens, H; Hendel, R; Mitrani, R; Pattany, P; Feigenbaum, G; Oskouei, B; Byrnes, J; Lowery, MH; Sierra, J; Pujol, MV; Delgado, C; Gonzalez, PJ; Rodriguez, JE; Bagno, LL; Rouy, D; Altman, P; Foo, CWP; da Silva, J; Anderson, E; Schwarz, R; Mendizabal, A; Hare, JM				Heldman, Alan W.; DiFede, Darcy L.; Fishman, Joel E.; Zambrano, Juan P.; Trachtenberg, Barry H.; Karantalis, Vasileios; Mushtaq, Muzammil; Williams, Adam R.; Suncion, Viky Y.; McNiece, Ian K.; Ghersin, Eduard; Soto, Victor; Lopera, Gustavo; Miki, Roberto; Willens, Howard; Hendel, Robert; Mitrani, Raul; Pattany, Pradip; Feigenbaum, Gary; Oskouei, Behzad; Byrnes, John; Lowery, Maureen H.; Sierra, Julio; Pujol, Mariesty V.; Delgado, Cindy; Gonzalez, Phillip J.; Rodriguez, Jose E.; Bagno, Luiza Lima; Rouy, Didier; Altman, Peter; Foo, Cheryl Wong Po; da Silva, Jose; Anderson, Erica; Schwarz, Richard; Mendizabal, Adam; Hare, Joshua M.			Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy The TAC-HFT Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESTORE CARDIAC-FUNCTION; MYOCARDIAL-INFARCTION; HEART-FAILURE; DOUBLE-BLIND; PROGENITOR CELLS; THERAPY; INJECTION; SAFETY; TRANSPLANTATION; REGENERATION	IMPORTANCE Whether culture-expanded mesenchymal stem cells or whole bone marrow mononuclear cells are safe and effective in chronic ischemic cardiomyopathy is controversial. OBJECTIVE To demonstrate the safety of transendocardial stem cell injection with autologous mesenchymal stem cells (MSCs) and bone marrow mononuclear cells (BMCs) in patients with ischemic cardiomyopathy. DESIGN, SETTING, AND PATIENTS A phase 1 and 2 randomized, blinded, placebo-controlled study involving 65 patients with ischemic cardiomyopathy and left ventricular (LV) ejection fraction less than 50% (September 1, 2009-July 12, 2013). The study compared injection of MSCs (n = 19) with placebo (n = 11) and BMCs (n = 19) with placebo (n = 10), with 1 year of follow-up. INTERVENTIONS Injections in 10 LV sites with an infusion catheter. MAIN OUTCOMES AND MEASURES Treatment-emergent 30-day serious adverse event rate defined as a composite of death, myocardial infarction, stroke, hospitalization for worsening heart failure, perforation, tamponade, or sustained ventricular arrhythmias. RESULTS No patient had a treatment-emergent serious adverse events at day 30. The 1-year incidence of serious adverse events was 31.6% (95% CI, 12.6% to 56.6%) for MSCs, 31.6% (95% CI, 12.6%-56.6%) for BMCs, and 38.1% (95% CI, 18.1%-61.6%) for placebo. Over 1 year, the Minnesota Living With Heart Failure score improved with MSCs (-6.3; 95% CI, -15.0 to 2.4; repeated measures of variance, P = .02) and with BMCs (-8.2; 95% CI, -17.4 to 0.97; P = .005) but not with placebo (0.4; 95% CI, -9.45 to 10.25; P = .38). The 6-minute walk distance increased with MSCs only (repeated measures model, P = .03). Infarct size as a percentage of LV mass was reduced by MSCs (-18.9%; 95% CI, -30.4 to -7.4; within-group, P = .004) but not by BMCs (-7.0%; 95% CI, -15.7% to 1.7%; within-group, P = .11) or placebo (-5.2%; 95% CI, -16.8% to 6.5%; within-group, P = .36). Regional myocardial function as peak Eulerian circumferential strain at the site of injection improved with MSCs (-4.9; 95% CI, -13.3 to 3.5; within-group repeated measures, P = .03) but not BMCs (-2.1; 95% CI, -5.5 to 1.3; P = .21) or placebo (-0.03; 95% CI, -1.9 to 1.9; P = .14). Left ventricular chamber volume and ejection fraction did not change. CONCLUSIONS AND RELEVANCE Transendocardial stem cell injection with MSCs or BMCs appeared to be safe for patients with chronic ischemic cardiomyopathy and LV dysfunction. Although the sample size and multiple comparisons preclude a definitive statement about safety and clinical effect, these results provide the basis for larger studies to provide definitive evidence about safety and to assess efficacy of this new therapeutic approach.	[Heldman, Alan W.; DiFede, Darcy L.; Zambrano, Juan P.; Trachtenberg, Barry H.; Karantalis, Vasileios; Mushtaq, Muzammil; Williams, Adam R.; Suncion, Viky Y.; McNiece, Ian K.; Soto, Victor; Lopera, Gustavo; Feigenbaum, Gary; Oskouei, Behzad; Byrnes, John; da Silva, Jose; Schwarz, Richard; Hare, Joshua M.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33101 USA; [Heldman, Alan W.; Zambrano, Juan P.; Trachtenberg, Barry H.; Mushtaq, Muzammil; McNiece, Ian K.; Soto, Victor; Lopera, Gustavo; Miki, Roberto; Willens, Howard; Hendel, Robert; Mitrani, Raul; Feigenbaum, Gary; Oskouei, Behzad; Byrnes, John; Lowery, Maureen H.; Hare, Joshua M.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33101 USA; [Fishman, Joel E.; Ghersin, Eduard] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33101 USA; [Williams, Adam R.] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33101 USA; [Lopera, Gustavo] Miami Vet Affairs Healthcare Syst, Miami, FL USA; [Rouy, Didier; Altman, Peter; Foo, Cheryl Wong Po] Biocardia Corp, San Carlos, CA USA; [Anderson, Erica; Mendizabal, Adam] EMMES Corp, Rockville, MD USA; [McNiece, Ian K.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Miami; University of Miami; University of Miami; University of Miami; Emmes Corporation; University of Texas System; UTMD Anderson Cancer Center	Hare, JM (corresponding author), Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Biomed Res Bldg,Room 908,POB 016960 R-125, Miami, FL 33101 USA.	jhare@med.miami.edu		Delgado, Cindy/0000-0002-7156-0107	Interdisciplinary Stem Cell Institute; Miller School of Medicine; Biocardia; National Heart, Lung, and Blood Institute's Specialized Center for Cell Therapy [U54HL081028]; National Institutes of Health [RO1 HL094849, P20 HL101443, RO1 HL084275, RO1 HL107110, RO1 HL110737, UM1HL113460]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110737, U54HL081028, UM1HL113460, R01HL084275, P20HL101443, R01HL107110, R01HL094849] Funding Source: NIH RePORTER	Interdisciplinary Stem Cell Institute; Miller School of Medicine; Biocardia; National Heart, Lung, and Blood Institute's Specialized Center for Cell Therapy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded in part by the Interdisciplinary Stem Cell Institute, Miller School of Medicine, Biocardia, and grant U54HL081028 from the National Heart, Lung, and Blood Institute's Specialized Center for Cell Therapy. Helical Infusion Catheters were provided by Biocardia Inc. Dr Hare is supported by grants RO1 HL094849, P20 HL101443, RO1 HL084275, RO1 HL107110, RO1 HL110737, and UM1HL113460 from the National Institutes of Health.	Amado LC, 2006, J AM COLL CARDIOL, V48, P2116, DOI 10.1016/j.jacc.2006.06.073; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Bello D, 2011, MAGN RESON IMAGING, V29, P50, DOI 10.1016/j.mri.2010.03.031; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Choi SI, 2009, INT J CARDIOVAS IMAG, V25, P23, DOI 10.1007/s10554-009-9443-4; Da Silva JS, 2013, METHODS MOL BIOL, V1037, P145, DOI 10.1007/978-1-62703-505-7_8; de la Fuente LM, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.04.051; Hamamoto H, 2009, ANN THORAC SURG, V87, P794, DOI 10.1016/j.athoracsur.2008.11.057; Hare JM, 2013, CIRCULATION, V127, P1630, DOI 10.1161/CIRCULATIONAHA.112.000779; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hatzistergos KE, 2011, CIRC RES, V108, P1300, DOI 10.1161/CIRCRESAHA.111.246611; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Hendrikx M, 2006, CIRCULATION, V114, pI101, DOI 10.1161/CIRCULATIONAHA.105.000505; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Junttila MJ, 2011, HEART, V97, P1852, DOI 10.1136/heartjnl-2011-300153; Karantalis V, 2012, AM J PHYSIOL-HEART C, V303, pH256, DOI 10.1152/ajpheart.00221.2012; Kinkaid HYM, 2010, J CARDIAC SURG, V25, P359, DOI 10.1111/j.1540-8191.2009.00984.x; LAMAS GA, 1989, AM J CARDIOL, V63, P1167, DOI 10.1016/0002-9149(89)90173-2; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Mahnken AH, 2005, J AM COLL CARDIOL, V45, P2042, DOI 10.1016/j.jacc.2005.03.035; Mak GS, 2012, CURR CARDIOVASC IMAG, V5, P328, DOI 10.1007/s12410-012-9150-8; Menasche P, 2011, J MOL CELL CARDIOL, V50, P258, DOI 10.1016/j.yjmcc.2010.06.010; Nihoyannopoulos P, 2011, EUR HEART J, V32, P810, DOI 10.1093/eurheartj/ehr002; Perin EC, 2004, CIRCULATION, V110, pII213, DOI 10.1161/01.CIR.0000138398.77550.62; Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Schuleri KH, 2008, AM J PHYSIOL-HEART C, V294, pH2002, DOI 10.1152/ajpheart.00762.2007; Schuleri KH, 2011, JACC-CARDIOVASC IMAG, V4, P1284, DOI 10.1016/j.jcmg.2011.09.013; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Suncion VY, 2012, STEM CELL TRANSL MED, V1, P29, DOI 10.5966/sctm.2011-0014; Telukuntla KS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000338; Trachtenberg B, 2011, AM HEART J, V161, P487, DOI 10.1016/j.ahj.2010.11.024; von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118; Williams AR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000140; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Zhou YF, 2011, ANN THORAC SURG, V91, P1206, DOI 10.1016/j.athoracsur.2011.01.021	43	365	379	2	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					62	73		10.1001/jama.2013.282909	http://dx.doi.org/10.1001/jama.2013.282909			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24247587	Bronze, Green Accepted			2022-12-28	WOS:000329161400019
J	Grinberg, I; West, DV; Torres, M; Gou, GY; Stein, DM; Wu, LY; Chen, GN; Gallo, EM; Akbashev, AR; Davies, PK; Spanier, JE; Rappe, AM				Grinberg, Ilya; West, D. Vincent; Torres, Maria; Gou, Gaoyang; Stein, David M.; Wu, Liyan; Chen, Guannan; Gallo, Eric M.; Akbashev, Andrew R.; Davies, Peter K.; Spanier, Jonathan E.; Rappe, Andrew M.			Perovskite oxides for visible-light-absorbing ferroelectric and photovoltaic materials	NATURE			English	Article							SUBSTITUTION; PHOTOCURRENT	Ferroelectrics have recently attracted attention as a candidate class of materials for use in photovoltaic devices, and for the coupling of light absorption with other functional properties(1-7). In these materials, the strong inversion symmetry breaking that is due to spontaneous electric polarization promotes the desirable separation of photo-excited carriers and allows voltages higher than the bandgap, which may enable efficiencies beyond the maximum possible in a conventional p-n junction solar cell(2,6,8-10). Ferroelectric oxides are also stable in a wide range of mechanical, chemical and thermal conditions and can be fabricated using low-cost methods such as sol-gel thin-film deposition and sputtering(3,5). Recent work(3,5,11) has shown how a decrease in ferroelectric layer thickness and judicious engineering of domain structures and ferroelectric-electrode interfaces can greatly increase the current harvested from ferroelectric absorber materials, increasing the power conversion efficiency from about 10(-4) to about 0.5 per cent. Further improvements in photovoltaic efficiency have been inhibited by the wide bandgaps (2.7-4 electronvolts) of ferroelectric oxides, which allow the use of only 8-20 per cent of the solar spectrum. Here we describe a family of single-phase solid oxide solutions made from low-cost and non-toxic elements using conventional solid-state methods: [KNbO3](1-x)[BaNi1/2Nb1/2O3-delta](x) (KBNNO). These oxides exhibit both ferroelectricity and a wide variation of direct bandgaps in the range 1.1-3.8 electronvolts. In particular, the x = 0.1 composition is polar at room temperature, has a direct bandgap of 1.39 electronvolts and has a photocurrent density approximately 50 times larger than that of the classic ferroelectric (Pb,La)(Zr,Ti)O-3 material. The ability of KBNNO to absorb three to six times more solar energy than the current ferroelectric materials suggests a route to viable ferroelectric semiconductor-based cells for solar energy conversion and other applications.	[Grinberg, Ilya; Gou, Gaoyang; Rappe, Andrew M.] Univ Penn, Dept Chem, Makineni Theoret Labs, Philadelphia, PA 19104 USA; [West, D. Vincent; Stein, David M.; Wu, Liyan; Davies, Peter K.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Torres, Maria; Chen, Guannan; Gallo, Eric M.; Akbashev, Andrew R.; Spanier, Jonathan E.] Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Drexel University	Rappe, AM (corresponding author), Univ Penn, Dept Chem, Makineni Theoret Labs, Philadelphia, PA 19104 USA.	rappe@sas.upenn.edu	Akbashev, Andrew/A-7533-2010; Rappe, Andrew Marshall/HFZ-8855-2022; Chen, Guannan/F-6440-2010; Wu, Liyan/Q-3280-2019; Gou, Gaoyang/D-9289-2011	Chen, Guannan/0000-0003-1868-4327; Gou, Gaoyang/0000-0003-1485-8115; Akbashev, Andrew/0000-0003-1573-1773; Spanier, Jonathan/0000-0002-3096-2644; Gallo, Eric/0000-0001-9086-3480	Energy Commercialization Institute of BFTP; US Department of Energy, Office of Basic Sciences [DE-AC02-06CH11357]; Army Research Office [W911NF-08-1-0067]; NSF [DMR 0907381, DMR 1124696, DMR 0722845]; ASEE Postdoctoral Fellowship; Department of Energy, Office of Basic Energy Sciences [DE-FG02-07ER46431]; Energy Commercialization Institute; Office of Naval Research [N00014-12-1-1033]; High Performance Computing Modernization Office of the US Department of Defense; National Energy Research Scientific Computing Center of the US Department of Energy; Division Of Materials Research [1124696] Funding Source: National Science Foundation	Energy Commercialization Institute of BFTP; US Department of Energy, Office of Basic Sciences(United States Department of Energy (DOE)); Army Research Office; NSF(National Science Foundation (NSF)); ASEE Postdoctoral Fellowship; Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Energy Commercialization Institute; Office of Naval Research(Office of Naval Research); High Performance Computing Modernization Office of the US Department of Defense; National Energy Research Scientific Computing Center of the US Department of Energy(United States Department of Energy (DOE)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Members of the Davies group-D.V.W., D.M.S., L.W. and P.K.D.-were supported by the Energy Commercialization Institute of BFTP. We also thank M. R. Suchomel for assistance with collection of the synchrotron X-ray data. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the US Department of Energy, Office of Basic Sciences, under contract number DE-AC02-06CH11357. Members of the Spanier group-M.T. and J.E.S.-were supported by the Army Research Office, under grant number W911NF-08-1-0067. G.C. was supported by NSF grant DMR 0907381. A.R.A. was supported by the Energy Commercialization Institute of BFTP and by NSF grant DMR 1124696. E.M.G. was supported by an ASEE Postdoctoral Fellowship. Support for instrumentation used in this project was provided by the ARO DURIP programme and the NSF under grant DMR 0722845. J.E.S. also acknowledges C. L. Schauer for permitting access to the spectroscopic ellipsometer and the Drexel Centralized Research Facilities for access to instrumentation. We thank F. Yan, M. A. Islam and C. L. Johnson for assistance in transparent electrode thin-film deposition, Raman scattering, and sample thinning and polishing, respectively. Of the Rappe group, I.G. was supported by the Department of Energy, Office of Basic Energy Sciences, under grant number DE-FG02-07ER46431, G.G. was supported by the Energy Commercialization Institute and A.M.R. was supported by the Office of Naval Research, under grant number N00014-12-1-1033. Computational support was provided by a Challenge Grant from the High Performance Computing Modernization Office of the US Department of Defense and the National Energy Research Scientific Computing Center of the US Department of Energy.	Alexe M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1261; Bartasyte A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3455326; Basu SR, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2887908; Bennett JW, 2008, J AM CHEM SOC, V130, P17409, DOI 10.1021/ja8052249; BRODY PS, 1976, FERROELECTRICS, V10, P143, DOI 10.1080/00150197608241966; Cao DW, 2012, NANO LETT, V12, P2803, DOI 10.1021/nl300009z; Choi T, 2009, SCIENCE, V324, P63, DOI 10.1126/science.1168636; Choi WS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1690; COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0; Fridkin V. M., 1979, PHOTOFERROELECTRICS; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; GLASS AM, 1974, APPL PHYS LETT, V25, P233, DOI 10.1063/1.1655453; Gou GY, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205115; Grinberg I, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.220101; HYBERTSEN MS, 1986, PHYS REV B, V34, P5390, DOI 10.1103/PhysRevB.34.5390; INOUE Y, 1986, J PHYS CHEM-US, V90, P2809, DOI 10.1021/j100404a006; Ji SM, 2009, J PHYS CHEM C, V113, P17824, DOI 10.1021/jp901882q; Kim TW, 2007, MATER RES BULL, V42, P1914, DOI 10.1016/j.materresbull.2006.12.010; Kondo M, 2001, J AM CERAM SOC, V84, P2469, DOI 10.1111/j.1151-2916.2001.tb01037.x; Kreisel J, 2012, NAT MATER, V11, P260, DOI 10.1038/nmat3282; Liang LY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3081418; Park J, 2013, J AM CERAM SOC, V96, P146, DOI 10.1111/j.1551-2916.2012.05430.x; Poosanaas P, 1998, J APPL PHYS, V84, P1508, DOI 10.1063/1.368216; Qi TT, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.224108; Reuter K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.046103; Srihari V, 2011, J APPL PHYS, V109, DOI 10.1063/1.3526300; Yang SY, 2010, NAT NANOTECHNOL, V5, P143, DOI [10.1038/nnano.2009.451, 10.1038/NNANO.2009.451]; Yang SY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3204695; Young SM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116601; Zhang GH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01265; Zhao XH, 2008, J AM CERAM SOC, V91, P3031, DOI 10.1111/j.1551-2916.2008.02552.x	32	899	909	54	2292	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					509	+		10.1038/nature12622	http://dx.doi.org/10.1038/nature12622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24213630				2022-12-28	WOS:000327464200039
J	Iida, N; Dzutsev, A; Stewart, CA; Smith, L; Bouladoux, N; Weingarten, RA; Molina, DA; Salcedo, R; Back, T; Cramer, S; Dai, RM; Kiu, H; Cardone, M; Naik, S; Patri, AK; Wang, E; Marincola, FM; Frank, KM; Belkaid, Y; Trinchieri, G; Goldszmid, RS				Iida, Noriho; Dzutsev, Amiran; Stewart, C. Andrew; Smith, Loretta; Bouladoux, Nicolas; Weingarten, Rebecca A.; Molina, Daniel A.; Salcedo, Rosalba; Back, Timothy; Cramer, Sarah; Dai, Ren-Ming; Kiu, Hiu; Cardone, Marco; Naik, Shruti; Patri, Anil K.; Wang, Ena; Marincola, Francesco M.; Frank, Karen M.; Belkaid, Yasmine; Trinchieri, Giorgio; Goldszmid, Romina S.			Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment	SCIENCE			English	Article							OXIDATIVE STRESS; DENDRITIC CELLS; IMMUNE-SYSTEM; MICROBIOTA; INFLAMMATION; APOPTOSIS; ACTIVATION; CALIBRATE; SIGNALS; IMPACT	The gut microbiota influences both local and systemic inflammation. Inflammation contributes to development, progression, and treatment of cancer, but it remains unclear whether commensal bacteria affect inflammation in the sterile tumor microenvironment. Here, we show that disruption of the microbiota impairs the response of subcutaneous tumors to CpG-oligonucleotide immunotherapy and platinum chemotherapy. In antibiotics-treated or germ-free mice, tumor-infiltrating myeloid-derived cells responded poorly to therapy, resulting in lower cytokine production and tumor necrosis after CpG-oligonucleotide treatment and deficient production of reactive oxygen species and cytotoxicity after chemotherapy. Thus, optimal responses to cancer therapy require an intact commensal microbiota that mediates its effects by modulating myeloid-derived cell functions in the tumor microenvironment. These findings underscore the importance of the microbiota in the outcome of disease treatment.	[Iida, Noriho; Dzutsev, Amiran; Stewart, C. Andrew; Smith, Loretta; Salcedo, Rosalba; Back, Timothy; Cramer, Sarah; Dai, Ren-Ming; Kiu, Hiu; Cardone, Marco; Trinchieri, Giorgio; Goldszmid, Romina S.] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Dzutsev, Amiran; Dai, Ren-Ming] Leidos Biomed Res Inc, Frederick Natl Lab, Frederick, MD 21702 USA; [Bouladoux, Nicolas; Naik, Shruti; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, Bethesda, MD 20892 USA; [Weingarten, Rebecca A.; Frank, Karen M.] NIH, Microbiol Serv, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Molina, Daniel A.] Tech Resources Int Inc, Bethesda, MD 20817 USA; [Patri, Anil K.] Leidos Biomed Res Inc, Nanotechnol Characterizat Lab, Adv Technol Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Wang, Ena; Marincola, Francesco M.] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Marincola, Francesco M.] Sidra Med & Res Ctr, Doha, Qatar	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Sidra Medical & Research Center	Trinchieri, G (corresponding author), NCI, Canc & Inflammat Program, Frederick, MD 21702 USA.	trinchig@mail.nih.gov; rgoldszmid@mail.nih.gov	Nanotechnology Characterization Lab, (NCL)/K-8454-2012; Stewart, Charles/G-2470-2012; Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464; Belkaid, Yasmine/0000-0001-9962-3571; Bouladoux, Nicolas/0000-0003-1593-671X	NIH (NCI); NIH (Center for Cancer Research); NIH (NIAID); Japanese Society for Promotion of Science (JSPS) Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH; NATIONAL CANCER INSTITUTE [ZIABC010793, ZIABC011153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115] Funding Source: NIH RePORTER	NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (Center for Cancer Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Japanese Society for Promotion of Science (JSPS) Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We greatly appreciate the support of D. Trageser-Cessler and A. Cesar in the NIAID germ-free facility; H. Zhou in the NIH Center for Human Immunology; T. Plona and K. Pike in the Laboratory of Molecular Technology, Leidos Biomedical Research, Inc.; and R. Winkler-Pickett, M. Karwan, and D. Zhao in the Cancer and Inflammation Program, CCR/NCI. We thank D. Klinman and A. Hurwitz for advice and R. Germain for critically reviewing the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This research was supported by the Intramural Research Program of the NIH (NCI, Center for Cancer Research, and NIAID) and the Japanese Society for Promotion of Science (JSPS) Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH. The 16S sequences were deposited in the Sequence Read Archive (SRA) under accession PRJNA221649. Array data were deposited at the Gene Expression Omnibus (GEO) with accession no. GSE51414.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Fang J, 2007, J DRUG TARGET, V15, P475, DOI 10.1080/10611860701498286; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Huang Y, 2012, GENES IMMUN, V13, P311, DOI 10.1038/gene.2011.87; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kim S, 2008, J CELL BIOCHEM, V105, P971, DOI 10.1002/jcb.21905; Laurent A, 2005, CANCER RES, V65, P948; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; McAleer JP, 2012, IMMUNITY, V37, P10, DOI 10.1016/j.immuni.2012.07.001; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Peran L, 2007, BRIT J NUTR, V97, P96, DOI 10.1017/S0007114507257770; Shirota Y, 2012, J IMMUNOL, V188, P1592, DOI 10.4049/jimmunol.1101304; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Simizu S, 1998, J BIOL CHEM, V273, P26900, DOI 10.1074/jbc.273.41.26900; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	25	1231	1313	22	404	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					967	970		10.1126/science.1240527	http://dx.doi.org/10.1126/science.1240527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264989	Green Accepted			2022-12-28	WOS:000327223500040
J	Binagwaho, A; Kyamanywa, P; Farmer, PE; Nuthulaganti, T; Umubyeyi, B; Nyemazi, JP; Mugeni, SD; Asiimwe, A; Ndagijimana, U; McPherson, HL; Ngirabega, JD; Sliney, A; Uwayezu, A; Rusanganwa, V; Wagner, CM; Nutt, CT; Eldon-Edington, M; Cancedda, C; Magaziner, IC; Goosby, E				Binagwaho, Agnes; Kyamanywa, Patrick; Farmer, Paul E.; Nuthulaganti, Tej; Umubyeyi, Benoite; Nyemazi, Jean Pierre; Mugeni, Soline Dusabeyesu; Asiimwe, Anita; Ndagijimana, Uzziel; McPherson, Helen Lamphere; Ngirabega, Jean de Dieu; Sliney, Anne; Uwayezu, Agnes; Rusanganwa, Vincent; Wagner, Claire M.; Nutt, Cameron T.; Eldon-Edington, Mark; Cancedda, Corrado; Magaziner, Ira C.; Goosby, Eric			The Human Resources for Health Program in Rwanda - A New Partnership	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE; LESSONS	The authors discuss the Human Resources for Health Program, which is working to improve the quality and quantity of health professionals in Rwanda by means of sustained collaborations with U.S. schools of medicine, nursing, dentistry, and public health. A global shortage of 4.3 million health professionals poses a major bottleneck to poor people worldwide with regard to benefiting from the fruits of modern medicine.(1) Among existing health professionals, there are also staggering inequities in skill levels and geographic distribution.(2)-(4) Unsurprisingly, the deepest national gaps in human resources for health run parallel to poor population-level health outcomes.(1) Sub-Saharan Africa bears 24% of the global burden of disease(5) but is served by only 4% of the global health workforce.(1) The health graduate schools in the region face overwhelming financial, infrastructural, and personnel constraints, limiting their ability to address the ...	[Binagwaho, Agnes; Asiimwe, Anita; Ndagijimana, Uzziel; Ngirabega, Jean de Dieu; Rusanganwa, Vincent] Minist Hlth Rwanda, Kigali, Rwanda; [Umubyeyi, Benoite] Kigali Hlth Inst, Kigali, Rwanda; [Nyemazi, Jean Pierre] Rwanda Biomed Ctr, Kigali, Rwanda; [Uwayezu, Agnes] Natl Council Nurses & Midw, Kigali, Rwanda; [Kyamanywa, Patrick] Natl Univ Rwanda, Butare, Rwanda; [Binagwaho, Agnes; Farmer, Paul E.; Cancedda, Corrado] Harvard Univ, Sch Med, Boston, MA USA; [Farmer, Paul E.; Cancedda, Corrado] Brigham & Womens Hosp, Boston, MA 02115 USA; [Farmer, Paul E.; Cancedda, Corrado] Partners Hlth, Boston, MA USA; [Nuthulaganti, Tej; Mugeni, Soline Dusabeyesu; McPherson, Helen Lamphere; Sliney, Anne; Magaziner, Ira C.] Clinton Hlth Access Initiat, Boston, MA USA; [Wagner, Claire M.] Global Hlth Delivery Partnership, Boston, MA USA; [Binagwaho, Agnes] Geisel Sch Med Dartmouth, Hanover, NH USA; [Nyemazi, Jean Pierre; Nutt, Cameron T.] Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH USA; [Eldon-Edington, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Goosby, Eric] USDA, Off Global AIDS Coordinator, Washington, DC 20250 USA; [Goosby, Eric] USDA, Off Global Hlth Diplomacy, Washington, DC 20250 USA	Rwanda Biomedical Center; University of Rwanda; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Dartmouth College; Dartmouth College; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Binagwaho, A (corresponding author), Minist Hlth Rwanda, Kigali, Rwanda.		Umubyeyi, Benoite/AAD-4354-2019					[Anonymous], 2011, RWAND HUM RES HLTH P; [Anonymous], 2010, AIDS RESP MILL DEV G; [Anonymous], 2012, RWAND HLTH STAT BOOK; [Anonymous], 2011, SUMM NAT SURV ANT RE; [Anonymous], 2009, HLTH SECT STRAT PLAN; [Anonymous], 2006, TREAT TRAIN RET IN A; [Anonymous], 2012, PEPFAR BLUEPR CREAT; Celletti F, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001108; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Committee for the Evaluation of the President's Emergency Plan for AIDS Relief, 2007, PEPFAR IMPL PROGR PR; DataBank, 2012, DATABANK WORLD DEV I; Dybul M, 2009, JAIDS-J ACQ IMM DEF, V52, pS12, DOI 10.1097/QAI.0b013e3181bbc98d; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; Goosby E, 2012, JAIDS-J ACQ IMM DEF, V60, pS158, DOI 10.1097/QAI.0b013e31825d057c; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Kim JY, 2012, 19 INT AIDS C WASH D; Mullan F, 2011, LANCET, V377, P1113, DOI 10.1016/S0140-6736(10)61961-7; National Institute of Statistics of Rwanda, 2012, 2012 POP HOUS CENS P; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Shepard DS, 2012, AM J TROP MED HYG, V86, P902, DOI 10.4269/ajtmh.2012.11-0202; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Syed SB, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-17; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	30	170	171	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					2054	2059		10.1056/NEJMsr1302176	http://dx.doi.org/10.1056/NEJMsr1302176			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256385				2022-12-28	WOS:000327163000016
J	Toledo, LI; Altmeyer, M; Rask, MB; Lukas, C; Larsen, DH; Povlsen, LK; Bekker-Jensen, S; Mailand, N; Bartek, J; Lukas, J				Toledo, Luis Ignacio; Altmeyer, Matthias; Rask, Maj-Britt; Lukas, Claudia; Larsen, Dorthe Helena; Povlsen, Lou Klitgaard; Bekker-Jensen, Simon; Mailand, Niels; Bartek, Jiri; Lukas, Jiri			ATR Prohibits Replication Catastrophe by Preventing Global Exhaustion of RPA	CELL			English	Article							COMMON FRAGILE SITES; HUMAN-CELLS; PROTEIN-A; STRESS; RESTART; MODEL; FORKS; INHIBITORS; ORIGINS; DOMAINS	ATR, activated by replication stress, protects replication forks locally and suppresses origin firing globally. Here, we show that these functions of ATR are mechanistically coupled. Although initially stable, stalled forks in ATR-deficient cells undergo nucleus-wide breakage after unscheduled origin firing generates an excess of single-stranded DNA that exhausts the nuclear pool of RPA. Partial reduction of RPA accelerated fork breakage, and forced elevation of RPA was sufficient to delay such "replication catastrophe'' even in the absence of ATR activity. Conversely, unscheduled origin firing induced breakage of stalled forks even in cells with active ATR. Thus, ATR-mediated suppression of dormant origins shields active forks against irreversible breakage via preventing exhaustion of nuclear RPA. This study elucidates how replicating genomes avoid destabilizing DNA damage. Because cancer cells commonly feature intrinsically high replication stress, this study also provides a molecular rationale for their hypersensitivity to ATR inhibitors.	[Toledo, Luis Ignacio; Altmeyer, Matthias; Rask, Maj-Britt; Lukas, Claudia; Larsen, Dorthe Helena; Lukas, Jiri] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Chromosome Stabil & Dynam Grp,Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Povlsen, Lou Klitgaard; Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ubiquitin Signaling Grp,Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Bartek, Jiri] Danish Canc Soc, Res Ctr, Genome Integr Unit, DK-2100 Copenhagen, Denmark; [Bartek, Jiri] Palacky Univ, Fac Med, Inst Mol & Translat Med, Olomouc 77515, Czech Republic	Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Danish Cancer Society; Palacky University Olomouc	Lukas, J (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Chromosome Stabil & Dynam Grp,Ctr Prot Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	jiri.lukas@cpr.ku.dk	Toledo, Luis/M-6685-2019; Altmeyer, Matthias/AAE-8186-2019; Larsen, Dorthe Helena/E-9771-2010; Larsen, Dorthe Helena/Z-6206-2019; Toledo, Luis/R-2065-2016; Bartek, Jiri/G-5870-2014	Toledo, Luis/0000-0001-9509-9944; Altmeyer, Matthias/0000-0003-3780-1170; Larsen, Dorthe Helena/0000-0002-8280-1252; Larsen, Dorthe Helena/0000-0002-8280-1252; Toledo, Luis/0000-0001-9509-9944; Bekker-Jensen, Simon/0000-0002-7308-4597; Lukas, Claudia/0000-0001-7169-6883; Lukas, Jiri/0000-0001-9087-506X	Novo Nordisk Foundation; Danish Cancer Society; European Commission; Danish National Research Foundation; EMBO; Novo Nordisk Fonden [NNF12OC0002290] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Jiri Lukas, PI Niels Mailand] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); European Commission(European CommissionEuropean Commission Joint Research Centre); Danish National Research Foundation(Danmarks Grundforskningsfond); EMBO(European Molecular Biology Organization (EMBO)); Novo Nordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Foundation Center for Protein Research	We thank Drs. Oskar Fernandez-Capetillo (CNIO, Madrid) and Marc S. Wold (University of Iowa) for reagents and members of the Lukas lab for helpful comments on the manuscript. This work was supported by the Novo Nordisk Foundation, Danish Cancer Society, European Commission (Projects DDResponse and Biomedreg), and Danish National Research Foundation. L. I. T. and M. A. are recipients of long-term EMBO fellowships. We dedicate this paper to the memory of Gabe Hayes, our handling editor at Cell, who tragically passed away. Gabe's unrestrained support of science and scientists, his insight, and his guidance of authors and reviewers will be sorely missed.	Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Brown EJ, 2000, GENE DEV, V14, P397; Cayrou C, 2010, CHROMOSOME RES, V18, P137, DOI 10.1007/s10577-009-9105-3; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Forment JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023517; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gillespie PJ, 2010, CELL CYCLE, V9, P3218, DOI 10.4161/cc.9.16.12644; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Hurley PJ, 2007, ONCOGENE, V26, P2535, DOI 10.1038/sj.onc.1210049; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jossen Rachel, 2013, Frontiers in Genetics, V4, DOI 10.3389/fgene.2013.00026; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Matos J, 2013, CELL REP, V4, P76, DOI 10.1016/j.celrep.2013.05.039; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Naim V, 2013, NAT CELL BIOL, V15, P1008, DOI 10.1038/ncb2793; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Sorensen CS, 2012, NUCLEIC ACIDS RES, V40, P477, DOI 10.1093/nar/gkr697; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Thompson R, 2013, BRIT J CLIN PHARMACO, V76, P358, DOI 10.1111/bcp.12139; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773; Yu DH, 2013, CELL BIOCHEM BIOPHYS, V67, P175, DOI 10.1007/s12013-013-9530-y	38	500	503	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1088	1103		10.1016/j.cell.2013.10.043	http://dx.doi.org/10.1016/j.cell.2013.10.043			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267891	Bronze			2022-12-28	WOS:000327500600013
J	Ahmed, F				Ahmed, Faheem			Doctors in Syria: saving the lifesavers	LANCET			English	Editorial Material									Kings Coll London, Sch Med, London SE1 1UL, England	University of London; King's College London	Ahmed, F (corresponding author), Kings Coll London, Sch Med, London SE1 1UL, England.	Faheem.ahmed@kcl.ac.uk						Cooper C., 2013, INDEPENDENT; Lambert PH, 2013, LANCET, V382, P1019, DOI [10.1016/S0140-6736(13)61969-8, 10.1016/S0140-6736(13)61968-6]; Medecins Sans Frontieres, 2013, SOM MSF FORC CLOS AL; Medecins Sans Frontieres, 2013, SYR 2 YEARS FAIL INT; World Health Organization (WHO), 2013, DON UPD SYR AR REP; World Medical Association, DECL GEN	6	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1619	1619		10.1016/S0140-6736(13)62248-5	http://dx.doi.org/10.1016/S0140-6736(13)62248-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	24238548				2022-12-28	WOS:000327140700010
J	Fried, LF; Emanuele, N; Zhang, JH; Brophy, M; Conner, TA; Duckworth, W; Leehey, DJ; McCullough, PA; O'Connor, T; Palevsky, PM; Reilly, RF; Seliger, SL; Warren, SR; Watnick, S; Peduzzi, P; Guarino, P				Fried, Linda F.; Emanuele, Nicholas; Zhang, Jane H.; Brophy, Mary; Conner, Todd A.; Duckworth, William; Leehey, David J.; McCullough, Peter A.; O'Connor, Theresa; Palevsky, Paul M.; Reilly, Robert F.; Seliger, Stephen L.; Warren, Stuart R.; Watnick, Suzanne; Peduzzi, Peter; Guarino, Peter		VA NEPHRON-D Investigators	Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVERTING ENZYME-INHIBITOR; RENAL OUTCOMES; RISK; PROTEINURIA; THERAPY; BLOCKER; SYSTEM; TARGET; TRIAL	Background Combination therapy with angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) decreases proteinuria; however, its safety and effect on the progression of kidney disease are uncertain. Methods We provided losartan (at a dose of 100 mg per day) to patients with type 2 diabetes, a urinary albumin-to-creatinine ratio (with albumin measured in milligrams and creatinine measured in grams) of at least 300, and an estimated glomerular filtration rate (GFR) of 30.0 to 89.9 ml per minute per 1.73 m(2) of body-surface area and then randomly assigned them to receive lisinopril (at a dose of 10 to 40 mg per day) or placebo. The primary end point was the first occurrence of a change in the estimated GFR (a decline of = 30 ml per minute per 1.73 m(2) if the initial estimated GFR was = 60 ml per minute per 1.73 m(2) or a decline of >= 50% if the initial estimated GFR was <60 ml per minute per 1.73 m(2)), end-stage renal disease (ESRD), or death. The secondary renal end point was the first occurrence of a decline in the estimated GFR or ESRD. Safety outcomes included mortality, hyperkalemia, and acute kidney injury. Results The study was stopped early owing to safety concerns. Among 1448 randomly assigned patients with a median follow-up of 2.2 years, there were 152 primary end-point events in the monotherapy group and 132 in the combination-therapy group (hazard ratio with combination therapy, 0.88; 95% confidence interval [CI], 0.70 to 1.12; P = 0.30). A trend toward a benefit from combination therapy with respect to the secondary end point (hazard ratio, 0.78; 95% CI, 0.58 to 1.05; P = 0.10) decreased with time (P = 0.02 for nonproportionality). There was no benefit with respect to mortality (hazard ratio for death, 1.04; 95% CI, 0.73 to 1.49; P = 0.75) or cardiovascular events. Combination therapy increased the risk of hyperkalemia (6.3 events per 100 person-years, vs. 2.6 events per 100 person-years with monotherapy; P<0.001) and acute kidney injury (12.2 vs. 6.7 events per 100 person-years, P<0.001). Conclusions Combination therapy with an ACE inhibitor and an ARB was associated with an increased risk of adverse events among patients with diabetic nephropathy.	[Fried, Linda F.; Palevsky, Paul M.] Vet Affairs VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Fried, Linda F.; Palevsky, Paul M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Emanuele, Nicholas; Leehey, David J.] Hines VA Hosp, Hines, IL USA; [Emanuele, Nicholas; Leehey, David J.] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Zhang, Jane H.; O'Connor, Theresa; Peduzzi, Peter; Guarino, Peter] VA Connecticut Healthcare Syst, Cooperat Studies Program Coordinating Ctr, West Haven, CT USA; [Peduzzi, Peter] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Brophy, Mary] VA Boston Healthcare Syst, Boston, MA USA; [Brophy, Mary] Boston Univ, Sch Med, Boston, MA 02118 USA; [Conner, Todd A.; Warren, Stuart R.] VA Cooperat Studies Program Res Pharm, Albuquerque, NM USA; [Conner, Todd A.; Warren, Stuart R.] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; [Duckworth, William] Arizona State Univ, Carl T Hayden VA Med Ctr, Tempe, AZ USA; [Duckworth, William] Univ Arizona, Phoenix, AZ USA; [McCullough, Peter A.] St John Providence Hlth Syst, Warren, MI USA; [McCullough, Peter A.] St Johns Hosp, Detroit, MI USA; [McCullough, Peter A.] Med Ctr, Detroit, MI USA; [McCullough, Peter A.] St John Oakland Macomb Ctr, Warren, MI USA; [McCullough, Peter A.] St John Oakland Macomb Ctr, Madison Hts, MI USA; [McCullough, Peter A.] Providence Hosp, Southfield, MI 48037 USA; [McCullough, Peter A.] Med Ctr, Southfield, MI USA; [McCullough, Peter A.] Providence Hosp, Novi, MI USA; [McCullough, Peter A.] Med Ctr, Novi, MI USA; [Reilly, Robert F.] VA North Texas Healthcare Syst, Dallas, TX USA; [Reilly, Robert F.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Seliger, Stephen L.] VA Maryland Healthcare Syst, Baltimore, MD USA; [Seliger, Stephen L.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Watnick, Suzanne] Portland VA Med Ctr & Oregon Hlth, Portland, OR 97239 USA; [Watnick, Suzanne] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; University of New Mexico; Arizona State University; Arizona State University-Tempe; University of Arizona; St. John Hospital & Medical Center; Detroit Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University	Fried, LF (corresponding author), VA Pittsburgh Healthcare Syst, Univ Dr C,Mailstop 111F-U, Pittsburgh, PA 15240 USA.	linda.fried@va.gov	Palevsky, Paul M./Q-1491-2019	Palevsky, Paul M./0000-0002-7334-5400	Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development	Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs)	Funded by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development; VA NEPHRON-D ClinicalTrials.gov number, NCT00555217.	Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; COGAN MG, 1990, HYPERTENSION, V15, P451, DOI 10.1161/01.HYP.15.5.451; de Zeeuw D, 2004, KIDNEY INT, V66, pS2, DOI 10.1111/j.1523-1755.2004.09201.x; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fried LF, 2009, CLIN J AM SOC NEPHRO, V4, P361, DOI 10.2215/CJN.03350708; Harmonisation ICo, 1995, FED REGISTER, V60, P11284; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LEWIS EJ, 1994, NEW ENGL J MED, V330, P152; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Rahman M, 2005, ARCH INTERN MED, V165, P936, DOI 10.1001/archinte.165.8.936; Rose BD, 1994, CLINICAL PHYSIOLOGY; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Schrier RW, 2000, KIDNEY INT, V57, P1418, DOI 10.1046/j.1523-1755.2000.00986.x; Siragy HM, 2010, AM J NEPHROL, V31, P541, DOI 10.1159/000313363; United States Renal Data System, 2012, USRDS 2012 ANNUAL DA; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	21	717	751	1	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1892	1903		10.1056/NEJMoa1303154	http://dx.doi.org/10.1056/NEJMoa1303154			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300MP	24206457				2022-12-28	WOS:000330468300008
J	Moss, RH; Meehl, GA; Lemos, MC; Smith, JB; Arnold, JR; Arnott, JC; Behar, D; Brasseur, GP; Broomell, SB; Busalacchi, AJ; Dessai, S; Ebi, KL; Edmonds, JA; Furlow, J; Goddard, L; Hartmann, HC; Hurrell, JW; Katzenberger, JW; Liverman, DM; Mote, PW; Moser, SC; Kumar, A; Pulwarty, RS; Seyller, EA; Turner, BL; Washington, WM; Wilbanks, TJ				Moss, R. H.; Meehl, G. A.; Lemos, M. C.; Smith, J. B.; Arnold, J. R.; Arnott, J. C.; Behar, D.; Brasseur, G. P.; Broomell, S. B.; Busalacchi, A. J.; Dessai, S.; Ebi, K. L.; Edmonds, J. A.; Furlow, J.; Goddard, L.; Hartmann, H. C.; Hurrell, J. W.; Katzenberger, J. W.; Liverman, D. M.; Mote, P. W.; Moser, S. C.; Kumar, A.; Pulwarty, R. S.; Seyller, E. A.; Turner, B. L., II; Washington, W. M.; Wilbanks, T. J.			Hell and High Water: Practice-Relevant Adaptation Science	SCIENCE			English	Editorial Material							CLIMATE					rhm@pnnl.gov	Mote, Philip/AAB-3500-2021; Dessai, Suraje/D-4219-2009; Arnott, James/O-1029-2015; , AK/B-6517-2008	Dessai, Suraje/0000-0002-7879-9364; Arnott, James/0000-0003-3989-6724; Hurrell, James Wilson/0000-0002-3169-6384; Moss, Richard/0000-0001-5005-0063; Lemos, Maria Carmen/0000-0001-6686-730X	ESRC [ES/K006576/1] Funding Source: UKRI; Economic and Social Research Council [ES/K006576/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2013, SUCCESSFUL ADAPTATIO; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Bierbaum R, 2013, MITIG ADAPT STRAT GL, V18, P361, DOI 10.1007/s11027-012-9423-1; Brown C, 2011, J AM WATER RESOUR AS, V47, P524, DOI 10.1111/j.1752-1688.2011.00552.x; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; Council on Environmental Quality (CEQ), 2010, PROGR REP INT AD TAS; Dilling L, 2011, GLOBAL ENVIRON CHANG, V21, P680, DOI 10.1016/j.gloenvcha.2010.11.006; Dow K, 2013, NAT CLIM CHANGE, V3, P305, DOI 10.1038/nclimate1847; Hewitt C, 2012, NAT CLIM CHANGE, V2, P831, DOI 10.1038/nclimate1745; Hurrell J, 2009, B AM METEOROL SOC, V90, P1819, DOI 10.1175/2009BAMS2752.1; Kerr RA, 2011, SCIENCE, V334, P1052, DOI 10.1126/science.334.6059.1052; Kucharski F, 2013, B AM METEOROL SOC, V94, P25, DOI 10.1175/BAMS-D-11-00238.1; Lemos MC, 2012, NAT CLIM CHANGE, V2, P789, DOI [10.1038/NCLIMATE1614, 10.1038/nclimate1614]; Mearns LO, 2012, B AM METEOROL SOC, V93, P1337, DOI 10.1175/BAMS-D-11-00223.1; Meehl GA, 2014, B AM METEOROL SOC, V95, P243, DOI 10.1175/BAMS-D-12-00241.1; National Research Council, 2010, AM CLIM CHOIC INF EF; National Research Council, 2009, INF DEC CHANG CLIM; National Research Council, 2010, AM CLIM CHOIC AD IMP; National Research Council, 2012, NAT STRAT ADV CLIM M; Palmer TN, 2008, B AM METEOROL SOC, V89, P459, DOI 10.1175/BAMS-89-4-459; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Pulwarty R. S., 2009, INTEGRATED REGIONAL, P367; Smith DM, 2013, CLIM DYNAM, V41, P3325, DOI 10.1007/s00382-013-1683-2; Stern PC, 2013, NAT CLIM CHANGE, V3, P607, DOI 10.1038/nclimate1929; Tang S, 2012, WEATHER CLIM SOC, V4, P300, DOI 10.1175/WCAS-D-12-00028.1; Tompkins EL, 2008, J ENVIRON MANAGE, V88, P1580, DOI 10.1016/j.jenvman.2007.07.025; U.S. National Research Council, 2012, REV US GLOB CHANG RE; Wilby R.L., 2011, MODELLING IMPACT CLI, P34, DOI 10.1002/9781444324921.ch1; Zwiers F. W., 2013, CLIMATE SCI SERVING, P339, DOI [DOI 10.1007/978-94-007-6692-1_13, 10.1007/978-94-007-6692-1_13]	29	136	138	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					696	698		10.1126/science.1239569	http://dx.doi.org/10.1126/science.1239569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247UK	24202163	Green Submitted			2022-12-28	WOS:000326647600026
J	Bloodgood, BL; Sharma, N; Browne, HA; Trepman, AZ; Greenberg, ME				Bloodgood, Brenda L.; Sharma, Nikhil; Browne, Heidi Adlman; Trepman, Alissa Z.; Greenberg, Michael E.			The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition	NATURE			English	Article							FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR; NEURONAL-ACTIVITY; SYNAPSES; INTERNEURONS; EXPRESSION; MEMORY; CELLS	A heterogeneous population of inhibitory neurons controls the flow of information through a neural circuit(1-3). Inhibitory synapses that form on pyramidal neuron dendrites modulate the summation of excitatory synaptic potentials(4-6) and prevent the generation of dendritic calcium spikes(7,8). Precisely timed somatic inhibition limits both the number of action potentials and the time window during which firing can occur(8,9). The activity-dependent transcription factor NPAS4 regulates inhibitory synapse number and function in cell culture(10), but how this transcription factor affects the inhibitory inputs that form on distinct domains of a neuron in vivo was unclear. Here we show that in the mouse hippocampus behaviourally driven expression of NPAS4 coordinates the redistribution of inhibitory synapses made onto a CA1 pyramidal neuron, simultaneously increasing inhibitory synapse number on the cell body while decreasing the number of inhibitory synapses on the apical dendrites. This rearrangement of inhibition is mediated in part by the NPAS4 target gene brain derived neurotrophic factor (Bdnf), which specifically regulates somatic, and not dendritic, inhibition. These findings indicate that sensory stimuli, by inducing NPAS4 and its target genes, differentially control spatial features of neuronal inhibition in a way that restricts the output of the neuron while creating a dendritic environment that is permissive for plasticity.	[Bloodgood, Brenda L.; Sharma, Nikhil; Browne, Heidi Adlman; Trepman, Alissa Z.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bloodgood, Brenda L.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Sharma, Nikhil] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; University of California System; University of California San Diego; Harvard University	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	Michael_Greenberg@hms.harvard.edu	Core, Vector/CAF-4832-2022	Bloodgood, Brenda/0000-0002-4797-9119	Helen Hay Whitney Foundation; L'Oreal USA Fellowship for Women in Science; Medical Foundation/Charles A. King Trust Postdoctoral Fellowship; NSF graduate student research fellowship; National Institutes of Health [NS028829];  [P30 NS047101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028829, P01NS047572, R37NS028829, P30NS047101] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; L'Oreal USA Fellowship for Women in Science; Medical Foundation/Charles A. King Trust Postdoctoral Fellowship; NSF graduate student research fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Greenberg laboratory for comments, suggestions and critical reading of the manuscript. We thank A. Mardinly for observations and comments on NPAS4 protein induction, P. Greer and S. Flavell for observations and comments on Npas4 mRNA induction in response to enriched environment and B. Cruz Moreno for help with sectioning. We thank M. During for the gift of the AAV-Cre-GFP plasmid. GFP-gephyrin images were collected at the UCSD Neuroscience Microscopy Shared Facility sponsored by grant P30 NS047101. This work was funded by Helen Hay Whitney Foundation, L'Oreal USA Fellowship for Women in Science and The Medical Foundation/Charles A. King Trust Postdoctoral Fellowship (B. L. B.), NSF graduate student research fellowship (N.S.) and National Institutes of Health grant NS028829 (M.E.G.).	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Baldelli P, 2005, J NEUROSCI, V25, P3358, DOI 10.1523/JNEUROSCI.4227-04.2005; Brigadski T, 2005, J NEUROSCI, V25, P7601, DOI 10.1523/JNEUROSCI.1776-05.2005; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Dean C, 2012, J NEUROSCI, V32, P5398, DOI 10.1523/JNEUROSCI.4515-11.2012; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lein ES, 2000, J NEUROSCI, V20, P1470; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Marty S, 2000, J NEUROSCI, V20, P8087; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Pattabiraman PP, 2005, MOL CELL NEUROSCI, V28, P556, DOI 10.1016/j.mcn.2004.11.010; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rocamora N, 1996, J NEUROSCI, V16, P4411; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; TURNER DA, 1990, J PHYSIOL-LONDON, V422, P333, DOI 10.1113/jphysiol.1990.sp017987; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015	30	181	184	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					121	+		10.1038/nature12743	http://dx.doi.org/10.1038/nature12743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201284	Green Accepted			2022-12-28	WOS:000326585600044
J	Sanloup, C; Drewitt, JWE; Konopkova, Z; Dalladay-Simpson, P; Morton, DM; Rai, N; van Westrenen, W; Morgenroth, W				Sanloup, Chrystele; Drewitt, James W. E.; Konopkova, Zuzana; Dalladay-Simpson, Philip; Morton, Donna M.; Rai, Nachiketa; van Westrenen, Wim; Morgenroth, Wolfgang			Structural change in molten basalt at deep mantle conditions	NATURE			English	Article							EARTHS LOWER MANTLE; HIGH-PRESSURE; MAGMA OCEAN; COORDINATION CHANGES; LIQUID; METAL; GPA; DENSITY; CORE; MELT	Silicate liquids play a key part at all stages of deep Earth evolution, ranging from core and crust formation billions of years ago to present-day volcanic activity. Quantitative models of these processes require knowledge of the structural changes and compression mechanisms that take place in liquid silicates at the high pressures and temperatures in the Earth's interior. However, obtaining such knowledge has long been impeded by the challenging nature of the experiments. In recent years, structural and density information for silica glass was obtained at record pressures of up to 100 GPa (ref. 1), a major step towards obtaining data on the molten state. Here we report the structure of molten basalt up to 60 GPa by means of in situ X-ray diffraction. The coordination of silicon increases from four under ambient conditions to six at 35 GPa, similar to what has been reported in silica glass(1-3). The compressibility of the melt after the completion of the coordination change is lower than at lower pressure, implying that only a high-order equation of state can accurately describe the density evolution of silicate melts over the pressure range of the whole mantle. The transition pressure coincides with a marked change in the pressure-evolution of nickel partitioning between molten iron and molten silicates, indicating that melt compressibility controls siderophile-element partitioning.	[Sanloup, Chrystele; Drewitt, James W. E.; Dalladay-Simpson, Philip; Morton, Donna M.] Univ Edinburgh, Scottish Univ Phys Alliance, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland; [Sanloup, Chrystele; Drewitt, James W. E.; Dalladay-Simpson, Philip; Morton, Donna M.] Univ Edinburgh, Scottish Univ Phys Alliance, Sch Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland; [Sanloup, Chrystele] Univ Paris 06, CNRS, UMR 7193, Inst Sci Terre Paris, F-75005 Paris, France; [Konopkova, Zuzana; Morgenroth, Wolfgang] DESY Photon Sci, D-22607 Hamburg, Germany; [Rai, Nachiketa; van Westrenen, Wim] Vrije Univ Amsterdam, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [Morgenroth, Wolfgang] Goethe Univ Frankfurt, Inst Geowissensch, D-60438 Frankfurt, Germany	University of Edinburgh; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Vrije Universiteit Amsterdam; Goethe University Frankfurt	Sanloup, C (corresponding author), Univ Edinburgh, Scottish Univ Phys Alliance, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland.	chrystele.sanloup@ed.ac.uk	Morgenroth, Wolfgang/AAT-7606-2020; Morgenroth, Wolfgang HW/I-4541-2014; Konopkova, Zuzana/B-2130-2015; Drewitt, James W E/A-1631-2010; Rai, Nachiketa/D-9859-2015; Sanloup, Chrystele/AAI-3610-2020; Sanloup, Chrystele/D-9923-2015	Morgenroth, Wolfgang HW/0000-0001-8921-0052; Drewitt, James W E/0000-0002-3510-4155; Rai, Nachiketa/0000-0002-2358-7962; van Westrenen, Wim/0000-0001-5828-8885; Sanloup, Chrystele/0000-0003-2412-6073	European Community under European Research Council [312284, 259649]; BMBF (the German Federal Ministry of Education and Research) [05K10RFA]; Engineering and Physical Sciences Research Council [1110865] Funding Source: researchfish	European Community under European Research Council; BMBF (the German Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant numbers 312284 and 259649 (European Research Council starting grant to C. S.). The laser heating system on beamline P02.2 is funded by the BMBF (the German Federal Ministry of Education and Research, project number 05K10RFA). We acknowledge G. Prouteau for providing the starting basalt glass, and PETRAIII for provision of synchrotron radiation facilities.	Agee CB, 1998, PHYS EARTH PLANET IN, V107, P63, DOI 10.1016/S0031-9201(97)00124-6; Asimow PD, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007145; Benmore CJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054105; de Koker N, 2010, GEOCHIM COSMOCHIM AC, V74, P5657, DOI 10.1016/j.gca.2010.02.024; de Koker N, 2009, GEOPHYS J INT, V178, P162, DOI 10.1111/j.1365-246X.2009.04142.x; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Eggert JH, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.174105; Farges F, 2001, GEOCHIM COSMOCHIM AC, V65, P1665, DOI 10.1016/S0016-7037(00)00625-6; Funamori N, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002650; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Hirose K, 1999, NATURE, V397, P53, DOI 10.1038/16225; Hosemann R., 1962, DIRECT ANAL DIFFRACT; Karki BB, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.104205; KEPPLER H, 1993, NATURE, V364, P54, DOI 10.1038/364054a0; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Lee CTA, 2010, NATURE, V463, P930, DOI 10.1038/nature08824; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; MEADE C, 1992, PHYS REV LETT, V69, P1387, DOI 10.1103/PhysRevLett.69.1387; Murakami M, 2011, P NATL ACAD SCI USA, V108, P17286, DOI 10.1073/pnas.1109748108; Nishihara Y, 2005, PHYS CHEM MINER, V31, P660, DOI 10.1007/s00269-004-0426-7; O'Neill HS, 1998, J GEOPHYS RES-SOL EA, V103, P12239, DOI 10.1029/97JB02601; Ohtani E, 1996, GEOPHYS RES LETT, V23, P1993, DOI 10.1029/96GL01469; Ohtani E, 2001, EARTH PLANET SC LETT, V193, P69, DOI 10.1016/S0012-821X(01)00505-2; Perrillat JP, 2006, PHYS EARTH PLANET IN, V157, P139, DOI 10.1016/j.pepi.2006.04.001; Pichavant M, 2009, J PETROL, V50, P601, DOI 10.1093/petrology/egp014; Ricolleau A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006709; RIGDEN SM, 1984, SCIENCE, V226, P1071, DOI 10.1126/science.226.4678.1071; Sanloup C, 2013, GEOCHIM COSMOCHIM AC, V118, P118, DOI 10.1016/j.gca.2013.05.012; Sanloup C, 2011, EARTH PLANET SC LETT, V306, P118, DOI 10.1016/j.epsl.2011.03.039; Sanloup C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.075701; Sato T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184102; Sato T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.255502; Siebert J, 2012, EARTH PLANET SC LETT, V321, P189, DOI 10.1016/j.epsl.2012.01.013; Stixrude L, 2005, SCIENCE, V310, P297, DOI 10.1126/science.1116952; Sun N, 2011, GEOCHIM COSMOCHIM AC, V75, P3792, DOI 10.1016/j.gca.2011.04.004; THIBAULT Y, 1995, GEOCHIM COSMOCHIM AC, V59, P991, DOI 10.1016/00167-0379(50)00178-; Tschauner O, 1999, NATURE, V398, P604, DOI 10.1038/19287; YARGER JL, 1995, SCIENCE, V270, P1964, DOI 10.1126/science.270.5244.1964	39	123	125	4	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					104	+		10.1038/nature12668	http://dx.doi.org/10.1038/nature12668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201283				2022-12-28	WOS:000326585600040
J	Schwartz, MW; Seeley, RJ; Tschop, MH; Woods, SC; Morton, GJ; Myers, MG; D'Alessio, D				Schwartz, Michael W.; Seeley, Randy J.; Tschoep, Matthias H.; Woods, Stephen C.; Morton, Gregory J.; Myers, Martin G.; D'Alessio, David			Cooperation between brain and islet in glucose homeostasis and diabetes	NATURE			English	Review							Y GASTRIC BYPASS; GROWTH-FACTOR 19; INSULIN-RESISTANCE; BARIATRIC SURGERY; MEDICAL THERAPY; BODY-WEIGHT; FOOD-INTAKE; LEPTIN; OBESITY; SENSITIVITY	Although a prominent role for the brain in glucose homeostasis was proposed by scientists in the nineteenth century, research throughout most of the twentieth century focused on evidence that the function of pancreatic islets is both necessary and sufficient to explain glucose homeostasis, and that diabetes results from defects of insulin secretion, action or both. However, insulin-independent mechanisms, referred to as 'glucose effectiveness', account for roughly 50% of overall glucose disposal, and reduced glucose effectiveness also contributes importantly to diabetes pathogenesis. Although mechanisms underlying glucose effectiveness are poorly understood, growing evidence suggests that the brain can dynamically regulate this process in ways that improve or even normalize glycaemia in rodent models of diabetes. Here we present evidence of a brain-centred glucoregulatory system (BCGS) that can lower blood glucose levels via both insulin-dependent and - independent mechanisms, and propose a model in which complex and highly coordinated interactions between the BCGS and pancreatic islets promote normal glucose homeostasis. Because activation of either regulatory system can compensate for failure of the other, defects in both may be required for diabetes to develop. Consequently, therapies that target the BCGS in addition to conventional approaches based on enhancing insulin effects may have the potential to induce diabetes remission, whereas targeting just one typically does not.	[Schwartz, Michael W.; Morton, Gregory J.] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98109 USA; [Seeley, Randy J.; D'Alessio, David] Univ Cincinnati, Dept Med, Cincinnati, OH 45237 USA; [Tschoep, Matthias H.] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Diabet & Obes, D-85764 Munich, Germany; [Tschoep, Matthias H.] Tech Univ Munich, Dept Med, Div Metab Dis, D-85764 Munich, Germany; [Woods, Stephen C.] Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45237 USA; [Myers, Martin G.] Univ Michigan, Dept Physiol, Ann Arbor, MI 48105 USA	University of Washington; University of Washington Seattle; University System of Ohio; University of Cincinnati; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan	Schwartz, MW (corresponding author), Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98109 USA.	mschwart@u.washington.edu	Tschoep, Matthias H/I-5443-2014	Seeley, Randy/0000-0002-3721-5625; Tschoep, Matthias/0000-0002-4744-371X	National Institutes of Health (NIH) [DK083042, DK093848, DK089053]; Nutrition Obesity Research Centre and Diabetes Research Centre at the University of Washington; Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases), through the Initiative and Networking Fund of the Helmholtz Association.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P30DK017047, R01DK093848, P30DK035816, R01DK090320, R01DK089056, R01DK083042] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition Obesity Research Centre and Diabetes Research Centre at the University of Washington; Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases), through the Initiative and Networking Fund of the Helmholtz Association.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank A. G. Bell for inspiration and D. Porte Jr for comments. This work was partly funded by National Institutes of Health (NIH) grants DK083042 (M. W. S.), DK093848 (R.J.S.) and DK089053 (G.J.M.), and the Nutrition Obesity Research Centre and Diabetes Research Centre at the University of Washington, and the Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases), through the Initiative and Networking Fund of the Helmholtz Association.	Ai-Luen W., 2011, SCI TRANSL MED, V3; Alkemade A, 2012, J CLIN ENDOCR METAB, V97, pE925, DOI 10.1210/jc.2011-3259; Bernard C, 1854, LECONS OHYSIOLOGIE E; Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Cai DS, 2012, ENDOCRINOLOGY, V153, P1010, DOI 10.1210/en.2011-2183; Cheng ZY, 2012, NAT MED, V18, P351, DOI 10.1038/nm.2694; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Cummings DE, 2008, JAMA-J AM MED ASSOC, V299, P341, DOI 10.1001/jama.299.3.341; DALESSIO DA, 1994, J CLIN INVEST, V93, P2263, DOI 10.1172/JCI117225; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Edgerton DS, 2009, DIABETES, V58, P2766, DOI 10.2337/db09-0328; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255; German JP, 2011, ENDOCRINOLOGY, V152, P394, DOI 10.1210/en.2010-0890; German JP, 2010, DIABETES, V59, P1626, DOI 10.2337/db09-1918; Havel PJ, 1998, AM J PHYSIOL-REG I, V274, pR1482, DOI 10.1152/ajpregu.1998.274.5.R1482; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Jiao J, 2013, DIABETES, V62, P1074, DOI 10.2337/db12-0681; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; KAHN SE, 1990, J CLIN ENDOCR METAB, V71, P994, DOI 10.1210/jcem-71-4-994; Kashyap SR, 2013, DIABETES CARE, V36, P2175, DOI 10.2337/dc12-1596; Kishore P, 2011, J CLIN INVEST, V121, P4916, DOI 10.1172/JCI58035; Kruger AJ, 2011, AUTOIMMUNITY, V44, P137, DOI 10.3109/08916934.2010.482116; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Mittelman SD, 1997, J CLIN INVEST, V100, P3121, DOI 10.1172/JCI119867; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Morton GJ, 2013, J CLIN INVEST; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Osundiji MA, 2013, ENDOCRIN METAB CLIN, V42, P1, DOI 10.1016/j.ecl.2012.11.006; Paranjape SA, 2013, DIABETOLOGIA, V56, P2055, DOI 10.1007/s00125-013-2952-7; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Ramnanan CJ, 2011, J CLIN INVEST, V121, P3713, DOI 10.1172/JCI45472; Ryan KK, 2013, ENDOCRINOLOGY, V154, P9, DOI 10.1210/en.2012-1891; Sandoval D, 2008, ANNU REV PHYSIOL, V70, P513, DOI 10.1146/annurev.physiol.70.120806.095256; Sandoval DA, 2008, DIABETES, V57, P2046, DOI 10.2337/db07-1824; Schaap FG, 2012, CURR OPIN CLIN NUTR, V15, P386, DOI 10.1097/MCO.0b013e3283547171; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Semple RK, 2011, ENDOCR REV, V32, P498, DOI 10.1210/er.2010-0020; Shin AC, 2012, ANN SURG, V255, P294, DOI 10.1097/SLA.0b013e31823e71b7; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105	57	204	213	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					59	66		10.1038/nature12709	http://dx.doi.org/10.1038/nature12709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201279	Green Accepted			2022-12-28	WOS:000326585600032
J	Vaidya, JS; Wenz, F; Bulsara, M; Tobias, JS; Joseph, DJ; Keshtgar, M; Flyger, HL; Massarut, S; Alvarado, M; Saunders, C; Eiermann, W; Metaxas, M; Sperk, E; Sutterlin, M; Brown, D; Esserman, L; Roncadin, M; Thompson, A; Dewar, JA; Holtveg, HMR; Pigorsch, S; Falzon, M; Harris, E; Matthews, A; Brew-Graves, C; Potyka, I; Corica, T; Williams, NR; Baum, M				Vaidya, Jayant S.; Wenz, Frederik; Bulsara, Max; Tobias, Jeffrey S.; Joseph, David J.; Keshtgar, Mohammed; Flyger, Henrik L.; Massarut, Samuele; Alvarado, Michael; Saunders, Christobel; Eiermann, Wolfgang; Metaxas, Marinos; Sperk, Elena; Suetterlin, Marc; Brown, Douglas; Esserman, Laura; Roncadin, Mario; Thompson, Alastair; Dewar, John A.; Holtveg, Helle M. R.; Pigorsch, Steffi; Falzon, Mary; Harris, Eleanor; Matthews, April; Brew-Graves, Chris; Potyka, Ingrid; Corica, Tammy; Williams, Norman R.; Baum, Michael		TARGIT Trialists Grp	Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial	LANCET			English	Article							LUMPECTOMY PLUS TAMOXIFEN; ENERGY X-RAYS; ADJUVANT RADIOTHERAPY; CONSERVING SURGERY; RADIATION-THERAPY; CLINICAL-TRIALS; IRRADIATION; WOMEN; RECURRENCE; MULTICENTRICITY	Background The TARGIT-A trial compared risk-adapted radiotherapy using single-dose targeted intraoperative radiotherapy (TARGIT) versus fractionated external beam radiotherapy (EBRT) for breast cancer. We report 5-year results for local recurrence and the first analysis of overall survival. Methods TARGIT-A was a randomised, non-inferiority trial. Women aged 45 years and older with invasive ductal carcinoma were enrolled and randomly assigned in a 1: 1 ratio to receive TARGIT or whole-breast EBRT, with blocks stratified by centre and by timing of delivery of targeted intraoperative radiotherapy: randomisation occurred either before lumpectomy (prepathology stratum, TARGIT concurrent with lumpectomy) or after lumpectomy (postpathology stratum, TARGIT given subsequently by reopening the wound). Patients in the TARGIT group received supplemental EBRT (excluding a boost) if unforeseen adverse features were detected on final pathology, thus radiotherapy was risk-adapted. The primary outcome was absolute difference in local recurrence in the conserved breast, with a prespecified non-inferiority margin of 2.5% at 5 years; prespecified analyses included outcomes as per timing of randomisation in relation to lumpectomy. Secondary outcomes included complications and mortality. This study is registered with ClinicalTrials.gov, number NCT00983684. Findings Patients were enrolled at 33 centres in 11 countries, between March 24, 2000, and June 25, 2012. 1721 patients were randomised to TARGIT and 1730 to EBRT. Supplemental EBRT after TARGIT was necessary in 15.2% [239 of 1571] of patients who received TARGIT (21.6% prepathology, 3.6% postpathology). 3451 patients had a median follow-up of 2 years and 5 months (IQR 12-52 months), 2020 of 4 years, and 1222 of 5 years. The 5-year risk for local recurrence in the conserved breast was 3.3% (95% CI 2.1-5.1) for TARGIT versus 1.3% (0.7-2.5) for EBRT (p=0.042). TARGIT concurrently with lumpectomy (prepathology, n=2298) had much the same results as EBRT: 2.1% (1.1-4.2) versus 1.1% (0.5-2.5; p=0.31). With delayed TARGIT (postpathology, n=1153) the between-group diff erence was larger than 2.5% (TARGIT 5.4% [3.0-9.7] vs EBRT 1.7% [0.6-4.9]; p=0.069). Overall, breast cancer mortality was much the same between groups (2.6% [1.5-4.3] for TARGIT vs 1.9% [1.1-3.2] for EBRT; p=0.56) but there were significantly fewer non-breast-cancer deaths with TARGIT (1.4% [0.8-2.5] vs 3.5% [2.3-5.2]; p=0.0086), attributable to fewer deaths from cardiovascular causes and other cancers. Overall mortality was 3.9% (2.7-5.8) for TARGIT versus 5.3% (3.9-7.3) for EBRT (p=0.099). Wound-related complications were much the same between groups but grade 3 or 4 skin complications were significantly reduced with TARGIT (four of 1720 vs 13 of 1731, p=0.029). Interpretation TARGIT concurrent with lumpectomy within a risk-adapted approach should be considered as an option for eligible patients with breast cancer carefully selected as per the TARGIT-A trial protocol, as an alternative to postoperative EBRT.	[Vaidya, Jayant S.; Metaxas, Marinos; Brew-Graves, Chris; Potyka, Ingrid; Williams, Norman R.; Baum, Michael] UCL, Clin Trials Grp, Div Surg & Intervent Sci, London W1W 7EJ, England; [Wenz, Frederik; Sperk, Elena] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Radiat Oncol, Heidelberg, Germany; [Suetterlin, Marc] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Gynecol & Obstet, Heidelberg, Germany; [Bulsara, Max] Univ Notre Dame, Dept Biostat, Fremantle, WA, Australia; [Joseph, David J.; Corica, Tammy] Sir Charles Gairdner Hosp, Dept Radiat Oncol, Perth, WA, Australia; [Saunders, Christobel] Sir Charles Gairdner Hosp, Dept Surg, Perth, WA, Australia; [Tobias, Jeffrey S.] Univ Coll London Hosp, Dept Clin Oncol, London, England; [Falzon, Mary] Univ Coll London Hosp, Dept Pathol, London, England; [Keshtgar, Mohammed] Royal Free Hosp, Dept Surg, London NW3 2QG, England; [Vaidya, Jayant S.; Keshtgar, Mohammed] Whittington Hosp, Dept Surg, London N19 5NF, England; [Flyger, Henrik L.; Holtveg, Helle M. R.] Univ Copenhagen, Dept Breast Surg, Copenhagen, Denmark; [Massarut, Samuele] Ctr Riferimento Oncol, Dept Surg, I-33081 Aviano, Italy; [Roncadin, Mario] Ctr Riferimento Oncol, Dept Radiat Oncol, I-33081 Aviano, Italy; [Saunders, Christobel] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Alvarado, Michael; Esserman, Laura] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Eiermann, Wolfgang] Red Cross Hosp, Dept Gynecol & Obstet, Munich, Germany; [Dewar, John A.] Ninewells Hosp, Dept Radiat Oncol, Dundee DD1 9SY, Scotland; [Brown, Douglas; Thompson, Alastair] Ninewells Hosp, Dept Surg, Dundee DD1 9SY, Scotland; [Pigorsch, Steffi] Tech Univ Munich, Dept Radiat Oncol, D-80290 Munich, Germany; [Harris, Eleanor] E Carolina Univ, Brody Sch Med, Dept Radiat Oncol, Greenville, NC USA; [Matthews, April] Natl Inst Canc Res, Psychosocial Oncol Clin Studies Grp, London, England; [Matthews, April] Independent Canc Patients Voice, London, England	University of London; University College London; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Notre Dame Australia; University of Western Australia; University of Western Australia; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of Copenhagen; IRCCS Aviano (CRO); IRCCS Aviano (CRO); University of Western Australia; University of California System; University of California San Francisco; University of Dundee; University of Dundee; Technical University of Munich; University of North Carolina; East Carolina University	Vaidya, JS (corresponding author), UCL, Clin Trials Grp, Div Surg & Intervent Sci, Dept Surg, London W1W 7EJ, England.	jayant.vaidya@ucl.ac.uk	Corica, Tammy/J-4670-2013; Massarut, Samuele/J-2995-2018; Vaidya, Jayant S/F-7717-2010; Vaidya, Jayant S/A-7218-2008; Saunders, Christobel M/H-5779-2014; Flyger, Henrik/AAM-6494-2021; WILLIAMS, Norman/C-2002-2008	Corica, Tammy/0000-0002-1197-0120; Massarut, Samuele/0000-0003-4717-0544; Vaidya, Jayant S/0000-0003-1760-1278; Vaidya, Jayant S/0000-0003-1760-1278; Saunders, Christobel M/0000-0003-2281-9829; WILLIAMS, Norman/0000-0001-6496-312X; Sperk, Elena/0000-0002-8771-8124; Brew-Graves, Chris/0000-0002-0266-0315	University College London Hospitals (UCLH)/UCL Comprehensive Biomedical Research Centre; UCLH Charities; National Institute for Health Research Health Technology Assessment programme; Ninewells Cancer Campaign; National Health and Medical Research Council; German Federal Ministry of Education and Research; German Federal Ministry of Education and Research (BMBF) [FKZ 01ZP0508]; Cancer Research UK; National Institute for Health Research [07/60/49, 10/104/07] Funding Source: researchfish	University College London Hospitals (UCLH)/UCL Comprehensive Biomedical Research Centre; UCLH Charities; National Institute for Health Research Health Technology Assessment programme(National Institute for Health Research (NIHR)); Ninewells Cancer Campaign; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	University College London Hospitals (UCLH)/UCL Comprehensive Biomedical Research Centre, UCLH Charities, National Institute for Health Research Health Technology Assessment programme, Ninewells Cancer Campaign, National Health and Medical Research Council, and German Federal Ministry of Education and Research.; The trial was initiated by an academic insight and collaboration with the industry was solely for the development of the device. The manufacturers of the Intrabeam device (Carl Zeiss) did not have any part in concept, design, or management of the trial, or in data analysis, data interpretation, or writing of the report. The study was sponsored by University College London Hospitals (UCLH)/UCL Comprehensive Biomedical Research Centre. Funding was provided by UCLH Charities, National Institute for Health Research (NIHR) Health Technology Assessment programme, Ninewells Cancer Campaign, National Health and Medical Research Council, and German Federal Ministry of Education and Research (BMBF) FKZ 01ZP0508. The infrastructure of the trial operations office in London, UK, was supported by core funding from Cancer Research Campaign (now Cancer Research UK) when the trial was initiated. We thank Michael D O'Shea (Woodward Informatics, Oxfordshire, UK) for database development, Stephen Ebbs (Croydon Health Services, Croydon, UK) for independently assessing the cause of death, Andrew Lee (Ninewells Hospital, Dundee, UK), for help in data collection, and Hrisheekesh J Vaidya for help with the appendix and editing of the report, and several contributors who have now left the individual centres. Travel and accommodation for meetings of the international steering committee and data monitoring committee were provided by Carl Zeiss. Funding for the TARGIT Trials Operations Office was provided by the NIHR Health Technology Assessment programme. Individual centres were self-financed. We thank all the patients who kindly participated in the trial. Manuscript preparation was helped by the trial operations staff and their respective families.	Abe O, 2005, LANCET, V366, P2087; Alvarado M, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.6081; Alvarado M, 2010, EJC SUPPL, V8, P2; Athas WF, 2000, J NATL CANCER I, V92, P269, DOI 10.1093/jnci/92.3.269; Baum M, 1997, LANCET, V349, P208, DOI 10.1016/S0140-6736(05)60950-6; Baum M, 1999, EUR J CANCER, V35, P886, DOI 10.1016/S0959-8049(99)00067-2; Belletti B, 2008, CLIN CANCER RES, V14, P1325, DOI 10.1158/1078-0432.CCR-07-4453; Blamey RW, 2013, EUR J CANCER, V49, P2294, DOI 10.1016/j.ejca.2013.02.031; Corica T, 2012, EUR J CANCER, V48, pS187; Csaba P, 2010, RADIOTHER ONCOL, V94, P264, DOI 10.1016/j.radonc.2010.01.014; CUZICK J, 1987, CANCER TREAT REP, V71, P15; da Silva GT, 2009, BIOL BLOOD MARROW TR, V15, P120, DOI 10.1016/j.bbmt.2008.10.004; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Fisher B, 2002, J CLIN ONCOL, V20, P4141, DOI 10.1200/JCO.2002.11.101; Fyles AW, 2004, NEW ENGL J MED, V351, P963, DOI 10.1056/NEJMoa040595; Herskind C, 2005, RADIAT RES, V163, P208, DOI 10.1667/RR3292; Herskind C, 2010, STRAHLENTHER ONKOL, V186, P444, DOI 10.1007/s00066-010-2147-9; Herskind C, 2008, INT J RADIAT ONCOL, V72, P1575, DOI 10.1016/j.ijrobp.2008.08.009; HOLLAND R, 1985, CANCER, V56, P979, DOI 10.1002/1097-0142(19850901)56:5<979::AID-CNCR2820560502>3.0.CO;2-N; Hughes KS, 2013, J CLIN ONCOL, V31, P2382, DOI 10.1200/JCO.2012.45.2615; Keshtgar M, 2011, ANN SURG ONCOL, V18, pS171; Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210; Kraus-Tiefenbacher U, 2006, INT J RADIAT ONCOL, V66, P377, DOI 10.1016/j.ijrobp.2006.05.042; Laster LL, 2006, STAT MED, V25, P1115, DOI 10.1002/sim.2476; Liu Q, 2013, INT J RADIAT ONCOL, V85, P1127, DOI 10.1016/j.ijrobp.2012.08.005; Offersen BV, 2009, RADIOTHER ONCOL, V90, P1, DOI 10.1016/j.radonc.2008.08.005; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Potter R, 2007, INT J RADIAT ONCOL, V68, P334, DOI 10.1016/j.ijrobp.2006.12.045; Smith BD, 2009, INT J RADIAT ONCOL, V74, P987, DOI 10.1016/j.ijrobp.2009.02.031; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Sperk E, 2012, BREAST CANCER RES TR, V135, P253, DOI 10.1007/s10549-012-2168-4; Tobias JS, 2004, BRIT J RADIOL, V77, P279, DOI 10.1259/bjr/17186381; Vaidya JS, 2007, NAT CLIN PRACT ONCOL, V4, P384, DOI 10.1038/ncponc0850; Vaidya JS, 2011, INT J RADIAT ONCOL, V81, P1091, DOI 10.1016/j.ijrobp.2010.07.1996; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; Vaidya JS, 2009, INT J RADIAT ONCOL, V74, P976, DOI 10.1016/j.ijrobp.2009.02.041; Vaidya JS, 2004, LANCET ONCOL, V5, P165, DOI 10.1016/S1470-2045(04)01412-3; Vaidya JS, 2002, EUR J SURG ONCOL, V28, P447, DOI 10.1053/ejso.2002.1275; Vaidya JS, 2001, ANN ONCOL, V12, P1075, DOI 10.1023/A:1011609401132; Vaidya JS, 1996, BRIT J CANCER, V74, P820, DOI 10.1038/bjc.1996.442; VAIDYA JS, 2002, THESIS U LONDON; VAIDYA JS, 1995, HONG KONG INT CANC C; Veronesi U, 2008, ECANCERMEDICALSCIENC, V2, DOI 10.3332/eCMS.2008.65; Welzel G, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-9	47	588	606	2	77	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					603	613		10.1016/S0140-6736(13)61950-9	http://dx.doi.org/10.1016/S0140-6736(13)61950-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KP	24224997	hybrid, Green Published			2022-12-28	WOS:000331137700029
J	Hellard, ME; Doyle, JS				Hellard, Margaret E.; Doyle, Joseph S.			Interferon-free hepatitis C treatment: one pill to fit all?	LANCET			English	Editorial Material							INJECT DRUGS; VIRUS-INFECTION; EPIDEMIOLOGY; PEOPLE; PREVENTION		[Hellard, Margaret E.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic 3004, Australia; Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; Monash Univ, Dept Epidemiol & Preventat Med, Clayton, Vic 3800, Australia	Burnet Institute; Florey Institute of Neuroscience & Mental Health; Monash University	Hellard, ME (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic 3004, Australia.	hellard@burnet.edu.au		Doyle, Joseph S/0000-0001-7198-0833				Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Chen JM, 2013, GASTROENTEROLOGY, V144, P1450, DOI 10.1053/j.gastro.2013.02.039; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; Doyle JS, 2013, BRIT J CLIN PHARMACO, V75, P931, DOI 10.1111/j.1365-2125.2012.04419.x; Grebely J, 2013, CLIN INFECT DIS, V57, P1014, DOI 10.1093/cid/cit377; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Thompson A, 2009, J HEPATOL, V50, P184, DOI 10.1016/j.jhep.2008.10.011; Zeuzem S, 2013, HEPATOLOGY, V58, P1516, DOI 10.1002/hep.26363	14	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					491	492		10.1016/S0140-6736(13)62151-0	http://dx.doi.org/10.1016/S0140-6736(13)62151-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24209978				2022-12-28	WOS:000331136400006
J	Lawitz, E; Poordad, FF; Pang, PS; Hyland, RH; Ding, X; Mo, HM; Symonds, WT; McHutchison, JG; Membreno, FE				Lawitz, Eric; Poordad, Fred F.; Pang, Phillip S.; Hyland, Robert H.; Ding, Xiao; Mo, Hongmei; Symonds, William T.; McHutchison, John G.; Membreno, Fernando E.			Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial	LANCET			English	Article							ANTIVIRAL AGENTS; TRIPLE THERAPY; DOUBLE-BLIND; INTERFERON; INHIBITOR; BOCEPREVIR; TELAPREVIR; ALPHA-2A	Background Interferon-based treatment is not suitable for many patients with hepatitis C virus (HCV) infection because of contraindications such as psychiatric illness, and a high burden of adverse events. We assessed the efficacy and safety of an interferon-free regimen-a fixed-dose combination of the nucleotide polymerase inhibitor sofosbuvir (400 mg) and the HCV NS5A inhibitor ledipasvir (90 mg), with and without ribavirin-in patients with genotype-1 hepatitis C infection who were treatment-naive or previously treated with a protease-inhibitor regimen. Methods For this open-label study, we enrolled 100 adult patients (> 18 years) with HCV infection at a centre in the USA between Nov 2, 2012, and Dec 21, 2012. In cohort A, we used a computer-generated sequence to randomly assign (1:1:1; stratified by HCV genotype [1a vs 1b]) 60 non-cirrhotic, treatment-naive patients to receive sofosbuvir plus ledipasvir for 8 weeks (group 1), sofosbuvir plus ledipasvir and ribavirin for 8 weeks (group 2), or sofosbuvir plus ledipasvir for 12 weeks (group 3). In cohort B, we randomly allocated (1:1; stratified by genotype and presence or absence of cirrhosis) 40 patients who previously had virological failure after receiving a protease inhibitor regimen to receive sofosbuvir plus ledipasvir for 12 weeks (group 4) or sofosbuvir plus ledipasvir and ribavirin for 12 weeks (group 5). 22 (55%) of 40 patients in cohort B had compensated cirrhosis. The primary endpoint was sustained virological response 12 weeks after treatment (SVR12), analysed by intention to treat. Findings In cohort A, SVR12 was achieved by 19 (95%) of 20 patients (95% CI 75-100) in group 1, by 21 (100%) of 21 patients (84-100) in group 2, and by 18 (95%) of 19 patients (74-100) in group 3. In cohort B, SVR12 was achieved by 18 (95%) of 19 patients (74-100) in group 4 and by all 21 (100%) of 21 patients (84-100) in group 5. Two patients had viral relapse; one patient was lost to follow-up after achieving sustained virological response 8 weeks after treatment. The most common adverse events were nausea, anaemia, upper respiratory tract infection, and headache. One patient in group five had a serious adverse event of anaemia, thought to be related to ribavirin treatment. Interpretation These findings suggest that the fixed-dose combination of sofosbuvir-ledipasvir alone or with ribavirin has the potential to cure most patients with genotype-1 HCV, irrespective of treatment history or the presence of compensated cirrhosis. Further clinical trials are needed to establish the best treatment duration and to further assess the contribution of ribavirin.	[Lawitz, Eric; Poordad, Fred F.; Membreno, Fernando E.] Texas Liver Inst, San Antonio, TX USA; [Lawitz, Eric; Poordad, Fred F.; Membreno, Fernando E.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78215 USA; [Pang, Phillip S.; Hyland, Robert H.; Ding, Xiao; Mo, Hongmei; Symonds, William T.; McHutchison, John G.] Gilead Sci Inc, Foster City, CA 94404 USA	University of Texas System; University of Texas Health San Antonio; Gilead Sciences	Lawitz, E (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, 607 Camden St, San Antonio, TX 78215 USA.	lawitz@txliver.com			Gilead Sciences	Gilead Sciences(Gilead Sciences)	This study was sponsored by Gilead Sciences. Editorial assistance was provided by David McNeel and Kellie Chu of Gilead Sciences. We thank the patients who took part in this study, as well as Juan Betular and Meredith Gonzalez of Gilead Sciences for their contributions to study conduct.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Chen EY, 2013, CLIN GASTROENTEROL H, V11, P1014, DOI 10.1016/j.cgh.2013.03.032; Cheng G., 2012, ANTIVIRAL ACTIVITY R; Gane ED, 2013, 48 ANN M EUR ASS STU; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; German P, 2012, 63 ANN M AM ASS STUD; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; HOOFNAGLE JH, 1986, NEW ENGL J MED, V315, P1575, DOI 10.1056/NEJM198612183152503; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Lawitz E, 2013, 20 C RETR OPP INF AT; Lawitz E, 2013, J HEPATOL, V59, P18, DOI 10.1016/j.jhep.2013.02.009; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Shah N, 2013, EXPERT OPIN INV DRUG, V22, P1107, DOI 10.1517/13543784.2013.806482; Sulkowski M, 2012, EASL 2012; Sulkowski MS, 2011, NAT REV GASTRO HEPAT, V8, P212, DOI 10.1038/nrgastro.2011.21; Sulkowski MS, 2013, 48 ANN M EUR ASS STU; Sulkowski MS, 2012, 63 ANN M AM ASS STUD; Svarovskaia ES, 2012, 63 ANN M AM ASS STUD; Svarovskaia WS, 2013, 64 ANN M AM ASS STUD; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	31	428	444	0	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					515	523		10.1016/S0140-6736(13)62121-2	http://dx.doi.org/10.1016/S0140-6736(13)62121-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24209977				2022-12-28	WOS:000331136400027
J	Arpaia, N; Campbell, C; Fan, XY; Dikiy, S; van der Veeken, J; deRoos, P; Liu, H; Cross, JR; Pfeffer, K; Coffer, PJ; Rudensky, AY				Arpaia, Nicholas; Campbell, Clarissa; Fan, Xiying; Dikiy, Stanislav; van der Veeken, Joris; deRoos, Paul; Liu, Hui; Cross, Justin R.; Pfeffer, Klaus; Coffer, Paul J.; Rudensky, Alexander Y.			Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation	NATURE			English	Article							CHAIN FATTY-ACIDS; RECEPTOR; RELB; INDUCTION	Intestinal microbes provide multicellular hosts with nutrients and confer resistance to infection. The delicate balance between pro-and anti-inflammatory mechanisms, essential for gut immune homeostasis, is affected by the composition of the commensal microbial community. Regulatory T cells (T-reg cells) expressing transcription factor Foxp3 have a key role in limiting inflammatory responses in the intestine(1). Although specific members of the commensal microbial community have been found to potentiate the generation of anti-inflammatory T-reg or pro-inflammatory T helper 17 (T(H)17) cells(2-6), the molecular cues driving this process remain elusive. Considering the vital metabolic function afforded by commensal microorganisms, we reasoned that their metabolic by-products are sensed by cells of the immune system and affect the balance between pro-and anti-inflammatory cells. We tested this hypothesis by exploring the effect of microbial metabolites on the generation of anti-inflammatory T-reg cells. We found that in mice a short-chain fatty acid (SCFA), butyrate, produced by commensal microorganisms during starch fermentation, facilitated extrathymic generation of T-reg cells. A boost in T-reg-cell numbers after provision of butyrate was due to potentiation of extrathymic differentiation of T-reg cells, as the observed phenomenon was dependent on intronic enhancer CNS1 (conserved non-coding sequence 1), essential for extrathymic but dispensable for thymic T-reg-cell differentiation(1,7). In addition to butyrate, de novo T-reg-cell generation in the periphery was potentiated by propionate, another SCFA of microbial origin capable of histone deacetylase (HDAC) inhibition, but not acetate, which lacks this HDAC-inhibitory activity. Our results suggest that bacterial metabolites mediate communication between the commensal microbiota and the immune system, affecting the balance between pro- and anti-inflammatory mechanisms.	[Arpaia, Nicholas; Campbell, Clarissa; Fan, Xiying; Dikiy, Stanislav; van der Veeken, Joris; deRoos, Paul; Coffer, Paul J.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Arpaia, Nicholas; Campbell, Clarissa; Fan, Xiying; Dikiy, Stanislav; van der Veeken, Joris; deRoos, Paul; Coffer, Paul J.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Arpaia, Nicholas; Campbell, Clarissa; Fan, Xiying; Dikiy, Stanislav; van der Veeken, Joris; deRoos, Paul; Coffer, Paul J.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Liu, Hui; Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, New York, NY 10065 USA; [Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Heinrich Heine University Dusseldorf; Utrecht University; Utrecht University Medical Center	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Coffer, Paul/AAF-7970-2020; Dikiy, Stanislav/GWR-2104-2022; Dikiy, Stanislav/HIR-5027-2022; Arpaia, Nicholas/R-2549-2018	Pfeffer, Klaus/0000-0002-5652-6330; Fan, Xiying/0000-0003-3090-381X; Dikiy, Stanislav/0000-0002-8287-6561; Campbell, Clarissa/0000-0002-1918-0318; Arpaia, Nicholas/0000-0002-0657-0528; Cross, Justin/0000-0002-6356-057X	Damon Runyon Cancer Research Foundation [DRG-2143-13]; Ludwig Center at Memorial Sloan Kettering Cancer Center; US National Institutes of Health (NIH) [T32 A1007621, R37 AI034206]; NATIONAL CANCER INSTITUTE [P30CA008748, T32CA009149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, T32AI007621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Ludwig Center at Memorial Sloan Kettering Cancer Center; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Robert Black Fellowship of the Damon Runyon Cancer Research Foundation DRG-2143-13 (N.A.), Ludwig Center at Memorial Sloan Kettering Cancer Center and the US National Institutes of Health (NIH) grant T32 A1007621(N.A.) and R37 AI034206 (A.Y.R.). A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Annison G, 2003, J NUTR, V133, P3523, DOI 10.1093/jn/133.11.3523; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; MacDonald KPA, 2007, BLOOD, V109, P5049, DOI 10.1182/blood-2007-01-067249; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song XM, 2012, CELL REPORTS, V1, P665, DOI 10.1016/j.celrep.2012.04.012; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Zhang HT, 2012, IMMUNOL CELL BIOL, V90, P95, DOI 10.1038/icb.2011.101; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhu HC, 2012, CELL IMMUNOL, V274, P12, DOI 10.1016/j.cellimm.2012.02.012	25	2410	2508	44	522	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					451	+		10.1038/nature12726	http://dx.doi.org/10.1038/nature12726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24226773	Green Accepted			2022-12-28	WOS:000328575300055
J	Sancak, Y; Markhard, AL; Kitami, T; Kovacs-Bogdan, E; Kamer, KJ; Udeshi, ND; Carr, SA; Chaudhuri, D; Clapham, DE; Li, AA; Calvo, SE; Goldberger, O; Mootha, VK				Sancak, Yasemin; Markhard, Andrew L.; Kitami, Toshimori; Kovacs-Bogdan, Erika; Kamer, Kimberli J.; Udeshi, Namrata D.; Carr, Steven A.; Chaudhuri, Dipayan; Clapham, David E.; Li, Andrew A.; Calvo, Sarah E.; Goldberger, Olga; Mootha, Vamsi K.			EMRE Is an Essential Component of the Mitochondrial Calcium Uniporter Complex	SCIENCE			English	Article							CA2+ UPTAKE; PROTEIN; MICU1; MCU	The mitochondrial uniporter is a highly selective calcium channel in the organelle's inner membrane. Its molecular components include the EF-hand-containing calcium-binding proteins mitochondrial calcium uptake 1 (MICU1) and MICU2 and the pore-forming subunit mitochondrial calcium uniporter (MCU). We sought to achieve a full molecular characterization of the uniporter holocomplex (uniplex). Quantitative mass spectrometry of affinity-purified uniplex recovered MICU1 and MICU2, MCU and its paralog MCUb, and essential MCU regulator (EMRE), a previously uncharacterized protein. EMRE is a 10-kilodalton, metazoan-specific protein with a single transmembrane domain. In its absence, uniporter channel activity was lost despite intact MCU expression and oligomerization. EMRE was required for the interaction of MCU with MICU1 and MICU2. Hence, EMRE is essential for in vivo uniporter current and additionally bridges the calcium-sensing role of MICU1 and MICU2 with the calcium-conducting role of MCU.	[Sancak, Yasemin; Markhard, Andrew L.; Kitami, Toshimori; Kovacs-Bogdan, Erika; Kamer, Kimberli J.; Li, Andrew A.; Calvo, Sarah E.; Goldberger, Olga; Mootha, Vamsi K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Dept Syst Biol, Boston, MA 02115 USA; [Sancak, Yasemin; Kitami, Toshimori; Udeshi, Namrata D.; Carr, Steven A.; Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Chaudhuri, Dipayan; Clapham, David E.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cardiol,Childrens Hosp, Boston, MA 02115 USA; [Chaudhuri, Dipayan; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Chaudhuri, Dipayan] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Mootha, VK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Dept Syst Biol, Boston, MA 02115 USA.	vamsi@hms.harvard.edu	Clapham, David/R-5974-2019; Carr, Steven A./AAH-8366-2019; Kitami, Toshimori/N-7460-2019; Clapham, David/S-1123-2019	Kitami, Toshimori/0000-0001-8418-5230; Clapham, David/0000-0002-4459-9428; Chaudhuri, Dipayan/0000-0003-0605-7334; Li, Andrew/0000-0002-1295-8115	Helen Hay Whitney Foundation; NIH [F32HL107021, DK080261]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL107021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Z. Grabarek and D. M. Shechner for helpful discussions. Y.S. received support from the Helen Hay Whitney Foundation. D. C. received support from NIH F32HL107021. D. E. C. is an Investigator of the Howard Hughes Medical Institute. This work was supported by grants to V. K. M from NIH DK080261 and a gift from W. Dan and Pat Wright.	Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bick AG, 2012, SCIENCE, V336, P886, DOI 10.1126/science.1214977; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Feng SJ, 2013, P NATL ACAD SCI USA, V110, P11011, DOI 10.1073/pnas.1309531110; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palty R, 2004, J BIOL CHEM, V279, P25234, DOI 10.1074/jbc.M401229200; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556	20	430	442	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1379	1382		10.1126/science.1242993	http://dx.doi.org/10.1126/science.1242993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24231807	Green Accepted			2022-12-28	WOS:000328196000053
J	Lane, R				Lane, Richard			Kaye Wellings: pioneering figure in sexual health	LANCET			English	Biographical-Item																		WELLINGS K, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1773	1773		10.1016/S0140-6736(13)62346-6	http://dx.doi.org/10.1016/S0140-6736(13)62346-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259QF	24286783				2022-12-28	WOS:000327540700014
J	Miao, JW; Chen, CC; Zhu, C; Scott, MC; White, ER; Chiu, CY; Regan, BC; Huang, Y; Marks, LD				Miao, Jianwei; Chen, Chien-Chun; Zhu, Chun; Scott, M. C.; White, Edward R.; Chiu, Chin-Yi; Regan, B. C.; Huang, Yu; Marks, Laurence D.			Three-dimensional imaging of dislocations Reply	NATURE			English	Letter							ELECTRON TOMOGRAPHY; ENHANCEMENT		[Miao, Jianwei; Chen, Chien-Chun; Zhu, Chun; Scott, M. C.; White, Edward R.; Regan, B. C.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Miao, Jianwei; Chen, Chien-Chun; Zhu, Chun; Scott, M. C.; White, Edward R.; Chiu, Chin-Yi; Regan, B. C.; Huang, Yu] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Chiu, Chin-Yi; Huang, Yu] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Marks, Laurence D.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60201 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University	Miao, JW (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	miao@physics.ucla.edu	Huang, Yu/AAZ-9747-2020; Marks, Laurence/B-7527-2009	Huang, Yu/0000-0003-1793-0741; Regan, B. C./0000-0003-3923-2688				Arslan I, 2005, SCIENCE, V309, P2195, DOI 10.1126/science.1116745; Brown R. G., 1996, INTRO RANDOM SIGNALS, V3rd; Chen CC, 2013, NATURE, V496, P74, DOI 10.1038/nature12009; Lee E, 2008, J STRUCT BIOL, V164, P221, DOI 10.1016/j.jsb.2008.07.011; Marks LD, 1996, ULTRAMICROSCOPY, V62, P43, DOI 10.1016/0304-3991(95)00085-2; Miao JW, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.052103; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Pennycook S. J., 2011, SCANNING TRANSMISSIO; Rez P, 2013, NATURE, V503, pE1, DOI 10.1038/nature12660; Van den Broek W, 2009, ULTRAMICROSCOPY, V109, P1485, DOI 10.1016/j.ultramic.2009.08.003; Zhu C, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.100201	12	3	3	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					E1	E2		10.1038/nature12661	http://dx.doi.org/10.1038/nature12661			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24256806				2022-12-28	WOS:000327163200002
J	Shim, J; Mukherjee, T; Mondal, BC; Liu, T; Young, GC; Wijewarnasuriya, DP; Banerjee, U				Shim, Jiwon; Mukherjee, Tina; Mondal, Bama Charan; Liu, Ting; Young, Gloria Chin; Wijewarnasuriya, Dinali Priasha; Banerjee, Utpal			Olfactory Control of Blood Progenitor Maintenance	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; AMINOBUTYRIC-ACID GABA; DROSOPHILA-LYMPH GLAND; INTRACELLULAR CA2+; BETA-CELLS; DUAL ROLE; CALCIUM; NICHE; RECEPTORS; DIFFERENTIATION	Drosophila hematopoietic progenitor maintenance involves both near neighbor and systemic interactions. This study shows that olfactory receptor neurons (ORNs) function upstream of a small set of neurosecretory cells that express GABA. Upon olfactory stimulation, GABA from these neurosecretory cells is secreted into the circulating hemolymph and binds to metabotropic GABAB receptors expressed on blood progenitors within the hematopoietic organ, the lymph gland. The resulting GABA signal causes high cytosolic Ca2+, which is necessary and sufficient for progenitor maintenance. Thus, the activation of an odorant receptor is essential for blood progenitor maintenance, and consequently, larvae raised on minimal odor environments fail to sustain a pool of hematopoietic progenitors. This study links sensory perception and the effects of its deprivation on the integrity of the hematopoietic and innate immune systems in Drosophila.	[Shim, Jiwon; Mukherjee, Tina; Mondal, Bama Charan; Liu, Ting; Young, Gloria Chin; Wijewarnasuriya, Dinali Priasha; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Shim, Jiwon; Banerjee, Utpal] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu	Shim, Jiwon/AAQ-4501-2021	Shim, Jiwon/0000-0003-2409-1130; Mondal, Bama Charan/0000-0001-9694-7714	NHLBI grant [R01 HL067395]; California Institute for Regenerative Medicine postdoctoral fellowship [TG2-01169]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067395] Funding Source: NIH RePORTER	NHLBI grant; California Institute for Regenerative Medicine postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank members of the Banerjee lab and J. Wang (UCSD) for helpful discussions. We acknowledge the Bloomington, VDRC, DGRC, and NIG Drosophila stock centers and the DSHB hybridoma bank. We thank the following individuals for stocks and reagents: I. Ando, K. Brueckner, T. Clandinin, S. Cohen, C. Evans, J. Fessler, G. Hasan, A. Hofmann, F.R. Jackson, Y.-N. Jan, T. Kitamoto, G. Korge, P. Leopold, D. Naessel, K. Ngo, S. Noselli, E. Olson, E. Rulifson, S. Sinenko, and J. Wang. This work was supported by NHLBI grant R01 HL067395 to U.B.; The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research awards to U. B. and J. S.; and a California Institute for Regenerative Medicine postdoctoral fellowship TG2-01169 to J.S.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Bao Jun, 1994, Journal of Biomedical Science, V1, P237, DOI 10.1007/BF02253308; Benmimoun B, 2012, DEVELOPMENT, V139, P1713, DOI 10.1242/dev.080259; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; Dragojlovic-Munther M, 2012, DEVELOPMENT, V139, P3752, DOI 10.1242/dev.074203; Erecinska M, 1996, J NEUROCHEM, V67, P2325; FERKANY JW, 1978, LIFE SCI, V22, P2121, DOI 10.1016/0024-3205(78)90456-3; Gancz D, 2013, ANNU REV CELL DEV BI, V29, P137, DOI 10.1146/annurev-cellbio-101512-122331; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; JACKSON FR, 1990, J NEUROCHEM, V54, P1068, DOI 10.1111/j.1471-4159.1990.tb02359.x; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Li Ke, 2008, Neurosci Bull, V24, P195, DOI 10.1007/s12264-008-0109-3; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; Mendez-Ferrer S, 2009, CURR OPIN HEMATOL, V16, P235, DOI 10.1097/MOH.0b013e32832bd0f5; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Muto Akira, 2011, Commun Integr Biol, V4, P566, DOI 10.4161/cib.4.5.15848; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; NILSSON M, 1993, NEUROSCIENCE, V54, P605, DOI 10.1016/0306-4522(93)90232-5; Ohmasa M, 2004, NEUROSCI RES, V49, P219, DOI 10.1016/j.neures.2004.02.015; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; PARRAMON M, 1995, J NEUROSCI RES, V41, P65, DOI 10.1002/jnr.490410108; Pennetier D, 2012, P NATL ACAD SCI USA, V109, P3389, DOI 10.1073/pnas.1109407109; Roberts MR, 2007, PLANT SIGNAL BEHAV, V2, P408, DOI 10.4161/psb.2.5.4335; Schwirtlich M, 2010, FASEB J, V24, P1218, DOI 10.1096/fj.09-143586; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Sinenko SA, 2012, EMBO REP, V13, P83, DOI 10.1038/embor.2011.223; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Steidl U, 2004, BLOOD, V104, P81, DOI 10.1182/blood-2004-01-0373; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Strous RD, 2006, AUTOIMMUN REV, V6, P54, DOI 10.1016/j.autrev.2006.07.002; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tokusumi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041604; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x	53	72	72	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1141	1153		10.1016/j.cell.2013.10.032	http://dx.doi.org/10.1016/j.cell.2013.10.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267893	Bronze, Green Accepted			2022-12-28	WOS:000327500600017
J	Elder, RW				Elder, Robert W.			Learning From Improbable Longevity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Elder, Robert W.] Yale Univ, Sch Med, Dept Pediat, Sect Pediat Cardiol, New Haven, CT 06510 USA; [Elder, Robert W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University; Yale University	Elder, RW (corresponding author), Yale Univ, Sch Med, Dept Pediat, Sect Pediat Cardiol, New Haven, CT 06510 USA.	robert.elder@yale.edu		Elder, Robert/0000-0002-4956-8604				Book Wendy, 2006, Congenit Heart Dis, V1, P233, DOI 10.1111/j.1747-0803.2006.00041.x; Kirklin JW, 1993, CARDIAC SURGERY MORP; MCGOON DC, 1968, J AMER MED ASSOC, V205, P69, DOI 10.1001/jama.205.2.69	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2041	2042		10.1001/jama.2013.276685	http://dx.doi.org/10.1001/jama.2013.276685			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240928				2022-12-28	WOS:000327098900017
J	Turner, JA				Turner, John A.			A Nickel Finish Protects Silicon Photoanodes for Water Splitting	SCIENCE			English	Editorial Material							HYDROGEN-PRODUCTION; PHOTOELECTROCHEMISTRY		Natl Renewable Energy Lab, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Turner, JA (corresponding author), Natl Renewable Energy Lab, 1617 Cole Blvd, Golden, CO 80401 USA.	john.turner@nrel.gov						BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; Esposito DV, 2013, NAT MATER, V12, P562, DOI [10.1038/nmat3626, 10.1038/NMAT3626]; Hanna MC, 2006, J APPL PHYS, V100, DOI 10.1063/1.2356795; Hu S, 2013, ENERG ENVIRON SCI, V6, P2984, DOI 10.1039/c3ee40453f; James D., 2009, TECHNOECONOMIC ANAL; Kaneshiro J, 2010, PHOT SPEC C PVSC 201, DOI DOI 10.1109/PVSC.2010.5614163; Kenney MJ, 2013, SCIENCE, V342, P836, DOI 10.1126/science.1241327; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; NOZIK AJ, 1978, ANNU REV PHYS CHEM, V29, P189, DOI 10.1146/annurev.pc.29.100178.001201; NOZIK AJ, 1977, APPL PHYS LETT, V30, P567, DOI 10.1063/1.89262; Pinaud BA, 2013, ENERG ENVIRON SCI, V6, P1983, DOI 10.1039/c3ee40831k; Rocheleau RE, 1997, INT J HYDROGEN ENERG, V22, P771, DOI 10.1016/S0360-3199(96)00221-2; Turner JA, 1999, SCIENCE, V285, P687, DOI 10.1126/science.285.5428.687	13	33	35	0	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					811	812		10.1126/science.1246766	http://dx.doi.org/10.1126/science.1246766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233713				2022-12-28	WOS:000326923000022
J	Sherman, RE; Li, J; Shapley, S; Robb, M; Woodcock, J				Sherman, Rachel E.; Li, Jun; Shapley, Stephanie; Robb, Melissa; Woodcock, Janet			Expediting Drug Development - The FDA's New "Breakthrough Therapy" Designation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sherman, Rachel E.; Li, Jun; Shapley, Stephanie; Robb, Melissa; Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Sherman, RE (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							Food and Drug Administration, GUID IND EXP PROGR S	1	92	98	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1877	1880		10.1056/NEJMp1311439	http://dx.doi.org/10.1056/NEJMp1311439			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300MP	24224621				2022-12-28	WOS:000330468300005
J	Berwick, DM				Berwick, Donald M.			The Toxic Politics of Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard, Inst Healthcare Improvement, Newton, MA 02459 USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Harvard, Inst Healthcare Improvement, 131 Lake Ave, Newton, MA 02459 USA.	donberwick@gmail.com						Baicker K, 2012, NEW ENGL J MED, V366, P2433, DOI 10.1056/NEJMp1204891; Bureau of Labor Statistics, CURRENT EMPLOYMENT S; Hayes C., 2012, TWILIGHT OF THE EILT; Johnston JM, 2013, INT J CIRCUMPOL HEAL, V72, P361, DOI 10.3402/ijch.v72i0.20960; Knaus W, 2001, ICPSRO2957V1; Rest KM, 2007, AM J PUBLIC HEALTH, V97, P1939, DOI 10.2105/AJPH.2007.118455; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; The Organisation for Economic Co-operation and Development, OECD HEALTH DATA 201; World Health Organization, 2005, PREVENTING CHRONIC D	9	14	14	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1921	1922		10.1001/jama.2013.281965	http://dx.doi.org/10.1001/jama.2013.281965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219938				2022-12-28	WOS:000326832900007
J	Behrman, A; Offley, W				Behrman, Amy; Offley, Will			Should influenza vaccination be mandatory for healthcare workers?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOME STAFF; IMMUNIZATION; MORTALITY; RESIDENTS; CANADA		[Behrman, Amy] Univ Penn Hlth Syst, Philadelphia, PA 19104 USA; [Offley, Will] Vancouver Gen Hosp, Emergency Dept, Vancouver, BC, Canada	University of Pennsylvania; University of British Columbia	Behrman, A (corresponding author), Univ Penn Hlth Syst, 3400 Spruce St, Philadelphia, PA 19104 USA.	behrman@mail.med.upenn.edu; willo@lynx.bc.ca						American College of Occupational and Environmental Medicine, 2008, SEAS INFL PREV HLTH; American College of Physicians, 2010, ACP POL INFL VACC HL; American Public Health Association, 2010, ANN INFL VACC REQ HL; [Anonymous], 2012, HOSP INF CONTR PREV; [Anonymous], COMPELLING NEED GAME; [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD005187.PUB4; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Bernstein HH, 2010, PEDIATRICS, V126, P809, DOI 10.1542/peds.2010-2376; Bryce E, 2012, CAN J INFECT DIS MED, V23, pE93, DOI 10.1155/2012/756824; Caplan A, 2011, LANCET, V378, P310, DOI 10.1016/S0140-6736(11)61156-2; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Centers for Disease Control and Prevention, 2013, EST SEAS INFL ASS DE; De Serres G, 2012, CMAJ, V184, P1873; deSante JE, 2010, VACCINE, V28, P2517, DOI 10.1016/j.vaccine.2010.01.042; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3037; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Gaughan BA., 2010, AM J INFECT CONTROL, V38, pe51; Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Hollmeyer H, 2013, INFLUENZA OTHER RESP, V7, P604, DOI 10.1111/irv.12002; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P119; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Murphy S. L., 2013, NATL VITAL STAT REPO, V61; Neuzil KM, 2013, JAMA-J AM MED ASSOC, V310, P1681, DOI 10.1001/jama.2013.279207; Pebody R., 2013, EURO SURVEILL, V18; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210; Shefer A, 2011, MMWR-MORBID MORTAL W, V60, P8; Shugarman LR, 2006, J AM MED DIR ASSOC, V7, P562, DOI 10.1016/j.jamda.2006.06.002; Skowronski DM, 2013, EUROSURVEILLANCE, V18, P7; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2005, PEDIATR INFECT DIS J, V24, P63, DOI 10.1097/01.inf.0000148924.89558.d5; Stokes BP, 2010, MINISTERIAL REV PUBL; Talbot TR, 2010, INFECT CONT HOSP EP, V31, P987, DOI 10.1086/656558; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; van den Dool C, 2009, VACCINE, V27, P6261, DOI 10.1016/j.vaccine.2009.07.104; van den Dool C, 2008, PLOS MED, V5, P1453, DOI 10.1371/journal.pmed.0050200; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908	41	7	8	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2013	347								f6705	10.1136/bmj.f6705	http://dx.doi.org/10.1136/bmj.f6705			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FR	24222482				2022-12-28	WOS:000327150600005
J	Davies, E				Davies, Edward			MEDICAL EDUCATION A shot in the arm for medical education	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												edavies@bmj.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2013	347								f6756	10.1136/bmj.f6756	http://dx.doi.org/10.1136/bmj.f6756			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FR	24222674				2022-12-28	WOS:000327150600015
J	Flemr, M; Malik, R; Franke, V; Nejepinska, J; Sedlacek, R; Vlahovicek, K; Svoboda, P				Flemr, Matyas; Malik, Radek; Franke, Vedran; Nejepinska, Jana; Sedlacek, Radislav; Vlahovicek, Kristian; Svoboda, Petr			A Retrotransposon-Driven Dicer Isoform Directs Endogenous Small Interfering RNA Production in Mouse Oocytes	CELL			English	Article							DOUBLE-STRANDED-RNA; MICRORNA BIOGENESIS; GENE; PROTEIN; MICROPROCESSOR; METHYLATION; EXPRESSION; DOMAINS; SIRNAS; CELLS	In mammals, a single Dicer participates in biogenesis of small RNAs in microRNA (miRNA) and RNAi pathways. In mice, endogenous RNAi is highly active in oocytes, but not in somatic cells, which we ascribe here to an oocyte-specific Dicer isoform (Dicer(O)). Dicer(O) lacks the N-terminal DExD helicase domain and has higher cleavage activity than the full-length Dicer in somatic cells (Dicer(S)). Unlike Dicer(S), Dicer(O) efficiently produces small RNAs from long double-stranded (dsRNA) substrates. Expression of the Dicer(O) isoform is driven by an intronic MT-C retrotransposon promoter, deletion of which causes loss of Dicer(O) and female sterility. Oocytes from females lacking the MT-C element show meiotic spindle defects and increased levels of endogenous small interfering RNA (endo-siRNA) targets, phenocopying the maternal Dicer null phenotype. The alternative Dicer isoform, whose phylogenetic origin demonstrates evolutionary plasticity of RNA-silencing pathways, is the main determinant of endogenous RNAi activity in the mouse female germline.	[Flemr, Matyas; Malik, Radek; Nejepinska, Jana; Sedlacek, Radislav; Svoboda, Petr] Acad Sci Czech Republ, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Franke, Vedran; Vlahovicek, Kristian] Univ Zagreb, Div Biol, Dept Mol Biol, Bioinformat Grp,Fac Sci, Zagreb 10000, Croatia; [Vlahovicek, Kristian] Univ Oslo, Dept Informat, NO-0316 Oslo, Norway	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Zagreb; University of Oslo	Svoboda, P (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Videnska 1083, CR-14220 Prague, Czech Republic.	svobodap@img.cas.cz	Svoboda, Petr/G-3890-2012; Sedlacek, Radislav/G-4408-2014; Urbanova, Jana/G-2748-2014; Vlahoviček, Kristian/D-9661-2011; Malik, Radek/G-3578-2014	Svoboda, Petr/0000-0002-4370-3705; Urbanova, Jana/0000-0001-9778-6289; Vlahoviček, Kristian/0000-0002-5705-2464; Malik, Radek/0000-0002-6783-1146; Franke, Vedran/0000-0003-3606-6792	Czech Science Foundation [GACR P305/10/2215, GACR P305/12/G034]; EMBO Young Investigator Program [1488/2006, 1431/2006]; GACR [204/09/0085]; MEYS [LM2011032]; project BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University [CZ.1.05/1.1.00/02.0109]; EC Seventh Framework Program [315997]; Croatian MSES [119-0982913-1211]; Academy of Sciences of the Czech Republic [M200521202];  [RVO 68378050]	Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); GACR(Grant Agency of the Czech Republic); MEYS; project BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University; EC Seventh Framework Program; Croatian MSES(Ministry of Science, Education and Sports, Republic of Croatia); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); 	We thank W. Filipowicz, G.J. Hannon, and K. Podolska for reagents and material; K. Burdova, V. Libova, M. Moravec, I. Necheva, and V. Urban for technical help; M. Dowle and F. Hahne for help with bioinformatics; and W. Filipowicz, D. T. Odom, and R. M. Schultz for discussions and comments. The main support was provided by the Czech Science Foundation grant GACR P305/10/2215 and the EMBO Young Investigator Program (installation grant 1488/2006) to P. S., GACR 204/09/0085 to J.N.; LM2011032 (MEYS) and the project BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (CZ.1.05/1.1.00/02.0109; European Regional Development Fund) to R. S.; and the EC Seventh Framework Program (Integra-Life grant 315997 to K. V.), EMBO Young Investigator Program (installation grant 1431/2006 to K. V.), and Croatian MSES grant 119-0982913-1211 to K. V. and V. F. Collaboration between P.S.'s and K.V.'s groups is supported by The Academy of Sciences of the Czech Republic international collaboration project M200521202. P. S. is a member of the Centre for RNA Biology funded by the Czech Science Foundation grant GACR P305/12/G034. The work was institutionally supported by RVO 68378050.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Flemr M, 2010, BIOL REPROD, V82, P1008, DOI 10.1095/biolreprod.109.082057; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kaneda M, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-9; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nagy A., 2003, MANIPULATING MOUSE E; Nejepinska J, 2012, NUCLEIC ACIDS RES, V40, P399, DOI 10.1093/nar/gkr702; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Podolska K, 2014, J BIOMOL SCREEN, V19, P417, DOI 10.1177/1087057113497400; Sawh AN, 2013, CELL REP, V4, P454, DOI 10.1016/j.celrep.2013.07.013; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Shenoy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006971; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Stein P, 2003, DEV BIOL, V256, P187, DOI 10.1016/S0012-1606(02)00122-7; Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Svoboda P, 2001, BIOCHEM BIOPH RES CO, V287, P1099, DOI 10.1006/bbrc.2001.5707; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016	46	168	177	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					807	816		10.1016/j.cell.2013.10.001	http://dx.doi.org/10.1016/j.cell.2013.10.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209619	Bronze			2022-12-28	WOS:000326934300011
J	Guerreiro, R; Bras, J; Hardy, J				Guerreiro, Rita; Bras, Jose; Hardy, John			SnapShot: Genetics of Alzheimer's Disease	CELL			English	Editorial Material									[Guerreiro, Rita; Bras, Jose; Hardy, John] UCL, Reta Lilla Weston Inst, London WC1N 1PJ, England	University of London; University College London	Guerreiro, R (corresponding author), UCL, Reta Lilla Weston Inst, London WC1N 1PJ, England.		Guerreiro, Rita J L/A-1327-2011; Hardy, John/C-2451-2009; Bras, Jose MT/A-1428-2011	Hardy, John/0000-0002-3122-0423; Guerreiro, Rita/0000-0001-5879-3486; Bras, Jose/0000-0001-8186-0333	Alzheimers Research UK [ARUK-TRFUS2012-3] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; Parkinson&apos;s UK [G-0907] Funding Source: Medline	Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Parkinson&quot;s UK(Parkinson&apos;s UK); Parkinson&apos;s UK(Parkinson&apos;s UK)		Bras J, 2012, NAT REV NEUROSCI, V13, P453, DOI 10.1038/nrn3271; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494	6	73	75	4	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					968	+		10.1016/j.cell.2013.10.037	http://dx.doi.org/10.1016/j.cell.2013.10.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209629	Bronze			2022-12-28	WOS:000326934300025
J	Kim, F; Nichol, G; Maynard, C; Hallstrom, A; Kudenchuk, PJ; Rea, T; Copass, MK; Carlbom, D; Deem, S; Longstreth, WT; Olsufka, M; Cobb, LA				Kim, Francis; Nichol, Graham; Maynard, Charles; Hallstrom, Al; Kudenchuk, Peter J.; Rea, Thomas; Copass, Michael K.; Carlbom, David; Deem, Steven; Longstreth, W. T., Jr.; Olsufka, Michele; Cobb, Leonard A.			Effect of Prehospital Induction of Mild Hypothermia on Survival and Neurological Status Among Adults With Cardiac Arrest A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNATIONAL LIAISON COMMITTEE; EMERGENCY CARDIOVASCULAR CARE; AMERICAN-HEART-ASSOCIATION; THERAPEUTIC HYPOTHERMIA; COMATOSE SURVIVORS; RESUSCITATION; CARDIOPULMONARY; STATEMENT; LONG	IMPORTANCE Hospital cooling improves outcome after cardiac arrest, but prehospital cooling immediately after return of spontaneous circulation may result in better outcomes. OBJECTIVE To determine whether prehospital cooling improves outcomes after resuscitation from cardiac arrest in patients with ventricular fibrillation (VF) and without VF. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial that assigned adults with prehospital cardiac arrest to standard care with or without prehospital cooling, accomplished by infusing up to 2 L of 4 degrees C normal saline as soon as possible following return of spontaneous circulation. Adults in King County, Washington, with prehospital cardiac arrest and resuscitated by paramedics were eligible and 1359 patients (583 with VF and 776 without VF) were randomized between December 15, 2007, and December 7, 2012. Patient follow-up was completed by May 1, 2013. Nearly all of the patients resuscitated from VF and admitted to the hospital received hospital cooling regardless of their randomization. MAIN OUTCOMES AND MEASURES The primary outcomes were survival to hospital discharge and neurological status at discharge. RESULTS The intervention decreased mean core temperature by 1.20 degrees C (95% CI, -1.33 degrees C to -1.07 degrees C) in patients with VF and by 1.30 degrees C (95% CI, -1.40 degrees C to -1.20 degrees C) in patients without VF by hospital arrival and reduced the time to achieve a temperature of less than 34 degrees C by about 1 hour compared with the control group. However, survival to hospital discharge was similar among the intervention and control groups among patients with VF (62.7% [95% CI, 57.0%-68.0%] vs 64.3% [95% CI, 58.6%-69.5%], respectively; P = .69) and among patients without VF (19.2% [95% CI, 15.6%-23.4%] vs 16.3% [95% CI, 12.9%-20.4%], respectively; P = .30). The intervention was also not associated with improved neurological status of full recovery or mild impairment at discharge for either patients with VF (57.5% [95% CI, 51.8%-63.1%] of cases had full recovery or mild impairment vs 61.9%[95% CI, 56.2%-67.2%] of controls; P = .69) or those without VF (14.4% [95% CI, 11.3%-18.2%] of cases vs 13.4% [95% CI, 10.4%-17.2%] of controls; P = .30). Overall, the intervention group experienced rearrest in the field more than the control group (26% [95% CI, 22%-29%] vs 21% [95% CI, 18%-24%], respectively; P = .008), as well as increased diuretic use and pulmonary edema on first chest x-ray, which resolved within 24 hours after admission. CONCLUSION AND RELEVANCE Although use of prehospital cooling reduced core temperature by hospital arrival and reduced the time to reach a temperature of 34 degrees C, it did not improve survival or neurological status among patients resuscitated from prehospital VF or those without VF.	[Kim, Francis; Nichol, Graham; Kudenchuk, Peter J.; Rea, Thomas; Carlbom, David; Olsufka, Michele; Cobb, Leonard A.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98104 USA; [Maynard, Charles] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98104 USA; [Hallstrom, Al] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98104 USA; [Copass, Michael K.; Longstreth, W. T., Jr.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98104 USA; [Deem, Steven] Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98104 USA; [Longstreth, W. T., Jr.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kim, F (corresponding author), Univ Washington, Harborview Med Ctr, 325 9th Ave, Seattle, WA 98104 USA.	fkim@u.washington.edu	Nichol, Graham/Z-4996-2019; Maynard, Charles/N-3906-2015	Maynard, Charles/0000-0002-1644-7814	National Heart, Lung, and Blood Institute [RO1 HL089554, 5U01HL07786]; Medic One Foundation (Seattle, Washington); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089554] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medic One Foundation (Seattle, Washington); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by grants RO1 HL089554 and 5U01HL07786 from the National Heart, Lung, and Blood Institute and with additional support from the Medic One Foundation (Seattle, Washington).	Bernard S, 2004, CRIT CARE MED, V32, P897, DOI 10.1097/01.CCM.0000115263.08805.EF; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard SA, 2012, CRIT CARE MED, V40, P747, DOI 10.1097/CCM.0b013e3182377038; Bernard SA, 2010, CIRCULATION, V122, P737, DOI 10.1161/CIRCULATIONAHA.109.906859; Castren M, 2010, CIRCULATION, V122, P729, DOI 10.1161/CIRCULATIONAHA.109.931691; Holzer M, 2002, NEW ENGL J MED, V346, P549; JENNETT B, 1975, LANCET, V1, P480; KELSEY SF, 1991, CONTROL CLIN TRIALS, V12, P525; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; Longstreth W T Jr, 1988, Acta Anaesthesiol Belg, V39, P115; Longstreth WT, 2002, NEUROLOGY, V59, P506, DOI 10.1212/WNL.59.4.506; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Phelps R, 2013, CRIT CARE MED, V41, P1252, DOI 10.1097/CCM.0b013e31827ca975; RAICHLE ME, 1983, ANN NEUROL, V13, P2, DOI 10.1002/ana.410130103; Rea TD, 2003, ANN EMERG MED, V41, P494, DOI 10.1067/mem.2003.149; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; Yannopoulos D, 2009, CIRCULATION, V120, P1426, DOI 10.1161/CIRCULATIONAHA.109.848424	21	407	441	1	38	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					45	52		10.1001/jama.2013.282173	http://dx.doi.org/10.1001/jama.2013.282173			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24240712	Bronze			2022-12-28	WOS:000329161400017
J	Zullig, LL; Peterson, ED; Bosworth, HB				Zullig, Leah L.; Peterson, Eric D.; Bosworth, Hayden B.			Ingredients of Successful Interventions to Improve Medication Adherence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zullig, Leah L.; Bosworth, Hayden B.] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; [Peterson, Eric D.] Duke Univ, Div Cardiol, Durham, NC 27715 USA; [Bosworth, Hayden B.] Duke Univ, Dept Med, Div Gen Internal Med, Durham, NC 27715 USA; [Bosworth, Hayden B.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27715 USA; [Bosworth, Hayden B.] Duke Univ, Sch Nursing, Durham, NC 27715 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; Duke University; Duke University	Peterson, ED (corresponding author), Duke Univ, Med Ctr, POB 17969, Durham, NC 27715 USA.	eric.peterson@duke.edu	Peterson, Eric David/ABF-5033-2021					Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Gwadry-Sridhar FH, 2013, VALUE HEALTH, V16, P863, DOI 10.1016/j.jval.2013.03.1631; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Sinnott SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064914; Steinhubl SR, 2013, JAMA-J AM MED ASSOC, V310, P2395, DOI 10.1001/jama.2013.281078; Viswanathan M, 2012, MED ADHERENCE INTERV; WHO, ADHERENCE LONG TERM; Zullig LL, 2013, J ONCOL PRACT, V9, p60S, DOI 10.1200/JOP.2013.000971	9	94	95	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2611	2612		10.1001/jama.2013.282818	http://dx.doi.org/10.1001/jama.2013.282818			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24264605				2022-12-28	WOS:000328818000008
J	Louiset, E; Duparc, C; Young, J; Renouf, S; Nomigni, MT; Boutelet, I; Libe, R; Bram, Z; Groussin, L; Caron, P; Tabarin, A; Grunenberger, F; Christin-Maitre, S; Bertagna, X; Kuhn, JM; Anouar, Y; Bertherat, J; Lefebvre, H				Louiset, Estelle; Duparc, Celine; Young, Jacques; Renouf, Sylvie; Nomigni, Milene Tetsi; Boutelet, Isabelle; Libe, Rossella; Bram, Zakariae; Groussin, Lionel; Caron, Philippe; Tabarin, Antoine; Grunenberger, Fabienne; Christin-Maitre, Sophie; Bertagna, Xavier; Kuhn, Jean-Marc; Anouar, Youssef; Bertherat, Jerome; Lefebvre, Herve			Intraadrenal Corticotropin in Bilateral Macronodular Adrenal Hyperplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; PHOSPHODIESTERASE 11A PDE11A; CUSHINGS-SYNDROME; PROOPIOMELANOCORTIN TRANSCRIPTS; ADRENOCORTICAL HYPERPLASIA; IN-VIVO; RECEPTORS; TUMORS; EXPRESSION; ACTH	BackgroundBilateral macronodular adrenal hyperplasia is a rare cause of primary adrenal Cushing's syndrome. In this form of hyperplasia, hypersecretion of cortisol suppresses the release of corticotropin by pituitary corticotrophs, which results in low plasma corticotropin levels. Thus, the disease has been termed corticotropin-independent macronodular adrenal hyperplasia. We examined the abnormal production of corticotropin in these hyperplastic adrenal glands. MethodsWe obtained specimens of hyperplastic macronodular adrenal tissue from 30 patients with primary adrenal disease. The corticotropin precursor proopiomelanocortin and corticotropin expression were assessed by means of a polymerase-chain-reaction assay and immunohistochemical analysis. The production of corticotropin and cortisol was assessed in 11 specimens with the use of incubated explants and cell cultures coupled with hormone assays. Corticotropin levels were measured in adrenal and peripheral venous blood samples from 2 patients. ResultsThe expression of proopiomelanocortin messenger RNA (mRNA) was detected in all samples of hyperplastic adrenal tissue. Corticotropin was detected in steroidogenic cells arranged in clusters that were disseminated throughout the adrenal specimens. Adrenal corticotropin levels were higher in adrenal venous blood samples than in peripheral venous samples, a finding that was consistent with local production of the peptide within the hyperplastic adrenals. The release of adrenal corticotropin was stimulated by ligands of aberrant membrane receptors but not by corticotropin-releasing hormone or dexamethasone. A semiquantitative score for corticotropin immunostaining in the samples correlated with basal plasma cortisol levels. Corticotropin-receptor antagonists significantly inhibited in vitro cortisol secretion. ConclusionsCortisol secretion by the adrenals in patients with macronodular hyperplasia and Cushing's syndrome appears to be regulated by corticotropin, which is produced by a subpopulation of steroidogenic cells in the hyperplastic adrenals. Thus, the hypercortisolism associated with bilateral macronodular adrenal hyperplasia appears to be corticotropin-dependent. (Funded by the Agence Nationale de la Recherche and others.)	[Louiset, Estelle; Duparc, Celine; Renouf, Sylvie; Nomigni, Milene Tetsi; Boutelet, Isabelle; Bram, Zakariae; Kuhn, Jean-Marc; Anouar, Youssef; Lefebvre, Herve] INSERM Unite 982, Lab Neuronal & Neuroendocrine Differentiat & Comm, Inst Res & Innovat Biomed, Mont St Aignan, France; [Louiset, Estelle; Duparc, Celine; Renouf, Sylvie; Nomigni, Milene Tetsi; Boutelet, Isabelle; Bram, Zakariae; Kuhn, Jean-Marc; Anouar, Youssef; Lefebvre, Herve] Univ Rouen, Mont St Aignan, France; [Young, Jacques] Univ Paris Sud, Hop Bicetre, AP HP, Dept Endocrinol,INSERM Unite 693, F-94275 Le Kremlin Bicetre, France; [Libe, Rossella; Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] Inst Cochin, INSERM Unite 1016, Paris, France; [Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] Hop Cochin, Dept Endocrinol AP HP, F-75674 Paris, France; [Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] Univ Paris 05, Paris, France; [Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] CNRS, UMR 8104, Paris, France; [Christin-Maitre, Sophie] Hop St Antoine, AP HP, Dept Endocrinol, F-75571 Paris, France; [Caron, Philippe] Ctr Hosp Univ Larrey, Dept Endocrinol & Metab Dis, Toulouse, France; [Tabarin, Antoine] Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Dept Endocrinol, Pessac, France; [Grunenberger, Fabienne] Ctr Hosp Reg Univ Strasbourg, Serv Med Interne & Nutr, Strasbourg, France; [Kuhn, Jean-Marc; Lefebvre, Herve] Rouen Univ Hosp, Dept Endocrinol Diabet & Metab Dis, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; CHU Bordeaux; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Rouen	Lefebvre, H (corresponding author), Univ Hosp Rouen, INSERM Unite 982, Dept Endocrinol, IRIB, F-76031 Rouen, France.	herve.lefebvre@chu-rouen.fr	Anouar, Youssef/F-9683-2017; Young, Jacques/N-5251-2019; Louiset, Estelle/N-5530-2018; Young, Jacques/T-2976-2018	Young, Jacques/0000-0001-9286-5631; Young, Jacques/0000-0001-9286-5631; BERTHERAT, Jerome/0000-0003-2551-3008; Lefebvre, Herve/0000-0002-6181-9648; libe, rossella/0000-0003-2881-6362; Groussin, Lionel/0000-0003-1476-475X; Duparc, Celine/0000-0002-7301-6287; Louiset, Estelle/0000-0002-4723-095X	INSERM Unite 982; Agence Nationale de la Recherche; Centre Hospitalier Universitaire de Rouen; Reseau COMETE; Assistance Publique-Hopitaux de Paris; Conseil Regional de Haute-Normandie	INSERM Unite 982; Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre Hospitalier Universitaire de Rouen; Reseau COMETE; Assistance Publique-Hopitaux de Paris; Conseil Regional de Haute-Normandie(Region Normandie)	Supported by grants from INSERM Unite 982, Agence Nationale de la Recherche (Programme blanc 2010, GePAH project), Centre Hospitalier Universitaire de Rouen, Reseau COMETE, Assistance Publique-Hopitaux de Paris, and Conseil Regional de Haute-Normandie.	Assie G, 2010, J CLIN ENDOCR METAB, V95, pE253, DOI 10.1210/jc.2009-2281; Bertherat J, 2005, J CLIN ENDOCR METAB, V90, P1302, DOI 10.1210/jc.2004-1256; Cartier D, 2003, J CLIN ENDOCR METAB, V88, P248, DOI 10.1210/jc.2002-021107; Claahsen-van der Grinten HL, 2009, INT J PEDIAT ENDOCRI, V23, P209; Connelly MA, 2009, MOL CELL ENDOCRINOL, V300, P83, DOI 10.1016/j.mce.2008.09.011; de Groot JWB, 2010, EUR J ENDOCRINOL, V163, P293, DOI 10.1530/EJE-10-0058; DEKEYZER Y, 1990, J CLIN INVEST, V86, P871, DOI 10.1172/JCI114787; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Hiroi N, 2001, J CLIN ENDOCR METAB, V86, P2631, DOI 10.1210/jc.86.6.2631; Hsiao HP, 2009, J CLIN ENDOCR METAB, V94, P2930, DOI 10.1210/jc.2009-0516; Ivell R, 1997, MOL HUM REPROD, V3, P459, DOI 10.1093/molehr/3.6.459; Iwata M, 2012, INTERNAL MED, V51, P2181, DOI 10.2169/internalmedicine.51.7547; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; LACAZEMASMONTEIL T, 1987, P NATL ACAD SCI USA, V84, P7261, DOI 10.1073/pnas.84.20.7261; LACROIX A, 1992, NEW ENGL J MED, V327, P974, DOI 10.1056/NEJM199210013271402; Lacroix A, 1997, NEW ENGL J MED, V337, P1429, DOI 10.1056/NEJM199711133372004; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lefebvre H, 2003, J CLIN ENDOCR METAB, V88, P3035, DOI 10.1210/jc.2002-030014; Libe R, 2008, CLIN CANCER RES, V14, P4016, DOI 10.1158/1078-0432.CCR-08-0106; Louiset E, 2006, J CLIN ENDOCR METAB, V91, P4578, DOI 10.1210/jc.2006-0538; Marx C, 1997, J CLIN ENDOCR METAB, V82, P3136, DOI 10.1210/jc.82.9.3136; Mazzuco TL, 2007, ARQ BRAS ENDOCRINOL, V51, P1452, DOI 10.1590/S0004-27302007000900007; MEYER WJ, 1987, J CLIN ENDOCR METAB, V64, P98, DOI 10.1210/jcem-64-1-98; Mune T, 2002, J CLIN ENDOCR METAB, V87, P5706, DOI 10.1210/jc.2002-020067; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; REZNIK Y, 1992, NEW ENGL J MED, V327, P981, DOI 10.1056/NEJM199210013271403; Stratakis CA, 2007, NAT CLIN PRACT ENDOC, V3, P748, DOI 10.1038/ncpendmet0648; SUDA T, 1984, J CLIN ENDOCR METAB, V58, P919, DOI 10.1210/jcem-58-5-919; Swain JM, 1998, ARCH SURG-CHICAGO, V133, P541, DOI 10.1001/archsurg.133.5.541; Swords FM, 2002, MOL ENDOCRINOL, V16, P2746, DOI 10.1210/me.2002-0099; Thomas M, 2004, ENDOCRINOLOGY, V145, P4320, DOI 10.1210/en.2004-0179; Vallette-Kasic S, 2003, J CLIN ENDOCR METAB, V88, P3050, DOI 10.1210/jc.2002-021934; van Aken MO, 2005, J CLIN ENDOCR METAB, V90, P1570, DOI 10.1210/jc.2004-1281; Vezzosi D, 2007, EUR J ENDOCRINOL, V156, P21, DOI 10.1530/eje.1.02324; Vezzosi D, 2012, J CLIN ENDOCR METAB, V97, pE2063, DOI 10.1210/jc.2012-2275	36	128	135	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2115	2125		10.1056/NEJMoa1215245	http://dx.doi.org/10.1056/NEJMoa1215245			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24283225	Green Published			2022-12-28	WOS:000327467500009
J	Rudolph, ML; Zhong, SJ				Rudolph, Maxwell L.; Zhong, Shijie			Does quadrupole stability imply LLSVP fixity?	NATURE			English	Letter							OCEAN; MA		[Rudolph, Maxwell L.; Zhong, Shijie] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Rudolph, ML (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	maxwell.rudolph@colorado.edu	Rudolph, Maxwell/AAT-7673-2021; Zhong, Shijie/A-5290-2010	Rudolph, Maxwell/0000-0001-7721-4224; 	Directorate For Geosciences [1015669] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bower DJ, 2013, GEOCHEM GEOPHY GEOSY, V14, P44, DOI 10.1029/2012GC004267; Conrad CP, 2013, NATURE, V498, P479, DOI 10.1038/nature12203; HAGER BH, 1978, TECTONOPHYSICS, V50, P111, DOI 10.1016/0040-1951(78)90130-0; Jellinek AM, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000144; Lawver L. A., 2004, 207 U TEX I GEOPH PL; LITHGOWBERTELLONI C, 1993, GEOPHYS RES LETT, V20, P375, DOI 10.1029/93GL00168; McNamara AK, 2005, NATURE, V437, P1136, DOI 10.1038/nature04066; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Tan E, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003665; Zhang N, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006896; Zhong SJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002048	11	7	7	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					E3	E4		10.1038/nature12792	http://dx.doi.org/10.1038/nature12792			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24284729				2022-12-28	WOS:000327464200001
J	Bao, Y; Han, JL; Hu, FB; Giovannucci, EL; Stampfer, MJ; Willett, WC; Fuchs, CS				Bao, Ying; Han, Jiali; Hu, Frank B.; Giovannucci, Edward L.; Stampfer, Meir J.; Willett, Walter C.; Fuchs, Charles S.			Association of Nut Consumption with Total and Cause-Specific Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; WALNUT CONSUMPTION; METABOLIC SYNDROME; WEIGHT-GAIN; LIFE-STYLE; ALL-CAUSE	BackgroundIncreased nut consumption has been associated with a reduced risk of major chronic diseases, including cardiovascular disease and type 2 diabetes mellitus. However, the association between nut consumption and mortality remains unclear. MethodsWe examined the association between nut consumption and subsequent total and cause-specific mortality among 76,464 women in the Nurses' Health Study (1980-2010) and 42,498 men in the Health Professionals Follow-up Study (1986-2010). Participants with a history of cancer, heart disease, or stroke were excluded. Nut consumption was assessed at baseline and updated every 2 to 4 years. ResultsDuring 3,038,853 person-years of follow-up, 16,200 women and 11,229 men died. Nut consumption was inversely associated with total mortality among both women and men, after adjustment for other known or suspected risk factors. The pooled multivariate hazard ratios for death among participants who ate nuts, as compared with those who did not, were 0.93 (95% confidence interval [CI], 0.90 to 0.96) for the consumption of nuts less than once per week, 0.89 (95% CI, 0.86 to 0.93) for once per week, 0.87 (95% CI, 0.83 to 0.90) for two to four times per week, 0.85 (95% CI, 0.79 to 0.91) for five or six times per week, and 0.80 (95% CI, 0.73 to 0.86) for seven or more times per week (P<0.001 for trend). Significant inverse associations were also observed between nut consumption and deaths due to cancer, heart disease, and respiratory disease. ConclusionsIn two large, independent cohorts of nurses and other health professionals, the frequency of nut consumption was inversely associated with total and cause-specific mortality, independently of other predictors of death.	[Bao, Ying; Hu, Frank B.; Giovannucci, Edward L.; Stampfer, Meir J.; Willett, Walter C.; Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Bao, Ying; Hu, Frank B.; Giovannucci, Edward L.; Stampfer, Meir J.; Willett, Walter C.; Fuchs, Charles S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hu, Frank B.; Giovannucci, Edward L.; Stampfer, Meir J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Frank B.; Giovannucci, Edward L.; Stampfer, Meir J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Fuchs, Charles S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Han, Jiali] Indiana Univ, Dept Epidemiol, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Han, Jiali] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Bao, Y (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA.	ying.bao@channing.harvard.edu			National Institutes of Health; International Tree Nut Council Nutrition Research and Education Foundation; NATIONAL CANCER INSTITUTE [UM1CA167552, P50CA127003, U54CA155626, R01CA124908, P01CA087969, P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Tree Nut Council Nutrition Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and the International Tree Nut Council Nutrition Research and Education Foundation.	Baer HJ, 2011, AM J EPIDEMIOL, V173, P319, DOI 10.1093/aje/kwq368; Bes-Rastrollo M, 2007, OBESITY, V15, P107, DOI 10.1038/oby.2007.507; Bes-Rastrollo M, 2009, AM J CLIN NUTR, V89, P1913, DOI 10.3945/ajcn.2008.27276; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, P126, DOI 10.1016/j.numecd.2009.08.005; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Djousse L, 2009, CLIN NUTR, V28, P10, DOI 10.1016/j.clnu.2008.08.005; Ellsworth JL, 2001, NUTR METAB CARDIOVAS, V11, P372; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fernandez-Montero A, 2013, PUBLIC HEALTH NUTR, V16, P2064, DOI 10.1017/S1368980012004442; Food and Drug Administration, 2003, QUAL HLTH CLAIMS LET; Fraser GE, 1997, ARCH INTERN MED, V157, P2249, DOI 10.1001/archinte.157.19.2249; Fraser GE, 1997, EPIDEMIOLOGY, V8, P168, DOI 10.1097/00001648-199703000-00008; GOLDSTEIN MR, 1992, ARCH INTERN MED, V152, P2507, DOI 10.1001/archinte.1992.00400240119025; Gonzalez CA, 2008, BR J NUTR, V99, P447; Gonzalez CA, 2006, BRIT J NUTR, V96, pS87, DOI 10.1017/BJN20061868; Gopinath B, 2011, AM J CLIN NUTR, V93, P1073, DOI 10.3945/ajcn.110.009977; Guasch-Ferre M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-164; Jenkins DJA, 2006, J NUTR, V136, P2987, DOI 10.1093/jn/136.12.2987; Jenkins DJA, 2011, DIABETES CARE, V34, P1706, DOI 10.2337/dc11-0338; Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033; Jiang R, 2002, JAMA-J AM MED ASSOC, V288, P2554, DOI 10.1001/jama.288.20.2554; Kris-Etherton PN, 2008, J NUTR, V138, p1746S; Ma YY, 2010, DIABETES CARE, V33, P227, DOI 10.2337/dc09-1156; Mann JI, 1997, HEART, V78, P450, DOI 10.1136/hrt.78.5.450; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; O'Neil CE, 2011, J AM COLL NUTR, V30, P502, DOI 10.1080/07315724.2011.10719996; Pan A, 2013, J NUTR, V143, P512, DOI 10.3945/jn.112.172171; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79; Salas-Salvado J, 2008, ARCH INTERN MED, V168, P2449, DOI 10.1001/archinte.168.22.2449; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; Strate LL, 2008, JAMA-J AM MED ASSOC, V300, P907, DOI 10.1001/jama.300.8.907; Tapsell LC, 2009, EUR J CLIN NUTR, V63, P1008, DOI 10.1038/ejcn.2009.19; Torabian S, 2009, J HUM NUTR DIET, V22, P64, DOI 10.1111/j.1365-277X.2008.00923.x; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tsai CJ, 2004, AM J EPIDEMIOL, V160, P961, DOI 10.1093/aje/kwh302; Tsai CJ, 2004, AM J CLIN NUTR, V80, P76; van den Brandt PA, 2011, AM J CLIN NUTR, V94, P913, DOI 10.3945/ajcn.110.008250; Villegas R, 2008, AM J CLIN NUTR, V87, P162, DOI 10.1093/ajcn/87.1.162	41	224	230	1	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					2001	2011		10.1056/NEJMoa1307352	http://dx.doi.org/10.1056/NEJMoa1307352			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256379	Green Published, Green Accepted			2022-12-28	WOS:000327163000008
J	Bird, JC; Dhiman, R; Kwon, HM; Varanasi, KK				Bird, James C.; Dhiman, Rajeev; Kwon, Hyuk-Min; Varanasi, Kripa K.			Reducing the contact time of a bouncing drop	NATURE			English	Article							IMPACT; TRANSITIONS; IMPALEMENT; DYNAMICS; SURFACES; LIQUID; WALL	Surfaces designed so that drops do not adhere to them but instead bounce off have received substantial attention because of their ability to stay dry(1-4), self-clean(5-7) and resist icing(8-10). A drop striking a non-wetting surface of this type will spread out to a maximum diameter(11-14) and then recoil to such an extent that it completely rebounds and leaves the solid material(15-18). The amount of time that the drop is in contact with the solid-the 'contact time'-depends on the inertia and capillarity of the drop(1), internal dissipation(19) and surface-liquid interactions(20-22). And because contact time controls the extent to which mass, momentum and energy are exchanged between drop and surface(23), it is often advantageous to minimize it. The conventional approach has been to minimize surface-liquid interactions that can lead to contact line pinning(20-22); but even in the absence of any surface interactions, drop hydrodynamics imposes a minimum contact time that was conventionally assumed to be attained with axisymmetrically spreading and recoiling drops(21,24). Here we demonstrate that it is possible to reduce the contact time below this theoretical limit by using superhydrophobic surfaces with a morphology that redistributes the liquid mass and thereby alters the drop hydrodynamics. We show theoretically and experimentally that this approach allows us to reduce the overall contact time between a bouncing drop and a surface below what was previously thought possible.	[Bird, James C.] Boston Univ, Dept Mech Engn, Boston, MA 02155 USA; [Dhiman, Rajeev; Kwon, Hyuk-Min; Varanasi, Kripa K.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Boston University; Massachusetts Institute of Technology (MIT)	Varanasi, KK (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	varanasi@mit.edu			DARPA; MIT Energy Initiative; NSF [0952564, DMS1004678]; MIT-Deshpande Center; Div Of Chem, Bioeng, Env, & Transp Sys [0952564] Funding Source: National Science Foundation	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); MIT Energy Initiative; NSF(National Science Foundation (NSF)); MIT-Deshpande Center; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	K.K.V. was supported by a DARPA Young Faculty Award, the MIT Energy Initiative, an NSF Career Award (0952564) and the MIT-Deshpande Center. J.C.B. was supported by an NSF Postdoctoral Research Fellowship (DMS1004678). We thank T. Buonassisi, Y. Cui, A. Paxson and J. Bales at MIT for the use of equipment, and D. Quere, G. McKinley, J. Bush, K. Corriveau and P. Barbone for reading and commenting on the manuscript.	Aziz SD, 2000, INT J HEAT MASS TRAN, V43, P2841, DOI 10.1016/S0017-9310(99)00350-6; Bartolo D, 2006, EUROPHYS LETT, V74, P299, DOI 10.1209/epl/i2005-10522-3; Bartolo D, 2005, J FLUID MECH, V545, P329, DOI 10.1017/S0022112005007184; Bergeron V, 2000, NATURE, V405, P772, DOI 10.1038/35015525; Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856; Brunet P, 2008, LANGMUIR, V24, P11203, DOI 10.1021/la801268v; Byron Bird R, 2007, TRANSPORT PHENOMENA, V2nd, DOI DOI 10.1002/AIC.690070245; CHANDRA S, 1991, P R SOC-MATH PHYS SC, V432, P13, DOI 10.1098/rspa.1991.0002; Clanet C, 2004, J FLUID MECH, V517, P199, DOI 10.1017/S0022112004000904; Corrigan R., 1985, NASATM86986; Cotton K.C., 1993, EVALUATING IMPROVING; CULICK FEC, 1960, J APPL PHYS, V31, P1128, DOI 10.1063/1.1735765; De Gennes P-G., 2004, CAPILLARITY WETTING, V336; Deng T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3110054; Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115; Eggers J, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3432498; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Jung S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1630; Jung YC, 2008, LANGMUIR, V24, P6262, DOI 10.1021/la8003504; Kwon DH, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4705296; Kwon Y, 2009, LANGMUIR, V25, P6129, DOI 10.1021/la803249t; Legendre D, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2010527; Li XY, 2010, LANGMUIR, V26, P4831, DOI 10.1021/la903603z; Liu JP, 2006, J MATER CHEM, V16, P4427, DOI 10.1039/b611691d; Meuler AJ, 2010, ACS NANO, V4, P7048, DOI 10.1021/nn103214q; Mishchenko L, 2010, ACS NANO, V4, P7699, DOI 10.1021/nn102557p; Okumura K, 2003, EUROPHYS LETT, V62, P237, DOI 10.1209/epl/i2003-00340-1; Quere D, 2005, REP PROG PHYS, V68, P2495, DOI 10.1088/0034-4885/68/11/R01; Rayleigh L., 1879, P R SOC LOND, V29, P71, DOI [10.1098/rspl.1879.0015, DOI 10.1098/RSPL.1879.0015]; REIN M, 1993, FLUID DYN RES, V12, P61, DOI 10.1016/0169-5983(93)90106-K; Reyssat M, 2006, EUROPHYS LETT, V74, P306, DOI 10.1209/epl/i2005-10523-2; Reyssat M, 2010, FARADAY DISCUSS, V146, P19, DOI 10.1039/c000410n; Richard D, 2000, EUROPHYS LETT, V50, P769, DOI 10.1209/epl/i2000-00547-6; Richard D, 2002, NATURE, V417, P811, DOI 10.1038/417811a; TAYLOR G, 1959, PROC R SOC LON SER-A, V253, P313, DOI 10.1098/rspa.1959.0196; Tsai PC, 2009, LANGMUIR, V25, P12293, DOI 10.1021/la900330q; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Tuteja A, 2008, P NATL ACAD SCI USA, V105, P18200, DOI 10.1073/pnas.0804872105; WACHTERS LH, 1966, CHEM ENG SCI, V21, P1047, DOI 10.1016/0009-2509(66)85100-X; Zou J, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3575298	40	644	673	35	562	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					385	+		10.1038/nature12740	http://dx.doi.org/10.1038/nature12740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24256803				2022-12-28	WOS:000327163200038
J	Raymond, PA; Hartmann, J; Lauerwald, R; Sobek, S; McDonald, C; Hoover, M; Butman, D; Striegl, R; Mayorga, E; Humborg, C; Kortelainen, P; Durr, H; Meybeck, M; Ciais, P; Guth, P				Raymond, Peter A.; Hartmann, Jens; Lauerwald, Ronny; Sobek, Sebastian; McDonald, Cory; Hoover, Mark; Butman, David; Striegl, Robert; Mayorga, Emilio; Humborg, Christoph; Kortelainen, Pirkko; Duerr, Hans; Meybeck, Michel; Ciais, Philippe; Guth, Peter			Global carbon dioxide emissions from inland waters	NATURE			English	Article							SIZE DISTRIBUTION; LAKES; RESERVOIRS; ABUNDANCE; STREAMS; FLUXES; BUDGET; LAND; TRENDS; RIVERS	Carbon dioxide (CO2) transfer from inland waters to the atmosphere, known as CO2 evasion, is a component of the global carbon cycle. Global estimates of CO2 evasion have been hampered, however, by the lack of a framework for estimating the inland water surface area and gas transfer velocity and by the absence of a global CO2 database. Here we report regional variations in global inland water surface area, dissolved CO2 and gas transfer velocity. We obtain global CO2 evasion rates of 1.8(-0.25)(+0.25) petagrams of carbon (Pg C) per year from streams and rivers and 0.32(-0.26)(+0.52) Pg C yr(-1) from lakes and reservoirs, where the upper and lower limits are respectively the 5th and 95th confidence interval percentiles. The resulting global evasion rate of 2.1 Pg C yr(-1) is higher than previous estimates owing to a larger stream and river evasion rate. Our analysis predicts global hotspots in stream and river evasion, with about 70 per cent of the flux occurring over just 20 per cent of the land surface. The source of inland water CO2 is still not known with certainty and new studies are needed to research the mechanisms controlling CO2 evasion globally.	[Raymond, Peter A.; Hoover, Mark; Butman, David] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Hartmann, Jens; Lauerwald, Ronny] Univ Hamburg, Inst Geol, D-20146 Hamburg, Germany; [Lauerwald, Ronny] Univ Libre Bruxelles, Dept Earth & Environm Sci, B-1050 Brussels, Belgium; [Sobek, Sebastian] Uppsala Univ, Dept Ecol & Genet, SE-75236 Uppsala, Sweden; [McDonald, Cory] Wisconsin Dept Nat Resources, Madison, WI 53716 USA; [Butman, David; Striegl, Robert] US Geol Survey, Natl Res Program, Boulder, CO 80303 USA; [Mayorga, Emilio] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Humborg, Christoph] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Kortelainen, Pirkko] Finnish Environm Inst, FI-00251 Helsinki, Finland; [Duerr, Hans] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada; [Meybeck, Michel] Univ Paris 06, Unite Mixte Rech CNRS UPMC Sisyphe, F-75252 Paris 05, France; [Ciais, Philippe] LSCE IPSL, F-91191 Gif Sur Yvette, France; [Guth, Peter] US Naval Acad, Dept Oceanog, Annapolis, MD 21402 USA	Yale University; University of Hamburg; Universite Libre de Bruxelles; Uppsala University; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; Stockholm University; Finnish Environment Institute; University of Waterloo; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); United States Department of Defense; United States Navy; United States Naval Academy	Raymond, PA (corresponding author), Yale Univ, Sch Forestry & Environm Studies, 195 Prospect St, New Haven, CT 06511 USA.	peter.raymond@yale.edu	Butman, David/T-9380-2019; Raymond, Peter A/C-4087-2009; Dürr, Hans/F-6370-2010; Ciais, Philippe/A-6840-2011; Humborg, Christoph/C-4756-2015; Hartmann, Jens/AAB-3313-2020; Hartmann, Jens/A-6306-2008; Kortelainen, Pirkko/AAN-7045-2020	Raymond, Peter A/0000-0002-8564-7860; Dürr, Hans/0000-0001-5787-3994; Ciais, Philippe/0000-0001-8560-4943; Humborg, Christoph/0000-0002-0649-5599; Hartmann, Jens/0000-0003-1878-9321; Hartmann, Jens/0000-0003-1878-9321; McDonald, Cory/0000-0002-1208-8471; Kortelainen, Pirkko/0000-0002-1448-0688; Mayorga, Emilio/0000-0003-2574-4623; Lauerwald, Ronny/0000-0001-5554-0897; Butman, David/0000-0003-3520-7426	NASA [NNX11AH68G]; L-IPSL labex program; Formas; EU project GeoCarbon [U4603EUU1104]; DFG [EXC 177, DFG HA 4472/6-1]	NASA(National Aeronautics & Space Administration (NASA)); L-IPSL labex program; Formas(Swedish Research Council Formas); EU project GeoCarbon; DFG(German Research Foundation (DFG))	P.A.R. and M.H were partly funded by a NASA grant (NNX11AH68G) to P.A.R. P.A.R. also received support from a fellowship from L-IPSL labex program. S.S. was supported by Formas. R.L. and J.H. were funded by the EU project GeoCarbon (U4603EUU1104) and by DFG (EXC 177 and DFG HA 4472/6-1). This represents a contribution to the RECCAP process. R.S. and D.B. are part of the Inland Water Science Group of the USGS LandCarbon Project.	Abril G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002457; Abril G, NATURE IN PRESS; Alin SR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001398; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Buffam I, 2011, GLOBAL CHANGE BIOL, V17, P1193, DOI 10.1111/j.1365-2486.2010.02313.x; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Christensen TR, 2007, PHILOS T R SOC A, V365, P1643, DOI 10.1098/rsta.2007.2035; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; Cole JJ, 2001, MAR FRESHWATER RES, V52, P101, DOI 10.1071/MF00084; Davidson EA, 2010, J GEOPHYS RES-BIOGEO, V115, DOI [10.1029/20091G001202, 10.1029/2009JG001202]; Dodds PS, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.016115; Downing J., 2009, ENCY INLAND WATERS, P469, DOI DOI 10.1016/B978-012370626-3.00025-9; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Downing JA, 2012, INLAND WATERS, V2, P229, DOI 10.5268/IW-2.4.502; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Fekete BM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/1999GB001254; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; Humborg C, 2010, GLOBAL CHANGE BIOL, V16, P1966, DOI 10.1111/j.1365-2486.2009.02092.x; Johnson MS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034619; Jonsson A, 2007, J HYDROL, V334, P141, DOI 10.1016/j.jhydrol.2006.10.003; KEMPE S, 1984, J GEOPHYS RES-ATMOS, V89, P4657, DOI 10.1029/JD089iD03p04657; KLING GW, 1991, SCIENCE, V251, P298, DOI 10.1126/science.251.4991.298; Kortelainen P, 2006, GLOBAL CHANGE BIOL, V12, P1554, DOI 10.1111/j.1365-2486.2006.01167.x; Lauerwald R, 2013, CHEM GEOL, V337, P114, DOI 10.1016/j.chemgeo.2012.11.011; Lauerwald R, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001820; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Leopold L., 1953, HYDRAULIC GEOMETRY S, P1; Maberly SC, 2013, NAT CLIM CHANGE, V3, P391, DOI [10.1038/NCLIMATE1748, 10.1038/nclimate1748]; McDonald CP, 2013, GLOBAL BIOGEOCHEM CY, V27, P285, DOI 10.1002/gbc.20032; McDonald CP, 2012, LIMNOL OCEANOGR, V57, P597, DOI 10.4319/lo.2012.57.2.0597; Meybeck M, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002540; Meybeck M., 1995, PHYS CHEM LAKES, P1, DOI DOI 10.1007/978-3-642-85132-2_1; PARK PK, 1969, SCIENCE, V166, P867, DOI 10.1126/science.166.3907.867; Prigent C, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007847; Raymond P.A., 2012, LIMNOL OCEANOGR FLUI, V2, P41, DOI [10.1215/21573689-1597669, DOI 10.1215/21573689-1597669]; Raymond PA, 1997, ESTUARIES, V20, P381, DOI 10.2307/1352351; Raymond PA, 2008, NATURE, V451, P449, DOI 10.1038/nature06505; Read JS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051886; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/NGEO1830, 10.1038/ngeo1830]; Richey JE, 2004, SCOPE SER, V62, P329; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Sabine CL, 2004, SCOPE SER, V62, P17; Striegl RG, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004306; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298	50	1272	1349	79	994	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					355	359		10.1038/nature12760	http://dx.doi.org/10.1038/nature12760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24256802	Green Submitted			2022-12-28	WOS:000327163200032
J	Martin, SS; Blaha, MJ; Elshazly, MB; Toth, PP; Kwiterovich, PO; Blumenthal, RS; Jones, SR				Martin, Seth S.; Blaha, Michael J.; Elshazly, Mohamed B.; Toth, Peter P.; Kwiterovich, Peter O.; Blumenthal, Roger S.; Jones, Steven R.			Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTEGRATED APPROACH; FAT TRANSPORT; LDL-CHOLESTEROL; MECHANISMS; FORMULA; PARTICIPANTS; TRIGLYCERIDE; METAANALYSIS; GUIDELINES; MANAGEMENT	IMPORTANCE In clinical and research settings worldwide, low-density lipoprotein cholesterol (LDL-C) is typically estimated using the Friedewald equation. This equation assumes a fixed factor of 5 for the ratio of triglycerides to very low-density lipoprotein cholesterol (TG:VLDL-C); however, the actual TG:VLDL-C ratio varies significantly across the range of triglyceride and cholesterol levels. OBJECTIVE To derive and validate a more accurate method for LDL-C estimation from the standard lipid profile using an adjustable factor for the TG:VLDL-C ratio. DESIGN, SETTING, AND PARTICIPANTS We used a convenience sample of consecutive clinical lipid profiles obtained from 2009 through 2011 from 1 350 908 children, adolescents, and adults in the United States. Cholesterol concentrations were directly measured after vertical spin density-gradient ultracentrifugation, and triglycerides were directly measured. Lipid distributions closely matched the population-based National Health and Nutrition Examination Survey (NHANES). Samples were randomly assigned to derivation (n = 900 605) and validation (n = 450 303) data sets. MAIN OUTCOMES AND MEASURES Individual patient-level concordance in clinical practice guideline LDL-C risk classification using estimated vs directly measured LDL-C (LDL-CD). RESULTS In the derivation data set, the median TG:VLDL-C was 5.2 (IQR, 4.5-6.0). The triglyceride and non-high-density lipoprotein cholesterol (HDL-C) levels explained 65% of the variance in the TG:VLDL-C ratio. Based on strata of triglyceride and non-HDL-C values, a 180-cell table of median TG:VLDL-C values was derived and applied in the validation data set to estimate the novel LDL-C (LDL-CN). For patients with triglycerides lower than 400 mg/dL, overall concordance in guideline risk classification with LDL-CD was 91.7% (95% CI, 91.6%-91.8%) for LDL-CN vs 85.4% (95% CI, 85.3%-85.5%) for Friedewald LDL-C (LDL-CF) (P<.001). The greatest improvement in concordance occurred in classifying LDL-C lower than 70 mg/dL, especially in patients with high triglyceride levels. In patients with an estimated LDL-C lower than 70 mg/dL, LDL-CD was also lower than 70 mg/dL in 94.3% (95% CI, 93.9%-94.7%) for LDL-CN vs 79.9% (95% CI, 79.3%-80.4%) for LDL-CF in samples with triglyceride levels of 100 to 149 mg/dL; 92.4% (95% CI, 91.7%-93.1%) for LDL-CN vs 61.3% (95% CI, 60.3%-62.3%) for LDL-CF in samples with triglyceride levels of 150 to 199 mg/dL; and 84.0% (95% CI, 82.9%-85.1%) for LDL-CN vs 40.3% (95% CI, 39.4%-41.3%) for LDL-CF in samples with triglyceride levels of 200 to 399 mg/dL (P<.001 for each comparison). CONCLUSIONS AND RELEVANCE A novel method to estimate LDL-C using an adjustable factor for the TG:VLDL-C ratio provided more accurate guideline risk classification than the Friedewald equation. These findings require external validation, as well as assessment of their clinical importance. The implementation of these findings into clinical practice would be straightforward and at virtually no cost.	[Martin, Seth S.; Blaha, Michael J.; Elshazly, Mohamed B.; Blumenthal, Roger S.; Jones, Steven R.] Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21287 USA; [Toth, Peter P.] CGH Med Ctr, Dept Prevent Cardiol, Sterling, IL USA; [Toth, Peter P.] Univ Illinois, Coll Med, Peoria, IL 61656 USA; [Kwiterovich, Peter O.] Johns Hopkins Univ, Lipid Clin, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; University of Illinois System; University of Illinois Peoria; Johns Hopkins University	Martin, SS (corresponding author), Johns Hopkins Ciccarone Ctr Prevent Heart Dis, 600 N Wolfe St,Blalock 524-C, Baltimore, MD 21287 USA.	smart100@jhmi.edu	Toth, Peter/GMW-6552-2022; Elshazly, Mohamed/V-8579-2019; Blumenthal, Roger S/H-3223-2018	Elshazly, Mohamed/0000-0002-5802-692X; Blumenthal, Roger S/0000-0003-1910-3168; Martin, Seth/0000-0002-7021-7622	Pollin Cardiovascular Prevention Fellowship; Marie-Josee and Henry R. Kravis endowed fellowship; Kenneth Jay Pollin Professorship in Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER	Pollin Cardiovascular Prevention Fellowship; Marie-Josee and Henry R. Kravis endowed fellowship; Kenneth Jay Pollin Professorship in Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Atherotech participated in the collection of data by providing the investigators with deidentified data generated from commercial lipid analyses. Dr Martin is supported by the Pollin Cardiovascular Prevention Fellowship, as well as the Marie-Josee and Henry R. Kravis endowed fellowship. Dr Blumenthal is supported by the Kenneth Jay Pollin Professorship in Cardiology.	Ahmadi SA, 2008, ARCH IRAN MED, V11, P318, DOI 08113/AIM.0014; Anandaraja S, 2005, INT J CARDIOL, V102, P117, DOI 10.1016/j.ijcard.2004.05.009; BACHORIK PS, 1995, CLIN CHEM, V41, P1414; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Brunzell JD, 2008, J AM COLL CARDIOL, V51, P1512, DOI 10.1016/j.jacc.2008.02.034; Chen YQ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-52; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DELONG DM, 1986, JAMA-J AM MED ASSOC, V256, P2372, DOI 10.1001/jama.256.17.2372; FREDRICK.DS, 1967, NEW ENGL J MED, V276, P148, DOI 10.1056/NEJM196701192760305; FREDRICK.DS, 1967, NEW ENGL J MED, V276, P273, DOI 10.1056/NEJM196702022760507; FREDRICKSON DONALD S., 1967, N ENGL J MED, V276, P34, DOI 10.1056/NEJM196701052760107; FREDRICKSON DS, 1967, NEW ENGL J MED, V276, P94, DOI 10.1056/NEJM196701122760206; FREDRICKSON DS, 1967, NEW ENGL J MED, V276, P215, DOI 10.1056/NEJM196701262760406; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaziano JM, 2012, ARCH INTERN MED, V172, P1705, DOI 10.1001/jamainternmed.2013.1771; Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P816, DOI 10.1001/2012.jama.10456; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hattori Y, 1998, ATHEROSCLEROSIS, V138, P289, DOI 10.1016/S0021-9150(98)00034-3; HEGSTED DM, 1987, P NATL ACAD SCI USA, V84, P6259, DOI 10.1073/pnas.84.17.6259; Hopkins PN, 2011, J CLIN LIPIDOL, V5, pS9, DOI 10.1016/j.jacl.2011.03.452; Ioannidis JPA, 2012, JAMA-J AM MED ASSOC, V308, P575, DOI 10.1001/jama.2012.8144; Kuklina EV, 2009, JAMA-J AM MED ASSOC, V302, P2104, DOI 10.1001/jama.2009.1672; Kulkarni KR, 2006, CLIN LAB MED, V26, P787, DOI 10.1016/j.cll.2006.07.004; Martin SS, 2013, J AM COLL CARDIOL, V62, P732, DOI 10.1016/j.jacc.2013.01.079; Martin SS, 2013, CLIN CARDIOL; de Cordova CMM, 2013, ANN CLIN BIOCHEM, V50, P13, DOI 10.1258/acb.2012.011259; Mora S, 2008, CIRCULATION, V118, P993, DOI 10.1161/CIRCULATIONAHA.108.777334; RAO A, 1988, CLIN CHEM, V34, P2532; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Sidhu D, 2012, ARCH INTERN MED, V172, P1707, DOI 10.1001/archinternmed.2012.3708; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Thomas L, 2012, JAMA-J AM MED ASSOC, V308, P773, DOI 10.1001/jama.2012.9502; Wang T, 1999, CLIN CHEM, V45, P1981	36	383	424	2	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2061	2068		10.1001/jama.2013.280532	http://dx.doi.org/10.1001/jama.2013.280532			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240933	Green Accepted, Bronze			2022-12-28	WOS:000327098900022
J	Peters, DH; Adam, T; Alonge, O; Agyepong, IA; Tran, N				Peters, David H.; Adam, Taghreed; Alonge, Olakunle; Agyepong, Irene Akua; Tran, Nhan			Implementation research: what it is and how to do it	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-SERVICES; DISSEMINATION; GUIDELINES; QUALITY; DESIGNS		[Peters, David H.; Alonge, Olakunle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Adam, Taghreed] World Hlth Org, Alliance Hlth Policy & Syst Res, CH-1211 Geneva 27, Switzerland; [Agyepong, Irene Akua] Univ Ghana, Sch Publ Hlth, Ghana Hlth Serv, Accra, Ghana; [Tran, Nhan] World Hlth Org, Alliance Hlth Policy & Syst Res, Implementat Res Platform, CH-1211 Geneva 27, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; Ghana Health Service; University of Ghana; World Health Organization	Peters, DH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	dpeters@jhsph.edu		Agyepong, Irene Akua/0000-0002-0193-5882; Peters, David/0000-0001-8377-3444; Alonge, Olakunle/0000-0001-7642-2806	government of Norway; government of Sweden; UK Department for International Development (DFID); Future Health Systems research programme consortium; DFID [H050474]	government of Norway; government of Sweden; UK Department for International Development (DFID); Future Health Systems research programme consortium; DFID	Funding was provided by the governments of Norway and Sweden and the UK Department for International Development (DFID) in support of the WHO Implementation Research Platform, which financed a meeting of authors and salary support for NT. DHP is supported by the Future Health Systems research programme consortium, funded by DFID for the benefit of developing countries (grant number H050474). The funders played no role in the design, conduct, or reporting of the research.	Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; Brownson RC, 2012, DISSEMINATION IMPLEM, DOI 10.1093/acprof:oso/9780199751877.001.0001; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Chambers R., 2008, REVOLUTIONS DEV INQU, DOI 10.4324/9781849772426; Ciliska D, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-13; Cornwall A, 1995, SOC SCI MED, V41, P1667, DOI 10.1016/0277-9536(95)00127-S; Creswell J.W., 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; Creswell JW KA, 2011, BEST PRACTICES MIXED; Creswell W. C., 2011, DESIGNING CONDUCTING; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Davidoff F, 2008, QUAL SAF HEALTH CARE, V17, P3, DOI 10.1136/qshc.2008.029066; Edward A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001066; Gilson L, 2012, HLTH POLICY SYSTEMS; Green LW, 2006, EVAL HEALTH PROF, V29, P126, DOI 10.1177/0163278705284445; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Health Facility Assessment Technical Working Group, 2008, PROF HLTH FAC ASS ME; Hotchkiss D., 2012, CAN ROUTINE HLTH INF; Lindelow M, 2008, ARE YOU BEING SERVED: NEW TOOLS FOR MEASURING SERVICE DELIVERY, P19; McKibbon KA, 2012, IMPL RES; MERGLER D, 1987, INT J HEALTH SERV, V17, P151, DOI 10.2190/FPWF-C2ET-Q4DB-NMNQ; Paina L, 2012, HEALTH POLICY PLANN, V27, P365, DOI 10.1093/heapol/czr054; Peters DH, 2007, B WORLD HEALTH ORGAN, V85, P146, DOI 10.2471/BLT.06.033746; Peters DH, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7888-5; Peters DH., 2013, IMPLEMENTATION RES H; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Remme JHF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001000; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; Sabatier PaulA., 1986, J PUBLIC POLICY, V6, P21, DOI DOI 10.1017/S0143814X00003846; Speroff Theodore, 2004, Qual Manag Health Care, V13, P17; Tabak RG, 2012, AM J PREV MED, V43, P337, DOI 10.1016/j.amepre.2012.05.024; Tashakkori A, 2003, MIXED METHODOLOGY CO; Victora CG, 2005, HEALTH POLICY PLANN, V20, pI18, DOI 10.1093/heapol/czi050; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390; 1971, COMPACT EDITION OXFO	36	540	555	8	71	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6753	10.1136/bmj.f6753	http://dx.doi.org/10.1136/bmj.f6753			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	258KF	24259324				2022-12-28	WOS:000327457400004
J	Ferrada, M; O'Grady, NP				Ferrada, Marcela; O'Grady, Naomi P.			A microbial preparation did not reduce diarrhea in older inpatients receiving antibiotics	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIFFICILE-ASSOCIATED DIARRHEA; PREVENTION; PROBIOTICS		[Ferrada, Marcela; O'Grady, Naomi P.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Ferrada, M (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.							Johnston BC, 2012, ANN INTERN MED, V157, P878, DOI 10.7326/0003-4819-157-12-201212180-00563; Parkes GC, 2009, LANCET INFECT DIS, V9, P237, DOI 10.1016/S1473-3099(09)70059-3	2	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10							JC9	10.7326/0003-4819-159-10-201311190-02009	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247699				2022-12-28	WOS:000328732700008
J	Kosik, KS				Kosik, Kenneth S.			Study neuron networks to tackle Alzheimer's	NATURE			English	Editorial Material									[Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kenneth.kosik@lifesci.ucsb.edu						Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Lambert J.-C., 2013, NATURE GENET; Peter IS, 2012, P NATL ACAD SCI USA, V109, P16434, DOI 10.1073/pnas.1207852109; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; van Rooden S., 2013, ALZHEIMERS DEMENT; Zamrini Edward, 2011, Int J Alzheimers Dis, V2011, P280289, DOI 10.4061/2011/280289	8	12	14	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					31	32		10.1038/503031a	http://dx.doi.org/10.1038/503031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24218661	Bronze			2022-12-28	WOS:000326585600014
J	Boyce, N				Boyce, Niall			Sarah-Jayne Blakemore: rethinking the adolescent brain	LANCET			English	Biographical-Item																		BLAKEMORE SJ, PUBLICATION LIST	1	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1395	1395		10.1016/S0140-6736(13)62201-1	http://dx.doi.org/10.1016/S0140-6736(13)62201-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242JW	24243123				2022-12-28	WOS:000326237500012
J	Banos, A; Agelopoulos, M; Thanos, D				Banos, Aggelos; Agelopoulos, Marios; Thanos, Dimitris			Stochastic Responses Are Not Left to Pure "Chance"	CELL			English	Editorial Material							GENE-EXPRESSION	Many coregulated genes assemble in multigene complexes via stochastic inter- and intrachromosomal interactions. In this issue, Fanucchi et al. report that chromatin loop formation governs hierarchical cotranscription within a multigene complex.	[Banos, Aggelos; Agelopoulos, Marios; Thanos, Dimitris] Acad Athens, Biomed Res Fdn, Athens 11527, Greece	Academy of Athens	Thanos, D (corresponding author), Acad Athens, Biomed Res Fdn, 4 Soranou Efesiou St, Athens 11527, Greece.	thanos@bioacademy.gr	Thanos, Dimitris/AAE-5720-2019					Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Fanucchi S, 2013, CELL, V155, P606, DOI 10.1016/j.cell.2013.09.051; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Magklara A, 2013, TRENDS CELL BIOL, V23, P449, DOI 10.1016/j.tcb.2013.04.005; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Papantonis A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000419; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013	8	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					499	502		10.1016/j.cell.2013.10.002	http://dx.doi.org/10.1016/j.cell.2013.10.002			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243008	Bronze			2022-12-28	WOS:000326571800004
J	Joshi, NV; Vesey, AT; Williams, MC; Shah, ASV; Calvert, PA; Craighead, FHM; Yeoh, SE; Wallace, W; Salter, D; Fletcher, AM; van Beek, EJR; Flapan, AD; Uren, NG; Behan, MWH; Cruden, NLM; Mills, NL; Fox, KAA; Rudd, JHF; Dweck, MR; Newby, DE				Joshi, Nikhil V.; Vesey, Alex T.; Williams, Michelle C.; Shah, Anoop S. V.; Calvert, Patrick A.; Craighead, Felicity H. M.; Yeoh, Su Ern; Wallace, William; Salter, Donald; Fletcher, Alison M.; van Beek, Edwin J. R.; Flapan, Andrew D.; Uren, Neal G.; Behan, Miles W. H.; Cruden, Nicholas L. M.; Mills, Nicholas L.; Fox, Keith A. A.; Rudd, James H. F.; Dweck, Marc R.; Newby, David E.			F-18-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; VULNERABLE PLAQUE; VASCULAR CALCIFICATION; F-18-FDG UPTAKE; FLUORIDE UPTAKE; ARTERY CALCIUM; INFLAMMATION; ASSOCIATION; ANGIOGRAPHY; FEASIBILITY	Background The use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We used combined PET and CT to identify ruptured and high-risk atherosclerotic plaques using the radioactive tracers F-18-sodium fluoride (F-18-NaF) and F-18-fluorodeoxyglucose (F-18-FDG). Methods In this prospective clinical trial, patients with myocardial infarction (n=40) and stable angina (n=40) underwent F-18-NaF and F-18-FDG PET-CT, and invasive coronary angiography. F-18-NaF uptake was compared with histology in carotid endarterectomy specimens from patients with symptomatic carotid disease, and with intravascular ultrasound in patients with stable angina. The primary endpoint was the comparison of F-18-fluoride tissue-to-background ratios of culprit and non-culprit coronary plaques of patients with acute myocardial infarction. Findings In 37 (93%) patients with myocardial infarction, the highest coronary F-18-NaF uptake was seen in the culprit plaque (median maximum tissue-to-background ratio: culprit 1.66 [IQR 1.40-2.25] vs highest non-culprit 1.24 [1.06-1.38], p<0.0001). By contrast, coronary F-18-FDG uptake was commonly obscured by myocardial uptake and where discernible, there were no differences between culprit and non-culprit plaques (1.71 [1.40-2.13] vs 1.58 [1.28-2.01], p=0.34). Marked F-18-NaF uptake occurred at the site of all carotid plaque ruptures and was associated with histological evidence of active calcification, macrophage infiltration, apoptosis, and necrosis. 18 (45%) patients with stable angina had plaques with focal F-18-NaF uptake (maximum tissue-to-background ratio 1.90 [IQR 1.61-2.17]) that were associated with more high-risk features on intravascular ultrasound than those without uptake: positive remodelling (remodelling index 1.12 [1.09-1.19] vs 1.01 [0.94-1.06]; p=0.0004), microcalcification (73% vs 21%, p=0.002), and necrotic core (25% [21-29] vs 18% [14-22], p=0.001). Interpretation F-18-NaF PET-CT is the first non-invasive imaging method to identify and localise ruptured and high-risk coronary plaque. Future studies are needed to establish whether this method can improve the management and treatment of patients with coronary artery disease.	[Joshi, Nikhil V.; Vesey, Alex T.; Williams, Michelle C.; Shah, Anoop S. V.; Craighead, Felicity H. M.; Yeoh, Su Ern; Salter, Donald; Fletcher, Alison M.; van Beek, Edwin J. R.; Mills, Nicholas L.; Fox, Keith A. A.; Dweck, Marc R.; Newby, David E.] Univ Edinburgh, Ctr Cardiovasc Sci, Clin Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Joshi, Nikhil V.; Vesey, Alex T.; Williams, Michelle C.; Shah, Anoop S. V.; Craighead, Felicity H. M.; Yeoh, Su Ern; Wallace, William; Salter, Donald; Fletcher, Alison M.; van Beek, Edwin J. R.; Mills, Nicholas L.; Fox, Keith A. A.; Dweck, Marc R.; Newby, David E.] Univ Edinburgh, Div Pathol, Edinburgh, Midlothian, Scotland; [Flapan, Andrew D.; Uren, Neal G.; Behan, Miles W. H.; Cruden, Nicholas L. M.] Royal Infirm Edinburgh NHS Trust, Edinburgh Heart Ctr, Edinburgh, Midlothian, Scotland; [Calvert, Patrick A.; Rudd, James H. F.] Univ Cambridge, Div Cardiovasc Med, Cambridge, England	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Cambridge	Joshi, NV (corresponding author), Univ Edinburgh, BHF Ctr Cardiovasc Sci, SU 305,Chancellors Bldg, Edinburgh, Midlothian, Scotland.	nikhil.joshi@ed.ac.uk	Williams, Michelle C/K-7555-2012; Fox, keith A A/I-3742-2013; Newby, David Ernest/AAB-1364-2019; Dweck, Marc/AAY-1509-2021	Williams, Michelle C/0000-0003-3556-2428; Yeoh, Su Ern/0000-0003-0410-0810; Shah, Anoop/0000-0002-2825-3419; Rudd, James/0000-0003-2243-3117; dweck, marc/0000-0001-9847-5917; Mills, Nicholas/0000-0003-0533-7991; Fox, Keith/0000-0002-0140-2752	Chief Scientist Office Scotland [ETM/160]; British Heart Foundation [PG/12/8/29371, CH/09/002, FS/10/024, FS/10/026]; NIHR Cambridge Biomedical Research Centre; NHS Research Scotland (NRS) through NHS Lothian; MRC [G0701127] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL1-Rudd, AMS-SGCL7-Calvert] Funding Source: researchfish; British Heart Foundation [FS/14/78/31020, FS/10/026/28209, FS/13/77/30488, PG/09/083/27667, FS/11/14/28692, FS/12/29/29463, FS/10/024/28266] Funding Source: researchfish; Medical Research Council [G0701127] Funding Source: researchfish; Chief Scientist Office [ETM/160] Funding Source: researchfish	Chief Scientist Office Scotland; British Heart Foundation(British Heart Foundation); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NHS Research Scotland (NRS) through NHS Lothian; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	Chief Scientist Office Scotland and British Heart Foundation.; The study was funded by the Chief Scientist Office, Scotland (ETM/160) and the British Heart Foundation (PG/12/8/29371). MRD, NLM, and DEN are supported by the British Heart Foundation (CH/09/002, FS/10/024, FS/10/026). JHFR and PAC are part-funded by the NIHR Cambridge Biomedical Research Centre and the British Heart Foundation. The Wellcome Trust Clinical Research Facility and the Clinical Research Imaging Centre are supported by NHS Research Scotland (NRS) through NHS Lothian. We acknowledge the support of staff at the Edinburgh Heart Centre at the Royal Infirmary of Edinburgh, the radiography and radiochemistry staff of the Clinical Research Imaging Centre, and the histology staff at the Queens Medical Research Institute.	Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; [Anonymous], 2006, J Am Coll Cardiol, V47, pC1; Beheshti M, 2011, HELL J NUCL MED, V14, P114; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Calvert PA, 2011, JACC-CARDIOVASC IMAG, V4, P894, DOI 10.1016/j.jcmg.2011.05.005; Cheng VY, 2012, J NUCL MED, V53, P575, DOI 10.2967/jnumed.111.097550; Derlin T, 2011, J NUCL MED, V52, P1020, DOI 10.2967/jnumed.111.087452; Derlin T, 2010, J NUCL MED, V51, P862, DOI 10.2967/jnumed.110.076471; Dunphy MPS, 2005, J NUCL MED, V46, P1278; Dweck MR, 2013, EUR HEART J, V34, P1567, DOI 10.1093/eurheartj/eht034; Dweck MR, 2012, J AM COLL CARDIOL, V59, P1539, DOI 10.1016/j.jacc.2011.12.037; Dweck MR, 2012, CIRCULATION, V125, P76, DOI 10.1161/CIRCULATIONAHA.111.051052; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29; Janssen T, 2013, J NUCL CARDIOL, V20, P569, DOI 10.1007/s12350-013-9680-8; Li YX, 2012, NUCL MED COMMUN, V33, P14, DOI 10.1097/MNM.0b013e32834c187e; Libby P, 2010, J NUCL MED, V51, p33S, DOI 10.2967/jnumed.109.069633; McEvoy JW, 2010, J AM COLL CARDIOL, V56, P1613, DOI 10.1016/j.jacc.2010.06.038; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Murray SW, 2013, EUR HEART J-CARD IMG, V14, P167, DOI 10.1093/ehjci/jes138; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Raggi P, 2004, ARTERIOSCL THROM VAS, V24, P1272, DOI 10.1161/01.ATV.0000127024.40516.ef; Rogers Ian S, 2011, Curr Cardiol Rep, V13, P138, DOI 10.1007/s11886-011-0168-3; Rogers IS, 2010, JACC-CARDIOVASC IMAG, V3, P388, DOI 10.1016/j.jcmg.2010.01.004; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Saam T, 2010, EUR J NUCL MED MOL I, V37, P1203, DOI 10.1007/s00259-010-1432-2; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wykrzykowska J, 2009, J NUCL MED, V50, P563, DOI 10.2967/jnumed.108.055616	35	640	656	8	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					705	713		10.1016/S0140-6736(13)61754-7	http://dx.doi.org/10.1016/S0140-6736(13)61754-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB2WR	24224999	hybrid, Green Published			2022-12-28	WOS:000331653300031
J	Cooper, CJ; Murphy, TP; Cutlip, DE; Jamerson, K; Henrich, W; Reid, DM; Cohen, DJ; Matsumoto, AH; Steffes, M; Jaff, MR; Prince, MR; Lewis, EF; Tuttle, KR; Shapiro, JI; Rundback, JH; Massaro, JM; D'Agostino, RB; Dworkin, LD				Cooper, Christopher J.; Murphy, Timothy P.; Cutlip, Donald E.; Jamerson, Kenneth; Henrich, William; Reid, Diane M.; Cohen, David J.; Matsumoto, Alan H.; Steffes, Michael; Jaff, Michael R.; Prince, Martin R.; Lewis, Eldrin F.; Tuttle, Katherine R.; Shapiro, Joseph I.; Rundback, John H.; Massaro, Joseph M.; D'Agostino, Ralph B.; Dworkin, Lance D.		Coral Investigators	Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTOLIC BLOOD-PRESSURE; BALLOON ANGIOPLASTY; HYPERTENSION; REVASCULARIZATION; PREVALENCE; PREVENTION; PLACEMENT	BackgroundAtherosclerotic renal-artery stenosis is a common problem in the elderly. Despite two randomized trials that did not show a benefit of renal-artery stenting with respect to kidney function, the usefulness of stenting for the prevention of major adverse renal and cardiovascular events is uncertain. MethodsWe randomly assigned 947 participants who had atherosclerotic renal-artery stenosis and either systolic hypertension while taking two or more antihypertensive drugs or chronic kidney disease to medical therapy plus renal-artery stenting or medical therapy alone. Participants were followed for the occurrence of adverse cardiovascular and renal events (a composite end point of death from cardiovascular or renal causes, myocardial infarction, stroke, hospitalization for congestive heart failure, progressive renal insufficiency, or the need for renal-replacement therapy). ResultsOver a median follow-up period of 43 months (interquartile range, 31 to 55), the rate of the primary composite end point did not differ significantly between participants who underwent stenting in addition to receiving medical therapy and those who received medical therapy alone (35.1% and 35.8%, respectively; hazard ratio with stenting, 0.94; 95% confidence interval [CI], 0.76 to 1.17; P=0.58). There were also no significant differences between the treatment groups in the rates of the individual components of the primary end point or in all-cause mortality. During follow-up, there was a consistent modest difference in systolic blood pressure favoring the stent group (-2.3 mm Hg; 95% CI, -4.4 to -0.2; P=0.03). ConclusionsRenal-artery stenting did not confer a significant benefit with respect to the prevention of clinical events when added to comprehensive, multifactorial medical therapy in people with atherosclerotic renal-artery stenosis and hypertension or chronic kidney disease. (Funded by the National Heart, Lung and Blood Institute and others; ClinicalTrials.gov number, NCT00081731.)	[Cooper, Christopher J.] Univ Toledo, Dept Med, Toledo, OH 43614 USA; [Murphy, Timothy P.; Dworkin, Lance D.] Rhode Isl Hosp, Providence, RI USA; [Murphy, Timothy P.; Dworkin, Lance D.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Cutlip, Donald E.; Massaro, Joseph M.; D'Agostino, Ralph B.] Harvard Clin Res Inst, Boston, MA USA; [Cutlip, Donald E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Jaff, Michael R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lewis, Eldrin F.] Brigham & Womens Hosp, Boston, MA 02115 USA; [D'Agostino, Ralph B.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Jamerson, Kenneth] Univ Michigan, Ann Arbor, MI 48109 USA; [Henrich, William] Univ Texas San Antonio, Hlth Sci Ctr, San Antonio, TX USA; [Reid, Diane M.] NHLBI, Bethesda, MD 20892 USA; [Cohen, David J.] Univ Missouri, Kansas City Sch Med, St Lukes Mid Amer Heart Inst, Kansas City, KS USA; [Matsumoto, Alan H.] Univ Virginia, Charlottesville, VA USA; [Steffes, Michael] Univ Minnesota, Minneapolis, MN USA; [Prince, Martin R.] Weill Cornell Med Ctr, New York, NY USA; [Tuttle, Katherine R.] Providence Sacred Heart Med Ctr, Spokane, WA USA; [Tuttle, Katherine R.] Univ Washington, Sch Med, Spokane, WA USA; [Shapiro, Joseph I.] Marshall Univ, Huntington, WV USA; [Rundback, John H.] Holy Name Med Ctr, Teaneck, NJ USA	University System of Ohio; University of Toledo; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Boston University; University of Michigan System; University of Michigan; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of Virginia; University of Minnesota System; University of Minnesota Twin Cities; Cornell University; University of Washington; Washington State University; Marshall University	Cooper, CJ (corresponding author), Univ Toledo, Dept Med, 3000 Arlington Ave,MS 1036, Toledo, OH 43614 USA.	christopher.cooper@utoledo.edu	Prince, Martin R./S-6850-2016; Mudge, David W./C-1438-2011; Cohen, David/AAF-1648-2019; Nicholls, Kathleen/N-5002-2017	Prince, Martin R./0000-0002-9883-0584; Mudge, David W./0000-0002-4112-5550; Narayanan, Mohanram/0000-0001-5501-7617; Nicholls, Kathleen/0000-0002-1297-8722; Brilakis, Emmanouil/0000-0001-9416-9701; Tuttle, Katherine/0000-0002-2235-0103; Luft, Friedrich/0000-0002-8635-1199	National Heart, Lung, and Blood Institute of the National Institutes of Health [U01HL071556, U01HL072734, U01HL072735, U01HL072736, U01HL072737]; Abbott; AstraZeneca; Eli Lilly; Medtronic; Boston Scientific; Biomet; Janssen; Medicines Company; Novartis; Amgen; Sanofi Aventis; VIVA Physicians; Covidien; Biotronik; St. Jude; CSI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072737, U01HL072734, U01HL072735, U01HL072736, U01HL071556] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Abbott(Abbott Laboratories); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Medtronic(Medtronic); Boston Scientific(Boston Scientific); Biomet; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medicines Company; Novartis(Novartis); Amgen(Amgen); Sanofi Aventis(Sanofi-Aventis); VIVA Physicians; Covidien; Biotronik; St. Jude(St. Jude Medical); CSI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U01HL071556, U01HL072734, U01HL072735, U01HL072736, and U01HL072737) from the National Heart, Lung, and Blood Institute of the National Institutes of Health.; Dr. Murphy reports holding equity interest in Summa Therapeutics. Dr. Cutlip reports that his institution holds research contracts with Medtronic, Boston Scientific, and Abbott Vascular. Dr. Cohen reports receiving personal fees from Abbott, AstraZeneca, Eli Lilly, and Medtronic, and grant support from Abbott, AstraZeneca, Eli Lilly, Medtronic, Boston Scientific, Biomet, and Janssen. Dr. Matsumoto reports receiving consulting fees from Boston Scientific and the Medicines Company and grant support from Medtronic, Cook and W. L. Gore. Dr. Jaff reports receiving consulting fees from AstraZeneca and serving as an uncompensated advisor to Cordis, Boston Scientific, Abbott, Covidien, and Medtronic. Dr. Lewis reports receiving grant support from Novartis, Amgen, and Sanofi Aventis. Dr. Tuttle reports receiving consulting fees and grant support from Eli Lilly. Dr. Rundback reports receiving fees for board membership from VIVA Physicians, personal fees from Covidien, Biotronik, and St. Jude, and lecture fees from Covidien and CSI. No other potential conflict of interest relevant to this article was reported.	Bax L, 2009, ANN INTERN MED, V150, P840, DOI 10.7326/0003-4819-150-12-200906160-00119; Blum U, 1997, NEW ENGL J MED, V336, P459, DOI 10.1056/NEJM199702133360702; Burket MW, 2000, AM HEART J, V139, P64, DOI 10.1016/S0002-8703(00)90310-7; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper CJ, 2006, AM HEART J, V152, P59, DOI 10.1016/j.ahj.2005.09.011; DERKX FHM, 1994, LANCET, V344, P237, DOI 10.1016/S0140-6736(94)93002-3; Foy A, 2012, CARDIOL REV, V20, P189, DOI 10.1097/CRD.0b013e31824a72e9; Goldblatt H, 1934, J EXP MED, V59, P347, DOI 10.1084/jem.59.3.347; Hansen KJ, 2002, J VASC SURG, V36, P443, DOI 10.1067/mva.2002.127351; Harden PN, 1997, LANCET, V349, P1133, DOI 10.1016/S0140-6736(96)10093-3; HARDING MB, 1992, J AM SOC NEPHROL, V2, P1608; Jaff MR, 2012, CATHETER CARDIO INTE, V80, P343, DOI 10.1002/ccd.24449; Murphy TP, 2004, AM J ROENTGENOL, V183, P561, DOI 10.2214/ajr.183.3.1830561; OLIN JW, 1990, AM J MED, V88, pN46; Plouin PF, 1998, HYPERTENSION, V31, P823, DOI 10.1161/01.HYP.31.3.823; Rocha-Singh K, 2005, J AM COLL CARDIOL, V46, P776, DOI 10.1016/j.jacc.2004.11.073; Rocha-Singh K, 2008, CATHETER CARDIO INTE, V72, P853, DOI 10.1002/ccd.21749; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Trinquart L, 2010, HYPERTENSION, V56, P525, DOI 10.1161/HYPERTENSIONAHA.110.152918; van Jaarsveld BC, 2000, NEW ENGL J MED, V342, P1007, DOI 10.1056/NEJM200004063421403; Venkata C, 1997, CURR OPIN NEPHROL HY, V6, P575, DOI 10.1097/00041552-199711000-00014; Watson PS, 2000, CIRCULATION, V102, P1671, DOI 10.1161/01.CIR.102.14.1671; Webster J, 1998, J HUM HYPERTENS, V12, P329, DOI 10.1038/sj.jhh.1000599; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368; Yu HF, 2011, VASC MED, V16, P331, DOI 10.1177/1358863X11419998	26	572	615	3	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					13	22		10.1056/NEJMoa1310753	http://dx.doi.org/10.1056/NEJMoa1310753			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284XA	24245566	Green Accepted			2022-12-28	WOS:000329354100006
J	Tang, L; El-Din, TMG; Payandeh, J; Martinez, GQ; Heard, TM; Scheuer, T; Zheng, N; Catterall, WA				Tang, Lin; El-Din, Tamer M. Gamal; Payandeh, Jian; Martinez, Gilbert Q.; Heard, Teresa M.; Scheuer, Todd; Zheng, Ning; Catterall, William A.			Structural basis for Ca2+ selectivity of a voltage-gated calcium channel	NATURE			English	Article							CRYSTAL-STRUCTURE; ION SELECTIVITY; SODIUM-CHANNEL; CONCERTED ACTION; FROG-MUSCLE; PERMEATION; CONDUCTION; LOCUS; PORE; BACTERIORHODOPSIN	Voltage-gated calcium (Ca-V) channels catalyse rapid, highly selective influx of Ca2+ into cells despite a 70-fold higher extracellular concentration of Na+. How Ca-V channels solve this fundamental biophysical problem remains unclear. Here we report physiological and crystallographic analyses of a calcium selectivity filter constructed in the homotetrameric bacterial Na-V channel Na(V)Ab. Our results reveal interactions of hydrated Ca2+ with two high-affinity Ca2+-binding sites followed by a third lower-affinity site that would coordinate Ca2+ as it moves inward. At the selectivity filter entry, Site 1 is formed by four carboxyl side chains, which have a critical role in determining Ca2+ selectivity. Four carboxyls plus four backbone carbonyls form Site 2, which is targeted by the blocking cations Cd2+ and Mn2+, with single occupancy. The lower-affinity Site 3 is formed by four backbone carbonyls alone, which mediate exit into the central cavity. This pore architecture suggests a conduction pathway involving transitions between two main states with one or two hydrated Ca2+ ions bound in the selectivity filter and supports a 'knock-off' mechanism of ion permeation through a stepwise-binding process. The multi-ion selectivity filter of our Ca(V)Ab model establishes a structural framework for understanding the mechanisms of ion selectivity and conductance by vertebrate Ca-V channels.	[Tang, Lin; El-Din, Tamer M. Gamal; Payandeh, Jian; Martinez, Gilbert Q.; Heard, Teresa M.; Scheuer, Todd; Zheng, Ning; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Tang, Lin; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nzheng@uw.edu; wcatt@uw.edu			National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) [R01NS015751]; National Heart, Lung, and Blood Institute (NHLBI) of the NIH [R01HL112808]; National Research Service Award from training grant [T32GM008268]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117896, R01HL112808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute (NHLBI) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Service Award from training grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the beamline staff at the Advanced Light Source (BL8.2.1 and BL8.2.2) for their assistance during data collection. Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under award number R01NS015751 (W. A. C.), the National Heart, Lung, and Blood Institute (NHLBI) of the NIH under award number R01HL112808 (W. A. C. and N.Z.) and a National Research Service Award from training grant T32GM008268 (T. M. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was also supported by the Howard Hughes Medical Institute (N.Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P35, DOI 10.1038/nsmb.1537; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P565, DOI 10.1113/jphysiol.1984.sp015351; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; ARMSTRONG CM, 1991, ANN NY ACAD SCI, V635, P18, DOI 10.1111/j.1749-6632.1991.tb36477.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen XH, 1997, J BIOL CHEM, V272, P30002, DOI 10.1074/jbc.272.48.30002; Cibulsky SM, 2000, J GEN PHYSIOL, V116, P349, DOI 10.1085/jgp.116.3.349; Cibulsky SM, 2003, BIOPHYS J, V84, P1709, DOI 10.1016/S0006-3495(03)74979-0; Cloues RK, 2000, J GEN PHYSIOL, V116, P569, DOI 10.1085/jgp.116.4.569; Dang TX, 1998, J GEN PHYSIOL, V111, P185, DOI 10.1085/jgp.111.2.185; DeLano W. L., 2002, PYMOL MOL VIEWER V 1; Derebe MG, 2011, P NATL ACAD SCI USA, V108, P598, DOI 10.1073/pnas.1013636108; El-Din TMG, 2013, J GEN PHYSIOL, V142, P181, DOI 10.1085/jgp.201311012; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2005, PROTEIN SCI, V14, P836, DOI 10.1110/ps.041167605; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; KIM MS, 1993, FEBS LETT, V318, P145, DOI 10.1016/0014-5793(93)80009-J; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lopin KV, 2010, J MEMBRANE BIOL, V235, P131, DOI 10.1007/s00232-010-9264-3; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Shaya D., J MOL BIOL; Williamson AV, 1999, BIOPHYS J, V77, P2575, DOI 10.1016/S0006-3495(99)77092-X; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	42	220	224	7	156	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					56	+		10.1038/nature12775	http://dx.doi.org/10.1038/nature12775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24270805	Green Accepted			2022-12-28	WOS:000329163300022
J	Fries, LF; Smith, GE; Glenn, GM				Fries, Louis F.; Smith, Gale E.; Glenn, Gregory M.			A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Fries, Louis F.; Smith, Gale E.; Glenn, Gregory M.] Novavax, Gaithersburg, MD USA		Fries, LF (corresponding author), Novavax, Gaithersburg, MD USA.	lfries@novavax.com						Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Hahn T, 2013, TANZ, P12; Smith GE, 2013, VACCINE, V31, P4305, DOI 10.1016/j.vaccine.2013.07.043; WHO, 2013, HUM INF AV INFL A H7	5	134	141	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2564	2566		10.1056/NEJMc1313186	http://dx.doi.org/10.1056/NEJMc1313186			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278BT	24224560	Bronze			2022-12-28	WOS:000328863700024
J	Lin, Y; Gaebler, JP; Reiter, F; Tan, TR; Bowler, R; Sorensen, AS; Leibfried, D; Wineland, DJ				Lin, Y.; Gaebler, J. P.; Reiter, F.; Tan, T. R.; Bowler, R.; Sorensen, A. S.; Leibfried, D.; Wineland, D. J.			Dissipative production of a maximally entangled steady state of two quantum bits	NATURE			English	Article							SIMULATION; DRIVEN	Entangled states are a key resource in fundamental quantum physics, quantum cryptography and quantum computation(1). Introduction of controlled unitary processes-quantum gates-to a quantum system has so far been the most widely used method to create entanglement deterministically(2). These processes require high-fidelity state preparation and minimization of the decoherence that inevitably arises from coupling between the system and the environment, and imperfect control of the system parameters. Here we combine unitary processes with engineered dissipation to deterministically produce and stabilize an approximate Bell state of two trapped-ion quantum bits (qubits), independent of their initial states. Compared with previous studies that involved dissipative entanglement of atomic ensembles(3) or the application of sequences of multiple time-dependent gates to trapped ions(4), we implement our combined process using trapped-ion qubits in a continuous time-independent fashion (analogous to optical pumping of atomic states). By continuously driving the system towards the steady state, entanglement is stabilized even in the presence of experimental noise and decoherence. Our demonstration of an entangled steady state of two qubits represents a step towards dissipative state engineering, dissipative quantum computation and dissipative phase transitions(5-7). Following this approach, engineered coupling to the environment may be applied to a broad range of experimental systems to achieve desired quantum dynamics or steady states. Indeed, concurrently with this work, an entangled steady state of two superconducting qubits was demonstrated using dissipation(8).	[Lin, Y.; Gaebler, J. P.; Tan, T. R.; Bowler, R.; Leibfried, D.; Wineland, D. J.] NIST, Boulder, CO 80305 USA; [Reiter, F.; Sorensen, A. S.] Univ Copenhagen, Niels Bohr Inst, QUANTOP, DK-2100 Copenhagen O, Denmark	National Institute of Standards & Technology (NIST) - USA; University of Copenhagen; Niels Bohr Institute	Lin, Y (corresponding author), NIST, 325 Broadway, Boulder, CO 80305 USA.	yiheng.lin@colorado.edu	Tan, Ting Rei/D-4687-2019; Reiter, Florentin/E-3820-2015; Lin, Yiheng/J-9681-2015; Sørensen, Anders Søndberg/L-1868-2013	Tan, Ting Rei/0000-0003-4520-6419; Reiter, Florentin/0000-0002-5217-3064; Lin, Yiheng/0000-0003-1738-3805; Sørensen, Anders Søndberg/0000-0003-1337-9163; Gaebler, John/0000-0002-2616-7410	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA); ONR; NIST Quantum Information Program; European Union [600645]; ERC [306576]	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA); ONR(Office of Naval Research); NIST Quantum Information Program; European Union(European Commission); ERC(European Research Council (ERC)European Commission)	This research was funded in part by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA). All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA or the ODNI. This work was also supported by ONR, by the NIST Quantum Information Program, and by the European Union's Seventh Framework Program through SIQS (grant no. 600645) and through the ERC grant QIOS (grant no. 306576). We thank D. Allcock and B. Sawyer for comments on the manuscript and E. Knill for conversations. F.R. acknowledges conversations with B. Lanyon, R. Blatt and J. Home and support from the Studienstiftung des deutschen Volkes. This Letter is a contribution of NIST and is not subject to US copyright.	Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Bermudez A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.110502; Brakhane S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.173601; Campagne-Ibarcq P, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021008; Cho JY, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.020504; Clark S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.177901; Cormick C, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/7/073027; Diehl S, 2008, NAT PHYS, V4, P878, DOI 10.1038/nphys1073; Hanneke D, 2010, NAT PHYS, V6, P13, DOI 10.1038/NPHYS1453; Jost JD, 2009, NATURE, V459, P683, DOI 10.1038/nature08006; Kastoryano MJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.090502; Kraus B, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.042307; Krauter H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.080503; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Lanyon BP, 2011, SCIENCE, V334, P57, DOI 10.1126/science.1208001; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Ozeri R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042329; Parkins AS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.053602; Plenio MB, 1999, PHYS REV A, V59, P2468, DOI 10.1103/PhysRevA.59.2468; Poyatos JF, 1996, PHYS REV LETT, V77, P4728, DOI 10.1103/PhysRevLett.77.4728; Reiter F, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.032111; Riste D, 2013, NATURE, V502, P350, DOI 10.1038/nature12513; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.240502; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Schindler P, 2013, NAT PHYS, V9, P361, DOI [10.1038/nphys2630, 10.1038/NPHYS2630]; Tan SM, 1999, J OPT B-QUANTUM S O, V1, P424, DOI 10.1088/1464-4266/1/4/312; Ticozzi F., 2013, QUANTUM INF IN PRESS; Uys H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.200401; Verstraete F, 2009, NAT PHYS, V5, P633, DOI 10.1038/NPHYS1342; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505	34	271	271	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					415	+		10.1038/nature12801	http://dx.doi.org/10.1038/nature12801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24270806	Green Submitted			2022-12-28	WOS:000328575300047
J	Conrad, CP; Steinberger, B; Torsvik, TH				Conrad, Clinton P.; Steinberger, Bernhard; Torsvik, Trond H.			Does quadrupole stability imply LLSVP fixity? Reply	NATURE			English	Letter									[Conrad, Clinton P.] Univ Hawaii Manoa, SOEST, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Steinberger, Bernhard] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany; [Steinberger, Bernhard; Torsvik, Trond H.] Univ Oslo, CEED, N-0316 Oslo, Norway; [Torsvik, Trond H.] Geol Survey Norway, N-7491 Trondheim, Norway; [Torsvik, Trond H.] Univ Witwatersrand, Sch Geosci, ZA-2050 Johannesburg, South Africa	University of Hawaii System; University of Hawaii Manoa; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Oslo; Geological Survey of Norway; University of Witwatersrand	Conrad, CP (corresponding author), Univ Hawaii Manoa, SOEST, Dept Geol & Geophys, Honolulu, HI 96822 USA.	clintc@hawaii.edu	Steinberger, Bernhard/ABB-9204-2021; Steinberger, Bernhard/AAG-7148-2019; Conrad, Clinton/ABG-4901-2020	Steinberger, Bernhard/0000-0002-3643-3049; Conrad, Clinton/0000-0003-4314-2351	Division Of Earth Sciences [1151241] Funding Source: National Science Foundation	Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Conrad CP, 2013, NATURE, V498, P479, DOI 10.1038/nature12203; GURNIS M, 1988, NATURE, V332, P695, DOI 10.1038/332695a0; Lowman JP, 1999, J GEOPHYS RES-SOL EA, V104, P12733, DOI 10.1029/1999JB900108; Rudolph ML, 2013, NATURE, V503, pE3, DOI 10.1038/nature12792; Torsvik TH, 2012, EARTH-SCI REV, V114, P325, DOI 10.1016/j.earscirev.2012.06.007; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; Zhang N, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006896	7	0	0	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					E4	E4		10.1038/nature12793	http://dx.doi.org/10.1038/nature12793			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24284730				2022-12-28	WOS:000327464200002
J	Giugliano, RP; Ruff, CT; Braunwald, E; Murphy, SA; Wiviott, SD; Halperin, JL; Waldo, AL; Ezekowitz, MD; Weitz, JI; Spinar, J; Ruzyllo, W; Ruda, M; Koretsune, Y; Betcher, J; Shi, MG; Grip, LT; Patel, SP; Patel, I; Hanyok, JJ; Mercuri, M; Vogelmann, O; Gonzalez, C; Guerrero, R; Rodriguez, M; Albisu, J; Rosales, E; Allall, O; Reguero, M; Alvarez, C; Garcia, M; Ameriso, S; Ameriso, P; Amuchastegui, M; Caceres, M; Beloscar, J; Petrucci, J; Berli, M; Budassi, N; Valle, M; Labarta, GB; Saravia, M; Caccavo, A; Fracaro, V; Cartasegna, L; Novas, V; Caruso, O; Zarandon, RS; Colombo, H; Morandini, M; Cuello, J; Rosell, M; Cuneo, C; Bocanera, M; D'Amico, A; Cendali, G; Dran, R; Moreno, V; Estol, C; Davolos, M; Facello, A; Facello, M; Falu, E; Iriarte, M; Femenia, F; Arrieta, M; Fuselli, J; Zanotti, A; Lopez, JG; Meiller, F; Duran, RG; Perlo, D; Garrido, M; Ceirano, C; Giacomi, G; Eden, M; Giannaula, R; Huerta, M; Goicoechea, R; von Wulffen, M; Hominal, M; Bianchini, M; Jure, H; Jure, D; Kevorkian, R; Monaco, F; Lanternier, G; Belcuore, M; Liniado, G; Iglesias, M; Litvak, B; Nigro, A; Llanos, J; Vignau, S; Lorente, C; Shatsky, K; Lotti, J; Raimondi, G; Mackinnon, I; Carne, M; Manuale, O; Calderon, M; Marino, J; Funes, I; Muntaner, J; Gandur, H; Nul, D; Verdini, E; Piskorz, D; Tommasi, A; Povedano, G; Casares, E; Pozzer, D; Fernandez, E; Prado, A; Venturini, C; Ramos, H; Navarrete, S; Rodriguez, M; Alvarez, M; Sanchez, A; Bowen, L; Sanjurjo, M; Codutti, O; Toledo, SS; Formoso, I; Schmidberg, J; Goloboulicz, A; Schygiel, P; Buzzetti, C; Severino, P; Morara, P; Liprandi, MS; Teves, M; Vico, M; Morell, Y; Anderson, C; Anderson, C; Paraskevaidis, T; Arstall, M; Hoffmann, B; Colquhoun, D; Price-Smith, S; Crimmins, D; Slattery, A; Dart, A; Kay, S; Davis, S; Silver, G; Flecknoe-Brown, S; Roberts, J; Gates, P; Jones, S; Lehman, R; Morrison, H; McKeirnan, M; Li, J; Paul, V; Batta, C; Purnell, P; Perrett, L; Szto, G; O'Shea, V; Capiau, L; Banaeian, F; De Bleecker, J; de Koning, K; De Tollenaere, M; De Bruyne, L; Desfontaines, P; Tincani, G; Heidbuchel, H; Meeusen, K; Herzet, J; Malmendier, D; Mairesse, G; Raepers, M; Parque, J; Clinckemaille, N; Scavee, C; Huyberechts, D; Stockman, D; Jacobs, C; Vandekerckhove, Y; Derycker, K; Vanwelden, J; van Welden, J; Vervoort, G; Mestdagh, I; Vrolix, M; Beerts, C; Wollaert, B; Denie, D; de Paola, AAV; Coutinho, E; Lotufo, PA; de Melo, RF; Atie, J; Motta, C; da Costa, FAA; Ferraz, RF; Precoma, DB; Sehnem, E; Botelho, R; Cunha, S; Brondani, R; Fleck, N; Chaves, H; Silva, J; Costantini, C; Barroso, D; De Patta, M; Pereira, V; Duda, N; Laimer, R; Dutra, O; Morgado, S; Saporito, WF; Seroqui, M; Ferreira, L; Araujo, E; Finimundi, H; Daitz, C; Gagliardi, R; Pereira, G; Gomes, M; Gomes, A; Guimaraes, A; Ninho, L; Jaeger, C; Pereira, L; Jorge, J; Cury, C; Kaiser, S; Almeida, A; Kalil, C; Radaelli, G; de Souza, WKSB; Morales, K; Leaes, P; Luiz, RO; Almeida, JP; Gozalo, A; Reis, G; Avellar, K; Weiand, LRK; Leipelt, J; Rocha, J; Barros, R; Rodrigues, L; Rocha, MR; Rodrigues, A; Rodrigues, D; dos Santos, FR; Pagnan, LG; Sampaio, R; do Val, R; Saraiva, J; Vicente, C; Simoes, M; Carraro, A; Sobral, D; Lustosa, E; Boas, FV; Almeida, M; Zimmermann, S; Zimmermann, EB; Chompalova, B; Parishev, G; Denchev, S; Milcheva, N; Donova, T; Gergova, V; Georgiev, B; Kostova, E; Goudev, A; Kinova, E; Hergeldjieva, V; Kamenova, P; Manolova, A; Vasilev, I; Mihov, A; Miteva, B; Mincheva, V; Stoyanovski, V; Nikolov, F; Vasilev, D; Pencheva, G; Kostov, K; Petranov, S; Milusheva, T; Popov, A; Vasilev, I; Staneva, A; Momchilova-Lozeva, D; Todorov, G; Nyagina, M; Tumbev, H; Tumbeva, D; Tzekova, M; Kitova, M; Manoylov, E; Archibald, J; Antle, S; Bhargava, R; Stafford, C; Bose, S; Hundseth, M; Cha, J; Otis, J; Chehayeb, R; Lepage, C; Chilvers, M; Vansickle, L; Cleveland, D; Valley, S; Constance, C; Gauthier, M; Costi, P; Masson, C; Coutu, B; Denis, I; du Preez, M; Kubanska, A; Dufresne, M; Krider, J; Eikelboom, J; Zondag, M; Fortin, C; Viau, C; Green, M; Houbraken, D; Hatheway, R; Mabee, J; Heath, J; Scott, L; Ho, K; Ho, V; Hoag, G; Standring, R; Huynh, T; Perkins, L; Kouz, S; Roy, M; Labonte, R; Dewar, C; Lainesse, A; St-Germain, L; Lam, S; Lam, H; Lichtenstein, T; Roberts, P; Luton, R; Douglas, S; Ma, P; Seib, M; MacCallum, C; Matthews, J; Malette, P; Vaillancourt, T; Maranda, C; Studenikow, E; Mawji, A; Morely, A; Morrison, D; Roth, M; Mucha, M; Krider, J; Najarali, A; Lamoureux, U; Nicholson, R; O'Hara, G; Banville, P; O'Mahony, W; Bolton, R; Parkash, R; Carroll, L; Pesant, Y; Sardin, V; Polasek, P; Turri, L; Qureshi, A; Nethercott, C; Ricci, J; Bozek, B; Rupka, D; Marchand, C; Shu, D; Silverio, G; St-Hilaire, R; Morissette, A; Sussman, J; Kailey, P; Syan, G; Bobbie, C; Talajic, M; David, D; Talbot, P; Tremblay, M; Teitelbaum, I; Teitelbaum, J; Velthuysen, G; Giesbrecht, L; Wahby, R; Morley, A; Wharton, S; Caterini, T; Woodford, T; Mabee, J; Balboa, W; Matus, LR; Bugueno, C; Mondaca, PM; Cobos, J; Obreque, C; Corbalan, R; Parada, A; Florenzano, F; Diaz, PA; Lopetegui, M; Rebolledo, C; Manriquez, L; Silva, LM; Martinez, D; Llamas, RR; Opazo, M; Perez, MC; Pincetti, C; Carrasco, GT; Potthoff, S; Staub, JZ; Rodriguez, M; Campisto, Y; Stockins, B; Lara, CL; Yovaniniz, P; Azua, MG; Bai, F; Xu, GL; Chen, JZ; Xie, XD; Chen, XP; Zhang, X; Dong, YG; Feng, C; Fu, GS; Zhang, P; Hong, K; You, ZG; Hong, L; Qiu, Y; Jiang, XJ; Qu, Z; Li, L; Liu, H; Li, TF; Kong, YQ; Li, WM; Liu, B; Li, ZQ; Liu, Y; Liao, DN; Gu, XJ; Liu, L; Lu, ZH; Ma, SM; Yang, ZY; Wang, DM; Qi, SY; Wang, GP; Shi, XJ; Wei, M; Huang, D; Wu, SL; Li, YE; Xu, JH; Gu, JY; Xu, YM; Liang, YZ; Yang, K; Li, AY; Yang, YJ; Zheng, X; Zheng, Y; Gao, M; Yin, YH; Xu, YP; Yu, B; Li, LL; Yuan, ZY; Qiang, H; Zhang, HQ; Lin, YN; Zhang, Z; Kang, H; Zhao, RP; Han, RJ; Zhao, XL; Wang, JQ; Zheng, ZQ; Li, BG; Zhou, SX; Zhang, YL; Accini, J; Accini, M; Cano, N; Pineda, LL; Restrepo, JD; Arroyave, C; Ruiz, RF; Diaz, IA; Hernandez, H; Delgado, P; Munoz, C; Builes, A; Manzur, F; Rodriguez, ER; Corredor, MM; Giraldo, DL; Linares, LO; Fonseca, J; Quintero, A; Gonzales, C; Vallejo, GS; Mejia, IP; Bagatin, J; Carevic, V; Car, S; Jeric, M; Ciglenecki, N; Tusek, S; Certic, JF; Romic, I; Francetic, I; Ausperger, KM; Jelic, V; Jurinjak, SJ; Knezevic, A; Buksa, B; Samardzic, P; Lukenda, KC; Steiner, R; Kirner, D; Sutalo, K; Bakliza, Z; Vrazic, H; Bergovec, M; Bar, M; Brodova, P; Berka, L; Kunkelova, V; Brtko, M; Burianova, H; Cermak, O; Elbl, L; Ferkl, R; Florian, J; Francek, L; Golan, L; Gregor, P; Honkova, M; Hubac, J; Jandik, J; Jarkovsky, P; Jelinek, Z; Jerabek, O; Jirmar, R; Kobza, R; Kochrt, M; Kostkova, G; Kosek, Z; Kovar, P; Kuchar, R; Kvasnicka, J; Ludka, O; Ludka, O; Machova, V; Krocova, E; Melichar, M; Nechanicky, R; Olsr, J; Peterka, K; Petrova, I; Havlova, I; Pisova, J; Podrazil, P; Jirsova, E; Reichert, P; Slaby, J; Spacek, R; Spinar, J; Labrova, R; Vodnansky, P; Samkova, D; Zidkova, E; Dodt, K; Christensen, H; Christensen, L; Hassager, C; Loof, A; Ibsen, H; Madsen, H; Iversen, H; Veng-Olsen, T; Nielsen, H; Olsen, R; Overgaard, K; Petrovic, V; Raymond, I; Raae, D; Sand, N; Svenningsen, A; Torp-Pedersen, C; Jakobsen, U; Wiggers, H; Serup-Hansen, K; Kaik, J; Stern, A; Kolk, R; Laane, E; Rivis, L; Paumets, M; Voitk, J; Rosenthal, A; Rajasalu, R; Vahula, V; Ratnik, E; Huikuri, H; Kaarleenkaski, S; Hussi, E; Valpas, S; Jakala, P; Lappalainen, T; Lucijanic, T; Laheaar, M; Maenpaa, A; Viitaniemi, J; Nyman, K; Sankari, T; Rasi, H; Salminen, O; Virtanen, V; Nappila, H; Le Heuzey, J; Agraou, B; El Jarroudi, F; Amarenco, P; Boursin, P; Babuty, D; Boyer, M; Belhassane, A; Berbari, H; Blanc, J; Dias, P; Coisne, D; Berger, N; Decoulx, E; El Jarroudi, M; Dinanian, S; Arfaoui, M; Hermida, J; Deruche, E; Kacet, S; Corbut, S; Poulard, J; Leparree, S; Roudaut, R; Duprat, C; Al-Zoebi, A; Wurow, A; Bernhardt, P; Dichristin, U; Berrouschot, J; Vierbeck, S; Beyer-Westendorf, J; Sehr, B; Bouzo, M; Schnelzer, P; Braun, R; Ladenburger, K; Buhr, M; Weihrauch, D; Contzen, C; Kara, M; Daut, W; Ayasse, D; Degtyareva, E; Kranz, P; Drescher, T; Herfurth, B; Faghih, M; Forck-Boedeker, K; Schneider, K; Fuchs, R; Manuela, W; Grigat, C; Otto, A; Hartmann, A; Peitz, M; Heuer, H; Dieckheuer, U; Hoffmann, U; Dorn, S; Hoffmann, S; Schuppe, M; Horacek, T; Fink, P; Junggeburth, J; Schmid, S; Jungmair, W; Schoen, B; Kleinecke-Pohl, U; Meusel, P; Koenig, H; Bauch, F; Lohrbaecher-Kozak, I; Grosse, B; Lueders, S; Venneklaas, U; Luttermann, M; Wulf, M; Maus, O; Hoefer, K; Meissner, G; Braemer, U; Meyer-Pannwitt, U; Frahm, E; Mitrovic, V; Vogt, S; Muegge, A; Barbera, S; Mueller-Glamann, M; Raddatz, K; Piechatzek, R; Lewinsky, D; Pohl, W; Proskynitopoulos, N; Kuhlmann, M; Rack, K; Pilipenko, H; Rinke, A; Kuhlenborg, A; Schaefer, A; Szymanowski, N; Schellong, S; Frommhold, R; Schenkenberger, I; Finsterbusch, T; Dreykluft, K; Schiewe, C; Schmidt, A; Schmidt, M; Schreckenberg, A; Hellmers, J; Seibert, H; Gold, G; Sohn, H; Baylacher, M; Spitzer, S; Bonin, K; Stoehring, R; Taggeselle, J; Zarpentin, C; Veltkamp, R; Ludwig, I; Voehringer; Buchholz, M; Weyland, K; Winkelmann, B; Buelow-Johansen, B; Wolde, C; Winter, K; Alexopoulos, D; Mavronasiou, E; Bourlios, P; Tziortziotis, A; Karamitsos, C; Exarchou, E; Kifnidis, K; Daskalaki, A; Moschos, N; Dimitra, K; Olympios, C; Kartsagkoulis, E; Pyrgakis, V; Korantanis, K; Milla, OA; Ramirez, VD; Melgar, IG; Jimenez, T; Lavagnino, AO; Guevara, S; Estrada, MR; Sanchez, M; Pozuelos, JM; Samayoa, CS; Guerra, L; Camas, LV; Almaraz, SP; Dioszeghy, P; Muskoczki, E; Edes, I; Szatmari, J; Fiok, J; Varga, A; Kanakaridisz, N; Kosztyu, M; Kis, E; Feil, JF; Kiss, R; Jakal, A; Koczka, M; Kovacs, I; Baranyai, M; Kovacs, Z; Lupkovics, G; Karakai, HH; Matoltsy, A; Kiss, T; Medvegy, M; Kiss, K; Merkely, B; Kolumban, E; Nagy, A; Palinkas, A; Toth, SR; Sayour, A; Bognar, A; Simor, T; Ruzsa, D; Sipos, T; Szakal, I; Tomcsanyi, J; Marosi, A; Vertes, A; Kincses, M; Malhan, S; Abdullakutty, J; Agarwal, D; Ranka, R; Arneja, J; Memon, A; Arora, V; Shree, R; Avvaru, G; Shaikh, A; Babu, P; Rao, B; Babu, R; Reddy, J; Banker, D; Sheth, T; Benjarge, P; Surushe, S; Bharani, A; Solanki, R; Bhargava, V; Rathi, A; Biniwale, A; Bhuti, M; Calambur, N; Somaraju, B; Karnwal, N; Chopda, M; Mali, N; Goyal, N; Saini, A; Gupta, J; Singh, P; Hadan, S; Savanth, P; Hardas, S; Thakor, G; Hiremath, J; Ghume, A; Jain, R; Pahuja, M; Joseph, S; Oommen, D; Joseph, J; Thomas, R; Joshi, H; Kale, V; Raut, N; Kandekar, B; Kandekar, S; Kishore, R; Krishnan, H; Kotiwale, V; Kulkarni, R; Deokar, M; Kulkarni, G; Lawande, A; Kumar, P; Karpuram, M; Kumar, A; Francis, J; Kumbla, M; Anthony, A; Lavhe, P; Kale, M; Mardikar, H; Bhaskarwar, P; Mathur, A; Sharma, P; Menon, J; Francis, V; Namjoshi, D; Shelke, S; Narendra, J; Natarajan, S; Oomaan, A; Gurusamy, P; Angel, J; Purayil, MP; Shams, S; Pandurangi, U; Sababathi, R; Parekh, P; Jasani, B; Patki, N; Babbar, A; Pinto, B; Kharalkar, H; Premchand, R; Jambula, H; Rao, M; Vuriya, A; Shankar, AR; Reddy, R; Bekal, S; Roy, D; Barai, A; Saha, D; Gadepalli, R; Sant, H; Jadhav, D; Sarna, M; Arora, T; Sawhney, J; Singh, R; Sethi, K; Bansal, N; Sethia, A; Sethia, S; Shetty, G; Sudheer, R; Singh, G; Gupta, R; Srinivas, A; Thankaraj, L; Varma, S; Kaur, A; Vinod, MV; Thakur, B; Zanwar, I; Dharmarao, A; Atar, S; Lasri, E; Dicker, D; Marcoviciu, D; Lahav, M; Gilat, T; Elias, M; Ron, GA; Francis, A; Ghantous, R; Goldhaber, A; Goldhaber, M; Gottlieb, S; Rouwaida, S; Grossman, E; Dagan, T; Hasin, Y; Roshrosh, M; Hayek, T; Majdoub, A; Klainman, E; Genin, I; Lewis, B; Ben Ari, M; Lishner, M; Karny, M; Ouzan, E; Givoni, H; Rozenman, Y; Logvinenko, S; Schiff, E; Sterlin, J; Shochat, M; Aloni, I; Swissa, M; Belatsky, V; Tsalihin, D; Kisos, D; Zeltser, D; Platner, N; Berni, A; Giovannelli, F; Boriani, G; Cervi, E; Comi, G; Peruzzotti, L; Cuccia, C; Forgione, C; De Caterina, R; De Pace, D; De Servi, S; Mariani, M; Di Lenarda, A; Mazzone, C; Di Pasquale, G; Di Niro, M; Fattore, L; Bosco, B; Grassia, V; Murena, E; Laffi; Gaggioli, G; Lo Pinto, G; Raggi, F; Marino, P; Francalacci, G; Merlini, P; Babbolin, M; Metra, M; Bulgari, M; Penco, M; Lioy, E; Filardi, PP; Marciano, C; Pirelli, S; Paradiso, G; Piseddu, G; Fenu, L; Raisaro, A; Granzow, K; Rasura, M; Cannoni, S; Severi, S; Breschi, M; Toschi, V; Gagliano, M; Zaca, V; Furiozzi, F; Hirahara, T; Akihisa, U; Masaki, W; Ajioka, M; Matsushita, C; Anzai, T; Mino, K; Arakawa, S; Tsukimine, A; Endo, H; Fujiwara, M; Fujii, K; Kozeni, S; Fujii, E; Kotera, M; Fujimoto, S; Omae, K; Fujimoto, K; Ichishita, Y; Fujita, T; Ito, Y; Fukamizu, S; Harada, J; Fukuda, N; Fujimoto, C; Funazaki, T; Yamaguchi, A; Furukawa, Y; Kamitake, C; Hagiwara, N; Naganuma, M; Hara, S; Kumagai, S; Harada, K; Fuki, Y; Haruna, T; Nakahara, Y; Hashimoto, Y; Shimazu, Y; Hiasa, Y; Oga, Y; Higashikata, T; Nakagawa, Y; Hirayama, A; Kawaguchi, A; Iesaka, Y; Miyamoto, C; Iijima, T; Higuchi, K; Ino, H; Noguchi, H; Inomata, T; Nakamura, K; Ishibashi, Y; Nozaki, T; Ishii, Y; Tomita, H; Ishimaru, S; Ise, M; Itamoto, K; Ito, T; Ito, Y; Onishi, M; Iwade, K; Sakuma, Y; Iwasaki, T; Nagatome, H; Kakinoki, S; Adachi, C; Kamakura, S; Nakahara, F; Kamijo, M; Iida, S; Kamiyama, K; Fujii, R; Kato, K; Ishida, A; Kazatani, Y; Ichikawa, Y; Kitazawa, H; Igarashi, C; Kobayashi, Y; Kikuchi, R; Kohno, M; Tamura, S; Koretsune, Y; Yumoto, I; Kurabayashi, M; Koya, E; Masuyama, T; Kaneno, Y; Matsuda, K; Ebina, E; Meno, H; Satake, M; Mita, T; Takeda, M; Miyamoto, N; Kimizu, T; Miyauchi, Y; Sakamoto, S; Munemasa, M; Murata, J; Nagai, Y; Sakata, Y; Naito, S; Oyama, H; Nishi, Y; Nagase, T; Ochiai, J; Junko, H; Ogawa, T; Sugeno, M; Oguro, H; Tanabe, M; Okada, K; Moriyama, Y; Okajima, K; Nakashima, M; Okazaki, O; Wada, H; Okishige, K; Kitani, S; Okumura, K; Narita, Y; Onaka, H; Moriyama, H; Ozaki, Y; Tanikawa, I; Sakagami, S; Nakano, A; Sakuragi, S; Hayashi, N; Sakurai, S; Ooki, H; Sasaki, T; Oosawa, N; Satoh, A; Fujimoto, E; Seino, Y; Narumi, M; Shirai, T; Shigenari, M; Shoji, Y; Ueda, J; Sugi, K; Miyazaki, E; Sumii, K; Asakura, H; Takagi, M; Mohri, S; Takahashi, W; Yoshida, K; Takahashi, A; Kishi, N; Takahashi, T; Sakurai, Y; Takeda, K; Yahata, A; Takenaka, T; Yamagishi, K; Takeuchi, S; Watanabe, E; Tanaka, K; Uchida, M; Tanouchi, J; Nishiya, Y; Tsuboi, H; Yoshida, K; Tsuboi, N; Terakura, K; Uematsu, M; Yasumoto, S; Ueyama, Y; Onishi, M; Usuda, K; Sakai, Y; Yagi, M; Sato, A; Yagi, H; Kuroda, T; Yamabe, H; Sakamoto, Y; Yamada, T; Yamano, R; Yamagishi, T; Sasaki, S; Yamamoto, Y; Ito, Y; Yamashina, A; Takiguchi, M; Yamashita, T; Matsuda, K; Yonehara, T; Tanaka, K; Yoshino, H; Nomura, H; Yoshioka, K; Fujiwara, Y; Llamas, EB; Hurtado, A; Vargas, CC; Limon, MC; Munoz, EC; Hernandez, S; Carrillo, J; Delgadillo, T; Ramirez, MC; Valles, JF; Garcia, N; Colin, MA; Garcia-Castillo, A; Jaramillo, A; Leiva-Pons, J; de la Mora, S; Esperon, GL; Grajales, A; Mendez-Machado, G; Avila, H; Ruiz, LN; Magallanes, G; Diaz, CS; Ortiz, A; Sanchez, RV; Velazquez, EM; Alhakim, M; van Welsen, I; Bruning, T; Jones, A; Buiks, C; de Groot, J; Radder, I; de Vos, R; Hazeleger, R; Daniels, R; Kietselaer, B; Muijs, L; Mannaerts, H; Kooiman, E; Mevissen, H; van der Heijden, D; Hofmeyer, H; Anscombe, R; O'Meeghan, T; Kjentjes, M; Benatar, J; White, H; Borthwick, L; Doughty, R; Copley, M; Fisher, R; Monkley, R; Green, B; Scott, D; Hamer, A; Tomlinson, J; Hart, H; Turner, A; Scott, D; Cammell, R; Troughton, R; Skelton, L; Young, C; Kennett, K; Atar, D; Claussen, H; Hofsoy, K; Melbue, R; Sandvik, J; Thunhaug, H; Tveit, A; Enger, S; Bustamante, G; Guillen, MT; Cabrera, J; Mendoza, RE; Chavez, C; Luna, C; Lema, J; Carrion, A; Llerena, N; Bedregal, SA; Palomino, FM; Rodriguez, J; Minchola, J; Bautista, C; Miguel, SN; Armas, BH; Rodriguez, A; Romero, N; Torres, P; Rodriguez, KF; Chavez, PY; Horna, M; Delgado, S; Babilonia, N; Sambaz, CM; Barcinas, R; Zapanta, M; Coching, R; Vallenas, M; Matiga, G; Enad, C; Rogelio, G; Joaquin, F; Roxas, A; Gilo, L; To, R; Aquino, M; Villamor, L; Nario, K; Adamus, J; Korzeniowska-Adamus, J; Baszak, J; Bronisz, M; Cieslak, B; Busz-Papiez, B; Krzystolik, A; Cymerman, K; Dabrowska, M; Ptak, A; Derlaga, B; Laskowska-Derlaga, E; Domanska, E; Guziewicz, M; Gieroba, A; Zajac, E; Gniot, J; Mroczkowski, P; Januszewicz, A; Makowiecka-Ciesla, M; Jazwinska-Tarnawska, E; Ciezak, P; Jurowiecki, J; Kaczmarek, B; Pacholska, A; Kaminski, L; Kania, G; Tymendorf, K; Karczmarczyk, A; Kaliszczak, R; Konieczny, M; Benicka, E; Korzeniak, R; Borowski, W; Krzyzanowski, W; Muzyk-Osikowicz, M; Sklodowskiej-Curie, M; Kus, W; Lesnik, J; Wierzykowski, T; Lewczuk, J; Stopyra-Poczatek, M; Lubinski, A; Szymanska, K; Lysek, R; Jaguszewska, G; Matyszczak-Toniak, L; Sznajder, R; Wnetrzak-Michalska, R; Kosmaczewska, A; Mazur, S; Chmielowski, A; Miekus, P; Kosmalska, K; Mosiewicz, J; Myslinski, W; Napora, P; Biniek, D; Nessler, J; Nessler, B; Niezgoda, K; Nej, A; Nowak, J; Olszewski, M; Podjacka, D; Janczewska, D; Pogorzelska, H; Polaszewska-Pulkownik, V; Bojanowska, E; Raczak, G; Zienciuk-Krajka, A; Rewinska, H; Rozmyslowicz-Szerminska, W; Ronkowski, R; Ruzyllo, W; Norwa-Otto, B; Sendrowski, D; Spyra, J; Szolkiewicz, M; Malanska, A; Turbak, R; Wrobel, W; Muzalewski, P; Wysokinski, A; Kudlicki, J; Zarebinski, M; Krauze, R; Zielinski, M; Nawrot, M; Matias, F; Correia, J; Gil, V; Lopes, S; Madeira, J; Maymone, D; Martins, D; Neves, E; Monteiro, P; Oliveira, D; Marques, AL; Salgado, A; Goncalves, A; Santos, O; Nunes, LVP; Santos, J; Soares, D; Albulescu, P; Ciortea, M; Apetrei, E; Matei, C; Bartos, D; Badila, E; Bengus, C; Ochean, V; Bobescu, E; Doka, B; Bolohan, F; Ciobotaru, G; Andor, M; Coman, I; Ghionea, M; Constantinescu, M; Creteanu, M; Parasteac, M; Cristea, M; Anciu, M; Crisu, D; Jemna, D; Dobre, I; Voicu, O; Dobreanu, D; Sirbu, I; Dragomir, D; Jurca, S; Iosipescu, L; Costache, L; Minescu, B; Serban, D; Pop, C; Cozma, M; Popescu, M; Ardelean, A; Sipciu, D; Plosca, P; Stamate, S; Spinu, C; Topolnitchi, L; Tudoran, M; Tudoran, C; Zhukova, N; Arutyunov, G; Chernyavskaya, T; Ballyuzek, M; Alexandrova, L; Barbarash, O; Bashkireva, A; Bart, B; Larina, V; Belenky, D; Kosolapov, Y; Berns, S; Yukhno, E; Bokarev, I; Khlevchuk, T; Chumakova, G; Pokutneva, O; Demko, A; Masin, A; Dovgalevsky, P; Puchinyan, N; Drapkina, O; Zyatenkova, E; Egorova, L; Esip, V; Kirichek, N; Filatov, A; Soin, I; Gilinskaya, O; Valuyshkih, E; Glezer, M; Valovyeva, S; Golitsyn, S; Kratskina, T; Goloshchekin, B; Laptev, I; Gratsiansky, N; Mazovets, O; Karpov, Y; Buza, V; Kosenko, B; Khirmanov, V; Kireenkov, I; Khokhlov, A; Sinitsina, O; Khokhlov, R; Tsareva, E; Khrustalev, O; Khrustalev, A; Kostenko, V; Karabalieva, S; Koziolova, N; Polyanskaya, E; Kozyrev, O; Kostenko, O; Kuznetsov, V; Rychkov, A; Lavrova, O; Tereschenko, L; Levashov, S; Volkova, E; Libis, R; Maslova, A; Libov, I; Moiseeva, Y; Lila, A; Belousova, L; Lukyanov, Y; Lamden, D; Nikolaev, K; Nikolaev, A; Nikolskaya, I; Khromova, O; Novikova, N; Patrusheva, S; Panchenko, E; Laguta, P; Panov, A; Nilk, R; Polkanova, E; Matveeva, I; Poluyanova, N; Pikalova, N; Raskina, T; Letaeva, M; Rebrov, A; Karoli, N; Repin, M; Rodina, N; Shaposhnik, I; Lebedev, E; Shogenov, Z; Agirov, M; Sidorenko, B; Vorontsova, S; Sinitsina, I; Orlov, V; Sizova, Z; Lapidus, N; Sobolev, K; Erofeeva, S; Suprun, E; Dronov, D; Tarasov, N; Isakov, L; Tereshenko, S; Kositsyna, I; Tikhonova, E; Solovyev, A; Timofeev, A; Bulygin, S; Ustyugov, S; Rossovskaya, M; Vishnevsky, A; Kirgizova, A; Volkov, D; Rodina, N; Yakusevich, V; Petrochenko, A; Yakushin, S; Nikulina, N; Zateyshchikov, D; Zotova, I; Zateyshchikova, A; Mankhaeva, B; Zenin, S; Kononenko, O; Zubeeva, G; Motylev, I; Apostolovic, S; Djordjevic-Radojkovic, D; Celic, V; Majstorovic, A; Adjic, NC; Bjelobrk, M; Despotovic, N; Erceg, P; Ilic, S; Ilic, B; Krotin, M; Djokovic, A; Miloradovic, V; Djokic, I; Otasevic, P; Tasic, N; Potpara, T; Polovina, M; Putnikovic, B; Kalezic, T; Seferovic, P; Milinkovic, I; Tavciovski, D; Davicevic, Z; Vasiljevic-Pokrajcic, Z; Mitrovic, P; Tesic, BV; Ostojic, M; Castro, C; Topolnitchi, O; Ruda, M; Golshmid, M; Tesic, M; Ambrovicova, V; Ambrovic, I; Banikova, A; Dukat, A; Kosmalova, V; Dulkova, K; Dulka, T; Duris, T; Vankova, L; Dzupina, A; Dzupinova, M; Hatalova, K; Hatala, R; Hranai, M; Hofmanova, J; Kasperova, V; Reptova, A; Mazur, J; Pella, D; Fedacko, J; Ruffini, L; Morsky, J; Slanina, M; Kmec, J; Zachar, A; Kokles, M; Zareczky, P; Bollova, D; Badenhorst, J; Erasmus, L; Basson, M; Poynton, M; Dalby, A; Allman, J; Ellis, G; Botha, L; Engelbrecht, J; Mostert, M; Essop, M; Nunkoo, T; Gani, M; Wilson, L; Kelfkens, Y; Mitha, I; Taljaard, J; Naidoo, D; Duki, Y; Snyders, F; Munnik, M; Soma, P; Johnston, H; Van Der Merwe, N; Goosen, Y; Van Zyl, L; Le Roux, M; Venter, T; Wessels, L; Bae, HJ; Han, MG; Cha, JK; Kim, DH; Cho, BR; Ryu, DR; Choi, HH; Hong, KS; Chung, WS; Oh, YS; Han, SH; Lee, KH; Hong, TJ; Lee, HW; Hyon, MS; Jung, JW; Jeon, HK; Lee, JM; Kang, DH; Choi, KJ; Kim, CJ; Jin, ES; Kim, DS; Seo, JS; Kim, HS; Cha, MJ; Kim, JT; Park, MS; Kim, JH; Park, JH; Kim, JS; Park, SJ; Kim, SH; Seo, JB; Kim, YJ; Chun, MY; Lee, MH; Joung, BY; Lee, SH; Shin, DG; Namgung, J; Kwak, JJ; Rha, SW; Na, JO; Rim, SJ; Kim, JY; Torres, MA; Rey, AM; Coronado, JB; Puertas, I; Cortada, JB; Cabero, P; Calvo, C; Calvo, G; Borda, AD; Asensio, A; Tejedor, ED; Guevara, MP; Juanatey, JG; Moure, M; Madrid, AH; Delgado, A; Garcia-Aranda, VL; Barquero, R; Manzano, L; Abril, SB; Merino, J; Diaz-Pintado, M; Arias, J; Fernandez, M; Alvarez, RF; Terns, M; Delgado, MD; Villuendas, R; Astier, L; Appelros, P; Akerberg, A; Blom, KB; Andersson, R; Blomstrom, P; Persson, L; Carlsson, T; Bengtsson, AS; Dettmann, S; Ostberg, S; Engdahl, J; Karlsson, L; Herlitz, J; Winberg, L; Juul-Moller, S; Jernhed, H; Koskinen, P; Hakansson, E; Kozak, P; Edlund, M; Malmqvist, L; Eriksson, G; Randers, F; Moodh, J; Rautio, A; Johansson, M; Ronn, F; Sundholm, C; Stenberg, A; Gunnarsson, A; Thulin, J; Broberg, M; Moccetti, T; Slater, IP; Cheng, CC; Wu, WS; Chiang, CE; Yu, WC; Chiang, FT; Wu, YW; Chiou, CW; Yeh, TC; Hsia, CH; Chen, YP; Huang, JL; Chen, YF; Kuo, CT; Wang, CL; Lai, WT; Lin, TH; Lee, JT; Pai, PY; Lin, KH; Shyu, KG; Chiu, CZ; Tseng, WK; Pan, YF; Ueng, KC; Lee, SC; Wang, JH; Tsai, WC; Yeh, HI; Kuo, JY; Jirasirirojanakorn, K; Pornchaiyasit, K; Kaewsuwanna, P; Sinthusopa, W; Kiatchoosakun, S; Sriprasert, S; Laothavorn, P; Bamrungpong, P; Piyayotai, D; Sripracha, A; Sritara, P; Panpunuan, P; Sukonthasarn, A; Mekara, W; Vorasettakarnkij, Y; Puripun, E; Acikel, M; Akilli, H; Demir, H; Ata, N; Bayata, S; Cakmak, N; Calik, A; Cayli, M; Ceyhan, C; Erdogan, D; Ermis, C; Kabul, K; Kanadasi, M; Oto, A; Turgut, O; Tandogan, I; Yalcin, R; Yigit, F; Yigit, Z; Zoghi, M; Batushkin, V; Azhdari, M; Bazylevych, A; Vlasyuk, Z; Bereznyakov, I; Lebedynskaya, M; Dotsenko, S; Kulynych, R; Dzyak, G; Vasilyeva, L; Faynyk, A; Sorokivskyy, M; Gavrysyuk, V; Dzublik, Y; Horbach, L; Husyev, V; Godlevska, O; Samburg, Y; Karpenko, O; Nevolina, I; Karpenko, Y; Blihar, O; Kaydashev, I; Gerasimenko, N; Kolomyyits, S; Vasylets, V; Kopytsya, M; Petyunina, O; Kotseruba, V; Dvoieglazova, M; Koval, V; Ohirko, O; Koval', O; Kaplan, P; Kraiz, I; Usan, N; Kraydashenko, O; Stets, R; Kupnovytska, I; Kyyak, Y; Lizogub, V; Gorna, O; Malynovsky, Y; Fedotov, S; Ostrovska, L; Ushakova-Sokolova, L; Parkhomenko, A; Dovgan, N; Potapenko, P; Nekrasa, A; Prokhorov, O; Leonidova, V; Rebrov, B; Gamachek, O; Rishko, M; Chendey, T; Rudyk, I; Shatilo, V; Ishchuk, V; Shcherbak, V; Goncharova, I; Shvetz, N; Zamlynskyy, M; Sirenko, Y; Stanislavchuk, M; Perebetiuk, L; Sychov, O; Lyzohub, S; Tseluyko, V; Kuznetsov, I; Tykhonova, S; Vakaliuk, I; Drapchak, I; Vatutin, M; Sklyanna, O; Vizir, V; Goncharov, O; Volkov, V; Serik, S; Yagensky, A; Nahrebetskyy, V; Yena, L; Mudruk, I; Zharinov, O; Logvinov, Y; Zhurba, S; Shandra, T; Aggarwal, R; Smith, S; Beeton, I; Dunn, S; Blagden, M; Price, R; Camm, J; Dougal, K; Chapman, O; Davies, D; Choy, A; Duff, J; Cohen, A; Wilmott, R; D'Costa, D; Green, M; Douglas, H; Dickinson, D; Lie, F; Ramasamy, V; Lindsay, S; Atkinson, C; Linker, N; Finlayson, M; Lip, G; Brown, R; MacCallum, P; Ebano, P; MacLeod, M; McGhee, C; Marazzi, P; Jones, D; Maxwell, T; Isted, C; More, R; Helliwell, L; Moriarty, A; Mackin, A; Murdoch, D; Andrews, A; Newby, D; Flint, L; Pye, M; Wright, L; Roberts, J; Avery, D; Senior, R; Young, G; Sopher, M; Kennard, S; Storey, R; Bridge, C; Turner, W; Walker, M; Venkataraman, A; Gilchrist, M; Watkin, R; Chung, A; Wright, A; Wright, J; Abi-Mansour, P; Panella, M; Adams, K; Lohman, J; Adler, J; Barash, B; Adler, P; Reiling, S; Aggarwal, R; Beck, P; Ahmad, A; Hussain, A; Ahmadpour, H; Lim, G; Akhter, F; Brubaker, S; Alexander, J; Genova-Peeva, E; Aliyar, P; Godsey, W; Allison, J; Biscardi, R; Almquist, A; MacDonald, H; Alsheikh, T; Lane, B; Amin, K; Khetarpal, S; Amin, M; Persechino, F; Anderson, J; York, T; Arnold, T; Shoaf, R; Arouni, A; Rasmussen, L; Attanti, S; Strickland, S; Aude, Y; Cobos, D; Awasty, V; Baldwin, E; Ayesu, K; Thompson, B; Baine, S; Batista, M; Baman, R; Campbell, G; Barber, M; Altonen, D; Barker, T; Faircloth, C; Barrington, P; Gordon, L; Bartkowiak, A; Benton, J; Beasley, R; Hoffman, T; Bedoya, R; Luis-Valdes, M; Bedwell, N; Craig, M; Beinart, S; Swaim, D; Bensimhon, D; Garman, V; Berk, M; Ibarra, M; Bernard, J; Eldred, R; Bilal, B; Preston, S; Bilazarian, S; Langone, L; Bingham, S; Antonino, M; Block, T; Talbot-Lawson, C; Blonder, R; Ensminger, E; Bloomberg, R; Bloomberg, K; Blue, B; Vernon, M; Borsheim, M; Hickenbotham, D; Bouchard, A; Wade, W; Bowden, W; Ziegler, K; Bradley, A; Terry, P; Brilakis, E; Frey, W; Brown, H; Triano, A; Bybee, K; Al-Maliky, T; Cader, C; Morton, S; Canaday, D; Dickinson, D; Canosa, R; Hartranft, E; Caplan, J; Jameson, L; Carr, K; Phan, D; Chang, M; Hatfield, G; Charlat, M; Tamayo, M; Chaturvedi, S; Sawaya, K; Ciaramita, J; Bagby, J; Clapp, T; Clay, A; McClelland, M; Cohen, A; Dutka, C; Cohen, R; Bossaers, J; Colan, D; Salpas, S; Cole, J; Fisher, M; Concha, M; Martinez, E; Corbett, B; Svadbik, L; Cossu, S; Mullinax, K; Cottiero, R; Masson, E; Cowan, L; Nelson, L; Curtis, B; Sarpola, N; Dang, N; Morgan, T; Daniels, S; Leka, G; Datta, S; Wulf, A; Dave, K; Dave, B; Davuluri, A; Ebreo, N; De Lemos, J; Debes, C; Dean, J; Warmack, D; DeGarmo, R; Carey, J; Desai, A; Steward, A; Desire, A; Waters, L; Devenport, S; Briscoe, C; Dhar, S; Ucik, S; DiGiovanna, M; Tisdale, L; Donovan, D; Rodriguez, L; Dotani, I; Olson, A; Drozdiak, R; Habibi, S; D'Souza, A; Cullen, T; Eade, J; Dunn, K; Eldadah, Z; Quick, R; Ellis, J; Cristaldi, J; Erenrich, N; Johnson, C; O'Brien, J; Ettinger, N; Shipp, A; Everhart, B; DeSalle, D; Fahmy, R; Watkins, D; Feld, L; Tameron, A; Feldman, J; Tang, N; Felten, W; Prior, J; Fialkow, J; Calvo, M; Finkel, M; Shriver, D; Finkelstein, S; Lim, G; Fischell, T; Drew, B; Fishbein, G; Donahue, S; Flores, E; Slayton, C; Forman, S; Solis, A; Frais, M; Thrope, C; Franco, M; Gentry, P; French, W; Morales, C; Friedlander, I; Smith, K; Gaffney, M; Jones, J; Garb, J; Miranda, J; George, F; Valentine, H; Gerber, J; Hinchion, N; Gillespie, E; Keane-Richmond, P; Gogia, H; Ewing, B; Goldscher, D; Latteri, J; Goldstein, M; Fisher, M; Gowda, S; Rafala, E; Graham, S; Bonora, M; Griffin, S; Aull, L; Griffin, J; Goodman, V; Grossman, C; Davis, A; Grove, D; Mabe, K; Guarino, J; Gabela, W; Guarnieri, T; Fisher, M; Guerrero; Foster, B; Guthrie, R; Felsman, D; Gvora, T; McLean, R; Hack, T; Morelli, L; Hamroff, G; Bentivenga, L; Han, M; Cavanna, L; Harris, J; Bobade, M; Hearne, S; Krater, C; Heiman, M; Dandekar, U; Shah, D; Henderson, D; Millard, D; Henry, S; Harkins, V; Hermany, P; Batchell, K; Herrod, J; Miranda, D; Herson, S; Carey, G; Hinchman, D; Vieira, P; Hippert, R; Dutter, S; Hoekstra, J; Young, C; Homan, J; Homayouni, A; Horton, K; Sloss, D; Hotchkiss, D; Turner, N; Houchin, V; Adams, K; Howard, V; Hays, D; Howard, L; Craft, D; Huang, P; Truva, C; Hunter, J; Battistelli, E; Hurst, P; Garza, M; Hussain, M; Tambawala, M; Ison, R; Butcher, S; Jardula, M; Andresen, T; Johnson, F; Phillips, T; Jones, R; Hughett, G; Jovin, I; Nichols, M; Judson, P; Royes, A; Kahn, B; Coombs, V; Kai, W; Dugal, J; Kandath, D; Kostedt, G; Kaplan, K; Cook, S; Kapoor, A; Ruggiero, M; Karunaratne, H; Behm, K; Kastelic, R; Davis, C; Keller, R; Keller, J; Kerkering, M; Bartholomaus, D; Kersh, R; Buhler, A; Kesselbrenner, M; DiCorcia, L; Khan, B; Binns, M; Khan, M; Khan, G; Kindman, L; Averett, P; Korpas, D; Godfrey, C; Kotha, P; Sanchez, E; Kozlowski, J; Watts, S; Krichmar, P; Marquez, D; Laliotis, A; Jauregui, V; Lambert, C; Coyle, GS; Landau, C; Ferguson, D; Lang, J; Simmons, T; Langevin, E; Faucett, S; Ledbetter, L; Royse, H; Lentz, M; Smith, D; Lesser, M; Hartley, L; Lewis, D; Bonds, C; Lillestol, M; Miller, D; Ling, L; Murphy, R; Littlefield, R; Wofford, E; Lomnitz, D; Shah, D; Lone, B; Davids, M; Looby, R; Ault, S; Lui, H; Wright, H; Lurie, M; Edelstein, J; Macomber, J; Bush, D; Magee, A; Doctor, A; Mainigi, S; Lisiecki, B; Makam, S; Casas, R; Mandviwala, M; Hernandez, S; Marar, I; Rabadi-Marar, D; Marenberg, M; Bedenko, E; Massin, E; Hicks, T; McCartney, M; Stubbs, L; McGarvey, J; Schwarz, L; McGuire, K; Miranda, J; McKenzie, M; Rodkey, K; McKnight, T; Paul, J; McLaurin, B; Lack, A; Mega, J; Marti, J; Meholick, A; Skinner, J; Mehrle, A; Wall, J; Mendelson, R; Cervellione, K; Mercado, A; Cajulis, C; Michlin, B; Romero-Colon, J; Milas, J; Sanders, D; Miller, R; Sanchez, S; Miller, S; Gryczan, J; Mody, F; Strugatsky, S; Moran, J; Garner, S; Morledge, J; Bowman, B; Mouhaffel, A; Parrott, N; Mounsey, P; Schuler, C; Mowdy, M; Todd, S; Mullen, P; Raziano, S; Murphy, A; Oehmann, V; Nadar, V; Parker, A; Naidu, J; West, M; Nallasivan, M; Goza, J; Nguyen, T; Nomanee, S; Nielsen, R; Wilmot, M; Oberoi, M; Thakkar, N; Oppenheimer, K; McCormick, J; Orchard, R; Garcia, L; Osborne, J; Gonzalez, M; Oza, S; Joseph, L; Patnam, S; Dennison, K; Pavon, H; Gorry, N; Pearlstein, R; Montayne, S; Pentz, W; Duncan, D; Peters, P; Chacon, L; Petruzziello, F; Morlando, F; Pettis, K; Brown, F; Pezzella, S; Kirk, D; Poulathas, A; Cush, S; Pratt, R; Neeper, L; Pribble, A; Lowe, K; Pudi, K; Sham, L; Pugeda, J; Ebert, J; Quadrel, M; Rafla, E; Quinlan, E; Reed, C; Quinn, J; Hemmen, C; Rama, P; Domingo, D; Redondo, V; Wroblewski, J; Renzi, M; Stanley, E; Richwine, R; Pazier, P; Roberts, J; Riofrio, K; Braun, D; Robinson, J; Cherrico, M; Roehll, W; Hollihan, P; Rosado, J; Barnhorst, M; Rosen, R; Martin, C; Ross, S; Freeman, R; Ruoff, G; Nelson, T; Sacco, J; Ball, E; Samal, A; Schomburg, J; Sandberg, J; Lafave, J; Savin, V; Clifton, R; Schaefer, S; Fekete, A; Schneider, R; Schneider, W; Schulman, D; Mercer, S; Seals, A; Ullig, T; Holt, A; Seide, H; Mather, N; Shah, G; Witt, P; Shalaby, A; Seese, M; Shanes, J; Fleets, J; Shaoulian, E; Hren, A; Sheikh, K; Hengerer, T; Shih, H; Browning, J; Shoukfeh, M; Stephenson, L; Siler, T; Champagne, M; Simpson, P; Meyer, R; Singh, N; Turner, K; Singh, V; Nelson, M; Skierka, R; Hughes, B; Smith, S; Keene, R; Smith, R; Hodnett, P; Spangenthal, S; Thomason, L; Sperling, M; Vasquez, E; Spivack, E; McCartney, P; Staniloae, C; Liu, M; Steljes, A; Cox, C; Struble, R; Vittitow, T; Suresh, D; Frost, J; Swerchowsky, V; Freemyer, D; Szulawski, I; Herwehe, S; Tahirkheli, N; Springer, K; Takata, T; Bruton, T; Talano, J; Leo, L; Tami, L; Corchado, D; Tatarko, M; Swauger, M; Tawney, K; Dastoli, K; Teague, S; Young, K; Tee, H; Mitchell, T; Teixeira, J; Southam, D; Torres, M; Romero, N; Tucker, P; Salas, L; Updegrove, J; Hanna, K; Val-Mejias, J; Harrelson, KG; Vemireddy, D; Cardoza, T; Verma, S; Parsons, T; Vicari, R; Warren, K; Vijay, N; Washam, M; Vossler, M; Kilcup, S; Walsh, R; Renaud, K; Ward, S; Locklear, T; Waxman, F; Sanchez, G; Weiss, R; St Laurent, B; Westcott, J; Truva, C; Williams, D; Gibson, C; Williams, R; Dowling, C; Willis, J; VonGerichten, S; Wood, K; Capasso-Gulve, E; Worley, S; Pointer, S; Yarows, S; Sheehan, T; Yasin, M; Preston, S; Yi, J; Dongas, B; Yousuf, K; Fisher, M; Zakhary, B; Curtis, S; Zeig, S; Mason, T; Zellner, C; Harden, M; Roper, E; Waseem, M; Grammer, M				Giugliano, Robert P.; Ruff, Christian T.; Braunwald, Eugene; Murphy, Sabina A.; Wiviott, Stephen D.; Halperin, Jonathan L.; Waldo, Albert L.; Ezekowitz, Michael D.; Weitz, Jeffrey I.; Spinar, Jindrich; Ruzyllo, Witold; Ruda, Mikhail; Koretsune, Yukihiro; Betcher, Joshua; Shi, Minggao; Grip, Laura T.; Patel, Shirali P.; Patel, Indravadan; Hanyok, James J.; Mercuri, Michele; Vogelmann, O.; Gonzalez, C.; Ahuad Guerrero, R.; Rodriguez, M.; Albisu, J.; Rosales, E.; Allall, O.; Reguero, M.; Alvarez, C.; Garcia, M.; Ameriso, S.; Ameriso, P.; Amuchastegui, M.; Caceres, M.; Beloscar, J.; Petrucci, J.; Berli, M.; Budassi, N.; Valle, M.; Bustamante Labarta, G.; Saravia, M.; Caccavo, A.; Fracaro, V.; Cartasegna, L.; Novas, V.; Caruso, O.; Saa Zarandon, R.; Colombo, H.; Morandini, M.; Cuello, J.; Rosell, M.; Cuneo, C.; Bocanera, M.; D'Amico, A.; Cendali, G.; Dran, R.; Moreno, V.; Estol, C.; Davolos, M.; Facello, A.; Facello, M.; Falu, E.; Iriarte, M.; Femenia, F.; Arrieta, M.; Fuselli, J.; Zanotti, A.; Gant Lopez, J.; Meiller, F.; Garcia Duran, R.; Perlo, D.; Garrido, M.; Ceirano, C.; Giacomi, G.; Eden, M.; Giannaula, R.; Huerta, M.; Goicoechea, R.; von Wulffen, M.; Hominal, M.; Bianchini, M.; Jure, H.; Jure, D.; Kevorkian, R.; Monaco, F.; Lanternier, G.; Belcuore, M.; Liniado, G.; Iglesias, M.; Litvak, B.; Nigro, A.; Llanos, J.; Vignau, S.; Lorente, C.; Shatsky, K.; Lotti, J.; Raimondi, G.; Mackinnon, I.; Carne, M.; Manuale, O.; Calderon, M.; Marino, J.; Funes, I.; Muntaner, J.; Gandur, H.; Nul, D.; Verdini, E.; Piskorz, D.; Tommasi, A.; Povedano, G.; Casares, E.; Pozzer, D.; Fernandez, E.; Prado, A.; Venturini, C.; Ramos, H.; Navarrete, S.; Rodriguez, M.; Alvarez, M.; Sanchez, A.; Bowen, L.; Sanjurjo, M.; Codutti, O.; Saravia Toledo, S.; Formoso, I.; Schmidberg, J.; Goloboulicz, A.; Schygiel, P.; Buzzetti, C.; Severino, P.; Morara, P.; Sosa Liprandi, M.; Teves, M.; Vico, M.; Morell, Y.; Anderson, C.; Anderson, C.; Paraskevaidis, T.; Arstall, M.; Hoffmann, B.; Colquhoun, D.; Price-Smith, S.; Crimmins, D.; Slattery, A.; Dart, A.; Kay, S.; Davis, S.; Silver, G.; Flecknoe-Brown, S.; Roberts, J.; Gates, P.; Jones, S.; Lehman, R.; Morrison, H.; McKeirnan, M.; Li, J.; Paul, V.; Batta, C.; Purnell, P.; Perrett, L.; Szto, G.; O'Shea, V.; Capiau, L.; Banaeian, F.; De Bleecker, J.; de Koning, K.; De Tollenaere, M.; De Bruyne, L.; Desfontaines, P.; Tincani, G.; Heidbuchel, H.; Meeusen, K.; Herzet, J.; Malmendier, D.; Mairesse, G.; Raepers, M.; Parque, J.; Clinckemaille, N.; Scavee, C.; Huyberechts, D.; Stockman, D.; Jacobs, C.; Vandekerckhove, Y.; Derycker, K.; Vanwelden, J.; van Welden, J.; Vervoort, G.; Mestdagh, I.; Vrolix, M.; Beerts, C.; Wollaert, B.; Denie, D.; Vincenzo de Paola, A. Amato; Coutinho, E.; Lotufo, P. Andrade; de Melo, R. Ferreira; Atie, J.; Motta, C.; Alves da Costa, F. Augusto; Ferraz, R. Franchin; Precoma, D. Bertolim; Sehnem, E.; Botelho, R.; Cunha, S.; Brondani, R.; Fleck, N.; Chaves Junior, H.; Silva, J.; Costantini, C.; Barroso, D.; De Patta, M.; Pereira, V.; Duda, N.; Laimer, R.; Dutra, O.; Morgado, S.; Saporito, W. Faustino; Seroqui, M.; Ferreira, L.; Araujo, E.; Finimundi, H.; Daitz, C.; Gagliardi, R.; Pereira, G.; Gomes, M.; Gomes, A.; Guimaraes, A.; Ninho, L.; Jaeger, C.; Pereira, L.; Jorge, J.; Cury, C.; Kaiser, S.; Almeida, A.; Kalil, C.; Radaelli, G.; Sebba Barroso de Souza, W. Kunz; Morales, K.; Leaes, P.; Luiz, R. Osorio; Almeida, J. Pimenta; Gozalo, A.; Reis, G.; Avellar, K.; Katz Weiand, L. Reis; Leipelt, J.; Rocha, J.; Barros, R.; Rodrigues, L.; Rocha, M. Rubia; Rodrigues, A.; Rodrigues, D.; dos Santos, F. Rossi; Pagnan, L. Goncalves; Sampaio, R.; do Val, R.; Saraiva, J.; Vicente, C.; Simoes, M.; Carraro, A.; Sobral Filho, D.; Lustosa, E.; Boas, F. Villas; Almeida, M.; Zimmermann, S.; Zimmermann, E. Burger; Chompalova, B.; Parishev, G.; Denchev, S.; Milcheva, N.; Donova, T.; Gergova, V.; Georgiev, B.; Kostova, E.; Goudev, A.; Kinova, E.; Hergeldjieva, V.; Kamenova, P.; Manolova, A.; Vasilev, I.; Mihov, A.; Miteva, B.; Mincheva, V.; Stoyanovski, V.; Nikolov, F.; Vasilev, D.; Pencheva, G.; Kostov, K.; Petranov, S.; Milusheva, T.; Popov, A.; Vasilev, I.; Staneva, A.; Momchilova-Lozeva, D.; Todorov, G.; Nyagina, M.; Tumbev, H.; Tumbeva, D.; Tzekova, M.; Kitova, M.; Manoylov, E.; Archibald, J.; Antle, S.; Bhargava, R.; Stafford, C.; Bose, S.; Hundseth, M.; Cha, J.; Otis, J.; Chehayeb, R.; Lepage, C.; Chilvers, M.; Vansickle, L.; Cleveland, D.; Valley, S.; Constance, C.; Gauthier, M.; Costi, P.; Masson, C.; Coutu, B.; Denis, I.; du Preez, M.; Kubanska, A.; Dufresne, M.; Krider, J.; Eikelboom, J.; Zondag, M.; Fortin, C.; Viau, C.; Green, M.; Houbraken, D.; Hatheway, R.; Mabee, J.; Heath, J.; Scott, L.; Ho, K.; Ho, V.; Hoag, G.; Standring, R.; Huynh, T.; Perkins, L.; Kouz, S.; Roy, M.; Labonte, R.; Dewar, C.; Lainesse, A.; St-Germain, L.; Lam, S.; Lam, H.; Lichtenstein, T.; Roberts, P.; Luton, R.; Douglas, S.; Ma, P.; Seib, M.; MacCallum, C.; Matthews, J.; Malette, P.; Vaillancourt, T.; Maranda, C.; Studenikow, E.; Mawji, A.; Morely, A.; Morrison, D.; Roth, M.; Mucha, M.; Krider, J.; Najarali, A.; Lamoureux, U.; Nicholson, R.; O'Hara, G.; Banville, P.; O'Mahony, W.; Bolton, R.; Parkash, R.; Carroll, L.; Pesant, Y.; Sardin, V.; Polasek, P.; Turri, L.; Qureshi, A.; Nethercott, C.; Ricci, J.; Bozek, B.; Rupka, D.; Marchand, C.; Shu, D.; Silverio, G.; St-Hilaire, R.; Morissette, A.; Sussman, J.; Kailey, P.; Syan, G.; Bobbie, C.; Talajic, M.; David, D.; Talbot, P.; Tremblay, M.; Teitelbaum, I.; Teitelbaum, J.; Velthuysen, G.; Giesbrecht, L.; Wahby, R.; Morley, A.; Wharton, S.; Caterini, T.; Woodford, T.; Mabee, J.; Balboa, W.; Retamal Matus, L.; Bugueno, C.; Mondaca Mondaca, P.; Cobos, J.; Obreque, C.; Corbalan, R.; Parada, A.; Florenzano, F.; Arratia Diaz, P.; Lopetegui, M.; Rebolledo, C.; Manriquez, L.; Manriquez Silva, L.; Martinez, D.; Romero Llamas, R.; Opazo, M.; Carmona Perez, M.; Pincetti, C.; Torres Carrasco, G.; Potthoff, S.; Zapata Staub, J.; Rodriguez, M.; Campisto, Y.; Stockins, B.; Lara Lara, C.; Yovaniniz, P.; Grandon Azua, M.; Bai, F.; Xu, G. L.; Chen, J. Z.; Xie, X. D.; Chen, X. P.; Zhang, X.; Dong, Y. G.; Feng, C.; Fu, G. S.; Zhang, P.; Hong, K.; You, Z. G.; Hong, L.; Qiu, Y.; Jiang, X. J.; Qu, Z.; Li, L.; Liu, H.; Li, T. F.; Kong, Y. Q.; Li, W. M.; Liu, B.; Li, Z. Q.; Liu, Y.; Liao, D. N.; Gu, X. J.; Liu, L.; Lu, Z. H.; Ma, S. M.; Yang, Z. Y.; Wang, D. M.; Qi, S. Y.; Wang, G. P.; Shi, X. J.; Wei, M.; Huang, D.; Wu, S. L.; Li, Y. E.; Xu, J. H.; Gu, J. Y.; Xu, Y. M.; Liang, Y. Z.; Yang, K.; Li, A. Y.; Yang, Y. J.; Zheng, X.; Zheng, Y.; Gao, M.; Yin, Y. H.; Xu, Y. P.; Yu, B.; Li, L. L.; Yuan, Z. Y.; Qiang, H.; Zhang, H. Q.; Lin, Y. N.; Zhang, Z.; Kang, H.; Zhao, R. P.; Han, R. J.; Zhao, X. L.; Wang, J. Q.; Zheng, Z. Q.; Li, B. G.; Zhou, S. X.; Zhang, Y. L.; Accini, J.; Accini, M.; Cano, N.; Leon Pineda, L.; Delgado Restrepo, J.; Arroyave, C.; Fernandez Ruiz, R.; Aldana Diaz, I.; Hernandez, H.; Delgado, P.; Jaramillo Munoz, C.; Builes, A.; Manzur, F.; Rivera Rodriguez, E.; Moncada Corredor, M.; Lopez Giraldo, D.; Orozco Linares, L.; Fonseca, J.; Quintero, A.; Gonzales, C.; Sanchez Vallejo, G.; Perdomo Mejia, I.; Bagatin, J.; Carevic, V.; Car, S.; Jeric, M.; Ciglenecki, N.; Tusek, S.; Ferri Certic, J.; Romic, I.; Francetic, I.; Makar Ausperger, K.; Jelic, V.; Jaksic Jurinjak, S.; Knezevic, A.; Buksa, B.; Samardzic, P.; Cvitkusic Lukenda, K.; Steiner, R.; Kirner, D.; Sutalo, K.; Bakliza, Z.; Vrazic, H.; Bergovec, M.; Bar, M.; Brodova, P.; Berka, L.; Kunkelova, V.; Brtko, M.; Burianova, H.; Cermak, O.; Elbl, L.; Ferkl, R.; Florian, J.; Francek, L.; Golan, L.; Gregor, P.; Honkova, M.; Hubac, J.; Jandik, J.; Jarkovsky, P.; Jelinek, Z.; Jerabek, O.; Jirmar, R.; Kobza, R.; Kochrt, M.; Kostkova, G.; Kosek, Z.; Kovar, P.; Kuchar, R.; Kvasnicka, J.; Ludka, O.; Ludka, O.; Machova, V.; Krocova, E.; Melichar, M.; Nechanicky, R.; Olsr, J.; Peterka, K.; Petrova, I.; Havlova, I.; Pisova, J.; Podrazil, P.; Jirsova, E.; Reichert, P.; Slaby, J.; Spacek, R.; Spinar, J.; Labrova, R.; Vodnansky, P.; Samkova, D.; Zidkova, E.; Dodt, K.; Christensen, H.; Christensen, L.; Hassager, C.; Loof, A.; Ibsen, H.; Madsen, H.; Iversen, H.; Veng-Olsen, T.; Nielsen, H.; Olsen, R.; Overgaard, K.; Petrovic, V.; Raymond, I.; Raae, D.; Sand, N.; Svenningsen, A.; Torp-Pedersen, C.; Jakobsen, U.; Wiggers, H.; Serup-Hansen, K.; Kaik, J.; Stern, A.; Kolk, R.; Laane, E.; Rivis, L.; Paumets, M.; Voitk, J.; Rosenthal, A.; Rajasalu, R.; Vahula, V.; Ratnik, E.; Huikuri, H.; Kaarleenkaski, S.; Hussi, E.; Valpas, S.; Jakala, P.; Lappalainen, T.; Lucijanic, T.; Laheaar, M.; Maenpaa, A.; Viitaniemi, J.; Nyman, K.; Sankari, T.; Rasi, H.; Salminen, O.; Virtanen, V.; Nappila, H.; Le Heuzey, J.; Agraou, B.; El Jarroudi, F.; Amarenco, P.; Boursin, P.; Babuty, D.; Boyer, M.; Belhassane, A.; Berbari, H.; Blanc, J.; Dias, P.; Coisne, D.; Berger, N.; Decoulx, E.; El Jarroudi, M.; Dinanian, S.; Arfaoui, M.; Hermida, J.; Deruche, E.; Kacet, S.; Corbut, S.; Poulard, J.; Leparree, S.; Roudaut, R.; Duprat, C.; Al-Zoebi, A.; Wurow, A.; Bernhardt, P.; Dichristin, U.; Berrouschot, J.; Vierbeck, S.; Beyer-Westendorf, J.; Sehr, B.; Bouzo, M.; Schnelzer, P.; Braun, R.; Ladenburger, K.; Buhr, M.; Weihrauch, D.; Contzen, C.; Kara, M.; Daut, W.; Ayasse, D.; Degtyareva, E.; Kranz, P.; Drescher, T.; Herfurth, B.; Faghih, M.; Forck-Boedeker, K.; Schneider, K.; Fuchs, R.; Manuela, W.; Grigat, C.; Otto, A.; Hartmann, A.; Peitz, M.; Heuer, H.; Dieckheuer, U.; Hoffmann, U.; Dorn, S.; Hoffmann, S.; Schuppe, M.; Horacek, T.; Fink, P.; Junggeburth, J.; Schmid, S.; Jungmair, W.; Schoen, B.; Kleinecke-Pohl, U.; Meusel, P.; Koenig, H.; Bauch, F.; Lohrbaecher-Kozak, I.; Grosse, B.; Lueders, S.; Venneklaas, U.; Luttermann, M.; Wulf, M.; Maus, O.; Hoefer, K.; Meissner, G.; Braemer, U.; Meyer-Pannwitt, U.; Frahm, E.; Mitrovic, V.; Vogt, S.; Muegge, A.; Barbera, S.; Mueller-Glamann, M.; Raddatz, K.; Piechatzek, R.; Lewinsky, D.; Pohl, W.; Proskynitopoulos, N.; Kuhlmann, M.; Rack, K.; Pilipenko, H.; Rinke, A.; Kuehlenborg, A.; Schaefer, A.; Szymanowski, N.; Schellong, S.; Frommhold, R.; Schenkenberger, I.; Finsterbusch, T.; Dreykluft, K.; Schiewe, C.; Schmidt, A.; Schmidt, M.; Schreckenberg, A.; Hellmers, J.; Seibert, H.; Gold, G.; Sohn, H.; Baylacher, M.; Spitzer, S.; Bonin, K.; Stoehring, R.; Taggeselle, J.; Zarpentin, C.; Veltkamp, R.; Ludwig, I.; Voehringer; Buchholz, M.; Weyland, K.; Winkelmann, B.; Buelow-Johansen, B.; Wolde, C.; Winter, K.; Alexopoulos, D.; Mavronasiou, E.; Bourlios, P.; Tziortziotis, A.; Karamitsos, C.; Exarchou, E.; Kifnidis, K.; Daskalaki, A.; Moschos, N.; Dimitra, K.; Olympios, C.; Kartsagkoulis, E.; Pyrgakis, V.; Korantanis, K.; Milla, O. Ayau; Ramirez, V. de Leon; Melgar, I. Guzman; Jimenez, T.; Lavagnino, A. Ovando; Guevara, S.; Estrada, M. Rodas; Sanchez, M.; Pozuelos, J. Mayen; Samayoa, C. Sanchez; Guerra, L.; Camas, L. Velasquez; Almaraz, S. Padilla; Dioszeghy, P.; Muskoczki, E.; Edes, I.; Szatmari, J.; Fiok, J.; Varga, A.; Kanakaridisz, N.; Kosztyu, M.; Kis, E.; Feil, J. Felfoldine; Kiss, R.; Jakal, A.; Koczka, M.; Kovacs, I.; Baranyai, M.; Kovacs, Z.; Lupkovics, G.; Karakai, H. Horvathne; Matoltsy, A.; Kiss, T.; Medvegy, M.; Kiss, K.; Merkely, B.; Kolumban, E.; Nagy, A.; Palinkas, A.; Toth, S. Rostasne; Sayour, A.; Bognar, A.; Simor, T.; Ruzsa, D.; Sipos, T.; Szakal, I.; Tomcsanyi, J.; Marosi, A.; Vertes, A.; Kincses, M.; Malhan, S.; Abdullakutty, J.; Agarwal, D.; Ranka, R.; Arneja, J.; Memon, A.; Arora, V.; Shree, R.; Avvaru, G.; Shaikh, A.; Babu, P.; Rao, B.; Babu, R.; Reddy, J.; Banker, D.; Sheth, T.; Benjarge, P.; Surushe, S.; Bharani, A.; Solanki, R.; Bhargava, V.; Rathi, A.; Biniwale, A.; Bhuti, M.; Calambur, N.; Somaraju, B.; Karnwal, N.; Chopda, M.; Mali, N.; Goyal, N.; Saini, A.; Gupta, J.; Singh, P.; Hadan, S.; Savanth, P.; Hardas, S.; Thakor, G.; Hiremath, J.; Ghume, A.; Jain, R.; Pahuja, M.; Joseph, S.; Oommen, D.; Joseph, J.; Thomas, R.; Joshi, H.; Kale, V.; Raut, N.; Kandekar, B.; Kandekar, S.; Kishore, R.; Krishnan, H.; Kotiwale, V.; Kulkarni, R.; Deokar, M.; Kulkarni, G.; Lawande, A.; Kumar, P.; Karpuram, M.; Kumar, A.; Francis, J.; Kumbla, M.; Anthony, A.; Lavhe, P.; Kale, M.; Mardikar, H.; Bhaskarwar, P.; Mathur, A.; Sharma, P.; Menon, J.; Francis, V.; Namjoshi, D.; Shelke, S.; Narendra, J.; Natarajan, S.; Oomaan, A.; Gurusamy, P.; Angel, J.; Purayil, M. Padinhare; Shams, S.; Pandurangi, U.; Sababathi, R.; Parekh, P.; Jasani, B.; Patki, N.; Babbar, A.; Pinto, B.; Kharalkar, H.; Premchand, R.; Jambula, H.; Rao, M.; Vuriya, A.; Shankar, A. Ravi; Reddy, R.; Bekal, S.; Roy, D.; Barai, A.; Saha, D.; Gadepalli, R.; Sant, H.; Jadhav, D.; Sarna, M.; Arora, T.; Sawhney, J.; Singh, R.; Sethi, K.; Bansal, N.; Sethia, A.; Sethia, S.; Shetty, G.; Sudheer, R.; Singh, G.; Gupta, R.; Srinivas, A.; Thankaraj, L.; Varma, S.; Kaur, A.; Vinod, M. Vijan; Thakur, B.; Zanwar, I.; Dharmarao, A.; Atar, S.; Lasri, E.; Dicker, D.; Marcoviciu, D.; Lahav, M.; Gilat, T.; Elias, M.; Ron, G. Avraham; Francis, A.; Ghantous, R.; Goldhaber, A.; Goldhaber, M.; Gottlieb, S.; Rouwaida, S.; Grossman, E.; Dagan, T.; Hasin, Y.; Roshrosh, M.; Hayek, T.; Majdoub, A.; Klainman, E.; Genin, I.; Lewis, B.; Ben Ari, M.; Lishner, M.; Karny, M.; Ouzan, E.; Givoni, H.; Rozenman, Y.; Logvinenko, S.; Schiff, E.; Sterlin, J.; Shochat, M.; Aloni, I.; Swissa, M.; Belatsky, V.; Tsalihin, D.; Kisos, D.; Zeltser, D.; Platner, N.; Berni, A.; Giovannelli, F.; Boriani, G.; Cervi, E.; Comi, G.; Peruzzotti, L.; Cuccia, C.; Forgione, C.; De Caterina, R.; De Pace, D.; De Servi, S.; Mariani, M.; Di Lenarda, A.; Mazzone, C.; Di Pasquale, G.; Di Niro, M.; Fattore, L.; Bosco, B.; Grassia, V.; Murena, E.; Laffi; Gaggioli, G.; Lo Pinto, G.; Raggi, F.; Marino, P.; Francalacci, G.; Merlini, P.; Babbolin, M.; Metra, M.; Bulgari, M.; Penco, M.; Lioy, E.; Filardi, P. Perrone; Marciano, C.; Pirelli, S.; Paradiso, G.; Piseddu, G.; Fenu, L.; Raisaro, A.; Granzow, K.; Rasura, M.; Cannoni, S.; Severi, S.; Breschi, M.; Toschi, V.; Gagliano, M.; Zaca, V.; Furiozzi, F.; Hirahara, T.; Akihisa, U.; Masaki, W.; Ajioka, M.; Matsushita, C.; Anzai, T.; Mino, K.; Arakawa, S.; Tsukimine, A.; Endo, H.; Fujiwara, M.; Fujii, K.; Kozeni, S.; Fujii, E.; Kotera, M.; Fujimoto, S.; Omae, K.; Fujimoto, K.; Ichishita, Y.; Fujita, T.; Ito, Y.; Fukamizu, S.; Harada, J.; Fukuda, N.; Fujimoto, C.; Funazaki, T.; Yamaguchi, A.; Furukawa, Y.; Kamitake, C.; Hagiwara, N.; Naganuma, M.; Hara, S.; Kumagai, S.; Harada, K.; Fuki, Y.; Haruna, T.; Nakahara, Y.; Hashimoto, Y.; Shimazu, Y.; Hiasa, Y.; Oga, Y.; Higashikata, T.; Nakagawa, Y.; Hirayama, A.; Kawaguchi, A.; Iesaka, Y.; Miyamoto, C.; Iijima, T.; Higuchi, K.; Ino, H.; Noguchi, H.; Inomata, T.; Nakamura, K.; Ishibashi, Y.; Nozaki, T.; Ishii, Y.; Tomita, H.; Ishimaru, S.; Ise, M.; Itamoto, K.; Ito, T.; Ito, Y.; Onishi, M.; Iwade, K.; Sakuma, Y.; Iwasaki, T.; Nagatome, H.; Kakinoki, S.; Adachi, C.; Kamakura, S.; Nakahara, F.; Kamijo, M.; Iida, S.; Kamiyama, K.; Fujii, R.; Kato, K.; Ishida, A.; Kazatani, Y.; Ichikawa, Y.; Kitazawa, H.; Igarashi, C.; Kobayashi, Y.; Kikuchi, R.; Kohno, M.; Tamura, S.; Koretsune, Y.; Yumoto, I.; Kurabayashi, M.; Koya, E.; Masuyama, T.; Kaneno, Y.; Matsuda, K.; Ebina, E.; Meno, H.; Satake, M.; Mita, T.; Takeda, M.; Miyamoto, N.; Kimizu, T.; Miyauchi, Y.; Sakamoto, S.; Munemasa, M.; Murata, J.; Nagai, Y.; Sakata, Y.; Naito, S.; Oyama, H.; Nishi, Y.; Nagase, T.; Ochiai, J.; Junko, H.; Ogawa, T.; Sugeno, M.; Oguro, H.; Tanabe, M.; Okada, K.; Moriyama, Y.; Okajima, K.; Nakashima, M.; Okazaki, O.; Wada, H.; Okishige, K.; Kitani, S.; Okumura, K.; Narita, Y.; Onaka, H.; Moriyama, H.; Ozaki, Y.; Tanikawa, I.; Sakagami, S.; Nakano, A.; Sakuragi, S.; Hayashi, N.; Sakurai, S.; Ooki, H.; Sasaki, T.; Oosawa, N.; Satoh, A.; Fujimoto, E.; Seino, Y.; Narumi, M.; Shirai, T.; Shigenari, M.; Shoji, Y.; Ueda, J.; Sugi, K.; Miyazaki, E.; Sumii, K.; Asakura, H.; Takagi, M.; Mohri, S.; Takahashi, W.; Yoshida, K.; Takahashi, A.; Kishi, N.; Takahashi, T.; Sakurai, Y.; Takeda, K.; Yahata, A.; Takenaka, T.; Yamagishi, K.; Takeuchi, S.; Watanabe, E.; Tanaka, K.; Uchida, M.; Tanouchi, J.; Nishiya, Y.; Tsuboi, H.; Yoshida, K.; Tsuboi, N.; Terakura, K.; Uematsu, M.; Yasumoto, S.; Ueyama, Y.; Onishi, M.; Usuda, K.; Sakai, Y.; Yagi, M.; Sato, A.; Yagi, H.; Kuroda, T.; Yamabe, H.; Sakamoto, Y.; Yamada, T.; Yamano, R.; Yamagishi, T.; Sasaki, S.; Yamamoto, Y.; Ito, Y.; Yamashina, A.; Takiguchi, M.; Yamashita, T.; Matsuda, K.; Yonehara, T.; Tanaka, K.; Yoshino, H.; Nomura, H.; Yoshioka, K.; Fujiwara, Y.; Bayram Llamas, E.; Hurtado, A.; Calvo Vargas, C.; Cedano Limon, M.; Cardona Munoz, E.; Hernandez, S.; Carrillo, J.; Delgadillo, T.; Casares Ramirez, M.; Franco Valles, J.; Garcia, N.; Alcantara Colin, M.; Garcia-Castillo, A.; Jaramillo, A.; Leiva-Pons, J.; de la Mora, S.; Llamas Esperon, G.; Grajales, A.; Mendez-Machado, G.; Avila, H.; Nevarez Ruiz, L.; Magallanes, G.; Sanchez Diaz, C.; Ortiz, A.; Velasco Sanchez, R.; Moran Velazquez, E.; Alhakim, M.; van Welsen, I.; Bruning, T.; Jones, A.; Buiks, C.; de Groot, J.; Radder, I.; de Vos, R.; Hazeleger, R.; Daniels, R.; Kietselaer, B.; Muijs, L.; Mannaerts, H.; Kooiman, E.; Mevissen, H.; van der Heijden, D.; Hofmeyer, H.; Anscombe, R.; O'Meeghan, T.; Kjentjes, M.; Benatar, J.; White, H.; Borthwick, L.; Doughty, R.; Copley, M.; Fisher, R.; Monkley, R.; Green, B.; Scott, D.; Hamer, A.; Tomlinson, J.; Hart, H.; Turner, A.; Scott, D.; Cammell, R.; Troughton, R.; Skelton, L.; Young, C.; Kennett, K.; Atar, D.; Claussen, H.; Hofsoy, K.; Melbue, R.; Sandvik, J.; Thunhaug, H.; Tveit, A.; Enger, S.; Bustamante, G.; Tejada Guillen, M.; Cabrera, J.; Esteves Mendoza, R.; Chavez, C.; Luna, C.; Lema, J.; Carrion, A.; Llerena, N.; Araoz Bedregal, S.; Medina Palomino, F.; Rodriguez, J.; Minchola, J.; Bautista, C.; Negron Miguel, S.; Honores Armas, B.; Rodriguez, A.; Romero, N.; Torres, P.; Fernandez Rodriguez, K.; Yanac Chavez, P.; Horna, M.; Delgado, S.; Babilonia, N.; Sambaz, C. M.; Barcinas, R.; Zapanta, M.; Coching, R.; Vallenas, M.; Matiga, G.; Enad, C.; Rogelio, G.; Joaquin, F.; Roxas, A., Jr.; Gilo, L.; To, R.; Aquino, M.; Villamor, L.; Nario, K.; Adamus, J.; Korzeniowska-Adamus, J.; Baszak, J.; Bronisz, M.; Cieslak, B.; Busz-Papiez, B.; Krzystolik, A.; Cymerman, K.; Dabrowska, M.; Ptak, A.; Derlaga, B.; Laskowska-Derlaga, E.; Domanska, E.; Guziewicz, M.; Gieroba, A.; Zajac, E.; Gniot, J.; Mroczkowski, P.; Januszewicz, A.; Makowiecka-Ciesla, M.; Jazwinska-Tarnawska, E.; Ciezak, P.; Jurowiecki, J.; Kaczmarek, B.; Pacholska, A.; Kaminski, L.; Kania, G.; Tymendorf, K.; Karczmarczyk, A.; Kaliszczak, R.; Konieczny, M.; Benicka, E.; Korzeniak, R.; Borowski, W.; Krzyzanowski, W.; Muzyk-Osikowicz, M.; Sklodowskiej-Curie, M.; Kus, W.; Lesnik, J.; Wierzykowski, T.; Lewczuk, J.; Stopyra-Poczatek, M.; Lubinski, A.; Szymanska, K.; Lysek, R.; Jaguszewska, G.; Matyszczak-Toniak, L.; Sznajder, R.; Wnetrzak-Michalska, R.; Kosmaczewska, A.; Mazur, S.; Chmielowski, A.; Miekus, P.; Kosmalska, K.; Mosiewicz, J.; Myslinski, W.; Napora, P.; Biniek, D.; Nessler, J.; Nessler, B.; Niezgoda, K.; Nej, A.; Nowak, J.; Olszewski, M.; Podjacka, D.; Janczewska, D.; Pogorzelska, H.; Polaszewska-Pulkownik, V.; Bojanowska, E.; Raczak, G.; Zienciuk-Krajka, A.; Rewinska, H.; Rozmyslowicz-Szerminska, W.; Ronkowski, R.; Ruzyllo, W.; Norwa-Otto, B.; Sendrowski, D.; Spyra, J.; Szolkiewicz, M.; Malanska, A.; Turbak, R.; Wrobel, W.; Muzalewski, P.; Wysokinski, A.; Kudlicki, J.; Zarebinski, M.; Krauze, R.; Zielinski, M.; Nawrot, M.; Matias, F.; Correia, J.; Gil, V.; Lopes, S.; Madeira, J.; Maymone, D.; Martins, D.; Neves, E.; Monteiro, P.; Oliveira, D.; Leitao Marques, A.; Salgado, A.; Goncalves, A.; Santos, O.; Veiga Pais Nunes, L.; Santos, J.; Soares, D.; Albulescu, P.; Ciortea, M.; Apetrei, E.; Matei, C.; Bartos, D.; Badila, E.; Bengus, C.; Ochean, V.; Bobescu, E.; Doka, B.; Bolohan, F.; Ciobotaru, G.; Andor, M.; Coman, I.; Ghionea, M.; Constantinescu, M.; Creteanu, M.; Parasteac, M.; Cristea, M.; Anciu, M.; Crisu, D.; Jemna, D.; Dobre, I.; Voicu, O.; Dobreanu, D.; Sirbu, I.; Dragomir, D.; Jurca, S.; Iosipescu, L.; Costache, L.; Minescu, B.; Serban, D.; Pop, C.; Cozma, M.; Popescu, M.; Ardelean, A.; Sipciu, D.; Plosca, P.; Stamate, S.; Spinu, C.; Topolnitchi, L.; Tudoran, M.; Tudoran, C.; Zhukova, N.; Arutyunov, G.; Chernyavskaya, T.; Ballyuzek, M.; Alexandrova, L.; Barbarash, O.; Bashkireva, A.; Bart, B.; Larina, V.; Belenky, D.; Kosolapov, Y.; Berns, S.; Yukhno, E.; Bokarev, I.; Khlevchuk, T.; Chumakova, G.; Pokutneva, O.; Demko, A.; Masin, A.; Dovgalevsky, P.; Puchinyan, N.; Drapkina, O.; Zyatenkova, E.; Egorova, L.; Esip, V.; Kirichek, N.; Filatov, A.; Soin, I.; Gilinskaya, O.; Valuyshkih, E.; Glezer, M.; Valovyeva, S.; Golitsyn, S.; Kratskina, T.; Goloshchekin, B.; Laptev, I.; Gratsiansky, N.; Mazovets, O.; Karpov, Y.; Buza, V.; Kosenko, B.; Khirmanov, V.; Kireenkov, I.; Khokhlov, A.; Sinitsina, O.; Khokhlov, R.; Tsareva, E.; Khrustalev, O.; Khrustalev, A.; Kostenko, V.; Karabalieva, S.; Koziolova, N.; Polyanskaya, E.; Kozyrev, O.; Kostenko, O.; Kuznetsov, V.; Rychkov, A.; Lavrova, O.; Tereschenko, L.; Levashov, S.; Volkova, E.; Libis, R.; Maslova, A.; Libov, I.; Moiseeva, Y.; Lila, A.; Belousova, L.; Lukyanov, Y.; Lamden, D.; Nikolaev, K.; Nikolaev, A.; Nikolskaya, I.; Khromova, O.; Novikova, N.; Patrusheva, S.; Panchenko, E.; Laguta, P.; Panov, A.; Nilk, R.; Polkanova, E.; Matveeva, I.; Poluyanova, N.; Pikalova, N.; Raskina, T.; Letaeva, M.; Rebrov, A.; Karoli, N.; Repin, M.; Rodina, N.; Shaposhnik, I.; Lebedev, E.; Shogenov, Z.; Agirov, M.; Sidorenko, B.; Vorontsova, S.; Sinitsina, I.; Orlov, V.; Sizova, Z.; Lapidus, N.; Sobolev, K.; Erofeeva, S.; Suprun, E.; Dronov, D.; Tarasov, N.; Isakov, L.; Tereshenko, S.; Kositsyna, I.; Tikhonova, E.; Solovyev, A.; Timofeev, A.; Bulygin, S.; Ustyugov, S.; Rossovskaya, M.; Vishnevsky, A.; Kirgizova, A.; Volkov, D.; Rodina, N.; Yakusevich, V.; Petrochenko, A.; Yakushin, S.; Nikulina, N.; Zateyshchikov, D.; Zotova, I.; Zateyshchikova, A.; Mankhaeva, B.; Zenin, S.; Kononenko, O.; Zubeeva, G.; Motylev, I.; Apostolovic, S.; Djordjevic-Radojkovic, D.; Celic, V.; Majstorovic, A.; Adjic, N. Cemerlic; Bjelobrk, M.; Despotovic, N.; Erceg, P.; Ilic, S.; Ilic, B.; Krotin, M.; Djokovic, A.; Miloradovic, V.; Djokic, I.; Otasevic, P.; Tasic, N.; Potpara, T.; Polovina, M.; Putnikovic, B.; Kalezic, T.; Seferovic, P.; Milinkovic, I.; Tavciovski, D.; Davicevic, Z.; Vasiljevic-Pokrajcic, Z.; Mitrovic, P.; Tesic, B. Vujisic; Ostojic, M.; Castro, C.; Topolnitchi, O.; Ruda, M.; Golshmid, M.; Tesic, M.; Ambrovicova, V.; Ambrovic, I.; Banikova, A.; Dukat, A.; Kosmalova, V.; Dulkova, K.; Dulka, T.; Duris, T.; Vankova, L.; Dzupina, A.; Dzupinova, M.; Hatalova, K.; Hatala, R.; Hranai, M.; Hofmanova, J.; Kasperova, V.; Reptova, A.; Mazur, J.; Pella, D.; Fedacko, J.; Ruffini, L.; Morsky, J.; Slanina, M.; Kmec, J.; Zachar, A.; Kokles, M.; Zareczky, P.; Bollova, D.; Badenhorst, J.; Erasmus, L.; Basson, M.; Poynton, M.; Dalby, A.; Allman, J.; Ellis, G.; Botha, L.; Engelbrecht, J.; Mostert, M.; Essop, M.; Nunkoo, T.; Gani, M.; Wilson, L.; Kelfkens, Y.; Mitha, I.; Taljaard, J.; Naidoo, D.; Duki, Y.; Snyders, F.; Munnik, M.; Soma, P.; Johnston, H.; Van Der Merwe, N.; Goosen, Y.; Van Zyl, L.; Le Roux, M.; Venter, T.; Wessels, L.; Bae, H. J.; Han, M. G.; Cha, J. K.; Kim, D. H.; Cho, B. R.; Ryu, D. R.; Choi, H. H.; Hong, K. S.; Chung, W. S.; Oh, Y. S.; Han, S. H.; Lee, K. H.; Hong, T. J.; Lee, H. W.; Hyon, M. S.; Jung, J. W.; Jeon, H. K.; Lee, J. M.; Kang, D. H.; Choi, K. J.; Kim, C. J.; Jin, E. S.; Kim, D. S.; Seo, J. S.; Kim, H. S.; Cha, M. J.; Kim, J. T.; Park, M. S.; Kim, J. H.; Park, J. H.; Kim, J. S.; Park, S. J.; Kim, S. H.; Seo, J. B.; Kim, Y. J.; Chun, M. Y.; Lee, M. H.; Joung, B. Y.; Lee, S. H.; Shin, D. G.; Namgung, J.; Kwak, J. J.; Rha, S. W.; Na, J. O.; Rim, S. J.; Kim, J. Y.; Arcocha Torres, M.; Manzanal Rey, A.; Blanco Coronado, J.; Puertas, I.; Bruguera Cortada, J.; Cabero, P.; Calvo, C.; Calvo, G.; De Arce Borda, A.; Asensio, A.; Diez Tejedor, E.; Perez Guevara, M.; Gonzalez Juanatey, J.; Moure, M.; Hernandez Madrid, A.; Delgado, A.; Lopez Garcia-Aranda, V.; Barquero, R.; Manzano, L.; Blanco Abril, S.; Merino, J.; Diaz-Pintado, M.; Arias, J.; Fernandez, M.; Fernandez Alvarez, R.; Terns, M.; Dachs Delgado, M.; Villuendas, R.; Astier, L.; Appelros, P.; Akerberg, A.; Blom, K. Berndtsson; Andersson, R.; Blomstrom, P.; Persson, L.; Carlsson, T.; Bengtsson, A. Stener; Dettmann, S.; Ostberg, S.; Engdahl, J.; Karlsson, L.; Herlitz, J.; Winberg, L.; Juul-Moller, S.; Jernhed, H.; Koskinen, P.; Hakansson, E.; Kozak, P.; Edlund, M.; Malmqvist, L.; Eriksson, G.; Randers, F.; Moodh, J.; Rautio, A.; Johansson, M.; Ronn, F.; Sundholm, C.; Stenberg, A.; Gunnarsson, A.; Thulin, J.; Broberg, M.; Moccetti, T.; Slater, I. Petrova; Cheng, C. C.; Wu, W. S.; Chiang, C. E.; Yu, W. C.; Chiang, F. T.; Wu, Y. W.; Chiou, C. W.; Yeh, T. C.; Hsia, C. H.; Chen, Y. P.; Huang, J. L.; Chen, Y. F.; Kuo, C. T.; Wang, C. L.; Lai, W. T.; Lin, T. H.; Lee, J. T.; Pai, P. Y.; Lin, K. H.; Shyu, K. G.; Chiu, C. Z.; Tseng, W. K.; Pan, Y. F.; Ueng, K. C.; Lee, S. C.; Wang, J. H.; Tsai, W. C.; Yeh, H. I.; Kuo, J. Y.; Jirasirirojanakorn, K.; Pornchaiyasit, K.; Kaewsuwanna, P.; Sinthusopa, W.; Kiatchoosakun, S.; Sriprasert, S.; Laothavorn, P.; Bamrungpong, P.; Piyayotai, D.; Sripracha, A.; Sritara, P.; Panpunuan, P.; Sukonthasarn, A.; Mekara, W.; Vorasettakarnkij, Y.; Puripun, E.; Acikel, M.; Akilli, H.; Demir, H.; Ata, N.; Bayata, S.; Cakmak, N.; Calik, A.; Cayli, M.; Ceyhan, C.; Erdogan, D.; Ermis, C.; Kabul, K.; Kanadasi, M.; Oto, A.; Turgut, O.; Tandogan, I.; Yalcin, R.; Yigit, F.; Yigit, Z.; Zoghi, M.; Batushkin, V.; Azhdari, M.; Bazylevych, A.; Vlasyuk, Z.; Bereznyakov, I.; Lebedynskaya, M.; Dotsenko, S.; Kulynych, R.; Dzyak, G.; Vasilyeva, L.; Faynyk, A.; Sorokivskyy, M.; Gavrysyuk, V.; Dzublik, Y.; Horbach, L.; Husyev, V.; Godlevska, O.; Samburg, Y.; Karpenko, O.; Nevolina, I.; Karpenko, Y.; Blihar, O.; Kaydashev, I.; Gerasimenko, N.; Kolomyyits, S.; Vasylets, V.; Kopytsya, M.; Petyunina, O.; Kotseruba, V.; Dvoieglazova, M.; Koval, V.; Ohirko, O.; Koval', O.; Kaplan, P.; Kraiz, I.; Usan, N.; Kraydashenko, O.; Stets, R.; Kupnovytska, I.; Kyyak, Y.; Lizogub, V.; Gorna, O.; Malynovsky, Y.; Fedotov, S.; Ostrovska, L.; Ushakova-Sokolova, L.; Parkhomenko, A.; Dovgan, N.; Potapenko, P.; Nekrasa, A.; Prokhorov, O.; Leonidova, V.; Rebrov, B.; Gamachek, O.; Rishko, M.; Chendey, T.; Rudyk, I.; Shatilo, V.; Ishchuk, V.; Shcherbak, V.; Goncharova, I.; Shvetz, N.; Zamlynskyy, M.; Sirenko, Y.; Stanislavchuk, M.; Perebetiuk, L.; Sychov, O.; Lyzohub, S.; Tseluyko, V.; Kuznetsov, I.; Tykhonova, S.; Vakaliuk, I.; Drapchak, I.; Vatutin, M.; Sklyanna, O.; Vizir, V.; Goncharov, O.; Volkov, V.; Serik, S.; Yagensky, A.; Nahrebetskyy, V.; Yena, L.; Mudruk, I.; Zharinov, O.; Logvinov, Y.; Zhurba, S.; Shandra, T.; Aggarwal, R.; Smith, S.; Beeton, I.; Dunn, S.; Blagden, M.; Price, R.; Camm, J.; Dougal, K.; Chapman, O.; Davies, D.; Choy, A.; Duff, J.; Cohen, A.; Wilmott, R.; D'Costa, D.; Green, M.; Douglas, H.; Dickinson, D.; Lie, F.; Ramasamy, V.; Lindsay, S.; Atkinson, C.; Linker, N.; Finlayson, M.; Lip, G.; Brown, R.; MacCallum, P.; Ebano, P.; MacLeod, M.; McGhee, C.; Marazzi, P.; Jones, D.; Maxwell, T.; Isted, C.; More, R.; Helliwell, L.; Moriarty, A.; Mackin, A.; Murdoch, D.; Andrews, A.; Newby, D.; Flint, L.; Pye, M.; Wright, L.; Roberts, J.; Avery, D.; Senior, R.; Young, G.; Sopher, M.; Kennard, S.; Storey, R.; Bridge, C.; Turner, W.; Walker, M.; Venkataraman, A.; Gilchrist, M.; Watkin, R.; Chung, A.; Wright, A.; Wright, J.; Abi-Mansour, P.; Panella, M.; Adams, K.; Lohman, J.; Adler, J.; Barash, B.; Adler, P.; Reiling, S.; Aggarwal, R.; Beck, P.; Ahmad, A.; Hussain, A.; Ahmadpour, H.; Lim, G.; Akhter, F.; Brubaker, S.; Alexander, J.; Genova-Peeva, E.; Aliyar, P.; Godsey, W.; Allison, J.; Biscardi, R.; Almquist, A.; MacDonald, H.; Alsheikh, T.; Lane, B.; Amin, K.; Khetarpal, S.; Amin, M.; Persechino, F.; Anderson, J.; York, T.; Arnold, T.; Shoaf, R.; Arouni, A.; Rasmussen, L.; Attanti, S.; Strickland, S.; Aude, Y.; Cobos, D.; Awasty, V.; Baldwin, E.; Ayesu, K.; Thompson, B.; Baine, S.; Batista, M.; Baman, R.; Campbell, G.; Barber, M.; Altonen, D.; Barker, T.; Faircloth, C.; Barrington, P.; Gordon, L.; Bartkowiak, A.; Benton, J.; Beasley, R.; Hoffman, T.; Bedoya, R.; Luis-Valdes, M.; Bedwell, N.; Craig, M.; Beinart, S.; Swaim, D.; Bensimhon, D.; Garman, V.; Berk, M.; Ibarra, M.; Bernard, J.; Eldred, R.; Bilal, B.; Preston, S.; Bilazarian, S.; Langone, L.; Bingham, S.; Antonino, M.; Block, T.; Talbot-Lawson, C.; Blonder, R.; Ensminger, E.; Bloomberg, R.; Bloomberg, K.; Blue, B.; Vernon, M.; Borsheim, M.; Hickenbotham, D.; Bouchard, A.; Wade, W.; Bowden, W.; Ziegler, K.; Bradley, A.; Terry, P.; Brilakis, E.; Frey, W.; Brown, H.; Triano, A.; Bybee, K.; Al-Maliky, T.; Cader, C.; Morton, S.; Canaday, D.; Dickinson, D.; Canosa, R.; Hartranft, E.; Caplan, J.; Jameson, L.; Carr, K.; Phan, D.; Chang, M.; Hatfield, G.; Charlat, M.; Tamayo, M.; Chaturvedi, S.; Sawaya, K.; Ciaramita, J.; Bagby, J.; Clapp, T.; Clay, A.; McClelland, M.; Cohen, A.; Dutka, C.; Cohen, R.; Bossaers, J.; Colan, D.; Salpas, S.; Cole, J.; Fisher, M.; Concha, M.; Martinez, E.; Corbett, B.; Svadbik, L.; Cossu, S.; Mullinax, K.; Cottiero, R.; Masson, E.; Cowan, L.; Nelson, L.; Curtis, B.; Sarpola, N.; Dang, N.; Morgan, T.; Daniels, S.; Leka, G.; Datta, S.; Wulf, A.; Dave, K.; Dave, B.; Davuluri, A.; Ebreo, N.; De Lemos, J.; Debes, C.; Dean, J.; Warmack, D.; DeGarmo, R.; Carey, J.; Desai, A.; Steward, A.; Desire, A.; Waters, L.; Devenport, S.; Briscoe, C.; Dhar, S.; Ucik, S.; DiGiovanna, M.; Tisdale, L.; Donovan, D.; Rodriguez, L.; Dotani, I.; Olson, A.; Drozdiak, R.; Habibi, S.; D'Souza, A.; Cullen, T.; Eade, J.; Dunn, K.; Eldadah, Z.; Quick, R.; Ellis, J.; Cristaldi, J.; Erenrich, N.; Johnson, C.; O'Brien, J.; Ettinger, N.; Shipp, A.; Everhart, B.; DeSalle, D.; Fahmy, R.; Watkins, D.; Feld, L.; Tameron, A.; Feldman, J.; Tang, N.; Felten, W.; Prior, J.; Fialkow, J.; Calvo, M.; Finkel, M.; Shriver, D.; Finkelstein, S.; Lim, G.; Fischell, T.; Drew, B.; Fishbein, G.; Donahue, S.; Flores, E.; Slayton, C.; Forman, S.; Solis, A.; Frais, M.; Thrope, C.; Franco, M.; Gentry, P.; French, W.; Morales, C.; Friedlander, I.; Smith, K.; Gaffney, M.; Jones, J.; Garb, J.; Miranda, J.; George, F.; Valentine, H.; Gerber, J.; Hinchion, N.; Gillespie, E.; Keane-Richmond, P.; Gogia, H.; Ewing, B.; Goldscher, D.; Latteri, J.; Goldstein, M.; Fisher, M.; Gowda, S.; Rafala, E.; Graham, S.; Bonora, M.; Griffin, S.; Aull, L.; Griffin, J.; Goodman, V.; Grossman, C.; Davis, A.; Grove, D.; Mabe, K.; Guarino, J.; Gabela, W.; Guarnieri, T.; Fisher, M.; Guerrero; Foster, B.; Guthrie, R.; Felsman, D.; Gvora, T.; McLean, R.; Hack, T.; Morelli, L.; Hamroff, G.; Bentivenga, L.; Han, M.; Cavanna, L.; Harris, J.; Bobade, M.; Hearne, S.; Krater, C.; Heiman, M.; Dandekar, U.; Shah, D.; Henderson, D.; Millard, D.; Henry, S.; Harkins, V.; Hermany, P.; Batchell, K.; Herrod, J.; Miranda, D.; Herson, S.; Carey, G.; Hinchman, D.; Vieira, P.; Hippert, R.; Dutter, S.; Hoekstra, J.; Young, C.; Homan, J.; Homayouni, A.; Horton, K.; Sloss, D.; Hotchkiss, D.; Turner, N.; Houchin, V.; Adams, K.; Howard, V.; Hays, D.; Howard, L.; Craft, D.; Huang, P.; Truva, C.; Hunter, J.; Battistelli, E.; Hurst, P.; Garza, M.; Hussain, M.; Tambawala, M.; Ison, R.; Butcher, S.; Jardula, M.; Andresen, T.; Johnson, F.; Phillips, T.; Jones, R.; Hughett, G.; Jovin, I.; Nichols, M.; Judson, P.; Royes, A.; Kahn, B.; Coombs, V.; Kai, W.; Dugal, J.; Kandath, D.; Kostedt, G.; Kaplan, K.; Cook, S.; Kapoor, A.; Ruggiero, M.; Karunaratne, H.; Behm, K.; Kastelic, R.; Davis, C.; Keller, R.; Keller, J.; Kerkering, M.; Bartholomaus, D.; Kersh, R.; Buhler, A.; Kesselbrenner, M.; DiCorcia, L.; Khan, B.; Binns, M.; Khan, M.; Khan, G.; Kindman, L.; Averett, P.; Korpas, D.; Godfrey, C.; Kotha, P.; Sanchez, E.; Kozlowski, J.; Watts, S.; Krichmar, P.; Marquez, D.; Laliotis, A.; Jauregui, V.; Lambert, C.; Coyle, G. Stagi; Landau, C.; Ferguson, D.; Lang, J.; Simmons, T.; Langevin, E.; Faucett, S.; Ledbetter, L.; Royse, H.; Lentz, M.; Smith, D.; Lesser, M.; Hartley, L.; Lewis, D.; Bonds, C.; Lillestol, M.; Miller, D.; Ling, L.; Murphy, R.; Littlefield, R.; Wofford, E.; Lomnitz, D.; Shah, D.; Lone, B.; Davids, M.; Looby, R.; Ault, S.; Lui, H.; Wright, H.; Lurie, M.; Edelstein, J.; Macomber, J.; Bush, D.; Magee, A.; Doctor, A.; Mainigi, S.; Lisiecki, B.; Makam, S.; Casas, R.; Mandviwala, M.; Hernandez, S.; Marar, I.; Rabadi-Marar, D.; Marenberg, M.; Bedenko, E.; Massin, E.; Hicks, T.; McCartney, M.; Stubbs, L.; McGarvey, J.; Schwarz, L.; McGuire, K.; Miranda, J.; McKenzie, M.; Rodkey, K.; McKnight, T.; Paul, J.; McLaurin, B.; Lack, A.; Mega, J.; Marti, J.; Meholick, A.; Skinner, J.; Mehrle, A.; Wall, J.; Mendelson, R.; Cervellione, K.; Mercado, A.; Cajulis, C.; Michlin, B.; Romero-Colon, J.; Milas, J.; Sanders, D.; Miller, R.; Sanchez, S.; Miller, S.; Gryczan, J.; Mody, F.; Strugatsky, S.; Moran, J.; Garner, S.; Morledge, J.; Bowman, B.; Mouhaffel, A.; Parrott, N.; Mounsey, P.; Schuler, C.; Mowdy, M.; Todd, S.; Mullen, P.; Raziano, S.; Murphy, A.; Oehmann, V.; Nadar, V.; Parker, A.; Naidu, J.; West, M.; Nallasivan, M.; Goza, J.; Nguyen, T.; Nomanee, S.; Nielsen, R.; Wilmot, M.; Oberoi, M.; Thakkar, N.; Oppenheimer, K.; McCormick, J.; Orchard, R.; Garcia, L.; Osborne, J.; Gonzalez, M.; Oza, S.; Joseph, L.; Patnam, S.; Dennison, K.; Pavon, H.; Gorry, N.; Pearlstein, R.; Montayne, S.; Pentz, W.; Duncan, D.; Peters, P.; Chacon, L.; Petruzziello, F.; Morlando, F.; Pettis, K.; Brown, F.; Pezzella, S.; Kirk, D.; Poulathas, A.; Cush, S.; Pratt, R.; Neeper, L.; Pribble, A.; Lowe, K.; Pudi, K.; Sham, L.; Pugeda, J.; Ebert, J.; Quadrel, M.; Rafla, E.; Quinlan, E.; Reed, C.; Quinn, J.; Hemmen, C.; Rama, P.; Domingo, D.; Redondo, V.; Wroblewski, J.; Renzi, M.; Stanley, E.; Richwine, R.; Pazier, P.; Roberts, J.; Riofrio, K.; Braun, D.; Robinson, J.; Cherrico, M.; Roehll, W.; Hollihan, P.; Rosado, J.; Barnhorst, M.; Rosen, R.; Martin, C.; Ross, S.; Freeman, R.; Ruoff, G.; Nelson, T.; Sacco, J.; Ball, E.; Samal, A.; Schomburg, J.; Sandberg, J.; Lafave, J.; Savin, V.; Clifton, R.; Schaefer, S.; Fekete, A.; Schneider, R.; Schneider, W.; Schulman, D.; Mercer, S.; Seals, A.; Ullig, T.; Holt, A.; Seide, H.; Mather, N.; Shah, G.; Witt, P.; Shalaby, A.; Seese, M.; Shanes, J.; Fleets, J.; Shaoulian, E.; Hren, A.; Sheikh, K.; Hengerer, T.; Shih, H.; Browning, J.; Shoukfeh, M.; Stephenson, L.; Siler, T.; Champagne, M.; Simpson, P.; Meyer, R.; Singh, N.; Turner, K.; Singh, V.; Nelson, M.; Skierka, R.; Hughes, B.; Smith, S.; Keene, R.; Smith, R.; Hodnett, P.; Spangenthal, S.; Thomason, L.; Sperling, M.; Vasquez, E.; Spivack, E.; McCartney, P.; Staniloae, C.; Liu, M.; Steljes, A.; Cox, C.; Struble, R.; Vittitow, T.; Suresh, D.; Frost, J.; Swerchowsky, V.; Freemyer, D.; Szulawski, I.; Herwehe, S.; Tahirkheli, N.; Springer, K.; Takata, T.; Bruton, T.; Talano, J.; Leo, L.; Tami, L.; Corchado, D.; Tatarko, M.; Swauger, M.; Tawney, K.; Dastoli, K.; Teague, S.; Young, K.; Tee, H.; Mitchell, T.; Teixeira, J.; Southam, D.; Torres, M.; Romero, N.; Tucker, P.; Salas, L.; Updegrove, J.; Hanna, K.; Val-Mejias, J.; Harrelson, K. Gonzalez; Vemireddy, D.; Cardoza, T.; Verma, S.; Parsons, T.; Vicari, R.; Warren, K.; Vijay, N.; Washam, M.; Vossler, M.; Kilcup, S.; Walsh, R.; Renaud, K.; Ward, S.; Locklear, T.; Waxman, F.; Sanchez, G.; Weiss, R.; St Laurent, B.; Westcott, J.; Truva, C.; Williams, D.; Gibson, C.; Williams, R.; Dowling, C.; Willis, J.; VonGerichten, S.; Wood, K.; Capasso-Gulve, E.; Worley, S.; Pointer, S.; Yarows, S.; Sheehan, T.; Yasin, M.; Preston, S.; Yi, J.; Dongas, B.; Yousuf, K.; Fisher, M.; Zakhary, B.; Curtis, S.; Zeig, S.; Mason, T.; Zellner, C.; Harden, M.; Roper, E.; Waseem, M.; Grammer, M.		ENGAGE AF-TIMI 48 Investigators	Edoxaban versus Warfarin in Patients with Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR XA INHIBITOR; ORAL ANTICOAGULANTS; STROKE; PHARMACOKINETICS; METAANALYSIS; GENERATION; PREVENTION; SAFETY	BackgroundEdoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. MethodsWe conducted a randomized, double-blind, double-dummy trial comparing two once-daily regimens of edoxaban with warfarin in 21,105 patients with moderate-to-high-risk atrial fibrillation (median follow-up, 2.8 years). The primary efficacy end point was stroke or systemic embolism. Each edoxaban regimen was tested for noninferiority to warfarin during the treatment period. The principal safety end point was major bleeding. ResultsThe annualized rate of the primary end point during treatment was 1.50% with warfarin (median time in the therapeutic range, 68.4%), as compared with 1.18% with high-dose edoxaban (hazard ratio, 0.79; 97.5% confidence interval [CI], 0.63 to 0.99; P<0.001 for noninferiority) and 1.61% with low-dose edoxaban (hazard ratio, 1.07; 97.5% CI, 0.87 to 1.31; P=0.005 for noninferiority). In the intention-to-treat analysis, there was a trend favoring high-dose edoxaban versus warfarin (hazard ratio, 0.87; 97.5% CI, 0.73 to 1.04; P=0.08) and an unfavorable trend with low-dose edoxaban versus warfarin (hazard ratio, 1.13; 97.5% CI, 0.96 to 1.34; P=0.10). The annualized rate of major bleeding was 3.43% with warfarin versus 2.75% with high-dose edoxaban (hazard ratio, 0.80; 95% CI, 0.71 to 0.91; P<0.001) and 1.61% with low-dose edoxaban (hazard ratio, 0.47; 95% CI, 0.41 to 0.55; P<0.001). The corresponding annualized rates of death from cardiovascular causes were 3.17% versus 2.74% (hazard ratio, 0.86; 95% CI, 0.77 to 0.97; P=0.01), and 2.71% (hazard ratio, 0.85; 95% CI, 0.76 to 0.96; P=0.008), and the corresponding rates of the key secondary end point (a composite of stroke, systemic embolism, or death from cardiovascular causes) were 4.43% versus 3.85% (hazard ratio, 0.87; 95% CI, 0.78 to 0.96; P=0.005), and 4.23% (hazard ratio, 0.95; 95% CI, 0.86 to 1.05; P=0.32). ConclusionsBoth once-daily regimens of edoxaban were noninferior to warfarin with respect to the prevention of stroke or systemic embolism and were associated with significantly lower rates of bleeding and death from cardiovascular causes. (Funded by Daiichi Sankyo Pharma Development; ENGAGE AF-TIMI 48 ClinicalTrials.gov number, NCT00781391.)	[Giugliano, Robert P.; Ruff, Christian T.; Braunwald, Eugene; Murphy, Sabina A.; Wiviott, Stephen D.; Grip, Laura T.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Giugliano, Robert P.; Ruff, Christian T.; Braunwald, Eugene; Murphy, Sabina A.; Wiviott, Stephen D.; Grip, Laura T.] Harvard Univ, Sch Med, Boston, MA USA; [Halperin, Jonathan L.] Mt Sinai Med Ctr, New York, NY 10029 USA; [Waldo, Albert L.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Ezekowitz, Michael D.] Thomas Jefferson Med Coll, Philadelphia, PA USA; [Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON, Canada; [Spinar, Jindrich] Univ Hosp, Brno, Czech Republic; [Ruzyllo, Witold] Inst Cardiol, Warsaw, Poland; [Ruda, Mikhail] Cardiol Res Ctr, Moscow 121552, Russia; [Koretsune, Yukihiro] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan; [Betcher, Joshua; Patel, Shirali P.] Quintiles, Durham, NC USA; [Shi, Minggao; Patel, Indravadan; Hanyok, James J.; Mercuri, Michele] Daiichi Sankyo Pharma Dev, Edison, NJ USA; [Vogelmann, O.; Gonzalez, C.] Hosp Alta Complejidad Presidente Juan Domingo Per, Formosa, For, Argentina; [Ahuad Guerrero, R.; Rodriguez, M.] Corporac Med Gral San Martin SA, San Martin, Bue, Argentina; [Albisu, J.; Rosales, E.] Inst Cardiovasc San Luis, San Luis, Sls, Argentina; [Allall, O.; Reguero, M.] Hosp Cordoba, Cordoba, Crd, Argentina; [Alvarez, C.; Garcia, M.] Hosp Italiano Reg Sur, Bahia Blanca, Bue, Argentina; [Ameriso, S.; Ameriso, P.] Inst Invest Neurol Raul Carrea FLENI, Buenos Aires, Bue, Argentina; [Amuchastegui, M.; Caceres, M.] Hosp Privado Ctr Med Cordoba, Cordoba, Crd, Argentina; [Beloscar, J.; Petrucci, J.] Hosp Prov Centenario, Rosario, Sfe, Argentina; [Berli, M.] Cedir, Santa Fe, Sfe, Argentina; [Budassi, N.; Valle, M.] Hosp Interzonal Gen Agudos Dr Jose Penna, Bahia Blanca, Bue, Argentina; [Bustamante Labarta, G.; Saravia, M.] Sanatorio Nuestra Senora Rosario, San Salvador De Jujuy, Juj, Argentina; [Caccavo, A.; Fracaro, V.] Clin Coronel Suarez, Coronel Suarez, Bue, Argentina; [Cartasegna, L.; Novas, V.] Hosp Italiano La Plata, La Plata, Argentina; [Caruso, O.; Saa Zarandon, R.] Hosp Cent Mendoza, Mendoza, Men, Argentina; [Colombo, H.; Morandini, M.] Clin Colombo, Cordoba, Crd, Argentina; [Cuello, J.; Rosell, M.] Inst Invest Clin Bahia Blanca, Bahia Blanca, Bue, Argentina; [Cuneo, C.; Bocanera, M.] Hosp San Bernardo, Salta, Sal, Argentina; [D'Amico, A.; Cendali, G.] Cedim Clin Privada, Ramos Mejia, Bue, Argentina; [Dran, R.; Moreno, V.] Ctr Salud Norte, Munro, Bue, Argentina; [Estol, C.; Davolos, M.] STAT Res, Ciudad Autonoma De Bs As, Cba, Argentina; [Facello, A.; Facello, M.] Ctr Privado Tomografia Computada Cordoba SA, Cordoba, Crd, Argentina; [Falu, E.; Iriarte, M.] Sanatorio Carmen, Salta, Argentina; [Femenia, F.; Arrieta, M.] Hosp Espanol Mendoza, Godoy Cruz, Men, Argentina; [Fuselli, J.; Zanotti, A.] Cemic Saavedra, Ciudad Autonoma De Bs As, Cba, Argentina; [Gant Lopez, J.; Meiller, F.] Hosp Aleman, Ciudad Autonoma De Bs As, Cba, Argentina; [Garcia Duran, R.; Perlo, D.] Inst Invest Clin San Nicolas, San Nicolas, Bue, Argentina; [Garrido, M.; Ceirano, C.] Clin Privada Prov SA, Merlo Buenos Aires, Bue, Argentina; [Giacomi, G.; Eden, M.] Unidad Cardiol Clin, Mar Del Plata, Bue, Argentina; [Giannaula, R.; Huerta, M.] Hosp Espanol, Buenos Aires, Cba, Argentina; [Goicoechea, R.; von Wulffen, M.] Hosp Jose Maria Ramos Mejia, Buenos Aires, Bue, Argentina; [Hominal, M.; Bianchini, M.] Ctr Invest Clin Litoral SRL, Santa Fe, Sfe, Argentina; [Jure, H.; Jure, D.] Clin Chutro SRL, Cordoba, Crd, Argentina; [Kevorkian, R.; Monaco, F.] Hosp Gen Agudos Donac Francisco Santojanni, Buenos Aires, Cba, Argentina; [Lanternier, G.; Belcuore, M.] Azira Clin Res, Pergamino, Bue, Argentina; [Liniado, G.; Iglesias, M.] ALPI Inst Rehabil Marcelo Fitte, Caba, Bue, Argentina; [Litvak, B.; Nigro, A.] Serv Hosp San Justo SA, Buenos Aires, Bue, Argentina; [Llanos, J.; Vignau, S.] Inst Invest Clin Rosario, Rosario, Sfe, Argentina; [Lorente, C.; Shatsky, K.] Sanatorio Julio Corzo, Rosario, Sjn, Argentina; [Lotti, J.; Raimondi, G.] Sanatorio Plaza, Rosario, Sfe, Argentina; [Mackinnon, I.; Carne, M.] Inst Invest Clin Mar Plata, Mar Del Plata, Bue, Argentina; [Manuale, O.; Calderon, M.] Hosp Britanico Buenos Aires, Buenos Aires, Cba, Argentina; [Marino, J.; Funes, I.] Ctr Med Alcorta, Ciudad Autonoma De Bs As, Cba, Argentina; [Muntaner, J.; Gandur, H.] Ctr Mod Cardiol, San Miguel De Tucuman, Tucuman, Argentina; [Nul, D.; Verdini, E.] Clin Constituyentes, Moron, Bue, Argentina; [Piskorz, D.; Tommasi, A.] Sanatorio Britanico SA, Rosario, Sfe, Argentina; [Povedano, G.; Casares, E.] Complejo Med PFA Churruca Vizca, Caba, Cba, Argentina; [Pozzer, D.; Fernandez, E.] Inst Cardiol Corrientes Juana Francisca Cabral, Corrientes, Cor, Argentina; [Prado, A.; Venturini, C.] Inves Clin Tucuman, San Miguel De Tucuman, Tucuman, Argentina; [Ramos, H.; Navarrete, S.] Clin Privada Caraffa, Cordoba, Crd, Argentina; [Rodriguez, M.; Alvarez, M.] Clin & Maternidad Colon SA, Mar Del Plata, Bue, Argentina; [Sanchez, A.; Bowen, L.] Inst Invest Clin Cipolletti, Cipolletti, Rio, Argentina; [Sanjurjo, M.; Codutti, O.] Cordis Inst Corazon, Resistencia, Cha, Argentina; [Saravia Toledo, S.; Formoso, I.] Inst Med Cenesa, Salta, Sal, Argentina; [Schmidberg, J.; Goloboulicz, A.] Inst Med Aguero, Moron, Bue, Argentina; [Schygiel, P.; Buzzetti, C.] Clin Inst Med Adrogue, Almirante Brown, Bue, Argentina; [Severino, P.; Morara, P.] Clin Independencia, Munro, Bue, Argentina; [Sosa Liprandi, M.; Teves, M.] Sanatorio Guemes, Ciudad Autonoma De Bs As, Bue, Argentina; [Vico, M.; Morell, Y.] Inst Invest Clin Zarate, Zarate, Bue, Argentina; [Anderson, C.; Paraskevaidis, T.] Royal Prince Alfred Hosp, Camperdown, NSW, Australia; [Arstall, M.; Hoffmann, B.] Lyell McEwin Hosp, Elizabeth Vale, SA, Australia; [Colquhoun, D.; Price-Smith, S.] Core Res Grp, Milton, Qld, Australia; [Crimmins, D.; Slattery, A.] Cent Coast Neurosci Res, East Gosford, NSW, Australia; [Dart, A.; Kay, S.] Baker Heart Res Inst, Melbourne, Vic, Australia; [Davis, S.; Silver, G.] Royal Melbourne Hosp, Parkville, Vic, Australia; [Flecknoe-Brown, S.; Roberts, J.] Broken Hill Hosp, Broken Hill, NSW, Australia; [Gates, P.; Jones, S.] Geelong Hosp, Geelong, Vic, Australia; [Lehman, R.; Morrison, H.] Adelaide Med Res, Adelaide, SA, Australia; [McKeirnan, M.; Li, J.] Brisbane South Clin Res Ctr, Carina Heights, Qld, Australia; [Paul, V.; Batta, C.] Royal Perth Hosp, Perth, WA, Australia; [Purnell, P.; Perrett, L.] Joondalup Cardiovascular Trials Fdn, Joondalup, WA, Australia; [Szto, G.; O'Shea, V.] Peninsula Private Hosp, Frankston, Vic, Australia; [De Bleecker, J.; de Koning, K.] AZ Sint Lucas, Ghent, Belgium; [De Tollenaere, M.; De Bruyne, L.] Sint Augustinusklin, Veurne, Belgium; [Desfontaines, P.; Tincani, G.] CHC Clin Esperance, Montegnee, Belgium; [Heidbuchel, H.; Meeusen, K.] UZ Leuven, Leuven, Belgium; [Herzet, J.; Malmendier, D.] Ctr Hosp Reg Citadelle Psychiat, Liege, Belgium; [Mairesse, G.; Raepers, M.] Clin St Joseph, Arlon, Belgium; [Parque, J.; Clinckemaille, N.] Parque JeanLuc, Mouscron, Belgium; [Scavee, C.; Huyberechts, D.] Clin Univ St Luc, Brussels, Belgium; [Stockman, D.; Jacobs, C.] ZNA Middelheim, Antwerp, Belgium; [Vandekerckhove, Y.; Derycker, K.] Acad Hosp St Jan, Brugge, Belgium; [Vanwelden, J.; van Welden, J.] AZ Jan Palfijn, Merksem, Belgium; [Vervoort, G.; Mestdagh, I.] AZ Sint Maarten, Campus Leopoldstraat, Mechelen, Belgium; [Vrolix, M.; Beerts, C.] ZOL Campus St Jan, Genk, Belgium; [Wollaert, B.; Denie, D.] ZNA Stuivenberg, Antwerp, Belgium; [Vincenzo de Paola, A. Amato; Coutinho, E.] Univ Fed Sao Paulo UNIFESP, Sao Paulo, SP, Brazil; [Lotufo, P. Andrade; de Melo, R. Ferreira] Hosp Univ FMUSP, Sao Paulo, SP, Brazil; [Atie, J.; Motta, C.] SMO Brazil, Rio De Janeiro, RJ, Brazil; [Alves da Costa, F. Augusto; Ferraz, R. Franchin] FGM Clin Paulista Doencas Cardiov LTDA, Sao Paulo, SP, Brazil; [Precoma, D. Bertolim; Sehnem, E.] Hosp Angelina Caron, Campina Grande Do Sul, PR, Brazil; [Botelho, R.; Cunha, S.] Inst Coracao Triangulo Mineiro, Uberlandia, MG, Brazil; [Brondani, R.; Fleck, N.] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Chaves Junior, H.; Silva, J.] Univ Fed Pernambuco, Hosp Clin, Recife, PE, Brazil; [Costantini, C.; Barroso, D.] Hosp Cardiol Costantini, Curitiba, Parana, Brazil; [De Patta, M.; Pereira, V.] Inst Cardiol Santa Catarina, Sao Jose, SC, Brazil; [Duda, N.; Laimer, R.] Hosp Sao Vicente de Paulo, Passo Fundo, RS, Brazil; [Dutra, O.; Morgado, S.] Inst Cardiol Rio Grande do Sul, Porto Alegre, RS, Brazil; [Saporito, W. Faustino; Seroqui, M.] Hosp Estadual Mario Covas, Santo Andre, SP, Brazil; [Ferreira, L.; Araujo, E.] Inst Cardiol Dist Fed, Brasilia, DF, Brazil; [Finimundi, H.; Daitz, C.] Inst Pesquisa Estudos Multicentr, Caxias Do Sul, RS, Brazil; [Gagliardi, R.; Pereira, G.] Santa Casa de Misericordia Sao Paulo, Sao Paulo, SP, Brazil; [Gomes, M.; Gomes, A.] Clinicor Hosp Coracao Alagoas, Maceio, AL, Brazil; [Guimaraes, A.; Ninho, L.] Hosp Geral Bonsucesso, Rio De Janeiro, RJ, Brazil; [Jaeger, C.; Pereira, L.] Hosp Mae Deus, Porto Alegre, RS, Brazil; [Jorge, J.; Cury, C.] Santa Casa Misericordia Curitiba PUCPR, Curitiba, PR, Brazil; [Kaiser, S.; Almeida, A.] CCBR Brasil, Rio De Janeiro, RJ, Brazil; [Kalil, C.; Radaelli, G.] Hosp Sao Lucas PUCRS, Porto Alegre, RS, Brazil; [Sebba Barroso de Souza, W. Kunz; Morales, K.] Via Med Ctr Clin, Goiania, Go, Brazil; [Leaes, P.; Luiz, R. Osorio] Santa Casa Porto Alegre, Porto Alegre, RS, Brazil; [Almeida, J. Pimenta; Gozalo, A.] Hosp Serv Publ Estadual Sao Paulo, Sao Paulo, SP, Brazil; [Reis, G.; Avellar, K.] Santa Casa Misericordia Belo Horizonte, Belo Horizonte, MG, Brazil; [Katz Weiand, L. Reis; Leipelt, J.] Hosp Bruno Born, Lajeado, RS, Brazil; [Rocha, J.; Barros, R.] Hosp Ctr Med Campinas, Campinas, SP, Brazil; [Rodrigues, L.; Rocha, M. Rubia] Encore Cardiol & Radiol Intervencionista, Aparecida De Goiania, Go, Brazil; [Rodrigues, A.; Rodrigues, D.] ICM Inst Coracao Marilia, Marilia, SP, Brazil; [dos Santos, F. Rossi; Pagnan, L. Goncalves] Loema Inst Pesquisa Clin, Campinas, SP, Brazil; [Sampaio, R.; do Val, R.] Inst Coracao Incor, Sao Paulo, SP, Brazil; [Saraiva, J.; Vicente, C.] Hosp & Maternidade Dr Celso Pierro PUC Campinas, Campinas, SP, Brazil; [Simoes, M.; Carraro, A.] Hosp Clin FMRP, Ribeirao Preto, SP, Brazil; [Sobral Filho, D.; Lustosa, E.] PS Cardiol Pernambuco PROCAPE Univ Pernambuco, Recife, PE, Brazil; [Boas, F. Villas; Almeida, M.] Hosp Espanhol, Salvador, BA, Brazil; [Zimmermann, S.; Zimmermann, E. Burger] Clin Procardio, Blumenau, SC, Brazil; [Chompalova, B.; Parishev, G.] MHAT Plovdiv AD, Plovdiv, Bulgaria; [Denchev, S.; Milcheva, N.; Donova, T.; Gergova, V.] UMHAT Alexandrovska EAD, Sofia, Bulgaria; [Georgiev, B.; Kostova, E.] MHAT Natl Heart Hosp EAD, Sofia, Bulgaria; [Goudev, A.; Kinova, E.] UMHAT Tzaritza Yoanna ISUL EAD, Sofia, Bulgaria; [Hergeldjieva, V.; Kamenova, P.] MHAT Ruse AD, Ruse, Bulgaria; [Manolova, A.; Vasilev, I.] MHAT Haskovo AD, Haskovo, Bulgaria; [Mihov, A.; Miteva, B.] MHAT Sveta Ekaterina EOOD, Dimitrovgrad, Bulgaria; [Mincheva, V.; Stoyanovski, V.] UNMTHAT Tzar Boris III Sofia, Sofia, Bulgaria; [Nikolov, F.; Vasilev, D.] UMHAT Sv Georgi EAD, Plovdiv, Bulgaria; [Pencheva, G.; Kostov, K.] Fourth MHAT Sofia AD, Sofia, Bulgaria; [Petranov, S.; Milusheva, T.] MHAT Burgas AD, Burgas, Bulgaria; [Vasilev, I.; Popov, A.] Diagnost Consultat Ctr Sveti Georgi EOOD, Haskovo, Bulgaria; [Staneva, A.; Momchilova-Lozeva, D.] Cent Clin Base, Med Inst MI, Sofia, Bulgaria; [Todorov, G.; Nyagina, M.] Second MHAT Sofia AD, Sofia, Bulgaria; [Tumbev, H.; Tumbeva, D.] DCC Chaika EOOD, Varna, Bulgaria; [Tzekova, M.; Kitova, M.; Manoylov, E.] UMHAT Dr Georgi Stranski EAD, Pleven, Bulgaria; [Archibald, J.; Antle, S.] Pharmaceut Integrated Res Co, Halifax, NS, Canada; [Bhargava, R.; Stafford, C.] Heart Care Res, Oshawa, ON, Canada; [Bose, S.; Hundseth, M.] Dr S Bose Med Profess Corp, North Saskatoon, SK, Canada; [Cha, J.; Otis, J.] Oshawa Med Arts Bldg, Oshawa, ON, Canada; [Chilvers, M.; Vansickle, L.] Sarnia Res Inst, Sarnia, ON, Canada; [Cleveland, D.; Valley, S.] Penticton Reg Hosp, Penticton, BC, Canada; [Constance, C.; Gauthier, M.] Clin Sante Cardio MC, Montreal, PQ, Canada; [Costi, P.; Masson, C.] Hop Pierre Le Gardeur, CSSS Sud Lanaudiere, Terrebonne, PQ, Canada; [Coutu, B.; Denis, I.] CHUM Hotel Dieu, Montreal, PQ, Canada; [du Preez, M.; Kubanska, A.] Med Arts Hlth Res Grp, Kamloops, BC, Canada; [Dufresne, M.; Krider, J.] Trainyards Hlth & Wellness Ctr, Ottawa, ON, Canada; [Eikelboom, J.; Zondag, M.] Hamilton Gen Hosp, Hamilton, ON, Canada; [Fortin, C.; Viau, C.] Neufort Inc, St Lambert, PQ, Canada; [Green, M.; Houbraken, D.] Univ Ottawa, Heart Inst, Ottawa, ON, Canada; [Hatheway, R.; Mabee, J.] Pharmaceut Integrated Res Co, Bridgewater, NS, Canada; [Heath, J.; Scott, L.] Alder Med Ctr, Campbell River, BC, Canada; [Hoag, G.; Standring, R.] Discovery Clin Serv Ltd, Victoria, BC, Canada; [Huynh, T.; Perkins, L.] Montreal Gen Hosp, Montreal, PQ, Canada; [Kouz, S.; Roy, M.] Ctr Hosp Reg Lanaudiere, St Charles Borromee, PQ, Canada; [Labonte, R.; Dewar, C.] Dr R Labonte Profess Med Corp, Sudbury, ON, Canada; [Lainesse, A.; St-Germain, L.] Ctr Investigat Clin Mauricie, Trois Rivieres, PQ, Canada; [Lam, S.; Lam, H.] Calgary West Med Ctr, Calgary, AB, Canada; [Lichtenstein, T.; Roberts, P.] Med Arts Hlth Res Grp, Kelowna, BC, Canada; [Ma, P.; Seib, M.] Heart Hlth Inst, Calgary, AB, Canada; [MacCallum, C.; Matthews, J.] Eastern Hlth, St John, NF, Canada; [Malette, P.; Vaillancourt, T.] Medicor Res Inc, Sudbury, ON, Canada; [Maranda, C.; Studenikow, E.] Cardiol & Res, Westmount, PQ, Canada; [Mawji, A.; Morely, A.] Pharmaceut Integrated Res Co, London, ON, Canada; [Morrison, D.; Roth, M.] Beamsville Med Ctr, Beamville, ON, Canada; [Krider, J.; Mucha, M.] Trainyards Hlth & Wellness Ctr, Ottawa, ON, Canada; [Najarali, A.; Lamoureux, U.] PIRC Res Off Brampton, Brampton, ON, Canada; [Morely, A.; Nicholson, R.] Pharmaceut Integrated Res Co, Kitchener, ON, Canada; [O'Hara, G.; Banville, P.] Quebec Heart Inst, Quebec City, PQ, Canada; [O'Mahony, W.; Bolton, R.] Corunna Med Res Ctr, Corunna, ON, Canada; [Parkash, R.; Carroll, L.] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Pesant, Y.; Sardin, V.] Rech Medicale St Jerome Inc, St Jerome, PQ, Canada; [Polasek, P.; Turri, L.] Kelowna Cardiol Res, Kelowna, BC, Canada; [Qureshi, A.; Nethercott, C.] PIRC Res Off Brampton, Listowel, ON, Canada; [Ricci, J.; Bozek, B.] Scarborough Cardiol Res, Scarborough, ON, Canada; [Rupka, D.; Marchand, C.] Fraser Clinical Trials Inc, New Westminster, BC, Canada; [Shu, D.; Silverio, G.] Gain Med Ctr, Coquitlam, BC, Canada; [St-Hilaire, R.; Morissette, A.] Ctr Hosp Beauce Etchemin, St Georges, PQ, Canada; [Syan, G.; Bobbie, C.] GS Cardiac Lab Med Professional Corp, Sudbury, ON, Canada; [Talajic, M.; David, D.] Montreal Heart Inst, Montreal, PQ, Canada; [Talbot, P.; Tremblay, M.] Ctr Rech Clin Quebec, Quebec City, PQ, Canada; [Teitelbaum, I.; Teitelbaum, J.] JJ Dig Res, Toronto, ON, Canada; [Velthuysen, G.; Giesbrecht, L.] Holley Clin, Quesnel, BC, Canada; [Wahby, R.; Morley, A.] Dorchester Med Ctr, Dorchester, ON, Canada; [Wharton, S.; Caterini, T.] Wharton Med Clin Clin Trials, Hamilton, ON, Canada; [Mabee, J.; Woodford, T.] Pharmaceut Integrated Res Co, Liverpool, NS, Canada; [Balboa, W.; Retamal Matus, L.] Victoria Hosp, Victoria, Chile; [Bugueno, C.; Mondaca Mondaca, P.] Hosp San Juan Dios Serena, La Serena, Chile; [Cobos, J.; Obreque, C.] Hosp El Pino, Santiago, Chile; [Corbalan, R.; Parada, A.] Pontificia Univ Catolica Chile, Hosp Clin, Santiago, Chile; [Florenzano, F.; Arratia Diaz, P.] Hosp Salvador, Santiago, Chile; [Lopetegui, M.; Rebolledo, C.] Hosp San Borja Arriaran, Santiago, Chile; [Manriquez, L.; Manriquez Silva, L.] Hosp Reg Rancagua, Rancagua, Chile; [Martinez, D.; Romero Llamas, R.] Clin Iquique, Iquique, Chile; [Opazo, M.; Carmona Perez, M.] Hosp Naval Almirante Nef, Vina del Mar, Chile; [Pincetti, C.; Torres Carrasco, G.] Ctr Investigac Clin, Temuco, Chile; [Potthoff, S.; Zapata Staub, J.] Corporac Beneficencia Osorno, Osorno, Chile; [Rodriguez, M.; Campisto, Y.] Hosp Dr Sotero del Rio, Santiago, Chile; [Stockins, B.; Lara Lara, C.] Hosp Dr Hernan Henriquez Aravena, Temuco, Chile; [Yovaniniz, P.; Grandon Azua, M.] Hosp Barros Luco, Santiago, Chile; [Bai, F.; Xu, G. L.] Lanzhou Univ, Hosp 2, Lanzhou, Peoples R China; [Chen, J. Z.; Xie, X. D.] Zhejiang Univ, Affiliated Hosp Coll Med 1, Hangzhou, Peoples R China; [Chen, X. P.; Zhang, X.] Sichuan Univ, West China Hosp, Chengdu, Peoples R China; [Dong, Y. G.; Feng, C.] Sun Yat sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China; [Fu, G. S.; Zhang, P.] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China; [Hong, K.; You, Z. G.] Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Hong, L.; Qiu, Y.] Renmin Hosp Jiang Xi Prov, Nanchang, Jiangxi, Peoples R China; [Jiang, X. J.; Qu, Z.] Ren Min Hosp Wu Han Univ, Wuhan, Peoples R China; [Li, L.; Liu, H.] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China; [Li, T. F.; Kong, Y. Q.] Hainan Med Coll, Affiliated Hosp, Haikou, Hainan, Peoples R China; [Li, W. M.; Liu, B.] Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China; [Li, Z. Q.; Liu, Y.] Peoples Hosp Liaoning Prov, Shenyang, Peoples R China; [Liao, D. N.; Gu, X. J.] Second Mil Med Univ, Changzheng Hosp, Shanghai, Peoples R China; [Liu, L.; Lu, Z. H.] Peoples Hosp Guangxi Zhuang Autonomous Region, Nanning, Peoples R China; [Ma, S. M.; Yang, Z. Y.] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China; [Wang, D. M.; Qi, S. Y.] Bethune Int Peace Hosp, Shijiazhuang, Hebei, Peoples R China; [Wang, G. P.; Shi, X. J.] Liaoning Med Coll, Hosp Affiliated 1, Jinzhou, Peoples R China; [Wei, M.; Huang, D.] Shanghai 6 Peoples Hosp, Shanghai, Peoples R China; [Wu, S. L.; Li, Y. E.] Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China; [Xu, J. H.; Gu, J. Y.] Tongji Univ, Tong Ji Hosp, Shanghai, Peoples R China; [Xu, Y. M.; Liang, Y. Z.] Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China; [Yang, K.; Li, A. Y.] Cent South Univ, Xiangya Hosp 3, Changsha, Peoples R China; [Yang, Y. J.; Zheng, X.] Chinese Acad Med Sci, Cardiovascular Inst, Fuwai Hosp, Beijing, Peoples R China; [Zheng, Y.; Gao, M.] Jilin Univ, Hosp 1, Changchun, Peoples R China; [Yin, Y. H.; Xu, Y. P.] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; [Yu, B.; Li, L. L.] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China; [Yuan, Z. Y.; Qiang, H.] Xian Med Univ, Hosp Affiliated 1, Xian, Peoples R China; [Lin, Y. N.; Zhang, Z.] Wenzhou Med Coll, Affiliated Hosp 1, Wenzhou, Peoples R China; [Zhang, Z.; Kang, H.] Lanzhou Univ, Hosp Affiliated 1, Lanzhou, Peoples R China; [Zhao, X. L.; Wang, J. Q.] Baotou Cent Hosp, Baotou, Peoples R China; [Zhao, X. L.; Wang, J. Q.] Capital Med Univ, Beijing Tong Ren Hosp Affiliated, Beijing, Peoples R China; [Zheng, Z. Q.; Li, B. G.] NanChang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Zhou, S. X.; Zhang, Y. L.] Zhongshan Univ, Affiliated Hosp 2, Guangzhou, Peoples R China; [Accini, J.; Accini, M.] Consultorio Privado Jose Luis Accini, Baranquilla, Colombia; [Cano, N.; Leon Pineda, L.] Hosp Santa Sofia, Manizales, Colombia; [Delgado Restrepo, J.; Arroyave, C.] Inst Corbic, Medellin, Colombia; [Fernandez Ruiz, R.; Aldana Diaz, I.] Clin Cardiovascular Santa Maria, Medellin, Colombia; [Hernandez, H.; Delgado, P.] Inst Corazon Bucaramanga, Bucaramanga, Colombia; [Jaramillo Munoz, C.; Builes, A.] Promotora Medica Amer SA, Medellin, Colombia; [Manzur, F.; Rivera Rodriguez, E.] Ctr Diagnostico Cardiologico Ltda, Cartagena, Colombia; [Moncada Corredor, M.; Lopez Giraldo, D.] Fdn Ctr Investigac Clin CIC, Medellin, Colombia; [Orozco Linares, L.; Fonseca, J.] Foqus LTDA, Bogota Cundinamarca, Colombia; [Quintero, A.; Gonzales, C.] Fdn Caribe Investigac Biomed, Barranquilla, Colombia; [Sanchez Vallejo, G.; Perdomo Mejia, I.] Ctr Estudios Clin Quindio, Armenia, Colombia; [Bagatin, J.; Carevic, V.] Clin Hosp Ctr Split, Split, Croatia; [Car, S.; Jeric, M.] Gen Hosp Varazdin, Varazhdin, Croatia; [Ciglenecki, N.; Tusek, S.] Special Hosp Med Rehabil, Krapinske Toplice, Croatia; [Ferri Certic, J.; Romic, I.] Gen Hosp Dubrovnik, Dubrovik, Croatia; [Francetic, I.; Makar Ausperger, K.] Univ Hosp Ctr Zagreb, Zagreb, Croatia; [Jelic, V.; Jaksic Jurinjak, S.] Gen Hosp Karlovac, Karlovac, Croatia; [Knezevic, A.; Buksa, B.] Gen Hosp Zadar, Zadar, Croatia; [Samardzic, P.; Cvitkusic Lukenda, K.] Gen Hosp Dr J Bencev, Slavonski Brod, Croatia; [Steiner, R.; Kirner, D.] Clin Hosp Osijek, Osijek, Croatia; [Sutalo, K.; Bakliza, Z.] Gen Hosp Dr Tomislav Bardek, Koprivn, Croatia; [Vrazic, H.; Bergovec, M.; Lucijanic, T.] Univ Hosp Dubrava, Zagreb, Croatia; [Bar, M.; Brodova, P.] Neurologicka ambulance Bormed, Ostrava Trebovice, Czech Republic; [Berka, L.; Kunkelova, V.] Ordinace pro choroby srdce cev, Jindrichuv Hradec, Czech Republic; [Brtko, M.] Fakultni nemocnice Hradec Kralove, Hradec Kralove, Czech Republic; [Burianova, H.] Poliklinika Humanitas, Bilovec, Czech Republic; [Cermak, O.] Nemocnice Slany, Slany, Czech Republic; [Elbl, L.] Kardiologicka ordinace, Brno, Czech Republic; [Ferkl, R.] Interni ambulance, Trutnov, Czech Republic; [Florian, J.] Nemocnice Cesky Krumlov, Cesky Krumlov, Czech Republic; [Francek, L.] Kromerizska nemocnice as, Kromeriz, Czech Republic; [Golan, L.] Kardiol, Revnice, Czech Republic; [Gregor, P.] Fakultni nemocnice Kralovske Vinohrady, Prague, Czech Republic; [Honkova, M.] Kardiologicka interni ambulance, Prague 1, Czech Republic; [Hubac, J.] Interni ambulance, Chrudim, Czech Republic; [Jandik, J.] Oblastni nemocnice Nachod, Nachod, Czech Republic; [Jarkovsky, P.] Ustredni vojenska nemocnice Praha, Prague 6, Czech Republic; [Jelinek, Z.] Nemocnice Hranice as, Hranice, Czech Republic; [Jerabek, O.] Poliklinika RAVAK, Pribram 8, Czech Republic; [Jirmar, R.] Poliklinika Malesice, Prague 10, Czech Republic; [Kobza, R.] Mediscan sro, Prague 11, Czech Republic; [Kochrt, M.; Kostkova, G.] Interni ordinace, Teplice, Czech Republic; [Kosek, Z.] Kardiologicka ambulance, Mlada Boleslav, Czech Republic; [Kovar, P.] Poliklinika Modrany, Prague 4, Czech Republic; [Kuchar, R.] INNEra sro, Benesov, Czech Republic; [Kvasnicka, J.; Lucijanic, T.] Kardiologicka ambulance, Prague 10, Czech Republic; [Ludka, O.] Privatni interni ambulance, Brno, Czech Republic; [Machova, V.; Krocova, E.] InterKardioML sro, Marianske Lazne, Czech Republic; [Melichar, M.] Interni ambulance, Pardubice, Czech Republic; [Nechanicky, R.] Nemocnice s poliklinikou Semily, Semily, Czech Republic; [Olsr, J.] Gen practitioner sro, Ostrava, Czech Republic; [Peterka, K.] Nemocnice Havlickuv Brod po, Havlickuv Brod, Czech Republic; [Petrova, I.; Havlova, I.] Kardiologicka ambulance, Usti Nad Labem, Czech Republic; [Pisova, J.] Kardiologicka ambulance, Hradec Kralove, Czech Republic; [Podrazil, P.; Jirsova, E.] Interni ambulance, Prague 6, Czech Republic; [Reichert, P.] Krajska zdravotni as Nemocnice Teplice po, Teplice, Czech Republic; [Slaby, J.] Oblastni nemocnice Kolin, Kolin, Czech Republic; [Spacek, R.] Nemocnice Na Frantisku, Prague 1, Czech Republic; [Spinar, J.; Labrova, R.] FN Brno Bohunice, Brno, Czech Republic; [Vodnansky, P.; Samkova, D.] Kardiologicka ordinace, Pardubice, Czech Republic; [Zidkova, E.] Ordinace interniho Iekarstvi, Prague 5, Czech Republic; [Dodt, K.] Horsens Sygehus, Horsens, Denmark; [Christensen, H.; Christensen, L.] Bispebjerg Hosp, Kobenhavn NV, Denmark; [Hassager, C.; Loof, A.] Rigshospitalet, Kobenhavn O, Denmark; [Ibsen, H.; Madsen, H.] Holbaek Sygehus, Holbaek, Denmark; [Iversen, H.; Veng-Olsen, T.] Glostrup Cty Hosp, Glostrup, Denmark; [Nielsen, H.; Olsen, R.] Bispebjerg Hosp, Kobenhavn NV, Denmark; [Overgaard, K.; Petrovic, V.] Herlev Hosp, Herlev, Denmark; [Raymond, I.; Raae, D.] Frederiksberg Univ Hosp, Frederiksberg, Denmark; [Sand, N.; Svenningsen, A.] Sydvestjyds Sygehus Esbjerg, Esbjerg, Denmark; [Torp-Pedersen, C.; Jakobsen, U.] Gentofte Univ Hosp, Hellerup, Denmark; [Wiggers, H.; Serup-Hansen, K.] Skejby Sygehus Aarhus University Hosp, Aarhus, Denmark; [Kaik, J.; Stern, A.] Fertilitas AS, Haabneeme, Estonia; [Kolk, R.] Tartu Univ Hosp, Tartu, Estonia; [Laane, E.; Rivis, L.] Orthopaed & Clin Res Ctr, Tartu, Estonia; [Paumets, M.; Voitk, J.; Laheaar, M.] North Estonia Med Ctr Fdn, Tallinn, Estonia; [Vahula, V.; Ratnik, E.] Parnu Hosp, Parnu, Estonia; [Huikuri, H.; Kaarleenkaski, S.] Oulun yliopistollinen sairaala, Oulu, Finland; [Hussi, E.; Valpas, S.] EtelaKarjalan keskussairaala, Lappeenranta, Finland; [Jakala, P.; Lappalainen, T.] Ita Suomen yliopisto Kuop kampus Kliininen tutkim, Kuopio, Finland; [Maenpaa, A.; Viitaniemi, J.] Seinajoen keskussairaala, Seinajoki, Finland; [Nyman, K.; Sankari, T.] Keski Suomen keskussairaala, Jyvaskyla, Finland; [Rasi, H.; Salminen, O.] Terveystalo Tampere, Tampere, Finland; [Virtanen, V.; Nappila, H.] Finn Medi 1, Tampere, Finland; [Le Heuzey, J.] Hop Europeen Georges Pompidou, Paris, France; [Agraou, B.; El Jarroudi, F.] Ctr Hosp Gen, Valenciennes 59, France; [Amarenco, P.; Boursin, P.] Hop Bichat Claude Bernard, Paris 75, France; [Babuty, D.; Boyer, M.] Hop Trousseau, Tours 37, France; [El Jarroudi, F.; Belhassane, A.] Ctr Hosp Cambrai, Cambrai 59, France; [Berbari, H.] Hop Instruct Armees Percy, Clamart 92, France; [Blanc, J.; Dias, P.] Chu Brest Hop Cavale Blanche, Brest 29, France; [Coisne, D.; Berger, N.] Chu Poitiers Hop Miletrie, Poitiers 86, France; [Decoulx, E.; El Jarroudi, M.] CH Chatiliez Tourcoing, Tourcoing 59, France; [Dinanian, S.; Arfaoui, M.] Hop Antoine Beclere, Clamart 92, France; [Hermida, J.; Deruche, E.] Ctr Hosp Sud, Amiens 80, France; [Kacet, S.; Corbut, S.] Hosp Cardiolog Chru Lille, Lille 59, France; [Poulard, J.; Leparree, S.] Ctr Hosp Abbeville, Abbeville 80, France; [Roudaut, R.; Duprat, C.] Hop Haut Eveque Cardiol, Pessac 33, France; [Al-Zoebi, A.; Wurow, A.] Kardiolog Praxis, Wermsdorf, SN, Germany; [Bernhardt, P.; Dichristin, U.] Univ Ulm Klinikum, Ulm, BW, Germany; [Berrouschot, J.; Vierbeck, S.] Klinikum Altenburger Land, Altenburg, TH, Germany; [Beyer-Westendorf, J.; Sehr, B.] Univ Klinikum Dresden, Dresden, SN, Germany; [Buhr, M.; Weihrauch, D.] Kardiol Praxen Spreebogen, Berlin, BE, Germany; [Contzen, C.; Kara, M.] Synexus ClinPharm Int GmbH, Frankfurt, HE, Germany; [Degtyareva, E.; Kranz, P.] Synexus ClinPharm Int GmbH, Leipzig, SN, Germany; [Drescher, T.; Herfurth, B.] Gemeinschaftspraxis, Stuhr, HB, Germany; [Faghih, M.] Hausarztzentrum, Essen, NW, Germany; [Forck-Boedeker, K.; Schneider, K.] Pro Scientia Med, Lubeck, SH, Germany; [Fuchs, R.; Manuela, W.] Orgamed Syst Fuchs & Partner KG, Giengen, BW, Germany; [Grigat, C.; Otto, A.] Clin Res Hamburg GmbH, Hamburg, HH, Germany; [Hartmann, A.; Peitz, M.] Klinikum St Georg Leipzig, Leipzig, SN, Germany; [Heuer, H.; Dieckheuer, U.] St Johannes Hosp PS, Dortmund, NW, Germany; [Hoffmann, U.; Dorn, S.] Univ Klinikum Mannheim, Mannheim, BW, Germany; [Hoffmann, S.; Schuppe, M.] Vivantes Klinikum Friedrichshain, Berlin, BE, Germany; [Horacek, T.; Fink, P.] Evangel Krankenhaus, Witten, NW, Germany; [Jungmair, W.; Schoen, B.] Kardiol Praxis, Bad Homburg, HE, Germany; [Kleinecke-Pohl, U.; Meusel, P.] Gemeinschaftspraxis Kleinecke Pohl Kirsch Benner, Cologne, NW, Germany; [Koenig, H.; Bauch, F.] Synexus Clin Res GmbH, Berlin, BE, Germany; [Koenig, H.; Bauch, F.] Synexus ClinPharm Int GmbH, Potsdam, BR, Germany; [Lohrbaecher-Kozak, I.; Grosse, B.] Synexus Clin Res GmbH, Dresden, SN, Germany; [Lueders, S.; Venneklaas, U.] St Josefs Hosp, Cloppenburg, NI, Germany; [Maus, O.; Hoefer, K.] Innomed Leipzig GmbH, Leipzig, SN, Germany; [Meissner, G.; Braemer, U.] Synexus ClinPharm Int GmbH, Magdeburg, ST, Germany; [Meyer-Pannwitt, U.; Frahm, E.] Mare Klinikum, Kiel, SH, Germany; [Mitrovic, V.; Vogt, S.] Kerckhoff Klin GmbH, Bad Nauheim, HE, Germany; [Muegge, A.; Barbera, S.] St Josef Hosp PS, Bochum, NW, Germany; [Mueller-Glamann, M.; Raddatz, K.] Gemeinschaftspraxis Drs Krohn Mueller Glamann, Hamburg, HH, Germany; [Piechatzek, R.; Lewinsky, D.] Synexus ClinPharm Int GmbH, Goerlitz, SN, Germany; [Pohl, W.] Gemeinschaftspraxis Dr Al Nakkash Dr Pohl Dr C Po, Dresden, SN, Germany; [Proskynitopoulos, N.; Kuhlmann, M.] Gemeinschaftspraxis, Nienburg, NI, Germany; [Rack, K.; Pilipenko, H.] Internist Praxis, Augsburg, BY, Germany; [Rinke, A.; Kuehlenborg, A.] Synexus ClinPharm Int GmbH, Bochum, NW, Germany; [Schellong, S.; Frommhold, R.] Staedt Klinikum Dresden Friedrichstadt, Dresden, SN, Germany; [Schenkenberger, I.; Finsterbusch, T.; Dreykluft, K.] Klin Forsch Berlin, Berlin, BE, Germany; [Schreckenberg, A.; Hellmers, J.] Internist Praxisgemeinschaft, Weyhe, NI, Germany; [Sohn, H.; Baylacher, M.] Ludwig Maximilians Univ Munchen, Munich, BY, Germany; [Spitzer, S.; Bonin, K.] Facharztzentrum Dresden Neustadt GBR, Dresden, SN, Germany; [Stoehring, R.] Kardiologische Praxis, Bad Homburg, HE, Germany; [Veltkamp, R.; Ludwig, I.] Univ Klinikum Heidelberg, Heidelberg, BW, Germany; [Voehringer; Buchholz, M.] DRK Kliniken Berlin Westend, Berlin, BE, Germany; [Winkelmann, B.; Buelow-Johansen, B.] ClinPhenomics GmbH & Co KG, Frankfurt, HE, Germany; [Alexopoulos, D.; Mavronasiou, E.] Patras Univ Hosp, Patras, Greece; [Bourlios, P.; Tziortziotis, A.] Gen Prefectural Hosp Trikala, Trikala, Greece; [Karamitsos, C.; Exarchou, E.] Gen Hosp Larissa, Larisa, Greece; [Kifnidis, K.; Daskalaki, A.] Gen Hosp Athens Asklipio Voulas, Athens, Greece; [Moschos, N.; Dimitra, K.] Gen Hosp Rhodes, Rhodes, Greece; [Pyrgakis, V.; Korantanis, K.] Gen Hosp Athens G Gennimatas, Athens, Greece; [Melgar, I. Guzman; Jimenez, T.] Edificio Plaza Dorada, Guatemala City, Guatemala; [Lavagnino, A. Ovando; Guevara, S.] Liga Corazon, Guatemala City, Guatemala; [Jimenez, T.; Estrada, M. Rodas] Clin Privada Dr Rodas Estrada, Guatemala City, Guatemala; [Sanchez, M.; Pozuelos, J. Mayen] CardioQuetzal, Quetzaltenango, Guatemala; [Samayoa, C. Sanchez; Guerra, L.] Clin Hosp Ctr Med, Guatemala City, Guatemala; [Camas, L. Velasquez; Almaraz, S. Padilla] Unicar, Guatemala City, Guatemala; [Dioszeghy, P.; Muskoczki, E.] Josa Andras Oktatokorhaz Egeszsegugyi Szolg Nonpr, Nyiregyhaza, Hungary; [Edes, I.; Szatmari, J.] Debreceni Egyet Orvos Egeszsegtudomanyi Centrum, Debrecen, Hungary; [Fiok, J.; Varga, A.] Sopron Med SMO Erzsebet Korhaz, Sopron, Hungary; [Kanakaridisz, N.; Kosztyu, M.] UNO Med Trials Kft, Budapest, Hungary; [Kis, E.; Feil, J. Felfoldine] Tolna Megyei Onkormanyzat Balassa Janos Korhaza, Szekszard, Hungary; [Kiss, R.; Jakal, A.] Honvedelmi Miniszterium Allami Egeszsegugyi Kozpo, Budapest, Hungary; [Kovacs, I.; Baranyai, M.] Vas Megyei Markusovszky Korhaz Nonprofit Zrt, Szombathely, Hungary; [Kovacs, Z.] Bajai Szent Rokus Korhaz, Baja, Hungary; [Lupkovics, G.; Karakai, H. Horvathne] Zala Megyei Korhaz, Zalaegerszeg, Hungary; [Matoltsy, A.; Kiss, T.] Kanizsai Dorottya Korhaz, Nagykanizsa, Hungary; [Medvegy, M.; Kiss, K.] Pest Megyei Flor Ferenc Korhaz, Kistarcsa, Hungary; [Merkely, B.; Kolumban, E.] Semmelweis Egyet, Budapest, Hungary; [Nagy, A.] Bacs Kiskun Megyei Onkormanyzat Korhaza, Kecskemet, Hungary; [Palinkas, A.; Toth, S. Rostasne] Erzsebet Korhaz Rendelointezet, Hodmezovasarhely, Hungary; [Sayour, A.; Bognar, A.] Magyar Imre Korhaz, Ajka, Hungary; [Simor, T.; Ruzsa, D.] Pecsi Tudomanyegyetem Altalanos Orvostudomanyi Ka, Pecs, Hungary; [Sipos, T.] Rethy Pal Korhaz, Bekescsaba, Hungary; [Szakal, I.] Selye Janos Korhaz, Komarom, Hungary; [Tomcsanyi, J.; Marosi, A.] Budai Irgalmasrendi Korhaz, Budapest, Hungary; [Vertes, A.; Kincses, M.] Fov Onk Egyesitett Szt Istvan & Szt Laszlo Korh R, Budapest, Hungary; [Malhan, S.] Sheth Vadilal Sarabhai Hosp & Municipal Med Colle, Ahmadabad, Gujarat, India; [Abdullakutty, J.] NH Lissie Hosp, Cochin, Kerala, India; [Agarwal, D.; Ranka, R.] SP Med Coll Associated Grp Hosp, Bikaner, Rajasthan, India; [Arneja, J.; Memon, A.] Arneja Heart Inst, Nagpur, Maharashtra, India; [Arora, V.; Shree, R.] Max Devki Devi Heart & Vasc Inst, New Delhi, Delhi, India; [Avvaru, G.; Shaikh, A.] Yashoda Hosp, Hyderabad, Andhra Pradesh, India; [Babu, P.; Rao, B.] Dr Ramesh Cardiac & Multi Special Hosp Ltd, Vijayawada, Andhra Pradesh, India; [Babu, R.; Reddy, J.] Medwin Hosp, Hyderabad, Andhra Pradesh, India; [Banker, D.; Sheth, T.] Bankers Heart Inst, Vadodara, Gujarat, India; [Benjarge, P.; Surushe, S.] Krishna Hosp & ICU, Aurangabad, Maharashtra, India; [Bharani, A.; Solanki, R.] MGM Med Coll & MY Hosp, Indore, Madhya Pradesh, India; [Rathi, A.] Care Hosp Nagpur, Nagpur, Maharashtra, India; [Biniwale, A.; Bhuti, M.] Biniwale Clin, Pune, Maharashtra, India; [Calambur, N.; Somaraju, B.; Karnwal, N.] Care Hosp, Hyderabad, Andhra Pradesh, India; [Chopda, M.; Mali, N.] Chopda Medicare & Res Ctr, Nasik, Maharashtra, India; [Goyal, N.; Saini, A.] Special Clin, New Delhi, Delhi, India; [Gupta, J.; Singh, P.] SR Kalla Mem Gen Hosp, Jaipur, Rajasthan, India; [Hadan, S.; Savanth, P.] Yenepoya Special Hosp, Mangalore, Karnataka, India; [Hardas, S.; Thakor, G.] Ruby Hall Clin, Pune, Maharashtra, India; [Hiremath, J.; Ghume, A.] Poona Hosp & Res Ctr, Pune, Maharashtra, India; [Jain, R.; Pahuja, M.] CHL Apollo Hosp, Indore, Madhya Pradesh, India; [Joseph, S.; Oommen, D.] Little Flower Hosp, Cochin, Kerala, India; [Joseph, J.; Thomas, R.] Caritas Hosp, Kottayam, Kerala, India; [Joshi, H.] Apollo Hosp Int Ltd, Iby, Gandhinagar, Gujarat, India; [Kale, V.; Raut, N.] Lokmanya Hosp, Pune, Maharashtra, India; [Kandekar, B.; Kandekar, S.] Nobel Hosp, Ahmednagar, Maharashtra, India; [Kishore, R.; Krishnan, H.] Narayana Hrudayalaya Inst Med Sci, Bangalore, Karnataka, India; [Kotiwale, V.] Kless Dr Prabhakar Kore Hosp & Med Res Ctr, Belgaum, Karnataka, India; [Kulkarni, R.; Deokar, M.] Moraya Multispecial Hosp, Pune, Maharashtra, India; [Kulkarni, G.; Lawande, A.] Shree Hosp, Pune, Maharashtra, India; [Kumar, P.; Karpuram, M.] Osmania Gen Hosp, Hyderabad, Andhra Pradesh, India; [Kumar, A.; Francis, J.] Lakeshore Hosp & Res Ctr, Cochin, Kerala, India; [Kumbla, M.; Anthony, A.] Omega Hosp, Mangalore, Karnataka, India; [Lavhe, P.; Kale, M.] Avanti Inst Cardiol, Nagpur, Maharashtra, India; [Mardikar, H.; Bhaskarwar, P.] Spandan Heart Inst, Nagpur, Maharashtra, India; [Mathur, A.; Sharma, P.] Escorts Heart Inst & Res Ctr, New Delhi, Delhi, India; [Menon, J.; Francis, V.] Mar Augustine Golden Jubilee Hosp, Ernakulam, Kerala, India; [Namjoshi, D.; Shelke, S.] Criti Care Hosp, Mumbai, Maharashtra, India; [Narendra, J.] ST Hosp, Shimoga, Karnataka, India; [Francis, V.; Natarajan, S.] G Kupuswami Naidu Mem Hosp, Coimbatore, Tamil Nadu, India; [Oomaan, A.; Gurusamy, P.] Apollo Hosp, Chennai, Tamil Nadu, India; [Angel, J.] Frontier Lifeline & Dr KM Cherian Heart Fdn, Chennai, Tamil Nadu, India; [Purayil, M. Padinhare; Shams, S.] West Ft Hi Tech Hosp Ltd, Trichur, Kerala, India; [Pandurangi, U.; Sababathi, R.] Inst Cardiovasc Dis Madras Med Miss, Chennai, Tamil Nadu, India; [Parekh, P.; Jasani, B.] Care Hosp, Surat, Gujarat, India; [Patki, N.; Babbar, A.] Deenanath Mangeshkar Hosp & Res Ctr, Pune, Maharashtra, India; [Pinto, B.; Kharalkar, H.] Bandra Holy Family Hosp & Res Ctr, Mumbai, Maharashtra, India; [Premchand, R.; Jambula, H.] Krishna Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Rao, M.; Vuriya, A.] Queens NRI Hosp, Vishakhapatnam, Andhra Pradesh, India; [Shankar, A. Ravi] Mysore Med Coll & Res Inst, RER, Mysore, Karnataka, India; [Reddy, R.; Bekal, S.] Mediciti Hosp, Hyderabad, Andhra Pradesh, India; [Roy, D.; Barai, A.] Rabindranath Tagore Int Inst Cardiac Scien, Kolkata, W Bengal, India; [Saha, D.; Gadepalli, R.] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Sant, H.; Jadhav, D.] Medipoint Hosp Pvt Ltd, Pune, Maharashtra, India; [Sarna, M.; Arora, T.] Monilek Hosp & Res Ctr, Jaipur, Rajasthan, India; [Sawhney, J.; Singh, R.] Dharmavira Heart Ctr, New Delhi, Delhi, India; [Sethi, K.; Bansal, N.] Delhi Heart & Lung Inst, New Delhi, Delhi, India; [Shetty, G.; Sudheer, R.] St Johns Med Coll & Hosp, Bangalore, Karnataka, India; [Singh, G.; Gupta, R.] Dayanand Med Coll & Hosp, Ludhiana, Punjab, India; [Srinivas, A.] Vikram Hosp & Heart Care, Mysore, Karnataka, India; [Thankaraj, L.] Sri Gokulam Heart Ctr, Trivandrum, Kerala, India; [Varma, S.; Kaur, A.] Sadbhavna Med & Heart Inst, Patiala, Punjab, India; [Vinod, M. Vijan; Thakur, B.] Vijan Cardiac Ctr, Nasik, Maharashtra, India; [Zanwar, I.; Dharmarao, A.] Hardas Heart Ctr, Pune, Maharashtra, India; [Atar, S.; Lasri, E.] Western Galilee Hosp Nahariya, Nahariyya, Israel; [Dicker, D.; Marcoviciu, D.; Lahav, M.; Gilat, T.] Rabin Med Ctr, Petah Tiqwa, Israel; [Elias, M.; Ron, G. Avraham] HaEmek Med Ctr, Afula, Israel; [Francis, A.; Ghantous, R.] Holy Family Hosp, Nazareth, Israel; [Goldhaber, A.; Goldhaber, M.] Clalit Hlth Serv, Shuali Community Clin, Raanana, Israel; [Gottlieb, S.; Rouwaida, S.] Bikur Cholim Hosp, Jerusalem, Israel; [Grossman, E.; Dagan, T.] Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Hasin, Y.; Roshrosh, M.] Poriya Govt Hosp, Tiberias, Israel; [Hayek, T.; Majdoub, A.] Rambam Hlth Care Campus, Haifa, Israel; [Klainman, E.; Genin, I.] Gefen Cardiac Ctr, Giv'atayim, Israel; [Lewis, B.; Ben Ari, M.] Lady Davis Carmel Med Ctr, Haifa, Israel; [Lishner, M.; Karny, M.] Sapir Med Ctr Meir Hosp, Kefar Sava, Israel; [Ouzan, E.; Givoni, H.] Hadassah Univ Hosp Ein Kerem, Jerusalem, Israel; [Rozenman, Y.; Logvinenko, S.] Wolfson Med Ctr, Holon, Israel; [Schiff, E.; Sterlin, J.] Bnai Zion Med Ctr, Haifa, Israel; [Shochat, M.; Aloni, I.] Hillel Yaffe Med Ctr, Hadera, Israel; [Swissa, M.; Belatsky, V.] Kaplan Med Ctr, Rehovot, Israel; [Tsalihin, D.; Kisos, D.] Clalit Hlth Serv, Ben Yair Community Clin, Beer Sheva, Israel; [Zeltser, D.; Platner, N.] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Berni, A.; Giovannelli, F.] Azienda Osped St Andrea, Rome, RM, Italy; [Boriani, G.; Cervi, E.] Osped S Orsola Malpighi, Bologna, Italy; [Comi, G.; Peruzzotti, L.] Fdn San Raffaele Monte Tabor, Milan, MI, Italy; [Cuccia, C.; Forgione, C.] Fdn Poliambulanza Ist Osped, Brescia, BS, Italy; [De Caterina, R.; De Pace, D.] Azienda Osped Univ G DAnnunzio, Chieti, CH, Italy; [De Servi, S.; Mariani, M.] AO Osped Civile Legnano, Legnano, MI, Italy; [Di Lenarda, A.; Mazzone, C.] ASS 1 Triestina, Trieste, TS, Italy; [Di Pasquale, G.; Di Niro, M.] Osped Maggiore CA Pizzardi, Bologna, BO, Italy; [Fattore, L.; Bosco, B.] Osped San Giuseppe & Melorio, Santa Maria Capua Vetere, CE, Italy; [Grassia, V.; Murena, E.] Osped Santa Maria Delle Grazie, Pozzuoli, NA, Italy; [Laffi; Gaggioli, G.] Azienda Osped Villa Scassi, Genoa, GE, Italy; [Lo Pinto, G.; Raggi, F.] Ente Osped Osped Galliera, Genoa, GE, Italy; [Marino, P.; Francalacci, G.] AO Maggiore Carita Novara, Novara, NO, Italy; [Merlini, P.; Babbolin, M.] Azienda Osped Osped Niguarda Ca Granda 2, Milan, MI, Italy; [Metra, M.; Bulgari, M.] Spedali Civili Brescia, Brescia, Italy; [Penco, M.; Lioy, E.] Policlin Casilino, Rome, RM, Italy; [Filardi, P. Perrone; Marciano, C.] Univ Napoli Federico II, Naples, NA, Italy; [Pirelli, S.; Paradiso, G.] Azienda Osped Ist Ospitalieri Cremona, Cremona, CR, Italy; [Piseddu, G.; Fenu, L.] Osped Ss Annunziata Az USL 1, Sassari, SS, Italy; [Raisaro, A.; Granzow, K.] IRCCS Policlin San Matteo, Pavia, PV, Italy; [Rasura, M.; Cannoni, S.] Univ La Sapienza Osped St Andrea, Rome, RM, Italy; [Severi, S.; Breschi, M.] Osped Misericordia, Grosseto, GR, Italy; [Toschi, V.; Gagliano, M.] AO Osped San Carlo Borromeo, Milan, MI, Italy; [Zaca, V.; Furiozzi, F.] AOU Senese Policlin Santa Maria Scotte, Siena, SI, Italy; [Hirahara, T.; Akihisa, U.; Masaki, W.] Kumamoto Univ Hosp, Kumamoto, Kumamoto, Japan; [Ajioka, M.; Matsushita, C.] Tosei Gen Hosp, Seto, Aichi, Japan; [Anzai, T.; Mino, K.] NHO Hakodate Natl Hosp, Hakodate, Hokkaido, Japan; [Arakawa, S.; Tsukimine, A.] JLHWO Kyushu Rosai Hosp, Kitakyushu, Fukuoka, Japan; [Endo, H.; Fujiwara, M.] Clin Horikawa, Kyoto, Kyoto, Japan; [Fujii, K.; Kozeni, S.] Watanabe Igakukai Sakurabashi Watanabe Hosp, Osaka, Osaka, Japan; [Fujii, E.; Kotera, M.] Mie Univ Hosp, Tsu, Mie, Japan; [Fujimoto, S.; Omae, K.] Nippon Steel Yawata Mem Hosp, Kitakyushu, Fukuoka, Japan; [Fujimoto, K.; Ichishita, Y.] NHO Kumamoto Med Ctr, Kumamoto, Kumamoto, Japan; [Fujita, T.; Ito, Y.] Nagaoka Red Cross Hosp, Nagaoka, Niigata, Japan; [Fukamizu, S.; Harada, J.] Tokyo Metropolitan Hiroo Gen Hosp, Shibuya Ku, Tokyo, Japan; [Fukuda, N.; Fujimoto, C.] NHO Zentsuji Natl Hosp, Zentsuji, Kagawa, Japan; [Funazaki, T.; Yamaguchi, A.] Saiseikai Kawaguchi Gen Hosp, Kawaguchi, Saitama, Japan; [Furukawa, Y.; Kamitake, C.] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan; [Hagiwara, N.; Naganuma, M.] Tokyo Womens Med Univ Hosp, Shinjuku Ku, Tokyo, Japan; [Hara, S.; Kumagai, S.] Iida Hosp, Iida, Nagano, Japan; [Harada, K.; Fuki, Y.] Tokyo Metropolitan Geriatr Hosp, Itabashi Ku, Tokyo, Japan; [Haruna, T.; Nakahara, Y.] TazukeKoufukai Igakukenkyujo Kitano Hosp, Osaka, Osaka, Japan; [Hashimoto, Y.; Shimazu, Y.] Tesshokai Kameda Clin, Kamogawa, Chiba, Japan; [Hiasa, Y.; Oga, Y.] Tokushima Red Cross Hosp, Komatsushima, Tokushima, Japan; [Higashikata, T.; Nakagawa, Y.] Komatsu Municipal Hosp, Komatsu, Ishikawa, Japan; [Hirayama, A.; Kawaguchi, A.] Nihon Univ Itabashi Hosp, Itabashi Ku, Tokyo, Japan; [Iesaka, Y.; Miyamoto, C.] Tsuchiura Kyodo Gen Hosp, Tsuchiura, Ibaraki, Japan; [Iijima, T.; Higuchi, K.] Fujioka Gen Hosp Outpatient, Fujioka, Gunma, Japan; [Ino, H.; Noguchi, H.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; [Inomata, T.; Nakamura, K.] Kitasato Univ Hosp, Sagamihara, Kanagawa, Japan; [Ishibashi, Y.; Nozaki, T.] Iwate Med Univ Hosp, Morioka, Iwate, Japan; [Ishii, Y.; Tomita, H.] Asahikawa City Hosp, Asahikawa, Hokkaido, Japan; [Ishimaru, S.; Ise, M.] Hokkaido Social Insurance Hosp, Sapporo, Hokkaido, Japan; [Itamoto, K.; Ito, T.] Teine Keijinkai Hosp, Sapporo, Hokkaido, Japan; [Ito, Y.; Onishi, M.] TOYOTA Mem Hosp, Toyota, Aichi, Japan; [Iwade, K.; Sakuma, Y.] NHO Yokohama Med Ctr, Yokohama, Kanagawa, Japan; [Iwasaki, T.; Nagatome, H.] Cardiovasc Hosp Cent Japan, Shibukawa, Gunma, Japan; [Kakinoki, S.; Adachi, C.] Otaru Kyokai Hosp, Otaru, Hokkaido, Japan; [Kamakura, S.; Nakahara, F.] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Kamijo, M.; Iida, S.] Chubu Rosai Hosp, Nagoya, Aichi, Japan; [Kamiyama, K.; Fujii, R.] Ijinkai Nakamura Mem Hosp, Sapporo, Hokkaido, Japan; [Kato, K.; Ishida, A.] JLHWO Yokohama Rosai Hosp, Yokohama, Kanagawa, Japan; [Kazatani, Y.; Ichikawa, Y.] Ehime Prefectural Cent Hosp, Matsuyama, Ehime, Japan; [Kitazawa, H.; Igarashi, C.] Tachikawa Gen Hosp, Nagaoka, Niigata, Japan; [Kobayashi, Y.; Kikuchi, R.] Showa Univ Hosp, Shinagawa Ku, Tokyo, Japan; [Kohno, M.; Tamura, S.] Kagawa Univ Hosp, Miki, Kagawa, Japan; [Koretsune, Y.; Yumoto, I.] NHO Osaka Natl Hosp, Osaka, Osaka, Japan; [Kurabayashi, M.; Koya, E.] Gunma Univ Hosp, Maebashi, Gumma, Japan; [Masuyama, T.; Kaneno, Y.] Hyogo Coll Med Hosp, Nishinomiya, Hyogo, Japan; [Matsuda, K.; Ebina, E.] MATSUDA Med Clin, Sapporo, Hokkaido, Japan; [Meno, H.; Satake, M.] Japanese Red Cross Fukuoka Hosp, Fukuoka, Fukuoka, Japan; [Mita, T.; Takeda, M.] Mita Med Cardiovasc Clin, Sapporo, Hokkaido, Japan; [Miyamoto, N.; Kimizu, T.] Saino Clin, Tokorozawa, Saitama, Japan; [Miyauchi, Y.; Sakamoto, S.] Nippon Med Coll Hosp, Bunkyo Ku, Tokyo, Japan; [Munemasa, M.; Murata, J.] NHO Okayama Med Ctr, Okayama, Okayama, Japan; [Nagai, Y.; Sakata, Y.] Rinku Gen Med Ctr, Izumisano, Osaka, Japan; [Naito, S.; Oyama, H.] Gunma Prefectural Cardiovasc Ctr, Maebashi, Gunma, Japan; [Nishi, Y.; Nagase, T.] Seiwakai Nagata Hosp, Yanagawa, Fukuoka, Japan; [Ochiai, J.; Junko, H.] Nagoya Ekisaikai Hosp, Nagoya, Aichi, Japan; [Ogawa, T.; Sugeno, M.] Fukushima Koseikai Fukushima Dai Hosp, Fukushima, Fukushima, Japan; [Oguro, H.; Tanabe, M.] Shimane Univ Hosp, Izumo, Shimane, Japan; [Okada, K.; Moriyama, Y.] Ohda Municipal Hosp, Ohda, Shimane, Japan; [Okajima, K.; Nakashima, M.] Hyogo Brain & Heart Ctr, Himeji, Hyogo, Japan; [Okazaki, O.; Wada, H.] Natl Ctr Global Hlth & Med Hosp, Shinjuku Ku, Tokyo, Japan; [Okishige, K.; Kitani, S.] Yokohama City Minato Red Cross Hosp, Yokohama, Kanagawa, Japan; [Okumura, K.; Narita, Y.] Hirosaki Univ Sch Med & Hosp, Hirosaki, Aomori, Japan; [Onaka, H.; Moriyama, H.] Takatsuki Red Cross Hosp, Takatsuki, Osaka, Japan; [Ozaki, Y.; Tanikawa, I.] Fujita Hlth Univ Hosp, Toyoake, Aichi, Japan; [Sakagami, S.; Nakano, A.] Kanazawa Med Ctr, Kanazawa, Ishikawa, Japan; [Sakuragi, S.; Hayashi, N.] NHO Iwakuni Clin Ctr, Iwakuni, Yamaguchi, Japan; [Sakurai, S.; Ooki, H.] Aizawa Hosp, Matsumoto, Nagano, Japan; [Sasaki, T.; Oosawa, N.] NHO Takasaki Gen Med Ctr, Takasaki, Gunma, Japan; [Satoh, A.; Fujimoto, E.] Shunkaikai Nagasaki Kita Hosp, Tokitsu, Nagasaki, Japan; [Seino, Y.; Narumi, M.] Nippon Med Sch Chiba Hokusoh Hosp, Inzai, Chiba, Japan; [Shirai, T.; Shigenari, M.] Tokyo Metropolitan Police Hosp, Nakano Ku, Tokyo, Japan; [Shoji, Y.; Ueda, J.] Makabe Hosp, Higashimatsushima, Miyagi, Japan; [Sugi, K.; Miyazaki, E.] Toho Univ Ohashi Med Ctr, Meguro Ku, Tokyo, Japan; [Sumii, K.; Asakura, H.] MAZDA Hosp MAZDA Co Ltd, Hiroshima, Japan; [Takagi, M.; Mohri, S.] Osaka City Univ Hosp, Osaka, Japan; [Takahashi, W.; Yoshida, K.] NHO Shinshu Ueda Med Ctr, Ueda, Nagano, Japan; [Takahashi, A.; Kishi, N.] Yokosuka Kyosai Hosp, Yokosuka, Kanagawa, Japan; [Takahashi, T.; Sakurai, Y.] Yokohama Med Ctr, Yokohama, Kanagawa, Japan; [Takeda, K.; Yahata, A.] Kagawa Prefectural Cent Hosp, Takamatsu, Kagawa, Japan; [Takenaka, T.; Yamagishi, K.] NHO Hokkaido Med Ctr, Sapporo, Hokkaido, Japan; [Takeuchi, S.; Watanabe, E.] Nagaoka Chuo Gen Hosp, Nagaoka, Niigata, Japan; [Tanaka, K.; Uchida, M.] Tokyo Metropolitan Canc & Infect Dis Ctr Kom, Bunkyo Ku, Tokyo, Japan; [Tanouchi, J.; Nishiya, Y.] Osaka Rosai Hosp, Sakai, Osaka, Japan; [Yoshida, K.; Tsuboi, H.] Ogaki Municipal Hosp, Ogaki, Gifu, Japan; [Tsuboi, N.; Terakura, K.] Social Insurance Chukyo Hosp, Nagoya, Aichi, Japan; [Uematsu, M.; Yasumoto, S.] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan; [Onishi, M.; Ueyama, Y.] Ueyama Clin, Suita, Osaka, Japan; [Usuda, K.; Sakai, Y.] Toyama Prefectural Cent Hosp, Toyama, Japan; [Yagi, M.; Sato, A.] Toyama Prefectural Cent Hosp, Toyama, Japan; [Yagi, H.; Kuroda, T.] Koseikai Takeda Hosp, Kyoto, Japan; [Yamabe, H.; Sakamoto, Y.] Kumamoto Univ Hosp, Kumamoto, Japan; [Yamada, T.; Yamano, R.] Kyuseiki Sogo Iryo C, Osaka Gen Med Ctr, Osaka, Japan; [Yamagishi, T.; Sasaki, S.] Isesaki City Hosp, Isesaki, Gunma, Japan; [Ito, Y.; Yamamoto, Y.] Kyoto Second Red Cross Hosp, Kamigyo Ku, Kyoto, Japan; [Yamashina, A.; Takiguchi, M.] Tokyo Med Univ Hosp, Shinjuku Ku, Tokyo, Japan; [Matsuda, K.; Yamashita, T.] Cardiovasc Inst Hosp, Minato Ku, Tokyo, Japan; [Tanaka, K.; Yonehara, T.] Saiseikai Kumamoto Hosp, Kumamoto, Japan; [Yoshino, H.; Nomura, H.] Kyorin Univ Hosp, Mitaka, Tokyo, Japan; [Yoshioka, K.; Fujiwara, Y.] Tokai Univ Hosp, Isehara, Kanagawa, Japan; [Bayram Llamas, E.; Hurtado, A.] Fdn Cardiovasc Aguascalientes AC, Aguascalientes, AGS, Mexico; [Calvo Vargas, C.; Cedano Limon, M.] Unidad Invest Med, Guadalajara, Jalisco, Mexico; [Cardona Munoz, E.; Hernandez, S.] ICLE SA, Guadalajara, Jalisco, Mexico; [Carrillo, J.; Delgadillo, T.] Hosp Cent Dr Ignacio Morones Prieto, San Luis Potosi, SLP, Mexico; [Casares Ramirez, M.; Franco Valles, J.] Hosp Gen Durango, Durango, DGO, Mexico; [Garcia, N.; Alcantara Colin, M.] Hosp Mocel, Mexico City, DF, Mexico; [Garcia-Castillo, A.; Jaramillo, A.] Cardiolink, Monterrey, NL, Mexico; [Leiva-Pons, J.; de la Mora, S.] Hosp Lomas San Luis, San Luis Potosi, SLP, Mexico; [Llamas Esperon, G.; Grajales, A.] Hosp Cardiol Aguascalientes, Aguascalientes, AGS, Mexico; [Mendez-Machado, G.; Avila, H.] Hosp Angeles Xalapa, Xalapa, Veracruz, Mexico; [Nevarez Ruiz, L.; Magallanes, G.] Hosp CIMA Chihuahua, Chihuahua, CHIH, Mexico; [Sanchez Diaz, C.; Ortiz, A.] Unidad Invest Clin Med SC, Monterrey, NL, Mexico; [Velasco Sanchez, R.; Moran Velazquez, E.] Hosp Gen Dr Angel Leano, Zapopan, JAL, Mexico; [Alhakim, M.; van Welsen, I.] Flevoresearch, Almere, Netherlands; [Bruning, T.; Jones, A.] Maasstad Ziekenhuis Zuider, Rotterdam, Netherlands; [Buiks, C.] Huisartsenpraktijk Buiks, Ewijk, Netherlands; [de Groot, J.; Radder, I.] Acad Med Ctr, Amsterdam, Netherlands; [de Vos, R.] Huisartsenpraktijk de Vos, Dordrecht, Netherlands; [Hazeleger, R.; Daniels, R.] VieCuri Med Ctr Venlo, Venlo, Netherlands; [Kietselaer, B.; Muijs, L.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Mannaerts, H.; Kooiman, E.] Ziekenhuis Amstelland, Amstelveen, Netherlands; [Mevissen, H.] Huisartsenpraktijk Westerhave, Wildervank, Netherlands; [van der Heijden, D.; Hofmeyer, H.] Rijnland Ziekenhuis Leiderdorp, Leiderdorp, Netherlands; [Anscombe, R.; O'Meeghan, T.; Kjentjes, M.] Hutt Valley Hlth Hosp, Lower Hutt, New Zealand; [Benatar, J.; White, H.; Borthwick, L.; Doughty, R.; Copley, M.] Auckland City Hosp, Auckland, New Zealand; [Fisher, R.; Monkley, R.] Waikato Hosp, Hamilton, New Zealand; [Green, B.; Scott, D.] Dunedin Publ Hosp, Dunedin, New Zealand; [Hamer, A.; Tomlinson, J.] Nelson Hosp, Nelson, Netherlands; [Hart, H.; Turner, A.] North Shore Hosp, Auckland, New Zealand; [Scott, D.; Cammell, R.] Middlemore Hosp, Otahuhu, New Zealand; [Troughton, R.; Skelton, L.] Christchurch Hosp, Christchurch, New Zealand; [Young, C.; Kennett, K.] P3 Res Ltd, Tauranga, New Zealand; [Atar, D.; Claussen, H.] Ulleval Univ, Oslo, Norway; [Hofsoy, K.; Melbue, R.] Halogalandsykehuset HF, Harstad, Norway; [Sandvik, J.; Thunhaug, H.] Nordland Hjertesenter AS, Bodo, Norway; [Tveit, A.; Enger, S.] Baerum Sykehus, Sykehuset Asker & Baerum, Rud, Norway; [Bustamante, G.; Tejada Guillen, M.] Clin San Borja, Lima 41, Peru; [Cabrera, J.; Esteves Mendoza, R.] Clin Vesalio, Lima, Peru; [Chavez, C.; Luna, C.] Hosp Nacl Daniel Alcides Carr, Callao, Peru; [Lema, J.; Carrion, A.] Hosp Nacl Arzobispo Loayza, Lima, Peru; [Llerena, N.; Araoz Bedregal, S.] Consultorio Privado Dr Nassil Llerena Navarro, Arequipa, Peru; [Medina Palomino, F.; Rodriguez, J.] Clin Med Cayetano Heredia, Lima, Peru; [Minchola, J.; Bautista, C.] Clin San gabriel, Lima, Peru; [Negron Miguel, S.; Honores Armas, B.] Ctr Med Naval Cirujano Mayor Santiago Tavar, San Borja, Peru; [Rodriguez, A.; Romero, N.] Hosp Nacl Alberto Sabogal Sologuren, Callao, Peru; [Torres, P.; Fernandez Rodriguez, K.] Consultorio Privado Dr Pedro Torres, Arequipa, Peru; [Yanac Chavez, P.; Horna, M.; Delgado, S.] Hosp Alberto Sabogal Sologuren, Callao, Peru; [Babilonia, N.; Sambaz, C. M.] Philippine Heart Ctr, Quezon City, Philippines; [Barcinas, R.; Zapanta, M.] Alexian Bros Hlth & Wellness Ctr, Davao, Philippines; [Coching, R.; Vallenas, M.] Davao Doctors Hosp, Davao, Philippines; [Matiga, G.; Enad, C.] Perpetual Succour Hosp Cebu, Cebu, Philippines; [Rogelio, G.; Joaquin, F.] St Lukes Med Ctr, Quezon City, Philippines; [Roxas, A., Jr.; Gilo, L.; To, R.; Aquino, M.] Med City, Pasig, Philippines; [Villamor, L.; Nario, K.] Cebu Doctors Univ Hosp, Cebu, Philippines; [Adamus, J.; Korzeniowska-Adamus, J.] Centrum Med Ostrobramska NZOZ Magodent, Warsaw, Poland; [Baszak, J.] NZOZ Przychodnia Specjalistyczna Med, Lublin, Poland; [Bronisz, M.; Cieslak, B.] Publiczny Specjalistyczny ZOZ Inowroclawiu, Inowroclaw, Poland; [Busz-Papiez, B.; Krzystolik, A.] Indywidualna Specjalistyczna Praktyka Lekarska B, Szczecin, Poland; [Cymerman, K.] Indywidualna Specjalistyczna Praktyka Lekarska, Gdynia, Poland; [Dabrowska, M.; Ptak, A.] Synexus SCM Sp Zoo Oddzial Warszawie, Warsaw, Poland; [Derlaga, B.; Laskowska-Derlaga, E.] Spec Gabinet Lekarski Internistyczno Kardiologicz, Tarnow, Poland; [Domanska, E.; Guziewicz, M.] Ctr Med CDS, Wroclaw, Poland; [Gieroba, A.; Zajac, E.] SPZOZ, Lubartow, Poland; [Gniot, J.; Mroczkowski, P.] SPZOZ Pulawach Szpital Specjalistyczny, Pulawy, Poland; [Januszewicz, A.; Makowiecka-Ciesla, M.; Pogorzelska, H.; Ruzyllo, W.; Norwa-Otto, B.] Inst Kardiol Kardynala St Wyszynskiego, Warsaw, Poland; [Jazwinska-Tarnawska, E.; Ciezak, P.] Synexus SCM Sp Zoo, Wroclaw, Poland; [Jurowiecki, J.] NZOZ Przychodnia Morena, Gdansk, Poland; [Kaczmarek, B.; Pacholska, A.] NZOZ Polimed, Lodz, Poland; [Kaminski, L.] SP ZOZ Przeworsku, Przeworsk, Poland; [Kania, G.; Tymendorf, K.] NZOZ Przychodnia Zdrowia ZADEBIE, Skierniewice, Poland; [Karczmarczyk, A.; Kaliszczak, R.] Indywidualna 16 Specjalistyczna Praktyka Lekarska, Szczecin, Poland; [Konieczny, M.; Benicka, E.] KO MED Marek Konieczny, Pulawy, Poland; [Korzeniak, R.; Borowski, W.] NZOZ Specjalistyczna Przychodnia Lekarska Medikar, Plock, Poland; [Krzyzanowski, W.; Muzyk-Osikowicz, M.] SPZZOZ Szpital Powiatowy M Sklodowskiej Curie, Ostrow Mazowiecka, Poland; [Kus, W.] Indywidualna Specjalistyczna Praktyka Lekarska, Lodz, Poland; [Lesnik, J.; Wierzykowski, T.] NZOZ Kutnowski Szpital Samorzadowy Sp Zoo, Kutno, Poland; [Lewczuk, J.; Stopyra-Poczatek, M.] Wojewodzki Szpital Specjalistyczny we Wroclawiu, Wroclaw, Poland; [Lubinski, A.; Szymanska, K.] Univ Szpital Klin WAM Cen Szpit Weteran, Lodz, Poland; [Lysek, R.; Jaguszewska, G.] Lecznice Citomed Sp Zoo, Torun, Poland; [Matyszczak-Toniak, L.; Sznajder, R.; Wnetrzak-Michalska, R.; Kosmaczewska, A.] Synexus SCM Sp Zoo Oddzial Katowicach, Katowice, Poland; [Mazur, S.; Chmielowski, A.] Ctr Med Medyk, Rzeszow, Poland; [Miekus, P.; Kosmalska, K.] NZOZ Pro Cordis Sopockie Ctr Bad Kardiol, Sopot, Poland; [Mosiewicz, J.; Myslinski, W.] Samodzielny Publiczny Szpital Kliniczny Nr 1 Lubl, Lublin, Poland; [Napora, P.; Biniek, D.] NZOZ Ctr Badan Klin, Wroclaw, Poland; [Nessler, J.; Nessler, B.] Specjalistyczny Gabinet Internistyczno Kardiol, Krakow, Poland; [Niezgoda, K.; Nej, A.] Elblaski Szpital Specjalistyczny Przychodnia, Elblag, Poland; [Nowak, J.] Gabinet Internistyczno Kardiol Dr N Med Jacek Now, Libiaz, Poland; [Olszewski, M.] Szpital Praski PW Przemienienia Panskiego, Warsaw, Poland; [Podjacka, D.; Janczewska, D.] NZOZ Kardiomed, Elblag, Poland; [Polaszewska-Pulkownik, V.; Bojanowska, E.] Specjalistyczny Szpital Miejski M Kopernika, Torun, Poland; [Raczak, G.; Zienciuk-Krajka, A.] NZOZ Ctr Med Kardiorytm, Gdansk, Poland; [Rewinska, H.; Rozmyslowicz-Szerminska, W.] Mazurskie Ctr Zdrowia Pro Med, Elk, Poland; [Ronkowski, R.] Regionalny Szpital Kolobrzegu, Kolobrzeg, Poland; [Sendrowski, D.] Przychodnia Specjalistyczna Falck, Gdansk, Poland; [Spyra, J.] Specjalistyczna Praktyka Lekarska Janusz Spyra, Ruda Slaska, Poland; [Szolkiewicz, M.; Malanska, A.] NZOZ Eter Med Sp Zoo, Gdansk, Poland; [Turbak, R.] NZOZ Zdrowy Checz, Linia, Poland; [Wrobel, W.; Muzalewski, P.] Wielospec Szpital Miejski Dr E Warminskiego SPZOZ, Bydgoszcz, Poland; [Wysokinski, A.; Kudlicki, J.] Samodzielny Publiczny Szpital Klin Nr 4 Lublinie, Lublin, Poland; [Zarebinski, M.; Krauze, R.] NZOZ Starowka, Warsaw, Poland; [Zielinski, M.; Nawrot, M.] Specjalistyczna Praktyka Lekarska, Chojnice, Poland; [Matias, F.] Cruz Vermelha Portuguesa Soc Gestao Hosp, Lisbon, Portugal; [Correia, J.] Hosp Santo Andre EPE, Leiria, Portugal; [Gil, V.; Lopes, S.] Hosp Fernando Fonseca Amadora Sintra, Amadora, Portugal; [Madeira, J.; Maymone, D.] Hosp Sao Bernardo, Setubal, Portugal; [Martins, D.; Neves, E.] Hosp Div Espirito Santo, Ponta Delgada, Portugal; [Monteiro, P.; Oliveira, D.] Hosp Univ Coimbra, Coimbra, Portugal; [Leitao Marques, A.; Castro, C.] Centro Hosp Coimbra, Coimbra, Portugal; [Salgado, A.; Goncalves, A.] H Sao Marcos, Braga, Portugal; [Santos, O.; Veiga Pais Nunes, L.] H Sao Teotonio, Viseu, Portugal; [Santos, J.; Soares, D.] Hosp Infante D Pedro SA, Aveiro, Portugal; [Albulescu, P.; Ciortea, M.] Spitalul Clin Judetean Urgenta Ilfov, Bucharest, Romania; [Apetrei, E.; Matei, C.] Inst Boli Cardiovasculare Prof Dr CC Iliescu, Bucharest, Romania; [Bartos, D.; Badila, E.] Spitalul Clin Urgenta Floreasca Bucuresti, Bucharest, Romania; [Bengus, C.; Ochean, V.] Spitalul Judetean Urgenta Sf Pantelimon Focsani, Focsani, Romania; [Bobescu, E.; Doka, B.] Spitalul Clin Judetean Urgenta Brasov, Brasov, Romania; [Bolohan, F.] Ctr Clin Urgenta Boli Cardiovasc Armatei, Bucharest, Romania; [Ciobotaru, G.; Andor, M.] Centrul Med Privat Med, Timisoara, Romania; [Coman, I.; Ghionea, M.] Inst Urgenta Boli Cardiovasc Prof Dr C C Iliescu, Bucharest, Romania; [Creteanu, M.; Parasteac, M.] Spitalul Judetean Urgenta Sf Ioan Cel Nou Suceava, Suceava, Romania; [Cristea, M.; Anciu, M.] Centrul Med Diagnost & Tratament, Bucharest, Romania; [Crisu, D.; Jemna, D.] Consultmed SRL, Iasi, Romania; [Dobre, I.; Voicu, O.] Spitalul Judetean Urgenta Targoviste, Targoviste, Romania; [Dobreanu, D.; Sirbu, I.] Spitalul Clin Judetean Urgenta Tg Mures, Targu Mures, Romania; [Dragomir, D.; Jurca, S.] CMDTA Dr Nicolae Kretulescu, Bucharest, Romania; [Iosipescu, L.; Costache, L.] Spitalul Clin Judetean Urgenta Bacau, Bacau, Romania; [Minescu, B.; Serban, D.] Spitalul Judetean Urgenta Braila, Braila, Romania; [Pop, C.; Cozma, M.] Cabinet Med Individual Cardiol Dr Calin Pop, Baia Mare, Romania; [Popescu, M.; Ardelean, A.] Spitalul Clin Judetean Urgenta Oradea, Oradea, Romania; [Stamate, S.; Spinu, C.] Spitalul Clin Urgenta Sf Pantelimon, Bucharest, Romania; [Topolnitchi, L.; Topolnitchi, O.] Spitalul Judetean Sf Gheorghe, Sfantu Gheorghe, Romania; [Tudoran, M.; Tudoran, C.] Spitalul Clin Judetean Urgenta Timisoara, Timisoara, Romania; [Zhukova, N.; Golitsyn, S.; Kratskina, T.; Karpov, Y.; Buza, V.; Panchenko, E.; Laguta, P.; Ruda, M.] FSBI Russian Cardiol Res & Prod Complex, Moscow, Russia; [Arutyunov, G.; Chernyavskaya, T.] Russian State Med Univ, Moscow, Russia; [Ballyuzek, M.; Alexandrova, L.] St Petersburg Clin Hosp, Russian Acad Sci, St Petersburg, Russia; [Barbarash, O.; Bashkireva, A.] MIH Kemerovo Cardiol Dispensary, Kemerovo, Russia; [Bart, B.; Larina, V.] SBEU Russia Natl RMU Na NI Pirogov MoH RF, Moscow, Russia; [Belenky, D.; Kosolapov, Y.] SBIH Novosibirsk Region Clin Emergency Hosp 2, Novosibirsk, Russia; [Berns, S.; Yukhno, E.] SI SRI Complex Problems CardioVasc Dis SB, Kemerovo, Russia; [Bokarev, I.; Khlevchuk, T.] Moscow City Clin Hosp 20, Moscow, Russia; [Chumakova, G.; Pokutneva, O.] TSIH Altay Territorial Cardiol Dispensary, Barnaul, Russia; [Demko, A.; Masin, A.] OAO Russian Railway, Dep Clin Hosp Stn Kemerovo, Kemerovo, Russia; [Dovgalevsky, P.; Puchinyan, N.] Saratov Inst Cardiol, Saratov, Russia; [Drapkina, O.; Zyatenkova, E.] First Moscow State Med Univ Na IM Sechenov, Moscow, Russia; [Egorova, L.] StP SHI Clin Hosp St Luka, St Petersburg, Russia; [Esip, V.; Kirichek, N.] St Petersburg State Healthcare Inst Diagnost Cent, St Petersburg, Russia; [Filatov, A.; Soin, I.] State Healthcare Facil Tula Reg Hosp, Tula, Russia; [Gilinskaya, O.; Valuyshkih, E.] SI SRI Physiol SB RAMS, Novosibirsk, Russia; [Glezer, M.; Valovyeva, S.] SBHI City Clin Hosp 59 HD City Moscow, Moscow, Russia; [Golitsyn, S.; Kratskina, T.] FSBI Russian Cardiol Res & Prod Complex, Moscow, Russia; [Goloshchekin, B.; Laptev, I.] St Petersburg SIH City Hosp 15, St Petersburg, Russia; [Gratsiansky, N.; Mazovets, O.] SIH Moscow City Clin Hosp 29 Na Baymana, Moscow, Russia; [Karpov, Y.; Buza, V.] FSBI Russian Cardiol Res & Prod Complex, Moscow, Russia; [Karpov, Y.; Kosenko, B.] Emergency Med Care Hosp 1, Voronezh, Russia; [Khirmanov, V.; Kireenkov, I.] All Russian Ctr Emergency & Radiat Med MCRS, St Petersburg, Russia; [Khokhlov, A.; Sinitsina, O.] Municipal MI Clin Hosp 2, Yaroslavl, Russia; [Khokhlov, R.; Tsareva, E.] Voronezh Reg Clin Hosp 1 Interreg Cardio, Voronezh, Russia; [Khrustalev, O.; Khrustalev, A.] Yaroslavl Reg SBHI Reg Clin Hosp, Yaroslavl, Russia; [Kostenko, V.; Karabalieva, S.] St Petersburg SHI City Polyclinic 109, St Petersburg, Russia; [Koziolova, N.; Polyanskaya, E.] SHI Perm Reg Hosp War Veterans, Perm, Russia; [Kozyrev, O.; Kostenko, O.] Smolensk State Med Acad Roszdrav, Smolensk, Russia; [Kuznetsov, V.; Rychkov, A.] SRI Cardiol SB RAMS Br Tumen Cardiol Ctr, Tumen, Russia; [Lavrova, O.; Tereschenko, L.] Pavlov State Med Univ St Petersburg, St Petersburg, Russia; [Levashov, S.; Volkova, E.] SBHI Reg Clin Hosp 3, Chelyabinsk, Russia; [Libis, R.; Maslova, A.] Orenburg State Med Acad RosZdrav, Orenburg, Russia; [Libov, I.; Moiseeva, Y.] City Clin Hosp, Moscow, Russia; [Lila, A.; Belousova, L.] SBEI HPE NWSMU Na II Mechnikov MoH RF, St Petersburg, Russia; [Lukyanov, Y.; Lamden, D.] SEIHPE SPb SMU Na Pavlov Affiliate 1 FAHSD, St Petersburg, Russia; [Nikolaev, K.; Nikolaev, A.] SBIH Novosibirsk Region City Clin Hosp 19, Novosibirsk, Russia; [Nikolskaya, I.; Khromova, O.] MBHI Novosibirsk City Clin Hosp 25, Novosibirsk, Russia; [Novikova, N.; Patrusheva, S.] Cent Clinin Hosp Siberian branch RAOS, Novosibirsk, Russia; [Panchenko, E.; Laguta, P.] FSBI Russian Cardiol Res & Prod Complex, Moscow, Russia; [Panov, A.; Nilk, R.] FSI FC Heart Blood & Endocrinol Na Almazov, St Petersburg, Russia; [Polkanova, E.; Matveeva, I.] SHI Ctr Occupat Pathol, St Petersburg, Russia; [Poluyanova, N.; Pikalova, N.] FSI Outpatient Clin 3 President RF, Moscow, Russia; [Raskina, T.; Letaeva, M.] SBHI Kem Reg Clin Hosp War Vet, Kemerovo, Russia; [Rebrov, A.; Karoli, N.] SEIHPE Saratov State Med Univ, Saratov, Russia; [Repin, M.; Rodina, N.] LLC Inst Med Investigat, St Petersburg, Russia; [Shaposhnik, I.; Lebedev, E.] City Hosp 1, Chelyabinsk, Russia; [Shogenov, Z.; Agirov, M.] CityClinicalHospital81, Moscow, Russia; [Sidorenko, B.; Vorontsova, S.] RF Cent Clin Hosp, FSD ESMC GMD, Moscow, Russia; [Sinitsina, I.; Orlov, V.; Golshmid, M.] RMA Post Grad Educ MoH & SD RF, Moscow, Russia; [Sizova, Z.; Lapidus, N.] State Healthcare Inst City Moscow Cardiol, Moscow, Russia; [Sobolev, K.; Erofeeva, S.] City Clin Hosp 61, Moscow, Russia; [Suprun, E.; Dronov, D.] Municipal Healthcare Inst Medicosanitary Unit 9, Omsk, Russia; [Tarasov, N.; Isakov, L.] RF Kemerovo Region, FGHI MSU, MoIA, Kemerovo, Russia; [Tereshenko, S.; Kositsyna, I.] Moscow State Medicostomat Univ City Hosp 68, Moscow, Russia; [Tikhonova, E.; Solovyev, A.] JSC Med Scient Prod Assoc Clin Dvizhenie, Volgograd, Russia; [Timofeev, A.; Bulygin, S.] MIH City Hosp 1, Barnaul, Russia; [Ustyugov, S.; Rossovskaya, M.] MBHI City Clin Emergency Hosp Na NS Karpovich, Krasnoyarsk, Russia; [Vishnevsky, A.; Kirgizova, A.] SPb SIH Pokrovskaya City Hosp, St Petersburg, Russia; [Rodina, N.; Volkov, D.] Med Inst Krestovsky, St Petersburg, Russia; [Yakusevich, V.; Petrochenko, A.] SHI Clin Hosp Emergency Med Care Na NV Solovyev, Yaroslavl, Russia; [Yakushin, S.; Nikulina, N.] Ryazan Reg Clin Cardiol Dispensary, Ryazan, Russia; [Zateyshchikov, D.; Zotova, I.] SBHI City Moscow City Hosp 17, Moscow, Russia; [Zateyshchikova, A.; Mankhaeva, B.] SBHI City Clin Hosp 51 Hd Moscow city, Moscow, Russia; [Zenin, S.; Kononenko, O.] SBIH Novosibirsk Reg Clin Cardiol Dispensary, Novosibirsk, Russia; [Zubeeva, G.; Motylev, I.] Municipal Medicoprophylact Inst City Hosp 33, Nizhnii Novgorod, Russia; [Apostolovic, S.; Djordjevic-Radojkovic, D.] Clin Ctr Nis, Nish, Serbia; [Celic, V.; Majstorovic, A.] Clin Ctr Dragisa Misovic, Belgrade, Serbia; [Adjic, N. Cemerlic; Bjelobrk, M.] Inst Cardiovasc Dis Sremska Kamen, Sremska Kamen, Serbia; [Despotovic, N.; Erceg, P.] Clin Ctr Zvezdara, Belgrade, Serbia; [Ilic, S.; Ilic, B.] Inst Treatment & Rehabil Niska Banja, Niska Banja, Serbia; [Krotin, M.; Djokovic, A.] Clin Ctr Bezanijska Kosa, Zemun, Serbia; [Miloradovic, V.; Djokic, I.] Clin Ctr Kragujevac, Kragujevac, Serbia; [Otasevic, P.; Tasic, N.] Dedinje Cardiovasc Inst, Belgrade, Serbia; [Potpara, T.; Polovina, M.; Vasiljevic-Pokrajcic, Z.; Mitrovic, P.] Clin Ctr Serbia, Belgrade, Serbia; [Putnikovic, B.; Kalezic, T.] Clin Ctr Zemun, Zemun, Serbia; [Seferovic, P.; Milinkovic, I.] Inst CV Dis Clin Ctr Serbia, Belgrade, Serbia; [Tavciovski, D.; Davicevic, Z.] Mil Med Acad, Belgrade, Serbia; [Tesic, B. Vujisic; Ostojic, M.; Tesic, M.] Inst CV Dis Clin Ctr Serbia, Belgrade, Serbia; [Ambrovicova, V.; Ambrovic, I.] CELL B sro, Levice, Slovakia; [Banikova, A.] Kardiomed sro, Lucenec, Slovakia; [Dukat, A.; Kosmalova, V.; Kasperova, V.; Reptova, A.] Univ nemocn Bratislava Nemocn Stare Mesto, Bratislava, Slovakia; [Dulkova, K.; Dulka, T.] Kardiovaskularne ctr sro, Bratislava, Slovakia; [Duris, T.; Vankova, L.] FNsP Nove Zamky, Nove Zamky, Slovakia; [Dzupina, A.; Dzupinova, M.] Alian sro, Bardejov, Slovakia; [Hatalova, K.; Hatala, R.] Cardioconsult sro, Bratislava, Slovakia; [Hranai, M.; Hofmanova, J.] Kardiocentrum Nitra sro, Nitra, Slovakia; [Mazur, J.] Kardioonkologia sro, Dolny Kubin, Slovakia; [Pella, D.; Fedacko, J.] Cardio D&R sro, Kosice, Slovakia; [Ruffini, L.; Morsky, J.] Nestatna kardiologicka ambulancia, Rimavska Sobota, Slovakia; [Slanina, M.; Kmec, J.] FNsP J A Reimana, Presov, Slovakia; [Zachar, A.; Kokles, M.] Univ nemocn Bratislava Nemocn ak L Derera, Bratislava, Slovakia; [Zareczky, P.; Bollova, D.] Cardio sro, Galanta, Slovakia; [Badenhorst, J.; Erasmus, L.] Unitas Hosp, Lyttelton, Gauteng, South Africa; [Basson, M.; Poynton, M.] Tiervlei Trial Ctr, Bellville, W Cape, South Africa; [Dalby, A.; Allman, J.] Millpark Hosp, Parktown West, Gauteng, South Africa; [Ellis, G.; Botha, L.] Helderberg Clin Trials, Somerset, W Cape, South Africa; [Essop, M.; Nunkoo, T.] Chris Hani Baragwanath Hosp, Diepkloof, Gauteng, South Africa; [Gani, M.; Wilson, L.] GCT Mercantile CTC, Port Elizabeth, E Cape, South Africa; [Kelfkens, Y.] Potchefstroom, NW, South Africa; [Mitha, I.; Taljaard, J.] Worthwhile Clin Trials, Benoni, Gauteng, South Africa; [Naidoo, D.; Duki, Y.] Res Clin, Durban, KZ Natal, South Africa; [Snyders, F.; Munnik, M.] Wilgers Med Consortium, Pretoria, Gauteng, South Africa; [Soma, P.; Johnston, H.] Univ Pretoria, Clin Trial Unit, Pretoria, Gauteng, South Africa; [Van Der Merwe, N.; Goosen, Y.] Medi Clin Bloemfontein, Bloemfontein, Free State, South Africa; [Van Zyl, L.; Le Roux, M.] Clin Project Res, Worcester, MA, South Africa; [Venter, T.; Wessels, L.] Union Hosp, Alberton, Gauteng, South Africa; [Bae, H. J.; Han, M. G.] Seoul Natl Univ Bundang Hosp, Gyeonggi Do, South Korea; [Cha, J. K.; Kim, D. H.] Dong Univ Med Ctr, Busan, South Korea; [Cho, B. R.; Ryu, D. R.] Kangwon Natl Univ Hosp, Gangwon Do, South Korea; [Choi, H. H.; Hong, K. S.] Chuncheon Sacred Heart Hosp, Gangwon Do, South Korea; [Chung, W. S.; Oh, Y. S.] Cathol Univ Korea Seoul St Mary Hosp, Seoul, South Korea; [Han, S. H.; Lee, K. H.] Gachon Univ Gil Hosp, Incheon, South Korea; [Hong, T. J.; Lee, H. W.] Pusan Natl Univ Hosp, Pusan, South Korea; [Hyon, M. S.; Jung, J. W.] Soonchunhyang Univ Hosp, Seoul, South Korea; [Jeon, H. K.; Lee, J. M.] Cathol Univ Korea, Uijeongbu St Marys Hosp, Gyeonggi Do, South Korea; [Kang, D. H.; Choi, K. J.] Asan Med Ctr, Seoul, South Korea; [Kim, C. J.; Jin, E. S.] Kyung Hee Univ Hosp Gandong, Seoul, South Korea; [Kim, D. S.; Seo, J. S.] Inje Univ, Busan Paik Hosp, Busan, South Korea; [Kim, H. S.; Cha, M. J.] Seoul Natl Univ Hosp, Seoul, South Korea; [Kim, J. T.; Park, M. S.] Chonnam Natl Univ Hosp, Gwangju, South Korea; [Kim, J. H.; Park, J. H.] Chungnam Natl Univ Hosp, Daejeon, South Korea; [Kim, J. S.; Park, S. J.] Samsung Med Ctr, Seoul, South Korea; [Kim, S. H.; Seo, J. B.] Seoul Metropolitan Govt Seoul Natl Univ, Seoul, South Korea; [Kim, Y. J.; Chun, M. Y.] Ewha Womans Univ, Mokdong Hosp, Seoul, South Korea; [Lee, M. H.; Joung, B. Y.] Severance Hosp Yonsei Univ Coll Med, Seoul, South Korea; [Lee, S. H.; Shin, D. G.] Yeungnam Univ Hosp, Daegu, South Korea; [Namgung, J.; Kwak, J. J.] Inje Univ, Ilsan Paik Hosp, Gyeonggi Do, South Korea; [Rha, S. W.; Na, J. O.] Korea Univ, Guro Hosp, Seoul, South Korea; [Rim, S. J.; Kim, J. Y.] Gangnam Severance Hosp, Seoul, South Korea; [Arcocha Torres, M.; Manzanal Rey, A.] Hosp Basurto, Bilbao 48, Spain; [Blanco Coronado, J.; Puertas, I.] Hosp Virgen Mar, Almeria 4, Spain; [Bruguera Cortada, J.; Cabero, P.] H Mar, Barcelona 8, Spain; [Calvo, C.; Calvo, G.] HCU Santiago, La Coruna 15, Spain; [De Arce Borda, A.; Asensio, A.] Hosp Donostia, San Sebastian 20, Spain; [Diez Tejedor, E.; Perez Guevara, M.] HGU Paz, Madrid 28, Spain; [Gonzalez Juanatey, J.; Moure, M.] HCU Santiago, Santiago De Compostela 15, Spain; [Hernandez Madrid, A.; Delgado, A.] HU Ramon Cajal, Madrid 28, Spain; [Lopez Garcia-Aranda, V.; Barquero, R.] HU Virgen Macarena, Seville 41, Spain; [Manzano, L.; Blanco Abril, S.] Hosp Univ Ramon Cajal, Madrid 28, Spain; [Merino, J.; Diaz-Pintado, M.] HGU Paz, Madrid 28, Spain; [Arias, J.; Fernandez, M.; Fernandez Alvarez, R.] Policlin Vigo Povisa, Vigo 36, Spain; [Terns, M.; Dachs Delgado, M.] CAP Remei, Barcelona 8, Spain; [Villuendas, R.; Astier, L.] Hosp Univ Germans Trias Pujol, Barcelona, Spain; [Appelros, P.; Akerberg, A.] Univ Orebro, Orebro, Sweden; [Blom, K. Berndtsson; Andersson, R.] Ladulaas klin studier, Skene, Sweden; [Blomstrom, P.; Persson, L.] Akad Sjukhuset, Uppsala, Sweden; [Carlsson, T.; Bengtsson, A. Stener] Hjarthuset AB, Varberg, Sweden; [Dettmann, S.; Ostberg, S.] Mora Iasarett, Mora, Sweden; [Engdahl, J.; Karlsson, L.] Lanssjukhuset Halmstad, Halmstad, Sweden; [Herlitz, J.; Winberg, L.] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Koskinen, P.; Hakansson, E.] Univ MAS, Malmo, Sweden; [Koskinen, P.; Hakansson, E.] PharmaSite AB, Malmo, Sweden; [Kozak, P.; Edlund, M.] ProbarE, Lund, Sweden; [Malmqvist, L.; Eriksson, G.] Kopings Iasarett, Koping, Sweden; [Randers, F.; Moodh, J.] Sahlgrenska Univ Molndal, Molndal, Sweden; [Rautio, A.; Johansson, M.] Sensia Forskning, Lulea, Sweden; [Ronn, F.; Sundholm, C.] Norrlands Univ, Umea, Sweden; [Stenberg, A.; Gunnarsson, A.] Lindesbergs Iasarett, Lindesberg, Sweden; [Thulin, J.; Broberg, M.] Capio Citykliniken Lund, Lund, Sweden; [Moccetti, T.; Slater, I. Petrova] Cardio Ctr Ticino, Lugano, Switzerland; [Cheng, C. C.; Wu, W. S.] Chi Mei Med Ctr Yongkang, Tainan, Taiwan; [Chiang, C. E.; Yu, W. C.] Taipei Vet Gen Hosp, Taipei, Taiwan; [Chiang, F. T.; Wu, Y. W.] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chiou, C. W.; Yeh, T. C.] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan; [Hsia, C. H.; Chen, Y. P.] Changhua Christian Hosp, Changhua, Taiwan; [Huang, J. L.; Chen, Y. F.] Taichung Vet Gen Hosp, Taichung, Taiwan; [Kuo, C. T.; Wang, C. L.] Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan; [Lai, W. T.; Lin, T. H.] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan; [Cheng, C. C.; Lee, J. T.] Tri Serv Gen Hosp, Taipei, Taiwan; [Pai, P. Y.; Lin, K. H.] China Med Univ Hosp, Taichung, Taiwan; [Shyu, K. G.; Chiu, C. Z.] Shin Kong Wu Ho Mem Hosp, Taipei, Taiwan; [Tseng, W. K.; Pan, Y. F.] E Da Hosp, Kaohsiung, Taiwan; [Ueng, K. C.; Lee, S. C.] ChungShan Med Univ Hosp, Taichung, Taiwan; [Wang, J. H.; Tsai, W. C.] Hualien Tzu Chi Hosp, Hualien, Taiwan; [Yeh, H. I.; Kuo, J. Y.] Mackay Mem Hosp Tamsui, New Taipei, Taiwan; [Jirasirirojanakorn, K.; Pornchaiyasit, K.] Bhumibol Adulyadej Hosp, Bangkok, Thailand; [Kaewsuwanna, P.; Sinthusopa, W.] Maharat Nakhon Ratchasima Hosp, Nakhon Ratchasima, Thailand; [Kiatchoosakun, S.; Sriprasert, S.] Srinagarind Hosp, Khon Kaen, Thailand; [Laothavorn, P.; Bamrungpong, P.] Phramongkutklao Hosp, Bangkok, Thailand; [Piyayotai, D.; Sripracha, A.] Thammasat Chalerm Prakiat Hosp, Pathum Thani, Thailand; [Laothavorn, P.; Bamrungpong, P.] Ramathibodi Hosp, Bangkok, Thailand; [Sukonthasarn, A.; Mekara, W.] Maharaj Nakorn Chiang Mai Hosp, Chiang Mai, Thailand; [Vorasettakarnkij, Y.; Puripun, E.] King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Acikel, M.] Ataturk Univ, Med Fac, Erzurum, Turkey; [Akilli, H.; Demir, H.] Konya Necmettin Erbakan Univ, Meram Fac Med, Konya, Turkey; [Ata, N.] Osmangazi Univ, Tip Fac Hosp, Eskisehir, Turkey; [Bayata, S.] Ataturk Training & Res Hosp, Izmir, Turkey; [Cakmak, N.; Calik, A.] Siyami Ersek Hosp, Istanbul, Turkey; [Cayli, M.] Adana Numune Training & Res Hosp, Adana, Turkey; [Ceyhan, C.] Adnan Menderes Univ, Med Fac, Aydin, Turkey; [Erdogan, D.] Suleyman Demirel Univ, Med Fac, Isparta, Turkey; [Ermis, C.] Akdeniz Univ, Med Fac, Antalya, Turkey; [Demir, H.; Kabul, K.] GATA Gulhane Mil Med Sch, Ankara, Turkey; [Kanadasi, M.] Cukurova Univ, Med Fac, Adana, Turkey; [Oto, A.] Hacettepe Univ, Sch Med, Ankara, Turkey; [Turgut, O.; Tandogan, I.] Cumhuriyet Univ, Med Fac, Sivas, Turkey; [Yalcin, R.] Gazi Univ, Ankara, Turkey; [Yigit, F.] Baskent Univ, Med Fac, Adana, Turkey; [Yigit, Z.] Istanbul Univ, Cardiol Inst, Istanbul, Turkey; [Zoghi, M.] Ege Univ, Med Fac Hosp, Izmir, Turkey; [Batushkin, V.; Azhdari, M.] Kyiv City Clin Hosp 5, Kiev, Ukraine; [Bazylevych, A.; Vlasyuk, Z.] Danylo Galytskiy Lviv Natl Med Univ, Outpatient Dept, City Communal Clin Hosp 5, Lvov, Ukraine; [Bereznyakov, I.; Lebedynskaya, M.] Dept Cardiol, City Clin Multifield Hosp 25, Kharkiv, Ukraine; [Bereznyakov, I.; Lebedynskaya, M.] Kharkiv Med Acad Postgrad Educ, Kharkiv, Ukraine; [Dotsenko, S.; Kulynych, R.] Zaporizhzhya State Med Univ, Communal Inst Zaporizhzhya Reg Clin Hosp, Chair Internal Dis 3, Zaporizhzhya, Ukraine; [Dzyak, G.; Vasilyeva, L.] Minist Hlth Ukraine, State Inst Dnipropetrovsk Med Acad, Communal Inst Dnipropetrovsk Reg Clin Ctr Cardiol, Dept Elect Res & Anaesthesiol Care,State Inst Dni, Dnepropetrovsk, Ukraine; [Faynyk, A.; Sorokivskyy, M.] Lviv Reg State Clin Med & Diagnost Cardiol Ctr, Lvov, Ukraine; [Gavrysyuk, V.; Dzublik, Y.] SI Natl Inst Phthisiol & Pulmonol, Kiev, Ukraine; [Horbach, L.; Husyev, V.] Communal City Clin Hosp 8, Lvov, Ukraine; [Godlevska, O.; Samburg, Y.] Kharkiv Med Acad Postgrad Educ, Dept Therapy 1, City Clin Emergency Hosp, Kharkiv, Ukraine; [Karpenko, O.; Nevolina, I.] Kiyv Municipal Clin Hosp 1, Kiev, Ukraine; [Karpenko, Y.; Blihar, O.] Odesa Reg Clin Hosp, Dept Cardiol, Odesa State Med, Odesa, Ukraine; [Kaydashev, I.; Gerasimenko, N.] City Clin Hosp 1, Dept Therapeut, Kiev, Ukraine; [Kaydashev, I.; Gerasimenko, N.] Ukrainian Med Stomatol Poltava, Kiev, Ukraine; [Kolomyyits, S.; Vasylets, V.] Odesa Municipal Clin Hosp 9, Odesa, Ukraine; [Kopytsya, M.; Petyunina, O.] State Inst Inst Therapy, Kharkiv, Ukraine; [Kotseruba, V.; Dvoieglazova, M.] Chernigiv City Hosp 1, Chernigiv, Ukraine; [Koval, V.; Ohirko, O.] Communal City Clin Hosp 8, Lvov, Ukraine; [Koval', O.; Kaplan, P.] Minist Hlth Ukraine, Communal Inst Dnipropetrovsk Clin Assoc Emergency, State Inst Dnipropetrovsk Med Acad, Dept Cardiol Treatment Patients Myocardial Infarc, Dnepropetrovsk, Ukraine; [Kraiz, I.; Usan, N.] Kharkiv Cent Clin Hosp Ukrzaliznitsi, Kharkiv, Ukraine; [Kraydashenko, O.; Stets, R.] Zaporizhzhya State Med Univ, Communal Inst City Clin Hosp 6, Chair Clin Pharmacol & Pharmacotherapy, Zaporizhzhia, Ukraine; [Kupnovytska, I.] Ivano Frankivsk State Med Univ, Dept Arterial Hypertens, Iv Frank Ivano Frankivsk Reg Clin Cardiol Ctr, Ivano Frankivsk, Ukraine; [Kyyak, Y.] Danilo Galytskiy Lviv State Med Univ, Dept Cardiol, Communal City Clin Emergency Hosp, Lvov, Ukraine; [Lizogub, V.; Gorna, O.] OO Bogomolets Natl Med Univ, Kyiv City Clin Hosp 12, Dept Cardiol, Kiev, Ukraine; [Malynovsky, Y.; Fedotov, S.] MI RMC Cardiovasc Dis Zaporizhzhia, Zaporizhzhia, Ukraine; [Ostrovska, L.; Ushakova-Sokolova, L.] Kherson Municipal Clin Hosp, Kherson, Ukraine; [Parkhomenko, A.; Dovgan, N.] Ukraine Acad Med Sci, Natl Sci Ctr 22, MD Strazhesko Inst Cardiol, Kiev, Ukraine; [Potapenko, P.; Nekrasa, A.] Luhansk Municipal Clin Hosp 1, Lugansk, Ukraine; [Prokhorov, O.; Leonidova, V.] Kharkiv City Clin Hosp 27, Kharkiv, Ukraine; [Rebrov, B.; Gamachek, O.] Lugansk Reg Clin Hosp, Lugansk, Ukraine; [Rishko, M.; Chendey, T.] Uzhgorod Natl Univ, Dept Cardiol, Transcarpathian Reg Cardiol Dispensary, Uzhgorod, Ukraine; [Rudyk, I.] SI Inst Therapy, Kharkiv, Ukraine; [Shatilo, V.; Ishchuk, V.] Inst Herontol AMS Ukraine, Kiev, Ukraine; [Shcherbak, V.; Goncharova, I.] Vinnytsya City Clin Hosp 1, Vinnitsya, Ukraine; [Shvetz, N.; Zamlynskyy, M.] City Clin Hosp 1, Mykolayiv, Ukraine; [Sirenko, Y.] Natl Acad Med Sci Ukraine, State Inst Natl Sci Ctr, MD Strazhesko Inst Cardiol, Kiev, Ukraine; [Stanislavchuk, M.; Perebetiuk, L.] Vinnytsya Natl Med Univ, Dept Cardiol, Vinnytsya Reg Clin Hosp, Vinnytsya, Ukraine; [Sychov, O.; Lyzohub, S.] NSC Cardiol Inst, Kiev, Ukraine; [Tseluyko, V.; Kuznetsov, I.] Kharkiv Med Acad Postgrad Educ, Communal Healthcare Inst, Dept Cardiol, Kharkiv City Clin Hosp 8, Kharkiv, Ukraine; [Tykhonova, S.] Odesa State Med Univ Ukraine, Odesa State Med Univ MoH Ukraine, Dept Therapeut, Univ Clin,Ctr Reconstruct & Rehabil Med, Odessa, Ukraine; [Vakaliuk, I.; Drapchak, I.] Ivano Frankivsk State Med Univ, Infarct Dept 2, Ivano Frankivsk Reg Clin Cardiol Ctr, Ivano Frankivsk, Ukraine; [Vatutin, M.; Sklyanna, O.] M Gorky Donetsk Natl Med Univ, VK Gusak Inst Urgent & Recovery Surg AMSU, Dept Urgent Cardiol & Rehabil, Donetsk, Ukraine; [Vizir, V.; Goncharov, O.] Zaporizhzhya State Med Univ, Communal Inst City Hosp 7, Dept Cardiol, Zaporizhzhia, Ukraine; [Volkov, V.; Serik, S.] Inst Therapy LT Malaya NAMS Ukraine, Kharkiv, Ukraine; [Yagensky, A.; Nahrebetskyy, V.] Lutsk City Clin Hosp, Volyn Reg Ctr Cardiovasc Dis & Thrombolysis, Lutsk, Ukraine; [Yena, L.; Mudruk, I.] Inst Herontol AMS Ukraine, Kiev, Ukraine; [Zharinov, O.; Logvinov, Y.] Natl Med Acad Postgrad Educ PL Shupyk, Dept Cardiol & Funct Diagnost, Kiev, Ukraine; [Zhurba, S.; Shandra, T.] Cherkaskiy Region Cardiol Ctr, Cherkassy, Ukraine; [Aggarwal, R.; Smith, S.] Basildon Univ Hosp, Basildon, Essex, England; [Beeton, I.; Dunn, S.] St Peters Hosp, Chertsey, Surrey, England; [Blagden, M.; Price, R.] Avondale Surg, Chesterfield, Derby, England; [Camm, J.; Dougal, K.] St George Hosp, London, England; [Chapman, O.; Davies, D.] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England; [Choy, A.; Duff, J.] Ninewells Hosp, Dundee, Scotland; [Cohen, A.; Wilmott, R.] Kings Coll Hosp London, London, England; [Green, M.; D'Costa, D.] New Cross Hosp, Wolverhampton, W Midlands, England; [Douglas, H.; Dickinson, D.] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Lie, F.; Ramasamy, V.] Whipps Cross Hosp & Chest Clin, London, England; [Lindsay, S.; Atkinson, C.] Bradford Royal Infirm, Bradford, W Yorkshire, England; [Linker, N.; Finlayson, M.] James Cook Hosp, Middlesbrough, England; [Lip, G.; Brown, R.] City Hosp, Birmingham, W Midlands, England; [MacCallum, P.; Ebano, P.] Barts & London NHS Trust, London, England; [MacCallum, P.; Ebano, P.] Wolfson Inst Prevent Med, London, England; [MacLeod, M.; McGhee, C.] Forth Valley Royal Hosp, Larbert, Scotland; [Marazzi, P.; Jones, D.] East Horsley Med Ctr, East Horsley, Surrey, England; [Maxwell, T.; Isted, C.] Little Common Surg, Bexhill On Sea, E Sussex, England; [More, R.; Helliwell, L.] Lancashire Cardiac Ctr, Blackpool, England; [Moriarty, A.; Mackin, A.] Craigavon Area Hosp, Belfast, Antrim, North Ireland; [Murdoch, D.; Andrews, A.] Southern Gen Hosp NHS Trust, Glasgow, Lanark, Scotland; [Newby, D.; Flint, L.] Royal Edinburgh Infirm, Edinburgh, Midlothian, Scotland; [Pye, M.; Wright, L.] York Hosp, York, N Yorkshire, England; [Roberts, P.; Avery, D.] Mayfield Med Ctr, Paignton, Devon, England; [Senior, R.; Young, G.] Northwick Pk Hosp & Clin Res Ctr, Middlesex, Middx, England; [Sopher, M.; Kennard, S.] Royal Bournemouth Hosp, Bournemouth, Dorset, England; [Storey, R.; Bridge, C.] Univ Sheffield SOM & Biomed Sci, Sheffield, S Yorkshire, England; [Turner, W.; Walker, M.] Burbage Surg, Leicester, Leics, England; [Venkataraman, A.; Gilchrist, M.] George Eliot Hosp, Nuneaton, Warwick, England; [Watkin, R.; Chung, A.] Good Hope Dist Gen Hosp, Birmingham, W Midlands, England; [Wright, A.; Wright, J.] Hathaway Med Ctr, Swindon, Wilts, England; [Abi-Mansour, P.; Panella, M.] Advocate Hlth & Hosp Corp, Oak Lawn, IL USA; [Adams, K.; Lohman, J.] Jacksonville Heart Ctr, Jacksonville, FL USA; [Adler, J.; Barash, B.] Clinicos Clin Res, Colorado Springs, CO USA; [Aggarwal, R.; Beck, P.] CVMS Res Inst LLC, Jupiter, FL USA; [Ahmad, A.; Hussain, A.] East Texas Cardiol PA, Houston, TX USA; [Ahmadpour, H.; Lim, G.] Adv Med Res, Lakewood, CA USA; [Akhter, F.; Brubaker, S.] Cardiologists Clark & Champaign Counties Inc, Springfield, OH USA; [Alexander, J.; Genova-Peeva, E.] North Shore Univ Hlth Syst, Bannockburn, IL USA; [Aliyar, P.; Godsey, W.] Midwest Internal Med, Lake Havasu City, AZ USA; [Allison, J.; Biscardi, R.] Three Rivers Med Associates, Columbia, SC USA; [Almquist, A.; MacDonald, H.] Minneapolis Heart Inst, Minneapolis, MN USA; [Alsheikh, T.; Lane, B.] Langhorne Cardiol Consultants Inc, Pensacola, FL USA; [Amin, K.; Persechino, F.] Res Alliance Inc, Clearwater, FL USA; [Anderson, J.; York, T.] Integris Cardiovasc Phys LLC, Oklahoma City, OK USA; [Arnold, T.; Shoaf, R.] Triangle Med Res, Lexington, NC USA; [Arouni, A.; Rasmussen, L.] Creighton Cardiac Ctr, Omaha, NE USA; [Attanti, S.; Strickland, S.] Citrus Cardiol Consultants PA, The Villages, FL USA; [Aude, Y.; Cobos, D.] Valley Heart Consultants, McAllen, TX USA; [Awasty, V.; Baldwin, E.] R&R Res, Marion, OH USA; [Ayesu, K.; Thompson, B.] Omega Res Consultants, Debary, FL USA; [Baine, S.; Batista, M.] Heart Associates Palm Beach Cty, Delray Beach, FL USA; [Baman, R.; Campbell, G.] Pottstown Med Specialists Inc, Pottstown, PA USA; [Barber, M.; Altonen, D.] Profess Clin Res, Interlochen, MI USA; [Barker, T.; Faircloth, C.] Res Inst Carolinas PLLC, Mooresville, NC USA; [Bartkowiak, A.; Benton, J.] Blair Med Associates Inc, Altoona, PA USA; [Beasley, R.; Hoffman, T.] Hlth Concepts, Rapid City, SD USA; [Bedwell, N.; Craig, M.] Mobile Heart Specialists, Mobile, AL USA; [Beinart, S.; Swaim, D.] Shady Grove Adventist Hosp, Rockville, MD USA; [Bensimhon, D.; Garman, V.] LeBauer Cardiovasc Res Fdn, Greensboro, NC USA; [Berk, M.; Ibarra, M.] Cardiovasc Res Inst Dallas, Dallas, TX USA; [Bilal, B.; Preston, S.] Integris Baptist Med Ctr, Oklahoma City, OK USA; [Bilazarian, S.; Langone, L.] Pentucket Med Associates Haverhill, Haverhill, MA USA; [Bingham, S.; Antonino, M.] Cent Utah Clin, Provo, UT USA; [Block, T.; Talbot-Lawson, C.] Rainier Clin Res Ctr Inc, Renton, WA USA; [Blonder, R.; Ensminger, E.] Colorado Hlth Med Grp, Colorado Springs, CO USA; [Blue, B.; Vernon, M.] Eminence Res LLC, Oklahoma City, OK USA; [Bouchard, A.; Wade, W.] Cardiol PC, Birmingham, AL USA; [Bowden, W.; Ziegler, K.] Healdsburg Cardiol, Healdsburg, CA USA; [Bradley, A.; Terry, P.] Adv Clin Res Grp LLC, Stuart, FL USA; [Brilakis, E.; Frey, W.] Dallas VA Med Ctr, VA North Texas Hlth Care Syst, Dallas, TX USA; [Brown, H.; Triano, A.] Tucson Clin Res, Tucson, AZ USA; [Bybee, K.; Al-Maliky, T.] St Lukes Hosp Kansas City, Kansas City, MO USA; [Cader, C.; Morton, S.] Crystal Coast Family Practice, Morehead City, NC USA; [Dickinson, D.; Canaday, D.] Rockwood Inland Cardiol Associates, Spokane, WA USA; [Caplan, J.; Jameson, L.] Hamilton Cardiol Associates, Hamilton, NJ USA; [Chang, M.; Hatfield, G.] Wellmont CVA Heart Inst, Johnson City, TN USA; [Charlat, M.; Tamayo, M.] San Diego Cardiovasc Associates, Encinitas, CA USA; [Chaturvedi, S.; Sawaya, K.] Wayne State Univ, Detroit Med Ctr, Detroit, MI USA; [Ciaramita, J.; Bagby, J.] Mercy Hosp St Louis, St Louis, MO USA; [Preston, S.; Clapp, T.] Integris Family Care Southwest, Oklahoma City, OK USA; [Cohen, A.; Dutka, C.] Aurora Denver Cardiol Associates, Aurora, CO USA; [Cohen, R.; Bossaers, J.] Cohen Med Associates, Delray Beach, FL USA; [Colan, D.; Salpas, S.] Internal Med Associates Grand Isl, Grand Isl, NE USA; [Cole, J.; Fisher, M.] Mid Atlantic Cardiovasc Associates, Baltimore, MD USA; [Concha, M.; Martinez, E.] Intercoastal Med Grp, Sarasota, FL USA; [Corbett, B.; Svadbik, L.] Southeastern Res Associates Inc, Taylors, SC USA; [Cossu, S.; Mullinax, K.] Charlotte Heart & Vasc Inst PA, Port Charlotte, FL USA; [Cottiero, R.; Masson, E.] Hypertens & Nephrol Inc, Providence, RI USA; [Cowan, L.; Nelson, L.] Adv Healthcare Serv Inc, Thornville, OH USA; [Curtis, B.; Sarpola, N.] Corvallis Clin PC, Corvallis, OR USA; [Dang, N.; Morgan, T.] Chest & Crit Care Consultants Med Grp, Anaheim, CA USA; [Daniels, S.; Leka, G.] Monmouth Cardiol Associates, Ocean, NJ USA; [Datta, S.; Wulf, A.] PMG Res Charleston LLC, Mt Pleasant, SC USA; [Dave, K.; Dave, B.] Heart Care Associates PC, Hopewell, VA USA; [Davuluri, A.; Ebreo, N.] Jacksonville Heart Ctr, Jacksonville, FL USA; [De Lemos, J.; Debes, C.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Dean, J.; Warmack, D.] St Vincents Cardiol, Jacksonville, FL USA; [DeGarmo, R.; Carey, J.] DeGarmo Inst Med Res, Greer, SC USA; [Desai, A.; Steward, A.] Cent Cardiol Associates, Elizabethtown, KY USA; [Devenport, S.; Briscoe, C.] Granger Med Clin, West Valley City, UT USA; [Dhar, S.; Ucik, S.] Radiant Res, Santa Rosa, CA USA; [DiGiovanna, M.; Tisdale, L.] DiGiovanna Inst Med Educ & Res, North Massapequa, NY USA; [Donovan, D.; Rodriguez, L.] Cardiol Clin San Antonio, San Antonio, TX USA; [Dotani, I.; Olson, A.] McFarland Clin, Ames, IA USA; [Drozdiak, R.; Habibi, S.] Ilumina Clin Associates, Clymer, PA USA; [Eade, J.; Dunn, K.] Internal Med Res Associates, Campbellsville, KY USA; [Eldadah, Z.; Quick, R.] Washington Hosp Ctr, Washington, DC 20010 USA; [Ellis, J.; Cristaldi, J.] Compass Med Associates PCHI, E Bridgewater, MA USA; [Erenrich, N.; Johnson, C.] Cardiol Associates Palm Beach, W Palm Beach, FL USA; [Erenrich, N.; O'Brien, J.] Cardiol Associates Palm Beach, Atlantis, FL USA; [Ettinger, N.; Shipp, A.] CardioPulm Associates, Chesterfield, MO USA; [Everhart, B.; DeSalle, D.] Heritage Valley Med Grp Inc, Beaver, PA USA; [Fahmy, R.; Watkins, D.] FHS Res Ctr, Tacoma, WA USA; [Feld, L.; Tameron, A.] Horizon Clin Res Associates, Gilbert, AZ USA; [Feldman, J.; Tang, N.] West Houston Area Clin Trial Consultants LLC, Katy, TX USA; [Felten, W.; Prior, J.] Michigan Cardiovasc Inst, Midland, MI USA; [Fialkow, J.; Calvo, M.] Cardiovasc Res Ctr South Florida, Miami, FL USA; [Finkel, M.; Shriver, D.] Louis A Johnson VA Med Ctr, Clarksburg, WV USA; [Lim, G.; Finkelstein, S.] Adv Med Res, Lakewood, CA USA; [Fischell, T.; Drew, B.] Borgess Res Inst, Borgess Cardiovasc Res, Kalamazoo, MI USA; [Fishbein, G.; Donahue, S.] Dayton Heart Ctr, Dayton, OH USA; [Flores, E.; Slayton, C.] Georgia Heart Specialists, Covington, LA USA; [Forman, S.; Solis, A.] Los Alamitos Cardiovasc, Los Alamitos, CA USA; [Franco, M.; Gentry, P.] MCA Res, Houston, TX USA; [French, W.; Morales, C.] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Friedlander, I.; Smith, K.] Aultman Hosp, Canton, OH USA; [Gaffney, M.; Jones, J.] Gaffney Hlth Serv, Charlotte, NC USA; [George, F.; Valentine, H.] East Coast Inst Res, St Augustine, FL USA; [Gerber, J.; Hinchion, N.] Cardiol Associates New Haven, Gullford, CT USA; [Gillespie, E.; Keane-Richmond, P.] Glacier View Cardiol PC, Kalispell, MT USA; [Gogia, H.; Ewing, B.] Cardiol Consultants Orange Cty Med Grp Inc, Anaheim, CA USA; [Fisher, M.; Goldscher, D.; Latteri, J.; Guarnieri, T.] MidAtlantic Cardiovasc Associates, Baltimore, MD USA; [Fisher, M.; Goldstein, M.] MidAtlantic Cardiovasc Associates, Towson, MD USA; [Gowda, S.; Rafala, E.] New Brunswick Cardiol Grp PA, Somerset, NJ USA; [Graham, S.; Bonora, M.] Buffalo Gen Hosp, Buffalo, NY USA; [Griffin, S.; Aull, L.] Athens Primary Care, Athens, GA USA; [Griffin, J.; Goodman, V.] Cardiovasc Associates Ltd, Virginia Beach, VA USA; [Grossman, C.; Davis, A.] Palmetto Clin Res, Summerville, SC USA; [Grove, D.; Mabe, K.] Medicat Management, Greensboro, NC USA; [Guarino, J.; Gabela, W.] Brick Cardiovasc Specialists PA, Brick, NJ USA; [Guerrero; Foster, B.] Regions Hosp, St Paul, MN USA; [Guthrie, R.; Felsman, D.] Arroyo Med Grp, Pismo Beach, CA USA; [Gvora, T.; McLean, R.] Med Associates Inc, Menomonee Falls, WI USA; [Hack, T.; Morelli, L.] Primary Care Cardiol Res Inc, Ayer, MA USA; [Hamroff, G.; Bentivenga, L.] Hudson Valley Cardiol Grp, Cortlandt Manor, NY USA; [Han, M.; Cavanna, L.] ProHealth Phys, Manchester, CT USA; [Harris, J.; Bobade, M.] Cardiol Consultants East MI, Lapeer, MI USA; [Hearne, S.; Krater, C.] Peninsula Reg Med Ctr, Salisbury, MD USA; [Heiman, M.; Dandekar, U.] Stamford Therapeut Consortium, Stamford, CT USA; [Heiman, M.; Shah, D.] Cardiol Associates Fairfield Cty PC, Trumbull, CT USA; [Henderson, D.; Millard, D.] Cardiol Res Associates, Daytona Beach, FL USA; [Henry, S.; Harkins, V.] Geisinger Med Grp, State Coll, PA USA; [Hermany, P.; Batchell, K.] Grand View Lehigh Valley Hlth Serv, Sellersville, PA USA; [Herrod, J.; Miranda, D.] Cochise Clin Res, Sierra Vista, AZ USA; [Herson, S.; Carey, G.] Emerson Hosp, Concord, MA USA; [Hinchman, D.; Vieira, P.] St Lukes Idaho Cardiol Associates, Boise, ID USA; [Hippert, R.; Dutter, S.] Fleetwood Clin Res, Fleetwood, PA USA; [Young, C.; Hoekstra, J.] Natl Clin Res Inc Richmond, Richmond, VA USA; [Homan, J.; Homayouni, A.] Avocado Med Grp, Newport Beach, CA USA; [Horton, K.; Sloss, D.] IMED Healthcare Associated PLLC, San Antonio, TX USA; [Hotchkiss, D.; Turner, N.] Charlotte Cardiovasc Inst, Port Charlotte, FL USA; [Adams, K.; Houchin, V.] Harrisburg Family Med Ctr, Harrisburg, AR USA; [Howard, V.; Hays, D.] VNH Heart Ctr Res, Port Charlotte, FL USA; [Howard, L.; Craft, D.] Cardiol Consultants PA Charleston, Charleston, SC USA; [Huang, P.; Truva, C.] Swedish Med Ctr, Seattle, WA USA; [Hunter, J.; Battistelli, E.] Santa Rosa Cardiol Med Grp Inc, Santa Rosa, CA USA; [Hurst, P.; Garza, M.] Cardiovasc Inst North Colorado, Greeley, CO USA; [Ison, R.; Butcher, S.] Community Hlth Care Inc, Canal Fulton, OH USA; [Jardula, M.; Andresen, T.] Desert Oasis Hlth Care Med Grp, Palm Springs, CA USA; [Johnson, F.; Phillips, T.] Holston Med Grp Clin Res, Johnson City, TN USA; [Jones, R.; Hughett, G.] Centennial Heart Cardio Consulants LLC, Nashville, TN USA; [Jovin, I.; Nichols, M.] McGuire VA Med Ctr, Richmond, VA USA; [Judson, P.; Royes, A.] Clin Res Associates Tidewater, Norfolk, VA USA; [Kahn, B.; Coombs, V.] Overlea Personal Phys, Baltimore, MD USA; [Kai, W.; Dugal, J.] Hawaii Pacific Hlth, Honolulu, HI USA; [Kandath, D.; Kostedt, G.] Saratoga Clin Res LLC, Saratoga Springs, NY USA; [Kaplan, K.; Cook, S.] Heart & Vasc Inst Florida, Clearwater, FL USA; [Kapoor, A.; Ruggiero, M.] Connecticut Heart Grp, New Haven, CT USA; [Karunaratne, H.; Behm, K.] Florida Hosp Med Ctr, Orlando, FL USA; [Kastelic, R.; Davis, C.] Kastelic & Associates, Johnstown, PA USA; [Keller, R.; Keller, J.] Plaza Med Specialists PLLC, Ft Worth, TX USA; [Kerkering, M.; Bartholomaus, D.] Spokane Internal Med, Spokane, WA USA; [Kersh, R.; Buhler, A.] Cardiopulm Associates, Plantation, FL USA; [Kesselbrenner, M.; DiCorcia, L.] Garden State Cardiol, Ridgewood, NJ USA; [Khan, B.; Binns, M.] Atlanta Clin Res Ctr, Atlanta, GA USA; [Khan, M.; Khan, G.] Springfield Med Ctr, Panama City, FL USA; [Kindman, L.; Averett, P.] Cardiovasc Care Northern Carolina PA, Oxford, NC USA; [Korpas, D.; Godfrey, C.] Nebraska Heart Inst, Lincoln, NE USA; [Kotha, P.; Sanchez, E.] Purushotham & Akther Kotha MD Inc, La Mesa, CA USA; [Kozlowski, J.; Watts, S.] Cardiol & Vasc Assoc, Commerce, MI USA; [Krichmar, P.; Marquez, D.] Res Phys Network Alliance, Pembroke Pines, FL USA; [Kumar, P.; Davis, C.] Ilumina Clin Associates, Greenville, PA USA; [Laliotis, A.; Jauregui, V.] Integrated Res Ctr Inc, San Diego, CA USA; [Lambert, C.; Coyle, G. Stagi] Pepin Heart Hosp, Dr Kiren C Patel Res Inst, Tampa, FL USA; [Landau, C.; Ferguson, D.] Connecticut Heart & Vasc Ctr, Bridgeport, CT USA; [Lang, J.; Simmons, T.] Midatlant Cardiovasc Associates, Bel Air, MD USA; [Langevin, E.; Faucett, S.] Freeman Hlth Syst, Joplin, MO USA; [Ledbetter, L.; Royse, H.] Tennessee Neurol Specialists Columbia, Columbia, TN USA; [Lentz, M.; Smith, D.] Geisinger Med Clin, Danville, PA USA; [Lesser, M.; Hartley, L.] Osler Clin Res, Melbourne, FL USA; [Lewis, D.; Bonds, C.] Arkansas Primary Care Clin PA, Little Rock, AR USA; [Lillestol, M.; Miller, D.] Lillestol Res LLC, Fargo, ND USA; [Ling, L.; Murphy, R.] Emerald Coast Clin Res, Pensacola, FL USA; [Littlefield, R.; Wofford, E.] Palmetto Res, Spartanburg, SC USA; [Shah, D.; Lomnitz, D.] Stamford Therapeut Consortium, Norwalk, CT USA; [Lone, B.; Davids, M.] Sisters Charity Providence Hosp, Columbia, SC USA; [Looby, R.; Ault, S.] Harrison Community Hosp, Cadiz, OH USA; [Lui, H.; Wright, H.] Res Associates Jackson, Jackson, TN USA; [Lurie, M.; Edelstein, J.] ARI Clin Trials Inc, Redondo Beach, CA USA; [Macomber, J.; Bush, D.] Clin Trials Amer Inc, Cary, NC USA; [Magee, A.; Doctor, A.] Clin Res Inst Northern Virginia, Springfield, VA USA; [Mainigi, S.; Lisiecki, B.] Albert Einstein Healthcare Network, Philadelphia, PA USA; [Makam, S.; Casas, R.] Cardiovasc Res Northwest Indiana LLC, Munster, IN USA; [Hernandez, S.; Mandviwala, M.] DM Clin Res, Tomball, TX USA; [Marar, I.; Rabadi-Marar, D.] West Broadway Clin, Council Bluffs, IA USA; [Marenberg, M.; Bedenko, E.] Lankenau Inst Med Res, Wynnewood, PA USA; [Massin, E.; Hicks, T.] Cardiol Consultants Houston LLP, Houston, TX USA; [McCartney, M.; Stubbs, L.] Activmed Practices & Res Inc, Haverhill, MA USA; [McGarvey, J.; Schwarz, L.] Doylestown Cardiol Associates VIAA, Doylestown, PA USA; [McKenzie, M.; Rodkey, K.] Legacy Heart Ctr, Plano, TX USA; [McKnight, T.; Paul, J.] Prairie Fields Family Med PC, Fremont, NE USA; [McLaurin, B.; Lack, A.] AnMed Hlth, Anderson, SC USA; [Mega, J.; Marti, J.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Meholick, A.; Skinner, J.] Buffalo Heart Grp, Buffalo, NY USA; [Mehrle, A.; Wall, J.] BlueStem Cardiol, Bartlesville, OK USA; [Mendelson, R.; Cervellione, K.] Jama Hosp Med Ctr, Jamaica, NY USA; [Mercado, A.; Cajulis, C.] Stewart Med Grp, Alhambra, CA USA; [Michlin, B.; Romero-Colon, J.] Wetlin Res Associates Inc, San Diego, CA USA; [Milas, J.; Sanders, D.] Internal Med Greer, Greer, SC USA; [Miller, R.; Sanchez, S.] San Diego Cardiac Ctr, San Diego, CA USA; [Miller, S.; Gryczan, J.] Walterboro Cardiol, Walterboro, SC USA; [Mody, F.; Strugatsky, S.] Greater Los Angeles VA Healthcare Ctr, Los Angeles, CA USA; [Moran, J.; Garner, S.] Piedmont Healthcare Res, Statesville, NC USA; [Morledge, J.; Bowman, B.] Univ Wisconsin, Madison, WI USA; [Mouhaffel, A.; Parrott, N.] Med Associates Northeast Louisiana, West Monroe, LA USA; [Mounsey, P.; Schuler, C.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Mowdy, M.; Todd, S.] Michael Mowdy DO Inc, Oklahoma City, OK USA; [Mullen, P.; Raziano, S.] Coast Cardiovasc Consultants PLLC, Biloxi, MS USA; [Murphy, A.; Oehmann, V.] Riverside Reg Med Ctr, Newport News, VA USA; [Nadar, V.; Parker, A.] Capital Area Res LLC, Camp Hill, PA USA; [Naidu, J.; West, M.] Naidu Clin, Odessa, TX USA; [Nallasivan, M.; Goza, J.] Merced Heart Associates, Merced, CA USA; [Nguyen, T.; Nomanee, S.] Natl Inst Clin Res, Los Angeles, CA USA; [Nielsen, R.; Wilmot, M.] Profess Clin Res, Benzonia, MI USA; [Oberoi, M.; Thakkar, N.] Cent Jersey Med Res Ctr, Elizabeth, NJ USA; [Oppenheimer, K.; McCormick, J.] Bend Mem Clin PC, Bend, OR USA; [Orchard, R.; Garcia, L.] New Mexico Heart Inst PA, Albuquerque, NM USA; [Osborne, J.; Gonzalez, M.] State Heart Cardiol, Grapevine, TX USA; [Oza, S.; Joseph, L.] St Vincents Ambulatory Care Inc, Jacksonville, FL USA; [Oza, S.; Joseph, L.] St Vincents Ambulatory Care Inc, Orange Pk, FL USA; [Patnam, S.; Dennison, K.] Preferred Primary Care Phys, Uniontown, PA USA; [Pavon, H.; Gorry, N.] Internal Med Kidney & Hypertens Ctr, Norfolk, VA USA; [Pearlstein, R.; Montayne, S.] Pearl Clin Res Inc, Norristown, PA USA; [Pentz, W.; Duncan, D.] Univ Penn, Philadelphia, PA 19104 USA; [Peters, P.; Chacon, L.] Texas Med Res Associates LLC, San Antonio, TX USA; [Petruzziello, F.; Morlando, F.] Caramedica, North Haven, CT USA; [Pettis, K.; Brown, F.] Metrolina Internal Med, Charlotte, NC USA; [Pezzella, S.; Kirk, D.] Reliant Med Grp Inc, Worcester, MA USA; [Poulathas, A.; Cush, S.] Deborah Heart & Lung Ctr, Browns Mills, NJ USA; [Pratt, R.; Neeper, L.] Colorado Neurol Inst, Englewood, CO USA; [Pribble, A.; Lowe, K.] Graves Gilbert Clin, Bowling Green, KY USA; [Pudi, K.; Sham, L.] Upstate Pharmaceut Res, Greenville, SC USA; [Pugeda, J.; Ebert, J.] Cardiac Study Ctr, Tacoma, WA USA; [Quadrel, M.; Rafla, E.] IMMC Clin Trials, Mine Hill, NJ USA; [Quinlan, E.; Reed, C.] Southern Maine Med Ctr, Biddeford, ME USA; [Quinn, J.; Hemmen, C.] Winchester Med Ctr, Winchester, VA USA; [Rama, P.; Domingo, D.] Baptist Heart Specialists, Jacksonville, FL USA; [Redondo, V.; Wroblewski, J.] Schoenherr Med Associates PC, Warren, MI USA; [Renzi, M.; Stanley, E.] Advocare Hts Primary Care, Haddon Hts, NJ USA; [Richwine, R.; Pazier, P.] Texas Hlth Phys Grp, Ft Worth, TX USA; [Roberts, J.; Riofrio, K.] South Florida Res LLC, Miami, FL USA; [Roberts, J.; Braun, D.] Comprehensive Heart Care Inc, Toledo, OH USA; [Robinson, J.; Cherrico, M.] Univ Iowa, Lipid Res Clin, Iowa City, IA USA; [Roehll, W.; Hollihan, P.] Atrium Med Ctr, Middletown, OH USA; [Rosado, J.; Barnhorst, M.] Florida Heart & Vasc Ctr, Leesburg, FL USA; [Rosado, J.; Barnhorst, M.] Florida Heart & Vasc Ctr, The Villages, FL USA; [Rosen, R.; Martin, C.] Ardmore Family Practice PA, Winston Salem, NC USA; [Ross, S.; Freeman, R.] Clin Res Associates LLC, Florence, SC USA; [Ruoff, G.; Nelson, T.] Westside Family Med Ctr PC, Kalamazoo, MI USA; [Sacco, J.; Ball, E.] Stratton Vet Affairs Med Ctr Albany, Albany, NY USA; [Samal, A.; Schomburg, J.] Northwest Houston Cardiol, Houston, TX USA; [Sandberg, J.; Lafave, J.] Oakland Med Res Ctr, Troy, MI USA; [Savin, V.; Clifton, R.] Kansas City VA Med Ctr, Kansas City, MO USA; [Schaefer, S.; Fekete, A.] VA Med Ctr, Mather, CA USA; [Schneider, R.; Schneider, W.] Holy Cross Hosp Inc, Coral Springs, FL USA; [Schulman, D.; Mercer, S.] Pittsburgh Cardiol Associates, Pittsburgh, PA USA; [Seals, A.; Ullig, T.] Baker & Gilmore Cardiovasc Inst, Jacksonville, FL USA; [Seals, A.; Holt, A.] East Coast Inst Res LLC, Jacksonville, FL USA; [Seide, H.; Mather, N.] Lewis & Klancke Cardiol PB DBA Cardiol Consultant, Daytona Beach, FL USA; [Shah, G.; Witt, P.] Gaurang B Shah MD PSC, Richmond, KY USA; [Shalaby, A.; Seese, M.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Shanes, J.; Fleets, J.] Consultants Cardiovasc Med, Melrose Pk, IL USA; [Shaoulian, E.; Hren, A.] Pacific Coast Cardiol, Newport Beach, CA USA; [Sheikh, K.; Hengerer, T.] Brevard Cardiovasc Res Associates Inc, Rockledge, FL USA; [Shih, H.; Browning, J.] Ctr Cardiac Arrhymias, Houston, TX USA; [Shoukfeh, M.; Stephenson, L.] Texas Cardiac Ctr, Lubbock, TX USA; [Siler, T.; Champagne, M.] Midwest Chest Consultants, St Charles, MO USA; [Simpson, P.; Meyer, R.] Pinehurst Med Clin Inc, Pinehurst, NC USA; [Singh, N.; Turner, K.] Atlanta Heart Specialists LLC, Cumming, GA USA; [Singh, V.; Nelson, M.] Suncoast Cardiovasc Res, St Petersburg, FL USA; [Skierka, R.; Hughes, B.] Shell Rock Family Practice, Shell Rock, IA USA; [Smith, S.; Keene, R.] Burke Primary Care, Morganton, NC USA; [Smith, R.; Hodnett, P.] Long Isl Heart Associates, Mineola, NY USA; [Spangenthal, S.; Thomason, L.] Amer Hlth Res Inc, Charlotte, NC USA; [Sperling, M.; Vasquez, E.] Edinger Med Grp Res Ctr, Fountain Valley, CA USA; [Spivack, E.; McCartney, P.] South Florida Med Res, Aventura, FL USA; [Staniloae, C.; Liu, M.] Gotham Cardiovasc Res PC, New York, NY USA; [Steljes, A.; Cox, C.] Steljes Cardiol, Henderson, NV USA; [Struble, R.; Vittitow, T.] Great Lakes Res Grp Inc, Bay City, MI USA; [Suresh, D.; Frost, J.] St Elizabeth Phys, Crestview Hills, KY USA; [Swerchowsky, V.; Freemyer, D.] Holy Family Mem Inc, Manitowoc, WI USA; [Szulawski, I.; Herwehe, S.] Geisinger Med Grp, Lewistown, PA USA; [Tahirkheli, N.; Springer, K.] South Oklahoma Heart Res, Oklahoma City, OK USA; [Takata, T.; Bruton, T.] Texas Hlth Res & Educ Inst, Ft Worth, TX USA; [Talano, J.; Leo, L.] Southwest Florida Res LLC, Naples, FL USA; [Tami, L.; Corchado, D.] Res Phys Network Alliance, Hollywood, FL USA; [Tatarko, M.; Swauger, M.] Ilumina Clin Associates, Somerset, PA USA; [Tawney, K.; Dastoli, K.] Lake Med Res, Willoughby Hills, OH USA; [Teague, S.; Young, K.] Anderson Heart Phys, Clinton, TN USA; [Tee, H.; Mitchell, T.] ADA Med Ltd, Vero Beach, FL USA; [Teixeira, J.; Southam, D.] Black Hills Clin Res Ctr, Rapid City, SD USA; [Romero, N.; Torres, M.] A Res Inc, Miami, FL USA; [Tucker, P.; Salas, L.] Tekton Res Inc, Austin, TX USA; [Updegrove, J.; Hanna, K.] Corsicana Med Res PLLC, Corsicana, TX USA; [Val-Mejias, J.; Harrelson, K. Gonzalez] Mid Kansas Res Partners LLC, Wichita, KS USA; [Cardoza, T.] Internal Med Inc, Los Banos, CA USA; [Verma, S.; Parsons, T.] Cardiol Consultants, Pensacola, FL USA; [Vicari, R.; Warren, K.] Melbourne Internal Med Associates, Melbourne, FL USA; [Vijay, N.; Washam, M.] Aurora Denver Cardiol Associates PC, Denver, CO USA; [Vossler, M.; Kilcup, S.] EvergreenHlth Cardiol Care, Kirkland, WA USA; [Walsh, R.; Renaud, K.] Heart & Vasc Inst Florida, Clearwater, FL USA; [Ward, S.; Locklear, T.] Hlth First Res Grp, Chipley, FL USA; [Waxman, F.; Sanchez, G.] Deerfield Beach Cardiol Associates, Deerfield Beach, FL USA; [Weiss, R.; St Laurent, B.] Maine Res Associates, Auburn, ME USA; [Truva, C.; Westcott, J.] Swedish Hlth Serv, Seattle, WA USA; [Williams, D.; Gibson, C.] Atlant Inst Clin Res, Daytona Beach, FL USA; [Williams, R.; Dowling, C.] Waycross Internal Med, Waycross, GA USA; [Willis, J.; VonGerichten, S.] San Gabriel Clin Res, Georgetown, TX USA; [Wood, K.; Capasso-Gulve, E.] Belleville Family Med Associates LTD, Belleville, IL USA; [Worley, S.; Pointer, S.] Heart Grp Lancaster Gen Hlth, Lancaster, PA USA; [Yarows, S.; Sheehan, T.] Chelsea Internal Med IHA, Chelsea, MI USA; [Preston, S.; Yasin, M.] Integris Cardiol Southwest, Oklahoma City, OK USA; [Yi, J.; Dongas, B.] Heartland Cardiovasc Ctr, Joliet, IL USA; [Fisher, M.; Yousuf, K.] Mid Atlant Cardiovasc Associates, Westminster, MD USA; [Zakhary, B.; Curtis, S.] Virginia Res Inst, Danville, VA USA; [Mason, T.] Pines Clin Res Inc, Pembroke Pines, FL USA; [Zellner, C.; Harden, M.] Springfield Clin LLP, Springfield, IL USA; [Roper, E.] Internists Fairfield, Fairfield, OH USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Case Western Reserve University; Case Western Reserve University Hospital; Jefferson University; McMaster University; University Hospital Brno; Institute of Cardiology - Poland; National Medical Research Center of Cardiology; Osaka National Hospital; IQVIA; Daiichi Sankyo Company Limited; Hospital Privado - Universitario de Cordoba; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Hospital Aleman; University of Buenos Aires; Hospital Ramos Mejia; Hospital Britanico de Buenos Aires; University of Sydney; Lyell McEwin Hospital; Baker Heart and Diabetes Institute; Royal Melbourne Hospital; Geelong Hospital; Royal Perth Hospital; University of Western Australia; KU Leuven; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; ZNA Middelheim Hospital; East Limburg Hospital; ZNA Stuivenberg; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Pernambuco; Fundacao Universitaria de Cardiologia; Center Clinical & Basic Research; Synarc; Pontificia Universidade Catolica Do Rio Grande Do Sul; Instituto de Assistencia Medica ao Servidor Publico Estadual (IAMSPE); Medical University Sofia; Medical University Sofia; Medical University Sofia; Medical University Pleven; Universite de Montreal; McMaster University; University of Ottawa; University of Ottawa Heart Institute; McGill University; Queen Elizabeth II Health Sciences Centre; Scarborough Hospital; Universite de Montreal; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Lanzhou University; Zhejiang University; Sichuan University; Sun Yat Sen University; Zhejiang University; Nanchang University; Guangxi Medical University; Hainan Medical University; Harbin Medical University; Naval Medical University; China Medical University; Jinzhou Medical University; Shanghai Jiao Tong University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Tongji University; Tianjin Medical University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Jilin University; Chongqing Medical University; Harbin Medical University; Xi'an Medical University; Wenzhou Medical University; Lanzhou University; Capital Medical University; Nanchang University; Sun Yat Sen University; University of Split; University of Zagreb; University of Zadar; University Hospital Brno; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Holbaek Hospital; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Seinajoki Central Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Ulm University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ruprecht Karls University Heidelberg; Kerckhoff Clinic; Ruhr University Bochum; Technische Universitat Dresden; Municipal Hospital Dresden; University of Munich; Ruprecht Karls University Heidelberg; University of Patras; Semmelweis University; University of Pecs; MGM Medical College Indore; Yenepoya (Deemed to be University); K.L.E. Academy of Higher Education & Research; Nizam's Institute of Medical Sciences; St. John's National Academy of Health Sciences; St. John's Medical College; Dayanand Medical College & Hospital; Western Galilee Hospital; Rabin Medical Center; Emek Medical Center; Clalit Health Services; Chaim Sheba Medical Center; Rambam Health Care Campus; Clalit Health Services; Carmel Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Bnai Zion Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Clalit Health Services; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; IRCCS Azienda Ospedaliero-Universitaria di Bologna; AUSL di Bologna; Ente Ospedaliero Ospedali Galliera; Azienda Ospedaliera Maggiore della Carita di Novara; University of Naples Federico II; IRCCS Fondazione San Matteo; San Carlo Borromeo Hospital; University of Siena; University Hospital of Siena; Kumamoto University; Tosei General Hospital; Mie University; Nagaoka Red Cross Hospital; Kobe City Medical Center General Hospital; Tsuchiura Kyodo Hospital; Kanazawa University; Kitasato University; Iwate Medical University; Teine Keijinkai Hospital; National Cerebral & Cardiovascular Center - Japan; Tachikawa Hospital; Kagawa University; Osaka National Hospital; Gunma University; Hyogo College of Medicine; Nippon Medical School; Shimane University; National Center for Global Health & Medicine - Japan; Fujita Health University; Osaka Metropolitan University; Osaka Rosai Hospital; Ogaki Municipal Hospital; Kansai Rosai Hospital; Kumamoto University; Tokyo Medical University; Saiseikai Kumamoto Hospital; Kyorin University; Tokai University; Hospital Central Dr. Ignacio Morones Prieto; University of Amsterdam; Academic Medical Center Amsterdam; VieCuri Medical Center; Maastricht University; Rijnland Hospital; Auckland City Hospital; Waikato Hospital; Dunedin Public Hospital; Christchurch Hospital New Zealand; University of Oslo; Philippine Heart Center; Saint Lukes Medical Center - Philippines; Cebu Doctors University; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Pirogov Russian National Research Medical University; Russian Academy of Sciences; Sechenov First Moscow State Medical University; Pavlov First Saint Petersburg State Medical University; Clinical Centre of Serbia; University of Pretoria; Kangwon National University; Kangwon National University Hospital; Gachon University; Pusan National University; Pusan National University Hospital; Soonchunhyang University; Soonchunhyang University Hospital; Catholic University of Korea; Kyung Hee University; Kyung Hee University Hospital; Inje University; Seoul National University (SNU); Seoul National University Hospital; Chonnam National University; Chonnam National University Hospital; Chungnam National University; Chungnam National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Ewha Womans University; Yeungnam University; Yeungnam University Hospital; Inje University; Korea University; Korea University Medicine (KU Medicine); Yonsei University; Yonsei University Health System; Basurto Hospital; University Hospital Donostia; Hospital Universitario Ramon y Cajal; Hospital Germans Trias i Pujol; Orebro University; Uppsala University; Uppsala University Hospital; Sahlgrenska University Hospital; Umea University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Veterans General Hospital; Changhua Christian Hospital; Taichung Veterans General Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Shin Kong Wu Ho Su Memorial Hospital; E-Da Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Khon Kaen University; Phramongkutklao Hospital; Mahidol University; Chiang Mai University; Chulalongkorn University; Ataturk University; Necmettin Erbakan University; Eskisehir Osmangazi University; Izmir Ataturk Training & Research Hospital; Dr. Siyami Ersek Cardiac & Vascular Surgery Training & Research Hospital; Adana Numune Training & Research Hospital; Ankara Numune Training & Research Hospital; Adnan Menderes University; Suleyman Demirel University; Akdeniz University; Cukurova University; Hacettepe University; Cumhuriyet University; Gazi University; Baskent University; Istanbul University; Ege University; Danylo Halytsky Lviv National Medical University; Kharkiv Medical Academy of Postgraduate Education; Zaporizhzhia State Medical University; Dnipro State Medical University; Ministry of Health of Ukraine; Kharkiv Medical Academy of Postgraduate Education; Poltava State Medical University; National Academy of Medical Sciences of Ukraine; L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine; Dnipro State Medical University; Ministry of Health of Ukraine; Zaporizhzhia State Medical University; Ivano-Frankivsk National Medical University; Danylo Halytsky Lviv National Medical University; Bogomolets National Medical University; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Ministry of Education & Science of Ukraine; Uzhgorod National University; National Academy of Medical Sciences of Ukraine; L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; National Pirogov Memorial Medical University Vinnytsya; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Kharkiv Medical Academy of Postgraduate Education; Ivano-Frankivsk National Medical University; Donetsk National Medical University; Zaporizhzhia State Medical University; National Academy of Medical Sciences of Ukraine; L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine; Shupyk National Healthcare University of Ukraine; St Georges University London; University of Warwick; University of Dundee; King's College Hospital NHS Foundation Trust; King's College Hospital; New Cross Hospital; Aintree University Hospitals NHS Foundation Trust; University of London; Queen Mary University London; Bradford Royal Infirmary; James Cook University; University of Birmingham; Barts Health NHS Trust; University of London; Queen Mary University London; Royal Infirmary of Edinburgh; Imperial College London; Heart of England NHS Foundation Trust; Good Hope Hospital; Minneapolis Heart Institute Foundation; Creighton University; LeBauer-Brodie Center for Cardiovascular Research & Education; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Saint Luke's Hospital - Missouri; Detroit Medical Center; Wayne State University; Saint Johns Mercy Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; MedStar Washington Hospital Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Buffalo General Medical Center; Saint Paul Ramsey Medical Center; Geisinger Medical Center; Swedish Medical Center; Hunter Holmes McGuire Veterinary Affairs Medical Center; Adventist Health Services; AdventHealth; Geisinger Medical Center; Yeshiva University; Lankenau Medical Center; Lankenau Institute for Medical Research; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Geisinger Medical Center; Swedish Medical Center	Giugliano, RP (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, 350 Longwood Ave,1st Flr, Boston, MA 02115 USA.	rgiugliano@partners.org	Dziak, Georgii/ABD-6506-2021; Paolo, Severino/V-3934-2019; Kanadaşı, Mehmet/V-1592-2018; ERDOĞAN, DİLEK/AAL-1294-2020; Fukamizu, Seiji/ABA-8739-2020; ameriso, sebastian/AAV-2296-2020; Beyer-Westendorf, Jan/K-7569-2019; Faynyk, Andriy/G-5152-2019; Celik, Ali/AAK-1138-2021; Jaksic Jurinjak, Sandra/AAJ-7084-2020; Brilakis, Emmanouil/B-5282-2009; Kmec, Ján/ABE-4250-2021; De Caterina, Raffaele/K-3857-2016; Serik, Serhii/T-3897-2018; Zharinov, Oleg J/U-8033-2018; Malynovsky, Yaroslav/T-1898-2017; Chendey, Taras/G-5066-2019; Puchinyan, Nikita/S-1384-2019; Bazylevych, Andriy/G-2834-2019; Rudyk, Iurii/AAG-4668-2021; Newby, David Ernest/AAB-1364-2019; Rha, Seung-Woon/AGE-5810-2022; De+Servi, Stefano/AAT-2631-2021; Ezekowitz, Michael/AAJ-2543-2021; Hoffmann, Ulrich/AAF-9798-2020; Shochat, Michael Kleiner/ABI-2898-2020; Bilonko, Oksana/AAH-3518-2019; Moiseeva, Yulia/GRN-8132-2022; Ardelean, Ioana Adriana/B-2807-2019; de Groot, Joris R/M-3282-2017; Kaidashev, Igor/L-2606-2019; Nikolaev, Konstantin/P-4750-2017; Srinivas, ANS/W-5377-2019; Tudoran, Mariana M/C-8126-2015; Libis, Roman/O-9193-2015; cervi, elena/A-7804-2012; Zotova, Irina/AAJ-3883-2021; Flecknoe-Brown, Stephen C/A-4927-2017; Filho, Dario Sobral/H-8624-2019; Zateyshchikov, Dmitry A/D-6575-2012; Zoghi, Prof. Dr. Mehdi/ABB-9550-2020; Bar, Michal/I-4516-2017; Brtko, Miroslav/ABE-3493-2020; Golitsyn, Sergey/ABH-2143-2020; Kraidashenko, Oleksandr/AAT-8167-2020; Sirenko, Yuriy M/C-8012-2019; Drapkina, Oxana/G-8443-2016; Berk, Michael/M-3585-2019; Macleod, Malcolm Robert/B-2052-2010; ERDOĞAN, DİLEK/AAL-1299-2020; Olsen, Rasmus Huan/G-2249-2010; Precoma, Dalton B/D-5674-2013; Shaposhnik, Igor I./P-2221-2015; Habibi, sharareh/AAU-8677-2021; Koziolova, Natalya/K-5657-2019; Di Lenarda, Andrea/AAC-2377-2022; Bobescu, Elena/AAC-6840-2021; Bobescu, Elena/ABD-6951-2020; Metra, marco/E-7101-2010; Verheugt, F.W.A./H-8105-2014; Colquhoun, David M/F-9078-2013; Djokovic, Aleksandra/G-1591-2017; Gavrysyuk, Volodymyr/AAT-8029-2021; Rishko, Mikola/ABD-5207-2021; Arutyunov, Gregory/M-7368-2019; Nicolau, Jose C/E-1487-2012; Berk, Michael/M-7891-2013; Calik, Ali Nazmi/AAE-5232-2019; Larina, Vera N/E-6211-2016; Eikelboom, John/AAG-6117-2019; Badila, Elisabeta/ABB-2142-2020; Khokhlov, Alexander L./E-2765-2017; Iversen, Helle Klingenberg/P-5726-2019; Libov, Igor/GRN-8152-2022; Kolomiets, Sergiy M/P-8059-2017; De Bleecker, Jan/B-7785-2013; Stanislavchuk, Mykola/GRX-8902-2022; Elbl, Lubomir/AAM-1074-2020; Yiğit, Fatma/ABC-8170-2021; Kozyrev, Oleg A/P-4788-2014; Kuo, Jen-Yuan/AAX-5448-2021; Piskorz, Daniel/AAJ-8751-2020; Weitz, Jeffrey/AAD-1929-2019; Heidbuchel, Hein/C-2331-2019; Kobza, Richard/AAE-5714-2022; Panchenko, Elizaveta/AAN-1884-2020; Reis, Gilmar/I-4500-2013; Nagy, Ivan/I-7419-2013; Halperin, Jonathan/AAJ-4721-2020; Hatala, Robert/ABV-9334-2022; Karoli, Nina/W-8077-2019; Storey, Robert/AAA-6853-2019; Wiviott, Stephen/HIK-2534-2022; Perrone Filardi, Pasquale/AAC-7590-2022; Brondani, Rosane/AAF-8798-2021; Drapkina, Oksana/AAE-5376-2021; Heidbuchel, Hein/AAU-2711-2021; Kaliszczak, Robert/A-6153-2016; Sussman, Jonathan/AAQ-1588-2021; Giugliano, Robert/N-7233-2017; Badenhorst, Melissa/E-8214-2010; Yakushin, Sergey/N-4165-2013	Dziak, Georgii/0000-0003-2352-1055; Paolo, Severino/0000-0001-6211-4482; ERDOĞAN, DİLEK/0000-0002-1930-3584; Beyer-Westendorf, Jan/0000-0002-6983-9993; Celik, Ali/0000-0002-1277-8739; Jaksic Jurinjak, Sandra/0000-0002-7349-6137; Kmec, Ján/0000-0002-3036-891X; De Caterina, Raffaele/0000-0003-1637-574X; Serik, Serhii/0000-0001-6257-3566; Malynovsky, Yaroslav/0000-0002-9118-1104; Puchinyan, Nikita/0000-0001-5029-1131; Bazylevych, Andriy/0000-0001-5053-2548; Rha, Seung-Woon/0000-0001-9456-9852; Bilonko, Oksana/0000-0002-9452-3296; Moiseeva, Yulia/0000-0002-5000-5454; Ardelean, Ioana Adriana/0000-0001-6976-5966; de Groot, Joris R/0000-0002-8122-7017; Kaidashev, Igor/0000-0002-4708-0859; Nikolaev, Konstantin/0000-0003-4601-6203; Tudoran, Mariana M/0000-0001-8989-5899; Libis, Roman/0000-0003-0130-990X; Zotova, Irina/0000-0001-8309-8231; Flecknoe-Brown, Stephen C/0000-0003-0834-1662; Filho, Dario Sobral/0000-0002-5301-7741; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Zoghi, Prof. Dr. Mehdi/0000-0002-8156-2675; Bar, Michal/0000-0002-5049-5844; Brtko, Miroslav/0000-0002-9577-9736; Golitsyn, Sergey/0000-0001-9913-9974; Kraidashenko, Oleksandr/0000-0002-8911-3292; Sirenko, Yuriy M/0000-0002-4091-4910; Drapkina, Oxana/0000-0002-4453-8430; Berk, Michael/0000-0002-5554-6946; Macleod, Malcolm Robert/0000-0001-9187-9839; ERDOĞAN, DİLEK/0000-0002-9981-9475; Olsen, Rasmus Huan/0000-0001-8114-365X; Habibi, sharareh/0000-0002-4196-5576; Di Lenarda, Andrea/0000-0001-8482-4872; Bobescu, Elena/0000-0002-0945-9067; Djokovic, Aleksandra/0000-0002-6094-7306; Gavrysyuk, Volodymyr/0000-0001-6942-4504; Arutyunov, Gregory/0000-0002-6645-2515; Nicolau, Jose C/0000-0002-9680-3689; Berk, Michael/0000-0002-5554-6946; Calik, Ali Nazmi/0000-0003-4153-4589; Larina, Vera N/0000-0001-7825-5597; Eikelboom, John/0000-0003-4126-1285; Khokhlov, Alexander L./0000-0002-0032-0341; Iversen, Helle Klingenberg/0000-0002-5880-6352; Yiğit, Fatma/0000-0003-1541-6167; Piskorz, Daniel/0000-0002-8615-5446; Weitz, Jeffrey/0000-0002-1092-7550; Heidbuchel, Hein/0000-0001-9301-8127; Kobza, Richard/0000-0003-3988-7262; Reis, Gilmar/0000-0002-4847-1034; Halperin, Jonathan/0000-0002-8318-5471; Drapkina, Oksana/0000-0002-4453-8430; Heidbuchel, Hein/0000-0001-9301-8127; Kaliszczak, Robert/0000-0001-5586-260X; Sizova, Daria/0000-0001-5471-6010; Aylward, Philip/0000-0002-5358-8552; Sizova, Zhanna/0000-0002-1242-7074; Troughton, Richard/0000-0001-7484-4036; Teitelbaum, Jeanne/0000-0002-9834-3882; Fedacko, Jan/0000-0002-4940-0393; Sussman, Jonathan/0000-0002-7702-8816; Kraidashenko, Oleh/0000-0001-8727-8889; choy, anna maria/0000-0002-4052-0591; Fukamizu, Seiji/0000-0002-0291-9702; Appelros, Peter/0000-0003-2810-6977; Godlevska, Olga/0000-0001-7473-9711; Lapidus, Natal'a/0000-0002-2222-836X; Yena, Larisa/0000-0001-9633-1848; Douglas, Pamela/0000-0001-9876-4049; Giugliano, Robert/0000-0003-4110-7675; Zienciuk-Krajka, Agnieszka/0000-0002-1341-9893; Kolomiets, Sergiy/0000-0002-3095-7386; Badenhorst, Melissa/0000-0002-4732-5027; Rudyk, Iurii/0000-0002-3363-868X; Wood, Kathryn/0000-0003-4671-2014; Brilakis, Emmanouil/0000-0001-9416-9701; PENCO, Maria/0000-0002-0711-9747; Pella, Daniel/0000-0001-9999-6271; Apostolovic, Svetlana/0000-0001-9015-297X; Marino, Paolo/0000-0002-8192-412X; Kietselaer, Bas/0000-0002-0096-8594; Murphy, Andrew/0000-0001-5549-8246; Sakata, Yasushi/0000-0002-5618-4721; Car, Sinisa/0000-0001-6439-123X; BADILA, ELISABETA/0000-0003-2683-3054; Manzur, Fernando/0000-0001-6679-5609; Nawrot, Martin Paul/0000-0003-4133-6419; Villuendas-Sabate, Roger/0000-0001-9110-905X; Ling, Liang-han/0000-0001-8393-2337; Azhdari, Maryam/0000-0003-2110-9817; Goessling, Wolfram/0000-0001-9972-1569; Merino, Jose Luis/0000-0002-1737-1903; Kaplan, Pavel/0000-0003-0455-2630; Peruzzotti-Jametti, Luca/0000-0002-9396-5607; Karoli, Nina/0000-0002-7464-826X; Christensen, Hanne/0000-0002-7472-3194; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; Talajic, Mario/0000-0001-8469-4748; Hassager, Christian/0000-0002-1199-0981; Yakushin, Sergey/0000-0001-7202-742X	Daiichi Sankyo Pharma Development; Daiichi Sankyo; Janssen Pharmaceuticals; Merck; Bristol-Myers Squibb; Sanofi; Johnson Johnson; AstraZeneca; Boehringer Ingelheim; Genzyme; Amorcyte; Medicines Company; Cardiorentis; Eli Lilly; Menarini; Medscape; Bayer HealthCare; GlaxoSmithKline; Beckman Coulter; Roche Diagnostics; Pfizer; Eisai; Arena Pharmaceuticals; Aegerion; AngelMed; Xoma; ICON Clinical Research; Boston Clinical Research Institute; Ortho-McNeil-Janssen Pharmaceuticals; Biotronik; Boston Scientific; Medtronic; Cardio-Insight; ChanRx; Portola Pharmaceuticals; Janssen Scientific Affairs; Pozen; Coherex Medical; Gilead; MRC [G0800777] Funding Source: UKRI; Medical Research Council [G0800777] Funding Source: researchfish	Daiichi Sankyo Pharma Development(Daiichi Sankyo Company Limited); Daiichi Sankyo(Daiichi Sankyo Company Limited); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Genzyme(Sanofi-AventisGenzyme Corporation); Amorcyte; Medicines Company; Cardiorentis; Eli Lilly(Eli Lilly); Menarini(Menarini Group); Medscape; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Beckman Coulter; Roche Diagnostics; Pfizer(Pfizer); Eisai(Eisai Co Ltd); Arena Pharmaceuticals; Aegerion; AngelMed; Xoma; ICON Clinical Research; Boston Clinical Research Institute; Ortho-McNeil-Janssen Pharmaceuticals; Biotronik; Boston Scientific(Boston Scientific); Medtronic(Medtronic); Cardio-Insight; ChanRx; Portola Pharmaceuticals; Janssen Scientific Affairs; Pozen; Coherex Medical; Gilead(Gilead Sciences); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Daiichi Sankyo Pharma Development.r Dr. Giugliano reports receiving consulting fees from Daiichi Sankyo, Janssen Pharmaceuticals, and Merck; lecture fees from Bristol-Myers Squibb, Daiichi Sankyo, Merck, and Sanofi; and grant support through his institution from Daiichi Sankyo, Merck, Johnson & Johnson, Sanofi, and AstraZeneca. Dr. Ruff reports receiving consulting fees from Daiichi Sankyo, Bristol-Myers Squibb, and Boehringer Ingelheim and grant support through his institution from Daiichi Sankyo. Dr. Braunwald reports receiving consulting fees from Sanofi, Genzyme, Amorcyte, the Medicines Company, and Cardiorentis; lecture fees from Eli Lilly, Menarini, Medscape, and Bayer HealthCare; and grant support through his institution from Daiichi Sankyo, AstraZeneca, Johnson & Johnson, GlaxoSmithKline, Bristol-Myers Squibb, Beckman Coulter, Roche Diagnostics, Pfizer, Merck, and Sanofi. He also reports serving as an unpaid consultant for Merck and providing uncompensated lectures for Merck and CVRx. Dr. Wiviott reports receiving consulting fees from AstraZeneca, Bristol-Myers Squibb, Eisai, Arena Pharmaceuticals, Eli Lilly, Daiichi Sankyo, Aegerion, AngelMed, Janssen Pharmaceuticals, Xoma, ICON Clinical Research, and Boston Clinical Research Institute and grant support through his institution from AstraZeneca, Bristol-Myers Squibb, Eisai, Arena Pharmaceuticals, Merck, Eli Lilly, Daiichi Sankyo, and Sanofi. Dr. Halperin reports receiving consulting fees from Bayer HealthCare, Boehringer Ingelheim, Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Pfizer, Sanofi, Biotronik, Boston Scientific, and Medtronic. Dr. Waldo reports receiving consulting fees from Daiichi Sankyo, Sanofi, Cardio-Insight, Pfizer, and ChanRx; lecture fees from Sanofi, Pfizer, Janssen Pharmaceuticals, and Bristol-Myers Squibb; honoraria for clinical trial-related activities from Biotronik, St. Jude Medical, Daiichi Sankyo, Biosense Webster, Gilead, and AtriCure; and grant support through his institution from Gilead. Dr. Ezekowitz reports receiving consulting fees from Boehringer Ingelheim, Pfizer, Sanofi, Bristol-Myers Squibb, Portola Pharmaceuticals, Bayer HealthCare, Daiichi Sankyo, Medtronic, Aegerion, Merck, Johnson & Johnson, Gilead, Janssen Scientific Affairs, Pozen, and Coherex Medical; and lecture fees from Boehringer Ingelheim. Dr. Weitz reports receiving consulting fees from Boehringer Ingelheim, Bayer HealthCare, Bristol-Myers Squibb, Daiichi Sankyo, Janssen Pharmaceuticals, Pfizer, Merck, and Portola Pharmaceuticals. Dr. Koretsune reports receiving lecture fees from Daiichi Sankyo, Boehringer Ingelheim, Pfizer, Bayer HealthCare, and Bristol-Myers Squibb; and grant support through his institution from Daiichi Sankyo and Boehringer Ingelheim. Drs. Shi, Patel, Hanyok, and Mercuri report being employees of Daiichi Sankyo. Dr. Mercuri also reports holding a pending patent related to the clinical properties of edoxaban. Ms. Murphy, Ms. Grip, and Dr. Antman report receiving grant support through their institution from Daiichi Sankyo. No other potential conflict of interest relevant to this article was reported.	[Anonymous], HOT TOPICS CARDIOL; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dogliotti A, 2013, CLIN CARDIOL, V36, P61, DOI 10.1002/clc.22081; Food and Drug Administration, 2010, GUIDANCE FOR INDUSTR; Fukuda T, 2012, THROMB HAEMOSTASIS, V107, P253, DOI 10.1160/TH11-09-0668; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Laliberte F, 2012, ADV THER, V29, P675, DOI 10.1007/s12325-012-0040-x; Laulicht B, 2013, J THROMB HAEMOST, V11, P75; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Matsushima N, 2013, CLIN PHARM DRUG DEV, V2, P358, DOI 10.1002/cpdd.53; Mendell J, 2013, AM J CARDIOVASC DRUG, V13, P331, DOI 10.1007/s40256-013-0029-0; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Renda G, 2013, VASC PHARMACOL, V59, P53, DOI 10.1016/j.vph.2013.07.003; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruff CT, 2010, AM HEART J, V160, P635, DOI 10.1016/j.ahj.2010.06.042; Salazar DE, 2012, THROMB HAEMOSTASIS, V107, P925, DOI 10.1160/TH11-08-0566; Samama MM, 2012, THROMB RES, V129, pE77, DOI 10.1016/j.thromres.2011.07.026; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Verhovsek Madeleine, 2008, BMC Geriatr, V8, P13, DOI 10.1186/1471-2318-8-13; Ware JH, 2012, NEW ENGL J MED, V367, P1353, DOI 10.1056/NEJMsm1210043; Weitz JI, 2010, THROMB HAEMOSTASIS, V104, P633, DOI 10.1160/TH10-01-0066	25	3073	3171	35	633	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2093	2104		10.1056/NEJMoa1310907	http://dx.doi.org/10.1056/NEJMoa1310907			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24251359	Green Published			2022-12-28	WOS:000327467500007
J	Kim, AY; Wu, RI				Kim, Arthur Y.; Wu, Roseann I.			Case 37-2013: A 41-Year-Old Woman with Malaise and Chest and Abdominal Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-C VIRUS; ALPHA-2A PLUS RIBAVIRIN; HIV; INFECTION; CLEARANCE		[Kim, Arthur Y.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Wu, Roseann I.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kim, Arthur Y.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wu, Roseann I.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kim, AY (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.			Wu, Roseann/0000-0001-8073-3965	Vertex Pharmaceuticals; AbbVie; Gilead; Bristol-Myers Squibb	Vertex Pharmaceuticals(Vertex Pharmaceuticals); AbbVie(AbbVie); Gilead(Gilead Sciences); Bristol-Myers Squibb(Bristol-Myers Squibb)	Dr. Kim reports receiving consulting fees from Vertex Pharmaceuticals, AbbVie, and Gilead and grant funding from Bristol-Myers Squibb. No other potential conflict of interest relevant to this article was reported.	Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Corey KE, 2009, INFECT CONT HOSP EP, V30, P1000, DOI 10.1086/605718; EYSTER ME, 1991, ANN INTERN MED, V115, P764, DOI 10.7326/0003-4819-115-10-764; Hofer H, 2003, HEPATOLOGY, V37, P60, DOI 10.1053/jhep.2003.50019; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Lucena MI, 2011, GASTROENTEROLOGY, V141, P338, DOI 10.1053/j.gastro.2011.04.001; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Malek J, 2011, AM J EMERG MED, V29, P278, DOI 10.1016/j.ajem.2009.09.034; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Nunez M, 2010, HEPATOLOGY, V52, P1143, DOI 10.1002/hep.23716; Onofrey Shauna, 2011, Morbidity and Mortality Weekly Report, V60, P537; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Victor JC, 2007, NEW ENGL J MED, V357, P1685, DOI 10.1056/NEJMoa070546	20	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2138	2145		10.1056/NEJMcpc1209651	http://dx.doi.org/10.1056/NEJMcpc1209651			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24283228				2022-12-28	WOS:000327467500012
J	Fernandez-Capetillo, O; Nussenzweig, A				Fernandez-Capetillo, Oscar; Nussenzweig, Andre			Naked Replication Forks Break apRPArt	CELL			English	Editorial Material							DNA; CHECKPOINT	Stalled replication forks occasionally collapse, leading to potentially catastrophic DNA double-strand breaks. Now, Toledo et al. (2013) reveal that fork breakage occurs when the pool of the single-strand DNA-binding protein RPA becomes exhausted. This study has important implications for the origin and treatment of cancers with high levels of replicative stress.	[Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid 28029, Spain; [Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA	Centro Nacional de Investigaciones Oncologicas (CNIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fernandez-Capetillo, O (corresponding author), Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid 28029, Spain.	ofernandez@cnio.es; andre_nussenzweig@nih.gov	Fernandez-Capetillo, Oscar/H-3508-2015	Fernandez-Capetillo, Oscar/0000-0002-2690-6885	Intramural NIH HHS [ZIA BC010283-21, ZIA BC010959-11] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Brown EJ, 2000, GENE DEV, V14, P397; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043	8	8	8	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					979	980		10.1016/j.cell.2013.10.049	http://dx.doi.org/10.1016/j.cell.2013.10.049			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267882	Green Accepted, Bronze			2022-12-28	WOS:000327500600002
J	Schulz, D; Schwalb, B; Kiesel, A; Baejen, C; Torkler, P; Gagneur, J; Soeding, J; Cramer, P				Schulz, Daniel; Schwalb, Bjoern; Kiesel, Anja; Baejen, Carlo; Torkler, Phillipp; Gagneur, Julien; Soeding, Johannes; Cramer, Patrick			Transcriptome Surveillance by Selective Termination of Noncoding RNA Synthesis	CELL			English	Article							CRYPTIC UNSTABLE TRANSCRIPTS; POLYMERASE-II TRANSCRIPTION; BINDING PROTEINS NRD1; ANTISENSE TRANSCRIPTION; PERVASIVE TRANSCRIPTION; BIDIRECTIONAL PROMOTERS; DIVERGENT TRANSCRIPTION; QUALITY-CONTROL; YEAST; REVEALS	Pervasive transcription of eukaryotic genomes stems to a large extent from bidirectional promoters that synthesize mRNA and divergent noncoding RNA (ncRNA). Here, we show that ncRNA transcription in the yeast S. cerevisiae is globally restricted by early termination that relies on the essential RNA-binding factor Nrd1. Depletion of Nrd1 from the nucleus results in 1,526 Nrd1-unterminated transcripts (NUTs) that originate from nucleosome-depleted regions (NDRs) and can deregulate mRNA synthesis by antisense repression and transcription interference. Transcriptome-wide Nrd1-binding maps reveal divergent NUTs at most promoters and antisense NUTs in most 30 regions of genes. Nrd1 and its partner Nab3 preferentially bind RNA motifs that are depleted in mRNAs and enriched in ncRNAs and some mRNAs whose synthesis is controlled by transcription attenuation. These results define a global mechanism for transcriptome surveillance that selectively terminates ncRNA synthesis to provide promoter directionality and to suppress antisense transcription.	[Schulz, Daniel; Schwalb, Bjoern; Kiesel, Anja; Baejen, Carlo; Torkler, Phillipp; Gagneur, Julien; Soeding, Johannes; Cramer, Patrick] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Schulz, Daniel; Schwalb, Bjoern; Kiesel, Anja; Baejen, Carlo; Torkler, Phillipp; Gagneur, Julien; Soeding, Johannes; Cramer, Patrick] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Soeding, J (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	soeding@lmb.uni-muenchen.de; cramer@lmb.uni-muenchen.de	Söding, Johannes/A-3341-2013	Söding, Johannes/0000-0001-9642-8244; Schulz, Daniel/0000-0002-0913-1678; Torkler, Phillipp/0000-0002-1450-5806; Gagneur, Julien/0000-0002-8924-8365; Schwalb, Bjorn/0000-0003-2987-2622	Bavarian Network for Molecular Biosystems (BaySysNet); Deutsche Forschungsgemeinschaft [SFB646, GRK1721, QBM]; Bundes-ministerium fur Bildung und Forschung (BMBF, ebio); Bavarian Network for Systems Biology (BaySysNet); DFG [SFB646, GRK1721, QBM, TR5, SFB960, CIPSM, NIM]; Deutsches Konsortium fur Translationale Krebsforschung DKTK; Jung-Stiftung; Vallee Foundation	Bavarian Network for Molecular Biosystems (BaySysNet); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundes-ministerium fur Bildung und Forschung (BMBF, ebio)(Federal Ministry of Education & Research (BMBF)); Bavarian Network for Systems Biology (BaySysNet); DFG(German Research Foundation (DFG)); Deutsches Konsortium fur Translationale Krebsforschung DKTK; Jung-Stiftung; Vallee Foundation	We would like to thank Stefan Krebs and Alexander Graf for sequencing and Galaxy maintenance, Christophe Jung for image analysis, and Domenico Libri for critically reading the manuscript. J.G. was supported by the Bavarian Network for Molecular Biosystems (BaySysNet). J.S. was supported by the Deutsche Forschungsgemeinschaft (SFB646, GRK1721, QBM), the Bundes-ministerium fur Bildung und Forschung (BMBF, ebio), and the Bavarian Network for Systems Biology (BaySysNet). P.C. was supported by the DFG (SFB646, TR5, SFB960, GRK1721, CIPSM, NIM, QBM), an Advanced Investigator Grant of the European Research Council, the Deutsches Konsortium fur Translationale Krebsforschung DKTK, the Jung-Stiftung, and the Vallee Foundation.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Colin J, 2011, GENET RES INT, V2011, DOI 10.4061/2011/653494; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hani J, 1998, NUCLEIC ACIDS RES, V26, P689, DOI 10.1093/nar/26.3.689; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Honorine R, 2011, NUCLEIC ACIDS RES, V39, P2809, DOI 10.1093/nar/gkq1192; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Kubicek K, 2012, GENE DEV, V26, P1891, DOI 10.1101/gad.192781.112; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Murray SC, 2012, NUCLEIC ACIDS RES, V40, P2432, DOI 10.1093/nar/gkr1121; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Peters JM, 2012, GENE DEV, V26, P2621, DOI 10.1101/gad.196741.112; Porrua O, 2012, EMBO J, V31, P3935, DOI 10.1038/emboj.2012.237; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Windhager L, 2012, GENOME RES, V22, P2031, DOI 10.1101/gr.131847.111; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87	67	145	147	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1075	1087		10.1016/j.cell.2013.10.024	http://dx.doi.org/10.1016/j.cell.2013.10.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24210918	Bronze, Green Published			2022-12-28	WOS:000327500600012
J	Hampton, SE				Hampton, Stephanie E.			Understanding Lakes Near and Far	SCIENCE			English	Editorial Material									Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Hampton, SE (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA.	hampton@nceas.ucsb.edu		Hampton, Stephanie/0000-0003-2389-4249	Division Of Environmental Biology [1136637] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Beisner BE, 2012, J PLANKTON RES, V34, P849, DOI 10.1093/plankt/fbs052; Edmondson W. T., 1994, Lake and Reservoir Management, V10, P75; Hampton SE, 2013, ECOLOGY, V94, P2663, DOI 10.1890/13-0996.1; Katz SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014688; Kozhova O. M., 1998, LAKE BAIKAL EVOLUTIO; Lenters J. D., 2012, EOS T AGU, V93, P427, DOI [10.1029/2012E0430004, DOI 10.1029/2012EO430004]; Lyche-Solheim A, 2013, HYDROBIOLOGIA, V704, P57, DOI 10.1007/s10750-012-1436-y; Maberly SC, 2012, FRESHWATER BIOL, V57, P233, DOI 10.1111/j.1365-2427.2011.02718.x; Moss B, 2012, SCI TOTAL ENVIRON, V434, P130, DOI 10.1016/j.scitotenv.2011.07.069; Schneider P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045059; Solomon CT, 2013, LIMNOL OCEANOGR, V58, P849, DOI 10.4319/lo.2013.58.3.0849; Straile D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045497; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273	13	12	12	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					815	816		10.1126/science.1244732	http://dx.doi.org/10.1126/science.1244732			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233716				2022-12-28	WOS:000326923000025
J	Lighthall, G; Harrison, TK; Chu, LF				Lighthall, Geoffrey; Harrison, T. Kyle; Chu, Larry F.			Laryngeal Mask Airway in Medical Emergencies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENDOTRACHEAL-TUBE; RESUSCITATION		[Lighthall, Geoffrey; Harrison, T. Kyle] Palo Alto Vet Affairs Hosp, Palo Alto, CA 94304 USA; [Lighthall, Geoffrey; Harrison, T. Kyle; Chu, Larry F.] Stanford Univ, Sch Med, Stanford, CA USA	Stanford University	Lighthall, G (corresponding author), Palo Alto Vet Affairs Hosp, Dept Anesthesia, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	geoffl@stanford.edu	Chu, Larry/B-5324-2008	Chu, Larry/0000-0003-0814-6402				[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; DAVIES PRF, 1990, LANCET, V336, P977, DOI 10.1016/0140-6736(90)92429-L; Foley LJ, 2000, CRIT CARE CLIN, V16, P429, DOI 10.1016/S0749-0704(05)70121-4; Grantham H, 1994, EMERGEN MED, V6, P193, DOI [10.1111/j.1442-2026.1994.tb00165.x, DOI 10.1111/J.1442-2026.1994.TB00165.X]; KOKKINIS K, 1995, RESUSCITATION, V30, P21, DOI 10.1016/0300-9572(95)00860-V; KOKKINIS K, 1994, RESUSCITATION, V27, P9, DOI 10.1016/0300-9572(94)90015-9; Nolan J D, 2001, Curr Opin Crit Care, V7, P413, DOI 10.1097/00075198-200112000-00008; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; PENNANT JH, 1992, ANESTH ANALG, V75, P1074, DOI 10.1213/00000539-199212000-00046; PENNANT JH, 1992, ANESTH ANALG, V74, P531; REINHART DJ, 1994, ANN EMERG MED, V24, P260, DOI 10.1016/S0196-0644(94)70139-3; Stone BJ, 1998, RESUSCITATION, V38, P3, DOI 10.1016/S0300-9572(98)00068-9; Verghese C, 1994, Eur J Emerg Med, V1, P123	13	3	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20								10.1056/NEJMvcm0909669	http://dx.doi.org/10.1056/NEJMvcm0909669			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300MP	24224639				2022-12-28	WOS:000330468300001
J	Maldovan, M				Maldovan, Martin			Sound and heat revolutions in phononics	NATURE			English	Review							PHOTONIC CRYSTAL FIBERS; BAND-GAPS; THERMOELECTRIC PERFORMANCE; THERMAL-CONDUCTIVITY; ACOUSTIC PHONONS; FIGURE; LOCALIZATION; ATTENUATION; REDUCTION; EXISTENCE	The phonon is the physical particle representing mechanical vibration and is responsible for the transmission of everyday sound and heat. Understanding and controlling the phononic properties of materials provides opportunities to thermally insulate buildings, reduce environmental noise, transform waste heat into electricity and develop earthquake protection. Here I review recent progress and the development of new ideas and devices that make use of phononic properties to control both sound and heat. Advances in sonic and thermal diodes, optomechanical crystals, acoustic and thermal cloaking, hypersonic phononic crystals, thermoelectrics, and thermocrystals herald the next technological revolution in phononics.	[Maldovan, Martin] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Maldovan, Martin] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Massachusetts Institute of Technology (MIT); University System of Georgia; Georgia Institute of Technology	Maldovan, M (corresponding author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	maldovan@gatech.edu						Akimov AV, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.033902; Bilal OR, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.065701; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Boechler N, 2011, NAT MATER, V10, P665, DOI [10.1038/NMAT3072, 10.1038/nmat3072]; Boukai AI, 2008, NATURE, V451, P168, DOI 10.1038/nature06458; Brun M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3068491; Chan C. T., 2011, PHYSICS, V4, P2; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Chang CW, 2006, SCIENCE, V314, P1121, DOI 10.1126/science.1132898; Chen HY, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2803315; Chen HY, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/11/113001; Chen TY, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988181; Cheng W, 2006, NAT MATER, V5, P830, DOI 10.1038/nmat1727; Cheng Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2903500; Chiritescu C, 2007, SCIENCE, V315, P351, DOI 10.1126/science.1136494; Cummer SA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.024301; Cummer SA, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/3/045; Dainese P, 2006, NAT PHYS, V2, P388, DOI 10.1038/nphys315; de Espinosa FRM, 1998, PHYS REV LETT, V80, P1208, DOI 10.1103/PhysRevLett.80.1208; Eichenfield M, 2009, NATURE, V462, P78, DOI 10.1038/nature08524; Fainstein A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.037403; Fan CZ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2951600; Farhat M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.134501; Farhat M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.024301; Garg J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.045901; Gavartin E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.203902; Gorishnyy T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.115501; Grudinin IS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.083901; Guenneau S, 2012, OPT EXPRESS, V20, P8207, DOI 10.1364/OE.20.008207; Harman TC, 2002, SCIENCE, V297, P2229, DOI 10.1126/science.1072886; Heinrich G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.043603; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Kang MS, 2009, NAT PHYS, V5, P276, DOI 10.1038/NPHYS1217; Kim W, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.045901; Kundu A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125426; KUSHWAHA MS, 1993, PHYS REV LETT, V71, P2022, DOI 10.1103/PhysRevLett.71.2022; Laude V, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045107; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Li BW, 2010, NAT MATER, V9, P962, DOI 10.1038/nmat2906; Li BW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.184301; Li XF, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.084301; Liang B, 2010, NAT MATER, V9, P989, DOI 10.1038/NMAT2881; Liang B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.104301; Liu ZY, 2000, SCIENCE, V289, P1734, DOI 10.1126/science.289.5485.1734; Maldovan M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2216885; Maldovan M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.025902; MARTINEZSALA R, 1995, NATURE, V378, P241, DOI 10.1038/378241a0; Milton GW, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/248; Mingo N, 2009, NANO LETT, V9, P711, DOI 10.1021/nl8031982; Mohammadi S, 2010, OPT EXPRESS, V18, P9164, DOI 10.1364/OE.18.009164; Narayana S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.214303; Papanikolaou N, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3453448; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pennec Y, 2010, OPT EXPRESS, V18, P14301, DOI 10.1364/OE.18.014301; Popa BI, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.253901; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Psarobas IE, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174303; Russell PS, 2003, OPT EXPRESS, V11, P2555, DOI 10.1364/OE.11.002555; Sadat-Saleh S, 2009, J APPL PHYS, V106, DOI 10.1063/1.3243276; Safavi-Naeini AH, 2011, NATURE, V472, P69, DOI 10.1038/nature09933; Safavi-Naeini AH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.033602; Safavi-Naeini AH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507288; Safavi-Naeini AH, 2010, OPT EXPRESS, V18, P14926, DOI 10.1364/OE.18.014926; Sanchez-Perez JV, 1998, PHYS REV LETT, V80, P5325, DOI 10.1103/PhysRevLett.80.5325; Schittny R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.195901; SIGALAS M, 1993, SOLID STATE COMMUN, V86, P141, DOI 10.1016/0038-1098(93)90888-T; Stenger N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.014301; Terraneo M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.094302; Thomas E. L., 2008, PERIODIC STRUCTURES; Thomas EL, 2006, NAT MATER, V5, P773, DOI 10.1038/nmat1744; Torrent D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063015; Trigo M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.227402; Vasseur JO, 2001, PHYS REV LETT, V86, P3012, DOI 10.1103/PhysRevLett.86.3012; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Wang L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.177208; Wang L, 2008, PHYS WORLD, V21, P27; Worlock JM, 2003, NATURE, V421, P802, DOI 10.1038/421802a; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Yang N, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.020301; Yu JK, 2010, NAT NANOTECHNOL, V5, P718, DOI 10.1038/nnano.2010.149; Zhang S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.024301	85	826	850	29	977	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					209	217		10.1038/nature12608	http://dx.doi.org/10.1038/nature12608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24226887				2022-12-28	WOS:000326894200041
J	Sanford, WE; Doughten, MW; Coplen, TB; Hunt, AG; Bullen, TD				Sanford, Ward E.; Doughten, Michael W.; Coplen, Tyler B.; Hunt, Andrew G.; Bullen, Thomas D.			Evidence for high salinity of Early Cretaceous sea water from the Chesapeake Bay crater	NATURE			English	Article							GROUNDWATER; AQUIFER; FLOW	High-salinity groundwater more than 1,000 metres deep in the Atlantic coastal plain of the USA has been documented in several locations(1,2), most recentlywithin the 35-million-year-old Chesapeake Bay impact crater(3-5). Suggestions for the origin of increased salinity in the crater have included evaporite dissolution(6), osmosis(6) and evaporation from heating(7) associated with the bolide impact. Here we present chemical, isotopic and physical evidence that together indicate that groundwater in the Chesapeake crater is remnant Early Cretaceous North Atlantic (ECNA) sea water. We find that the sea water is probably 100-145 million years old and that it has an average salinity of about 70 per mil, which is twice that of modern sea water and consistent with the nearly closed ECNA basin(8). Previous evidence for temperature and salinity levels of ancient oceans have been estimated indirectly from geochemical, isotopic and palaeontological analyses of solid materials in deep sediment cores. In contrast, our study identifies ancient sea water in situ and provides a direct estimate of its age and salinity. Moreover, we suggest that it is likely that remnants of ECNA sea water persist in deep sediments at many locations along the Atlantic margin.	[Sanford, Ward E.; Doughten, Michael W.; Coplen, Tyler B.] US Geol Survey, Reston, VA 20192 USA; [Hunt, Andrew G.] US Geol Survey, Fed Ctr, Denver, CO 80225 USA; [Bullen, Thomas D.] US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Sanford, WE (corresponding author), US Geol Survey, Mail Stop 431, Reston, VA 20192 USA.	wsanford@usgs.gov						Barth S, 1997, CHEM GEOL, V143, P255, DOI 10.1016/S0009-2541(97)00107-1; Beyerle U, 2000, ENVIRON SCI TECHNOL, V34, P2042, DOI 10.1021/es990840h; Bohlke, 2006, PERCHLORATE ENV OCCU, P93, DOI DOI 10.1007/0-387-31113-0_5; Brenna JT, 1997, MASS SPECTROM REV, V16, P227, DOI 10.1002/(SICI)1098-2787(1997)16:5<227::AID-MAS1>3.0.CO;2-J; Browning JV, 2009, GEOL SOC AM SPEC PAP, V458, P775, DOI 10.1130/2009.2458(33); Bullen TD, 1996, GEOCHIM COSMOCHIM AC, V60, P1807, DOI 10.1016/0016-7037(96)00052-X; Carmody R., 1997, 97234 US GEOL SURV; Cederstrom D., 1943, VIRGINIA GEOL SURV B, V58, P1; Coplen T., 2008, USGS TECHNIQUES METH, V10; Davis SN, 1998, GROUND WATER, V36, P338, DOI 10.1111/j.1745-6584.1998.tb01099.x; EVANS R, 1978, AAPG BULL, V62, P223; Friedrich O, 2008, NAT GEOSCI, V1, P453, DOI 10.1038/ngeo217; Gohn G., 2006, T AM GEOPHYS UNION, V87, P349; Gohn GS, 2008, SCIENCE, V320, P1740, DOI 10.1126/science.1158708; Gohn G.S., 2007, 20071094 US GEOL SUR; Hay WW, 1999, GEOL S AM S, P1; Ingebritsen S.E., 2006, GROUNDWATER GEOLOGIC; JONES CE, 1994, GEOCHIM COSMOCHIM AC, V58, P3061, DOI 10.1016/0016-7037(94)90179-1; MALINCONICO ML, 2009, SPEC PAP GEOL SOC AM, V458, P905; MANHEIM FT, 1981, J HYDROL, V54, P95, DOI 10.1016/0022-1694(81)90154-2; Mazurek M, 2011, APPL GEOCHEM, V26, P1035, DOI 10.1016/j.apgeochem.2011.03.124; McFarland E.R., 2005, US GEOL SURV PROF PA, pK1; McFarland E. R., 2006, 1731 US GEOL SURV; McFarland E.R., 2010, 1772 US GEOL SURV; Meisler H., 1989, 1404D US GEOL SURV; Neuzil CE, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006450; OXBURGH ER, 1986, NATURE, V324, P632, DOI 10.1038/324632a0; Plummer LN, 2012, HYDROGEOL J, V20, P1269, DOI 10.1007/s10040-012-0871-1; Poag C., 1999, CHESAPEAKE INVADER D; Poag C., 2003, CHESAPEAKE CRATER GE; Radford L., 1980, ET283731 DEP EN; Rostad CE, 2009, GEOL SOC AM SPEC PAP, V458, P891, DOI 10.1130/2009.2458(37); Sanford W, 2003, J GEOCHEM EXPLOR, V78-9, P243, DOI 10.1016/S0375-6742(03)00108-0; Sanford W.E., 2004, EOS T AM GEOPHYS UN, V85, P369, DOI DOI 10.1029/2004EO390001; Sanford WE, 2009, GEOL SOC AM SPEC PAP, V458, P867, DOI 10.1130/2009.2458(36); Sanford WE, 2005, GEOFLUIDS, V5, P185, DOI 10.1111/j.1468-8123.2005.00110.x; SPANGLER WB, 1950, AAPG BULL, V34, P100; Talawani M., 1979, DEEP DRILLING RESULT, V3, P375; Wagner T, 2008, GEOLOGY, V36, P203, DOI 10.1130/G24523A.1	39	14	16	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					252	+		10.1038/nature12714	http://dx.doi.org/10.1038/nature12714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24226889				2022-12-28	WOS:000326894200049
J	Volkow, ND; Swanson, JM				Volkow, Nora D.; Swanson, James M.			Adult Attention Deficit-Hyperactivity Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; PRESCRIPTION STIMULANTS; FOLLOW-UP; ADHD; METAANALYSIS; NEUROSCIENCE; ASSOCIATION; COMORBIDITY; MEDICATIONS; ATOMOXETINE	Short-term trials involving adults with ADHD have shown significant improvements in symptoms with stimulants and atomoxetine; however, data on long-term benefits and risks of these medications, particularly among older persons, have been insufficient. ForewordThis Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.StageA 31-year-old middle-school teacher sought medical help because she was having trouble keeping up with her job assignments and responsibilities. Her primary symptoms were an inability to stay focused and being easily distracted. She reported daydreaming with multiple thoughts at the same time, an inability to complete tasks on time, frequently forgetting to do things at work, and being unable to remain still during solitary activities (e.g., watching a movie and reading a book). Her friends described her as excessively talkative, disorganized, impatient, and careless. From childhood, her teachers noted that she was inattentive and messy and often did ... Attention Deficit-Hyperactivity Disorder in Adults The recognition that attention deficit-hyperactivity disorder (ADHD) persists after adolescence has led to an increase in its diagnosis and treatment in adults. Randomized trials show clinically significant improvements in ADHD symptoms and in daily functioning with the use of approved medications (stimulants and atomoxetine) for ADHD in adults. Clinical trials of medications for ADHD have been largely short-term and have predominantly involved young and middle-aged adults. Data are lacking on long-term benefits and risks and on risks among elderly patients. The absolute risk of serious cardiovascular adverse events associated with ADHD medications appears to be very low. However, the observed increases in pulse rate and blood pressure with stimulant use underscore the need for caution in prescribing these agents for patients with cardiovascular disease. The risk of addiction to stimulant medications prescribed for the treatment of ADHD in adults is low, but the clinician should be aware of their potential for abuse and dependence.	[Volkow, Nora D.] NIDA, Rockville, MD 20892 USA; [Swanson, James M.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California Irvine	Volkow, ND (corresponding author), NIDA, 6001 Executive Blvd,Rm 5274,MSC 9581, Rockville, MD 20892 USA.	nvolkow@nida.nih.gov			Noven Pharmaceuticals; Johnson Johnson; Janssen; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	Noven Pharmaceuticals; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Dr. Swanson reports receiving consulting fees to his institution from Noven Pharmaceuticals, lecture fees from Johnson & Johnson and Janssen, travel support from Shire, and payment for providing testimony as an expert witness for Janssen-Ortho on the pharmacokinetic and pharmacodynamic properties of methylphenidate, and filing a lawsuit to be named as an inventor on filed patents 6,930,129; 8,163,798; and 6,919,373 regarding a method for treating attention deficit-hyperactivity disorder. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2006, MODAFINIL CEP 1538 T; [Anonymous], 2011, FDA DRUG SAFETY COMM; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Barkley RA, 2002, J ABNORM PSYCHOL, V111, P279, DOI 10.1037//0021-843X.111.2.279; Barkley RA, 2008, ADHD IN ADULTS WHAT; Biederman J, 2011, J CLIN PSYCHIAT, V72, P11, DOI 10.4088/JCP.09m05420pur; Buss C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037758; Campbell BC, 2007, COLLEGIUM ANTROPOL, V31, P33; Christman AK, 2004, PHARMACOTHERAPY, V24, P1020, DOI 10.1592/phco.24.11.1020.36146; Conzelmann A, 2009, BIOL PSYCHIAT, V65, P578, DOI 10.1016/j.biopsych.2008.10.038; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Faraone SV, 2010, J CLIN PSYCHIAT, V71, P754, DOI 10.4088/JCP.08m04902pur; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Fredriksen M, 2013, EUR NEUROPSYCHOPHARM, V23, P508, DOI 10.1016/j.euroneuro.2012.07.016; Froehlich TE, 2009, PEDIATRICS, V124, pE1054, DOI 10.1542/peds.2009-0738; Goodman DW, 2013, THER CLIN RISK MANAG, V9, P121, DOI 10.2147/TCRM.S30762; Habel LA, 2011, JAMA-J AM MED ASSOC, V306, P2673, DOI 10.1001/jama.2011.1830; Hechtman L, 1999, PEDIATR CLIN N AM, V46, P1039, DOI 10.1016/S0031-3955(05)70171-1; Hinshaw SP, 2012, J CONSULT CLIN PSYCH, V80, P1041, DOI 10.1037/a0029451; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Kolar Dusan, 2008, Neuropsychiatr Dis Treat, V4, P107; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; Kuntsi Jonna, 2006, Behav Brain Funct, V2, P27, DOI 10.1186/1744-9081-2-27; Lensing MB, 2013, J CLIN PSYCHIAT, V74, pE87, DOI 10.4088/JCP.12m07714; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; McGough JJ, 2005, AM J PSYCHIAT, V162, P1621, DOI 10.1176/appi.ajp.162.9.1621; Mick E, 2013, EUR NEUROPSYCHOPHARM, V23, P534, DOI 10.1016/j.euroneuro.2012.06.011; Mongia M, 2012, CURR PSYCHIAT REP, V14, P561, DOI 10.1007/s11920-012-0303-x; Moriyama TS, 2013, CNS SPECTR; National Institute for Health and Clinical Excellence, 2009, ATTENTION DEFICIT HY; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Seixas M, 2012, J PSYCHOPHARMACOL, V26, P753, DOI 10.1177/0269881111412095; Shaw M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-99; Sibley MH, 2012, J CONSULT CLIN PSYCH, V80, P139, DOI 10.1037/a0026577; Smith ME, 2011, PSYCHOL BULL, V137, P717, DOI 10.1037/a0023825; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Spencer T, 1998, J CLIN PSYCHIAT, V59, P59; Swanson JM, 2009, J CHILD PSYCHOL PSYC, V50, P180, DOI 10.1111/j.1469-7610.2008.02062.x; Teter CJ, 2006, PHARMACOTHERAPY, V26, P1501, DOI 10.1592/phco.26.10.1501; Torrente F, 2011, J ATTEN DISORD, V15, P545, DOI 10.1177/1087054709359887; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1420; Volkow ND, 2003, AM J PSYCHIAT, V160, P1909, DOI 10.1176/appi.ajp.160.11.1909; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Weiss G, 1993, HYPERACTIVE CHILDREN; Wender PH, 1998, PSYCHIAT CLIN N AM, V21, P761, DOI 10.1016/S0193-953X(05)70039-3; Wilens TE, 2011, EXPERT REV NEUROTHER, V11, P1443, DOI [10.1586/ern.11.137, 10.1586/ERN.11.137]; Young S, 2010, J CHILD PSYCHOL PSYC, V51, P116, DOI 10.1111/j.1469-7610.2009.02191.x; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	51	134	137	2	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1935	1944		10.1056/NEJMcp1212625	http://dx.doi.org/10.1056/NEJMcp1212625			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251AN	24224626	Green Accepted			2022-12-28	WOS:000326899000002
J	Cutler, DM; Morton, FS				Cutler, David M.; Morton, Fiona Scott			Hospitals, Market Share, and Consolidation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY; VOLUME; COSTS	A large reduction in use of inpatient care combined with the incentives in the Affordable Care Act is leading to significant consolidation in the hospital industry. What was once a set of independent hospitals having arms-length relationships with physicians and clinicians who provide ambulatory care is becoming a small number of locally integrated health systems, generally built around large, prestigious academic medical centers. The typical region in the United States has 3 to 5 consolidated health systems, spanning a wide range of care settings, and a smaller fringe of health care centers outside those systems. Consolidated health systems have advantages and drawbacks. The advantages include the ability to coordinate care across different practitioners and sites of care. Offsetting this is the potential for higher prices resulting from greater market power. Market power increases because it is difficult for insurers to bargain successfully with one of only a few health systems. Antitrust authorities are examining these consolidated systems as they form, but broad conclusions are difficult to draw because typically the creation of a system will generate both benefit and harm and each set of facts will be different. Moreover, the remedies traditionally used (eg, blocking the transaction or requiring that the parties divest assets) by antitrust authorities in cases of net harm are limited. For this reason, local governments may want to introduce new policies that help ensure consumers gain protection in the event of consolidation, such as insurance products that charge consumers more for high-priced clinicians and health care centers, bundling payments to clinicians and health care organizations to eliminate the incentives of big institutions to simply provide more care, and establishing area-specific price or spending targets.	[Cutler, David M.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Morton, Fiona Scott] Yale Univ, Sch Management, New Haven, CT USA	Harvard University; Yale University	Cutler, DM (corresponding author), Harvard Univ, Dept Econ, Littauer Ctr 230, Cambridge, MA 02138 USA.	dcutler@harvard.edu		Cutler, David/0000-0002-4949-8917	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Cutler reported receiving institutional grant support from the National Institutes of Health; and honoraria, reimbursement for travel expenses, speaking fees, and reimbursement for parking from several universities, associations, organizations, and companies. Dr Scott Morton reported serving as a general antitrust consultant to and providing general antitrust testimony for Charles River Associates; and being employed by the US Department of Justice.	American Hospital Association, DAT CHARTB; [Anonymous], 2008, INNOVATORS PRESCRIPT; Bazzoli GJ, 2003, HEALTH AFFAIR, V22, P40, DOI 10.1377/hlthaff.22.6.40; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Brill Steven, 2013, Time, V181, P16; Congressional Budget Office, 2010, COMMUNICATION; Dranove D, 2003, J HEALTH ECON, V22, P983, DOI 10.1016/j.jhealeco.2003.05.001; Emanuel EJ, ARKANSAS INNOVATION; Federal Trade Commission; Department of Justice, 2011, STAT ANT ENF POL REG; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Gaynor M., HLTH CARE IND CONSOL; Gosline A, BLUE CROSS BLUE SHIE; Harrison TD, 2011, ECON INQ, V49, P1054, DOI 10.1111/j.1465-7295.2009.00246.x; Ho K, 2009, AM ECON REV, V99, P393, DOI 10.1257/aer.99.1.393; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Irving Levin Associates, 2012 HLTH CAR SERV A; Kaiser Family Foundation, STAT STAT ACT MED EX; Kendall B., FTC GETS MORE MUSCLE; Ladapo JA, 2009, HEALTH AFFAIR, V28, pW1122, DOI 10.1377/hlthaff.28.6.w1122; Medical Group Management Association, 2012, PHYS COMP PROD SURV; Office of Attorney General Martha Coakley, EX HLTH CAR COST TRE; Sloan FA, NOT FOR PROFIT OWNER; Stecker EC, 2013, NEW ENGL J MED, V368, P982, DOI 10.1056/NEJMp1214141; Steingart D, US NOT FOR PROF HEAL; Stewart JB, ANTITRUST SUIT IS SI; US Department of Justice; Federal Trade Commission, HOR MERG GUID; Wikipedia, BOND CRED RAT; Wikipedia, HERF IND	29	204	204	3	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1964	1970		10.1001/jama.2013.281675	http://dx.doi.org/10.1001/jama.2013.281675			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219952	Green Published			2022-12-28	WOS:000326832900021
J	Colebunders, R; Musiime, V				Colebunders, Robert; Musiime, Victor			Does the CHER trial open up new therapeutic perspectives?	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; HIV; MORTALITY; CHILDREN; INFANTS		[Colebunders, Robert] Inst Trop Med, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium; [Musiime, Victor] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Musiime, Victor] Joint Clin Res Ctr, Kampala, Uganda	Institute of Tropical Medicine (ITM); University of Antwerp; Makerere University; Joint Clinic Research Center - United Arab Emirates	Colebunders, R (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	bcoleb@itg.be		Musiime, Victor/0000-0001-7472-9054				[Anonymous], 2019, IDF DIABETES ATLAS, V9th; Cohen J, 2013, SCIENCE, V339, P1134, DOI 10.1126/science.339.6124.1134; Cotton MF, 2013, LANCET; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Persaud D, 2013, 20 C RETR OPP INF AT; Puthanakit T, 2012, LANCET INFECT DIS, V12, P933, DOI 10.1016/S1473-3099(12)70242-6; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Safrit J, 2013, POT HIV CUR TAK CTR; UNAIDS, GLOB REP UNAIDS REP; UNITAID, 2013, HIV AIDS DIAGN TECHN; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2008, PAED HIV ART CAR GUI	14	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1539	1540		10.1016/S0140-6736(13)61717-1	http://dx.doi.org/10.1016/S0140-6736(13)61717-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247NE	24209812				2022-12-28	WOS:000326623900007
J	Cotton, MF; Violari, A; Otwombe, K; Panchia, R; Dobbels, E; Rabie, H; Josipovic, D; Liberty, A; Lazarus, E; Innes, S; van Rensburg, AJ; Pelser, W; Truter, H; Madhi, SA; Handelsman, E; Jean-Philippe, P; McIntyre, JA; Gibb, DM; Babiker, AG				Cotton, Mark F.; Violari, Avy; Otwombe, Kennedy; Panchia, Ravindre; Dobbels, Els; Rabie, Helena; Josipovic, Deirdre; Liberty, Afaaf; Lazarus, Erica; Innes, Steve; van Rensburg, Anita Janse; Pelser, Wilma; Truter, Handre; Madhi, Shabir A.; Handelsman, Edward; Jean-Philippe, Patrick; McIntyre, James A.; Gibb, Diana M.; Babiker, Abdel G.		CHER Study Team	Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial	LANCET			English	Article							NEURODEVELOPMENTAL OUTCOMES; MORTALITY; AGE; NEVIRAPINE	Background Interim results from the children with HIV early antiretroviral (CHER) trial showed that early antiretroviral therapy (ART) was life-saving for infants infected with HIV. In view of the few treatment options and the potential toxicity associated with lifelong ART, in the CHER trial we compared early time-limited ART with deferred ART. Methods CHER was an open-label randomised controlled trial of HIV-infected asymptomatic infants younger than 12 weeks in two South African trial sites with a percentage of CD4-positive T lymphocytes (CD4%) of 25% or higher. 377 infants were randomly allocated to one of three groups: deferred ART (ART-Def), immediate ART for 40 weeks (ART-40W), or immediate ART for 96 weeks (ART-96W), with subsequent treatment interruption. The randomisation schedule was stratifi ed by clinical site with permuted blocks of random sizes to balance the numbers of infants allocated to each group. Criteria for ART initiation in the ART-Def group and re-initiation after interruption in the other groups were CD4% less than 25% in infancy; otherwise, the criteria were CD4% less than 20% or Centers for Disease Control and Prevention severe stage B or stage C disease. Combination therapy of lopinavir-ritonavir, zidovudine, and lamivudine was the fi rst-line treatment regimen at ART initiation and re-initiation. The primary endpoint was time to failure of fi rst-line ART (immunological, clinical, or virological) or death. Comparisons were done by intention-to-treat analysis, with use of time-to-event methods. This trial is registered with ClinicalTrials. gov, number NCT00102960. Findings 377 infants were enrolled, with a median age of 7 4 weeks, CD4% of 35%, and HIV RNA log 5 7 copies per mL. Median follow-up was 4 8 years; 34 infants (9%) were lost to follow-up. Median time to ART initiation in the ART-Def group was 20 weeks (IQR 16-25). Time to restarting of ART after interruption was 33 weeks (26-45) in ART40W and 70 weeks (35-109) in ART-96W; at the end of the trial, 19% of patients in ART-40W and 32% of patients in ART-96W remained off ART. Proportions of follow-up time spent on ART were 81% in the ART-Def group, 70% in the ART-40W group, and 69% in the ART-96W group. 48 (38%) of 125 children in the ART-Def group, 32 (25%) of 126 in the ART-40W group, and 26 (21%) of 126 in the ART-96W group reached the primary endpoint. The hazard ratio, relative to ART-Def, was 0 59 (95% CI 0 38-0 93, p= 0 02) for ART-40W and 0 47 (0 27-0 76, p= 0 002) for ART-96W. Three children in ART-Def, three in ART-40W, and one in ART-96W switched to second-line ART. Interpretation Early time-limited ART had better clinical and immunological outcomes than deferred ART, with no evidence of excess disease progression during subsequent treatment interruption and less overall ART exposure than deferred ART. Longer time on primary ART permits longer subsequent interruption, with marginally better outcomes.	[Cotton, Mark F.; Dobbels, Els; Rabie, Helena; Innes, Steve; van Rensburg, Anita Janse] Univ Stellenbosch, Fac Med & Hlth Sci, Childrens Infect Dis Clin Res Unit, ZA-7505 Tygerberg, South Africa; [Violari, Avy; Otwombe, Kennedy; Panchia, Ravindre; Josipovic, Deirdre; Liberty, Afaaf; Lazarus, Erica; Pelser, Wilma; Truter, Handre] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Med Res Council Resp & Meningeal Pathogens Res Un, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, South Africa; [Handelsman, Edward] NIAID, Div Aids, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Jean-Philippe, Patrick] HJF DAIDS, Bethesda, MD USA; [McIntyre, James A.] Univ Cape Town, Anova Hlth Inst, ZA-7925 Cape Town, South Africa; [McIntyre, James A.] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Gibb, Diana M.; Babiker, Abdel G.] Med Res Council Clin Trials Unit, London, England	Stellenbosch University; University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cape Town; University of Cape Town; Medical Research Council Clinical Trials Unit	Cotton, MF (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Childrens Infect Dis Clin Res Unit, ZA-7505 Tygerberg, South Africa.	mcot@sun.ac.za	McIntyre, James/V-7115-2019; Rabie, Helena/ABH-1437-2020; Cotton, Mark/AAQ-9936-2020	Rabie, Helena/0000-0001-6336-2963; Cotton, Mark/0000-0003-2559-6034; Glencross, Deborah/0000-0001-7106-769X; Innes, Steve/0000-0003-3969-8680	US National Institutes of Health; MRC [MC_U122886353] Funding Source: UKRI; Medical Research Council [MC_U122886353] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217, UM1AI069463] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding US National Institutes of Health.	[Anonymous], 1994, MMWR Recomm Rep, V43, P1; Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Castro H, 2010, AIDS, V24, P231, DOI 10.1097/QAD.0b013e328333d343; Chadwick EG, 2008, AIDS, V22, P249, DOI 10.1097/QAD.0b013e3282f2be1d; Church JD, 2008, J INFECT DIS, V198, P1075, DOI 10.1086/591503; Division of AIDS National Institute of Allergy and Infectious Diseases, 1994, TABL GRAD SEV AD PED; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; KINLOCHDELOES S, 1995, NEW ENGL J MED, V333, P408, DOI 10.1056/NEJM199508173330702; Laughton B, 2012, AIDS, V26, P1685, DOI 10.1097/QAD.0b013e328355d0ce; Madhi SA, 2010, J INFECT DIS, V202, P355, DOI 10.1086/653704; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Meyer-Rath G, 2010, 18 INT AIDS C VIENN; National Department of Health, 2004, NAT ANT TREATM GUID; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Panel on Antiretroviral Guidelines for Adult and Adolescents, 2007, GUID US ANT AG HIV I; Persaud D, 2013, 20 C RETR OPP INF AT; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Prendergast A, 2008, AIDS, V22, P1333, DOI 10.1097/QAD.0b013e32830437df; Puthanakit T, 2013, PEDIATR INFECT DIS J, V32, P501, DOI 10.1097/INF.0b013e31827fb19d; Ramos J, 2012, 19 C RETR OPP INF SE; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; UNAIDS, 2012, UNAIDS REP GLOB AIDS; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Wamalwa D, 2012, 19 C RETR OPP INF SE; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; *WORK GROUP ANT TH, 2008, GUID US ANT AG PED H; World Health Organisation, 2006, ANT THER HIV INF INF	32	169	170	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1555	1563		10.1016/S0140-6736(13)61409-9	http://dx.doi.org/10.1016/S0140-6736(13)61409-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247NE	24209829	Green Accepted			2022-12-28	WOS:000326623900027
J	Rice, SP; Boregowda, K; Williams, MT; Morris, GC; Okosieme, OE				Rice, Sam P.; Boregowda, Kusuma; Williams, Meurig T.; Morris, Granville C.; Okosieme, Onyebuchi E.			A Welsh-sparing dysphasia	LANCET			English	Editorial Material									[Rice, Sam P.; Boregowda, Kusuma; Williams, Meurig T.] Prince Philip Hosp, Hywel Dda Hlth Board, Endocrinol & Diabet Unit, Llanelli, England; [Morris, Granville C.] Prince Philip Hosp, Hywel Dda Hlth Board, Geriatr Med Unit, Llanelli, England; [Okosieme, Onyebuchi E.] Prince Charles Hosp, Endocrinol & Diabet Unit, Cwm Taf Hlth Board, Merthyr Tydfil CF47 9DT, M Glam, Wales		Okosieme, OE (corresponding author), Prince Charles Hosp, Endocrinol & Diabet Unit, Cwm Taf Hlth Board, Merthyr Tydfil CF47 9DT, M Glam, Wales.	okosiemeoe@cf.ac.uk						Aitchison J, 2004, SPREADING THE WORD T; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; Hull R, 2007, NEUROPSYCHOLOGIA, V45, P1987, DOI 10.1016/j.neuropsychologia.2007.03.002; Marrero MZ, 2002, CLIN PSYCHOL REV, V22, P463, DOI 10.1016/S0272-7358(01)00109-X; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087	5	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1608	1608		10.1016/S0140-6736(13)61837-1	http://dx.doi.org/10.1016/S0140-6736(13)61837-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247NE	24209830				2022-12-28	WOS:000326623900032
J	Slim, MAM				Slim, M. Atif Mohd			Harmful use of alcohol in Australasia-a sobering picture	LANCET			English	Editorial Material									Univ Auckland, Waikato Clin Sch, Peter Rothwell Acad Ctr, Waikato Hosp, Hamilton 3240, New Zealand	University of Auckland; Waikato Hospital	Slim, MAM (corresponding author), Univ Auckland, Waikato Clin Sch, Peter Rothwell Acad Ctr, Waikato Hosp, Hamilton 3240, New Zealand.	atif.matapena@gmail.com		Mohd Slim, M Atif/0000-0002-1442-8804				Davidson I., 2012, NEW ZEALND HERALD; Foundation for Alcohol Research and Education, 2013, ALCOHOL RELATED HARM; Foundation for Alcohol Research and Education, 2013, 2013 ANNUAL ALCOHOL; Health Promotion Agency, 2013, ALCOHOL ATTRIBUTABLE; Health Promotion Agency, SAY YEAH NAH CAMPAIG; IPSOS (Social Research Institute), 2013, ALCOHOL LABEL AUDIT; Kelsey J, 2012, ADDICTION, V107, P1719, DOI 10.1111/j.1360-0443.2012.03874.x; Legislative and Governance Forum on Food Regulation (convening as the Australia and New Zealand Food Regulation Ministerial Council), 2011, RESPONSE TO THE RECO	8	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1542	1543		10.1016/S0140-6736(13)61893-0	http://dx.doi.org/10.1016/S0140-6736(13)61893-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247NE	24209813				2022-12-28	WOS:000326623900009
J	Shyh-Chang, N; Zhu, H; de Soysa, TY; Shinoda, G; Seligson, MT; Tsanov, KM; Nguyen, L; Asara, JM; Cantley, LC; Daley, GQ				Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Liem Nguyen; Asara, John M.; Cantley, Lewis C.; Daley, George Q.			Lin28 Enhances Tissue Repair by Reprogramming Cellular Metabolism	CELL			English	Article							GENOME-WIDE ASSOCIATION; MEMBRANE VOLTAGE; GROWTH; REGENERATION; LIN-28; CELLS; MICE; TRANSLATION; EXPRESSION; AMPUTATION	Regeneration capacity declines with age, but why juvenile organisms show enhanced tissue repair remains unexplained. Lin28a, a highly conserved RNA-binding protein expressed during embryogenesis, plays roles in development, pluripotency, and metabolism. To determine whether Lin28a might influence tissue repair in adults, we engineered the reactivation of Lin28a expression in several models of tissue injury. Lin28a reactivation improved hair regrowth by promoting anagen in hair follicles and accelerated regrowth of cartilage, bone, and mesenchyme after ear and digit injuries. Lin28a inhibits let-7 microRNA biogenesis; however, let-7 repression was necessary but insufficient to enhance repair. Lin28a bound to and enhanced the translation of mRNAs for several metabolic enzymes, thereby increasing glycolysis and oxidative phosphorylation (OxPhos). Lin28a-mediated enhancement of tissue repair was negated by OxPhos inhibition, whereas a pharmacologically induced increase in OxPhos enhanced repair. Thus, Lin28a enhances tissue repair in some adult tissues by reprogramming cellular bioenergetics.	[Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Boston Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Shyh-Chang, Ng; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02115 USA; [Zhu, Hao] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Zhu, Hao; Liem Nguyen] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dept Pediat, Dallas, TX 75390 USA; [Zhu, Hao; Liem Nguyen] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dept Internal Med, Dallas, TX 75390 USA; [Cantley, Lewis C.] Cornell Weill Med Coll, Dept Med, New York, NY 10065 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University	Daley, GQ (corresponding author), Boston Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	/AAD-2039-2020; Cantley, Lewis C/D-1800-2014; Zhu, Hao/L-5114-2013; Tsanov, Kaloyan M/J-6852-2012	/0000-0001-9007-4844; Cantley, Lewis C/0000-0002-1298-7653; Zhu, Hao/0000-0002-8417-9698; DE SOYSA, TARJA/0000-0003-1394-3086; Shyh-Chang, Ng/0000-0003-3138-9525	A*STAR National Science Scholarship; Graduate Training in Cancer Research Grant; American Cancer Society Postdoctoral Fellowship; NIH; CPRIT; Herchel Smith Graduate Fellowship; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [K08CA157727] Funding Source: NIH RePORTER	A*STAR National Science Scholarship(Agency for Science Technology & Research (A*STAR)); Graduate Training in Cancer Research Grant; American Cancer Society Postdoctoral Fellowship(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Herchel Smith Graduate Fellowship; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank John Powers, Costas Lyssiotis, Charles Kaufman, Jessica Lehoczky, and Clifford Tabin for invaluable feedback and discussions; Jin Zhang and the lab of Marcia Haigis for help with the Seahorse Analyzer; Min Yuan and Susanne Breitkopf for help with metabolomics; Samar Shah and Akiko Yabuuchi for help with the mouse work; Asher Bomer for help with the scratch assays; James Thornton for help with northern blots; and Roderick Bronson and the Harvard Medical School Rodent Histopathology Core for mouse tissue pathology. This work was supported by an A*STAR National Science Scholarship to N.S.-C., a Graduate Training in Cancer Research Grant, an American Cancer Society Postdoctoral Fellowship, an NIH K08 grant, and a CPRIT award to H.Z.; a Herchel Smith Graduate Fellowship to K. M. T.; and a grant from the Ellison Medical Foundation to G. Q. D. G. Q. D. is an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Anchelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016955; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Angione AR, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-33; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Chadwick RB, 2007, WOUND REPAIR REGEN, V15, P275, DOI 10.1111/j.1524-475X.2007.00216.x; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Darwin C., 1887, VARIATION ANIMALS PL; DEUCHAR EM, 1976, J EMBRYOL EXP MORPH, V35, P345; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; GOSS RJ, 1975, J MORPHOL, V146, P533, DOI 10.1002/jmor.1051460408; Gourevitch DL, 2009, WOUND REPAIR REGEN, V17, P447, DOI 10.1111/j.1524-475X.2009.00492.x; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Leinonen JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048785; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu J, 2011, P NATL ACAD SCI USA, V108, P14560, DOI 10.1073/pnas.1111056108; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nakamura Y, 2012, AM J PATHOL, V180, P583, DOI 10.1016/j.ajpath.2011.10.006; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Ong KK, 2011, J CLIN ENDOCR METAB, V96, pE125, DOI 10.1210/jc.2010-0941; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; PEARSON RD, 1984, ACTA BIOTHEOR, V33, P51, DOI 10.1007/BF00045846; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x; Shah MV, 2011, MECH DEVELOP, V128, P342, DOI 10.1016/j.mod.2011.07.001; Shinoda G, 2013, STEM CELLS, V31, P1563, DOI 10.1002/stem.1423; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Widen E, 2010, AM J HUM GENET, V86, P773, DOI 10.1016/j.ajhg.2010.03.010; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; YOUNG HE, 1983, ANAT RECORD, V206, P295, DOI 10.1002/ar.1092060308; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	57	244	254	4	151	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					778	792		10.1016/j.cell.2013.09.059	http://dx.doi.org/10.1016/j.cell.2013.09.059			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209617	Green Accepted, Bronze			2022-12-28	WOS:000326934300009
J	Sok, D; Burton, DR				Sok, Devin; Burton, Dennis R.			SnapShot: Broadly Neutralizing Antibodies	CELL			English	Editorial Material							VACCINES; VIRUSES		[Sok, Devin; Burton, Dennis R.] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Sok, D (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI100663] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bellini WJ, 2011, VIRUS RES, V162, P72, DOI 10.1016/j.virusres.2011.09.023; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; EKLERT DC, 2012, CURR OPIN VIROL, V2, P134; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Tahara M, 2013, J VIROL, V87, P666, DOI 10.1128/JVI.02033-12; Thera MA, 2012, ANNU REV MED, V63, P345, DOI 10.1146/annurev-med-022411-192402	10	6	26	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					728	+		10.1016/j.cell.2013.10.009	http://dx.doi.org/10.1016/j.cell.2013.10.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243025	Bronze, Green Accepted			2022-12-28	WOS:000326571800025
J	Maselli, A; Melandri, A; Nava, L; Mundell, CG; Kawai, N; Campana, S; Covino, S; Cummings, JR; Cusumano, G; Evans, PA; Ghirlanda, G; Ghisellini, G; Guidorzi, C; Kobayashi, S; Kuin, P; La Parola, V; Mangano, V; Oates, S; Sakamoto, T; Serino, M; Virgili, F; Zhang, BB; Barthelmy, S; Beardmore, A; Bernardini, MG; Bersier, D; Burrows, D; Calderone, G; Capalbi, M; Chiang, J; D'Avanzo, P; D'Elia, V; De Pasquale, M; Fugazza, D; Gehrels, N; Gomboc, A; Harrison, R; Hanayama, H; Japelj, J; Kennea, J; Kopac, D; Kouveliotou, C; Kuroda, D; Levan, A; Malesani, D; Marshall, F; Nousek, J; O'Brien, P; Osborne, JP; Pagani, C; Page, KL; Page, M; Perri, M; Pritchard, T; Romano, P; Saito, Y; Sbarufatti, B; Salvaterra, R; Steele, I; Tanvir, N; Vianello, G; Weigand, B; Wiersema, K; Yatsu, Y; Yoshii, T; Tagliaferri, G				Maselli, A.; Melandri, A.; Nava, L.; Mundell, C. G.; Kawai, N.; Campana, S.; Covino, S.; Cummings, J. R.; Cusumano, G.; Evans, P. A.; Ghirlanda, G.; Ghisellini, G.; Guidorzi, C.; Kobayashi, S.; Kuin, P.; La Parola, V.; Mangano, V.; Oates, S.; Sakamoto, T.; Serino, M.; Virgili, F.; Zhang, B. -B.; Barthelmy, S.; Beardmore, A.; Bernardini, M. G.; Bersier, D.; Burrows, D.; Calderone, G.; Capalbi, M.; Chiang, J.; D'Avanzo, P.; D'Elia, V.; De Pasquale, M.; Fugazza, D.; Gehrels, N.; Gomboc, A.; Harrison, R.; Hanayama, H.; Japelj, J.; Kennea, J.; Kopac, D.; Kouveliotou, C.; Kuroda, D.; Levan, A.; Malesani, D.; Marshall, F.; Nousek, J.; O'Brien, P.; Osborne, J. P.; Pagani, C.; Page, K. L.; Page, M.; Perri, M.; Pritchard, T.; Romano, P.; Saito, Y.; Sbarufatti, B.; Salvaterra, R.; Steele, I.; Tanvir, N.; Vianello, G.; Weigand, B.; Wiersema, K.; Yatsu, Y.; Yoshii, T.; Tagliaferri, G.			GRB 130427A: A Nearby Ordinary Monster	SCIENCE			English	Article							GAMMA-RAY BURSTS; AFTERGLOW EMISSION; LIGHT-CURVE; PEAK ENERGY; TELESCOPE; SIMULATIONS; DISCOVERY; MISSION	Long-duration gamma-ray bursts (GRBs) are an extremely rare outcome of the collapse of massive stars and are typically found in the distant universe. Because of its intrinsic luminosity (L similar to 3 x 10(53) ergs per second) and its relative proximity (z = 0.34), GRB 130427A reached the highest fluence observed in the gamma-ray band. Here, we present a comprehensive multiwavelength view of GRB 130427A with Swift, the 2-meter Liverpool and Faulkes telescopes, and by other ground-based facilities, highlighting the evolution of the burst emission from the prompt to the afterglow phase. The properties of GRB 130427A are similar to those of the most luminous, high-redshift GRBs, suggesting that a common central engine is responsible for producing GRBs in both the contemporary and the early universe and over the full range of GRB isotropic energies.	[Maselli, A.; Cusumano, G.; La Parola, V.; Mangano, V.; Capalbi, M.; Romano, P.] Ist Astrofis Spaziale & Fis Cosm IASF Palermo, INAF, I-90146 Palermo, Italy; [Melandri, A.; Nava, L.; Campana, S.; Covino, S.; Ghirlanda, G.; Ghisellini, G.; Bernardini, M. G.; Calderone, G.; D'Avanzo, P.; Fugazza, D.; Sbarufatti, B.; Tagliaferri, G.] INAF Osservatorio Astron Brera, I-23807 Merate, Italy; [Nava, L.] Sorbonne Paris Cite, Observ Paris, Inst Rech Lois Fondamentales Univers, Commissariat Energie Atom & Energies,CNRS IN2P3,A, Paris, France; [Mundell, C. G.; Kobayashi, S.; Virgili, F.; Bersier, D.; Harrison, R.; Steele, I.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Kawai, N.; Saito, Y.; Yatsu, Y.; Yoshii, T.] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; [Kawai, N.; Serino, M.] RIKEN, Coordinated Space Observat & Expt Res Grp, Wako, Saitama 3510198, Japan; [Cummings, J. R.] NASA, Goddard Space Flight Ctr, Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Evans, P. A.; Beardmore, A.; O'Brien, P.; Osborne, J. P.; Pagani, C.; Page, K. L.; Tanvir, N.; Wiersema, K.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Guidorzi, C.] Univ Ferrara, Dept Phys, I-44122 Ferrara, Italy; [Kuin, P.; Oates, S.; De Pasquale, M.; Page, M.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Mangano, V.; Zhang, B. -B.; Burrows, D.; Kennea, J.; Nousek, J.; Pritchard, T.; Sbarufatti, B.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Sakamoto, T.] Aoyama Gakuin Univ, Dept Math & Phys, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Barthelmy, S.; Gehrels, N.; Marshall, F.; Weigand, B.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Calderone, G.] Univ Milano Bicocca, Dipartimento Fis G Occhialini, I-20126 Milan, Italy; [Chiang, J.; Vianello, G.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Chiang, J.; Vianello, G.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [D'Elia, V.; Perri, M.] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, Roma, Italy; [D'Elia, V.; Perri, M.] ASI Sci Data Ctr, I-00044 Frascati, Roma, Italy; [Gomboc, A.; Japelj, J.; Kopac, D.] Univ Ljubljana, Fac Math & Phys, Ljubljana 1000, Slovenia; [Gomboc, A.] Ctr Excellence Space Si, Ljubljana 1000, Slovenia; [Hanayama, H.] Natl Astron Observ Japan, Ishigakijima Astron Observ, Ishigaki, Okinawa 9070024, Japan; [Kouveliotou, C.] NASA, George C Marshall Space Flight Ctr, VP62, Space Sci Off, Huntsville, AL 35812 USA; [Kuroda, D.] Natl Astron Observ Japan, Okayama Astrophys Observ, Asaguchi, Okayama 7190232, Japan; [Levan, A.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Malesani, D.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr DARK, DK-2100 Copenhagen, Denmark; [Salvaterra, R.] INAF IASF Milano, I-20133 Milan, Italy	Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Liverpool John Moores University; Tokyo Institute of Technology; RIKEN; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Leicester; University of Ferrara; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Aoyama Gakuin University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Milano-Bicocca; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); University of Ljubljana; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Warwick; University of Copenhagen; Niels Bohr Institute; Istituto Nazionale Astrofisica (INAF)	Maselli, A (corresponding author), Ist Astrofis Spaziale & Fis Cosm IASF Palermo, INAF, Via Ugo La Malfa 153, I-90146 Palermo, Italy.	maselli@ifc.inaf.it	Tagliaferri, Gianpiero/ABD-7556-2021; Campana, Sergio/AAL-6012-2020; Yatsu, Yoichi/AAR-4645-2021; Maselli, Alessandro/P-5236-2018; Kennea, Jamie/AAF-2090-2019; Covino, Stefano/AAQ-5188-2021; Serino, Motoko/D-3890-2017; Bernardini, Maria Grazia/ABD-6115-2020; Zhang, Binbin/C-9035-2013; De Pasquale, Massimiliano/AAC-5695-2020; Levan, Andrew/F-6179-2014	Tagliaferri, Gianpiero/0000-0003-0121-0723; Campana, Sergio/0000-0001-6278-1576; Yatsu, Yoichi/0000-0003-1890-3913; Maselli, Alessandro/0000-0003-3760-1910; Kennea, Jamie/0000-0002-6745-4790; Covino, Stefano/0000-0001-9078-5507; Bernardini, Maria Grazia/0000-0001-6106-3046; Zhang, Binbin/0000-0003-2002-116X; Levan, Andrew/0000-0001-7821-9369; Guidorzi, Cristiano/0000-0001-6869-0835; Vianello, Giacomo/0000-0002-2553-0839; Wiersema, Klaas/0000-0002-9133-7957; D'Elia, Valerio/0000-0002-7320-5862; Salvaterra, Ruben/0000-0002-9393-8078; Hanayama, Hidekazu/0000-0001-8221-6048; Oates, Samantha/0000-0001-9309-7873; Romano, Patrizia/0000-0003-0258-7469; Mangano, Vanessa/0000-0003-4262-8616; Nava, Lara/0000-0001-5960-0455; Evans, Philip/0000-0002-8465-3353; D'Avanzo, Paolo/0000-0001-7164-1508; Cusumano, Giancarlo/0000-0002-8151-1990; Zhang, Binbin/0000-0003-4111-5958; Kuroda, Daisuke/0000-0002-7363-187X; Beardmore, Andrew/0000-0001-5186-5950; Sbarufatti, Boris/0000-0001-6620-8347; Melandri, Andrea/0000-0002-2810-2143; La Parola, Valentina/0000-0002-8087-6488; Ghisellini, Gabriele/0000-0002-0037-1974; Virgili, Fabio/0000-0002-9691-8742; Pritchard, Tyler/0000-0001-9227-8349; Ghirlanda, Giancarlo/0000-0001-5876-9259; Page, Kim/0000-0001-5624-2613; O'Brien, Paul/0000-0002-5128-1899; Fugazza, Dino Pierluigi/0000-0001-9942-277X; Perri, Matteo/0000-0003-3613-4409	ASI [I/004/11/0]; Progetto di Ricerca di Interesse Nazionale (PRIN)-Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2009ERC3HT]; NASA [NNX10AF62G]; Astrophysics Theory Program; NSF [AST-1009863]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [14GS0211, 19047001, 19047003, 24740186]; UK Space Agency; Royal Society; Wolfson Foundation; Science and Technology Facilities Council; Slovenian Research Agency; Centre of Excellence for Space Sciences and Technologies SPACE-SI; European Union; European Regional Development Fund; Republic of Slovenia; Danish National Research; STFC [ST/K001000/1, ST/J001465/1, ST/H00260X/1, ST/K000977/1, ST/L001306/1, ST/I001719/1, PP/E002064/1, ST/H001972/1, ST/G009465/1, ST/I505821/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K001000/1, ST/K000977/1, ST/J001465/1, ST/G009465/1, ST/I001719/1, ST/H001972/1, ST/H00260X/1, ST/I505821/1, PP/E002064/1, ST/L001306/1] Funding Source: researchfish; UK Space Agency [ST/J000841/1] Funding Source: researchfish	ASI(Agenzia Spaziale Italiana (ASI)); Progetto di Ricerca di Interesse Nazionale (PRIN)-Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); NASA(National Aeronautics & Space Administration (NASA)); Astrophysics Theory Program; NSF(National Science Foundation (NSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); UK Space Agency; Royal Society(Royal Society of London); Wolfson Foundation; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Centre of Excellence for Space Sciences and Technologies SPACE-SI; European Union(European Commission); European Regional Development Fund(European Commission); Republic of Slovenia; Danish National Research; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	This work has been supported by ASI grant I/004/11/0 and by Progetto di Ricerca di Interesse Nazionale (PRIN)-Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) grant 2009ERC3HT. Development of the BOXFIT code (25) was supported in part by NASA through grant NNX10AF62G issued through the Astrophysics Theory Program and by the NSF through grant AST-1009863. This research was partially supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), grants-in-aid 14GS0211, 19047001, 19047003, and 24740186. The Liverpool Telescope is operated by Liverpool John Moores University at the Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias. The Faulkes Telescopes, now owned by Las Cumbres Observatory, are operated with support from the Dill Faulkes Educational Trust. Swift support at the University of Leicester and the Mullard Space Science Laboratory is funded by the UK Space Agency. C. G. M. acknowledges financial support from the Royal Society, the Wolfson Foundation, and the Science and Technology Facilities Council. A. G. acknowledges funding from the Slovenian Research Agency and from the Centre of Excellence for Space Sciences and Technologies SPACE-SI, an operation partly financed by the European Union, European Regional Development Fund, and Republic of Slovenia. DARK is funded by the Danish National Research Foundation.	Ackermann M, 2014, SCIENCE, V343, P42, DOI 10.1126/science.1242353; Amati L, 2002, ASTRON ASTROPHYS, V390, P81, DOI 10.1051/0004-6361:20020722; APTEKAR RL, 1995, SPACE SCI REV, V71, P265, DOI 10.1007/BF00751332; Barthelmy SD, 2005, SPACE SCI REV, V120, P143, DOI 10.1007/s11214-005-5096-3; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Ghirlanda G, 2004, ASTROPHYS J, V616, P331, DOI 10.1086/424913; Ghisellini G, 2009, MON NOT R ASTRON SOC, V393, P253, DOI 10.1111/j.1365-2966.2008.14214.x; Golenetskii S., 2013, GCN, V1; Laskar T, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/119; Levan A. J., 2013, GRB COORDINATES NETW, V14455, P1; Liu RY, 2013, ASTROPHYS J LETT, V773, DOI 10.1088/2041-8205/773/2/L20; Maselli A., 2013, GCN CIRC, V14448, P1; Matsuoka M, 2009, PUBL ASTRON SOC JPN, V61, P999, DOI 10.1093/pasj/61.5.999; Meegan C, 2009, ASTROPHYS J, V702, P791, DOI 10.1088/0004-637X/702/1/791; Meszaros P, 2006, REP PROG PHYS, V69, P2259, DOI 10.1088/0034-4885/69/8/R01; Nava L, 2013, MON NOT R ASTRON SOC, V433, P2107, DOI 10.1093/mnras/stt872; Nousek JA, 2006, ASTROPHYS J, V642, P389, DOI 10.1086/500724; Panaitescu A, 2011, MON NOT R ASTRON SOC, V414, P3537, DOI 10.1111/j.1365-2966.2011.18653.x; Roming PWA, 2005, SPACE SCI REV, V120, P95, DOI 10.1007/s11214-005-5095-4; Salvaterra R, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/68; Sari R, 1999, ASTROPHYS J, V519, pL17, DOI 10.1086/312109; Tagliaferri G, 2005, NATURE, V436, P985, DOI 10.1038/nature03934; Tam PHT, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/1/L13; van Eerten H, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/44; van Eerten H, 2010, ASTROPHYS J, V722, P235, DOI 10.1088/0004-637X/722/1/235; van Eerten HJ, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/155; Vestrand WT, 2014, SCIENCE, V343, P38, DOI 10.1126/science.1242316; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; Xu D, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/98; Yonetoku D, 2004, ASTROPHYS J, V609, P935, DOI 10.1086/421285	30	90	92	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					48	51		10.1126/science.1242279	http://dx.doi.org/10.1126/science.1242279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24263134	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000329162000043
J	Preece, R; Burgess, JM; von Kienlin, A; Bhat, PN; Briggs, MS; Byrne, D; Chaplin, V; Cleveland, W; Collazzi, AC; Connaughton, V; Diekmann, A; Fitzpatrick, G; Foley, S; Gibby, M; Giles, M; Goldstein, A; Greiner, J; Gruber, D; Jenke, P; Kippen, RM; Kouveliotou, C; McBreen, S; Meegan, C; Paciesas, WS; Pelassa, V; Tierney, D; van der Horst, AJ; Wilson-Hodge, C; Xiong, S; Younes, G; Yu, HF; Ackermann, M; Ajello, M; Axelsson, M; Baldini, L; Barbiellini, G; Baring, MG; Bastieri, D; Bellazzini, R; Bissaldi, E; Bonamente, E; Bregeon, J; Brigida, M; Bruel, P; Buehler, R; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Cecchi, C; Charles, E; Chekhtman, A; Chiang, J; Chiaro, G; Ciprini, S; Claus, R; Cohen-Tanugi, J; Cominsky, LR; Conrad, J; D'Ammando, F; de Angelis, A; de Palma, F; Dermer, CD; Desiante, R; Digel, SW; Di Venere, L; Drell, PS; Drlica-Wagner, A; Favuzzi, C; Franckowiak, A; Fukazawa, Y; Fusco, P; Gargano, F; Gehrels, N; Germani, S; Giglietto, N; Giordano, F; Giroletti, M; Godfrey, G; Granot, J; Grenier, IA; Guiriec, S; Hadasch, D; Hanabata, Y; Harding, AK; Hayashida, M; Iyyani, S; Jogler, T; Joannesson, G; Kawano, T; Knodlseder, J; Kocevski, D; Kuss, M; Lande, J; Larsson, J; Larsson, S; Latronico, L; Longo, F; Loparco, F; Lovellette, MN; Lubrano, P; Mayer, M; Mazziotta, MN; Michelson, PF; Mizuno, T; Monzani, ME; Moretti, E; Morselli, A; Murgia, S; Nemmen, R; Nuss, E; Nymark, T; Ohno, M; Ohsugi, T; Okumura, A; Omodei, N; Orienti, M; Paneque, D; Perkins, JS; Pesce-Rollins, M; Piron, F; Pivato, G; Porter, TA; Racusin, JL; Raino, S; Rando, R; Razzano, M; Razzaque, S; Reimer, A; Reimer, O; Ritz, S; Roth, M; Ryde, F; Sartori, A; Scargle, JD; Schulz, A; Sgro, C; Siskind, EJ; Spandre, G; Spinelli, P; Suson, DJ; Tajima, H; Takahashi, H; Thayer, JG; Thayer, JB; Tibaldo, L; Tinivella, M; Torres, DF; Tosti, G; Troja, E; Usher, TL; Vandenbroucke, J; Vasileiou, V; Vianello, G; Vitale, V; Werner, M; Winer, BL; Wood, KS; Zhu, S				Preece, R.; Burgess, J. Michael; von Kienlin, A.; Bhat, P. N.; Briggs, M. S.; Byrne, D.; Chaplin, V.; Cleveland, W.; Collazzi, A. C.; Connaughton, V.; Diekmann, A.; Fitzpatrick, G.; Foley, S.; Gibby, M.; Giles, M.; Goldstein, A.; Greiner, J.; Gruber, D.; Jenke, P.; Kippen, R. M.; Kouveliotou, C.; McBreen, S.; Meegan, C.; Paciesas, W. S.; Pelassa, V.; Tierney, D.; van der Horst, A. J.; Wilson-Hodge, C.; Xiong, S.; Younes, G.; Yu, H. -F.; Ackermann, M.; Ajello, M.; Axelsson, M.; Baldini, L.; Barbiellini, G.; Baring, M. G.; Bastieri, D.; Bellazzini, R.; Bissaldi, E.; Bonamente, E.; Bregeon, J.; Brigida, M.; Bruel, P.; Buehler, R.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Cecchi, C.; Charles, E.; Chekhtman, A.; Chiang, J.; Chiaro, G.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Cominsky, L. R.; Conrad, J.; D'Ammando, F.; de Angelis, A.; de Palma, F.; Dermer, C. D.; Desiante, R.; Digel, S. W.; Di Venere, L.; Drell, P. S.; Drlica-Wagner, A.; Favuzzi, C.; Franckowiak, A.; Fukazawa, Y.; Fusco, P.; Gargano, F.; Gehrels, N.; Germani, S.; Giglietto, N.; Giordano, F.; Giroletti, M.; Godfrey, G.; Granot, J.; Grenier, I. A.; Guiriec, S.; Hadasch, D.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Iyyani, S.; Jogler, T.; Joannesson, G.; Kawano, T.; Knoedlseder, J.; Kocevski, D.; Kuss, M.; Lande, J.; Larsson, J.; Larsson, S.; Latronico, L.; Longo, F.; Loparco, F.; Lovellette, M. N.; Lubrano, P.; Mayer, M.; Mazziotta, M. N.; Michelson, P. F.; Mizuno, T.; Monzani, M. E.; Moretti, E.; Morselli, A.; Murgia, S.; Nemmen, R.; Nuss, E.; Nymark, T.; Ohno, M.; Ohsugi, T.; Okumura, A.; Omodei, N.; Orienti, M.; Paneque, D.; Perkins, J. S.; Pesce-Rollins, M.; Piron, F.; Pivato, G.; Porter, T. A.; Racusin, J. L.; Raino, S.; Rando, R.; Razzano, M.; Razzaque, S.; Reimer, A.; Reimer, O.; Ritz, S.; Roth, M.; Ryde, F.; Sartori, A.; Scargle, J. D.; Schulz, A.; Sgro, C.; Siskind, E. J.; Spandre, G.; Spinelli, P.; Suson, D. J.; Tajima, H.; Takahashi, H.; Thayer, J. G.; Thayer, J. B.; Tibaldo, L.; Tinivella, M.; Torres, D. F.; Tosti, G.; Troja, E.; Usher, T. L.; Vandenbroucke, J.; Vasileiou, V.; Vianello, G.; Vitale, V.; Werner, M.; Winer, B. L.; Wood, K. S.; Zhu, S.			The First Pulse of the Extremely Bright GRB 130427A: A Test Lab for Synchrotron Shocks	SCIENCE			English	Article							GAMMA-RAY BURSTS; BATSE OBSERVATIONS; PROMPT EMISSION; PEAK ENERGY; COMPONENT; SPECTRA	Gamma-ray burst (GRB) 130427A is one of the most energetic GRBs ever observed. The initial pulse up to 2.5 seconds is possibly the brightest well-isolated pulse observed to date. A fine time resolution spectral analysis shows power-law decays of the peak energy from the onset of the pulse, consistent with models of internal synchrotron shock pulses. However, a strongly correlated power-law behavior is observed between the luminosity and the spectral peak energy that is inconsistent with curvature effects arising in the relativistic outflow. It is difficult for any of the existing models to account for all of the observed spectral and temporal behaviors simultaneously.	[Preece, R.] Univ Alabama, Dept Space Sci, Huntsville, AL 35899 USA; [Burgess, J. Michael; Bhat, P. N.; Briggs, M. S.; Chaplin, V.; Connaughton, V.; Jenke, P.; Meegan, C.; Pelassa, V.; Xiong, S.] Univ Alabama, CSPAR, Huntsville, AL 35899 USA; [von Kienlin, A.; Foley, S.; Greiner, J.; Gruber, D.; McBreen, S.; Yu, H. -F.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Byrne, D.; Fitzpatrick, G.; Foley, S.; McBreen, S.; Tierney, D.] Univ Coll Dublin, Dublin 4, Ireland; [Cleveland, W.; Paciesas, W. S.; Younes, G.] USRA, Columbia, MD 21044 USA; [Collazzi, A. C.; Goldstein, A.; Kouveliotou, C.; Wilson-Hodge, C.; Younes, G.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Diekmann, A.; Gibby, M.; Giles, M.] Jacobs Technol, Huntsville, AL 35806 USA; [Kippen, R. M.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [van der Horst, A. J.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Ackermann, M.; Buehler, R.; Mayer, M.; Schulz, A.] Deutsch Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany; [Ajello, M.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Axelsson, M.; Larsson, S.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Axelsson, M.; Conrad, J.; Iyyani, S.; Larsson, J.; Larsson, S.; Moretti, E.; Nymark, T.] Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Axelsson, M.; Iyyani, S.; Larsson, J.; Moretti, E.; Nymark, T.; Ryde, F.] AlbaNova, Royal Inst Technol KTH, Dept Phys, SE-10691 Stockholm, Sweden; [Baldini, L.] Univ Pisa, I-56127 Pisa, Italy; [Baldini, L.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Barbiellini, G.; Desiante, R.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Baring, M. G.] Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; [Bastieri, D.; Buson, S.; Rando, R.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Chiaro, G.; Pivato, G.; Rando, R.] Univ Padua, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Bellazzini, R.; Bregeon, J.; Kuss, M.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.; Tinivella, M.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Bissaldi, E.; Reimer, A.; Reimer, O.; Werner, M.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Bissaldi, E.; Reimer, A.; Reimer, O.; Werner, M.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Bonamente, E.; Cecchi, C.; Germani, S.; Lubrano, P.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Germani, S.; Lubrano, P.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Caliandro, G. A.; Hadasch, D.; Torres, D. F.] CSIC, Inst CiEncies Espai IEEE, Barcelona 08193, Spain; [Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; Di Venere, L.; Drell, P. S.; Drlica-Wagner, A.; Franckowiak, A.; Godfrey, G.; Hayashida, M.; Jogler, T.; Kocevski, D.; Lande, J.; Michelson, P. F.; Monzani, M. E.; Murgia, S.; Okumura, A.; Omodei, N.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Tajima, H.; Thayer, J. G.; Thayer, J. B.; Tibaldo, L.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; Di Venere, L.; Drell, P. S.; Drlica-Wagner, A.; Franckowiak, A.; Godfrey, G.; Hayashida, M.; Jogler, T.; Kocevski, D.; Lande, J.; Michelson, P. F.; Monzani, M. E.; Murgia, S.; Okumura, A.; Omodei, N.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Tajima, H.; Thayer, J. G.; Thayer, J. B.; Tibaldo, L.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Caraveo, P. A.; Sartori, A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Chekhtman, A.] George Mason Univ, Coll Sci, Ctr Earth Observing & Space Res, Fairfax, VA 22030 USA; [Chekhtman, A.] Naval Res Lab, Washington, DC 20375 USA; [Ciprini, S.] ASI Sci Data Ctr, I-00044 Frascati, Roma, Italy; [Ciprini, S.] Osserv Astron Roma, Ist Nazl Astrofis, I-00040 Monte Porzio Catone, Roma, Italy; [Cohen-Tanugi, J.; Nuss, E.; Piron, F.; Vasileiou, V.] Univ Montpellier 2, CNRS, IN2P3, Lab Univers & Particules Montpellier, Montpellier, France; [Cominsky, L. R.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Conrad, J.; Iyyani, S.; Larsson, S.] Stockholm Univ, AlbaNova, Dept Phys, SE-10691 Stockholm, Sweden; [D'Ammando, F.; Giroletti, M.; Orienti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [de Angelis, A.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.] Ist Nazl Fis Nucl, Sez Trieste, Grp Collegato Udine, I-33100 Udine, Italy; [Dermer, C. D.; Lovellette, M. N.; Wood, K. S.] Naval Res Lab, Div Space Sci, Washington, DC 20375 USA; [Fukazawa, Y.; Hanabata, Y.; Kawano, T.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Gehrels, N.; Guiriec, S.; Harding, A. K.; Nemmen, R.; Perkins, J. S.; Racusin, J. L.; Troja, E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Granot, J.] Open Univ Israel, Dept Nat Sci, IL-43537 Raanana, Israel; [Grenier, I. A.] Univ Paris Diderot, CEA IRFU CNRS, Lab AIM, Serv Astrophys, F-91191 Gif Sur Yvette, France; [Hayashida, M.] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Joannesson, G.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Knoedlseder, J.] CNRS, IRAP, F-31028 Toulouse 4, France; [Knoedlseder, J.] Univ Toulouse, UPS OMP, IRAP, GAHEC, Toulouse, France; [Latronico, L.] Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy; [Mizuno, T.; Ohsugi, T.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Ohno, M.] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Okumura, A.; Tajima, H.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Paneque, D.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Perkins, J. S.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Perkins, J. S.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Perkins, J. S.] CRESST, Greenbelt, MD 20771 USA; [Perkins, J. S.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Razzano, M.; Ritz, S.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Razzano, M.; Ritz, S.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Razzaque, S.] Univ Johannesburg, Dept Phys, ZA-2006 Auckland Pk, South Africa; [Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; ICREA, Barcelona, Spain; [Troja, E.; Zhu, S.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Troja, E.; Zhu, S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Vianello, G.] CIFS, I-10133 Turin, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Winer, B. L.] Ohio State Univ, Ctr Cosmol & Astroparticle Phys, Dept Phys, Columbus, OH 43210 USA	University of Alabama System; University of Alabama Huntsville; University of Alabama System; University of Alabama Huntsville; Max Planck Society; University College Dublin; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Amsterdam; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of California System; University of California Berkeley; Stockholm University; Oskar Klein Centre; Royal Institute of Technology; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Rice University; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of Innsbruck; University of Innsbruck; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Istituto Nazionale Astrofisica (INAF); George Mason University; United States Department of Defense; United States Navy; Naval Research Laboratory; Agenzia Spaziale Italiana (ASI); Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; California State University System; Sonoma State University; Stockholm University; Istituto Nazionale Astrofisica (INAF); University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); United States Department of Defense; United States Navy; Naval Research Laboratory; Hiroshima University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Open University Israel; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Kyoto University; University of Iceland; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Istituto Nazionale di Fisica Nucleare (INFN); Hiroshima University; Istituto Nazionale di Fisica Nucleare (INFN); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Nagoya University; Max Planck Society; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Johannesburg; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Purdue University System; Purdue University; ICREA; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Rome Tor Vergata; University System of Ohio; Ohio State University	Preece, R (corresponding author), Univ Alabama, Dept Space Sci, Huntsville, AL 35899 USA.	preecer@uah.edu; James.Burgess@uah.edu; azk@mpe.mpg.de; charles.dermer@nrl.navy.mil; nicola.omodei@stanford.edu	giglietto, nicola/I-8951-2012; Bissaldi, Elisabetta/K-7911-2016; Reimer, Anita/K-5822-2015; Tajima, Hiroyasu/I-6228-2014; Troja, Eleonora/I-5282-2017; Torres, Diego F/ABD-7940-2020; Ryde, Felix/AAE-1086-2021; Bastieri, Denis/AAC-5917-2020; Gargano, Fabio/O-8934-2015; Mazziotta, Mario N/O-8867-2015; cohen-tanugi, Johann/ABB-1481-2021; Yu, Hoi-Fung/ABC-8507-2020; Torres, Diego F./AAF-7931-2019; Troja, Eleonora/AAB-3604-2020; Torres, Diego F./O-9422-2016; Caraveo, Patrizia/AAL-5708-2020; Giglietto, Nicola/Y-2425-2019; Fukazawa, Yasushi/G-2081-2017; Morselli, Aldo/G-6769-2011; Bissaldi, Elisabetta/AAB-2443-2021; Rando, Riccardo/O-1302-2019; Jóhannesson, Guðlaugur/ABC-7216-2020; Reimer, Olaf/A-3117-2013; Okumura, Akira/I-2468-2014; Di Venere, Leonardo/C-7619-2017; Loparco, Francesco/O-8847-2015; Jóhannesson, Guðlaugur/O-8741-2015; Hadasch, Daniela/N-7819-2016; Chaplin, Vandiver/AAN-6228-2021; Gargano, Fabio/AAD-5121-2021; Sgrò, Carmelo/K-3395-2016; Iyyani, Shabnam/D-8736-2017; Nemmen, Rodrigo/O-6841-2014; Takahashi, Hiromitsu H/T-2713-2017	giglietto, nicola/0000-0002-9021-2888; Bissaldi, Elisabetta/0000-0001-9935-8106; Reimer, Anita/0000-0001-8604-7077; Tajima, Hiroyasu/0000-0002-1721-7252; Troja, Eleonora/0000-0002-1869-7817; Ryde, Felix/0000-0002-9769-8016; Bastieri, Denis/0000-0002-6954-8862; Gargano, Fabio/0000-0002-5055-6395; Mazziotta, Mario N/0000-0001-9325-4672; cohen-tanugi, Johann/0000-0001-9022-4232; Yu, Hoi-Fung/0000-0001-5643-7445; Torres, Diego F./0000-0002-1522-9065; Troja, Eleonora/0000-0002-1869-7817; Torres, Diego F./0000-0002-1522-9065; Caraveo, Patrizia/0000-0003-2478-8018; Giglietto, Nicola/0000-0002-9021-2888; Fukazawa, Yasushi/0000-0002-0921-8837; Morselli, Aldo/0000-0002-7704-9553; Bissaldi, Elisabetta/0000-0001-9935-8106; Rando, Riccardo/0000-0001-6992-818X; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Reimer, Olaf/0000-0001-6953-1385; Okumura, Akira/0000-0002-3055-7964; Di Venere, Leonardo/0000-0003-0703-824X; Loparco, Francesco/0000-0002-1173-5673; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Hadasch, Daniela/0000-0001-8663-6461; Chaplin, Vandiver/0000-0002-4074-0391; Gargano, Fabio/0000-0002-5055-6395; Iyyani, Shabnam/0000-0002-2525-3464; Nemmen, Rodrigo/0000-0003-3956-0331; Takahashi, Hiromitsu H/0000-0001-6314-5897; Buson, Sara/0000-0002-3308-324X; Buehler, Rolf/0000-0003-4425-6641; Spandre, Gloria/0000-0003-0802-3453; Porter, Troy/0000-0002-2621-4440; Burgess, James/0000-0003-3345-9515; Baldini, Luca/0000-0002-9785-7726; Murgia, Simona/0000-0003-0516-9422; D'Ammando, Filippo/0000-0001-7618-7527; Raino', Silvia/0000-0002-9181-0345; de Palma, Francesco/0000-0001-5898-2834; Ajello, Marco/0000-0002-6584-1703; Razzaque, Soebur/0000-0002-0130-2460; van der Horst, Alexander/0000-0001-9149-6707; Larsson, Stefan/0000-0003-0716-107X; Grenier, Isabelle/0000-0003-3274-674X; Moretti, Elena/0000-0001-5477-9097; Vianello, Giacomo/0000-0002-2553-0839; Cecchi, Claudia/0000-0002-2192-8233; Cameron, Robert/0000-0003-0942-2747; Omodei, Nicola/0000-0002-5448-7577; Granot, Jonathan/0000-0001-8530-8941; Pesce-Rollins, Melissa/0000-0003-1790-8018; Monzani, Maria Elena/0000-0002-8254-5308; Preece, Robert/0000-0003-1626-7335; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Giroletti, Marcello/0000-0002-8657-8852; Fusco, Piergiorgio/0000-0002-9383-2425; Ackermann, Markus/0000-0001-8952-588X; McBreen, Sheila/0000-0002-1477-618X; Ciprini, Stefano/0000-0002-0712-2479; Charles, Eric/0000-0002-3925-7802; /0000-0003-0065-2933; Knodlseder, Jurgen/0000-0002-0014-7809; Giordano, Francesco/0000-0002-8651-2394; Tibaldo, Luigi/0000-0001-7523-570X; Sgro', Carmelo/0000-0001-5676-6214; orienti, monica/0000-0003-4470-7094	ICREA Funding Source: Custom; Grants-in-Aid for Scientific Research [25800151] Funding Source: KAKEN	ICREA(ICREA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ackermann M, 2014, SCIENCE, V343, P42, DOI 10.1126/science.1242353; Ackermann M, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/144; Axelsson M, 2012, ASTROPHYS J LETT, V757, DOI 10.1088/2041-8205/757/2/L31; BAND D, 1993, ASTROPHYS J, V413, P281, DOI 10.1086/172995; Burgess J. M., 2013, ARXIV13044628; Burgess JM, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/24; Daigne F, 1998, MON NOT R ASTRON SOC, V296, P275, DOI 10.1046/j.1365-8711.1998.01305.x; Dermer CD, 2004, ASTROPHYS J, V614, P284, DOI 10.1086/426532; EDELSON RA, 1988, ASTROPHYS J, V333, P646, DOI 10.1086/166773; FORD LA, 1995, ASTROPHYS J, V439, P307, DOI 10.1086/175174; Genet F, 2009, MON NOT R ASTRON SOC, V399, P1328, DOI 10.1111/j.1365-2966.2009.15355.x; Golenetskii S., 2013, GCN CIR, V2013, P14487; Guiriec S, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/32; Guiriec S, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L33; Iyyani S, 2013, MON NOT R ASTRON SOC, V433, P2739, DOI 10.1093/mnras/stt863; Levan A. J., 2013, GCN CIR, V2013, P14455; Lu RJ, 2010, ASTROPHYS J, V720, P1146, DOI 10.1088/0004-637X/720/2/1146; Lyutikov M., 2003, ARXIVASTROPH0312347; Maselli A, 2014, SCIENCE, V343, P48, DOI 10.1126/science.1242279; Maselli A., 2013, GCN CIR, V2013, P14448; Meegan C, 2009, ASTROPHYS J, V702, P791, DOI 10.1088/0004-637X/702/1/791; Norris JP, 1996, ASTROPHYS J, V459, P393, DOI 10.1086/176902; Pe'er A, 2007, ASTROPHYS J, V664, pL1, DOI 10.1086/520534; Pelassa V., 2010, ARXIV10022617; Ryde F, 2004, ASTROPHYS J, V614, P827, DOI 10.1086/423782; von Kienlin A., 2013, GCN CIR, V2013, P14473; Zhang B, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/90; Zhu S., 2013, GCN CIR, V2013, P14471	29	47	49	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					51	54		10.1126/science.1242302	http://dx.doi.org/10.1126/science.1242302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24263132	Green Published, Green Submitted			2022-12-28	WOS:000329162000044
J	Fujita, Y; Venterink, HO; van Bodegom, PM; Douma, JC; Heil, GW; Holzel, N; Jablonska, E; Kotowski, W; Okruszko, T; Pawlikowski, P; de Ruiter, PC; Wassen, MJ				Fujita, Yuki; Venterink, Harry Olde; van Bodegom, Peter M.; Douma, Jacob C.; Heil, Gerrit W.; Hoelzel, Norbert; Jablonska, Ewa; Kotowski, Wiktor; Okruszko, Tomasz; Pawlikowski, Pawel; de Ruiter, Peter C.; Wassen, Martin J.			Low investment in sexual reproduction threatens plants adapted to phosphorus limitation	NATURE			English	Article							BIOLOGICAL STOICHIOMETRY; ENDANGERED PLANTS; LIFE-HISTORY; NITROGEN; TRAITS; PATTERNS; ACQUISITION; STRATEGIES; ALLOCATION; DATABASE	Plant species diversity in Eurasian wetlands and grasslands depends not only on productivity but also on the relative availability of nutrients, particularly of nitrogen and phosphorus(1-4). Here we show that the impacts of nitrogen: phosphorus stoichiometry on plant species richness can be explained by selected plant life-history traits, notably by plant investments in growth versus reproduction. In 599 Eurasian sites with herbaceous vegetation we examined the relationship between the local nutrient conditions and community-mean life-history traits. We found that compared with plants in nitrogen-limited communities, plants in phosphorus-limited communities invest little in sexual reproduction (for example, less investment in seed, shorter flowering period, longer lifespan) and have conservative leaf economy traits (that is, a low specific leaf area and a high leaf dry-matter content). Endangered species were more frequent in phosphorus-limited ecosystems and they too invested little in sexual reproduction. The results provide new insight into how plant adaptations to nutrient conditions can drive the distribution of plant species in natural ecosystems and can account for the vulnerability of endangered species.	[Fujita, Yuki] KWR Watercycle Res Inst, NL-3430 BB Nieuwegein, Netherlands; [Venterink, Harry Olde] Vrije Univ Brussel, B-1050 Brussels, Belgium; [van Bodegom, Peter M.] Vrije Univ Amsterdam, Dept Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [Douma, Jacob C.] Wageningen Univ, Ctr Crop Syst Anal, NL-6708 PB Wageningen, Netherlands; [Heil, Gerrit W.] Univ Utrecht, Fac Sci, NL-3584 CC Utrecht, Netherlands; [Hoelzel, Norbert] Univ Munster, Fac Geosci, Inst Landscape Ecol, D-48149 Munster, Germany; [Jablonska, Ewa; Kotowski, Wiktor; Pawlikowski, Pawel] Univ Warsaw, Inst Bot, Dept Plant Ecol & Environm Conservat, Warsaw, Poland; [Okruszko, Tomasz] Warsaw Univ Life Sci, Fac Civil & Environm Engn, PL-02722 Warsaw, Poland; [de Ruiter, Peter C.] Wageningen Univ, NL-6700 AC Wageningen, Netherlands; [Wassen, Martin J.] Univ Utrecht, Copernicus Inst Sustainable Dev, Fac Geosci, NL-3508 TC Utrecht, Netherlands	KWR Watercycle Research Institute; Vrije Universiteit Brussel; Vrije Universiteit Amsterdam; Wageningen University & Research; Utrecht University; University of Munster; University of Warsaw; Warsaw University of Life Sciences; Wageningen University & Research; Utrecht University	Wassen, MJ (corresponding author), Univ Utrecht, Copernicus Inst Sustainable Dev, Fac Geosci, POB 80115, NL-3508 TC Utrecht, Netherlands.	m.j.wassen@uu.nl	Hölzel, Norbert/H-8753-2013; Douma, Jacob C./C-9721-2014; olde Venterink, Harry/K-9547-2015; van Bodegom, Peter M./N-8150-2015; Wassen, Martin J./L-9228-2013; Jabłońska, Ewa/AGH-5998-2022	Hölzel, Norbert/0000-0002-6367-3400; Douma, Jacob C./0000-0002-8779-838X; olde Venterink, Harry/0000-0002-8963-1153; van Bodegom, Peter M./0000-0003-0771-4500; Wassen, Martin J./0000-0002-9735-2103; Jabłońska, Ewa/0000-0002-2138-8927; Kotowski, Wiktor/0000-0002-1486-2408; Okruszko, Tomasz/0000-0002-5103-1638	Utrecht Centre of Geosciences; Polish Ministry of Science and Higher Education [N304 010 31/0414]	Utrecht Centre of Geosciences; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	We would like to thank N. A. Soudzilovskaia for obtaining the Russian Red List of plant species, M. Soons, D. Ertsen and D. van der Goes for permission to use their vegetation records, T. Markus and M. Stoete for drawing figures and J. Burrough for editing the near-final draft. Y.F. was funded by the Utrecht Centre of Geosciences, and the research in the Rospuda river valley was financed by the Polish Ministry of Science and Higher Education Grant no. N304 010 31/0414.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agren GI, 2004, ECOL LETT, V7, P185, DOI 10.1111/j.1461-0248.2004.00567.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Cade BS, 1999, ECOLOGY, V80, P311, DOI 10.1890/0012-9658(1999)080[0311:EEOLFW]2.0.CO;2; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Centraal Bureau voor Statistiek, DUTCH BOT DAT BIOBAS; Ceulemans T, 2011, J APPL ECOL, V48, P1155, DOI 10.1111/j.1365-2664.2011.02023.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Farnsworth EJ, 2008, AM J BOT, V95, P943, DOI 10.3732/ajb.0800013; FENNER M, 1986, J ECOL, V74, P385, DOI 10.2307/2260262; Fujita Y, 2010, OIKOS, V119, P1665, DOI 10.1111/j.1600-0706.2010.18427.x; Grace J.B., 2006, STRUCT EQ MOD NAT; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grime J.P., 2007, COMP PLANT ECOLOGY F; Gusewell S, 2005, NEW PHYTOL, V166, P537, DOI 10.1111/j.1469-8137.2005.01320.x; Gusewell S, 2005, FUNCT ECOL, V19, P344, DOI 10.1111/j.0269-8463.2005.00967.x; Hodgson J.-G., 1995, ELECT COMP PLANT ECO; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Howell D.C., 2012, STAT METHODS PSYCHOL, V8th; Icelandic Institute of Natural History, VAL HAPL; JNCC, VASC PLANT RED DAT L; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Klaus VH, 2011, PERSPECT PLANT ECOL, V13, P287, DOI 10.1016/j.ppees.2011.07.001; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klimesova J, 2009, J VEG SCI, V20, P511, DOI 10.1111/j.1654-1103.2009.01050.x; Klotz S, 2002, BIOLFLOR DATENBANK B; KUNIN WE, 1993, TRENDS ECOL EVOL, V8, P298, DOI 10.1016/0169-5347(93)90259-R; LAHTI T, 1991, BIOL CONSERV, V55, P299, DOI 10.1016/0006-3207(91)90034-7; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Lambers H, 2010, PLANT SOIL, V334, P11, DOI 10.1007/s11104-010-0444-9; Lannes LS, 2012, NEW PHYTOL, V196, P816, DOI 10.1111/j.1469-8137.2012.04363.x; Mirek Z., 2006, RED LIST PLANTS FUNG; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Royal Botanic Gardens Kew, 2011, SEED INF DAT SID VER; Schnittler M., 1996, SCHRIFTENREIHE VEGET, V28, P709; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Sprent J.I., 2001, NODULATION LEGUMES; State Committee for Environmental Protection of the Novosibirsk region, RED LIST PLANTS NOV; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Swedish Species Information Centre, ARTDATABANKEN; Tamis W. L. M., 2004, Gorteria, V30, P101; VANANDEL J, 1977, J ECOL, V65, P747, DOI 10.2307/2259377; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Venterink HO, 2011, PLANT SOIL, V345, P1, DOI 10.1007/s11104-011-0796-9; Venterink HO, 2010, FUNCT ECOL, V24, P877, DOI 10.1111/j.1365-2435.2010.01692.x; Venterink HO, 2003, ECOLOGY, V84, P2191, DOI 10.1890/01-0639; Venterink HO, 2001, J ECOL, V89, P1033, DOI 10.1111/j.1365-2745.2001.00616.x; Vergeer P, 2003, J ECOL, V91, P600, DOI 10.1046/j.1365-2745.2003.00785.x; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Willby NJ, 2001, NEW PHYTOL, V152, P463, DOI 10.1046/j.0028-646X.2001.00274.x	59	123	131	12	302	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					82	+		10.1038/nature12733	http://dx.doi.org/10.1038/nature12733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24240278				2022-12-28	WOS:000329163300028
J	Kimmel, SE; French, B; Kasner, SE; Johnson, JA; Anderson, JL; Gage, BF; Rosenberg, YD; Eby, CS; Madigan, RA; McBane, RB; Abdel-Rahman, SZ; Stevens, SM; Yale, S; Mohler, ER; Fang, MC; Shah, V; Horenstein, RB; Limdi, NA; Muldowney, JAS; Gujral, J; Delafontaine, P; Desnick, RJ; Ortel, TL; Billett, HH; Pendleton, RC; Geller, NL; Halperin, JL; Goldhaber, SZ; Caldwell, MD; Califf, RM; Ellenberg, JH				Kimmel, Stephen E.; French, Benjamin; Kasner, Scott E.; Johnson, Julie A.; Anderson, Jeffrey L.; Gage, Brian F.; Rosenberg, Yves D.; Eby, Charles S.; Madigan, Rosemary A.; McBane, Robert B.; Abdel-Rahman, Sherif Z.; Stevens, Scott M.; Yale, Steven; Mohler, Emile R., III; Fang, Margaret C.; Shah, Vinay; Horenstein, Richard B.; Limdi, Nita A.; Muldowney, James A. S., III; Gujral, Jaspal; Delafontaine, Patrice; Desnick, Robert J.; Ortel, Thomas L.; Billett, Henny H.; Pendleton, Robert C.; Geller, Nancy L.; Halperin, Jonathan L.; Goldhaber, Samuel Z.; Caldwell, Michael D.; Califf, Robert M.; Ellenberg, Jonas H.		COAG Investigators	A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPTIMAL ANTICOAGULATION; GENETICS; TRIAL; CLARIFICATION; PREDICT	BackgroundThe clinical utility of genotype-guided (pharmacogenetically based) dosing of warfarin has been tested only in small clinical trials or observational studies, with equivocal results. MethodsWe randomly assigned 1015 patients to receive doses of warfarin during the first 5 days of therapy that were determined according to a dosing algorithm that included both clinical variables and genotype data or to one that included clinical variables only. All patients and clinicians were unaware of the dose of warfarin during the first 4 weeks of therapy. The primary outcome was the percentage of time that the international normalized ratio (INR) was in the therapeutic range from day 4 or 5 through day 28 of therapy. ResultsAt 4 weeks, the mean percentage of time in the therapeutic range was 45.2% in the genotype-guided group and 45.4% in the clinically guided group (adjusted mean difference, [genotype-guided group minus clinically guided group], -0.2; 95% confidence interval, -3.4 to 3.1; P=0.91). There also was no significant between-group difference among patients with a predicted dose difference between the two algorithms of 1 mg per day or more. There was, however, a significant interaction between dosing strategy and race (P=0.003). Among black patients, the mean percentage of time in the therapeutic range was less in the genotype-guided group than in the clinically guided group. The rates of the combined outcome of any INR of 4 or more, major bleeding, or thromboembolism did not differ significantly according to dosing strategy. ConclusionsGenotype-guided dosing of warfarin did not improve anticoagulation control during the first 4 weeks of therapy. (Funded by the National Heart, Lung, and Blood Institute and others; COAG ClinicalTrials.gov number, NCT00839657.) In this trial, 1015 patients were assigned to the use of either a genotype-guided algorithm or a clinically guided algorithm for warfarin dosing during the first 5 days. At 4 weeks, there was no significant difference in the percentage of time in the therapeutic INR range. The need for clinical trials before widespread adoption of genotype-guided drug dosing and selection remains widely debated.(1)-(4) Warfarin therapy has served as a model for the potential for pharmacogenetics to improve patient care.(1) Observational studies have identified two genes, CYP2C9 and VKORC1, that are associated with variation in warfarin maintenance doses. However, the clinical utility of starting warfarin at the maintenance dose predicted by genotype-guided algorithms has been tested only in small trials, none of which were definitive.(5)-(8) In contrast, observational studies have suggested potential benefits from genotype-guided dosing.(9),(10) In addition, previous clinical trials could not determine ...	[Kimmel, Stephen E.; French, Benjamin; Kasner, Scott E.; Madigan, Rosemary A.; Mohler, Emile R., III; Ellenberg, Jonas H.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Johnson, Julie A.] Univ Florida, Gainesville, FL USA; [Anderson, Jeffrey L.; Stevens, Scott M.] Intermt Med Ctr, Murray, UT USA; [Gage, Brian F.; Eby, Charles S.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Rosenberg, Yves D.; Geller, Nancy L.] NHLBI, NIH, Bethesda, MD 20892 USA; [McBane, Robert B.] Mayo Clin, Coll Med, Rochester, MN USA; [Abdel-Rahman, Sherif Z.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Yale, Steven; Caldwell, Michael D.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI 54449 USA; [Fang, Margaret C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Shah, Vinay] Henry Ford Hosp, Detroit, MI 48202 USA; [Horenstein, Richard B.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Limdi, Nita A.] Univ Alabama Birmingham, Birmingham, AL USA; [Muldowney, James A. S., III] Vanderbilt Univ, Nashville, TN 37235 USA; [Gujral, Jaspal] Georgia Regents Med Ctr, Augusta, GA USA; [Delafontaine, Patrice] Tulane Univ, New Orleans, LA 70118 USA; [Desnick, Robert J.; Halperin, Jonathan L.] Mt Sinai Sch Med, New York, NY USA; [Billett, Henny H.] Montefiore Med Ctr, New York, NY USA; [Ortel, Thomas L.; Califf, Robert M.] Duke Univ, Med Ctr, Durham, NC USA; [Pendleton, Robert C.] Univ Utah Hlth Care, Provo, UT USA; [Goldhaber, Samuel Z.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; State University System of Florida; University of Florida; Intermountain Healthcare; Intermountain Medical Center; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic; University of Texas System; University of Texas Medical Branch Galveston; Marshfield Clinic; University of California System; University of California San Francisco; Henry Ford Health System; Henry Ford Hospital; University System of Maryland; University of Maryland Baltimore; University of Alabama System; University of Alabama Birmingham; Vanderbilt University; University System of Georgia; Augusta University; Tulane University; Icahn School of Medicine at Mount Sinai; Montefiore Medical Center; Duke University; Harvard University; Brigham & Women's Hospital	Kimmel, SE (corresponding author), Ctr Therapeut Effectiveness Res, 923 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	stevek@mail.med.upenn.edu	Halperin, Jonathan/AAJ-4721-2020; Caldwell, Michael DeFoix/ABB-1906-2021; elewa, hazem/AAH-8159-2021	Halperin, Jonathan/0000-0002-8318-5471; elewa, hazem/0000-0003-1594-1199; Mohamed, Mohamed-Eslam/0000-0003-0959-2025; Delafontaine, Patrice/0000-0003-3744-3617; Wang, Cong-Yi/0000-0001-7914-168X; McBane, Robert/0000-0001-8727-8029; Zhao, Richard Y./0000-0003-3424-2852; Gage, Brian/0000-0002-4727-8742	National Heart, Lung, and Blood Institute [HHSN-268200800003C]; Pfizer; Janssen; Novartis; Merck; Medtronic; Photothera; AstraZeneca; Cardionet; W.L. Gore; Acorda; Daiichi Asubio; Boehringer Ingelheim; Siemens; serving on an advisory board for Instrumentation Laboratory; Iverson Genetics; MCG; Bristol-Myers Squibb; Theravasc; Bayer; Instrumentation Laboratory; Eisai; GlaxoSmithKline; Daiichi Sankyo; Daiichi SanIcyo; Baxter; Portola; Sanofi-Aventis; Daiichi Sanlcyo; EKOS; Johnson Johnson; Roche; Bristol-Myers Squibb Foundation; Regeneron; CV Sight; Eli Lilly; Gambro; Kowa; Genentech; Laboratoires Servier; Amylin; Merck/Schering Plough; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092173] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pfizer(Pfizer); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Merck(Merck & Company); Medtronic(Medtronic); Photothera; AstraZeneca(AstraZeneca); Cardionet; W.L. Gore; Acorda; Daiichi Asubio(Daiichi Sankyo Company Limited); Boehringer Ingelheim(Boehringer Ingelheim); Siemens(Siemens AG); serving on an advisory board for Instrumentation Laboratory; Iverson Genetics; MCG; Bristol-Myers Squibb(Bristol-Myers Squibb); Theravasc; Bayer(Bayer AG); Instrumentation Laboratory; Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Daiichi Sankyo(Daiichi Sankyo Company Limited); Daiichi SanIcyo(Daiichi Sankyo Company Limited); Baxter; Portola; Sanofi-Aventis(Sanofi-Aventis); Daiichi Sanlcyo(Daiichi Sankyo Company Limited); EKOS; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Roche(Roche Holding); Bristol-Myers Squibb Foundation(Bristol-Myers Squibb); Regeneron(Regeneron); CV Sight; Eli Lilly(Eli Lilly); Gambro; Kowa; Genentech(Roche HoldingGenentech); Laboratoires Servier; Amylin; Merck/Schering Plough(Merck & CompanySchering Plough Corporation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported under a contract (HHSN-268200800003C) with the National Heart, Lung, and Blood Institute. Bristol-Myers Squibb donated Coumadin (warfarin). GenMark Diagnostics and AutoGenomics loaned genotyping platforms to the clinical centers.; Dr. Kimmel reports receiving consulting fees from Pfizer and Janssen; Dr. Kasner, receiving personal fees from Novartis, Pfizer, Merck, Medtronic, Photothera, AstraZeneca, and Cardionet and grant support from W.L. Gore, Acorda, and Daiichi Asubio; Dr. Gage, receiving consulting fees from Boehringer Ingelheim; Dr. Eby, receiving grant support from Siemens and serving on an advisory board for Instrumentation Laboratory; Dr. Stevens, receiving grant support from Iverson Genetics; Dr. Muldowney, receiving consulting fees from MCG (formerly Milliman Care Guidelines), lecture fees from Bristol-Myers Squibb, Pfizer, and Boehringer Ingelheim, and grant support from Novartis and Theravasc; Dr. Ortel, receiving consulting fees from Boehringer Ingelheim, Bayer, and Instrumentation Laboratory and grant support from Eisai, GlaxoSmithKline, Pfizer, Daiichi Sankyo, and Instrumentation Laboratory; Dr. Goldhaber, receiving consulting fees from Bristol-Myers Squibb, Daiichi SanIcyo, Baxter, Boehringer Ingelheim, Eisai, Merck, Pfizer, Portola, and Sanofi-Aventis and grant support from Bristol-Myers Squibb, Daiichi Sanlcyo, EKOS, and Johnson & Johnson; Dr. Caldwell, holding a patent, issued to the Marshfield Clinic, on the use of CYP4F2 for warfarin dosing; Dr. Califf, serving as a board member at Portola, receiving consulting fees from Novartis, Johnson & Johnson, Bayer, Roche, Pfizer, Bristol-Myers Squibb Foundation, Regeneron, CV Sight, Daiichi Sankyo, Eli Lilly, Gambro, Kowa, Genentech, GlaxoSmithKline, Laboratoires Servier, and Portola, receiving grant support from Amylin, Johnson & Johnson, Merck/Schering Plough, Novartis, Bristol-Myers Squibb Foundation, and Eli Lilly, and having an equity interest in N30 Pharma; and Dr. Ellenberg, receiving consulting fees from Bristol-Myers Squibb. No other potential conflict of interest relevant to this article was reported.	Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Ashley EA, 2012, CIRCULATION, V126, P142, DOI 10.1161/CIR.0b013e31825b07f8; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Burke W, 2010, PUBLIC HEALTH GENOM, V13, P215, DOI 10.1159/000279623; Burmester JK, 2011, GENET MED, V13, P509, DOI 10.1097/GIM.0b013e31820ad77d; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; Cavallari LH, 2012, FUTUR CARDIOL, V8, P563, DOI [10.2217/fca.12.31, 10.2217/FCA.12.31]; Centers for Medicare & Medicaid Services, MED COV DAT POT NCD; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; Do EJ, 2012, PHARMACOGENOMICS J, V12, P417, DOI 10.1038/tpj.2011.18; Epstein RS, 2010, J AM COLL CARDIOL, V55, P2804, DOI 10.1016/j.jacc.2010.03.009; Ezekowitz MD, 2010, CIRCULATION, V122, P2246, DOI 10.1161/CIRCULATIONAHA.110.973735; French B, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-108; Gage B, 2008, CLIN PHARMACOL THER, V84, P430; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Garcia DA, 2013, AM HEART J, V166, P549, DOI 10.1016/j.ahj.2013.05.016; Ginsburg GS, 2010, J AM COLL CARDIOL, V55, P2813, DOI 10.1016/j.jacc.2010.04.006; Horne BD, 2012, THROMB HAEMOSTASIS, V107, P232, DOI 10.1160/TH11-06-0388; Joo J, 2010, CLIN TRIALS, V7, P597, DOI 10.1177/1740774510381285; Kimmel SE, 2013, AM HEART J, V166, P435, DOI 10.1016/j.ahj.2013.04.009; Klein TE, 2009, NEW ENGL J MED, V361, P1613; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; *ROCKET AF STUD IN, 2010, AM HEART J, V159; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schelleman H, 2008, CLIN PHARMACOL THER, V84, P332, DOI 10.1038/clpt.2008.101; Wang MS, 2012, INT J MED SCI, V9, P472, DOI 10.7150/ijms.4637; Woodcock J, 2009, NEW ENGL J MED, V360, P811, DOI 10.1056/NEJMe0810630	30	556	587	0	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2283	2293		10.1056/NEJMoa1310669	http://dx.doi.org/10.1056/NEJMoa1310669			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24251361	Green Accepted			2022-12-28	WOS:000328156300006
J	Gillman, MW; Ludwig, DS				Gillman, Matthew W.; Ludwig, David S.			How Early Should Obesity Prevention Start?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OVERWEIGHT		[Gillman, Matthew W.] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA 02114 USA; [Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA USA; [Gillman, Matthew W.; Ludwig, David S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gillman, MW (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA 02114 USA.			Ludwig, David/0000-0003-3307-8544	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD034568] Funding Source: Medline; NIDDK NIH HHS [K24 DK082730] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boeke CE, 2013, OBESITY, V21, P1430, DOI 10.1002/oby.20314; Gillman MW, 2008, OBESITY, V16, P1651, DOI 10.1038/oby.2008.260; Huh SY, 2011, PEDIATRICS, V127, pE544, DOI 10.1542/peds.2010-0740; Li HT, 2013, INT J OBESITY, V37, P893, DOI 10.1038/ijo.2012.195; Taveras EM, 2013, JAMA PEDIATR, V167, P731, DOI 10.1001/jamapediatrics.2013.85	5	137	144	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2173	2175		10.1056/NEJMp1310577	http://dx.doi.org/10.1056/NEJMp1310577			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	263II	24224559				2022-12-28	WOS:000327801100002
J	Pasternak, B; Svanstrom, H; Melbye, M; Hviid, A				Pasternak, Bjorn; Svanstrom, Henrik; Melbye, Mads; Hviid, Anders			Association Between Oral Fluoroquinolone Use and Retinal Detachment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACHILLES-TENDON; RISK	IMPORTANCE A recent study of ophthalmologic patients found a strong association between fluoroquinolone use and retinal detachment. Given the prevalent use of fluoroquinolones, this could, if confirmed in the general population, translate to many excess cases of retinal detachment that are potentially preventable. OBJECTIVE To investigate if oral fluoroquinolone use is associated with an increased risk of retinal detachment. DESIGN, SETTING, AND PARTICIPANTS A nationwide, register-based cohort study in Denmark from 1997 through 2011, using linked data on participant characteristics, filled prescriptions, and cases of retinal detachment with surgical treatment (scleral buckling, vitrectomy, or pneumatic retinopexy). The cohort included 748 792 episodes of fluoroquinolone use (660 572 [88%] ciprofloxacin) and 5 520 446 control episodes of nonuse. MAIN OUTCOMES AND MEASURES Poisson regression was used to estimate rate ratios (RRs) for incident retinal detachment, adjusting for a propensity score that included a total of 21 variables. The risk windows were classified as current use (days 1-10 from start of treatment), recent use (days 11-30), past use (days 31-60), and distant use (days 61-180). RESULTS A total of 566 cases of retinal detachment occurred, of which 465 (82%) were rhegmatogenous detachments; 72 in fluoroquinolone users and 494 in control nonusers. The crude incidence rate was 25.3 cases per 100 000 person-years in current users, 18.9 in recent users, 26.8 in past users, and 24.8 in distant users compared with 19.0 in nonusers. Compared with nonuse, fluoroquinolone use was not associated with a significantly increased risk of retinal detachment: the adjusted RRs were 1.29 (95% CI, 0.53 to 3.13) for current use; 0.97 (95% CI, 0.46 to 2.05) for recent use; 1.37 (95% CI, 0.80 to 2.35) for past use; and 1.27 (95% CI, 0.93 to 1.75) for distant use. The absolute risk difference, estimated as the adjusted number of retinal detachment cases per 1 000 000 treatment episodes, was 1.5 (95% CI, -2.4 to 11.1) for current use. CONCLUSIONS AND RELEVANCE In this cohort study based on the general Danish population, oral fluoroquinolone use was not associated with increased risk of retinal detachment. Given its limited power, this study can only rule out more than a 3-fold increase in the relative risk associated with current fluoroquinolone use; however, any differences in absolute risk are likely to be of minor, if any, clinical significance.	[Pasternak, Bjorn; Svanstrom, Henrik; Melbye, Mads; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127; melbye, mads/0000-0001-8264-6785	Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by The Danish Medical Research Council.	Andersen TF, 1999, DAN MED BULL, V46, P263; Austin PC, 2008, CIRC-CARDIOVASC QUAL, V1, P62, DOI 10.1161/CIRCOUTCOMES.108.790634; Corps AN, 2002, ARTHRITIS RHEUM, V46, P3034, DOI 10.1002/art.10617; D'Amico DJ, 2008, NEW ENGL J MED, V359, P2346, DOI 10.1056/NEJMcp0804591; Etminan M, 2012, JAMA-J AM MED ASSOC, V307, P1414, DOI 10.1001/jama.2012.383; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Kang HK, 2008, BMJ-BRIT MED J, V336, P1235, DOI 10.1136/bmj.39581.525532.47; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Mitry D, 2010, BRIT J OPHTHALMOL, V94, P678, DOI 10.1136/bjo.2009.157727; Mitry D, 2011, BRIT J OPHTHALMOL, V95, P365, DOI 10.1136/bjo.2009.172296; Nordic Medico-Statistical Committee, NOMESCO CLASS SURG P; Parson LS, 2001, 26 ANN SAS US GROUP; Pedersen CB, 2006, DAN MED BULL, V53, P441; Sendzik J, 2010, INT J ANTIMICROB AG, V35, P366, DOI 10.1016/j.ijantimicag.2009.10.009; Shakibaei M, 2001, ARCH TOXICOL, V75, P97, DOI 10.1007/s002040000203; The Center for Disease Dynamics Economics and Policy, ANT US OV; Tsai WC, 2008, ARTHRITIS RHEUM-US, V58, P1657, DOI 10.1002/art.23518; US Food and Drug Administration, POT SIGN SER RISKS N; van der Linden PD, 2003, ARCH INTERN MED, V163, P1801, DOI 10.1001/archinte.163.15.1801; van der Linden PD, 2002, BRIT MED J, V324, P1306, DOI 10.1136/bmj.324.7349.1306; Wise BL, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.05.027; Zhang YT, 2012, ARCH INTERN MED, V172, P1465, DOI 10.1001/archinternmed.2012.3717	22	33	33	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2184	2190		10.1001/jama.2013.280500	http://dx.doi.org/10.1001/jama.2013.280500			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24281462	Bronze			2022-12-28	WOS:000327404400027
J	Smith, JM				Smith, Jeanette M.			A Quebec Village Street, Winter Clarence Alphonse Gagnon	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2132	2133		10.1001/jama.2013.5431	http://dx.doi.org/10.1001/jama.2013.5431			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24281440				2022-12-28	WOS:000327404400001
J	Quint, JK; Herrett, E; Bhaskaran, K; Timmis, A; Hemingway, H; Wedzicha, JA; Smeeth, L				Quint, J. K.; Herrett, E.; Bhaskaran, K.; Timmis, A.; Hemingway, H.; Wedzicha, J. A.; Smeeth, L.			Effect of beta blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; RISK; EXACERBATIONS; SURVIVAL; STROKE; IMPACT	Objectives To investigate whether the use and timing of prescription of beta blockers in patients with chronic obstructive pulmonary disease (COPD) having a first myocardial infarction was associated with survival and to identify factors related to their use. Design Population based cohort study in England. Setting UK national registry of myocardial infarction (Myocardial Ischaemia National Audit Project (MINAP)) linked to the General Practice Research Database (GPRD), 2003-11. Participants Patients with COPD with a first myocardial infarction in 1 January 2003 to 31 December 2008 as recorded in MINAP, who had no previous evidence of myocardial infarction in their GPRD or MINAP record. Data were provided by the Cardiovascular Disease Research using Linked Bespoke studies and Electronic Health Records (CALIBER) group at University College London. Main outcome measure Cox proportional hazards ratio for mortality after myocardial infarction in patients with COPD in those prescribed beta blockers or not, corrected for covariates including age, sex, smoking status, drugs, comorbidities, type of myocardial infarction, and severity of infarct. Results Among 1063 patients with COPD, treatment with beta blockers started during the hospital admission for myocardial infarction was associated with substantial survival benefits (fully adjusted hazard ratio 0.50, 95% confidence interval 0.36 to 0.69; P<0.001; median follow-up time 2.9 years). Patients already taking a beta blocker before their myocardial infarction also had a survival benefit (0.59, 0.44 to 0.79; P<0.001). Similar results were obtained with propensity scores as an alternative method to adjust for differences between those prescribed and not prescribed beta blockers. With follow-up started from date of discharge from hospital, the effect size was slightly attenuated but there was a similar protective effect of treatment with beta blockers started during hospital admission for myocardial infarction (0.64, 0.44 to 0.94; P=0.02). Conclusions The use of beta blockers started either at the time of hospital admission for myocardial infarction or before a myocardial infarction is associated with improved survival after myocardial infarction in patients with COPD.	[Quint, J. K.; Herrett, E.; Bhaskaran, K.; Smeeth, L.] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1E 7HT, England; [Timmis, A.] London Chest Hosp, Barts & London Sch Med & Dent, NIHR Biomed Res Unit, London E2 9JX, England; [Hemingway, H.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Hemingway, H.] UCL, Farr Inst Hlth Informat Res UCL Partners, London WC1E 6BT, England; [Wedzicha, J. A.] UCL, Ctr Resp Med, London NW3 2PF, England	University of London; London School of Hygiene & Tropical Medicine; University of London; Queen Mary University London; University of London; University College London; University of London; University College London; University of London; University College London	Quint, JK (corresponding author), London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1E 7HT, England.	Jennifer.quint@lshtm.ac.uk	quint, jennifer/ABE-3384-2020; Hemingway, Harry/C-1219-2009; Smeeth, Liam/X-5862-2018	Hemingway, Harry/0000-0003-2279-0624; Smeeth, Liam/0000-0002-9168-6022; Quint, Jennifer/0000-0003-0149-4869; Bhaskaran, Krishnan/0000-0001-5364-8757	Medical Research Council, UK; The Wellcome Trust; National Institute for Health Research postdoctoral fellowship [PDF-2011-04-007]; Barts Health Cardiovascular Biomedical Research Unit; National Institute for Health Research; UK National Institute for Health Research [RP-PG-0407-10314]; Wellcome Trust [086091/Z/08/Z]; MRC; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); Wellcome Trust; MRC [G0902135] Funding Source: UKRI; Medical Research Council [MR/K006584/1, G0902135] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090, PDF-2011-04-007, NF-SI-0510-10270, RP-PG-0407-10314] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research postdoctoral fellowship(National Institute for Health Research (NIHR)); Barts Health Cardiovascular Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR)); UK National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work. JKQ is funded by the Medical Research Council, UK, LS is funded by The Wellcome Trust, KB is funded by a National Institute for Health Research postdoctoral fellowship (PDF-2011-04-007). AT acknowledges support of Barts Health Cardiovascular Biomedical Research Unit, funded by the National Institute for Health Research. CALIBER is supported by grants from the UK National Institute for Health Research (grant No RP-PG-0407-10314) and the Wellcome Trust (086091/Z/08/Z). HH is supported by grants from the UK National Institute for Health Research (RP-PG-0407-10314) and the Wellcome Trust [086091/Z/08/Z], and by awards establishing the Farr Institute of Health Informatics Research at UCL Partners from the MRC, in partnership with Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates) and the Wellcome Trust. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR PHR Programme or the Department of Health.	Albouaini Khaled, 2007, Int J Chron Obstruct Pulmon Dis, V2, P535; [Anonymous], 2011, Drug Ther Bull, V49, P2, DOI 10.1136/dtb.2011.01.0003; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; Bursi F, 2010, AM HEART J, V160, P95, DOI 10.1016/j.ahj.2010.05.004; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Chen J, 2001, J AM COLL CARDIOL, V37, P1950, DOI 10.1016/S0735-1097(01)01225-6; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dransfield MT, 2008, THORAX, V63, P301, DOI 10.1136/thx.2007.081893; Feary JR, 2010, THORAX, V65, P956, DOI 10.1136/thx.2009.128082; *GOLD, 2006, GLOB STRAT DIAGN MAN; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Huiart Laetitia, 2006, Can Respir J, V13, P134; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kjoller E, 2004, EUR J HEART FAIL, V6, P71, DOI 10.1016/j.ejheart.2003.09.008; National Clinical Guideline Centre, 2010, CHRON HEART FAIL NAT; National Collaborating Centre for Primary Care (UK), 2007, POSTM INF SEC PREV P, V48; NICE, HYP CLIN MAN PRIM HY; Niewoehner DE, 2007, CHEST, V131, P20, DOI 10.1378/chest.06-1316; Olenchock BA, 2009, AM J CARDIOL, V103, P295, DOI 10.1016/j.amjcard.2008.09.081; Parkinson J, 2007, PHARMACOVIGILANCE, P341, DOI DOI 10.1002/9780470059210.CH27; Quint JK, 2011, THORAX, V66, pA45, DOI 10.1136/thoraxjnl-2011-201054b.96; Rutten FH, 2010, ARCH INTERN MED, V170, P880, DOI 10.1001/archinternmed.2010.112; Salisbury AC, 2007, AM J CARDIOL, V99, P636, DOI 10.1016/j.amjcard.2006.09.112; Salpeter S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003566.pub2; Schneider C, 2010, EUR J EPIDEMIOL, V25, P253, DOI 10.1007/s10654-010-9435-7; SHORT PM, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D2549; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Stefan MS, 2012, CHEST, V141, P1441, DOI 10.1378/chest.11-2032; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Suissa S, 2003, AM J RESP CRIT CARE, V168, P49, DOI 10.1164/rccm.200210-1231OC; Wakabayashi K, 2010, AM J CARDIOL, V106, P305, DOI 10.1016/j.amjcard.2010.03.026	33	82	87	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2013	347								f6650	10.1136/bmj.f6650	http://dx.doi.org/10.1136/bmj.f6650			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KZ	24270505	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000327459500001
J	Dahm, P				Dahm, Philipp			The 6-item CAPRA-S score predicted cancer recurrence after radical prostatectomy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dahm, Philipp] Univ Florida, Coll Med, Gainesville, FL 32610 USA; [Dahm, Philipp] Univ Florida, Malcom Randall Vet Adm Affairs Med Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Dahm, P (corresponding author), Univ Florida, Coll Med, Gainesville, FL 32610 USA.		Dahm, Philipp/I-1614-2019	Dahm, Philipp/0000-0003-2819-2553				Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10							JC13	10.7326/0003-4819-159-10-201311190-02013	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247691	Green Published			2022-12-28	WOS:000328732700012
J	Jones, G; Thompson, K; Johnson, M				Jones, Gareth; Thompson, Kate; Johnson, Mark			Acute compartment syndrome after minor trauma in a patient with undiagnosed mild haemophilia B	LANCET			English	Editorial Material									[Jones, Gareth; Thompson, Kate; Johnson, Mark] Leeds Metropolitan Univ, Fac Hlth & Social Sci, Leeds LS1 3HE, W Yorkshire, England	Leeds Beckett University	Jones, G (corresponding author), Leeds Metropolitan Univ, Fac Hlth & Social Sci, Leeds LS1 3HE, W Yorkshire, England.	g.j.jones@leedsmet.ac.uk						Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Elliott KGB, 2003, J BONE JOINT SURG BR, V85B, P625, DOI 10.1302/0301-620X.85B5.14352; HESonline, 2011, HOSP EP STAT ADM PAT; McQueen MM, 2000, J BONE JOINT SURG BR, V82B, P200, DOI 10.1302/0301-620X.82B2 .9799; Ojike NI, 2010, INJURY, V41, P133, DOI 10.1016/j.injury.2009.03.016	5	8	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1678	1678		10.1016/S0140-6736(13)61954-6	http://dx.doi.org/10.1016/S0140-6736(13)61954-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254CN	24238556				2022-12-28	WOS:000327140700028
J	Saeedi, K; Simmons, S; Salvail, JZ; Dluhy, P; Riemann, H; Abrosimov, NV; Becker, P; Pohl, HJ; Morton, JJL; Thewalt, MLW				Saeedi, Kamyar; Simmons, Stephanie; Salvail, Jeff Z.; Dluhy, Phillip; Riemann, Helge; Abrosimov, Nikolai V.; Becker, Peter; Pohl, Hans-Joachim; Morton, John J. L.; Thewalt, Mike L. W.			Room-Temperature Quantum Bit Storage Exceeding 39 Minutes Using Ionized Donors in Silicon-28	SCIENCE			English	Article							NUCLEAR-SPIN; SILICON; MEMORY; COMPUTER; FIDELITY	Quantum memories capable of storing and retrieving coherent information for extended times at room temperature would enable a host of new technologies. Electron and nuclear spin qubits using shallow neutral donors in semiconductors have been studied extensively but are limited to low temperatures (less than or similar to 10 kelvin); however, the nuclear spins of ionized donors have the potential for high-temperature operation. We used optical methods and dynamical decoupling to realize this potential for an ensemble of phosphorous-31 donors in isotopically purified silicon-28 and observed a room-temperature coherence time of over 39 minutes. We further showed that a coherent spin superposition can be cycled from 4.2 kelvin to room temperature and back, and we report a cryogenic coherence time of 3 hours in the same system.	[Saeedi, Kamyar; Salvail, Jeff Z.; Dluhy, Phillip; Thewalt, Mike L. W.] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Simmons, Stephanie] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Riemann, Helge; Abrosimov, Nikolai V.] Leibniz Inst Kristallzuchtung, D-12489 Berlin, Germany; [Becker, Peter] PTB Braunschweig, D-38116 Braunschweig, Germany; [Pohl, Hans-Joachim] VITCON Projectconsult, D-07743 Jena, Germany; [Morton, John J. L.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England	Simon Fraser University; University of Oxford; Leibniz Institut fur Kristallzuchtung (IKZ); Physikalisch-Technische Bundesanstalt (PTB); University of London; University College London	Thewalt, MLW (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	thewalt@sfu.ca	Morton, John/I-3515-2013	Saeedi, Kamyar/0000-0003-3653-3135	Natural Sciences and Engineering Research Council of Canada; Violette and Samuel Glasstone Fellowship; St. John's College, Oxford; Royal Society; EPSRC [EP/I035536/2, EP/I035536/1, EP/K025945/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I035536/2, EP/K025945/1, EP/I035536/1] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Violette and Samuel Glasstone Fellowship; St. John's College, Oxford; Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work at Simon Fraser University was supported by the Natural Sciences and Engineering Research Council of Canada. S. S. is supported by the Violette and Samuel Glasstone Fellowship and St. John's College, Oxford. J.J.L.M. is supported by the Royal Society.	Awschalom DD, 2013, SCIENCE, V339, P1174, DOI 10.1126/science.1231364; BURGER W, 1984, PHYS REV LETT, V53, P2035, DOI 10.1103/PhysRevLett.53.2035; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; DIRKSEN P, 1989, J PHYS-CONDENS MAT, V1, P7085, DOI 10.1088/0953-8984/1/39/020; Dreher L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.037601; Dreher L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.027602; FEHER G, 1959, PHYS REV, V114, P1245, DOI 10.1103/PhysRev.114.1245; JOZSA R, 1994, J MOD OPTIC, V41, P2315, DOI 10.1080/09500349414552171; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Koehl WF, 2011, NATURE, V479, P84, DOI 10.1038/nature10562; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Ladd TD, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014401; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; McCamey DR, 2010, SCIENCE, V330, P1652, DOI 10.1126/science.1197931; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Morton JJL, 2011, NATURE, V479, P345, DOI 10.1038/nature10681; Pastawski F, 2012, P NATL ACAD SCI USA, V109, P16079, DOI 10.1073/pnas.1203552109; Pla JJ, 2013, NATURE, V496, P334, DOI 10.1038/nature12011; SCHMID W, 1977, PHYS STATUS SOLIDI B, V84, P529, DOI 10.1002/pssb.2220840216; Steger M, 2012, SCIENCE, V336, P1280, DOI 10.1126/science.1217635; Steger M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3577614; Steger M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115204; Wiesner S., 1983, ACM SIGACT NEWS, V15, P78, DOI DOI 10.1145/1008908.1008920; Witzel WM, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035452	25	272	279	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					830	833		10.1126/science.1239584	http://dx.doi.org/10.1126/science.1239584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233718				2022-12-28	WOS:000326923000030
J	Klaas, S				Klaas, Sara			Avoiding injury	NATURE			English	Editorial Material									[Klaas, Sara] Shriners Hosp Children, Spinal Cord Injury Serv, Chicago, IL USA		Klaas, S (corresponding author), Shriners Hosp Children, Spinal Cord Injury Serv, Chicago, IL USA.	sklaas@shrinenet.org						Cosgrove L., 2011, REPORT NO DOT HS 811	1	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S18	S18		10.1038/503S18a	http://dx.doi.org/10.1038/503S18a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24227003				2022-12-28	WOS:000326894200009
J	Cortese, DA				Cortese, Denis A.			A Health Care Encounter of the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							US HEALTH; BURDEN		[Cortese, Denis A.] Arizona State Univ, Ctr Healthcare Delivery & Policy, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	Cortese, DA (corresponding author), Arizona State Univ, 13212 E Shea Blvd, Scottsdale, AZ 85259 USA.	Denis.Cortese@asu.edu						[Anonymous], HLTH CAR COSTS PRIM; [Anonymous], 2011, P CSEE, V31, P19; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Cryer L, 2012, HEALTH AFFAIR, V31, P1237, DOI 10.1377/hlthaff.2011.1132; Harrington P, COMMUNITY PARTNERSHI; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Wu SY, 2000, PROJECTION CHRONIC I	7	6	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1937	1938		10.1001/jama.2013.281856	http://dx.doi.org/10.1001/jama.2013.281856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219946				2022-12-28	WOS:000326832900015
J	Freemantle, N; Marston, L; Walters, K; Wood, J; Reynolds, MR; Petersen, I				Freemantle, Nick; Marston, Louise; Walters, Kate; Wood, John; Reynolds, Matthew R.; Petersen, Irene			Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research	BMJ-BRITISH MEDICAL JOURNAL			English	Article							APROTININ; MORTALITY		[Freemantle, Nick; Marston, Louise; Walters, Kate; Wood, John; Petersen, Irene] UCL Med Sch, Dept Primary Care & Populat Hlth, London NW3 2PF, England; [Freemantle, Nick; Marston, Louise; Wood, John; Petersen, Irene] UCL Med Sch, PRIMENT Clin Trials Unit, London NW3 2PF, England; [Reynolds, Matthew R.] Lahey Clin Med Ctr, Burlington, MA 01803 USA; [Reynolds, Matthew R.] Harvard Clin Res Inst, Boston, MA USA	University of London; University College London; University of London; University College London; Lahey Hospital & Medical Center; Harvard University; Harvard Medical School	Freemantle, N (corresponding author), UCL Med Sch, Dept Primary Care & Populat Hlth, Royal Free Campus, London NW3 2PF, England.	nicholas.freemantle@ucl.ac.uk	Marston, Louise/A-8535-2012; Petersen, Irene/C-5702-2009	Marston, Louise/0000-0002-9973-1131; Petersen, Irene/0000-0002-0037-7524; Walters, Kate/0000-0003-2173-2430; Freemantle, Nick/0000-0001-5807-5740				Avorn J, 2007, NEW ENGL J MED, V357, P2219, DOI 10.1056/NEJMp0706892; Fisher RA, 1966, DESIGN EXPT, P21; Howell N, 2013, J THORAC CARDIOV SUR, V145, P234, DOI 10.1016/j.jtcvs.2012.07.018; Mangano DT, 2007, JAMA-J AM MED ASSOC, V297, P471, DOI 10.1001/jama.297.5.471; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Saksena S, 2011, J AM COLL CARDIOL, V58, P1975, DOI 10.1016/j.jacc.2011.07.036; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	14	143	144	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2013	347								f6409	10.1136/bmj.f6409	http://dx.doi.org/10.1136/bmj.f6409			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FH	24217206	Bronze			2022-12-28	WOS:000327149500001
J	Jain, Y				Jain, Yogesh			India should introduce daily drug treatment for tuberculosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY TUBERCULOSIS; RESISTANCE; REGIMENS; RELAPSE		Jan Swasthya Sahyog, Peoples Hlth Support Grp, Bilaspur 495112, India		Jain, Y (corresponding author), Jan Swasthya Sahyog, Peoples Hlth Support Grp, Village & PO Ganiyari, Bilaspur 495112, India.							Bagcchi S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6663; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Chang KC, 2006, AM J RESP CRIT CARE, V174, P1153, DOI 10.1164/rccm.200605-637OC; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Mathew R, 1997, INT J TUBERC LUNG D, V1, P509; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; Paresh Dave, 2013, National Journal of Community Medicine, V4, P189; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	11	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2013	347								f6769	10.1136/bmj.f6769	http://dx.doi.org/10.1136/bmj.f6769			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FH	24217439				2022-12-28	WOS:000327149500011
J	Rico, F; Gonzalez, L; Casuso, I; Puig-Vidal, M; Scheuring, S				Rico, Felix; Gonzalez, Laura; Casuso, Ignacio; Puig-Vidal, Manel; Scheuring, Simon			High-Speed Force Spectroscopy Unfolds Titin at the Velocity of Molecular Dynamics Simulations	SCIENCE			English	Article							MUSCLE PROTEIN TITIN; IMMUNOGLOBULIN DOMAINS; SINGLE MOLECULES; IG DOMAIN; MICROSCOPY; AFM; KINETICS; BONDS	The mechanical unfolding of the muscle protein titin by atomic force microscopy was a landmark in our understanding of single-biomolecule mechanics. Molecular dynamics simulations offered atomic-level descriptions of the forced unfolding. However, experiment and simulation could not be directly compared because they differed in pulling velocity by orders of magnitude. We have developed high-speed force spectroscopy to unfold titin at velocities reached by simulation (similar to 4 millimeters per second). We found that a small beta-strand pair of an immunoglobulin domain dynamically unfolds and refolds, buffering pulling forces up to similar to 100 piconewtons. The distance to the unfolding transition barrier is larger than previously estimated but is in better agreement with atomistic predictions. The ability to directly compare experiment and simulation is likely to be important in studies of biomechanical processes.	[Rico, Felix; Casuso, Ignacio; Scheuring, Simon] Aix Marseille Univ, INSERM, U1006, F-13009 Marseille, France; [Gonzalez, Laura; Puig-Vidal, Manel] Univ Barcelona, Dept Elect, Bioelect Grp, E-08028 Barcelona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Barcelona	Scheuring, S (corresponding author), Aix Marseille Univ, INSERM, U1006, Parc Sci & Technol Luminy,163 Ave Luminy, F-13009 Marseille, France.	simon.scheuring@inserm.fr	Scheuring, Simon/L-9843-2018; Rico, Felix/K-6505-2012; Vidal, Manuel Puig/N-5017-2014; Casuso, Ignacio/E-5574-2016	Scheuring, Simon/0000-0003-3534-069X; Rico, Felix/0000-0002-7757-8340; Vidal, Manuel Puig/0000-0002-6074-9246; Gonzalez-Claramonte, Laura/0000-0002-1422-2734; Casuso, Ignacio/0000-0001-7192-0136	European Research Council [310080]; Agence National de la Recherche [ANR-12-BS10-009-01]; Spanish Ministerio de Economia y Competitividad [BES-2010-031186]; STSM COST Action [TD1002-10006]	European Research Council(European Research Council (ERC)European Commission); Agence National de la Recherche(French National Research Agency (ANR)); Spanish Ministerio de Economia y Competitividad(Spanish Government); STSM COST Action	We thank A. Sastre and J. Otero for helpful discussions. Supported by European Research Council starting grant 310080 and Agence National de la Recherche grant ANR-12-BS10-009-01. L. G. was a recipient of travel grants (FPI grant BES-2010-031186 from the Spanish Ministerio de Economia y Competitividad and STSM COST Action TD1002-10006).	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Berkovich R, 2012, P NATL ACAD SCI USA, V109, P14416, DOI 10.1073/pnas.1212167109; Best RB, 2003, J MOL BIOL, V330, P867, DOI 10.1016/S0022-2836(03)00618-1; Best RB, 2003, ANAL CHIM ACTA, V479, P87, DOI 10.1016/S0003-2670(02)01572-6; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Casuso I, 2012, NAT NANOTECHNOL, V7, P525, DOI [10.1038/nnano.2012.109, 10.1038/NNANO.2012.109]; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Friddle RW, 2012, P NATL ACAD SCI USA, V109, P13573, DOI 10.1073/pnas.1202946109; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Lannon H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.128301; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; MARUYAMA K, 1977, J BIOCHEM, V82, P317; Redondo-Morata L, 2012, LANGMUIR, V28, P6403, DOI 10.1021/la3005147; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039; Yew ZT, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031923; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8	35	181	183	5	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					741	743		10.1126/science.1239764	http://dx.doi.org/10.1126/science.1239764			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202172	Green Submitted			2022-12-28	WOS:000326647600044
J	Emerling, BM; Hurov, JB; Poulogiannis, G; Tsukazawa, KS; Choo-Wing, R; Wulf, GM; Bell, EL; Shim, HS; Lamia, KA; Rameh, LE; Bellinger, G; Sasaki, AT; Asara, JM; Yuan, X; Bullock, A; DeNicola, GM; Song, JX; Brown, V; Signoretti, S; Cantley, LC				Emerling, Brooke M.; Hurov, Jonathan B.; Poulogiannis, George; Tsukazawa, Kazumi S.; Choo-Wing, Rayman; Wulf, Gerburg M.; Bell, Eric L.; Shim, Hye-Seok; Lamia, Katja A.; Rameh, Lucia E.; Bellinger, Gary; Sasaki, Atsuo T.; Asara, John M.; Yuan, Xin; Bullock, Andrea; DeNicola, Gina M.; Song, Jiaxi; Brown, Victoria; Signoretti, Sabina; Cantley, Lewis C.			Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors	CELL			English	Article							INOSITOL POLYPHOSPHATE 4-PHOSPHATASE; METASTATIC BREAST-CANCER; SUBSTRATE-SPECIFICITY; SENESCENCE; SUPPRESSOR; PTDINS5P; MICE; ACTIVATION; PATHWAY; SYSTEM	Here, we show that a subset of breast cancers express high levels of the type 2 phosphatidylinositol-5-phosphate 4-kinases alpha and/or beta (PI5P4K alpha and beta) and provide evidence that these kinases are essential for growth in the absence of p53. Knocking down PI5P4K alpha and beta in a breast cancer cell line bearing an amplification of the gene encoding PI5P4K beta and deficient for p53 impaired growth on plastic and in xenografts. This growth phenotype was accompanied by enhanced levels of reactive oxygen species (ROS) leading to senescence. Mice with homozygous deletion of both TP53 and PIP4K2B were not viable, indicating a synthetic lethality for loss of these two genes. Importantly however, PIP4K2A(-/-), PIP4K2B(+/-), and TP53(-/-) mice were viable and had a dramatic reduction in tumor formation compared to TP53(-/-) littermates. These results indicate that inhibitors of PI5P4Ks could be effective in preventing or treating cancers with mutations in TP53.	[Emerling, Brooke M.; Poulogiannis, George; Tsukazawa, Kazumi S.; Choo-Wing, Rayman; Shim, Hye-Seok; DeNicola, Gina M.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Emerling, Brooke M.; Poulogiannis, George; Tsukazawa, Kazumi S.; Choo-Wing, Rayman; Wulf, Gerburg M.; Shim, Hye-Seok; Asara, John M.; Yuan, Xin; Bullock, Andrea; DeNicola, Gina M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Emerling, Brooke M.; Choo-Wing, Rayman; Bellinger, Gary; Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Hurov, Jonathan B.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Bell, Eric L.] MIT, Dept Biol, Paul F Glenn Lab, Cambridge, MA 02139 USA; [Lamia, Katja A.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Rameh, Lucia E.] Boston Univ, Dept Med, Sch Med, Boston, MA 02118 USA; [Sasaki, Atsuo T.] Univ Cincinnati, Coll Med, UC Neurosci Inst, Dept Internal Med,Brain Tumor Ctr, Cincinnati, OH 45267 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Song, Jiaxi; Brown, Victoria; Signoretti, Sabina] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Song, Jiaxi; Brown, Victoria; Signoretti, Sabina] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Cornell University; Agios Pharmaceuticals; Massachusetts Institute of Technology (MIT); Scripps Research Institute; Boston University; University System of Ohio; University of Cincinnati; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cantley, LC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	lcantley@med.cornell.edu	Poulogiannis, George/AAY-2210-2021; Wulf, Gerburg/AAS-6713-2021; Poulogiannis, George/AAE-1966-2019; Cantley, Lewis C/D-1800-2014	Poulogiannis, George/0000-0002-0529-8614; Cantley, Lewis C/0000-0002-1298-7653; Sasaki, Atsuo/0000-0003-2963-4501; DeNicola, Gina/0000-0001-6611-6696	NIH [R01 GM041890]; DF/HCC Career Development Award; Stand Up to Cancer Dream Team Translational Research Grant; Entertainment Industry Foundation [SU2C-AACR-DT0209]; NIH DK [R01-63219]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DF/HCC Career Development Award; Stand Up to Cancer Dream Team Translational Research Grant; Entertainment Industry Foundation; NIH DK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rodrick Bronson and the entire HMS Rodent Histopathology Core for technical help with the mouse histopathology and discussions concerning the project. Also, we would like to thank Jared Johnson for cloning expertise and the Nikon Imaging Center at Harvard Medical School for help with light microscopy. This work was supported by NIH grant R01 GM041890 to L. C. C., DF/HCC Career Development Award to B. M. E., and by a Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0209). G. P. is a Pfizer Fellow of the Life Sciences Research Foundation. NIH DK R01-63219 supports L.E.R.	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Dearth LR, 2007, CARCINOGENESIS, V28, P289, DOI 10.1093/carcin/bgl132; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Jones DR, 2013, FASEB J, V27, P1644, DOI 10.1096/fj.12-218842; Lamia KA, 2004, MOL CELL BIOL, V24, P5080, DOI 10.1128/MCB.24.11.5080-5087.2004; Luoh SW, 2004, ONCOGENE, V23, P1354, DOI 10.1038/sj.onc.1207251; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Morrison LE, 2007, GENE CHROMOSOME CANC, V46, P397, DOI 10.1002/gcc.20419; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Norris FA, 1997, J BIOL CHEM, V272, P23859, DOI 10.1074/jbc.272.38.23859; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, NEW ENGL J MED, V317, P955, DOI 10.1056/NEJM198710083171509; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wilson JRF, 2010, J MED GENET, V47, P771, DOI 10.1136/jmg.2010.078113; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	34	111	118	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					844	857		10.1016/j.cell.2013.09.057	http://dx.doi.org/10.1016/j.cell.2013.09.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209622	Green Accepted, Bronze			2022-12-28	WOS:000326934300014
J	Barouch, DH; Stephenson, KE; Borducchi, EN; Smith, K; Stanley, K; McNally, AG; Liu, JY; Abbink, P; Maxfield, LF; Seaman, MS; Dugast, AS; Alter, G; Ferguson, M; Li, WJ; Earl, PL; Moss, B; Giorgi, EE; Szinger, JJ; Eller, LA; Billings, EA; Rao, M; Tovanabutra, S; Sanders-Buell, E; Weijtens, M; Pau, MG; Schuitemaker, H; Robb, ML; Kim, JH; Korber, BT; Michael, NL				Barouch, Dan H.; Stephenson, Kathryn E.; Borducchi, Erica N.; Smith, Kaitlin; Stanley, Kelly; McNally, Anna G.; Liu, Jinyan; Abbink, Peter; Maxfield, Lori F.; Seaman, Michael S.; Dugast, Anne-Sophie; Alter, Galit; Ferguson, Melissa; Li, Wenjun; Earl, Patricia L.; Moss, Bernard; Giorgi, Elena E.; Szinger, James J.; Eller, Leigh Anne; Billings, Erik A.; Rao, Mangala; Tovanabutra, Sodsai; Sanders-Buell, Eric; Weijtens, Mo; Pau, Maria G.; Schuitemaker, Hanneke; Robb, Merlin L.; Kim, Jerome H.; Korber, Bette T.; Michael, Nelson L.			Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys	CELL			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE RESPONSES; IMMUNE CONTROL; BREADTH; AIDS; IMMUNOGENICITY; DIVERSITY; INFECTION; MACAQUES; COVERAGE	The global diversity of HIV-1 represents a critical challenge facing HIV-1 vaccine development. HIV-1 mosaic antigens are bioinformatically optimized immunogens designed for improved coverage of HIV-1 diversity. However, the protective efficacy of such global HIV-1 vaccine antigens has not previously been evaluated. Here, we demonstrate the capacity of bivalent HIV-1 mosaic antigens to protect rhesus monkeys against acquisition of infection following heterologous challenges with the difficult-to-neutralize simian-human immunodeficiency virus SHIV-SF162P3. Adenovirus/poxvirus and adenovirus/adenovirus vector-based vaccines expressing HIV-1 mosaic Env, Gag, and Pol afforded a significant reduction in the per-exposure acquisition risk following repetitive, intrarectal SHIV-SF162P3 challenges. Protection against acquisition of infection correlated with vaccine-elicited binding, neutralizing, and functional nonneutralizing antibodies, suggesting that the coordinated activity of multiple antibody functions may contribute to protection against difficult-to-neutralize viruses. These data demonstrate the protective efficacy of HIV-1 mosaic antigens and suggest a potential strategy for the development of a global HIV-1 vaccine.	[Barouch, Dan H.; Stephenson, Kathryn E.; Borducchi, Erica N.; Smith, Kaitlin; Stanley, Kelly; McNally, Anna G.; Liu, Jinyan; Abbink, Peter; Maxfield, Lori F.; Seaman, Michael S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.; Dugast, Anne-Sophie; Alter, Galit] Ragon Inst MGH Massachusetts Inst Technol & Harva, Boston, MA 02114 USA; [Ferguson, Melissa] Alpha Genesis Inc, Yemassee, SC 29945 USA; [Li, Wenjun] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Earl, Patricia L.; Moss, Bernard] NIAID, Bethesda, MD 20892 USA; [Giorgi, Elena E.; Szinger, James J.; Korber, Bette T.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Eller, Leigh Anne; Billings, Erik A.; Rao, Mangala; Tovanabutra, Sodsai; Sanders-Buell, Eric; Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD 20850 USA; [Weijtens, Mo; Pau, Maria G.; Schuitemaker, Hanneke] Crucell Holland BV, NL-2301 CA Leiden, Netherlands	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Johnson & Johnson	Barouch, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019; Li, Wenjun/F-5634-2015; Dugast, AnneSophie/L-9541-2015	Li, Wenjun/0000-0001-5335-7386; Moss, Bernard/0000-0002-2154-8564; Korber, Bette/0000-0002-2026-5757; Stephenson, Kathryn/0000-0002-3440-4105; Szinger, James/0000-0002-6605-9940	U.S. Military Research and Material Command; U.S. Military HIV Research Program [W81XWH-07-2-0067]; National Institutes of Health [AI052074, AI060354, AI078526, AI084794, AI095985, AI096040, AI100645]; NIAID Division of Intramural Research; Ragon Institute of MGH, MIT, and Harvard; Bill and Melinda Gates Foundation [OPP1033091, OPP1040741]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084794, ZIAAI000416, T32AI007387, P30AI060354, U19AI095985, UM1AI100663, T32AI052074, U19AI078526, U19AI096040, UM1AI100645] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD012217] Funding Source: NIH RePORTER	U.S. Military Research and Material Command; U.S. Military HIV Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ragon Institute of MGH, MIT, and Harvard; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Pensiero, S. Blackmore, R. Bradsky, C. Cabral, A. Cheung, J. Goudsmit, R. Hamel, B. Hibl, S. Howell, M. Iampietro, K. Kelly, D. Lynch, M. Marovich, C. Miller, J. Nkolola, A. O'Sullivan, L. Parenteau, J. Perry, W. Rinaldi, J. Sadoff, A. SanMiguel, N. Simmons, J. Smith, F. Stephens, D. van Manen, G. Westergaard, and L. Wyatt for generous advice, assistance, and reagents. The HIV-1 PTE peptides were obtained from the NIH AIDS Research and Reference Reagent Program. We acknowledge support from the U.S. Military Research and Material Command and the U.S. Military HIV Research Program (W81XWH-07-2-0067); the National Institutes of Health (AI052074, AI060354, AI078526, AI084794, AI095985, AI096040, and AI100645); the NIAID Division of Intramural Research; the Ragon Institute of MGH, MIT, and Harvard; and the Bill and Melinda Gates Foundation (OPP1033091 and OPP1040741). M. W., M. G. P., and H. S. are employees of Crucell. Beth Israel Deaconess Medical Center and Los Alamos National Laboratory are co-owners of an HIV-1 mosaic antigen patent that has been licensed to Crucell. The opinions in this manuscript are those of the authors and do not reflect the views of the U.S. Department of the Army or the Department of Defense.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fischer W, 2012, J VIROL, V86, P13217, DOI 10.1128/JVI.01862-12; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hudgens MG, 2009, BIOMETRICS, V65, P1223, DOI 10.1111/j.1541-0420.2009.01189.x; Hudgens MG, 2009, J INFECT DIS, V200, P609, DOI 10.1086/600891; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Montefiori D.C., 2004, CURRENT PROTOC IMMUN, V64; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Reimann KA, 1996, J VIROL, V70, P3198, DOI 10.1128/JVI.70.5.3198-3206.1996; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Ren WZ, 2013, J VIROL, V87, P6137, DOI 10.1128/JVI.00178-13; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Siddappa NB, 2011, J MED PRIMATOL, V40, P120, DOI 10.1111/j.1600-0684.2010.00454.x; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Stephenson KE, 2013, IMMUNOL REV, V254, P295, DOI 10.1111/imr.12073; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Walker BD, 2001, NAT IMMUNOL, V2, P473, DOI 10.1038/88656; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	37	267	284	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					531	539		10.1016/j.cell.2013.09.061	http://dx.doi.org/10.1016/j.cell.2013.09.061			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243013	Green Accepted, Bronze			2022-12-28	WOS:000326571800009
J	Fang, XY; Wang, JB; O'Carroll, IP; Mitchell, M; Zuo, XB; Wang, Y; Yu, P; Liu, Y; Rausch, JW; Dyba, MA; Kjems, J; Schwieters, CD; Seifert, S; Winans, RE; Watts, NR; Stahl, SJ; Wingfield, PT; Byrd, RA; Le Grice, SFJ; Rein, A; Wang, YX				Fang, Xianyang; Wang, Jinbu; O'Carroll, Ina P.; Mitchell, Michelle; Zuo, Xiaobing; Wang, Yi; Yu, Ping; Liu, Yu; Rausch, Jason W.; Dyba, Marzena A.; Kjems, Jorgen; Schwieters, Charles D.; Seifert, Soenke; Winans, Randall E.; Watts, Norman R.; Stahl, Stephen J.; Wingfield, Paul T.; Byrd, R. Andrew; Le Grice, Stuart F. J.; Rein, Alan; Wang, Yun-Xing			An Unusual Topological Structure of the HIV-1 Rev Response Element	CELL			English	Article							GENE-EXPRESSION REQUIRES; SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; SECONDARY STRUCTURE; VIRION EXPRESSION; TRANS-ACTIVATOR; RNA; BINDING; PROTEIN	Nuclear export of unspliced and singly spliced viral mRNA is a critical step in the HIV life cycle. The structural basis by which the virus selects its own mRNA among more abundant host cellular RNAs for export has been a mystery for more than 25 years. Here, we describe an unusual topological structure that the virus uses to recognize its own mRNA. The viral Rev response element (RRE) adopts an "A"-like structure in which the two legs constitute two tracks of binding sites for the viral Rev protein and position the two primary known Rev-binding sites similar to 55 angstrom apart, matching the distance between the two RNAbinding motifs in the Rev dimer. Both the legs of the "A" and the separation between them are required for optimal RRE function. This structure accounts for the specificity of Rev for the RRE and thus the specific recognition of the viral RNA.	[Fang, Xianyang; Wang, Jinbu; Zuo, Xiaobing; Yu, Ping; Liu, Yu; Wang, Yun-Xing] NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, HIV Drug Resistance Program,Ctr Canc Res,NIH, Frederick, MD 21702 USA; [O'Carroll, Ina P.; Rein, Alan] NCI, Retroviral Assembly Sect, HIV Drug Resistance Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Mitchell, Michelle; Wang, Yi; Rausch, Jason W.; Le Grice, Stuart F. J.] NCI, RT Biochem Sect, HIV Drug Resistance Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Yu, Ping; Dyba, Marzena A.] SAIC Frederick, Struct Biophys Lab, Frederick, MD 21702 USA; [Kjems, Jorgen] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Schwieters, Charles D.] NIH, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Seifert, Soenke; Winans, Randall E.] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Watts, Norman R.; Stahl, Stephen J.; Wingfield, Paul T.] NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA; [Byrd, R. Andrew] NCI, Macromol NMR Sect, Struct Biophys Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Aarhus University; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); United States Department of Energy (DOE); Argonne National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rein, A (corresponding author), NCI, Retroviral Assembly Sect, HIV Drug Resistance Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA.	reina@mail.nih.gov; wangyunx@mail.nih.gov	Byrd, R. Andrew/F-8042-2015; Kjems, Jorgen/I-3490-2016; O'Carroll, Ina Puleri/GZH-1001-2022	Byrd, R. Andrew/0000-0003-3625-4232; Kjems, Jorgen/0000-0003-4128-9317; O'Carroll, Ina Puleri/0000-0002-1331-9155; Wingfield, Paul/0000-0002-9515-4752; Fang, Xianyang/0000-0001-9432-9736; Winans, Randall/0000-0002-7080-7673	Intramural Research Program of the National Institutes of Health, National Cancer Institute (NCI) Center for Cancer Research; National Institute of Arthritis, Musculoskeletal and Skin Diseases; Center for Information Technology; SAIC-Frederick [HHSN26120080001E]; U.S. DOE [DE-AC02-06CH11357]; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010379, ZIABC011132] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute (NCI) Center for Cancer Research; National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center for Information Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); SAIC-Frederick; U.S. DOE(United States Department of Energy (DOE)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Stephen Hughes, Alexander Wlodawer, and Prof. James Williamson for discussion. This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute (NCI) Center for Cancer Research; National Institute of Arthritis, Musculoskeletal and Skin Diseases; Center for Information Technology; and SAIC-Frederick under contract HHSN26120080001E. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Bailor MH, 2011, CURR OPIN STRUC BIOL, V21, P296, DOI 10.1016/j.sbi.2011.03.009; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Chapman RL, 2002, ANTIVIR RES, V54, P149, DOI 10.1016/S0166-3542(01)00222-4; Clore GM, 2003, J AM CHEM SOC, V125, P1518, DOI 10.1021/ja028383j; COOK KS, 1991, NUCLEIC ACIDS RES, V19, P1577, DOI 10.1093/nar/19.7.1577; DALY TJ, 1993, BIOCHEMISTRY-US, V32, P10497, DOI 10.1021/bi00090a028; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; Daugherty MD, 2008, MOL CELL, V31, P824, DOI 10.1016/j.molcel.2008.07.016; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; Daugherty MD, 2010, P NATL ACAD SCI USA, V107, P12481, DOI 10.1073/pnas.1007022107; Debye P, 1915, ANN PHYS-BERLIN, V46, P809; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Funari SS, 2000, J BIOL CHEM, V275, P31283, DOI 10.1074/jbc.M004974200; Hajdin CE, 2010, RNA, V16, P1340, DOI 10.1261/rna.1837410; Hammarskjold ML, 2011, VIRUSES-BASEL, V3, P484, DOI 10.3390/v3050484; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HEAPHY S, 1991, P NATL ACAD SCI USA, V88, P7366, DOI 10.1073/pnas.88.16.7366; Hoffmann D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038305; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; Jacques DA, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-9; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Laing C, 2009, J MOL BIOL, V390, P547, DOI 10.1016/j.jmb.2009.04.084; Landt SG, 2005, J MOL BIOL, V351, P982, DOI 10.1016/j.jmb.2005.07.001; Legiewicz M, 2008, P NATL ACAD SCI USA, V105, P14365, DOI 10.1073/pnas.0804461105; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lipfert J, 2008, STRUCTURE, V16, P1357, DOI 10.1016/j.str.2008.07.007; Lusvarghi S, 2013, NUCLEIC ACIDS RES, V41, P6637, DOI 10.1093/nar/gkt353; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; McColl DJ, 1999, P NATL ACAD SCI USA, V96, P9521, DOI 10.1073/pnas.96.17.9521; Mishra SH, 2009, J MOL BIOL, V393, P369, DOI 10.1016/j.jmb.2009.07.066; Pond SJK, 2009, P NATL ACAD SCI USA, V106, P1404, DOI 10.1073/pnas.0807388106; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Reiter NJ, 2011, CURR OPIN STRUC BIOL, V21, P319, DOI 10.1016/j.sbi.2011.03.003; Schwieters CD, 2007, BIOCHEMISTRY-US, V46, P1152, DOI 10.1021/bi061943x; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Shuck-Lee D, 2008, ANTIMICROB AGENTS CH, V52, P3169, DOI 10.1128/AAC.00274-08; Srinivasakumar N, 1997, J VIROL, V71, P5841, DOI 10.1128/JVI.71.8.5841-5848.1997; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang H, 2010, BIOPHYS J, V99, P3454, DOI 10.1016/j.bpj.2010.09.051; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Xu W, 1996, P NATL ACAD SCI USA, V93, P7475, DOI 10.1073/pnas.93.15.7475; ZAPP ML, 1991, P NATL ACAD SCI USA, V88, P7734, DOI 10.1073/pnas.88.17.7734; Zuo XB, 2006, P NATL ACAD SCI USA, V103, P3534, DOI 10.1073/pnas.0600022103	57	96	98	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					594	605		10.1016/j.cell.2013.10.008	http://dx.doi.org/10.1016/j.cell.2013.10.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243017	Bronze, Green Accepted			2022-12-28	WOS:000326571800014
J	Van Gaal, LF; Maggioni, AP				Van Gaal, Luc F.; Maggioni, Aldo P.			Overweight, obesity, and outcomes: fat mass and beyond	LANCET			English	Editorial Material							BLOOD-PRESSURE; RISK-FACTOR; DISEASE; INTERVENTION; MECHANISMS; MORTALITY		[Van Gaal, Luc F.] Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab, Fac Med, B-2650 Antwerp, Belgium; [Maggioni, Aldo P.] ANMCO Res Ctr, Florence, Italy	University of Antwerp; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)	Van Gaal, LF (corresponding author), Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab, Fac Med, B-2650 Antwerp, Belgium.	luc.van.gaal@uza.be	Maggioni, Aldo Pietro/AAL-5334-2020	Maggioni, Aldo Pietro/0000-0003-2764-6779				Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Lavie P, 2007, J SLEEP RES, V16, P128, DOI 10.1111/j.1365-2869.2007.00578.x; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; McAlister FA, 2013, CAN J CARDIOL, V29, P598, DOI 10.1016/j.cjca.2012.12.004; Misiak B, 2012, BRAIN RES BULL, V89, P144, DOI 10.1016/j.brainresbull.2012.08.003; Samaranayake NR, 2012, ANN EPIDEMIOL, V22, P349, DOI 10.1016/j.annepidem.2012.01.001; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	12	30	30	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					935	936		10.1016/S0140-6736(13)62076-0	http://dx.doi.org/10.1016/S0140-6736(13)62076-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MR	24269110				2022-12-28	WOS:000333520700007
J	Raghavan, M; Skoglund, P; Graf, KE; Metspalu, M; Albrechtsen, A; Moltke, I; Rasmussen, S; Stafford, TW; Orlando, L; Metspalu, E; Karmin, M; Tambets, K; Rootsi, S; Magi, R; Campos, PF; Balanovska, E; Balanovsky, O; Khusnutdinova, E; Litvinov, S; Osipova, LP; Fedorova, SA; Voevoda, MI; DeGiorgio, M; Sicheritz-Ponten, T; Brunak, S; Demeshchenko, S; Kivisild, T; Villems, R; Nielsen, R; Jakobsson, M; Willerslev, E				Raghavan, Maanasa; Skoglund, Pontus; Graf, Kelly E.; Metspalu, Mait; Albrechtsen, Anders; Moltke, Ida; Rasmussen, Simon; Stafford, Thomas W., Jr.; Orlando, Ludovic; Metspalu, Ene; Karmin, Monika; Tambets, Kristiina; Rootsi, Siiri; Maegi, Reedik; Campos, Paula F.; Balanovska, Elena; Balanovsky, Oleg; Khusnutdinova, Elza; Litvinov, Sergey; Osipova, Ludmila P.; Fedorova, Sardana A.; Voevoda, Mikhail I.; DeGiorgio, Michael; Sicheritz-Ponten, Thomas; Brunak, Soren; Demeshchenko, Svetlana; Kivisild, Toomas; Villems, Richard; Nielsen, Rasmus; Jakobsson, Mattias; Willerslev, Eske			Upper Palaeolithic Siberian genome reveals dual ancestry of Native Americans	NATURE			English	Article							MITOCHONDRIAL-DNA; HUNTER-GATHERERS; GENETIC HISTORY; ANCIENT; RADIOCARBON; SEQUENCE; ORIGINS; DIVERSITY; ACCURACY; CAVE	The origins of the First Americans remain contentious. Although Native Americans seem to be genetically most closely related to east Asians(1-3), there is no consensus with regard to which specific Old World populations they are closest to(4-8). Here we sequence the draft genome of an approximately 24,000-year-old individual (MA-1), from Mal'ta in south-central Siberia(9), to an average depth of 1x. To our knowledge this is the oldest anatomically modern human genome reported to date. The MA-1 mitochondrial genome belongs to haplogroup U, which has also been found at high frequency among Upper Palaeolithic and Mesolithic European hunter-gatherers(10-12), and the Y chromosome of MA-1 is basal to modern-day western Eurasians and near the root of most Native American lineages(5). Similarly, we find autosomal evidence that MA-1 is basal to modern-day western Eurasians and genetically closely related to modern-day Native Americans, with no close affinity to east Asians. This suggests that populations related to contemporary western Eurasians had a more north-easterly distribution 24,000 years ago than commonly thought. Furthermore, we estimate that 14 to 38% of Native American ancestry may originate through gene flow from this ancient population. This is likely to have occurred after the divergence of Native American ancestors from east Asian ancestors, but before the diversification of Native American populations in the New World. Gene flow from the MA-1 lineage into Native American ancestors could explain why several crania from the First Americans have been reported as bearing morphological characteristics that do not resemble those of east Asians(2,13). Sequencing of another south-central Siberian, Afontova Gora-2 dating to approximately 17,000 years ago(14), revealed similar autosomal genetic signatures as MA-1, suggesting that the region was continuously occupied by humans throughout the Last Glacial Maximum. Our findings reveal that western Eurasian genetic signatures in modern-day Native Americans derive not only from post-Columbian admixture, as commonly thought, but also from a mixed ancestry of the First Americans.	[Raghavan, Maanasa; Stafford, Thomas W., Jr.; Orlando, Ludovic; Campos, Paula F.; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Skoglund, Pontus; Jakobsson, Mattias] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [Graf, Kelly E.] Texas A&M Univ, Ctr Study Amer 1, College Stn, TX 77845 USA; [Metspalu, Mait; Karmin, Monika; Tambets, Kristiina; Rootsi, Siiri; Litvinov, Sergey; Kivisild, Toomas; Villems, Richard] Estonian Bioctr, Evolutionary Biol Grp, EE-51010 Tartu, Estonia; [Metspalu, Mait; DeGiorgio, Michael; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Metspalu, Mait; Metspalu, Ene; Karmin, Monika; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Albrechtsen, Anders; Moltke, Ida] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Moltke, Ida] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Rasmussen, Simon] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Stafford, Thomas W., Jr.] Univ Aarhus, Dept Phys & Astron, AMS Dating Ctr 14C, DK-8000 Aarhus, Denmark; [Maegi, Reedik] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Balanovska, Elena; Balanovsky, Oleg] Russian Acad Med Sci, Res Ctr Med Genet, Moscow 115479, Russia; [Balanovsky, Oleg] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 119991, Russia; [Khusnutdinova, Elza; Litvinov, Sergey] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa 450054, Bashkorostan, Russia; [Khusnutdinova, Elza] Bashkir State Univ, Biol Dept, Ufa 450054, Bashkorostan, Russia; [Osipova, Ludmila P.; Voevoda, Mikhail I.] Russian Acad Sci, Siberian Branch, Ctr Brain Neurobiol & Neurogenet, Inst Cytol & Genet, Novosibirsk 630090, Russia; [Fedorova, Sardana A.] Russian Acad Med Sci, Yakut Res Ctr Complex Med Problems, Dept Mol Genet, Sakha 677010, Yakutia, Russia; [Fedorova, Sardana A.] North Eastern Fed Univ, Sakha 677010, Yakutia, Russia; [Voevoda, Mikhail I.] North Eastern Fed Univ, Sakha 677010, Yakutia, Russia; [Sicheritz-Ponten, Thomas; Brunak, Soren] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Demeshchenko, Svetlana] State Hermitage Museum, St Petersburg 190000, Russia; [Kivisild, Toomas] Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 1QH, England; [Villems, Richard] Estonian Acad Sci, EE-10130 Tallinn, Estonia; [Jakobsson, Mattias] Uppsala Univ, Sci Life Lab, S-75236 Uppsala, Sweden	University of Copenhagen; Uppsala University; Texas A&M University System; Texas A&M University College Station; Estonian Biocentre; University of California System; University of California Berkeley; University of Tartu; University of Copenhagen; University of Chicago; Technical University of Denmark; Aarhus University; University of Tartu; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Medical Sciences; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk; Technical University of Denmark; State Hermitage Museum; University of Cambridge; Estonian Academy of Sciences; Uppsala University	Willerslev, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.	ewillerslev@snm.ku.dk	Tambets, Kristiina/M-2568-2019; Jakobsson, Mattias/A-6116-2011; Willerslev, Eske/A-9619-2011; Metspalu, Mait/G-8671-2015; Rasmussen, Simon/AAA-2308-2020; Rasmussen, Simon/G-6258-2016; Albrechtsen, Anders/K-4281-2013; Fedorova, Sardana/K-5445-2017; Kivisild, Toomas/P-5889-2017; Balanovsky, Oleg/G-1549-2014; Voevoda, Mikhail/N-6713-2015; Osipova, Ludmila P/O-6480-2014; Litvinov, Sergey/L-1738-2013; Mägi, Reedik/AAJ-9679-2021; Khusnutdinova, Elza Kamilevna/A-4810-2013; Campos, Paula/ABF-9898-2021; Moltke, Ida/C-6158-2011; Orlando, Ludovic/A-8932-2013; Willerslev, Eske/AAA-5686-2019; Campos, Paula F/B-1634-2010; Sicheritz-Ponten, Thomas/A-4325-2017; Nielsen, Rasmus/D-4405-2009; Brunak, Soren/O-6621-2016	Tambets, Kristiina/0000-0002-8173-6380; Jakobsson, Mattias/0000-0001-7840-7853; Willerslev, Eske/0000-0002-7081-6748; Metspalu, Mait/0000-0003-3099-9161; Rasmussen, Simon/0000-0001-6323-9041; Rasmussen, Simon/0000-0001-6323-9041; Albrechtsen, Anders/0000-0001-7306-031X; Kivisild, Toomas/0000-0002-6297-7808; Voevoda, Mikhail/0000-0001-9425-413X; Osipova, Ludmila P/0000-0001-7602-1156; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Moltke, Ida/0000-0001-7052-8554; Orlando, Ludovic/0000-0003-3936-1850; Campos, Paula F/0000-0003-1285-4671; Skoglund, Pontus/0000-0002-3021-5913; Magi, Reedik/0000-0002-2964-6011; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Karmin, Monika/0000-0001-9827-5579; Raghavan, Maanasa/0000-0003-1997-0739; Nielsen, Rasmus/0000-0003-0513-6591; Fedorova, Sardana/0000-0002-6952-3868; Brunak, Soren/0000-0003-0316-5866	Danish National Research Foundation; Lundbeck Foundation; Arctic Social Sciences Program, National Science Foundation [PLR-1003725]; European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre; University of Tartu and Estonian Basic Research grant [SF0270177As08]; Estonian Science Foundation [8973]; Baltic-American Freedom Foundation Research Scholarship program; Government of Russian Federation [14.B25.31.0033]; US National Science Foundation [DBI-1103639]; Swedish National Infrastructure for Computing (SNIC-UPPMAX) [b2012063]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; Villum Fonden [00007171] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Arctic Social Sciences Program, National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre; University of Tartu and Estonian Basic Research grant; Estonian Science Foundation; Baltic-American Freedom Foundation Research Scholarship program; Government of Russian Federation; US National Science Foundation(National Science Foundation (NSF)); Swedish National Infrastructure for Computing (SNIC-UPPMAX); Novo Nordisk Fonden(Novo Nordisk Foundation); Villum Fonden(Villum Fonden); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Hermitage State Museum for providing access to the Mal'ta and Afontova Gora-2 human remains. We also thank the Danish National High-Throughput DNA Sequencing Centre and T. Reisberg for technical assistance. This work was supported by the Danish National Research Foundation and the Lundbeck Foundation (E. W. and M. R.) and the Arctic Social Sciences Program, National Science Foundation (grant PLR-1003725 to K. E. G.). R. V., M. M., M. K., E. M., K. T., S. Ro. and R. M. were supported by the European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre and University of Tartu and Estonian Basic Research grant SF0270177As08. M. M. thanks the Estonian Science Foundation grant no. 8973 and Baltic-American Freedom Foundation Research Scholarship program and M. I. V. thanks the Government of Russian Federation grant no. 14.B25.31.0033 (to E. I. Rogaev). M. D. was supported by the US National Science Foundation (grant DBI-1103639). Computational analyses were carried out at the High Performance Computing Center, University of Tartu, and the Swedish National Infrastructure for Computing (SNIC-UPPMAX, project b2012063).	Abramova Z.A., 1995, LART PALEOLITHIQUE D; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Astakhov S. N., 1999, PALEOLIT ENISEIA PAL; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bradley B, 2004, WORLD ARCHAEOL, V36, P459, DOI 10.1080/0043824042000303656; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; GAMBLE C, 1982, MAN, V17, P92, DOI 10.2307/2802103; Gerasimov M. M., 1964, THE ARCHAEOLOGY AND, P5; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hubbe M, 2011, AM J PHYS ANTHROPOL, V144, P442, DOI 10.1002/ajpa.21425; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Lipson M., 2013, MOL BIOL EVOL; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Owsley D. W., 2002, CLAIMING THE STONES; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; POWELL R, 2002, OXFORD PRACTICAL APP; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Regueiro M, 2013, AM J PHYS ANTHROPOL, V150, P333, DOI 10.1002/ajpa.22207; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; STAFFORD TW, 1988, GEOCHIM COSMOCHIM AC, V52, P2257, DOI 10.1016/0016-7037(88)90128-7; STAFFORD TW, 1991, J ARCHAEOL SCI, V18, P35, DOI 10.1016/0305-4403(91)90078-4; STAFFORD TW, 1987, RADIOCARBON, V29, P24; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Surakka I, 2010, GENOME RES, V20, P1344, DOI 10.1101/gr.106534.110; Svensson EM, 2007, ANIM GENET, V38, P378, DOI 10.1111/j.1365-2052.2007.01620.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turner C G 2nd, 1984, Acta Anthropogenet, V8, P23; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wall JD, 2011, MOL BIOL EVOL, V28, P2231, DOI 10.1093/molbev/msr049; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; White R, 2006, J ARCHAEOL METHOD TH, V13, P251, DOI 10.1007/s10816-006-9023-z; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	64	431	445	0	207	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					87	+		10.1038/nature12736	http://dx.doi.org/10.1038/nature12736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24256729	Green Accepted, Green Submitted			2022-12-28	WOS:000329163300029
J	Wang, X; Lu, ZK; Gomez, A; Hon, GC; Yue, YN; Han, DL; Fu, Y; Parisien, M; Dai, Q; Jia, GF; Ren, B; Pan, T; He, C				Wang, Xiao; Lu, Zhike; Gomez, Adrian; Hon, Gary C.; Yue, Yanan; Han, Dali; Fu, Ye; Parisien, Marc; Dai, Qing; Jia, Guifang; Ren, Bing; Pan, Tao; He, Chuan			N-6-methyladenosine-dependent regulation of messenger RNA stability	NATURE			English	Article							BINDING PROTEIN; SITES; DOMAIN; N6-METHYLADENOSINE; TRANSLATION; METHYLATION; SEQUENCES; GRANULES; DECAY; GENE	N-6-methyladenosine (m(6)A) is the most prevalent internal (non-cap) modification present in the messenger RNA of all higher eukaryotes(1,2). Although essential to cell viability and development(3-5), the exact role of m(6)A modification remains to be determined. The recent discovery of two m(6)A demethylases in mammalian cells highlighted the importance of m(6)A in basic biological functions and disease(6-8). Here we show that m(6)A is selectively recognized by the human YTH domain family 2 (YTHDF2) 'reader' protein to regulate mRNA degradation. We identified over 3,000 cellular RNA targets of YTHDF2, most of which are mRNAs, but which also include non-coding RNAs, with a conserved core motif of G(m(6)A)C. We further establish the role of YTHDF2 in RNA metabolism, showing that binding of YTHDF2 results in the localization of bound mRNA from the translatable pool to mRNA decay sites, such as processing bodies(9). The carboxy-terminal domain of YTHDF2 selectively binds to m(6)A-containing mRNA, whereas the amino-terminal domain is responsible for the localization of the YTHDF2-mRNA complex to cellular RNA decay sites. Our results indicate that the dynamic m(6)A modification is recognized by selectively binding proteins to affect the translation status and lifetime of mRNA.	[Wang, Xiao; Lu, Zhike; Gomez, Adrian; Yue, Yanan; Han, Dali; Fu, Ye; Dai, Qing; Jia, Guifang; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Wang, Xiao; Lu, Zhike; Gomez, Adrian; Yue, Yanan; Han, Dali; Fu, Ye; Parisien, Marc; Dai, Qing; Jia, Guifang; Pan, Tao; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Hon, Gary C.; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med,UCSD Moores Canc Ctr, La Jolla, CA 92093 USA; [Hon, Gary C.; Ren, Bing] Univ Calif San Diego, Sch Med, Inst Genome Med, La Jolla, CA 92093 USA; [Parisien, Marc; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Jia, Guifang] Peking Univ, Dept Chem Biol, Beijing 100871, Peoples R China; [Jia, Guifang] Peking Univ, Synthet & Funct Biomol Ctr, Coll Chem & Mol Engn, Beijing 100871, Peoples R China	University of Chicago; University of Chicago; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Chicago; Peking University; Peking University	He, C (corresponding author), Univ Chicago, Dept Chem, 929 East 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Dai, Qing/ABD-8444-2021; Han, Dali/I-4145-2016	Parisien, Marc/0000-0003-2924-5960; Wang, Xiao/0000-0002-3090-9894; Fu, Ye/0000-0002-3807-9717; Fu, Ye/0000-0003-4434-6014	National Institutes of Health [GM071440]; EUREKA [GM088599]; National Science Foundation [CHE-1048528]; Direct For Mathematical & Physical Scien [1048528] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088599, R01GM071440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUREKA; National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health GM071440 (C. H.) and EUREKA GM088599 (T. P. and C. H.). The Mass Spectrometry Facility of the University of Chicago is funded by National Science Foundation (CHE-1048528). We thank A. E. Kulozik, W. Filipowicz and J. A. Steitz for providing the sequence and plasmids of the tether reporter. We thank Dr. G. Zheng and W. Clark for help in polysome profiling. We also thank S. F. Reichard for editing the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bokar JA, 1997, RNA, V3, P1233; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cardelli M, 2006, J GERONTOL A-BIOL, V61, P547, DOI 10.1093/gerona/61.6.547; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Clement Sandra L., 2008, V419, P121, DOI 10.1007/978-1-59745-033-1_8; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Dandekar T., 2002, RNA MOTIFS REGULATOR, P1; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Morris D. R., 1997, MRNA FORMATION FUNCT; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TUCK MT, 1992, INT J BIOCHEM, V24, P379, DOI 10.1016/0020-711X(92)90028-Y; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	41	2094	2187	39	511	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					117	+		10.1038/nature12730	http://dx.doi.org/10.1038/nature12730			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24284625	Green Accepted			2022-12-28	WOS:000329163300035
J	Afsana, K; Wahid, SS				Afsana, Kaosar; Wahid, Syed Shabab			Health care for poor people in the urban slums of Bangladesh	LANCET			English	Editorial Material									[Afsana, Kaosar; Wahid, Syed Shabab] BRAC, Hlth Nutr & Populat, Dhaka 1212, Bangladesh; [Afsana, Kaosar] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh	Bangladesh Rural Advancement Committee BRAC; Bangladesh Rural Advancement Committee BRAC; BRAC University	Afsana, K (corresponding author), BRAC, Hlth Nutr & Populat, Dhaka 1212, Bangladesh.	afsana.k@brac.net		Wahid, Syed/0000-0003-0355-0537; Afsana, Kaosar/0000-0002-5197-8151				Bangladesh Bureau of Statistics UNICEF, 2010, MULT IND CLUST SURV; Democracy Watch, 2010, HLTH PROBL WOM LIV S; Dreze J., 2013, UNCERTAIN GLORY INDI, DOI 10.2307/j.ctt32bcbm; Islam N., 2006, SLUMS URBAN BANGLADE; Osman FA, 2009, ASIA PAC DEV J, V16, P27; Rashid SF, 2009, J HEALTH POPUL NUTR, V27, P574; Sabin KM, 2003, INT J STD AIDS, V14, P614, DOI 10.1258/095646203322301077; Saunders Doug., 2011, ARRIVAL CITY LARGEST; UN Population Division, 2012, COUNTR PROF BANGL; UNICEF, 2010, UNDERSTANDING URBAN; UNICEF, 2008, SAN HYG WAT SUPPL UR; Zhang LX, 2006, CHIN ECON, V39, P57, DOI 10.2753/CES1097-1475390404	12	20	20	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2049	2051		10.1016/S0140-6736(13)62295-3	http://dx.doi.org/10.1016/S0140-6736(13)62295-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24268606				2022-12-28	WOS:000328687800013
J	Yu, CC; Fornoni, A; Weins, A; Hakroush, S; Maiguel, D; Sageshima, J; Chen, L; Ciancio, G; Faridi, MH; Behr, D; Campbell, KN; Chang, JM; Chen, HC; Oh, J; Faul, C; Arnaout, MA; Fiorina, P; Gupta, V; Greka, A; Burke, GW; Mundel, P				Yu, Chih-Chuan; Fornoni, Alessia; Weins, Astrid; Hakroush, Samy; Maiguel, Dony; Sageshima, Junichiro; Chen, Linda; Ciancio, Gaetano; Faridi, Mohd Hafeez; Behr, Daniel; Campbell, Kirk N.; Chang, Jer-Ming; Chen, Hung-Chun; Oh, Jun; Faul, Christian; Arnaout, M. Amin; Fiorina, Paolo; Gupta, Vineet; Greka, Anna; Burke, George W., III; Mundel, Peter			Abatacept in B7-1-Positive Proteinuric Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RHEUMATOID-ARTHRITIS; INTEGRIN ACTIVATION; PODOCYTES; TALIN	Abatacept (cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion protein [CTLA-4-Ig]) is a costimulatory inhibitor that targets B7-1 (CD80). The present report describes five patients who had focal segmental glomerulosclerosis (FSGS) (four with recurrent FSGS after transplantation and one with primary FSGS) and proteinuria with B7-1 immunostaining of podocytes in kidney-biopsy specimens. Abatacept induced partial or complete remissions of proteinuria in these patients, suggesting that B7-1 may be a useful biomarker for the treatment of some glomerulopathies. Our data indicate that abatacept may stabilize 1-integrin activation in podocytes and reduce proteinuria in patients with B7-1-positive glomerular disease.	[Yu, Chih-Chuan; Weins, Astrid; Hakroush, Samy; Maiguel, Dony; Arnaout, M. Amin; Greka, Anna; Mundel, Peter] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Yu, Chih-Chuan; Weins, Astrid; Hakroush, Samy; Behr, Daniel; Arnaout, M. Amin; Greka, Anna; Mundel, Peter] Harvard Univ, Sch Med, Boston, MA USA; [Weins, Astrid] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Fiorina, Paolo] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Yu, Chih-Chuan] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chang, Jer-Ming; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Dept Internal Med, Kaohsiung, Taiwan; [Fornoni, Alessia; Maiguel, Dony; Faridi, Mohd Hafeez; Faul, Christian; Gupta, Vineet] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Sageshima, Junichiro; Chen, Linda; Ciancio, Gaetano; Burke, George W., III] Univ Miami, Miller Sch Med, Lilian Jean Kaplan Div Kidney Pancreas Transplant, Miami Transplant Inst,Dept Surg, Miami, FL 33136 USA; [Campbell, Kirk N.] Mt Sinai Sch Med, Div Nephrol, New York, NY USA; [Oh, Jun] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Hamburg, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Kaohsiung Medical University; Kaohsiung Medical University; University of Miami; University of Miami; Icahn School of Medicine at Mount Sinai; University of Hamburg; University Medical Center Hamburg-Eppendorf	Mundel, P (corresponding author), Massachusetts Gen Hosp, Div Nephrol, 149 13th St, Charlestown, MA 02129 USA.	mundel.peter@mgh.harvard.edu	Oh, Jun/K-4039-2013; Faul, Christian/AAG-7800-2022; Faul, Christian/AFL-7858-2022; Fiorina, Paolo/B-4532-2019	Faul, Christian/0000-0002-7512-0977; Faul, Christian/0000-0002-7512-0977; Hakroush, Samy/0000-0002-2843-3567; Fiorina, Paolo/0000-0002-1093-7724; fornoni, Alessia/0000-0002-1313-7773	National Institutes of Health [DK57683, DK062472, DK093783, DK068253, HL109582, DK0903616, DK090316, DK083511, DK093746]; Boston Area Diabetes Endocrinology Research Center; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK057521]; Deutsche Forschungsgemeinschaft [HA 6334/1-1]; NephCure Foundation; Transplant Foundation of South Florida; American Society of Nephrology; NephCure Young Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091218, R01DK048549, R56DK093746, K08DK083511, R01DK088327, P30DK057521, R01DK084195, R01DK090316, K08DK093783, K01DK068253, R01DK062472, R01DK057683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes Endocrinology Research Center; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NephCure Foundation; Transplant Foundation of South Florida; American Society of Nephrology; NephCure Young Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (DK57683 and DK062472, to Dr. Mundel; DK093783, to Dr. Weins; DK068253 and HL109582, to Dr. Gupta; DK0903616, to Drs. Fornoni and Burke; and DK090316, DK083511, and DK093746, to Dr. Greka), the Boston Area Diabetes Endocrinology Research Center and the National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, to Dr. Greka), Deutsche Forschungsgemeinschaft (HA 6334/1-1, to Dr. Hakroush), and the NephCure Foundation and Transplant Foundation of South Florida (to Drs. Fornoni and Burke), and by an American Society of Nephrology Gottschalk Career Development Award and a NephCure Young Investigator Award (to Dr. Greka).	Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Gupta V, 2007, BLOOD, V109, P3513, DOI 10.1182/blood-2005-11-056689; Hoi AY, 2012, EXPERT OPIN BIOL TH, V12, P1399, DOI 10.1517/14712598.2012.713934; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075	15	249	268	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2416	2423		10.1056/NEJMoa1304572	http://dx.doi.org/10.1056/NEJMoa1304572			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24206430	Green Accepted, Bronze			2022-12-28	WOS:000328586000009
J	Valentim, CLL; Cioli, D; Chevalier, FD; Cao, XH; Taylor, AB; Holloway, SP; Pica-Mattoccia, L; Guidi, A; Basso, A; Tsai, IJ; Berriman, M; Carvalho-Queiroz, C; Almeida, M; Aguilar, H; Frantz, DE; Hart, PJ; LoVerde, PT; Anderson, TJC				Valentim, Claudia L. L.; Cioli, Donato; Chevalier, Frederic D.; Cao, Xiaohang; Taylor, Alexander B.; Holloway, Stephen P.; Pica-Mattoccia, Livia; Guidi, Alessandra; Basso, Annalisa; Tsai, Isheng J.; Berriman, Matthew; Carvalho-Queiroz, Claudia; Almeida, Marcio; Aguilar, Hector; Frantz, Doug E.; Hart, P. John; LoVerde, Philip T.; Anderson, Timothy J. C.			Genetic and Molecular Basis of Drug Resistance and Species-Specific Drug Action in Schistosome Parasites	SCIENCE			English	Article							HYCANTHONE RESISTANCE; PLASMODIUM-FALCIPARUM; MANSONI; OXAMNIQUINE; SULFOTRANSFERASE; MECHANISMS; LINKAGE; GENOME	Oxamniquine resistance evolved in the human blood fluke (Schistosoma mansoni) in Brazil in the 1970s. We crossed parental parasites differing similar to 500-fold in drug response, determined drug sensitivity and marker segregation in clonally derived second-generation progeny, and identified a single quantitative trait locus (logarithm of odds = 31) on chromosome 6. A sulfotransferase was identified as the causative gene by using RNA interference knockdown and biochemical complementation assays, and we subsequently demonstrated independent origins of loss-of-function mutations in field-derived and laboratory-selected resistant parasites. These results demonstrate the utility of linkage mapping in a human helminth parasite, while crystallographic analyses of protein-drug interactions illuminate the mode of drug action and provide a framework for rational design of oxamniquine derivatives that kill both S. mansoni and S. haematobium, the two species responsible for >99% of schistosomiasis cases worldwide.	[Valentim, Claudia L. L.; Cao, Xiaohang; Taylor, Alexander B.; Holloway, Stephen P.; Carvalho-Queiroz, Claudia; Hart, P. John; LoVerde, Philip T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Valentim, Claudia L. L.; Cao, Xiaohang; Taylor, Alexander B.; Holloway, Stephen P.; Carvalho-Queiroz, Claudia; Hart, P. John; Anderson, Timothy J. C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Valentim, Claudia L. L.; Chevalier, Frederic D.; Almeida, Marcio; Anderson, Timothy J. C.] Texas Biomed Res Inst, San Antonio, TX 78245 USA; [Cioli, Donato; Pica-Mattoccia, Livia; Guidi, Alessandra; Basso, Annalisa] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Tsai, Isheng J.; Berriman, Matthew] Wellcome Trust Sanger Inst, Hinxton, England; [Aguilar, Hector; Frantz, Doug E.] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Wellcome Trust Sanger Institute; University of Texas System; University of Texas at San Antonio (UTSA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Hart, PJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	pjhart@biochem.uthscsa.edu; loverde@uthscsa.edu; tanderso@txbiomedgenetics.org	Guidi, Alessandra/P-1348-2018; Tsai, Isheng Jason/ABB-8273-2021; CHEVALIER, Frédéric D./E-6852-2010; Tsai, Isheng J/H-6606-2014; Berriman, Matthew/A-7618-2011; Guidi, Alessandra/AEO-0770-2022	Tsai, Isheng Jason/0000-0002-2123-5058; CHEVALIER, Frédéric D./0000-0003-2611-8106; Berriman, Matthew/0000-0002-9581-0377; Guidi, Alessandra/0000-0002-2537-1428; Taylor, Alexander/0000-0003-3517-6033	NIH [5R21-AI096277, 5R21-AI072704, R01-AI097576]; World Health Organization [HQNTD1206356]; Research Facilities Improvement Program Grant from National Center for Research Resources (NIH) [C06 RR013556]; Wellcome Trust [098051]; Robert A. Welch Foundation [AQ-1399]; NIH-National Institute of Allergy and Infectious Diseases [HHSN272201000005I]; University of Texas Health Science Center, San Antonio, Office of the Vice President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072704, R21AI096277, R01AI097576] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Health Organization(World Health Organization); Research Facilities Improvement Program Grant from National Center for Research Resources (NIH); Wellcome Trust(Wellcome TrustEuropean Commission); Robert A. Welch Foundation(The Welch Foundation); NIH-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Texas Health Science Center, San Antonio, Office of the Vice President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by NIH (5R21-AI096277, 5R21-AI072704, R01-AI097576) and World Health Organization (HQNTD1206356) in facilities constructed with support from Research Facilities Improvement Program Grant (C06 RR013556) from National Center for Research Resources (NIH). Work at Wellcome Trust Sanger Institute was supported by the Wellcome Trust (grant 098051). P.J.H. was funded by the Robert A. Welch Foundation (AQ-1399). B. glabrata snails were supplied by Fred Lewis (Biomedical Research Institute, Rockville, MD) under NIH-National Institute of Allergy and Infectious Diseases contract no. HHSN272201000005I. We thank W. Le Clec'h and C. Valle (capillary sequencing), Z. Lai (RNA sequencing), N. Holroyd (coordinated genome sequencing), Q. Bickle (RNAi support), and G. Anderson (movie compilation). The X-ray Crystallography Core Laboratory is supported by the University of Texas Health Science Center, San Antonio, Office of the Vice President for Research. The authors declare no competing financial interests. Data deposition: Illumina sequence reads (www.ebi.ac.uk/ena/accession#ERP000160); GenBank accessions (KF733459-61), RNAseq data (www.ncbi.nlm.nih.gov/geo/, GSE51847), structural data (www.wwpdb.org/, accession 4MUA, 4MUB)	Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; CIOLI D, 1985, LIFE SCI, V37, P161, DOI 10.1016/0024-3205(85)90419-9; CIOLI D, 1992, EXP PARASITOL, V75, P425, DOI 10.1016/0014-4894(92)90255-9; Criscione CD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r71; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; DRESCHER KM, 1993, MEM I OSWALDO CRUZ, V88, P89, DOI 10.1590/S0074-02761993000100014; FOSTER R, 1973, T ROY SOC TROP MED H, V67, P674, DOI 10.1016/0035-9203(73)90038-2; Gentile R, 2008, ACTA TROP, V108, P175, DOI 10.1016/j.actatropica.2008.09.003; Gower CM, 2004, EVOLUTION, V58, P1178, DOI 10.1111/j.0014-3820.2004.tb01698.x; Greenberg RM, 2013, PARASITOLOGY, V140, P1534, DOI 10.1017/S0031182013000231; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hotez PJ, 2006, DIS CONTROL PRIORITI, V2nd; Kalbe M, 2004, PARASITOLOGY, V128, P635, DOI 10.1017/S0031182004005037; KATZ N., 1973, Revista da Sociedade Brasileira de Medicina Tropical, V7, P381, DOI 10.1590/S0037-86821973000600008; Lawton SP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-131; LEWIS FA, 1986, J PARASITOL, V72, P813, DOI 10.2307/3281829; Negishi M, 2001, ARCH BIOCHEM BIOPHYS, V390, P149, DOI 10.1006/abbi.2001.2368; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; Pica-Mattoccia L, 2006, MEM I OSWALDO CRUZ, V101, P307, DOI 10.1590/S0074-02762006000900048; PICAMATTOCCIA L, 1993, EXP PARASITOL, V77, P445, DOI 10.1006/expr.1993.1104; PicaMattoccia L, 1997, PARASITOL RES, V83, P687, DOI 10.1007/s004360050320; PICAMATTOCCIA L, 1992, MOL BIOCHEM PARASIT, V55, P167, DOI 10.1016/0166-6851(92)90137-9; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Ranford-Cartwright LC, 2012, INT J PARASITOL, V42, P529, DOI 10.1016/j.ijpara.2012.03.004; ROGERS SH, 1971, SCIENCE, V172, P1057, DOI 10.1126/science.172.3987.1057; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; Sibley LD, 2009, INT J PARASITOL, V39, P915, DOI 10.1016/j.ijpara.2009.02.011; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; VARIN L, 1987, ANAL BIOCHEM, V161, P176, DOI 10.1016/0003-2697(87)90669-5	30	101	105	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1385	1389		10.1126/science.1243106	http://dx.doi.org/10.1126/science.1243106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24263136	Green Accepted			2022-12-28	WOS:000328196000055
J	Lazzerini, M; Martelossi, S; Magazzu, G; Pellegrino, S; Lucanto, MC; Barabino, A; Calvi, A; Arrigo, S; Lionetti, P; Lorusso, M; Mangiantini, F; Fontana, M; Zuin, G; Palla, G; Maggiore, G; Bramuzzo, M; Pellegrin, MC; Maschio, M; Villanacci, V; Manenti, S; Decorti, G; De Iudicibus, S; Paparazzo, R; Montico, M; Ventura, A				Lazzerini, Marzia; Martelossi, Stefano; Magazzu, Giuseppe; Pellegrino, Salvatore; Lucanto, Maria Cristina; Barabino, Arrigo; Calvi, Angela; Arrigo, Serena; Lionetti, Paolo; Lorusso, Monica; Mangiantini, Francesca; Fontana, Massimo; Zuin, Giovanna; Palla, Gabriella; Maggiore, Giuseppe; Bramuzzo, Matteo; Pellegrin, Maria Chiara; Maschio, Massimo; Villanacci, Vincenzo; Manenti, Stefania; Decorti, Giuliana; De Iudicibus, Sara; Paparazzo, Rossella; Montico, Marcella; Ventura, Alessandro			Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn Disease A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLAMMATORY-BOWEL-DISEASE; OPEN-LABEL; THROMBOEMBOLIC EVENTS; PEDIATRIC-PATIENTS; ACTIVITY INDEX; YOUNG-ADULTS; THERAPY; INFLIXIMAB; EFFICACY; SAFETY	IMPORTANCE Pediatric-onset Crohn disease is more aggressive than adult-onset disease, has high rates of resistance to existing drugs, and can lead to permanent impairments. Few trials have evaluated new drugs for refractory Crohn disease in children. OBJECTIVE To determine whether thalidomide is effective in inducing remission in refractory pediatric Crohn disease. DESIGN, SETTING, AND PATIENTS Multicenter, double-blind, placebo-controlled, randomized clinical trial of 56 children with active Crohn disease despite immunosuppressive treatment, conducted August 2008-September 2012 in 6 pediatric tertiary care centers in Italy. INTERVENTIONS Thalidomide, 1.5 to 2.5 mg/kg per day, or placebo once daily for 8 weeks. In an open-label extension, nonresponders to placebo received thalidomide for an additional 8 weeks. All responders continued to receive thalidomide for an additional minimum 52 weeks. MAIN OUTCOMES AND MEASURES Primary outcomes were clinical remission at week 8, measured by Pediatric Crohn Disease Activity Index (PCDAI) score and reduction in PCDAI by >= 25% or >= 75% at weeks 4 and 8. Primary outcomes during the open-label follow-up were clinical remission and 75% response. RESULTS Twenty-eight children were randomized to thalidomide and 26 to placebo. Clinical remission was achieved by significantly more children treated with thalidomide (13/28 [46.4%] vs 3/26 [11.5%]; risk ratio [RR], 4.0 [95% CI, 1.2-12.5]; P = .01; number needed to treat [NNT], 2.86). Responses were not different at 4 weeks, but greater improvement was observed at 8 weeks in the thalidomide group (75% response, 13/28 [46.4%] vs 3/26 [11.5%]; RR, 4.0 [95% CI, 1.2-12.5]; NNT = 2.86; P = .01; and 25% response, 18/28 [64.2%] vs 8/26 [30.8%]; RR, 2.1 [95% CI, 1.1-3.9]; NNT = 2.99; P = .01). Of the nonresponders to placebo who began receiving thalidomide, 11 of 21 (52.4%) subsequently reached remission at week 8 (RR, 4.5 [95% CI, 1.4-14.1]; NNT = 2.45; P = .01). Overall, 31 of 49 children treated with thalidomide (63.3%) achieved clinical remission, and 32 of 49 (65.3%) achieved 75% response. Mean duration of clinical remission in the thalidomide group was 181.1 weeks (95% CI, 144.53-217.76) vs 6.3 weeks (95% CI, 3.51-9.15) in the placebo group (P < .001). Cumulative incidence of severe adverse events was 2.1 per 1000 patient-weeks, with peripheral neuropathy the most frequent severe adverse event. CONCLUSIONS AND RELEVANCE In children and adolescents with refractory Crohn disease, thalidomide compared with placebo resulted in improved clinical remission at 8 weeks of treatment and longer-term maintenance of remission in an open-label follow-up. These findings require replication to definitively determine clinical utility of this treatment.	[Lazzerini, Marzia; Martelossi, Stefano; Maschio, Massimo; Paparazzo, Rossella; Montico, Marcella; Ventura, Alessandro] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy; [Magazzu, Giuseppe; Pellegrino, Salvatore; Lucanto, Maria Cristina] Univ Messina, Messina, Italy; [Barabino, Arrigo; Calvi, Angela; Arrigo, Serena] Inst Giannina Gaslini, Paediat Gastroenterol Unit, Genoa, Italy; [Lionetti, Paolo; Lorusso, Monica; Mangiantini, Francesca] Univ Florence, Meyer Children Hosp, Dept Sci Woman & Child Hlth, Florence, Italy; [Fontana, Massimo; Zuin, Giovanna] Childrens Hosp V Buzzi, Dept Paediat, Milan, Italy; [Palla, Gabriella; Maggiore, Giuseppe] Univ Pisa, Pisa, Italy; [Bramuzzo, Matteo; Pellegrin, Maria Chiara; Ventura, Alessandro] Univ Trieste, Trieste, Italy; [Villanacci, Vincenzo; Manenti, Stefania] Spedali Civil Brescia, Dept Pathol, I-25125 Brescia, Italy; [Decorti, Giuliana; De Iudicibus, Sara] Univ Trieste, Dept Life Sci, Trieste, Italy	IRCCS Burlo Garofolo; University of Messina; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Pisa; University of Trieste; Hospital Spedali Civili Brescia; University of Trieste	Lazzerini, M (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.	marzia.lazzerini@burlo.trieste.it	Maggiore, Giuseppe/N-1424-2017; Pellegrin, Maria Chiara/AAC-6557-2022; Arrigo, Serena/K-6006-2016; Bramuzzo, Matteo/K-2504-2018; Calvi, Angela/AAU-3530-2021; Lionetti, Paolo/AAC-2626-2019; Montico, Marcella/B-5290-2013	Maggiore, Giuseppe/0000-0001-8201-2416; Arrigo, Serena/0000-0002-5564-7018; Calvi, Angela/0000-0001-9702-8883; Montico, Marcella/0000-0003-0377-8232; Magazzu, Giuseppe/0000-0003-2622-4013; Pellegrino, Salvatore/0000-0003-1163-0748; bramuzzo, matteo/0000-0002-5249-8248; Decorti, Giuliana/0000-0002-9714-6246; Lionetti, Paolo/0000-0001-8029-3904; Ventura, Alessandro/0000-0002-4657-1760	Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) [FARM64J2EB]	Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA)	This work was supported by the Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA), on funds for Independent Research (FARM64J2EB). The drug producer (Pharmion until 2009; Celgene after 2009) provided the study drug.	[Anonymous], 2011, THAL INV BROCH VERS; Baldassano R, 2003, AM J GASTROENTEROL, V98, P833, DOI 10.1016/S0002-9270(03)00007-8; Bariol C, 2002, J GASTROEN HEPATOL, V17, P135, DOI 10.1046/j.1440-1746.2002.02564.x; Bauditz J, 2002, GUT, V50, P196, DOI 10.1136/gut.50.2.196; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; Bessmertny O, 2002, ANN PHARMACOTHER, V36, P521, DOI 10.1345/aph.1A098; Bousvaros A, 2001, DRUGS, V61, P777, DOI 10.2165/00003495-200161060-00006; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; de Silva S, 2010, NAT REV GASTRO HEPAT, V7, P93, DOI 10.1038/nrgastro.2009.221; Ehrenpreis ED, 1999, GASTROENTEROLOGY, V117, P1271, DOI 10.1016/S0016-5085(99)70276-3; Fabi SG, 2009, J DRUGS DERMATOL, V8, P765; Facchini S, 2001, J PEDIATR GASTR NUTR, V32, P178, DOI 10.1097/00005176-200102000-00016; Felipez LM, 2012, J PEDIATR GASTR NUTR, V54, P28, DOI 10.1097/MPG.0b013e318228349e; Franks ME, 2004, LANCET, V363, P1802, DOI 10.1016/S0140-6736(04)16308-3; Ghobrial Irene M, 2003, J Support Oncol, V1, P194; Ginsburg PM, 2001, ANN MED, V33, P516, DOI 10.3109/07853890108995961; Griffiths AM, 2004, BEST PRACT RES CL GA, V18, P509, DOI 10.1016/j.bpg.2004.01.002; Hyams J, 2005, J PEDIATR GASTR NUTR, V41, P416, DOI 10.1097/01.mpg.0000183350.46795.42; Hyams J, 2007, GASTROENTEROLOGY, V132, P863, DOI 10.1053/j.gastro.2006.12.003; Hyams JS, 2012, GASTROENTEROLOGY, V143, P365, DOI 10.1053/j.gastro.2012.04.046; Kane S, 2002, J CLIN GASTROENTEROL, V35, P149, DOI 10.1097/00004836-200208000-00006; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Kundhal PS, 2003, J PEDIATR GASTR NUTR, V36, P83, DOI 10.1097/00005176-200301000-00016; Laffitte Emmanuel, 2004, Expert Opin Drug Saf, V3, P47, DOI 10.1517/14740338.3.1.47; Lazzerini M, 2007, ALIMENT PHARM THERAP, V25, P419, DOI 10.1111/j.1365-2036.2006.03211.x; Lazzerini M, 2013, INFLAMM BOWEL DIS, V19, pE10, DOI 10.1002/ibd.22845; Lazzerini M, 2011, INFLAMM BOWEL DIS, V17, P2174, DOI 10.1002/ibd.21563; Marchetti F, 2004, EUR J CLIN PHARMACOL, V60, P607, DOI 10.1007/s00228-004-0819-z; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Petitpain N, 2009, BIO-MED MATER ENG, V19, P355, DOI 10.3233/BME-2009-0600; Ruemmele FM, 2009, INFLAMM BOWEL DIS, V15, P388, DOI 10.1002/ibd.20788; Sabate JM, 2002, ALIMENT PHARM THER, V16, P1117, DOI 10.1046/j.1365-2036.2002.01273.x; Sandhu BK, 2010, J PEDIATR GASTR NUTR, V50, pS1, DOI 10.1097/MPG.0b013e3181c92c53; Schaefer ME, 2010, CLIN GASTROENTEROL H, V8, P789, DOI 10.1016/j.cgh.2010.05.021; Turunen P, 2009, INFLAMM BOWEL DIS, V15, P56, DOI 10.1002/ibd.20558; Uhl K, 2006, DRUG SAFETY, V29, P321, DOI 10.2165/00002018-200629040-00003; Vasiliauskas EA, 1999, GASTROENTEROLOGY, V117, P1278, DOI 10.1016/S0016-5085(99)70277-5; Vernier-Massouille G, 2008, GASTROENTEROLOGY, V135, P1106, DOI 10.1053/j.gastro.2008.06.079	39	74	89	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2164	2173		10.1001/jama.2013.280777	http://dx.doi.org/10.1001/jama.2013.280777			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24281461	Green Published, Bronze			2022-12-28	WOS:000327404400025
J	Wright, CF; Middleton, A; Burton, H; Cunningham, F; Humphries, SE; Hurst, J; Birney, E; Firth, HV				Wright, Caroline F.; Middleton, Anna; Burton, Hilary; Cunningham, Fiona; Humphries, Steve E.; Hurst, Jane; Birney, Ewan; Firth, Helen V.			Policy challenges of clinical genome sequencing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCIDENTAL FINDINGS; RECOMMENDATIONS; MUTATION; PATIENT; RISK		[Wright, Caroline F.; Middleton, Anna] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Burton, Hilary] PHG Fdn, Cambridge, England; [Cunningham, Fiona; Birney, Ewan] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Humphries, Steve E.] UCL, Ctr Cardiovasc Genet, UCL Inst Cardiovasc Sci, London, England; [Hurst, Jane] Great Ormond St Hosp Sick Children, North E Thames Genet Serv, London, England; [Firth, Helen V.] Univ Cambridge, Hosp Fdn Trust, Addenbrookes Hosp, Cambridge, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Wright, CF (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	caroline.wright@sanger.ac.uk	Wright, Caroline/N-5355-2015	Middleton, Anna/0000-0003-3103-8098; Humphries, Stephen E/0000-0002-8221-6547; Wright, Caroline/0000-0003-2958-5076; Birney, Ewan/0000-0001-8314-8497; Cunningham, Fiona/0000-0002-7445-2419	British Heart Foundation; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	We thank European Bioinformatics Institute for supporting the meeting which gave rise to this article, John Firth for comments on the manuscript, and all the workshop attendees and presenters for their thoughtful contributions, including Stephanie Barton, David FitzPatrick, Matthew Hurles, Eamonn Maher, Helen Parkinson, Justin Paschall, and Vincent Plagnol. SEH is supported by the British Heart Foundation.	[Anonymous], 2013, CREATING GLOBAL ALLI; Bragin E, 2013, NUCL ACIDS RES; Bredenoord AL, 2011, TRENDS GENET, V27, P41, DOI 10.1016/j.tig.2010.11.004; Burn J., 2013, BMJ-BRIT MED J, V346, P3133; Burton H, 2013, NAT GENET, V45, P349, DOI 10.1038/ng.2582; Dalgleish R, 2010, GENOME MED, V2, DOI 10.1186/gm145; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Diamandis M, 2010, MOL CANCER RES, V8, P1175, DOI 10.1158/1541-7786.MCR-10-0264; Evans DGR, 2012, CANCER PREV RES, V5, P943, DOI 10.1158/1940-6207.CAPR-11-0458; Flinter F., 2013, BMJ-BRIT MED J, V346, P3132; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gliwa C, 2013, AM J BIOETHICS, V13, P32, DOI 10.1080/15265161.2012.754062; Green R, 2013, ACMG RECOMMENDATIONS; HM Government, 2012, STRAT UK LIF SCI ON; Holtzman NA, 2013, GENET MED, V15, P750, DOI 10.1038/gim.2013.96; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Middleton A, 2013, AM J MED GENET A, V161, P2099, DOI 10.1002/ajmg.a.36067; Nherera L, 2011, HEART, V97, P1175, DOI 10.1136/hrt.2010.213975; Tachi N, 2005, PEDIATR NEUROL, V32, P288, DOI 10.1016/j.pediatrneurol.2004.11.003; Torjesen I, 2013, BMJ-BRIT MED J, V347, pf6690; van El CG, 2013, EUR J HUM GENET, V21, P580, DOI 10.1038/ejhg.2013.46; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2012, GENET MED, V14, P355, DOI 10.1038/gim.2012.26; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Wright C., 2011, NEXT STEPS SEQUENCE; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	29	40	40	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2013	347								f6845	10.1136/bmj.f6845	http://dx.doi.org/10.1136/bmj.f6845			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KZ	24270507				2022-12-28	WOS:000327459500003
J	Bagcchi, S; Chaudhuri, P				Bagcchi, Sanjeet; Chaudhuri, Prasun			Suicide and the law in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Bagcchi S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5604; Bhaumik S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5349; Government of India. Ministry of Health and Family Welfare, 2013, MENT HLTH CAR BILL; National Crime Records Bureau, SUIC IND; PTI, 2013, HINDU; Vijaykumar Lakshmi, 2007, Indian J Psychiatry, V49, P81, DOI 10.4103/0019-5545.33252; WHO, 2020, MENT HLTH ATL 2011	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 21	2013	347								f6975	10.1136/bmj.f6975	http://dx.doi.org/10.1136/bmj.f6975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KL	24264769				2022-12-28	WOS:000327458100004
J	Miura, SK; Martins, A; Zhang, KX; Graveley, BR; Zipursky, SL				Miura, Satoru K.; Martins, Andre; Zhang, Kelvin X.; Graveley, Brenton R.; Zipursky, S. Lawrence			Probabilistic Splicing of Dscam1 Establishes Identity at the Level of Single Neurons	CELL			English	Article							DROSOPHILA SENSORY NEURONS; DENDRITIC SELF-AVOIDANCE; AXON GUIDANCE; EXPRESSION; BINDING; PROTOCADHERINS; RECOGNITION; SPECIFICITY; DIVERSITY; REPULSION	The Drosophila Dscam1 gene encodes a vast number of cell recognition molecules through alternative splicing. These exhibit isoform-specific homophilic binding and regulate self-avoidance, the tendency of neurites from the same cell to repel one another. Genetic experiments indicate that different cells must express different isoforms. How this is achieved is unknown, as expression of alternative exons in vivo has not been shown. Here, we modified the endogenous Dscam1 locus to generate splicing reporters for all variants of exon 4. We demonstrate that splicing does not occur in a cell-type-specific fashion, that cells sharing the same anatomical location in different individuals express different exon 4 variants, and that the splicing pattern in a given neuron can change over time. We conclude that splicing is probabilistic. This is compatible with a widespread role in neural circuit assembly through self-avoidance and is incompatible with models in which specific isoforms of Dscam1 mediate homophilic recognition between processes of different cells.	[Miura, Satoru K.; Martins, Andre; Zhang, Kelvin X.; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Martins, Andre] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099003 Oporto, Portugal; [Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Dev Biol, Farmington, CT 06030 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidade do Porto; University of Connecticut	Miura, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Graveley, Brenton R/C-3108-2013; Miura, Satoru/GZH-1685-2022	Miura, Satoru/0000-0002-6698-9435; Graveley, Brenton/0000-0001-5777-5892; Zipursky, Stephen/0000-0001-5630-7181	Nakajima Foundation; Canadian Institutes of Health Research (CIHR) Fellowship; University of California-Los Angeles Computational Bioscience Initiative Fellowship; National Institutes of Health [5R01GM067842, 5R01DC006485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485] Funding Source: NIH RePORTER	Nakajima Foundation; Canadian Institutes of Health Research (CIHR) Fellowship(Canadian Institutes of Health Research (CIHR)); University of California-Los Angeles Computational Bioscience Initiative Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Yasushi Hiromi, Yuh Nung Jan, Aljoscha Nern, Barret Pfeiffer, and Gerald Rubin for reagents, members of our laboratory for discussion, and Edward De Robertis, Wesley Grueber, Daisuke Hattori, Kelsey Martin, and Alex Plocik for their comments on the manuscript. We also thank Orkun Akin and Josh Trachtenberg for their help with the 2-photon microscope, Jinfei Ni for his early work in generating the reporter constructs, Wei Wu for her initial assistance in assessment of the transgenic flies, and GenetiVision and Genetic Services for their injection services. This work was supported by a fellowship from the Nakajima Foundation to S.K.M., Canadian Institutes of Health Research (CIHR) Fellowship and University of California-Los Angeles Computational Bioscience Initiative Fellowship to K.X.Z., and National Institutes of Health grants to B.R.G (5R01GM067842) and S.L.Z (5R01DC006485). S.L.Z. is an investigator of Howard Hughes Medical Institute.	Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Forbes EM, 2011, NEURAL COMPUT, V23, P2746, DOI 10.1162/NECO_a_00186; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Han C, 2012, NEURON, V73, P64, DOI 10.1016/j.neuron.2011.10.036; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; KRAMER AP, 1985, J NEUROSCI, V5, P768; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Millard SS, 2010, NEURON, V67, P761, DOI 10.1016/j.neuron.2010.08.030; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Wu W, 2012, NEURON, V74, P261, DOI 10.1016/j.neuron.2012.02.029; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	29	65	65	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1166	1177		10.1016/j.cell.2013.10.018	http://dx.doi.org/10.1016/j.cell.2013.10.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267895	Bronze, Green Accepted			2022-12-28	WOS:000327500600019
J	Wright, DE; Rosovsky, RP; Platt, MY				Wright, Douglas E.; Rosovsky, Rachel P.; Platt, Mia Y.			Case 36-2013: A 38-Year-Old Woman with Anemia and Thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOIMMUNE HEMOLYTIC-ANEMIA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; EVANS-SYNDROME; MYCOPHENOLATE-MOFETIL; REVISED CRITERIA; RITUXIMAB; CLASSIFICATION; INFUSION; EFFICACY; THERAPY	A 38-year-old woman was admitted to this hospital because of fatigue, malaise, and lightheadedness, with dyspnea on exertion, bruising, dark urine, and headache. Laboratory tests revealed anemia and thrombocytopenia. Diagnostic tests were performed. Presentation of CaseDr. Joanna Lopez (Medicine): A 38-year-old woman was admitted to this hospital because of anemia and thrombocytopenia. The patient had been well until approximately 3 months before admission, when fatigue, malaise, and light-headedness developed that she attributed to a viral illness. Three weeks before admission, fatigue worsened, and dyspnea on exertion, bruising on the legs, dark urine, and headache developed. She reported that she felt like staying in a bed all day and needed assistance with showering. Two days before admission, she went to another hospital. The physical examination was reportedly normal, as were the results of ...	[Wright, Douglas E.; Rosovsky, Rachel P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Platt, Mia Y.] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wright, Douglas E.; Rosovsky, Rachel P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Platt, Mia Y.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wright, DE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.		Rosovsky, Rachel/AAH-1166-2021					Akpek G, 1999, AM J HEMATOL, V61, P98, DOI 10.1002/(SICI)1096-8652(199906)61:2<98::AID-AJH4>3.3.CO;2-7; ALLGOOD JW, 1967, AM J MED, V43, P254, DOI 10.1016/0002-9343(67)90168-4; Anderson D, 2007, TRANSFUS MED REV, V21, pS9, DOI 10.1016/j.tmrv.2007.01.001; [Anonymous], 2006, MMWR-MORBID MORTAL W, V55, P158; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bussone G, 2009, AM J HEMATOL, V84, P153, DOI 10.1002/ajh.21341; Chang DK, 2001, CLIN RHEUMATOL, V20, P63, DOI 10.1007/s100670170107; COREY L, 1983, ANN INTERN MED, V98, P973, DOI 10.7326/0003-4819-98-6-973; DAMESHEK W, 1951, NEW ENGL J MED, V244, P117, DOI 10.1056/NEJM195101252440401; Dhaliwal G, 2004, AM FAM PHYSICIAN, V69, P2599; Dierickx D, 2009, J INTERN MED, V266, P484, DOI 10.1111/j.1365-2796.2009.02126.x; Emilia G, 1996, BRIT J HAEMATOL, V93, P341, DOI 10.1046/j.1365-2141.1996.4871026.x; EVANS RS, 1951, ARCH INTERN MED, V87, P48, DOI 10.1001/archinte.1951.03810010058005; EVANS RS, 1949, BLOOD, V4, P1196, DOI 10.1182/blood.V4.11.1196.1196; Gehrs BC, 2002, AM J HEMATOL, V69, P258, DOI 10.1002/ajh.10062; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Howard J, 2002, BRIT J HAEMATOL, V117, P712, DOI 10.1046/j.1365-2141.2002.03430.x; JANDL JH, 1963, NEW ENGL J MED, V268, P482, DOI 10.1056/NEJM196302282680909; Klutts JS, 2009, J CLIN MICROBIOL, V47, P3204, DOI 10.1128/JCM.00164-09; Kotb R, 2005, EUR J HAEMATOL, V75, P60, DOI 10.1111/j.1600-0609.2005.00437.x; Mak A, 2005, LUPUS, V14, P856, DOI 10.1191/0961203305lu2163cr; Mantadakis E, 2004, AM J HEMATOL, V77, P303, DOI 10.1002/ajh.20180; Mast EE, 2007, MMWR-MORBID MORTAL W, V56, P1267; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Mathew P, 1997, J PEDIAT HEMATOL ONC, V19, P433, DOI 10.1097/00043426-199709000-00005; Michel M, 2009, BLOOD, V114, P3167, DOI 10.1182/blood-2009-04-215368; ODA H, 1985, J PEDIATR-US, V107, P744, DOI 10.1016/S0022-3476(85)80405-4; Oyama Y, 2001, BONE MARROW TRANSPL, V28, P903, DOI 10.1038/sj.bmt.1703237; Parker CJ, 2009, HEMATOL ONCOL CLIN N, V23, P333, DOI 10.1016/j.hoc.2009.01.014; PIGNON JM, 1993, BRIT J HAEMATOL, V83, P343, DOI 10.1111/j.1365-2141.1993.tb08293.x; Salama A, 2009, EXPERT OPIN DRUG SAF, V8, P73, DOI [10.1517/14740330802577351 , 10.1182/asheducation-2009.1.73, 10.1517/14740330802577351]; Selo-Ojeme Dan O., 2005, Archives of Gynecology and Obstetrics, V271, P154, DOI 10.1007/s00404-004-0715-x; Shanafelt TD, 2003, MAYO CLIN PROC, V78, P1340, DOI 10.4065/78.11.1340; Shvidel L, 2006, AM J HEMATOL, V81, P423, DOI 10.1002/ajh.20632; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; WANG WC, 1988, AM J PEDIAT HEMATOL, V10, P330	36	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					2032	2043		10.1056/NEJMcpc1215972	http://dx.doi.org/10.1056/NEJMcpc1215972			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256382				2022-12-28	WOS:000327163000012
J	Preda, A				Preda, Adrian			Review: Antipsychotic drugs improve symptoms, with different levels of side effects, in schizophrenia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Irvine, Orange, CA 92668 USA	University of California System; University of California Irvine	Preda, A (corresponding author), Univ Calif Irvine, Orange, CA 92668 USA.		Preda, Adrian/K-8889-2013	Preda, Adrian/0000-0003-3373-2438				Attard A, 2012, CNS DRUGS, V26, P491, DOI 10.2165/11632020-000000000-00000; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553	2	3	3	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10							JC7	10.7326/0003-4819-159-10-201311190-02007	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247697				2022-12-28	WOS:000328732700006
J	Brown, S; Zarin, D				Brown, Sandra; Zarin, Daniel			What Does Zero Deforestation Mean?	SCIENCE			English	Editorial Material									[Brown, Sandra] Winrock Int Livestock Res & Training Ctr, Ecosyst Serv Unit, Arlington, VA 22202 USA; [Zarin, Daniel] Climate & Land Use Alliance, San Francisco, CA 94104 USA		Brown, S (corresponding author), Winrock Int Livestock Res & Training Ctr, Ecosyst Serv Unit, Arlington, VA 22202 USA.	sbrown@winrock.org	Noojipady, Praveen/B-2511-2010					[Anonymous], 2008, BBC NEWS; Baker DJ, 2010, ENVIRON SCI POLICY, V13, P249, DOI 10.1016/j.envsci.2010.03.004; FAO-FRA, 2000, 33 FAOFRA; FAO-FRA, 2010, 163 FAO; GOFC-GOLD, 2012, COP181 GOFCGOLD; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; IPCC, 2007, 2006 IPCC GUID NAT G, V4; OECD/FAO (Organization for Economic Cooperation and Development/ Food and Agriculture Organization of the United Nations), 2013, OECD FAO AGR OUTL 20; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sizer N., 2013, FALSE CHOICE PALM OI; UNFCCC, CP 2010 7 ADD 1	13	52	52	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					805	807		10.1126/science.1241277	http://dx.doi.org/10.1126/science.1241277			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	251IY	24233710				2022-12-28	WOS:000326923000019
J	Moses, H; Matheson, DHM; Dorsey, ER; George, BP; Sadoff, D; Yoshimura, S				Moses, Hamilton, III; Matheson, David H. M.; Dorsey, E. Ray; George, Benjamin P.; Sadoff, David; Yoshimura, Satoshi			The Anatomy of Health Care in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIANS; SYSTEM; COST	Health care in the United States includes a vast array of complex interrelationships among those who receive, provide, and finance care. In this article, publicly available data were used to identify trends in health care, principally from 1980 to 2011, in the source and use of funds ("economic anatomy"), the people receiving and organizations providing care, and the resulting value created and health outcomes. In 2011, US health care employed 15.7% of the workforce, with expenditures of $2.7 trillion, doubling since 1980 as a percentage of US gross domestic product (GDP) to 17.9%. Yearly growth has decreased since 1970, especially since 2002, but, at 3% per year, exceeds any other industry and GDP overall. Government funding increased from 31.1% in 1980 to 42.3% in 2011. Despite the increases in resources devoted to health care, multiple health metrics, including life expectancy at birth and survival with many diseases, shows the United States trailing peer nations. The findings from this analysis contradict several common assumptions. Since 2000, (1) price (especially of hospital charges [+4.2%/y], professional services [3.6%/y], drugs and devices [+4.0%/y], and administrative costs [+5.6%/y]), not demand for services or aging of the population, produced 91% of cost increases; (2) personal out-of-pocket spending on insurance premiums and co-payments have declined from 23% to 11%; and (3) chronic illnesses account for 84% of costs overall among the entire population, not only of the elderly. Three factors have produced the most change: (1) consolidation, with fewer general hospitals and more single-specialty hospitals and physician groups, producing financial concentration in health systems, insurers, pharmacies, and benefit managers; (2) information technology, in which investment has occurred but value is elusive; and (3) the patient as consumer, whereby influence is sought outside traditional channels, using social media, informal networks, new public sources of information, and self-management software. These forces create tension among patient aims for choice, personal care, and attention; physician aims for professionalism and autonomy; and public and private payer aims for aggregate economic value across large populations. Measurements of cost and outcome (applied to groups) are supplanting individuals' preferences. Clinicians increasingly are expected to substitute social and economic goals for the needs of a single patient. These contradictory forces are difficult to reconcile, creating risk of growing instability and political tensions. A national conversation, guided by the best data and information, aimed at explicit understanding of choices, tradeoffs, and expectations, using broader definitions of health and value, is needed.	[Moses, Hamilton, III] Alerion Inst, North Garden, VA 22959 USA; [Moses, Hamilton, III] Alerion Advisors LLC, North Garden, VA USA; [Moses, Hamilton, III; Dorsey, E. Ray] Johns Hopkins Sch Med, Baltimore, MD USA; [George, Benjamin P.] Univ Rochester, Sch Med, Rochester, NY USA; [Matheson, David H. M.; Sadoff, David; Yoshimura, Satoshi] Boston Consulting Grp Inc, Boston, MA USA	Johns Hopkins University; Johns Hopkins Medicine; University of Rochester; Boston Consulting Group (BCG)	Moses, H (corresponding author), Alerion Inst, POB 150, North Garden, VA 22959 USA.	hm@alerion.us			American Stroke Association; Parkinson Disease Foundation	American Stroke Association; Parkinson Disease Foundation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Moses reports membership in a variety of foundation and company boards in health care and financial services. Dr Dorsey reports consultancy for Amgen, Avid Radiopharmaceuticals, Clintrex, Lundbeck, Medtronic, the National Institute of Neurological Disorders and Stroke, and Transparency Life Sciences; a filed patent related to telemedicine and neurology; and stock/stock options in Grand Rounds (a second opinion service). Mr George reports grants/grants pending from the American Stroke Association and the Parkinson Disease Foundation. Drs Moses and Yoshimura and Messrs Matheson and Sadoff report providing management consulting services to hospital systems, insurers, foundations, and pharmaceutical, device, and IT companies. No other disclosures were reported.	Agency for Healthcare Research and Quality, MED EXP PAN SURV HOU; Anderson GF, 2008, JAMA-J AM MED ASSOC, V299, P2444, DOI 10.1001/jama.299.20.2444; [Anonymous], HLTH INS; [Anonymous], 2012, SURV AM PHYS PRACT P; [Anonymous], 2008, INNOVATORS PRESCRIPT; [Anonymous], 2012, 60 MINUTES      1202; Berry E, AM MED NEWS; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Callahan D, 2009, TAMING THE BELOVED BEAST: HOW MEDICAL TECHNOLOGY COSTS ARE DESTROYING OUR HEALTH CARE SYSTEM, P1; Casalino LP, 2009, HEALTH AFFAIR, V28, pW533, DOI 10.1377/hlthaff.28.4.w533; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Centers for Medicare & Medicaid Services, NAT HLTH EXP DAT AG; Centers for Medicare Medicaid Services, NAT HLTH EXP DAT; Chandler Jr Alfred, 1977, VISIBLE HAND; Citigroup, 2006, DRUG RET IND; Cooper RA, 2004, ANN INTERN MED, V141, P705, DOI 10.7326/0003-4819-141-9-200411020-00012; Donelan K, 1999, HEALTH AFFAIR, V18, P206, DOI 10.1377/hlthaff.18.3.206; EvaluatePharma, 2012, WORLD PREV 2018 CONS; Federal Reserve Bank of St Louis, EC RES; Fineberg HV, 2012, NEW ENGL J MED, V366, P1020, DOI 10.1056/NEJMsa1114777; Fox Susannah, 2013, INFORM TRIAGE; Fuchs VR, 2013, JAMA-J AM MED ASSOC, V309, P33, DOI 10.1001/jama.2012.125458; Galewitz Phil, 2012, KAISER HLTH NEWS; Gartner Group, 2013, FOR ENT IT SPEND HEA; Gawande A., 2012, NEW YORKER; Gustke C, 2012, CONCIERGE MED NOT JU; Henderson R, 2012, MON LABOR REV, V135, P65; Hoffman A, 2013, JAMA-J AM MED ASSOC, V309, P661, DOI 10.1001/jama.2012.214571; Howse K, 2009, REV LONGEVITY TRENDS; Information technology, 1998, INF TECHN; Institute for Health Metrics and Evaluation, LIF EXP US COUNT 201; Japsen B, 2012, NY TIMES, pB6; Jolly P, 2005, HEALTH AFFAIR, V24, P527, DOI 10.1377/hlthaff.24.2.527; Jones JM, 2012, MAJORITY US STILL SA; Kane C. K., 2001, PHYS MARKETPLACE REP; Kriner D. L., 2012, AM PUBLIC HLTH CARE; Lammers E, 2013, HEALTH ECON, V22, P1215, DOI 10.1002/hec.2878; Landon BE, 2003, JAMA-J AM MED ASSOC, V289, P442, DOI 10.1001/jama.289.4.442; Liberum Capital, 2012, US PRIC PRESS INCR; Manary MP, 2013, NEW ENGL J MED, V368, P201, DOI 10.1056/NEJMp1211775; Martin AB, 2012, HEALTH AFFAIR, V31, P208, DOI 10.1377/hlthaff.2011.1135; Martinson ML, 2012, AM J PUBLIC HEALTH, V102, P2049, DOI 10.2105/AJPH.2012.300929; Moses H, 2011, NEW ENGL J MED, V364, P567, DOI 10.1056/NEJMsb1007634; National Alliance for Caregiving in collaboration with AARP, CAR US 2009; National Institute for Health Care Management Foundation, 2011, UND US HLTH CAR SPEN; Organisation for Economic Cooperation and Development, HLTH STAT OECD STATE; Orszag PR, 2010, NEW ENGL J MED, V363, P601, DOI 10.1056/NEJMp1006571; Pipes SC, 2013, WALL STREET J, pA13; Rastegar DA, 2004, ANN FAM MED, V2, P79, DOI 10.1370/afm.18; Rein AS, 2012, J PUBLIC HEALTH MAN, V18, P299, DOI 10.1097/PHH.0b013e31825d25dd; Richman BD, 2007, U PENN LAW REV, V156, P121, DOI 10.2307/40041366; Robert Wood Johnson Foundation, 2010, CHRONIC CARE MAKING; Rosenbaum L, 2013, NEW ENGL J MED, V368, P959, DOI 10.1056/NEJMms1301576; Rosenthal JA, 2013, JAMA INTERN MED, V173, P427, DOI 10.1001/jamainternmed.2013.460; Sagers C., 2010, YALE LAW POLICY REV, V28, P325; Song ZR, 2013, JAMA-J AM MED ASSOC, V309, P35, DOI 10.1001/jama.2012.96870; U.S. Department of Labor, PROD PRIC IND; United States Census Bureau, POP EST; United States Department of Labor, OCC EMPL STAT; US Census Bureau, STAT US BUS; US Census Bureau, HLTH STAT HLTH INS M; Wagner ER, 2013, ESSENTIALS MANAGED H; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837; Woolf SH, 2013, JAMA-J AM MED ASSOC, V309, P771, DOI 10.1001/jama.2013.91; Wright A, 2013, NEW ENGL J MED, V368, P779, DOI 10.1056/NEJMc1213481; Wright S, 2012, MEMORANDUM REPORT LA; Yong PL, 2010, I MED ROUNDTABLE EVI	67	212	213	2	150	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1947	1963		10.1001/jama.2013.281425	http://dx.doi.org/10.1001/jama.2013.281425			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	250EJ	24219951				2022-12-28	WOS:000326832900020
J	Sox, HC				Sox, Harold C.			Resolving the Tension Between Population Health and Individual Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STATE		[Sox, Harold C.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Dartmouth College	Sox, HC (corresponding author), Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, 31 Faraway Ln, West Lebanon, NH 03784 USA.	hsox@comcast.net						IOM (Institute of Medicine), 2012, PRIM CAR PUBL HLTH E; Kindig D, 2003, AM J PUBLIC HEALTH, V93, P380, DOI 10.2105/AJPH.93.3.380; Kindig DA, 2008, JAMA-J AM MED ASSOC, V299, P2081, DOI 10.1001/jama.299.17.2081; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Shortell SM, 2013, JAMA-J AM MED ASSOC, V309, P1121, DOI 10.1001/jama.2013.887; Sox HC, 2012, NEW ENGL J MED, V367, P669, DOI 10.1056/NEJMe1207165; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012	8	35	35	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1933	1934		10.1001/jama.2013.281998	http://dx.doi.org/10.1001/jama.2013.281998			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	250EJ	24219944				2022-12-28	WOS:000326832900013
J	Washington, AE; Coye, MJ; Feinberg, DT				Washington, A. Eugene; Coye, Molly J.; Feinberg, David T.			Academic Health Centers and the Evolution of the Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Washington, A. Eugene; Coye, Molly J.; Feinberg, David T.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Washington, AE (corresponding author), Univ Calif Los Angeles, 10833 Le Conte Ave,12-138 CHS, Los Angeles, CA 90095 USA.	ewashington@mednet.ucla.edu						Baker LC, 2011, HEALTH AFFAIR, V30, P1689, DOI 10.1377/hlthaff.2011.0216; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Porter ME, 2013, HARVARD BUSINESS REV; Swensen SJ, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911199; Young JB, 2012, ACAD MED, V87, P552, DOI 10.1097/ACM.0b013e31824d5960	6	22	22	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1929	1930		10.1001/jama.2013.282012	http://dx.doi.org/10.1001/jama.2013.282012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219942				2022-12-28	WOS:000326832900011
J	Hammerer, K				Hammerer, Klemens			Quantum Mechanics Tackles Mechanics	SCIENCE			English	Editorial Material							GROUND-STATE; INDUCED TRANSPARENCY; LIGHT; OPTOMECHANICS; OSCILLATOR; RESONATOR; NOISE		[Hammerer, Klemens] Leibniz Univ Hannover, Inst Theoret Phys, Hannover, Germany; [Hammerer, Klemens] Leibniz Univ Hannover, Albert Einstein Inst, Hannover, Germany	Leibniz University Hannover; Leibniz University Hannover; Max Planck Society	Hammerer, K (corresponding author), Leibniz Univ Hannover, Inst Theoret Phys, Hannover, Germany.	klemens.hammerer@itp.uni-hannover.de	Hammerer, Klemens/C-3538-2008	Hammerer, Klemens/0000-0002-7179-0666				Braginsky V. B., 1995, QUANTUM MEASUREMENT; Brooks DWC, 2012, NATURE, V488, P476, DOI 10.1038/nature11325; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Hofer SG, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052327; Murch KW, 2008, NAT PHYS, V4, P561, DOI 10.1038/nphys965; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Palomaki TA, 2013, SCIENCE, V342, P710, DOI 10.1126/science.1244563; Palomaki TA, 2013, NATURE, V495, P210, DOI 10.1038/nature11915; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; Safavi-Naeini AH, 2011, NATURE, V472, P69, DOI 10.1038/nature09933; Safavi-Naeini AH, 2013, NATURE, V500, P185, DOI 10.1038/nature12307; Schwab KC, 2005, PHYS TODAY, V58, P36, DOI 10.1063/1.2012461; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596	15	1	1	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					702	703		10.1126/science.1245797	http://dx.doi.org/10.1126/science.1245797			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202166	Green Published			2022-12-28	WOS:000326647600029
J	Han, JH; Zhang, H; Zhang, HL; Wang, ZQ; Zhou, H; Zhang, ZG				Han, Junhong; Zhang, Hui; Zhang, Honglian; Wang, Zhiquan; Zhou, Hui; Zhang, Zhiguo			A Cul4 E3 Ubiquitin Ligase Regulates Histone Hand-Off during Nucleosome Assembly	CELL			English	Article							DNA-REPLICATION; PROTEIN COMPLEXES; STRUCTURAL BASIS; H3 METHYLATION; UBIQUITYLATION; ACETYLATION; CRL4(CDT2); ASF1; LYSINE-56; PCNA	Nucleosome assembly following DNA replication and gene transcription is important to maintain genome stability and epigenetic information. Newly synthesized histones H3-H4 first bind histone chaperone Asf1 and are then transferred to other chaperones for nucleosome assembly. However, it is unknown how H3-H4 is transferred from the Asf1-H3-H4 complex to other chaperones because Asf1 binds H3-H4 with high affinity. Here, we show that yeast Rtt101(Mms1) E3 ubiquitin ligase preferentially binds and ubiquitylates new histone H3 acetylated at lysine 56. Inactivation of Rtt101 or mutating H3 lysine residues ubiquitylated by the Rtt101(Mms1) ligase impairs nucleosome assembly and promotes Asf1-H3 interactions. Similar phenotypes occur in human cells in which the ortholog of Rtt101(Mms1), Cul4A(DDB1), is depleted. These results indicate that the transfer of H3-H4 from the Asf1-H3-H4 complex to other histone chaperones is regulated by a conserved E3 ligase and provide evidence for crosstalk between histone acetylation and ubiquitylation in nucleosome assembly.	[Han, Junhong; Zhang, Hui; Zhang, Honglian; Wang, Zhiquan; Zhou, Hui; Zhang, Zhiguo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu	Wang, Zhiquan/X-9242-2018; wang, jian/AAG-7378-2019	Wang, Zhiquan/0000-0002-8243-7251; Han, Junhong/0000-0002-3371-8698	NIH [GM72719, GM81838]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072719, R01GM081838] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Burgess, Lou, Katzmann, van Deursen, Ekker, and Wu and Mr. Dahlin for critical reading of this manuscript. We thank Dr. Kamura for plasmids and Dr. Verreault for a yeast histone purification protocol. This work is supported by NIH grants (GM72719 and GM81838).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Corpet A, 2011, EMBO J, V30, P480, DOI 10.1038/emboj.2010.335; Donham DC, 2011, NUCLEIC ACIDS RES, V39, P5449, DOI 10.1093/nar/gkr097; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Han JH, 2010, GENE DEV, V24, P1485, DOI 10.1101/gad.1887310; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Nakano S, 2011, CELL, V147, P1525, DOI 10.1016/j.cell.2011.11.053; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Silva AC, 2012, J BIOL CHEM, V287, P1709, DOI 10.1074/jbc.M111.316489; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Winkler DD, 2012, NUCLEIC ACIDS RES, V40, P10139, DOI 10.1093/nar/gks812; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	52	96	104	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					817	829		10.1016/j.cell.2013.10.014	http://dx.doi.org/10.1016/j.cell.2013.10.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209620	Green Accepted, Bronze			2022-12-28	WOS:000326934300012
J	Mesmin, B; Bigay, J; von Filseck, JM; Lacas-Gervais, S; Drin, G; Antonny, B				Mesmin, Bruno; Bigay, Joelle; von Filseck, Joachim Moser; Lacas-Gervais, Sandra; Drin, Guillaume; Antonny, Bruno			A Four-Step Cycle Driven by PI(4)P Hydrolysis Directs Sterol/PI(4)P Exchange by the ER-Golgi Tether OSBP	CELL			English	Article							OXYSTEROL-BINDING-PROTEIN; MEMBRANE CONTACT SITES; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; LIPID-TRANSFER; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; NONVESICULAR TRAFFICKING; STRUCTURAL BASIS; FFAT MOTIF; TRANSPORT	Several proteins at endoplasmic reticulum (ER)-Golgi membrane contact sites contain a PH domain that interacts with the Golgi phosphoinositide PI(4) P, a FFAT motif that interacts with the ER protein VAP-A, and a lipid transfer domain. This architecture suggests the ability to both tether organelles and transport lipids between them. We show that in oxysterol binding protein (OSBP) these two activities are coupled by a four-step cycle. Membrane tethering by the PH domain and the FFAT motif enables sterol transfer by the lipid transfer domain (ORD), followed by back transfer of PI(4) P by the ORD. Finally, PI(4) P is hydrolyzed in cis by the ER protein Sac1. The energy provided by PI(4) P hydrolysis drives sterol transfer and allows negative feedback when PI(4) P becomes limiting. Other lipid transfer proteins are tethered by the same mechanism. Thus, OSBP-mediated back transfer of PI(4) P might coordinate the transfer of other lipid species at the ER-Golgi interface.	[Mesmin, Bruno; Bigay, Joelle; von Filseck, Joachim Moser; Drin, Guillaume; Antonny, Bruno] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Mesmin, Bruno; Bigay, Joelle; von Filseck, Joachim Moser; Drin, Guillaume; Antonny, Bruno] CNRS, F-06560 Valbonne, France; [Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Appl, F-06000 Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Antonny, B (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France.	antonny@ipmc.cnrs.fr	Antonny, Bruno/ABH-7434-2020; Mesmin, Bruno/N-9246-2017	Antonny, Bruno/0000-0002-9166-8668; DRIN, Guillaume/0000-0002-3484-4581; Moser von Filseck, Joachim/0000-0001-9118-2986; Mesmin, Bruno/0000-0002-5437-3246; Joelle, BIGAY/0000-0002-7487-3416	CNRS; Agence Nationale de la Recherche [ANR-10-JCJC-1503-01, ANR-11-LABX-0028-01]; ERC [268888]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission)	We thank Celine Thonont, Frederic Brau, Julie Cazareth, and Nathalie Leroudier for technical assistance; Fabien Alpy, Scott Emr, and Franck Perez for reagents; Alenka Copic for comments on the manuscript; and all members of the laboratory for discussions. This work is supported by the CNRS, the Agence Nationale de la Recherche ("jeune chercheur" ANR-10-JCJC-1503-01 and "Investments for the Future" ANR-11-LABX-0028-01), and by an ERC advanced grant (268888).	Arita M, 2013, J VIROL, V87, P4252, DOI 10.1128/JVI.03546-12; Beh CT, 2012, J BIOL CHEM, V287, P11481, DOI 10.1074/jbc.R111.338400; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kim YJ, 2013, TRENDS CELL BIOL, V23, P270, DOI 10.1016/j.tcb.2013.01.009; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Mesmin B, 2013, CELL MOL LIFE SCI, V70, P3405, DOI 10.1007/s00018-012-1247-3; Mikitova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030455; Mousley CJ, 2012, CELL, V148, P702, DOI 10.1016/j.cell.2011.12.026; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039	39	452	461	3	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					830	843		10.1016/j.cell.2013.09.056	http://dx.doi.org/10.1016/j.cell.2013.09.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209621	Bronze			2022-12-28	WOS:000326934300013
J	Maurizi, MR; Stan, G				Maurizi, Michael R.; Stan, George			ClpX Shifts into High Gear to Unfold Stable Proteins	CELL			English	Editorial Material							ATP; MACHINE	Protein degradation by the ClpXP protease requires collaboration among the six AAA+ domains of ClpX. Using single-molecule optical tweezers, Sen et al. show that ClpX uses a coordinated succession of power strokes to translocate polypeptides in ATP-tunable bursts before reloading with nucleotide. This strategy allows ClpX to kinetically capture transiently unfolded intermediates.	[Maurizi, Michael R.] NCI, Cell Biol Lab, Bethesda, MD 20892 USA; [Stan, George] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; University of Cincinnati	Maurizi, MR (corresponding author), NCI, Cell Biol Lab, Bldg 37, Bethesda, MD 20892 USA.	mmaurizi@helix.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC005597] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Sen M, 2013, CINEMA J, V52, P155, DOI 10.1353/cj.2013.0046; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245	10	7	7	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					502	504		10.1016/j.cell.2013.10.007	http://dx.doi.org/10.1016/j.cell.2013.10.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243009	Bronze			2022-12-28	WOS:000326571800005
J	Wapinski, OL; Vierbuchen, T; Qu, K; Lee, QY; Chanda, S; Fuentes, DR; Giresi, PG; Ng, YH; Marro, S; Neff, NF; Drechsel, D; Martynoga, B; Castro, DS; Webb, AE; Sudhof, TC; Brunet, A; Guillemot, F; Chang, HY; Wernig, M				Wapinski, Orly L.; Vierbuchen, Thomas; Qu, Kun; Lee, Qian Yi; Chanda, Soham; Fuentes, Daniel R.; Giresi, Paul G.; Ng, Yi Han; Marro, Samuele; Neff, Norma F.; Drechsel, Daniela; Martynoga, Ben; Castro, Diogo S.; Webb, Ashley E.; Suedhof, Thomas C.; Brunet, Anne; Guillemot, Francois; Chang, Howard Y.; Wernig, Marius			Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons	CELL			English	Article							ACHAETE-SCUTE HOMOLOG-1; FUNCTIONAL-NEURONS; TRANSCRIPTIONAL ACTIVATION; DEFINED FACTORS; STEM-CELLS; CONVERSION; CHROMATIN; DEMETHYLASES; FINGER; GENOME	Direct lineage reprogramming is a promising approach for human disease modeling and regenerative medicine, with poorly understood mechanisms. Here, we reveal a hierarchical mechanism in the direct conversion of fibroblasts into induced neuronal (iN) cells mediated by the transcription factors Ascl1, Brn2, and Myt1l. Ascl1 acts as an "on-target" pioneer factor by immediately occupying most cognate genomic sites in fibroblasts. In contrast, Brn2 and Myt1l do not access fibroblast chromatin productively on their own; instead, Ascl1 recruits Brn2 to Ascl1 sites genome wide. A unique trivalent chromatin signature in the host cells predicts the permissiveness for Ascl1 pioneering activity among different cell types. Finally, we identified Zfp238 as a key Ascl1 target gene that can partially substitute for Ascl1 during iN cell reprogramming. Thus, a precise match between pioneer factors and the chromatin context at key target genes is determinative for transdifferentiation to neurons and likely other cell types.	[Wapinski, Orly L.; Qu, Kun; Giresi, Paul G.; Suedhof, Thomas C.; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wapinski, Orly L.; Qu, Kun; Giresi, Paul G.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Wapinski, Orly L.; Vierbuchen, Thomas; Fuentes, Daniel R.; Brunet, Anne; Chang, Howard Y.; Wernig, Marius] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Vierbuchen, Thomas; Lee, Qian Yi; Chanda, Soham; Fuentes, Daniel R.; Ng, Yi Han; Marro, Samuele; Wernig, Marius] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Vierbuchen, Thomas; Lee, Qian Yi; Chanda, Soham; Fuentes, Daniel R.; Ng, Yi Han; Marro, Samuele; Wernig, Marius] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Lee, Qian Yi; Neff, Norma F.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ng, Yi Han] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Webb, Ashley E.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Drechsel, Daniela; Martynoga, Ben; Guillemot, Francois] Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; [Castro, Diogo S.] Inst Gulbenkian Ciencias, Div Mol Neurobiol, P-2780156 Oeiras, Portugal	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; MRC National Institute for Medical Research; Instituto Gulbenkian de Ciencia	Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu; wernig@stanford.edu	Marro, Samuele G./I-4493-2014; Castro, Diogo S/I-6217-2016; Guillemot, Francois/AAV-1482-2021; Qu, Kun/G-3359-2012	Marro, Samuele G./0000-0002-9326-6945; Castro, Diogo S/0000-0001-8178-9565; Vierbuchen, Thomas/0000-0002-5690-5680; Lee, Qian Yi/0000-0001-9200-0910; Fuentes, Daniel/0000-0002-0412-6933; Chanda, Soham/0000-0002-2327-6224	National Institutes of Health [RC4NS073015]; National Science Foundation; California Institute for Regenerative Medicine predoctoral fellowship; Agency of Science, Technology, and Research of Singapore; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); California Institute for Regenerative Medicine predoctoral fellowship; Agency of Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. C. Tsai, M. Kareta, and P. Lovelace for their invaluable initial help with sequencing protocols, cell culture, and cell sorting. We thank other members of the Chang and Wernig labs for their discussions and support. This work was supported by the National Institutes of Health (RC4NS073015) (to M. W. and H. Y. C.), the National Science Foundation (to O. L. W.), and a California Institute for Regenerative Medicine predoctoral fellowship (to T. V.). Q. Y. L. and Y. H. N. are supported by the Agency of Science, Technology, and Research of Singapore. T. C. S. is a Howard Hughes Medical Institute Investigator. H. Y. C. is an Early Career Scientist of the Howard Hughes Medical Institute. M. W. is a New York Stem Cell Foundation-Robertson Investigator.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Castro DS, 2011, CELL CYCLE, V10, P4026, DOI 10.4161/cc.10.23.18578; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dominguez MH, 2013, CEREB CORTEX, V23, P2632, DOI 10.1093/cercor/bhs252; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fong AP, 2012, DEV CELL, V22, P721, DOI 10.1016/j.devcel.2012.01.015; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; KIM JG, 1992, MOL CELL BIOL, V12, P5632, DOI 10.1128/MCB.12.12.5632; Krishnan S, 2013, STRUCTURE, V21, P98, DOI 10.1016/j.str.2012.10.018; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weiner JA, 1997, J COMP NEUROL, V381, P130, DOI 10.1002/(SICI)1096-9861(19970505)381:2<130::AID-CNE2>3.0.CO;2-4; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	40	377	388	4	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					621	635		10.1016/j.cell.2013.09.028	http://dx.doi.org/10.1016/j.cell.2013.09.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243019	Green Accepted, Bronze			2022-12-28	WOS:000326571800016
J	Conlon, BP; Nakayasu, ES; Fleck, LE; LaFleur, MD; Isabella, VM; Coleman, K; Leonard, SN; Smith, RD; Adkins, JN; Lewis, K				Conlon, B. P.; Nakayasu, E. S.; Fleck, L. E.; LaFleur, M. D.; Isabella, V. M.; Coleman, K.; Leonard, S. N.; Smith, R. D.; Adkins, J. N.; Lewis, K.			Activated ClpP kills persisters and eradicates a chronic biofilm infection	NATURE			English	Article							TANDEM MASS-SPECTRA; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; MULTIDRUG TOLERANCE; PSEUDOMONAS-AERUGINOSA; BACTERIAL PERSISTENCE; IN-VIVO; CELLS; ANTIBIOTICS; RESISTANCE	Chronic infections are difficult to treat with antibiotics but are caused primarily by drug-sensitive pathogens. Dormant persister cells that are tolerant to killing by antibiotics are responsible for this apparent paradox. Persisters are phenotypic variants of normal cells and pathways leading to dormancy are redundant, making it challenging to develop anti-persister compounds. Biofilms shield persisters from the immune system, suggesting that an antibiotic for treating a chronic infection should be able to eradicate the infection on its own. We reasoned that a compound capable of corrupting a target in dormant cells will kill persisters. The acyldepsipeptide antibiotic (ADEP4) has been shown to activate the ClpP protease, resulting in death of growing cells. Here we show that ADEP4-activated ClpP becomes a fairly nonspecific protease and kills persisters by degrading over 400 proteins, forcing cells to self-digest. Null mutants of clpP arise with high probability, but combining ADEP4 with rifampicin produced complete eradication of Staphylococcus aureus biofilms in vitro and in a mouse model of a chronic infection. Our findings indicate a general principle for killing dormant cells-activation and corruption of a target, rather than conventional inhibition. Eradication of a biofilm in an animal model by activating a protease suggests a realistic path towards developing therapies to treat chronic infections.	[Conlon, B. P.; Fleck, L. E.; Isabella, V. M.; Lewis, K.] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA; [Nakayasu, E. S.; Smith, R. D.; Adkins, J. N.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [LaFleur, M. D.; Coleman, K.] Arietis Corp, Boston, MA 02118 USA; [Leonard, S. N.] Northeastern Univ, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA	Northeastern University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Northeastern University	Lewis, K (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu	Smith, Richard D/J-3664-2012; Nakayasu, Ernesto S./AAJ-8374-2020	Smith, Richard D/0000-0002-2381-2349; Nakayasu, Ernesto S./0000-0002-4056-2695; Conlon, Brian/0000-0002-2155-8375	NIH [T-RO1 AI085585]; Arietis Corporation; NIH-NIAID IAA [Y1-AI-8401, P41 GM103493-11]; DOE [DE-AC05-76RLO 1830]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085585, R22AI008401, R01AI008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061162, P41GM103493] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arietis Corporation; NIH-NIAID IAA; DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Wright and C. Blinn of AstraZeneca for assisting with the establishment of the mouse infection model, R. E. Lee, M. Pollastri and Z. Maglika for critical discussions and advice, I. Keren and S. Rowe for reading of the manuscript, H. Brewer, V. Petyuk and D. Camp II for assistance with proteomics, and Z. Zheng for assistance with ChemDraw. This work was supported by NIH award T-RO1 AI085585 to K.L., by Arietis Corporation to M.D.L and K.C., by the NIH-NIAID IAA Y1-AI-8401 to J.N.A. and P41 GM103493-11 to R.D.S. Proteomic analysis was performed in the EMSL, a DOE-BER national scientific user facility at Pacific Northwest National Laboratory (PNNL). PNNL is a multi-program national laboratory operated by Battelle Memorial Institute for the DOE under contract DE-AC05-76RLO 1830.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Bigger JW, 1944, LANCET, V2, P497; BLASER J, 1985, J ANTIMICROB CHEMOTH, V15, P125, DOI 10.1093/jac/15.suppl_A.125; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Buske PJ, 2013, MOL MICROBIOL, V89, P249, DOI 10.1111/mmi.12272; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gurnev PA, 2012, FEBS LETT, V586, P2529, DOI 10.1016/j.febslet.2012.06.021; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Hung C, 2013, MBIO, V4, DOI 10.1128/mBio.00645-13; HUSSAIN M, 1991, J MED MICROBIOL, V34, P143, DOI 10.1099/00222615-34-3-143; Johnson PJT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003123; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Leung E, 2011, CHEM BIOL, V18, P1167, DOI 10.1016/j.chembiol.2011.07.023; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lewis K, 2012, NATURE, V485, P439, DOI 10.1038/485439a; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Mayampurath AM, 2008, BIOINFORMATICS, V24, P1021, DOI 10.1093/bioinformatics/btn063; Michalik S, 2009, PROTEOMICS, V9, P4468, DOI 10.1002/pmic.200900168; Michel K.H., 1985, US Pat., Patent No. [4492650, 4,492,650]; Miyazaki M, 2011, ANTIMICROB AGENTS CH, V55, P1819, DOI 10.1128/AAC.01536-10; Monroe ME, 2008, COMPUT BIOL CHEM, V32, P215, DOI 10.1016/j.compbiolchem.2008.02.006; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	50	437	459	6	258	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					365	+		10.1038/nature12790	http://dx.doi.org/10.1038/nature12790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24226776	Green Accepted			2022-12-28	WOS:000327163200034
J	Macilwain, C				Macilwain, Colin			Thrill of space exploration is a universal constant	NATURE			English	Editorial Material												cfmworldview@googlemail.com						1984, NATURE, V307, P1	1	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					313	313		10.1038/503313a	http://dx.doi.org/10.1038/503313a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24256771	Bronze			2022-12-28	WOS:000327163200006
J	Ellison, CE; Bachtrog, D				Ellison, Christopher E.; Bachtrog, Doris			Dosage Compensation via Transposable Element Mediated Rewiring of a Regulatory Network	SCIENCE			English	Article							DROSOPHILA-PSEUDOOBSCURA; Y-CHROMOSOME; SELFISH DNA; EVOLUTION; GENE; ADAPTATION	Transposable elements (TEs) may contribute to evolutionary innovations through the rewiring of networks by supplying ready-to-use cis regulatory elements. Genes on the Drosophila X chromosome are coordinately regulated by the male specific lethal (MSL) complex to achieve dosage compensation in males. We show that the acquisition of dozens of MSL binding sites on evolutionarily new X chromosomes was facilitated by the independent co-option of a mutant helitron TE that attracts the MSL complex (TE domestication). The recently formed neo-X recruits helitrons that provide dozens of functional, but suboptimal, MSL binding sites, whereas the older XR chromosome has ceased acquisition and appears to have fine-tuned the binding affinities of more ancient elements for the MSL complex. Thus, TE-mediated rewiring of regulatory networks through domestication and amplification may be followed by fine-tuning of the cis-regulatory element supplied by the TE and erosion of nonfunctional regions.	[Ellison, Christopher E.; Bachtrog, Doris] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bachtrog, D (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	dbachtrog@berkeley.edu			NIH [R01GM076007, R01GM093182]; Packard Fellowship; National Center for Biotechnology Information [PRJNA77213]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103186, R01GM076007, R01GM093182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); National Center for Biotechnology Information; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grants (R01GM076007 and R01GM093182) and a Packard Fellowship to D. B. and a NIH postdoctoral fellowship to C. E. E. All DNA-sequencing reads generated in this study are deposited at the National Center for Biotechnology Information Short Reads Archive (www.ncbi.nlm.nih.gov/sra) under the accession no. SRS402821. The genome assemblies are available at the National Center for Biotechnology Information under BioProject PRJNA77213. We thank Z. Walton and A. Gorchakov for technical assistance.	Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Alekseyenko AA, 2013, GENE DEV, V27, P853, DOI 10.1101/gad.215426.113; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; CHARLESWORTH B, 1983, GENET RES, V42, P1, DOI 10.1017/S0016672300021455; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; HICKEY DA, 1982, GENETICS, V101, P519; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Jurka J., 2012, REPBASE REPORTS, V12, P1376; Kapitonov VV, 2007, TRENDS GENET, V23, P521, DOI 10.1016/j.tig.2007.08.004; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Marin I, 1996, NATURE, V383, P160, DOI 10.1038/383160a0; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; STEINEMANN M, 1992, P NATL ACAD SCI USA, V89, P7591, DOI 10.1073/pnas.89.16.7591; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Zhou Q, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001711; Zhou Q, 2012, SCIENCE, V337, P341, DOI 10.1126/science.1225385	26	105	109	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					846	850		10.1126/science.1239552	http://dx.doi.org/10.1126/science.1239552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233721	Green Accepted			2022-12-28	WOS:000326923000035
J	Kenney, MJ; Gong, M; Li, YG; Wu, JZ; Feng, J; Lanza, M; Dai, HJ				Kenney, Michael J.; Gong, Ming; Li, Yanguang; Wu, Justin Z.; Feng, Ju; Lanza, Mario; Dai, Hongjie			High-Performance Silicon Photoanodes Passivated with Ultrathin Nickel Films for Water Oxidation	SCIENCE			English	Article							THIN-FILMS; N-SILICON; SEMICONDUCTOR ELECTRODES; OXYGEN EVOLUTION; CELLS; SI; ELECTROCHEMISTRY; ELECTROLYSIS; CATALYSTS; PLANET	Silicon's sensitivity to corrosion has hindered its use in photoanode applications. We found that deposition of a similar to 2-nanometer nickel film on n-type silicon (n-Si) with its native oxide affords a high-performance metal-insulator-semiconductor photoanode for photoelectrochemical (PEC) water oxidation in both aqueous potassium hydroxide (KOH, pH = 14) and aqueous borate buffer (pH = 9.5) solutions. The Ni film acted as a surface protection layer against corrosion and as a nonprecious metal electrocatalyst for oxygen evolution. In 1 M aqueous KOH, the Ni/n-Si photoanodes exhibited high PEC activity with a low onset potential (similar to 1.07 volts versus reversible hydrogen electrode), high photocurrent density, and durability. The electrode showed no sign of decay after similar to 80 hours of continuous PEC water oxidation in a mixed lithium borate-potassium borate electrolyte. The high photovoltage was attributed to a high built-in potential in a metal-insulator-semiconductor-like device with an ultrathin, incomplete screening Ni/NiOx layer from the electrolyte.	[Kenney, Michael J.; Gong, Ming; Li, Yanguang; Wu, Justin Z.; Feng, Ju; Lanza, Mario; Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hdai@stanford.edu	Liu, Peisong/AAE-3952-2019; Lanza, Mario/GLV-3473-2022; Li, Yanguang/A-2319-2014; Dai, Hongjie/ABC-4574-2021; Lanza, Mario/AAE-3986-2019	Lanza, Mario/0000-0003-4756-8632; Li, Yanguang/0000-0003-0506-0451; Lanza, Mario/0000-0003-4756-8632; Gong, Ming/0000-0002-1584-1211	Stanford Precourt Institute for Energy; Stanford GCEP grant; NSF Graduate Fellowship	Stanford Precourt Institute for Energy; Stanford GCEP grant; NSF Graduate Fellowship(National Science Foundation (NSF))	Supported by a Stinehart/Reed Award from the Stanford Precourt Institute for Energy, a Stanford GCEP grant, and an NSF Graduate Fellowship (M.J.K.). We thank C. Chidsey for helpful discussions.	Bediako DK, 2012, J AM CHEM SOC, V134, P6801, DOI 10.1021/ja301018q; Behura S. K., 2011, J ELECT DEVICES, V10, P471; Chen YW, 2011, NAT MATER, V10, P539, DOI [10.1038/nmat3047, 10.1038/NMAT3047]; CONTRACTOR AQ, 1984, ELECTROCHIM ACTA, V29, P1427, DOI 10.1016/0013-4686(84)87022-X; CORRIGAN DA, 1989, J ELECTROCHEM SOC, V136, P613, DOI 10.1149/1.2096697; CORRIGAN DA, 1989, J ELECTROCHEM SOC, V136, P723, DOI 10.1149/1.2096717; Cox CR, 2013, ENERG ENVIRON SCI, V6, P532, DOI 10.1039/c2ee23932a; Dinca M, 2010, P NATL ACAD SCI USA, V107, P10337, DOI 10.1073/pnas.1001859107; Esposito DV, 2013, NAT MATER, V12, P562, DOI [10.1038/nmat3626, 10.1038/NMAT3626]; FAN FRF, 1981, J ELECTROCHEM SOC, V128, P2042, DOI 10.1149/1.2127794; FAN FRF, 1983, J AM CHEM SOC, V105, P220, DOI 10.1021/ja00340a013; GERISCHER H, 1980, FARADAY DISCUSS, V70, P137, DOI 10.1039/dc9807000137; Gong M, 2013, J AM CHEM SOC, V135, P8452, DOI 10.1021/ja4027715; Gray HB, 2009, NAT CHEM, V1, P7, DOI 10.1038/nchem.141; Jun K, 2012, ANGEW CHEM INT EDIT, V51, P423, DOI 10.1002/anie.201104367; KAINTHLA RC, 1986, J ELECTROCHEM SOC, V133, P248, DOI 10.1149/1.2108556; LEROY RL, 1983, INT J HYDROGEN ENERG, V8, P401, DOI 10.1016/0360-3199(83)90162-3; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; LI GZ, 1987, J ELECTROANAL CHEM, V227, P213, DOI 10.1016/0022-0728(87)80076-1; MACDOUGALL B, 1980, J ELECTROCHEM SOC, V127, P1248, DOI 10.1149/1.2129864; OLIVA P, 1982, J POWER SOURCES, V8, P229, DOI 10.1016/0378-7753(82)80057-8; Reece SY, 2011, SCIENCE, V334, P645, DOI 10.1126/science.1209816; Smith RDL, 2013, SCIENCE, V340, P60, DOI 10.1126/science.1233638; Strandwitz NC, 2013, J PHYS CHEM C, V117, P4931, DOI 10.1021/jp311207x; Sun K, 2013, NANO LETT, V13, P2064, DOI 10.1021/nl400343a; Sun K, 2012, ENERG ENVIRON SCI, V5, P7872, DOI 10.1039/c2ee21708b; TUOMI D, 1965, J ELECTROCHEM SOC, V112, P1, DOI 10.1149/1.2423457; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; WU X, 1990, IEEE ELECTR DEVICE L, V11, P315, DOI 10.1109/55.56486	29	536	540	23	905	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					836	840		10.1126/science.1241327	http://dx.doi.org/10.1126/science.1241327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233719				2022-12-28	WOS:000326923000032
J	Guttmacher, AE; Hirschfeld, S; Collins, FS				Guttmacher, Alan E.; Hirschfeld, Steven; Collins, Francis S.			The National Children's Study-A Proposed Plan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Guttmacher, Alan E.; Hirschfeld, Steven] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA; [Collins, Francis S.] NIH, Off Director, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA	Guttmacher, AE (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA.		Hirschfeld, Steven/E-2987-2016	Hirschfeld, Steven/0000-0003-0627-7249				The National Children's Study, 2012, NAT CHILDR STUD I ME	1	18	18	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1873	1875		10.1056/NEJMp1311150	http://dx.doi.org/10.1056/NEJMp1311150			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300MP	24224620	Green Published			2022-12-28	WOS:000330468300003
J	Gwynne, P				Gwynne, Peter			TECHNOLOGY Mobility machines	NATURE			English	Editorial Material							POWERED EXOSKELETON											Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P911, DOI 10.1097/PHM.0b013e318269d9a3; Fineberg DB, 2013, J SPINAL CORD MED, V36, P313, DOI 10.1179/2045772313Y.0000000126; Pedrocchi A, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-66; Wiggin MB, 2011, INT C REHAB ROBOT	4	12	12	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S16	S17		10.1038/503S16a	http://dx.doi.org/10.1038/503S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24227002	Bronze			2022-12-28	WOS:000326894200008
J	Hartenstein, V; Jacobs, D				Hartenstein, Volker; Jacobs, David			Developmental Plasticity, Straight from the Worm's Mouth	CELL			English	Editorial Material							PHENOTYPIC PLASTICITY; EVOLUTION; POLYPHENISM	Developmental plasticity in response to environmental conditions (polyphenism) plays an important role in evolutionary theory. Analyzing the nematode taxon Pristionchus, Ragsdale et al. demonstrate that a single gene underlies the nematode's ability to develop distinct mouth forms in response to environmental changes.	[Hartenstein, Volker] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Jacobs, David] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jacobs, D (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	volkerh@mcdb.ucla.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054814] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS054814] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Kiontke K, 2010, CURR BIOL, V20, pR710, DOI 10.1016/j.cub.2010.07.009; Krug PJ, 2012, INTEGR COMP BIOL, V52, P161, DOI 10.1093/icb/ics059; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Ragsdale EJ, 2013, CELL, V155, P922, DOI 10.1016/j.cell.2013.09.054; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888	9	1	1	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					742	743		10.1016/j.cell.2013.10.038	http://dx.doi.org/10.1016/j.cell.2013.10.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209614	Green Accepted, Bronze			2022-12-28	WOS:000326934300005
J	Sattiraju, S; Missov, E				Sattiraju, Srinivasan; Missov, Emil			Delayed presentation of acute aortic syndrome	LANCET			English	Editorial Material									[Sattiraju, Srinivasan] Carle Clin Assoc, Div Cardiol, Urbana, IL USA; [Missov, Emil] Univ Minnesota, Med Ctr, Div Cardiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Missov, E (corresponding author), Univ Minnesota, Med Ctr, Div Cardiol, Minneapolis, MN 55455 USA.	misso001@umn.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2238	2238		10.1016/S0140-6736(13)60846-6	http://dx.doi.org/10.1016/S0140-6736(13)60846-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24211042				2022-12-28	WOS:000338657600028
J	Ding, BS; Cao, ZW; Lis, R; Nolan, DJ; Guo, PP; Simons, M; Penfold, ME; Shido, K; Rabbany, SY; Rafii, S				Ding, Bi-Sen; Cao, Zhongwei; Lis, Raphael; Nolan, Daniel J.; Guo, Peipei; Simons, Michael; Penfold, Mark E.; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin			Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis	NATURE			English	Article							BETA-ARRESTIN; CELLS; RECEPTOR; INJURY; REPAIR; ANGIOGENESIS; CXCR4	Chemical or traumatic damage to the liver is frequently associated with aberrant healing (fibrosis) that overrides liver regeneration(1-5). The mechanism by which hepatic niche cells differentially modulate regeneration and fibrosis during liver repair remains to be defined(6-8). Hepatic vascular niche predominantly represented by liver sinusoidal endothelial cells deploys paracrine trophogens, known as angiocrine factors, to stimulate regeneration(9-15). Nevertheless, it is not known how pro-regenerative angiocrine signals from liver sinusoidal endothelial cells is subverted to promote fibrosis(16,17). Here, by combining an inducible endothelial-cell-specific mouse gene deletion strategy and complementary models of acute and chronic liver injury, we show that divergent angiocrine signals from liver sinusoidal endothelial cells stimulate regeneration after immediate injury and provoke fibrosis after chronic insult. The pro-fibrotic transition of vascular niche results from differential expression of stromal-derived factor-1 receptors, CXCR7 and CXCR4 (refs 18-21), in liver sinusoidal endothelial cells. After acute injury, CXCR7 upregulation in liver sinusoidal endothelial cells acts with CXCR4 to induce transcription factor Id1, deploying pro-regenerative angiocrine factors and triggering regeneration. Inducible deletion of Cxcr7 in sinusoidal endothelial cells (Cxcr7(i Delta EC/i Delta EC)) from the adult mouse liver impaired liver regeneration by diminishing Id1-mediated production of angiocrine factors(9-11). By contrast, after chronic injury inflicted by iterative hepatotoxin (carbon tetrachloride) injection and bile duct ligation, constitutive FGFR1 signalling in liver sinusoidal endothelial cells counterbalanced CXCR7-dependent pro-regenerative response and augmented CXCR4 expression. This predominance of CXCR4 over CXCR7 expression shifted angiocrine response of liver sinusoidal endothelial cells, stimulating proliferation of desmin(+) hepatic stellate-like cells(22,23) and enforcing apro-fibrotic vascular niche. Endothelial-cell-specific ablation of either Fgfr1 (Fgfr1(i Delta EC/i Delta EC)) or Cxcr4 (Cxcr4(i Delta EC/i Delta EC)) in mice restored the pro-regenerative pathway and prevented FGFR1-mediated maladaptive subversion of angiocrine factors. Similarly, selective CXCR7 activation in liver sinusoidal endothelial cells abrogated fibrogenesis. Thus, we demonstrate that in response to liver injury, differential recruitment of pro-regenerative CXCR7-Id1 versus pro-fibrotic FGFR1-CXCR4 angiocrine pathways in vascular niche balances regeneration and fibrosis. These results provide a therapeutic roadmap to achieve hepatic regeneration without provoking fibrosis(1,2,4).	[Ding, Bi-Sen; Cao, Zhongwei; Lis, Raphael; Nolan, Daniel J.; Guo, Peipei; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, Howard Hughes Med Inst, Dept Med Genet, New York, NY 10065 USA; [Nolan, Daniel J.] Angiocrine Biosci, New York, NY 10065 USA; [Simons, Michael] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Penfold, Mark E.] ChemoCentryx Inc, Mountain View, CA 94043 USA; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY 11549 USA	Cornell University; Howard Hughes Medical Institute; Yale University; Hofstra University	Rafii, S (corresponding author), Weill Cornell Med Coll, Ansary Stem Cell Inst, Howard Hughes Med Inst, Dept Med Genet, New York, NY 10065 USA.	bid2004@med.cornell.edu; srafii@med.cornell.edu	Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	National Scientist Development Grant from the American Heart Association [12SDG1213004]; New York Stem Cell Foundation; Ansary Stem Cell Institute; Howard Hughes Medical Institute; Empire State Stem Cell Board; New York State Department of Health [C024180, C026438, C026878, C028117]; National Heart, Lung, and Blood Institute [R01HL097797, R01HL119872, RC2HL101846, R01 HL053793]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK095039]; National Cancer Institute [U54CA163167]; Qatar National Priorities Research Foundation [NPRP08-663-3-140]; Qatar Foundation; Tri-Institutional Weill Cornell Starr Stem Cell Scholar Program; NATIONAL CANCER INSTITUTE [U54CA163167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097797, RC2HL101846, R01HL119872, R01HL053793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	National Scientist Development Grant from the American Heart Association; New York Stem Cell Foundation; Ansary Stem Cell Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Empire State Stem Cell Board; New York State Department of Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Qatar National Priorities Research Foundation; Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Tri-Institutional Weill Cornell Starr Stem Cell Scholar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to T. Hla for reading the manuscript, R. Berahovich and K. Eggan for their suggestions on CXCR7 signalling for liver repair, R. H. Adams for providing mouse inducible endothelial-cell-specific Cre (Cdh5-PAC-Cre<SUP>ERT2</SUP>) line and Y.-R. Zou for offering the floxed Cxcr4 mouse line. B.-S.D. is supported by a National Scientist Development Grant from the American Heart Association (number 12SDG1213004) and a Druckenmiller Fellowship from the New York Stem Cell Foundation. S. R. is supported by the Ansary Stem Cell Institute, the Howard Hughes Medical Institute, Empire State Stem Cell Board and New York State Department of Health grants (C024180, C026438, C026878, C028117), National Heart, Lung, and Blood Institute grants R01HL097797, R01HL119872 and RC2HL101846, National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK095039, National Cancer Institute grant U54CA163167, Qatar National Priorities Research Foundation grant NPRP08-663-3-140 and the Qatar Foundation BioMedical Research Program. R. L., P. G. and K. S. are supported by Empire State Stem Cell Board and New York State Department of Health training grants (C026878). D.N. is supported by the Tri-Institutional Weill Cornell Starr Stem Cell Scholar Program. M. S. is supported by National Heart, Lung, and Blood Institute grant R01 HL053793.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bohm F, 2010, GASTROENTEROLOGY, V139, P1385, DOI 10.1053/j.gastro.2010.06.069; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Diehl AM, 2012, NAT MED, V18, P497, DOI 10.1038/nm.2719; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Huebert RC, 2010, HEPATOLOGY, V52, P238, DOI 10.1002/hep.23628; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Sakaguchi TF, 2008, CURR BIOL, V18, P1565, DOI 10.1016/j.cub.2008.08.065; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Yu SH, 2011, DEV DYNAM, V240, P384, DOI 10.1002/dvdy.22549; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	32	379	406	2	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					97	+		10.1038/nature12681	http://dx.doi.org/10.1038/nature12681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24256728	Green Accepted			2022-12-28	WOS:000329163300031
J	Fortmann, SP; Burda, BU; Senger, CA; Lin, JS; Whitlock, EP				Fortmann, Stephen P.; Burda, Brittany U.; Senger, Caitlyn A.; Lin, Jennifer S.; Whitlock, Evelyn P.			Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer: An Updated Systematic Evidence Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							BETA-CAROTENE SUPPLEMENTATION; RANDOMIZED CLINICAL-TRIAL; STOPPING ANTIOXIDANT VITAMINS; BASE-LINE CHARACTERISTICS; PLACEBO-CONTROLLED TRIAL; 5-YEAR FOLLOW-UP; PHYSICIANS HEALTH; CALCIUM SUPPLEMENTATION; PROSTATE-CANCER; SELENIUM SUPPLEMENTATION	Background: Vitamin and mineral supplements are commonly used to prevent chronic diseases. Purpose: To systematically review evidence for the benefit and harms of vitamin and mineral supplements in community-dwelling, nutrient-sufficient adults for the primary prevention of cardiovascular disease (CVD) and cancer. Data Sources: MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Database of Abstracts of Reviews of Effects were searched from January 2005 to 29 January 2013, with manual searches of reference lists and gray literature. Study Selection: Two investigators independently selected and reviewed fair-and good-quality trials for benefit and fair-and good-quality trials and observational studies for harms. Data Extraction: Dual quality assessments and data abstraction. Data Synthesis: Two large trials (n = 27 658) reported lower cancer incidence in men taking a multivitamin for more than 10 years (pooled unadjusted relative risk, 0.93 [95% CI, 0.87 to 0.99]). The study that included women showed no effect in that group. High-quality studies (k = 24; n = 324 653) of single and paired nutrients (such as vitamins A, C, or D; folic acid; selenium; or calcium) were scant and heterogeneous and showed no clear evidence of benefit or harm. Neither vitamin E nor beta-carotene prevented CVD or cancer, and beta-carotene increased lung cancer risk in smokers. Limitations: The analysis included only primary prevention studies in adults without known nutritional deficiencies. Studies were conducted in older individuals and included various supplements and doses under the set upper tolerable limits. Duration of most studies was less than 10 years. Conclusion: Limited evidence supports any benefit from vitamin and mineral supplementation for the prevention of cancer or CVD. Two trials found a small, borderline-significant benefit from multivitamin supplements on cancer in men only and no effect on CVD.	[Fortmann, Stephen P.; Burda, Brittany U.; Senger, Caitlyn A.; Lin, Jennifer S.; Whitlock, Evelyn P.] Kaiser Permanente Ctr Hlth Res, Portland, OR 97227 USA	Kaiser Permanente	Fortmann, SP (corresponding author), Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.	Abner Erin L, 2011, Curr Aging Sci, V4, P158; AlFaris E, 2007, ANN SAUDI MED, V27, P54; [Anonymous], 2008, US PREV SERV TASK FO; [Anonymous], 2011, NUTR BUSINESS J; Atkins D, 2003, ROUTINE VITAMIN SUPP; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Baron JA, 2005, CANCER EPIDEM BIOMAR, V14, P586, DOI 10.1158/1055-9965.EPI-04-0319; Beil T.L., 2013, VITAMIN MINERAL MULT; Berg AO, 2003, ANN INTERN MED, V139, P51, DOI 10.7326/0003-4819-139-1-200307010-00013; Bin Q, 2011, THROMB HAEMOSTASIS, V105, P579, DOI 10.1160/TH10-11-0729; Bjelakovic G, 2008, ALIMENT PHARM THER, V28, P689, DOI 10.1111/j.1365-2036.2008.03785.x; Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]; Bjelakovic Goran, 2008, Cochrane Database Syst Rev, pCD004183, DOI 10.1002/14651858.CD004183.pub3; Bolland MJ, 2008, BMJ-BRIT MED J, V336, P262, DOI 10.1136/bmj.39440.525752.BE; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Borenstein M., 2009, INTRO METAANALYSIS; BRADBURN MJ, 1998, META ANAL STATA, P3; Byers T, 2010, AM J EPIDEMIOL, V172, P1, DOI 10.1093/aje/kwq112; Centers for Disease Control and Prevention, 2013, LEAD CAUS DEATH 2012; Chang YJ, 2011, DERMATOLOGY, V223, P36, DOI 10.1159/000329439; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Chylack LT, 2002, OPHTHAL EPIDEMIOL, V9, P49; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Cook NR, 2000, CANCER CAUSE CONTROL, V11, P617, DOI 10.1023/A:1008995430664; Dean AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025966; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Ezzedine K, 2010, EUR J CANCER, V46, P3316, DOI 10.1016/j.ejca.2010.06.008; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Flores-Mateo G, 2006, AM J CLIN NUTR, V84, P762, DOI 10.1093/ajcn/84.4.762; Ford JA, 2012, CIRCULATION, V126; Fritz H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026259; Gahche Jamie, 2011, NCHS Data Brief, P1; Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P1871, DOI 10.1001/jama.2012.14641; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; Graat JM, 2002, JAMA-J AM MED ASSOC, V288, P715, DOI 10.1001/jama.288.6.715; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; GREENBERG ER, 1990, NEW ENGL J MED, V323, P789, DOI 10.1056/NEJM199009203231204; Greenberg ER, 1996, JAMA-J AM MED ASSOC, V275, P699, DOI 10.1001/jama.275.9.699; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Hercberg S, 1998, INT J VITAM NUTR RES, V68, P3; Hercberg S, 2007, J NUTR, V137, P2098, DOI 10.1093/jn/137.9.2098; Hercberg S, 2006, BRIT J NUTR, V96, pS28, DOI 10.1079/BJN20061695; Hercberg S, 2010, INT J CANCER, V127, P1875, DOI 10.1002/ijc.25201; Huang Han-Yo, 2006, Evid Rep Technol Assess (Full Rep), P1; Institute of Medicine (IOM), 2006, DIETARY REFERENCE IN, DOI [10.17226/11537, DOI 10.17226/11537]; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lappe JM, 2012, DERM-ENDOCRINOL, V4, P95, DOI 10.4161/derm.19833; Lee EH, 2011, NUTR CANCER, V63, P1185, DOI [10.1080/01635581.2011.607544, 10.1080/01635581.2011.607541]; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Levine N, 1997, CANCER EPIDEM BIOMAR, V6, P957; Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345; Lichtenstein AH, 2005, JAMA-J AM MED ASSOC, V294, P351, DOI 10.1001/jama.294.3.351; Lim LS, 2004, OSTEOPOROSIS INT, V15, P552, DOI 10.1007/s00198-003-1577-y; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Meyer F, 2005, INT J CANCER, V116, P182, DOI 10.1002/ijc.21058; Moon TE, 1997, CANCER EPIDEM BIOMAR, V6, P949; Morris CD, 2003, ROUTINE VITAMIN SUPP; Moye LA, 2001, CIRCULATION, V103, P3150, DOI 10.1161/hc2501.090955; National Institute for Health and Clinical Excellence, 2006, GUID MAN; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Papaioannou D, 2011, COLORECTAL DIS, V13, P1085, DOI 10.1111/j.1463-1318.2010.02289.x; Prentice RL, 2013, OSTEOPOROSIS INT, V24, P567, DOI 10.1007/s00198-012-2224-2; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Rayman MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045269; Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009671.pub2; Ritenbaugh C, 2003, ROUTINE VITAMIN SUPP; Salonen JT, 2000, J INTERN MED, V248, P377, DOI 10.1046/j.1365-2796.2000.00752.x; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Sesso HD, 2012, JAMA-J AM MED ASSOC, V308, P1751, DOI 10.1001/jama.2012.14805; Shekelle P, 2003, EFFECT SUPPLEMENTAL; Shekelle PG, 2004, J GEN INTERN MED, V19, P380, DOI 10.1111/j.1525-1497.2004.30090.x; Stranges S, 2006, AM J EPIDEMIOL, V163, P694, DOI 10.1093/aje/kwj097; Tanvetyanon T, 2008, CANCER-AM CANCER SOC, V113, P150, DOI 10.1002/cncr.23527; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; United Nations Development Program, 2011, HUM DEV REP 2011 SUS; Virtamo J, 2003, JAMA-J AM MED ASSOC, V290, P476, DOI 10.1001/jama.290.4.476; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283	91	264	271	7	90	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12					824	+		10.7326/0003-4819-159-12-201312170-00729	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-00729			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24217421				2022-12-28	WOS:000329735300015
J	Nielsen, N; Wettersley, J; Cronberg, T; Erlinge, D; Gasche, Y; Hassager, C; Horn, J; Hovdenes, J; Kjaergaard, J; Kuiper, M; Pellis, T; Stammet, P; Wanscher, M; Wise, MP; Aneman, A; Al-Subaie, N; Boesgaard, S; Bro-Jeppesen, J; Brunetti, I; Bugge, JF; Hingston, CD; Juffermans, NP; Koopmans, M; Kober, L; Langorgen, J; Lilja, G; Moller, JE; Rundgren, M; Rylander, C; Smid, O; Werer, C; Winkel, P; Friberg, H				Nielsen, Niklas; Wettersley, Jorn; Cronberg, Tobias; Erlinge, David; Gasche, Yvan; Hassager, Christian; Horn, Janneke; Hovdenes, Jan; Kjaergaard, Jesper; Kuiper, Michael; Pellis, Tommaso; Stammet, Pascal; Wanscher, Michael; Wise, Matt P.; Aneman, Anders; Al-Subaie, Nawaf; Boesgaard, Soren; Bro-Jeppesen, John; Brunetti, Iole; Bugge, Jan Frederik; Hingston, Christopher D.; Juffermans, Nicole P.; Koopmans, Matty; Kober, Lars; Langorgen, Jorund; Lilja, Gisela; Moller, Jacob Eifer; Rundgren, Malin; Rylander, Christian; Smid, Ondrej; Werer, Christophe; Winkel, Per; Friberg, Hans		TTM Trial Investigators	Targeted Temperature Management at 33 degrees C versus 36 degrees C after Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; THERAPEUTIC HYPOTHERMIA; CARDIOPULMONARY-RESUSCITATION; CARE; SURVIVAL; INCREASE; OUTCOMES	BackgroundUnconscious survivors of out-of-hospital cardiac arrest have a high risk of death or poor neurologic function. Therapeutic hypothermia is recommended by international guidelines, but the supporting evidence is limited, and the target temperature associated with the best outcome is unknown. Our objective was to compare two target temperatures, both intended to prevent fever. MethodsIn an international trial, we randomly assigned 950 unconscious adults after out-of-hospital cardiac arrest of presumed cardiac cause to targeted temperature management at either 33 degrees C or 36 degrees C. The primary outcome was all-cause mortality through the end of the trial. Secondary outcomes included a composite of poor neurologic function or death at 180 days, as evaluated with the Cerebral Performance Category (CPC) scale and the modified Rankin scale. ResultsIn total, 939 patients were included in the primary analysis. At the end of the trial, 50% of the patients in the 33 degrees C group (235 of 473 patients) had died, as compared with 48% of the patients in the 36 degrees C group (225 of 466 patients) (hazard ratio with a temperature of 33 degrees C, 1.06; 95% confidence interval [CI], 0.89 to 1.28; P=0.51). At the 180-day follow-up, 54% of the patients in the 33 degrees C group had died or had poor neurologic function according to the CPC, as compared with 52% of patients in the 36 degrees C group (risk ratio, 1.02; 95% CI, 0.88 to 1.16; P=0.78). In the analysis using the modified Rankin scale, the comparable rate was 52% in both groups (risk ratio, 1.01; 95% CI, 0.89 to 1.14; P=0.87). The results of analyses adjusted for known prognostic factors were similar. ConclusionsIn unconscious survivors of out-of-hospital cardiac arrest of presumed cardiac cause, hypothermia at a targeted temperature of 33 degrees C did not confer a benefit as compared with a targeted temperature of 36 degrees C. (Funded by the Swedish Heart-Lung Foundation and others; TTM ClinicalTrials.gov number, NCT01020916.)	[Nielsen, Niklas] Helsingborg Hosp, Dept Anesthesiol & Intens Care, S-25187 Helsingborg, Sweden; [Nielsen, Niklas; Cronberg, Tobias; Erlinge, David; Lilja, Gisela; Rundgren, Malin; Friberg, Hans] Lund Univ, Dept Clin Sci, Lund, Sweden; [Erlinge, David] Lund Univ, Dept Cardiol, Lund, Sweden; [Cronberg, Tobias] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Rundgren, Malin; Friberg, Hans] Skane Univ Hosp, Dept Anesthesiol & Intens Care, Lund, Sweden; [Lilja, Gisela] Skane Univ Hosp, Dept Rehabil Med, Lund, Sweden; [Rylander, Christian] Sahlgrens Univ Hosp, Dept Anesthesiol & Intens Care, Gothenburg, Sweden; [Wettersley, Jorn; Winkel, Per] Rigshosp, Copenhagen Univ Hosp, Copenhagen Trial Unit, Ctr Clin Intervent Res,Heart Ctr, DK-2100 Copenhagen, Denmark; [Hassager, Christian; Kjaergaard, Jesper; Boesgaard, Soren; Bro-Jeppesen, John; Kober, Lars; Moller, Jacob Eifer] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Ctr Heart, DK-2100 Copenhagen, Denmark; [Wanscher, Michael] Rigshosp, Copenhagen Univ Hosp, Dept Cardiothorac Anesthesiol, Ctr Heart, DK-2100 Copenhagen, Denmark; [Gasche, Yvan] Univ Hosp Geneva, Dept Anesthesiol Pharmacol & Intens Care, Geneva, Switzerland; [Horn, Janneke; Kuiper, Michael; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands; [Hovdenes, Jan; Bugge, Jan Frederik] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Anesthesiol, N-0027 Oslo, Norway; [Kuiper, Michael; Koopmans, Matty] Med Ctr Leeuwarden, Dept Intens Care, Leeuwarden, Netherlands; [Pellis, Tommaso] Santa Maria Angeli, Intens Care Unit, Pordenone, Italy; [Brunetti, Iole] Univ Genoa, Ist Sci Tumori, Dept Intens Care, Ist Ricovero & Cura Carattere Sci San Martino, Genoa, Italy; [Stammet, Pascal; Werer, Christophe] Ctr Hosp Luxembourg, Dept Anesthesiol & Intens Care, Luxembourg, Luxembourg; [Wise, Matt P.; Hingston, Christopher D.] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales; [Aneman, Anders] Liverpool Hosp, Dept Intens Care, Sydney, NSW, Australia; [Al-Subaie, Nawaf] St George Hosp, Dept Intens Care, London, England; [Langorgen, Jorund] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Smid, Ondrej] Gen Univ Hosp Prague, Dept Internal Med Cardiol & Angiol 2, Prague, Czech Republic	Helsingborgs Hospital; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Sahlgrenska University Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Geneva; University of Amsterdam; Academic Medical Center Amsterdam; University of Oslo; National Hospital Norway; Medical Center Leeuwarden; Azienda Ospedaliera Santa Maria degli Angeli Pordenone; University of Genoa; Luxembourg Hospital Center; Cardiff University; Liverpool Hospital; St Georges University London; University of Bergen; Haukeland University Hospital; General University Hospital Prague	Nielsen, N (corresponding author), Helsingborg Hosp, Dept Anesthesia & Intens Care, Intens Care Unit, S Vallgatan 5, S-25187 Helsingborg, Sweden.	niklas.nielsen@med.lu.se	Horn, Janneke/ACB-3607-2022; Malik, Jan/K-8681-2019; Kuiper, Michael/AAG-9878-2019; Stammet, Pascal/CAA-1681-2022; Šmíd, Ondřej/M-7545-2017; Mellinghoff, Johannes/V-4844-2019; Laake, Jon Henrik/L-3224-2019; Rylander, Christian/AAV-3713-2020; Malik, Jan/C-4826-2008; Kander, Thomas/H-8206-2019; Wetterslev, Jørn/ABF-1251-2020; Stammet, Pascal/ABA-7580-2020; Ostermann, Marlies/B-8777-2015	Malik, Jan/0000-0002-2386-3293; Šmíd, Ondřej/0000-0001-9260-6509; Mellinghoff, Johannes/0000-0002-5455-8953; Laake, Jon Henrik/0000-0001-6157-5359; Rylander, Christian/0000-0002-4534-7150; Malik, Jan/0000-0002-2386-3293; Kander, Thomas/0000-0002-5404-2981; Wetterslev, Jørn/0000-0001-7778-1771; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Micallef, Sharon/0000-0002-8496-2324; Thompson, Kelly/0000-0003-2304-8931; Wise, Matt/0000-0002-2763-4316; Furgani, Andrea/0000-0003-1898-6034; Fredholm, Merete/0000-0002-3563-7648; Rulisek, Jan/0000-0002-9063-313X; Aneman, Anders/0000-0003-2096-5304; Hassager, Christian/0000-0002-1199-0981; Kober, Lars/0000-0002-6635-1466; Ostermann, Marlies/0000-0001-9500-9080; Lilja, Gisela/0000-0003-1860-1456; Kuiper, Michael/0000-0001-6201-7332; Bro-Jeppesen, John/0000-0001-7187-5734; Kjaergaard, Jesper/0000-0001-5244-0399	Swedish Heart-Lung Foundation	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	Funded by the Swedish Heart-Lung Foundation and others; TTM ClinicalTrials.gov number, NCT01020916.	ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; Adielsson A, 2011, HEART, V97, P1391, DOI 10.1136/hrt.2011.222711; [Anonymous], 1999, STAT MED, V18, P1905; Arrich J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub3; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bro-Jeppessen J, 2013, RESUSCITATION; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; Dumas F, 2012, RESUSCITATION, V83, P1001, DOI 10.1016/j.resuscitation.2012.01.029; Dumas F, 2011, CIRCULATION, V123, P877, DOI 10.1161/CIRCULATIONAHA.110.987347; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Fisher GC, 2008, ANAESTHESIA, V63, P885, DOI 10.1111/j.1365-2044.2008.05614_1.x; Gibson Alistair, 2013, F1000Prime Rep, V5, P26, DOI 10.12703/P5-26; Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4; Grasner JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10035; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2010, NEW ENGL J MED, V363, P1256, DOI 10.1056/NEJMct1002402; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Leary M, 2013, RESUSCITATION, V84, P1056, DOI 10.1016/j.resuscitation.2012.11.003; Lindner TW, 2013, CRIT CARE, V17, DOI 10.1186/cc12826; Logue ES, 2007, ACAD EMERG MED, V14, P293, DOI 10.1197/j.aem.2006.10.097; Mooney MR, 2011, CIRCULATION, V124, P206, DOI 10.1161/CIRCULATIONAHA.110.986257; Moran John L, 2006, Crit Care Resusc, V8, P151; Moulaert VRMP, 2009, RESUSCITATION, V80, P297, DOI 10.1016/j.resuscitation.2008.10.034; Nichol G, 2013, RESUSCITATION, V84, P620, DOI 10.1016/j.resuscitation.2012.12.009; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Nielsen N, 2010, INT J CARDIOL; Nielsen N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-300; Nielsen N, 2012, AM HEART J, V163, P541, DOI 10.1016/j.ahj.2012.01.013; Nielsen N, 2011, CRIT CARE MED, V39, P57, DOI 10.1097/CCM.0b013e3181fa4301; Peberdy MA, 2011, CIRCULATION, V124, pE403, DOI 10.1161/CIR.0b013e318235d047; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; RANKIN J, 1957, Scott Med J, V2, P200; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; Tomte O, 2011, RESUSCITATION, V82, P1186, DOI 10.1016/j.resuscitation.2011.05.003; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; World Medical Association, 2008, 59 WMA GEN ASS OCT; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	40	1820	1887	1	127	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2197	2206		10.1056/NEJMoa1310519	http://dx.doi.org/10.1056/NEJMoa1310519			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24237006	Green Published			2022-12-28	WOS:000327801100006
J	Eggan, K				Eggan, Kevin			Picking the Lock on Pluripotency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS		[Eggan, Kevin] Howard Hughes Med Inst, Chevy Chase, MD USA; [Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02138 USA; [Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Eggan, K (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.		Eggan, Kevin/P-7119-2018					Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	5	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2150	2151		10.1056/NEJMcibr1311880	http://dx.doi.org/10.1056/NEJMcibr1311880			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24283230				2022-12-28	WOS:000327467500014
J	Oostvogels, R; Kemperman, H; Hubeek, I; ter Braak, EWMT				Oostvogels, Rimke; Kemperman, Hans; Hubeek, Isabelle; ter Braak, Edith W. M. T.			The importance of the osmolality gap in ethylene glycol intoxication	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FALSELY ELEVATED LACTATE		[Oostvogels, Rimke; ter Braak, Edith W. M. T.] Univ Med Ctr Utrecht, Dept Internal Med, NL-3584 CX Utrecht, Netherlands; [Kemperman, Hans; Hubeek, Isabelle] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Oostvogels, R (corresponding author), Univ Med Ctr Utrecht, Dept Internal Med, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	R.Oostvogels@umcutrecht.nl		ter Braak, Edith/0000-0002-3882-5804				Brent J, 2009, NEW ENGL J MED, V360, P2216, DOI 10.1056/NEJMct0806112; Brindley PG, 2007, CAN MED ASSOC J, V176, P1097, DOI 10.1503/cmaj.061288; Bronstein AC, 2012, CLIN TOXICOL, V50, P911, DOI 10.3109/15563650.2012.746424; Chaudbry SD, 2008, EUR J ANAESTH, V25, P511, DOI 10.1017/S0265021507003092; Fijen JW, 2006, INTENS CARE MED, V32, P626, DOI 10.1007/s00134-006-0076-y; Pernet P, 2009, AM J EMERG MED, V27, p132e1; Rose BD, 2001, CLIN PHYSL ACID BASE, P583; Sandberg Y, 2010, NETH J MED, V68, P320; Verelst S, 2009, CLIN TOXICOL, V47, P236, DOI 10.1080/15563650802432954; Woo MY, 2003, J EMERG MED, V25, P289, DOI 10.1016/S0736-4679(03)00203-8	10	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2013	347								f6904	10.1136/bmj.f6904	http://dx.doi.org/10.1136/bmj.f6904			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263GF	24284338				2022-12-28	WOS:000327794500003
J	Elias, TCN; Partridge, JSL; McCorkell, SA; Dhesi, JK				Elias, Tania C. N.; Partridge, Judith S. L.; McCorkell, Stuart A.; Dhesi, Jugdeep K.			A patient with hypertrophic cardiomyopathy undergoing non-cardiac surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-COURSE; RISK		[Elias, Tania C. N.; Partridge, Judith S. L.; Dhesi, Jugdeep K.] Guys & St Thomas NHS Fdn Trust, Dept Ageing & Hlth, London SE1 7EH, England; [McCorkell, Stuart A.] Guys & St Thomas NHS Fdn Trust, Anaesthet Dept, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Elias, TCN (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Ageing & Hlth, London SE1 7EH, England.	taniacnelias@gmail.com	Dhesi, Jugdeep/K-5631-2019	Dhesi, Jugdeep/0000-0003-0815-0233; Partridge, Judith Stephanie Louise/0000-0003-0176-5307; McCorkell, Stuart/0000-0003-3905-2775				Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230; Haering JM, 1996, ANESTHESIOLOGY, V85, P254, DOI 10.1097/00000542-199608000-00005; Hreybe H, 2006, CLIN CARDIOL, V29, P65, DOI 10.1002/clc.4960290206; Kuroiwa Masayuki, 2003, Masui, V52, P733; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; Maron BJ, 2004, AM J MED, V116, P63, DOI 10.1016/j.amjmed.2003.10.012; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Poliac LC, 2006, ANESTHESIOLOGY, V104, P183, DOI 10.1097/00000542-200601000-00025; Sahoo RK, 2010, ANN CARD ANAESTH, V13, P253, DOI 10.4103/0971-9784.69049	11	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2013	347								f6910	10.1136/bmj.f6910	http://dx.doi.org/10.1136/bmj.f6910			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FA	24277340				2022-12-28	WOS:000327791000005
J	Schlich, T				Schlich, Thomas			Railways, Industry, and Surgery - The Introduction of Risk Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Risk management was introduced into surgery in the 1870s in part because of precedents in the railroads and manufacturing arenas. This new attitude toward risk led to greater use of surgical interventions and was key to the development of the field. Trains sometimes derail, planes crash, factories collapse yet we take trains and planes and keep building factories. We have learned to live with risk. The notion of risk is so common that it has been described as a defining feature of modern societies. Modern risk management has made risk calculable and to some extent controllable. It is also a central feature of medical intervention, most notably in surgery. But when risk management was initially introduced into surgery, in the 1870s, it was not only because of developments in medicine (such as antisepsis) but also because of precedents in the ...	McGill Univ, Dept Social Studies Med, Montreal, PQ, Canada	McGill University	Schlich, T (corresponding author), McGill Univ, Dept Social Studies Med, Montreal, PQ, Canada.							Kocher T., 1907, CHIRURG OPERATIONSLE; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Mikulicz J., 1897, DEUT MED WOCHENSCHR, V33, p[409, 411]; Trohler U., 1984, NOBELPREISTRAGER THE; Volkmann R., 1881, SAMMLUNG KLIN VORTRA	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					1978	1979		10.1056/NEJMp1309194	http://dx.doi.org/10.1056/NEJMp1309194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254KE	24256376				2022-12-28	WOS:000327163000004
J	Moayyedi, P				Moayyedi, Paul			Crohn disease was not associated with increased risk for mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada	McMaster University	Moayyedi, P (corresponding author), Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.		Moayyedi, Paul/M-6178-2014	Moayyedi, Paul/0000-0002-3616-9292				Duricova D, 2010, INFLAMM BOWEL DIS, V16, P347, DOI 10.1002/ibd.21007	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10							JC12	10.7326/0003-4819-159-10-201311190-02012	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247690				2022-12-28	WOS:000328732700011
J	Hawkes, N				Hawkes, Nigel			Sailing without a lookout: cuts to the Office for National Statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Cadman E, 2013, FINANCIAL TIMES; Hawkes N, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6824; Marmot M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6576	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2013	347								f6739	10.1136/bmj.f6739	http://dx.doi.org/10.1136/bmj.f6739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254GO	24227829				2022-12-28	WOS:000327153200003
J	Crickmore, MA; Vosshall, LB				Crickmore, Michael A.; Vosshall, Leslie B.			Opposing Dopaminergic and GABAergic Neurons Control the Duration and Persistence of Copulation in Drosophila	CELL			English	Article							SEXUAL-BEHAVIOR; NEURAL MECHANISMS; MANTIS-RELIGIOSA; PRAYING-MANTIS; IN-VIVO; MELANOGASTER; EXPRESSION; COURTSHIP; MALES; CELLS	Behavioral persistence is a major factor in determining when and under which circumstances animals will terminate their current activity and transition into more profitable, appropriate, or urgent behavior. We show that, for the first 5 min of copulation in Drosophila, stressful stimuli do not interrupt mating, whereas 10 min later, even minor perturbations are sufficient to terminate copulation. This decline in persistence occurs as the probability of successful mating increases and is promoted by approximately eight sexually dimorphic, GABAergic interneurons of the male abdominal ganglion. When these interneurons were silenced, persistence increased and males copulated far longer than required for successful mating. When these interneurons were stimulated, persistence decreased and copulations were shortened. In contrast, dopaminergic neurons of the ventral nerve cord promote copulation persistence and extend copulation duration. Thus, copulation duration in Drosophila is a product of gradually declining persistence controlled by opposing neuronal populations using conserved neurotransmission systems.	[Crickmore, Michael A.; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie.vosshall@rockefeller.edu		Vosshall, Leslie/0000-0002-6060-8099	Marco Stoffel Mind, Brain, and Behavior Fellowship; Helen Hay Whitney Postdoctoral Fellowship	Marco Stoffel Mind, Brain, and Behavior Fellowship; Helen Hay Whitney Postdoctoral Fellowship	We thank Kevin J. Lee, Gaby Maimon, Alex Nectow, Dragana Rogulja, Vanessa Ruta, and members of the Vosshall Lab for discussion and comments on the manuscript; David Anderson, Barry Dickson, Yuh Nung Jan, Tzumin Lee, Julie Simpson, and Markus Noll for providing fly stocks; Daisuke Yamamoto and Brian Oliver for antibodies; Alison Hill, Sarah Puhr, and Stephen Conway for expert technical assistance; Roman Corfas and Ben Matthews for help with the simulated wind experiments; and Dragana Rogulja and Mike Young for help measuring circadian rhythms. Rachel Zipursky helped initiate experiments with the decapitated males in Figures 1F and 1G. Veronica Burnham helped with heat shock of copulating pairs in Figure 3B. L. B. V. is an investigator of the Howard Hughes Medical Institute. M. A. C. was supported by Marco Stoffel Mind, Brain, and Behavior and Helen Hay Whitney Postdoctoral Fellowships.	Acebes A, 2004, CURR BIOL, V14, P704, DOI 10.1016/j.cub.2004.04.003; Atkinson J.W., 1970, DYNAMICS ACTION; Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Beaver LM, 2004, CURR BIOL, V14, P1492, DOI 10.1016/j.cub.2004.08.022; Boisvert MJ, 2006, CURR BIOL, V16, P1636, DOI 10.1016/j.cub.2006.06.064; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchmann J, 2007, ENDOCRINOLOGY, V148, P1561, DOI 10.1210/en.2006-1244; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Carlson N.R., 2007, PSYCHOL SCI BEHAV; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; GRANT B, 1983, EVOLUTION, V37, P854, DOI 10.1111/j.1558-5646.1983.tb05607.x; Hall JK, 2008, CURR OPIN OPHTHALMOL, V19, P454, DOI 10.1097/ICU.0b013e328310da01; Hempel LU, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-113; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; Kim WJ, 2012, NAT NEUROSCI, V15, P876, DOI 10.1038/nn.3104; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEFEVRE G, 1962, GENETICS, V42, P1719; Linklater JR, 2007, EVOLUTION, V61, P2027, DOI 10.1111/j.1558-5646.2007.00157.x; MACBEAN IT, 1967, GENETICS, V56, P233; Mazzi D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-132; Met Office, 2010, FACT SHEET 6 BEAUF S; Ostrovsky A., 2010, DROSOPHILA NEUROBIOL; Pavlov I.P., 1927, CONDITIONED REFLEXES; Perry CJ, 2013, ANNU REV ENTOMOL, V58, P543, DOI 10.1146/annurev-ento-120811-153631; Prokop P, 2005, ETHOLOGY, V111, P836, DOI 10.1111/j.1439-0310.2005.01113.x; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Roeder KD, 1935, BIOL BULL-US, V69, P203, DOI 10.2307/1537420; RUBIN HB, 1967, J EXP ANAL BEHAV, V10, P219, DOI 10.1901/jeab.1967.10-219; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tayler TD, 2012, P NATL ACAD SCI USA, V109, P20697, DOI 10.1073/pnas.1218246109; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Xue L, 2000, P NATL ACAD SCI USA, V97, P3272, DOI 10.1073/pnas.060018897; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	42	45	46	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					881	893		10.1016/j.cell.2013.09.055	http://dx.doi.org/10.1016/j.cell.2013.09.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209625	Green Accepted, Bronze			2022-12-28	WOS:000326934300017
J	Hendrix, CW				Hendrix, Craig W.			Exploring Concentration Response in HIV Pre-Exposure Prophylaxis to Optimize Clinical Care and Trial Design	CELL			English	Review							ANTIRETROVIRAL PROPHYLAXIS; PREVENTION; TENOFOVIR; INFECTION; ACCEPTABILITY	HIV pre-exposure prophylaxis trials with antiretroviral drugs have been variably successful. Even trials demonstrating the best efficacy leave room for improvement. Pharmacological data illuminate several sources of outcome variability, especially the impact of poor adherence, which is critical to manage PrEP in the clinic and to develop the next generation of PrEP candidates.	Johns Hopkins Univ, Sch Med, Dept Med Clin Pharmacol, Baltimore, MD 21287 USA	Johns Hopkins University	Hendrix, CW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med Clin Pharmacol, Baltimore, MD 21287 USA.	chendrix@jhmi.edu	Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665	Gilead Sciences	Gilead Sciences(Gilead Sciences)	C.W.H. has received partial funding for a clinical study from Gilead Sciences, managed by Johns Hopkins University.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Chen JM, 2012, JAIDS-J ACQ IMM DEF, V61, P593, DOI 10.1097/QAI.0b013e3182717c98; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Duwal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040382; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Louissaint NA, 2013, AIDS RES HUM RETROV, V29, P1443, DOI [10.1089/aid.2013.0044, 10.1089/AID.2013.0044]; Minnis AM, 2013, AIDS BEHAV, V17, P737, DOI 10.1007/s10461-012-0333-8; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614	19	51	51	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					515	518		10.1016/j.cell.2013.09.030	http://dx.doi.org/10.1016/j.cell.2013.09.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243011	Bronze			2022-12-28	WOS:000326571800007
J	Colver, A; Fairhurst, C; Pharoah, POD				Colver, Allan; Fairhurst, Charles; Pharoah, Peter O. D.			Cerebral palsy	LANCET			English	Article							QUALITY-OF-LIFE; SELECTIVE DORSAL RHIZOTOMY; RANDOMIZED CONTROLLED-TRIAL; DEEP BRAIN-STIMULATION; YOUNG-CHILDREN; 8-12-YEAR-OLD CHILDREN; CLASSIFICATION-SYSTEM; CONDUCTIVE EDUCATION; WESTERN-AUSTRALIA; BIRTH-WEIGHT	The syndrome of cerebral palsy encompasses a large group of childhood movement and posture disorders. Severity, patterns of motor involvement, and associated impairments such as those of communication, intellectual ability, and epilepsy vary widely. Overall prevalence has remained stable in the past 40 years at 2-3.5 cases per 1000 livebirths, despite changes in antenatal and perinatal care. The few studies available from developing countries suggest prevalence of comparable magnitude. Cerebral palsy is a lifelong disorder; approaches to intervention, whether at an individual or environmental level, should recognise that quality of life and social participation throughout life are what individuals with cerebral palsy seek, not improved physical function for its own sake. In the past few years, the cerebral palsy community has learned that the evidence of benefit for the numerous drugs, surgery, and therapies used over previous decades is weak. Improved understanding of the role of multiple gestation in pathogenesis, of gene environment interaction, and how to influence brain plasticity could yield significant advances in treatment of the disorder. Reduction in the prevalence of post-neonatal cerebral palsy, especially in developing countries, should be possible through improved nutrition, infection control, and accident prevention.	[Colver, Allan] Newcastle Univ, Royal Victoria Infirm, Inst Hlth & Soc, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Fairhurst, Charles] Guys & St Thomas NHS Fdn Trust, Evelina Childrens Hosp, Dept Paediat Neurosci, London, England; [Pharoah, Peter O. D.] Univ Liverpool, Liverpool L69 3GB, Merseyside, England	Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; University of Liverpool	Pharoah, POD (corresponding author), Univ Liverpool, Liverpool L69 3GB, Merseyside, England.	p.o.d.pharoah@liv.ac.uk						Adams MS, 2012, CHILD CARE HLTH DEV, V38, P878, DOI 10.1111/j.1365-2214.2011.01327.x; [Anonymous], 2013, REP AUSTR CER PALS R; Anttila H, 2008, AM J PHYS MED REHAB, V87, P478, DOI 10.1097/PHM.0b013e318174ebed; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; Bahtiyar MO, 2007, J ULTRAS MED, V26, P1491, DOI 10.7863/jum.2007.26.11.1491; Bennet L, 2012, ANN NEUROL, V71, P589, DOI 10.1002/ana.22670; Bjornson KF, 2008, ARCH PHYS MED REHAB, V89, P121, DOI 10.1016/j.apmr.2007.09.016; Blair E, 2006, SEMIN FETAL NEONAT M, V11, P117, DOI 10.1016/j.siny.2005.10.010; Blair E, 2001, DEV MED CHILD NEUROL, V43, P508, DOI 10.1017/S0012162201000949; Blair E, 1997, MENT RETARD DEV D R, V3, P184; Buckon CE, 2004, ARCH PHYS MED REHAB, V85, P457, DOI 10.1016/j.apmr.2003.05.009; Burguet A, 1999, BIOL NEONATE, V75, P177, DOI 10.1159/000014094; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Carranza-del Rio J, 2011, PEDIATR NEUROL, V44, P202, DOI 10.1016/j.pediatrneurol.2010.09.008; CHANDRA RK, 1994, J NUTR, V124, pS1433, DOI 10.1093/jn/124.suppl_8.1433S; Cloud LJ, 2010, EXPERT OPIN PHARMACO, V11, P5, DOI 10.1517/14656560903426171; Colver AF, 2003, ARCH DIS CHILD, V88, P286, DOI 10.1136/adc.88.4.286; Croen LA, 2001, J PEDIATR-US, V138, P804, DOI 10.1067/mpd.2001.114473; Damiano DL, 2009, J CHILD NEUROL, V24, P1200, DOI 10.1177/0883073809337919; Dan B, 2010, EUR J PAEDIATR NEURO, V14, P19, DOI 10.1016/j.ejpn.2009.05.002; Delgardo M, 2010, NEUROLOGY, V24, P336; Dickinson HO, 2007, LANCET, V369, P2171, DOI 10.1016/S0140-6736(07)61013-7; Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3; Dunn J, 1986, ERADICATION ENDEMIC; Dutton G.N., 2010, CLIN DEV MED; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; EVANS PM, 1991, ARCH DIS CHILD, V66, P325, DOI 10.1136/adc.66.3.325; Fairhurst CBR, 2011, ARCH DIS CHILDHOOD-E, V96, P25, DOI 10.1136/adc.2007.129478; Fauconnier J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1458; Fehlings D, 2012, DEV MED CHILD NEUROL, V54, P106, DOI 10.1111/j.1469-8749.2011.04091.x; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Freud S., 1968, INFANTILE CEREBRAL P; FUSI L, 1991, OBSTET GYNECOL, V78, P517; Gaspard N, 2011, DEV MED CHILD NEUROL, V53, P13, DOI 10.1111/j.1469-8749.2010.03827.x; Gladstone M, 2010, ANN TROP PAEDIATR, V30, P181, DOI 10.1179/146532810X12786388978481; Gough M, 2009, DEV MED CHILD NEUROL, V51, P105, DOI 10.1111/j.1469-8749.2008.03160.x; GRETHER JK, 1993, PEDIATRICS, V92, P854; Grunt S, 2011, DEV MED CHILD NEUROL, V53, P490, DOI 10.1111/j.1469-8749.2011.03912.x; Haak P, 2009, DEV MED CHILD NEUROL, V51, P16, DOI 10.1111/j.1469-8749.2009.03428.x; Hadden KL, 2002, PAIN, V99, P281, DOI 10.1016/S0304-3959(02)00123-9; Hadjipanayis A, 1997, DEV MED CHILD NEUROL, V39, P659; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Hammal D, 2004, DEV MED CHILD NEUROL, V46, P292, DOI 10.1017/S0012162204000489; Heinen F, 2010, EUR J PAEDIATR NEURO, V14, P45, DOI 10.1016/j.ejpn.2009.09.005; Hidecker MJC, 2011, DEV MED CHILD NEUROL, V53, P704, DOI 10.1111/j.1469-8749.2011.03996.x; HOYME HE, 1981, PEDIATRICS, V67, P288; Hutton JL, 2006, ARCH DIS CHILD, V91, P254, DOI 10.1136/adc.2005.075002; Hvidtjorn D, 2010, HUM REPROD, V25, P2115, DOI 10.1093/humrep/deq070; Hvidtjorn D, 2006, PEDIATRICS, V118, P475, DOI 10.1542/peds.2005-2585; Ibrahim SH, 2013, DEV MED CHILD NEUROL, V55, P357, DOI 10.1111/dmcn.12103; Imms C, 2008, DEV MED CHILD NEUROL, V50, P363, DOI 10.1111/j.1469-8749.2008.02051.x; Imms C, 2008, DISABIL REHABIL, V30, P1867, DOI 10.1080/09638280701673542; Jarvis S, 2003, LANCET, V62, P1106; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Jones-Quaidoo SM, 2010, J NEUROSURG-SPINE, V13, P672, DOI 10.3171/2010.5.SPINE09669; Kan P, 2008, CHILD NERV SYST, V24, P239, DOI 10.1007/s00381-007-0457-8; Katalinic OM, 2011, PHYS THER, V91, P11, DOI 10.2522/ptj.20100265; Khan NZ, 1998, DEV MED CHILD NEUROL, V40, P749, DOI 10.1111/j.1469-8749.1998.tb12343.x; King G, 2006, CHILD HEALTH CARE, V35, P209, DOI 10.1207/s15326888chc3503_2; Kirk S, 2008, CHILD CARE HLTH DEV, V34, P567, DOI 10.1111/j.1365-2214.2008.00862.x; Ko B, 2004, CHILD CARE HLTH DEV, V30, P317, DOI 10.1111/j.1365-2214.2004.00422.x; Koy A, 2013, MOVEMENT DISORD, V28, P647, DOI 10.1002/mds.25339; Krageloh-Mann I, 2007, DEV MED CHILD NEUROL, V49, P144; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Kuperminc MN, 2008, DEV DISABIL RES REV, V14, P137, DOI 10.1002/ddrr.14; Landy H, 1995, VANISHING TWIN; Landy HJ, 1998, HUM REPROD UPDATE, V4, P177, DOI 10.1093/humupd/4.2.177; Law MC, 2011, DEV MED CHILD NEUROL, V53, P621, DOI 10.1111/j.1469-8749.2011.03962.x; Little WJ., 1861, T OBSTET SOC LOND, P293; Lundy CT, 2009, DEV MED CHILD NEUROL, V51, P705, DOI 10.1111/j.1469-8749.2009.03315.x; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; Majnemer A., 2012, MEASURES CHILDREN DE; Majnemer A, 2008, DEV MED CHILD NEUROL, V50, P751, DOI 10.1111/j.1469-8749.2008.03068.x; Maudsley G, 1999, ARCH DIS CHILD, V81, P390, DOI 10.1136/adc.81.5.390; McConachie H, 2000, J PEDIATR-US, V137, P769, DOI 10.1067/mpd.2000.110135; McIntyre S, 2013, DEV MED CHILD NEUROL, V55, P499, DOI 10.1111/dmcn.12017; McPherson RJ, 2010, CURR OPIN PEDIATR, V22, P139, DOI 10.1097/MOP.0b013e328336eb57; Michael J., 2008, HEALTHCARE ALL REPOR; Michelsen SI, 2005, DEV MED CHILD NEUROL, V47, P511, DOI 10.1017/S0012162205001015; Michelsen SI, 2009, EUR J PAEDIATR NEURO, V13, P165, DOI 10.1016/j.ejpn.2008.03.005; Michelsen SI, 2006, DEV MED CHILD NEUROL, V48, P643, DOI 10.1017/S0012162206001368; Moll LR, 2013, DISABIL REHABIL, V35, P1276, DOI 10.3109/09638288.2012.726689; MOORE CM, 1969, J PEDIATR, V74, P523, DOI 10.1016/S0022-3476(69)80034-X; Moreno-De-Luca A, 2012, LANCET NEUROL, V11, P283, DOI 10.1016/S1474-4422(11)70287-3; Morgan F, 2011, CHILD CARE HLTH DEV, V37, P161, DOI 10.1111/j.1365-2214.2010.01170.x; National Perinatal Epidemiology Unit, 2002, OXF REG EARL CHILDH; NICE, 2009, IP3182 NICE NAT I HL; NICE, 2012, GUID 145 SPAST CHILD, V145; Nieuwenhuijsen C, 2009, ARCH PHYS MED REHAB, V90, P1891, DOI 10.1016/j.apmr.2009.06.014; O'Callaghan ME, 2012, PEDIATRICS, V129, pE414, DOI 10.1542/peds.2011-0739; Oliver M, 1998, BRIT MED J, V317, P1446, DOI 10.1136/bmj.317.7170.1446; Opheim A, 2009, DEV MED CHILD NEUROL, V51, P381, DOI 10.1111/j.1469-8749.2008.03250.x; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Paneth N, 1984, CLIN DEV MED, V87, P46; Parkes J, 2008, J CHILD PSYCHOL PSYC, V49, P405, DOI 10.1111/j.1469-7610.2007.01845.x; Parkinson KN, 2010, ACTA PAEDIATR, V99, P446, DOI 10.1111/j.1651-2227.2009.01626.x; Parkinson KN, 2013, ARCH DIS CHILD, V98, P434, DOI 10.1136/archdischild-2012-303482; Pennington L, 2013, RES DEV DISABIL, V34, P3202, DOI 10.1016/j.ridd.2013.06.035; PETTERSON B, 1993, BRIT MED J, V307, P1239, DOI 10.1136/bmj.307.6914.1239; Pharoah POD, 2009, HUM REPROD UPDATE, V15, P639, DOI 10.1093/humupd/dmp019; Pharoah POD, 2007, ARCH DIS CHILD-FETAL, V92, P489, DOI 10.1136/adc.2006.107375; PHAROAH POD, 1974, LANCET, V2, P1038; Pharoah POD, 1997, DEV MED CHILD NEUROL, V39, P292; Pharoah POD, 2005, TWIN RES HUM GENET, V8, P543, DOI 10.1375/twin.8.6.543; Pharoah POD, 1998, ARCH DIS CHILD-FETAL, V79, pF21, DOI 10.1136/fn.79.1.F21; PHAROAH POD, 1971, LANCET, V1, P308; Pharoah POD, 2001, ARCH DIS CHILD-FETAL, V84, pF111, DOI 10.1136/fn.84.2.F111; Pharoah POD, 1996, ARCH DIS CHILD-FETAL, V75, pF174, DOI 10.1136/fn.75.3.F174; Platt MJ, 2007, LANCET, V369, P43, DOI 10.1016/S0140-6736(07)60030-0; Ramstad K, 2011, DEV MED CHILD NEUROL, V53, P1013, DOI 10.1111/j.1469-8749.2011.04070.x; Rankin J, 2010, DEV MED CHILD NEUROL, V52, P345, DOI 10.1111/j.1469-8749.2009.03415.x; Reddihough DS, 1998, DEV MED CHILD NEUROL, V40, P763; Reid SM, 2012, DEV MED CHILD NEUROL, V54, P353, DOI 10.1111/j.1469-8749.2012.04218.x; Reid SM, 2010, DEV MED CHILD NEUROL, V52, pe23, DOI 10.1111/j.1469-8749.2009.03519.x; Robb J, 2010, MANAGEMENT CEREBRAL, P307; Roebroeck ME, 2009, DEV MED CHILD NEUROL, V51, P670, DOI 10.1111/j.1469-8749.2009.03322.x; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Rosenbaum P, 2011, DEV MED CHILD NEUROL, V53, P68, DOI 10.1111/j.1469-8749.2011.04068.x; Sanger TD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e89; Scrutton D, 2001, DEV MED CHILD NEUROL, V43, P586, DOI 10.1017/S0012162201001086; Sellier E, 2010, EUR J EPIDEMIOL, V25, P635, DOI 10.1007/s10654-010-9474-0; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Shields N, 2007, DEV MED CHILD NEUROL, V49, P350, DOI 10.1111/j.1469-8749.2007.00350.x; Shikako-Thomas K, 2009, QUAL LIFE RES, V18, P825, DOI 10.1007/s11136-009-9501-3; Sigurdardottir S, 2010, DEV MED CHILD NEUROL, V52, P1056, DOI 10.1111/j.1469-8749.2010.03698.x; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Sponseller PD, 2010, CLIN ORTHOP RELAT R, V468, P711, DOI 10.1007/s11999-009-0933-4; Stanley F, 1984, CLIN DEV MED, V87, P57; STANLEY FJ, 1992, BRIT MED J, V304, P1658, DOI 10.1136/bmj.304.6843.1658; Strauss D, 1999, DEV MED CHILD NEUROL, V41, P580, DOI 10.1017/S001216229900122X; Strauss D, 2008, DEV MED CHILD NEUROL, V50, P487, DOI 10.1111/j.1469-8749.2008.03000.x; Strax TE, 2010, PHYS MED REH CLIN N, V21, P419, DOI 10.1016/j.pmr.2009.12.009; Sullivan PB, 2006, ARCH DIS CHILD, V91, P478, DOI 10.1136/adc.2005.084442; The Centre for Cerebral Palsy and Cerebral Palsy League of Queensland, FUNCT COMM CLASS SYS; Thomason P, 2013, GAIT POSTURE, V37, P23, DOI 10.1016/j.gaitpost.2012.05.022; UN, 1989, CONV RIGHTS CHILD; Van der Slot WMA, 2012, DEV MED CHILD NEUROL, V54, P836, DOI 10.1111/j.1469-8749.2012.04371.x; Vargus-Adams J, 2005, ARCH PHYS MED REHAB, V86, P940, DOI 10.1016/j.apmr.2004.10.036; Vidailhet M, 2009, LANCET NEUROL, V8, P709, DOI 10.1016/S1474-4422(09)70151-6; Watson N., 1999, LIFE DISABLED CHILD; WHO, 2001, WHO INT CLASS FUNCT; Wong AMK, 2005, J NEUROSURG, V102, P385, DOI 10.3171/ped.2005.102.4.0385; Woolfson L, 2004, BRIT J HEALTH PSYCH, V9, P1, DOI 10.1348/135910704322778687; Wu YW, 2011, PEDIATR RES, V70, P642, DOI 10.1203/PDR.0b013e31823240dd; Wynter M, 2011, J PEDIATR REHAB MED, V4, P183, DOI 10.3233/PRM-2011-0174; Yeargin-Allsopp M, 2008, PEDIATRICS, V121, P547, DOI 10.1542/peds.2007-1270	147	283	320	7	139	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1240	1249		10.1016/S0140-6736(13)61835-8	http://dx.doi.org/10.1016/S0140-6736(13)61835-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24268104				2022-12-28	WOS:000334104600028
J	Nicholls, SJ; Kastelein, JJP; Schwartz, GG; Bash, D; Rosenson, RS; Cavender, MA; Brennan, DM; Koenig, W; Jukema, JW; Nambi, V; Wright, RS; Menon, V; Lincoff, AM; Nissen, SE				Nicholls, Stephen J.; Kastelein, John J. P.; Schwartz, Gregory G.; Bash, Dianna; Rosenson, Robert S.; Cavender, Matthew A.; Brennan, Danielle M.; Koenig, Wolfgang; Jukema, J. Wouter; Nambi, Vijay; Wright, R. Scott; Menon, Venu; Lincoff, A. Michael; Nissen, Steven E.		VISTA-16 Investigators	Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome The VISTA-16 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SECRETORY PHOSPHOLIPASE A(2); RATIONALE; DESIGN; ATHEROSCLEROSIS; OUTCOMES; STABILIZATION; INHIBITION; PREVENTION; DARAPLADIB; PLACEBO	IMPORTANCE Secretory phospholipase A(2) (sPLA(2)) generates bioactive phospholipid products implicated in atherosclerosis. The sPLA2 inhibitor varespladib has favorable effects on lipid and inflammatory markers; however, its effect on cardiovascular outcomes is unknown. OBJECTIVE To determine the effects of sPLA2 inhibition with varespladib on cardiovascular outcomes. DESIGN, SETTING, AND PARTICIPANTS A double-blind, randomized, multicenter trial at 362 academic and community hospitals in Europe, Australia, New Zealand, India, and North America of 5145 patients randomized within 96 hours of presentation of an acute coronary syndrome (ACS) to either varespladib (n = 2572) or placebo (n = 2573) with enrollment between June 1, 2010, and March 7, 2012 (study termination on March 9, 2012). INTERVENTIONS Participants were randomized to receive varespladib (500 mg) or placebo daily for 16 weeks, in addition to atorvastatin and other established therapies. MAIN OUTCOMES AND MEASURES The primary efficacy measure was a composite of cardiovascular mortality, nonfatal myocardial infarction (MI), nonfatal stroke, or unstable angina with evidence of ischemia requiring hospitalization at 16 weeks. Six-month survival status was also evaluated. RESULTS At a prespecified interim analysis, including 212 primary end point events, the independent data and safety monitoring board recommended termination of the trial for futility and possible harm. The primary end point occurred in 136 patients (6.1%) treated with varespladib compared with 109 patients (5.1%) treated with placebo (hazard ratio [HR], 1.25; 95% CI, 0.97-1.61; log-rank P = .08). Varespladib was associated with a greater risk of MI (78 [3.4%] vs 47 [2.2%]; HR, 1.66; 95% CI, 1.16-2.39; log-rank P = .005). The composite secondary end point of cardiovascular mortality, MI, and stroke was observed in 107 patients (4.6%) in the varespladib group and 79 patients (3.8%) in the placebo group (HR, 1.36; 95% CI, 1.02-1.82; P = .04). CONCLUSIONS AND RELEVANCE In patients with recent ACS, varespladib did not reduce the risk of recurrent cardiovascular events and significantly increased the risk of MI. The sPLA2 inhibition with varespladib may be harmful and is not a useful strategy to reduce adverse cardiovascular outcomes after ACS.	[Nicholls, Stephen J.] South Australian Hlth & Med Res Inst, Adelaide, SA 5001, Australia; [Nicholls, Stephen J.] Univ Adelaide, Adelaide, SA, Australia; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Schwartz, Gregory G.] Vet Affairs Med Ctr, Denver, CO USA; [Schwartz, Gregory G.] Univ Colorado, Denver, CO 80202 USA; [Bash, Dianna; Brennan, Danielle M.; Menon, Venu; Lincoff, A. Michael; Nissen, Steven E.] Cleveland Clin, Coordinating Ctr Clin Res, Cleveland, OH 44106 USA; [Rosenson, Robert S.] Icahn Sch Med Mt Sinai, New York, NY USA; [Cavender, Matthew A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Koenig, Wolfgang] Univ Ulm, Med Ctr, D-89069 Ulm, Germany; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Leiden, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Nambi, Vijay] Michael E DeBakey Vet Affairs Hosp, Houston, TX USA; [Nambi, Vijay] Baylor Coll Med, Houston, TX 77030 USA; [Wright, R. Scott] Mayo Clin, Rochester, MN USA	South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Amsterdam; Academic Medical Center Amsterdam; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Denver; Cleveland Clinic Foundation; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Ulm University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Baylor College of Medicine; Mayo Clinic	Nicholls, SJ (corresponding author), South Australian Hlth & Med Res Inst, POB 11060, Adelaide, SA 5001, Australia.	stephen.nicholls@sahmri.com	Sangiorgi, Giuseppe M/H-5141-2019; Jukema, J. Wouter/ABD-6503-2021; Motovska, Zuzana/J-1122-2016; Frey, Norbert/A-9695-2010; Ponikowski, Piotr/O-6454-2015; Shvarts, Yury Григорьевич/AAB-4929-2022; Kozhukhov, Sergey/E-6498-2018; Kastelein, John/AAF-7950-2020; Menon, Venu/AAF-1871-2019; Barón-Esquivias, Gonzalo/T-7436-2019; Libis, Roman/O-9193-2015; Zateyshchikov, Dmitry/AGN-8590-2022; Arkhipov, Mikhail V/Q-2316-2015; Zateyshchikov, Dmitry A/D-6575-2012; Lavi, Shahar/G-3317-2011; corrada, elena/GZK-5818-2022; martin, luis/C-7900-2013	Sangiorgi, Giuseppe M/0000-0001-5862-1967; Jukema, J. Wouter/0000-0002-3246-8359; Motovska, Zuzana/0000-0002-5319-473X; Ponikowski, Piotr/0000-0002-3391-7064; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Kozhukhov, Sergey/0000-0002-7973-7894; Barón-Esquivias, Gonzalo/0000-0002-9103-4753; Libis, Roman/0000-0003-0130-990X; Zateyshchikov, Dmitry/0000-0001-7065-2045; Arkhipov, Mikhail V/0000-0002-7924-7668; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Lavi, Shahar/0000-0002-6105-8084; corrada, elena/0000-0002-6200-5152; Valgimigli, Marco/0000-0002-4353-7110; Nicholls, Stephen/0000-0002-9668-4368; Sanmartin-Fernandez, Marcelo/0000-0001-5469-4579; Koenig, Wolfgang/0000-0002-2064-9603; martin, luis/0000-0003-1435-7994; Brilakis, Emmanouil/0000-0001-9416-9701; Fes'kov, Aleksandr/0000-0003-2601-8252; Marenzi, Giancarlo/0000-0003-4410-4461; Rynkiewicz, Andrzej/0000-0002-5284-9511	Anthera Pharmaceuticals	Anthera Pharmaceuticals	The study was funded by Anthera Pharmaceuticals.	Ait-Oufella H, 2013, ARTERIOSCL THROM VAS, V33, P466, DOI 10.1161/ATVBAHA.112.300309; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Holmes MV, 2013, J AM COLL CARDIOL, V62, P1966, DOI 10.1016/j.jacc.2013.06.044; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Koenig WG, 2009, CARDIOVASC DRUG THER, V23, P85, DOI 10.1007/s10557-008-6135-6; Menschikowski M, 1995, ATHEROSCLEROSIS, V118, P173, DOI 10.1016/0021-9150(95)05604-1; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Nicholls SJ, 2012, CARDIOVASC DRUG THER, V26, P71, DOI 10.1007/s10557-011-6358-9; O'Donoghue ML, 2011, AM HEART J, V162, P613, DOI 10.1016/j.ahj.2011.07.018; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Rosenson RS, 2012, EUR HEART J, V33, P2899, DOI 10.1093/eurheartj/ehs148; Rosenson RS, 2011, EUR HEART J, V32, P999, DOI 10.1093/eurheartj/ehq374; Rosenson RS, 2010, J AM COLL CARDIOL, V56, P1079, DOI 10.1016/j.jacc.2010.06.015; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; Rosenson RS, 2009, CARDIOVASC DRUG THER, V23, P93, DOI 10.1007/s10557-008-6148-1; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shaposhnik Z, 2009, J LIPID RES, V50, P623, DOI 10.1194/jlr.M800361-JLR200; White H, 2010, AM HEART J, V160, P655, DOI 10.1016/j.ahj.2010.07.006	20	212	216	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					252	262		10.1001/jama.2013.282836	http://dx.doi.org/10.1001/jama.2013.282836			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24247616	Bronze			2022-12-28	WOS:000329566400017
J	Mukherjee, S; Zheng, H; Derebe, MG; Callenberg, KM; Partch, CL; Rollins, D; Propheter, DC; Rizo, J; Grabe, M; Jiang, QX; Hooper, LV				Mukherjee, Sohini; Zheng, Hui; Derebe, Mehabaw G.; Callenberg, Keith M.; Partch, Carrie L.; Rollins, Darcy; Propheter, Daniel C.; Rizo, Josep; Grabe, Michael; Jiang, Qiu-Xing; Hooper, Lora V.			Antibacterial membrane attack by a pore-forming intestinal C-type lectin	NATURE			English	Article							ANTIMICROBIAL PEPTIDES; PROMOTES; CHANNELS; SOLVENT	Human body-surface epithelia coexist in close association with complex bacterial communities and are protected by a variety of antibacterial proteins. C-type lectins of the RegIII family are bactericidal proteins that limit direct contact between bacteria and the intestinal epithelium and thus promote tolerance to the intestinal microbiota(1,2). RegIII lectins recognize their bacterial targets by binding peptidoglycan carbohydrate(1,3), but the mechanism by which they kill bacteria is unknown. Here we elucidate the mechanistic basis for RegIII bactericidal activity. We show that human RegIII alpha (also known as HIP/PAP) binds membrane phospholipids and kills bacteria by forming a hexameric membrane-permeabilizing oligomeric pore. We derive a three-dimensional model of the RegIII alpha pore by docking the RegIII alpha crystal structure into a cryo-electron microscopic map of the pore complex, and show that the model accords with experimentally determined properties of the pore. Lipopolysaccharide inhibits RegIII alpha pore-forming activity, explaining why RegIII alpha is bactericidal for Gram-positive but not Gram-negative bacteria. Our findings identify C-type lectins as mediators of membrane attack in the mucosal immune system, and provide detailed insight into an antibacterial mechanism that promotes mutualism with the resident microbiota.	[Mukherjee, Sohini; Derebe, Mehabaw G.; Rollins, Darcy; Propheter, Daniel C.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Zheng, Hui; Jiang, Qiu-Xing] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Callenberg, Keith M.; Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Callenberg, Keith M.; Grabe, Michael] Univ Pittsburgh, PhD Program Computat Biol, Joint Carnegie Mellon Univ, Pittsburgh, PA 15261 USA; [Partch, Carrie L.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Santa Cruz; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	qiu-xing.jiang@utsouthwestern.edu; lora.hooper@utsouthwestern.edu	Jiang, Qiu-Xing/ABF-1143-2021; Jiang, Qiu-Xing/AAI-8579-2020	Propheter, Daniel/0000-0002-8665-0885	NIH [R01 DK070855, R01GM088745, GM093271, R01 NS40944, C06 RR30414]; Welch Foundation [I-1684]; NSF CAREER [MCB0845286]; Helen Hay Whitney Fellowship; Burroughs Wellcome Foundation New Investigators in the Pathogenesis of Infectious Diseases Award; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR030414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855, F32DK100074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093271, R01GM088745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Helen Hay Whitney Fellowship; Burroughs Wellcome Foundation New Investigators in the Pathogenesis of Infectious Diseases Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Craig for assistance with the liposome disruption assays. The MODE-K cell line was provided by D. Kaiserlian, INSERM U851, Lyon, France. We thank E. Egelman for sharing his programs and for offering advice on cryoEM data analysis. This work was supported by NIH R01 DK070855 (L. V. H.), NIH R01GM088745 and GM093271 (Q.-X.J.), NIH R01 NS40944 (J.R.), Welch Foundation (I-1684 to Q.-X.J.), NSF CAREER MCB0845286 (M. G.), a Helen Hay Whitney Fellowship (S. M.), a Burroughs Wellcome Foundation New Investigators in the Pathogenesis of Infectious Diseases Award (L. V. H.), and the Howard Hughes Medical Institute (L. V. H.). Part of this work was performed in laboratories constructed with support from NIH grant C06 RR30414.	Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Callenberg KM, 2012, J GEN PHYSIOL, V140, P55, DOI 10.1085/jgp.201110766; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fuller N, 2003, BIOPHYS J, V85, P1667, DOI 10.1016/S0006-3495(03)74596-2; Henriksen J, 2006, BIOPHYS J, V90, P1639, DOI 10.1529/biophysj.105.067652; Ho MR, 2006, J BIOL CHEM, V281, P33566, DOI 10.1074/jbc.M604513200; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kraft CA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.299pl4; Kucerka N, 2006, BIOPHYS J, V90, pL83, DOI 10.1529/biophysj.106.086017; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Lodish H, 2000, MOL CELL BIOL; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Nielsen C, 1998, BIOPHYS J, V74, P1966, DOI 10.1016/S0006-3495(98)77904-4; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; WHITE SH, 1978, BIOPHYS J, V23, P337, DOI 10.1016/S0006-3495(78)85453-8; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j	27	199	204	5	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					103	+		10.1038/nature12729	http://dx.doi.org/10.1038/nature12729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24256734	Green Accepted			2022-12-28	WOS:000329163300032
J	Reiserer, A; Ritter, S; Rempe, G				Reiserer, Andreas; Ritter, Stephan; Rempe, Gerhard			Nondestructive Detection of an Optical Photon	SCIENCE			English	Article							QUANTUM-NONDEMOLITION MEASUREMENTS; SINGLE-PHOTON; ATOM; CAVITY	All optical detectors to date annihilate photons upon detection, thus excluding repeated measurements. Here, we demonstrate a robust photon detection scheme that does not rely on absorption. Instead, an incoming photon is reflected from an optical resonator containing a single atom prepared in a superposition of two states. The reflection toggles the superposition phase, which is then measured to trace the photon. Characterizing the device with faint laser pulses, a single-photon detection efficiency of 74% and a survival probability of 66% are achieved. The efficiency can be further increased by observing the photon repeatedly. The large single-photon nonlinearity of the experiment should enable the development of photonic quantum gates and the preparation of exotic quantum states of light.	[Reiserer, Andreas; Ritter, Stephan; Rempe, Gerhard] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Max Planck Society	Ritter, S (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	stephan.ritter@mpq.mpg.de	Reiserer, Andreas/J-3243-2014; Ritter, Stephan/F-1579-2010; Reiserer, Andreas/G-4980-2017	Reiserer, Andreas/0000-0001-9595-7363; Ritter, Stephan/0000-0001-9002-7407; Reiserer, Andreas/0000-0001-9595-7363	European Union; Bundesministerium fur Bildung und Forschung via IKT 2020 (QK_QuOReP)	European Union(European Commission); Bundesministerium fur Bildung und Forschung via IKT 2020 (QK_QuOReP)(Federal Ministry of Education & Research (BMBF))	We thank N. Kalb for experimental assistance. This work was supported by the European Union (Collaborative Project SIQS) and the Bundesministerium fur Bildung und Forschung via IKT 2020 (QK_QuOReP).	Bochmann J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203601; Braginsky VB, 1996, REV MOD PHYS, V68, P1, DOI 10.1103/RevModPhys.68.1; Chen W, 2013, SCIENCE, V341, P768, DOI 10.1126/science.1238169; Cho JY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.160501; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; Dayan B, 2008, SCIENCE, V319, P1062, DOI 10.1126/science.1152261; Duan LM, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.032333; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Eisaman MD, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3610677; Gisin N, 2007, NAT PHOTONICS, V1, P165, DOI 10.1038/nphoton.2007.22; GLAUBER RJ, 1963, PHYS REV, V130, P2529, DOI 10.1103/PhysRev.130.2529; Grangier P, 1998, NATURE, V396, P537, DOI 10.1038/25059; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Johnson BR, 2010, NAT PHYS, V6, P663, DOI 10.1038/NPHYS1710; Junge C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.213604; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Mandel L, 1995, OPTICAL COHERENCE QU; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Nolleke C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140403; Nogues G, 1999, NATURE, V400, P239, DOI 10.1038/22275; O'Brien JL, 2007, SCIENCE, V318, P1567, DOI 10.1126/science.1142892; Reiserer A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.223003; Sorensen AS, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.097905; Thompson JD, 2013, SCIENCE, V340, P1202, DOI 10.1126/science.1237125; Vandersypen LMK, 2004, REV MOD PHYS, V76, P1037, DOI 10.1103/RevModPhys.76.1037; Walls D., 2008, QUANTUM OPT, DOI DOI 10.1007/978-3-540-28574-8; Wang B, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.022320; Wiseman HM, 2009, QUANTUM MEASUREMENT; Xiao YF, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.042314	31	158	159	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1349	1351		10.1126/science.1246164	http://dx.doi.org/10.1126/science.1246164			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24231809	Green Submitted			2022-12-28	WOS:000328196000044
J	Taylor, FC; Huffman, M; Ebrahim, S				Taylor, Fiona C.; Huffman, Mark; Ebrahim, Shah			Statin Therapy for Primary Prevention of Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Taylor, Fiona C.; Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1 7HT, England; [Huffman, Mark] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Huffman, Mark] Northwestern Univ, Feinberg Sch Med, Dept Med Cardiol, Chicago, IL 60611 USA	University of London; London School of Hygiene & Tropical Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Taylor, FC (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Fac Epidemiol & Publ Hlth, Cochrane Heart Grp, Keppel St, London WC1 7HT, England.	fiona.taylor@lshtm.ac.uk		Huffman, Mark/0000-0001-7412-2519	National Heart, Lung, and Blood Institute; AstraZeneca; Wellcome Trust; National Institute of Health Research	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AstraZeneca(AstraZeneca); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research(National Institute for Health Research (NIHR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Huffman reports receiving grant funding from the National Heart, Lung, and Blood Institute and AstraZeneca and travel accommodations from AstraZeneca. Dr Ebrahim reports receiving grant funding from Wellcome Trust and the National Institute of Health Research and royalties from Open University Press. No other disclosures were reported.	Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Golomb BA, 2012, ARCH INTERN MED, V172, P1180, DOI 10.1001/archinternmed.2012.2171; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Institute for Health and Clinical Excellence (NICE), 2006, TECHNOLOGY APPRAISAL; Stagnitti MN., TRENDS IN STATINS UT; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; The Health and Social Care Information Centre, PRESCRIPTIONS DISPEN	9	91	98	0	72	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2451	2452		10.1001/jama.2013.281348	http://dx.doi.org/10.1001/jama.2013.281348			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24276813				2022-12-28	WOS:000328030900026
J	Ridker, PM; Cook, NR				Ridker, Paul M.; Cook, Nancy R.			Statins: new American guidelines for prevention of cardiovascular disease	LANCET			English	Editorial Material							EVENTS; ROSUVASTATIN; TRIAL; ATORVASTATIN; CORONARY; AVERAGE; WOMEN; MEN		[Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, Boston, MA 02215 USA.	pridker@partners.org		Venkatasubramanian, Siddharth/0000-0002-5860-0768				Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Goff DC, 2013, J AM COLL CARDIOL, V2014, P63, DOI DOI 10.1016/J.JACC.2013.11.005; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2013, JAMA-J AM MED ASSOC, V310, P1123, DOI 10.1001/jama.2013.276529; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002	15	353	363	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1762	1765		10.1016/S0140-6736(13)62388-0	http://dx.doi.org/10.1016/S0140-6736(13)62388-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24268611				2022-12-28	WOS:000327540700009
J	Baum, MK; Campa, A; Lai, SH; Martinez, SS; Tsalaile, L; Burns, P; Farahani, M; Li, YH; van Widenfelt, E; Page, JB; Bussmann, H; Fawzi, WW; Moyo, S; Makhema, J; Thior, I; Essex, M; Marlink, R				Baum, Marianna K.; Campa, Adriana; Lai, Shenghan; Martinez, Sabrina Sales; Tsalaile, Lesedi; Burns, Patricia; Farahani, Mansour; Li, Yinghui; van Widenfelt, Erik; Page, John Bryan; Bussmann, Hermann; Fawzi, Wafaie W.; Moyo, Sikhulele; Makhema, Joseph; Thior, Ibou; Essex, Myron; Marlink, Richard			Effect of Micronutrient Supplementation on Disease Progression in Asymptomatic, Antiretroviral-Naive, HIV-Infected Adults in Botswana A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VIRAL LOAD; MORTALITY; SELENIUM; INDIVIDUALS; RESPONSES; THERAPY; AIDS	IMPORTANCE Micronutrient deficiencies occur early in human immunodeficiency virus (HIV) infection, and supplementation with micronutrients may be beneficial; however, its effectiveness has not been investigated early in HIV disease among adults who are antiretroviral therapy (ART) naive. OBJECTIVE To investigate whether long-term micronutrient supplementation is effective and safe in delaying disease progression when implemented early in adults infected with HIV subtype C who are ART-naive. DESIGN, SETTING, AND PARTICIPANTS Randomized clinicaltrial of supplementation with either daily multivitamins (B vitamins and vitamins C and E), selenium alone, or multivitamins with selenium vs placebo in a factorial design for 24 months. The study was conducted in 878 patients infected with HIV subtype C with a CD4 cell count greater than 350/mu L who were not receiving ART at Princess Marina Hospital in Gaborone, Botswana, between December 2004 and July 2009. INTERVENTIONS Daily oral supplements of B vitamins and vitamins C and E, selenium alone, or multivitamins plus selenium, compared with placebo. MAIN OUTCOMES AND MEASURES Reaching a CD4 cell count less than 200/mu L until May 2008; after this date, reaching a CD4 cell count of 250/mu L or less, consistent with the standard of care in Botswana for initiation of ART at the time of the study. RESULTS There were 878 participants enrolled and randomized into the study. All participants were ART-naive throughout the study. In intent-to-treat analysis, participants receiving the combined supplement of multivitamins plus selenium had a significantly lower risk vs placebo of reaching CD4 cell count 250/mu L or less (adjusted hazard ratio [HR], 0.46; 95% CI, 0.25-0.85; P =.01; absolute event rate [AER], 4.79/100 person-years; censoring rate, 0.92; 17 events; placebo AER, 9.22/100 person-years; censoring rate, 0.85; 32 events). Multivitamins plus selenium in a single supplement, vs placebo, also reduced the risk of secondary events of combined outcomes for disease progression (CD4 cell count <= 250/mu L, AIDS-defining conditions, or AIDS-related death, whichever occurred earlier [adjusted HR, 0.56; 95% CI, 0.33-0.95; P =.03; AER, 6.48/100 person-years; censoring rate, 0.90; 23 events]). Therewas no effect of supplementation on HIV viral load. Multivitamins alone and selenium supplementation alone were not statistically different from placebo for any end point. Reported adverse events were adjudicated as unlikely to be related to the intervention, and there were no notable differences in incidence of HIV-related and health-related events among study groups. CONCLUSIONS AND RELEVANCE In ART-naive HIV-infected adults, 24-month supplementation with a single supplement containing multivitamins and selenium was safe and significantly reduced the risk of immune decline and morbidity. Micronutrient supplementation may be effective when started in the early stages of HIV disease.	[Baum, Marianna K.; Campa, Adriana; Martinez, Sabrina Sales; Li, Yinghui] Florida Int Univ, R Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Tsalaile, Lesedi; van Widenfelt, Erik; Bussmann, Hermann; Moyo, Sikhulele; Makhema, Joseph; Thior, Ibou] Botswana Harvard Partnership, Gaborone, Botswana; [Burns, Patricia; Farahani, Mansour; Fawzi, Wafaie W.; Essex, Myron; Marlink, Richard] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Page, John Bryan] Univ Miami, Miami, FL USA; [Lai, Shenghan] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	State University System of Florida; Florida International University; Harvard University; Harvard T.H. Chan School of Public Health; University of Miami; Johns Hopkins University	Baum, MK (corresponding author), Florida Int Univ, R Stempel Coll Publ Hlth & Social Work, 11200 SW 8th St,Room AHC 1-337, Miami, FL 33199 USA.	baumm@fiu.edu	Sales Martinez, Sabrina/ABB-9294-2021; Moyo, Sikhulile/E-1464-2015	Sales Martinez, Sabrina/0000-0002-0158-8104; Moyo, Sikhulile/0000-0003-3821-4592; Farahani, Mansour/0000-0002-8968-9822	National Institute on Drug Abuse [RO1-DA-016551]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016551] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institute on Drug Abuse (RO1-DA-016551).	Baum M, 2010, 18 INT HIV AIDS C JU; Baum MK, 2000, J ACQ IMMUN DEF SYND, V25, pS49, DOI 10.1097/00126334-200010001-00008; BAUM MK, 1995, AIDS, V9, P1051, DOI 10.1097/00002030-199509000-00010; BEACH RS, 1992, AIDS, V6, P701, DOI 10.1097/00002030-199207000-00013; BEISEL WR, 1982, AM J CLIN NUTR, V35, P417, DOI 10.1093/ajcn/35.2.417; Beisel WR, 2000, NUTRITION AND IMMUNOLOGY, P389; Bussmann H, 2009, JAIDS-J ACQ IMM DEF, V51, P37, DOI 10.1097/QAI.0b013e31819ff102; Carter GM, 2002, SCIENCE, V297, P1276; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; De Cock KM, 2013, NEW ENGL J MED, V368, P886, DOI 10.1056/NEJMp1300458; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; GROSS RL, 1975, AM J CLIN NUTR, V28, P225, DOI 10.1093/ajcn/28.3.225; HEMILA H, 1997, VITAMIN C HLTH DIS; Hughes MD, 1995, AIDS CLIN TRIALS, P177; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; JACOB RA, 1991, AM J CLIN NUTR, V54, pS1302, DOI 10.1093/ajcn/54.6.1302s; Jiamton S, 2003, AIDS, V17, P2461, DOI 10.1097/00002030-200311210-00008; Kaiser JD, 2006, JAIDS-J ACQ IMM DEF, V42, P523, DOI 10.1097/01.qai.0000230529.25083.42; Kelly P, 2008, AM J CLIN NUTR, V88, P1010, DOI 10.1093/ajcn/88.4.1010; Lee J, 1999, AIDS COMPLEMENTARY A, P56; Mazhani L., 2008, HDB 2008 BOTSWANA NA; McClelland RS, 2004, JAIDS-J ACQ IMM DEF, V37, P1657, DOI 10.1097/00126334-200412150-00021; Mlotshwa M, 2010, J VIROL, V84, P12018, DOI 10.1128/JVI.01472-10; PERETZ A, 1991, AM J CLIN NUTR, V53, P1323, DOI 10.1093/ajcn/53.5.1323; Piot P, 2013, NEW ENGL J MED, V368, P2210, DOI 10.1056/NEJMra1201533; Range N, 2006, BRIT J NUTR, V95, P762, DOI 10.1079/BJN20051684; ROBSON LC, 1980, VITAMIN B6 METABOLIS, P205; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schoenfeld DA, 1995, AIDS CLIN TRIALS; SELF SG, 1988, BIOMETRICS, V44, P79, DOI 10.2307/2531897; SELF SG, 1992, BIOMETRICS, V48, P31, DOI 10.2307/2532736; SPALLHOLZ JE, 1990, ANN NY ACAD SCI, V587, P123, DOI 10.1111/j.1749-6632.1990.tb00140.x; Stone CA, 2010, NUTR REV, V68, P671, DOI 10.1111/j.1753-4887.2010.00337.x; Sullivan PS, 2012, AIDS, V26, P175, DOI 10.1097/QAD.0b013e32834ed8c8; TENGERDY RP, 1990, ANN NY ACAD SCI, V587, P24, DOI 10.1111/j.1749-6632.1990.tb00130.x; Villamor E, 2008, J INFECT DIS, V197, P1499, DOI 10.1086/587846; WANG YJ, 1994, J NUTR, V124, P2024, DOI 10.1093/jn/124.10.2024; World Bank, PREV HIV TOT POP AG; Zhao LJ, 2000, P NATL ACAD SCI USA, V97, P6356, DOI 10.1073/pnas.97.12.6356	39	68	69	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2154	2163		10.1001/jama.2013.280923	http://dx.doi.org/10.1001/jama.2013.280923			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24281460	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000327404400024
J	Little, P; Stuart, B; Hobbs, R; Butler, CC; Hay, AD; Campbell, J; Delaney, B; Broomfield, S; Barratt, P; Hood, K; Everitt, H; Mullee, M; Williamson, I; Mant, D; Moore, M				Little, Paul; Stuart, Beth; Hobbs, Richard; Butler, Chris C.; Hay, Alastair D.; Campbell, John; Delaney, Brendan; Broomfield, Sue; Barratt, Paula; Hood, Kerenza; Everitt, Hazel; Mullee, Mark; Williamson, Ian; Mant, David; Moore, Michael		DESCARTE Investigators	Predictors of suppurative complications for acute sore throat in primary care: prospective clinical cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRESCRIBING STRATEGIES; RANDOMIZED-TRIAL; ACUTE COUGH; ANTIBIOTICS; PHARYNGITIS; INFECTIONS; VALIDATION; PENICILLIN; DIAGNOSIS; CHILDREN	Objective To document whether elements of a structured history and examination predict adverse outcome of acute sore throat. Design Prospective clinical cohort. Setting Primary care. Participants 14 610 adults with acute sore throat (<= 2 weeks' duration). Main outcome measures Common suppurative complications (quinsy or peritonsillar abscess, otitis media, sinusitis, impetigo or cellulitis) and reconsultation with new or unresolving symptoms within one month. Results Complications were assessed reliably (inter-rater k=0.95). 1.3% (177/13445) of participants developed complications overall and 14.2% (1889/13288) reconsulted with new or unresolving symptoms. Independent predictors of complications were severe tonsillar inflammation (documented among 13.0% (1652/12717); odds ratio 1.92, 95% confidence interval 1.28 to 2.89) and severe earache (5% (667/13 323); 3.02, 1.91 to 4.76), but the model including both variables had modest prognostic utility (bootstrapped area under the receiver operator curve 0.61, 0.57 to 0.65), and 70% of complications (124/177) occurred when neither was present. Clinical prediction rules for bacterial infection (Centor criteria and FeverPAIN) also predicted complications, but predictive values were also poor and most complications occurred with low scores (67% (118/175) scoring <= 2 for Centor; 126/173 (73%) scoring <= 2 for FeverPAIN). Previous medical problems, sex, temperature, and muscle aches were independently but weakly associated with reconsultation with new or unresolving symptoms. Conclusion Important suppurative complications after an episode of acute sore throat in primary care are uncommon. History and examination and scores to predict bacterial infection cannot usefully identify those who will develop complications. Clinicians will need to rely on strategies such as safety netting or delayed prescription in managing the uncertainty and low risk of complications.	[Little, Paul; Stuart, Beth; Broomfield, Sue; Barratt, Paula; Everitt, Hazel; Mullee, Mark; Williamson, Ian; Moore, Michael] Univ Southampton, Primary Care & Populat Sci Div, Southampton SO16 5ST, Hants, England; [Hobbs, Richard; Mant, David] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Butler, Chris C.; Hood, Kerenza] Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Wales Sch Primary Care Res, Cardiff CF10 3AX, S Glam, Wales; [Hay, Alastair D.] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol BS8 1TH, Avon, England; [Campbell, John] Univ Exeter, Sch Med, Exeter, Devon, England; [Delaney, Brendan] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England	University of Southampton; University of Oxford; Cardiff University; University of Bristol; University of Exeter; University of London; King's College London	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	p.little@soton.ac.uk	Hood, Kerenza/C-2528-2008; Campbell, John/A-5792-2011; Hay, Alastair/L-1818-2019; Moore, Michael/C-3447-2011	Hood, Kerenza/0000-0002-5268-8631; Campbell, John/0000-0002-6752-3493; Stuart, Beth/0000-0001-5432-7437; Hay, Alastair/0000-0003-3012-375X; Delaney, Brendan/0000-0002-3518-0131; Butler, Christopher/0000-0002-0102-3453; Little, Paul/0000-0003-3664-1873; hobbs, richard/0000-0001-7976-7172; Everitt, Hazel/0000-0001-7362-8403; Moore, Michael/0000-0002-5127-4509	University of Southampton; Medical Research council [G0500977]; National Institute for Health Research Service; MRC [G0500977] Funding Source: UKRI; Medical Research Council [G0500977] Funding Source: researchfish; National Institute for Health Research [CDF-2009-02-10, CL-2006-26-002, NF-SI-0611-10273] Funding Source: researchfish	University of Southampton; Medical Research council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Service; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was sponsored by the University of Southampton, funded by the Medical Research council (grant No G0500977) and through costs by the National Institute for Health Research Service Support. Neither sponsor nor funder had any role in specifying the analysis or in the write up.	Almond S, 2009, BRIT J GEN PRACT, V59, P872, DOI 10.3399/bjgp09X472971; [Anonymous], 2001, PRINCIPLES APPROPRIA; BREESE BB, 1977, AM J DIS CHILD, V131, P514, DOI 10.1001/archpedi.1977.02120180028003; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; Dagnelie CF, 1998, BRIT J GEN PRACT, V48, P959; Dagnelie CF, 1996, BRIT J GEN PRACT, V46, P589; DELMAR C, 1992, MED J AUSTRALIA, V156, P572, DOI 10.5694/j.1326-5377.1992.tb121422.x; Dobbs F, 1996, BRIT J GEN PRACT, V46, P461; Dunn N, 2007, BRIT J GEN PRACT, V57, P45; Fine AM, 2012, ARCH INTERN MED, V172, P847, DOI 10.1001/archinternmed.2012.950; Francis NA, 2012, BRIT J GEN PRACT, V62, P304, DOI 10.3399/bjgp12X649124; Fuller H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004883; Harrel F.E., 2001, REGRESSION MODELING; Hay AD, 2004, BRIT J GEN PRACT, V54, P9; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; Lindbaek M, 2005, BRIT J GEN PRACT, V55, P615; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5806; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Little P, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X658322; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; Nice, 2011, PRESCR ANT SELF LIM; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Standing Medical Advisory Committee (SMAC) Sub-Group on Antimicrobial resistance, 1998, PATH LEAST RES; Vincent MT, 2004, AM FAM PHYSICIAN, V69, P1465; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	29	39	39	0	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2013	347								f6867	10.1136/bmj.f6867	http://dx.doi.org/10.1136/bmj.f6867			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FA	24277339	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000327791000004
J	Kadaga, R; da Silva, JB; Featherstone, L				Kadaga, Rebecca; da Silva, Jarbas Barbosa, Jr.; Featherstone, Lynne			Caring for preterm babies is a test of how we respond to our most vulnerable citizens	LANCET			English	Editorial Material									[Kadaga, Rebecca] Parliament Republ Uganda, Kampala, Uganda; [da Silva, Jarbas Barbosa, Jr.] Minist Hlth, Brasilia, DF, Brazil; [Featherstone, Lynne] Dept Int Dev, London, England		Kadaga, R (corresponding author), Parliament Republ Uganda, POB 7178, Kampala, Uganda.	ikasirye@parliament.go.ug						Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Darmstadt G, 2013, GRAND CHALLENGES BRA; Fundacao Oswaldo Cruz, 2013, RED BRAS BANC LEIT H; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Leadsom A, 2013, 1001 CRITICAL DAYS I; Ministerio da Saude, 2011, MET CANG MAN TECN; Paranjothy S, 2009, ARCH DIS CHILD, V94, P239, DOI 10.1136/adc.2007.115915; Portal de Saude Ministerio da Saude, 2013, RED CEG; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Silveira MF, 2013, REV SAUDE P IN PRESS; The Partnership for Maternal Newborn & Child Health, 2013, EV NEWB ACT PLAN END; UN Commission on Life-Saving Commodities for Women and Children, 2012, COM REP; UNICEF, 2015, COMMITTING CHILD SUR	14	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1613	1614		10.1016/S0140-6736(13)62305-3	http://dx.doi.org/10.1016/S0140-6736(13)62305-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	24238547				2022-12-28	WOS:000327140700006
J	Bartoloni, E; Mirabelli, G				Bartoloni, Elena; Mirabelli, Giulia			Unusual Bursal Fluid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bartoloni, Elena; Mirabelli, Giulia] Univ Perugia, I-06100 Perugia, Italy	University of Perugia	Bartoloni, E (corresponding author), Univ Perugia, I-06100 Perugia, Italy.	elena.bartolonibocci@unipg.it	Bartoloni, Elena/R-5842-2019	Bartoloni, Elena/0000-0003-4776-2136					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1945	1945		10.1056/NEJMicm1304040	http://dx.doi.org/10.1056/NEJMicm1304040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300MP	24224627				2022-12-28	WOS:000330468300011
J	Cully, M				Cully, Megan			DRUG DEVELOPMENT Chemical brace	NATURE			English	Editorial Material														Cully, Megan/0000-0003-4726-134X				Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Grossman R. G., 2013, J NEUROTRAUM, DOI [10.1089/neu.2013.2968, DOI 10.1089/NEU.2013.2968]; Kempf A, 2013, PHYSIOLOGY, V28, P151, DOI 10.1152/physiol.00052.2012; Thompson CK, 2011, JOVE-J VIS EXP, DOI 10.3791/2148	6	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S10	S12		10.1038/503S10a	http://dx.doi.org/10.1038/503S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24226999	Bronze			2022-12-28	WOS:000326894200005
J	Mace, G				Mace, Georgina			Ecology must evolve	NATURE			English	Editorial Material									[Mace, Georgina] UCL, Ctr Biodivers & Environm Res, London WC1E 6BT, England	University of London; University College London	Mace, G (corresponding author), UCL, Ctr Biodivers & Environm Res, London WC1E 6BT, England.	g.mace@ucl.ac.uk	Mace, Georgina M/I-3072-2016	Mace, Georgina M/0000-0001-8965-5211				British Ecological Society, 2013, 100 INFL PAP; Carpenter SR, 2009, BIOSCIENCE, V59, P699, DOI 10.1525/bio.2009.59.8.11; Hampton SE, 2011, BIOSCIENCE, V61, P900, DOI 10.1525/bio.2011.61.11.9; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Michener WK, 2012, TRENDS ECOL EVOL, V27, P85, DOI 10.1016/j.tree.2011.11.016; Purves D, 2013, NATURE, V493, P295, DOI 10.1038/493295a; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025	9	27	32	3	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					191	192		10.1038/503191a	http://dx.doi.org/10.1038/503191a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24236316	Bronze			2022-12-28	WOS:000326894200023
J	Lynn, J				Lynn, Joanne			Reliable and Sustainable Comprehensive Care for Frail Elderly People	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Altarum Inst, Ctr Elder Care & Adv Illness, Washington, DC 20036 USA		Lynn, J (corresponding author), Altarum Inst, Ctr Elder Care & Adv Illness, 2000 M St NW,Ste 400, Washington, DC 20036 USA.	joanne.lynn@altarum.org						Alzheimer's Association, 2011, 2011 ALZH DIS FACTS; [Anonymous], MEDICARING4LIFE MAK; [Anonymous], PROF OLD AM 2011; Beales JL, 2009, CLIN GERIATR MED, V25, P149, DOI 10.1016/j.cger.2008.11.002; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Kemper P, 2005, INQUIRY-J HEALTH CAR, V42, P335, DOI 10.5034/inquiryjrnl_42.4.335; POLST, PROGR YOUR STAT; Shrestha L., 2006, C RES SERV C	8	17	17	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1935	1936		10.1001/jama.2013.281923	http://dx.doi.org/10.1001/jama.2013.281923			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	250EJ	24219945				2022-12-28	WOS:000326832900014
J	Nicholson, JM; Kellar, LC; Ural, S				Nicholson, James M.; Kellar, Lisa C.; Ural, Serdar			New Definition of Term Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Nicholson, James M.] Penn State Coll Med, Dept Family & Community Med, Hershey, PA 17033 USA; [Kellar, Lisa C.] Wright State Univ, Dept Family Med, Dayton, OH 45435 USA; [Ural, Serdar] Penn State Coll Med, Dept Obstet & Gynecol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University System of Ohio; Wright State University Dayton; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Nicholson, JM (corresponding author), Penn State Coll Med, 500 Univ Dr,Mail Code H154, Hershey, PA 17033 USA.	jnicholson@hmc.psu.edu		Kellar, Lisa/0000-0002-6164-0197				Cheng YW, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.08.008; Clark SL, 2012, AM J OBSTET GYNECOL, V206, P387, DOI 10.1016/j.ajog.2011.08.017; Nicholson JM, 2006, J PERINATOL, V26, P392, DOI 10.1038/sj.jp.7211528; Nicholson JM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.037; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235	5	3	3	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1985	1986		10.1001/jama.2013.277993	http://dx.doi.org/10.1001/jama.2013.277993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219957				2022-12-28	WOS:000326832900027
J	Parikh, RB				Parikh, Ravi B.			Removing the "Me" From "MD"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; STUDENTS		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Parikh, RB (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	ravi_parikh@hms.harvard.edu						Blue AV, 2010, ACAD MED, V85, P1290, DOI 10.1097/ACM.0b013e3181e53e07; Council on Graduate Medical Education/ National Advisory Council on Nursing Education and Practice, 2001, COLL ED ENS PAT SAF; Interprofessional Education Collaborative Panel, 2011, COR COMP INT COLL PR; Jain A, 2012, ACAD MED, V87, P1292, DOI 10.1097/ACM.0b013e31826216d0; Parsell G, 1999, MED EDUC, V33, P95, DOI 10.1046/j.1365-2923.1999.00298.x; Reeves S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub2; Simpson SA, 2007, J GEN INTERN MED, V22, P352, DOI 10.1007/s11606-006-0073-4; World Health Organization, 2010, FRAM ACT INT ED COLL	8	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1943	1944		10.1001/jama.2013.280722	http://dx.doi.org/10.1001/jama.2013.280722			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219949				2022-12-28	WOS:000326832900018
J	Hanf, M; Nacher, M; Guihenneuc, C; Tubert-Bitter, P; Chavance, M				Hanf, Matthieu; Nacher, Mathieu; Guihenneuc, Chantal; Tubert-Bitter, Pascale; Chavance, Michel			Global determinants of mortality in under 5s: 10 year worldwide longitudinal study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILD-MORTALITY; UNDER-5 MORTALITY; HEALTH; COUNTRIES; INFANT; SANITATION; TRENDS; INCOME; WATER	Objective To assess at country level the association of mortality in under 5s with a large set of determinants. Design Longitudinal study. Setting 193 United Nations member countries, 2000-09. Methods Yearly data between 2000 and 2009 based on 12 world development indicators were used in a multivariable general additive mixed model allowing for non-linear relations and lag effects. Main outcome measure National rate of deaths in under 5s per 1000 live births Results The model retained the variables: gross domestic product per capita; percentage of the population having access to improved water sources, having access to improved sanitation facilities, and living in urban areas; adolescent fertility rate; public health expenditure per capita; prevalence of HIV; perceived level of corruption and of violence; and mean number of years in school for women of reproductive age. Most of these variables exhibited non-linear behaviours and lag effects. Conclusions By providing a unified framework for mortality in under 5s, encompassing both high and low income countries this study showed non-linear behaviours and lag effects of known or suspected determinants of mortality in this age group. Although some of the determinants presented a linear action on log mortality indicating that whatever the context, acting on them would be a pertinent strategy to effectively reduce mortality, others had a threshold based relation potentially mediated by lag effects. These findings could help designing efficient strategies to achieve maximum progress towards millennium development goal 4, which aims to reduce mortality in under 5s by two thirds between 1990 and 2015.	[Hanf, Matthieu; Guihenneuc, Chantal; Tubert-Bitter, Pascale; Chavance, Michel] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Hanf, Matthieu; Tubert-Bitter, Pascale; Chavance, Michel] Univ Paris 11, UMRS 1018, Villejuif, France; [Nacher, Mathieu] Cayenne Gen Hosp, Ctr Invest Clin Epidemiol Clin Antilles Guyane CI, Cayenne, French Guiana; [Nacher, Mathieu] Univ Antilles Guyane, EPaT EA3593, Cayenne, French Guiana; [Tubert-Bitter, Pascale] Univ Paris 05, Sorbonne Paris Cite, EA 4064, Lab Sante Publ & Environm, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Hanf, M (corresponding author), Ctr Rech Epidemiol & Sante Populat Equipe 1 Biost, INSERM, U1018, 16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	matthieu@hanf.fr	guihenneuc, chantal/AAZ-9296-2020; Tubert-Bitter, Pascale/E-6118-2016; nacher, mathieu/AAH-4796-2021	guihenneuc, chantal/0000-0001-7237-7120; nacher, mathieu/0000-0001-9397-3204; Hanf, Matthieu/0000-0001-7133-1323	Agence Nationale de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was supported by the Agence Nationale de la Recherche. The funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Aber JL, 1997, ANNU REV PUBL HEALTH, V18, P463, DOI 10.1146/annurev.publhealth.18.1.463; Adetunji J, 2000, B WORLD HEALTH ORGAN, V78, P1200; Alkema L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001288; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Bureau for Development Policy, 2011, FIGHT CORR HLTH SEC; Collison D, 2007, J PUBLIC HEALTH-UK, V29, P114, DOI 10.1093/pubmed/fdm009; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Franco A, 2004, BMJ-BRIT MED J, V329, P1421, DOI 10.1136/bmj.329.7480.1421; Frees E.W., 2004, LONGITUDINAL PANEL D, DOI 10.1198/jasa.2006.s88; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gracey M, 2002, ACTA PAEDIATR, V91, P1, DOI 10.1080/080352502753457842; Gupta S, 2000, IMF WORKING PAPER; Hanf M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026990; Hastie TJ., 2017, GEN ADDITIVE MODELS; Ip S, 2007, 07E007 AG HEALTHC RE; Lewis M., 2006, SSRN ELECT J, DOI [10.2139/ssrn.984046, DOI 10.2139/SSRN.984046]; McGuire JW, 2006, WORLD DEV, V34, P405, DOI 10.1016/j.worlddev.2005.08.004; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Muldoon KA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-42; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Rubin D. B., 2004, MULTIPLE IMPUTATION; Rutstein SO, 2000, B WORLD HEALTH ORGAN, V78, P1256; Schell CO, 2007, SCAND J PUBLIC HEALT, V35, P288, DOI 10.1080/14034940600979171; TOOLE MJ, 1993, LANCET, V341, P1193, DOI 10.1016/0140-6736(93)91013-C; WHO Department of Maternal Newborn Child and Adolescent Health, 2011, PREV EARL PREGN POOR; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177; You D., 2012, LEVELS TRENDS CHILD	32	11	11	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2013	347								f6427	10.1136/bmj.f6427	http://dx.doi.org/10.1136/bmj.f6427			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	250XT	24212105	hybrid, Green Published			2022-12-28	WOS:000326890800001
J	Heikkila, TT				Heikkila, Tero T.			Cold-Atom Thermoelectrics	SCIENCE			English	Editorial Material							HEAT		[Heikkila, Tero T.] Univ Jyvaskyla, Dept Phys, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Heikkila, Tero T.] Aalto Univ, Low Temp Lab, FI-00076 Aalto, Finland	University of Jyvaskyla; Aalto University	Heikkila, TT (corresponding author), Univ Jyvaskyla, Dept Phys, Nanosci Ctr, POB 35 YFL, FI-40014 Jyvaskyla, Finland.	tero.t.heikkila@jyu.fi	Heikkila, Tero/B-2973-2009; Heikkila, Tero/B-2973-2009	Heikkila, Tero/0000-0002-7732-691X; Heikkila, Tero/0000-0001-7408-9384				Ashcroft N.W., 1976, SOLID STATE PHYS; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Brantut JP, 2013, SCIENCE, V342, P713, DOI 10.1126/science.1242308; Brantut JP, 2012, SCIENCE, V337, P1069, DOI 10.1126/science.1223175; Hazlett E. L., ARXIV13064018; Heikkila TT., 2013, PHYS NANOELECTRONICS; MAHAN GD, 1989, J APPL PHYS, V65, P1578, DOI 10.1063/1.342976; Peltier J. C., 1839, OBSERVATIONS MULTIPL; Seebeck T. J., 1822, ABH PREUSS AKAD WISS, V1822, P265; Stadler D, 2012, NATURE, V491, P736, DOI 10.1038/nature11613	12	3	3	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					703	704		10.1126/science.1245981	http://dx.doi.org/10.1126/science.1245981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202167				2022-12-28	WOS:000326647600030
J	Barr, DA; Aitken, C; Bell, DJ; Brown, CS; Cropley, I; Dawood, N; Hopkins, S; Jacobs, M; Jeffs, B; MacConnachie, A; Mulvaney, DW; Nicol, E; Fox, R				Barr, David A.; Aitken, Celia; Bell, David J.; Brown, Colin S.; Cropley, Ian; Dawood, Naghum; Hopkins, Susan; Jacobs, Michael; Jeffs, Benjamin; MacConnachie, Alisdair; Mulvaney, David W.; Nicol, Edward; Fox, Raymond			First confirmed case of Crimean-Congo haemorrhagic fever in the UK	LANCET			English	Editorial Material									[Barr, David A.; Aitken, Celia; Bell, David J.; Jeffs, Benjamin; MacConnachie, Alisdair; Fox, Raymond] Gartnavel Royal Hosp, Brownlee Ctr Infect Dis, Glasgow, Lanark, Scotland; [Brown, Colin S.] St Thomas Hosp, Directorate Infect, London, England; [Cropley, Ian; Dawood, Naghum; Hopkins, Susan; Jacobs, Michael] Royal Free London NHS Fdn Trust, Dept Infect Dis, London NW3 2QG, England; [Nicol, Edward] Queen Elizabeth Hosp, Dept Mil Med, Royal Ctr Def Med, Birmingham B15 2TH, W Midlands, England	Gartnavel Royal Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; Royal Centre for Defence Medicine; University of Birmingham	Jacobs, M (corresponding author), Royal Free London NHS Fdn Trust, Dept Infect Dis, Pond St, London NW3 2QG, England.	michael.jacobs@ucl.ac.uk	Brown, Colin/AAF-9597-2021	Brown, Colin/0000-0003-4776-3403; Barr, David/0000-0002-2922-9381; Hopkins, Susan/0000-0001-5179-5702				Atkinson B, 2012, EURO SURVEILL, V17; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Ftika L, 2013, J HOSP INFECT, V83, P185, DOI 10.1016/j.jhin.2012.10.013; Health and Safety Executive Advisory Committee on Dangerous Pathogens, 2012, MANAGEMENT OF HAZARD	4	17	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1458	1458		10.1016/S0140-6736(13)61718-3	http://dx.doi.org/10.1016/S0140-6736(13)61718-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242JW	24243135				2022-12-28	WOS:000326237500030
J	Krum, H; Schlaich, MP; Sobotka, PA; Bohm, M; Mahfoud, F; Rocha-Singh, K; Katholi, R; Esler, MD				Krum, Henry; Schlaich, Markus P.; Sobotka, Paul A.; Boehm, Michael; Mahfoud, Felix; Rocha-Singh, Krishna; Katholi, Richard; Esler, Murray D.			Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study	LANCET			English	Article							ESH POSITION PAPER; SYMPATHETIC DENERVATION; BLOOD-PRESSURE; INTERVENTIONAL THERAPY; GLUCOSE-METABOLISM; DISEASE; SPIRONOLACTONE; ACTIVATION; ABLATION; TRIAL	Background Renal denervation (RDN) with radiofrequency ablation substantially reduces blood pressure in patients with treatment-resistant hypertension. We assessed the long-term antihypertensive effects and safety. Methods Symplicity HTN-1 is an open-label study that enrolled 153 patients, of whom 111 consented to follow-up for 36 months. Eligible patients had a systolic blood pressure of at least 160 mm Hg and were taking at least three antihypertensive drugs, including a diuretic, at the optimum doses. Changes in office systolic blood pressure and safety were assessed every 6 months and reported every 12 months. This study is registered with ClinicalTrials.gov, numbers NCT00483808, NCT00664638, and NCT00753285. Findings 88 patients had complete data at 36 months. At baseline the mean age was 57 (SD 11) years, 37 (42%) patients were women, 25 (28%) had type 2 diabetes mellitus, the mean estimated glomerular filtration rate was 85 (SD 19) mL/min per 1.73 m(2), and mean blood pressure was 175/98 (SD 16/14) mm Hg. At 36 months significant changes were seen in systolic (-32.0 mm Hg, 95% CI -35.7 to -28.2) and diastolic blood pressure (-14.4 mm Hg, -16.9 to -11.9). Drops of 10 mm Hg or more in systolic blood pressure were seen in 69% of patients at 1 month, 81% at 6 months, 85% at 12 months, 83% at 24 months, and 93% at 36 months. One new renal artery stenosis requiring stenting and three deaths unrelated to RDN occurred during follow-up. Interpretation Changes in blood pressure after RDN persist long term in patients with treatment-resistant hypertension, with good safety.	[Krum, Henry] Monash Univ, Alfred Hosp, Sch Publ Hlth & Prevent, Monash Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Schlaich, Markus P.] Alfred Hosp, Baker IDI Heart & Diabet Inst, Neurovasc Hypertens & Kidney Dis Lab, Melbourne, Vic, Australia; [Schlaich, Markus P.] Alfred Hosp, Ctr Heart, Melbourne, Vic, Australia; [Sobotka, Paul A.] Ohio State Univ, Heart & Lung Res Inst, Columbus, OH 43210 USA; [Boehm, Michael; Mahfoud, Felix] Univ Saarlandes Kliniken, Homburg, Germany; [Rocha-Singh, Krishna; Katholi, Richard] St Johns Hosp, Prairie Heart Inst, Springfield, IL USA; [Esler, Murray D.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; University System of Ohio; Ohio State University; Universitatsklinikum des Saarlandes; Baker Heart and Diabetes Institute	Krum, H (corresponding author), Monash Univ, Alfred Hosp, Sch Publ Hlth & Prevent, Ctr Cardiovasc Res & Educ Therapeut,Dept Epidemio, Melbourne, Vic 3004, Australia.	henry.krum@monash.edu	Mahfoud, Felix/D-7707-2011; Böhm, Michael/C-3638-2011	Katholi, Richard/0000-0002-5625-7417; Schlaich, Markus/0000-0002-1765-0195	Ardian LLC/Medtronic Inc.; Ardian LLC; Medtronic	Ardian LLC/Medtronic Inc.; Ardian LLC; Medtronic(Medtronic)	Funding Ardian LLC/Medtronic Inc.; Ardian LLC was the sponsor of this study until January, 2011, when it was acquired by Medtronic, who continued sponsorship. We wish to thank Colleen Gilbert for liaising with Medtronic and providing editorial support, Martin Fahy and Minglei Liu for statistical analysis, Christina Hawley for data management support, and Sidney A Cohen for review of and suggestions to improve the text.	Bakris GL, 2001, J HUM HYPERTENS, V15, P81, DOI 10.1038/sj.jhh.1001135; Bohm M, 2013, EUROINTERVENTION, V9, P484, DOI 10.4244/EIJV9I4A78; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Cannon B, 1931, AM J PHYSIOL, V97, P592, DOI 10.1152/ajplegacy.1931.97.4.592; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CURTIS JJ, 1981, TRANSPLANTATION, V31, P125, DOI 10.1097/00007890-198102000-00007; Dzau VJ, 2006, CIRCULATION, V114, P2850, DOI 10.1161/CIRCULATIONAHA.106.655688; ESLER M, 1988, HYPERTENSION, V11, P3, DOI 10.1161/01.HYP.11.1.3; ESLER M, 1991, HYPERTENSION, V17, pS29; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Ewen S, 2013, HEART, V99, P1129, DOI 10.1136/heartjnl-2012-301725; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Hering D, 2013, J HYPERTENS, V31, P1893, DOI 10.1097/HJH.0b013e3283622e58; Hering D, 2013, EUROINTERVENTION, V9, pR127, DOI 10.4244/EIJV9SRA22; Hering D, 2013, HYPERTENSION, V61, P457, DOI 10.1161/HYPERTENSIONAHA.111.00194; Hering D, 2012, J AM SOC NEPHROL, V23, P1250, DOI 10.1681/ASN.2011111062; Kaltenbach B, 2012, J AM COLL CARDIOL, V60, P2694, DOI 10.1016/j.jacc.2012.09.027; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mahfoud F, 2013, EUR HEART J, V34, P2149, DOI 10.1093/eurheartj/eht154; Mahfoud F, 2013, CIRCULATION, V128, P132, DOI 10.1161/CIRCULATIONAHA.112.000949; Mahfoud F, 2012, HYPERTENSION, V60, P419, DOI 10.1161/HYPERTENSIONAHA.112.193870; Mahfoud F, 2011, CIRCULATION, V123, P1940, DOI 10.1161/CIRCULATIONAHA.110.991869; ONESTI G, 1975, CIRC RES, V36, P145, DOI 10.1161/01.RES.36.6.145; Ormiston JA, 2013, EUROINTERVENTION, V9, P70, DOI 10.4244/EIJV9I1A11; Ott C, 2013, CLIN J AM SOC NEPHRO, V8, P1195, DOI 10.2215/CJN.08500812; Rippy MK, 2011, CLIN RES CARDIOL, V100, P1095, DOI 10.1007/s00392-011-0346-8; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Schlaich MP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00010; Schlaich MP, 2009, NEW ENGL J MED, V361, P932, DOI 10.1056/NEJMc0904179; Schlaich MP, 2004, HYPERTENSION, V43, P169, DOI 10.1161/01.HYP.0000103160.35395.9E; Schmid A, 2013, CARDIOVASC INTER RAD, V36, P987, DOI 10.1007/s00270-013-0652-9; Schmieder RE, 2013, EUROINTERVENTION, V9, pR58, DOI 10.4244/EIJV9SRA11; Schmieder RE, 2012, J HYPERTENS, V30, P837, DOI 10.1097/HJH.0b013e328352ce78; Segura J, 2010, CURR HYPERTENS REP, V12, P325, DOI 10.1007/s11906-010-0136-0; SMITHWICK RH, 1953, JAMA-J AM MED ASSOC, V152, P1501, DOI 10.1001/jama.1953.03690160001001; Sobotka PA, 2011, CLIN RES CARDIOL, V100, P1049, DOI 10.1007/s00392-011-0335-y; Ukena C, 2011, J AM COLL CARDIOL, V58, P1176, DOI 10.1016/j.jacc.2011.05.036; Vaclavik J, 2011, HYPERTENSION, V57, P1069, DOI 10.1161/HYPERTENSIONAHA.111.169961; Waeber B, 2013, EUROINTERVENTION, V9, pR29, DOI 10.4244/EIJV9SRA6; Witkowski A, 2011, HYPERTENSION, V58, P559, DOI 10.1161/HYPERTENSIONAHA.111.173799; Worthley SG, 2013, EUR HEART J, V34, P2132, DOI 10.1093/eurheartj/eht197	46	435	480	2	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					622	629		10.1016/S0140-6736(13)62192-3	http://dx.doi.org/10.1016/S0140-6736(13)62192-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KP	24210779				2022-12-28	WOS:000331137700031
J	Psaty, BM; Weiss, NS				Psaty, Bruce M.; Weiss, Noel S.			2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol A Fresh Interpretation of Old Evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98121 USA; [Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NHLBI NIH HHS [R01 HL103612, HL103612, HL078888, HL080295, HL105756] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL103612, R01HL078888, R01HL080295, R01HL105756] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2013, PREV GUID TOOLS CV R; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children, 2011, PEDIATRICS, V128, pS1; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Psaty BM, 1999, JAMA-J AM MED ASSOC, V282, P786, DOI 10.1001/jama.282.8.786; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	10	22	22	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					461	462		10.1001/jama.2013.284203	http://dx.doi.org/10.1001/jama.2013.284203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302GF	24264722				2022-12-28	WOS:000330589800012
J	de Zeeuw, D; Akizawa, T; Audhya, P; Bakris, GL; Chin, M; Christ-Schmidt, H; Goldsberry, A; Houser, M; Krauth, M; Heerspink, HJL; McMurray, JJ; Meyer, CJ; Parving, HH; Remuzzi, G; Toto, RD; Vaziri, ND; Wanner, C; Wittes, J; Wrolstad, D; Chertow, GM				de Zeeuw, Dick; Akizawa, Tadao; Audhya, Paul; Bakris, George L.; Chin, Melanie; Christ-Schmidt, Heidi; Goldsberry, Angie; Houser, Mark; Krauth, Melissa; Heerspink, Hiddo J. Lambers; McMurray, John J.; Meyer, Colin J.; Parving, Hans-Henrik; Remuzzi, Giuseppe; Toto, Robert D.; Vaziri, Nosratola D.; Wanner, Christoph; Wittes, Janet; Wrolstad, Danielle; Chertow, Glenn M.		BEACON Trial Investigators	Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEPHROPATHY; EVENTS; TRIAL; IRBESARTAN; ANALOGS; NRF2	Background Although inhibitors of the renin-angiotensin-aldosterone system can slow the progression of diabetic kidney disease, the residual risk is high. Whether nuclear 1 factor (erythroid-derived 2)-related factor 2 activators further reduce this risk is unknown. Methods We randomly assigned 2185 patients with type 2 diabetes mellitus and stage 4 chronic kidney disease (estimated glomerular filtration rate [GFR], 15 to <30 ml per minute per 1.73 m(2) of body-surface area) to bardoxolone methyl, at a daily dose of 20 mg, or placebo. The primary composite outcome was end-stage renal disease (ESRD) or death from cardiovascular causes. Results The sponsor and the steering committee terminated the trial on the recommendation of the independent data and safety monitoring committee; the median follow-up was 9 months. A total of 69 of 1088 patients (6%) randomly assigned to bardoxolone methyl and 69 of 1097 (6%) randomly assigned to placebo had a primary composite outcome (hazard ratio in the bardoxolone methyl group vs. the placebo group, 0.98; 95% confidence interval [CI], 0.70 to 1.37; P=0.92). In the bardoxolone methyl group, ESRD developed in 43 patients, and 27 patients died from cardiovascular causes; in the placebo group, ESRD developed in 51 patients, and 19 patients died from cardiovascular causes. A total of 96 patients in the bardoxolone methyl group were hospitalized for heart failure or died from heart failure, as compared with 55 in the placebo group (hazard ratio, 1.83; 95% CI, 1.32 to 2.55; P<0.001). Estimated GFR, blood pressure, and the urinary albumin-to-creatinine ratio increased significantly and body weight decreased significantly in the bardoxolone methyl group, as compared with the placebo group. Conclusions Among patients with type 2 diabetes mellitus and stage 4 chronic kidney disease, bardoxolone methyl did not reduce the risk of ESRD or death from cardiovascular causes. A higher rate of cardiovascular events with bardoxolone methyl than with placebo prompted termination of the trial. (Funded by Reata Pharmaceuticals; BEACON ClinicalTrials.gov number, NCT01351675.)	[de Zeeuw, Dick; Heerspink, Hiddo J. Lambers] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Akizawa, Tadao] Showa Univ, Sch Med, Tokyo 142, Japan; [Audhya, Paul; Chin, Melanie; Goldsberry, Angie; Krauth, Melissa; Meyer, Colin J.] Reata Pharmaceut, Irving, TX USA; [Bakris, George L.] Univ Chicago, Chicago, IL 60637 USA; [Houser, Mark] AbbVie Pharmaceut, Chicago, IL USA; [Christ-Schmidt, Heidi; Wittes, Janet; Wrolstad, Danielle] Stat Collaborat, Washington, DC USA; [McMurray, John J.] Univ Glasgow, Glasgow, Lanark, Scotland; [Parving, Hans-Henrik] Univ Copenhagen, Rigshosp, DK-2100 Copenhagen, Denmark; [Remuzzi, Giuseppe] Ist Ric Farmacol Mario Negri, Ist Ricovero & Cura Carattere Sci, Bergamo, Italy; [Toto, Robert D.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Vaziri, Nosratola D.] Univ Calif Irvine, Irvine, CA USA; [Wanner, Christoph] Univ Wurzburg, D-97070 Wurzburg, Germany; [Chertow, Glenn M.] Stanford Univ, Palo Alto, CA 93034 USA	University of Groningen; Showa University; University of Chicago; AbbVie; University of Glasgow; Rigshospitalet; University of Copenhagen; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Irvine; University of Wurzburg; Stanford University	Chertow, GM (corresponding author), Stanford Univ, Sch Med, 777 Welch Rd,Suite DE, Palo Alto, CA 93034 USA.	gchertow@stanford.edu	de Zeeuw, Dick/E-9080-2014; Portoles, Jose/C-3337-2013; Heerspink, Hiddo J Lambers/K-3358-2014; PRAGA, MANUEL/W-4091-2017; Tesar, Vladimir/O-2312-2017; Colussi, Giacomo/AFV-2812-2022; Irish, Ashley/H-5468-2019; Combe, Christian/N-3726-2015; mcmurray, John/B-2467-2013; Remuzzi, Giuseppe/V-9766-2017	de Zeeuw, Dick/0000-0003-3434-7777; Portoles, Jose/0000-0002-2114-1385; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Tesar, Vladimir/0000-0001-6982-0689; Colussi, Giacomo/0000-0001-6133-1899; Irish, Ashley/0000-0002-9577-3764; Combe, Christian/0000-0002-0360-573X; mcmurray, John/0000-0002-6317-3975; Rizk, Dana/0000-0002-6877-2811; Holt, Stephen/0000-0001-5004-5539; Sunder-Plassmann, Gere/0000-0002-9253-9921; Wittert, Gary/0000-0001-6818-6065; Van der Niepen, Patricia/0000-0002-6401-1580; Cigarran Guldris, Secundino/0000-0001-5624-2605; Chertow, Glenn/0000-0002-7599-0534; Ali, Sameh Saad/0000-0002-0339-6106; Dixon, Bradley/0000-0002-2534-3259; Bhalla, Vivek/0000-0002-5420-9657; Le Meur, Yannick/0000-0001-8913-415X; gnudi, luigi/0000-0002-6353-630X; Remuzzi, Giuseppe/0000-0002-6194-3446; Taal, Maarten/0000-0002-9065-212X; Jardine, Alan/0000-0001-5815-9370; Holt, Steve/0000-0001-6936-9736; Schernthaner, Gerit-Holger/0000-0002-9587-1727	Reata Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	Reata Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by Reata Pharmaceuticals	Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chin M, 2013, AM J PHYSIOL-RENAL, V304, pF1438, DOI 10.1152/ajprenal.00387.2012; de Zeeuw D, 2013, AM J NEPHROL, V37, P212, DOI 10.1159/000346948; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Heerspink HJL, 2013, NEPHROL DIAL TRANSPL, V28, P2841, DOI 10.1093/ndt/gft445; Heerspink Hiddo J Lambers, 2011, Rev Diabet Stud, V8, P392, DOI 10.1900/RDS.2011.8.392; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Mann JFE, 2010, J AM SOC NEPHROL, V21, P527, DOI 10.1681/ASN.2009060593; Packham DK, 2012, J AM SOC NEPHROL, V23, P123, DOI 10.1681/ASN.2011040378; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; PARVING HH, 1983, LANCET, V1, P1175; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pergola PE, 2011, AM J NEPHROL, V33, P469, DOI 10.1159/000327599; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Reisman SA, 2012, J AM SOC NEPHROL, V23, P1663, DOI 10.1681/ASN.2012050457; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Zoja C, 2013, AM J PHYSIOL-RENAL, V304, pF808, DOI 10.1152/ajprenal.00376.2012	22	657	671	2	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2492	2503		10.1056/NEJMoa1306033	http://dx.doi.org/10.1056/NEJMoa1306033			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278BT	24206459	Green Accepted, Green Published			2022-12-28	WOS:000328863700007
J	Lloyd, DJ; St Jean, DJ; Kurzeja, RJM; Wahl, RC; Michelsen, K; Cupples, R; Chen, M; Wu, J; Sivits, G; Helmering, J; Komorowski, R; Ashton, KS; Pennington, LD; Fotsch, C; Vazir, M; Chen, K; Chmait, S; Zhang, JD; Liu, LB; Norman, MH; Andrews, KL; Bartberger, MD; Van, G; Galbreath, EJ; Vonderfecht, SL; Wang, MH; Jordan, SR; Veniant, MM; Hale, C				Lloyd, David J.; St Jean, David J., Jr.; Kurzeja, Robert J. M.; Wahl, Robert C.; Michelsen, Klaus; Cupples, Rod; Chen, Michelle; Wu, John; Sivits, Glenn; Helmering, Joan; Komorowski, Renee; Ashton, Kate S.; Pennington, Lewis D.; Fotsch, Christopher; Vazir, Mukta; Chen, Kui; Chmait, Samer; Zhang, Jiandong; Liu, Longbin; Norman, Mark H.; Andrews, Kristin L.; Bartberger, Michael D.; Van, Gwyneth; Galbreath, Elizabeth J.; Vonderfecht, Steven L.; Wang, Minghan; Jordan, Steven R.; Veniant, Murielle M.; Hale, Clarence			Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors	NATURE			English	Article							LIVER GLUCOKINASE; ACTIVATOR; GLUCOSE; IDENTIFICATION; TRANSLOCATION; FRUCTOSE; MK-0941; DEFECT; CELLS	Glucose homeostasis is a vital and complex process, and its disruption can cause hyperglycaemia and type II diabetes mellitus(1). Glucokinase (GK), a key enzyme that regulates glucose homeostasis, converts glucose to glucose-6-phosphate(2,3) in pancreatic beta-cells, liver hepatocytes, specific hypothalamic neurons, and gut enterocytes(4). In hepatocytes, GK regulates glucose uptake and glycogen synthesis, suppresses glucose production(3,5), and is subject to the endogenous inhibitor GK regulatory protein (GKRP)(6-8). During fasting, GKRP binds, inactivates and sequesters GK in the nucleus, which removes GK from the gluconeogenic process and prevents a futile cycle of glucose phosphorylation. Compounds that directly hyperactivate GK (GK activators) lower blood glucose levels and are being evaluated clinically as potential therapeutics for the treatment of type II diabetes mellitus(1,9,10). However, initial reports indicate that an increased risk of hypoglycaemia is associated with some GK activators(11). To mitigate the risk of hypoglycaemia, we sought to increase GK activity by blocking GKRP. Here we describe the identification of two potent small-molecule GK-GKRP disruptors (AMG-1694 and AMG-3969) that normalized blood glucose levels in several rodent models of diabetes. These compounds potently reversed the inhibitory effect of GKRP on GK activity and promoted GK translocation both in vitro (isolated hepatocytes) and in vivo (liver). A co-crystal structure of full-length human GKRP in complex with AMG-1694 revealed a previously unknown binding pocket in GKRP distinct from that of the phosphofructose-binding site. Furthermore, with AMG-1694 and AMG-3969 (but not GK activators), blood glucose lowering was restricted to diabetic and not normoglycaemic animals. These findings exploit a new cellular mechanism for lowering blood glucose levels with reduced potential for hypoglycaemic risk in patients with type II diabetes mellitus.	[Lloyd, David J.; Cupples, Rod; Chen, Michelle; Wu, John; Sivits, Glenn; Helmering, Joan; Komorowski, Renee; Wang, Minghan; Veniant, Murielle M.; Hale, Clarence] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA; [St Jean, David J., Jr.; Kurzeja, Robert J. M.; Wahl, Robert C.; Michelsen, Klaus; Ashton, Kate S.; Pennington, Lewis D.; Fotsch, Christopher; Vazir, Mukta; Chen, Kui; Chmait, Samer; Zhang, Jiandong; Liu, Longbin; Norman, Mark H.; Andrews, Kristin L.; Bartberger, Michael D.; Jordan, Steven R.] Amgen Inc, Dept Therapeut Discovery, Thousand Oaks, CA 91320 USA; [Van, Gwyneth; Galbreath, Elizabeth J.; Vonderfecht, Steven L.] Amgen Inc, Dept Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen	Lloyd, DJ (corresponding author), Amgen Inc, Dept Metab Disorders, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	dlloyd@amgen.com; chale@amgen.com		Galbreath, Elizabeth/0000-0003-0162-8329; Lloyd, David/0000-0001-5924-0672				AGIUS L, 1993, BIOCHEM J, V296, P785, DOI 10.1042/bj2960785; Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Anderka O, 2008, J BIOL CHEM, V283, P31333, DOI 10.1074/jbc.M805434200; Ashton K., 2012, PCT Int. Appl, Patent No. [WO 2012027261, 2012027261]; Choi JM, 2013, P NATL ACAD SCI USA, V110, P10171, DOI 10.1073/pnas.1300457110; Coghlan M, 2008, EXPERT OPIN INV DRUG, V17, P145, DOI 10.1517/13543784.17.2.145; DETHEUX M, 1991, EUR J BIOCHEM, V200, P553, DOI 10.1111/j.1432-1033.1991.tb16218.x; Eiki J, 2011, MOL PHARMACOL, V80, P1156, DOI 10.1124/mol.111.074401; Frenette R, 2002, BIOORG MED CHEM LETT, V12, P3009, DOI 10.1016/S0960-894X(02)00615-7; Fujimoto Y, 2004, AM J PHYSIOL-ENDOC M, V287, pE414, DOI 10.1152/ajpendo.00575.2003; Fyfe MCT, 2007, DIABETOLOGIA, V50, P1277, DOI 10.1007/s00125-007-0646-8; Grimsby J, 2008, CURR TOP MED CHEM, V8, P1524, DOI 10.2174/156802608786413483; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Hogan PJ, 2009, ORG PROCESS RES DEV, V13, P875, DOI 10.1021/op9000862; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; JETTON TL, 1994, J BIOL CHEM, V269, P3641; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shin JS, 2007, AM J PHYSIOL-REG I, V292, pR1381, DOI 10.1152/ajpregu.00260.2006; VANDERCAMMEN A, 1990, EUR J BIOCHEM, V191, P483, DOI 10.1111/j.1432-1033.1990.tb19147.x; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; Veiga-da-Cunha M, 2002, J BIOL CHEM, V277, P8466, DOI 10.1074/jbc.M105984200; Veiga-da-Cunha M, 2009, BIOCHEM J, V423, P323, DOI 10.1042/BJ20090986; Verspohl EJ, 2012, PHARMACOL REV, V64, P188, DOI 10.1124/pr.110.003319	28	75	77	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					437	+		10.1038/nature12724	http://dx.doi.org/10.1038/nature12724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24226772				2022-12-28	WOS:000328575300052
J	Li, Q; Bohin, N; Wen, T; Ng, V; Magee, J; Chen, SC; Shannon, K; Morrison, SJ				Li, Qing; Bohin, Natacha; Wen, Tiffany; Ng, Victor; Magee, Jeffrey; Chen, Shann-Ching; Shannon, Kevin; Morrison, Sean J.			Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness	NATURE			English	Article							HEMATOPOIETIC STEM; SELF-RENEWAL; RAS; ACTIVATION; PROLIFERATION; INACTIVATION; MUTATIONS; LEUKEMIA; STAT5; KRAS	'Pre-leukaemic' mutations are thought to promote clonal expansion of haematopoietic stem cells (HSCs) by increasing self-renewal and competitiveness(1); however, mutations that increase HSC proliferation tend to reduce competitiveness and self-renewal potential, raising the question of how a mutant HSC can sustainably outcompete wild-type HSCs. Activating mutations in NRAS are prevalent in human myeloproliferative neoplasms and leukaemia(2). Here we show that a single allele of oncogenic Nras(G12D) increases HSC proliferation but also increases reconstituting and self-renewal potential upon serial transplantation in irradiated mice, all prior to leukaemia initiation. Nras(G12D) also confers long-term self-renewal potential to multipotent progenitors. To explore the mechanism by which Nras(G12D) promotes HSC proliferation and self-renewal, we assessed cell-cycle kinetics using H2B-GFP label retention and 5-bromodeoxyuridine (BrdU) incorporation. Nras(G12D) had a bimodal effect on HSCs, increasing the frequency with which some HSCs divide and reducing the frequency with which others divide. This mirrored bimodal effects on reconstituting potential, as rarely dividing Nras(G12D) HSCs outcompeted wild-type HSCs, whereas frequently dividing Nras(G12D) HSCs did not. Nras(G12D) caused these effects by promoting STAT5 signalling, inducing different transcriptional responses in different subsets of HSCs. One signal can therefore increase HSC proliferation, competitiveness and self-renewal through bimodal effects on HSC gene expression, cycling and reconstituting potential.	[Li, Qing; Bohin, Natacha; Wen, Tiffany; Ng, Victor] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Magee, Jeffrey; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Magee, Jeffrey; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Chen, Shann-Ching] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; St Jude Children's Research Hospital; University of California System; University of California San Francisco	Li, Q (corresponding author), Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA.	lqing@umich.edu; Sean.Morrison@UTSouthwestern.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329; Bohin, Natacha/0000-0001-8571-9898	Cancer Prevention and Research Institute of Texas; NIH [K08-CA-134649]; V Foundation V Scholar award; NATIONAL CANCER INSTITUTE [R37CA072614, K08CA134649, T32CA128583, P30CA046592] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation V Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	S.J.M. is a Howard Hughes Medical Institute Investigator and the Mary McDermott Cook Chair in Pediatric Genetics. This work was supported by the Cancer Prevention and Research Institute of Texas. Q. L. was supported by NIH K08-CA-134649 and V Foundation V Scholar award. Thanks to L. Hennighausen, K. Haigis and H. Hock for generously providing Stat5ab<SUP>fl</SUP>, Nras<SUP>G12D</SUP> and Col1A1-H2B-GFP; Rosa26-M2-rtTA mice. Thanks to M. Heeren and K. Rajan for help with genotyping and to R. Coolon and N. Vanderveen for mouse colony management.	Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Buza-Vidas N, 2006, GENE DEV, V20, P2018, DOI 10.1101/gad.385606; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; De Filippi P, 2009, BRIT J HAEMATOL, V147, P706, DOI 10.1111/j.1365-2141.2009.07894.x; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Itzykson R, 2013, BLOOD, V121, P2186, DOI 10.1182/blood-2012-06-440347; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Kraoua L, 2012, AM J MED GENET A, V158A, P2407, DOI 10.1002/ajmg.a.35513; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Li LX, 2010, J IMMUNOL, V184, P1728, DOI 10.4049/jimmunol.0903023; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Matsuda K, 2007, BLOOD, V109, P5477, DOI 10.1182/blood-2006-09-046649; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; R Core Team, 2020, R LANG ENV STAT COMP; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takizawa H, 2006, BLOOD, V107, P2968, DOI 10.1182/blood-2005-05-2138; Wang JY, 2013, BLOOD, V121, P5203, DOI 10.1182/blood-2012-12-475863; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; Ward AF, 2012, BLOOD, V120, P3397, DOI 10.1182/blood-2012-05-378596; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang YY, 2001, J CLIN INVEST, V108, P709, DOI 10.1172/JCI12758	34	82	84	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					143	+		10.1038/nature12830	http://dx.doi.org/10.1038/nature12830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24284627	Green Accepted, Green Submitted			2022-12-28	WOS:000327851700048
J	Ahmed, SM; Evans, TG; Standing, H; Mahmud, S				Ahmed, Syed Masud; Evans, Timothy G.; Standing, Hilary; Mahmud, Simeen			Bangladesh: Innovation for Universal Health Coverage 2 Harnessing pluralism for better health in Bangladesh	LANCET			English	Article							NATIONAL DRUG POLICY; RURAL BANGLADESH; CARE; POOR; PRACTITIONERS; INTERVENTION; GOVERNMENT; PROVIDERS; MARKETS; WORKERS	How do we explain the paradox that Bangladesh has made remarkable progress in health and human development, yet its achievements have taken place within a health system that is frequently characterised as weak, in terms of inadequate physical and human infrastructure and logistics, and low performing? We argue that the development of a highly pluralistic health system environment, defined by the participation of a multiplicity of different stakeholders and agents and by ad hoc, diffused forms of management has contributed to these outcomes by creating conditions for rapid change. We use a combination of data from official sources, research studies, case studies of specific innovations, and in-depth knowledge from our own long-term engagement with health sector issues in Bangladesh to lay out a conceptual framework for understanding pluralism and its outcomes. Although we argue that pluralism has had positive effects in terms of stimulating change and innovation, we also note its association with poor health systems governance and regulation, resulting in endemic problems such as overuse and misuse of drugs. Pluralism therefore requires active management that acknowledges and works with its polycentric nature. We identify four key areas where this management is needed: participatory governance, accountability and regulation, information systems, and capacity development. This approach challenges some mainstream frameworks for managing health systems, such as the building blocks approach of the WHO Health Systems Framework. However, as pluralism increasingly defines the nature and the challenge of 21st century health systems, the experience of Bangladesh is relevant to many countries across the world.	[Ahmed, Syed Masud] Icddr B, Ctr Equ & Hlth Syst, Dhaka, Bangladesh; [Ahmed, Syed Masud] BRAC Univ, James P Grant Sch Publ Hlth, Ctr Excellence Universal Hlth Coverage, Dhaka 1212, Bangladesh; [Evans, Timothy G.] World Bank, Washington, DC 20433 USA; [Standing, Hilary] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England; [Mahmud, Simeen] BRAC Univ, BRAC Dev Inst, Dhaka 1212, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; The World Bank; University of Sussex; Bangladesh Rural Advancement Committee BRAC; BRAC University	Ahmed, SM (corresponding author), BRAC Univ, James P Grant Sch Publ Hlth, Ctr Excellence Universal Hlth Coverage, Icddr B, 68 Shahid Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh.	ahmed.sm@icddrb.org	Ahmed, Syed/GSN-7305-2022; Ahmed, Syed Masud/AGQ-4786-2022	Ahmed, Syed Masud/0000-0001-5032-7181	Rockefeller Foundation	Rockefeller Foundation	We thank Abbas Bhuiya of icddr,b, Mushtaque Chowdhury of Rockefeller Foundation, and Lincoln Chen of China Medical Board for providing constructive comments on an earlier draft of the paper. We also thank the Rockefeller Foundation for financing authors' meeting in Bangkok, Thailand. Thanks are also due to Hasan Shareef Ahmed, BRAC Research and Evaluation Division, for editing the manuscript.	Adams AM, 2013, LANCET; Afsana K, 2011, LANCET, V377, P2178, DOI 10.1016/S0140-6736(11)60960-4; Ahmed A., 2007, PROVISION OF PRIMARY; Ahmed J, 2005, TROP DOCT, V35, P160, DOI 10.1258/0049475054620879; Ahmed SM, 2006, SOC SCI MED, V63, P2899, DOI 10.1016/j.socscimed.2006.07.024; Ahmed SM, 2012, J HEALTH POPUL NUTR, V30, P99; Ahmed SM, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-3; Ahmed SM, 2009, HEALTH POLICY PLANN, V24, P467, DOI 10.1093/heapol/czp037; Ahsan SM, 2012, UTILISATION OF FORMA; Alam SMN, 2011, PUBLIC ADMIN DEVELOP, V31, P273, DOI 10.1002/pad.608; Ali M, 2008, SOUTH ASIAN YEARBOOK, P205; [Anonymous], 2012, THE ECONOMIST; Applbaum K, 2006, PLOS MED, V3, P445, DOI 10.1371/journal.pmed.0030189; Asian Development Bank, 2007, COMPLETION REPORT; Bangladesh Bureau of Statistics, 2011, PRELIMINARY REPORT O; Bangladesh Health Watch, 2008, HEALTH WORKFORCE IN; Bloom G, 2001, IDS WORKING PAPER 13; Bloom G, 2008, SOC SCI MED, V66, P2076, DOI 10.1016/j.socscimed.2008.01.034; Bloom G, 2011, HEALTH POLICY PLANN, V26, pi45, DOI 10.1093/heapol/czr025; BRAC, 2012, BRAC ANNUAL REPORT 2; BRAC Health Programme, 2011, MAKING TUBERCULOSIS; Buse K, 2000, B WORLD HEALTH ORGAN, V78, P699; Cash RA, 2013, LANCET; Chowdhury A.M.R., 1996, SIMPLE SOLUTION TEAC; Chowdhury AMR, 1997, LANCET, V350, P169, DOI 10.1016/S0140-6736(96)11311-8; Chowdhury AMR, 2013, LANCET; Chowdhury AMR, 1999, THE NEAR MIRACLE REV; Cockcroft Anne, 2007, Health Res Policy Syst, V5, P1, DOI 10.1186/1478-4505-5-1; Commission on Social Determinants of Health, 2008, CLOSING THE GAP IN A; Directorate General of Health Services, 2012, HEALTH BULLETIN 2012; El Arifeen S, 2013, LANCET; Gruen R, 2002, SOC SCI MED, V54, P267, DOI 10.1016/S0277-9536(01)00026-0; Han G, 2002, SOC RES ONLINE, V6, P4; Haque MA, 2010, BANGLADESH HEALTH WA; Health Economics Unit Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh, 2003, BANGLADESH NATIONAL; Hogerzeil HV, 2004, BRIT MED J, V329, P1169, DOI 10.1136/bmj.329.7475.1169; Islam N, 1999, TROP DOCT, V29, P78, DOI 10.1177/004947559902900206; James P, 2013, MOVE IT BANGLADESH F; Kakade D., 2012, BMC PROC SUPPL 1, V6, pO9; Kamat VR, 2001, SOC SCI MED, V52, P885, DOI 10.1016/S0277-9536(00)00191-X; Khan MM, 2010, BANGLADESH HEALTH FA; Lagomarsino G, 2009, LANCET, V374, P1577, DOI 10.1016/S0140-6736(09)61241-1; Mahmud S., 2007, RIGHTS RESOURCES AND; Mercer A, 2004, HEALTH POLICY PLANN, V19, P187, DOI 10.1093/heapol/czh024; Nahar S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-11; NIPORT Mitra and Associates and ICF International, 2013, BANGLADESH DEMOGRAPH; Nishtar S, 2010, CHOKED PIPES REFORMI; Omaswa F, 2006, B WORLD HEALTH ORGAN, V84, P83, DOI 10.2471/BLT.05.027979; OSTROM V, 1961, AM POLIT SCI REV, V55, P831, DOI 10.2307/1952530; Pagel C, 2009, LANCET, V374, P1441, DOI 10.1016/S0140-6736(09)61566-X; Palmer N, 2006, PUBLIC ADMIN DEVELOP, V26, P231, DOI 10.1002/pad.421; Rannan-Eliya RP, 2010, BANGLADESH NATIONAL; Saad KS, 2012, AN OVERVIEW OF THE P; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; The Organisation for Economic Co-operation and Development, 2008, PARIS DECLARATION ON; Theobald Sally, 2009, Health Res Policy Syst, V7, P26, DOI 10.1186/1478-4505-7-26; UN Development Programme, 2010, 2010 HUMAN DEVELOPME; UNICEF Bangladesh, 2010, UNDERSTANDING URBAN; United States Pharmacopeia Drug Quality and Information Program, 2004, REV DRUG QUAL AS FOC; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; WHO Regional Office for South-East Asia, EPI FACT SHEET BANGL; World Bank, 2003, BANGLADESH PRIVATE S; World Bank, 2008, PUBLIC AND PRIVATE S; World Bank, 2005, THE ECONOMICS AND GO; World Health Organization, 2007, EVERYBODYS BUSINESS; World Health Organization, 2008, WORLD HEALTH REPORT	66	105	105	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1746	1755		10.1016/S0140-6736(13)62147-9	http://dx.doi.org/10.1016/S0140-6736(13)62147-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259PX	24268003				2022-12-28	WOS:000327539900032
J	Chowdhury, AMR; Bhuiya, A; Chowdhury, ME; Rasheed, S; Hussain, Z; Chen, LC				Chowdhury, A. Mushtaque R.; Bhuiya, Abbas; Chowdhury, Mahbub Elahi; Rasheed, Sabrina; Hussain, Zakir; Chen, Lincoln C.			Bangladesh: Innovation for Universal Health Coverage 1 The Bangladesh paradox: exceptional health achievement despite economic poverty	LANCET			English	Article							CIVIL-SOCIETY	Bangladesh, the eighth most populous country in the world with about 153 million people, has recently been applauded as an exceptional health performer. In the first paper in this Series, we present evidence to show that Bangladesh has achieved substantial health advances, but the country's success cannot be captured simplistically because health in Bangladesh has the paradox of steep and sustained reductions in birth rate and mortality alongside continued burdens of morbidity. Exceptional performance might be attributed to a pluralistic health system that has many stakeholders pursuing women-centred, gender-equity-oriented, highly focused health programmes in family planning, immunisation, oral rehydration therapy, maternal and child health, tuberculosis, vitamin A supplementation, and other activities, through the work of widely deployed community health workers reaching all households. Government and non-governmental organisations have pioneered many innovations that have been scaled up nationally. However, these remarkable achievements in equity and coverage are counterbalanced by the persistence of child and maternal malnutrition and the low use of maternity-related services. The Bangladesh paradox shows the net outcome of successful direct health action in both positive and negative social determinants of health-ie, positives such as women's empowerment, widespread education, and mitigation of the effect of natural disasters; and negatives such as low gross domestic product, pervasive poverty, and the persistence of income inequality. Bangladesh offers lessons such as how gender equity can improve health outcomes, how health innovations can be scaled up, and how direct health interventions can partly overcome socioeconomic constraints.	[Chowdhury, A. Mushtaque R.] BRAC, Dhaka 1212, Bangladesh; [Chowdhury, A. Mushtaque R.] Columbia Univ, New York, NY USA; [Bhuiya, Abbas; Chowdhury, Mahbub Elahi; Rasheed, Sabrina] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Hussain, Zakir] WHO, Southeast Asia Reg Off, New Delhi, India; [Chen, Lincoln C.] China Med Board, Cambridge, MA USA	Bangladesh Rural Advancement Committee BRAC; Columbia University; International Centre for Diarrhoeal Disease Research (ICDDR); World Health Organization	Chowdhury, AMR (corresponding author), BRAC, Dhaka 1212, Bangladesh.	mushtaque.chowdhury@brac.net	rasheed, sabrina/A-4145-2010	rasheed, sabrina/0000-0002-7444-200X	Rockefeller Foundation	Rockefeller Foundation	We thank the many people who contributed to different stages of this review, including Faruque Ahmed (BRAC, Dhaka, Bangladesh); Syed Masud Ahmed (BRAC University, Dhaka, Bangladesh); Shireen Huq (Naripkkho, Dhaka, Bangladesh); and Monjur Rahman and Lumbini Roy (International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh). We particularly thank Alayne Adams (International Centre for Diarrhoeal Disease Research, Bangladesh) for her contributions, including to the panel on non-governmental organisations. We are grateful to the Rockefeller Foundation for a grant that allowed this work, and to International Centre for Diarrhoeal Disease Research, Bangladesh, for logistical support.	ABED FH, 1989, INTERNATIONAL COOPERATION FOR HEALTH, P76; Abed FH, 2013, LANCET; Adams AM, 2013, LANCET; Adams P, 2013, LANCET, V382, P1693, DOI 10.1016/S0140-6736(13)62391-0; Afsana K, 2013, LANCET; Ahmed S., 2004, REVISITING FOREIGN A; Ahmed SM, 2013, LANCET; [Anonymous], 2012, THE ECONOMIST; [Anonymous], 2010, THE DAILY STAR; Bangladesh Bureau of Statistics, CENSUS REPORT; Bangladesh Health Watch, 2008, THE STATE OF HEALTH; Bangladesh Health Watch, 2011, MOVING TOWARDS UNIVE; BBS, 2011, HOUSEHOLD INCOME AND; Bhuiya A, 2002, SOC SCI MED, V55, P1553, DOI 10.1016/S0277-9536(01)00287-8; Bhuiya A, 2013, LANCET, V382, P1699, DOI 10.1016/S0140-6736(13)62394-6; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; BRAC, 2013, ANNUAL REPORT 2012; BRAC University, 2012, THE STATE OF THE GOV; Cash RA, 2013, LANCET; Chaudhury RH, 2008, ASIA PAC POPUL J, V23, P55; CHOWDHURY AKMA, 1977, FOOD RES I STUD, V16, P47; Chowdhury AMR, 2004, J INT DEV, V16, P369, DOI DOI 10.1002/JID.1083; Chowdhury AMR, 2004, SCI AM          0702; Chowdhury AMR, 1996, SIMPLE SOLUTION; Chowdhury DSS, 2011, UN CEDAW MEETING UN; CHOWDHURY S, 1975, LANCET, V2, P567; Chowdhury Z., 1996, THE POLITICS OF ESSE; Dawson A, 2011, HUMAN RESOURCES FOR; Diabetic Association of Bangladesh, ADDRESSING ACCESSIBI; El Arifeen S, 2013, LANCET; Fuller M, 1977, STATISTICS WORKBOOK; Gill Z, 2004, INT J GYNECOL OBSTET, V85, P213, DOI 10.1016/j.ijgo.2004.01.004; Government of the People's Republic of Bangladesh, 2009, STEPS TOWARDS CHANGE; Government of the People's Republic of Bangladesh, 2011, SIXTH FIVE YEAR PLAN; Government of the People's Republic of Bangladesh Ministry of Health and Family welfare, 2012, HEALTH BULLETIN; Gupta MD, 2005, INDIAS UNDERNOURISHE; Helen Keller International (HKI) and James P Grant School of Public Health (JPGSPH), 2010, STATE OF FOOD SECURI; iccdr,b, 2012, MATLAB DEMOGRAPHIC W; icddr b. Health and demographic surveillance system, 2012, SCIENTIFIC REPORT NU; Kabeer N, 2010, IDS WORKING PAPER 34; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Khan I, 2011, THE DAILY STAR; Koehlmoos T.P., 2011, GOOD HLTH LOW COST, V25, P47; Lewis D, 2004, CONTRIB INDIAN SOC, V38, P299, DOI 10.1177/006996670403800301; Lewis D., 2011, BANGLADESH POLITICS, DOI 10.1017/CBO9781139017138; May MA, 2011, MAKING TUBERCULOSIS; MEASURE DHS Demographic and Health Surveys, PUBLICATIONS BY COUN; Ministry of Health and Family Welfare, 2011, HRD DATA SHEET 2011; MITRA S, 1997, BANGLADESH DEMOGRAPH; MITRA SNA, 1994, BANGLADESH DEMOGRAPH; Mridha MK, 2011, ASSESSMENT OF MATERN; Nazneen S., 2011, IDS WORKING PAPERS, V368, P1; NIPORT MEASURE Evaluation icddrb, 2012, BANGLADESH MATERNAL; NIPORT Mitra and Associates and ICF International, 2013, BANGLADESH DEMOGRAPH; NIPORT Mitra and Associates Macro International, 2009, BANGLADESH DEMOGRAPH; NIPORT Mitra and Associates ORC Macro, 2001, BANGLADESH DEMOGRAPH; NIPORT Mitra and Associates ORC Macro, 2005, BANGLADESH DEMOGRAPH; Population Reference Bureau, 2012, 2012 WORLD POPULATIO; Quibria MG, AID EFFECTIVENESS IN; Rahman HZ, 1993, RETHINKING RURAL POV; Raynor J., 2006, J ED INT DEV, V2, P2; Schurmann AT, 2009, J HEALTH POPUL NUTR, V27, P536; Smillie I, 2009, FREEDOM FROM WANT TH; Sobhan R., 1998, OECD DEVELOPMENT CEN; Sobhan R., 1982, THE CRISIS OF EXTERN; Standing H, 2008, SOC SCI MED, V66, P2096, DOI 10.1016/j.socscimed.2008.01.046; Transparency International, CORRUPTION BY COUNTR; Transparency International Bangladesh (TIB), 2011, CORRUPTION AND ANTIC; UN, UN DATA A WORLD OF I; UNDP, 2011, HUMAN DEVELOPMENT RE; UNDP, 2003, HUMAN DEVELOPMENT RE; UNICEF, COUNTRY STATISTICS B; WHO, GLOBAL HEALTH OBSERV; WHO, 2011, WORLD HEALTH STATIST; World Bank, 2006, ECONOMICS AND GOVERN; World Data Bank, WORLD DEVELOPMENT IN; World Health Organization (WHO), 2006, THE WORLD HEALTH REP	77	199	200	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1734	1745		10.1016/S0140-6736(13)62148-0	http://dx.doi.org/10.1016/S0140-6736(13)62148-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259PX	24268002				2022-12-28	WOS:000327539900031
J	Munoz-Espin, D; Canamero, M; Maraver, A; Gomez-Lopez, G; Contreras, J; Murillo-Cuesta, S; Rodriguez-Baeza, A; Varela-Nieto, I; Ruberte, J; Collado, M; Serrano, M				Munoz-Espin, Daniel; Canamero, Marta; Maraver, Antonio; Gomez-Lopez, Gonzalo; Contreras, Julio; Murillo-Cuesta, Silvia; Rodriguez-Baeza, Alfonso; Varela-Nieto, Isabel; Ruberte, Jesus; Collado, Manuel; Serrano, Manuel			Programmed Cell Senescence during Mammalian Embryonic Development	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; REPLICATIVE SENESCENCE; ENDOLYMPHATIC DUCT; CANCER DEVELOPMENT; ANIMAL DEVELOPMENT; TUMOR SUPPRESSION; TGF-BETA; DEATH; MICE; P53	Cellular senescence disables proliferation in damaged cells, and it is relevant for cancer and aging. Here, we show that senescence occurs during mammalian embryonic development at multiple locations, including the mesonephros and the endolymphatic sac of the inner ear, which we have analyzed in detail. Mechanistically, senescence in both structures is strictly dependent on p21, but independent of DNA damage, p53, or other cell-cycle inhibitors, and it is regulated by the TGF-beta/SMAD and PI3K/FOXO pathways. Developmentally programmed senescence is followed by macrophage infiltration, clearance of senescent cells, and tissue remodeling. Loss of senescence due to the absence of p21 is partially compensated by apoptosis but still results in detectable developmental abnormalities. Importantly, the mesonephros and endolymphatic sac of human embryos also show evidence of senescence. We conclude that the role of developmentally programmed senescence is to promote tissue remodeling and propose that this is the evolutionary origin of damage-induced senescence.	[Munoz-Espin, Daniel; Maraver, Antonio; Collado, Manuel; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain; [Canamero, Marta] Spanish Natl Canc Res Ctr CNIO, Histopathol Unit, E-28029 Madrid, Spain; [Gomez-Lopez, Gonzalo] Spanish Natl Canc Res Ctr CNIO, Bioinformat Unit, E-28029 Madrid, Spain; [Contreras, Julio] Univ Complutense Madrid, Sch Vet Med, Dept Anat, E-28040 Madrid, Spain; [Contreras, Julio; Murillo-Cuesta, Silvia; Varela-Nieto, Isabel] CSIC UAM, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain; [Contreras, Julio; Murillo-Cuesta, Silvia; Varela-Nieto, Isabel] Ctr Biomed Network Res Rare Dis CIBERER, E-46010 Valencia, Spain; [Rodriguez-Baeza, Alfonso] Univ Autonoma Barcelona, Fac Med, Dept Ciencies Morfol, E-08193 Barcelona, Spain; [Ruberte, Jesus] Univ Autonoma Barcelona, Sch Vet Med, Dept Anat & Anim Hlth, Ctr Anim Biotechnol & Gene Therapy CBATEG, E-08193 Barcelona, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain.	mserrano@cnio.es	Ruberte, Jesus/AAS-9240-2021; Maraver, Antonio/G-2666-2015; Rodriguez, Julio Contreras/AAB-6492-2019; Murillo-Cuesta, Silvia/T-5828-2019; Murillo-Cuesta, Silvia/C-3557-2016; Serrano, Manuel/H-2634-2015; Collado, Manuel/K-8140-2014; Rodríguez-Baeza, Alfonso/L-8284-2014; /AAI-3238-2021; Varela-Nieto, Isabel/G-5289-2015; Gomez-Lopez, Gonzalo/D-9123-2016	Rodriguez, Julio Contreras/0000-0002-2145-4090; Murillo-Cuesta, Silvia/0000-0002-8706-4327; Serrano, Manuel/0000-0001-7177-9312; Collado, Manuel/0000-0002-0330-0880; Rodríguez-Baeza, Alfonso/0000-0002-9181-5613; Varela-Nieto, Isabel/0000-0003-3077-0500; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Maraver, Antonio/0000-0002-5527-5680; RUBERTE, JESUS/0000-0003-1540-1432	Juan de la Cierva Program; Miguel Servet Program; CNIO; MICINN (SAF); Regional Government of Madrid; European Research Council (Advanced ERC Grant); Botin Foundation; Ramon Areces Foundation; AXA Foundation; MINECO [SAF2011-24391]; Fundacion de Investigacion Medica Mutua Madrilena; AFHELO (European Union)	Juan de la Cierva Program; Miguel Servet Program; CNIO; MICINN (SAF)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Research Council (Advanced ERC Grant)(European Research Council (ERC)); Botin Foundation; Ramon Areces Foundation; AXA Foundation; MINECO(Spanish Government); Fundacion de Investigacion Medica Mutua Madrilena; AFHELO (European Union)	We thank Marcos Malumbres, Oscar Fernandez-Capetillo, Mirna Perez-Moreno, and Donatello Castellano for sharing critical reagents. We also thank for excellent technical support the CNIO Genomics, Animal Facility, Histopathology, Confocal Microscopy, and Molecular Imaging Units. D. M.-E. has been funded by the Juan de la Cierva Program. A. M. and M. Collado were funded by the Miguel Servet Program. S. M.-C. holds a CIBERER (ISCIII) postdoctoral contract. Work in the laboratory of M. S. is funded by the CNIO and by grants from the MICINN (SAF), the Regional Government of Madrid, the European Research Council (Advanced ERC Grant), the Botin Foundation, the Ramon Areces Foundation, and the AXA Foundation. Work in the I.V.-N. group is supported by grants from MINECO (SAF2011-24391), Fundacion de Investigacion Medica Mutua Madrilena (2012), and AFHELO (FP7, European Union).	Abad M, 2007, J BIOL CHEM, V282, P31060, DOI 10.1074/jbc.M701639200; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Camp V, 1996, ANAT EMBRYOL, V194, P341; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Conradt B, 2009, ANNU REV GENET, V43, P493, DOI 10.1146/annurev.genet.42.110807.091533; CUNLIFFEBEAMER TL, 1976, LAB ANIM SCI, V26, P895; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Davidson A.J., 2008, STEMBOOK; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108; Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124; HULTCRANTZ M, 1987, ACTA OTO-LARYNGOL, V104, P406, DOI 10.3109/00016488709128268; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kim HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017949; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Kurita T, 2010, DIFFERENTIATION, V80, P99, DOI 10.1016/j.diff.2010.06.007; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lafferty-Whyte K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-532; Lezmi S, 2011, VET PATHOL, V48, P964, DOI 10.1177/0300985810391113; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lo WWM, 1997, AM J NEURORADIOL, V18, P881; Nacher V, 2006, J VASC RES, V43, P581, DOI 10.1159/000096076; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Orvis GD, 2007, DEV BIOL, V306, P493, DOI 10.1016/j.ydbio.2007.03.027; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Rovillain E, 2011, ONCOGENE, V30, P2356, DOI 10.1038/onc.2010.611; Sainio K., 2003, KIDNEY, P75; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Vazquez MD, 1998, ANAT HISTOL EMBRYOL, V27, P283, DOI 10.1111/j.1439-0264.1998.tb00194.x; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	51	796	815	6	111	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1104	1118		10.1016/j.cell.2013.10.019	http://dx.doi.org/10.1016/j.cell.2013.10.019			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24238962	Bronze, Green Published			2022-12-28	WOS:000327500600014
J	Wu, XB; Sharp, PA				Wu, Xuebing; Sharp, Phillip A.			Divergent Transcription: A Driving Force for New Gene Origination?	CELL			English	Review							LONG NONCODING RNAS; BIDIRECTIONAL PROMOTERS; HUMAN GENOME; U1 SNRNP; CHROMATIN INTERACTIONS; MUTATIONAL ASYMMETRY; MAMMALIAN GENOMES; ACTIVE PROMOTERS; SUPER-ENHANCERS; MESSENGER-RNAS	The mammalian genome is extensively transcribed, a large fraction of which is divergent transcription from promoters and enhancers that is tightly coupled with active gene transcription. Here, we propose that divergent transcription may shape the evolution of the genome by new gene origination.	[Wu, Xuebing; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Wu, Xuebing] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu	Wu, Xuebing/C-9152-2013	Wu, Xuebing/0000-0003-0369-5269	United States Public Health Service grants from the National Institutes of Health [RO1-GM34277, R01-CA133404]; Koch Institute Support from the National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [R01CA133404, P01CA042063, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085319, R01GM034277] Funding Source: NIH RePORTER	United States Public Health Service grants from the National Institutes of Health; Koch Institute Support from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all the Sharp lab members, especially Andrea Kriz, Anthony Chiu, Albert Almada, Mohini Jangi, and Jesse Zamudio for comments and Christopher Burge, Qifang Liu, Jianrong Wang, and Jeremy Wilusz for critical reading of the manuscript. This work was supported by United States Public Health Service grants RO1-GM34277 and R01-CA133404 from the National Institutes of Health (P.A.S.) and partially by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute. X.W. is a Howard Hughes Medical Institute International Student Research fellow.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Anamika K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038769; Andersen PK, 2012, GENE DEV, V26, P2169, DOI 10.1101/gad.189126.112; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Chen SD, 2013, NAT REV GENET, V14, P645, DOI 10.1038/nrg3521; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Edelman LB, 2012, CURR OPIN GENET DEV, V22, P110, DOI 10.1016/j.gde.2012.01.010; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; Gotea V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057323; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Janssen JWG, 2000, BLOOD, V95, P2691; Janssen JWG, 2002, INT J CANCER, V102, P608, DOI 10.1002/ijc.10765; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kruesi WS, 2013, ELIFE, V2, DOI 10.7554/eLife.00808; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Leyden J, 2006, BRIT J CANCER, V94, P1204, DOI 10.1038/sj.bjc.6603054; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Long M., 2013, ANN REV GENET; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Majewski J, 2003, AM J HUM GENET, V73, P688, DOI 10.1086/378134; McVicker G, 2010, GENOME RES, V20, P1503, DOI 10.1101/gr.106666.110; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Moss AC, 2006, BIOCHEM BIOPH RES CO, V345, P216, DOI 10.1016/j.bbrc.2006.04.094; Mugal CF, 2009, MOL BIOL EVOL, V26, P131, DOI 10.1093/molbev/msn245; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Park C, 2012, EMBO REP, V13, P1123, DOI 10.1038/embor.2012.165; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Piontkivska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-189; Polak P, 2008, GENOME RES, V18, P1216, DOI 10.1101/gr.076570.108; Polak P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-187; Preker P, 2011, NUCLEIC ACIDS RES, V39, P7179, DOI 10.1093/nar/gkr370; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tay SK, 2009, P NATL ACAD SCI USA, V106, P12019, DOI 10.1073/pnas.0904569106; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wakano C, 2012, BBA-GENE REGUL MECH, V1819, P688, DOI 10.1016/j.bbagrm.2012.02.006; Wang GZ, 2011, GENOME BIOL EVOL, V3, P320, DOI [10.1093/gbe/evr049, 10.1093/gbe/evr025]; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xie C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002942; Xu Chao, 2012, BMC Syst Biol, V6 Suppl 1, pS21, DOI 10.1186/1752-0509-6-S1-S21; Yang LD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-65	77	115	118	0	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					990	996		10.1016/j.cell.2013.10.048	http://dx.doi.org/10.1016/j.cell.2013.10.048			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267885	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000327500600005
J	Cole, TB				Cole, Thomas B.			Ice (2) Gerhard Richter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2018	2019		10.1001/jama.2013.5418	http://dx.doi.org/10.1001/jama.2013.5418			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240911				2022-12-28	WOS:000327098900001
J	Sarfo-Annin, JK; Stafford, PJ				Sarfo-Annin, Jason Kwasi; Stafford, Peter James			A patient with chest pain and electrocardiographic changes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BRUGADA-SYNDROME; RISK STRATIFICATION		[Sarfo-Annin, Jason Kwasi; Stafford, Peter James] Glenfield Hosp, Dept Cardiol, Leicester LE3 9QP, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Stafford, PJ (corresponding author), Glenfield Hosp, Dept Cardiol, Leicester LE3 9QP, Leics, England.	peter.stafford@uhl-tr.nhs.uk		/0000-0002-0930-7805				Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; de Luna AB, 2012, J ELECTROCARDIOL, V45, P433, DOI 10.1016/j.jelectrocard.2012.06.004; Brugada J, 1999, EUROPACE, V1, P156, DOI 10.1053/eupc.1999.0033; Brugada J, 2009, CARDIAC ELECTROPHYSI; Brugada P, 2005, CIRCULATION, V112, P279, DOI 10.1161/CIRCULATIONAHA.104.485326; CAMM AJ, 2009, ESC TXB CARDIOLOGY; Corrado D, 2010, EUR HEART J, V31, P243, DOI 10.1093/eurheartj/ehp473; Miura D, 2008, HEART RHYTHM, V5, P1495, DOI 10.1016/j.hrthm.2008.07.026; Morita H, 2008, CIRCULATION, V118, P1697, DOI 10.1161/CIRCULATIONAHA.108.770917; Postema PG, 2009, HEART RHYTHM, V6, P1335, DOI 10.1016/j.hrthm.2009.07.002; Priori SG, 2002, CIRCULATION, V105, P1342, DOI 10.1161/hc1102.105288; Priori SG, 2012, J AM COLL CARDIOL, V59, P37, DOI 10.1016/j.jacc.2011.08.064	12	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6839	10.1136/bmj.f6839	http://dx.doi.org/10.1136/bmj.f6839			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KF	24259326				2022-12-28	WOS:000327457400007
J	Weetman, AP				Weetman, Anthony P.			Investigating low thyroid stimulating hormone (TSH) level	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERTHYROIDISM; DISEASE		Univ Sheffield, Fac Med Dent & Hlth, Dept Human Metab, Sheffield S10 2HQ, S Yorkshire, England	University of Sheffield	Weetman, AP (corresponding author), Univ Sheffield, Fac Med Dent & Hlth, Dept Human Metab, Sheffield S10 2HQ, S Yorkshire, England.	a.p.weetman@sheffield.ac.uk						[Anonymous], 2003, THYROID, V13, P3; Association for Clinical Biochemistry, UK GUID US THYR FUNC; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Franklyn JA, 2013, CLIN ENDOCRINOL, V78, P1, DOI 10.1111/cen.12011; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Meyerovitch J, 2007, ARCH INTERN MED, V167, P1533, DOI 10.1001/archinte.167.14.1533	8	1	1	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6842	10.1136/bmj.f6842	http://dx.doi.org/10.1136/bmj.f6842			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KF	24259327				2022-12-28	WOS:000327457400008
J	Cooper, RA				Cooper, Richard A.			Unraveling the Physician Supply Dilemma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									New York Inst Technol, Ctr Future Healthcare Workforce, New York, NY 10022 USA	New York Institute Technology	Cooper, RA (corresponding author), New York Inst Technol, Ctr Future Healthcare Workforce, 400 E 56th St,Ste 32R, New York, NY 10022 USA.	buz@nyit.edu						[Anonymous], OCC OUTL HDB; COOPER RA, 1994, JAMA-J AM MED ASSOC, V272, P680, DOI 10.1001/jama.272.9.680; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; Cooper RA, 2012, J URBAN HEALTH, V89, P828, DOI 10.1007/s11524-012-9689-3; Cuckler GA, 2013, HEALTH AFFAIR, V32, P1820, DOI 10.1377/hlthaff.2013.0721; Dill M. J., 2008, COMPLEXITIES PHYS SU; Institute of Medicine, 2010, HEALTHC IMP LOW COST; Organisation for Economic Co-operation and Development, STATEXTRACTS; Sargen M, 2011, J AM COLL SURGEONS, V212, P991, DOI 10.1016/j.jamcollsurg.2011.03.005; Wennbeg JE, 2008, IMPROVING QUALITY CU	10	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1931	1932		10.1001/jama.2013.282170	http://dx.doi.org/10.1001/jama.2013.282170			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219943				2022-12-28	WOS:000326832900012
J	Emanuel, EJ				Emanuel, Ezekiel J.			Going to the Moon in Health Care Medicine's Big Hairy Audacious Goal (BHAG)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel J.] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Off Provost, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, 122 Coll Hall, Philadelphia, PA 19104 USA.	vp-global@upenn.edu						[Anonymous], 1962, COMMUNICATION; Buchanan L., 2012, ACHIEVE BIG HAIRY AU; Collins J, 1994, SUCCESSFUL HABITS VI; Hoffman A, 2013, JAMA-J AM MED ASSOC, V309, P661, DOI 10.1001/jama.2012.214571; *I HEALTHC IMPR, OV 100000 LIV CAMP	5	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1925	1926		10.1001/jama.2013.281967	http://dx.doi.org/10.1001/jama.2013.281967			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219940				2022-12-28	WOS:000326832900009
J	He, J; Zhang, YH; Xu, T; Zhao, Q; Wang, DL; Chen, CS; Tong, WJ; Liu, CJ; Xu, T; Ju, Z; Peng, YB; Peng, H; Li, QW; Geng, DQ; Zhang, JT; Li, D; Zhang, FS; Guo, LB; Sun, YX; Wang, XM; Cui, Y; Li, YQ; Ma, DH; Yang, G; Gao, YJ; Yuan, XD; Bazzano, LA; Chen, J				He, Jiang; Zhang, Yonghong; Xu, Tan; Zhao, Qi; Wang, Dali; Chen, Chung-Shiuan; Tong, Weijun; Liu, Changjie; Xu, Tian; Ju, Zhong; Peng, Yanbo; Peng, Hao; Li, Qunwei; Geng, Deqin; Zhang, Jintao; Li, Dong; Zhang, Fengshan; Guo, Libing; Sun, Yingxian; Wang, Xuemei; Cui, Yong; Li, Yongqiu; Ma, Dihui; Yang, Guang; Gao, Yanjun; Yuan, Xiaodong; Bazzano, Lydia A.; Chen, Jing		CATIS Investigators	Effects of Immediate Blood Pressure Reduction on Death and Major Disability in Patients With Acute Ischemic Stroke The CATIS Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; NIMODIPINE; GUIDELINE; RECOVERY; EVENTS	IMPORTANCE Although the benefit of reducing blood pressure for primary and secondary prevention of stroke has been established, the effect of antihypertensive treatment in patients with acute ischemic stroke is uncertain. OBJECTIVE To evaluate whether immediate blood pressure reduction in patients with acute ischemic stroke would reduce death and major disability at 14 days or hospital discharge. DESIGN, SETTING, AND PARTICIPANTS The China Antihypertensive Trial in Acute Ischemic Stroke, a single-blind, blinded end-points randomized clinical trial, conducted among 4071 patients with nonthrombolysed ischemic stroke within 48 hours of onset and elevated systolic blood pressure. Patients were recruited from 26 hospitals across China between August 2009 and May 2013. INTERVENTIONS Patients (n = 2038) were randomly assigned to receive antihypertensive treatment (aimed at lowering systolic blood pressure by 10% to 25% within the first 24 hours after randomization, achieving blood pressure less than 140/90 mm Hg within 7 days, and maintaining this level during hospitalization) or to discontinue all antihypertensive medications (control) during hospitalization (n = 2033). MAIN OUTCOMES AND MEASURES Primary outcome was a combination of death and major disability (modified Rankin Scale score >= 3) at 14 days or hospital discharge. RESULTS Mean systolic blood pressure was reduced from 166.7 mm Hg to 144.7 mm Hg (-12.7%) within 24 hours in the antihypertensive treatment group and from 165.6 mm Hg to 152.9 mm Hg (-7.2%) in the control group within 24 hours after randomization (difference, -5.5%[95% CI, -4.9 to -6.1%]; absolute difference, -9.1 mm Hg [95% CI, -10.2 to -8.1]; P < .001). Mean systolic blood pressure was 137.3 mm Hg in the antihypertensive treatment group and 146.5 mm Hg in the control group at day 7 after randomization (difference, -9.3 mm Hg [95% CI, -10.1 to -8.4]; P < .001). The primary outcome did not differ between treatment groups (683 events [antihypertensive treatment] vs 681 events [control]; odds ratio, 1.00 [95% CI, 0.88 to 1.14]; P = .98) at 14 days or hospital discharge. The secondary composite outcome of death and major disability at 3-month posttreatment follow-up did not differ between treatment groups (500 events [antihypertensive treatment] vs 502 events [control]; odds ratio, 0.99 [95% CI, 0.86 to 1.15]; P = .93). CONCLUSION AND RELEVANCE Among patients with acute ischemic stroke, blood pressure reduction with antihypertensive medications, compared with the absence of hypertensive medication, did not reduce the likelihood of death and major disability at 14 days or hospital discharge.	[He, Jiang; Zhang, Yonghong; Xu, Tan; Tong, Weijun; Xu, Tian; Peng, Hao] Soochow Univ, Dept Epidemiol, Sch Publ Hlth, Coll Med, Suzhou 215123, Peoples R China; [He, Jiang; Zhang, Yonghong; Zhao, Qi; Chen, Chung-Shiuan; Bazzano, Lydia A.; Chen, Jing] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [He, Jiang; Bazzano, Lydia A.; Chen, Jing] Tulane Univ, Dept Med, Sch Med, New Orleans, LA 70112 USA; [He, Jiang; Bazzano, Lydia A.; Chen, Jing] Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA USA; [Wang, Dali; Peng, Yanbo] Hebei United Univ, Dept Neurol, Affiliated Hosp, Tangshan, Hebei, Peoples R China; [Liu, Changjie] Yutian Cty Hosp, Dept Neurol, Xinjiang, Hebei, Peoples R China; [Ju, Zhong] Kerqin Dist First Peoples Hosp Tongliao City, Dept Neurol, Tongliao City, Inner Mongolia, Peoples R China; [Li, Qunwei] Taishan Med Coll, Dept Epidemiol, Sch Publ Hlth, Tai An, Shandong, Peoples R China; [Geng, Deqin] Xuzhou Med Coll, Dept Neurol, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China; [Li, Dong] Feicheng City Peoples Hosp, Dept Internal Med, Tai An, Shandong, Peoples R China; [Zhang, Fengshan] Tongliao Municipal Hosp, Dept Neurol, Tongliao, Inner Mongolia, Peoples R China; [Guo, Libing] Siping Cent Hosp, Dept Neurol, Siping, Jilin, Peoples R China; [Sun, Yingxian] China Med Univ, Affiliated Hosp 1, Dept Cardiol, Liaoning, Peoples R China; [Wang, Xuemei] Jilin Cent Hosp, Dept Neurol, Changchun, Jilin, Peoples R China; [Cui, Yong] First Automobile Works, Dept Neurol, Gen Hosp, Changchun, Jilin, Peoples R China; [Li, Yongqiu] Tangshan Workers Hosp, Dept Neurol, Tangshan, Hebei, Peoples R China; [Ma, Dihui] Jilin Univ, Dept Neurol, Affiliated Hosp 1, Changchun, Jilin, Peoples R China; [Yang, Guang] Second Peoples Hosp Huaian City, Dept Neurol, Huaian, Jiangsu, Peoples R China; [Gao, Yanjun] Chengde Med Coll, Dept Neurol, Affiliated Hosp, Chengde, Hebei, Peoples R China; [Yuan, Xiaodong] Kailuan Gen Hosp, Dept Neurol, Tangshan, Hebei, Peoples R China	Soochow University - China; Tulane University; Tulane University; Tulane University; North China University of Science & Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; Xuzhou Medical University; Jilin University; Chengde Medical University	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St,Ste 2000, New Orleans, LA 70112 USA.	jhe@tulane.edu; yhzhang@suda.edu.cn	Zhao, Qi/Y-9866-2019; Xu, Tan/HCJ-0743-2022; Peng, Hao/AAB-4759-2022; He, Jiang/AAF-5303-2020; Wang, Xuemei/GXF-3702-2022; Peng, Hao/I-1134-2014	He, Jiang/0000-0002-8286-9652; Peng, Hao/0000-0001-6277-662X; Sun, Yingxian/0000-0002-1905-0935	Tulane University; Collins C. Diboll Private Foundation; Soochow University; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions, China; National Natural Science Foundation of China [81320108026]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER	Tulane University; Collins C. Diboll Private Foundation; Soochow University; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by Tulane University and Collins C. Diboll Private Foundation, both in New Orleans, Louisiana; Soochow University, a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions, China, and the National Natural Science Foundation of China (grant 81320108026). The Changzhou Pharmaceutical Factory provided the study drug (enalapril) for this trial.	Ahmed N, 2000, STROKE, V31, P1250, DOI 10.1161/01.STR.31.6.1250; Allen NB, 2009, CEREBROVASC DIS, V27, P254, DOI 10.1159/000196824; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), ANT LIP LOW TREATM P; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Castillo J, 2004, STROKE, V35, P520, DOI 10.1161/01.STR.0000109769.22917.B0; Chamorro A, 1998, STROKE, V29, P1850, DOI 10.1161/01.STR.29.9.1850; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; China National Guidelines for Prevention and Treatment of Cerebrovascular Diseases Committee, 2005, CHIN NAT GUID PREV T; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; KASTE M, 1994, STROKE, V25, P1348, DOI 10.1161/01.STR.25.7.1348; Lakshminarayan Kamakshi, 2008, J Vasc Interv Neurol, V1, P87; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Pickering Thomas G, 2005, J Clin Hypertens (Greenwich), V7, P102, DOI 10.1111/j.1524-6175.2005.04377.x; Potter JF, 2009, LANCET NEUROL, V8, P48, DOI 10.1016/S1474-4422(08)70263-1; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Robinson TG, 2010, LANCET NEUROL, V9, P767, DOI 10.1016/S1474-4422(10)70163-0; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Schrader J, 2003, STROKE, V34, P1699, DOI 10.1161/01.STR.0000075777.18006.89; Thompson AM, 2011, JAMA-J AM MED ASSOC, V305, P913, DOI 10.1001/jama.2011.250; Turnbull F, 2003, LANCET, V362, P1527; Tyrrell P, 2009, HEART, V95, P843, DOI 10.1136/hrt.2009.167684; Wang PL, 2013, CHINESE MED J-PEKING, V126, P1236, DOI 10.3760/cma.j.issn.0366-6999.20122573; Wang YL, 2011, STROKE, V42, P1658, DOI 10.1161/STROKEAHA.110.604249; Weaver CS, 2004, STROKE, V35, P1216, DOI 10.1161/01.STR.0000125010.70652.93; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Zhang J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001928.pub2; Zhang YH, 2008, J HYPERTENS, V26, P1446, DOI 10.1097/HJH.0b013e328300a24a	35	278	301	6	78	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					479	489		10.1001/jama.2013.282543	http://dx.doi.org/10.1001/jama.2013.282543			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302GF	24240777	Bronze			2022-12-28	WOS:000330589800021
J	Vestrand, WT; Wren, JA; Panaitescu, A; Wozniak, PR; Davis, H; Palmer, DM; Vianello, G; Omodei, N; Xiong, S; Briggs, MS; Elphick, M; Paciesas, W; Rosing, W				Vestrand, W. T.; Wren, J. A.; Panaitescu, A.; Wozniak, P. R.; Davis, H.; Palmer, D. M.; Vianello, G.; Omodei, N.; Xiong, S.; Briggs, M. S.; Elphick, M.; Paciesas, W.; Rosing, W.			The Bright Optical Flash and Afterglow from the Gamma-Ray Burst GRB 130427A	SCIENCE			English	Article							LIGHT CURVES; EMISSION; 080319B; PROMPT	The optical light generated simultaneously with x-rays and gamma rays during a gamma-ray burst (GRB) provides clues about the nature of the explosions that occur as massive stars collapse. We report on the bright optical flash and fading afterglow from powerful burst GRB 130427A. The optical and >100-megaelectron volt (MeV) gamma-ray flux show a close correlation during the first 7000 seconds, which is best explained by reverse shock emission cogenerated in the relativistic burst ejecta as it collides with surrounding material. At later times, optical observations show the emergence of emission generated by a forward shock traversing the circumburst environment. The link between optical afterglow and >100-MeV emission suggests that nearby early peaked afterglows will be the best candidates for studying gamma-ray emission at energies ranging from gigaelectron volts to teraelectron volts.	[Vestrand, W. T.; Wren, J. A.; Panaitescu, A.; Wozniak, P. R.; Davis, H.; Palmer, D. M.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Vianello, G.; Omodei, N.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Vianello, G.; Omodei, N.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Xiong, S.; Briggs, M. S.] Univ Alabama, Ctr Space Plasma & Aeron Res, Huntsville, AL 35899 USA; [Elphick, M.; Rosing, W.] Las Cumbres Observ Global Telescope Network, Santa Barbara, CA 93117 USA; [Paciesas, W.] Univ Space Res Assoc, Huntsville, AL 35899 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Alabama System; University of Alabama Huntsville; Universities Space Research Association (USRA)	Vestrand, WT (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	vestrand@lanl.gov		Omodei, Nicola/0000-0002-5448-7577; Wozniak, Przemyslaw/0000-0002-9919-3310; Vianello, Giacomo/0000-0002-2553-0839	NASA; Laboratory Directed Research and Development program at Los Alamos National Laboratory	NASA(National Aeronautics & Space Administration (NASA)); Laboratory Directed Research and Development program at Los Alamos National Laboratory	This GRB research was supported by NASA and the Laboratory Directed Research and Development program at Los Alamos National Laboratory. The optical measurements reported in this paper are available online in the supplementary materials.	Ackermann M, 2014, SCIENCE, V343, P42, DOI 10.1126/science.1242353; Akerlof C, 1999, NATURE, V398, P400, DOI 10.1038/18837; Bloom JS, 2009, ASTROPHYS J, V691, P723, DOI 10.1088/0004-637X/691/1/723; Giblin TW, 1999, ASTROPHYS J, V524, pL47, DOI 10.1086/312285; Golenetskii S., 2013, 14486 GCN NASA; Laskar T., 2013, PREPRINT; Levan A. J., 2013, 14455 GCN NASA; Maselli A, 2014, SCIENCE, V343, P48, DOI 10.1126/science.1242279; MESZAROS P, 1993, ASTROPHYS J, V405, P278, DOI 10.1086/172360; Meszaros P, 1997, ASTROPHYS J, V476, P232, DOI 10.1086/303625; Metzger BD, 2011, MON NOT R ASTRON SOC, V413, P2031, DOI 10.1111/j.1365-2966.2011.18280.x; Metzger MR, 1997, NATURE, V387, P878, DOI 10.1038/43132; Panaitescu A, 2008, MON NOT R ASTRON SOC, V387, P497, DOI 10.1111/j.1365-2966.2008.13231.x; Racusin JL, 2008, NATURE, V455, P183, DOI 10.1038/nature07270; Rykoff ES, 2009, ASTROPHYS J, V702, P489, DOI 10.1088/0004-637X/702/1/489; Sari R, 1999, ASTROPHYS J, V520, P641, DOI 10.1086/307508; Uhm ZL, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/147; Vestrand WT, 2006, NATURE, V442, P172, DOI 10.1038/nature04913; Vestrand WT, 2005, NATURE, V435, P178, DOI 10.1038/nature03515; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; Wozniak PR, 2009, ASTROPHYS J, V691, P495, DOI 10.1088/0004-637X/691/1/495; Wren J, 2010, PROC SPIE, V7737, DOI 10.1117/12.859039; Xu D, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/98	23	59	61	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					38	41		10.1126/science.1242316	http://dx.doi.org/10.1126/science.1242316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24263131	Green Submitted			2022-12-28	WOS:000329162000041
J	Wiser, MJ; Ribeck, N; Lenski, RE				Wiser, Michael J.; Ribeck, Noah; Lenski, Richard E.			Long-Term Dynamics of Adaptation in Asexual Populations	SCIENCE			English	Article							ESCHERICHIA-COLI; EXPERIMENTAL EVOLUTION; BENEFICIAL MUTATIONS; BACTERIAL POPULATION; CLONAL INTERFERENCE; FITNESS LANDSCAPES; EPISTASIS; SELECTION	Experimental studies of evolution have increased greatly in number in recent years, stimulated by the growing power of genomic tools. However, organismal fitness remains the ultimate metric for interpreting these experiments, and the dynamics of fitness remain poorly understood over long time scales. Here, we examine fitness trajectories for 12 Escherichia coli populations during 50,000 generations. Mean fitness appears to increase without bound, consistent with a power law. We also derive this power-law relation theoretically by incorporating clonal interference and diminishing-returns epistasis into a dynamical model of changes in mean fitness over time.	[Wiser, Michael J.; Ribeck, Noah; Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Wiser, Michael J.; Lenski, Richard E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Ribeck, Noah; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Lenski, RE (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.	lenski@msu.edu	Wiser, Mike/AFN-9188-2022	Wiser, Mike/0000-0003-1686-9272; Lenski, Richard/0000-0002-1064-8375	National Science Foundation [DEB-1019989]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; Hannah Chair Endowment at Michigan State University; Division Of Environmental Biology [1019989] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; Hannah Chair Endowment at Michigan State University; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (DEB-1019989) including the BEACON Center for the Study of Evolution in Action (DBI-0939454), and by funds from the Hannah Chair Endowment at Michigan State University. We thank three reviewers for comments; I. Dworkin, J. Krug, A. McAdam, C. Wilke, and L. Zaman for discussions; and N. Hajela for technical assistance. R. E. L. will make strains available to qualified recipients, subject to completion of a material transfer agreement that can be found at www.technologies.msu.edu/inventors/mta-cda/mta/mta-forms. Datasets and analysis scripts are available at the Dryad Digital Repository (doi: 10.5061/dryad.0hc2m).	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Burch CL, 1999, GENETICS, V151, P921; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; EAGON RG, 1962, J BACTERIOL, V83, P736, DOI 10.1128/JB.83.4.736-737.1962; Elena SF, 1997, EVOLUTION, V51, P1058, DOI 10.1111/j.1558-5646.1997.tb03953.x; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goyal S, 2012, GENETICS, V191, P1309, DOI 10.1534/genetics.112.141291; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; Park SC, 2007, P NATL ACAD SCI USA, V104, P18135, DOI 10.1073/pnas.0705778104; Sibani P, 1998, INT J MOD PHYS B, V12, P361, DOI 10.1142/S0217979298000259; Szendro IG, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/01/P01005; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Wielgoss S, 2011, G3-GENES GENOM GENET, V1, P183, DOI 10.1534/g3.111.000406; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	24	288	291	1	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1364	1367		10.1126/science.1243357	http://dx.doi.org/10.1126/science.1243357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24231808				2022-12-28	WOS:000328196000049
J	Storer, M; Mas, A; Robert-Moreno, A; Pecoraro, M; Ortells, MC; Di Giacomo, V; Yosef, R; Pilpel, N; Krizhanovsky, V; Sharpe, J; Keyes, WM				Storer, Mekayla; Mas, Alba; Robert-Moreno, Alexandre; Pecoraro, Matteo; Ortells, M. Carmen; Di Giacomo, Valeria; Yosef, Reut; Pilpel, Noam; Krizhanovsky, Valery; Sharpe, James; Keyes, William M.			Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning	CELL			English	Article							APICAL ECTODERMAL RIDGE; CELL-CYCLE ARREST; LIMB DEVELOPMENT; HUMAN FIBROBLASTS; VERTEBRATE LIMB; UP-REGULATION; ROOF PLATE; CANCER; P21; DIFFERENTIATION	Senescence is a form of cell-cycle arrest linked to tumor suppression and aging. However, it remains controversial and has not been documented in nonpathologic states. Here we describe senescence as a normal developmental mechanism found throughout the embryo, including the apical ectodermal ridge (AER) and the neural roof plate, two signaling centers in embryonic patterning. Embryonic senescent cells are nonproliferative and share features with oncogene-induced senescence (OIS), including expression of p21, p15, and mediators of the senescence-associated secretory phenotype (SASP). Interestingly, mice deficient in p21 have defects in embryonic senescence, AER maintenance, and patterning. Surprisingly, the underlying mesenchyme was identified as a source for senescence instruction in the AER, whereas the ultimate fate of these senescent cells is apoptosis and macrophage-mediated clearance. We propose that senescence is a normal programmed mechanism that plays instructive roles in development, and that OIS is an evolutionarily adapted reactivation of a developmental process.	[Storer, Mekayla; Mas, Alba; Robert-Moreno, Alexandre; Pecoraro, Matteo; Ortells, M. Carmen; Di Giacomo, Valeria; Sharpe, James; Keyes, William M.] Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Storer, Mekayla; Mas, Alba; Robert-Moreno, Alexandre; Pecoraro, Matteo; Ortells, M. Carmen; Di Giacomo, Valeria; Sharpe, James; Keyes, William M.] UPF, Barcelona 08003, Spain; [Yosef, Reut; Pilpel, Noam; Krizhanovsky, Valery] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Weizmann Institute of Science	Keyes, WM (corresponding author), Ctr Genom Regulat CRG, Barcelona 08003, Spain.	bill.keyes@crg.eu	Robert-Moreno, Alex/K-8640-2014; Sharpe, James/AAB-7948-2019; Sharpe, James/L-1150-2014	Robert-Moreno, Alex/0000-0001-9042-1316; Sharpe, James/0000-0002-1434-9743; Keyes, William M./0000-0002-8917-2268; Storer, Mekayla/0000-0003-0242-1418	"La Caixa" fellowship; Spanish Ministry; Plan Nacional grant; Spanish Ministry for Science and Innovation [SAF2010-18829]; CRG core funding	"La Caixa" fellowship(La Caixa Foundation); Spanish Ministry(Spanish Government); Plan Nacional grant; Spanish Ministry for Science and Innovation(Spanish Government); CRG core funding	We are grateful to the CRG genomics, histology, and mouse facilities for technical help, Manuela Hummel for bioinformatics analysis, Juan Valcarcel for helpful discussions, Juan-Martin Caballero for mouse models, and Juan Jose Sanz and Jelena Raspopovic for technical advice. In addition, we thank Manuel Serrano for sharing unpublished data, technical assistance, and submission coordination. M. S. and V. D. G. are funded by "La Caixa'' fellowships, and M. P. by an FPI fellowship from the Spanish Ministry. This work was funded in part by a Plan Nacional grant to W.M.K. from the Spanish Ministry for Science and Innovation (SAF2010-18829) and CRG core funding.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chizhikov VV, 2004, NAT REV NEUROSCI, V5, P808, DOI 10.1038/nrn1520; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Devgan V, 2006, J BIOL CHEM, V281, P30463, DOI 10.1074/jbc.M604684200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kim SH, 2006, J CELL SCI, V119, P2435, DOI 10.1242/jcs.02989; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Vasey DB, 2011, TRANSGENIC RES, V20, P23, DOI 10.1007/s11248-010-9385-6; Wood W, 2000, DEVELOPMENT, V127, P5245; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	56	655	671	5	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1119	1130		10.1016/j.cell.2013.10.041	http://dx.doi.org/10.1016/j.cell.2013.10.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24238961	Green Published, Bronze			2022-12-28	WOS:000327500600015
J	Reinhardt, UE				Reinhardt, Uwe E.			The Disruptive Innovation of Price Transparency in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Reinhardt, UE (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, 351 Wallace Hall, Princeton, NJ 08544 USA.	reinhard@princeton.edu						Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; CAREOperative, HEALTHC BLUE BOOK; Christensen CM, WILL DISRUPTIVE INNO; PAULY MV, 1995, HEALTH AFFAIR, V14, P68, DOI 10.1377/hlthaff.14.2.68; Reinhardt UE, 2011, HEALTH AFFAIR, V30, P2125, DOI 10.1377/hlthaff.2011.0813; Robinson JC, 2013, HEALTH AFFAIR, V32, P1392, DOI 10.1377/hlthaff.2013.0188; Wall JK, WELLPOINT ROLLS PROG	7	42	42	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1927	1928		10.1001/jama.2013.281854	http://dx.doi.org/10.1001/jama.2013.281854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219941				2022-12-28	WOS:000326832900010
J	Roos, N; Neovius, M; Cnattingius, S; Lagerros, YT; Saaf, M; Granath, F; Stephansson, O				Roos, Nathalie; Neovius, Martin; Cnattingius, Sven; Lagerros, Ylva Trolle; Saaf, Maria; Granath, Fredrik; Stephansson, Olof			Perinatal outcomes after bariatric surgery: nationwide population based matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; PREGNANCY OUTCOMES; RISK; OBESITY; BIRTH; WEIGHT; TRENDS	Objective To compare perinatal outcomes in births of women with versus without a history of bariatric surgery. Design Population based matched cohort study. Setting Swedish national health service. Participants 1 742 702 singleton births identified in the Swedish medical birth register between 1992 and 2009. For each birth to a mother with a history of bariatric surgery (n=2562), up to five control births were matched by maternal age, parity, early pregnancy body mass index, early pregnancy smoking status, educational level, and year of delivery. Secondary control cohorts, including women eligible for bariatric surgery (body mass index >= 35 or >= 40), were matched for the same factors except body mass index. History of maternal bariatric surgery was ascertained through the Swedish national patient register from 1980 to 2009. Main outcome measures Preterm birth (<37 weeks), small for gestational age birth, large for gestational age birth, stillbirth (>= 28 weeks), and neonatal death (0-27 days). Results Post-surgery births were more often preterm than in matched controls (9.7% (243/2511) v 6.1% (750/12 379); odds ratio 1.7, 95% confidence interval 1.4 to 2.0; P<0.001). Body mass index seemed to be an effect modifier (P=0.01), and the increased risk of preterm birth was only observed in women with a body mass index <35. A history of bariatric surgery was associated with increased risks of both spontaneous (5.2% (130/2511) v 3.6% (441/12 379); odds ratio 1.5, 1.2 to 1.9; P<0.001) and medically indicated preterm birth (4.5% (113/2511) v 2.5% (309/12 379); odds ratio 1.8, 1.4 to 2.3; P<0.001). A history of bariatric surgery was also associated with an increased risk of a small for gestational age birth (5.2% (131/2507) v 3.0% (369/12 338); odds ratio 2.0, 1.5 to 2.5; P<0.001) and lower risk of a large for gestational age birth (4.2% (105/2507) v 7.3% (895/12 338); odds ratio 0.6, 0.4 to 0.7; P<0.001). No differences were detected for stillbirth or neonatal death. The increased risks for preterm and small for gestational age birth, as well as the decreased risk for large for gestational age birth, remained when post-surgery births were compared with births of women eligible for bariatric surgery. Conclusion Women with a history of bariatric surgery were at increased risk of preterm and small for gestational age births and should be regarded as a risk group during pregnancy.	[Roos, Nathalie; Neovius, Martin; Cnattingius, Sven; Lagerros, Ylva Trolle; Granath, Fredrik; Stephansson, Olof] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden; [Roos, Nathalie; Stephansson, Olof] Karolinska Inst, Div Obstet & Gynaecol, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Saaf, Maria] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Saaf, Maria] Karolinska Univ Hosp, Dept Diabet Endocrinol & Metab, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Neovius, M (corresponding author), Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden.	martin.neovius@ki.se	Lagerros, Ylva Trolle/AAH-7683-2020	Lagerros, Ylva Trolle/0000-0001-6816-7577; Neovius, Martin/0000-0003-2300-3055; Roos, Nathalie/0000-0001-9752-2355; Stephansson, Olof/0000-0003-1528-4563	Karolinska Institutet; board of postgraduate education at the Karolinska Institutet; Swedish Society of Medicine; Stockholm County Council; Abbott; Sanofi-Aventis; Itrim International; Strategic Health Resources; Cambridge Weight Plan; Novo Nordisk	Karolinska Institutet(Karolinska Institutet); board of postgraduate education at the Karolinska Institutet; Swedish Society of Medicine; Stockholm County Council(Stockholm County Council); Abbott(Abbott Laboratories); Sanofi-Aventis(Sanofi-Aventis); Itrim International; Strategic Health Resources; Cambridge Weight Plan; Novo Nordisk(Novo Nordisk)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare that SC was supported by a distinguished professor award (Karolinska Institutet); MN was supported by the strategic young scholar award in epidemiology (Karolinska Institutet); NR was supported by the board of postgraduate education at the Karolinska Institutet (Karolinska Institutet Doctoral Student Financing Fund); OS was supported by the Swedish Society of Medicine and the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet; and that SC, NR, MS, and YT-L have had no financial relationships with any organisations that might have an interest in the submitted work in the previous three years. MN has received lecture or consulting fees from Abbott, Sanofi-Aventis, Itrim International, and Strategic Health Resources; research grants from Cambridge Weight Plan and Novo Nordisk; and royalty payments for co-authoring chapters in a Swedish textbook on obesity. The authors declare that they have no other relationships or activities that could appear to have influenced the submitted work.	Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Ducarme G, 2007, INT J GYNECOL OBSTET, V98, P244, DOI 10.1016/j.ijgo.2007.02.020; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Josefsson A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.025; Kjaer MM, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.046; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lesko J, 2012, OBSTET GYNECOL, V119, P547, DOI 10.1097/AOG.0b013e318239060e; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Odlind V, 2003, ACTA OBSTET GYN SCAN, V82, P516, DOI 10.1034/j.1600-0412.2003.00112.x; Patel JA, 2008, SURG OBES RELAT DIS, V4, P39, DOI 10.1016/j.soard.2007.10.008; Rao A, 2004, BEST PRACT RES CL OB, V18, P557, DOI 10.1016/j.bpobgyn.2004.04.007; Rao KR, 2012, REV ENDOCR METAB DIS, V13, P103, DOI 10.1007/s11154-012-9211-y; SFOAK, 2011, PROP NAT MED IND QUA; Singh J, 2012, J MATERN-FETAL NEO M, V25, P5, DOI 10.3109/14767058.2012.626920; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SOREG, 2012, ANN REP SOREG 2011; Stephansson O, 2001, AM J OBSTET GYNECOL, V184, P463, DOI 10.1067/mob.2001.109591; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd; Walsh SW, 2007, TRENDS ENDOCRIN MET, V18, P365, DOI 10.1016/j.tem.2007.09.003; Wax JR, 2008, OBES SURG, V18, P540, DOI 10.1007/s11695-008-9459-1; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	28	100	104	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2013	347								f6460	10.1136/bmj.f6460	http://dx.doi.org/10.1136/bmj.f6460			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FR	24222480	Green Published, hybrid			2022-12-28	WOS:000327150600001
J	Furey, TS; Sethupathy, P				Furey, Terrence S.; Sethupathy, Praveen			Genetics Driving Epigenetics	SCIENCE			English	Editorial Material							CHROMATIN; VARIANT		[Furey, Terrence S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Furey, Terrence S.; Sethupathy, Praveen] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Furey, Terrence S.; Sethupathy, Praveen] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Furey, Terrence S.; Sethupathy, Praveen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Furey, TS (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	tsfurey@email.unc.edu; praveen_sethupathy@med.unc.edu		Furey, Terry/0000-0001-5546-9672				Dodd AW, 2013, EUR J HUM GENET, V21, P517, DOI 10.1038/ejhg.2012.197; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412	9	43	43	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					705	706		10.1126/science.1246755	http://dx.doi.org/10.1126/science.1246755			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202168				2022-12-28	WOS:000326647600031
J	Owusu-Ansah, E; Song, W; Perrimon, N				Owusu-Ansah, Edward; Song, Wei; Perrimon, Norbert			Muscle Mitohormesis Promotes Longevity via Systemic Repression of Insulin Signaling	CELL			English	Article							LIFE-SPAN; MITOCHONDRIAL-FUNCTION; OXIDATIVE STRESS; PROTEIN; GROWTH; DETERMINANT; HOMEOSTASIS; MODULATION; AUTOPHAGY; HOMOLOG	Mitochondrial dysfunction is usually associated with aging. To systematically characterize the compensatory stress signaling cascades triggered in response to muscle mitochondrial perturbation, we analyzed a Drosophila model of muscle mitochondrial injury. We find that mild muscle mitochondrial distress preserves mitochondrial function, impedes the agedependent deterioration of muscle function and architecture, and prolongs lifespan. Strikingly, this effect is mediated by at least two prolongevity compensatory signaling modules: one involving a muscle-restricted redox-dependent induction of genes that regulate the mitochondrial unfolded protein response (UPR mt) and another involving the transcriptional induction of the Drosophila ortholog of insulin-like growth factor-binding protein 7, which systemically antagonizes insulin signaling and facilitates mitophagy. Given that several secreted IGFbinding proteins (IGFBPs) exist in mammals, our work raises the possibility that muscle mitochondrial injury in humans may similarly result in the secretion of IGFBPs, with important ramifications for diseases associated with aberrant insulin signaling.	[Owusu-Ansah, Edward; Song, Wei; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Owusu-Ansah, E (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	ekowuans@genetics.med.harvard.edu; perrimon@receptor.med.harvard.edu	Song, Wei/HHZ-8716-2022	Song, Wei/0000-0002-7007-5281; Perrimon, Norbert/0000-0001-7542-472X	F32 NRSA Postdoctoral Fellowship [5F32AR57291]; career Development Grant from the Muscular Dystrophy Association [202260]; Howard Hughes Medical Institute;  [AR057352]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057291, R01AR057352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	F32 NRSA Postdoctoral Fellowship; career Development Grant from the Muscular Dystrophy Association; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Rexford Ahima for critical discussions, and Eileen Furlong, Ernst Hafen, Liqun Luo, Fannis Missirlis, Linda Partridge, and David Walker for stocks and reagents. We thank the DSHB for antibodies; the BDSC, the NIG (Japan), and the TRiP for various fly strains; Christians Villalta for embryo injections; and Elizabeth Bennechi for assistance with electron microscopy. This work was supported by an F32 NRSA Postdoctoral Fellowship (5F32AR57291) and a career Development Grant from the Muscular Dystrophy Association (Award #202260) to E. O.-A., and RO1 grant #AR057352 to N. P. N. P. is an investigator of the Howard Hughes Medical Institute.	Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Bai J, 2007, DEV CELL, V13, P828, DOI 10.1016/j.devcel.2007.10.003; Berger I, 1996, CLIN CHIM ACTA, V256, P197, DOI 10.1016/S0009-8981(96)06420-0; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hollinshead M, 1997, J HISTOCHEM CYTOCHEM, V45, P1053, DOI 10.1177/002215549704500803; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Karpac J, 2011, DEV CELL, V20, P841, DOI 10.1016/j.devcel.2011.05.011; Kirchman PA, 1999, GENETICS, V152, P179; Kutsukake M, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-54; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Peternelj TT, 2011, SPORTS MED, V41, P1043, DOI 10.2165/11594400-000000000-00000; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505	39	256	258	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					699	712		10.1016/j.cell.2013.09.021	http://dx.doi.org/10.1016/j.cell.2013.09.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243023	Green Accepted, Bronze			2022-12-28	WOS:000326571800022
J	Schoggins, JW; MacDuff, DA; Imanaka, N; Gainey, MD; Shrestha, B; Eitson, JL; Mar, KB; Richardson, RB; Ratushny, AV; Litvak, V; Dabelic, R; Manicassamy, B; Aitchison, JD; Aderem, A; Elliott, RM; Garcia-Sastre, A; Racaniello, V; Snijder, EJ; Yokoyama, WM; Diamond, MS; Virgin, HW; Rice, CM				Schoggins, John W.; MacDuff, Donna A.; Imanaka, Naoko; Gainey, Maria D.; Shrestha, Bimmi; Eitson, Jennifer L.; Mar, Katrina B.; Richardson, R. Blake; Ratushny, Alexander V.; Litvak, Vladimir; Dabelic, Rea; Manicassamy, Balaji; Aitchison, John D.; Aderem, Alan; Elliott, Richard M.; Garcia-Sastre, Adolfo; Racaniello, Vincent; Snijder, Eric J.; Yokoyama, Wayne M.; Diamond, Michael S.; Virgin, Herbert W.; Rice, Charles M.			Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity	NATURE			English	Article							CYCLIC GMP-AMP; INTERFERON-STIMULATED GENES; WEST-NILE-VIRUS; FLUORESCENT PROTEIN; IN-VITRO; IDENTIFICATION; 2ND-MESSENGER; INFECTION; EFFECTORS; MICE	The type I interferon (IFN) response protects cells from viral infection by inducing hundreds of interferon-stimulated genes (ISGs), some of which encode direct antiviral effectors(1-3). Recent screening studies have begun to catalogue ISGs with antiviral activity against several RNA and DNA viruses(4-13). However, antiviral ISG specificity across multiple distinct classes of viruses remains largely unexplored. Here we used an ectopic expression assay to screen a library of more than 350 human ISGs for effects on 14 viruses representing 7 families and 11 genera. We show that 47 genes inhibit one or more viruses, and 25 genes enhance virus infectivity. Comparative analysis reveals that the screened ISGs target positive-sense single-stranded RNA viruses more effectively than negative-sense single-stranded RNA viruses. Gene clustering highlights the cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS, also known as MB21D1) as a gene whose expression also broadly inhibits several RNA viruses. In vitro, lentiviral delivery of enzymatically active cGAS triggers a STING-dependent, IRF3-mediated antiviral program that functions independently of canonical IFN/STAT1 signalling. In vivo, genetic ablation of murine cGAS reveals its requirement in the antiviral response to two DNA viruses, and an unappreciated contribution to the innate control of an RNA virus. These studies uncover new paradigms for the preferential specificity of IFN-mediated antiviral pathways spanning several virus families.	[Schoggins, John W.; Imanaka, Naoko; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [MacDuff, Donna A.; Diamond, Michael S.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gainey, Maria D.; Yokoyama, Wayne M.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Gainey, Maria D.; Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Shrestha, Bimmi; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Shrestha, Bimmi; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Eitson, Jennifer L.; Mar, Katrina B.; Richardson, R. Blake] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Ratushny, Alexander V.; Litvak, Vladimir; Aitchison, John D.; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Ratushny, Alexander V.; Aitchison, John D.] Inst Syst Biol, Seattle, WA 98109 USA; [Dabelic, Rea; Racaniello, Vincent] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Manicassamy, Balaji] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Elliott, Richard M.] Univ St Andrews, Sch Biol, St Andrews KY16 9ST, Fife, Scotland; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Snijder, Eric J.] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands	Rockefeller University; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Center for Infectious Disease Research; Institute for Systems Biology (ISB); Columbia University; University of Chicago; University of St Andrews; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.	john.schoggins@utsouthwestern.edu; ricec@rockefeller.edu	MacDuff, Donna/AAD-2786-2019; Diamond, Michael/AAH-1733-2019; Snijder, Eric J./E-6073-2018	MacDuff, Donna/0000-0002-6183-6827; Diamond, Michael/0000-0002-8791-3165; Snijder, Eric J./0000-0003-3297-2309; Mar, Katrina/0000-0003-3640-2418; Virgin, Herbert/0000-0001-8580-7628; Manicassamy, Balaji/0000-0003-1964-0967; Garcia-Sastre, Adolfo/0000-0002-6551-1827	National Institutes of Health [AI091707, AI057158, DK095031, AI057160, HHSN272200900041CU19, AI104972, AI083025, AI095611]; CEIRS [AI057160, HHSN266200700010C, GM076547, GM103511]; Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M.D. Memorial Fund;  [T32 AR007279]; MRC [G0801822] Funding Source: UKRI; Medical Research Council [G0801822] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032972, R01AI102597, R01AI104972, U54AI057158, R00AI095320, R01AI025032, T32AI005284, U19AI083025, U01AI095611, R01AI091707, U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103511, P50GM076547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CEIRS; Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M.D. Memorial Fund; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following investigators for contributing viral molecular clones or viral stocks: R. Cattaneo (MV), P. Collins (PIV3, HMPV, RSV), I Frolov (VEEV), M. Heise (SINV), S. Higgs (ONNV), P. Traktman (VV), J. L. Whitton (CVB). We thank E. Jouanguy and J.-L. Casanova for STAT1<SUP>-/-</SUP> fibroblasts. We acknowledge the support of C. Zhao, X. Wang and W. Zhang at The Rockefeller University Genomics Resource Center. We thank E. Castillo, B. Flatley, A. Webson, E. Duan and A. McLees for laboratory support, and D. Kraemalmeyer for managing mouse colonies. This work was supported in part by National Institutes of Health grants AI091707 to C.M.R., AI057158 to I. Lipkin (Northeast Biodefense Center, subcontract to C.M.R.), DK095031 to J.W.S., AI057160 to H.W.V., HHSN272200900041CU19 to M.S.D. and H.W.V., AI104972 to M. S. D., AI083025, AI095611 and CEIRS contract HHSN266200700010C to A.G-S., GM076547 and GM103511 to J.D.A. and AI057160 to W.M.Y., an investigator of the Howard Hughes Medical Institute. M.D.G. is supported by T32 AR007279. Additional funding was provided by the Greenberg Medical Research Institute, the Starr Foundation and the Ronald A. Shellow, M. D. Memorial Fund (C.M.R.).	Biacchesi S, 2004, VIROLOGY, V321, P247, DOI 10.1016/j.virol.2003.12.020; Brault AC, 2004, INSECT MOL BIOL, V13, P625, DOI 10.1111/j.0962-1075.2004.00521.x; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; del Valle JR, 2007, J VIROL, V81, P10597, DOI 10.1128/JVI.00923-07; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Feuer R, 2002, J VIROL, V76, P4430, DOI 10.1128/JVI.76.9.4430-4440.2002; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fusco DN, 2013, GASTROENTEROLOGY, V144, P1438, DOI 10.1053/j.gastro.2013.02.026; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Karki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037398; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Meng XZ, 2012, J VIROL, V86, P4538, DOI 10.1128/JVI.06140-11; Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shi XH, 2010, J VIROL, V84, P8460, DOI 10.1128/JVI.00902-10; Simmons JD, 2010, J VIROL, V84, P11429, DOI 10.1128/JVI.00577-10; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Teterina NL, 2010, J VIROL, V84, P1477, DOI 10.1128/JVI.01578-09; van den Born E, 2007, J GEN VIROL, V88, P1196, DOI 10.1099/vir.0.82590-0; Wilson SJ, 2012, CELL HOST MICROBE, V12, P585, DOI 10.1016/j.chom.2012.08.012; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zhao H, 2012, J HEPATOL, V56, P326, DOI 10.1016/j.jhep.2011.07.026	39	594	610	9	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					691	+		10.1038/nature12862	http://dx.doi.org/10.1038/nature12862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24284630	Green Accepted			2022-12-28	WOS:000330321000043
J	Keaney, JF; Curfman, GD; Jarcho, JA				Keaney, John F., Jr.; Curfman, Gregory D.; Jarcho, John A.			A Pragmatic View of the New Cholesterol Treatment Guidelines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								New ACC-AHA guidelines represent a substantial departure from previous recommendations for lipid management and may have a major effect on clinical practice. Overall, they will move treatment toward statins and deemphasize other agents for a broader range of patients. On November 12, 2013, updated guidelines for the treatment of high blood cholesterol levels were released by the American College of Cardiology-American Heart Association (ACC-AHA) Task Force on Practice Guidelines.(1) This update represents the first major guideline revision since the National Cholesterol Education Program released its Adult Treatment Panel III report in 2002.(2) The previous guidelines were widely accepted and applied with relative consistency. In contrast, the new guidelines have already been the subject of controversy, with some observers arguing that some elements of the recommendations are not evidence-based.(3) Nevertheless, these recommendations may have a major effect on the clinical ...	[Keaney, John F., Jr.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Keaney, JF (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.			Keaney, John/0000-0002-0866-1837				[Anonymous], 2013, PREV GUID TOOLS CV R; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Ridker PM, LANCET IN PRESS; Stone NJ, 2013, CIRCULATION	4	46	48	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					275	278		10.1056/NEJMms1314569	http://dx.doi.org/10.1056/NEJMms1314569			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294HK	24283199				2022-12-28	WOS:000330035600015
J	Matsuo, Y; Granneman, S; Thoms, M; Manikas, RG; Tollervey, D; Hurt, E				Matsuo, Yoshitaka; Granneman, Sander; Thoms, Matthias; Manikas, Rizos-Georgios; Tollervey, David; Hurt, Ed			Coupled GTPase and remodelling ATPase activities form a checkpoint for ribosome export	NATURE			English	Article							NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; BIOGENESIS FACTORS; ADAPTER PROTEIN; RNA-BINDING; MATURATION; SUBUNIT; ASSOCIATION; COMPLEX; KINASE	Eukaryotic ribosomes are assembled by a complex pathway that extends from the nucleolus to the cytoplasm and is powered by many energy-consuming enzymes(1-3). Nuclear export is a key, irreversible step in pre-ribosome maturation(4-8), but mechanisms underlying the timely acquisition of export competence remain poorly understood. Here we show that a conserved Saccharomyces cerevisiae GTPase Nug2 (also known as Nog2, and as NGP-1, GNL2 or nucleostemin 2 in human(9)) has a key role in the timing of export competence. Nug2 binds the inter-subunit face of maturing, nucleoplasmic pre-60S particles, and the location clashes with the position of Nmd3, a key pre-60S export adaptor(10). Nug2 and Nmd3 are not present on the same pre-60S particles, with Nug2 binding before Nmd3. Depletion of Nug2 causes premature Nmd3 binding to the pre-60S particles, whereas mutations in the G-domain of Nug2 block Nmd3 recruitment, resulting in severe 60S export defects. Two pre-60S remodelling factors, the Rea1 ATPase and its co-substrate Rsa4, are present on Nug2-associated particles, and both show synthetic lethal interactions with nug2 mutants. Release of Nug2 from pre-60S particles requires both its K+-dependent GTPase activity and the remodelling ATPase activity of Rea1. We conclude that Nug2 is a regulatory GTPase that monitors pre-60S maturation, with release from its placeholder site linked to recruitment of the nuclear export machinery.	[Matsuo, Yoshitaka; Thoms, Matthias; Manikas, Rizos-Georgios; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Granneman, Sander; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Granneman, Sander] Univ Edinburgh, Ctr Synthet & Syst Biol, Edinburgh EH9 3JD, Midlothian, Scotland	Ruprecht Karls University Heidelberg; University of Edinburgh; University of Edinburgh	Hurt, E (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni.heidelberg.de	Granneman, Sander/A-3150-2015; Tollervey, David/AAR-6662-2020; Ed Hurt, Dr./AAE-8874-2019	Granneman, Sander/0000-0003-4387-1271; Tollervey, David/0000-0003-2894-2772; Ed Hurt, Dr./0000-0002-4535-8255; Thoms, Matthias/0000-0001-8084-6097	Alexander von Humboldt Foundation; Wellcome Trust [077248]; Deutsche Forschungsgemeinschaft [DFG Hu363/10-4]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Remacha, M. Fromont- Racine, A. W. Johnson, C. Dargemont, M. Seedorf and J. Warner for antibodies. We thank the GenePool at the University of Edinburgh for performing the MiSeq sequencing, and E. Petfalski for performing the initial crosslinking experiments. We thank E. Thomson for careful reading the manuscript. This work was supported by a postdoctoral fellowship from Alexander von Humboldt Foundation to Y.M., and by the Wellcome Trust to S. G. and D. T. (077248), and by grants from the Deutsche Forschungsgemeinschaft to E. H. (DFG Hu363/10-4).	Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Ash MR, 2012, FEBS LETT, V586, P2218, DOI 10.1016/j.febslet.2012.06.030; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bassler J, 2006, J BIOL CHEM, V281, P24737, DOI 10.1074/jbc.M604261200; Bassler J, 2010, MOL CELL, V38, P712, DOI 10.1016/j.molcel.2010.05.024; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bradatsch B, 2012, NAT STRUCT MOL BIOL, V19, P1234, DOI 10.1038/nsmb.2438; Bussiere C, 2012, J CELL BIOL, V197, P747, DOI 10.1083/jcb.201112131; Chennupati V, 2011, BIOCHEMISTRY-US, V50, P4521, DOI 10.1021/bi200425b; de la Cruz J, 2005, NUCLEIC ACIDS RES, V33, P5728, DOI 10.1093/nar/gki887; Dembowski JA, 2013, NUCLEIC ACIDS RES, V41, P7889, DOI 10.1093/nar/gkt545; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; Ferreira-Cerca S, 2012, NAT STRUCT MOL BIOL, V19, P1316, DOI 10.1038/nsmb.2403; Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hung NJ, 2006, MOL CELL BIOL, V26, P3718, DOI 10.1128/MCB.26.10.3718-3727.2006; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KIKKAWA S, 1990, J BIOL CHEM, V265, P21536; Lafontaine DLJ, 2010, TRENDS BIOCHEM SCI, V35, P267, DOI 10.1016/j.tibs.2009.12.006; Lapik YR, 2007, MOL CELL BIOL, V27, P7735, DOI 10.1128/MCB.01161-07; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Lebreton A, 2006, J BIOL CHEM, V281, P27099, DOI 10.1074/jbc.M602199200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Staley JP, 2009, CURR OPIN CELL BIOL, V21, P109, DOI 10.1016/j.ceb.2009.01.003; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tsai RYL, 2009, INT J BIOCHEM CELL B, V41, P2122, DOI 10.1016/j.biocel.2009.05.020; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Vilardell J, 1997, MOL CELL BIOL, V17, P1959, DOI 10.1128/MCB.17.4.1959; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WERTHEIMER AM, 1977, BIOCHEM BIOPH RES CO, V78, P565, DOI 10.1016/0006-291X(77)90216-9; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	47	95	97	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					112	+		10.1038/nature12731	http://dx.doi.org/10.1038/nature12731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24240281	Green Accepted			2022-12-28	WOS:000329163300034
J	Abed, FH				Abed, Fazle Hasan			Bangladesh's health revolution	LANCET			English	Editorial Material									BRAC, Dhaka 1212, Bangladesh	Bangladesh Rural Advancement Committee BRAC	Abed, FH (corresponding author), BRAC, Dhaka 1212, Bangladesh.	abed.fh@brac.net						Bhuiya A, 2002, SOC SCI MED, V55, P1553, DOI 10.1016/S0277-9536(01)00287-8; BHUIYA A, 2001, CHALLENGING INEQUITI, P227; BRAC, 2000, BRAC ANN REP; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Chowdhury AMR, 2004, J INT DEV, V16, P369, DOI DOI 10.1002/JID.1083; Chowdhury AMR, 1996, SIMPLE SOLUTION; El Arifeen S, 2013, LANCET; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jonker K., 2009, STANFORD SOCIAL INNO, P74; NALIN DR, 1968, LANCET, V2, P370; Smilley I., 2009, FREEDOM WANT; The Economist, 2012, ECONOMIST	12	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2048	2049		10.1016/S0140-6736(13)62112-1	http://dx.doi.org/10.1016/S0140-6736(13)62112-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24268608				2022-12-28	WOS:000328687800012
J	Furusawa, Y; Obata, Y; Fukuda, S; Endo, TA; Nakato, G; Takahashi, D; Nakanishi, Y; Uetake, C; Kato, K; Kato, T; Takahashi, M; Fukuda, NN; Murakami, S; Miyauchi, E; Hino, S; Atarashi, K; Onawa, S; Fujimura, Y; Lockett, T; Clarke, JM; Topping, DL; Tomita, M; Hori, S; Ohara, O; Morita, T; Koseki, H; Kikuchi, J; Honda, K; Hase, K; Ohno, H				Furusawa, Yukihiro; Obata, Yuuki; Fukuda, Shinji; Endo, Takaho A.; Nakato, Gaku; Takahashi, Daisuke; Nakanishi, Yumiko; Uetake, Chikako; Kato, Keiko; Kato, Tamotsu; Takahashi, Masumi; Fukuda, Noriko N.; Murakami, Shinnosuke; Miyauchi, Eiji; Hino, Shingo; Atarashi, Koji; Onawa, Satoshi; Fujimura, Yumiko; Lockett, Trevor; Clarke, Julie M.; Topping, David L.; Tomita, Masaru; Hori, Shohei; Ohara, Osamu; Morita, Tatsuya; Koseki, Haruhiko; Kikuchi, Jun; Honda, Kenya; Hase, Koji; Ohno, Hiroshi			Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells	NATURE			English	Article							ARABIDOPSIS-THALIANA; METABOLIC DYNAMICS; GUT MICROBIOTA; INHIBITION; COLONIZATION; INFLAMMATION; RECEPTORS; RESPONSES; COLITIS; SUBSETS	Gut commensal microbes shape the mucosal immune system by regulating the differentiation and expansion of several types of T cell(1-5). Clostridia, a dominant class of commensal microbe, can induce colonic regulatory T (T-reg) cells, which have a central role in the suppression of inflammatory and allergic responses(3). However, the molecular mechanisms by which commensal microbes induce colonic T-reg cells have been unclear. Here we show that a large bowel microbial fermentation product, butyrate, induces the differentiation of colonic T-reg cells in mice. A comparative NMR-based metabolome analysis suggests that the luminal concentrations of short-chain fatty acids positively correlates with the number of T-reg cells in the colon. Among short-chain fatty acids, butyrate induced the differentiation of T-reg cells in vitro and in vivo, and ameliorated the development of colitis induced by adoptive transfer of CD4(+) CD45RB(hi) T cells in Rag1(-/-) mice. Treatment of naive T cells under the T-reg-cell-polarizing conditions with butyrate enhanced histone H3 acetylation in the promoter and conserved non-coding sequence regions of the Foxp3 locus, suggesting a possible mechanism for how microbial-derived butyrate regulates the differentiation of T-reg cells. Our findings provide new insight into the mechanisms by which host-microbe interactions establish immunological homeostasis in the gut.	[Furusawa, Yukihiro; Obata, Yuuki; Fukuda, Shinji; Endo, Takaho A.; Nakato, Gaku; Takahashi, Daisuke; Uetake, Chikako; Kato, Keiko; Kato, Tamotsu; Takahashi, Masumi; Miyauchi, Eiji; Atarashi, Koji; Onawa, Satoshi; Hori, Shohei; Ohara, Osamu; Koseki, Haruhiko; Honda, Kenya; Hase, Koji; Ohno, Hiroshi] RIKEN Ctr Integrat Med Sci IMS RCAI, Wako, Kanagawa 2300045, Japan; [Furusawa, Yukihiro; Obata, Yuuki; Fujimura, Yumiko; Hase, Koji] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Obata, Yuuki; Koseki, Haruhiko; Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Chiba 2608670, Japan; [Fukuda, Shinji; Nakanishi, Yumiko; Fukuda, Noriko N.; Murakami, Shinnosuke; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Kato, Keiko; Koseki, Haruhiko; Kikuchi, Jun] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 2300045, Japan; [Hino, Shingo] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan; [Atarashi, Koji; Hase, Koji] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Lockett, Trevor; Clarke, Julie M.; Topping, David L.] CSIRO Food & Nutr Sci, Preventat Hlth Natl Res Flagship, Adelaide, SA 5000, Australia; [Kikuchi, Jun] RIKEN Ctr Sustainable Resource Sci, Kanagawa 2300045, Japan; [Honda, Kenya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; Chiba University; Keio University; Yokohama City University; Shizuoka University; Japan Science & Technology Agency (JST); Commonwealth Scientific & Industrial Research Organisation (CSIRO); RIKEN; Japan Science & Technology Agency (JST)	Ohno, H (corresponding author), RIKEN Ctr Integrat Med Sci IMS RCAI, Wako, Kanagawa 2300045, Japan.	sfukuda@sfc.keio.ac.jp; hase@ims.u-tokyo.ac.jp; ohno@rcai.riken.jp	Kikuchi, Jun/O-4725-2019; Koseki, Haruhiko/I-3825-2014; Endo, Takaho/B-5763-2017; Clarke, Julie M/H-6762-2013; Hori, Shohei/O-6163-2019; Atarashi, Koji/I-5363-2014; Lockett, Trevor J/H-8970-2013; topping, david l/H-7969-2013; Ohno, Hiroshi/L-7899-2014; Takahashi, Daisuke/C-3799-2019; Honda, Kenya/N-5297-2015; Ohara, Osamu/G-5448-2015; Kikuchi, Jun/M-5512-2015	Kikuchi, Jun/0000-0002-6809-394X; Koseki, Haruhiko/0000-0001-8424-5854; Endo, Takaho/0000-0002-2801-2463; Clarke, Julie M/0000-0003-4676-0366; Hori, Shohei/0000-0001-8770-4593; Atarashi, Koji/0000-0001-5422-0736; Lockett, Trevor J/0000-0002-8063-071X; topping, david l/0000-0002-8481-9384; Ohno, Hiroshi/0000-0001-8776-9661; Takahashi, Daisuke/0000-0001-8624-1160; Ohara, Osamu/0000-0002-3328-9571; Kikuchi, Jun/0000-0002-6809-394X; Fukuda, Shinji/0000-0001-5161-9880; Murakami, Shinnosuke/0000-0002-1101-9255; Kato, Tamotsu/0000-0002-8407-4327; Hase, Koji/0000-0001-9550-2334; Obata, Yuuki/0000-0001-5461-3521; HINO, Shingo/0000-0003-2644-2301	Japanese Ministry of Education, Culture, Sports, Science and Technology [24117524, 21022049, 20113003]; The Japan Society for the Promotion of Science [24890293, 252667, 24380072, 24658129, 22689017, 21390155]; The Japan Science and Technology Agency; RIKEN; RIKEN RCAI Young Chief Investigator program; Institute for Fermentation, Osaka; Mishima Kaiun Memorial Foundation; The Takeda Science Foundation; The Mitsubishi Foundation; The Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [24117524, 24117723] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); The Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); RIKEN; RIKEN RCAI Young Chief Investigator program; Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); The Takeda Science Foundation(Takeda Science Foundation (TSF)); The Mitsubishi Foundation; The Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank P. Carninci, Y. Shinkai and M. Yoshida for discussion; Y. Chiba and S. Yamada for technical support; H. Sugahara for technical advice; and P. D. Burrows for critical reading and editing of the manuscript. This work was supported in part by grants from Japanese Ministry of Education, Culture, Sports, Science and Technology (24117524 to S. F.; 21022049 to K. Ha.; 20113003 to H.O.), The Japan Society for the Promotion of Science (24890293 to Y. F.; 252667 to Y.O.; 24380072 and 24658129 to S. F.; 22689017 to K. Ha.; 21390155 to H.O.), The Japan Science and Technology Agency (K. Ha., K. A. and K. Ho.), RIKEN President's Special Research Grant (H.O.), RIKEN RCAI Young Chief Investigator program (K. Ha.), the Institute for Fermentation, Osaka (S. F.), the Mishima Kaiun Memorial Foundation (S. F.), The Takeda Science Foundation (S. F. and H.O.), The Mitsubishi Foundation (H.O.), and The Uehara Memorial Foundation (S. F. and K.Ha.).	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Annison G, 2003, J NUTR, V133, P3523, DOI 10.1093/jn/133.11.3523; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Date Y, 2010, J BIOSCI BIOENG, V110, P87, DOI 10.1016/j.jbiosc.2010.01.004; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Furusawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029012; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; ITOH K, 1985, LAB ANIM, V19, P111, DOI 10.1258/002367785780942589; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kruger NJ, 2008, NAT PROTOC, V3, P1001, DOI 10.1038/nprot.2008.64; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Morita T, 1998, J NUTR, V128, P1156, DOI 10.1093/jn/128.7.1156; Obata Y, 2012, J IMMUNOL, V188, P2427, DOI 10.4049/jimmunol.1101128; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sannasiddappa TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023227; SCHEPPACH W, 1992, GASTROENTEROLOGY, V103, P51, DOI 10.1016/0016-5085(92)91094-K; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thibault R, 2007, GASTROENTEROLOGY, V133, P1916, DOI 10.1053/j.gastro.2007.08.041; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	50	2785	2920	41	528	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					446	+		10.1038/nature12721	http://dx.doi.org/10.1038/nature12721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24226770				2022-12-28	WOS:000328575300054
J	Zumla, A; George, A; Sharma, V; Herbert, N; Masham, B				Zumla, Alimuddin; George, Andrew; Sharma, Virendra; Herbert, Nick; Masham, Baroness			WHO's 2013 global report on tuberculosis: successes, threats, and opportunities	LANCET			English	Editorial Material							DIAGNOSTICS; CHALLENGES		[Zumla, Alimuddin] UCL, Div Infect & Immun, London NW3 2PF, England; [Zumla, Alimuddin] Univ Coll London Hosp NHS Fdn Trust, London NW3 2PF, England; [George, Andrew; Sharma, Virendra; Herbert, Nick; Masham, Baroness] Houses Parliament, All Party Parliamentary Grp Global TB, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Zumla, A (corresponding author), UCL, Div Infect & Immun, UCL Royal Free Campus, London NW3 2PF, England.	a.zumla@ucl.ac.uk	Oliveira, Claudia DL/G-8618-2011; ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735				Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, MDG 6 COMB HIV AIDS; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	10	153	164	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1765	1767		10.1016/S0140-6736(13)62078-4	http://dx.doi.org/10.1016/S0140-6736(13)62078-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24269294				2022-12-28	WOS:000327540700010
J	Prieto-Merino, D; Smeeth, L; van Staa, TP; Roberts, I				Prieto-Merino, David; Smeeth, Liam; van Staa, Tjeerd P.; Roberts, Ian			Dangers of non-specific composite outcome measures in clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							END-POINTS		[Prieto-Merino, David; Roberts, Ian] London Sch Hyg & Trop Med, Clin Trials Unit, London WC1E 7HT, England; [Smeeth, Liam; van Staa, Tjeerd P.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [van Staa, Tjeerd P.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Utrecht University	Prieto-Merino, D (corresponding author), London Sch Hyg & Trop Med, Clin Trials Unit, London WC1E 7HT, England.	david.prieto@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Prieto-Merino, David/0000-0001-5001-0061; Smeeth, Liam/0000-0002-9168-6022; van Staa, Tjeerd/0000-0001-9363-742X	National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Cockburn J, 2012, HEART, V98, P1431, DOI 10.1136/heartjnl-2012-302211; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; CRASH-2 Collaborators, 2010, LANCET, V376, P1; European Network for Health Technology Assessment, 2013, ENDP US REA PHARM CO; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Ferreira-Gonzalez I, 2007, J CLIN EPIDEMIOL, V60, p[651, 658]; Ferreira-Gonzalez I, 2007, J CLIN EPIDEMIOL, V60, P660, DOI 10.1016/j.jclinepi.2006.10.021; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Freemantle N, 2007, J CLIN EPIDEMIOL, V60, P658, DOI 10.1016/j.jclinepi.2006.10.024; ICH Expert Working Group, 1998, TECHNICAL REPORT; Kessler KM, 2003, CIRCULATION, V107, pE70, DOI 10.1161/01.CIR.0000057824.54126.67; Lubsen J, 2002, STAT MED, V21, P2959, DOI 10.1002/sim.1300; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; RODGERS A, 1995, THROMB HAEMOSTASIS, V73, P167; Rothman KJ., 2012, MODERN EPIDEMIOLOGY, V3rd	17	21	21	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2013	347								f6782	10.1136/bmj.f6782	http://dx.doi.org/10.1136/bmj.f6782			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KZ	24270506	Bronze, Green Accepted			2022-12-28	WOS:000327459500002
J	Head, SJ; Kaul, S; Tijssen, JGP; Serruys, PW; Kappetein, AP				Head, Stuart J.; Kaul, Sanjay; Tijssen, Jan G. P.; Serruys, Patrick W.; Kappetein, A. Pieter			Subgroup Analyses in Trial Reports Comparing Percutaneous Coronary Intervention With Coronary Artery Bypass Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Head, Stuart J.; Kappetein, A. Pieter] Erasmus Univ, Med Ctr, Dept Cardiothorac Surg, NL-3000 CA Rotterdam, Netherlands; [Kaul, Sanjay] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA; [Tijssen, Jan G. P.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Tijssen, Jan G. P.] Univ Amsterdam, Amsterdam, Netherlands; [Serruys, Patrick W.] Erasmus Univ, Med Ctr, Dept Cardiol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Cedars Sinai Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Erasmus University Rotterdam; Erasmus MC	Kappetein, AP (corresponding author), Erasmus Univ, Med Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.kappetein@erasmusmc.nl						Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Kolh P, 2010, EUR J CARDIO-THORAC, V38, pS1, DOI 10.1016/j.ejcts.2010.08.019; Pocock S, 2013, EUR HEART J, V34, P1846, DOI 10.1093/eurheartj/eht071; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003	6	12	12	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2097	2098		10.1001/jama.2013.281630	http://dx.doi.org/10.1001/jama.2013.281630			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240937	Bronze			2022-12-28	WOS:000327098900026
J	Ballew, KA				Ballew, Kenneth A.			Combined vasopressin, steroids, and epinephrine improved survival in in-hospital cardiac arrest	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Virginia, Charlottesville, VA 22903 USA	University of Virginia	Ballew, KA (corresponding author), Univ Virginia, Charlottesville, VA 22903 USA.							Gueugniaud PY, 2008, NEW ENGL J MED, V359, P21, DOI 10.1056/NEJMoa0706873; Mentzelopoulos SD, 2009, ARCH INTERN MED, V169, P15, DOI 10.1001/archinternmed.2008.509	2	2	2	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10							JC4	10.7326/0003-4819-159-10-201311190-02004	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247694				2022-12-28	WOS:000328732700003
J	Cho, H; Klabunde, CN; Yabroff, KR; Wang, ZQ; Meekins, A; Lansdorp-Vogelaar, I; Mariotto, AB				Cho, Hyunsoon; Klabunde, Carrie N.; Yabroff, K. Robin; Wang, Zhuoqiao; Meekins, Angela; Lansdorp-Vogelaar, Iris; Mariotto, Angela B.			Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening Strategies	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICARE CLAIMS; CERVICAL-CANCER; SURVIVAL; BREAST; GUIDELINES; MODEL	Background: Many guidelines recommend considering health status and life expectancy when making cancer screening decisions for elderly persons. Objective: To estimate life expectancy for elderly persons without a history of cancer, taking into account comorbid conditions. Design: Population-based cohort study. Setting: A 5% sample of Medicare beneficiaries in selected geographic areas, including their claims and vital status information. Participants: Medicare beneficiaries aged 66 years or older between 1992 and 2005 without a history of cancer (n = 407 749). Measurements: Medicare claims were used to identify comorbid conditions included in the Charlson index. Survival probabilities were estimated by comorbidity group (no, low/medium, and high) and for the 3 most prevalent conditions (diabetes, chronic obstructive pulmonary disease, and congestive heart failure) by using the Cox proportional hazards model. Comorbidity-adjusted life expectancy was calculated based on comparisons of survival models with U. S. life tables. Survival probabilities from the U. S. life tables providing the most similar survival experience to the cohort of interest were used. Results: Persons with higher levels of comorbidity had shorter life expectancies, whereas those with no comorbid conditions, including very elderly persons, had favorable life expectancies relative to an average person of the same chronological age. The estimated life expectancy at age 75 years was approximately 3 years longer for persons with no comorbid conditions and approximately 3 years shorter for those with high comorbidity relative to the average U. S. population. Limitations: The cohort was limited to Medicare fee-for-service beneficiaries aged 66 years or older living in selected geographic areas. Data from the Surveillance, Epidemiology, and End Results cancer registry and Medicare claims lack information on functional status and severity of comorbidity, which might influence life expectancy in elderly persons. Conclusion: Life expectancy varies considerably by comorbidity status in elderly persons. Comorbidity-adjusted life expectancy may help physicians tailor recommendations for stopping or continuing cancer screening for individual patients.	NCI, Bethesda, MD 20892 USA; Informat Serv Management, Calverton, MD USA; Erasmus MC, Rotterdam, Netherlands	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Erasmus University Rotterdam; Erasmus MC	Cho, H (corresponding author), NCI, Data Modeling Branch, Surveillance Res Program, Div Canc Control & Populat Sci, 9609 Med Ctr Dr, Bethesda, MD 20892 USA.	hyunsoon.cho@nih.gov		Yabroff, K. Robin/0000-0003-0644-5572	National Cancer Institute at the National Institutes of Health; Centers for Disease Control [U01-CA-152959 and U01 CA152926]	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study received no external funding. Dr. Lansdorp-ogelaar was supported by the National Cancer Institute at the National Institutes of Health and the Centers for Disease Control (grants U01-CA-152959 and U01 CA152926.	Amer Geriatrics Soc Ethics Comm, 2003, J AM GERIATR SOC, V51, P270; American Medical Association, 2004, CPT 2005 CURR PROC T; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], 2011, Obstet Gynecol, V118, P372, DOI 10.1097/AOG.0b013e31822c98e5; Arias Elizabeth, 2008, Natl Vital Stat Rep, V57, P1; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cho H, 2013, AM J EPIDEMIOL, V178, P339, DOI 10.1093/aje/kws580; Chow E, 2005, INT J RADIAT ONCOL, V61, P870, DOI 10.1016/j.ijrobp.2004.07.697; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Feuer EJ, 2012, CANCER-AM CANCER SOC, V118, P5652, DOI 10.1002/cncr.27615; FORSTER LE, 1988, ARCH INTERN MED, V148, P2540, DOI 10.1001/archinte.148.12.2540; Gill TM, 2012, JAMA-J AM MED ASSOC, V307, P199, DOI 10.1001/jama.2011.1992; Howard DH, 2005, J HEALTH ECON, V24, P891, DOI 10.1016/j.jhealeco.2005.03.002; Jeldres Claudio, 2009, Curr Opin Support Palliat Care, V3, P166, DOI 10.1097/SPC.0b013e32832e9c80; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2006, MED CARE, V44, P921, DOI 10.1097/01.mlr.0000223480.52713.b9; Klabunde CN, 2002, MED CARE, V40, P26; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lamarca R, 1998, J GERONTOL A-BIOL, V53, pM337, DOI 10.1093/gerona/53A.5.M337; Lansdorp-Vogelaar I, 2012, INT CANC SCREEN NETW; Lantz PM, 2005, J GEN INTERN MED, V20, P552, DOI 10.1111/j.1525-1497.2005.41012.x; Mandelblatt JS, 2005, J GEN INTERN MED, V20, P487, DOI 10.1111/j.1525-1497.2005.0116.x; Mariotto AB, 2013, J CLIN EPIDEMIOL; MCBEAN AM, 1994, CANCER, V73, P2417, DOI 10.1002/1097-0142(19940501)73:9<2417::AID-CNCR2820730927>3.0.CO;2-L; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; Therneau TM, 2000, MODELING SURVIVAL DA; U.S. Public Health Service, 2003, INT CLASS DIS; Walter LC, 2005, AM J MED, V118, P1078, DOI 10.1016/j.amjmed.2005.01.063; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; WARDLE J, 1992, J PSYCHOSOM RES, V36, P609, DOI 10.1016/0022-3999(92)90051-3; Warren JL, 2002, MED CARE, V40, P3	39	111	112	2	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10					667	+		10.7326/0003-4819-159-10-201311190-00005	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-00005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	276FB	24247672				2022-12-28	WOS:000328732700015
J	Chatterjee, P				Chatterjee, Patralekha			India's deadly roads	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		National Qualifications Authority, 2012, ACC DEATHS SUIC IND, P10; Rajasekaran S., ALARMING FACTS ROAD; World Health Organization, 2013, GLOB STAT REP ROAD S	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2013	347								f6912	10.1136/bmj.f6912	http://dx.doi.org/10.1136/bmj.f6912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258JQ	24247073				2022-12-28	WOS:000327455900008
J	Barnes, JA; Abramson, JS; Scott, JA; Sohani, AR				Barnes, Jeffrey A.; Abramson, Jeremy S.; Scott, James A.; Sohani, Aliyah R.			Case 35-2013: A 77-Year-Old Man with Confusion and Malaise	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL LYMPHOMA; CLINICAL-FEATURES; BURKITTS-LYMPHOMA; ADULT BURKITT; CODOX-M/IVAC; T-CELL; REARRANGEMENTS; T(14/18); MYC; IMMUNOPHENOTYPE		[Barnes, Jeffrey A.; Abramson, Jeremy S.] Massachusetts Gen Hosp, Div Hematol & Oncol, Dept Med, Boston, MA 02114 USA; [Scott, James A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Barnes, Jeffrey A.; Abramson, Jeremy S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Scott, James A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sohani, Aliyah R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Barnes, JA (corresponding author), Massachusetts Gen Hosp, Div Hematol & Oncol, Dept Med, Boston, MA 02114 USA.		Abramson, Jeremy/N-5178-2019					Abramson JS, 2010, CANCER-AM CANCER SOC, V116, P4283, DOI 10.1002/cncr.25278; Abramson JS, 2012, ANN M AM SOC HEM ATL; Akyurek N, 2012, CANCER-AM CANCER SOC, V118, P4173, DOI 10.1002/cncr.27396; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Barnes JA, 2011, ANN ONCOL, V22, P1859, DOI 10.1093/annonc/mdq677; Blum KA, 2004, BLOOD, V104, P3009, DOI 10.1182/blood-2004-02-0405; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Johnson NA, 2009, BLOOD, V114, P2273, DOI 10.1182/blood-2009-03-212191; Le Gouill S, 2007, HAEMATOLOGICA, V92, P1335, DOI 10.3324/haematol.11305; Leoncini L, 2008, WHO CLASSIFICATION T, P262; Li SY, 2012, MODERN PATHOL, V25, P145, DOI 10.1038/modpathol.2011.147; Lin P, 2007, HAEMATOLOGICA, V92, P1297, DOI 10.3324/haematol.11263; Macpherson N, 1999, J CLIN ONCOL, V17, P1558, DOI 10.1200/JCO.1999.17.5.1558; Mead GM, 2008, BLOOD, V112, P2248, DOI 10.1182/blood-2008-03-145128; Moller MB, 2004, BRIT J HAEMATOL, V124, P151, DOI 10.1046/j.1365-2141.2003.04749.x; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Niitsu N, 2009, LEUKEMIA, V23, P777, DOI 10.1038/leu.2008.344; Phillips AA, 2010, CANCER-AM CANCER SOC, V116, P3438, DOI 10.1002/cncr.25147; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Sohani Aliyah R, 2010, Surg Pathol Clin, V3, P1035, DOI 10.1016/j.path.2010.09.010; Swerdlow SH, 2008, WHO CLASSIFICATION T, P265; Thomas DA, 2006, CANCER-AM CANCER SOC, V106, P1569, DOI 10.1002/cncr.21776; Tomita N, 2009, HAEMATOL-HEMATOL J, V94, P935, DOI 10.3324/haematol.2008.005355; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558	26	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1946	1957		10.1056/NEJMcpc1209274	http://dx.doi.org/10.1056/NEJMcpc1209274			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300MP	24224628				2022-12-28	WOS:000330468300012
J	May, M				May, Mike			The Spine	NATURE			English	Editorial Material																			0	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S1	S1		10.1038/503S1a	http://dx.doi.org/10.1038/503S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24226998	Bronze			2022-12-28	WOS:000326894200001
J	Moojen, WA; Arts, MP; Jacobs, WCH; van Zwet, EW; van den Akker-van Marle, ME; Koes, BW; Vleggeert-Lankamp, CLAM; Peul, WC				Moojen, Wouter A.; Arts, Mark P.; Jacobs, Wilco C. H.; van Zwet, Erik W.; van den Akker-van Marle, M. Elske; Koes, Bart W.; Vleggeert-Lankamp, Carmen L. A. M.; Peul, Wilco C.		Leiden-The Hague Spine Interventio	Interspinous process device versus standard conventional surgical decompression for lumbar spinal stenosis: randomized controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEUROGENIC INTERMITTENT CLAUDICATION; MCGILL PAIN QUESTIONNAIRE; SHUTTLE WALKING TEST; X-STOP DEVICE; BACK-PAIN; NONOPERATIVE TREATMENT; NATURAL-HISTORY; OUTCOME MEASURE; HEALTH-STATUS; SURGERY	Objective To assess whether interspinous process device implantation is more effective in the short term than conventional surgical decompression for patients with intermittent neurogenic claudication due to lumbar spinal stenosis. Design Randomized controlled trial. Setting Five neurosurgical centers (including one academic and four secondary level care centers) in the Netherlands. Participants 203 participants were referred to the Leiden-The Hague Spine Prognostic Study Group between October 2008 and September 2011; 159 participants with intermittent neurogenic claudication due to lumbar spinal stenosis at one or two levels with an indication for surgery were randomized. Interventions 80 participants received an interspinous process device and 79 participants underwent spinal bony decompression. Main outcome measures The primary outcome at short term (eight weeks) and long term (one year) follow-up was the Zurich Claudication Questionnaire score. Repeated measurements were made to compare outcomes over time. Results At eight weeks, the success rate according to the Zurich Claudication Questionnaire for the interspinous process device group (63%, 95% confidence interval 51% to 73%) was not superior to that for standard bony decompression (72%, 60% to 81%). No differences in disability (Zurich Claudication Questionnaire; P=0.44) or other outcomes were observed between groups during the first year. The repeat surgery rate in the interspinous implant group was substantially higher (n=21; 29%) than that in the conventional group (n=6; 8%) in the early post-surgical period (P<0.001). Conclusions This double blinded study could not confirm the hypothesized short term advantage of interspinous process device over conventional "simple" decompression and even showed a fairly high reoperation rate after interspinous process device implantation.	[Moojen, Wouter A.; Jacobs, Wilco C. H.; Vleggeert-Lankamp, Carmen L. A. M.; Peul, Wilco C.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Moojen, Wouter A.; Arts, Mark P.; Peul, Wilco C.] Med Ctr Haaglanden, Dept Neurosurg, The Hague, Netherlands; [van Zwet, Erik W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Rotterdam, Netherlands; [van den Akker-van Marle, M. Elske] Leiden Univ, Med Ctr, Dept Med Decis Making, Rotterdam, Netherlands; [Koes, Bart W.] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Moojen, WA (corresponding author), Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands.	w.a.moojen@lumc.nl	Koes, Bart w/K-4614-2016; Vleggeert-Lankamp, Carmen/AGX-9660-2022	Koes, Bart w/0000-0002-0450-9969; Vleggeert-Lankamp, Carmen/0000-0001-9597-7225; van den Akker-van Marle, M. Elske/0000-0002-5269-509X	Paradigm Spine	Paradigm Spine	Paradigm Spine funded this trial. Paradigm Spine had no role in data collection, design of the study, data analysis, interpretation of data, or writing the report and had no influence over whether to submit the manuscript. All the researchers were individually independent from funders.	Airaksinen O, 1996, Eur Spine J, V5, P193, DOI 10.1007/BF00395513; Arts MP, 2009, JAMA-J AM MED ASSOC, V302, P149, DOI 10.1001/jama.2009.972; Bartels RHMA, 2007, J NEUROSURG-SPINE, V6, P620, DOI 10.3171/spi.2007.6.6.19; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Carragee EJ, 2010, JAMA-J AM MED ASSOC, V303, P1309, DOI 10.1001/jama.2010.402; Chiu John C, 2006, Surg Technol Int, V15, P265; Davis RJ, 2013, SPINE, V38, P1529, DOI 10.1097/BRS.0b013e31829a6d0a; Deyo RA, 2004, NEW ENGL J MED, V350, P722, DOI 10.1056/NEJMsb031771; DEYO RA, 1986, SPINE, V11, P28, DOI 10.1097/00007632-198601000-00008; DEYO RA, 1995, MED CARE, V33, pAS286; Deyo RA, 2010, SPINE J, V10, P625, DOI 10.1016/j.spinee.2010.05.006; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Eichholz DM, 2006, NAT CLIN PRACT NEURO, V2, P22, DOI 10.1038/ncpneuro0092; EVANS JG, 1964, BMJ-BRIT MED J, V2, P985, DOI 10.1136/bmj.2.5415.985; Fox M W, 1997, Neurosurg Focus, V3, pe4; Fox MW, 1996, J NEUROSURG, V85, P793, DOI 10.3171/jns.1996.85.5.0793; GIBSON JN, 2000, COCHRANE DB SYST REV; Gibson JNA, 2005, SPINE, V30, P2312, DOI 10.1097/01.brs.0000182315.88558.9c; HANRAETS P R, 1953, Folia Psychiatr Neurol Neurochir Neerl, V56, P3; Hutchinson PJA, 2000, BRIT J NEUROSURG, V14, P195; Ishimoto Y, 2012, OSTEOARTHR CARTILAGE, V20, P1103, DOI 10.1016/j.joca.2012.06.018; JOHNSSON KE, 1991, SPINE, V16, P615, DOI 10.1097/00007632-199106000-00003; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Kondrashov DG, 2006, J SPINAL DISORD TECH, V19, P323, DOI 10.1097/01.bsd.0000211294.67508.3b; Lee JB, 2004, J SPINAL DISORD TECH, V17, P72, DOI 10.1097/00024720-200402000-00013; Liu Jin, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P693; MAIN CJ, 1992, SPINE, V17, P42, DOI 10.1097/00007632-199201000-00007; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; Mariottini A, 2005, ACT NEUR S, V92, P129; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Melzack R, 2005, ANESTHESIOLOGY, V103, P199, DOI 10.1097/00000542-200507000-00028; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Moojen WA, 2011, EUR SPINE J, V20, P1596, DOI 10.1007/s00586-011-1873-8; Moojen WA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-100; Oppenheimer JH, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.7.FOCUS09121; Park SC, 2009, J KOREAN NEUROSURG S, V46, P292, DOI 10.3340/jkns.2009.46.4.292; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Pratt RK, 2002, SPINE, V27, P84, DOI 10.1097/00007632-200201010-00020; Rabe-Jablonska J, 1994, Psychiatr Pol, V28, P255; Richter A, 2012, J SPINAL DISORD TECH; Richter A, 2010, EUR SPINE J, V19, P283, DOI 10.1007/s00586-009-1229-9; ROLAND M, 1983, SPINE, V8, P145, DOI 10.1097/00007632-198303000-00005; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Schoppink LEM, 1996, PHYS THER, V76, P268, DOI 10.1093/ptj/76.3.268; Senegas J, 1991, Acta Orthop Belg, V57 Suppl 1, P221; Siddiqui M, 2006, J SPINAL DISORD TECH, V19, P328, DOI 10.1097/01.bsd.0000211297.52260.d5; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Sobottke R, 2009, EUR SPINE J, V18, P1494, DOI 10.1007/s00586-009-1081-y; Stromqvist BH, 2013, SPINE, V38, P1436, DOI 10.1097/BRS.0b013e31828ba413; Stucki G, 1996, SPINE, V21, P796, DOI 10.1097/00007632-199604010-00004; STUCKI G, 1995, J CLIN EPIDEMIOL, V48, P1369, DOI 10.1016/0895-4356(95)00054-2; Talwar V, 2006, EUR SPINE J, V15, P908, DOI 10.1007/s00586-005-0891-9; Thome C, 2005, J NEUROSURG-SPINE, V3, P129, DOI 10.3171/spi.2005.3.2.0129; Tsai Kai-Jow, 2006, J Surg Orthop Adv, V15, P167; Tuli SK, 2006, SPINE, V31, P1276, DOI 10.1097/01.brs.0000217615.20018.6c; TURNER JA, 1992, SPINE, V17, P1, DOI 10.1097/00007632-199201000-00001; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; VERBIEST H, 1954, J BONE JOINT SURG BR, V36, P230, DOI 10.1302/0301-620X.36B2.230; VERBIEST H, 1950, Ned Tijdschr Geneeskd, V94, P2415; VERBIEST H, 1951, Ned Tijdschr Geneeskd, V95, P1965; Verhoof OJ, 2008, EUR SPINE J, V17, P188, DOI 10.1007/s00586-007-0492-x; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302; Weinstein JN, 2009, J BONE JOINT SURG AM, V91A, P1295, DOI 10.2106/JBJS.H.00913; Wilke HJ, 2008, EUR SPINE J, V17, P1049, DOI 10.1007/s00586-008-0657-2; Zucherman JF, 2005, SPINE, V30, P1351, DOI 10.1097/01.brs.0000166618.42749.d1; Zucherman JF, 2004, EUR SPINE J, V13, P22, DOI 10.1007/s00586-003-0581-4	71	59	65	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 14	2013	347								f6415	10.1136/bmj.f6415	http://dx.doi.org/10.1136/bmj.f6415			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254HF	24231273	Green Published, hybrid			2022-12-28	WOS:000327155000001
J	Spong, CY				Spong, Catherine Y.			New Definition of Term Pregnancy Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							LATE-PRETERM; RISK		[Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Spong, CY (corresponding author), NICHHD, 6100 Execut Blvd,Room 4B03,MSC 7510, Bethesda, MD 20892 USA.	spongc@mail.nih.gov						Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Melamed N, 2009, OBSTET GYNECOL, V114, P253, DOI 10.1097/AOG.0b013e3181af6931; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Reddy UM, 2011, OBSTET GYNECOL, V117, P1279, DOI 10.1097/AOG.0b013e3182179e28; Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267	6	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1986	1987		10.1001/jama.2013.277999	http://dx.doi.org/10.1001/jama.2013.277999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219959				2022-12-28	WOS:000326832900028
J	Doshi, P				Doshi, Peter			HIDDEN DATA Putting GlaxoSmithKline to the test over paroxetine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-TRIALS; MAJOR DEPRESSION					pdoshi@bmj.com						[Anonymous], 2013, FOX BUSINESS    1010; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; GlaxoSmithKline, DAT SHAR AGR; Hawkes N., 2013, BMJ-BRIT MED J, V347, pf5390; Jureidini J, 2003, J AM ACAD CHILD PSY, V42, P514, DOI 10.1097/01.CHI.0000046825.95464.DA; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f819; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Newman M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6985; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541; Olfson M, 2008, ARCH GEN PSYCHIAT, V65, P94, DOI 10.1001/archgenpsychiatry.2007.5; Shannon J., 2013, HUFFINGTON POST; US Department of Justice, 2012, GLAXOSMITHKLINE PLEA; Vallance P, 2013, LANCET, V382, P1073, DOI 10.1016/S0140-6736(13)62001-2; Zito JM, 2002, PEDIATRICS, V109, P721, DOI 10.1542/peds.109.5.721	16	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2013	347								f6754	10.1136/bmj.f6754	http://dx.doi.org/10.1136/bmj.f6754			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FR	24222673				2022-12-28	WOS:000327150600014
J	Davies, SC; Lemer, C; Strelitz, J; Weil, L				Davies, Sally C.; Lemer, Claire; Strelitz, Jason; Weil, Leonora			Our children deserve better: prevention pays	LANCET			English	Editorial Material									[Davies, Sally C.] Dept Hlth, Off Chief Med Officer, London SE1 6TE, England; [Lemer, Claire] Evelina London Childrens Hosp, London SE1 7EH, England; [Strelitz, Jason; Weil, Leonora] London Deanery, London, England		Lemer, C (corresponding author), Evelina London Childrens Hosp, London SE1 7EH, England.	claire.lemer@gstt.nhs.uk						[Anonymous], 2010, FAIR SOCIETY HEALTHY; BMA Board of Science, 2013, GROWING UP IN THE UK; Brooks F, 2011, HBSC ENGLAND NATIONA; Davies SC., 2013, ANNUAL REPORT OF THE; Department of Health, CHILDREN AND YOUNG P; Health England, 2009, HEALTH ENGLAND REPOR; Heckman JJ, 2010, J PUBLIC ECON, V94, P114, DOI 10.1016/j.jpubeco.2009.11.001; Kennedy I., 2010, GETTING IT RIGHT FOR; Lopez Vilaplana C., 2013, CHILDREN AT RISK OF; National Audit Office, 2013, EARLY ACTION LANDSCA; National Children's Bureau, 2013, GREATER EXPECTATIONS; National Paediatric Diabetes Audit Project Board Royal College of Paediatrics and Child Health, 2012, NATIONAL PAEDIATRIC; Spencer N., 2013, ARCH DIS CHILD, DOI [10.1136/archdischild-304347, DOI 10.1136/ARCHDISCHILD-304347]; Wolfe I, 2013, LANCET, V381, P1224, DOI 10.1016/S0140-6736(12)62085-6	14	32	32	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1383	1384		10.1016/S0140-6736(13)62004-8	http://dx.doi.org/10.1016/S0140-6736(13)62004-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242JW	24243121				2022-12-28	WOS:000326237500004
J	Fanucchi, S; Shibayama, Y; Burd, S; Weinberg, MS; Mhlanga, MM				Fanucchi, Stephanie; Shibayama, Youtaro; Burd, Shaun; Weinberg, Marc S.; Mhlanga, Musa M.			Chromosomal Contact Permits Transcription between Coregulated Genes	CELL			English	Article							RANGE DNA INTERACTIONS; DOUBLE-STRAND BREAKS; INTERCHROMOSOMAL ASSOCIATIONS; CHROMATIN INTERACTIONS; TAL EFFECTORS; HUMAN-CELLS; IN-VIVO; GENOME; ORGANIZATION; EXPRESSION	Transcription of coregulated genes occurs in the context of long-range chromosomal contacts that form multigene complexes. Such contacts and transcription are lost in knockout studies of transcription factors and structural chromatin proteins. To ask whether chromosomal contacts are required for cotranscription in multigene complexes, we devised a strategy using TALENs to cleave and disrupt gene loops in a well-characterized multigene complex. Monitoring this disruption using RNA FISH and immunofluorescence microscopy revealed that perturbing the site of contact had a direct effect on transcription of other interacting genes. Unexpectedly, this effect on cotranscription was hierarchical, with dominant and subordinate members of the multigene complex engaged in both intra-and interchromosomal contact. This observation reveals the profound influence of these chromosomal contacts on the transcription of coregulated genes in a multigene complex.	[Fanucchi, Stephanie; Shibayama, Youtaro; Burd, Shaun; Mhlanga, Musa M.] CSIR, Gene Express & Biophys Grp, Synthet Biol Emerging Res Area, Biosci Unit, ZA-0001 Pretoria, Gauteng, South Africa; [Mhlanga, Musa M.] Univ Lisbon, Fac Med, Inst Mol Med, Unidade Biofis & Expressao Genet, P-1649028 Lisbon, Portugal; [Weinberg, Marc S.] Univ Witwatersrand, Antiviral Gene Therapy Res Unit, Dept Mol Med & Haematol, Sch Pathol,Fac Hlth Sci, ZA-2193 Johannesburg, Gauteng, South Africa; [Weinberg, Marc S.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Council for Scientific & Industrial Research (CSIR) - South Africa; Universidade de Lisboa; University of Witwatersrand; Scripps Research Institute	Mhlanga, MM (corresponding author), CSIR, Gene Express & Biophys Grp, Synthet Biol Emerging Res Area, Biosci Unit, ZA-0001 Pretoria, Gauteng, South Africa.	yoda@mhlangalab.org	Weinberg, Marc/B-4669-2009; Mhlanga, Musa/D-1283-2011	Weinberg, Marc/0000-0002-1997-2171; Mhlanga, Musa/0000-0003-1381-3409	Claude Leon Foundation, South Africa; Council for Industrial and Scientific Research (CSIR, South Africa) [PGV2KYP07]; Emerging Research Area Program of The Department of Science and Technology (DST, South Africa); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PTDC/SAU- GMG/115652/2009]	Claude Leon Foundation, South Africa; Council for Industrial and Scientific Research (CSIR, South Africa); Emerging Research Area Program of The Department of Science and Technology (DST, South Africa); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology)	We thank all members of the Gene Expression and Biophysics Laboratory. We thank A. Lenox for experimental help and advice. We thank A. Premo for assistance with graphics and cartoons and S. Barichievy, A. Gontijo, F. Brombacher, P. Tomancak, and D. Henriques for comments on the manuscript. S. F. and Y. S. are recipients of postdoctoral fellowships from the Claude Leon Foundation, South Africa. This research is supported by grant PGV2KYP07 from the Council for Industrial and Scientific Research (CSIR, South Africa) and by a grant from the Emerging Research Area Program of The Department of Science and Technology (DST, South Africa) and grant PTDC/SAU- GMG/115652/2009 from the Fundacao para a Ciencia e a Tecnologia (FCT, Portugal), all to M.M.M.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Barbieri M, 2013, BIOCHEM SOC T, V41, P508, DOI 10.1042/BST20120238; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cisse II, 2013, SCIENCE, V341, P664, DOI 10.1126/science.1239053; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Harewood L, 2010, GENOME RES, V20, P554, DOI 10.1101/gr.103622.109; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Larkin JD, 2013, J CELL SCI, V126, P2052, DOI 10.1242/jcs.123653; Larkin JD, 2012, MOL CELL BIOL, V32, P2738, DOI 10.1128/MCB.00179-12; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Orlova DY, 2012, J CELL BIOCHEM, V113, P3313, DOI 10.1002/jcb.24208; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Papantonis A., 2010, PLOS BIOL, V8; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sandhu KS, 2012, CELL REP, V2, P1207, DOI 10.1016/j.celrep.2012.09.022; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106	41	141	147	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					606	620		10.1016/j.cell.2013.09.051	http://dx.doi.org/10.1016/j.cell.2013.09.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243018	Bronze			2022-12-28	WOS:000326571800015
J	Lu, Y; Hajifathalian, K; Ezzati, M; Woodward, M; Rimm, EB; Danaei, G				Lu, Yuan; Hajifathalian, Kaveh; Ezzati, Majid; Woodward, Mark; Rimm, Eric B.; Danaei, Goodarz		Global Burden Metab Risk Factors C	Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants	LANCET			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; WEIGHT-LOSS; NONCOMMUNICABLE DISEASES; SCIENTIFIC STATEMENT; SYSTEMATIC ANALYSIS; PHYSICAL-ACTIVITY; GLOBAL TRENDS	Background Body-mass index (BMI) and diabetes have increased worldwide, whereas global average blood pressure and cholesterol have decreased or remained unchanged in the past three decades. We quantified how much of the effects of BMI on coronary heart disease and stroke are mediated through blood pressure, cholesterol, and glucose, and how much is independent of these factors. Methods We pooled data from 97 prospective cohort studies that collectively enrolled 1.8 million participants between 1948 and 2005, and that included 57 161 coronary heart disease and 31 093 stroke events. For each cohort we excluded participants who were younger than 18 years, had a BMI of lower than 20 kg/m(2), or who had a history of coronary heart disease or stroke. We estimated the hazard ratio (HR) of BMI on coronary heart disease and stroke with and without adjustment for all possible combinations of blood pressure, cholesterol, and glucose. We pooled HRs with a random-effects model and calculated the attenuation of excess risk after adjustment for mediators. Findings The HR for each 5 kg/m(2) higher BMI was 1.27 (95% CI 1.23-1.31) for coronary heart disease and 1.18 (1.14-1.22) for stroke after adjustment for confounders. Additional adjustment for the three metabolic risk factors reduced the HRs to 1.15 (1.12-1.18) for coronary heart disease and 1.04 (1.01-1.08) for stroke, suggesting that 46% (95% CI 42-50) of the excess risk of BMI for coronary heart disease and 76% (65-91) for stroke is mediated by these factors. Blood pressure was the most important mediator, accounting for 31% (28-35) of the excess risk for coronary heart disease and 65% (56-75) for stroke. The percentage excess risks mediated by these three mediators did not differ significantly between Asian and western cohorts (North America, western Europe, Australia, and New Zealand). Both overweight (BMI >= 25 to < 30 kg/m(2)) and obesity (BMI >= 30 kg/m(2)) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI >= 20 to < 25 kg/m(2)), with 50% (44-58) of the excess risk of overweight and 44% (41-48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators. The percentages for stroke were 98% (69-155) for overweight and 69% (64-77) for obesity. Interpretation Interventions that reduce high blood pressure, cholesterol, and glucose might address about half of excess risk of coronary heart disease and three-quarters of excess risk of stroke associated with high BMI. Maintenance of optimum bodyweight is needed for the full benefits.	[Lu, Yuan; Hajifathalian, Kaveh; Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, London, England; [Woodward, Mark] George Inst Global Hlth, Sydney, NSW, Australia; [Rimm, Eric B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; George Institute for Global Health; University of Sydney; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Danaei, G (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	gdanaei@hsph.harvard.edu	Sundström, Johan/A-6286-2009; Knuiman, Matthew W/I-5549-2013; Cefalu', Angelo B/K-9491-2016; Huxley, Rachel R/C-7032-2013; Nannipieri, Monica/AAA-1464-2019; vhmpp, aks/F-9756-2012; Ulmer, Hanno/S-6615-2019; Sundstrom, Johan/R-2139-2019; Nagel, Gabriele/C-3635-2012; Davey Smith, George/A-7407-2013; Ärnlöv, Johan/AAF-2746-2019; Huxley, Rachel R/J-4638-2013; Averna, Maurizio/U-9527-2017; Geleijnse, Johanna Marianna M/B-5749-2012; Wittchen, Hans-Ulrich/ABA-8901-2020; Woodward, Mark/L-6817-2017; Hajifathalian, Kaveh/AAX-6179-2021; Van Herck, Koen/L-2549-2019; Woodward, Mark/D-8492-2015; Danaei, Goodarz/B-6085-2008; Van Herck, Koen/G-5223-2013; Okamura, Tomonori/L-1693-2013; Lu, Yuan/D-4941-2015	Sundström, Johan/0000-0003-2247-8454; Cefalu', Angelo B/0000-0003-1259-8284; Huxley, Rachel R/0000-0002-2705-6616; Nannipieri, Monica/0000-0003-1346-2813; Ulmer, Hanno/0000-0001-5911-1002; Sundstrom, Johan/0000-0003-2247-8454; Nagel, Gabriele/0000-0001-6185-8535; Davey Smith, George/0000-0002-1407-8314; Ärnlöv, Johan/0000-0002-6933-4637; Huxley, Rachel R/0000-0002-2705-6616; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Wittchen, Hans-Ulrich/0000-0002-6311-7711; Hajifathalian, Kaveh/0000-0002-3931-2576; Van Herck, Koen/0000-0003-0717-2406; Van Herck, Koen/0000-0003-0717-2406; Tolonen, Hanna/0000-0003-3121-4303; He, Yao/0000-0001-6205-7895; Okamura, Tomonori/0000-0003-0488-0351; Parapid, Biljana/0000-0002-1071-2496; Christensen, Hanne/0000-0002-7472-3194; Noto, Davide/0000-0002-5346-2829; Kita, Yoshikuni/0000-0002-2366-1106; de Groot, Lisette/0000-0003-2778-2789; De Bacquer, Dirk/0000-0002-3202-7238; Jensen, Majken Karoline/0000-0003-4729-7545; Knuiman, Matthew/0000-0001-8874-2305; Kivimaki, Mika/0000-0002-4699-5627; Jacobs, David/0000-0002-7232-0543; Rosengren, Annika/0000-0002-5409-6605; Batty, George/0000-0003-1822-5753; Hadaegh, Farzad/0000-0002-8935-2744; Rodgers, Anthony/0000-0003-1282-1896; Pereira, Mark/0000-0002-6704-5276; Lu, Yuan/0000-0001-5264-2169; Visseren, Frank/0000-0003-3951-5223; Woodward, Mark/0000-0001-9800-5296; hadaegh, farzad/0000-0002-0352-8666; Overvad, Kim/0000-0001-6429-7921; Maegawa, Hiroshi/0000-0002-4611-8149; Clays, Els/0000-0002-1092-945X; MacMahon, Stephen/0000-0003-2064-7699	US National Institute of Health; UK Medical Research Council; National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust; Lown Scholars in Residence Program on cardiovascular disease prevention; Harvard Global Health Institute Doctoral Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090435] Funding Source: NIH RePORTER; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MC_UU_12013/1, MR/K013351/1, MR/K005901/1] Funding Source: UKRI; British Heart Foundation [RG/13/2/30098, PG/11/63/29011] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K005901/1, MR/K013351/1, MC_UU_12013/1] Funding Source: researchfish; Stroke Association [TSA2008/05] Funding Source: researchfish	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust; Lown Scholars in Residence Program on cardiovascular disease prevention; Harvard Global Health Institute Doctoral Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Stroke Association	US National Institute of Health, UK Medical Research Council, National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust, Lown Scholars in Residence Program on cardiovascular disease prevention, and Harvard Global Health Institute Doctoral Research Grant.	Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Batty GD, 2006, HEART, V92, P886, DOI 10.1136/hrt.2005.072637; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Carroll K, 2003, J PUBLIC HEALTH MED, V25, P29, DOI 10.1093/pubmed/fdg007; Corden B, 2013, HYPERTENSION, V61, P1322, DOI 10.1161/HYPERTENSIONAHA.113.01177; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Farzadfar F, 2012, LANCET, V379, P47, DOI 10.1016/S0140-6736(11)61349-4; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Gray LJ, 2012, OBES REV, V13, P483, DOI 10.1111/j.1467-789X.2011.00981.x; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu G, 2007, ARCH INTERN MED, V167, P1420, DOI 10.1001/archinte.167.13.1420; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; JACKSON R, 1987, INT J EPIDEMIOL, V16, P377, DOI 10.1093/ije/16.3.377; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Laverty AA, 2011, J PUBLIC HEALTH-UK, V33, P302, DOI 10.1093/pubmed/fdq078; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Mora S, 2005, CIRCULATION, V111, P1871, DOI 10.1161/01.CIR.0000161956.75255.7B; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Sacks FM, 2010, NEW ENGL J MED, V362, P2102, DOI 10.1056/NEJMct0911013; Singh GP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064893, 10.1371/journal.pone.0065174]; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Strickler HD, 2005, JAMA-J AM MED ASSOC, V294, P551, DOI 10.1001/jama.294.5.551-b; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willett WC, 2013, JAMA-J AM MED ASSOC, V309, P1681, DOI 10.1001/jama.2013.3075; Wilson PWF, 2008, CIRCULATION, V118, P124, DOI 10.1161/CIRCULATIONAHA.108.772962; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	53	619	645	7	115	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					970	983		10.1016/S0140-6736(13)61836-X	http://dx.doi.org/10.1016/S0140-6736(13)61836-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MR	24269108	Green Published, Green Submitted			2022-12-28	WOS:000333520700028
J	Chen, HH; Anstrom, KJ; Givertz, MM; Stevenson, LW; Semigran, MJ; Goldsmith, SR; Bart, BA; Bull, DA; Stehlik, J; LeWinter, MM; Konstam, MA; Huggins, GS; Rouleau, JL; O'Meara, E; Tang, WHW; Starling, RC; Butler, J; Deswal, A; Felker, GM; O'Connor, CM; Bonita, RE; Margulies, KB; Cappola, TP; Ofili, EO; Mann, DL; Davila-Roman, VG; McNulty, SE; Borlaug, BA; Velazquez, EJ; Lee, KL; Shah, MR; Hernandez, AF; Braunwald, E; Redfield, MM				Chen, Horng H.; Anstrom, Kevin J.; Givertz, Michael M.; Stevenson, Lynne W.; Semigran, Marc J.; Goldsmith, Steven R.; Bart, Bradley A.; Bull, David A.; Stehlik, Josef; LeWinter, Martin M.; Konstam, Marvin A.; Huggins, Gordon S.; Rouleau, Jean L.; O'Meara, Eileen; Tang, W. H. Wilson; Starling, Randall C.; Butler, Javed; Deswal, Anita; Felker, G. Michael; O'Connor, Christopher M.; Bonita, Raphael E.; Margulies, Kenneth B.; Cappola, Thomas P.; Ofili, Elizabeth O.; Mann, Douglas L.; Davila-Roman, Victor G.; McNulty, Steven E.; Borlaug, Barry A.; Velazquez, Eric J.; Lee, Kerry L.; Shah, Monica R.; Hernandez, Adrian F.; Braunwald, Eugene; Redfield, Margaret M.		NHLBI Heart Failure Clin Res Netwo	Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction The ROSE Acute Heart Failure Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RELAX-AHF; STRATEGIES; SERELAXIN; BENEFIT	IMPORTANCE Small studies suggest that low-dose dopamine or low-dose nesiritide may enhance decongestion and preserve renal function in patients with acute heart failure and renal dysfunction; however, neither strategy has been rigorously tested. OBJECTIVE To test the 2 independent hypotheses that, compared with placebo, addition of low-dose dopamine (2 mu g/kg/min) or low-dose nesiritide (0.005 mu g/kg/min without bolus) to diuretic therapy will enhance decongestion and preserve renal function in patients with acute heart failure and renal dysfunction. DESIGN, SETTING, AND PARTICIPANTS Multicenter, double-blind, placebo-controlled clinical trial (Renal Optimization Strategies Evaluation [ROSE]) of 360 hospitalized patients with acute heart failure and renal dysfunction (estimated glomerular filtration rate of 15-60 mL/min/1.73 m(2)), randomized within 24 hours of admission. Enrollment occurred from September 2010 to March 2013 across 26 sites in North America. INTERVENTIONS Participants were randomized in an open, 1:1 allocation ratio to the dopamine or nesiritide strategy. Within each strategy, participants were randomized in a double-blind, 2:1 ratio to active treatment or placebo. The dopamine (n = 122) and nesiritide (n = 119) groups were independently compared with the pooled placebo group (n = 119). MAIN OUTCOMES AND MEASURES Coprimary end points included 72-hour cumulative urine volume (decongestion end point) and the change in serum cystatin C from enrollment to 72 hours (renal function end point). RESULTS Compared with placebo, low-dose dopamine had no significant effect on 72-hour cumulative urine volume (dopamine, 8524 mL; 95% CI, 7917-9131 vs placebo, 8296 mL; 95% CI, 7762-8830; difference, 229 mL; 95% CI, -714 to 1171 mL; P = .59) or on the change in cystatin C level (dopamine, 0.12 mg/L; 95% CI, 0.06-0.18 vs placebo, 0.11 mg/L; 95% CI, 0.06-0.16; difference, 0.01; 95% CI, -0.08 to 0.10; P = .72). Similarly, low-dose nesiritide had no significant effect on 72-hour cumulative urine volume (nesiritide, 8574 mL; 95% CI, 8014-9134 vs placebo, 8296 mL; 95% CI, 7762-8830; difference, 279 mL; 95% CI, -618 to 1176 mL; P = .49) or on the change in cystatin C level (nesiritide, 0.07 mg/L; 95% CI, 0.01-0.13 vs placebo, 0.11 mg/L; 95% CI, 0.06-0.16; difference, -0.04; 95% CI, -0.13 to 0.05; P = .36). Compared with placebo, there was no effect of low-dose dopamine or nesiritide on secondary end points reflective of decongestion, renal function, or clinical outcomes. CONCLUSION AND RELEVANCE In participants with acute heart failure and renal dysfunction, neither low-dose dopamine nor low-dose nesiritide enhanced decongestion or improved renal function when added to diuretic therapy.	[Chen, Horng H.; Borlaug, Barry A.; Redfield, Margaret M.] Mayo Clin, Rochester, MN 55905 USA; [Anstrom, Kevin J.; McNulty, Steven E.; Lee, Kerry L.; Hernandez, Adrian F.] Duke Clin Res Inst, Durham, NC USA; [Givertz, Michael M.; Stevenson, Lynne W.; Braunwald, Eugene] Brigham & Womens Hosp, Boston, MA 02115 USA; [Semigran, Marc J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Goldsmith, Steven R.; Bart, Bradley A.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Bull, David A.; Stehlik, Josef] Univ Utah, Salt Lake City, UT USA; [LeWinter, Martin M.] Univ Vermont, Burlington, VT 05405 USA; [Konstam, Marvin A.; Huggins, Gordon S.] Tufts Med Ctr, Boston, MA USA; [Rouleau, Jean L.; O'Meara, Eileen] Univ Montreal, Montreal, PQ, Canada; [Rouleau, Jean L.; O'Meara, Eileen] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Tang, W. H. Wilson; Starling, Randall C.] Cleveland Clin, Cleveland, OH 44106 USA; [Butler, Javed] Emory Univ, Atlanta, GA 30322 USA; [Deswal, Anita] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Deswal, Anita] Baylor Coll Med, Houston, TX USA; [Felker, G. Michael; O'Connor, Christopher M.; Velazquez, Eric J.] Duke Univ, Med Ctr, Durham, NC USA; [Felker, G. Michael; O'Connor, Christopher M.; Velazquez, Eric J.] Duke Heart Ctr, Durham, NC USA; [Bonita, Raphael E.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Margulies, Kenneth B.; Cappola, Thomas P.] Univ Penn, Philadelphia, PA 19104 USA; [Ofili, Elizabeth O.] Morehouse Sch Med, Atlanta, GA 30310 USA; [Mann, Douglas L.; Davila-Roman, Victor G.] Washington Univ, Sch Med, St Louis, MO USA; [Shah, Monica R.] NHLBI, Bethesda, MD 20892 USA	Mayo Clinic; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Hennepin County Medical Center; Utah System of Higher Education; University of Utah; University of Vermont; Tufts Medical Center; Universite de Montreal; Universite de Montreal; Cleveland Clinic Foundation; Emory University; Baylor College of Medicine; Baylor College of Medicine; Duke University; Duke University; Jefferson University; University of Pennsylvania; Morehouse School of Medicine; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Chen, HH (corresponding author), Mayo Clin Cardiovasc Res, Guggenheim 9,Mayo Clin,200 1st St SW, Rochester, MN 55905 USA.	chen.horng@mayo.edu	Tang, Wai Hong Wilson/I-1238-2013; Aguilar, David/GZM-1928-2022; Mann, Douglas Lowell/AAQ-3524-2021; Hernandez, Adrian F/A-7818-2016; Rame, J. Eduardo/ABF-2208-2021; Felker, Michael/AAX-2288-2021	Aguilar, David/0000-0002-0916-2722; Hernandez, Adrian F/0000-0003-3387-9616; Rame, J. Eduardo/0000-0002-2936-1702; Mann, Douglas/0000-0002-2516-0145; Patel, Ayan/0000-0003-1984-1400; Stehlik, Josef/0000-0002-7362-0513; Felker, Gary/0000-0002-5931-1239; Tang, W. H. Wilson/0000-0002-8335-735X; Bozkurt, Biykem/0000-0002-6362-0253	National Heart, Lung, and Blood Institute (NHLBI) [U10 HL084904, U01 HL084861, U10 HL110312, U109 HL110337, U01 HL084889, U01 HL084890, U01 HL084891, U10 HL110342, U10 HL110262, U01 HL084931, U10 HL110297, U10 HL110302, U10 HL110309, U10 HL110336, U10 HL110338]; National Center for Advancing Translational Sciences [UL1TR000454, UL1TR000135, UL1RR025008, UL1TR000439]; National Institute on Minority Health and Health Disparities [8 U54 MD007588]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135, UL1TR000454, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084891, U10HL084904, U10HL110337, R01HL084155, U10HL110312, U10HL110338, U01HL084861, U10HL110302, U10HL110262, U01HL084889, U10HL110309, U01HL084931, U10HL110336, U10HL110297, K23HL095661, U10HL110342, U01HL084890] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007588] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (coordinating center: U10 HL084904; regional clinical centers: U01 HL084861, U10 HL110312, U109 HL110337, U01 HL084889, U01 HL084890, U01 HL084891, U10 HL110342, U10 HL110262, U01 HL084931, U10 HL110297, U10 HL110302, U10 HL110309, U10 HL110336, U10 HL110338). This work is also supported by the National Center for Advancing Translational Sciences (UL1TR000454, UL1TR000135, UL1RR025008, UL1TR000439) and the National Institute on Minority Health and Health Disparities (8 U54 MD007588).	Bart BA, 2012, NEW ENGL J MED, V367, P2296, DOI 10.1056/NEJMoa1210357; Chen HH, 1999, P ASSOC AM PHYSICIAN, V111, P406, DOI 10.1111/paa.1999.111.5.406; Chen HH, 2007, CIRCULATION, V116, pI134, DOI 10.1161/CIRCULATIONAHA.106.697250; Chen HH, 2013, CIRC-HEART FAIL, V6, P1087, DOI 10.1161/CIRCHEARTFAILURE.113.000347; Chen HH, 2009, J AM COLL CARDIOL, V53, P1302, DOI 10.1016/j.jacc.2009.01.030; Cotter G, 1997, CLIN PHARMACOL THER, V62, P187, DOI 10.1016/S0009-9236(97)90067-9; Elkayam U, 2008, CIRCULATION, V117, P200, DOI 10.1161/CIRCULATIONAHA.107.737106; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Giamouzis G, 2010, J CARD FAIL, V16, P922, DOI 10.1016/j.cardfail.2010.07.246; Givertz MM, 2013, J CARD FAIL, V19, P371, DOI 10.1016/j.cardfail.2013.04.002; Gottlieb SS, 2013, J AM COLL CARDIOL, V62, P1177, DOI 10.1016/j.jacc.2013.04.073; Hauptman PJ, 2008, AM HEART J, V155, P978, DOI 10.1016/j.ahj.2008.01.015; Lindenfeld J, 2010, J CARD FAIL, V16, pe1, DOI DOI 10.1016/J.CARDFAIL.2010.04.004; MASKIN CS, 1985, CIRCULATION, V72, P846, DOI 10.1161/01.CIR.72.4.846; Massie BM, 2010, NEW ENGL J MED, V363, P1419, DOI 10.1056/NEJMoa0912613; Metra M, 2013, J AM COLL CARDIOL, V61, P196, DOI 10.1016/j.jacc.2012.11.005; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Owan TE, 2008, J CARD FAIL, V14, P267, DOI 10.1016/j.cardfail.2007.12.002; Riter HG, 2006, J AM COLL CARDIOL, V47, P2334, DOI 10.1016/j.jacc.2006.03.013; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Schwartzenberg S, 2012, J AM COLL CARDIOL, V59, P442, DOI 10.1016/j.jacc.2011.09.062; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Varriale P, 1997, CLIN CARDIOL, V20, P627, DOI 10.1002/clc.4960200709; Wang DJ, 2004, CIRCULATION, V110, P1620, DOI 10.1161/01.CIR.0000141829.04031.25; Yancy CW, 2013, CIRCULATION, V3, DOI [10.1161/CIR.0b013e31829e8776, DOI 10.1161/CIR.OBO13E31829E8776]; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	26	293	304	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2533	2543		10.1001/jama.2013.282190	http://dx.doi.org/10.1001/jama.2013.282190			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24247300	Green Accepted			2022-12-28	WOS:000328503600023
J	Pirmohamed, M; Burnside, G; Eriksson, N; Jorgensen, AL; Toh, CH; Nicholson, T; Kesteven, P; Christersson, C; Wahlstrom, B; Stafberg, C; Zhang, JE; Leathart, JB; Kohnke, H; Maitland-van der Zee, AH; Williamson, PR; Daly, AK; Avery, P; Kamali, F; Wadelius, M				Pirmohamed, Munir; Burnside, Girvan; Eriksson, Niclas; Jorgensen, Andrea L.; Toh, Cheng Hock; Nicholson, Toby; Kesteven, Patrick; Christersson, Christina; Wahlstrom, Bengt; Stafberg, Christina; Zhang, J. Eunice; Leathart, Julian B.; Kohnke, Hugo; Maitland-van der Zee, Anke H.; Williamson, Paula R.; Daly, Ann K.; Avery, Peter; Kamali, Farhad; Wadelius, Mia		EU-PACT Grp	A Randomized Trial of Genotype-Guided Dosing of Warfarin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VKORC1 GENOTYPES; PHARMACOGENETICS; CYP2C9; THERAPY; FUTURE; RISK; CARE	BackgroundThe level of anticoagulation in response to a fixed-dose regimen of warfarin is difficult to predict during the initiation of therapy. We prospectively compared the effect of genotype-guided dosing with that of standard dosing on anticoagulation control in patients starting warfarin therapy. MethodsWe conducted a multicenter, randomized, controlled trial involving patients with atrial fibrillation or venous thromboembolism. Genotyping for CYP2C9*2, CYP2C9*3, and VKORC1 (-1639GA) was performed with the use of a point-of-care test. For patients assigned to the genotype-guided group, warfarin doses were prescribed according to pharmacogenetic-based algorithms for the first 5 days. Patients in the control (standard dosing) group received a 3-day loading-dose regimen. After the initiation period, the treatment of all patients was managed according to routine clinical practice. The primary outcome measure was the percentage of time in the therapeutic range of 2.0 to 3.0 for the international normalized ratio (INR) during the first 12 weeks after warfarin initiation. ResultsA total of 455 patients were recruited, with 227 randomly assigned to the genotype-guided group and 228 assigned to the control group. The mean percentage of time in the therapeutic range was 67.4% in the genotype-guided group as compared with 60.3% in the control group (adjusted difference, 7.0 percentage points; 95% confidence interval, 3.3 to 10.6; P<0.001). There were significantly fewer incidences of excessive anticoagulation (INR 4.0) in the genotype-guided group. The median time to reach a therapeutic INR was 21 days in the genotype-guided group as compared with 29 days in the control group (P<0.001). ConclusionsPharmacogenetic-based dosing was associated with a higher percentage of time in the therapeutic INR range than was standard dosing during the initiation of warfarin therapy. (Funded by the European Commission Seventh Framework Programme and others; ClinicalTrials.gov number, NCT01119300.)	[Pirmohamed, Munir; Burnside, Girvan; Jorgensen, Andrea L.; Toh, Cheng Hock; Zhang, J. Eunice; Williamson, Paula R.] Univ Liverpool, Liverpool L69 3GL, Merseyside, England; [Pirmohamed, Munir; Toh, Cheng Hock] Royal Liverpool & Broadgreen Univ Hosp Natl Hlth, Liverpool, Merseyside, England; [Nicholson, Toby] Whiston Hosp, Prescot, Merseyside, England; [Kesteven, Patrick] Newcastle Upon Tyne NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Leathart, Julian B.; Daly, Ann K.; Avery, Peter; Kamali, Farhad] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Eriksson, Niclas; Christersson, Christina; Kohnke, Hugo; Wadelius, Mia] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Eriksson, Niclas] Uppsala Clin Res Ctr, Uppsala, Sweden; [Christersson, Christina; Wahlstrom, Bengt; Wadelius, Mia] Univ Uppsala Hosp, Uppsala, Sweden; [Stafberg, Christina] Enkoping Hosp, Enkoping, Sweden; [Maitland-van der Zee, Anke H.] Univ Utrecht, Utrecht, Netherlands	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; Whiston Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital; Utrecht University	Pirmohamed, M (corresponding author), Univ Liverpool, Inst Translat Med, Wolfson Ctr Personalised Med, Block A Waterhouse Bldg,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England.	munirp@liverpool.ac.uk	Williamson, Paula R/B-6425-2016; Daly, Ann/H-3144-2011; Burnside, Girvan/AAO-4490-2020; Christersson, Christina/ABD-4294-2021; Pirmohamed, Munir/H-6004-2011; Wadelius, Mia/C-7740-2016; Maitland-van der Zee, Anke/I-9572-2016	Williamson, Paula R/0000-0001-9802-6636; Daly, Ann/0000-0002-7321-0629; Christersson, Christina/0000-0001-9116-8084; Pirmohamed, Munir/0000-0002-7534-7266; Wadelius, Mia/0000-0002-6368-2622; Maitland-van der Zee, Anke/0000-0002-0414-3442; Burnside, Girvan/0000-0001-7398-1346; Redekop, Ken/0000-0001-9538-4083	European Commission Seventh Framework Programme [FP7-223062]; Cheshire and Merseyside National Institute for Health Research (NIHR) Comprehensive Local Research Network (CLRN); Stroke Research Network; NIHR Biomedical Research Centre; Northern CLRN; Senior Investigator Award from the NIHR; NHS Chair of Pharmacogenetics from the U.K. Department of Health; Medical Research Council Centre for Drug Safety Science; Swedish Research Council [Medicine 523-2008-5568, 521-2011-2440]; Swedish Heart-Lung Foundation; Uppsala University; Medical Research Council [G0400488] Funding Source: researchfish; MRC [G0400488] Funding Source: UKRI	European Commission Seventh Framework Programme(European Commission); Cheshire and Merseyside National Institute for Health Research (NIHR) Comprehensive Local Research Network (CLRN); Stroke Research Network; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Northern CLRN; Senior Investigator Award from the NIHR; NHS Chair of Pharmacogenetics from the U.K. Department of Health; Medical Research Council Centre for Drug Safety Science(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Uppsala University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by funding from the European Commission Seventh Framework Programme (FP7-223062); the Cheshire and Merseyside National Institute for Health Research (NIHR) Comprehensive Local Research Network (CLRN) and the Stroke Research Network (to Dr. Pirmohamed); the NIHR Biomedical Research Centre and the Northern CLRN (to Dr. Kamali); a Senior Investigator Award from the NIHR, the NHS Chair of Pharmacogenetics from the U.K. Department of Health, and the Medical Research Council Centre for Drug Safety Science (all to Dr. Pirmohamed); and the Swedish Research Council (Medicine 523-2008-5568 and 521-2011-2440), the Swedish Heart-Lung Foundation, and Uppsala University (all to Dr. Wadelius).	Ageno W, 2012, CHEST S, V141, pe44S; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Avery PJ, 2011, CLIN PHARMACOL THER, V90, P701, DOI 10.1038/clpt.2011.186; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; Cavallari LH, 2012, FUTUR CARDIOL, V8, P563, DOI [10.2217/fca.12.31, 10.2217/FCA.12.31]; Daly AK, 2013, ARCH TOXICOL, V87, P407, DOI 10.1007/s00204-013-1013-9; Finkelman BS, 2011, J AM COLL CARDIOL, V57, P612, DOI 10.1016/j.jacc.2010.08.643; Hillman MA, 2005, CLIN MED RES, V3, P137, DOI 10.3121/cmr.3.3.137; Holbrook A, 2012, CHEST S, V141, pe152S; Horne BD, 2012, THROMB HAEMOSTASIS, V107, P232, DOI 10.1160/TH11-06-0388; Howard R, 2011, CLIN CHIM ACTA, V412, P2063, DOI 10.1016/j.cca.2011.07.013; Hylek Elaine M, 2003, Semin Vasc Med, V3, P271; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Jorgensen AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044064; Jorgensen AL, 2009, PHARMACOGENET GENOM, V19, P800, DOI 10.1097/FPC.0b013e3283317ab5; Klein TE, 2009, NEW ENGL J MED, V361, P1613; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Kovacs MJ, 2003, ANN INTERN MED, V138, P714, DOI 10.7326/0003-4819-138-9-200305060-00007; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Mahtani KR, 2012, COCHRANE DATABASE SY, V12; Perera MA, 2013, LANCET, V382, P790, DOI 10.1016/S0140-6736(13)60681-9; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; van Schie RMF, 2009, PHARMACOGENOMICS, V10, P1687, DOI [10.2217/pgs.09.125, 10.2217/PGS.09.125]; Wadelius M, 2007, PHARMACOGENOMICS J, V7, P99, DOI 10.1038/sj.tpj.6500417; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; Yang J, 2013, INT J CARDIOL, V168, P4234, DOI 10.1016/j.ijcard.2013.07.151	30	594	632	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2294	2303		10.1056/NEJMoa1311386	http://dx.doi.org/10.1056/NEJMoa1311386			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24251363	Bronze			2022-12-28	WOS:000328156300007
J	van Panhuis, WG; Grefenstette, J; Jung, SY; Chok, NS; Cross, A; Eng, H; Lee, BY; Zadorozhny, V; Brown, S; Cummings, D; Burke, DS				van Panhuis, Willem G.; Grefenstette, John; Jung, Su Yon; Chok, Nian Shong; Cross, Anne; Eng, Heather; Lee, Bruce Y.; Zadorozhny, Vladimir; Brown, Shawn; Cummings, Derek; Burke, Donald S.			Contagious Diseases in the United States from 1888 to the Present	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINE-PREVENTABLE DISEASES; TRAVELING-WAVES; MEASLES; PERTUSSIS; IMMUNIZATION; EPIDEMIC; RESURGENCE; COVERAGE; POLICIES; CHILDREN		[van Panhuis, Willem G.; Jung, Su Yon; Chok, Nian Shong; Eng, Heather; Burke, Donald S.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Grefenstette, John; Cross, Anne; Brown, Shawn] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Lee, Bruce Y.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Med, Sch Med, Pittsburgh, PA 15261 USA; [Zadorozhny, Vladimir] Univ Pittsburgh, Sch Informat Sci, Grad Informat Sci & Technol Program, Pittsburgh, PA 15261 USA; [Cummings, Derek] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	van Panhuis, WG (corresponding author), Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.		Van Panhuis, Willem/S-5495-2019	Van Panhuis, Willem/0000-0002-7278-9982; Brown, Shawn/0000-0001-6980-8372; Jung, Su Yon/0000-0002-0513-1830; /0000-0002-5704-8094	NIGMS NIH HHS [U54 GM088491] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1909, Cal State J Med, V7, P157; [Anonymous], 2012, MMWR-MORBID MORTAL W, V61; ATKINSON WL, 1992, ANNU REV MED, V43, P451, DOI 10.1146/annurev.med.43.1.451; BART KJ, 1991, JAMA-J AM MED ASSOC, V266, P1547; Centers for Disease Control and Prevention, 2012, MMWR-MORBID MORTAL W, V61, P994; Centers for Disease Control and Prevention, 1982, MORB MORT WEEKL REP; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Diekema DS, 2012, NEW ENGL J MED, V366, P391, DOI 10.1056/NEJMp1113008; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; Ferguson Kitty, 2002, TYCHO KEPLER UNLIKEL; FINE PEM, 1986, AM J EPIDEMIOL, V124, P1012, DOI 10.1093/oxfordjournals.aje.a114471; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Greby Stacie M., 2012, Morbidity and Mortality Weekly Report, V61, P647; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Gust DA, 2004, PEDIATRICS, V114, pE16, DOI 10.1542/peds.114.1.e16; Hathi Trust Digital Library, MORB MORT WEEKL REP; Hinman AR, 2011, AM J EPIDEMIOL, V174, pS16, DOI 10.1093/aje/kwr306; Hinman Alan R, 2011, MMWR Suppl, V60, P49; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P619; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; National Center for Biotechnology Information, PUBL HLTH REP 1974 2; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Shim E, 2012, J THEOR BIOL, V295, P194, DOI 10.1016/j.jtbi.2011.11.005; Stokley S, 2011, PEDIATRICS, V128, P1078, DOI 10.1542/peds.2011-1048; Sugerman DE, 2010, PEDIATRICS, V125, P747, DOI 10.1542/peds.2009-1653	31	163	163	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2152	2158		10.1056/NEJMms1215400	http://dx.doi.org/10.1056/NEJMms1215400			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	258OB	24283231	Green Accepted			2022-12-28	WOS:000327467500015
J	Bozic, I; Nowak, MA				Bozic, Ivana; Nowak, Martin A.			Unwanted Evolution	SCIENCE			English	Editorial Material							MUTATIONS; DYNAMICS; CANCERS		[Bozic, Ivana; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Bozic, Ivana; Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Bozic, I (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Bozic, Ivana/C-5003-2008	Bozic, Ivana/0000-0003-2761-825X				Araten DJ, 2005, CANCER RES, V65, P8111, DOI 10.1158/0008-5472.CAN-04-1198; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Durrett R, 2010, THEOR POPUL BIOL, V78, P54, DOI 10.1016/j.tpb.2010.05.001; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Nowak MA, 2003, P NATL ACAD SCI USA, V100, P14966, DOI 10.1073/pnas.2535419100; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wodarz D., 2008, LECTURE NOTES AND MA	15	19	19	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					938	939		10.1126/science.1247887	http://dx.doi.org/10.1126/science.1247887			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264980				2022-12-28	WOS:000327223500027
J	Parikshak, NN; Luo, R; Zhang, A; Won, H; Lowe, JK; Chandran, V; Horvath, S; Geschwind, DH				Parikshak, Neelroop N.; Luo, Rui; Zhang, Alice; Won, Hyejung; Lowe, Jennifer K.; Chandran, Vijayendran; Horvath, Steve; Geschwind, Daniel H.			Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism	CELL			English	Article							COMMON GENETIC-VARIANTS; DE-NOVO MUTATIONS; TRANSCRIPTIONAL REGULATION; INTELLECTUAL DISABILITY; BRAIN-DEVELOPMENT; MESSENGER-RNAS; SPECTRUM; NETWORK; COEXPRESSION; PATTERNS	Genetic studies have identified dozens of autism spectrum disorder (ASD) susceptibility genes, raising two critical questions: (1) do these genetic loci converge on specific biological processes, and (2) where does the phenotypic specificity of ASD arise, given its genetic overlap with intellectual disability (ID)? To address this, we mapped ASD and ID risk genes onto coexpression networks representing developmental trajectories and transcriptional profiles representing fetal and adult cortical laminae. ASD genes tightly coalesce in modules that implicate distinct biological functions during human cortical development, including early transcriptional regulation and synaptic development. Bioinformatic analyses suggest that translational regulation by FMRP and transcriptional coregulation by common transcription factors connect these processes. At a circuit level, ASD genes are enriched in superficial cortical layers and glutamatergic projection neurons. Furthermore, we show that the patterns of ASD and ID risk genes are distinct, providing a biological framework for further investigating the pathophysiology of ASD.	[Parikshak, Neelroop N.; Won, Hyejung; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA; [Parikshak, Neelroop N.; Zhang, Alice; Geschwind, Daniel H.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA 90095 USA; [Luo, Rui; Horvath, Steve; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Luo, Rui; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Ctr Autism Treatment & Res, Los Angeles, CA 90095 USA; [Chandran, Vijayendran; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA.	dhg@ucla.edu		Parikshak, Neel/0000-0003-2027-1871	Simons Foundation Autism Research Initiative; Autism Genetic Resource Exchange; Brain Span consortium; Allen Brain Institute; NIMH Training; NRSA Fellowship [T32MH073526, F30MH099886]; NIMH [5R37MH060233, 5R01MH094714]; Autism Center for Excellence network grant [9R01MH100027]; Simons Foundation [SFARI 206744]; Medical Scientist Training Program at UCLA; NINDS Informatics Center for Neurogenetics and Neurogenomics [P30NS062691]; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH099886, R01MH094714, RC2MH089921, R37MH060233, T32MH073526, R01MH100027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative; Autism Genetic Resource Exchange; Brain Span consortium; Allen Brain Institute; NIMH Training; NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism Center for Excellence network grant; Simons Foundation; Medical Scientist Training Program at UCLA; NINDS Informatics Center for Neurogenetics and Neurogenomics; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Simons Foundation Autism Research Initiative (http://www.sfari.org) and the Autism Genetic Resource Exchange (http://www.agre.org) and all families involved for making this work possible. We gratefully acknowledge data resources from the Brain Span consortium and the Allen Brain Institute http://www.brain-map.org). This work was supported by a NIMH Training and NRSA Fellowship (T32MH073526 and F30MH099886, N.N.P.), NIMH grants (5R37MH060233 and 5R01MH094714, D. H. G.), an Autism Center for Excellence network grant (9R01MH100027), the Simons Foundation (SFARI 206744, D. H. G.), and the Medical Scientist Training Program at UCLA. We thank the NINDS Informatics Center for Neurogenetics and Neurogenomics (funded by grant P30NS062691) at UCLA for computing resources, and we specifically thank Yeongshnn Ong and Giovanni Coppola for making the interactive network available. We thank Jason Chen, Michael Gandal, and Jason Stein for critically reading the manuscript, as well as Willsey et al. (2013) for sharing their findings prior to publication.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Ben-David E, 2013, MOL PSYCHIATR, V18, P1054, DOI 10.1038/mp.2012.148; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb4034, 10.1186/gb-2012-13-7-247]; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; BrainSpan, 2013, BRAINSPAN ATL DEV HU; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de la Torre-Ubieta L, 2011, NEURON, V72, P22, DOI 10.1016/j.neuron.2011.09.018; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Denaxa M, 2012, CELL REP, V2, P1351, DOI 10.1016/j.celrep.2012.10.003; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Ecker C, 2012, ARCH GEN PSYCHIAT, V69, P195, DOI 10.1001/archgenpsychiatry.2011.1251; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gratten J, 2013, NAT GENET, V45, P234, DOI 10.1038/ng.2555; Halgren C, 2012, CLIN GENET, V82, P248, DOI 10.1111/j.1399-0004.2011.01755.x; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018; Luo R, 2012, AM J HUM GENET, V91, P38, DOI 10.1016/j.ajhg.2012.05.011; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Matson JL, 2009, RES DEV DISABIL, V30, P1107, DOI 10.1016/j.ridd.2009.06.003; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Ramani AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.19; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Srinivasan K, 2012, P NATL ACAD SCI USA, V109, P19071, DOI 10.1073/pnas.1216793109; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tuoc TC, 2013, DEV CELL, V25, P256, DOI 10.1016/j.devcel.2013.04.005; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zheng XF, 2012, STEM CELLS, V30, P910, DOI 10.1002/stem.1070	66	638	646	1	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1008	1021		10.1016/j.cell.2013.10.031	http://dx.doi.org/10.1016/j.cell.2013.10.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267887	Bronze, Green Accepted			2022-12-28	WOS:000327500600007
J	Bhaumik, S				Bhaumik, Soumyadeep			Can India end the corruption in nurses' training?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												soumyadeepbhaumik@rediffmail.com		Bhaumik, Soumyadeep/0000-0001-9579-4453				Bagga R, 2012, STUDY NURSING MIDWIF; Bhaumik S, 2013, BMJ-BRIT MED J, V346, pf4024; Evans C, 2013, BMC NURS, V12, DOI 10.1186/1472-6955-12-8; Global Health Workforce Alliance, 2008, HLTH WORK ALL ALL HL; Ministry of Health and Family Welfare Government of India, 2005, REP NAT COMM MACR HL; Nair S., 2006, PROFESSION MARGINS S; Nandan D, ASSESSMENT NURSING M; Oulton J, 2009, DFID REV NURSING CRI; Raha S, 2009, SOME PRIORITY CHALLE; Swamy HMC, 2013, NURSING STUDENT GANG; Times of India, 2013, TIMES INDIA 0916; TNN (Times News Network), 2013, TIMES INDIA	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2013	347								f6881	10.1136/bmj.f6881	http://dx.doi.org/10.1136/bmj.f6881			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258JQ	24247121				2022-12-28	WOS:000327455900003
J	Rahman, H; Dupont, P; Cohen, M; Vancheeswaran, R				Rahman, Haseeb; Dupont, Peter; Cohen, Mark; Vancheeswaran, Rama			A case of profound hypercalcaemia and acute kidney injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BONE; BISPHOSPHONATES; GADOLINIUM; DISEASE; SAFETY		[Rahman, Haseeb; Cohen, Mark; Vancheeswaran, Rama] Barnet Gen Hosp, London EN5 3DJ, England; [Dupont, Peter] Royal Free Hosp, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Rahman, H (corresponding author), Barnet Gen Hosp, London EN5 3DJ, England.	haseebrahman1@gmail.com	Rah'man, Ha\\si'm O/A-8915-2011	Rah'man, Ha\\si'm O/0000-0002-9903-3341				Asif A, 2004, AM J KIDNEY DIS, V44, P12, DOI 10.1053/j.ajkd.2004.04.001; AUSTIN LA, 1981, NEW ENGL J MED, V304, P269, DOI 10.1056/NEJM198101293040505; BAYLIS PH, 1981, CLIN ENDOCRINOL, V15, P343, DOI 10.1111/j.1365-2265.1981.tb00674.x; Berenson JR, 2002, SEMIN ONCOL, V29, P12, DOI 10.1053/sonc.2002.37417; Clines GA, 2011, CURR OPIN ENDOCRINOL, V18, P339, DOI 10.1097/MED.0b013e32834b4401; DOMINGUEZ JH, 1992, J LAB CLIN MED, V119, P640; Dunford JE, 2010, CURR PHARM DESIGN, V16, P2961; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ergun I, 2006, NEPHROL DIAL TRANSPL, V21, P697, DOI 10.1093/ndt/gfi304; GARABEDIAN M, 1972, P NATL ACAD SCI USA, V69, P1673, DOI 10.1073/pnas.69.7.1673; Koo WS, 1996, NEPHRON, V72, P424, DOI 10.1159/000188907; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; LeGrand SB, 2008, ANN INTERN MED, V149, P259, DOI 10.7326/0003-4819-149-4-200808190-00007; Makras P, 2009, HORM-INT J ENDOCRINO, V8, P83, DOI 10.14310/horm.2002.1225; RATCLIFFE WA, 1992, LANCET, V339, P164, DOI 10.1016/0140-6736(92)90220-W; Roodman GD, 2010, J CELL BIOCHEM, V109, P283, DOI 10.1002/jcb.22403; ROSE BD, 1991, KIDNEY INT, V39, P336, DOI 10.1038/ki.1991.43; Ruda JM, 2005, OTOLARYNG HEAD NECK, V132, P359, DOI 10.1016/j.otohns.2004.10.005; Sendur MAN, 2012, MED ONCOL, V29, P827, DOI 10.1007/s12032-011-9947-3; SEYMOUR JF, 1993, BLOOD, V82, P1383; Silverberg SJ, 1997, NEW ENGL J MED, V337, P1506, DOI 10.1056/NEJM199711203372104; Suki W N, 1990, Verh K Acad Geneeskd Belg, V52, P203; SUKI WN, 1970, NEW ENGL J MED, V283, P836, DOI 10.1056/NEJM197010152831603; Toussaint ND, 2009, CLIN J AM SOC NEPHRO, V4, P221, DOI 10.2215/CJN.02550508; Townsend RR, 2000, AM J KIDNEY DIS, V36, P1207, DOI 10.1053/ajkd.2000.19836; WARRELL RP, 1984, J CLIN INVEST, V73, P1487, DOI 10.1172/JCI111353; WINEARLS CG, 1995, KIDNEY INT, V48, P1347, DOI 10.1038/ki.1995.421	27	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2013	347								f6744	10.1136/bmj.f6744	http://dx.doi.org/10.1136/bmj.f6744			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258JQ	24246839				2022-12-28	WOS:000327455900002
J	Yosca, TH; Rittle, J; Krest, CM; Onderko, EL; Silakov, A; Calixto, JC; Behan, RK; Green, MT				Yosca, Timothy H.; Rittle, Jonathan; Krest, Courtney M.; Onderko, Elizabeth L.; Silakov, Alexey; Calixto, Julio C.; Behan, Rachel K.; Green, Michael T.			Iron(IV)hydroxide pK(a) and the Role of Thiolate Ligation in C-H Bond Activation by Cytochrome P450	SCIENCE			English	Article							CHLOROPEROXIDASE COMPOUND-II; COUPLED ELECTRON-TRANSFER; LIVER MICROSOMAL CYTOCHROME-P-450; RESONANCE RAMAN-SPECTROSCOPY; HYDROGEN-ATOM TRANSFER; THERMOPHILIC CYTOCHROME-P450; SULFOLOBUS-SOLFATARICUS; FERRYL PROTONATION; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II	Cytochrome P450 enzymes activate oxygen at heme iron centers to oxidize relatively inert substrate carbon-hydrogen bonds. Cysteine thiolate coordination to iron is posited to increase the pK(a) (where K-a is the acid dissociation constant) of compound II, an iron(IV)hydroxide complex, correspondingly lowering the one-electron reduction potential of compound I, the active catalytic intermediate, and decreasing the driving force for deleterious auto-oxidation of tyrosine and tryptophan residues in the enzyme's framework. Here, we report on the preparation of an iron(IV) hydroxide complex in a P450 enzyme (CYP158) in >= 90% yield. Using rapid mixing technologies in conjunction with Mossbauer, ultraviolet/visible, and x-ray absorption spectroscopies, we determine a pK(a) value for this compound of 11.9. Marcus theory analysis indicates that this elevated pK(a) results in a >10,000-fold reduction in the rate constant for oxidations of the protein framework, making these processes noncompetitive with substrate oxidation.	[Yosca, Timothy H.; Rittle, Jonathan; Krest, Courtney M.; Onderko, Elizabeth L.; Silakov, Alexey; Calixto, Julio C.; Behan, Rachel K.; Green, Michael T.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Green, MT (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	mtg10@psu.edu	Silakov, Alexey/D-6318-2018	Silakov, Alexey/0000-0002-9285-1253	NIH [R01-GM101390]; DOE Office of Biological and Environmental Research; NIH National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101390, P41GM103393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Latimer and E. Nelson for onsite assistance at the synchrotron. This work was supported by NIH (R01-GM101390). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIH National Institute of General Medical Sciences (including P41GM103393).	Ahlbrink R, 1998, BIOCHEMISTRY-US, V37, P1131, DOI 10.1021/bi9719152; Annino G, 2009, IEEE T MICROW THEORY, V57, P775, DOI 10.1109/TMTT.2009.2015028; [Anonymous], 2009, GAUSS 09 REV C 01; ATKINS WM, 1987, J AM CHEM SOC, V109, P3754, DOI 10.1021/ja00246a038; Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; Behan RK, 2006, J AM CHEM SOC, V128, P11471, DOI 10.1021/ja062428p; Bollinger JM, 2009, CURR OPIN CHEM BIOL, V13, P51, DOI 10.1016/j.cbpa.2009.03.018; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Challand MR, 2011, NAT PROD REP, V28, P1696, DOI 10.1039/c1np00036e; DAVIES DM, 1976, BIOCHEM J, V157, P247, DOI 10.1042/bj1570247; de Visser SP, 2004, J AM CHEM SOC, V126, P8362, DOI 10.1021/ja048528h; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; GILSON MK, 1986, BIOPOLYMERS, V25, P2097, DOI 10.1002/bip.360251106; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; Green MT, 2009, CURR OPIN CHEM BIOL, V13, P84, DOI 10.1016/j.cbpa.2009.02.028; Green MT, 2006, J AM CHEM SOC, V128, P1902, DOI 10.1021/ja054074s; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Grinkova YV, 2013, BIOCHEM BIOPH RES CO, V430, P1223, DOI 10.1016/j.bbrc.2012.12.072; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; HANSON LK, 1976, J AM CHEM SOC, V98, P2672, DOI 10.1021/ja00425a050; Hay S, 2005, BIOCHEMISTRY-US, V44, P11891, DOI 10.1021/bi050901q; Immoos CE, 2004, INORG CHEM, V43, P3593, DOI 10.1021/ic049741h; Irebo T, 2008, J AM CHEM SOC, V130, P9194, DOI 10.1021/ja802076v; Jung C, 2005, BIOCHEM BIOPH RES CO, V338, P355, DOI 10.1016/j.bbrc.2005.08.166; KADKHODAYAN S, 1995, J BIOL CHEM, V270, P28042; Kang Y, 2009, CHEM-EUR J, V15, P10039, DOI 10.1002/chem.200901238; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Markle TF, 2008, P NATL ACAD SCI USA, V105, P8185, DOI 10.1073/pnas.0708967105; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; Mayer JM, 2011, J PHYS CHEM LETT, V2, P1481, DOI 10.1021/jz200021y; Mayer JM, 2011, ACCOUNTS CHEM RES, V44, P36, DOI 10.1021/ar100093z; Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU, V3rd; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Parsell TH, 2009, J AM CHEM SOC, V131, P2762, DOI 10.1021/ja8100825; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Prokop KA, 2010, ANGEW CHEM INT EDIT, V49, P5091, DOI 10.1002/anie.201001172; Reijerse E, 2012, J MAGN RESON, V214, P237, DOI 10.1016/j.jmr.2011.11.011; Rhile IJ, 2006, J AM CHEM SOC, V128, P6075, DOI 10.1021/ja054167+; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Sastri CV, 2007, P NATL ACAD SCI USA, V104, P19181, DOI 10.1073/pnas.0709471104; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; Simmons JM, 2008, DALTON T, P5132, DOI 10.1039/b803512a; Sjodin M, 2000, J AM CHEM SOC, V122, P3932, DOI 10.1021/ja993044k; Sligar SG, 2010, SCIENCE, V330, P924, DOI 10.1126/science.1197881; SONO M, 1982, J BIOL CHEM, V257, P8308; Stone KL, 2006, P NATL ACAD SCI USA, V103, P12307, DOI 10.1073/pnas.0603159103; Stone KL, 2006, J AM CHEM SOC, V128, P6147, DOI 10.1021/ja057876w; Terner J, 2006, J INORG BIOCHEM, V100, P480, DOI 10.1016/j.jinorgbio.2006.01.008; Tommos C, 2013, BIOCHEMISTRY-US, V52, P1409, DOI 10.1021/bi301613p; Warren JJ, 2012, FEBS LETT, V586, P596, DOI 10.1016/j.febslet.2011.12.014; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200; Zhang MT, 2011, J AM CHEM SOC, V133, P13224, DOI 10.1021/ja203483j; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200; Zhao B, 2005, J BIOL CHEM, V280, P42188, DOI 10.1074/jbc.M509220200	56	220	221	6	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					825	829		10.1126/science.1244373	http://dx.doi.org/10.1126/science.1244373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233717	Green Accepted			2022-12-28	WOS:000326923000029
J	Nieto, MA				Angela Nieto, M.			Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells	SCIENCE			English	Review							NEGATIVE FEEDBACK LOOP; MESENCHYMAL TRANSITION; STEM-CELLS; TUMOR PROGRESSION; METASTASIS; SNAIL; EMT; INITIATION; EXPRESSION; FIBROSIS	During embryonic development, many cells are born far from their final destination and must travel long distances. To become motile and invasive, embryonic epithelial cells undergo a process of mesenchymal conversion known as epithelial-to-mesenchymal transition (EMT). Likewise, EMT can be seen in cancer cells as they leave the primary tumor and disseminate to other parts of the body to colonize distant organs and form metastases. In addition, through the reverse process (mesenchymal-to-epithelial transition), both normal and carcinoma cells revert to the epithelial phenotype to, respectively, differentiate into organs or form secondary tumors. The parallels in phenotypic plasticity in normal morphogenesis and cancer highlight the importance of studying the embryo to understand tumor progression and to aid in the design of improved therapeutic strategies.	UMH, CSIC, Inst Neurociencias, Alacant 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Nieto, MA (corresponding author), UMH, CSIC, Inst Neurociencias, Ave Ramon & Cajal S-N, Alacant 03550, Spain.	anieto@umh.es	Nieto, M. Angela/A-6531-2008	Nieto, M. Angela/0000-0002-3538-840X	Spanish Ministry of Science and Innovation [BFU2008-01042, CSD2007-00017, 00023]; Generalitat Valenciana [Prometeo II/2013/002, ISIC 2012/010]; European Research Council (ERC) [AdG322694]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission)	I thank members of my lab for helpful discussions, in particular R. Corcoles for contributing the Review Summary figure and movies S1 and S2. I would also like to thank S. Ingham (Instituto de Neurociencias de Alicante-CSIC-UMH) for his help with the figures. Work in my lab is supported by grants from the Spanish Ministry of Science and Innovation (BFU2008-01042 and CONSOLIDER-INGENIO 2010 CSD2007-00017 and 00023), the Generalitat Valenciana (Prometeo II/2013/002 and ISIC 2012/010), and the European Research Council (ERC AdG322694).	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; CHANG C, 2013, FILM COMMENT, V49, P73, DOI DOI 10.1158/0008-5472.CAN-12-4085;PMID:23687336; Dale JK, 2006, DEV CELL, V10, P355, DOI 10.1016/j.devcel.2006.02.011; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Ell B, 2013, TRENDS CELL BIOL, V23, P603, DOI 10.1016/j.tcb.2013.06.001; Entenberg D., 2013, CURR PROTOC CELL BIO, V58; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KASAI Y, 1992, P NATL ACAD SCI USA, V89, P3414, DOI 10.1073/pnas.89.8.3414; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; NAVARRO P, 1993, J CELL SCI, V105, P923; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng CG, 2012, J NEUROSCI, V32, P13292, DOI 10.1523/JNEUROSCI.2124-12.2012; Pierga JY, 2012, ANN ONCOL, V23, P618, DOI 10.1093/annonc/mdr263; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Scribner KC, 2013, ONCOGENE, V32, P2631, DOI 10.1038/onc.2012.286; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Spruce T, 2010, DEV CELL, V19, P207, DOI 10.1016/j.devcel.2010.07.014; Steder M, 2013, CANCER CELL, V24, P512, DOI 10.1016/j.ccr.2013.08.023; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; van Denderen BJW, 2013, NATURE, V493, P487, DOI 10.1038/493487a; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P7467, DOI 10.1073/pnas.0902859106; Wu CY, 2012, TRENDS GENET, V28, P454, DOI 10.1016/j.tig.2012.05.005; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	84	680	701	4	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					708	+		10.1126/science.1234850	http://dx.doi.org/10.1126/science.1234850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202173	Green Submitted			2022-12-28	WOS:000326647600033
J	Miljkovic, K; Wieczorek, MA; Collins, GS; Laneuville, M; Neumann, GA; Melosh, HJ; Solomon, SC; Phillips, RJ; Smith, DE; Zuber, MT				Miljkovic, Katarina; Wieczorek, Mark A.; Collins, Gareth S.; Laneuville, Matthieu; Neumann, Gregory A.; Melosh, H. Jay; Solomon, Sean C.; Phillips, Roger J.; Smith, David E.; Zuber, Maria T.			Asymmetric Distribution of Lunar Impact Basins Caused by Variations in Target Properties	SCIENCE			English	Article							MOON; ORIGIN; CRUST; DEFORMATION; BOMBARDMENT; EVOLUTION; SURFACE	Maps of crustal thickness derived from NASA's Gravity Recovery and Interior Laboratory (GRAIL) mission revealed more large impact basins on the nearside hemisphere of the Moon than on its farside. The enrichment in heat-producing elements and prolonged volcanic activity on the lunar nearside hemisphere indicate that the temperature of the nearside crust and upper mantle was hotter than that of the farside at the time of basin formation. Using the iSALE-2D hydrocode to model impact basin formation, we found that impacts on the hotter nearside would have formed basins with up to twice the diameter of similar impacts on the cooler farside hemisphere. The size distribution of lunar impact basins is thus not representative of the earliest inner solar system impact bombardment.	[Miljkovic, Katarina; Wieczorek, Mark A.; Laneuville, Matthieu] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, F-75205 Paris 13, France; [Collins, Gareth S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Neumann, Gregory A.] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Melosh, H. Jay] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Phillips, Roger J.] SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA; [Smith, David E.; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	UDICE-French Research Universities; Universite Paris Cite; Imperial College London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Carnegie Institution for Science; Columbia University; Massachusetts Institute of Technology (MIT)	Miljkovic, K (corresponding author), Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, Case 7011,Lamarck A 5,35 Rue Helene Brion, F-75205 Paris 13, France.	miljkovic@ipgp.fr	Neumann, Gregory A/I-5591-2013; Miljkovic, Katarina/O-3769-2019; Wieczorek, Mark A/G-6427-2010; Laneuville, Matthieu/F-8523-2010; Miljkovic, Katarina/D-4844-2013	Neumann, Gregory A/0000-0003-0644-9944; Miljkovic, Katarina/0000-0001-8644-8903; Wieczorek, Mark A/0000-0001-7007-4222; Laneuville, Matthieu/0000-0001-6022-0046; Miljkovic, Katarina/0000-0001-8644-8903; Collins, Gareth/0000-0002-6087-6149	UnivEarthS LabEx project of the University of Sorbonne Paris Cite [ANR-10-LABX-0023, ANR-11-IDEX-0005-02]; UK Science & Technology Facilities Council [ST/J001260/1]; French Space Agency (CNES); Discovery Program of NASA; Science and Technology Facilities Council [ST/G002452/1, ST/J001260/1] Funding Source: researchfish; STFC [ST/G002452/1, ST/J001260/1] Funding Source: UKRI	UnivEarthS LabEx project of the University of Sorbonne Paris Cite; UK Science & Technology Facilities Council; French Space Agency (CNES)(Centre National D'etudes Spatiales); Discovery Program of NASA; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Supported by UnivEarthS LabEx project of the University of Sorbonne Paris Cite grants ANR-10-LABX-0023 and ANR-11-IDEX-0005-02 (K.M.), UK Science & Technology Facilities Council grant ST/J001260/1 (G.S.C.), and the French Space Agency (CNES). The GRAIL mission is supported by the Discovery Program of NASA and is performed under contract to the Massachusetts Institute of Technology and the Jet Propulsion Laboratory, California Institute of Technology. We gratefully acknowledge the developers of iSALE-2D/3D (www.isale-code.de).	Amsden A.A., 1980, LA8095 LOS AL NAT LA; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P3049, DOI 10.1029/JB090iB04p03049; Collins GS, 2004, METEORIT PLANET SCI, V39, P217, DOI 10.1111/j.1945-5100.2004.tb00337.x; Fassett CI, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003951; Fassett CI, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004154; Fernandes VA, 2013, METEORIT PLANET SCI, V48, P241, DOI 10.1111/maps.12054; Hess PC, 2001, J GEOPHYS RES-PLANET, V106, P28023, DOI 10.1029/2000JE001416; Hikida H, 2007, ICARUS, V192, P150, DOI 10.1016/j.icarus.2007.06.015; Huttig C, 2008, PHYS EARTH PLANET IN, V171, P137, DOI 10.1016/j.pepi.2008.07.007; Ivanov BA, 2010, GEOL SOC AM SPEC PAP, V465, P29, DOI 10.1130/2010.2465(03); Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Kamata S, 2013, J GEOPHYS RES-PLANET, V118, P398, DOI 10.1002/jgre.20056; Korotev RL, 2000, J GEOPHYS RES-PLANET, V105, P4317, DOI 10.1029/1999JE001063; Kring DA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001529; Laneuville M, 2013, J GEOPHYS RES-PLANET, V118, P1435, DOI 10.1002/jgre.20103; Lawrence DJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002050; Le Feuvre M, 2011, ICARUS, V214, P1, DOI 10.1016/j.icarus.2011.03.010; Neumann GA, 1996, J GEOPHYS RES-PLANET, V101, P16841, DOI 10.1029/96JE01246; Norman MD, 2010, GEOCHIM COSMOCHIM AC, V74, P763, DOI 10.1016/j.gca.2009.10.024; Pierazzo E, 2005, GEOL SOC AM SPEC PAP, V384, P443, DOI 10.1130/0-8137-2384-1.443; Potter RWK, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052981; SOLOMON SC, 1982, J GEOPHYS RES, V87, P3975, DOI 10.1029/JB087iB05p03975; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Turtle EP, 2005, GEOL SOC AM SPEC PAP, V384, P1, DOI 10.1130/0-8137-2384-1.1; Wieczorek MA, 1999, ICARUS, V139, P246, DOI 10.1006/icar.1999.6102; Wieczorek MA, 2000, J GEOPHYS RES-PLANET, V105, P20417, DOI 10.1029/1999JE001092; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; Williams JP, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003655; Wunnemann K, 2006, ICARUS, V180, P514, DOI 10.1016/j.icarus.2005.10.013; Zhong SJ, 2000, EARTH PLANET SC LETT, V177, P131, DOI 10.1016/S0012-821X(00)00041-8; Zuber MT, 2013, SCIENCE, V339, P668, DOI 10.1126/science.1231507	32	80	82	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					724	726		10.1126/science.1243224	http://dx.doi.org/10.1126/science.1243224			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202170				2022-12-28	WOS:000326647600039
J	Ruelas, DS; Greene, WC				Ruelas, Debbie S.; Greene, Warner C.			An Integrated Overview of HIV-1 Latency	CELL			English	Review							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; NF-KAPPA-B; RETROVIRUSES HTLV-III; RNA-POLYMERASE-II; LONG TERMINAL REPEAT; P-TEFB; TRANSCRIPTIONAL ELONGATION; GENE-EXPRESSION	Despite significant advances in our understanding of HIV, a cure has not been realized for the more than 34 million infected with this virus. HIV is incurable because infected individuals harbor cells where the HIV provirus is integrated into the host's DNA but is not actively replicating and thus is not inhibited by antiviral drugs. Similarly, these latent viruses are not detected by the immune system. In this Review, we discuss HIV-1 latency and the mechanisms that allow this pathogenic retrovirus to hide and persist by exploiting the cellular vehicles of immunological memory.	[Ruelas, Debbie S.; Greene, Warner C.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Ruelas, Debbie S.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA.	wgreene@gladstone.ucsf.edu			Martin Delaney CARE Collaboratory [NIH NIAID U19 AI096113]; UCSF Microbial Pathogenesis and Host Defense Program [NIH NIAID 5 T32 AI60537-9]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113, T32AI060537] Funding Source: NIH RePORTER	Martin Delaney CARE Collaboratory; UCSF Microbial Pathogenesis and Host Defense Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Anna Lisa Lucido and Gary Howard for editorial assistance; John C.W. Carroll for graphic arts; and Robin Givens and Sue Cammack for administrative assistance. This work was supported by the Martin Delaney CARE Collaboratory (NIH NIAID U19 AI096113) and the UCSF Microbial Pathogenesis and Host Defense Program (NIH NIAID 5 T32 AI60537-9).	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; BEDNARIK DP, 1991, NEW BIOL, V3, P969; Blazkova J, 2012, J VIROL, V86, P5390, DOI 10.1128/JVI.00040-12; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Dybul M, 2002, J INFECT DIS, V185, P61, DOI 10.1086/338123; Evering TH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002506; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FRIEDMANKIEN AE, 1981, J AM ACAD DERMATOL, V5, P468, DOI 10.1016/S0190-9622(81)80010-2; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Glaser KB, 2003, MOL CANCER THER, V2, P151; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Gras G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-30; Greger IH, 1998, NUCLEIC ACIDS RES, V26, P1294, DOI 10.1093/nar/26.5.1294; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; Hezareh Marjan, 2004, Antiviral Chemistry & Chemotherapy, V15, P207; HO DD, 1986, J CLIN INVEST, V77, P1712, DOI 10.1172/JCI112491; Hu WY, 2004, VIRUS RES, V102, P59, DOI 10.1016/j.virusres.2004.01.016; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Kaehlcke K, 2003, MOL CELL, V12, P167, DOI 10.1016/S1097-2765(03)00245-4; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; Kim YK, 2011, J MOL BIOL, V410, P896, DOI 10.1016/j.jmb.2011.03.054; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Lafeuillade A, 2001, J ACQ IMMUN DEF SYND, V26, P44, DOI 10.1097/00126334-200101010-00006; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; OTT M, 2004, NOVART FDN SYMP, V259, P223; Ott M., 2004, NOVART FDN SYMP, V259, P193; Ott Melanie, 2004, Novartis Found Symp, V259, P182; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Perez M, 2010, CURR HIV RES, V8, P418, DOI 10.2174/157016210793499312; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Popov S, 2005, J VIROL, V79, P602, DOI 10.1128/JVI.79.1.602-608.2005; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; SCHUPBACH J, 1984, SCIENCE, V224, P503, DOI 10.1126/science.6200937; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; SIEGAL FP, 1981, NEW ENGL J MED, V305, P1439, DOI 10.1056/NEJM198112103052403; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith BA, 2001, J IMMUNOL, V166, P690, DOI 10.4049/jimmunol.166.1.690; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	96	198	209	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					519	529		10.1016/j.cell.2013.09.044	http://dx.doi.org/10.1016/j.cell.2013.09.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243012	Green Accepted, Bronze			2022-12-28	WOS:000326571800008
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Oral Cancer: U.S. Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS; UNITED-STATES; MORTALITY; KERALA	Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for oral cancer. Methods: The USPSTF reviewed the evidence on whether screening for oral cancer reduces morbidity or mortality and on the accuracy of the oral screening examination for identifying oral cancer or potentially malignant disorders that have a high likelihood of progression to oral cancer. Population: This recommendation applies to asymptomatic adults aged 18 years or older who are seen by primary care providers. This recommendation focuses on screening of the oral cavity performed by primary care providers and not dental providers or otolaryngologists. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.	US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), USPSTF, Washington, DC 20024 USA.		Phillips, William/V-1065-2017	Phillips, William/0000-0003-2802-4349; Pignone, Michael/0000-0002-6657-7342				American Academy of Family Physicians, 2004, CLIN REC OR CANC; American Cancer Society, 2013, AM CANC SOC GUID EAR; BLOT WJ, 1988, CANCER RES, V48, P3282; Brown LM, 2011, CANCER CAUSE CONTROL, V22, P753, DOI 10.1007/s10552-011-9748-1; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cleveland JL, 2011, J AM DENT ASSOC, V142, P915, DOI 10.14219/jada.archive.2011.0298; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Moyer VA, 2013, ANN INTERN MED, V159, P210, DOI 10.7326/0003-4819-159-3-201308060-00652; National Cancer Institute, 2012, SEER STAT FACT SHEET; National Institute of Dental and Craniofacial Research, 2011, DET OR CANC GUID HLT; Olson CM, 2013, AHRQ PUBLICATION; Rethman MP, 2010, J AM DENT ASSOC, V141, P509, DOI 10.14219/jada.archive.2010.0223; Sankaranarayanan R, 2005, LANCET, V365, P1927, DOI 10.1016/S0140-6736(05)66658-5; Sankaranarayanan R, 2013, ORAL ONCOL, V49, P314, DOI 10.1016/j.oraloncology.2012.11.004; U.S. Preventive Services Task Force, 2004, AHRQ PUBLICATION, V05-0564-A; US Cancer Statistics Working Group, 2013, US CANC STAT 1999 20; US Preventive Serv Task Force, 2009, ANN INTERN MED, V150, P551, DOI 10.7326/0003-4819-150-8-200904210-00009	17	57	59	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					55	+		10.7326/M13-2568	http://dx.doi.org/10.7326/M13-2568			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297IS	24276469				2022-12-28	WOS:000330249700007
J	Zhang, YB; Wong, CH; Birnbaum, RY; Li, GL; Favaro, R; Ngan, CY; Lim, J; Tai, E; Poh, HM; Wong, E; Mulawadi, FH; Sung, WK; Nicolis, S; Ahituv, N; Ruan, YJ; Wei, CL				Zhang, Yubo; Wong, Chee-Hong; Birnbaum, Ramon Y.; Li, Guoliang; Favaro, Rebecca; Ngan, Chew Yee; Lim, Joanne; Tai, Eunice; Poh, Huay Mei; Wong, Eleanor; Mulawadi, Fabianus Hendriyan; Sung, Wing-Kin; Nicolis, Silvia; Ahituv, Nadav; Ruan, Yijun; Wei, Chia-Lin			Chromatin connectivity maps reveal dynamic promoter-enhancer long-range associations	NATURE			English	Article							NEURAL STEM-CELLS; REGULATORY SEQUENCES; GENE-EXPRESSION; MOUSE; PLURIPOTENT; VERTEBRATE; CIRCUITRY	In multicellular organisms, transcription regulation is one of the central mechanisms modelling lineage differentiation and cell-fate determination(1). Transcription requires dynamic chromatin configurations between promoters and their corresponding distal regulatory elements(2). It is believed that their communication occurs within large discrete foci of aggregated RNA polymerases termed transcription factories in three-dimensional nuclear space(3). However, the dynamic nature of chromatin connectivity has not been characterized at the genome-wide level. Here, through a chromatin interaction analysis with paired-end tagging approach(3-5) using an antibody that primarily recognizes the pre-initiation complexes of RNA polymerase II6, we explore the transcriptional interactomes of three mouse cells of progressive lineage commitment, including pluripotent embryonic stem cells(7), neural stem cells(8) and neurosphere stem/progenitor cells(9). Our global chromatin connectivity maps reveal approximately 40,000 long-range interactions, suggest precise enhancer-promoter associations and delineate cell-type-specific chromatin structures. Analysis of the complex regulatory repertoire shows that there are extensive colocalizations among promoters and distal-acting enhancers. Most of the enhancers associate with promoters located beyond their nearest active genes, indicating that the linear juxtaposition is not the only guiding principle driving enhancer target selection. Although promoter-enhancer interactions exhibit high cell-type specificity, promoters involved in interactions are found to be generally common and mostly active among different cells. Chromatin connectivity networks reveal that the pivotal genes of reprogramming functions are transcribed within physical proximity to each other in embryonic stem cells, linking chromatin architecture to coordinated gene expression. Our study sets the stage for the full-scale dissection of spatial and temporal genome structures and their roles in orchestrating development.	[Zhang, Yubo; Wong, Chee-Hong; Ngan, Chew Yee; Wei, Chia-Lin] Lawrence Berkeley Natl Lab, Joint Genome Inst, Sequencing Technol Grp, Walnut Creek, CA 94598 USA; [Birnbaum, Ramon Y.; Ahituv, Nadav] UCSF, Inst Human Genet, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Li, Guoliang; Ruan, Yijun] Univ Connecticut, Jackson Lab Genom Med, Farmington, CT 06030 USA; [Li, Guoliang; Ruan, Yijun] Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Li, Guoliang; Lim, Joanne; Tai, Eunice; Poh, Huay Mei; Wong, Eleanor; Mulawadi, Fabianus Hendriyan; Sung, Wing-Kin; Wei, Chia-Lin] Genome Inst Singapore, Singapore 138672, Singapore; [Favaro, Rebecca; Nicolis, Silvia] Univ Milano Bicocca, Dept Biol Sci & Biotechnol, I-20126 Milan, Italy	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; Jackson Laboratory; University of Connecticut; University of Connecticut; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Milano-Bicocca	Wei, CL (corresponding author), Lawrence Berkeley Natl Lab, Joint Genome Inst, Sequencing Technol Grp, Walnut Creek, CA 94598 USA.	cwei@lbl.gov	Favaro, Rebecca/HHZ-8978-2022; Li, Guoliang/D-8014-2012	Favaro, Rebecca/0000-0002-6195-5711; Li, Guoliang/0000-0003-1601-6640; NICOLIS, SILVIA KIRSTEN/0000-0003-0378-3808; Zhang, Yubo/0000-0002-4121-8853; Ahituv, Nadav/0000-0002-7434-8144; Sung, Wing-Kin/0000-0001-7806-7086; Wong, Eleanor/0000-0001-7094-7679; Birnbaum, Ramon/0000-0002-3792-1095; ngan, chew yee/0000-0001-6055-1072	ASTIL Regione Lombardia (SAL-19) [16874]; Telethon [GGP12152]; Cariplo [2010-0673]; AIRC [IG-5801]; NINDS [R01NS079231]; NICHD [R01HD059862]; NHGRI [R01HG005058, R01HG006768]; NIDDK [R01DK090382]; NIGMS [GM61390]; Simons Foundation SFARI [256769]; UCSF Program for Biomedical Breakthrough Research (PBBR); Agency for Science, Technology and Research (A*STAR), Singapore; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; National Institutes of Health ENCODE [R01 HG004456-01, R01HG003521-01, 1U54HG004557-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005058, R01HG004456, U54HG004557, R01HG006768, R01HG003521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061390, U01GM061390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079231] Funding Source: NIH RePORTER	ASTIL Regione Lombardia (SAL-19); Telethon(Fondazione Telethon); Cariplo(Fondazione Cariplo); AIRC(Fondazione AIRC per la ricerca sul cancro); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Simons Foundation SFARI; UCSF Program for Biomedical Breakthrough Research (PBBR); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health ENCODE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank J. Mariani for the preparation of RNA from NPC; K. Murphy and A. Ku for their assistance with zebrafish enhancer assays; and A. Visel and A. Nord for discussion and their comments on the manuscript. S.N. and R. F. were supported by grants from ASTIL Regione Lombardia (SAL-19 ref. no. 16874), Telethon (GGP12152), Cariplo (Rif. 2010-0673) and AIRC (IG-5801). N.A. is supported by NINDS grant number R01NS079231, NICHD grant number R01HD059862, NHGRI grant numbers R01HG005058 and R01HG006768, NIDDK award number R01DK090382, NIGMS award number GM61390 and Simons Foundation SFARI no. 256769. R.Y.B. is supported by NINDS grant number R01NS079231 and the UCSF Program for Biomedical Breakthrough Research (PBBR). This work was supported by Agency for Science, Technology and Research (A*STAR), Singapore, the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231 and National Institutes of Health ENCODE grants (R01 HG004456-01, R01HG003521-01 and 1U54HG004557-01) to Y.R. and C.-L.W.	Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bolli N, 2010, BLOOD, V115, P3329, DOI 10.1182/blood-2009-02-207225; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zappone MV, 2000, DEVELOPMENT, V127, P2367	30	294	305	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					306	+		10.1038/nature12716	http://dx.doi.org/10.1038/nature12716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24213634	Green Accepted			2022-12-28	WOS:000328121500042
J	Wellings, K; Johnson, AM				Wellings, Kaye; Johnson, Anne M.			Framing sexual health research: adopting a broader perspective	LANCET			English	Editorial Material							PLEASURE; RISK		[Wellings, Kaye] Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Sexual & Reprod Hlth Res, London WC1H 9SH, England; [Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Wellings, K (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Sexual & Reprod Hlth Res, London WC1H 9SH, England.	kaye.wellings@lshtm.ac.uk		Johnson, Anne/0000-0003-1330-7100	Medical Research Council [G0701757] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10244] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Charnetski CJ, 2004, PSYCHOL REP, V94, P839; Department of Health, 2001, UK NAT SERV FRAM OLD; Department of Health, 2001, NAT SEX HLTH HIV STR; DIXONMUELLER R, 1993, STUD FAMILY PLANN, V24, P269, DOI 10.2307/2939221; Ebrahim S, 2002, J EPIDEMIOL COMMUN H, V56, P99, DOI 10.1136/jech.56.2.99; Higgins JA, 2008, AM J PUBLIC HEALTH, V98, P1803, DOI 10.2105/AJPH.2007.115790; Ingham R., 2005, SEX ED, V5, P375, DOI [DOI 10.1080/14681810500278451, 10.1080/14681810500278451]; JOHNSON AM, 1992, NATURE, V360, P410, DOI 10.1038/360410a0; Khan Sharful Islam, 2004, Sex Health, V1, P217, DOI 10.1071/SH04009; Light KC, 2005, BIOL PSYCHOL, V69, P5, DOI 10.1016/j.biopsycho.2004.11.002; Macdowall W, 2013, LANCET; MADDOX J, 1989, NATURE, V341, P181, DOI 10.1038/341181a0; Mercer CH, 2013, LANCET; Miller E, 2010, CONTRACEPTION, V81, P457, DOI 10.1016/j.contraception.2010.02.023; Mitchell KR, 2013, LANCET; National Institute on Aging, 2007, LIV LONG WELL 21 CEN; Pettifor A, 2009, INT PERSPECT SEX R H, V35, P82, DOI [10.1363/3508209, 10.1363/ifpp.35.082.09]; Philpott A, 2006, LANCET, V368, P2028, DOI 10.1016/S0140-6736(06)69810-3; Sareen J, 2009, GEN HOSP PSYCHIAT, V31, P274, DOI 10.1016/j.genhosppsych.2009.02.004; Smit J, 2002, SOC SCI MED, V55, P1511, DOI 10.1016/S0277-9536(01)00284-2; Smith GD, 1997, BMJ-BRIT MED J, V315, P1641, DOI 10.1136/bmj.315.7123.1641; Sonnenberg P, 2013, LANCET; Sonnenberg P, 2013, LANCET; Sprecher S, 2004, HANDBOOK OF SEXUALITY IN CLOSE RELATIONSHIPS, P235; Wellings K, 2001, SEX TRANSM INFECT, V77, P238, DOI 10.1136/sti.77.4.238; Wellings K., 2013, LANCET; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; World Health Organization, 2006, DEF SEX HLTH REP TEC; World Health Organization, 2010, DEV SEX HLTH PROGR F; Yeh HC, 2006, J FAM PSYCHOL, V20, P339, DOI 10.1037/0893-3200.20.2.339; 2005, CONTRACEPT TECHNOL U, V26, P4	31	40	40	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1759	1762		10.1016/S0140-6736(13)62378-8	http://dx.doi.org/10.1016/S0140-6736(13)62378-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24286782	hybrid, Green Accepted			2022-12-28	WOS:000327540700008
J	Norman, TM; Lord, ND; Paulsson, J; Losick, R				Norman, Thomas M.; Lord, Nathan D.; Paulsson, Johan; Losick, Richard			Memory and modularity in cell-fate decision making	NATURE			English	Article							STOCHASTIC GENE-EXPRESSION; BACILLUS-SUBTILIS; SINGLE-CELL; MASTER REGULATOR; POPULATION HETEROGENEITY; EPIGENETIC INHERITANCE; BIOFILM FORMATION; NOISE; SWITCH; PROTEIN	Genetically identical cells sharing an environment can display markedly different phenotypes. It is often unclear how much of this variation derives from chance, external signals, or attempts by individual cells to exert autonomous phenotypic programs. By observing thousands of cells for hundreds of consecutive generations under constant conditions, we dissect the stochastic decision between a solitary, motile state and a chained, sessile state in Bacillus subtilis. We show that the motile state is 'memoryless', exhibiting no autonomous control over the time spent in the state. In contrast, the time spent as connected chains of cells is tightly controlled, enforcing coordination among related cells in the multicellular state. We show that the three-protein regulatory circuit governing the decision is modular, as initiation and maintenance of chaining are genetically separable functions. As stimulation of the same initiating pathway triggers biofilm formation, we argue that autonomous timing allows a trial commitment to multicellularity that external signals could extend.	[Norman, Thomas M.; Lord, Nathan D.; Paulsson, Johan] Harvard Univ, Sch Med, Dept Systemat Bot, Boston, MA 02115 USA; [Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Paulsson, J (corresponding author), Harvard Univ, Sch Med, Dept Systemat Bot, Boston, MA 02115 USA.	Johan_Paulsson@hms.harvard.edu; losick@mcb.harvard.edu		Lord, Nathan/0000-0001-9553-2779	National Science Foundation [ECS-0335765]; NIH [GM18568, GM081563]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM081563, R01GM018568] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Lindner for sharing an early version of the microfluidic mother machine with our groups. We thank Y. Chai for discussions and C. Saenz, V. Lien, S. Hickman, J. Tresback and J. Deng for technical help with microfluidic fabrication. This work was performed in part at the Harvard Medical School Microfluidics Facility and in part at the Center for Nanoscale Systems(CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. CNS is part of Harvard University. This work was supported by grants from the NIH to R.L. (GM18568) and J.P (GM081563).	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Aldous D., 1989, PROBABILITY APPROXIM; BAI U, 1993, GENE DEV, V7, P139, DOI 10.1101/gad.7.1.139; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Chai YR, 2010, MOL MICROBIOL, V78, P218, DOI 10.1111/j.1365-2958.2010.07335.x; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chen R, 2009, J BACTERIOL, V191, P5775, DOI 10.1128/JB.00521-09; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DELANGE RJ, 1976, J BIOL CHEM, V251, P705; Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huang GH, 2006, P NATL ACAD SCI USA, V103, P12813, DOI 10.1073/pnas.0605270103; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kolodkin-Gal I, 2013, GENE DEV, V27, P887, DOI 10.1101/gad.215244.113; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Mather W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.208101; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; MUTH EJ, 1980, IEEE T RELIAB, V29, P160, DOI 10.1109/TR.1980.5220764; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Newman JA, 2013, J BIOL CHEM, V288, P10766, DOI 10.1074/jbc.M113.455592; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rubinstein SM, 2012, MOL MICROBIOL, V86, P426, DOI 10.1111/j.1365-2958.2012.08201.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Teng SW, 2013, SCIENCE, V340, P737, DOI 10.1126/science.1230996; Tolkamp BJ, 2010, APPL ANIM BEHAV SCI, V124, P1, DOI 10.1016/j.applanim.2010.02.004; Ullman G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0025; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; WEHRLI M, 1995, DEVELOPMENT, V121, P2451	51	156	156	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					481	+		10.1038/nature12804	http://dx.doi.org/10.1038/nature12804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24256735	Green Accepted, Green Submitted			2022-12-28	WOS:000327464200034
J	Reipurth, B				Reipurth, Bo			George Herbig (1920-2013) OBITUARY	NATURE			English	Biographical-Item									Univ Hawaii, Honolulu, HI 96822 USA	University of Hawaii System	Reipurth, B (corresponding author), Univ Hawaii, Honolulu, HI 96822 USA.	reipurth@ifa.hawaii.edu						HERBIG GH, PUBLICATION LIST	1	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					470	470		10.1038/503470a	http://dx.doi.org/10.1038/503470a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24284724	Bronze			2022-12-28	WOS:000327464200027
J	Benson, RA; Palin, R; Holt, PJE; Loftus, IM				Benson, R. A.; Palin, R.; Holt, P. J. E.; Loftus, I. M.			Diagnosis and management of hyperhidrosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TOXIN TYPE-A; PRIMARY AXILLARY HYPERHIDROSIS; PRIMARY FOCAL HYPERHIDROSIS; BOTULINUM-TOXIN; DOUBLE-BLIND; PALMAR HYPERHIDROSIS; TUMESCENT LIPOSUCTION; TOPICAL GLYCOPYRROLATE; SURGICAL-TREATMENT; NORMAL SALINE		[Benson, R. A.; Loftus, I. M.] St George Hosp, St Georges Vasc Inst, London SW17 0QT, England; [Palin, R.] East Leicestershire & Rutland Clin Commissioning, Leicester, Leics, England; [Holt, P. J. E.] St George Hosp, Dept Outcomes Res, London SW17 0QT, England	St Georges University London; St Georges University London	Benson, RA (corresponding author), St George Hosp, St Georges Vasc Inst, London SW17 0QT, England.	ruth.benson@gmail.com	Holt, Peter J.E./B-2003-2013	Holt, Peter J.E./0000-0002-5739-2813	National Institute for Health Research [NIHR-CS-011-008] Funding Source: researchfish; Department of Health [NIHR-CS-011-008] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		ADAR R, 1977, ANN SURG, V186, P34, DOI 10.1097/00000658-197707000-00006; Amini M, 2008, ACTA DERM-VENEREOL, V88, P356, DOI 10.2340/00015555-0440; Arneja JS, 2007, PLAST RECONSTR SURG, V119, P562, DOI 10.1097/01.prs.0000246490.52593.ec; Askari A, 2013, SURG-J R COLL SURG E, V11, P130, DOI 10.1016/j.surge.2012.09.002; Bajaj V, 2007, BRIT J DERMATOL, V157, P118, DOI 10.1111/j.1365-2133.2007.07884.x; Basra MKA, 2008, BRIT J DERMATOL, V159, P997, DOI 10.1111/j.1365-2133.2008.08832.x; Bechara FG, 2012, DERMATOL SURG, V38, P736, DOI 10.1111/j.1524-4725.2012.02339.x; Bellet JS, 2010, SEMIN CUTAN MED SURG, V29, P121, DOI 10.1016/j.sder.2010.03.004; Cerfolio RJ, 2011, ANN THORAC SURG, V91, P1642, DOI 10.1016/j.athoracsur.2011.01.105; Cetindag Ibrahim B, 2008, Thorac Surg Clin, V18, P217, DOI 10.1016/j.thorsurg.2008.01.009; Davarian S, 2008, AUSTRALAS J DERMATOL, V49, P75, DOI 10.1111/j.1440-0960.2008.00441.x; Deng B, 2011, SURG ENDOSC, V25, P1893, DOI 10.1007/s00464-010-1482-3; Dewey TM, 2006, ANN THORAC SURG, V81, P1227, DOI 10.1016/j.athoracsur.2005.11.006; Doft MA, 2012, AESTHET SURG J, V32, P238, DOI 10.1177/1090820X11434506; Dolianitis Con, 2004, Australas J Dermatol, V45, P208, DOI 10.1111/j.1440-0960.2004.00098.x; Dressler D, 2010, J NEURAL TRANSM, V117, P317, DOI 10.1007/s00702-010-0372-0; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Flanagan KH, 2009, J DRUGS DERMATOL, V8, P477; Frasson E, 2011, ARCH DERMATOL, V147, P122, DOI 10.1001/archdermatol.2010.408; Glass GE, 2009, J PLAST RECONSTR AES, V62, P571, DOI [10.1016/j.bjps.2007.11.047, 10.1016/j.bjps.2008.11.117]; Gregoriou S, 2010, DERMATOL SURG, V36, P496, DOI 10.1111/j.1524-4725.2010.01473.x; Grunfeld A, 2009, AM J CLIN DERMATOL, V10, P87, DOI 10.2165/00128071-200910020-00002; Guimaraes PSF, 2013, SURG LAPARO ENDO PER, V23, P223, DOI 10.1097/SLE.0b013e31828a0aec; Gulec AT, 2012, J EUR ACAD DERMATOL, V26, P314, DOI 10.1111/j.1468-3083.2011.04066.x; Hayton MJ, 2003, BRIT J DERMATOL, V149, P447, DOI 10.1046/j.1365-2133.2003.05593.x; Henteleff Harry J, 2008, Thorac Surg Clin, V18, P209, DOI 10.1016/j.thorsurg.2008.01.008; Hoorens I, 2012, J EUR ACAD DERMATOL, V26, P1, DOI 10.1111/j.1468-3083.2011.04173.x; Hornberger J, 2004, J AM ACAD DERMATOL, V51, P274, DOI 10.1016/j.jaad.2003.12.029; Huang YH, 2010, DERMATOL SURG, V36, P1573, DOI 10.1111/j.1524-4725.2010.01685.x; Hund Martina, 2004, J Dtsch Dermatol Ges, V2, P343, DOI 10.1046/j.1439-0353.2004.04765.x; Ibrahim O, 2013, J AM ACAD DERMATOL, V69, P88, DOI 10.1016/j.jaad.2013.02.013; Kavanagh GM, 2006, J AM ACAD DERMATOL, V55, pS115, DOI 10.1016/j.jaad.2005.07.017; Kim WO, 2008, BRIT J DERMATOL, V158, P1094, DOI 10.1111/j.1365-2133.2008.08476.x; Kontochristopoulos G, 2006, DERMATOL SURG, V32, P873, DOI 10.1111/j.1524-4725.2006.32181.x; Kreyden OP, 2004, CLIN DERMATOL, V22, P40, DOI 10.1016/j.clindermatol.2003.12.029; Lakraj AAD, 2013, TOXINS, V5, P821, DOI 10.3390/toxins5040821; Lear W, 2007, DERMATOL SURG, V33, pS69, DOI 10.1111/j.1524-4725.2006.32334.x; Lee D, 2006, DERMATOL SURG, V32, P505, DOI 10.1111/j.1524-4725.2006.32103.x; Li YJ, 2012, J PLAST RECONSTR AES, V65, pE320, DOI 10.1016/j.bjps.2012.05.020; Lonsdale-Eccles A, 2003, CLIN EXP DERMATOL, V28, P2, DOI 10.1046/j.1365-2230.2003.01162.x; MacKenzie A, 2013, BRIT J DERMATOL, V169, P483, DOI 10.1111/bjd.12320; McAleer MA, 2013, J DERMATOL TREAT; Moreau MS, 2003, BRIT J DERMATOL, V149, P1041, DOI 10.1111/j.1365-2133.2003.05620.x; Muller C, 2013, J EUR ACAD DERMATOL, V27, P1278, DOI 10.1111/j.1468-3083.2012.04708.x; National Institute for Health and Care Excellence, HYP CLIN KNOWL SUMM; Naumann M, 2001, BRIT MED J, V323, P596, DOI 10.1136/bmj.323.7313.596; Naumann MK, 2002, BRIT J DERMATOL, V8, P247; NHS Choices, TREAT HYP; PLAS EG, 1995, SURGERY, V118, P493, DOI 10.1016/S0039-6060(05)80364-2; Ro KM, 2002, J VASC SURG, V35, P382, DOI 10.1067/mva.2002.119507; Rosell K, 2013, ACTA DERM-VENEREOL, V93, P335, DOI 10.2340/00015555-1464; Roustit M, 2013, BR J CLIN PHARM; SATO K, 1987, AM J PHYSIOL, V252, pR166, DOI 10.1152/ajpregu.1987.252.1.R166; Schlereth T, 2009, DTSCH ARZTEBL INT, V106, P32, DOI 10.3238/arztebl.2009.0032; Shams K, 2011, INTERVENTIONS EXCESS; Solish N, 2007, DERMATOL SURG, V33, P908, DOI 10.1111/j.1524-4725.2007.33192.x; Streker M, 2012, J DTSCH DERMATOL GES, V10, P115, DOI 10.1111/j.1610-0387.2011.07750.x; Strutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040; Swinehart JM, 2000, DERMATOL SURG, V26, P392, DOI 10.1046/j.1524-4725.2000.00604.x; Talarico S, 2007, DERMATOL SURG, V33, pS44, DOI 10.1111/j.1524-4725.2006.32331.x; Vadoud-Seyedi J, 2007, BRIT J DERMATOL, V156, P986, DOI 10.1111/j.1365-2133.2007.07760.x; Vorkamp T, 2010, SURG-J R COLL SURG E, V8, P287, DOI 10.1016/j.surge.2010.06.002; Walling HW, 2012, J AM ACAD DERMATOL, V66, P387, DOI 10.1016/j.jaad.2011.01.023; Wolosker N, 2013, INT J DERMATOL, V52, P620, DOI 10.1111/j.1365-4632.2012.05746.x; Wolosker N, 2012, J VASC SURG, V55, P1696, DOI 10.1016/j.jvs.2011.12.039	65	26	30	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2013	347								f6800	10.1136/bmj.f6800	http://dx.doi.org/10.1136/bmj.f6800			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FA	24277380				2022-12-28	WOS:000327791000003
J	Nathanson, V				Nathanson, Vivienne			Doctors must confront homophobia because it causes harm	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMA, London WC1H 9JR, England		Nathanson, V (corresponding author), BMA, London WC1H 9JR, England.	vnathanson@bma.org.uk							0	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2013	347								f7012	10.1136/bmj.f7012	http://dx.doi.org/10.1136/bmj.f7012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KZ	24270508				2022-12-28	WOS:000327459500011
J	Hooper, R; Froud, RJ; Bremner, SA; Perera, R; Eldridge, S				Hooper, Richard; Froud, Robert J.; Bremner, Stephen A.; Perera, Rafael; Eldridge, Sandra			Cascade diagrams for depicting complex interventions in randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BEHAVIOR-CHANGE		[Hooper, Richard; Bremner, Stephen A.; Eldridge, Sandra] Queen Mary Univ London, Blizard Inst, Ctr Primary Care & Publ Hlth, London E1 2AT, England; [Froud, Robert J.] Univ Warwick, Clin Trials Unit, Div Hlth Sci, Warwick, England; [Froud, Robert J.] Norges Helsehoyskole, Oslo, Norway; [Perera, Rafael] Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford, England	University of London; Queen Mary University London; University of Warwick; University of Oxford	Hooper, R (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Primary Care & Publ Hlth, London E1 2AT, England.	r.l.hooper@qmul.ac.uk	Froud, Robert/AAQ-2429-2021; Bremner, Stephen/R-4038-2016	Froud, Robert/0000-0002-9193-2297; Bremner, Stephen/0000-0003-0790-7070; Hooper, Richard/0000-0002-1063-0917; Eldridge, Sandra/0000-0001-5638-2317; Perera, Rafael/0000-0003-2418-2091				Abraham C, 2013, WIDER RECOMMENDATION; Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Donner A, 2000, STAT METHODS MED RES, V9, P79, DOI 10.1191/096228000669355658; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Johnson S, 2009, J PEDIATR-US, V155, P488, DOI 10.1016/j.jpeds.2009.04.013; Kumarapeli Pushpa, 2007, Inform Prim Care, V15, P245; Michie S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-40; Perera R, 2013, PAT PLOT; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Pino C, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-63; Pitt M, 2009, INT J TECHNOL ASSESS, V25, P555, DOI 10.1017/S0266462309990286; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; UK Medical Research Council, 2008, COMPL INT GUID; Underwood M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-27; Wells M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-95	20	11	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 15	2013	347								f6681	10.1136/bmj.f6681	http://dx.doi.org/10.1136/bmj.f6681			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254HR	24243975	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000327156300001
J	Thammavongsa, V; Missiakas, DM; Schneewind, O				Thammavongsa, Vilasack; Missiakas, Dominique M.; Schneewind, Olaf			Staphylococcus aureus Degrades Neutrophil Extracellular Traps to Promote Immune Cell Death	SCIENCE			English	Article							ACTIVATION; EXPRESSION; APOPTOSIS; VIRULENCE; TOXICITY	Bacterial invasion of host tissues triggers polymorphonuclear leukocytes to release DNA [neutrophil extracellular traps (NETs)], thereby immobilizing microbes for subsequent clearance by innate defenses including macrophage phagocytosis. We report here that Staphylococcus aureus escapes these defenses by converting NETs to deoxyadenosine, which triggers the caspase-3-mediated death of immune cells. Conversion of NETs to deoxyadenosine requires two enzymes, nuclease and adenosine synthase, that are secreted by S. aureus and are necessary for the exclusion of macrophages from staphylococcal abscesses. Thus, the pathogenesis of S. aureus infections has evolved to anticipate host defenses and to repurpose them for the destruction of the immune system.	[Thammavongsa, Vilasack; Missiakas, Dominique M.; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu			National Institute of Allergy and Infectious Diseases [AI038897, AI052474, AI057153]; American Heart Association [POST4590023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052474, T32AI007090, R01AI038897, U54AI057153] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. D. Sauer for macrophages. This work was supported by grants from the National Institute of Allergy and Infectious Diseases (AI038897, AI052474, and AI057153) and the American Heart Association (POST4590023). We declare no conflicting financial interests. V. T. performed experiments; V. T., D. M. M., and O.S. interpreted data, designed experiments, and wrote the paper.	Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Bestebroer J, 2009, BLOOD, V113, P328, DOI 10.1182/blood-2008-04-153882; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CARSON DA, 1979, P NATL ACAD SCI USA, V76, P2430, DOI 10.1073/pnas.76.5.2430; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Franco R, 2007, CRIT REV IMMUNOL, V27, P495, DOI 10.1615/CritRevImmunol.v27.i6.10; GIBLETT ER, 1972, LANCET, V2, P1067; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; KREDICH NM, 1977, CELL, V12, P931, DOI 10.1016/0092-8674(77)90157-X; Laarman AJ, 2012, EMBO J, V31, P3607, DOI 10.1038/emboj.2012.212; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Niitsu N, 1998, BLOOD, V92, P3368, DOI 10.1182/blood.V92.9.3368.421k27_3368_3375; REDDI KK, 1960, NATURE, V187, P74, DOI 10.1038/187074a0; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Thammavongsa V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-56; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097	20	243	259	5	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					863	866		10.1126/science.1242255	http://dx.doi.org/10.1126/science.1242255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233725	Green Accepted			2022-12-28	WOS:000326923000040
J	Levey, NN				Levey, Noam N.			The Media and Health Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Levey, Noam N.] Los Angeles Times, Los Angeles, CA 90053 USA		Levey, NN (corresponding author), 1090 Vermont Ave NW,Ste 1000, Washington, DC 20005 USA.	Noam.Levey@latimes.com						Democracy Corps, INS GOP REP FOC GROU; Fisher M, 9 QUESTIONS SYRIA YO; Jensen E., 2013, NEWSPRO, V4, P4; Jensen E., 2013, NEWSPRO, V4, P30; Kulkarni SC, FALLING LIFE EXPECTA; Newport F, 2 3 UNINSURED AM PLA; Nyhan B, HAZARDS CORRECTING M; Scripps Interactive Newspapers Group, COST DIAB SPEC REP; The Commonwealth Fund, US HLTH SYST SCOR	9	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1941	1942		10.1001/jama.2013.281852	http://dx.doi.org/10.1001/jama.2013.281852			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219948				2022-12-28	WOS:000326832900017
J	Malik, S; Roeder, RG				Malik, Sohail; Roeder, Robert G.			Have Your PIC!	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; TRANSCRIPTION INITIATION; MEDIATOR COACTIVATOR; COMPLEX; MECHANISM; ARCHITECTURE		[Malik, Sohail; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA	Rockefeller University	Malik, S (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, 1230 York Ave, New York, NY 10065 USA.	maliks@rockefeller.edu; roeder@rockefeller.edu						Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Malik S, 2007, P NATL ACAD SCI USA, V104, P6182, DOI 10.1073/pnas.0608717104; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Treutlein B, 2012, MOL CELL, V46, P136, DOI 10.1016/j.molcel.2012.02.008; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023	15	1	1	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					706	707		10.1126/science.1246170	http://dx.doi.org/10.1126/science.1246170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202169				2022-12-28	WOS:000326647600032
J	Mastny, M; Heuck, A; Kurzbauer, R; Heiduk, A; Boisguerin, P; Volkmer, R; Ehrmann, M; Rodrigues, CDA; Rudner, DZ; Clausen, T				Mastny, Markus; Heuck, Alexander; Kurzbauer, Robert; Heiduk, Anja; Boisguerin, Prisca; Volkmer, Rudolf; Ehrmann, Michael; Rodrigues, Christopher D. A.; Rudner, David Z.; Clausen, Tim			CtpB Assembles a Gated Protease Tunnel Regulating Cell-Cell Signaling during Spore Formation in Bacillus subtilis	CELL			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTOR; PDZ DOMAIN; INTRAMEMBRANE PROTEOLYSIS; ACTIVATION MECHANISM; GENE-EXPRESSION; STRESS-RESPONSE; DEGS PROTEASE; SPORULATION; COMPLEX; PRO-SIGMA(K)	Spore formation in Bacillus subtilis relies on a regulated intramembrane proteolysis (RIP) pathway that synchronizes mother-cell and forespore development. To address the molecular basis of this SpoIV transmembrane signaling, we carried out a structure- function analysis of the activating protease CtpB. Crystal structures reflecting distinct functional states show that CtpB constitutes a ring-like protein scaffold penetrated by two narrow tunnels. Access to the proteolytic sites sequestered within these tunnels is controlled by PDZ domains that rearrange upon substrate binding. Accordingly, CtpB resembles a minimal version of a self-compartmentalizing protease regulated by a unique allosteric mechanism. Moreover, biochemical analysis of the PDZgated channel combined with sporulation assays reveal that activation of the SpoIV RIP pathway is induced by the concerted activity of CtpB and a second signaling protease, SpoIVB. This proteolytic mechanism is of broad relevance for cell-cell communication, illustrating how distinct signaling pathways can be integrated into a single RIP module.	[Mastny, Markus; Heuck, Alexander; Kurzbauer, Robert; Clausen, Tim] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Heiduk, Anja; Boisguerin, Prisca; Volkmer, Rudolf] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Ehrmann, Michael] Univ Duisburg Essen, Ctr Med Biotechnol, D-45117 Essen, Germany; [Ehrmann, Michael] Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Rodrigues, Christopher D. A.; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen; Cardiff University; Harvard University; Harvard Medical School	Clausen, T (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	clausen@imp.univie.ac.at	Ehrmann, Michael/A-7307-2012; Rodrigues, Christopher/AAA-5112-2021; Boisguerin, Prisca/AAG-6565-2020	Ehrmann, Michael/0000-0002-1927-260X; Boisguerin, Prisca/0000-0002-6955-1340; Volkmer, Rudolf/0000-0003-4710-1143; Rodrigues, Christopher/0000-0003-4541-0145; Clausen, Tim/0000-0003-1582-6924	Austrian Science Fund [W1221]; EMBO Long-Term Fellowship; Deutsche Forschungsgemeinschaft [VO885/2]; National Institute of Health [GM086466]; Boehringer Ingelheim; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086466] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the beamline staff at the DESY, SLS, and ESRF for their assistance during data collection and Mathias Madalinski for peptide synthesis. We thank members of the Clausen lab for support and encouragement. This work was supported by grants from the Austrian Science Fund (W1221 "DK Structure and Interaction of Biological Macromolecules'' to M.M.), EMBO Long-Term Fellowship (A H.), Deutsche Forschungsgemeinschaft (M.E.; VO885/2 to R.V and P.B.), and the National Institute of Health (GM086466 to D.Z.R.). The IMP is funded by Boehringer Ingelheim.	Boisguerin P, 2007, CHEMBIOCHEM, V8, P2302, DOI 10.1002/cbic.200700518; Brandstetter H, 2001, NATURE, V414, P466, DOI 10.1038/35106609; Campo N, 2007, J BACTERIOL, V189, P6021, DOI 10.1128/JB.00399-07; Campo N, 2006, MOL CELL, V23, P25, DOI 10.1016/j.molcel.2006.05.019; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; CUTTING S, 1990, CELL, V62, P239, DOI 10.1016/0092-8674(90)90362-I; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Fokine A, 2008, J BIOL CHEM, V283, P7242, DOI 10.1074/jbc.M709398200; Goettig P, 2005, J BIOL CHEM, V280, P33387, DOI 10.1074/jbc.M505030200; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; HARA H, 1991, J BACTERIOL, V173, P4799, DOI 10.1128/jb.173.15.4799-4813.1991; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Hoa NT, 2002, J BACTERIOL, V184, P191, DOI 10.1128/JB.184.1.191-199.2002; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; KROOS L, 1989, SCIENCE, V243, P526, DOI 10.1126/science.2492118; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; LOSICK R, 1992, NATURE, V355, P601, DOI 10.1038/355601a0; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Pan Q, 2003, J BACTERIOL, V185, P6051, DOI 10.1128/JB.185.20.6051-6056.2003; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; Resnekov O, 1998, P NATL ACAD SCI USA, V95, P3162, DOI 10.1073/pnas.95.6.3162; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; TAKAHASHI M, 1988, FEBS LETT, V240, P6, DOI 10.1016/0014-5793(88)80330-2; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Zhou RB, 2005, MOL MICROBIOL, V58, P835, DOI 10.1111/j.1365-2958.2005.04870.x	33	23	24	2	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					647	658		10.1016/j.cell.2013.09.050	http://dx.doi.org/10.1016/j.cell.2013.09.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243021	Green Published, hybrid			2022-12-28	WOS:000326571800018
J	Sen, M; Maillard, RA; Nyquist, K; Rodriguez-Aliaga, P; Presse, S; Martin, A; Bustamante, C				Sen, Maya; Maillard, Rodrigo A.; Nyquist, Kristofor; Rodriguez-Aliaga, Piere; Presse, Steve; Martin, Andreas; Bustamante, Carlos			The ClpXP Protease Unfolds Substrates Using a Constant Rate of Pulling but Different Gears	CELL			English	Article							HOMOMERIC RING ATPASE; AAA PLUS MOTORS; OPERATING PRINCIPLES; MACHINE; DEGRADATION; MOLECULE; FORCE; MECHANOCHEMISTRY; TRANSLOCATION; COORDINATION	ATP-dependent proteases are vital to maintain cellular protein homeostasis. Here, we study the mechanisms of force generation and intersubunit coordination in the ClpXP protease from E. coli to understandhowthesemachines couple ATPhydrolysis to mechanical protein unfolding. Single-molecule analyses reveal that phosphate release is the forcegenerating step in the ATP-hydrolysis cycle and that ClpXP translocates substrate polypeptides in bursts resulting from highly coordinated conformational changes in two to four ATPase subunits. ClpXP must use its maximum successive firing capacity of four subunits to unfold stable substrates like GFP. The average dwell duration between individual bursts of translocation is constant, regardless of the number of translocating subunits, implying that ClpXP operates with constant "rpm" but uses different "gears."	[Sen, Maya; Maillard, Rodrigo A.; Rodriguez-Aliaga, Piere; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Sen, Maya; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Maillard, Rodrigo A.; Nyquist, Kristofor; Rodriguez-Aliaga, Piere; Martin, Andreas; Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Nyquist, Kristofor; Rodriguez-Aliaga, Piere] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Martin, Andreas; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Presse, Steve] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46202 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Indiana University System; Indiana University-Purdue University Indianapolis	Martin, A (corresponding author), Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA.	a.martin@berkeley.edu; carlos@alice.berkeley.edu	Rodriguez-Aliaga, Piere/HHS-8446-2022	Rodriguez-Aliaga, Piere/0000-0002-3828-4235; Bustamante, Carlos/0000-0002-2970-0073; Martin, Andreas/0000-0003-0923-3284	NSF; Searle Scholars Program; NIH [R01-GM094497-01A1, R01-GM0325543]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-05CH11231]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790, T32GM008295, R01GM032543, R01GM071552, R01GM094497] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Searle Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Shixin Liu, Gheorghe Chistol, Ninning Liu, Christian Kaiser, and Mary Matyskiela for helpful discussions. M.S. and K.N. acknowledge support from the NSF Graduate Research Fellowship. This research was supported in part by the Searle Scholars Program (A.M.), the NIH grant R01-GM094497-01A1 (A.M.), the NIH grant R01-GM0325543 (C.B.), the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under contract no. DE-AC02-05CH11231 (C.B.), and the Howard Hughes Medical Institute (C.B.).	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chistol G, 2012, CELL, V151, P1017, DOI 10.1016/j.cell.2012.10.031; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hwang W, 2013, CELL MOL BIOENG, V6, P65, DOI 10.1007/s12195-012-0264-5; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kalafut B, 2008, COMPUT PHYS COMMUN, V179, P716, DOI 10.1016/j.cpc.2008.06.008; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	33	96	96	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					636	646		10.1016/j.cell.2013.09.022	http://dx.doi.org/10.1016/j.cell.2013.09.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243020	Bronze, Green Accepted			2022-12-28	WOS:000326571800017
J	Ruiz, R; Silva, GR; Menchaca, HRM				Ruiz, Ricardo; Rivera Silva, Gerardo; Martinez Menchaca, Hector R.			Focal epithelial hyperplasia	LANCET			English	Editorial Material									[Ruiz, Ricardo; Rivera Silva, Gerardo; Martinez Menchaca, Hector R.] Univ Monterrey, Div Hlth Sci, Monterrey, NL, Mexico	Universidad de Monterrey	Menchaca, HRM (corresponding author), Ave I Morones Prieto 4500 Pte, San Pedro Garza Garcia 66238, NL, Mexico.	hector.martinez@udem.edu.mx	Silva, Gerardo Rivera/AAH-6871-2021	Silva, Gerardo Rivera/0000-0003-2587-5914					0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					173	173		10.1016/S0140-6736(13)62221-7	http://dx.doi.org/10.1016/S0140-6736(13)62221-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	24269109				2022-12-28	WOS:000338921500036
J	Sami, S; Williams, HA; Krause, S; Onyango, MA; Burton, A; Tomczyk, B				Sami, Samira; Williams, Holly A.; Krause, Sandra; Onyango, Monica A.; Burton, Ann; Tomczyk, Barbara			Responding to the Syrian crisis: the needs of women and girls	LANCET			English	Editorial Material							REPRODUCTIVE HEALTH; COMPLEX EMERGENCIES		[Sami, Samira; Williams, Holly A.; Tomczyk, Barbara] US Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Atlanta, GA 30341 USA; [Krause, Sandra] Womens Refugee Commiss, New York, NY USA; [Onyango, Monica A.] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA USA; [Burton, Ann] UN High Commissioner Refugees, Amman, Jordan	Centers for Disease Control & Prevention - USA; Boston University	Tomczyk, B (corresponding author), US Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Atlanta, GA 30341 USA.	bet8@cdc.gov		Onyango, Monica Adhiambo/0000-0003-4998-1682				Austin J, 2008, REPROD HEALTH MATTER, V16, P10, DOI 10.1016/S0968-8080(08)31351-2; CARE International, 2013, SYR REF URB JORD; Chynoweth SK, 2008, REPROD HEALTH MATTER, V16, P93, DOI 10.1016/S0968-8080(08)31348-2; Coutts A, 2013, LANCET, V381, pE6, DOI 10.1016/S0140-6736(13)60053-7; Inter-agency Working Group on Reproductive Health in Crisis, 2010, INT FIELD MAN REPR H; International Committee of the Red Cross, WAT INT HUM LAW; Kastrup MC, 2006, WORLD PSYCHIATRY, V5, P33; Lautze S, 2004, LANCET, V364, P2134, DOI 10.1016/S0140-6736(04)17555-7; Lindsey C., 2001, WOMEN FACING WAR; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; UN High Commissioner for Refugees, SYR REG REF RESP INT; UN High Commissioner for Refugees, 2013, INT REG RESP SYR REF; UN High Commissioner for Refugees, 2012, REP PART ASS UNHCR; UN High Commissioner for Refugees, 2012, REP PART ASS UNHCR A; UN Office for the Coordination of Humanitarian Affairs, 2013, SYR HUM B; UN Population Fund, 2013, UNFPA REG SIT REP SY; United Nations High Commissioner for Refugees, 2013, SYR REG RESP PLAN JA; Usta J., 2013, ASSESSMENT REPROD HL; World Vision, 2013, ADV REP PRESS IMP SY	19	36	36	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1179	1181		10.1016/S0140-6736(13)62034-6	http://dx.doi.org/10.1016/S0140-6736(13)62034-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4MH	24211044				2022-12-28	WOS:000333956000037
J	Starling, RC; Moazami, N; Silvestry, SC; Ewald, G; Rogers, JG; Milano, CA; Rame, JE; Acker, MA; Blackstone, EH; Ehrlinger, J; Thuita, L; Mountis, MM; Soltesz, EG; Lytle, BW; Smedira, NG				Starling, Randall C.; Moazami, Nader; Silvestry, Scott C.; Ewald, Gregory; Rogers, Joseph G.; Milano, Carmelo A.; Rame, J. Eduardo; Acker, Michael A.; Blackstone, Eugene H.; Ehrlinger, John; Thuita, Lucy; Mountis, Maria M.; Soltesz, Edward G.; Lytle, Bruce W.; Smedira, Nicholas G.			Unexpected Abrupt Increase in Left Ventricular Assist Device Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BackgroundWe observed an apparent increase in the rate of device thrombosis among patients who received the HeartMate II left ventricular assist device, as compared with preapproval clinical-trial results and initial experience. We investigated the occurrence of pump thrombosis and elevated lactate dehydrogenase (LDH) levels, LDH levels presaging thrombosis (and associated hemolysis), and outcomes of different management strategies in a multi-institutional study. MethodsWe obtained data from 837 patients at three institutions, where 895 devices were implanted from 2004 through mid-2013; the mean (SD) age of the patients was 5514 years. The primary end point was confirmed pump thrombosis. Secondary end points were confirmed and suspected thrombosis, longitudinal LDH levels, and outcomes after pump thrombosis. ResultsA total of 72 pump thromboses were confirmed in 66 patients; an additional 36 thromboses in unique devices were suspected. Starting in approximately March 2011, the occurrence of confirmed pump thrombosis at 3 months after implantation increased from 2.2% (95% confidence interval [CI], 1.5 to 3.4) to 8.4% (95% CI, 5.0 to 13.9) by January 1, 2013. Before March 1, 2011, the median time from implantation to thrombosis was 18.6 months (95% CI, 0.5 to 52.7), and from March 2011 onward, it was 2.7 months (95% CI, 0.0 to 18.6). The occurrence of elevated LDH levels within 3 months after implantation mirrored that of thrombosis. Thrombosis was presaged by LDH levels that more than doubled, from 540 IU per liter to 1490 IU per liter, within the weeks before diagnosis. Thrombosis was managed by heart transplantation in 11 patients (1 patient died 31 days after transplantation) and by pump replacement in 21, with mortality equivalent to that among patients without thrombosis; among 40 thromboses in 40 patients who did not undergo transplantation or pump replacement, actuarial mortality was 48.2% (95% CI, 31.6 to 65.2) in the ensuing 6 months after pump thrombosis. ConclusionsThe rate of pump thrombosis related to the use of the HeartMate II has been increasing at our centers and is associated with substantial morbidity and mortality.	[Starling, Randall C.; Mountis, Maria M.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Moazami, Nader; Blackstone, Eugene H.; Soltesz, Edward G.; Lytle, Bruce W.; Smedira, Nicholas G.] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA; [Blackstone, Eugene H.; Ehrlinger, John; Thuita, Lucy] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Starling, Randall C.; Moazami, Nader; Blackstone, Eugene H.; Mountis, Maria M.; Soltesz, Edward G.; Smedira, Nicholas G.] Cleveland Clin, Kaufman Ctr Heart Failure, Cleveland, OH 44195 USA; [Silvestry, Scott C.] Washington Univ, Barnes Jewish Hosp, Div Cardiovasc Surg, St Louis, MO 63130 USA; [Ewald, Gregory] Washington Univ, Barnes Jewish Hosp, Div Cardiovasc, St Louis, MO 63130 USA; [Rogers, Joseph G.] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA; [Milano, Carmelo A.] Duke Univ, Sch Med, Div Cardiovasc Surg, Durham, NC USA; [Rame, J. Eduardo] Univ Penn, Div Cardiol, Philadelphia, PA 19104 USA; [Acker, Michael A.] Univ Penn, Div Cardiovasc Surg, Philadelphia, PA 19104 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Duke University; Duke University; University of Pennsylvania; University of Pennsylvania	Starling, RC (corresponding author), Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave,Desk J3-4, Cleveland, OH 44195 USA.	starlir@ccf.org	Rame, J. Eduardo/ABF-2208-2021	Rame, J. Eduardo/0000-0002-2936-1702; Moazami, Nader/0000-0001-5306-070X				Andersen PK., 1993, STAT MODELS BASED CO, P176; [Anonymous], 2013, INITIAL ANAL SUSPECT; BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Goldstein DJ, 2013, J HEART LUNG TRANSPL, V32, P667, DOI 10.1016/j.healun.2013.05.002; Ishwaran H., 2007, R NEWS, V7, P25; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kirklin JK, 2013, J HEART LUNG TRANSPL, V32, P141, DOI 10.1016/j.healun.2012.12.004; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; R Core Team, R LANG ENV STAT COMP; Shah P, 2013, J HEART LUNG TRANSPL; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Starling RC, 2011, J AM COLL CARDIOL, V57, P1890, DOI 10.1016/j.jacc.2010.10.062; Steffen RJ, 2013, J HEART LUNG TRANSPL; Taghavi S, 2013, ANN THORAC SURG, V96, P1259, DOI 10.1016/j.athoracsur.2013.05.081	17	578	585	1	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					33	40		10.1056/NEJMoa1313385	http://dx.doi.org/10.1056/NEJMoa1313385			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284XA	24283197	Green Published			2022-12-28	WOS:000329354100008
J	Cheerambathur, DK; Gassmann, R; Cook, B; Oegema, K; Desai, A				Cheerambathur, Dhanya K.; Gassmann, Reto; Cook, Brian; Oegema, Karen; Desai, Arshad			Crosstalk Between Microtubule Attachment Complexes Ensures Accurate Chromosome Segregation	SCIENCE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; KINETOCHORE; DYNEIN; COMPONENTS; INTERFACE; MECHANISM; PROTEIN	The microtubule-based mitotic spindle segregates chromosomes during cell division. During chromosome segregation, the centromeric regions of chromosomes build kinetochores that establish end-coupled attachments to spindle microtubules. Here, we used the Caenorhabditis elegans embryo as a model system to examine the crosstalk between two kinetochore protein complexes implicated in temporally distinct stages of attachment formation. The kinetochore dynein module, which mediates initial lateral microtubule capture, inhibited microtubule binding by the Ndc80 complex, which ultimately forms the end-coupled attachments that segregate chromosomes. The kinetochore dynein module directly regulated Ndc80, independently of phosphorylation by Aurora B kinase, and this regulation was required for accurate segregation. Thus, the conversion from initial dynein-mediated, lateral attachments to correctly oriented, Ndc80-mediated end-coupled attachments is actively controlled.	[Cheerambathur, Dhanya K.; Gassmann, Reto; Cook, Brian; Oegema, Karen; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Desai, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Gassmann, Reto/M-6488-2013	Gassmann, Reto/0000-0002-0360-2977; Cook, Brian/0000-0002-5777-3464; Cheerambathur, Dhanya/0000-0001-8525-8366	NIH [GM074215]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Japanese National BioResource Project for the ndc-80 deletion strain, K. Corbett for helpful discussions, and B. Green for comments on the manuscript. The data described here are tabulated in the main paper and the supplementary materials. This work was supported by an NIH grant (GM074215) to A. D; A. D. and K.O. receive salary and other support from the Ludwig Institute for Cancer Research.	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Barisic M, 2010, MOL BIOL CELL, V21, P1968, DOI 10.1091/mbc.E09-04-0356; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Civril F, 2010, STRUCTURE, V18, P616, DOI 10.1016/j.str.2010.02.014; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Lampert F, 2013, J CELL BIOL, V200, P21, DOI 10.1083/jcb.201210091; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Scaerou F, 1999, J CELL SCI, V112, P3757; Schmidt JC, 2012, DEV CELL, V23, P968, DOI 10.1016/j.devcel.2012.09.012; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Stein KK, 2007, GENETICS, V175, P107, DOI 10.1534/genetics.106.059105; Umbreit NT, 2012, P NATL ACAD SCI USA, V109, P16113, DOI 10.1073/pnas.1209615109; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034	27	60	77	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1239	1242		10.1126/science.1246232	http://dx.doi.org/10.1126/science.1246232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24231804	Green Accepted			2022-12-28	WOS:000327857900049
J	Stecker, EC; Schroeder, SA				Stecker, Eric C.; Schroeder, Steven A.			Adding Value to Relative-Value Units	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PAYMENT; CARE	Many important physician activities are not measurable by means of the current relative-value unit system. But a reconfigured RVU system could evolve into the best method for accounting for physicians' services in new value-based delivery and payment systems. Relative-value units (RVUs) were developed in 1988 as a method of accounting for physicians' work effort and hospital or clinic expenses. Because RVUs provided a uniform, formulaic metric for myriad clinical services, they quickly became the prevailing method for setting fee-for-service payments for Medicare and private insurance. However, the dominance of the fee-for-service model has created strong structural impediments to physicians' participation in value-focused health care.(1) The success of new models of care will require not only changes in the way that health systems are organized and paid but also vigorous engagement by generalists and specialists, yet RVU formulas for ...	[Stecker, Eric C.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Schroeder, Steven A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Oregon Health & Science University; University of California System; University of California San Francisco	Stecker, EC (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA.							Christianson JB, 2011, EXPLORING ALTERNATIV; Houle SKD, 2012, ANN INTERN MED, V157, P889, DOI 10.7326/0003-4819-157-12-201212180-00009; Landon BE, 2012, NEW ENGL J MED, V366, P393, DOI 10.1056/NEJMp1112637; McMahon LF, 2012, JAMA-J AM MED ASSOC, V307, P671, DOI 10.1001/jama.2012.136; Schroeder SA, 2013, NEW ENGL J MED, V368, P2029, DOI 10.1056/NEJMsb1302322	5	39	39	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2176	2179		10.1056/NEJMp1310583	http://dx.doi.org/10.1056/NEJMp1310583			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	263II	24256346				2022-12-28	WOS:000327801100003
J	Hay, S				Hay, Simon			Football fever could be a dose of dengue	NATURE			English	Editorial Material									Univ Oxford, Wellcome Trust, Oxford OX1 2JD, England	University of Oxford	Hay, S (corresponding author), Univ Oxford, Wellcome Trust, Oxford OX1 2JD, England.	simon.hay@zoo.ox.ac.uk	Brady, Oliver/P-9421-2019; Hay, Simon Iain/F-8967-2015	Brady, Oliver/0000-0002-3235-2129; Hay, Simon Iain/0000-0002-0611-7272	Wellcome Trust [095066] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [1090403] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))			0	20	20	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					439	439		10.1038/503439a	http://dx.doi.org/10.1038/503439a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24284696	Bronze			2022-12-28	WOS:000327464200006
J	Ostrem, JM; Peters, U; Sos, ML; Wells, JA; Shokat, KM				Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Wells, James A.; Shokat, Kevan M.			K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions	NATURE			English	Article							ONCOGENE PRODUCT P21; H-RAS P21; PROTEIN; KRAS; SITE; MUTAGENESIS; DISCOVERY; MUTATION; REVEALS; DOMAIN	Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally associated with poor response to standard therapies(1-3). Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP(4) and the absence of known allosteric regulatory sites. Oncogenic mutations result in functional activation of Ras family proteins by impairing GTP hydrolysis(5,6). With diminished regulation by GTPase activity, the nucleotide state of Ras becomes more dependent on relative nucleotide affinity and concentration. This gives GTP an advantage over GDP(7) and increases the proportion of active GTP-bound Ras. Here we report the development of small molecules that irreversibly bind to a common oncogenic mutant, K-Ras(G12C). These compounds rely on the mutant cysteine for binding and therefore do not affect the wild-type protein. Crystallographic studies reveal the formation of a new pocket that is not apparent in previous structures of Ras, beneath the effector binding switch-II region. Binding of these inhibitors to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favour GDP over GTP and impairing binding to Raf. Our data provide structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.	[Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	kevan.shokat@ucsf.edu	Wells, Jim A/O-9854-2016; Sos, Martin L/I-1852-2014	Peters, Ulf/0000-0003-4664-8198; Ostrem, Jonathan/0000-0001-9085-1615	postdoctoral fellowship of the Tobacco-related Disease Research Program [19FT-0069]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Prostate Cancer Foundation (PCF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER	postdoctoral fellowship of the Tobacco-related Disease Research Program; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Prostate Cancer Foundation (PCF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Burlingame and J. Sadowsky for assistance with the tethering screen; P. Ren and Y. Liu for assistance in chemical design and discussions; N. Younger for preparing several compounds; J. Kuriyan for sharing SOS and H-Ras constructs; F. McCormick and T. Yuan for discussion and sharing K-Ras reagents; R. Goody, K. Shannon and F. Wittinghofer for discussion. U.P. was supported by a postdoctoral fellowship of the Tobacco-related Disease Research Program (19FT-0069). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231. M.L.S. is a fellow of the International Association for the Study of Lung Cancer (IASLC) and receives a Young Investigator Award of the Prostate Cancer Foundation (PCF).	Ahmadian MR, 1999, P NATL ACAD SCI USA, V96, P7065, DOI 10.1073/pnas.96.12.7065; Bar-Sagi D, 2001, MOL CELL BIOL, V21, P1441, DOI 10.1128/MCB.21.5.1441-1443.2001; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Burlingame MA, 2011, ACS COMB SCI, V13, P205, DOI 10.1021/co200038g; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Forbes SA, 2008, CURR PROTOC HUM GENE, V57, DOI DOI 10.11.1-10.11.26; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Hwang MCC, 1996, J BIOL CHEM, V271, P8196, DOI 10.1074/jbc.271.14.8196; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1993, J BIOL CHEM, V268, P923; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Naven RT, 2013, TOXICOL RES-UK, V2, P235, DOI 10.1039/c3tx50027f; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Sadowsky JD, 2011, P NATL ACAD SCI USA, V108, P6056, DOI 10.1073/pnas.1102376108; SCHERER A, 1989, J MOL BIOL, V206, P257, DOI 10.1016/0022-2836(89)90540-8; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Sun Q., 2012, ANGEW CHEM, V124, P6244, DOI DOI 10.1002/ange.201201358; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; SUNG YJ, 1995, BIOCHEMISTRY-US, V34, P3470, DOI 10.1021/bi00010a040; Taveras AG, 1997, BIOORGAN MED CHEM, V5, P125, DOI 10.1016/S0968-0896(96)00202-7; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624	30	1192	1261	30	323	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					548	+		10.1038/nature12796	http://dx.doi.org/10.1038/nature12796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24256730	Green Accepted			2022-12-28	WOS:000327464200048
J	Sokol, DK				Sokol, Daniel K.			Where law and ethics diverge: the ethics of intimate body searches	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London, England	University of London; King's College London	Sokol, DK (corresponding author), Kings Coll London, London, England.	daniel.sokol@talk21.com						British Medical Association, 2010, REC HEALTHC PROF ASK	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2013	347								f6974	10.1136/bmj.f6974	http://dx.doi.org/10.1136/bmj.f6974			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KZ	24270369				2022-12-28	WOS:000327459500006
J	Kwon, I; Kato, M; Xiang, SH; Wu, L; Theodoropoulos, P; Mirzaei, H; Han, T; Xie, SH; Corden, JL; McKnight, SL				Kwon, Ilmin; Kato, Masato; Xiang, Siheng; Wu, Leeju; Theodoropoulos, Pano; Mirzaei, Hamid; Han, Tina; Xie, Shanhai; Corden, Jeffry L.; McKnight, Steven L.			Phosphorylation-Regulated Binding of RNA Polymerase II to Fibrous Polymers of Low-Complexity Domains	CELL			English	Article							CARBOXY-TERMINAL DOMAIN; CELL-FREE FORMATION; EWING SARCOMA; IN-VITRO; CTD; TRANSCRIPTION; PROTEIN; KINASE; FUS; EXPRESSION	The low-complexity (LC) domains of the products of the fused in sarcoma (FUS), Ewings sarcoma (EWS), and TAF15 genes are translocated onto a variety of different DNA-binding domains and thereby assist in driving the formation of cancerous cells. In the context of the translocated fusion proteins, these LC sequences function as transcriptional activation domains. Here, we show that polymeric fibers formed from these LC domains directly bind the C-terminal domain (CTD) of RNA polymerase II in a manner reversible by phosphorylation of the iterated, heptad repeats of the CTD. Mutational analysis indicates that the degree of binding between the CTD and the LC domain polymers correlates with the strength of transcriptional activation. These studies offer a simple means of conceptualizing how RNA polymerase II is recruited to active genes in its unphosphorylated state and released for elongation following phosphorylation of the CTD.	[Kwon, Ilmin; Kato, Masato; Xiang, Siheng; Wu, Leeju; Theodoropoulos, Pano; Mirzaei, Hamid; Han, Tina; Xie, Shanhai; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Corden, Jeffry L.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu	Xiang, Siheng/A-5063-2010	Xiang, Siheng/0000-0003-4475-5707	NIH [GM066108]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the shared resource cores in Microscopic Imaging, Proteomics and DNA Sequencing at UTSWMC for technical support; Dr. Robert Tycko for provision of the electron micrograph of amyloid fibers included in the graphical abstract; Dr. David Trudgian for help with mass spectrometry; and Drs. Bruce Alberts, Deepak Nijhawan, Michael Brown, and Michael Rosen for helpful comments on the composition of the manuscript. This work was funded by an unrestricted endowment provided S.L.M. by an anonymous donor and NIH grant GM066108 for J.L.C.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Bertolotti A, 1999, ONCOGENE, V18, P8000, DOI 10.1038/sj.onc.1203207; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Guipaud O, 2006, PROTEOMICS, V6, P5962, DOI 10.1002/pmic.200600259; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Ichikawa H, 1999, MOL CELL BIOL, V19, P7639; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Ramanathan Y, 2001, J BIOL CHEM, V276, P10913, DOI 10.1074/jbc.M010975200; Rasband W., 2006, IMAGEJ; Rickert P, 1999, ONCOGENE, V18, P1093, DOI 10.1038/sj.onc.1202399; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513	38	347	350	3	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1049	1060		10.1016/j.cell.2013.10.033	http://dx.doi.org/10.1016/j.cell.2013.10.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267890	Bronze, Green Accepted			2022-12-28	WOS:000327500600010
J	Landry, CR; Levy, ED; Abd Rabbo, D; Tarassov, K; Michnick, SW				Landry, Christian R.; Levy, Emmanuel D.; Abd Rabbo, Diala; Tarassov, Kirill; Michnick, Stephen W.			Extracting Insight from Noisy Cellular Networks	CELL			English	Review							PROTEIN-PROTEIN INTERACTIONS; INTERACTION MAP; IN-VIVO; YEAST; COMPLEXES; IDENTIFICATION; INTERACTOME; EVOLUTION; GRANULES; ORIGINS	Network biologists attempt to extract meaningful relationships among genes or their products from very noisy data. We argue that what we categorize as noisy data may sometimes reflect noisy biology and therefore may shield a hidden meaning about how networks evolve and how matter is organized in the cell. We present practical solutions, based on existing evolutionary and biophysical concepts, through which our understanding of cell biology can be enormously enriched.	[Landry, Christian R.] Univ Laval, Dept Biol, IBIS, Quebec City, PQ G1V 0A6, Canada; [Landry, Christian R.] Univ Laval, PROTEO, Quebec City, PQ G1V 0A6, Canada; [Levy, Emmanuel D.] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Abd Rabbo, Diala; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Tarassov, Kirill] Zora Biosci Oy, Espoo 02150, Finland	Laval University; Laval University; Weizmann Institute of Science; Universite de Montreal	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca		Landry, Christian/0000-0003-3028-6866	Canadian Institutes of Health Research (CIHR) [MOP-GMX-152556, MOP-GMX-231013, GMX-299432, GMX-191597]; Natural Sciences and Engineering Research Council of Canada (NSERC) [194582]; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [1775/12]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	Many of the ideas discussed in this manuscript were inspired by the results of research funded by the Canadian Institutes of Health Research (CIHR) grants MOP-GMX-152556 and MOP-GMX-231013 to S.W.M. and the Natural Sciences and Engineering Research Council of Canada (NSERC) grant 194582 to S.W.M.C.R.L. is a CIHR New Investigator, and his research on PINs is funded by CIHR grants (GMX-299432 and GMX-191597) and by NSERC. E.D.L. acknowledges the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (grant 1775/12).	Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Balaji S, 2008, TRENDS GENET, V24, P319, DOI 10.1016/j.tig.2008.04.006; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Braberg H, 2013, CELL, V154, P775, DOI 10.1016/j.cell.2013.07.033; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2011, SOFT MATTER, V7, P3052, DOI 10.1039/c0sm00981d; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Diss G, 2013, CELL REP, V3, P2155, DOI 10.1016/j.celrep.2013.05.004; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Dreze M, 2009, NAT METHODS, V6, P843, DOI [10.1038/NMETH.1394, 10.1038/nmeth.1394]; Ear PH, 2009, NAT METHODS, V6, P813, DOI [10.1038/NMETH.1389, 10.1038/nmeth.1389]; Elcock AH, 2001, P NATL ACAD SCI USA, V98, P2990, DOI 10.1073/pnas.061411798; Euskirchen G, 2004, NAT GENET, V36, P325, DOI 10.1038/ng0404-325; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Gagnon-Arsenault I, 2013, J PROTEOMICS, V81, P112, DOI 10.1016/j.jprot.2012.09.038; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Hahn MW, 2003, MOL BIOL EVOL, V20, P901, DOI 10.1093/molbev/msg096; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hyman AA, 2011, DEV CELL, V21, P14, DOI 10.1016/j.devcel.2011.06.013; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jensen LJ, 2008, SCIENCE, V322, P56, DOI 10.1126/science.1164801; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Leducq JB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003161; Levy ED, 2012, P NATL ACAD SCI USA, V109, P20461, DOI 10.1073/pnas.1209312109; Levy ED, 2012, PHILOS T R SOC B, V367, P2594, DOI 10.1098/rstb.2012.0078; Levy ED, 2010, SCIENCE, V328, P983, DOI 10.1126/science.1190993; Levy ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.260pe11; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Maher B., 2012, FIGHTING ENCODE JUNK; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Messier V, 2013, CELL, V153, P1080, DOI 10.1016/j.cell.2013.04.035; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valdar WSJ, 2001, J MOL BIOL, V313, P399, DOI 10.1006/jmbi.2001.5034; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wodak SJ, 2013, CURR OPIN STRUC BIOL, V23, P941, DOI 10.1016/j.sbi.2013.08.002; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang JS, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.48; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503	67	37	39	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					983	989		10.1016/j.cell.2013.11.003	http://dx.doi.org/10.1016/j.cell.2013.11.003			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267884	Bronze			2022-12-28	WOS:000327500600004
J	Pope, TM				Pope, Thaddeus Mason			Making Medical Decisions for Patients without Surrogates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								People who are decisionally incapacitated but haven't provided advance directives and have no health care surrogates are often powerless and marginalized. Yet medical decision making for these patients often lacks minimally sufficient safeguards and protections. People who are decisionally incapacitated but haven't provided advance directives for their health care and have no health care surrogates sometimes called the unbefriended or unrepresented are some of the most powerless and marginalized members of society. Most of the unrepresented are elderly, homeless, mentally disabled, or socially alienated. Yet medical decision making for these vulnerable patients often lacks even minimally sufficient safeguards and protections. Consequently, health care decisions made on their behalf are at risk of being biased, arbitrary, corrupt, or careless. Most U.S. states have similar processes for making treatment decisions on behalf of patients without ...	Hamline Univ, Sch Law, Hlth Law Inst, St Paul, MN 55104 USA	Mitchell Hamline School of Law	Pope, TM (corresponding author), Hamline Univ, Sch Law, Hlth Law Inst, St Paul, MN 55104 USA.		Pope, Thaddeus/K-9452-2019	Pope, Thaddeus/0000-0002-7163-505X				[Anonymous], 2013, CAR GEORG UNB ELD VI; Pope Thaddeus Mason, 2012, J Clin Ethics, V23, P177; Pope TM, 2012, CHEST, V141, P1074, DOI 10.1378/chest.11-2336; Pope Thaddeus Mason, 2012, J Clin Ethics, V23, P84; White DB, 2007, ANN INTERN MED, V147, P34, DOI 10.7326/0003-4819-147-1-200707030-00006; White DB, 2012, AM J CRIT CARE, V21, P202, DOI [10.4037/ajcc2012514, 10.4037/AJCC2012514]	6	36	36	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					1976	1978		10.1056/NEJMp1308197	http://dx.doi.org/10.1056/NEJMp1308197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254KE	24256375				2022-12-28	WOS:000327163000003
J	Wilson, M; Goh, T; Voss, U; Bishopp, A; Peret, B; Bennett, M				Wilson, Michael; Goh, Tatsuaki; Voss, Ute; Bishopp, Anthony; Peret, Benjamin; Bennett, Malcolm			SnapShot: Root Development	CELL			English	Editorial Material							ARABIDOPSIS; AUXIN		[Wilson, Michael; Goh, Tatsuaki; Voss, Ute; Bishopp, Anthony; Bennett, Malcolm] Univ Nottingham, Sch Biosci, Ctr Plant Integrat Biol, Nottingham LE12 5RD, England; [Peret, Benjamin] CEA, CNRS, AMU, UMR 7265,Lab Biol Dev Plantes, F-13108 Cadarache, St Paul Lez Dur, France	University of Nottingham; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Wilson, M (corresponding author), Univ Nottingham, Sch Biosci, Ctr Plant Integrat Biol, Nottingham LE12 5RD, England.		Voss, Ute/X-3755-2019; Goh, Tatsuaki/H-4538-2011; Bennett, Malcolm/G-4004-2010	Voss, Ute/0000-0003-2124-9334; Bishopp, Anthony/0000-0003-2962-9542; Goh, Tatsuaki/0000-0002-1064-5801; Wilson, Michael/0000-0002-6323-6059; PERET, Benjamin/0000-0003-1336-0796; Bennett, Malcolm/0000-0003-0475-390X	BBSRC [BB/G023972/1, BB/D019613/1, BB/H020314/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H020314/1, BB/G023972/1, BB/D019613/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Dello Ioio R, 2012, CURR BIOL, V22, P1699, DOI 10.1016/j.cub.2012.07.005; Grebe M, 2012, CURR OPIN PLANT BIOL, V15, P31, DOI 10.1016/j.pbi.2011.10.010; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501	5	4	4	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1190	+		10.1016/j.cell.2013.11.007	http://dx.doi.org/10.1016/j.cell.2013.11.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267898	Bronze			2022-12-28	WOS:000327500600023
J	McCartney, M				McCartney, Margaret			How many new cancers are diagnosed after emergency admission?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2012, DAILY EXPRESS   0921; [Anonymous], 2012, BBC NEWS; Baughan P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606591; Borland S, 2012, DAILY MAIL; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; National Cancer Intelligence Network, 2013, ROUT DIAGN EXPL EM A; North West Cancer Intelligence Service, 2013, ROUT DIAGN INV DIFF; Teenage Cancer Trust, 2013, YOUNG CANC PAT 3 TIM; Teenage Cancer Trust, 2013, IMPR DIAGN REP; Tsang C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-308	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6857	10.1136/bmj.f6857	http://dx.doi.org/10.1136/bmj.f6857			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KF	24259328				2022-12-28	WOS:000327457400009
J	Goldzweig, CL; Orshansky, G; Paige, NM; Towfigh, AA; Haggstrom, DA; Miake-Lye, I; Beroes, JM; Shekelle, PG				Goldzweig, Caroline Lubick; Orshansky, Greg; Paige, Neil M.; Towfigh, Ali Alexander; Haggstrom, David A.; Miake-Lye, Isomi; Beroes, Jessica M.; Shekelle, Paul G.			Electronic Patient Portals: Evidence on Health Outcomes, Satisfaction, Efficiency, and Attitudes	ANNALS OF INTERNAL MEDICINE			English	Review							SHARED MEDICAL-RECORD; CONGESTIVE-HEART-FAILURE; INFORMATION-TECHNOLOGY; HYPERTENSION CONTROL; COLLABORATIVE CARE; ONLINE; INTERNET; ACCESS; COMMUNICATION; MANAGEMENT	Background: Patient portals tied to provider electronic health record (EHR) systems are increasingly popular. Purpose: To systematically review the literature reporting the effect of patient portals on clinical care. Data Sources: PubMed and Web of Science searches from 1 January 1990 to 24 January 2013. Study Selection: Hypothesis-testing or quantitative studies of patient portals tethered to a provider EHR that addressed patient outcomes, satisfaction, adherence, efficiency, utilization, attitudes, and patient characteristics, as well as qualitative studies of barriers or facilitators, were included. Data Extraction: Two reviewers independently extracted data and addressed discrepancies through consensus discussion. Data Synthesis: From 6508 titles, 14 randomized, controlled trials; 21 observational, hypothesis-testing studies; 5 quantitative, descriptive studies; and 6 qualitative studies were included. Evidence is mixed about the effect of portals on patient outcomes and satisfaction, although they may be more effective when used with case management. The effect of portals on utilization and efficiency is unclear, although patient race and ethnicity, education level or literacy, and degree of comorbid conditions may influence use. Limitation: Limited data for most outcomes and an absence of reporting on organizational and provider context and implementation processes. Conclusion: Evidence that patient portals improve health outcomes, cost, or utilization is insufficient. Patient attitudes are generally positive, but more widespread use may require efforts to overcome racial, ethnic, and literacy barriers. Portals represent a new technology with benefits that are still unclear. Better understanding requires studies that include details about context, implementation factors, and cost.	Univ Calif Los Angeles, David Geffen Sch Med, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; Indianapolis Vet Affairs Med Ctr, Indianapolis, IN USA; Indiana Univ Sch Med, Indianapolis, IN 46202 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; Indiana University System; Indiana University Bloomington	Goldzweig, CL (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, 11301 Wilshire Blvd,111-G, Los Angeles, CA 90073 USA.	caroline.goldzweig@va.gov			U.S. Department of Veterans Affairs	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs.	Ammenwerth E, 2012, J MED INTERNET RES, V14, P325, DOI 10.2196/jmir.2238; Bates DW, 2010, HEALTH AFFAIR, V29, P614, DOI 10.1377/hlthaff.2010.0007; Burke RP, 2010, CARDIOL YOUNG, V20, P477, DOI 10.1017/S1047951110000363; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Cho AH, 2010, TELEMED J E-HEALTH, V16, P595, DOI 10.1089/tmj.2009.0164; Day Karen, 2012, Stud Health Technol Inform, V178, P39; Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002; Earnest MA, 2004, J AM MED INFORM ASSN, V11, P410, DOI 10.1197/jamia.M1479; Eklund Benny, 2004, Stud Health Technol Inform, V100, P182; Emani S, 2012, J MED INTERNET RES, V14, P310, DOI 10.2196/jmir.2278; Goel MS, 2011, J AM MED INFORM ASSN, V18, pI8, DOI 10.1136/amiajnl-2011-000473; Grant RW, 2008, ARCH INTERN MED, V168, P1776, DOI 10.1001/archinte.168.16.1776; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Haggstrom DA, 2011, J AM MED INFORM ASSN, V18, pI13, DOI 10.1136/amiajnl-2010-000082; Hassol A, 2004, J AM MED INFORM ASSN, V11, P505, DOI 10.1197/jamia.M1593; Hess R, 2007, TELEMED J E-HEALTH, V13, P509, DOI 10.1089/tmj.2006.0089; Jung C, 2011, AMIA Annu Symp Proc, V2011, P1070; Krist AH, 2012, ANN FAM MED, V10, P312, DOI 10.1370/afm.1383; Lin CT, 2005, J MED INTERNET RES, V7, P13, DOI 10.2196/jmir.7.4.e47; Lyles CR, 2012, MED CARE, V50, P434, DOI 10.1097/MLR.0b013e318249d81b; McCarrier KP, 2009, DIABETES TECHNOL THE, V11, P211, DOI 10.1089/dia.2008.0063; McInnes KD, 2013, AIDS BEHAV; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Palen TE, 2012, JAMA-J AM MED ASSOC, V308, P2012, DOI 10.1001/jama.2012.14126; Ralston JD, 2007, J AM MED INFORM ASSN, V14, P798, DOI 10.1197/jamia.M2302; Ralston JD, 2009, DIABETES CARE, V32, P234, DOI 10.2337/dc08-1220; Ralston JD, 2004, BMJ-BRIT MED J, V328, P1159, DOI 10.1136/bmj.328.7449.1159; Roblin DW, 2009, J AM MED INFORM ASSN, V16, P683, DOI 10.1197/jamia.M3169; Ross SE, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.2.e12; Sarkar U, 2010, J HEALTH COMMUN, V15, P183, DOI 10.1080/10810730.2010.499988; Schnipper JL, 2012, J AM MED INFORM ASSN, V19, P728, DOI 10.1136/amiajnl-2011-000723; Schnipper Jeffrey L, 2008, Inform Prim Care, V16, P147; Shekelle PG, 2010, AHRQ PUBLICATION; Shekelle PG, 2013, HLTH INFORM IN PRESS; Simon GE, 2011, J GEN INTERN MED, V26, P698, DOI 10.1007/s11606-011-1679-8; Tang PC, 2013, J AM MED INFORM ASSN, V20, P526, DOI 10.1136/amiajnl-2012-001263; Tenforde M, 2012, J GEN INTERN MED, V27, P420, DOI 10.1007/s11606-011-1889-0; Terry K., PATIENT PORTAL EXPLO; Tom JO, 2012, PEDIATRICS, V130, pE183, DOI 10.1542/peds.2011-1786; Tsai J, 2012, J AM MED INFORM ASSN, V19, P1089, DOI 10.1136/amiajnl-2012-000971; Tuil WS, 2007, FERTIL STERIL, V88, P361, DOI 10.1016/j.fertnstert.2006.11.197; Volk Lynn A, 2005, AMIA Annu Symp Proc, P1147; Wade-Vuturo AE, 2013, J AM MED INFORM ASSN, V20, P519, DOI 10.1136/amiajnl-2012-001253; Wagner PJ, 2012, J AM MED INFORM ASSN, V19, P626, DOI 10.1136/amiajnl-2011-000349; Wald Jonathan S, 2010, AMIA Annu Symp Proc, V2010, P837; Wald JS, 2010, J AM MED INFORM ASSN, V17, P502, DOI 10.1136/jamia.2009.001362; Wald Jonathan S, 2009, AMIA Annu Symp Proc, V2009, P678; Weppner WG, 2010, DIABETES CARE, V33, P2314, DOI 10.2337/dc10-1124; Wiljer D, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-46; Wright A, 2012, J GEN INTERN MED, V27, P85, DOI 10.1007/s11606-011-1859-6; Yamin CK, 2011, ARCH INTERN MED, V171, P568, DOI 10.1001/archinternmed.2011.34; Zhou Yi Y, 2007, Am J Manag Care, V13, P418; Zickmund SL, 2008, J GEN INTERN MED, V23, P20, DOI 10.1007/s11606-007-0273-6	53	312	313	5	89	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10					677	+		10.7326/0003-4819-159-10-201311190-00006	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-00006			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	276FB	24247673				2022-12-28	WOS:000328732700016
J	Gurm, HS; Hosman, C; Share, D; Moscucci, M; Hansen, BB				Gurm, Hitinder S.; Hosman, Carrie; Share, David; Moscucci, Mauro; Hansen, Ben B.		Michigan Cardiovasc Consortium	Comparative Safety of Vascular Closure Devices and Manual Closure Among Patients Having Percutaneous Coronary Intervention	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIAC-CATHETERIZATION; COMPLICATIONS; METAANALYSIS; RISK; ASSOCIATION; COMPRESSION; ANGIOGRAPHY; MANAGEMENT; MORTALITY; SELECTION	Background: The role of vascular closure devices (VCDs) in patients having percutaneous coronary intervention (PCI) is controversial, and recommendations for use vary. Objective: To examine the use of and outcomes associated with VCDs in real-world practice. Design: Observational cohort study. Setting: 32 hospitals in Michigan that participate in a large multicenter quality improvement collaborative. Patients: Consecutive patients having emergent and nonemergent PCI from 2007 to 2009. Measurements: Vascular complications and the need for transfusion. Results: Of the 85 048 PCIs performed during the study that met the inclusion criteria, 28 528 (37%) procedures used VCDs. In propensity score-matched analysis, VCDs were associated with reductions in vascular complications (odds ratio [OR], 0.78 [95% CI, 0.67 to 0.90]; P = 0.001) and postprocedure transfusions (OR, 0.85 [CI, 0.74 to 0.96]; P = 0.011). These findings were consistent across many prespecified subgroups except for patients with a body mass index (BMI) less than 25 kg/m(2) and those treated with platelet glycoprotein (GP) IIb/IIIa inhibitors, in whom the benefit of VCDs over manual closure was attenuated. When the specific subtypes of vascular complications were evaluated, VCDs were associated with fewer hematomas (OR, 0.69 [CI, 0.58 to 0.83]; P < 0.001) or pseudoaneurysms (OR, 0.54 [CI, 0.38 to 0.76]; P < 0.001) but an increase in the odds of retroperitoneal bleeding (OR, 1.57 [CI, 1.12 to 2.20]; P = 0.009). Limitation: Unmeasured confounding cannot be excluded despite the study having measured and balanced many confounders. Conclusion: Vascular closure devices were associated with a significant reduction in vascular complications and need for transfusion in this large cohort of patients having transfemoral PCI. This benefit was lost in patients receiving GP IIb/IIIa inhibitors and those with normal or lean BMI and was counterbalanced by a small increase in the more serious risk for retroperitoneal bleeding.	Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Blue Cross & Blue Shield Michigan, Detroit, MI USA; Univ Miami, Miami, FL USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Miami	Gurm, HS (corresponding author), Univ Michigan, Ctr Cardiovasc, Div Cardiovasc Med, 2A394,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.	hgurm@med.umich.edu		Gurm, Hitinder/0000-0002-1646-0218; Moscucci, Mauro/0000-0002-9123-4472	Blue Cross Blue Shield of Michigan; National Science Foundation	Blue Cross Blue Shield of Michigan; National Science Foundation(National Science Foundation (NSF))	Blue Cross Blue Shield of Michigan and the National Science Foundation.	Agresti A., 2002, INTRO CATEGORICAL DA, P250; Arora N, 2007, AM HEART J, V153, P606, DOI 10.1016/j.ahj.2006.12.014; Biancari F, 2010, AM HEART J, V159, P518, DOI 10.1016/j.ahj.2009.12.027; Dangas G, 2001, J AM COLL CARDIOL, V38, P638, DOI 10.1016/S0735-1097(01)01449-8; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Gurm HS, 2008, J AM COLL CARDIOL, V51, P529, DOI 10.1016/j.jacc.2007.09.053; Hansen BB, 2004, J AM STAT ASSOC, V99, P609, DOI 10.1198/016214504000000647; Hansen BB, 2008, STAT SCI, V23, P219, DOI 10.1214/08-STS254; Joffe MM, 2004, AM STAT, V58, P272, DOI 10.1198/000313004X5824; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Koreny M, 2004, JAMA-J AM MED ASSOC, V291, P350, DOI 10.1001/jama.291.3.350; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; Marso SP, 2010, JAMA-J AM MED ASSOC, V303, P2156, DOI 10.1001/jama.2010.708; Morgan SL, 2006, SOCIOL METHOD RES, V35, P3, DOI 10.1177/0049124106289164; Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995; Nikolsky E, 2004, J AM COLL CARDIOL, V44, P1200, DOI 10.1016/j.jacc.2004.06.048; Pinto DS, 2008, J AM COLL CARDIOL, V52, P1758, DOI 10.1016/j.jacc.2008.08.021; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; Share DA, 2011, HEALTH AFFAIR, V30, P636, DOI 10.1377/hlthaff.2010.0526; Thomas MP, 2012, J INVASIVE CARDIOL, V24, P97; Trimarchi S, 2010, JACC-CARDIOVASC INTE, V3, P845, DOI 10.1016/j.jcin.2010.05.013	22	23	24	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10					660	+		10.7326/0003-4819-159-10-201311190-00004	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24247671				2022-12-28	WOS:000328732700014
J	Hede, K				Hede, Karyn			EMERGENCY MEDICINE The need for speed	NATURE			English	Editorial Material													Hede, Karyn/AGR-8461-2022	Hede, Karyn/0000-0003-2815-0636				Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6	3	3	4	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S14	S15		10.1038/503S14a	http://dx.doi.org/10.1038/503S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24227001	Bronze			2022-12-28	WOS:000326894200007
J	Smith, RN; Nolan, JP				Smith, Reston N.; Nolan, Jerry P.			Central venous catheters	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BLOOD-STREAM INFECTION; CLINICAL-PRACTICE GUIDELINES; INSERTED CENTRAL CATHETERS; OF-THE-LITERATURE; VEIN CANNULATION; APPLIED ANATOMY; CARE; COMPLICATIONS; CHLORHEXIDINE; THROMBOSIS		[Smith, Reston N.] North Bristol NHS Trust, Bristol, Avon, England; [Nolan, Jerry P.] Royal United Hosp NHS Trust, Bath, Avon, England	North Bristol NHS Trust	Nolan, JP (corresponding author), Royal United Hosp NHS Trust, Bath, Avon, England.	jerry.nolan@nhs.net	Nolan, Jerry P./ABF-2561-2020	Nolan, Jerry/0000-0003-3141-3812				Akl EA, 2011, COCHRANE DB SYST REV, V4; Albrecht K, 2004, BRIT J ANAESTH, V92, P75, DOI 10.1093/bja/aeh013; Bion J, 2013, BMJ QUAL SAF, V22, P110, DOI 10.1136/bmjqs-2012-001325; Chaiyakunapruk N, 2002, ANN INTERN MED, V136, P792, DOI 10.7326/0003-4819-136-11-200206040-00007; Chopra V, 2013, LANCET, V382, P311, DOI 10.1016/S0140-6736(13)60592-9; Chopra V, 2012, AM J MED, V125, P733, DOI 10.1016/j.amjmed.2012.04.010; Cook D, 1997, CRIT CARE MED, V25, P1417, DOI 10.1097/00003246-199708000-00033; Debourdeau P, 2013, J THROMB HAEMOST, V11, P71, DOI 10.1111/jth.12071; Dezfulian C, 2003, CRIT CARE MED, V31, P2385, DOI 10.1097/01.CCM.0000084843.31852.01; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fragou M, 2011, CRIT CARE MED, V39, P1607, DOI 10.1097/CCM.0b013e318218a1ae; Gallieni M, 2008, CA-CANCER J CLIN, V58, P323, DOI 10.3322/CA.2008.0015; Ge X, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004084.pub3; Gibson F, 2013, BRIT J ANAESTH, V110, P333, DOI 10.1093/bja/aes497; Hill R, 2012, COCHRANE DB SYST REV, V4; Hind D, 2003, BMJ-BRIT MED J, V327, P361, DOI 10.1136/bmj.327.7411.361; Hopkins S., 2012, ENGLISH NATL POINT P; Kirkpatrick A, 2007, AM J MED, V120, P901, DOI 10.1016/j.amjmed.2007.05.010; Lai NM, 2013, COCHRANE DB SYST REV, V6; Lamperti M, 2012, INTENS CARE MED, V38, P1105, DOI 10.1007/s00134-012-2597-x; Loveday HP, 2013, EPIC3 NATL EVIDENCE; Maiwald M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044277; Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331; Marik PE, 2012, CRIT CARE MED, V40, P2479, DOI 10.1097/CCM.0b013e318255d9bc; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Monnet X, 2008, INTENS CARE MED, V34, P659, DOI 10.1007/s00134-008-0994-y; National Institute for Health and Care Excellence, 2002, GUID US ULTR IOC DEV; O'Horo JC, 2012, INFECT CONT HOSP EP, V33, P257, DOI 10.1086/664496; Pikwer A, 2012, ANAESTHESIA, V67, P65, DOI 10.1111/j.1365-2044.2011.06911.x; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Pratt RJ, 2007, J HOSP INFECT, V65, pS1, DOI 10.1016/S0195-6701(07)60002-4; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, pc309; Sharma A, 2004, BRIT J ANAESTH, V93, P188, DOI 10.1093/bja/aeh187; Shivakumar SP, 2009, J CLIN ONCOL, V27, P4858, DOI 10.1200/JCO.2009.22.6126; Snaterse M, 2010, J HOSP INFECT, V75, P1, DOI 10.1016/j.jhin.2009.12.017; van de Wetering MD, 2007, COCHRANE DB SYST REV, V1; Van Rooden CJ, 2005, J THROMB HAEMOST, V3, P2409, DOI 10.1111/j.1538-7836.2005.01398.x; WAGHORN DJ, 1994, J HOSP INFECT, V28, P91, DOI 10.1016/0195-6701(94)90136-8; Webster J, 2011, COCHRANE DB SYST REV, V11	41	70	72	4	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2013	347								f6570	10.1136/bmj.f6570	http://dx.doi.org/10.1136/bmj.f6570			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FH	24217269				2022-12-28	WOS:000327149500003
J	Bricard, A; Caussin, JB; Desreumaux, N; Dauchot, O; Bartolo, D				Bricard, Antoine; Caussin, Jean-Baptiste; Desreumaux, Nicolas; Dauchot, Olivier; Bartolo, Denis			Emergence of macroscopic directed motion in populations of motile colloids	NATURE			English	Article							DENSITY-FLUCTUATIONS; COLLECTIVE MOTION; ACTIVE MATTER; HYDRODYNAMICS	From the formation of animal flocks to the emergence of coordinated motion in bacterial swarms, populations of motile organisms at all scales display coherent collective motion. This consistent behaviour strongly contrasts with the difference in communication abilities between the individuals. On the basis of this universal feature, it has been proposed that alignment rules at the individual level could solely account for the emergence of unidirectional motion at the group level(1-4). This hypothesis has been supported by agent-based simulations(1,5,6). However, more complex collective behaviours have been systematically found in experiments, including the formation of vortices(7-9), fluctuating swarms(7,10), clustering(11,12) and swirling(13-16). All these (living and man-made) model systems (bacteria(9,10,16), biofilaments and molecular motors(7,8,13), shaken grains(14,15) and reactive colloids(11,12)) predominantly rely on actual collisions to generate collective motion. As a result, the potential local alignment rules are entangled with more complex, and often unknown, interactions. The large-scale behaviour of the populations therefore strongly depends on these uncontrolled microscopic couplings, which are extremely challenging to measure and describe theoretically. Here we report that dilute populations of millions of colloidal rolling particles self-organize to achieve coherentmotion in a unique direction, with very few density and velocity fluctuations. Quantitatively identifying the microscopic interactions between the rollers allows a theoretical description of this polar-liquid state. Comparison of the theory with experiment suggests that hydrodynamic interactions promote the emergence of collective motion either in the form of a single macroscopic 'flock', at low densities, or in that of a homogenous polar phase, at higher densities. Furthermore, hydrodynamics protects the polar-liquid state from the giant density fluctuations that were hitherto considered the hallmark of populations of self-propelled particles(2,3,17). Our experiments demonstrate that genuine physical interactions at the individual level are sufficient to set homogeneous active populations into stable directed motion.	[Bricard, Antoine; Caussin, Jean-Baptiste; Desreumaux, Nicolas; Bartolo, Denis] Univ Paris Diderot, ESPCI ParisTech, CNRS UMR7636, PMMH, F-75005 Paris, France; [Bricard, Antoine; Caussin, Jean-Baptiste; Desreumaux, Nicolas; Bartolo, Denis] Univ Paris 06, F-75005 Paris, France; [Caussin, Jean-Baptiste; Bartolo, Denis] Ecole Normale Super Lyon, Phys Lab, CNRS UMR5672, F-69007 Lyon, France; [Dauchot, Olivier] ESPCI ParisTech, EC2M, CNRS Gulliver UMR7083, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Bartolo, D (corresponding author), Univ Paris Diderot, ESPCI ParisTech, CNRS UMR7636, PMMH, 10 Rue Vauquelin, F-75005 Paris, France.	denis.bartolo@ens-lyon.fr	Dartolo, Denis/B-5537-2015; Dauchot, Olivier/D-7156-2015	Dartolo, Denis/0000-0001-5035-6898; Dauchot, Olivier/0000-0002-7039-5787	Paris Emergence programme; C'Nano IdF; Institut Universitaire de France	Paris Emergence programme; C'Nano IdF(Region Ile-de-France); Institut Universitaire de France	We acknowledge support from the Paris Emergence programme (D. B.), C'Nano IdF (D. B.) and the Institut Universitaire de France (D. B.). We thank L. S. Tuckerman and H. Chate for their useful comments and suggestions.	Bertin E, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/44/445001; Brotto T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.038101; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Chate H, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046113; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Deseigne J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.098001; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Farrell FDC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.248101; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; HACKBORN WW, 1990, J FLUID MECH, V218, P531, DOI 10.1017/S0022112090001100; Kudrolli A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058001; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; MELCHER JR, 1969, ANNU REV FLUID MECH, V1, P111, DOI 10.1146/annurev.fl.01.010169.000551; O'Loan OJ, 1999, J PHYS A-MATH GEN, V32, pL99, DOI 10.1088/0305-4470/32/8/002; Palacci J, 2013, SCIENCE, V339, P936, DOI 10.1126/science.1230020; Quincke G., 1896, ANN PHYS-BERLIN, V295, P417; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Schaller V, 2013, P NATL ACAD SCI USA, V110, P4488, DOI 10.1073/pnas.1215368110; Schaller V, 2010, NATURE, V467, P73, DOI 10.1038/nature09312; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Sumino Y, 2012, NATURE, V483, P448, DOI 10.1038/nature10874; Theurkauff I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268303; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wioland H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.268102; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107	27	573	575	17	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					95	98		10.1038/nature12673	http://dx.doi.org/10.1038/nature12673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201282	Green Submitted			2022-12-28	WOS:000326585600038
J	Kim, TM; Laird, PW; Park, PJ				Kim, Tae-Min; Laird, Peter W.; Park, Peter J.			The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes	CELL			English	Article							MITOCHONDRIAL TRANSCRIPTION FACTOR; NONPOLYPOSIS COLON-CANCER; FRAMESHIFT MUTATIONS; BETA RECEPTOR; DNA; GENE; EXPRESSION; CARCINOMA; CELLS; PATTERNS	Microsatellites-simple tandem repeats present at millions of sites in the human genome-can shorten or lengthen due to a defect in DNA mismatch repair. We present here a comprehensive genome-wide analysis of the prevalence, mutational spectrum, and functional consequences of microsatellite instability (MSI) in cancer genomes. We analyzed MSI in 277 colorectal and endometrial cancer genomes (including 57 microsatellite-unstable ones) using exome and whole-genome sequencing data. Recurrent MSI events in coding sequences showed tumor type specificity, elevated frameshift-to-inframe ratios, and lower transcript levels than wild-type alleles. Moreover, genome-wide analysis revealed differences in the distribution of MSI versus point mutations, including overrepresentation of MSI in euchromatic and intronic regions compared to heterochromatic and intergenic regions, respectively, and depletion of MSI at nucleosome-occupied sequences. Our results provide a panoramic view of MSI in cancer genomes, highlighting their tumor type specificity, impact on gene expression, and the role of chromatin organization.	[Kim, Tae-Min; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kim, Tae-Min] Catholic Univ Korea, Coll Med, Canc Evolut Res Ctr, Seoul 137701, South Korea; [Laird, Peter W.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Dept Surg & Biochem & Mol Biol,USC Norris Compreh, Los Angeles, CA 90033 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Catholic University of Korea; University of Southern California; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Park, PJ (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	peter_park@harvard.edu	Laird, Peter W/G-8683-2012	Laird, Peter W/0000-0001-9117-3641; Park, Peter/0000-0001-9378-960X	National Institutes of Health [R01 GM082798, U24CA144025]; National Research Foundation of Korea [2012R1A5A2047939]; NATIONAL CANCER INSTITUTE [U24CA144025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank The Cancer Genome Atlas Research Network for generating the data used in this work. We also thank the members of the Park laboratory (especially Drs. Eunjung Lee, Nils Gehlenborg, and Semin Lee) and Dr. Peter Kharchenko for providing comments on the manuscript, Dr. David Wheeler for helpful discussions, and the Research Information Technology Group at Harvard Medical School for providing computational resources. This work was supported by grants from the National Institutes of Health (R01 GM082798 and U24CA144025 to P.J.P.) and the National Research Foundation of Korea (2012R1A5A2047939 to T.-M.K.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Brough R, 2012, EMBO J, V31, P1160, DOI 10.1038/emboj.2011.490; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dorard C, 2011, NAT MED, V17, P1283, DOI 10.1038/nm.2457; DUGGAN BD, 1994, J NATL CANCER I, V86, P1216, DOI 10.1093/jnci/86.16.1216; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gurin CC, 1999, CANCER RES, V59, P462; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027; Kuismanen SA, 2002, AM J PATHOL, V160, P1953, DOI 10.1016/S0002-9440(10)61144-3; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Metzgar D, 2000, GENOME RES, V10, P72; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakayama Y, 2012, ONCOL REP, V27, P1325, DOI 10.3892/or.2012.1640; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; PARSONS R, 1995, CANCER RES, V55, P5548; Paun BC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007715; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Plaschke J, 2012, INT J COLORECTAL DIS, V27, P911, DOI 10.1007/s00384-011-1408-0; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012; Tsao JL, 2000, P NATL ACAD SCI USA, V97, P1236, DOI 10.1073/pnas.97.3.1236; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yuan ZQ, 2009, CANCER RES, V69, P7811, DOI 10.1158/0008-5472.CAN-09-0986; Zhou XP, 1997, ONCOGENE, V15, P1713, DOI 10.1038/sj.onc.1201337	56	235	242	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					858	868		10.1016/j.cell.2013.10.015	http://dx.doi.org/10.1016/j.cell.2013.10.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209623	Green Accepted, Bronze			2022-12-28	WOS:000326934300015
J	Watts, G				Watts, Geoff			Anthony James Pawson Obituary	LANCET			English	Biographical-Item																		PAWSON AJ, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1398	1398		10.1016/S0140-6736(13)62204-7	http://dx.doi.org/10.1016/S0140-6736(13)62204-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242JW	24206610				2022-12-28	WOS:000326237500013
J	Folkmann, AW; Collier, SE; Zhan, XY; Aditi; Ohi, MD; Wente, SR				Folkmann, Andrew W.; Collier, Scott E.; Zhan, Xiaoyan; Aditi; Ohi, Melanie D.; Wente, Susan R.			Gle1 Functions during mRNA Export in an Oligomeric Complex that Is Altered in Human Disease	CELL			English	Article							NUCLEAR-PORE COMPLEX; SPINAL MUSCULAR-ATROPHY; BOX PROTEIN DBP5; CONSERVED MECHANISM; NUCLEOPORIN RIP1P; YEAST; ARCHITECTURE; ACTIVATION; INTERACTS; SURVIVAL	The conserved multifunctional protein Gle1 regulates gene expression at multiple steps: nuclear mRNA export, translation initiation, and translation termination. A GLE1 mutation (FinMajor) is causally linked to human lethal congenital contracture syndrome-1 (LCCS1); however, the resulting perturbations on Gle1 molecular function were unknown. FinMajor results in a proline-phenylalanine-glutamine peptide insertion within the uncharacterized Gle1 coiled-coil domain. Here, we find that Gle1 self-associates both in vitro and in living cells via the coiled-coil domain. Electron microscopy reveals that highmolecular- mass Gle1 oligomers form similar to 26 nm diameter disk-shaped particles. With the Gle1-Fin(Major) protein, these particles are malformed. Moreover, functional assays document a specific requirement for proper Gle1 oligomerization during mRNA export, but not for Gle1's roles in translation. These results identify a mechanistic step in Gle1's mRNA export function at nuclear pore complexes and directly implicate altered export in LCCS1 disease pathology.	[Folkmann, Andrew W.; Collier, Scott E.; Zhan, Xiaoyan; Aditi; Ohi, Melanie D.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu	Gupta, Aditi/HGD-9632-2022		National Cancer Institute Cancer Center [P30 CA068485]; NIH [R37GM051219, F31NS070431, 1DP2OD004483, T32CA119925, T32GM008320]; NATIONAL CANCER INSTITUTE [P30CA068485, T32CA119925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051219, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS070431] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004483] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank T.R. Dawson for advice and critical reading of the manuscript; the Wente laboratory, M. Rout, and C. Cole for discussions; C. Cole for yeast strains; and Y. Takizawa for technical assistance with cryo-EM. This work was supported in part by the National Cancer Institute Cancer Center Support Grant P30 CA068485 utilizing the Cell Imaging Shared Resource and grants NIH R37GM051219 (to S.R.W.), NIH F31NS070431 (to A.W.F.), NIH 1DP2OD004483 (to M.D.O.) and training positions on T32CA119925 (to A.W.F.) and T32GM008320 (to S.E.C.).	Al-Qattan MM, 2012, GENE, V500, P216, DOI 10.1016/j.gene.2012.03.009; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Bolger TA, 2011, J BIOL CHEM, V286, P39750, DOI 10.1074/jbc.M111.299321; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010; HALL JG, 1985, CLIN ORTHOP RELAT R, P44; HERVA R, 1985, AM J MED GENET, V20, P431, DOI 10.1002/ajmg.1320200303; Hurt JA, 2008, DIS MODEL MECH, V1, P103, DOI 10.1242/dmm.000745; Jao LE, 2012, DEVELOPMENT, V139, P1316, DOI 10.1242/dev.074344; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Muller-McNicoll M, 2013, NAT REV GENET, V14, P275, DOI 10.1038/nrg3434; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Renoux AJ, 2012, PROG NEUROBIOL, V97, P173, DOI 10.1016/j.pneurobio.2011.10.006; Roberts-Galbraith RH, 2010, MOL CELL, V39, P86, DOI 10.1016/j.molcel.2010.06.012; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Stutz F, 1997, GENE DEV, V11, P2857, DOI 10.1101/gad.11.21.2857; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tzschach A, 2012, AM J MED GENET A, V158A, P1709, DOI 10.1002/ajmg.a.35398; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	42	54	57	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					582	593		10.1016/j.cell.2013.09.023	http://dx.doi.org/10.1016/j.cell.2013.09.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243016	Green Accepted, Bronze			2022-12-28	WOS:000326571800013
J	Thomas, GS; Haraszti, RA				Thomas, Gregory S.; Haraszti, Reka A.			A new frontier in atherosclerotic coronary imaging	LANCET			English	Editorial Material							FLUORIDE UPTAKE; CALCIFICATION; DISEASE		[Thomas, Gregory S.] Long Beach & Univ Calif, Long Beach Mem Med Ctr, Irvine, CA 90806 USA; [Haraszti, Reka A.] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Thomas, GS (corresponding author), Long Beach & Univ Calif, Long Beach Mem Med Ctr, Irvine, CA 90806 USA.	gthomas1@memorialcare.org		Haraszti, Reka Agnes/0000-0001-9925-6337; Thomas, Gregory S./0000-0002-9705-304X				AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; Beheshti M, 2011, HELL J NUCL MED, V14, P114; Derlin T, 2010, J NUCL MED, V51, P862, DOI 10.2967/jnumed.110.076471; Dweck MR, 2012, J AM COLL CARDIOL, V59, P1539, DOI 10.1016/j.jacc.2011.12.037; Joshi NV, 2014, LANCET, V383, P705, DOI 10.1016/S0140-6736(13)61754-7; Li YX, 2012, NUCL MED COMMUN, V33, P14, DOI 10.1097/MNM.0b013e32834c187e; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Thomas GS, 2004, J AM COLL CARDIOL, V43, P213, DOI 10.1016/j.jacc.2003.07.041	10	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					674	675		10.1016/S0140-6736(13)61911-X	http://dx.doi.org/10.1016/S0140-6736(13)61911-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB2WR	24225000	Green Submitted, hybrid			2022-12-28	WOS:000331653300006
J	Evans, LDB; Poulter, S; Terentjev, EM; Hughes, C; Fraser, GM				Evans, Lewis D. B.; Poulter, Simon; Terentjev, Eugene M.; Hughes, Colin; Fraser, Gillian M.			A chain mechanism for flagellum growth	NATURE			English	Article							III PROTEIN EXPORT; HIGH-LEVEL EXPRESSION; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; BACTERIAL FLAGELLUM; MEMBRANE ATPASE; HOOK; SECRETION; APPARATUS	Bacteria swim by means of long flagella extending from the cell surface. These are assembled from thousands of protein subunits translocated across the cell membrane by an export machinery at the base of each flagellum. Unfolded subunits(1-3) then transit through a narrow channel at the core of the growing flagellum to the tip, where they crystallize into the nascent structure. As the flagellum lengthens outside the cell, the rate of flagellum growth does not change(4). The mystery is how subunit transit is maintained at a constant rate without a discernible energy source in the channel of the external flagellum(5). We present evidence for a simple physical mechanism for flagellum growth that harnesses the entropic force of the unfolded subunits themselves. We show that a subunit docked at the export machinery can be captured by a free subunit through head-to-tail linkage of juxtaposed amino (N)- and carboxy (C)-terminal helices. We propose that sequential rounds of linkage would generate a multisubunit chain that pulls successive subunits into and through the channel to the flagellum tip, and by isolating filaments growing on bacterial cells we reveal the predicted chain of head-to-tail linked subunits in the transit channel of flagella. Thermodynamic analysis confirms that links in the subunit chain can withstand the pulling force generated by rounds of subunit crystallization at the flagellum tip, and polymer theory predicts that as the N terminus of each unfolded subunit crystallizes, the entropic force at the subunit C terminus would increase, rapidly overcoming the threshold required to pull the next subunit from the export machinery. This pulling force would adjust automatically over the increasing length of the growing flagellum, maintaining a constant rate of subunit delivery to the tip.	[Evans, Lewis D. B.; Poulter, Simon; Hughes, Colin; Fraser, Gillian M.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Terentjev, Eugene M.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge; University of Cambridge	Fraser, GM (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	gmf25@cam.ac.uk	Terentjev, Eugene M/B-7623-2011; Fraser, Gillian/I-1846-2013	Terentjev, Eugene M/0000-0003-3517-6578; Fraser, Gillian/0000-0002-4874-8734; Evans, Lewis/0000-0001-7279-7651	Wellcome Trust; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish; EPSRC [EP/F032773/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank P. Hinchliffe for help with analysis of atomic structures, K. Yonekura and K. Namba for providing information on filament structure, H. Berg and N. Greene for discussions, A. Crow for advice on ITC, and P. Dhillon for technical assistance. The work was supported by a Wellcome Trust Programme Grant (C. H. and G.M.F.).	Abrusci P, 2013, NAT STRUCT MOL BIOL, V20, P99, DOI 10.1038/nsmb.2452; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Blundell JR, 2009, SOFT MATTER, V5, P4015, DOI 10.1039/b903583d; Blundell JR, 2011, SOFT MATTER, V7, P3967, DOI 10.1039/c0sm01322f; CHEN LL, 1991, J BIOL CHEM, V266, P18237; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ERLANDER SR, 1960, ARCH BIOCHEM BIOPHYS, V90, P139, DOI 10.1016/0003-9861(60)90625-1; Evans LDB, 2006, P NATL ACAD SCI USA, V103, P17474, DOI 10.1073/pnas.0605197103; Evans LDB, 2009, FEMS MICROBIOL LETT, V293, P292, DOI 10.1111/j.1574-6968.2009.01535.x; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Fujii T, 2009, STRUCTURE, V17, P1485, DOI 10.1016/j.str.2009.08.017; Galan JE, 2008, NAT STRUCT MOL BIOL, V15, P127, DOI 10.1038/nsmb0208-127; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HOMMA M, 1984, J BACTERIOL, V159, P1056, DOI 10.1128/JB.159.3.1056-1059.1984; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Mescheryakov V. A., 2007, ACTA CRYSTALLOGR D, V69, P812; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 1999, BIOSCI BIOTECH BIOCH, V63, P1301, DOI 10.1271/bbb.63.1301; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; OHNISHI K, 1994, J BACTERIOL, V176, P2272, DOI 10.1128/JB.176.8.2272-2281.1994; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Samatey FA, 2004, NATURE, V431, P1062, DOI 10.1038/nature02997; Shaikh TR, 2005, P NATL ACAD SCI USA, V102, P1023, DOI 10.1073/pnas.0409020102; Sotta P, 2000, J CHEM PHYS, V112, P1565, DOI 10.1063/1.480704; Stafford GP, 2007, J MOL BIOL, V374, P877, DOI 10.1016/j.jmb.2007.09.080; Stafford GP, 2007, MICROBIOL-SGM, V153, P541, DOI 10.1099/mic.0.2006/002576-0; Stern AS, 2013, BIOPHYS J, V105, P182, DOI 10.1016/j.bpj.2013.05.030; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tanner DE, 2011, BIOPHYS J, V100, P2548, DOI 10.1016/j.bpj.2011.04.036; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; Turner L, 2012, J BACTERIOL, V194, P2437, DOI 10.1128/JB.06735-11; VONDERVISZT F, 1992, J MOL BIOL, V226, P575, DOI 10.1016/0022-2836(92)90616-R; VONDERVISZT F, 1995, J MOL BIOL, V251, P520, DOI 10.1006/jmbi.1995.0453; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P3339; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	44	63	63	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					287	+		10.1038/nature12682	http://dx.doi.org/10.1038/nature12682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24213633	Green Submitted, Green Accepted			2022-12-28	WOS:000328121500038
J	Kendal, AR; Prieto-Alhambra, D; Arden, NK; Carr, A; Judge, A				Kendal, Adrian R.; Prieto-Alhambra, Daniel; Arden, Nigel K.; Carr, Andrew; Judge, Andrew			Mortality rates at 10 years after metal-on-metal hip resurfacing compared with total hip replacement in England: retrospective cohort analysis of hospital episode statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FINNISH ARTHROPLASTY REGISTER; ION LEVELS; SURFACES; NICKEL; CANCER; BONE; WEAR	Objectives To compare 10 year mortality rates among patients undergoing metal-on-metal hip resurfacing and total hip replacement in England. Design Retrospective cohort study. Setting English hospital episode statistics database linked to mortality records from the Office for National Statistics. Population All adults who underwent primary elective hip replacement for osteoarthritis from April 1999 to March 2012. The exposure of interest was prosthesis type: cemented total hip replacement, uncemented total hip replacement, and metal-on-metal hip resurfacing. Confounding variables included age, sex, Charlson comorbidity index, rurality, area deprivation, surgical volume, and year of operation. Main outcome measures All cause mortality. Propensity score matching was used to minimise confounding by indication. Kaplan-Meier plots estimated the probability of survival up to 10 years after surgery. Multilevel Cox regression modelling, stratified on matched sets, described the association between prosthesis type and time to death, accounting for variation across hospital trusts. Results 7437 patients undergoing metal-on-metal hip resurfacing were matched to 22 311 undergoing cemented total hip replacement; 8101 patients undergoing metal-on-metal hip resurfacing were matched to 24 303 undergoing uncemented total hip replacement. 10 year rates of cumulative mortality were 271 (3.6%) for metal-on-metal hip resurfacing versus 1363 (6.1%) for cemented total hip replacement, and 239 (3.0%) for metal-on-metal hip resurfacing versus 999 (4.1%) for uncemented total hip replacement. Patients undergoing metal-on-metal hip resurfacing had an increased survival probability (hazard ratio 0.51 (95% confidence interval 0.45 to 0.59) for cemented hip replacement; 0.55 (0.47 to 0.65) for uncemented hip replacement). There was no evidence for an interaction with age or sex. Conclusions Patients with hip osteoarthritis undergoing metal-on-metal hip resurfacing have reduced mortality in the long term compared with those undergoing cemented or uncemented total hip replacement. This difference persisted after extensive adjustment for confounding factors available in our data. The study results can be applied to matched populations, which exclude patients who are very old and have had complex total hip replacements. Although residual confounding is possible, the observed effect size is large. These findings require validation in external cohorts and randomised clinical trials.	[Kendal, Adrian R.; Prieto-Alhambra, Daniel; Arden, Nigel K.; Carr, Andrew; Judge, Andrew] Univ Oxford, Botnar Res Ctr, Natl Inst Hlth Res Oxford Musculoskeletal Biomed, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Prieto-Alhambra, Daniel; Arden, Nigel K.; Judge, Andrew] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Prieto-Alhambra, Daniel] URFOA IMIM, Barcelona, Spain; [Prieto-Alhambra, Daniel] RETICEF Red Temat Invest Cooperat Envejecimiento, Barcelona, Spain; [Prieto-Alhambra, Daniel] Univ Autonoma Barcelona, Jordi Gol Primary Care Res Inst, IDIAP Inst Invest Atencio Primaria, GREMPAL Grp Recerca Malalties Prevalents Aparell, E-08193 Barcelona, Spain	University of Oxford; University of Southampton; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona	Carr, A (corresponding author), Univ Oxford, Botnar Res Ctr, Natl Inst Hlth Res Oxford Musculoskeletal Biomed, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.	andrew.carr@ndorms.ox.ac.uk		Prieto-Alhambra, Daniel/0000-0002-3950-6346; Judge, Andrew/0000-0003-3015-0432	Oxford National Institute for Health Research Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford; National Institute for Health Research [ACF-2013-13-006, NF-SI-0611-10216] Funding Source: researchfish	Oxford National Institute for Health Research Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford; National Institute for Health Research(National Institute for Health Research (NIHR))	Support was received from the Oxford National Institute for Health Research Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford. The views expressed in this article are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. AK and AJ had full access to the dataset under the terms of the Hospital Episode Statistics Data Re-Use Agreement. The study sponsors had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7; Amstutz HC, 2004, J BONE JOINT SURG AM, V86A, P1874, DOI 10.2106/00004623-200409000-00003; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Breusch SJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7137; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Costa ML, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2147; Coulter G, 2012, J BONE JOINT SURG BR, V94B, P315, DOI 10.1302/0301-620X.94B3.28185; Daniel J, 2010, J BONE JOINT SURG BR, V92B, P20, DOI 10.1302/0301-620X.92B1.21530; Daniel J, 2009, J BONE JOINT SURG BR, V91B, P176, DOI 10.1302/0301-620X.91B2.21654; Daniel J, 2004, J BONE JOINT SURG BR, V86B, P177, DOI 10.1302/0301-620X.86B2.14600; de Steiger RN, 2011, J BONE JOINT SURG AM, V93A, P2287, DOI [10.2106/JBJS.J.01727, 10.2106/JBJSJ.01727]; Donaldson AJ, 2009, BRIT J ANAESTH, V102, P12, DOI 10.1093/bja/aen328; Dunstan E, 2005, J BONE JOINT SURG BR, V87B, P628, DOI 10.1302/0301-620X.87B5.15384; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Goldsmith AAJ, 2000, P I MECH ENG H, V214, P39, DOI 10.1243/0954411001535228; Heneghan C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1349; Hirsch K, 2012, COMPUT METH PROG BIO, V107, P582, DOI 10.1016/j.cmpb.2011.05.004; Isaac GH, 2006, P I MECH ENG H, V220, P119, DOI 10.1243/095441105X68953; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6688; Lafont ND, 1997, CAN J ANAESTH, V44, P112, DOI 10.1007/BF03012997; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; LUMB GD, 1994, SCI TOTAL ENVIRON, V148, P185, DOI 10.1016/0048-9697(94)90395-6; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; McMinn DJW, 2009, MODERN HIP RESURFACING, P1, DOI 10.1007/978-1-84800-088-9; Medicines and Healthcare Products Regulatory Agency, 2012, MDA2012016 MHRA; Murray DW, 2012, J BONE JOINT SURG BR, V94B, P1180, DOI 10.1302/0301-620X.94B9.29462; MURRAY DW, 1995, J BONE JOINT SURG BR, V77B, P520, DOI 10.1302/0301-620X.77B4.7615593; National Institute for Health and Care Excellence, 2002, CLIN EFF COST EFF ME; National Joint Registry, 2012, 9 NAT JOINT REG ENGL; Onega T, 2006, CANCER EPIDEM BIOMAR, V15, P1532, DOI 10.1158/1055-9965.EPI-06-0127; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Puolakka TJS, 2001, ACTA ORTHOP SCAND, V72, P433, DOI 10.1080/000164701753532745; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Schaffer AW, 1999, J TOXICOL-CLIN TOXIC, V37, P839, DOI 10.1081/CLT-100102463; Schmalzried TP, 1996, J ARTHROPLASTY, V11, P322, DOI 10.1016/S0883-5403(96)80085-4; Smith AJ, 2012, BRIT MED J, P344; Smith AJ, 2012, LANCET, V380, P1759, DOI 10.1016/S0140-6736(12)60989-1; Urban RM, 2004, J ARTHROPLASTY, V19, P94, DOI 10.1016/j.arth.2004.09.013; Vendittoli PA, 2006, J BONE JOINT SURG BR, V88B, P997, DOI 10.1302/0301-620X.88B8; Visuri T, 2010, ACTA ORTHOP, V81, P77, DOI 10.3109/17453671003667150; Wroblewski BM, 1999, J BONE JOINT SURG BR, V81B, P427, DOI 10.1302/0301-620X.81B3.9521	44	43	43	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2013	347								f6549	10.1136/bmj.f6549	http://dx.doi.org/10.1136/bmj.f6549			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263GF	24284336	hybrid, Green Published			2022-12-28	WOS:000327794500001
J	Luo, HM; Zhang, Y; Wang, XQ; Yu, WZ; Wen, N; Yan, DM; Wang, HQ; Wushouer, F; Wang, HB; Xu, AQ; Zheng, JS; Li, DX; Cui, H; Wang, JP; Zhu, SL; Feng, ZJ; Cui, FQ; Ning, J; Hao, LX; Fan, CX; Ning, GJ; Yu, HJ; Wang, SW; Liu, DW; Wang, DY; Fu, JP; Gou, AL; Zhang, GM; Huang, GH; Chen, YS; Mi, SS; Liu, YM; Yin, DP; Zhu, H; Fan, XC; Li, XL; Ji, YX; Li, KL; Tang, HS; Xu, WB; Wang, Y; Yang, WZ				Luo, Hui-Ming; Zhang, Yong; Wang, Xin-Qi; Yu, Wen-Zhou; Wen, Ning; Yan, Dong-Mei; Wang, Hua-Qing; Wushouer, Fuerhati; Wang, Hai-Bo; Xu, Ai-Qiang; Zheng, Jing-Shan; Li, De-Xin; Cui, Hui; Wang, Jian-Ping; Zhu, Shuang-Li; Feng, Zi-Jian; Cui, Fu-Qiang; Ning, Jing; Hao, Li-Xin; Fan, Chun-Xiang; Ning, Gui-Jun; Yu, Hong-Jie; Wang, Shi-Wen; Liu, Da-Wei; Wang, Dong-Yan; Fu, Jian-Ping; Gou, Ai-Li; Zhang, Guo-Min; Huang, Guo-Hong; Chen, Yuan-Sheng; Mi, Sha-Sha; Liu, Yan-Min; Yin, Da-Peng; Zhu, Hui; Fan, Xin-Chun; Li, Xin-Lan; Ji, Yi-Xin; Li, Ke-Li; Tang, Hai-Shu; Xu, Wen-Bo; Wang, Yu; Yang, Wei-Zhong			Identification and Control of a Poliomyelitis Outbreak in Xinjiang, China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINE-DERIVED POLIOVIRUS; ACUTE FLACCID PARALYSIS; NETHERLANDS; TRANSMISSION; CIRCULATION	BackgroundThe last case of infection with wild-type poliovirus indigenous to China was reported in 1994, and China was certified as a poliomyelitis-free region in 2000. In 2011, an outbreak of infection with imported wild-type poliovirus occurred in the province of Xinjiang. MethodsWe conducted an investigation to guide the response to the outbreak, performed sequence analysis of the poliovirus type 1 capsid protein VP1 to determine the source, and carried out serologic and coverage surveys to assess the risk of viral propagation. Surveillance for acute flaccid paralysis was intensified to enhance case ascertainment. ResultsBetween July 3 and October 9, 2011, investigators identified 21 cases of infection with wild-type poliovirus and 23 clinically compatible cases in southern Xinjiang. Wild-type poliovirus type 1 was isolated from 14 of 673 contacts of patients with acute flaccid paralysis (2.1%) and from 13 of 491 healthy persons who were not in contact with affected persons (2.6%). Sequence analysis implicated an imported wild-type poliovirus that originated in Pakistan as the cause of the outbreak. A public health emergency was declared in Xinjiang after the outbreak was confirmed. Surveillance for acute flaccid paralysis was enhanced, with daily reporting from all public and private hospitals. Five rounds of vaccination with live, attenuated oral poliovirus vaccine (OPV) were conducted among children and adults, and 43 million doses of OPV were administered. Trivalent OPV was used in three rounds, and monovalent OPV type 1 was used in two rounds. The outbreak was stopped 1.5 months after laboratory confirmation of the index case. ConclusionsThe 2011 outbreak in China showed that poliomyelitis-free countries remain at risk for outbreaks while the poliovirus circulates anywhere in the world. Global eradication of poliomyelitis will benefit all countries, even those that are currently free of poliomyelitis.	[Luo, Hui-Ming; Yu, Wen-Zhou; Wen, Ning; Wang, Hua-Qing; Wang, Hai-Bo; Zheng, Jing-Shan; Cui, Fu-Qiang; Hao, Li-Xin; Fan, Chun-Xiang; Ning, Gui-Jun; Liu, Da-Wei; Zhang, Guo-Min; Chen, Yuan-Sheng; Liu, Yan-Min; Yin, Da-Peng; Li, Ke-Li; Wang, Yu; Yang, Wei-Zhong] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 102206, Peoples R China; [Zhang, Yong; Yan, Dong-Mei; Li, De-Xin; Zhu, Shuang-Li; Wang, Shi-Wen; Wang, Dong-Yan; Huang, Guo-Hong; Zhu, Hui; Ji, Yi-Xin; Xu, Wen-Bo] Natl Inst Viral Dis Control & Prevent, Minist Hlth Key Lab Med Virol, Beijing, Peoples R China; [Feng, Zi-Jian] Hlth Emergency Control Ctr, Beijing, Peoples R China; [Yu, Hong-Jie] Chinese Ctr Dis Control & Prevent, Div Infect Dis Control, Beijing 102206, Peoples R China; [Wang, Xin-Qi; Wushouer, Fuerhati; Cui, Hui; Ning, Jing; Gou, Ai-Li; Fan, Xin-Chun; Li, Xin-Lan; Tang, Hai-Shu] Xinjiang Uyghur Autonomous Reg Ctr Dis Control &, Jinan, Peoples R China; [Wang, Jian-Ping; Fu, Jian-Ping; Mi, Sha-Sha] Xinjiang Prod & Construct Corps, Ctr Dis Control & Prevent, Jinan, Peoples R China; [Xu, Ai-Qiang] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Yang, WZ (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China.	wenbo_xu1@aliyun.com; wangyu@chinacdc.cn; yangwz@chinacdc.cn	Yu, Hongjie/GZK-5351-2022	Yang, Weizhong/0000-0002-6599-825X; Zhang, Yong/0000-0002-2692-5437				[Anonymous], 2000, JAMA, V283, P1414; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P104; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P153; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1393; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P157; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P425; [Anonymous], 1991, WKLY EPIDEMIOL REC, V66, P49; Arya SC, 1999, J CLIN MICROBIOL, V37, P276; Aylward B, 2011, VACCINE, V29, pD80, DOI 10.1016/j.vaccine.2011.10.005; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1198; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145; Chiba Y, 2001, B WORLD HEALTH ORGAN, V79, P103; ConynvanSpaendonck MAE, 1996, AM J EPIDEMIOL, V143, P929, DOI 10.1093/oxfordjournals.aje.a008836; Francis PT, 2007, LANCET, V370, P129, DOI 10.1016/S0140-6736(07)61076-9; Grassly NC, 2007, LANCET, V369, P1790; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; Le Menach A, 2011, EMERG INFECT DIS, V17, P1506, DOI 10.3201/eid1708.110195; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; National Bureau of Statistics of China, 2012, CHIN STAT YB, P101; OOSTVOGEL PM, 1994, LANCET, V344, P665, DOI 10.1016/S0140-6736(94)92091-5; Oostvogel PM, 2001, J INFECT DIS, V184, P1451, DOI 10.1086/324327; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; Prevots DR, 1998, CLIN INFECT DIS, V26, P419, DOI 10.1086/516312; WHO, 1988, WKLY EPIDEMIOL REC, V63, P161; World Health Organization, 2004, POL LAB MAN, V4th; Zhang Y, 2010, J INFECT DIS, V202, P1780, DOI 10.1086/657410; 2010, EURO SURVEILL, V15	27	69	76	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					1981	1990		10.1056/NEJMoa1303368	http://dx.doi.org/10.1056/NEJMoa1303368			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256377				2022-12-28	WOS:000327163000006
J	Praetorius, C; Grill, C; Stacey, SN; Metcalf, AM; Gorkin, DU; Robinson, KC; Van Otterloo, E; Kim, RSQ; Bergsteinsdottir, K; Ogmundsdottir, MH; Magnusdottir, E; Mishra, PJ; Davis, SR; Guo, T; Zaidi, MR; Helgason, AS; Sigurdsson, MI; Meltzer, PS; Merlino, G; Petit, V; Larue, L; Loftus, SK; Adams, DR; Sobhiafshar, U; Emre, NCT; Pavan, WJ; Cornell, R; Smith, AG; McCallion, AS; Fisher, DE; Stefansson, K; Sturm, RA; Steingrimsson, E				Praetorius, Christian; Grill, Christine; Stacey, Simon N.; Metcalf, Alexander M.; Gorkin, David U.; Robinson, Kathleen C.; Van Otterloo, Eric; Kim, Reuben S. Q.; Bergsteinsdottir, Kristin; Ogmundsdottir, Margret H.; Magnusdottir, Erna; Mishra, Pravin J.; Davis, Sean R.; Guo, Theresa; Zaidi, M. Raza; Helgason, Agnar S.; Sigurdsson, Martin I.; Meltzer, Paul S.; Merlino, Glenn; Petit, Valerie; Larue, Lionel; Loftus, Stacie K.; Adams, David R.; Sobhiafshar, Ulduz; Emre, N. C. Tolga; Pavan, William J.; Cornell, Robert; Smith, Aaron G.; McCallion, Andrew S.; Fisher, David E.; Stefansson, Kari; Sturm, Richard A.; Steingrimsson, Eirikur			A Polymorphism in IRF4 Affects Human Pigmentation through a Tyrosinase-Dependent MITF/TFAP2A Pathway	CELL			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; GENETIC-DETERMINANTS; EXPRESSION; VARIANTS; ENHANCER; RECEPTOR; LOCUS; INVOLVEMENT; MELANOCYTES; RS6983267	Sequence polymorphisms linked to human diseases and phenotypes in genome-wide association studies often affect noncoding regions. A SNP within an intron of the gene encoding Interferon Regulatory Factor 4 (IRF4), a transcription factor with no known role in melanocyte biology, is strongly associated with sensitivity of skin to sun exposure, freckles, blue eyes, and brown hair color. Here, we demonstrate that this SNP lies within an enhancer of IRF4 transcription in melanocytes. The allele associated with this pigmentation phenotype impairs binding of the TFAP2A transcription factor that, together with the melanocyte master regulator MITF, regulates activity of the enhancer. Assays in zebrafish and mice reveal that IRF4 cooperates with MITF to activate expression of Tyrosinase (TYR), an essential enzyme in melanin synthesis. Our findings provide a clear example of a noncoding polymorphism that affects a phenotype by modulating a developmental gene regulatory network.	[Praetorius, Christian; Grill, Christine; Bergsteinsdottir, Kristin; Ogmundsdottir, Margret H.; Magnusdottir, Erna; Sigurdsson, Martin I.; Steingrimsson, Eirikur] Univ Iceland, Fac Med, Dept Biochem & Mol Biol, Biomed Ctr, IS-101 Reykjavik, Iceland; [Stacey, Simon N.; Helgason, Agnar S.; Stefansson, Kari] Decode Genet, IS-101 Reykjavik, Iceland; [Metcalf, Alexander M.; Kim, Reuben S. Q.; Smith, Aaron G.; Sturm, Richard A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Gorkin, David U.; McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Gorkin, David U.] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD 21205 USA; [Robinson, Kathleen C.; Fisher, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Dermatol, Boston, MA 02114 USA; [Van Otterloo, Eric; Cornell, Robert] Univ Iowa, Iowa City, IA 52242 USA; [Kim, Reuben S. Q.; Smith, Aaron G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Mishra, Pravin J.; Guo, Theresa; Zaidi, M. Raza; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Davis, Sean R.; Meltzer, Paul S.] NCI, Genet Branch, Bethesda, MD 20892 USA; [Petit, Valerie; Larue, Lionel] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Loftus, Stacie K.; Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Adams, David R.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Sobhiafshar, Ulduz; Emre, N. C. Tolga] Bogazici Univ, Dept Mol Biol & Genet, Lab Genome Regulat, TR-34342 Istanbul, Turkey	University of Iceland; University of Queensland; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Iowa; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Bogazici University	Steingrimsson, E (corresponding author), Univ Iceland, Fac Med, Dept Biochem & Mol Biol, Biomed Ctr, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland.	eirikurs@hi.is	Smith, Aaron/A-8329-2010; Helgason, Agnar/K-1522-2015; Sturm, Richard A/C-9943-2009; Stefansson, Kari/AAE-7187-2019; Emre, Tolga/A-1787-2016; Sigurdsson, Martin Ingi/I-9655-2016; Davis, Sean/AAD-1801-2021; Magnúsdóttir, Erna/T-8993-2019; Larue, Lionel/I-6532-2016; Magnúsdóttir, Erna/H-5181-2013; Guo, Theresa/AAF-2216-2021; Fisher, David/AAH-2878-2019; Zaidi, M. Raza/H-1386-2016	Sturm, Richard A/0000-0003-1301-0294; Emre, Tolga/0000-0001-8021-5228; Sigurdsson, Martin Ingi/0000-0001-7054-0844; Davis, Sean/0000-0002-8991-6458; Magnúsdóttir, Erna/0000-0002-3369-4390; Pavan, William/0000-0001-8281-5120; Steingrimsson, Eirikur/0000-0001-5826-7486; Loftus, Stacie/0000-0002-1958-4689; Cornell, Robert/0000-0003-4207-9100; Helgason, Agnar/0000-0002-8545-3767; Praetorius, Christian/0000-0001-7514-5333; PETIT, Valerie/0000-0003-1645-9396; Gorkin, David/0000-0003-4944-4107; Zaidi, M. Raza/0000-0003-0480-3188; Smith, Aaron/0000-0003-2937-1713; Sobhiafshar, Ulduz/0000-0002-4698-3909	NIH [5R01 AR043369-16]; Melanoma Research Alliance; Dr. Miriam and Sheldon Adelson Medical Research Foundation; US-Israel Binational Science Foundation; Ligue Nationale Contre le Cancer; INCa; Icelandic Research Fund; Research Fund of the University of Iceland; Haskolasjodur Student Fund; Jules Verne Fund; National Institute of General Medical Sciences [GM071648]; National Institute of Neurological Disease and Stroke [NS062972]; National Human Genome Research Institute's Intramural Research Program; NSF Graduate Research Fellowship; NATIONAL CANCER INSTITUTE [ZIABC011091, P01CA163222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062547, R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062972] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Dr. Miriam and Sheldon Adelson Medical Research Foundation; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); Icelandic Research Fund; Research Fund of the University of Iceland(Istanbul University); Haskolasjodur Student Fund; Jules Verne Fund; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute's Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Thorunn Rafnar, Magnus Karl Magnusson, Unnur Thorsteinsdottir, Colin R. Goding, and Thorarinn Gudjonsson for critical comments on the manuscript. This work was supported by grants from NIH (5R01 AR043369-16), Melanoma Research Alliance, Dr. Miriam and Sheldon Adelson Medical Research Foundation, US-Israel Binational Science Foundation (to D.E.F.), Ligue Nationale Contre le Cancer (Equipe labellisee) and INCa (to L.L.), the Icelandic Research Fund and the Research Fund of the University of Iceland (to E.S.), the Haskolasjodur Student Fund (to E.S., C.P., and C.G.), the Jules Verne Fund (to E.S. and L.L.), by the National Institute of General Medical Sciences (GM071648) and National Institute of Neurological Disease and Stroke (NS062972; to A.S.M.), the National Human Genome Research Institute's Intramural Research Program (to W.J.P. and S.L.), and an NSF Graduate Research Fellowship (to D.U.G.).	Adachi S, 2000, J IMMUNOL, V164, P855, DOI 10.4049/jimmunol.164.2.855; Aoki H, 2002, LIFE SCI, V71, P2171, DOI 10.1016/S0024-3205(02)01996-3; Bastiaens M, 2001, HUM MOL GENET, V10, P1701, DOI 10.1093/hmg/10.16.1701; Beleza S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003372; Bertolotto C, 1996, J CELL BIOL, V134, P747, DOI 10.1083/jcb.134.3.747; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; Debbache J, 2012, GENETICS, V191, P133, DOI 10.1534/genetics.111.135996; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Do TN, 2010, BBA-MOL BASIS DIS, V1802, P292, DOI 10.1016/j.bbadis.2009.10.015; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Duffy DL, 2010, AM J HUM GENET, V87, P6, DOI 10.1016/j.ajhg.2010.05.017; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Gorkin DU, 2012, GENOME RES, V22, P2290, DOI 10.1101/gr.139360.112; Grossman A, 1996, GENOMICS, V37, P229, DOI 10.1006/geno.1996.0547; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Smith AG, 2001, GENE, V281, P81, DOI 10.1016/S0378-1119(01)00791-0; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Sundram U, 2003, MODERN PATHOL, V16, P802, DOI 10.1097/01.MP.0000081726.49886.CF; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tsuboi K, 2000, LEUKEMIA, V14, P449, DOI 10.1038/sj.leu.2401696; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Van Otterloo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001122; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	51	137	142	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1022	1033		10.1016/j.cell.2013.10.022	http://dx.doi.org/10.1016/j.cell.2013.10.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267888	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000327500600008
J	Gaziano, JM; Peterson, E				Gaziano, J. Michael; Peterson, Eric			The Cardiovascular Disease Researcher	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AORTIC-VALVE-REPLACEMENT		[Gaziano, J. Michael] Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA 02120 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Div Aging, Boston, MA 02120 USA; [Peterson, Eric] Duke Univ, Med Ctr, Durham, NC USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Duke University	Gaziano, JM (corresponding author), Brigham & Womens Hosp, Div Aging, 1620 Tremont St, Boston, MA 02120 USA.	jmgaziano@partners.org	Peterson, Eric David/ABF-5033-2021					Abed HS, 2013, JAMA-J AM MED ASSOC, V310, P2050, DOI 10.1001/jama.2013.280521; Barreto JA, 2013, JAMA-J AM MED ASSOC, V310, P2078, DOI 10.1001/jama.2013.282437; Butler J, 2013, JAMA-J AM MED ASSOC, V310, P2035, DOI 10.1001/jama.2013.282815; Califf RM, 2013, JAMA-J AM MED ASSOC, V310, P2037, DOI 10.1001/jama.2013.282771; Deb S, 2013, JAMA-J AM MED ASSOC, V310, P2086, DOI 10.1001/jama.2013.281718; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532; McLean RC, 2013, JAMA-J AM MED ASSOC, V310, P2033, DOI 10.1001/jama.2013.282773; Mordwinkin NM, 2013, JAMA-J AM MED ASSOC, V310, P2039, DOI 10.1001/jama.2013.282409	9	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2048	2049		10.1001/jama.2013.282990	http://dx.doi.org/10.1001/jama.2013.282990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240931				2022-12-28	WOS:000327098900020
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE A conversation with great doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Smith SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub4	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2013	347								f6746	10.1136/bmj.f6746	http://dx.doi.org/10.1136/bmj.f6746			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XT	24212767				2022-12-28	WOS:000326890800013
J	Cho, Y; Sloutsky, R; Naegle, KM; Cavalli, V				Cho, Yongcheol; Sloutsky, Roman; Naegle, Kristen M.; Cavalli, Valeria			Injury-Induced HDAC5 Nuclear Export Is Essential for Axon Regeneration	CELL			English	Article							PROTEIN-KINASE-C; NEURITE GROWTH; TRANSCRIPTION; EXPRESSION; AXOTOMY; NEURONS; MECHANISMS; INHIBITION; CALCIUM; ACTIVATION	Reactivation of a silent transcriptional program is a critical step in successful axon regeneration following injury. Yet how such a program is unlocked after injury remains largely unexplored. We found that axon injury in peripheral sensory neurons elicits a back-propagating calcium wave that invades the soma and causes nuclear export of HDAC5 in a PKC mu-dependent manner. Injury-induced HDAC5 nuclear export enhances histone acetylation to activate a proregenerative gene-expression program. HDAC5 nuclear export is required for axon regeneration, as expression of a nuclear-trapped HDAC5 mutant prevents axon regeneration, whereas enhancing HDAC5 nuclear export promotes axon regeneration in vitro and in vivo. Components of this HDAC5 pathway failed to be activated in a model of central nervous system injury. These studies reveal a signaling mechanism from the axon injury site to the soma that controls neuronal growth competence and suggest a role for HDAC5 as a transcriptional switch controlling axon regeneration.	[Cho, Yongcheol; Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Sloutsky, Roman; Naegle, Kristen M.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Cavalli, V (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu		Naegle, Kristen/0000-0001-7146-9592; Sloutsky, Roman/0000-0002-0794-1255	NIH [DE022000, NS082446]; McDonnell Center for Cellular and Molecular Neurobiology; Hope Center for Neurological Disorders; National Research Foundation of Korea [NRF-2012R1A6A3A03039290]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082446] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Cellular and Molecular Neurobiology; Hope Center for Neurological Disorders; National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Vitaly Klyachko for critical reading of the manuscript. We thank Eric Olson for the generous gift of the HDAC5 KO mice. We thank Domini Montgomery for technical support, Dennis Oakley for assistance with imaging, Ernie Gonzales and the Animal Surgery Core of the Hope Center for Neurological Disorders for assistance with optic nerve surgeries, and Seth Crosby and the Genome Technology Access Center at Washington University for microarray analysis. This work was supported in part by grants from NIH (DE022000 and NS082446), the McDonnell Center for Cellular and Molecular Neurobiology, the Hope Center for Neurological Disorders (to V. C.), and the National Research Foundation of Korea (NRF-2012R1A6A3A03039290) (to Y.C.).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; Befort K, 2003, EUR J NEUROSCI, V18, P911, DOI 10.1046/j.1460-9568.2003.02827.x; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Blesch A, 2012, EXP NEUROL, V235, P162, DOI 10.1016/j.expneurol.2011.12.037; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Buschmann T, 1998, NEUROSCIENCE, V84, P163, DOI 10.1016/S0306-4522(97)00487-9; CAMPENOT RB, 1994, J NEUROCHEM, V63, P868; Cayrou C, 2002, ENDOCRINOLOGY, V143, P2242, DOI 10.1210/en.143.6.2242; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gaub P, 2010, CELL DEATH DIFFER, V17, P1392, DOI 10.1038/cdd.2009.216; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Kamber D, 2009, EXP NEUROL, V219, P112, DOI 10.1016/j.expneurol.2009.05.004; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; LEAH JD, 1993, NEUROSCIENCE, V57, P53, DOI 10.1016/0306-4522(93)90111-R; Mandolesi G, 2004, FASEB J, V18, P1934, DOI 10.1096/fj.04-1805fje; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; MCQUARRIE IG, 1973, ARCH NEUROL-CHICAGO, V29, P53, DOI 10.1001/archneur.1973.00490250071008; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Pelzel HR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-62; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perry RB, 2012, NEURON, V75, P294, DOI 10.1016/j.neuron.2012.05.033; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Rishal I, 2010, EXP NEUROL, V223, P5, DOI 10.1016/j.expneurol.2009.08.010; Shadiack AM, 2001, J NEUROSCI, V21, P363, DOI 10.1523/JNEUROSCI.21-02-00363.2001; Shields SD, 2012, PAIN, V153, P2017, DOI 10.1016/j.pain.2012.04.022; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Smith DS, 1997, J NEUROSCI, V17, P646; Tedeschi A, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmo1.2011.00060; Tsai SY, 2007, J NEUROSCI RES, V85, P321, DOI 10.1002/jnr.21119; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wu DY, 2003, INVEST OPHTH VIS SCI, V44, P2783, DOI 10.1167/iovs.02-0715; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Zhang XF, 2010, NEUROPHARMACOLOGY, V59, P201, DOI 10.1016/j.neuropharm.2010.05.009; ZIV NE, 1993, EUR J NEUROSCI, V5, P657, DOI 10.1111/j.1460-9568.1993.tb00531.x; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	52	211	215	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					894	908		10.1016/j.cell.2013.10.004	http://dx.doi.org/10.1016/j.cell.2013.10.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209626	Bronze, Green Accepted			2022-12-28	WOS:000326934300018
J	Reddien, PW				Reddien, Peter W.			Lin28: Time for Tissue Repair	CELL			English	Editorial Material							REGENERATION; TIPS	Embryos and juveniles in many organisms repair tissue injuries better than adults. In this issue, Shyh-Chang et al. find that postnatal activation of Lin28a, a gene typically active in embryonic development, promotes better than normal tissue repair in mice, including following ear and digit injuries.	[Reddien, Peter W.] MIT Biol, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Reddien, Peter W.] Whitehead Inst, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Reddien, PW (corresponding author), MIT Biol, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	reddien@wi.mit.edu		/0000-0002-5569-333X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; DEUCHAR EM, 1976, J EMBRYOL EXP MORPH, V35, P345; ILLINGWORTH CM, 1974, J PEDIATR SURG, V9, P853, DOI 10.1016/S0022-3468(74)80220-4; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Shinoda G, 2013, STEM CELLS, V31, P1563, DOI 10.1002/stem.1423; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	11	5	5	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					738	739		10.1016/j.cell.2013.10.025	http://dx.doi.org/10.1016/j.cell.2013.10.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209612	Bronze			2022-12-28	WOS:000326934300003
J	Hansen, MC; Potapov, PV; Moore, R; Hancher, M; Turubanova, SA; Tyukavina, A; Thau, D; Stehman, SV; Goetz, SJ; Loveland, TR; Kommareddy, A; Egorov, A; Chini, L; Justice, CO; Townshend, JRG				Hansen, M. C.; Potapov, P. V.; Moore, R.; Hancher, M.; Turubanova, S. A.; Tyukavina, A.; Thau, D.; Stehman, S. V.; Goetz, S. J.; Loveland, T. R.; Kommareddy, A.; Egorov, A.; Chini, L.; Justice, C. O.; Townshend, J. R. G.			High-Resolution Global Maps of 21st-Century Forest Cover Change	SCIENCE			English	Article							DEFORESTATION; TRANSITION; EMISSIONS	Quantification of global forest change has been lacking despite the recognized importance of forest ecosystem services. In this study, Earth observation satellite data were used to map global forest loss (2.3 million square kilometers) and gain (0.8 million square kilometers) from 2000 to 2012 at a spatial resolution of 30 meters. The tropics were the only climate domain to exhibit a trend, with forest loss increasing by 2101 square kilometers per year. Brazil's well-documented reduction in deforestation was offset by increasing forest loss in Indonesia, Malaysia, Paraguay, Bolivia, Zambia, Angola, and elsewhere. Intensive forestry practiced within subtropical forests resulted in the highest rates of forest change globally. Boreal forest loss due largely to fire and forestry was second to that in the tropics in absolute and proportional terms. These results depict a globally consistent and locally relevant record of forest change.	[Hansen, M. C.; Potapov, P. V.; Turubanova, S. A.; Tyukavina, A.; Chini, L.; Justice, C. O.; Townshend, J. R. G.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Moore, R.; Hancher, M.; Thau, D.] Google, Mountain View, CA USA; [Stehman, S. V.] SUNY Syracuse, Dept Forest & Nat Resources Management, Syracuse, NY USA; [Goetz, S. J.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Loveland, T. R.] US Geol Survey, Sioux Falls, SD 57198 USA; [Kommareddy, A.; Egorov, A.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA	University System of Maryland; University of Maryland College Park; Google Incorporated; State University of New York (SUNY) System; Woods Hole Research Center; United States Department of the Interior; United States Geological Survey; South Dakota State University	Hansen, MC (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	mhansen@umd.edu	Noojipady, Praveen/B-2511-2010; Tyukavina, Alexandra/AGW-0785-2022; potapov, peter/AAE-7388-2019; Goetz, Scott J/A-3393-2015; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLT-1531-2022; Loveland, Thomas/AAW-3332-2020; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022; Hansen, Matthew C/ABE-7226-2020	Goetz, Scott J/0000-0002-6326-4308; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; Tyukavina, Alexandra/0000-0003-3872-9844; Jo, Euijung/0000-0003-1131-2723; Potapov, Peter/0000-0003-3977-0021	NASA [NNH05ZDA001N, NNH07ZDA001N, NNX12AB43G, NNX12AC78G, NNX08AP33A, NNG06GD95G]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074564, R01AI055509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for Landsat data analysis and characterization was provided by the Gordon and Betty Moore Foundation, the United States Geological Survey, and Google, Inc. GLAS data analysis was supported by the David and Lucile Packard Foundation. Development of all methods was supported by NASA through its Land Cover and Land Use Change, Terrestrial Ecology, Applied Sciences, and MEaSUREs programs (grants NNH05ZDA001N, NNH07ZDA001N, NNX12AB43G, NNX12AC78G, NNX08AP33A, and NNG06GD95G) and by the U.S. Agency for International Development through its CARPE program. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U. S. government. Results are depicted and viewable online at full resolution: http://earthenginepartners.appspot.com/science-2013-global-forest.	Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Edwards DP, 2011, NATURE, V477, P33, DOI 10.1038/477033a; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Food and Agricultural Organization of the United Nations, 2012, 169 FAO; Gardiner B., 2010, Destructive storms in European forests: past and forthcoming impacts; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hansen MC, 2004, ECOSYSTEMS, V7, P695, DOI 10.1007/s10021-004-0243-3; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Houghton R., 2001, CARBON MANAG, V1, P253; Instituto Nacional de Pesquisas Especias, 2013, MON BRAZ AM FOR SAT; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Potapov P, 2008, REMOTE SENS ENVIRON, V112, P3708, DOI 10.1016/j.rse.2008.05.006; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Prishchepov AV, 2013, LAND USE POLICY, V30, P873, DOI 10.1016/j.landusepol.2012.06.011; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rudel TK, 1998, RURAL SOCIOL, V63, P533, DOI 10.1111/j.1549-0831.1998.tb00691.x; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; United Nations Framework Convention on Climate Change, 2005, RED EM DEF DEV COUNT; Waterworth RM, 2007, FOREST ECOL MANAG, V238, P231, DOI 10.1016/j.foreco.2006.10.014	23	6084	6344	172	613	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					850	853		10.1126/science.1244693	http://dx.doi.org/10.1126/science.1244693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	22344443				2022-12-28	WOS:000326923000036
J	Hanson, MA; Roth, CB; Jo, EJ; Griffith, MT; Scott, FL; Reinhart, G; Desale, H; Clemons, B; Cahalan, SM; Schuerer, SC; Sanna, MG; Han, GW; Kuhn, P; Rosen, H; Stevens, RC				Hanson, Michael A.; Roth, Christopher B.; Jo, Euijung; Griffith, Mark T.; Scott, Fiona L.; Reinhart, Greg; Desale, Hans; Clemons, Bryan; Cahalan, Stuart M.; Schuerer, Stephan C.; Sanna, M. Germana; Han, Gye Won; Kuhn, Peter; Rosen, Hugh; Stevens, Raymond C.			Crystal Structure of a Lipid G Protein-Coupled Receptor	SCIENCE			English	Article							LIGAND-BINDING POCKET; S1P(1); IDENTIFICATION; AGONIST; GPCR; RHODOPSIN; DISCOVERY; EDG1	The lyso-phospholipid sphingosine 1-phosphate modulates lymphocyte trafficking, endothelial development and integrity, heart rate, and vascular tone and maturation by activating G protein-coupled sphingosine 1-phosphate receptors. Here, we present the crystal structure of the sphingosine 1-phosphate receptor 1 fused to T4-lysozyme (S1P(1)-T4L) in complex with an antagonist sphingolipid mimic. Extracellular access to the binding pocket is occluded by the amino terminus and extracellular loops of the receptor. Access is gained by ligands entering laterally between helices I and VII within the transmembrane region of the receptor. This structure, along with mutagenesis, agonist structure-activity relationship data, and modeling, provides a detailed view of the molecular recognition and requirement for hydrophobic volume that activates S1P(1), resulting in the modulation of immune and stromal cell responses.	[Hanson, Michael A.; Roth, Christopher B.; Griffith, Mark T.; Scott, Fiona L.; Reinhart, Greg; Desale, Hans; Clemons, Bryan] Receptos, San Diego, CA 92121 USA; [Jo, Euijung; Cahalan, Stuart M.; Sanna, M. Germana; Rosen, Hugh] Scripps Res Inst, Dept Biol Chem, La Jolla, CA 92037 USA; [Schuerer, Stephan C.; Han, Gye Won; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Kuhn, Peter] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Rosen, Hugh] Scripps Res Inst, Mol Screening Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Hanson, MA (corresponding author), Receptos, 10835 Rd Cure,Suite 205, San Diego, CA 92121 USA.	mhanson@receptos.com; hrosen@scripps.edu; stevens@scripps.edu	Noojipady, Praveen/B-2511-2010; Tyukavina, Alexandra/AGW-0785-2022; potapov, peter/AAE-7388-2019; Goetz, Scott J/A-3393-2015; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLT-1531-2022; Loveland, Thomas/AAW-3332-2020; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022; Hansen, Matthew C/ABE-7226-2020	Goetz, Scott J/0000-0002-6326-4308; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; Tyukavina, Alexandra/0000-0003-3872-9844; Jo, Euijung/0000-0003-1131-2723; Potapov, Peter/0000-0003-3977-0021	Protein Structure Initiative (PSI) [U54 GM094618]; NIH [P50 GM073197]; NIH Roadmap Molecular Libraries Probe Production Centers [U54 MH084512];  [AI074564];  [AI055509]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074564, R01AI055509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	Protein Structure Initiative (PSI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap Molecular Libraries Probe Production Centers; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the Protein Structure Initiative (PSI): Biology grant U54 GM094618 for structure production, NIH Roadmap grant P50 GM073197 for technology development, NIH Roadmap Molecular Libraries Probe Production Centers grant U54 MH084512 for antagonist and class II agonist identification, and AI074564 and AI055509 to H. R. and M. B. Oldstone for studying the role of S1P in infection and immunity. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences (NIGMS) or the NIH. We thank E. Chien for preliminary analysis; M. Mileni for critical evaluation of the structure; V. Cherezov, V. Katritch, and I. Wilson for careful review of the manuscript; J. Johnson, A. Leslie, W. Kabsch, and A. Perrakis for discussion and review of the experimental microdiffraction data assembly processing method; and A. Walker for assistance with manuscript preparation. We acknowledge J. Smith, R. Fischetti, and N. Sanishvili at the GM/CA-CAT beamline at the Advanced Photon Source, for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (Y1-CO-1020) and the NIGMS (Y1-GM-1104). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3V2W and 3V3Y. R. C. S. is a founder and on the Board of Directors, and H. R. is a founder and on the Scientific Advisory Board, of Receptos, a GPCR structure-based drug discovery company with an S1P<INF>1</INF> clinical compound. H. R. is an inventor on a patent application by The Scripps Research Institute (TSRI) on CYM-5442 and related S1P receptor modulators (US2010/0010001). Materials will be made available under a Material Transfer Agreement with TSRI.	[Anonymous], 2011, GLID VERS 5 7; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Fujiwara Y, 2007, J BIOL CHEM, V282, P2374, DOI 10.1074/jbc.M609648200; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schrodinger LLC, 2011, PRIM VERS 3 0; Schurer SC, 2008, ACS CHEM BIOL, V3, P486, DOI 10.1021/cb800051m; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Suite S., 2011, 2011 IND FIT DOCK PR; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	35	6084	6344	172	613	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					851	855		10.1126/science.1215904	http://dx.doi.org/10.1126/science.1215904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344443	Green Accepted			2022-12-28	WOS:000300356400043
